PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eng, GP; Bouchelouche, P; Bartels, EM; Bliddal, H; Bendtzen, K; Stoltenberg, M				Eng, Grith Petersen; Bouchelouche, Pierre; Bartels, Else Marie; Bliddal, Henning; Bendtzen, Klaus; Stoltenberg, Michael			Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; DISEASE-ACTIVITY; INFLAMMATORY DISEASES; MONOCLONAL-ANTIBODY; ALPHA THERAPY; IMMUNOGENICITY; EFFICACY; PREDICT; METHOTREXATE; ETANERCEPT	Objectives With the present study we wanted to explore the impact of treatment with a tumor necrosis factor-alpha -inhibitor (TNFi) on levels of soluble biomarkers in rheumatoid arthritis (RA) patients and to identify predictors of impaired drug levels and development of anti-TNFi antibodies (anti-TNFi Abs). Methods Blood samples from 26 patients with established RA were taken at baseline and following 6 months of treatment with adalimumab or infliximab. Samples were analyzed for levels of TNFi, interleukin (IL)-6, and soluble TNF-receptors 1 and -2 (sTNF-R1 and -2) and for presence of anti-TNFi Abs. Clinical and demographic data were recorded as well. Results During the initial 6 months treatment, DAS28(CRP) (Disease activity score in 28 joints using C-reactive protein) and levels of IL-6 and sTNF-R2 decreased significantly in patients without anti-TNFi Abs and in patients retaining detectable drug levels. The levels of other tested cytokines (TNF-alpha, TNF-beta, IL-1ra, IL-1b, IL-8, IL-10, IL-12(p70), IL-13, IL-17A, IL-17F, and IL-33) were generally below detection limits. Higher baseline levels of IL-6 associated with undetectable levels of TNFi at follow-up. Anti-TNFi Abs were associated with decreased drug levels, but no predictors for anti-TNFi Ab development could be found. Conclusion The effect of treatment with TNFi on RA disease activity depends on levels of active drug, and by presence of anti-TNFi Abs. In patients who retain detectable drug levels, and in the absence of anti-TNFi Abs, clinical outcome is improved during treatment, and circulating levels of IL-6 and sTNF-R2 decrease. Baseline levels of IL-6 may predict depletion of TNFi and may identify patients at risk of treatment failure.	[Eng, Grith Petersen; Bouchelouche, Pierre] Zealand Universityhosp Koge, Dept Clin Biochem, Koge, Denmark; [Eng, Grith Petersen; Stoltenberg, Michael] Zealand Universityhosp Koge, Dept Rheumatol, Koge, Denmark; [Eng, Grith Petersen; Bartels, Else Marie; Bliddal, Henning] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Bispebjerg, Denmark; [Eng, Grith Petersen; Bartels, Else Marie; Bliddal, Henning] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Frederiksberg, Denmark; [Bendtzen, Klaus] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Eng, GP (corresponding author), Zealand Universityhosp Koge, Dept Clin Biochem, Koge, Denmark.; Eng, GP (corresponding author), Zealand Universityhosp Koge, Dept Rheumatol, Koge, Denmark.; Eng, GP (corresponding author), Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Bispebjerg, Denmark.; Eng, GP (corresponding author), Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Frederiksberg, Denmark.	eng@dadlnet.dk	Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668; Bouchelouche, Pierre/0000-0002-0441-8194; Stoltenberg, Michael Bo/0000-0001-7982-0105; Petersen Eng, Grith/0000-0002-2587-8421	Research Foundation of Region Zealand	Research Foundation of Region Zealand	The study was supported by the Research Foundation of Region Zealand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Bendtzen K, 2011, ARTHRITIS RHEUM-US, V63, P867, DOI 10.1002/art.30207; Charles P, 1999, J IMMUNOL, V163, P1521; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Ducourau E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3386; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Ellegaard K, 2011, RHEUMATOLOGY, V50, P506, DOI 10.1093/rheumatology/keq336; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1243, DOI 10.1136/annrheumdis-2011-200975; Hayashi S, 2016, RHEUMATOL THER, V3, P155, DOI 10.1007/s40744-015-0022-y; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Krieckaert CL, 2012, ARTHRITIS RHEUM-US, V64, P3850, DOI 10.1002/art.34680; Krintel S. B., 2013, RHEUMATOLOGY OXFORD; Lallemand C, 2011, J IMMUNOL METHODS, V373, P229, DOI 10.1016/j.jim.2011.08.022; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini Ravinder N, 2002, Arthritis Res, V4 Suppl 2, pS22, DOI 10.1186/ar549; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Mok CC, 2013, CLIN RHEUMATOL, V32, P1429, DOI 10.1007/s10067-013-2336-x; Ongaro A, 2008, RHEUMATOL INT, V28, P901, DOI 10.1007/s00296-008-0552-5; Pascual-Salcedo D, 2011, RHEUMATOLOGY, V50, P1445, DOI 10.1093/rheumatology/ker124; Pouw M. F., 2013, ANN RHEUM DIS; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Schulz M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675108; Spoettl T, 2007, INFLAMM BOWEL DIS, V13, P727, DOI 10.1002/ibd.20107; Valle Y, 2009, SCAND J RHEUMATOL, V38, P332, DOI 10.1080/03009740902865456; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van der Maas A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-184; Vincent FB, 2013, ANN RHEUM DIS, V72, P165, DOI 10.1136/annrheumdis-2012-202545; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	35	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162316	10.1371/journal.pone.0162316	http://dx.doi.org/10.1371/journal.pone.0162316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606615	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255600038
J	Mandrioli, D; Kearns, CE; Bero, LA				Mandrioli, Daniele; Kearns, Cristin E.; Bero, Lisa A.			Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews	PLOS ONE			English	Review							CONSUMPTION PATTERNS; INTEREST DISCLOSURE; CHILDREN; SCIENCE; HEALTH; METAANALYSES; ASPARTAME; JOURNALS; DISEASE; TRIALS	Background Artificially sweetened beverage consumption has steadily increased in the last 40 years. Several reviews examining the effects of artificially sweetened beverages on weight outcomes have discrepancies in their results and conclusions. Objectives To determine whether risk of bias, results, and conclusions of reviews of effects of artificially sweetened beverage consumption on weight outcomes differ depending on review sponsorship and authors' financial conflicts of interest. Methods We performed a systematic review of reviews of the effects of artificially sweetened beverages on weight. Two assessors independently screened articles for inclusion, extracted data, and assessed risks of bias. We compared risk of bias, results and conclusions of reviews by different industry sponsors, authors' financial conflict of interest and journal sponsor. We also report the concordance between review results and conclusions. Results Artificial sweetener industry sponsored reviews were more likely to have favorable results 3/4) than non-industry sponsored reviews (1/23), RR: 17.25 (95% CI: 2.34 to 127.29), as D well as favorable conclusions (4/4 vs. 15/23), RR: 1.52 (95% CI: 1.14 to 2.06). All reviews funded by competitor industries reported unfavorable conclusions (4/4). In 42% of the reviews (13/31), authors' financial conflicts of interest were not disclosed. Reviews performed by authors that had a financial conflict of interest with the food industry (disclosed in the article or not) were more likely to have favorable conclusions (18/22) than reviews performed by authors without conflicts of interest (4/9), RR: 7.36 (95% CI: 1.15 to 47.22). Risk of bias was similar and high in most of the reviews. Conclusions Review sponsorship and authors' financial conflicts of interest introduced bias affecting the outcomes of reviews of artificially sweetened beverage effects on weight that could not be explained by other sources of bias.	[Mandrioli, Daniele] Ramazzini Inst, Cesare Maltoni Canc Res Ctr, Bologna, Italy; [Mandrioli, Daniele] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Kearns, Cristin E.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Kearns, Cristin E.] Univ Calif San Francisco, Sch Dent, Dept Orofacial Sci, San Francisco, CA USA; [Bero, Lisa A.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Bero, Lisa A.] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Sydney; University of Sydney	Mandrioli, D (corresponding author), Ramazzini Inst, Cesare Maltoni Canc Res Ctr, Bologna, Italy.; Mandrioli, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	mandriolid@ramazzini.it		Mandrioli, Daniele/0000-0001-6156-6516; Bero, Lisa/0000-0003-1893-6651	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Abdel-Sattar Maher, 2014, Evid Based Preclin Med, V1, P11; Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1462; American Diabetes A, 2016, OUR CORP SUPP; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; Anton SD, 2010, APPETITE, V55, P37, DOI 10.1016/j.appet.2010.03.009; Araujo JR, 2014, REPROD TOXICOL, V49, P196, DOI 10.1016/j.reprotox.2014.09.007; Axelson O, 2003, INT J OCCUP ENV HEAL, V9, P386; Baethge C, 2013, PEERJ, V1, DOI 10.7717/peerj.128; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; BCC, 2015, GLOB MARK SUG SWEET; Bero LA, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.Ed000075.WOS:000343045600002, DOI 10.1002/14651858.ED000075.WOS:000343045600002]; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; BIRCH LL, 1989, PHYSIOL BEHAV, V45, P387, DOI 10.1016/0031-9384(89)90145-5; Blum JW, 2005, J AM COLL NUTR, V24, P93, DOI 10.1080/07315724.2005.10719449; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Bruyere O, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0092-x; Cogliano VJ, 2004, ENVIRON HEALTH PERSP, V112, P1269, DOI 10.1289/ehp.6950; CSPI, 2016, NONPR ORG TIES IND; DGAC, 2016, DIET GUID AM 2015 20; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; FDA, 2009, GUID IND EV BAS REV; FDA, 2015, ADD INF HIGH INT SWE; Forsyth SR, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-122; French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9; Grandjean P, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-70; Horel S, 2013, UNHAPPY MEAL EUROPEA; ICMJE ICoMJE-, ICMJE FORM DISCL POT; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Kearns CE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001798; Kral TVE, 2008, OBESITY, V16, P1802, DOI 10.1038/oby.2008.287; Krauth D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001770; Lo B, 2009, CONFLICT INTEREST ME; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Lundh A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000354; McCarthy M, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2018; Mesirow MSC, 2015, J ACAD NUTR DIET, V115, P559, DOI 10.1016/j.jand.2014.09.004; Millstone E, 2013, EFSA ON ASPARTAME; National Research Council (NRC), 2014, REV EPAS INT RISK IN; NCI, 2013, MEAN INT ADD SUG PER; Neltner TG, 2013, JAMA INTERN MED, V173, P2032, DOI 10.1001/jamainternmed.2013.10559; Ng SW, 2012, J ACAD NUTR DIET, V112, P1828, DOI 10.1016/j.jand.2012.07.009; NTP-OHAT, 2015, HDB COND LIT BAS HLT; OECD, 2014, OB UPD 2014; Palmnas MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109841; Pereira MA, 2013, NUTR REV, V71, P433, DOI 10.1111/nure.12038; Popelut A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010274; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Portier CJ, 2016, J EPIDEMIOL COMMUN H, V70, P741, DOI 10.1136/jech-2015-207005; Ramazzini Collegium, 2015, 17 C RAM STAT MOST T; Resnik DB, 2014, J MICROBIOL BIOL EDU, V15, P159, DOI 10.1128/jmbe.v15i2.792; Robinson C, 2013, J EPIDEMIOL COMMUN H, V67, P717, DOI 10.1136/jech-2012-202185; Roseman M, 2011, JAMA-J AM MED ASSOC, V305, P1008, DOI 10.1001/jama.2011.257; Ruff K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0035-6; SACN (Scientific Advisory Committee on Nutrition), 2015, CARB HLTH; Schernhammer ES, 2012, AM J CLIN NUTR, V96, P1419, DOI 10.3945/ajcn.111.030833; Shah RV, 2005, SPINE, V30, P1099, DOI 10.1097/01.brs.0000161004.15308.b4; Siler K, 2015, P NATL ACAD SCI USA, V112, P360, DOI 10.1073/pnas.1418218112; Singh GM, 2015, CIRCULATION, V132, P639, DOI 10.1161/CIRCULATIONAHA.114.010636; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Soffritti M, 2014, AM J IND MED, V57, P383, DOI 10.1002/ajim.22296; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Suez Jotham, 2014, Nature, V514, P181, DOI 10.1038/nature13793; Sylvetsky AC, 2016, PHYSIOL BEHAV, V164, P446, DOI 10.1016/j.physbeh.2016.03.030; Taubes G, 2014, MOTHER JONES, DOI DOI 10.1371/JOURNAL.PMED.1001578; Viswanathan M, 2012, ASSESSING RISK BIAS; Walton RG, 1999, SURVEY ASPARTAME STU; Wire B, 2015, RES CONF CUTT BACK A; Woodruff TJ, 2014, ENVIRON HEALTH PERSP, V122, P1007, DOI 10.1289/ehp.1307175; World Health Organization, 2015, GUID SUG INT AD CHIL; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	74	101	101	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162198	10.1371/journal.pone.0162198	http://dx.doi.org/10.1371/journal.pone.0162198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606602	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600027
J	Bidkar, M; Vassallo, R; Luckey, D; Smart, M; Mouapi, K; Taneja, V				Bidkar, Mitali; Vassallo, Robert; Luckey, David; Smart, Michele; Mouapi, Kelly; Taneja, Veena			Cigarette Smoke Induces Immune Responses to Vimentin in both, Arthritis-Susceptible and -Resistant Humanized Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTI-CCP ANTIBODY; RHEUMATOID-ARTHRITIS; SHARED EPITOPE; CITRULLINATED VIMENTIN; PROTEIN ANTIBODIES; TRANSGENIC MICE; SYNOVIAL-FLUID; MACROPHAGES; INTERLEUKIN-13	Rheumatoid arthritis (RA) is an autoimmune disease marked by chronic synovial inflammation and both, genetic and environmental factors are involved in its pathogenesis. Human leukocyte antigen (HLA) DRB1*0401 is associated with susceptibility to develop RA, while cigarette smoke (CS) exposure promotes seropositive disease with increased severity in DRB1*0401+ individuals. Smokers have higher levels of antibodies against citrullinated peptides. In this study, we determined whether the response to a known autoantigen, Vimentin (Vim) is shared epitope specific and how CS influences this response using transgenic-mice carrying RA-susceptible,*0401, and -resistant, *0402, genes. Following relatively brief exposure to CS, peptidyl arginine deiminase (PAD) enzyme expression was increased in murine lungs. Cigarette smoking led to production of Interferon (IFN)-gamma with reduced levels of Interleukin (IL)-10 by splenocytes of *0401 mice. In contrast, CS augmented Th2 cytokines along with T-regulatory cells in *0402 mice. An increase in levels of antibodies to native and citrullinated Vim was observed in naive mice of both strains following CS exposure. Our data showed that both arthritis-susceptible and -resistant mice can generate cellular and humoral immunity to Vim; however CS-induced modulation of host immunity is dependent on the interaction with the host HLA genes.	[Bidkar, Mitali; Luckey, David; Smart, Michele; Mouapi, Kelly; Taneja, Veena] Mayo Clin, Dept Immunol, Rochester, MN 55902 USA; [Vassallo, Robert] Mayo Clin, Div Pulm & Crit Care Med, Dept Internal Med, Rochester, MN USA; [Taneja, Veena] Mayo Clin, Div Rheumatol, Rochester, MN 55902 USA; [Bidkar, Mitali] Ipca Labs Ltd, Clin Res & Dev, Bombay, Maharashtra, India	Mayo Clinic; Mayo Clinic; Mayo Clinic	Taneja, V (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55902 USA.; Taneja, V (corresponding author), Mayo Clin, Div Rheumatol, Rochester, MN 55902 USA.	taneja.veena@mayo.edu	Vassallo, Robert/R-7752-2019	Vassallo, Robert/0000-0003-2328-0255; Taneja, Veena/0000-0003-2401-694X	National Institutes of Health (NIH) [AR30752, AR060077]; Flight Attendant Medical Research Institute (FAMRI) grant; FAMRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060077, R01AR030752, R56AR030752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI) grant; FAMRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by National Institutes of Health (NIH) grants AR30752 and AR060077 to VT, and Flight Attendant Medical Research Institute (FAMRI) grant to RV. VT received some salary from AR30752 and AR060077. MS and DL received some salary from AR30752. RV received some salary from FAMRI. Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Chella David for providing the transgenic mice and Julie Hanson and her staff for breeding and maintaining the mice. This study was supported by National Institute of Health (NIH) grants AR30752 and AR060077 to VT and Flight Attendant Medical Research Institute (FAMRI) grant to RV. VT received some salary from AR30752 and AR060077. MS and DL received some salary from AR30752. RV received some salary from FAMRI. Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baka Z, 2011, INT IMMUNOL, V23, P405, DOI 10.1093/intimm/dxr026; Behrens M, 2010, J AUTOIMMUN, V35, P1, DOI 10.1016/j.jaut.2009.12.007; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Claudia M, 2003, J EXP MED, V197, P489; Damgaard D, 2015, CLIN EXP RHEUMATOL, V33, P405; Damgaard D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0498-9; El-Gabalawy HS, 2004, ARTHRITIS RES THER, V6, P86, DOI 10.1186/ar1171; Esensten JH, 2009, NAT REV RHEUMATOL, V5, P560, DOI 10.1038/nrrheum.2009.183; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Gonzalo-Gil E, 2014, REUMATOL CLIN, V10, P174, DOI 10.1016/j.reuma.2014.01.009; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hensvold AH, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0760-9; Hsu PC, 2014, MOL CELLS, V37, P426, DOI 10.14348/molcells.2014.2359; Isomaki P, 1997, ANN MED, V29, P499, DOI 10.3109/07853899709007474; Karlson EW, 2012, RHEUM DIS CLIN N AM, V38, P405, DOI 10.1016/j.rdc.2012.04.002; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Ma B, 2005, J CLIN INVEST, V115, P3460, DOI 10.1172/JCI24858; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nashleanas M, 2000, INFECT IMMUN, V68, P1428, DOI 10.1128/IAI.68.3.1428-1434.2000; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Spadaro A, 2002, ANN RHEUM DIS, V61, P174, DOI 10.1136/ard.61.2.174; Taneja V, 2003, J IMMUNOL, V171, P4431, DOI 10.4049/jimmunol.171.8.4431; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Taneja V, 2007, ARTHRITIS RHEUM-US, V56, P69, DOI 10.1002/art.22213; Taneja V, 2014, FEBS LETT, V588, P4244, DOI 10.1016/j.febslet.2014.05.034; Taneja V, 2010, IMMUNOL REV, V233, P62, DOI 10.1111/j.0105-2896.2009.00858.x; Tokayer A, 2002, J RHEUMATOL, V29, P454; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Vassallo R, 2014, CLIN IMMUNOL, V152, P25, DOI 10.1016/j.clim.2014.02.002; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Zanelli E, 1996, P NATL ACAD SCI USA, V93, P1814, DOI 10.1073/pnas.93.5.1814	39	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162341	10.1371/journal.pone.0162341	http://dx.doi.org/10.1371/journal.pone.0162341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602574	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200058
J	Du, H; Lv, P; Ayouz, M; Besserer, A; Perre, P				Du, Huan; Lv, Pin; Ayouz, Mehdi; Besserer, Arnaud; Perre, Patrick			Morphological Characterization and Quantification of the Mycelial Growth of the Brown-Rot Fungus Postia placenta for Modeling Purposes	PLOS ONE			English	Article							SCANNING CONFOCAL MICROSCOPY; HYPHAL GROWTH; PHYSISPORINUS-VITREUS; VESICLE TRAFFICKING; NEUROSPORA-CRASSA; FILAMENTOUS FUNGI; FLUORESCENT DYES; WOOD-DECAY; VISUALIZATION; DYNAMICS	Continuous observation was performed using confocal laser scanning microscopy to visualize the three-dimensional microscopic growth of the brown-rot fungus, Postia placenta, for seventeen days. The morphological characterization of Postia placenta was quantitatively determined, including the tip extension rate, branch angle and branching length, (hyphal length between two adjacent branch sites). A voxel method has been developed to measure the growth of the biomass. Additionally, the tip extension rate distribution, the branch angle distribution and the branching length distribution, which quantified the hyphal growth characteristics, were evaluated. Statistical analysis revealed that the extension rate of tips was randomly distributed in space. The branch angle distribution did not change with the development of the colony, however, the branching length distribution did vary with the development of the colony. The experimental data will be incorporated into a lattice-based model simulating the growth of Postia placenta.	[Du, Huan; Lv, Pin; Ayouz, Mehdi; Perre, Patrick] Univ Paris Saclay, Cent Supelec, LGPM, F-92290 Chatenay Malabry, France; [Besserer, Arnaud] Univ Lorraine, ENSTIB LERMAB, F-88000 Epinal, France	UDICE-French Research Universities; Universite Paris Saclay; Universite de Lorraine	Perre, P (corresponding author), Univ Paris Saclay, Cent Supelec, LGPM, F-92290 Chatenay Malabry, France.	patrick.perre@centralesupelec.fr	LV, PIN/AAT-7107-2020; Perre, Patrick/F-6150-2011; Perré, Patrick/AAC-6354-2020	Perre, Patrick/0000-0003-0419-4810; Perré, Patrick/0000-0003-0419-4810; DU, HUAN/0000-0002-0020-149X	LabeX LaSIPS [ANR-10-LABX-0040-LaSIPS]; French National Research Agency under the "Investissements d'avenir" program [ANR-11-IDEX-0003-02]; China Scholarship Council (CSC)	LabeX LaSIPS; French National Research Agency under the "Investissements d'avenir" program(French National Research Agency (ANR)); China Scholarship Council (CSC)(China Scholarship Council)	This work was financially supported by the LabeX LaSIPS (ANR-10-LABX-0040-LaSIPS), managed by the French National Research Agency (ANR - http://www.agence-nationale-recherche.fr/) under the "Investissements d'avenir" program (no ANR-11-IDEX-0003-02). Grant holder was PP. This work was also financially supported by the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Boswell Graeme P., 2012, Fungal Biology Reviews, V26, P30, DOI 10.1016/j.fbr.2012.02.002; de Ulzurrun GVD, 2015, FUNGAL GENET BIOL, V84, P12, DOI 10.1016/j.fgb.2015.09.004; Dickson S, 1999, MYCORRHIZA, V9, P205, DOI 10.1007/s005720050268; Dijksterhuis J, 2003, PROTOPLASMA, V222, P53, DOI 10.1007/s00709-003-0006-6; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fuhr MJ, 2011, FUNGAL BIOL-UK, V115, P919, DOI 10.1016/j.funbio.2011.06.017; Gonzalez JM, 2012, WOOD FIBER SCI, V44, P343; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Heaton LLM, 2010, P ROY SOC B-BIOL SCI, V277, P3265, DOI 10.1098/rspb.2010.0735; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hoch HC, 2005, MYCOLOGIA, V97, P580, DOI 10.3852/mycologia.97.3.580; HUTCHINSON SA, 1980, T BRIT MYCOL SOC, V75, P177, DOI 10.1016/S0007-1536(80)80078-7; Jacobs H, 2002, FEMS MICROBIOL ECOL, V40, P65, DOI 10.1111/j.1574-6941.2002.tb00937.x; JIN L, 1990, HOLZFORSCHUNG, V44, P133, DOI 10.1515/hfsg.1990.44.2.133; JONES CL, 1993, APPL MICROBIOL BIOT, V39, P242; Kim KW, 2009, MICRON, V40, P519, DOI 10.1016/j.micron.2009.04.006; Koch AP, 1985, WOOD DECAY DANISH BU; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P478, DOI 10.1128/JCM.39.2.478-484.2001; Refshauge S, 2006, NEW PHYTOL, V172, P369, DOI 10.1111/j.1469-8137.2006.01825.x; RITZ K, 1990, MYCOL RES, V94, P1138, DOI 10.1016/S0953-7562(09)81346-4; Sampson KN, 2003, MICROBIOL-SGM, V149, P3111, DOI 10.1099/mic.0.26509-0; Schmidt O, 2005, WOOD AND TREE FUNGI; Schubert M, 2014, HOLZFORSCHUNG, V68, P727, DOI 10.1515/hf-2013-0183; Schweiger PF, 2002, MYCOL RES, V106, P349, DOI 10.1017/S0953756202005579; Vierheilig H, 2001, CAN J BOT, V79, P231, DOI 10.1139/cjb-79-2-231; Viitanen H., 1991, BROWN ROT DECAY WOOD; Villena GK, 2010, BIORESOURCE TECHNOL, V101, P1920, DOI 10.1016/j.biortech.2009.10.036; Wadso L, 2013, ENG LIFE SCI, V13, P536, DOI 10.1002/elsc.201200096; WALLIS JW, 1990, J NUCL MED, V31, P1421; Wilcox WW, 1997, WOOD FIBER SCI, V29, P291; Xie Y, 1997, HOLZFORSCHUNG, V51, P201, DOI 10.1515/hfsg.1997.51.3.201; Yelle DJ, 2011, ENVIRON MICROBIOL, V13, P1091, DOI 10.1111/j.1462-2920.2010.02417.x	37	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162469	10.1371/journal.pone.0162469	http://dx.doi.org/10.1371/journal.pone.0162469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602575	Green Published, gold			2022-12-27	WOS:000383255200068
J	Lorenzo, D; Duarte, A; Mundiano, J; Berguer, P; Nepomnaschy, I; Piazzon, I				Lorenzo, Daniela; Duarte, Alejandra; Mundiano, Juliana; Berguer, Paula; Nepomnaschy, Irene; Piazzon, Isabel			A B-Cell Superantigen Induces the Apoptosis of Murine and Human Malignant B Cells	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; IN-VIVO; PROTEIN-L; CUTTING EDGE; T-CELLS; BIM; ACTIVATION; BCL-2; BAX; DELETION	B-cell superantigens (Sags) bind to conserved sites of the VH or VL regions of immunoglobulin molecules outside their complementarity-determining regions causing the apoptosis of normal cognate B cells. No attempts to investigate whether B-cell Sags are able to induce the apoptosis of cognate malignant B cells were reported. In the present study we show that protein L (PpL), secreted by Finegoldia magna, a B-cell Sag which interacts with kappa+ bearing cells, induces the apoptosis of murine and human kappa+ lymphoma B cells both in vitro and in vivo. Apoptosis was not altered by caspase-8 inhibitor. No alterations in the levels of Bid, Fas and Fas-L were found suggesting that PpL does not activate the extrinsic pathway of apoptosis. The involvement of the intrinsic pathway was clearly indicated by: i) alterations in mitochondrial membrane potential (Iota psi m) both in murine and human lymphoma cells exposed to PpL; ii) decreased levels of apoptosis in the presence of caspase-9 inhibitor; iii) significant increases of Bim and Bax protein levels and downregulation of Bcl-2; iv) the translocation from the cytoplasm to the mitochondria of Bax and Bim pro-apoptotic proteins and its inhibition by caspase-9 inhibitor but not by caspase-8 inhibitor and v) the translocation of Bcl-2 protein from the mitochondria to the cytosol and its inhibition by caspase-9 inhibitor but not by caspase-8 inhibitor. The possibility of a therapeutic use of Sags in lymphoma/leukemia B cell malignancies is discussed.	[Lorenzo, Daniela; Duarte, Alejandra; Mundiano, Juliana; Nepomnaschy, Irene; Piazzon, Isabel] Acad Nacl Med Buenos Aires, IMEX CONICET, Caba, Argentina; [Berguer, Paula] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Piazzon, I (corresponding author), Acad Nacl Med Buenos Aires, IMEX CONICET, Caba, Argentina.	ipiazzon@yahoo.com	Berguer, Paula/AAI-6353-2020		Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2494, PIP 0614]; Fundacion para la Lucha contra la Leucemia (FUNDALEU)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion para la Lucha contra la Leucemia (FUNDALEU)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), www.conicet.gov.ar, PIP 2494 to IP, PIP 0614 to IP, and Fundacion para la Lucha contra la Leucemia (FUNDALEU), www.fundaleu.org, to IP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; BJORCK L, 1988, J IMMUNOL, V140, P1194; Bomben R, 2010, CLIN CANCER RES, V16, P620, DOI 10.1158/1078-0432.CCR-09-1638; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; DomiatiSaad R, 1996, J IMMUNOL, V156, P3608; ENGEL P, 1994, BLOOD, V84, P1402, DOI 10.1182/blood.V84.5.1402.bloodjournal8451402; Genovese A, 2003, J IMMUNOL, V170, P1854, DOI 10.4049/jimmunol.170.4.1854; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; Goodyear CS, 2007, J IMMUNOL, V178, P2636, DOI 10.4049/jimmunol.178.5.2636; Goodyear CS, 2004, J IMMUNOL, V172, P2870, DOI 10.4049/jimmunol.172.5.2870; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; Hockings C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.105; Housden NG, 2003, BIOCHEM SOC T, V31, P716, DOI 10.1042/BST0310716; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; KIM KJ, 1979, J IMMUNOL, V122, P549; KIM KJ, 1978, J IMMUNOL, V121, P339; KLEIN E, 1968, CANCER RES, V28, P1300; Kostareli E, 2009, LEUKEMIA, V23, P919, DOI 10.1038/leu.2008.379; Kozlowski LM, 1996, J IMMUNOL, V157, P1200; LEVINSON AI, 1995, J CLIN IMMUNOL, V15, pS26, DOI 10.1007/BF01540891; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; Mundinano J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015694; NEWELL KA, 1991, P NATL ACAD SCI USA, V88, P1074, DOI 10.1073/pnas.88.3.1074; Badano MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061347; Perabo FG, 2005, INT J CANCER, V115, P591, DOI 10.1002/ijc.20941; Renno T, 1999, J IMMUNOL, V162, P6312; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; SILVERMAN GJ, 1995, J CLIN INVEST, V96, P417, DOI 10.1172/JCI118051; Silverman GJ, 1997, IMMUNOL TODAY, V18, P379, DOI 10.1016/S0167-5699(97)01101-8; Sundstedt A, 2009, INT IMMUNOPHARMACOL, V9, P1063, DOI 10.1016/j.intimp.2009.04.013; Viau M, 2004, IMMUNOL LETT, V92, P91, DOI 10.1016/j.imlet.2003.10.016; Viau M, 2004, INFECT IMMUN, V72, P3515, DOI 10.1128/IAI.72.6.3515-3523.2004	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162456	10.1371/journal.pone.0162456	http://dx.doi.org/10.1371/journal.pone.0162456			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603942	Green Published, gold			2022-12-27	WOS:000383255200067
J	Marques, LM; Rezende, IS; Barbosa, MS; Guimaraes, AMS; Martins, HB; Campos, GB; do Nascimento, NC; dos Santos, AP; Amorim, AT; Santos, VM; Farias, ST; Barrence, FAC; de Souza, LM; Buzinhani, M; Arana-Chavez, VE; Zenteno, ME; Amarante-Mendes, GP; Messick, JB; Timenetsky, J				Marques, Lucas M.; Rezende, Izadora S.; Barbosa, Maysa S.; Guimaraes, Ana M. S.; Martins, Hellen B.; Campos, Guilherme B.; do Nascimento, Naila C.; dos Santos, Andrea P.; Amorim, Aline T.; Santos, Verena M.; Farias, Savio T.; Barrence, Fernanda A. C.; de Souza, Lauro M.; Buzinhani, Melissa; Arana-Chavez, Victor E.; Zenteno, Maria E.; Amarante-Mendes, Gustavo P.; Messick, Joanne B.; Timenetsky, Jorge			Ureaplasma diversum Genome Provides New Insights about the Interaction of the Surface Molecules of This Bacterium with the Host	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MYCOPLASMA-GALLISEPTICUM; EXPERIMENTAL-INFECTION; PHYLOGENETIC ANALYSIS; NUCLEASE ACTIVITIES; CYTOTOXIC NUCLEASE; SIGNAL PEPTIDES; UREALYTICUM; VIRULENCE; LIPOPROTEINS	Whole genome sequencing and analyses of Ureaplasma diversum ATCC 49782 was undertaken as a step towards understanding U. diversum biology and pathogenicity. The complete genome showed 973,501 bp in a single circular chromosome, with 28.2% of G+C content. A total of 782 coding DNA sequences (CDSs), and 6 rRNA and 32 tRNA genes were predicted and annotated. The metabolic pathways are identical to other human urea-plasmas, including the production of ATP via hydrolysis of the urea. Genes related to pathogenicity, such as urease, phospholipase, hemolysin, and a Mycoplasma Ig binding protein (MIB)-Mycoplasma Ig protease (MIP) system were identified. More interestingly, a large number of genes (n = 40) encoding surface molecules were annotated in the genome (lipoproteins, multiple-banded antigen like protein, membrane nuclease lipoprotein and variable surface antigens lipoprotein). In addition, a gene encoding glycosyltransferase was also found. This enzyme has been associated with the production of capsule in mycoplasmas and ureaplasma. We then sought to detect the presence of a capsule in this organism. A polysaccharide capsule from 11 to 17 nm of U. diversum was observed trough electron microscopy and using specific dyes. This structure contained arabinose, xylose, mannose, galactose and glucose. In order to understand the inflammatory response against these surface molecules, we evaluated the response of murine macrophages J774 against viable and non-viable U. diversum. As with viable bacteria, non-viable bacteria were capable of promoting a significant inflammatory response by activation of Toll like receptor 2 (TLR2), indicating that surface molecules are important for the activation of inflammatory response. Furthermore, a cascade of genes related to the inflammasome pathway of macrophages was also up-regulated during infection with viable organisms when compared to noninfected cells. In conclusion, U. diversum has a typical ureaplasma genome and metabolism, and its surface molecules, including the identified capsular material, represent major components of the organism immunopathogenesis.	[Marques, Lucas M.; Rezende, Izadora S.; Barbosa, Maysa S.; Campos, Guilherme B.; Amorim, Aline T.; Santos, Verena M.; Buzinhani, Melissa; Timenetsky, Jorge] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Marques, Lucas M.; Rezende, Izadora S.; Barbosa, Maysa S.; Martins, Hellen B.] Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, Brazil; [Marques, Lucas M.; Martins, Hellen B.] Univ Santa Cruz UESC, Campus Soane Nazare de Andrade, Iheus, Brazil; [Guimaraes, Ana M. S.] Univ Sao Paulo, Coll Vet Med & Anim Sci, Dept Anim Hlth & Prevent Vet Med, Sao Paulo, Brazil; [Guimaraes, Ana M. S.; do Nascimento, Naila C.; dos Santos, Andrea P.; Messick, Joanne B.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Farias, Savio T.] Univ Fed Paraiba, Evolutionary Genet Lab, Dept Mol Biol, Joao Pessoa, Paraiba, Brazil; [Barrence, Fernanda A. C.; Arana-Chavez, Victor E.] Univ Sao Paulo, Lab Biol Mineralized Tissues, Inst Biomed Sci, Sao Paulo, Brazil; [de Souza, Lauro M.] Inst Pesquisa Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, Parana, Brazil; [Arana-Chavez, Victor E.] Univ Sao Paulo, Dept Dent Mat, Sch Dent, Sao Paulo, Brazil; [Zenteno, Maria E.; Amarante-Mendes, Gustavo P.] Univ Sao Paulo, Lab Cellular & Mol Biol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade Federal da Paraiba; Universidade de Sao Paulo; Hospital Pequeno Principe; Universidade de Sao Paulo; Universidade de Sao Paulo	Marques, LM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.; Marques, LM (corresponding author), Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, Brazil.; Marques, LM (corresponding author), Univ Santa Cruz UESC, Campus Soane Nazare de Andrade, Iheus, Brazil.	lucasm@ufba.br	Mendes, Gustavo P Amarante/C-8187-2012; Souza, Lauro/AAE-3273-2019; Marques, Lucas M/L-2507-2018; dos Santos, Andrea Pires/O-5371-2019; Silva, Lucas/GQH-8201-2022; Guimaraes, Ana M. S./N-5603-2016; AMORIM, ALINE TEIXEIRA/H-3026-2016	Mendes, Gustavo P Amarante/0000-0002-7851-6205; Souza, Lauro/0000-0001-9166-2146; Marques, Lucas M/0000-0002-8276-8149; dos Santos, Andrea Pires/0000-0002-1037-970X; AMORIM, ALINE TEIXEIRA/0000-0003-2597-8665; Cannes do Nascimento, Naila/0000-0001-6233-2447	FAPESB [APP0097/2009]; FAPESP [2012/00719-2]; PROPI/UFBA [01/2013]	FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPI/UFBA	This study was supported by FAPESB (No APP0097/2009) (Lucas Miranda Marques), FAPESP (2012/00719-2) (Jorge Timenetsky) and PROPI/UFBA (01/2013) (Lucas Miranda Marques). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA RA, 1992, INFECT IMMUN, V60, P2914, DOI 10.1128/IAI.60.7.2914-2919.1992; ALMEIDA RA, 1991, INFECT IMMUN, V59, P3119, DOI 10.1128/IAI.59.9.3119-3125.1991; Amorim AT, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-38; Arfi Y, 2016, P NATL ACAD SCI USA, V113, P5406, DOI 10.1073/pnas.1600546113; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068373; BLANCHARD A, 1988, J BACTERIOL, V170, P2692, DOI 10.1128/jb.170.6.2692-2697.1988; BRITTON AP, 1987, CAN J VET RES, V51, P198; BRITTON AP, 1989, CAN J VET RES, V53, P172; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Buchenau I, 2010, RES VET SCI, V89, P223, DOI 10.1016/j.rvsc.2010.03.014; Buzinhani M, 2007, VET J, V173, P688, DOI 10.1016/j.tvjl.2006.02.001; Buzinhani Melissa, 2011, BMC Res Notes, V4, P455, DOI 10.1186/1756-0500-4-455; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Chelmonska-Soyta A, 1994, CAN J VET RES, V58, P275; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; DeSilva NS, 1999, MOL CELL BIOCHEM, V201, P159, DOI 10.1023/A:1007082507407; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DOIG PA, 1980, CAN J COMP MED, V44, P252; Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234; Garcia J, MYCOPLASMA FERMENTAN, P34391; Glass JI, 2001, TRENDS MICROBIOL, V9, P163, DOI 10.1016/S0966-842X(01)01951-5; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; GOEBEL W, 1988, A VAN LEEUW J MICROB, V54, P453, DOI 10.1007/BF00461864; Guimaraes AMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091445; Guimaraes AMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019574; Harasawa R, 1996, INT J SYST BACTERIOL, V46, P827, DOI 10.1099/00207713-46-3-827; Harasawa R, 1996, J VET MED SCI, V58, P191, DOI 10.1292/jvms.58.191; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Hobson N, 2013, AUST VET J, V91, P469, DOI 10.1111/avj.12113; HOWARD CJ, 1973, J HYG-CAMBRIDGE, V71, P163, DOI 10.1017/S0022172400046337; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inoue R, 2011, FEMS IMMUNOL MED MIC, V61, P94, DOI 10.1111/j.1574-695X.2010.00752.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KIM JJ, 1994, INFECT IMMUN, V62, P1528, DOI 10.1128/IAI.62.5.1528-1533.1994; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Kokkayil P, 2015, INDIAN J MED MICROBI, V33, P205, DOI 10.4103/0255-0857.154850; KREPLIN CMA, 1987, CAN J VET RES, V51, P440; LI Y, 2011, EURASIP J WIREL COMM, V2011, P1, DOI DOI 10.1093/ECAM/NEQ044; Li YH, 2000, INFECT IMMUN, V68, P7087, DOI 10.1128/IAI.68.12.7087-7093.2000; Li YH, 2000, PEDIATR RES, V48, P114, DOI 10.1203/00006450-200007000-00020; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; LLOYD LC, 1971, J MED MICROBIOL, V4, P425, DOI 10.1099/00222615-4-4-425; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MANILOFF J, 1972, BACTERIOL REV, V36, P263, DOI 10.1128/MMBR.36.3.263-290.1972; Marques LM, 2011, VET MICROBIOL, V152, P205, DOI 10.1016/j.vetmic.2011.04.007; Marques LM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-83; Masukagami Y, 2013, INFECT IMMUN, V81, P3220, DOI 10.1128/IAI.00365-13; MILLER RB, 1983, THERIOGENOLOGY, V20, P367, DOI 10.1016/0093-691X(83)90071-7; MINION FC, 1986, INFECT IMMUN, V51, P352, DOI 10.1128/IAI.51.1.352-354.1986; MINION FC, 1993, J BACTERIOL, V175, P7842, DOI 10.1128/JB.175.24.7842-7847.1993; Neyrolles O, 1996, J BACTERIOL, V178, P2725, DOI 10.1128/jb.178.9.2725-2725.1996; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Peltier MR, 2007, AM J REPROD IMMUNOL, V57, P186, DOI 10.1111/j.1600-0897.2006.00460.x; Pollack JD, 2001, TRENDS MICROBIOL, V9, P169, DOI 10.1016/S0966-842X(01)01950-3; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Rawadi G, 2000, MICROBES INFECT, V2, P955, DOI 10.1016/S1286-4579(00)00395-6; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062746; ROMANO N, 1976, J BACTERIOL, V128, P170, DOI 10.1128/JB.128.1.170-173.1976; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; RUHNKE HL, 1978, CAN J COMP MED, V42, P151; RUHNKE HL, 1984, THERIOGENOLOGY, V21, P295, DOI 10.1016/0093-691X(84)90415-1; Sachs G, 2006, J MEMBRANE BIOL, V212, P71, DOI 10.1007/s00232-006-0867-7; Sacht G, 1998, EUR J IMMUNOL, V28, P4207, DOI 10.1002/(SICI)1521-4141(199812)28:12<4207::AID-IMMU4207>3.0.CO;2-R; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos AP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-102; Silva JR, 2016, AN ACAD BRAS CIENC, V88, P643, DOI 10.1590/0001-3765201620150244; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Somarajan SR, 2010, CELL MICROBIOL, V12, P1821, DOI 10.1111/j.1462-5822.2010.01513.x; Sugiyama M, 2016, MOL ORAL MICROBIOL, V31, P259, DOI 10.1111/omi.12117; TAJIMA M, 1982, INFECT IMMUN, V36, P830, DOI 10.1128/IAI.36.2.830-833.1982; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viscardi RM, 2014, ARCH DIS CHILD-FETAL, V99, pF87, DOI 10.1136/archdischild-2012-303351; Waite ER, 2002, J COMP PATHOL, V126, P171, DOI 10.1053/jcpa.2001.0540; Xu J, 2015, APPL MICROBIOL BIOT, V99, P1859, DOI 10.1007/s00253-014-6185-6; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077955; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZHENG XT, 1995, INFECT IMMUN, V63, P891, DOI 10.1128/IAI.63.3.891-898.1995; Zuo LL, 2009, J ZHEJIANG UNIV-SC B, V10, P67, DOI 10.1631/jzus.B0820256	89	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161926	10.1371/journal.pone.0161926	http://dx.doi.org/10.1371/journal.pone.0161926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603136	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200030
J	Collins, KM; Penman, TD; Price, OF				Collins, Kathryn M.; Penman, Trent D.; Price, Owen F.			Some Wildfire Ignition Causes Pose More Risk of Destroying Houses than Others	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; FIRE WEATHER; FUEL TREATMENT; INITIAL ATTACK; SPATIAL-PATTERNS; FOREST-FIRES; LAND-USE; CALIFORNIA; AUSTRALIA; MANAGEMENT	Many houses are at risk of being destroyed by wildfires. While previous studies have improved our understanding of how, when and why houses are destroyed by wildfires, little attention has been given to how these fires started. We compiled a dataset of wildfires that destroyed houses in New South Wales and Victoria and, by comparing against wildfires where no houses were destroyed, investigated the relationship between the distribution of ignition causes for wildfires that did and did not destroy houses. Powerlines, lightning and deliberate ignitions are the main causes of wildfires that destroyed houses. Powerlines were 6 times more common in the wildfires that destroyed houses data than in the wildfires where no houses were destroyed data and lightning was 2 times more common. For deliberate- and powerline-caused wildfires, temperature, wind speed, and forest fire danger index were all significantly higher and relative humidity significantly lower (P < 0.05) on the day of ignition for wildfires that destroyed houses compared with wildfires where no houses were destroyed. For all powerline-caused wildfires the first house destroyed always occurred on the day of ignition. In contrast, the first house destroyed was after the day of ignition for 78% of lightning-caused wildfires. Lightning-caused wildfires that destroyed houses were significantly larger (P < 0.001) in area than human-caused wildfires that destroyed houses. Our results suggest that targeting fire prevention strategies around ignition causes, such as improving powerline safety and targeted arson reduction programmes, and reducing fire spread may decrease the number of wildfires that destroy houses.	[Collins, Kathryn M.; Price, Owen F.] Univ Wollongong, Ctr Environm Risk Management Bushfires, Wollongong, NSW, Australia; [Penman, Trent D.] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia	University of Wollongong; University of Melbourne	Collins, KM (corresponding author), Univ Wollongong, Ctr Environm Risk Management Bushfires, Wollongong, NSW, Australia.	kmc624@uowmail.edu.au	Price, Owen F/H-4033-2012; Penman, Trent D/A-7242-2012	Price, Owen F/0000-0001-5327-568X; Penman, Trent D/0000-0002-5203-9818				Abt KL, 2015, INT J WILDLAND FIRE, V24, P749, DOI 10.1071/WF14168; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2011, FIN REP 2011; Arienti MC, 2006, CAN J FOREST RES, V36, P3155, DOI 10.1139/X06-188; Barber EHE, 1977, REPORT BOARD INQUIRY; Beadle N., 1981, VEGETATION AUSTR; Blanchi R., 2008, Community bushfire safety, P77; Blanchi R, 2014, ENVIRON SCI POLICY, V37, P192, DOI 10.1016/j.envsci.2013.09.013; Blanchi R, 2010, INT J WILDLAND FIRE, V19, P914, DOI 10.1071/WF08175; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Bradstock RA, 2012, J ENVIRON MANAGE, V105, P66, DOI 10.1016/j.jenvman.2012.03.050; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Bradstock RA, 2001, J MEDITERRANEAN ECOL, V2, P179; Bryant BP, 2014, ENVIRONMETRICS, V25, P454, DOI 10.1002/env.2280; Butsic V, 2015, LAND-BASEL, V4, P140, DOI 10.3390/land4010140; Cal Fire, 2016, TOP 20 MOST DAM CAL; Cary GJ, 2009, INT J WILDLAND FIRE, V18, P147, DOI 10.1071/WF07085; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; Cohen JD, 2000, J FOREST, V98, P15; Collins KM, 2015, INT J WILDLAND FIRE, V24, P1098, DOI 10.1071/WF15054; CUNNINGHAM CJ, 1984, APPL GEOGR, V4, P5, DOI 10.1016/0143-6228(84)90002-X; Doogan M., 2006, CANBERRA FIRESTORM I; Dowling VP., 1996, P LINN SOC N S W, P133; Ducat L, 2011, PSYCHIAT PSYCHOL LAW, V18, P341, DOI 10.1080/13218719.2011.598633; Filmon G, 2003, FIRESTORM 2003 PROVI; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; Gill A. M., 2005, Environmental Hazards, V6, P65, DOI 10.1016/j.hazards.2005.10.005; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Gralewicz NJ, 2012, INT J WILDLAND FIRE, V21, P230, DOI 10.1071/WF10095; Haight RG, 2007, INFOR, V45, P31, DOI 10.3138/infor.45.1.31; Hammer RB, 2009, SOC NATUR RESOUR, V22, P777, DOI 10.1080/08941920802714042; Hasson AEA, 2009, CLIM RES, V39, P159, DOI 10.3354/cr00817; Heath J., 2011, FEBRUARY 2011 FIRES; Hirsch KG, 1996, INT J WILDLAND FIRE, V6, P199, DOI 10.1071/WF9960199; Hughes R, 2009, GEOGR RES-AUST, V47, P124, DOI 10.1111/j.1745-5871.2008.00556.x; Keeley JE, 2004, J FOREST, V102, P26; Keeley JE, 2009, J FOREST, V107, P287; Keelty M., 2011, SHARED RESPONSIBILIT; Keith D.A., 2004, OCEAN SHORES DESERT; Lansdell GT, 2011, PSYCHIAT PSYCHOL LAW, V18, P357, DOI 10.1080/13218719.2011.559900; Long M, 2006, AUST METEOROL MAG, V55, P3; Luke R.H., 1978, BUSHFIRES AUSTR; Mann ML, 2014, LAND USE POLICY, V41, P438, DOI 10.1016/j.landusepol.2014.06.020; McArthur AG, 1967, FIRE BEHAVIOUR IN EU; McCarthy GJ, 2012, AUST FORESTRY, V75, P54, DOI 10.1080/00049158.2012.10676385; Mees R., 1991, International Journal of Wildland Fire, V1, P97, DOI 10.1071/WF9910097; Mell WE, 2010, INT J WILDLAND FIRE, V19, P238, DOI 10.1071/WF07131; Miller SI, 1984, REPORT BUSHFIRE REV; Miranda BR, 2012, INT J WILDLAND FIRE, V21, P141, DOI 10.1071/WF10133; Mitchell JW, 2013, ENG FAIL ANAL, V35, P726, DOI 10.1016/j.engfailanal.2013.07.006; Morin AA, 2015, INT J WILDLAND FIRE, V24, P964, DOI 10.1071/WF14158; Moritz MA, 2004, FRONT ECOL ENVIRON, V2, P67, DOI 10.1890/1540-9295(2004)002[0067:TABAOS]2.0.CO;2; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Muller DA, 2009, RES PUBLIC POLICY SE; Murphy BP, 2013, J BIOGEOGR, V40, P1048, DOI 10.1111/jbi.12065; Narayanaraj G, 2012, APPL GEOGR, V32, P878, DOI 10.1016/j.apgeog.2011.09.004; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Penman TD, 2013, INT J DISAST RISK RE, V6, P67, DOI 10.1016/j.ijdrr.2013.09.001; Penman TD, 2014, ENVIRON MODELL SOFTW, V52, P166, DOI 10.1016/j.envsoft.2013.09.030; Penman TD, 2013, J ENVIRON MANAGE, V131, P325, DOI 10.1016/j.jenvman.2013.10.007; Penman TD, 2013, INT J WILDLAND FIRE, V22, P469, DOI 10.1071/WF12027; Penman TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111414; Plucinski MP, 2014, FIRE SAFETY J, V67, P42, DOI 10.1016/j.firesaf.2014.05.012; Plucinski MP, 2013, INT J WILDLAND FIRE, V22, P459, DOI 10.1071/WF12019; Plucinski MP, 2012, FOREST SCI, V58, P390, DOI 10.5849/forsci.10-096; Price OF, 2013, NAT HAZARD EARTH SYS, V13, P3385, DOI 10.5194/nhess-13-3385-2013; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Price OF, 2010, INT J WILDLAND FIRE, V19, P35, DOI 10.1071/WF08167; San-Miguel-Ayanz J, 2013, FOREST ECOL MANAG, V294, P11, DOI 10.1016/j.foreco.2012.10.050; Serra L, 2014, ENVIRON ECOL STAT, V21, P531, DOI 10.1007/s10651-013-0267-y; Smith R, 2004, P 11 ANN AFAC C IN B; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2015, INT J WILDLAND FIRE, V24, P37, DOI 10.1071/WF14024; Syphard AD, 2014, INT J WILDLAND FIRE, V23, P1165, DOI 10.1071/WF13158; Syphard AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033954; Syphard AD, 2011, FOREST ECOL MANAG, V261, P2038, DOI 10.1016/j.foreco.2011.02.030; Teague B, 2009, 2009 VICTORIAL BUSHF; Vasquez T, 2011, WEATHERWISE, V62, P20; Victorian Department of Economic Development Jobs Transport and Resources, 2016, POW BUSHF SAF PROGR; Whittaker J, 2013, INT J WILDLAND FIRE, V22, P841, DOI 10.1071/WF12010; Willis M., 2005, Environmental Hazards, V6, P93, DOI 10.1016/j.hazards.2005.10.001; WILSON AAG, 1986, J ENVIRON MANAGE, V23, P259	82	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162083	10.1371/journal.pone.0162083	http://dx.doi.org/10.1371/journal.pone.0162083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598325	gold, Green Published			2022-12-27	WOS:000383254800038
J	Kim, J; Wang, J; Wedell, DH; Shinkareva, SV				Kim, Jongwan; Wang, Jing; Wedell, Douglas H.; Shinkareva, Svetlana V.			Identifying Core Affect in Individuals from fMRI Responses to Dynamic Naturalistic Audiovisual Stimuli	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; NEURAL REPRESENTATIONS; PATTERN-CLASSIFICATION; FACIAL EXPRESSIONS; EMOTIONAL AROUSAL; MUSICAL EMOTIONS; VALENCE; ACTIVATION; BRAIN; PERCEPTION	Recent research has demonstrated that affective states elicited by viewing pictures varying in valence and arousal are identifiable from whole brain activation patterns observed with functional magnetic resonance imaging (fMRI). Identification of affective states from more naturalistic stimuli has clinical relevance, but the feasibility of identifying these states on an individual trial basis from fMRI data elicited by dynamic multimodal stimuli is unclear. The goal of this study was to determine whether affective states can be similarly identified when participants view dynamic naturalistic audiovisual stimuli. Eleven participants viewed 5s audiovisual clips in a passive viewing task in the scanner. Valence and arousal for individual trials were identified both within and across participants based on distributed patterns of activity in areas selectively responsive to audiovisual naturalistic stimuli while controlling for lower level features of the stimuli. In addition, the brain regions identified by searchlight analyses to represent valence and arousal were consistent with previously identified regions associated with emotion processing. These findings extend previous results on the distributed representation of affect to multimodal dynamic stimuli.	[Kim, Jongwan; Wedell, Douglas H.; Shinkareva, Svetlana V.] Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA; [Wang, Jing] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of South Carolina System; University of South Carolina Columbia; Carnegie Mellon University	Shinkareva, SV (corresponding author), Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA.	shinkareva@sc.edu		Kim, Jongwan/0000-0003-1316-1041; Shinkareva, Svetlana/0000-0001-5112-4829	Social Sciences Grant Program, Office of the Provost, University of South Carolina	Social Sciences Grant Program, Office of the Provost, University of South Carolina	This work was funded in part by the Social Sciences Grant Program, Office of the Provost, University of South Carolina, awarded to SVS and DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2012, WILEY INTERDISCIPLIN, DOI DOI 10.1016/J.NEUROIMAGE.2010.10.011; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Anders S, 2008, SOC COGN AFFECT NEUR, V3, P233, DOI 10.1093/scan/nsn017; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Baucom LB, 2012, NEUROIMAGE, V59, P718, DOI 10.1016/j.neuroimage.2011.07.037; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bertelson P, 2004, CROSSMODAL SPACE CRO, P141, DOI DOI 10.1093/ACPROF:OSO/9780198524861.003.0007; Bishop C. M, 2006, PATTERN RECOGNITION; Bradley M., 1999, INT AFFECTIVE DIGITI; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brosnan M, 2015, J AUTISM DEV DISORD, V45, P1785, DOI 10.1007/s10803-014-2338-9; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Chikazoe J, 2014, NAT NEUROSCI, V17, P1114, DOI 10.1038/nn.3749; Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700; Daselaar SM, 2008, CEREB CORTEX, V18, P217, DOI 10.1093/cercor/bhm048; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2005, SCHIZOPHR RES, V72, P195, DOI 10.1016/j.schres.2004.02.013; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Jong JJ, 2010, SCHIZOPHR RES, V122, P136, DOI 10.1016/j.schres.2010.04.010; Erez J, 2015, CEREB CORTEX; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Etzel JA, 2013, NEUROIMAGE, V78, P261, DOI 10.1016/j.neuroimage.2013.03.041; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Gabrielsson A., 2001, MUSIC EMOTION THEORY, P223, DOI DOI 10.1525/MP.2004.21.4.561; Garrido-Vasquez P, 2011, SOC NEUROSCI-UK, V6, P515, DOI 10.1080/17470919.2011.620771; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Gomez P, 2004, INT J PSYCHOPHYSIOL, V53, P91, DOI 10.1016/j.ijpsycho.2004.02.002; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Habes I, 2013, NEUROIMAGE-CLIN, V2, P675, DOI 10.1016/j.nicl.2013.05.001; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Haller S, 2006, EUR J NEUROSCI, V24, P2672, DOI 10.1111/j.1460-9568.2006.05147.x; Harry B, 2013, EMOTIONAL EXPRESSION; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Henriksson L, 2015, NEUROIMAGE, V114, P275, DOI 10.1016/j.neuroimage.2015.04.026; HUBERT W, 1990, BIOL PSYCHOL, V31, P73, DOI 10.1016/0301-0511(90)90079-C; HUBERT W, 1991, INT J PSYCHOPHYSIOL, V11, P131, DOI 10.1016/0167-8760(91)90005-I; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Kay KN, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00247; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kim J, 2015, J NEUROSCI, V35, P5655, DOI 10.1523/JNEUROSCI.4059-14.2015; Klasen M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00822; Klasen M, 2011, J NEUROSCI, V31, P13635, DOI 10.1523/JNEUROSCI.2833-11.2011; Kotz SA, 2013, HUM BRAIN MAPP, V34, P1971, DOI 10.1002/hbm.22041; Kragel PA, 2015, SOC COGN AFFECT NEUR, V10, P1437, DOI 10.1093/scan/nsv032; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lakens D, 2013, COGNITION EMOTION, V27, P1225, DOI 10.1080/02699931.2013.781501; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; LINDQUIST KA, 2016, CEREB CORTEX, V26, P1910, DOI [DOI 10.1093/CERCOR/BHV001, 10.1093/cercor/bhv001]; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Magnee MJCM, 2009, NEUROPSYCHOLOGIA, V47, P1728, DOI 10.1016/j.neuropsychologia.2009.02.012; Maurage P, 2013, EXPT CLIN USEFULNESS; Mourao-Miranda J, 2003, NEUROIMAGE, V20, P1955, DOI 10.1016/j.neuroimage.2003.08.011; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Rottenberg J., 2007, HDB EMOTION ELICITAT; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Satpute A. B., 2015, BRAIN MAPPING ENCY R, P65; Shinkareva SV, 2014, HUM BRAIN MAPP, V35, P3558, DOI 10.1002/hbm.22421; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Stelzer J, 2013, NEUROIMAGE, V65, P69, DOI 10.1016/j.neuroimage.2012.09.063; Tseng A, 2016, HUM BRAIN MAPP, V37, P443, DOI 10.1002/hbm.23041; Viinikainen M, 2012, HUM BRAIN MAPP, V33, P2295, DOI 10.1002/hbm.21362; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; Weisberg J, 2014, CEREB CORTEX, V24, P37, DOI 10.1093/cercor/bhs276; Wilson-Mendenhall CD, 2013, PSYCHOL SCI, V24, P947, DOI 10.1177/0956797612464242; Yuen KSL, 2012, TRANSL NEUROSCI, V3, P278, DOI 10.2478/s13380-012-0029-6; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	86	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161589	10.1371/journal.pone.0161589	http://dx.doi.org/10.1371/journal.pone.0161589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598534	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800011
J	Estevinho, LM; Chambo, ED; Pereira, APR; de Carvalho, CAL; de Toledo, VDA				Estevinho, Leticia M.; Chambo, Emerson Dechechi; Rodrigues Pereira, Ana Paula; Lopes de Carvalho, Carlos Alfredo; Arnaut de Toledo, Vagner de Alencar			Characterization of Lavandula spp. Honey Using Multivariate Techniques	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; FLORAL ORIGIN MARKERS; PHYSICOCHEMICAL CHARACTERISTICS; ANTIOXIDANT CAPACITY; ORGANIC HONEY; POLLEN; LAVENDER; EUCALYPTUS; REGION; THYME	Traditionally, melissopalynological and physicochemical analyses have been the most used to determine the botanical origin of honey. However, when performed individually, these analyses may provide less unambiguous results, making it difficult to discriminate between mono and multifloral honeys. In this context, with the aim of better characterizing this beehive product, a selection of 112 Lavandula spp. monofloral honey samples from several regions were evaluated by association of multivariate statistical techniques with physicochemical, melissopalynological and phenolic compounds analysis. All honey samples fulfilled the quality standards recommended by international legislation, except regarding sucrose content and diastase activity. The content of sucrose and the percentage of Lavandula spp. pollen have a strong positive association. In fact, it was found that higher amounts of sucrose in honey are related with highest percentage of pollen of Lavandula spp.. The samples were very similar for most of the physicochemical parameters, except for proline, flavonoids and phenols (bioactive factors). Concerning the pollen spectrum, the variation of Lavandula spp. pollen percentage in honey had little contribution to the formation of samples groups. The formation of two groups regarding the physicochemical parameters suggests that the presence of other pollen types in small percentages influences the factor termed as "bioactive", which has been linked to diverse beneficial health effects.	[Estevinho, Leticia M.; Rodrigues Pereira, Ana Paula] Escola Super Agr, Inst Politecn Braganca, Dept Biol & Biotecnol, Braganca, Portugal; [Chambo, Emerson Dechechi; Lopes de Carvalho, Carlos Alfredo] Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Cruz Das Almas, BA, Brazil; [Arnaut de Toledo, Vagner de Alencar] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil	Instituto Politecnico de Braganca; Universidade Federal do Reconcavo da Bahia; Universidade Estadual de Maringa	Chambo, ED (corresponding author), Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Cruz Das Almas, BA, Brazil.	chamboed@gmail.com	Estevinho, Leticia M./L-2656-2017; Pereira, Ana Paula/AAK-4584-2020; de Carvalho, Carlos Alfredo Lopes/N-6717-2019; Carvalho, Carlos A L/N-3321-2016; Arnaut de Toledo, Vagner De Alencar/I-8195-2012	Estevinho, Leticia M./0000-0002-9249-1948; de Carvalho, Carlos Alfredo Lopes/0000-0002-3306-3003; Carvalho, Carlos A L/0000-0002-3306-3003; Arnaut de Toledo, Vagner De Alencar/0000-0003-1814-9703; Pereira, Ana Paula/0000-0003-1489-5207	CAPES [88887.116238/2016-00]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding for the present study was provided by CAPES (http://www.capes.gov.br/), process number 88887.116238/2016-00. The authors declare that this entity had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anklam E, 2001, AM LAB, V33, P60; [Anonymous], 2014, R LANG ENV STAT COMP; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Baroni MV, 2006, J AGR FOOD CHEM, V54, P7235, DOI 10.1021/jf061080e; Finco FDBA, 2010, CIENCIA TECNOL ALIME, V30, P706, DOI 10.1590/S0101-20612010000300022; Bianchi F, 2005, FOOD CHEM, V89, P527, DOI 10.1016/j.foodchem.2004.03.009; Bocard D., 2011, NUMERICAL ECOLOGY R; Bogdanov S., 1997, APIDOLOGIE, P1, DOI DOI 10.1007/S13398-014-0173-7.2; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bouseta A, 1996, J FOOD SCI, V61, P683, DOI 10.1111/j.1365-2621.1996.tb12181.x; Castro-Vazquez L, 2009, FOOD CHEM, V112, P1022, DOI 10.1016/j.foodchem.2008.06.036; Castro-Vazquez L, 2014, FOOD CONTROL, V37, P362, DOI 10.1016/j.foodcont.2013.09.003; Ciappini MC, 2014, J APIC SCI, V58, P103, DOI 10.2478/JAS-2014-0010; Cordella CBY, 2003, J AGR FOOD CHEM, V51, P3234, DOI 10.1021/jf021100m; de la Fuente E, 2005, J SEP SCI, V28, P1093, DOI 10.1002/jssc.200500018; de la Fuente E, 2011, FOOD CHEM, V129, P1483, DOI 10.1016/j.foodchem.2011.05.121; ERDTMAN G., 1966, Pollen morphology and plant taxonomy. Angiosperms. An introduction to palynology I.; Estevinho LM, 2012, FOOD CHEM TOXICOL, V50, P258, DOI 10.1016/j.fct.2011.10.034; Goldberg Loretta, 2009, Rev. biol. trop, V57, P161; Gomes S, 2010, FOOD CHEM TOXICOL, V48, P544, DOI 10.1016/j.fct.2009.11.029; Gomes T, 2011, MOLECULES, V16, P5374, DOI 10.3390/molecules16075374; Guyot C, 1998, J AGR FOOD CHEM, V46, P625, DOI 10.1021/jf970510l; Hair J., 2010, MULTIVARIATE DATA AN, V7; Jaworska N, 2009, TUTOR QUANT METHODS, V5, P1, DOI 10.20982/tqmp.05.1.p001; Khoudja NK, 2014, IND CROP PROD, V52, P177, DOI 10.1016/j.indcrop.2013.10.004; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Lachman J, 2010, LWT-FOOD SCI TECHNOL, V43, P52, DOI 10.1016/j.lwt.2009.06.008; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Marchini Luís Carlos, 2005, Food Sci. Technol (Campinas), V25, P8, DOI 10.1590/S0101-20612005000100003; Marghitas LA, 2009, FOOD CHEM, V112, P863, DOI 10.1016/j.foodchem.2008.06.055; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Nogueira C, 2012, INT J MOL SCI, V13, P11173, DOI 10.3390/ijms130911173; Oddo L., 2004, APIDOLOGIE, V35, pS38, DOI [10.1051/apido:2004049, DOI 10.1051/APIDO:2004049]; PALFI G, 1984, BIOCHEM PHYSIOL PFL, V179, P237, DOI 10.1016/S0015-3796(84)80082-7; Persano Oddo L., 2004, APIDOLOGIE, V35, P82, DOI [10.1051/apido:2004045, DOI 10.1051/APIDO:2004045]; Silici S, 2010, FOOD CHEM, V121, P238, DOI 10.1016/j.foodchem.2009.11.078; SNEATH P H, 1973, P573; Sodre GD, 2011, REV BRAS ZOOTECN, V40, P1837; Sousa MEBC, 2014, TALANTA, V128, P284, DOI 10.1016/j.talanta.2014.05.004; Szczesna T, 2011, J APIC SCI, V55, P111; Tanzadehpanah H, 2012, FOOD RES INT, V49, P105, DOI 10.1016/j.foodres.2012.08.022; Terrab A, 2004, FOOD CHEM, V88, P537, DOI 10.1016/j.foodchem.2004.01.068; Truchado P, 2009, J CHROMATOGR A, V1216, P7241, DOI 10.1016/j.chroma.2009.07.057; Von Der Ohe W., 2004, APIDOLOGIE, V35, P18, DOI [10.1051/apido:2004050, DOI 10.1051/APIDO]; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	46	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162206	10.1371/journal.pone.0162206	http://dx.doi.org/10.1371/journal.pone.0162206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588420	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800034
J	Dautriche, I; Chemla, E				Dautriche, Isabelle; Chemla, Emmanuel			What Homophones Say about Words	PLOS ONE			English	Article							MEANINGS; LABELS; SHAPE; REPRESENTATION; CLASSIFICATION; CONSTRAINTS; SIMILARITY; CATEGORIES; ATTENTION; KNOWLEDGE	The number of potential meanings for a new word is astronomic. To make the word-learning problem tractable, one must restrict the hypothesis space. To do so, current word learning accounts often incorporate constraints about cognition or about the mature lexicon directly in the learning device. We are concerned with the convexity constraint, which holds that concepts (privileged sets of entities that we think of as "coherent") do not have gaps (if A and B belong to a concept, so does any entity "between" A and B). To leverage from it a linguistic constraint, learning algorithms have percolated this constraint from concepts, to word forms: some algorithms rely on the possibility that word forms are associated with convex sets of objects. Yet this does have to be the case: homophones are word forms associated with two separate words and meanings. Two sets of experiments show that when evidence suggests that a novel label is associated with a disjoint (non-convex) set of objects, either a) because there is a gap in conceptual space between the learning exemplars for a given word or b) because of the intervention of other lexical items in that gap, adults prefer to postulate homophony, where a single word form is associated with two separate words and meanings, rather than inferring that the word could have a disjunctive, discontinuous meaning. These results about homophony must be integrated to current word learning algorithms. We conclude by arguing for a weaker specialization of word learning algorithms, which too often could miss important constraints by focusing on a restricted empirical basis (e.g., non-homophonous content words).	[Dautriche, Isabelle; Chemla, Emmanuel] DEC ENS EHESS CNRS, Lab Sci Cognit & Psycholinguist, Paris, France	Centre National de la Recherche Scientifique (CNRS)	Dautriche, I (corresponding author), DEC ENS EHESS CNRS, Lab Sci Cognit & Psycholinguist, Paris, France.	isabelle.dautriche@gmail.com		Chemla, Emmanuel/0000-0002-8423-5880; Dautriche, Isabelle/0000-0002-2297-985X	Direction Generale de l'Armement (PhD program Frontieres du Vivant); European Research Council under FP-ERC [313610]; Agence Nationale de la Recherche [ANR-10-IDEX-0001-02, ANR-10-LABX-0087]	Direction Generale de l'Armement (PhD program Frontieres du Vivant); European Research Council under FP-ERC; Agence Nationale de la Recherche(French National Research Agency (ANR))	ID was supported by a Graduate Fellowship from the Direction Generale de l'Armement (PhD program Frontieres du Vivant). The research was supported by grants from the European Research Council under FP/2007-2013-ERC no 313610 to EC, and from the Agence Nationale de la Recherche ANR-10-IDEX-0001-02, ANR-10-LABX-0087 for the facilities provided by the Departement d'Etudes Cognitives. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APRESJAN JD, 1974, LINGUISTICS, P5; Atran S, 1998, BEHAV BRAIN SCI, V21, P547, DOI 10.1017/S0140525X98001277; BARSALOU LW, 1983, MEM COGNITION, V11, P211, DOI 10.3758/BF03196968; Bates D., IME4 LIB; Bloom P, 2001, BEHAV BRAIN SCI, V24, P1095, DOI 10.1017/S0140525X01000139; Breal M., 1904, ESSAI SEMANTIQUE; Caramazza A., 1976, SEMANTICS THEORY APP, P181; Copestake A., 1995, J SEMANT, V12, P15, DOI DOI 10.1093/J0S/12.1.15; Cruse D., 1986, LEXICAL SEMANTICS; Dautriche I, 2016, LANG LEARN DEV, V12, P231, DOI 10.1080/15475441.2015.1127163; Frege Gottlob., 1892, VIERTELJAHRSSCHRIFT, V16, P192; Gardenfors P., 2004, MIND MATTER, V2, P9; Geeraerts D., 1993, COGN LINGUIST, V4, P223, DOI [10.1515/cogl.1993.4.3.223, DOI 10.1515/C0GL.1993.4.3.223, DOI 10.1515/COGL.1993.4.3.223]; GELMAN SA, 1990, DEV PSYCHOL, V26, P796, DOI 10.1037/0012-1649.26.5.796; GELMAN SA, 1987, CHILD DEV, V58, P1532, DOI 10.1111/j.1467-8624.1987.tb03864.x; Goldstone R. L., 1994, ARGUMENTS INSUFFICIE; Goodman N., 1955, FACT FICTION FORECAS; Graham SA, 2004, CHILD DEV, V75, P409, DOI 10.1111/j.1467-8624.2004.00683.x; Graham SA, 1999, J CHILD LANG, V26, P295, DOI 10.1017/S0305000999003815; Hochmann JR, 2013, COGNITION, V128, P13, DOI 10.1016/j.cognition.2013.02.014; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; KEIL FC, 1981, PSYCHOL REV, V88, P197, DOI 10.1037/0033-295X.88.3.197; Keil FrankC., 1989, CONCEPTS KINDS COGNI; LANDAU B, 1988, COGNITIVE DEV, V3, P299, DOI 10.1016/0885-2014(88)90014-7; Markman E. M., 1989, CATEGORIZATION NAMIN; MARKMAN EM, 1984, COGNITIVE PSYCHOL, V16, P1, DOI 10.1016/0010-0285(84)90002-1; MARKMAN EM, 1988, COGNITIVE PSYCHOL, V20, P121, DOI 10.1016/0010-0285(88)90017-5; Markson L, 1997, NATURE, V385, P813, DOI 10.1038/385813a0; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Mitchell TM, 1980, CBMTR117; MURPHY GL, 1985, PSYCHOL REV, V92, P289, DOI 10.1037/0033-295X.92.3.289; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; NUNBERG G, 1979, LINGUIST PHILOS, V3, P143, DOI 10.1007/BF00126509; Nunberg Geoffrey, 1995, J SEMANT, V12, P109, DOI [DOI 10.1093/JOS/12.2.109, DOI 10.1093/J0S/12.2.109]; OSHERSON DN, 1978, COGNITION, V6, P263, DOI 10.1016/0010-0277(78)90001-X; Piantadosi ST, 2012, COGNITION, V123, P199, DOI 10.1016/j.cognition.2011.11.005; Plunkett K, 2008, COGNITION, V106, P665, DOI 10.1016/j.cognition.2007.04.003; PoulinDubois D, 1996, COGNITIVE DEV, V11, P19, DOI 10.1016/S0885-2014(96)90026-X; Pustejovsky J., 1991, Computational Linguistics, V17, P409; Rabagliati H., 2013, PSYCHOL SCI; Regier T, 2005, COGNITIVE SCI, V29, P819, DOI 10.1207/s15516709cog0000_31; SEIDENBERG MS, 1982, COGNITIVE PSYCHOL, V14, P489, DOI 10.1016/0010-0285(82)90017-2; SHEPARD RN, 1964, J MATH PSYCHOL, V1, P54, DOI 10.1016/0022-2496(64)90017-3; Siskind JM, 1996, COGNITION, V61, P39, DOI 10.1016/S0010-0277(96)00728-7; Smith EE, 1981, CATEGORIES CONCEPTS; Srinivasan M, 2014, LANG LEARN DEV, V10, P97, DOI 10.1080/15475441.2013.820121; Srinivasan M, 2011, COGNITIVE PSYCHOL, V62, P245, DOI 10.1016/j.cogpsych.2011.03.002; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; WAXMAN S, 1986, COGNITIVE DEV, V1, P139, DOI 10.1016/S0885-2014(86)80016-8; Xu F, 2007, PSYCHOL REV, V114, P245, DOI 10.1037/0033-295X.114.2.245; Zwicky Arnold., 1973, SYNTAX SEMANTICS, V16, P1	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162176	10.1371/journal.pone.0162176	http://dx.doi.org/10.1371/journal.pone.0162176			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DV3WN	27583384	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600115
J	Gaston, AF; Durand, F; Roca, E; Doucende, G; Hapkova, I; Subirats, E				Gaston, Anne-Fleur; Durand, Fabienne; Roca, Emma; Doucende, Gregory; Hapkova, Ilona; Subirats, Enric			Exercise-Induced Hypoxaemia Developed at Sea-Level Influences Responses to Exercise at Moderate Altitude	PLOS ONE			English	Article							INDUCED ARTERIAL HYPOXEMIA; MAXIMAL OXYGEN-UPTAKE; PEAK HEART-RATE; ACUTE-HYPOXIA; INTERMITTENT HYPOXIA; ISOMETRIC CONTRACTION; VENTILATORY RESPONSE; RAT-HEART; VO2 MAX; DECREASE	Purpose The aim of this study was to investigate the impact of exercise-induced hypoxaemia (EIH) developed at sea-level on exercise responses at moderate acute altitude. Methods Twenty three subjects divided in three groups of individuals: highly trained with EIH (n = 7); highly trained without EIH (n = 8) and untrained participants (n = 8) performed two maximal incremental tests at sea-level and at 2,150 m. Haemoglobin O-2 saturation (SpO(2)), heart rate, oxygen uptake (VO2) and several ventilatory parameters were measured continuously during the tests. Results EIH athletes had a drop in SpO(2) from 99 +/- 0.8% to 91 +/- 1.2% from rest to maximal exercise at sea-level, while the other groups did not exhibit a similar decrease. EIH athletes had a greater decrease in VO2max at altitude compared to non-EIH and untrained groups (-22 +/- 7.9%, -16 +/- 5.3% and -13 +/- 9.4%, respectively). At altitude, non-EIH athletes had a similar drop in SpO(2) as EIH athletes (13 +/- 0.8%) but greater than untrained participants (6 +/- 1.0%). EIH athletes showed greater decrease in maximal heart rate than non-EIH athletes at altitude (8 +/- 3.3 bpm and 5 +/- 2.9 bpm, respectively). Conclusion EIH athletes demonstrated specific cardiorespiratory response to exercise at moderate altitude compared to non-EIH athletes with a higher decrease in VO2max certainly due to the lower ventilator and HRmax responses. Thus EIH phenomenon developed at sea-level negatively impact performance and cardiorespiratory responses at acute moderate altitude despite no potentiated O-2 desaturation.	[Gaston, Anne-Fleur; Durand, Fabienne; Roca, Emma; Doucende, Gregory; Hapkova, Ilona; Subirats, Enric] Univ Perpignan Via Domitia, EA4604, Lab Europeen Performance Sante Altitude, Font Romeu, France; [Roca, Emma; Subirats, Enric] Univ Girona, Fac Med, Girona, Spain	Universitat de Girona	Gaston, AF (corresponding author), Univ Perpignan Via Domitia, EA4604, Lab Europeen Performance Sante Altitude, Font Romeu, France.	anne-fleur.gaston@univ-perp.fr						BADIER M, 1994, MUSCLE NERVE, V17, P500, DOI 10.1002/mus.880170506; Bendahan D, 1998, CLIN SCI, V94, P279, DOI 10.1042/cs0940279; Benoit H, 2003, EUR J APPL PHYSIOL, V90, P514, DOI 10.1007/s00421-003-0899-y; Caquelard F, 2000, CLIN SCI, V98, P329, DOI 10.1042/CS19990263; Chapman RF, 1999, MED SCI SPORT EXER, V31, P658, DOI 10.1097/00005768-199905000-00006; Chapman Robert F, 2013, Br J Sports Med, V47 Suppl 1, pi40, DOI 10.1136/bjsports-2013-092837; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Derchak PA, 2000, MED SCI SPORT EXER, V32, P1873, DOI 10.1097/00005768-200011000-00009; Dousset E, 2001, MUSCLE NERVE, V24, P364, DOI 10.1002/1097-4598(200103)24:3<364::AID-MUS1007>3.3.CO;2-2; Durand F, 2000, MED SCI SPORT EXER, V32, P926; Dwinell MR, 1997, J APPL PHYSIOL, V82, P118, DOI 10.1152/jappl.1997.82.1.118; Faulhaber M, 2010, J SPORT SCI, V28, P513, DOI 10.1080/02640410903581588; Foster GE, 2005, J PHYSIOL-LONDON, V567, P689, DOI 10.1113/jphysiol.2005.091462; Gavin TP, 1998, MED SCI SPORT EXER, V30, P195, DOI 10.1097/00005768-199802000-00004; Gore CJ, 1996, J APPL PHYSIOL, V80, P2204, DOI 10.1152/jappl.1996.80.6.2204; Grataloup O, 2007, INT J SPORTS MED, V28, P181, DOI 10.1055/s-2006-924216; Grataloup O, 2005, EUR J APPL PHYSIOL, V94, P641, DOI 10.1007/s00421-005-1361-0; HARMS CA, 1995, J APPL PHYSIOL, V79, P575, DOI 10.1152/jappl.1995.79.2.575; Hopkins SR, 2006, ADV EXP MED BIOL, V588, P17; KACIMI R, 1992, J APPL PHYSIOL, V73, P1377, DOI 10.1152/jappl.1992.73.4.1377; KACIMI R, 1993, J APPL PHYSIOL, V75, P1123, DOI 10.1152/jappl.1993.75.3.1123; Katayama B, 1998, EUR J APPL PHYSIOL, V78, P189, DOI 10.1007/s004210050406; Katayama K, 2007, INT J SPORTS MED, V28, P480, DOI 10.1055/s-2006-955895; Katayama K, 2001, J APPL PHYSIOL, V90, P1431, DOI 10.1152/jappl.2001.90.4.1431; Koehle MS, 2007, J APPL PHYSIOL, V103, P1973, DOI 10.1152/japplphysiol.00545.2007; LAWLER J, 1988, J APPL PHYSIOL, V64, P1486, DOI 10.1152/jappl.1988.64.4.1486; Lusina SJC, 2006, J PHYSIOL-LONDON, V575, P961, DOI 10.1113/jphysiol.2006.114660; MARTIN D, 1992, J APPL PHYSIOL, V72, P455, DOI 10.1152/jappl.1992.72.2.455; Martin D, 1993, J SPORT SCI, V11, P37, DOI 10.1080/02640419308729961; MIYAMURA M, 1990, EUR J APPL PHYSIOL O, V60, P353, DOI 10.1007/BF00713498; Mollard P, 2007, EUR J APPL PHYSIOL, V100, P663, DOI 10.1007/s00421-007-0457-0; Mollard P, 2010, RESP PHYSIOL NEUROBI, V172, P179, DOI 10.1016/j.resp.2010.05.017; Peltonen JE, 2001, EUR J APPL PHYSIOL, V85, P82, DOI 10.1007/s004210100411; Prefaut C, 2000, SPORTS MED, V30, P47, DOI 10.2165/00007256-200030010-00005; SCOGGIN CH, 1978, J APPL PHYSIOL, V44, P464, DOI 10.1152/jappl.1978.44.3.464; TERRADOS N, 1985, CLIN PHYSIOL, V5, P75, DOI 10.1111/j.1475-097X.1985.tb00605.x; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9; WERLE EO, 1990, LIFE SCI, V46, P9, DOI 10.1016/0024-3205(90)90051-R	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161819	10.1371/journal.pone.0161819	http://dx.doi.org/10.1371/journal.pone.0161819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583364	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600064
J	Ringling, RE; Gastecki, ML; Woodford, ML; Lum-Naihe, KJ; Grant, RW; Pulakat, L; Vieira-Potter, VJ; Padilla, J				Ringling, Rebecca E.; Gastecki, Michelle L.; Woodford, Makenzie L.; Lum-Naihe, Kelly J.; Grant, Ryan W.; Pulakat, Lakshmi; Vieira-Potter, Victoria J.; Padilla, Jaume			Loss of Nlrp3 Does Not Protect Mice from Western Diet-Induced Adipose Tissue Inflammation and Glucose Intolerance	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; ARTERIAL STIFFNESS; URIC-ACID; OBESITY; DYSFUNCTION; INFLAMMASOMES; ACTIVATION; INJURY; FAT	We tested the hypothesis that loss of Nlrp3 would protect mice from Western diet-induced adipose tissue (AT) inflammation and associated glucose intolerance and cardiovascular complications. Five-week old C57BL6J wild-type (WT) and Nlrp3 knockout (Nlrp3(-/-)) mice were randomized to either a control diet (10% kcal from fat) or Western diet (45% kcal from fat and 1% cholesterol) for 24 weeks (n = 8/group). Contrary to our hypothesis that obesity-mediated white AT inflammation is Nlrp3-dependent, we found that Western diet-induced expression of AT inflammatory markers (i.e., Cd68, Cd11c, Emr1, Itgam, Lgals, Il18, Mcp1, Tnf, Ccr2, Ccl5 mRNAs, and Mac-2 protein) were not accompanied by increased caspase-1 cleavage, a hallmark feature of NLRP3 inflammasome activation. Furthermore, Nlrp3 null mice were not protected from Western diet-induced white or brown AT inflammation. Although Western diet promoted glucose intolerance in both WT and Nlrp3(-/-) mice, Nlrp3(-/-) mice were protected from Western diet-induced aortic stiffening. Additionally, Nlrp3-/- mice exhibited smaller cardiomyocytes and reduced cardiac fibrosis, independent of diet. Collectively, these findings suggest that presence of the Nlrp3 gene is not required for Western diet-induced AT inflammation and/or glucose intolerance; yet Nlrp3 appears to play a role in potentiating arterial stiffening, cardiac hypertrophy and fibrosis.	[Ringling, Rebecca E.; Gastecki, Michelle L.; Woodford, Makenzie L.; Pulakat, Lakshmi; Vieira-Potter, Victoria J.; Padilla, Jaume] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Lum-Naihe, Kelly J.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Grant, Ryan W.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Pulakat, Lakshmi] Univ Missouri, Dept Med, Columbia, MO USA; [Pulakat, Lakshmi] Harry S Truman Mem Vet Affairs Hosp, Res Serv, Columbia, MO USA; [Padilla, Jaume] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Padilla, Jaume] Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Padilla, J (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA.; Padilla, J (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA.; Padilla, J (corresponding author), Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA.	padillaja@missouri.edu		Grant, Ryan/0000-0002-8940-4196	National Institutes of Health [K01 HL-125503, R21 DK-105368, 1R01 HL-118376-01]; Diversity Supplement award [5R01 HL-118376-02S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125503, R01HL118376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diversity Supplement award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants K01 HL-125503 and R21 DK-105368 (JP), 1R01 HL-118376-01 (LP), and Diversity Supplement award 5R01 HL-118376-02S (KJLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando S, 2015, ATHEROSCLEROSIS, V242, P407, DOI 10.1016/j.atherosclerosis.2015.07.043; Bigford GE, 2013, ASN NEURO, V5, P243, DOI 10.1042/AN20130021; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438; Coll RC, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.19; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; DeMarco VG, 2015, HYPERTENSION, V66, P99, DOI 10.1161/HYPERTENSIONAHA.115.05674; Dixit VD, 2013, DIABETES, V62, P22, DOI 10.2337/db12-1115; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Farb MG, 2015, HORM MOL BIOL CLIN I, V21, P125, DOI 10.1515/hmbci-2014-0047; Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x; Gong W, 2016, AM J PHYSIOL-RENAL, DOI [10.1152/ajprenal.00534, DOI 10.1152/AJPRENAL.00534]; Grant RW, 2015, AM J PHYSIOL-ENDOC M, V309, pE205, DOI 10.1152/ajpendo.00053.2015; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Jacobi D, 2012, ADIPOCYTE, V1, P4, DOI 10.4161/adip.19036; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Jia GH, 2015, HYPERTENSION, V65, P531, DOI 10.1161/HYPERTENSIONAHA.114.04737; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kayama Y, 2015, INT J MOL SCI, V16, P25234, DOI 10.3390/ijms161025234; Kotas ME, 2013, P NATL ACAD SCI USA, V110, P4810, DOI 10.1073/pnas.1301996110; Luo BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104771; Marchetti C, 2015, J CARDIOVASC PHARM, V66, P1, DOI 10.1097/FJC.0000000000000247; Matyas C, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0309-x; Mehta T, 2015, AM J HYPERTENS, V28, P877, DOI 10.1093/ajh/hpu253; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mori MA, 2011, CIRC RES, V108, P1160, DOI 10.1161/RES.0b013e318220b57b; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3; Patel MN, 2015, P NATL ACAD SCI USA, V112, P506, DOI 10.1073/pnas.1414536112; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Potter VJV, 2012, ENDOCRINOLOGY, V153, P4266, DOI 10.1210/en.2011-2006; Reaven GM, 2011, MED CLIN N AM, V95, P875, DOI 10.1016/j.mcna.2011.06.002; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vieira-Potter VJ, 2015, EXERC SPORT SCI REV, V43, P172, DOI 10.1249/JES.0000000000000046; Vieira-Potter VJ, 2015, AM J PHYSIOL-REG I, V308, pR530, DOI 10.1152/ajpregu.00401.2014; Vieira-Potter VJ, 2014, CELL MICROBIOL, V16, P1484, DOI 10.1111/cmi.12336; Vlachopoulos C, 2010, AM J HYPERTENS, V23, P1183, DOI 10.1038/ajh.2010.144; Wainright KS, 2015, AM J PHYSIOL-REG I, V309, pR594, DOI 10.1152/ajpregu.00042.2015; Youm YH, 2013, CELL METAB, V18, P519, DOI 10.1016/j.cmet.2013.09.010	44	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161939	10.1371/journal.pone.0161939	http://dx.doi.org/10.1371/journal.pone.0161939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583382	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600075
J	Tan, J; Cheong, SA				Tan, James; Cheong, Siew Ann			The Regime Shift Associated with the 2004-2008 US Housing Market Bubble	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; SUBPRIME; SECURITIZATION; DEREGULATION; RISK	The Subprime Bubble preceding the Subprime Crisis of 2008 was fueled by risky lending practices, manifesting in the form of a large abrupt increase in the proportion of subprime mortgages issued in the US. This event also coincided with critical slowing down signals associated with instability, which served as evidence of a regime shift or phase transition in the US housing market. Here, we show that the US housing market underwent a regime shift between alternate stable states consistent with the observed critical slowing down signals. We modeled this regime shift on a universal transition path and validated the model by estimating when the bubble burst. Additionally, this model reveals loose monetary policy to be a plausible cause of the phase transition, implying that the bubble might have been deflatable by a timely tightening of monetary policy.	[Tan, James] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore, Singapore; [Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore, Singapore; [Tan, James; Cheong, Siew Ann] Nanyang Technol Univ, Complex Inst, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, J (corresponding author), Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore, Singapore.; Tan, J (corresponding author), Nanyang Technol Univ, Complex Inst, Singapore, Singapore.	tanp0100@e.ntu.edu.sg	Cheong, Siew Ann/B-6991-2011	Cheong, Siew Ann/0000-0002-8589-6699				Bostic RW, 2008, AM ECON REV, V98, P310, DOI 10.1257/aer.98.2.310; Boulton CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6752; Brunnermeier MK, 2009, J ECON PERSPECT, V23, P77, DOI 10.1257/jep.23.1.77; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Dell'Ariccia G, 2012, J MONEY CREDIT BANK, V44, P367, DOI 10.1111/j.1538-4616.2011.00491.x; Demyanyk Y, 2011, REV FINANC STUD, V24, P1848, DOI 10.1093/rfs/hhp033; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Immergluck D, 2009, CITY COMMUNITY, V8, P341, DOI 10.1111/j.1540-6040.2009.01292_1.x; Ioannidou V, 2015, REV FINANC, V19, P95, DOI 10.1093/rof/rfu035; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Keys BJ, 2010, Q J ECON, V125, P307, DOI 10.1162/qjec.2010.125.1.307; Krkosek M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3221; Maddaloni A, 2011, REV FINANC STUD, V24, P2121, DOI 10.1093/rfs/hhr015; Matsuyama K, 2007, AM ECON REV, V97, P503, DOI 10.1257/aer.97.1.503; Meisel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030371; Meng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03655; Mian A, 2009, Q J ECON, V124, P1449, DOI 10.1162/qjec.2009.124.4.1449; Mishkin FS, 2011, J ECON PERSPECT, V25, P49, DOI 10.1257/jep.25.1.49; Ohnishi Takaaki, 2012, International Journal of Modern Physics: Conference Series, V16, P61, DOI 10.1142/S2010194512007787; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Tan JPL, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-41038-1; van de Leemput IA, 2014, P NATL ACAD SCI USA, V111, P87, DOI 10.1073/pnas.1312114110; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Wachter SusanM., 2009, CONN LAW REV, V41, P493; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Wray R.L., 2008, CHALLENGE, V51, P40, DOI DOI 10.2753/0577-; Xu YL, 2014, REG SCI URBAN ECON, V46, P126, DOI 10.1016/j.regsciurbeco.2014.03.003; Zhou WX, 2006, PHYSICA A, V361, P297, DOI 10.1016/j.physa.2005.06.098	29	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162140	10.1371/journal.pone.0162140	http://dx.doi.org/10.1371/journal.pone.0162140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583633	gold, Green Published			2022-12-27	WOS:000382855600111
J	Varas, C; Ravit, M; Mimoun, C; Panel, P; Huchon, C; Fauconnier, A				Varas, Catalina; Ravit, Marion; Mimoun, Camille; Panel, Pierre; Huchon, Cyrille; Fauconnier, Arnaud			Optimal Combination of Non-Invasive Tools for the Early Detection of Potentially Life-Threatening Emergencies in Gynecology	PLOS ONE			English	Article							SUSPECTED ECTOPIC PREGNANCY; PELVIC-INFLAMMATORY-DISEASE; CLINICAL-PREDICTION MODEL; PHYSICAL-EXAMINATION; TRANSVAGINAL ULTRASONOGRAPHY; ADNEXAL TORSION; TUBAL RUPTURE; SHOCK INDEX; OF-CARE; DIAGNOSIS	Objectives Potentially life-threatening gynecological emergencies (G-PLEs) are acute pelvic conditions that may spontaneously evolve into a life-threatening situation, or those for which there is a risk of sequelae or death in the absence of prompt diagnosis and treatment. The objective of this study was to identify the best combination of non-invasive diagnostic tools to ensure an accurate diagnosis and timely response when faced with G-PLEs for patients arriving with acute pelvic pain at the Gynecological Emergency Department (ED). Methods The data on non-invasive diagnostic tools were sourced from the records of patients presenting at the ED of two hospitals in the Parisian suburbs (France) with acute pelvic pain between September 2006 and April 2008. The medical history of the patients was obtained through a standardized questionnaire completed for a prospective observational study, and missing information was completed with data sourced from the medical forms. Diagnostic tool categories were predefined as a collection of signs or symptoms. We analyzed the association of each sign/symptom with G-PLEs using Pearson's Chi-Square or Fischer's exact tests. Symptoms and signs associated with G-PLEs (p-value < 0.20) were subjected to logistic regression to evaluate the diagnostic value of each of the predefined diagnostic tools and in various combinations. Results The data of 365 patients with acute pelvic pain were analyzed, of whom 103 were confirmed to have a PLE. We analyzed five diagnostic tools by logistic regression: Triage Process, History-Taking, Physical Examination, Ultrasonography, and Biological Exams. The combination of History-Taking and Ultrasonography had a C-index of 0.83, the highest for a model combining two tools. Conclusions The use of a standardized self-assessment questionnaire for history-taking and focal ultrasound examination were found to be the most successful tool combination for the diagnosis of gynecological emergencies in a Gynecological ED. Additional tools, such as physical examination, do not add substantial diagnostic value.	[Varas, Catalina; Ravit, Marion; Mimoun, Camille; Huchon, Cyrille; Fauconnier, Arnaud] Versailles St Quentin Univ UVSQ, EA Res Unit Risk & Safety Clin Med Women & Perina, Montigny Le Bretonneux, France; [Varas, Catalina; Mimoun, Camille; Huchon, Cyrille; Fauconnier, Arnaud] Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Gynecol & Obstet, Poissy, France; [Panel, Pierre] Mignot Hosp, Dept Gynecol & Obstet, Le Chesnay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles	Fauconnier, A (corresponding author), Versailles St Quentin Univ UVSQ, EA Res Unit Risk & Safety Clin Med Women & Perina, Montigny Le Bretonneux, France.; Fauconnier, A (corresponding author), Intercommunal Hosp Ctr Poissy St Germain En Laye, Dept Gynecol & Obstet, Poissy, France.	afauconnier@chi-poissy-st-germain.fr			Woman's Health Research Institute (France)	Woman's Health Research Institute (France)	CV received a research grant from the Woman's Health Research Institute (France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1990, AM J EMERG MED, V8, P515, DOI 10.1016/0735-6757(90)90154-R; Adhikari S, 2007, AM J EMERG MED, V25, P591, DOI 10.1016/j.ajem.2006.11.020; Adhikari S, 2013, J EMERG MED, V44, P194, DOI 10.1016/j.jemermed.2012.05.008; ANKUM WM, 1993, HUM REPROD, V8, P1307, DOI 10.1093/oxfordjournals.humrep.a138247; Barnhart KT, 2009, NEW ENGL J MED, V361, P379, DOI 10.1056/NEJMcp0810384; Bignardi T, 2010, ULTRASOUND OBST GYN, V35, P344, DOI 10.1002/uog.7523; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Birkhahn RH, 2002, ACAD EMERG MED, V9, P115, DOI 10.1197/aemj.9.2.115; Bouquier J, 2014, SEX TRANSM DIS, V41, P525, DOI 10.1097/OLQ.0000000000000169; Buckley RG, 1998, ACAD EMERG MED, V5, P951, DOI 10.1111/j.1553-2712.1998.tb02770.x; Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Cohen J., 2003, APPL MULTIPLE REGRES; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Eschenbach DA, 1997, OBSTET GYNECOL, V89, P184, DOI 10.1016/S0029-7844(96)00429-2; Eskelinen M, 1998, EUR UROL, V34, P467, DOI 10.1159/000019785; Fauconnier Arnaud, 2007, World J Emerg Surg, V2, P23; Haider Z, 2006, ULTRASOUND OBST GYN, V28, P207, DOI 10.1002/uog.2801; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HIRATA AJ, 1991, SOUTHERN MED J, V84, P1467, DOI 10.1097/00007611-199112000-00014; Huchon C, 2012, ACAD EMERG MED; Huchon C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-46; Huchon C, 2012, HUM REPROD, V27, P2359, DOI 10.1093/humrep/des186; Huchon C, 2010, HUM REPROD, V25, P2276, DOI 10.1093/humrep/deq173; KAHN JG, 1991, JAMA-J AM MED ASSOC, V266, P2594, DOI 10.1001/jama.266.18.2594; Kontoravdis A, 1996, INT J GYNECOL OBSTET, V52, P243, DOI 10.1016/0020-7292(95)02611-8; McWilliams GDE, 2008, SURG CLIN N AM, V88, P265, DOI 10.1016/j.suc.2007.12.007; Mignini L, 2007, INTERVENTIONS TUBAL; Miller TD, 2002, AM J MED, V112, P290, DOI 10.1016/S0002-9343(01)01111-1; Mol BWJ, 1999, FERTIL STERIL, V71, P167, DOI 10.1016/S0015-0282(98)00418-X; Moore C, 2007, ACAD EMERG MED, V14, P755, DOI 10.1197/j.aem.2007.04.010; Polena V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114189; Popowski T, 2015, J ULTRAS MED, V34, P829, DOI 10.7863/ultra.34.5.829; Popowski T, 2012, INT J GYNECOL OBSTET, V116, P97, DOI 10.1016/j.ijgo.2011.09.019; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; van Mello NM, 2012, FERTIL STERIL, V97, P623, DOI 10.1016/j.fertnstert.2011.12.021; Walker J W, 1987, Emerg Med Clin North Am, V5, P425; Workowski KA., 2010, SEXUALLY TRANSMITTED	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162301	10.1371/journal.pone.0162301	http://dx.doi.org/10.1371/journal.pone.0162301			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583697	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600127
J	Rogerson, T; Jayaprakash, B; Cai, DJ; Sano, Y; Lee, YS; Zhou, Y; Bekal, P; Deisseroth, K; Silva, AJ				Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Deisseroth, Karl; Silva, Alcino J.			Molecular and Cellular Mechanisms for Trapping and Activating Emotional Memories	PLOS ONE			English	Article							FEAR MEMORY; LATERAL AMYGDALA; NEURAL CIRCUITS; NEURONS; ALLOCATION; ENGRAM; EXCITABILITY; EXPRESSION; CONTRIBUTE; BEHAVIOR	Recent findings suggest that memory allocation to specific neurons (i.e., neuronal allocation) in the amygdala is not random, but rather the transcription factor cAMP-response element binding protein (CREB) modulates this process, perhaps by regulating the transcription of channels that control neuronal excitability. Here, optogenetic studies in the mouse lateral amygdala (LA) were used to demonstrate that CREB and neuronal excitability regulate which neurons encode an emotional memory. To test the role of CREB in memory allocation, we overexpressed CREB in the lateral amygdala to recruit the encoding of an auditory-fear conditioning (AFC) memory to a subset of neurons. Then, post-training activation of these neurons with Channelrhodopsin-2 was sufficient to trigger recall of the memory for AFC, suggesting that CREB regulates memory allocation. To test the role of neuronal excitability in memory allocation, we used a step function opsin (SFO) to transiently increase neuronal excitability in a subset of LA neurons during AFC. Post-training activation of these neurons with Volvox Channelrhodopsin-1 was able to trigger recall of that memory. Importantly, our studies show that activation of the SFO did not affect AFC by either increasing anxiety or by strengthening the unconditioned stimulus. Our findings strongly support the hypothesis that CREB regulates memory allocation by modulating neuronal excitability.	[Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA USA; [Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Integrat Ctr Learning & Memory, Dept Psychol, Los Angeles, CA USA; [Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Integrat Ctr Learning & Memory, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Rogerson, Thomas; Jayaprakash, Balaji; Cai, Denise J.; Sano, Yoshitake; Lee, Yong-Seok; Zhou, Yu; Bekal, Pallavi; Silva, Alcino J.] Brain Res Inst, Los Angeles, CA USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Neurosci Program,Dept Bioengn Psychiat & Behav Sc, Stanford, CA 94305 USA; [Rogerson, Thomas] Stanford Univ, Dept Biol, CNC Program, Stanford, CA 94305 USA; [Jayaprakash, Balaji] Indian Inst Sci, Ctr Neurosci, Bangalore, Karnataka, India; [Sano, Yoshitake] Toyama Univ, Grad Sch Med, Toyama, Japan; [Lee, Yong-Seok] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Zhou, Yu] Qingdao Univ, Coll Med, Dept Physiol, Qingdao, Shandong, Peoples R China	Howard Hughes Medical Institute; Stanford University; Stanford University; Indian Institute of Science (IISC) - Bangalore; University of Toyama; Seoul National University (SNU); Qingdao University	Silva, AJ (corresponding author), Integrat Ctr Learning & Memory, Dept Neurobiol, Los Angeles, CA USA.	silvaa@mednet.ucla.edu	Cai, Denise J/N-7229-2017; Silva, Alcino/ABD-7684-2021	Cai, Denise J/0000-0002-7729-0523; Silva, Alcino/0000-0002-1587-4558; Sano, Yoshitake/0000-0001-5188-3104	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation [1T32NS058280, 1F31MH092057-01]; Graduate Division Dissertation Year Fellowship; NIH-NCRR shared resources grant [CJX1-443835-WS-29646]; NSF Major Research Instrumentation grant [CHE-0722519];  [P50 MH077972];  [R37 AG013622];  [JCCC/P30CA016042];  [CURE/P30 DK041301]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084315] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Graduate Division Dissertation Year Fellowship; NIH-NCRR shared resources grant; NSF Major Research Instrumentation grant; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This was supported by grants P50 MH077972, R37 AG013622, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to AJS and grants 1T32NS058280, 1F31MH092057-01 and the 2012-13 Graduate Division Dissertation Year Fellowship to TR. Confocal laser scanning microscopy was performed at the CNSI Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding from NIH-NCRR shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). Viral packaging was performed by the UCLA Vectorcore, supported with funding from JCCC/P30CA016042 and CURE/P30 DK041301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cai DJ, 2016, NATURE IN PRESS; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kim J, 2014, NAT NEUROSCI, V17, P65, DOI 10.1038/nn.3592; Kwon JT, 2014, LEARN MEMORY, V21, P627, DOI 10.1101/lm.035816.114; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Pavlov I.P., 1927, CONDITIONED REFLEXES; Paxinos G, 2004, THE MOUSE BRAIN IN S; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Ramirez S, 2015, NATURE, V522, P335, DOI 10.1038/nature14514; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogerson T, 2014, NAT REV NEUROSCI, V15, P157, DOI 10.1038/nrn3667; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017; Yaguchi M, 2013, HUM GENE THER METHOD, V24, P333, DOI 10.1089/hgtb.2012.238; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhou Y, 2009, NAT NEUROSCI	40	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161655	10.1371/journal.pone.0161655	http://dx.doi.org/10.1371/journal.pone.0161655			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579481	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400034
J	Sistla, SA; Roddy, AB; Williams, NE; Kramer, DB; Stevens, K; Allison, SD				Sistla, Seeta A.; Roddy, Adam B.; Williams, Nicholas E.; Kramer, Daniel B.; Stevens, Kara; Allison, Steven D.			Agroforestry Practices Promote Biodiversity and Natural Resource Diversity in Atlantic Nicaragua	PLOS ONE			English	Article							SOIL CARBON SEQUESTRATION; LAND-USE CHANGE; PHYLOGENETIC DIVERSITY; FUNCTIONAL DIVERSITY; FOREST MANAGEMENT; TROPICAL FORESTS; CONSERVATION; PASTURE; CLIMATE; AGRICULTURE	Tropical forest conversion to pasture, which drives greenhouse gas emissions, soil degradation, and biodiversity loss, remains a pressing socio-ecological challenge. This problem has spurred increased interest in the potential of small-scale agroforestry systems to couple sustainable agriculture with biodiversity conservation, particularly in rapidly developing areas of the tropics. In addition to providing natural resources (i.e. food, medicine, lumber), agroforestry systems have the potential to maintain higher levels of biodiversity and greater biomass than lower diversity crop or pasture systems. Greater plant diversity may also enhance soil quality, further supporting agricultural productivity in nutrient-limited tropical systems. Yet, the nature of these relationships remains equivocal. To better understand how different land use strategies impact ecosystem services, we characterized the relationships between plant diversity (including species richness, phylogenetic diversity, and natural resource diversity), and soil quality within pasture, agroforests, and secondary forests, three common land use types maintained by small-scale farmers in the Pearl Lagoon Basin, Nicaragua. The area is undergoing accelerated globalization following the 2007 completion of the region's first major road; a change which is expected to increase forest conversion for agriculture. However, farmer agrobiodiversity maintenance in the Basin was previously found to be positively correlated with affiliation to local agricultural NGOs through the maintenance of agroforestry systems, despite these farmers residing in the communities closest to the new road, highlighting the potential for maintaining diverse agroforestry agricultural strategies despite heightened globalization pressures. We found that agroforestry sites tended to have higher surface soil % C, % N, and pH relative to neighboring to secondary forest, while maintaining comparable plant diversity. In contrast, pasture reduced species richness, phylogenetic diversity, and natural resource diversity. No significant relationships were found between plant diversity and the soil properties assessed; however higher species richness and phylodiversity was positively correlated with natural resource diversity. These finding suggest that small, diversified agroforestry systems may be a viable strategy for promoting both social and ecological functions in eastern Nicaragua and other rapidly developing areas of the tropics.	[Sistla, Seeta A.] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA; [Sistla, Seeta A.; Allison, Steven D.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Roddy, Adam B.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Williams, Nicholas E.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Williams, Nicholas E.] Univ Colorado, Dept Environm Studies, Boulder, CO USA; [Kramer, Daniel B.; Stevens, Kara] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Allison, Steven D.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; Yale University; University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder; Michigan State University; University of California System; University of California Irvine	Sistla, SA (corresponding author), Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA.; Sistla, SA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	ssistla@hampshire.edu	Roddy, Adam/M-4523-2013; Allison, Steven D./E-2978-2010	Roddy, Adam/0000-0002-4423-8729; Allison, Steven D./0000-0003-4629-7842	U.S. National Socio-Environmental Synthesis Center (SESYNC); Helmholtz Centre for Environmental Research (UFZ); German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group; National Oceanic and Atmospheric Agency Climate and Global Change Postdoctoral Fellowship; NOAA Climate and Global Change Postdoctoral Fellowship; Direct For Biological Sciences [1639145] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	U.S. National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Helmholtz Centre for Environmental Research (UFZ)(Helmholtz Association); German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group; National Oceanic and Atmospheric Agency Climate and Global Change Postdoctoral Fellowship; NOAA Climate and Global Change Postdoctoral Fellowship(National Oceanic Atmospheric Admin (NOAA) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U.S. National Socio-Environmental Synthesis Center (SESYNC), the Helmholtz Centre for Environmental Research (UFZ), and the German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group. SS was supported by the National Oceanic and Atmospheric Agency Climate and Global Change Postdoctoral Fellowship Program, administered by the University Corporation for Atmospheric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Vanny Brown for expert field assistance, the Foundation for the Autonomy and Development of the Atlantic Coast of Nicaragua (FADCANIC) for field support, Inigo Granzo de la Cerda for help with plant identification, and Anna Schurkmann for GIS support. This work was supported by the U.S. National Socio-Environmental Synthesis Center (SESYNC), the Helmholtz Centre for Environmental Research (UFZ), and the German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group. SS was supported by the NOAA Climate and Global Change Postdoctoral Fellowship Program, administered by the University Corporation for Atmospheric Research.	Albrecht A, 2003, AGR ECOSYST ENVIRON, V99, P15, DOI 10.1016/S0167-8809(03)00138-5; Alfaia SS, 2004, AGR ECOSYST ENVIRON, V102, P409, DOI 10.1016/j.agee.2003.08.011; BARRETT B, 1994, ECON BOT, V48, P8, DOI 10.1007/BF02901375; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; BOUCHER DH, 1990, ECOLOGY, V71, P2022, DOI 10.2307/1937611; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Cadotte MW, 2015, FUNCT ECOL, V29, P718, DOI 10.1111/1365-2435.12429; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Coe FG, 2008, J ETHNOPHARMACOL, V117, P136, DOI 10.1016/j.jep.2008.01.027; Coe Felix G., 1997, Journal of Ethnobiology, V17, P171; Coe FG, 1996, ECON BOT, V50, P71, DOI 10.1007/BF02862114; Coe FG, 2005, J ETHNOPHARMACOL, V96, P303, DOI 10.1016/j.jep.2004.09.026; Coe FG, 1999, ECON BOT, V53, P363, DOI 10.1007/BF02866715; DENNIS PA, 1988, ECON BOT, V42, P16, DOI 10.1007/BF02859024; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garcia-Oliva F, 2004, CLIMATIC CHANGE, V65, P347, DOI 10.1023/B:CLIM.0000038211.84327.d9; Giardina CP, 2000, SOIL SCI SOC AM J, V64, P399, DOI 10.2136/sssaj2000.641399x; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; JOHNSON DW, 1992, WATER AIR SOIL POLL, V64, P83, DOI 10.1007/BF00477097; Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kirby KR, 2007, FOREST ECOL MANAG, V246, P208, DOI 10.1016/j.foreco.2007.03.072; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; Mayfield MM, 2005, ECOL APPL, V15, P423, DOI 10.1890/03-5369; McCloskey TA, 2012, QUATERNARY RES, V78, P454, DOI 10.1016/j.yqres.2012.07.003; McNeely JA, 2006, BIODIVERS CONSERV, V15, P549, DOI 10.1007/s10531-005-2087-3; Milcu A, 2013, ECOLOGY, V94, P1878, DOI 10.1890/12-1936.1; Montagnini F, 2004, AGROFOREST SYST, V61-2, P281, DOI 10.1023/B:AGFO.0000029005.92691.79; Nair PKR, 2009, ENVIRON SCI POLICY, V12, P1099, DOI 10.1016/j.envsci.2009.01.010; Norris K, 2008, CONSERV LETT, V1, P2, DOI 10.1111/j.1755-263X.2008.00007.x; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; R Core Team, 2021, R LANGUAGE ENV STAT; REINERS WA, 1994, ECOL APPL, V4, P363, DOI 10.2307/1941940; Scales BR, 2008, ENVIRON CONSERV, V35, P160, DOI 10.1017/S0376892908004840; Schelhas J, 2009, CONSERV LETT, V2, P278, DOI 10.1111/j.1755-263X.2009.00079.x; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Stevens K, 2011, BIODIVERS CONSERV, V20, P2597, DOI 10.1007/s10531-011-0093-1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Townsend AR, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000650; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Williams NE, 2016, J POLIT ECOL, V23, P223, DOI 10.2458/v23i1.20210; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Zimmerer KS, 2015, RESILIENCE, V3, P183, DOI 10.1080/21693293.2015.1072311	65	23	23	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162529	10.1371/journal.pone.0162529	http://dx.doi.org/10.1371/journal.pone.0162529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606619	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255600058
J	Whitfield, CA; Hawkins, RJ				Whitfield, Carl A.; Hawkins, Rhoda J.			Immersed Boundary Simulations of Active Fluid Droplets	PLOS ONE			English	Article							INTERFACIAL FLOWS; CONTRACTILITY; DEFORMATION; SURFACTANTS; DYNAMICS; CORTEX; GELS	We present numerical simulations of active fluid droplets immersed in an external fluid in 2-dimensions using an Immersed Boundary method to simulate the fluid droplet interface as a Lagrangian mesh. We present results from two example systems, firstly an active isotropic fluid boundary consisting of particles that can bind and unbind from the interface and generate surface tension gradients through active contractility. Secondly, a droplet filled with an active polar fluid with homeotropic anchoring at the droplet interface. These two systems demonstrate spontaneous symmetry breaking and steady state dynamics resembling cell motility and division and show complex feedback mechanisms with minimal degrees of freedom. The simulations outlined here will be useful for quantifying the wide range of dynamics observable in these active systems and modelling the effects of confinement in a consistent and adaptable way.	[Whitfield, Carl A.; Hawkins, Rhoda J.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Whitfield, Carl A.] Univ Warwick, Dept Phys, Coventry CV3 7AL, W Midlands, England	University of Sheffield; University of Warwick	Whitfield, CA (corresponding author), Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England.; Whitfield, CA (corresponding author), Univ Warwick, Dept Phys, Coventry CV3 7AL, W Midlands, England.	carl.whitfield@physics.org	Whitfield, Carl/J-5751-2019; Hawkins, Rhoda/G-5053-2011	Whitfield, Carl/0000-0001-5913-735X; Hawkins, Rhoda/0000-0002-9027-7622	EPSRC [EP-K503149-1]; Engineering and Physical Sciences Research Council [1294939] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC https://www.epsrc.ac.uk, grant no. EP-K503149-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the EPSRC for funding this work, grant reference EP-K503149-1. We also thank Suzanne Fielding for useful discussion and insight, and Davide Marenduzzo and Elsen Tjhung for sharing the simulation source code used in [14].	[Anonymous], NAG LIB; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Chen KY, 2014, J COMPUT PHYS, V257, P1, DOI 10.1016/j.jcp.2013.10.003; Conn JJA, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.043121; De Gennes P.-G., 1993, PHYS LIQUID CRYSTALS; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Furthauer S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023001; GINZBURG VL, 1958, SOV PHYS JETP-USSR, V7, P78; Giomi L, 2012, NONLINEARITY, V25, P2245, DOI 10.1088/0951-7715/25/8/2245; Giomi L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.147802; Giomi L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228101; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Herminghaus S, 2014, SOFT MATTER, V10, P7008, DOI 10.1039/c4sm00550c; James AJ, 2004, J COMPUT PHYS, V201, P685, DOI 10.1016/j.jcp.2004.06.013; Joanny JF, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13052-9; Joanny JF, 2009, HFSP J, V3, P94, DOI 10.2976/1.3054712; Keber FC, 2014, SCIENCE, V345, P1135, DOI 10.1126/science.1254784; Khoromskaia D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062311; Kruse K, 2006, PHYS BIOL, V3, P130, DOI 10.1088/1478-3975/3/2/005; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lai MC, 2008, J COMPUT PHYS, V227, P7279, DOI 10.1016/j.jcp.2008.04.014; Lee J, 2006, COMPUT FLUIDS, V35, P43, DOI 10.1016/j.compfluid.2004.11.004; LEVEQUE RJ, 1994, SIAM J NUMER ANAL, V31, P1019, DOI 10.1137/0731054; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Masoud H, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.128304; Pawar Y, 1996, PHYS FLUIDS, V8, P1738, DOI 10.1063/1.868958; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; PESKIN CS, 1982, ANNU REV FLUID MECH, V14, P235, DOI 10.1146/annurev.fl.14.010182.001315; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Teigen KE, 2009, COMMUN MATH SCI, V7, P1009; Tjhung E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6420; Tjhung E, 2012, P NATL ACAD SCI USA, V109, P12381, DOI 10.1073/pnas.1200843109; Tjhung E, 2011, SOFT MATTER, V7, P7453, DOI 10.1039/c1sm05396e; Tsai FC, 2011, LANGMUIR, V27, P10061, DOI 10.1021/la201604z; UNVERDI SO, 1992, J COMPUT PHYS, V100, P25, DOI 10.1016/0021-9991(92)90307-K; Vladescu ID, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.268101; Whitfield CA, 2016, 1605018642016 ARXIV; Whitfield CA, 2015, THESIS; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; Xu JJ, 2014, COMMUN COMPUT PHYS, V15, P451, DOI 10.4208/cicp.241012.310513a; Yon S, 1998, COMPUT FLUIDS, V27, P879, DOI 10.1016/S0045-7930(98)00013-9; Yue PT, 2004, J FLUID MECH, V515, P293, DOI 10.1017/S0022112004000370; Ziebert F, 2012, J R SOC INTERFACE, V9, P1084, DOI 10.1098/rsif.2011.0433; Zumdieck A, 2005, PHYS REV LETT, V95, DOI [10.1103/PhysRevLett.95.258103, 10.1103/PhysREvLett.95.258103]	48	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162474	10.1371/journal.pone.0162474	http://dx.doi.org/10.1371/journal.pone.0162474			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606609	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000383255600048
J	Magnan, C; Yu, J; Chang, I; Jahn, E; Kanomata, Y; Wu, J; Zeller, M; Oakes, M; Baldi, P; Sandmeyer, S				Magnan, Christophe; Yu, James; Chang, Ivan; Jahn, Ethan; Kanomata, Yuzo; Wu, Jenny; Zeller, Michael; Oakes, Melanie; Baldi, Pierre; Sandmeyer, Suzanne			Sequence Assembly of Yarrowia lipolytica Strain W29/CLIB89 Shows Transposable Element Diversity	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; MUTATOR-LIKE ELEMENT; HEMIASCOMYCETOUS YEASTS; GENOMIC EXPLORATION; DIMORPHIC YEAST; RETROTRANSPOSON; EVOLUTION; EXPRESSION; PREDICTION; HOMOLOGY	Yarrowia lipolytica, an oleaginous yeast, is capable of accumulating significant cellular mass in lipid making it an important source of biosustainable hydrocarbon-based chemicals. In spite of a similar number of protein-coding genes to that in other Hemiascomycetes, the Y. lipolytica genome is almost double that of model yeasts. Despite its economic importance and several distinct strains in common use, an independent genome assembly exists for only one strain. We report here a de novo annotated assembly of the chromosomal genome of an industrially-relevant strain, W29/CLIB89, determined by hybrid next-generation sequencing. For the first time, each Y. lipolytica chromosome is represented by a single contig. The telomeric rDNA repeats were localized by Irys long-range genome mapping and one complete copy of the rDNA sequence is reported. Two large structural variants and retroelement differences with reference strain CLIB122 including a full-length, novel Ty3/Gypsy long terminal repeat (LTR) retrotransposon and multiple LTR-like sequences are described. Strikingly, several of these are adjacent to RNA polymerase III-transcribed genes, which are almost double in number in Y. lipolytica compared to other Hemiascomycetes. In addition to previously-reported dimeric RNA polymerase III-transcribed genes, tRNA pseudogenes were identified. Multiple full-length and truncated LINE elements are also present. Therefore, although identified transposons do not constitute a significant fraction of the Y. lipolytica genome, they could have played an active role in its evolution. Differences between the sequence of this strain and of the existing reference strain underscore the utility of an additional independent genome assembly for this economically important organism.	[Magnan, Christophe; Kanomata, Yuzo; Zeller, Michael; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Sch Comp Sci, Irvine, CA USA; [Magnan, Christophe; Kanomata, Yuzo; Baldi, Pierre; Sandmeyer, Suzanne] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Yu, James; Chang, Ivan; Jahn, Ethan; Wu, Jenny; Oakes, Melanie; Baldi, Pierre; Sandmeyer, Suzanne] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Jahn, Ethan] Rice Univ, Houston, TX USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Rice University	Sandmeyer, S (corresponding author), Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA.; Sandmeyer, S (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	sbsandme@uci.edu			National Science Foundation through the Engineering Research Center for Biorenewable Chemicals, CBiRC [EEC-0813570]; National Institutes of Health [LM010235]; NIH-National Library of Medicine [07443]; NSF [IIS-1321053]; Genomic High Throughput Facility Shared Resource of the National Cancer Institute Cancer Center Support Grant at the University of California, Irvine [CA-62203]; NIH [1S10RR025496-01, 1S10OD010794-01]	National Science Foundation through the Engineering Research Center for Biorenewable Chemicals, CBiRC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NSF(National Science Foundation (NSF)); Genomic High Throughput Facility Shared Resource of the National Cancer Institute Cancer Center Support Grant at the University of California, Irvine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Science Foundation (Grant no. EEC-0813570, B.Shanks, PI; subcontract SS) through the Engineering Research Center for Biorenewable Chemicals, CBiRC), and National Institutes of Health LM010235, NIH-National Library of Medicine 07443, and NSF IIS-1321053 to PB. This work was made possible, in part, through access to the Genomic High Throughput Facility Shared Resource of the National Cancer Institute Cancer Center Support Grant (CA-62203, R. Van Etten, PI) at the University of California, Irvine and NIH shared instrumentation grants 1S10RR025496-01 and 1S10OD010794-01 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J, 2008, NUCLEIC ACIDS RES, V36, P5832, DOI 10.1093/nar/gkn549; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Barth G, 1996, NONCONVENTIONAL YEAS, P313, DOI [DOI 10.1007/978-3-642-79856-6_10, 10.1007/978-3-642-79856-6_10]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Beopoulos A, 2014, APPL MICROBIOL BIOT, V98, P251, DOI 10.1007/s00253-013-5295-x; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Burge CB, 1998, N COMP BIOC, V32, P129; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Casaregola S, 1997, CHROMOSOMA, V106, P380, DOI 10.1007/s004120050259; Casaregola S, 2002, MOL BIOL EVOL, V19, P664, DOI 10.1093/oxfordjournals.molbev.a004125; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Casaregola S, 2013, TRANSPOSABLE ELEMENT; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; CLARE JJ, 1986, CURR GENET, V10, P449, DOI 10.1007/BF00419872; Craig NL, 2015, MOBILE DNA 3, P3, DOI [10.1128/9781555819217.ch1, DOI 10.1128/MICROBIOLSPEC.MDNA3-0062-2014Z]; Curcio MJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0053-2014; DABOUSSI MJ, 1992, MOL GEN GENET, V232, P12, DOI 10.1007/BF00299131; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Durrens P, 2005, YEAST, V22, P337, DOI 10.1002/yea.1214; Duvick J, 2016, PLANT CELL, V28, P840, DOI 10.1105/tpc.15.00933; Forbes EM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-94; Gabus C, 1998, EMBO J, V17, P4873, DOI 10.1093/emboj/17.16.4873; Gaillardin C, 2013, COMP GENOMICS YARROW; Gaillardin C, 2012, FEMS YEAST RES, V12, P317, DOI 10.1111/j.1567-1364.2011.00782.x; Goodwin TJD, 2001, CURR GENET, V39, P83, DOI 10.1007/s002940000181; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; Holton NJ, 2001, NUCLEIC ACIDS RES, V29, P4014, DOI 10.1093/nar/29.19.4014; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079288; Kerkhoven EJ, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.5; Kerscher S, 2001, COMPAR FUNCT GENOM, V2, P80, DOI 10.1002/cfg.72; Kovalchuk A, 2005, YEAST, V22, P979, DOI 10.1002/yea.1287; Kramerov DA, 2011, HEREDITY, V107, P487, DOI 10.1038/hdy.2011.43; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang F, RNAWEASEL MFANNOT PR; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Liu LQ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00652-14; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Neuveglise C, 2005, EUKARYOT CELL, V4, P615, DOI 10.1128/EC.4.3.615-624.2005; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; Neuveglise C, 2013, NONCODING RNA GENES; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; NICAUD JM, 1989, CURR GENET, V16, P253, DOI 10.1007/BF00422111; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Pomraning KR, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01211-15; Pomraning KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123188; Proux-Wera E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-237; Reid I, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-229; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; SANDMEYER S, 2015, MICROBIOL SPECTR, V3, DOI DOI 10.1128/MICROBILSPEC.MDNA3-0057-2014; SCHMIDBERGER N, 1994, J BACTERIOL, V176, P2477, DOI 10.1128/JB.176.9.2477-2482.1994; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Standage DS, 2010, AEGEAN INT TOOLK AN; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sun J, 2015, J IND MICROBIOL BIOT, V42, P423, DOI 10.1007/s10295-014-1539-8; Symer DE, 2010, RETROVIRUSES: MOLECULAR BIOLOGY, GENOMICS AND PATHOGENESIS, P1; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANHEERIKHUIZEN H, 1985, GENE, V39, P213, DOI 10.1016/0378-1119(85)90315-4; Vassetzky NS, 2013, NUCLEIC ACIDS RES, V41, pD83, DOI 10.1093/nar/gks1263; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; WEBER H, 1989, YEAST, V5, P279; Wolf K., 1996, NONCONVENTIONAL YEAS; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu Q, 2015, CURR OPIN BIOTECH, V36, P65, DOI 10.1016/j.copbio.2015.08.010	79	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162363	10.1371/journal.pone.0162363	http://dx.doi.org/10.1371/journal.pone.0162363			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603307	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200062
J	Wang, JB; Lin, NT; Tseng, YH; Weng, SF				Wang, Jian-Bin; Lin, Nien-Tsung; Tseng, Yi-Hsiung; Weng, Shu-Fen			Genomic Characterization of the Novel Aeromonas hydrophila Phage Ahp1 Suggests the Derivation of a New Subgroup from phiKMV-Like Family	PLOS ONE			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; CONTAINING BACTERIAL-VIRUS; SOLUBLE LYTIC TRANSGLYCOSYLASE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA-POLYMERASE; GENE; INFECTIONS	Aeromonas hydrophila is an opportunistic pathogenic bacterium causing diseases in human and fish. The emergence of multidrug-resistant A. hydrophila isolates has been increasing in recent years. In this study, we have isolated a novel virulent podophage of A. hydrophila, designated as Ahp1, from waste water. Ahp1 has a rapid adsorption (96% adsorbed in 2 min), a latent period of 15 min, and a burst size of 112 PFU per infected cell. At least eighteen Ahp1 virion proteins were visualized in SDS-polyacrylamide gel electrophoresis, with a 36-kDa protein being the predicted major capsid protein. Genome analysis of Ahp1 revealed a linear doubled-stranded DNA genome of 42,167 bp with a G + C content of 58.8%. The genome encodes 46 putative open reading frames, 5 putative phage promoters, and 3 transcriptional terminators. Based on high degrees of similarity in overall genome organization and among most of the corresponding ORFs, as well as phylogenetic relatedness among their DNAP, RNAP and major capsid proteins, we propose a new subgroup, designated Ahp1-like subgroup. This subgroup contains Ahp1 and members previously belonging to phiKMV-like subgroup, phiAS7, phi80-18, GAP227, phiR8-01, and ISAO8. Since Ahp1 has a narrow host range, for effective phage therapy, different phages are needed for preparation of cocktails that are capable of killing the heterogeneous A. hydrophila strains.	[Wang, Jian-Bin; Lin, Nien-Tsung; Tseng, Yi-Hsiung] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan; [Lin, Nien-Tsung] Tzu Chi Univ, Sch Med, Master Program Microbiol & Immunol, Hualien 970, Taiwan; [Tseng, Yi-Hsiung; Weng, Shu-Fen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan	Tzu Chi University; Tzu Chi University; National Chung Hsing University	Tseng, YH (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan.; Tseng, YH; Weng, SF (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	yhtseng@dragon.nchu.edu.tw; sfweng@dragon.nchu.edu.tw		Weng, Shu Fen/0000-0001-8300-8929	Tzu Chi University [TCIRP98003-01]	Tzu Chi University	This work was supported by grant TCIRP98003-01 from Tzu Chi University.	Adriaenssens EM, 2011, APPL ENVIRON MICROB, V77, P3443, DOI 10.1128/AEM.00128-11; Alavandi SV, 1999, INDIAN J MED RES, V110, P50; Anand T, 2016, J BASIC MICROB, V56, P432, DOI 10.1002/jobm.201500318; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; BOWMAN BU, 1973, AM REV RESPIR DIS, V107, P42; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P1069, DOI 10.1007/s10096-013-1852-6; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P543, DOI 10.1007/s10096-012-1771-y; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P245, DOI 10.1007/s10096-012-1736-1; Chao CM, 2012, AM J TROP MED HYG, V87, P933, DOI 10.4269/ajtmh.2012.12-0275; Chauret C, 2001, CAN J MICROBIOL, V47, P782, DOI 10.1139/cjm-47-8-782; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen PL, 2012, J MICROBIOL IMMUNOL, V45, P398, DOI 10.1016/j.jmii.2012.08.008; CHOW MS, 1983, APPL ENVIRON MICROB, V45, P1670, DOI 10.1128/AEM.45.5.1670-1676.1983; COTAROBLES E, 1968, J VIROL, V2, P56, DOI 10.1128/JVI.2.1.56-68.1968; Danaher PJ, 2011, MIL MED, V176, P1444, DOI 10.7205/MILMED-D-11-00211; DIJKSTRA BW, 1994, CURR OPIN STRUC BIOL, V4, P810, DOI 10.1016/0959-440X(94)90261-5; Doherty AJ, 2000, J MOL BIOL, V296, P43, DOI 10.1006/jmbi.1999.3423; Gibb EA, 2007, J BACTERIOL, V189, P4648, DOI 10.1128/JB.00321-07; Giltner CL, 2013, J CLIN MICROBIOL, V51, P1324, DOI 10.1128/JCM.03217-12; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANYCH B, 1993, GENE, V129, P1, DOI 10.1016/0378-1119(93)90689-Z; Igbinosa IH, 2012, THESCIENTIFICWORLDJO, V2012, DOI [10.1100/2012/764563, DOI 10.1100/2012/764563]; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; JONES WD, 1970, AM REV RESPIR DIS, V102, P814; Joseph Sam W., 1994, Annual Review of Fish Diseases, V4, P315, DOI 10.1016/0959-8030(94)90033-7; Jun JW, 2015, ARCH VIROL, V160, P561, DOI 10.1007/s00705-014-2221-1; Jun JW, 2013, AQUACULTURE, V416, P289, DOI 10.1016/j.aquaculture.2013.09.045; Kedzierska S, 1996, GENE, V168, P1, DOI 10.1016/0378-1119(95)00712-1; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Kivela HM, 1999, VIROLOGY, V262, P364, DOI 10.1006/viro.1999.9838; Lai CC, 2007, BURNS, V33, P255, DOI 10.1016/j.burns.2006.06.003; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Liakopoulos V, 2011, CLIN NEPHROL, V75, pS65, DOI 10.2379/CNP75065; Lin WT, 2013, INTERNAL MED, V52, P2517, DOI 10.2169/internalmedicine.52.0180; MAKSIMOVA TG, 1991, EUR J BIOCHEM, V195, P841, DOI 10.1111/j.1432-1033.1991.tb15773.x; Mann NH, 2005, PLOS BIOL, V3, P753, DOI 10.1371/journal.pbio.0030182; Mannisto RH, 1999, VIROLOGY, V262, P355, DOI 10.1006/viro.1999.9837; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; MERINO S, 1990, FEMS MICROBIOL LETT, V68, P239, DOI 10.1016/S0378-1097(05)80047-3; MERINO S, 1990, FEMS MICROBIOL LETT, V69, P277; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLSEN RH, 1974, J VIROL, V14, P689, DOI 10.1128/JVI.14.3.689-699.1974; Pablos M, 2010, EUR J CLIN MICROBIOL, V29, P1163, DOI 10.1007/s10096-010-0982-3; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Roucourt B, 2009, VIROLOGY, V387, P50, DOI 10.1016/j.virol.2009.01.033; Sau Keya, 2007, Journal of Microbiology Immunology and Infection, V40, P24; Shen CJ, 2012, J VIROL, V86, P10900, DOI 10.1128/JVI.01882-12; Skwor T, 2014, APPL ENVIRON MICROB, V80, P841, DOI 10.1128/AEM.03645-13; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Tseng YH, 1999, J BACTERIOL, V181, P117, DOI 10.1128/JB.181.1.117-125.1999; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	61	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162060	10.1371/journal.pone.0162060	http://dx.doi.org/10.1371/journal.pone.0162060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603936	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200037
J	Fan, JJ; Zareyan, S; Zhao, W; Shimizu, Y; Pfeifer, TA; Tak, JH; Isman, MB; Van den Hoven, B; Duggan, ME; Wood, MW; Wellington, CL; Kulic, I				Fan, Jianjia; Zareyan, Shahab; Zhao, Wenchen; Shimizu, Yoko; Pfeifer, Tom A.; Tak, Jun-Hyung; Isman, Murray B.; Van den Hoven, Bernard; Duggan, Mark E.; Wood, Michael W.; Wellington, Cheryl L.; Kulic, Iva			Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; BETA-AMYLOID LEVELS; LIVER-X-RECEPTORS; ALZHEIMERS-DISEASE; APOE LEVELS; E GENOTYPE; A-BETA; PYRETHROID INSECTICIDES; CEREBROSPINAL-FLUID; LIPID-METABOLISM	The apolipoprotein E (APOE) gene is the most highly associated susceptibility locus for late onset Alzheimer's Disease (AD), and augmenting the beneficial physiological functions of apoE is a proposed therapeutic strategy. In a high throughput phenotypic screen for small molecules that enhance apoE secretion from human CCF-STTG1 astrocytoma cells, we show the chrysanthemic ester 82879 robustly increases expressed apoE up to 9.4-fold and secreted apoE up to 6-fold and is associated with increased total cholesterol in conditioned media. Compound 82879 is unique as structural analogues, including pyrethroid esters, show no effect on apoE expression or secretion. 82879 also stimulates liver x receptor (LXR) target genes including ATP binding cassette A1 (ABCA1), LXR alpha and inducible degrader of low density lipoprotein receptor (IDOL) at both mRNA and protein levels. In particular, the lipid transporter ABCA1 was increased by up to 10.6-fold upon 82879 treatment. The findings from CCF-STTG1 cells were confirmed in primary human astrocytes from three donors, where increased apoE and ABCA1 was observed along with elevated secretion of high-density lipoprotein (HDL)-like apoE particles. Nuclear receptor transactivation assays revealed modest direct LXR agonism by compound 82879, yet 10 mu M of 82879 significantly upregulated apoE mRNA in mouse embryonic fibroblasts (MEFs) depleted of both LXRa and LXR beta, demonstrating that 82879 can also induce apoE expression independent of LXR transactivation. By contrast, deletion of LXRs in MEFs completely blocked mRNA changes in ABCA1 even at 10 mu M of 82879, indicating the ability of 82879 to stimulate ABCA1 expression is entirely dependent on LXR transactivation. Taken together, compound 82879 is a novel chrysanthemic ester capable of modulating apoE secretion as well as apoE-associated lipid metabolic pathways in astrocytes, which is structurally and mechanistically distinct from known LXR agonists.	[Fan, Jianjia; Zareyan, Shahab; Zhao, Wenchen; Wellington, Cheryl L.; Kulic, Iva] Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Shimizu, Yoko; Pfeifer, Tom A.] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Tak, Jun-Hyung; Isman, Murray B.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada; [Van den Hoven, Bernard] TC Sci Inc, Edmonton, AB, Canada; [Duggan, Mark E.; Wood, Michael W.] AstraZeneca, Cambridge, MA USA	University of British Columbia; University of British Columbia; AstraZeneca	Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	wcheryl@mail.ubc.ca			Alzheimer Drug Discovery Foundation [209102.01]; Centre for Drug Research and Development; AstraZeneca; Robert and Kazuko Barker Award; J. Fred Muir Memorial Scholarship in Science; Canadian Institutes of Health Research [MOP 106706]	Alzheimer Drug Discovery Foundation; Centre for Drug Research and Development; AstraZeneca(AstraZeneca); Robert and Kazuko Barker Award; J. Fred Muir Memorial Scholarship in Science; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Initial screening efforts were funded in part by grant 209102.01 from the Alzheimer Drug Discovery Foundation (https://www.alzdiscovery.org) and Centre for Drug Research and Development with subsequent operating support from the Canadian Institutes of Health Research (MOP 106706, http://www.cihr-irsc.gc.ca) to CLW. ADDF and CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salaries for MED, MWW, indirect salary support for JF and IK, and support with data collection and analysis for the following techniques, independent of overall study design: analytical chemistry and nuclear receptor agonist assays. The specific roles of these authors are articulated in the 'author contributions' section. SZ was supported by a Robert and Kazuko Barker Award and a J. Fred Muir Memorial Scholarship in Science.	ABERNATHY CO, 1973, SCIENCE, V179, P1235, DOI 10.1126/science.179.4079.1235; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Coccaro EF, 2015, CNS SPECTRUMS, V20, P295, DOI 10.1017/S1092852915000310; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corona AW, 2016, J NEUROIMMUNE PHARM, V11, P61, DOI 10.1007/s11481-015-9627-8; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Donover PS, 2013, COMB CHEM HIGH T SCR, V16, P180; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fan JJ, 2013, J LIPID RES, V54, P3139, DOI 10.1194/jlr.M042473; Fan JJ, 2011, J LIPID RES, V52, P1605, DOI 10.1194/jlr.M014365; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Grimes JM, 2002, PHARMACOL BIOCHEM BE, V73, P713, DOI 10.1016/S0091-3057(02)00880-8; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Harrewijn P, 2000, NATURAL TERPENOIDS M, P297; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Jahn Holger, 2013, Dialogues Clin Neurosci, V15, P445; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kainu T, 1996, J MOL NEUROSCI, V7, P29, DOI 10.1007/BF02736846; Karasinska JM, 2009, J NEUROSCI, V29, P3579, DOI 10.1523/JNEUROSCI.4741-08.2009; Keene CD, 2011, CURR OPIN NEUROBIOL, V21, P920, DOI 10.1016/j.conb.2011.08.002; Kim J, 2015, J NEUROSCI, V35, P14717, DOI 10.1523/JNEUROSCI.2053-15.2015; Kim WK, 2009, MOL ENDOCRINOL, V23, P1532, DOI 10.1210/me.2008-0453; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2014, NEUROBIOL DIS, V72, P13, DOI 10.1016/j.nbd.2014.05.007; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lowe M N, 2000, Am J Clin Dermatol, V1, P245, DOI 10.2165/00128071-200001040-00006; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Morris JC, 1997, NEUROLOGY, V49, pS7, DOI 10.1212/WNL.49.3_Suppl_3.S7; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Nguyen U., 2011, NAT METHODS, V8, P11; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Nordestgaard LT, 2015, ALZHEIMERS DEMENT, V11, P1430, DOI 10.1016/j.jalz.2015.04.006; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Robinson S, 2012, HORM BEHAV, V61, P67, DOI 10.1016/j.yhbeh.2011.10.004; Saad F, 2011, EUR J ENDOCRINOL, V165, P675, DOI 10.1530/EJE-11-0221; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tak JH, 2016, PEST MANAG SCI, V72, P474, DOI 10.1002/ps.4010; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Toledo JB, 2014, ACTA NEUROPATHOL, V127, P621, DOI 10.1007/s00401-013-1236-0; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	79	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162384	10.1371/journal.pone.0162384	http://dx.doi.org/10.1371/journal.pone.0162384			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598782	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800062
J	Guo, BJ; Wei, YF; Xu, RB; Lin, S; Luan, HY; Lv, C; Zhang, XZ; Song, XY; Xu, RG				Guo, Baojian; Wei, Yafeng; Xu, Ruibin; Lin, Shen; Luan, Haiye; Lv, Chao; Zhang, Xinzhong; Song, Xiyun; Xu, Rugen			Genome-Wide Analysis of APETALA2/Ethylene-Responsive Factor (AP2/ERF) Gene Family in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; SALT STRESS; TRANSCRIPTION FACTORS; EXPRESSION; ARABIDOPSIS; TOLERANCE; DROUGHT; RICE; DEHYDRATION; RESPONSES	APETALA2/Ethylene-Responsive Factor (AP2/ERF) gene family is plant specific transcription factor. It plays critical roles in development process, tolerance to biotic and abiotic stresses, and responses to plant hormones. However, limited data are available on the contributions of AP2/ERF gene family in barley (Hordeum vulgare L.). In the present study, 121 HvAP2/ERF genes in barley were identified by using bioinformatics methods. A total of 118 HvAP2/ERF (97.5%) genes were located on seven chromosomes. According to phylogenetic classification of AP2/ERF family in Arabidopsis, HvAP2/ERF proteins were divided into AP2 (APETALA2), RAV ( Related to ABI3/VP), DREB (dehydration responsive element binding), ERF (ethylene responsive factors) and soloist sub families. The analysis of duplication events indicated that tandem repeat and segmental duplication contributed to the expansion of the AP2/ERF family in barley. HvDREB1s/2s genes displayed various expression patterns under abiotic stress and phytohormone. Taken together, the data generated in this study will be useful for genome-wide analysis to determine the precise role of the HvAP2/ERF gene during barley development, abiotic stress and phytohormone responses with the ultimate goal of improving crop production.	[Guo, Baojian; Lin, Shen; Luan, Haiye; Lv, Chao; Zhang, Xinzhong; Xu, Rugen] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol, Key Lab Plant Funct Genom,Minist Educ,Barley Res, Yangzhou, Jiangsu, Peoples R China; [Wei, Yafeng] JiangSu Yanjiang Inst Agr Sci, Nantong, Peoples R China; [Xu, Ruibin; Song, Xiyun] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China	Yangzhou University; Jiangsu Academy of Agricultural Sciences; Qingdao Agricultural University	Xu, RG (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol, Key Lab Plant Funct Genom,Minist Educ,Barley Res, Yangzhou, Jiangsu, Peoples R China.	rgxu@yzu.edu.cn			National Natural Science Foundation of China [31401370, 31571648]; National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China [CARS-05]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(14)2123]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China; Jiangsu Agriculture Science and Technology Innovation Fund; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported from the National Natural Science Foundation of China (31401370 and 31571648), National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China (CARS-05), Jiangsu Agriculture Science and Technology Innovation Fund (CX(14)2123) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Ferdous J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118503; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu LQ, 2008, J PLANT RES, V121, P215, DOI 10.1007/s10265-007-0140-x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallikarjuna G, 2011, BIOTECHNOL LETT, V33, P1689, DOI 10.1007/s10529-011-0620-x; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Sun ZM, 2014, FUNCT INTEGR GENOMIC, V14, P453, DOI 10.1007/s10142-014-0372-5; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taketa S, 2008, P NATL ACAD SCI USA, V105, P4062, DOI 10.1073/pnas.0711034105; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thamilarasan SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-422; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang QY, 2008, PLANT MOL BIOL, V67, P589, DOI 10.1007/s11103-008-9340-6; Wessler SR, 2005, TRENDS PLANT SCI, V10, P54, DOI 10.1016/j.tplants.2004.12.007; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; WU DD, 2011, PLOS GENET, V7, P9390, DOI DOI 10.1371/JOURNAL.PONE.0022938; Yan HW, 2013, GENET MOL RES, V12, P2038, DOI 10.4238/2013.May.13.1; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu XL, 2014, PLANT PHYSIOL, V164, P1499, DOI 10.1104/pp.113.229575	58	60	66	10	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161322	10.1371/journal.pone.0161322	http://dx.doi.org/10.1371/journal.pone.0161322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598245	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800006
J	Spencer, NG; Schilling, T; Miralles, F; Eder, C				Spencer, Nicholas G.; Schilling, Tom; Miralles, Francesc; Eder, Claudia			Mechanisms Underlying Interferon-gamma-Induced Priming of Microglial Reactive Oxygen Species Production	PLOS ONE			English	Article							MEDIATED NEUROTOXICITY; SUPEROXIDE-PRODUCTION; ION CHANNELS; K+ CHANNEL; PROTEIN; ACTIVATION; CELLS; NOX2; PHOSPHORYLATION; PROLIFERATION	Microglial priming and enhanced reactivity to secondary insults cause substantial neuronal damage and are hallmarks of brain aging, traumatic brain injury and neurodegenerative diseases. It is, thus, of particular interest to identify mechanisms involved in microglial priming. Here, we demonstrate that priming of microglia with interferon-gamma(IFN gamma) substantially enhanced production of reactive oxygen species (ROS) following stimulation of microglia with ATP. Priming of microglial ROS production was substantially reduced by inhibition of p38 MAPK activity with SB203580, by increases in intracellular glutathione levels with N-Acetyl-L-cysteine, by blockade of NADPH oxidase subunit NOX2 activity with gp91ds-tat or by inhibition of nitric oxide production with L-NAME. Together, our data indicate that priming of microglial ROS production involves reduction of intracellular glutathione levels, upregulation of NADPH oxidase subunit NOX2 and increases in nitric oxide production, and suggest that these simultaneously occurring processes result in enhanced production of neurotoxic peroxynitrite. Furthermore, IFN gamma-induced priming of microglial ROS production was reduced upon blockade of Kir2.1 inward rectifier K+ channels with ML133. Inhibitory effects of ML133 on microglial priming were mediated via regulation of intracellular glutathione levels and nitric oxide production. These data suggest that microglial Kir2.1 channels may represent novel therapeutic targets to inhibit excessive ROS production by primed microglia in brain pathology.	[Spencer, Nicholas G.; Schilling, Tom; Eder, Claudia] St Georges Univ London, Infect & Immun Res Inst, London, England; [Miralles, Francesc] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Miralles, Francesc] St Georges Univ London, Inst Med & Biomed Educ, London, England	St Georges University London; St Georges University London; St Georges University London	Eder, C (corresponding author), St Georges Univ London, Infect & Immun Res Inst, London, England.	ceder@sgul.ac.uk		Miralles, Francesc/0000-0003-3069-2725; Schilling, Tom/0000-0002-0274-5482	European Union FP7 grant "TargetBraIn" [279017]	European Union FP7 grant "TargetBraIn"	This work was supported by European Union FP7 grant "TargetBraIn" (#279017) to CE.	Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bhattacharya A, 2016, GLIA, V64, P1772, DOI 10.1002/glia.23001; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; Dale E, 2016, GLIA, V64, P1733, DOI 10.1002/glia.22992; Diebold BA, 2015, ANTIOXID REDOX SIGN, V23, P375, DOI 10.1089/ars.2014.5862; Eder C, 2010, J NEUROIMMUNOL, V224, P51, DOI 10.1016/j.jneuroim.2010.05.008; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Franciosi S, 2002, J NEUROSCI RES, V69, P607, DOI 10.1002/jnr.10331; HALLETT MB, 1995, IMMUNOL TODAY, V16, P264, DOI 10.1016/0167-5699(95)80178-2; Haslund-Vinding J, 2017, BRIT J PHARMACOL, V174, P1733, DOI 10.1111/bph.13425; HU SX, 1995, GLIA, V13, P45, DOI 10.1002/glia.440130106; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Klegeris A, 1997, J NEUROSCI RES, V49, P229, DOI 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W; Lam D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00185; LOWRY OH, 1964, J BIOL CHEM, V239, P18; Mangano EN, 2012, NEUROBIOL AGING, V33, P1411, DOI 10.1016/j.neurobiolaging.2011.02.016; McLarnon JG, 1997, NEUROSCIENCE, V78, P1217, DOI 10.1016/S0306-4522(96)00680-X; McManus RM, 2014, NEUROBIOL AGING, V35, P109, DOI 10.1016/j.neurobiolaging.2013.07.025; Milton RH, 2008, J NEUROSCI, V28, P11488, DOI 10.1523/JNEUROSCI.2431-08.2008; Minogue AM, 2014, NEUROBIOL AGING, V35, P1442, DOI 10.1016/j.neurobiolaging.2013.12.026; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Park YC, 1996, IMMUNOLOGY, V87, P296, DOI 10.1046/j.1365-2567.1996.456544.x; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Purisai MG, 2007, NEUROBIOL DIS, V25, P392, DOI 10.1016/j.nbd.2006.10.008; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Schilling T, 2014, J CELL SCI, V127, P4561, DOI 10.1242/jcs.151068; Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675; Schilling T, 2010, J NEUROIMMUNOL, V225, P190, DOI 10.1016/j.jneuroim.2010.05.024; Schilling T, 2009, J NEUROIMMUNOL, V216, P118, DOI 10.1016/j.jneuroim.2009.07.008; Schmitz M, 2015, NEUROBIOL AGING, V36, P2597, DOI 10.1016/j.neurobiolaging.2015.05.013; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; vanMuiswinkel FL, 1996, J NEUROCHEM, V66, P2468; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965	46	33	33	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162497	10.1371/journal.pone.0162497	http://dx.doi.org/10.1371/journal.pone.0162497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598576	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800071
J	Courtwright, AM; Fried, S; Villalba, JA; Moniodis, A; Guleria, I; Wood, I; Milford, E; Mallidi, HH; Hunninghake, GM; Raby, BA; Agarwal, S; Camp, PC; Rosas, IO; Goldberg, HJ; El-Chemaly, S				Courtwright, Andrew M.; Fried, Sabrina; Villalba, Julian A.; Moniodis, Anna; Guleria, Indira; Wood, Isabelle; Milford, Edgar; Mallidi, Hari H.; Hunninghake, Gary M.; Raby, Benjamin A.; Agarwal, Suneet; Camp, Philip C.; Rosas, Ivan O.; Goldberg, Hilary J.; El-Chemaly, Souheil			Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; PULMONARY-FIBROSIS; SENESCENCE; MUTATIONS; SURVIVAL; DISEASE; AGE; EMPHYSEMA; COHORT	Background Patients with short telomere syndromes and pulmonary fibrosis have increased complications after lung transplant. However, the more general impact of donor and recipient telomere length in lung transplant has not been well characterized. Methods This was an observational cohort study of patients who received lung transplant at a single center between January 1st 2012 and January 31st 2015. Relative donor lymphocyte telomere length was measured and classified into long (third tertile) and short (other tertiles). Relative recipient lung telomere length was measured and classified into short (first tertile) and long (other tertiles). Outcome data included survival, need for modification of immunosuppression, liver or kidney injury, cytomegalovirus reactivation, and acute rejection. Results Recipient lung tissue telomere lengths were measured for 54 of the 79 patients (68.3%) who underwent transplant during the study period. Donor lymphocyte telomeres were measured for 45 (83.3%) of these recipients. Neither long donor telomere length (hazard ratio [HR] = 0.58, 95% confidence interval [CI], 0.12-2.85, p = 0.50) nor short recipient telomere length (HR = 1.01, 95% CI = 0.50-2.05, p = 0.96) were associated with adjusted survival following lung transplant. Recipients with short telomeres were less likely to have acute cellular rejection (23.5% vs. 58.8%, p = 0.02) but were not more likely to have other organ dysfunction. Conclusions In this small cohort, neither long donor lymphocyte telomeres nor short recipient lung tissue telomeres were associated with adjusted survival after lung transplantation. Larger studies are needed to confirm these findings.	[Courtwright, Andrew M.; Fried, Sabrina; Villalba, Julian A.; Moniodis, Anna; Hunninghake, Gary M.; Raby, Benjamin A.; Rosas, Ivan O.; Goldberg, Hilary J.; El-Chemaly, Souheil] Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA; [Guleria, Indira; Wood, Isabelle; Milford, Edgar] Brigham & Womens Hosp, Tissue Typing Lab, Boston, MA 02115 USA; [Mallidi, Hari H.; Camp, Philip C.] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Raby, Benjamin A.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Agarwal, Suneet] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	El-Chemaly, S (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care, Boston, MA 02115 USA.	sel-chemaly@partners.org	Villalba, Julian/AAK-4222-2020; Raby, Benjamin/AAK-3866-2021	Villalba, Julian/0000-0001-9230-8747; GULERIA, INDIRA/0000-0002-0622-3585	National Institutes of Health [5T32HL007633-30, NIH R01 HL130275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633, R01HL111024, R01HL130275, R01HL130974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this research was provided by grants from the National Institutes of Health (5T32HL007633-30 and NIH R01 HL130275). This research was also supported by a generous donation from a patient and his family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aini W, 2012, TRANSPL INT, V25, P956, DOI 10.1111/j.1432-2277.2012.01523.x; Akiyama M, 2000, BONE MARROW TRANSPL, V25, P441, DOI 10.1038/sj.bmt.1702144; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Awaya N, 2002, BIOL BLOOD MARROW TR, V8, P597, DOI 10.1053/bbmt.2002.v8.abbmt080597; Birch J, 2016, AM J RESP CRIT CARE, V193, P929, DOI 10.1164/rccm.201510-2035LE; Borie R, 2015, J HEART LUNG TRANSPL, V34, P538, DOI 10.1016/j.healun.2014.11.010; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Crepin T, 2015, AM J TRANSPLANT, V15, P1028, DOI 10.1111/ajt.13092; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Crous-Bou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6674; de Latour RP, 2012, BLOOD, V120, P3353, DOI 10.1182/blood-2012-01-403337; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; Gadalla SM, 2015, JAMA-J AM MED ASSOC, V313, P594, DOI 10.1001/jama.2015.7; George G, 2015, CHEST, V147, P1549, DOI 10.1378/chest.14-0631; Giri Neelam, 2011, BMC Blood Disord, V11, P3, DOI 10.1186/1471-2326-11-3; Hayes D, 2015, J HEART LUNG TRANSPL, V34, P43, DOI 10.1016/j.healun.2014.08.017; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Koppelstaetter C, 2008, AGING CELL, V7, P491, DOI 10.1111/j.1474-9726.2008.00398.x; Meyer DM, 2000, CHEST, V118, P1255, DOI 10.1378/chest.118.5.1255; Pechet TV, 2003, J HEART LUNG TRANSPL, V22, P154, DOI 10.1016/S1053-2498(02)00671-X; Silhan LL, 2014, EUR RESPIR J, V44, P178, DOI 10.1183/09031936.00060014; Stanley SE, 2015, J CLIN INVEST, V125, P563, DOI 10.1172/JCI78554; Stuart BD, 2014, LANCET RESP MED, V2, P557, DOI 10.1016/S2213-2600(14)70124-9; Tokman S, 2015, J HEART LUNG TRANSPL, V34, P1318, DOI 10.1016/j.healun.2015.05.002; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Wong JYY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087348	26	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162409	10.1371/journal.pone.0162409	http://dx.doi.org/10.1371/journal.pone.0162409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589328	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800058
J	Jacob, G; Prevot, AC; Baudry, E				Jacob, Gwenael; Prevot, Anne-Caroline; Baudry, Emmanuelle			Feral Pigeons (Columba livia) Prefer Genetically Similar Mates despite Inbreeding Depression	PLOS ONE			English	Article							GREAT REED WARBLER; NO EVIDENCE; AVOIDANCE; RELATEDNESS; POPULATION; DISPERSAL; CHOICE; SPARROWS; ANIMALS; RECOGNITION	Avoidance of mating between related individuals is usually considered adaptive because it decreases the probability of inbreeding depression in offspring. However, mating between related partners can be adaptive if outbreeding depression is stronger than inbreeding depression or if females gain inclusive fitness benefits by mating with close kin. In the present study, we used microsatellite data to infer the parentage of juveniles born in a French colony of feral pigeons, which allowed us to deduce parent pairs. Despite detectable inbreeding depression, we found that pairwise relatedness between mates was significantly higher than between nonmates, with a mean coefficient of relatedness between mates of 0.065, approximately half the theoretical value for first cousins. This higher relatedness between mates cannot be explained by spatial genetic structure in this colonial bird; it therefore probably results from an active choice. As inbreeding but not outbreeding depression is observed in the study population, this finding accords with the idea that mating with genetically similar mates can confer a benefit in terms of inclusive fitness. Our results and published evidence suggest that preference for related individuals as mates might be relatively frequent in birds.	[Jacob, Gwenael; Prevot, Anne-Caroline; Baudry, Emmanuelle] Univ Paris 11, Univ Paris Saclay, AgroParisTech, CNRS,Ecol Systemat Evolut, F-91400 Orsay, France; [Jacob, Gwenael] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Prevot, Anne-Caroline] Museum Natl Hist Nat, CNRS MNHN UPMC, Ctr Sci Conservat CESCO, UMR7204, CP 51,55 Rue Buffon, Paris 5, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Fribourg; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Baudry, E (corresponding author), Univ Paris 11, Univ Paris Saclay, AgroParisTech, CNRS,Ecol Systemat Evolut, F-91400 Orsay, France.	emmanuelle.baudry@u-psud.fr	Baudry, Emmanuelle/G-4005-2010; Jacob, Gwenaël/I-3644-2014	Jacob, Gwenaël/0000-0003-3064-9954	ANRJC - Agence Nationale de la Recherche, programme Jeune Chercheur [ANR-05-JCJC-0098-01]; Region Ile-de-France [06 - 1064 MN 07]	ANRJC - Agence Nationale de la Recherche, programme Jeune Chercheur(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France)	This study is a part of a general research program that was supported by grants from the ANRJC - Agence Nationale de la Recherche, programme Jeune Chercheur (ANR-05-JCJC-0098-01) and the Region Ile-de-France (no 06 - 1064 MN 07).	Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Arct A, 2015, BEHAV ECOL, V26, P959, DOI 10.1093/beheco/arv004; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; Bateson P., 1983, P257; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; BENSCH S, 1994, EVOLUTION, V48, P317, DOI 10.1111/j.1558-5646.1994.tb01314.x; Bichet C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-47; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; BROOKER MG, 1990, BEHAV ECOL SOCIOBIOL, V26, P191; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cherry JL, 2013, TRENDS ECOL EVOL, V28, P683, DOI 10.1016/j.tree.2013.08.001; Cohen LB, 2004, ANIM BEHAV, V68, P1229, DOI 10.1016/j.anbehav.2003.12.021; Edly-Wright C, 2007, ANIM BEHAV, V73, P367, DOI 10.1016/j.anbehav.2006.08.008; Foerster K, 2006, MOL ECOL, V15, P4555, DOI 10.1111/j.1365-294X.2006.03091.x; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Freeman-Gallant CR, 2006, BEHAV ECOL, V17, P952, DOI 10.1093/beheco/arl031; Giunchi D, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P215; GREENWOOD PJ, 1978, NATURE, V271, P52, DOI 10.1038/271052a0; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Jacob G, 2015, BIOL INVASIONS, V17, P23, DOI 10.1007/s10530-014-0713-2; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Johnston RF, 1995, FERAL PIGEONS; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 1998, AM NAT, V152, P380, DOI 10.1086/286176; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kimura M, 1991, RES B FACULTY AGR, V56, P7; Kleven O, 2005, BIOL LETT-UK, V1, P389, DOI 10.1098/rsbl.2005.0376; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Krokene C, 2000, BEHAVIOUR, V137, P1317, DOI 10.1163/156853900501944; Marshall T, 2001, CERVUS VERSION 2 0; Mulard H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-147; Nakagawa S, 2004, BIOL REV, V79, P101, DOI 10.1017/S1464793103006249; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reynolds SM, 2014, BEHAV ECOL; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; Soulaymani A, 1999, J ANIM BREED GENET, V116, P139, DOI 10.1046/j.1439-0388.1999.00182.x; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Szulkin M, 2009, J ANIM ECOL, V78, P778, DOI 10.1111/j.1365-2656.2009.01544.x; Traxler B, 2000, MOL ECOL, V9, P366, DOI 10.1046/j.1365-294x.2000.00874-2.x; Van de Casteele T, 2006, MOL ECOL, V15, P2557, DOI 10.1111/j.1365-294X.2006.02946.x; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; WOLFF JO, 1992, NATURE, V359, P409, DOI 10.1038/359409a0	53	8	9	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162451	10.1371/journal.pone.0162451	http://dx.doi.org/10.1371/journal.pone.0162451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588754	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800063
J	Neaves, LE; Frankham, GJ; Dennison, S; FitzGibbon, S; Flannagan, C; Gillett, A; Hynes, E; Handasyde, K; Helgen, KM; Tsangaras, K; Greenwood, AD; Eldridge, MDB; Johnson, RN				Neaves, Linda E.; Frankham, Greta J.; Dennison, Siobhan; FitzGibbon, Sean; Flannagan, Cheyne; Gillett, Amber; Hynes, Emily; Handasyde, Kathrine; Helgen, Kristofer M.; Tsangaras, Kyriakos; Greenwood, Alex D.; Eldridge, Mark D. B.; Johnson, Rebecca N.			Phylogeography of the Koala, (Phascolarctos cinereus), and Harmonising Data to Inform Conservation	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; GENETIC DIVERSITY; CONTROL REGION; POPULATION; PATTERNS; QUEENSLAND; SEQUENCE; IMPACT; ISLAND; DIFFERENTIATION	The Australian continent exhibits complex biogeographic patterns but studies of the impacts of Pleistocene climatic oscillation on the mesic environments of the Southern Hemisphere are limited. The koala (Phascolarctos cinereus), one of Australia's most iconic species, was historically widely distributed throughout much of eastern Australia but currently represents a complex conservation challenge. To better understand the challenges to koala genetic health, we assessed the phylogeographic history of the koala. Variation in the maternally inherited mitochondrial DNA (mtDNA) Control Region (CR) was examined in 662 koalas sampled throughout their distribution. In addition, koala CR haplotypes accessioned to Gen-bank were evaluated and consolidated. A total of 53 unique CR haplotypes have been isolated from koalas to date (including 15 haplotypes novel to this study). The relationships among koala CR haplotypes were indicative of a single Evolutionary Significant Unit and do not support the recognition of subspecies, but were separated into four weakly differentiated lineages which correspond to three geographic clusters: a central lineage, a southern lineage and two northern lineages co-occurring north of Brisbane. The three geographic clusters were separated by known Pleistocene biogeographic barriers: the Brisbane River Valley and Clarence River Valley, although there was evidence of mixing amongst clusters. While there is evidence for historical connectivity, current koala populations exhibit greater structure, suggesting habitat fragmentation may have restricted female-mediated gene flow. Since mtDNA data informs conservation planning, we provide a summary of existing CR haplotypes, standardise nomenclature and make recommendations for future studies to harmonise existing datasets. This holistic approach is critical to ensuring management is effective and small scale local population studies can be integrated into a wider species context.	[Neaves, Linda E.; Frankham, Greta J.; Dennison, Siobhan; Eldridge, Mark D. B.; Johnson, Rebecca N.] Australian Museum Res Inst, Australian Ctr Wildlife Genom, 1 William St, Sydney, NSW 2010, Australia; [Neaves, Linda E.] Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland; [FitzGibbon, Sean] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia; [Flannagan, Cheyne] Koala Hosp Port Macquarie, POB 236, Port Macquarie, NSW 2444, Australia; [Gillett, Amber] Australia Zoo Wildlife Hosp, Beerwah, Qld 4519, Australia; [Hynes, Emily] Ecoplan Australia Pty Ltd, POB 968, Torquay, Vic 3228, Australia; [Handasyde, Kathrine] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Helgen, Kristofer M.] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; [Tsangaras, Kyriakos] Cyprus Inst Neurol & Genet, Dept Translat Genet, 6 Int Airport Ave, CY-2370 Nicosia, Cyprus; [Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, D-10315 Berlin, Germany; [Greenwood, Alex D.] Free Univ Berlin, Dept Vet Med, D-14163 Berlin, Germany	Australian Museum; University of Queensland; University of Melbourne; Smithsonian Institution; Smithsonian National Museum of Natural History; Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin	Neaves, LE (corresponding author), Australian Museum Res Inst, Australian Ctr Wildlife Genom, 1 William St, Sydney, NSW 2010, Australia.; Neaves, LE (corresponding author), Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland.	lneaves@gmail.com	Greenwood, Alex/GWU-8292-2022; Helgen, Kristofer M./AAB-8348-2019; Hynes, Emily/ABC-5591-2020; Johnson, Rebecca N/U-6514-2017; Neaves, Linda/AAY-6886-2020	Helgen, Kristofer M./0000-0002-8776-4040; Neaves, Linda/0000-0002-5626-1029; Johnson, Rebecca/0000-0003-3035-2827; Eldridge, Mark/0000-0002-7109-0600; Dennison, Siobhan/0000-0002-3308-2810	New South Wales Environmental Trust [2014/RD/0015]; New South Wales National Parks Foundation; Australian Museum Foundation; Australian Bluegum Plantations; PF Olsen Australia, New Forests; Ecoplan Australia Pty Ltd.; National Institute of General Medical Sciences (NIGMS) [R01 GM092706]; New South Wales National Parks; Parks Victoria	New South Wales Environmental Trust; New South Wales National Parks Foundation; Australian Museum Foundation; Australian Bluegum Plantations; PF Olsen Australia, New Forests; Ecoplan Australia Pty Ltd.; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New South Wales National Parks; Parks Victoria	This work was supported by the New South Wales Environmental Trust (2014/RD/0015), New South Wales National Parks Foundation and the Australian Museum Foundation. EH was supported by the Australian Bluegum Plantations and PF Olsen Australia, New Forests. Ecoplan Australia Pty Ltd. provided support in the form of salary for EH. Sequencing of historical samples was supported by the National Institute of General Medical Sciences to ADG (NIGMS; grant number R01 GM092706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yasuko Ishida, Alfred Roca, Kyle Ewart, Zhoamin Zhou and Andrew King for assistance with generating sequence data and Sandy Ingleby, Anja Divljan, Scott Ginn, Bill Sherwin and Martin Taube for assistance with sample collection. We also wish to thank the New South Wales Environmental Trust, New South Wales National Parks and the Australian Museum Foundation, Australian Bluegum Plantations, PF Olsen Australia, New Forests and the National Institute of General Medical Sciences and Parks Victoria for support.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Adams-Hosking Christine, 2011, Australian Zoologist, V35, P983; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Briscoe NJ, 2015, J BIOGEOGR, V42, P791, DOI 10.1111/jbi.12445; Bryant LM, 2016, BIOL J LINN SOC, V119, P238, DOI 10.1111/bij.12821; Bryant LM, 2014, J BIOGEOGR, V41, P1923, DOI 10.1111/jbi.12341; Burbidge A.A., 2014, P15; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Clement M., 2002, P 16 INT PARALLEL DI, P7; Colgan DJ, 2009, AUST J ZOOL, V57, P317, DOI 10.1071/ZO08088; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Cristescu R, 2009, WILDLIFE RES, V36, P299, DOI 10.1071/WR08010; De Groot GA, 2016, MAMMAL REV, V46, P44, DOI 10.1111/mam.12052; Dennison S, AUST J ZOOL UNPUB; Department of the Environment, 2016, PHASC CIN COMB POP Q; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dique DS, 2003, WILDLIFE RES, V30, P281, DOI 10.1071/WR02043; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edwards DL, 2010, J BIOGEOGR, V37, P1543, DOI 10.1111/j.1365-2699.2010.02293.x; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fowler EV, 2000, MOL ECOL, V9, P155, DOI 10.1046/j.1365-294x.2000.00844.x; Frankham GJ, 2016, J BIOGEOGR, V43, P653, DOI 10.1111/jbi.12659; Fu YX, 1997, GENETICS, V147, P915; Fumagalli L, 1997, MOL ECOL, V6, P1199, DOI 10.1046/j.1365-294X.1997.00298.x; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handasyde, 1999, KOALA NATURAL HIST C; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hazlitt SL, 2014, ECOL EVOL, V4, P1102, DOI 10.1002/ece3.1009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Houlden BA, 1996, J HERED, V87, P149, DOI 10.1093/oxfordjournals.jhered.a022972; Houlden BA, 1996, MOL ECOL, V5, P269, DOI 10.1111/j.1365-294X.1996.tb00314.x; Houlden BA, 1999, MOL ECOL, V8, P999, DOI 10.1046/j.1365-294x.1999.00656.x; Hynes EF, 2010, REPROD FERT DEVELOP, V22, P913, DOI 10.1071/RD09253; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keogh SJ, 2003, CONSERV GENET, V4, P57, DOI 10.1023/A:1021823423944; Kershaw J.A., 1934, VICTORIAN NAT, V51, P76; Kjeldsen SR, 2016, CONSERV GENET, V17, P337, DOI 10.1007/s10592-015-0784-3; Lee KE, 2012, AUST J ZOOL, V60, P303, DOI 10.1071/ZO12075; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Lee T, 2012, AUST MAMMAL, V34, P68, DOI 10.1071/AM10035; Lee T, 2010, WILDLIFE RES, V37, P156, DOI 10.1071/WR09134; lindsay HA, 1950, WILD LIFE, V12, P257; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Martin RW, 2008, MAMMALS AUSTR, P112; Masters P, 2004, WILDLIFE RES, V31, P267, DOI 10.1071/WR03007; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McGuigan K, 1998, MOL ECOL, V7, P175, DOI 10.1046/j.1365-294x.1998.00329.x; McInnes LM, 2011, PARASITOLOGY, V138, P873, DOI 10.1017/S0031182011000369; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Menkhorst P, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P73; Middleton DR, 2003, WILDLIFE RES, V30, P207, DOI 10.1071/WR02052; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Pereira L, 2004, FORENSIC SCI INT, V141, P99, DOI 10.1016/j.forsciint.2003.12.014; PHILLIPS B, 1990, KOALAS LITTLE AUSTR; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Robinson A.C., 1978, P132; Rousset F, 1997, GENETICS, V145, P1219; Rowe KMC, 2011, AUST J ZOOL, V59, P186, DOI 10.1071/ZO11046; Ruiz-Rodriguez CT, 2014, CONSERV GENET RESOUR, V6, P429, DOI 10.1007/s12686-013-0115-2; Schneider S, 1999, GENETICS, V152, P1079; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Seddon JM, 2014, WILDLIFE RES, V41, P277, DOI 10.1071/WR13103; Seymour AM, 2001, ANIM CONSERV, V4, P211, DOI 10.1017/S1367943001001251; Sherwin WB, 2000, CONSERV BIOL, V14, P639, DOI 10.1046/j.1523-1739.2000.99384.x; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR AC, 1991, BIOCHEM GENET, V29, P355, DOI 10.1007/BF00554143; Taylor AC, 1997, GENET RES, V69, P25, DOI 10.1017/S0016672397002607; TEMPLETON AR, 1992, GENETICS, V132, P619; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109101; Tsangaras K, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-92; Whisson DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144348	90	19	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162207	10.1371/journal.pone.0162207	http://dx.doi.org/10.1371/journal.pone.0162207			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588685	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800035
J	Hameed, W; Azmat, SK; Ali, M; Ishaque, M; Abbas, G; Munroe, E; Harrison, R; Shamsi, WH; Mustafa, G; Khan, OF; Ali, S; Ahmed, A				Hameed, Waqas; Azmat, Syed Khurram; Ali, Moazzam; Ishaque, Muhammad; Abbas, Ghazunfer; Munroe, Erik; Harrison, Rebecca; Shamsi, Wajahat Hussain; Mustafa, Ghulam; Khan, Omar Farooq; Ali, Safdar; Ahmed, Aftab			Comparing Effectiveness of Active and Passive Client Follow-Up Approaches in Sustaining the Continued Use of Long Acting Reversible Contraceptives (LARC) in Rural Punjab: A Multicentre, Non-Inferiority Trial	PLOS ONE			English	Article							INTRAUTERINE-DEVICE; DISCONTINUATION; RATES; VISITS; PAKISTAN	Background The use of long-acting reversible contraceptive (LARC) methods is very low in Pakistan with high discontinuation rates mainly attributed to method-related side effects. Mixed evidence is available on the effectiveness of different client follow-up approaches used to ensure method continuation. We compared the effectiveness of active and passive follow-p approaches in sustaining the use of LARC-and within 'active' follow-up, we further compared a telephone versus home-based approach in rural Punjab, Pakistan. Methods This was a 12-month multicentre non-inferiority trial conducted in twenty-two (16 rural-and 6 urban-based) franchised reproductive healthcare facilities in district Chakwal of Punjab province, between November 2013 and December 2014. The study comprised of three groups of LARC clients: a) home-based follow-up, b) telephone-based follow-up, and c) passive or needs-based follow-up. Participants in the first two study groups received counselling on scheduled follow-up from the field workers at 1, 3, 6, 9, and 12 month post-insertion whereas participants in the third group were asked to contact the health facility if in need of medical assistance relating to LARC method use. Study participants were recruited with equal allocation to each study group, but participants were not randomized. The analyses are based on 1,246 LARC (intra-uterine contraceptive device and implant) users that completed approximately 12-months of follow-up. The non-inferiority margin was kept at five percentage points for the comparison of active and passive follow-up and six percentage points for telephone and home-based approach. The primary outcome was cumulative probability of method continuation at 12-month among LARC users. Results Women recruited in home-based, telephone-based, and passive groups were 400, 419 and 427, respectively. The cumulative probability of LARC continuation at 12 month was 87.6% (95% CI 83.8 to 90.6) among women who received home-based follow-up; 89.1% (95% CI 85.7, 91.8) who received telephone-based follow-up; and 83.8% (95% CI 79.8 to 87.1) who were in the passive or needs-based follow-up group. The probability of continuation among women who were actively followed-up by field health educators-either through home-based visit or telephone-based follow-up was, 88.3% (95% CI 85.9 to 90.0). An adjusted risk difference of -4.1 (95% CI -7.8 to -0.28; p-value = 0.035) was estimated between active and passive follow-up. Whereas, within the active client follow-up, the telephone-based follow-up was found to be as effective as the home-based follow-up with an adjusted risk difference of 1.8 (95% CI -2.7 to 6.4; p-value = 0.431). Conclusion A passive follow-up approach was 5% inferior to an active follow-up approach; whereas telephone-based follow-up was as effective as the home-based visits in sustaining the use of LARC, and was far more resource efficient. Therefore, active follow-up could improve method continuation especially in the critical post-insertion period.	[Hameed, Waqas; Ishaque, Muhammad; Abbas, Ghazunfer; Shamsi, Wajahat Hussain; Mustafa, Ghulam; Khan, Omar Farooq; Ali, Safdar; Ahmed, Aftab] Marie Stopes Soc, Tech Serv, Res Monitoring & Evaluat Dept, Karachi, Pakistan; [Azmat, Syed Khurram] Univ Ghent, Dept Urogynecol, B-9000 East Flanders, Belgium; [Azmat, Syed Khurram] Hosp Sick Children, Dept Paediat Emergency Med, Toronto, ON, Canada; [Ali, Moazzam] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Munroe, Erik; Harrison, Rebecca] Marie Stopes Int, Res Monitoring & Evaluat Dept, London, England	Ghent University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); World Health Organization	Hameed, W (corresponding author), Marie Stopes Soc, Tech Serv, Res Monitoring & Evaluat Dept, Karachi, Pakistan.; Ali, M (corresponding author), WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.	waqas.hameed1@gmail.com; alimoa@who.int	Azmat, Syed Khurram/C-7244-2019	Ali, Moazzam/0000-0001-6949-8976; Azmat, Syed Khurram/0000-0003-0158-8734	David and Lucile Packard Foundation [2011-37284]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by The David and Lucile Packard Foundation, Grant number: 2011-37284, URL: https://www.packard.org/what-we-fund/grants-database/world-health-organization/.	Alam ME, 2009, JAHANGIRNAGAR U J SC, V32, P123; Ali MM, 2014, CONTRACEPTION, V90, P47, DOI 10.1016/j.contraception.2014.03.008; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Azmat SK, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-9; Azmat SK, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-39; Azmat Syed Khurram, 2013, J Pak Med Assoc, V63, pS46; Azmat SK, 2013, INT J WOMENS HEALTH, V5, P19, DOI 10.2147/IJWH.S36785; Azmat SK, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-8; Casterline JB, 2001, STUD FAMILY PLANN, V32, P95, DOI 10.1111/j.1728-4465.2001.00095.x; Castle S, 2015, CONTRACEPTIVE DISCON, DOI DOI 10.1108/JHASS-09-2019-0056/FULL/HTML; Cleland J, 2012, CAUSES CONSEQUENCES; Family Advancement For Life and Health, 2009, MAN NAT STNAD FAM PL; Government of Punjab, 2011, NAT PROGR FAM PLANN; Hameed W, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0040-9; Hennink M, 2001, 3 MAR STOP INT LOND; HERCEGBARON R, 1986, FAM PLANN PERSPECT, V18, P61, DOI 10.2307/2135030; Hubacher D, 1999, INT FAM PLAN PERSPEC, V25, P21, DOI 10.2307/2991898; Khan A., 2008, WOMENS EMPOWERMENT L; Kirby D, 2010, PERSPECT SEX REPRO H, V42, P251, DOI 10.1363/4225110; Lambert O., 2009, Finance & Development, V46, P48; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S2; Lendvay A, 2014, CONTRACEPTION, V89, P197, DOI 10.1016/j.contraception.2013.11.002; Lopez LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001863.pub2; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Ministry of Health, 2006, PC1 NAT MAT NEWB CHI; Mumtaz Z, 2013, SOC SCI MED, V91, P48, DOI 10.1016/j.socscimed.2013.05.007; National Institute of Population Studies P, 1990, PAK DEM HLTH SURV 19; National Institute of Population Studies Pakistan Macro International Inc., 2008, PAK DEM HLTH SURV 20; National Institute of Population Studies Pakistan Macro International Inc., 2014, PAK DEM HLTH SURV 20; Neuteboom K, 2003, CONTRACEPTION, V68, P101, DOI 10.1016/S0010-7824(03)00111-2; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Staveteig S., 2015, DHS ANAL STUDIES, V54; Steenland MW, 2013, CONTRACEPTION, V87, P625, DOI 10.1016/j.contraception.2012.09.018; United Nations Department of Economic and Social Affairs Population Division, 2011, WORD CONTR US 2011; WHO Global Observatory for eHealth, 2011, GLOBAL OBSERVATORY E	35	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160683	10.1371/journal.pone.0160683	http://dx.doi.org/10.1371/journal.pone.0160683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584088	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600010
J	Kluge, S; Bekeschus, S; Bender, C; Benkhai, H; Sckell, A; Below, H; Stope, MB; Kramer, A				Kluge, Susanne; Bekeschus, Sander; Bender, Claudia; Benkhai, Hicham; Sckell, Axel; Below, Harald; Stope, Matthias B.; Kramer, Axel			Investigating the Mutagenicity of a Cold Argon-Plasma Jet in an HET-MN Model	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; TISSUE-TOLERABLE PLASMA; HENS EGG TEST; ANTIOXIDANT DEFENSE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; RISK-ASSESSMENT; DNA-DAMAGE; YOLK-SAC; EMBRYO	Objective So-called cold physical plasmas for biomedical applications generate reactive oxygen and nitrogen species and the latter can trigger DNA damage at high concentrations. Therefore, the mutagenic risks of a certified atmospheric pressure argon plasma jet (kINPen MED) and its predecessor model (kINPen 09) were assessed. Methods Inner egg membranes of fertilized chicken eggs received a single treatment with either the kINPen 09 (1.5, 2.0, or 2.5 min) or the kINPen MED (3, 4, 5, or 10 min). After three days of incubation, blood smears (panoptic May-Grunwald-Giemsa stain) were performed, and 1000 erythrocytes per egg were evaluated for the presence of polychromatic and normochromic nuclear staining as well as nuclear aberrations and binucleated cells (hen's egg test for micronuclei induction, HET-MN). At the same time, the embryo mortality was documented. For each experiment, positive controls (cyclophosphamide and methotrexate) and negative controls (NaCl-solution, argon gas) were included. Additionally, the antioxidant potential of the blood plasma was assessed by ascorbic acid oxidation assay after treatment. Results For both plasma sources, there was no evidence of genotoxicity, although at the longest plasma exposure time of 10 min the mortality of the embryos exceeded 40%. The antioxidant potential in the egg's blood plasma was not significantly reduced immediately (p = 0.32) or 1 h (p = 0.19) post exposure to cold plasma. Conclusion The longest plasma treatment time with the kINPen MED was 5-10 fold above the recommended limit for treatment of chronic wounds in clinics. We did not find mutagenic effects for any plasma treatment time using the either kINPen 09 or kINPen MED. The data provided with the current study seem to confirm the lack of a genotoxic potential suggesting that a veterinary or clinical application of these argon plasma jets does not pose mutagenic risks.	[Kluge, Susanne; Bender, Claudia; Benkhai, Hicham; Below, Harald; Kramer, Axel] Univ Med Greifswald, Inst Hyg & Environm Med, Walther Rathenau Str 49a, D-17485 Greifswald, Germany; [Bekeschus, Sander] ZIK Plasmatis, Leibniz Inst Plasma Sci & Technol, Felix Hausdorff Str 2, D-17489 Greifswald, Germany; [Sckell, Axel] Univ Med Greifswald, Dept Trauma & Reconstruct Surg, Sauerbruchstr, D-17475 Greifswald, Germany; [Stope, Matthias B.] Univ Med Greifswald, Dept Urol, Sauerbruchstr, D-17475 Greifswald, Germany	Greifswald Medical School; Leibniz Institut fur Plasmaforschung und Technologie; Greifswald Medical School; Greifswald Medical School	Bekeschus, S (corresponding author), ZIK Plasmatis, Leibniz Inst Plasma Sci & Technol, Felix Hausdorff Str 2, D-17489 Greifswald, Germany.	sander.bekeschus@inp-greifswald.de		Bekeschus, Sander/0000-0002-8773-8862	German Federal Ministry of Education and Research (BMBF) [13N9779, 03Z22DN11]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors acknowledge that this work was supported by grants funded by the German Federal Ministry of Education and Research (BMBF): grant numbers 13N9779 (SK, CB, HiB, AS, HaB, AK) and 03Z22DN11 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; ALLS AA, 1964, AVIAN DIS, V8, P245, DOI 10.2307/1588067; Barbabosa-Pliego, 2013, APPL PHYS RES, V5, P21, DOI [10.5539/apr.v5n5p21, DOI 10.5539/APR.V5N5P21]; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Bekeschus S., 2013, PLASMA MED, V3, P267, DOI DOI 10.1615/PLASMAMED.2014011972; Bekeschus S, 2016, CLIN PLASMA MED, V4, P19, DOI 10.1016/j.cpme.2016.01.001; Bekeschus S, 2015, IEEE T PLASMA SCI, V43, P776, DOI 10.1109/TPS.2015.2393379; Bekeschus S, 2013, PLASMA PROCESS POLYM, V10, P706, DOI 10.1002/ppap.201300008; Bender C, 2011, TOXICOL IN VITRO, V25, P530, DOI 10.1016/j.tiv.2010.11.012; Bender C, 2010, PLASMA PROCESS POLYM, V7, P318, DOI 10.1002/ppap.200900119; Benkhai H, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000146; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; BRUNS GAP, 1973, PHILOS T ROY SOC B, V266, P225, DOI 10.1098/rstb.1973.0050; Bundscherer L., 2013, PLASMA MED, V3, P71, DOI DOI 10.1615/PLASMAMED.2013008538; BUSING WR, 1965, J CHEM PHYS, V42, P3054, DOI 10.1063/1.1696379; Bussiahn R., 2013, HYGMED, V38, P212; Chang TK, 1993, CANC RES, V53; Choucroun P, 2001, MUTAT RES-FUND MOL M, V478, P89, DOI 10.1016/S0027-5107(01)00123-3; DARZYNKIEWICZ Z, 1971, EXP CELL RES, V69, P477; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Dunnbier M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435203; Gaal T, 1995, COMP BIOCHEM PHYS B, V112, P711, DOI 10.1016/0305-0491(95)00125-5; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Greywe D, 2012, MUTAT RES-GEN TOX EN, V747, P118, DOI 10.1016/j.mrgentox.2012.04.012; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; HAMILTON JW, 1983, P NATL ACAD SCI-BIOL, V80, P3372, DOI 10.1073/pnas.80.11.3372; Hammann A, 2010, SKIN PHARMACOL PHYS, V23, P328, DOI 10.1159/000314724; HEINRICHHIRSCH B, 1990, ARCH TOXICOL, V64, P128, DOI 10.1007/BF01974398; Isbary G, 2013, CLIN PLASMA MED, V1, P25, DOI 10.1016/j.cpme.2013.06.001; Iseni S, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/123011; Jablonowski H, 2015, CLIN PLASMA MED, V3, P42, DOI 10.1016/j.cpme.2015.11.003; Kalghatgi S., 2011, PLASMA MED J, V1, P167, DOI [10.1615/PlasmaMed.2011003798, DOI 10.1615/PLASMAMED.2011003798]; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kramer A, 2013, CLIN PLASMA MED, V1, P11, DOI 10.1016/j.cpme.2013.03.002; KUTCHAI H, 1971, RESP PHYSIOL, V11, P265, DOI 10.1016/0034-5687(71)90001-6; Lademann J, 2013, CLIN PLASMA MED, V1, P5, DOI 10.1016/j.cpme.2013.01.001; LASSILA O, 1982, BLOOD, V59, P377; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Lucas AM, 1961, ATLAS OF AVIAN HEMAT; Morales-Ramirez P, 2013, RADIAT RES, V179, P669, DOI 10.1667/RR3223.1; MULLER WU, 1994, ADV MUTAGENESIS RES, V5, P1; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nowicka AM, 2010, ANGEW CHEM INT EDIT, V49, P3006, DOI 10.1002/anie.201000485; Nowicka AM, 2010, ANGEW CHEM INT EDIT, V49, P1061, DOI 10.1002/anie.200906358; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Piaton E, 2015, ANN PATHOL; Ptasinska S, 2010, PHYS CHEM CHEM PHYS, V12, P7779, DOI [10.1039/c001188f, 10.1039/e001188f]; REID WM, 1961, POULTRY SCI, V40, P1497, DOI 10.3382/ps.0401497; Schmidt A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9816072; Schmidt-Bleker A, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/14/145201; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; SOMASHEKARAIAH BV, 1992, FREE RADICAL BIO MED, V13, P107, DOI 10.1016/0891-5849(92)90071-N; SORRELL JM, 1982, J MORPHOL, V171, P183, DOI 10.1002/jmor.1051710206; Surai PF, 1999, BRIT POULTRY SCI, V40, P397, DOI 10.1080/00071669987511; Surai PF, 1996, BBA-LIPID LIPID MET, V1304, P1, DOI 10.1016/S0005-2760(96)00099-9; Tarricone E, 2012, ITAL J ANAT EMBRYOL, V117, P186; Tresp H, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435401; Ulrich C, 2015, J WOUND CARE, V24, P196, DOI 10.12968/jowc.2015.24.5.196; Weiss M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130350; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Welz C, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/4/045401; Wende K, 2016, MUTAT RES-GEN TOX EN, V798, P48, DOI 10.1016/j.mrgentox.2016.02.003; Wende K., 2013, PLASMA MED, V3, P81, DOI DOI 10.1615/PLASMAMED.2014009690; WILSON JX, 1992, NEUROCHEM RES, V17, P571, DOI 10.1007/BF00968785; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wolf T, 2002, MUTAT RES-GEN TOX EN, V514, P59, DOI 10.1016/S1383-5718(01)00317-5; Wolf T, 1997, MUTAT RES-GEN TOX EN, V394, P163, DOI 10.1016/S1383-5718(97)00136-8; Wolf T, 2008, MUTAT RES-GEN TOX EN, V650, P150, DOI 10.1016/j.mrgentox.2007.11.009; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; YASSINE F, 1989, CELL DIFFER DEV, V27, P29, DOI 10.1016/0922-3371(89)90042-7	73	78	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160667	10.1371/journal.pone.0160667	http://dx.doi.org/10.1371/journal.pone.0160667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584003	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600009
J	Moran, LJ; Brinkworth, GD; Martin, S; Wycherley, TP; Stuckey, B; Lutze, J; Clifton, PM; Wittert, GA; Noakes, M				Moran, Lisa J.; Brinkworth, Grant D.; Martin, Sean; Wycherley, Thomas P.; Stuckey, Bronwyn; Lutze, Janna; Clifton, Peter M.; Wittert, Gary A.; Noakes, Manny			Long-Term Effects of a Randomised Controlled Trial Comparing High Protein or High Carbohydrate Weight Loss Diets on Testosterone, SHBG, Erectile and Urinary Function in Overweight and Obese Men	PLOS ONE			English	Article							LIFE-STYLE CHANGES; REDUCED-FAT DIET; LOW-ENERGY DIET; TRACT SYMPTOMS; INTERNATIONAL INDEX; ENDOTHELIAL FUNCTION; MEAL REPLACEMENTS; SEXUAL FUNCTION; FUNCTION IIEF; DYSFUNCTION	Introduction Obesity is associated with reduced testosterone and worsened erectile and sexual function in men. Weight loss improves these outcomes. High protein diets potentially offer anthropometric and metabolic benefits, but their effects on reproductive and sexual outcomes is not known. Aim To examine the long-term effects of weight loss with a higher protein or carbohydrate diet on testosterone, sex hormone binding globulin, erectile dysfunction, lower urinary tract symptoms and sexual desire in overweight and obese men. Methods One-hundred and eighteen overweight or obese men (body mass index 27-40 kg/m(2), age 20-65 years) were randomly assigned to an energy restricted higher protein low fat (35% protein, 40% carbohydrate, 25% fat; n = 57) or higher carbohydrate low fat diet (17% protein, 58% carbohydrate, 25% fat, n = 61) diet for 52 weeks (12 weeks weight loss, 40 weeks weight maintenance). Primary outcomes were serum total testosterone, sex hormone binding globulin and calculated free testosterone. Secondary outcomes were erectile function as assessed by the International Index of Erectile Function (IIEF) (total score and erectile function domain), lower urinary tract symptoms and sexual desire. Results Total testosterone, sex hormone binding globulin and free testosterone increased (P<0.001) and the total IIEF increased (P = 0.017) with no differences between diets (P >= 0.244). Increases in testosterone (P = 0.037) and sex hormone binding globulin (P<0.001) and improvements in the total IIEF (P = 0.041) occurred from weeks 0-12 with a further increase in testosterone from week 12-52 (P = 0.002). Increases in free testosterone occurred from week 12-52 (p = 0.002). The IIEF erectile functon domain, lower urinary tract symptoms and sexual desire did not change in either group (P >= 0.126). Conclusions In overweight and obese men, weight loss with both high protein and carbohydrate diets improve testosterone, sex hormone binding globulin and overall sexual function.	[Moran, Lisa J.] Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Res Inst, Adelaide, SA, Australia; [Brinkworth, Grant D.; Lutze, Janna; Noakes, Manny] CSIRO Food & Nutr, Adelaide, SA, Australia; [Martin, Sean; Wittert, Gary A.] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia; [Martin, Sean; Wittert, Gary A.] South Australian Inst Hlth & Med Res, Adelaide, SA, Australia; [Wycherley, Thomas P.; Clifton, Peter M.] Univ South Australia, Div Hlth Sci, Adelaide, SA, Australia; [Stuckey, Bronwyn] Univ Western Australia, Keogh Inst Med Res, Perth, WA, Australia	Robinson Research Institute; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; University of South Australia; University of Western Australia	Moran, LJ (corresponding author), Univ Adelaide, Discipline Obstet & Gynaecol, Robinson Res Inst, Adelaide, SA, Australia.	lisa.moran@monash.edu	noakes, manny/H-2813-2013; wittert, gary/AAE-2398-2019; Brinkworth, Grant D/H-2815-2013	Wycherley, Thomas/0000-0003-3096-1796; Wittert, Gary/0000-0001-6818-6065; Brinkworth, Grant/0000-0001-9017-8395	CSIRO; Meat and Livestock Australia; South Australian Cardiovascular Research Development Program Fellowship; National Heart Foundation; South Australian Department of Health; South Australian Health and Medical Research Institute	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Meat and Livestock Australia(Meat and Livestock Australia); South Australian Cardiovascular Research Development Program Fellowship; National Heart Foundation(National Heart Foundation of Australia); South Australian Department of Health; South Australian Health and Medical Research Institute	This work was supported by CSIRO and with a project grant from Meat and Livestock Australia. LJM is supported by a South Australian Cardiovascular Research Development Program Fellowship; a program collaboratively funded by the National Heart Foundation, the South Australian Department of Health and the South Australian Health and Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2007, HYPERTENS RES, V30, P1029, DOI 10.1291/hypres.30.1029; ANDERSON KE, 1987, LIFE SCI, V40, P1761, DOI 10.1016/0024-3205(87)90086-5; Bekaert M, 2015, ENDOCRINE; Collins CE, 2013, OBES RES CLIN PRACT, V7, pE450, DOI 10.1016/j.orcp.2013.07.004; Corona G, 2013, EUR J ENDOCRINOL, V168, P829, DOI 10.1530/EJE-12-0955; DEHAVEN J, 1980, NEW ENGL J MED, V302, P477, DOI 10.1056/NEJM198002283020901; elDin KE, 1996, J UROLOGY, V155, P1959; Esposito K, 2004, JAMA-J AM MED ASSOC, V291, P2978, DOI 10.1001/jama.291.24.2978; Esposito K, 2009, J SEX MED, V6, P243, DOI 10.1111/j.1743-6109.2008.01030.x; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Henning PC, 2014, METABOLISM, V63, P628, DOI 10.1016/j.metabol.2014.02.007; HOFFER LJ, 1986, J CLIN ENDOCR METAB, V62, P288, DOI 10.1210/jcem-62-2-288; Isidori AM, 2014, EUR UROL, V65, P99, DOI 10.1016/j.eururo.2013.08.048; Jovanovski Elena, 2015, Clin Nutr Res, V4, P69, DOI 10.7762/cnr.2015.4.2.69; Kaukua J, 2003, OBES RES, V11, P689, DOI 10.1038/oby.2003.98; Khoo J, 2014, J HUM NUTR DIET, V27, P219, DOI 10.1111/jhn.12151; Khoo J, 2014, INT J IMPOT RES, V26, P61, DOI 10.1038/ijir.2013.36; Khoo J, 2010, INT J OBESITY, V34, P1396, DOI 10.1038/ijo.2010.76; Khoo J, 2011, J SEX MED, V8, P2868, DOI 10.1111/j.1743-6109.2011.02417.x; Kolotkin RL, 2012, OBESITY, V20, P2325, DOI 10.1038/oby.2012.104; Lutze J, 2013, E SPEN J, V8; Martin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137903; Maserejian NN, 2009, EUR UROL, V55, P1179, DOI 10.1016/j.eururo.2008.07.058; McVary KT, 2005, EUR UROL, V47, P838, DOI 10.1016/j.eururo.2005.02.001; Muller MJ, 2015, AM J CLIN NUTR, V102, P807, DOI 10.3945/ajcn.115.109173; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Reis LO, 2010, INT J ANDROL, V33, P736, DOI 10.1111/j.1365-2605.2009.01017.x; Roberts CK, 2002, CIRCULATION, V106, P2530, DOI 10.1161/01.CIR.0000040584.91836.0D; Rohrmann S, 2004, AM J EPIDEMIOL, V159, P390, DOI 10.1093/aje/kwh060; Rosen RC, 2011, EUR UROL, V60, P1010, DOI 10.1016/j.eururo.2011.07.053; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Schwingshackl L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097656; Spector IP, 1996, J SEX MARITAL THER, V22, P175; St Sauver JL, 2011, UROLOGY, V78, P437, DOI 10.1016/j.urology.2011.03.054; TSITOURAS PD, 1982, J GERONTOL, V37, P288, DOI 10.1093/geronj/37.3.288; Van Anders SM, 2006, HUM NATURE-INT BIOS, V17, P212, DOI 10.1007/s12110-006-1018-7; Wing RR, 2010, J SEX MED, V7, P156, DOI 10.1111/j.1743-6109.2009.01458.x; Wycherley TP, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.11; Wycherley TP, 2012, AM J CLIN NUTR, V96, P1281, DOI 10.3945/ajcn.112.044321	41	45	46	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161297	10.1371/journal.pone.0161297	http://dx.doi.org/10.1371/journal.pone.0161297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584019	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000382855600019
J	Sugi, H; Yamaguchi, M; Ohno, T; Kobayashi, T; Chaen, S; Okuyama, H				Sugi, Haruo; Yamaguchi, Maki; Ohno, Tetsuo; Kobayashi, Takakazu; Chaen, Shigeru; Okuyama, Hiroshi			Tension Recovery following Ramp-Shaped Release in High-Ca and Low-Ca Rigor Muscle Fibers: Evidence for the Dynamic State of AMADP Myosin Heads in the Absence of ATP	PLOS ONE			English	Article							SKELETAL-MUSCLE; DONNAN POTENTIALS; MECHANISM; BINDING; LOAD	During muscle contraction, myosin heads (M) bound to actin (A) perform power stroke associated with reaction, AMADPPi -> AM + ADP + Pi. In this scheme, A . M is believed to be a high-affinity complex after removal of ATP. Biochemical studies on extracted protein samples show that, in the AM complex, actin-binding sites are located at both sides of junctional peptide between 50K and 20K segments of myosin heavy chain. Recently, we found that a monoclonal antibody (IgG) to the junctional peptide had no effect on both in vitro actin-myosin sliding and skinned muscle fiber contraction, though it covers the actin-binding sites on myosin. It follows from this that, during muscle contraction, myosin heads do not pass through the static rigor AM configuration, determined biochemically and electron microscopically using extracted protein samples. To study the nature of AM and AMADP myosin heads, actually existing in muscle, we examined mechanical responses to ramp-shaped releases (0.5% of Lo, complete in 5ms) in single skinned rabbit psoas muscle fibers in high-Ca (pCa, 4) and low-Ca (pCa, >9) rigor states. The fibers exhibited initial elastic tension drop and subsequent small but definite tension recovery to a steady level. The tension recovery was present over many minutes in high-pCa rigor fibers, while it tended to decrease quickly in low-Ca rigor fibers. EDTA (10mM, with MgCl2 removed) had no appreciable effect on the tension recovery in high-Ca rigor fibers, while it completely eliminated the tension recovery in low-Ca rigor fibers. These results suggest that the AMADP myosin heads in rigor muscle have long lifetimes and dynamic properties, which show up as the tension recovery following applied release. Possible AM linkage structure in muscle is discussed in connection with the X-ray diffraction pattern from contracting muscle, which is intermediate between resting and rigor muscles.	[Sugi, Haruo] Teikyo Univ, Dept Physiol, Sch Med, Tokyo, Japan; [Yamaguchi, Maki; Ohno, Tetsuo; Okuyama, Hiroshi] Jikei Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kobayashi, Takakazu] Shibaura Inst Technol, Dept Elect Engn, Tokyo, Japan; [Chaen, Shigeru] Nihon Univ, Dept Integrated Sci Phys & Biol, Coll Humanities & Sci, Tokyo, Japan	Teikyo University; Jikei University; Shibaura Institute of Technology; Nihon University	Sugi, H (corresponding author), Teikyo Univ, Dept Physiol, Sch Med, Tokyo, Japan.	sugi@kyf.biglobe.ne.jp						Bagshaw CR, 1993, MUSCLE CONTRACTION, P93; BARTELS EM, 1985, BIOPHYS J, V48, P61, DOI 10.1016/S0006-3495(85)83760-7; BARTELS EM, 1993, BIOCHIM BIOPHYS ACTA, V1157, P63, DOI 10.1016/0304-4165(93)90079-N; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; IWAMOTO H, 1990, J PHYSIOL-LONDON, V422, P185, DOI 10.1113/jphysiol.1990.sp017979; KUSHMERICK MJ, 1969, SCIENCE, V166, P1297, DOI 10.1126/science.166.3910.1297; Levine B.A., 1990, MOL MECHANISMS MUSCL, P171; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MILLIGAN RA, 1990, NATURE, V348, P217, DOI 10.1038/348217a0; NAYLOR GRS, 1985, BIOPHYS J, V48, P47, DOI 10.1016/S0006-3495(85)83759-0; Radocaj A, 2009, BIOPHYS J, V96, P1430, DOI 10.1016/j.bpj.2008.11.023; Squire JM, 1981, STRUCTURAL BASIS MUS, P534; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Sugi H, 1998, P NATL ACAD SCI USA, V95, P2273, DOI 10.1073/pnas.95.5.2273; Sugi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093272; Sugi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063658; SUZUKI S, 1983, J GEN PHYSIOL, V81, P531, DOI 10.1085/jgp.81.4.531	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162003	10.1371/journal.pone.0162003	http://dx.doi.org/10.1371/journal.pone.0162003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583360	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600084
J	Zimmer, C				Zimmer, Christoph			Experimental Design for Stochastic Models of Nonlinear Signaling Pathways Using an Interval-Wise Linear Noise Approximation and State Estimation	PLOS ONE			English	Article							BAYESIAN-INFERENCE; NUMERICAL-METHODS; GENE; FLUCTUATIONS; NETWORKS; CALCIUM	Background Computational modeling is a key technique for analyzing models in systems biology. There are well established methods for the estimation of the kinetic parameters in models of ordinary differential equations (ODE). Experimental design techniques aim at devising experiments that maximize the information encoded in the data. For ODE models there are well established approaches for experimental design and even software tools. However, data from single cell experiments on signaling pathways in systems biology often shows intrinsic stochastic effects prompting the development of specialized methods. While simulation methods have been developed for decades and parameter estimation has been targeted for the last years, only very few articles focus on experimental design for stochastic models. Methods The Fisher information matrix is the central measure for experimental design as it evaluates the information an experiment provides for parameter estimation. This article suggest an approach to calculate a Fisher information matrix for models containing intrinsic stochasticity and high nonlinearity. The approach makes use of a recently suggested multiple shooting for stochastic systems (MSS) objective function. The Fisher information matrix is calculated by evaluating pseudo data with the MSS technique. Results The performance of the approach is evaluated with simulation studies on an Immigration-Death, a Lotka-Volterra, and a Calcium oscillation model. The Calcium oscillation model is a particularly appropriate case study as it contains the challenges inherent to signaling pathways: high nonlinearity, intrinsic stochasticity, a qualitatively different behavior from an ODE solution, and partial observability. The computational speed of the MSS approach for the Fisher information matrix allows for an application in realistic size models.	[Zimmer, Christoph] Heidelberg Univ, BIOMS, Neuenheimer Feld 267, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Zimmer, C (corresponding author), Heidelberg Univ, BIOMS, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	christoph.zimmer@bioquant.uni-heidelberg.de			Bioms	Bioms	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CZ was supported by Bioms.	Andreychenko A, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-9; Bauer I, 2000, J COMPUT APPL MATH, V120, P1, DOI 10.1016/S0377-0427(00)00300-9; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bock H.G., 2007, REACTIVE FLOWS DIFFU, P117, DOI DOI 10.1007/978-3-540-28396-6_6; Boys RJ, 2008, STAT COMPUT, V18, P125, DOI 10.1007/s11222-007-9043-x; Chaloner K, 1995, STAT SCI, V10, P273, DOI 10.1214/ss/1177009939; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Faller D, 2003, SIMUL-T SOC MOD SIM, V79, P717, DOI 10.1177/0037549703040937; Fearnhead P, 2014, BIOMETRICS, V70, P457, DOI 10.1111/biom.12152; Fedorov V.V, 1997, MODEL ORIENTED DESIG; Finkenstadt B, 2013, ANN APPL STAT, V7, P1960, DOI 10.1214/13-AOAS669; Frohlich F, COMPUTATIONAL METHOD; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gillespie CS, 2009, IET SYST BIOL, V3, P52, DOI 10.1049/iet-syb:20070031; Gillespie CS, 2010, J R STAT SOC C-APPL, V59, P341, DOI 10.1111/j.1467-9876.2009.00696.x; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2015, J CHEM PHYS, P136; Hasenauer J, 2013, J MATH BIOL; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Korkel S, 2005, MODELLING, SIMULATION AND OPTIMIZATION OF COMPLEX PROCESSES, P255, DOI 10.1007/3-540-27170-8_20; Korkel S, 2004, OPTIM METHOD SOFTW, V19, P327, DOI 10.1080/10556780410001683078; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Kummer U, 2005, BIOPHYS J, V89, P1603, DOI 10.1529/biophysj.104.057216; KURTZ TG, 1972, J CHEM PHYS, V57, P2976, DOI 10.1063/1.1678692; Lehmann EL, 1998, THEORY OF POINT ESTI; Mikeev L., 2012, HSCC 12; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Munsky B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.75; Nandy P, 2012, OPTIMAL PERTURBATION, P686; Pagendam DE, 2010, THESIS; Pahle J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-86; Pahle J, 2009, BRIEF BIOINFORM, V10, P53, DOI 10.1093/bib/bbn050; Piaggio HTH, 1982, AN ELEMENTARY TREATI; PORAT B, 1986, IEEE T ACOUST SPEECH, V34, P118, DOI 10.1109/TASSP.1986.1164786; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Raue A, BIOINFORMATICS, V25; Ruess J, 2015, P NATL ACAD SCI USA, V112, P8148, DOI 10.1073/pnas.1423947112; Ruess J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0588; Steiert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040052; Thomas P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S5; Wang YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-99; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wilkinson DJ, 2006, MATHEMATICAL AND COM; Wu S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3576123; Zimmer C., 2012, J COMPUT SCI SYST BI, V6, P11, DOI DOI 10.4172/JCSB.1000095); Zimmer C, 2015, MATH BIOSCI, V269, P117, DOI 10.1016/j.mbs.2015.08.015; Zimmer C, 2015, IET SYST BIOL, V9, P181, DOI 10.1049/iet-syb.2014.0020; Zimmer C, 2015, IET SYST BIOL, V9, P64, DOI 10.1049/iet-syb.2014.0010	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0159902	10.1371/journal.pone.0159902	http://dx.doi.org/10.1371/journal.pone.0159902			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583802	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600002
J	Beyene, HB; Beyene, MB; Ebstie, YA; Desalegn, Z				Beyene, Habtamu Bedimo; Beyene, Melkamu Bedimo; Ebstie, Yehenew Asmamaw; Desalegn, Zelalem			Efficacy of Chloroquine for the Treatment of Vivax malaria in Northwest Ethiopia	PLOS ONE			English	Article							PLASMODIUM-VIVAX; FALCIPARUM-MALARIA; RESISTANCE	Background Resistance to anti-malarials is a major challenge for effective malaria control in sub-Saharan Africa. This triggered a need for routine monitoring of the efficacy of the antimalarial drugs every two years in all malaria endemic countries. Chloroquine remained the drug of choice for the treatment of vivax malaria in Ethiopia. Though, a strong scientific evidence of chloroquine resistance to P. vivax that could have brought change of treatment regimen is yet to be established in Ethiopia, continuous and regular monitoring of drug's efficacy is critical for establishing rational anti-malarial drug policies. This study therefore, assessed the therapeutic efficacy of Chloroquine (CQ) for the treatment of Plasmodium vivax infections in Northwestern Ethiopia. Methods An observational, 28-day therapeutic clinical efficacy study was conducted from August to December, 2014, in Northwest Ethiopia. Patients confirmed to have monoinfection of vivax malaria, aged above 6 months were included. All subjects were treated with standard chloroquine dose of 25 mg/kg for three (3) days. Parasitological and clinical outcomes of treated patients were then evaluated on days 1, 2, 3, 7, 14, 21, and 28 during the entire 28-day follow-up period. A portable spectrophotometer (HemoCue Hb 301 System, Sweden) was used to estimate hemoglobin concentration. Results A total of 69 subjects had completed follow up. Some 57/69 (82.6%) had fever at enrolment and the rest 12 patients 48 hours before enrollment. Out of total, 65/69 (94.2%) and 66/69 (95.6%) of the study subjects were free of fever by day 1 and day 2 respectively but fever was cleared in all subjects by day 3. At base line the mean asexual parasitemia was 3540 parasites/mu L of blood. Parasite carriage on day 3 was 3%. The overall cure rate (an adequate and clinical parasitological response) was very high (97%) [(95% CI = 93.1-99.4)]. The time to parasite, fever and gametocyte clearance as expressed in mean (SD) was 35 (3), 25 (4.6), 28 (3.2) hours respectively. Mean hemoglobin was significantly increased (P<0.001) from 12.2 (7-15) g/dl at day 0 to 13.3 (10-16) g/dl on day 28. Conclusions In view of our findings, CQ remains efficacious for the treatment of vivax malaria in the study area. However, there is a need to monitor CQR regularly using molecular and or biochemical tools for better evaluation of treatment outcomes.	[Beyene, Habtamu Bedimo; Ebstie, Yehenew Asmamaw; Desalegn, Zelalem] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia; [Beyene, Melkamu Bedimo] Bahir Dar Univ, Dept Publ Hlth, Coll Hlth Sci, Bahir Dar, Ethiopia	Addis Ababa University; Bahir Dar University	Beyene, HB (corresponding author), Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia.	habtish1976@gmail.com	beyene, habtamu/AAN-2485-2021	Asemamaw Ebstie, Yehenew/0000-0002-6188-5039; Beyene, Melkamu Bedimo/0000-0003-4349-9887				Abebe Workeabeba, 2006, Ethiop Med J, V44, P133; Adugna A, 2013, MALARIA IN ETHIOPIA; [Anonymous], 2008, J VECTOR DIS, V45, P176; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Assefa M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0983-x; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; BAIRD JK, 1991, AM J TROP MED HYG, V44, P547, DOI 10.4269/ajtmh.1991.44.547; BGRS, 2014, ETH DEM HLTH; Degefa T, 2004, ETHIOPIAN MED J, V42, P35; Drug Administration and Control Authority (DACA) of Ethiopia Contents, 2010, STAND TREATM GUID PR; Ebstie YA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0744-x; Erko Berhanu, 1995, Tropical Medicine, V37, P73; Farooq Umar, 2004, Journal of Vector Borne Diseases, V41, P45; FMoH, 2014, EP PROF MAL ETH; FMOH (Federal ministry of Health of Ethiopia), 2012, NAT MAL GUID; FOSTER SD, 1991, B WORLD HEALTH ORGAN, V69, P349; Galappaththy GNL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub2; Gebru-Woldearegai T, 2005, AM J TROP MED HYG, V73, P1131, DOI 10.4269/ajtmh.2005.73.1131; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Getachew S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1041-4; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; JELKMANN W, 1992, LIFE SCI, V50, P301, DOI 10.1016/0024-3205(92)90338-P; Ketema T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-177; Ketema T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-46; Mekonnen SK, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0826-9; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; RIECKMANN KH, 1989, LANCET, V2, P1183, DOI 10.1016/S0140-6736(89)91792-3; Sowunmi A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-53; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Teka H, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-220; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Tulu AN, 1996, T ROY SOC TROP MED H, V90, P556, DOI 10.1016/S0035-9203(96)90322-3; Vaca G, 2002, BLOOD CELL MOL DIS, V28, P436, DOI 10.1006/bcmd.2002.0532; White NJ, 1998, BRIT MED BULL, V54, P703, DOI 10.1093/oxfordjournals.bmb.a011721; WHO, 2015, TREATM MAL; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2014, MAL REP; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS; Yeshiwondim AK, 2010, ACTA TROP, V113, P105, DOI 10.1016/j.actatropica.2009.10.001	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161483	10.1371/journal.pone.0161483	http://dx.doi.org/10.1371/journal.pone.0161483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579480	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400026
J	Birkenmeier, G; Hemdan, NYA; Kurz, S; Bigl, M; Pieroh, P; Debebe, T; Buchold, M; Thieme, R; Wichmann, G; Dehghani, F				Birkenmeier, Gerd; Hemdan, Nasr Y. A.; Kurz, Susanne; Bigl, Marina; Pieroh, Philipp; Debebe, Tewodros; Buchold, Martin; Thieme, Rene; Wichmann, Gunnar; Dehghani, Faramarz			Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; WIDE THERAPEUTIC WINDOW; OXIDATIVE STRESS; CANCER CELLS; ISCHEMIC-INJURY; IN-VIVO; GROWTH; INHIBITION; APOPTOSIS; DISEASE	Ethyl pyruvate, a known ROS scavenger and anti-inflammatory drug was found to combat leukemia cells. Tumor cell killing was achieved by concerted action of necrosis/apoptosis induction, ATP depletion, and inhibition of glycolytic and para-glycolytic enzymes. Ethyl lactate was less harmful to leukemia cells but was found to arrest cell cycle in the G0/G1 phase. Both, ethyl pyruvate and ethyl lactate were identified as new inhibitors of GSK-3 beta. Despite the strong effect of ethyl pyruvate on leukemia cells, human cognate blood cells were only marginally affected. The data were compiled by immune blotting, flow cytometry, enzyme activity assay and gene array analysis. Our results inform new mechanisms of ethyl pyruvate-induced cell death, offering thereby a new treatment regime with a high therapeutic window for leukemic tumors.	[Birkenmeier, Gerd; Hemdan, Nasr Y. A.; Kurz, Susanne; Bigl, Marina; Buchold, Martin] Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany; [Pieroh, Philipp] Univ Leipzig, Dept Orthoped Trauma & Plast Surg, Liebigstr 20, D-04103 Leipzig, Germany; [Debebe, Tewodros] Univ Leipzig, Inst Med Microbiol, Fac Med, Liebigstr 21, D-04103 Leipzig, Germany; [Debebe, Tewodros] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Thieme, Rene] Univ Leipzig, Univ Med Ctr, Dept Visceral Transplantat Thorac & Vasc Surg, Liebigstr 19, D-04103 Leipzig, Germany; [Wichmann, Gunnar] Univ Leipzig, Fac Med, Univ Hosp Leipzig, Dept Otolaryngol Head & Neck Surg,ENT Res Lab, Liebigstr 21, D-04103 Leipzig, Germany; [Pieroh, Philipp; Dehghani, Faramarz] Univ Halle Wittenberg, Dept Anat & Cell Biol, Grosse Steinstr 52, D-06097 Halle, Saale, Germany	Leipzig University; Leipzig University; Leipzig University; Bahir Dar University; Leipzig University; Leipzig University; Martin Luther University Halle Wittenberg	Birkenmeier, G (corresponding author), Univ Leipzig, Inst Biochem, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	gerd.birkenmeier@medizin.uni-leipzig.de	Hemdan, Nasr Y. A./H-5430-2019; Wichmann, Gunnar/AGW-9592-2022	Hemdan, Nasr Y. A./0000-0002-6748-0649; Wichmann, Gunnar/0000-0001-6191-2095; Pieroh, Philipp/0000-0003-0906-5479; Aklilu, Tewodros Debebe/0000-0002-8421-1651				Aneja R, 2007, TRENDS MICROBIOL, V15, P31, DOI 10.1016/j.tim.2006.11.005; Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Bigl M, 1999, J NEURAL TRANSM, V106, P499, DOI 10.1007/s007020050174; Birkenmeier G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010399; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clary JJ, 1998, REGUL TOXICOL PHARM, V27, P88, DOI 10.1006/rtph.1997.1175; DELARUE JC, 1988, BREAST CANCER RES TR, V11, P273, DOI 10.1007/BF01807287; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Eguchi Y, 1997, CANCER RES, V57, P1835; Fink M P, 2001, Minerva Anestesiol, V67, P190; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; Gozzini A, 2005, ANN HEMATOL, V84, P54, DOI 10.1007/s00277-005-0006-z; Hicsonmez G, 2006, LEUKEMIA RES, V30, P60, DOI 10.1016/j.leukres.2005.05.015; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Hu XR, 2012, MOL BIOL REP, V39, P227, DOI 10.1007/s11033-011-0730-5; Huh SH, 2011, J IMMUNOL, V187, P960, DOI 10.4049/jimmunol.1100009; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Jaworski T, 2011, NATURE, V480, pE4, DOI 10.1038/nature10615; Jope RS, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00016; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Liang XY, 2009, J LEUKOCYTE BIOL, V86, P599, DOI 10.1189/jlb.0908578; Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Miyazawa N, 2010, FREE RADICAL RES, V44, P101, DOI 10.3109/10715760903321788; Niehrs C, 2010, CELL, V143, P1044, DOI 10.1016/j.cell.2010.12.003; Obajimi O, 2008, CANCER CHEMOTH PHARM, V62, P215, DOI 10.1007/s00280-007-0593-6; Pardee TS, 2012, BLOOD, V119, P3561, DOI 10.1182/blood-2011-06-362442; Rabbani N, 2008, BIOCHEM SOC T, V36, P1045, DOI 10.1042/BST0361045; Shangari N, 2004, BIOCHEM PHARMACOL, V68, P1433, DOI 10.1016/j.bcp.2004.06.013; Shiohara M, 1996, J CELL PHYSIOL, V166, P568, DOI 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3; Song EY, 2010, EXP HEMATOL, V38, P908, DOI 10.1016/j.exphem.2010.06.001; Su JW, 2008, CRIT CARE MED, V36, P1059, DOI 10.1097/CCM.0B013E318164403B; Su ZY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0321-5; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thieme R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130470; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Verma D, 2009, CANCER-AM CANCER SOC, V115, P101, DOI 10.1002/cncr.24005; Wang Q, 2009, ANESTHESIOLOGY, V110, P1279, DOI 10.1097/ALN.0b013e3181a160d6; WARBURG O, 1956, SCIENCE, V124, P269; Worku N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137353; Yu YM, 2005, STROKE, V36, P2238, DOI 10.1161/01.STR.0000181779.83472.35; Zhang J, 2012, ONCOL REP, V27, P1511, DOI 10.3892/or.2012.1623; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161571	10.1371/journal.pone.0161571	http://dx.doi.org/10.1371/journal.pone.0161571			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579985	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877400029
J	Diaz-Perez, L; Rodriguez-Zaragoza, FA; Ortiz, M; Cupul-Magana, AL; Carriquiry, JD; Rios-Jara, E; Rodriguez-Troncoso, AP; Garcia-Rivas, MD				Diaz-Perez, Leopoldo; Alejandro Rodriguez-Zaragoza, Fabian; Ortiz, Marco; Levi Cupul-Magana, Amilcar; Carriquiry, Jose D.; Rios-Jara, Eduardo; Paola Rodriguez-Troncoso, Alma; del Carmen Garcia-Rivas, Maria			Coral Reef Health Indices versus the Biological, Ecological and Functional Diversity of Fish and Coral Assemblages in the Caribbean Sea	PLOS ONE			English	Article							TAXONOMIC DISTINCTNESS; COMMUNITY STRUCTURE; BUILDING CORALS; CLIMATE-CHANGE; BIODIVERSITY; CONSERVATION; HABITAT; DECLINE; EXTINCTION; MANAGEMENT	This study evaluated the relationship between the indices known as the Reef Health Index (RHI) and two-dimensional Coral Health Index (2D-CHI) and different representative metrics of biological, ecological and functional diversity of fish and corals in 101 reef sites located across seven zones in the western Caribbean Sea. Species richness and average taxonomic distinctness were used to asses biological estimation; while ecological diversity was evaluated with the indices of Shannon diversity and Pielou's evenness, as well as by taxonomic diversity and distinctness. Functional diversity considered the number of functional groups, the Shannon diversity and the functional Pielou's evenness. According to the RHI, 57.15% of the zones were classified as presenting a "poor" health grade, while 42.85% were in "critical" grade. Based on the 2D-CHI, 28.5% of the zones were in "degraded" condition and 71.5% were "very degraded". Differences in fish and coral diversity among sites and zones were demonstrated using permutational ANOVAs. Differences between the two health indices (RHI and 2D-CHI) and some indices of biological, ecological and functional diversity of fish and corals were observed; however, only the RHI showed a correlation between the health grades and the species and functional group richness of fish at the scale of sites, and with the species and functional group richness and Shannon diversity of the fish assemblages at the scale of zones. None of the health indices were related to the metrics analyzed for the coral diversity. In general, our study suggests that the estimation of health indices should be complemented with classic community indices, or should at least include diversity indices of fish and corals, in order to improve the accuracy of the estimated health status of coral reefs in the western Caribbean Sea.	[Diaz-Perez, Leopoldo; Alejandro Rodriguez-Zaragoza, Fabian; Rios-Jara, Eduardo] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Lab Ecosistemas Marinos & Acuicultura, Zapopan Jalisco, Mexico; [Ortiz, Marco] Univ Antofagasta, Fac Recursos Mar, Fac Ciencias Mar & Recursos Biol Invest Oceanol, Inst Ciencias Nat AvH,LAMSEC, Antofagasta, Chile; [Levi Cupul-Magana, Amilcar; Paola Rodriguez-Troncoso, Alma] Univ Guadalajara, Ctr Univ La Costa, Ctr Invest Costeras, Dept Ciencias Biol, Puerto Vallarta, Jalisco, Mexico; [Carriquiry, Jose D.] Univ Autonoma Baja California, Inst Invest Oceanol, Ensenada, Baja California, Mexico; [del Carmen Garcia-Rivas, Maria] Reserva Biosfera Banco Chinchorro CONANP, Chetmal, Quintana Roo, Mexico	Universidad de Guadalajara; Universidad de Antofagasta; Universidad de Guadalajara; Universidad Autonoma de Baja California	Rodriguez-Zaragoza, FA (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Dept Ecol, Lab Ecosistemas Marinos & Acuicultura, Zapopan Jalisco, Mexico.	fabianrz@cucba.udg.mx	CARRIQUIRY, JOSE D/R-9190-2017; Rodríguez-Troncoso, Alma P/B-2495-2014; Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015	Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275	National Commission of Natural Protected Areas (PROCODES); Universidad de GUadalajara [P3E2009-2011]; University of Baja California - National Biodiversity Commission [GM006]; World Wildlife Fund-CA [KL82]; PROMEP-SEP [PROMEP / 103.5 / 12/9144]	National Commission of Natural Protected Areas (PROCODES); Universidad de GUadalajara; University of Baja California - National Biodiversity Commission; World Wildlife Fund-CA; PROMEP-SEP	This work was supported by the National Commission of Natural Protected Areas (PROCODES 2007, 2008, 2009, 2011), Universidad de GUadalajara (project P3E2009-2011), University of Baja California - National Biodiversity Commission (project GM006), and World Wildlife Fund-CA (Agreement KL82). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the National Commission of Natural Protected Areas (CONANP by its Spanish acronym), the University of Guadalajara, University of Baja California-National Biodiversity Commission (CONABIO, by its Spanish acronym), as well as the Nicaraguan Institute of Fishery (INPESCA, by its Spanish acronym), World Wildlife Fund (WWF - CA), Cayo Cochinos Foundation and Mario Dary Foundation for your cooperation for this research. We also thank to PROMEP-SEP for the postdoctoral fellowship No. PROMEP / 103.5 / 12/9144 assigned to Dr. Leopoldo Diaz Perez of faculty of Aquatic Ecosystems and Fisheries of the University of Guadalajara. The authors thank all the people involved in the field work of the government and nongovernmental institutions of the different countries involved in this project, particularly Felipe Fonseca (CONANP), Alicia Medina and Pablo Rico (WWF-CA), Renaldy Barnutti and Oscar Gonzaga (INPESCA), Rosario Priego, Brenda Hermosillo and Irving Chavez (U. de G.) and Julio Villaescusa (UABC). Finally, we want to thank Melanie McField (Director of Healthy Reefs Initiative), and one anonymous reviewer, as well as PLOS ONE editors for providing comments that improved the manuscript.	Acosta-Gonzalez G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065665; Alvarez-Filip L, 2006, MAR ECOL-EVOL PERSP, V27, P253, DOI 10.1111/j.1439-0485.2006.00108.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arias-Gonzalez JE, 2011, CIENC MAR, V37, P87, DOI 10.7773/cm.v37i1.1746; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barber RT, 2001, HUM ECOL RISK ASSESS, V7, P1255, DOI 10.1080/20018091094989; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Ben-Tzvi O, 2004, MAR POLLUT BULL, V48, P954, DOI 10.1016/j.marpolbul.2003.11.022; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carriquiry JD, 2013, CONSERVATION SUSTAIN, DOI [10.5772/54339, DOI 10.5772/54339]; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; Done Terence J., 1996, SCOPE, V55, P393; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Arias-Gonzalez JE, 2012, BIODIVERS CONSERV, V21, P115, DOI 10.1007/s10531-011-0169-y; Arias-Gonzalez JE, 2008, J EXP MAR BIOL ECOL, V366, P28, DOI 10.1016/j.jembe.2008.07.035; Froese R., 2014, FISHBASE; Galvan-Villa CM, 2010, REV BIOL MAR OCEANOG, V45, P311; Garcia-Salgado M, 2008, STATUS CORAL REEFS W, P253; GOMEZ ED, 1994, MAR POLLUT BULL, V29, P62, DOI 10.1016/0025-326X(94)90427-8; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heino J, 2008, LANDSCAPE ECOL, V23, P417, DOI 10.1007/s10980-008-9199-6; HIRATA H, 1986, ECOL MODEL, V31, P79, DOI 10.1016/0304-3800(86)90057-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; HRI, 2010, 2010 REP CARD MES RE; HRI, 2008, 2008 REP CARD MES RE; HRI, 2015, 2015 REP CARD MES RE; HRI, 2012, 2012 REP CARD MES RE; Humann P, 2006, REEF FISH IDENTIFICA; Jameson SC, 2001, B MAR SCI, V69, P701; Jameson SC, 1999, CORAL REEFS, V18, P333, DOI 10.1007/s003380050208; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Jorgensen S.E., 2005, HDB ECOLOGICAL INDIC; Kaufman L, 2011, CORAL HLTH INDEX CHI; Kuhlmann KJ, 2002, AQUACULT INT, V10, P527, DOI 10.1023/A:1023955626357; Lasagna R, 2014, ECOL INDIC, V40, P1, DOI 10.1016/j.ecolind.2013.12.020; Levins R., 1998, ECOSYSTEM HLTH EDITE, P178; LOYA Y, 1976, ECOLOGY, V57, P278, DOI 10.2307/1934816; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McField M., 2007, HLTH REEFS HLTH PEOP; Mcfield MD, 2005, P 10 INT COR REEF S, P1118; McField Melanie, 2011, University of British Columbia Fisheries Centre Research Reports, V19, P129; Monaco ME, 1997, MAR ECOL PROG SER, V161, P239, DOI 10.3354/meps161239; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Nunez-Lara Enrique, 2003, Atoll Research Bulletin, V496, P338; Opitz S, 43 ICLARM, V43, P341; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rodriguez-Zaragoza FA, 2012, LAT AM J AQUAT RES, V40, P992, DOI 10.3856/vol40-issue4-fulltext-15; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smith M.J., 2001, DESIGN IMPLEMENTATIO; Smith TB, 2008, MAR POLLUT BULL, V56, P1983, DOI 10.1016/j.marpolbul.2008.08.015; Sweatman H, 2007, CORAL REEF HLT UNPUB; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Wilkinson C, 2008, STATUS CARIBBEAN COR; ZAHL S, 1977, ECOLOGY, V58, P907, DOI 10.2307/1936227	71	25	25	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161812	10.1371/journal.pone.0161812	http://dx.doi.org/10.1371/journal.pone.0161812			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579575	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400042
J	Navratilova, Z; Novosadova, E; Hagemann-Jensen, M; Kullberg, S; Kolek, V; Grunewald, J; Petrek, M				Navratilova, Zdenka; Novosadova, Eva; Hagemann-Jensen, Michael; Kullberg, Susanna; Kolek, Vitezslav; Grunewald, Johan; Petrek, Martin			Expression Profile of Six RNA-Binding Proteins in Pulmonary Sarcoidosis	PLOS ONE			English	Article							INDUCED MATRIX-METALLOPROTEINASE-9 EXPRESSION; IDIOPATHIC INTERSTITIAL PNEUMONIAS; AIRWAY EPITHELIAL-CELLS; CD4(+) T-CELLS; MESSENGER-RNA; MATRIX METALLOPROTEINASES; NITRIC-OXIDE; HUR; DISEASE; NUCLEOLIN	Background Sarcoidosis is characterised by up-regulation of cytokines and chemokine ligands/receptors and proteolytic enzymes. This pro-inflammatory profile is regulated post-transcriptionally by RNA-binding proteins (RBPs). We investigated in vivo expression of six RBPs (AUF1, HuR, NCL, TIA, TIAR, PCBP2) and two inhibitors of proteolytic enzymes (RECK, PTEN) in pulmonary sarcoidosis and compared it to the expression in four control groups of healthy individuals and patients with other respiratory diseases: chronic obstructive pulmonary disease (COPD), asthma and idiopathic interstitial pneumonias (IIPs). Methods RT-PCR was used to quantify the mRNAs in bronchoalveolar (BA) cells obtained from 50 sarcoidosis patients, 23 healthy controls, 30 COPD, 19 asthmatic and 19 IIPs patients. Flow cytometry was used to assess intracellular protein expression of AUF1 and HuR in peripheral blood T lymphocytes (PBTLs) obtained from 9 sarcoidosis patients and 6 healthy controls. Results Taking the stringent conditions for multiple comparisons into consideration, we consistently observed in the primary analysis including all patients regardless of smoking status as well as in the subsequent sub-analysis limited for never smokers that the BA mRNA expression of AUF1 (p<0.001), TIA (p<0.001), NCL (p<0.01) and RECK (p<0.05) was decreased in sarcoidosis compared to healthy controls. TIA mRNA was also decreased in sarcoidosis compared to both obstructive pulmonary diseases (COPD and asthma; p<0.001) but not compared to IIPs. There were several positive correlations between RECK mRNA and RBP mRNAs in BA cells. Also sarcoidosis CD3+ ,CD4+ and CD8+ PBTLs displayed lower mean fluorescence intensity of AUF1 (p <= 0.02) and HuR (p <= 0.03) proteins than control healthy PBTLs. Conclusion mRNA expressions of three RBPs (AUF1, TIA and NCL) and their potential target mRNA encoding RECK in BA cells and additionally protein expression of AUF1 and HuR in PBTLs were down-regulated in our sarcoidosis patients compared to healthy individuals. Its significance, e.g. for stability of mRNAs encoding pro-inflammatory factors, should be further explored in sarcoidosis.	[Navratilova, Zdenka; Novosadova, Eva; Petrek, Martin] Palacky Univ, Lab Immunogen & Immunoprote, Dept Pathol Physiol, Fac Med & Dent, Olomouc, Czech Republic; [Navratilova, Zdenka; Kullberg, Susanna; Grunewald, Johan] Karolinska Inst, Resp Med Unit, Dept Med, Stockholm, Sweden; [Navratilova, Zdenka; Petrek, Martin] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic; [Hagemann-Jensen, Michael] Dept Med, Resp Med Unit, Solna, Sweden; [Hagemann-Jensen, Michael] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Kolek, Vitezslav] Palacky Univ, Dept Resp Med, Olomouc, Czech Republic	Palacky University Olomouc; Karolinska Institutet; Palacky University Olomouc; Karolinska Institutet; Palacky University Olomouc	Navratilova, Z; Petrek, M (corresponding author), Palacky Univ, Lab Immunogen & Immunoprote, Dept Pathol Physiol, Fac Med & Dent, Olomouc, Czech Republic.; Navratilova, Z (corresponding author), Karolinska Inst, Resp Med Unit, Dept Med, Stockholm, Sweden.; Navratilova, Z; Petrek, M (corresponding author), Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.	zdenka1navratilova@gmail.com; martin.petrek@fnol.cz	Kullberg, Susanna/AAF-4057-2020; Hagemann-Jensen, Michael/AAO-8176-2020; Petrek, Martin/AAV-8962-2020; Grunewald, Johan/GQZ-8122-2022	Kullberg, Susanna/0000-0003-2844-4773; Hagemann-Jensen, Michael/0000-0002-6423-8216; Petrek, Martin/0000-0002-4517-7825; Navratilova, Zdenka/0000-0002-7983-3333; Grunewald, Johan/0000-0003-0473-3984	Swedish Heart Lung Foundation; Swedish Research Council; Stockholm County Council; Swedish Association for Chest Physicians; Karolinska Institutet;  [LO1304];  [CZ.1.07/2.3.00/30.0004];  [IGA PU LF_2016_009]	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Association for Chest Physicians; Karolinska Institutet(Karolinska Institutet); ; ; 	The work was supported by grant project LO1304, CZ.1.07/2.3.00/30.0004 and IGA PU LF_2016_009. Financial support was also received from The Swedish Heart Lung Foundation, The Swedish Research Council, The Stockholm County Council, The Swedish Association for Chest Physicians, and Karolinska Institutet.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Chowdhury S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003747; Dancer RCA, 2011, EUR RESPIR J, V38, P1461, DOI 10.1183/09031936.00024711; Fahling M, 2005, BBA-GENE STRUCT EXPR, V1731, P32, DOI 10.1016/j.bbaexp.2005.08.005; Fireman E, 2002, CLIN EXP IMMUNOL, V130, P331, DOI 10.1046/j.1365-2249.2002.t01-1-02001.x; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Glader P, 2006, RESP MED, V100, P818, DOI 10.1016/j.rmed.2005.09.008; Global Initiative for Asthma, 2007, MED NET, V13, P14; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Gubin MM, 2014, MOL MED, V20, P93, DOI 10.2119/molmed.2013.00127; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Hirano K, 2005, J BIOL CHEM, V280, P39284, DOI 10.1074/jbc.M505275200; Hudy MH, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-88; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Kafasla P, 2014, NAT IMMUNOL, V15, P492, DOI 10.1038/ni.2884; Katzenstein ALA, 2000, AM J SURG PATHOL, V24, P1, DOI 10.1097/00000478-200001000-00001; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Kriegova E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-69; Liu WL, 2006, J NEUROSCI RES, V84, P360, DOI 10.1002/jnr.20895; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Navratilova Z, 2012, RESPIROLOGY, V17, P1006, DOI 10.1111/j.1440-1843.2012.02197.x; Oshita Y, 2003, THORAX, V58, P757, DOI 10.1136/thorax.58.9.757; Park MJ, 2002, CANCER RES, V62, P6318; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Patterson KC, 2012, TRANSL RES, V160, P321, DOI 10.1016/j.trsl.2012.03.005; Paulissen G, 2006, MOL MED, V12, P171, DOI 10.2119/2006-00028.Paulissen; Petrek M, 2002, IMMUNOL LETT, V80, P189, DOI 10.1016/S0165-2478(01)00324-8; Piotrowski WJ, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0123-y; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Skjot-Arkil H, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-34; Stellato C, 2011, J IMMUNOL, V187, P441, DOI 10.4049/jimmunol.1001881; Takahashi C, 1998, P NATL ACAD SCI USA, V95, P13221, DOI 10.1073/pnas.95.22.13221; Techasintana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129321; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Valeyre D, 2014, LANCET, V383, P1155, DOI 10.1016/S0140-6736(13)60680-7; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Yoon JH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6248; 1999, AM J RESP CRIT CARE, V160, P736, DOI DOI 10.1164/AJRCCM.160.2.ATS4-99	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161669	10.1371/journal.pone.0161669	http://dx.doi.org/10.1371/journal.pone.0161669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575817	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877200032
J	Hung, WC; Wan, TW; Kuo, YC; Yamamoto, T; Tsai, JC; Lin, YT; Hsueh, PR; Teng, LJ				Hung, Wei-Chun; Wan, Tsai-Wen; Kuo, Yu-Chia; Yamamoto, Tatsuo; Tsai, Jui-Chang; Lin, Yu-Tzu; Hsueh, Po-Ren; Teng, Lee-Jene			Molecular Evolutionary Pathways toward Two Successful Community-Associated but Multidrug-Resistant ST59 Methicillin-Resistant Staphylococcus aureus Lineages in Taiwan: Dynamic Modes of Mobile Genetic Element Salvages	PLOS ONE			English	Article							EPIDEMIOLOGY; EMERGENCE; INFECTION; CHILDREN; HOST; MRSA; COLONIZATION; VIRULENCE; STRAINS; IV	Clonal complex 59 (CC59) Staphylococcus aureus in Taiwan includes both methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). As the most prominent community-associated MRSA (CA-MRSA) in Taiwan, CC59 has two major clones characterized as PVL-negative SCCmec IV (carrying the staphylococcal cassette chromosome mec IV but Panton-Valentine leukocidin-negative) and PVL-positive SCCmec V (5C2&5). We investigated the drug resistance, phylogeny and the distribution and sequence variation of SCCmec, staphylococcal bacteriophage phi SA3, genomic island nu Sa beta and MES (an enterococcal mobile genetic element conferring multidrug resistance) in 195 CC59 S. aureus. Sequencing and PCR mapping revealed that all of the CC59/SCCmec V (5C2&5) MRSA strains had acquired MESPM1 or its segregants, and obtained a phi SA3-related fragment in nu Sa beta. In contrast, MES6272-2 and MES4578, which showed gentamicin resistance that was not encoded by MESPM1, were dominant in SCCmec IVg MRSA. Translocation of a whole fSA3 into nu Sa beta instead of only a fSA3-related fragment was common in SCCmec IVg MRSA. However, the non-subtype-g SCCmec IV MRSA (SCCmec IVa is the major) still carried MES and nu Sa beta structures similar to those in SCCmec V (5C2&5) MRSA. A minimum spanning tree constructed by multiple-locus variable-number tandem repeat analysis revealed that SCCmec IVg MRSA and SCCmec V (5C2&5) MRSA grouped respectively in two major clades. The CC59 MSSA was equally distributed among the two clades, while the non-subtype-g SCCmec IV MRSA mostly clustered with SCCmec V (5C2&5) MRSA. Our	[Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Wan, Tsai-Wen; Kuo, Yu-Chia; Lin, Yu-Tzu; Teng, Lee-Jene] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan; [Yamamoto, Tatsuo] Int Med Educ & Res Ctr, Dept Epidemiol Genom & Evolut, Niigata, Japan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Hsueh, Po-Ren; Teng, Lee-Jene] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	Kaohsiung Medical University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Teng, LJ (corresponding author), Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan.; Teng, LJ (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	ljteng@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	TSAI, JUI-CHANG/0000-0003-2723-6841; Lin, Yu-Tzu/0000-0002-3815-6305; TENG, LEE-JENE/0000-0003-0104-741X; HSUEH, PO-REN/0000-0002-7502-9225	Ministry of Science and Technology of Taiwan [MOST 103-2320-B-002-056-MY3]; Kaohsiung Medical University Research Foundation [KMU-Q104012, KMU-Q105006]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 103-2320-B-002-056-MY3) and from the Kaohsiung Medical University Research Foundation (KMU-Q104012 and KMU-Q105006).	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063210; Chen CJ, 2013, J CLIN MICROBIOL, V51, P2508, DOI 10.1128/JCM.00572-13; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chen FJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-343; Chen FJ, 2009, DIAGN MICR INFEC DIS, V65, P351, DOI 10.1016/j.diagmicrobio.2009.07.024; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Geng WJ, 2010, FEMS IMMUNOL MED MIC, V58, P356, DOI [10.1111/j.1574-695X.2009.00648.x, 10.1111/j.1574-695X.2010.00648.x]; Glasner C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.010; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gomez JAL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016720; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Higuchi W, 2010, J INFECT CHEMOTHER, V16, P144, DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ho CM, J MICROBIOL IMMUNOL; Ho PL, 2007, DIAGN MICR INFEC DIS, V57, P145, DOI 10.1016/j.diagmicrobio.2006.08.003; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YH, 2007, CLIN MICROBIOL INFEC, V13, P717, DOI 10.1111/j.1469-0691.2007.01718.x; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Hung WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143106; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Katayama Y, 2013, J BACTERIOL, V195, P1194, DOI 10.1128/JB.01786-12; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070602; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Patel JB, 2015, 25 INFORMATIONAL SUP; Pourcel C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09; Qu TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089235; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Salgado-Pabon W, 2014, J INFECT DIS, V210, P784, DOI 10.1093/infdis/jiu146; Sawanobori E, 2015, J MICROBIOL IMMUNOL, V48, P565, DOI 10.1016/j.jmii.2014.04.015; Sobral D, 2013, PLOS ONE, V7; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Yamamoto T, 2013, BIOMEDICINE-TAIWAN, V3, P2, DOI 10.1016/j.biomed.2012.12.001; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	6	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162526	10.1371/journal.pone.0162526	http://dx.doi.org/10.1371/journal.pone.0162526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606427	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600056
J	Rawal, R; Vijay, S; Kadian, K; Singh, J; Pande, V; Sharma, A				Rawal, Ritu; Vijay, Sonam; Kadian, Kavita; Singh, Jagbir; Pande, Veena; Sharma, Arun			Towards a Proteomic Catalogue and Differential Annotation of Salivary Gland Proteins in Blood Fed Malaria Vector Anopheles culicifacies by Mass Spectrometry	PLOS ONE			English	Article							AEDES-AEGYPTI; JUVENILE-HORMONE; FEMALE MOSQUITO; BOMBYX-MORI; DAP-KINASE; CELL-DEATH; GAMBIAE; GENE; TRANSCRIPTOME; AUTOPHAGY	In order to understand the importance of functional proteins in mosquito behavior, following blood meal, a baseline proteomic dataset is essential for providing insights into the physiology of blood feeding. Therefore, in this study as first step, in solution and 1-D electrophoresis digestion approach combined with tandem mass spectrometry (nano LC-MS/MS) and computational bioinformatics for data mining was used to prepare a baseline proteomic catalogue of salivary gland proteins of sugar fed An. culicifacies mosquitoes. A total of 106 proteins were identified and analyzed by SEQUEST algorithm against mosquito protein database from Uniprot/NCBI. Importantly, D7r1, D7r2, D7r4, salivary apyrase, anti-platelet protein, calreticulin, antigen 5 family proteins were identified and grouped on the basis of biological and functional roles. Secondly, differential protein expression and annotations between salivary glands of sugar fed vs blood fed mosquitoes was analyzed using 2-Delectrophoresis combined with MALDI-TOF mass spectrometry. The alterations in the differential expression of total 38 proteins was observed out of which 29 proteins like beclin-1, phosphorylating proteins, heme oxygenase 1, ferritin, apoptotic proteins, coagulation and immunity like, serine proteases, serpins, c-type lectin and protein in regulation of blood feeding behavior were found to be up regulated while 9 proteins related to blood feeding, juvenile hormone epoxide hydrolase ii, odorant binding proteins and energy metabolic enzymes were found to be down regulated. To our knowledge, this study provides a first time baseline proteomic dataset and functional annotations of An. culicifacies salivary gland proteins that may be involved during the blood feeding. Identification of differential salivary proteins between sugar fed and blood fed mosquitoes and their plausible role may provide insights into the physiological processes associated with feeding behavior and sporozoite transmission during the process of blood feeding.	[Rawal, Ritu; Vijay, Sonam; Kadian, Kavita; Singh, Jagbir; Sharma, Arun] Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol, Sect 8, New Delhi, India; [Pande, Veena] Kumaun Univ, Dept Biotechnol, Naini Tal, Uttarakhand, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Kumaun University	Sharma, A (corresponding author), Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol, Sect 8, New Delhi, India.	arushar@gmail.com		Pande, Veena/0000-0002-4839-7276	Department of Science and Technology, Government of India [SR/WOS-A/LS-590/2012]; Department of Biotechnology, New Delhi, Government of India [BT/PR8221/MED/12/617/2013]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, New Delhi, Government of India(Department of Biotechnology (DBT) India)	This work has been financially supported by the grant from Department of Science and Technology, Government of India (Ritu Rawal, SR/WOS-A/LS-590/2012 and Department of Biotechnology, New Delhi, Government of India (Dr. Arun Sharma, BT/PR8221/MED/12/617/2013).	Adak T, 1999, T ROY SOC TROP MED H, V93, P573, DOI 10.1016/S0035-9203(99)90052-4; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; Amsalem E, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-45; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; Das Suchismita, 2008, BMC Physiology, V8, P23, DOI 10.1186/1472-6793-8-23; deLeon AAP, 1996, VET PARASITOL, V61, P327, DOI 10.1016/0304-4017(95)00828-4; Dixit R, 2009, INT J INFECT DIS, V13, P636, DOI 10.1016/j.ijid.2008.07.027; Fu Q, 2011, INSECT MOL BIOL, V20, P541, DOI 10.1111/j.1365-2583.2011.01087.x; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Goswami G, 2006, AM J TROP MED HYG, V75, P454, DOI 10.4269/ajtmh.2006.75.454; Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; JAMES AA, 1989, GENE, V75, P73, DOI 10.1016/0378-1119(89)90384-3; Jariyapan N, 2012, PARASITOL RES, V111, P1239, DOI 10.1007/s00436-012-2958-y; Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lv ZB, 2012, GENE, V502, P118, DOI 10.1016/j.gene.2012.03.035; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Paaijmans KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055777; Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Rodriguez MH, 2004, INSECT BIOCHEM MOLEC, V34, P615, DOI 10.1016/j.ibmb.2004.03.014; Rost-Roszkowska MM, 2015, PROTOPLASMA, V252, P1387, DOI 10.1007/s00709-015-0774-9; Rund SSC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02494; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; Seino A, 2010, BIOSCI BIOTECH BIOCH, V74, P1421, DOI 10.1271/bbb.100104; Sharma AK, 2014, J ARTHROPOD-BORNE DI, V8, P186; Sharma P, 2015, BIOL OPEN, V4, P1002, DOI 10.1242/bio.012294; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Sor-suwan S, 2013, PARASITOL RES, V112, P1065, DOI 10.1007/s00436-012-3233-y; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Vijay S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119666; Vijay S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/686319; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wasinpiyamongkol A, 2010, PROTEOMICS, V10, P1; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009; Zhu JS, 2010, INSECT BIOCHEM MOLEC, V40, P23, DOI 10.1016/j.ibmb.2009.12.004	59	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161870	10.1371/journal.pone.0161870	http://dx.doi.org/10.1371/journal.pone.0161870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602567	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200028
J	Gonzalez-Wevar, CA; Rosenfeld, S; Segovia, NI; Hune, M; Gerard, K; Ojeda, J; Mansilla, A; Brickle, P; Diaz, A; Poulin, E				Gonzalez-Wevar, Claudio A.; Rosenfeld, Sebastian; Segovia, Nicolas I.; Hune, Mathias; Gerard, Karin; Ojeda, Jaime; Mansilla, Andres; Brickle, Paul; Diaz, Angie; Poulin, Elie			Genetics, Gene Flow, and Glaciation: The Case of the South American Limpet Nacella mytilina	PLOS ONE			English	Article							FISH ELEGINOPS-MACLOVINUS; LONG-DISTANCE DISPERSAL; TIERRA-DEL-FUEGO; COMPARATIVE PHYLOGEOGRAPHY; POPULATION-STRUCTURE; FALKLAND-ISLANDS; CLIMATE-CHANGE; HISTORICAL BIOGEOGRAPHY; GIGARTINA-SKOTTSBERGII; EVOLUTIONARY HISTORY	Glacial episodes of the Quaternary, and particularly the Last Glacial Maximum (LGM) drastically altered the distribution of the Southern-Hemisphere biota, principally at higher latitudes. The irregular coastline of Patagonia expanding for more than 84.000 km constitutes a remarkable area to evaluate the effect of Quaternary landscape and seascape shifts over the demography of near-shore marine benthic organisms. Few studies describing the bio-geographic responses of marine species to the LGM have been conducted in Patagonia, but existing data from coastal marine species have demonstrated marked genetic signatures of post-LGM recolonization and expansion. The kelp-dweller limpet Nacella mytilina is broadly distributed along the southern tip of South America and at the Falkland/Malvinas Islands. Considering its distribution, abundance, and narrow bathymetry, N. mytilina represents an appropriate model to infer how historical and contemporary processes affected the distribution of intraspecific genetic diversity and structure along the southern tip of South America. At the same time, it will be possible to determine how life history traits and the ecology of the species are responsible for the current pattern of gene flow and connectivity across the study area. We conducted phylogeographic and demographic inference analyses in N. mytilina from 12 localities along Pacific Patagonia (PP) and one population from the Falkland/Malvinas Islands (FI). Analyses of the mitochondrial gene COI in 300 individuals of N. mytilina revealed low levels of genetic polymorphism and the absence of genetic differentiation along PP. In contrast, FI showed a strong and significant differentiation from Pacific Patagonian populations. Higher levels of genetic diversity were also recorded in the FI population, together with a more expanded genealogy supporting the hypothesis of glacial persistence of the species in these islands. Haplotype genealogy, and mismatch analyses in the FI population recognized an older and more complex demographic history than in PP. Demographic reconstructions along PP suggest a post-LGM expansion process (7.5 ka), also supported by neutrality tests, mismatch distribution and maximum parsimony haplotype genealogies. Migration rate estimations showed evidence of asymmetrical gene flow from PP to FI. The absence of genetic differentiation, the presence of a single dominant haplotype, high estimated migration rates, and marked signal of recent demographic growth, support the hypothesis of rapid post-glacial expansion in N. mytilina along PP. This expansion could have been sustained by larval and rafting-mediated dispersal of adults from northernmost populations following the Cape Horn Current System. Marked genetic differentiation between PP and FI could be explained through differences in their respective glacial histories. During the LGM, Pacific Patagonia (PP) was almost fully covered by the Patagonian Ice Sheet, while sheet coverage in the FI ice was restricted to small cirques and valleys. As previously recorded in the sister-species N. magellanica, the FI rather than represent a classical glacial refugium for N. mytilina, seems to represent a sink area and/or a secondary contact zone. Accordingly, historical and contemporary processes, contrasting glacial histories between the analyzed sectors, as well as life history traits constitute the main factors explaining the current biogeographical patterns of most shallow Patagonian marine benthic organisms.	[Gonzalez-Wevar, Claudio A.; Gerard, Karin] GAIA Antartica Univ Magallanes, Dept Recursos Nat, Bulnes 01890, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio A.; Rosenfeld, Sebastian; Segovia, Nicolas I.; Hune, Mathias; Ojeda, Jaime; Mansilla, Andres; Poulin, Elie] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, IEB, Las Palmeras 3425, Santiago, Chile; [Gonzalez-Wevar, Claudio A.; Rosenfeld, Sebastian; Gerard, Karin; Ojeda, Jaime; Mansilla, Andres] Univ Magallanes, Lab Macroalgas Antarticas & Subantarticas, Casilla 113-D, Punta Arenas, Chile; [Hune, Mathias] Fdn Ictiol, Providencia Santiago, Chile; [Brickle, Paul] SAERI, POB 609, Stanley Cottage, Stanley, Falkland Island; [Diaz, Angie] Univ Concepcion, Dept Zool, Fac Ciencias Nat & Oceanog, Concepcion, Chile	Universidad de Chile; Universidad de Magallanes; Universidad de Concepcion	Gonzalez-Wevar, CA (corresponding author), GAIA Antartica Univ Magallanes, Dept Recursos Nat, Bulnes 01890, Punta Arenas, Chile.; Gonzalez-Wevar, CA (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, IEB, Las Palmeras 3425, Santiago, Chile.; Gonzalez-Wevar, CA (corresponding author), Univ Magallanes, Lab Macroalgas Antarticas & Subantarticas, Casilla 113-D, Punta Arenas, Chile.	claudio.gonzalez@umag.cl	Gérard, Karin/AAC-4911-2021; Ojeda, Jaime/HHN-1455-2022; Gerard, Karin/H-6245-2014; Poulin, Elie/C-2654-2012; González-Wevar, Claudio Alejandro/AAD-6513-2021; Hüne, Mathias/ABE-6000-2020; Diaz, Angie/I-8033-2016	Gérard, Karin/0000-0003-0596-1348; Poulin, Elie/0000-0001-7736-0969; Diaz, Angie/0000-0003-4944-588X; Rosenfeld, Sebastian/0000-0002-4363-8018; Brickle, Paul/0000-0002-9870-3518	Fondecyt [3120075, 3130677, 1151336, 1140940]; Initiation Fondecyt Project [11140087]; Instituto de Ecologia y Biodiversidad IEB [P05-002 ICM, PFB 023]; postdoctorate fellowship CD GAIA/UMAG	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Initiation Fondecyt Project; Instituto de Ecologia y Biodiversidad IEB; postdoctorate fellowship CD GAIA/UMAG	This study was completely funded by different projects and institutions including a post-doctorate fellowship (Fondecyt 3120075) and an Initiation Fondecyt Project (11140087) to CAG-W. We also appreciate the following projects: AD (postdoctorate Fondecyt project 3130677), KG (postdoctorate fellowship CD GAIA/UMAG), EP (regular Fondecyt project 1151336), and AM (regular Fondecyt project 1140940). Finally, we mostly appreciate the support of the projects P05-002 ICM and PFB 023 (Instituto de Ecologia y Biodiversidad IEB) to EP, AM, SR, JO and CAG-W and CD GAIA Antartica Universidad de Magallanes to CAG-W and KG. There was no additional external funding received for this study.r This study was completely funded by different projects and institutions including a post-doctorate fellowship (Fondecyt 3120075) and an Initiation Fondecyt Project (11140087) to CAG-W. We also appreciate the following projects: AD (postdoctorate Fondecyt project 3130677), KG (postdoctorate fellowship CD GAIA/UMAG), EP (regular Fondecyt project 1151336), and AM (regular Fondecyt project 1140940). Finally, we mostly appreciate the support of the projects P05-002 ICM and PFB 023 (Instituto de Ecologia y Biodiversidad IEB) to EP, AM, SR, JO and CAG-W and CD GAIA Antartica Universidad de Magallanes to CAG-W and KG. There was no additional external funding received for this study. All the specimens were collected under the Chilean legislation (Technical Memorandum P. INV No 429/2015 SUBPESCA). Permits to undertake field studies and collect specimens in Falkland Islands was issued by the Environmental Planning Department, the Falkland Islands Government. We mostly appreciate the comments and suggestions of the reviewers (Dr. Tom DeVries and an anonymous one) who helped us significantly to improve the manuscript. We recognize the SCAR AntEco and EBA programs, CAML and SAERI, for encouraging and supporting Antarctic and Subantarctic evolutionary biology studies. This manuscript contributes to the SCAR 'State of Antarctic Ecosystem' (AntEco) programme.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; BASTIDA R, 1992, OCEANOL ACTA, V15, P687; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Billard E, 2015, POLAR BIOL, V38, P2021, DOI 10.1007/s00300-015-1762-4; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bowden DA, 2006, MAR ECOL PROG SER, V316, P1, DOI 10.3354/meps316001; Bowden DA, 2009, MAR BIOL, V156, P2033, DOI 10.1007/s00227-009-1235-9; BRATTSTROM H, 1983, SARSIA, V68, P289, DOI 10.1080/00364827.1983.10420583; Cardenas J, 2009, ANDEAN GEOL, V36, P81, DOI 10.4067/S0718-71062009000100007; de Aranzamendi MC, 2014, J EXP MAR BIOL ECOL, V460, P53, DOI 10.1016/j.jembe.2014.06.008; Ceballos SG, 2016, HEREDITY, V116, P372, DOI 10.1038/hdy.2015.106; Ceballos SG, 2012, MAR BIOL, V159, P499, DOI 10.1007/s00227-011-1830-4; Clapperton C. M., 1976, J GLACIOL, V17, P73, DOI [DOI 10.1017/S0022143000030732, 10.3189/S0022143000030732, DOI 10.3189/S0022143000030732]; CLAPPERTON CM, 1994, REV CHIL HIST NAT, V67, P369; Clark R, 1998, J QUATERNARY SCI, V13, P95; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crame JA, 1997, J BIOGEOGR, V24, P1, DOI 10.1111/j.1365-2699.1997.tb00045.x; Cumming RA, 2014, J BIOGEOGR, V41, P2357, DOI 10.1111/jbi.12376; Dambach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046283; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Aranzamendi MC, 2011, MAR BIOL, V158, P2405, DOI 10.1007/s00227-011-1742-3; De Aranzamendi MC, 2009, J MOLLUS STUD, V75, P241, DOI 10.1093/mollus/eyp025; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Palma RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032206; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraser CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069138; Fraser CI, 2012, TRENDS ECOL EVOL, V27, P462, DOI 10.1016/j.tree.2012.04.011; Fraser CI, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-203; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Gonzalez-Wevar CA, 2013, MOL ECOL, V22, P5221, DOI 10.1111/mec.12465; Gonzalez-Wevar CA, 2011, MOL ECOL, V20, P1936, DOI 10.1111/j.1365-294X.2011.05065.x; Gonzalez-Wevar C, 2015, J HERED, V106, P439, DOI 10.1093/jhered/esv005; Gonzalez-Wevar CA, 2016, POLAR BIOL, V39, P77, DOI 10.1007/s00300-014-1620-9; Gonzalez-Wevar CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131289; Gonzalez-Wevar CA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-139; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; Gonzalez-Wevar CA, 2010, MOL PHYLOGENET EVOL, V56, P115, DOI 10.1016/j.ympev.2010.02.001; Gordillo S, 2005, SCI MAR, V69, P337, DOI 10.3989/scimar.2005.69s2337; Gordillo S, 2010, I PATAGON CHILE, V37, P5; Gordillo S, 2008, REV GEOL CHILE, V35, P321; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Guller M, 2016, J MOLLUS STUD, V82, P80, DOI 10.1093/mollus/eyv036; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hein AS, 2010, QUATERNARY SCI REV, V29, P1212, DOI 10.1016/j.quascirev.2010.01.020; Heusser CJ, 1998, PALAEOGEOGR PALAEOCL, V141, P277, DOI 10.1016/S0031-0182(98)00053-4; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Hodgson DA, 2014, QUATERNARY SCI REV, V100, P137, DOI 10.1016/j.quascirev.2013.12.001; Hudson RR, 2000, GENETICS, V155, P2011; Hune M, 2015, POLAR BIOL, V38, P607, DOI 10.1007/s00300-014-1623-6; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KNOX GA, 1960, PROC R SOC SER B-BIO, V152, P577, DOI 10.1098/rspb.1960.0068; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marin JC, 2013, MOL ECOL, V22, P463, DOI 10.1111/mec.12111; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; McCulloch RD, 2005, GEOGR ANN, V87, P1; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Moreno PI, 2003, J QUATERNARY SCI, V18, P787, DOI 10.1002/jqs.801; Morrone JJ, 2011, J BIOGEOGR, V38, P2078, DOI 10.1111/j.1365-2699.2011.02553.x; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nielsen R, 2001, GENETICS, V158, P885; Nikula R, 2010, MAR ECOL PROG SER, V405, P221, DOI 10.3354/meps08523; Nunez JD, 2015, MAR BIOL, V162, P595, DOI 10.1007/s00227-014-2607-3; Nunez JJ, 2010, REV BIOL MAR OCEANOG, V45, P565, DOI 10.4067/S0718-19572010000400005; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Pardinas UFJ, 2011, BIOL J LINN SOC, V103, P495, DOI 10.1111/j.1095-8312.2011.01679.x; PARMESAN C, 2006, ANNU REV ECOL EVOL, V37, P1, DOI DOI 10.1146/annurev.ecolsys.37.091305.110035; Pastorino MJ, 2002, J BIOGEOGR, V29, P1167, DOI 10.1046/j.1365-2699.2002.00731.x; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; Peck LS, 2016, POLAR BIOL, V39, P2273, DOI 10.1007/s00300-016-1894-1; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Powell AWB, 1973, PATELLID LIMPETS WOR, P1; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rabassa J, 2005, J S AM EARTH SCI, V20, P81, DOI 10.1016/j.jsames.2005.07.004; Reid David G., 2000, Bulletin of the Natural History Museum Zoology Series, V66, P109; Reisser CMO, 2011, MOL ECOL, V20, P3399, DOI 10.1111/j.1365-294X.2011.05185.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenfeld S., 2016, THESIS; Rosenfeld S, 2015, ZOOKEYS, P49, DOI 10.3897/zookeys.519.9676; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P514, DOI 10.1111/j.1095-8312.2011.01682.x; Sanchez R, 2011, MAR ECOL PROG SER, V434, P121, DOI 10.3354/meps09184; Schneider S, 1999, GENETICS, V152, P1079; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1995, GENETICS, V139, P457; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toro JE, 2004, AQUAC RES, V35, P1466, DOI 10.1111/j.1365-2109.2004.01172.x; Valdovinos C, 2005, REV CHIL HIST NAT, V78, P497; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; Vidal MA, 2012, AUSTRAL ECOL, V37, P67, DOI 10.1111/j.1442-9993.2011.02241.x; Wares JP, 2001, EVOLUTION, V55, P2455; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Wilson P, 2002, QUATERNARY SCI REV, V21, P1821, DOI 10.1016/S0277-3791(02)00008-2; Wilson P, 2008, J QUATERNARY SCI, V23, P461, DOI 10.1002/jqs.1156; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	136	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161963	10.1371/journal.pone.0161963	http://dx.doi.org/10.1371/journal.pone.0161963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598461	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800030
J	Tsoi, TH; Chan, CF; Chan, WL; Chiu, KF; Wong, WT; Ng, CF; Wong, KL				Tsoi, Tik-Hung; Chan, Chi-Fai; Chan, Wai-Lun; Chiu, Ka-Fung; Wong, Wing-Tak; Ng, Chi-Fai; Wong, Ka-Leung			Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers	PLOS ONE			English	Article							DIGITAL RECTAL EXAMINATION; MARKERS; SPERMINE; ANTIGEN; TISSUE; SPECTROSCOPY; PSA; N-1,N-12-DIACETYLSPERMINE; MULTICENTER; DIAGNOSIS	Current screening methods towards prostate cancer (PCa) are not without limitations. Research work has been on-going to assess if there are other better tests suitable for primary or secondary screening of PCa to supplement the serum prostate specific antigen (PSA) test, which fails to work accurately in a grey zone of 4-10ng/ml. In this pilot study, the potential roles of urinary polyamines as prostate cancer biomarkers were evaluated. PCa, benign prostatic hyperplasia (BPH) patients and healthy controls (HC) showing PSA>4.0ng/ml were enrolled in the study. Their urine samples were obtained, and the urinary levels of putrescine (Put), spermidine (Spd) and spermine (Spm) were determined by ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometer (UPLC-MS/MS). Receiver operating characteristics (ROC) curve and Student's t-test were used to evaluate their diagnostic accuracies. Among the three biogenic polyamines, Spm had demonstrated a good diagnostic performance when comparing their levels in PCa patients with BPH patients (1.47 in PCa vs 5.87 in BPH; p<0.0001). Results are in accordance with transrectal ultrasound prostatic biopsy (TRUSPB) results, with an area under curve (AUC) value of 0.83 +/- 0.03. Therefore urinary Spm shows potential to serve as a novel PCa diagnostic biomarker, which in turn can help to address the limited sensitivity and specificity problem of serum PSA test.	[Tsoi, Tik-Hung; Chan, Chi-Fai; Wong, Wing-Tak] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Chan, Wai-Lun] Natl Univ Singapore, Dept Chem, 21 Lower Kent Ridge Rd, Singapore, Singapore; [Chiu, Ka-Fung; Ng, Chi-Fai] Chinese Univ Hong Kong, SH Ho Urol Ctr, Div Urol, Dept Surg, Shatin, Hong Kong, Peoples R China; [Wong, Ka-Leung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; National University of Singapore; Chinese University of Hong Kong; Hong Kong Baptist University	Wong, WT (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China.; Ng, CF (corresponding author), Chinese Univ Hong Kong, SH Ho Urol Ctr, Div Urol, Dept Surg, Shatin, Hong Kong, Peoples R China.; Wong, KL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	w.t.wong@polyu.edu.hk; ngcf@surgery.cuhk.edu.hk; klwong@hkbu.edu.hk	CHAN, Kulice Wai-Lun/E-3888-2016; Ng, Chi-Fai/E-5134-2011; Chi-fai, NG/AAV-8270-2021	CHAN, Kulice Wai-Lun/0000-0002-3995-5985; Ng, Chi-Fai/0000-0002-1723-9646; Wong, Wing-tak/0000-0002-3453-1825; Chan, Chi Fai/0000-0002-7236-4052	Hong Kong Research Grants Council [HKBU 203013, HKPolyU 5032/11P]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The authors thank the staffs and patients of this pilot study for their important contributions and are grateful for the financial support from the grants from The Hong Kong Research Grants Council (HKBU 203013 and HKPolyU 5032/11P), http://www.ugc.edu.hk/eng/rgc/.	Bachrach U, 2004, AMINO ACIDS, V26, P307, DOI 10.1007/s00726-004-0076-6; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; BENSON MC, 1992, J UROLOGY, V147, P815, DOI 10.1016/S0022-5347(17)37393-7; Bhavsar T, 2013, SEMIN ONCOL, V40, P259, DOI 10.1053/j.seminoncol.2013.04.002; BONSNES RW, 1945, J BIOL CHEM, V158, P581; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Chan ESY, 2012, CHINESE MED J-PEKING, V125, P2432, DOI 10.3760/cma.j.issn.0366-6999.2012.14.006; Cheng LL, 2001, FEBS LETT, V494, P112, DOI 10.1016/S0014-5793(01)02329-8; Djavan B, 1999, UROLOGY, V54, P517, DOI 10.1016/S0090-4295(99)00153-3; Downes MR, 2007, BJU INT, V99, P263, DOI 10.1111/j.1464-410X.2006.06610.x; FAIR WR, 1975, J UROLOGY, V114, P88, DOI 10.1016/S0022-5347(17)66951-9; Ferro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067687; Giskeodegard GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062375; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Hakkinen MR, 2013, J CHROMATOGR B, V941, P81, DOI 10.1016/j.jchromb.2013.10.009; Hiramatsu K, 2005, CLIN CANCER RES, V11, P2986, DOI 10.1158/1078-0432.CCR-04-2275; Hiramatsu K, 1997, J CANCER RES CLIN, V123, P539, DOI 10.1007/s004320050102; HORN Y, 1984, CANCER RES, V44, P4675; Jamaspishvili T, 2010, PROSTATE CANCER P D, V13, P12, DOI 10.1038/pcan.2009.31; JUNG K, 1991, EUR J CLIN CHEM CLIN, V29, P725; Lee SH, 2003, CANCER LETT, V201, P121, DOI 10.1016/S0304-3835(03)00014-4; Leveque J, 2000, BREAST CANCER RES TR, V60, P99, DOI 10.1023/A:1006319818530; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Liu R, 2013, ANAL CHIM ACTA, V791, P36, DOI 10.1016/j.aca.2013.06.044; LOSER C, 1990, CANCER, V65, P958, DOI 10.1002/1097-0142(19900215)65:4<958::AID-CNCR2820650423>3.0.CO;2-Z; Ng CF, 2014, INT UROL NEPHROL, V46, P711, DOI 10.1007/s11255-013-0582-0; Rigau M, 2013, INT J MOL SCI, V14, P12620, DOI 10.3390/ijms140612620; RUSSELL DH, 1971, NATURE-NEW BIOL, V233, P144, DOI 10.1038/newbio233144a0; Schipper RG, 2003, BIOCHEM SOC T, V31, P375, DOI 10.1042/BST0310375; Schroder FH, 1998, JNCI-J NATL CANCER I, V90, P1817, DOI 10.1093/jnci/90.23.1817; Serkova NJ, 2008, PROSTATE, V68, P620, DOI 10.1002/pros.20727; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; van der Graaf M, 2000, MAGN RESON MATER PHY, V10, P153, DOI 10.1016/S1352-8661(00)00082-X; van Gils MPMQ, 2007, CLIN CANCER RES, V13, P939, DOI 10.1158/1078-0432.CCR-06-2679; VanCangh PJ, 1996, UROLOGY, V48, P67, DOI 10.1016/S0090-4295(96)00613-9; Vargas AJ, 2014, NUTR CANCER, V66, P1144, DOI 10.1080/01635581.2014.949801; Wagenlehner FME, 2013, EUR UROL, V63, P521, DOI 10.1016/j.eururo.2012.06.003; Wilkosz J, 2011, CENT EUR J UROL, V64, P9, DOI 10.5173/ceju.2011.01.art2; Wu CL, 2001, UROLOGY, V57, P925, DOI 10.1016/S0090-4295(01)00930-X	44	28	31	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162217	10.1371/journal.pone.0162217	http://dx.doi.org/10.1371/journal.pone.0162217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598335	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800048
J	Ngufor, C; Critchley, J; Fagbohoun, J; N'Guessan, R; Todjinou, D; Rowland, M				Ngufor, Corine; Critchley, Jessica; Fagbohoun, Josias; N'Guessan, Raphael; Todjinou, Damien; Rowland, Mark			Chlorfenapyr (A Pyrrole Insecticide) Applied Alone or as a Mixture with Alpha-Cypermethrin for Indoor Residual Spraying against Pyrethroid Resistant Anopheles gambiae sl: An Experimental Hut Study in Cove, Benin	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS MOSQUITOS	Background Indoor spraying of walls and ceilings with residual insecticide remains a primary method of malaria control. Insecticide resistance in malaria vectors is a growing problem. Novel insecticides for indoor residual spraying (IRS) which can improve the control of pyrethroid resistant malaria vectors are urgently needed. Insecticide mixtures have the potential to improve efficacy or even to manage resistance in some situations but this possibility remains under-explored experimentally. Chlorfenapyr is a novel pyrrole insecticide which has shown potential to improve the control of mosquitoes which are resistant to current WHO-approved insecticides. Method The efficacy of IRS with chlorfenapyr applied alone or as a mixture with alpha-cypermeththrin (a pyrethroid) was evaluated in experimental huts in Cove, Southern Benin against wild free flying pyrethroid resistant Anopheles gambiae sl. Comparison was made with IRS with alpha-cypermethrin alone. Fortnightly 30-minute in situ cone bioassays were performed to assess the residual efficacy of the insecticides on the treated hut walls. Results Survival rates of wild An gambiae from the Cove hut site in WHO resistance bioassays performed during the trial were >90% with permethrin and deltamethrin treated papers. Mortality of free-flying mosquitoes entering the experimental huts was 4% in the control hut. Mortality with alpha-cypermethrin IRS did not differ from the control (5%, P>0.656). The highest mortality was achieved with chlorfenapyr alone (63%). The alpha-cypermethrin + chlorfenapyr mixture killed fewer mosquitoes than chlorfenapyr alone (43% vs. 63%, P<0.001). While the cone bioassays showed a more rapid decline in residual mortality with chlorfenapyr IRS to <30% after only 2 weeks, fortnightly mortality rates of wild free-flying An gambiae entering the chlorfenapyr IRS huts were consistently high (50-70%) and prolonged, lasting over 4 months. Conclusion IRS with chlorfenapyr shows potential to significantly improve the control of malaria transmission in pyrethroid resistant areas compared to pyrethroid IRS or the mixture. Thirty minute in situ cone bioassays are not predictive of the performance of chlorfenapyr IRS under field conditions.	[Ngufor, Corine; Critchley, Jessica; N'Guessan, Raphael; Rowland, Mark] London Sch Hyg & Trop Med, London, England; [Ngufor, Corine; Fagbohoun, Josias; Todjinou, Damien] Ctr Rech Entomol Cotonou, Cotonou, Benin	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Ngufor, C (corresponding author), London Sch Hyg & Trop Med, London, England.; Ngufor, C (corresponding author), Ctr Rech Entomol Cotonou, Cotonou, Benin.	corine.ngufor@lshtm.ac.uk		NGuessan, Raphael/0000-0003-4930-4534; Ngufor, Corine/0000-0002-7755-9609	BASF	BASF(BASF)	This work was supported by a grant from BASF to the London School of Hygiene and Tropical Medicine.	Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; [Anonymous], 2013, WHO REC INS IND RES; [Anonymous], 2006, WHOCDSWHOPESGCDPP200; BLACK BC, 1994, PESTIC BIOCHEM PHYS, V50, P115, DOI 10.1006/pest.1994.1064; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Essandoh J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-404; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087710; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ngufor C, 2015, MALARIA J, V14; Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083897; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Oxborough RM, 2010, T ROY SOC TROP MED H, V104, P639, DOI 10.1016/j.trstmh.2010.07.008; Oxborough RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0639-x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO (World Health Organization), 2011, TECHN BAS COORD ACT; World Health Organization, 2012, WHO GLOB MAL PROGR G	19	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162210	10.1371/journal.pone.0162210	http://dx.doi.org/10.1371/journal.pone.0162210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588945	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000382877800037
J	Bedasso, K; Bedaso, A; Feyera, F; Gebeyehu, A; Yohannis, Z				Bedasso, Kufa; Bedaso, Asres; Feyera, Fetuma; Gebeyehu, Abebaw; Yohannis, Zegeye			Prevalence of Common Mental Disorders and Associated Factors among People with Glaucoma Attending Outpatient Clinic at Menelik II Referral Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; POPULATION; POVERTY	Background The burden of blindness from glaucoma is high. Therefore, people suffering from a serious eye disease such as glaucoma, which can lead to blindness, usually have an emotional disturbance on the patient. Untreated psychiatric illness is associated with increased morbidity and increased costs of care. Objective This study aimed to assess prevalence of common mental disorders and associated factors among people with Glaucoma attending Menelik II referral hospital, Addis Ababa, Ethiopia, 2014. Methods Institution based Cross-sectional study design was conducted in the Department of Ophthalmology Menelik II Referral Hospital from April 10 to May 15, 2014. 423 participants who had undergone through investigation, examination and diagnosed as patients of glaucoma were selected randomly from the glaucoma clinic. Data were collected through face to face interview using Self Reporting Questionnaire consisted of 20 items. Study subjects who scored >= 11 from SRQ-20 were considered as having common mental disorders. Bivariate and multivariable logistic regression analysis with 95% CI were done and variables with P<0.05 in the final model were identified as independent factors associated with common mental disorders. Results Four hundred five patients with glaucoma were included in our study with response rate of 95.7% and 64.5% were males. The average age was 59 +/- 13.37 years. Common mental disorders were observed in 23.2% of Glaucoma patients. It is quite obvious that levels of CMDs were high among patients with glaucoma. There was a significant association between age, sex, chronic physical illness, income and duration of illness at P < 0.05. Conclusion and Recommendation Symptoms of common mental disorders were the commonest comorbidities among patients with glaucoma. It will be better to assess and treat Common mental disorders as a separate illness in patients with glaucoma.	[Bedasso, Kufa] Menelik II Hlth Sci Coll, Dept Psychiat, Addis Ababa, Ethiopia; [Bedaso, Asres] Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Feyera, Fetuma] Debre Markos Univ, Coll Med & Hlth Sci, Dept Nursing, POB 296, Debre Markos, Ethiopia; [Gebeyehu, Abebaw] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [Yohannis, Zegeye] Amanuel Mental Specialized Hosp, Dept Psychiat, POB 1976, Addis Ababa, Ethiopia	Hawassa University; University of Gondar	Bedasso, K (corresponding author), Menelik II Hlth Sci Coll, Dept Psychiat, Addis Ababa, Ethiopia.	kufbed@gmail.com	Tilahune, Asres Bedaso/AAP-9118-2020; Tilahune, Asres Bedaso/AAP-9464-2020	Tilahune, Asres Bedaso/0000-0001-7859-0264; Worku, Abebaw Gebeyehu/0000-0002-1146-3399				Bank World, COUNTR LEND GROUPS L; Dawodo OA, J MED BIOM RES, V3, P42; Dawodu O. A., 2004, Journal of Medicine and Biomedical Research, V3, P42; GIEL R, 1968, PSYCHIAT NEUROL NEUR, V71, P169; Goldberg D, 1992, COMMON MENTAL DISORD, P1324; Gomez J., 1987, LIAISON PSYCHIAT MEN, V3, P356; JACOBSSON L, 1985, ACTA PSYCHIAT SCAND, V71, P417, DOI 10.1111/j.1600-0447.1985.tb02542.x; Kong XM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004632; Leekassa R, 2004, LEPROSY REV, V75, P367; Lopez AD, 1995, GLOBAL BURDEN DIS RI, V14, P375; Mitsonis C, ANN GEN PSYCHIAT, V200, P510; Muinde T, 2013, JOECSA, V14; Musisi S, 2001, MAKERERE U MED SCH J, V35, P4; Nyman SR, 2010, BRIT J OPHTHALMOL, V94, P1427, DOI 10.1136/bjo.2009.164814; Oheari JU, 1992, W AFR J MED, V11, P234; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2006, RISK FACTORS COMMON, V189, P547; Pothen M, 2003, INT J SOC PSYCHIATR, V49, P119, DOI 10.1177/0020764003049002005; Saulo V., 2010, BA BRAZIL, V13, P1; Weich S, 1998, BMJ-BRIT MED J, V317, P115, DOI 10.1136/bmj.317.7151.115; WHO, GEND DISP MENT HLTH; WHO, 2011, R SECR; World Health Organization, 2001, WORLD HLTH REPORT 20, V123, P435; World Health Organization Division of Mental Health, 1994, US GUID SELF REP QUE, V5, P655	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161442	10.1371/journal.pone.0161442	http://dx.doi.org/10.1371/journal.pone.0161442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584147	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600030
J	Dysthe, JC; Carim, KJ; Paroz, YM; McKelvey, KS; Young, MK; Schwartz, MK				Dysthe, Joseph C.; Carim, Kellie J.; Paroz, Yvette M.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.			Quantitative PCR Assays for Detecting Loach Minnow (Rhinichthys cobitis) and Spikedace (Meda fulgida) in the Southwestern United States	PLOS ONE			English	Article							ENVIRONMENTAL DNA; TIAROGA-COBITIS	Loach minnow (Rhinichthys cobitis) and spikedace (Meda fulgida) are legally protected with the status of Endangered under the U.S. Endangered Species Act and are endemic to the Gila River basin of Arizona and New Mexico. Efficient and sensitive methods for monitoring these species' distributions are critical for prioritizing conservation efforts. We developed quantitative PCR assays for detecting loach minnow and spikedace DNA in environmental samples. Each assay reliably detected low concentrations of target DNA without detection of non-target species, including other cyprinid fishes with which they co-occur.	[Dysthe, Joseph C.; Carim, Kellie J.; McKelvey, Kevin S.; Young, Michael K.; Schwartz, Michael K.] Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59807 USA; [Paroz, Yvette M.] Forest Serv, USDA, Albuquerque, NM USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service	Dysthe, JC (corresponding author), Forest Serv, USDA, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59807 USA.	jdysthe@fs.fed.us		Dysthe, Joseph/0000-0002-6790-7841	USDA Forest Service Southwestern Region; USDA Forest Service Region 1	USDA Forest Service Southwestern Region; USDA Forest Service Region 1	This work was completed through funding issued to Yvette M Paroz by the USDA Forest Service Southwestern Region with in-kind support from the USDA Forest Service Region 1. As the authors of this study, the funders did have a role in all aspects of the study and manuscript preparation.	BARBER WE, 1970, COPEIA, P9; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carim KJ, 2016, CONSERV GENET RESOUR; Carim KJ, 2015, PROTOCOL COLLECTING; Dejean T, 2012, J APPL ECOL, V49, P953, DOI 10.1111/j.1365-2664.2012.02171.x; Marsh PC, 2003, SOUTHWEST NAT, V48, P666, DOI 10.1894/0038-4909(2003)048<0666:NARPOL>2.0.CO;2; McKelvey KS, 2016, J FISH BIOL, V88, P1215, DOI 10.1111/jfb.12863; Paroz YM, 2007, DISTRIBUTION SPIKEDA; PROPST DL, 1991, COPEIA, P29; Propst DL, 1988, 17 US FISH WILDL SER; R Core Development Team, 2013, R LANG ENV STAT COMP; Sigsgaard EE, 2015, BIOL CONSERV, V183, P46, DOI 10.1016/j.biocon.2014.11.023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; USFWS, 1986, FED REGISTER, V51, P39468; USFWS, 2012, FED REGISTER, V77, P10810; USFWS, 1986, FED REGISTER, V51, P23769; USFWS, 1990, SPIK REC PLAN; USFWS (United States Fish and Wildlife Service), 1990, LOACH MINN REC PLAN; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259	21	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162200	10.1371/journal.pone.0162200	http://dx.doi.org/10.1371/journal.pone.0162200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583576	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600119
J	Mayer, N; Lopa, S; Talo, G; Lovati, AB; Pasdeloup, M; Riboldi, SA; Moretti, M; Mallein-Gerin, F				Mayer, Nathalie; Lopa, Silvia; Talo, Giuseppe; Lovati, Arianna B.; Pasdeloup, Marielle; Riboldi, Stefania A.; Moretti, Matteo; Mallein-Gerin, Frederic			Interstitial Perfusion Culture with Specific Soluble Factors Inhibits Type I Collagen Production from Human Osteoarthritic Chondrocytes in Clinical-Grade Collagen Sponges	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; BONE MORPHOGENETIC PROTEIN-2; CARTILAGE REPAIR; MATRIX SYNTHESIS; SCAFFOLDS; IMPLANTATION; KNEE; EXPRESSION; DEFECTS; JOINTS	Articular cartilage has poor healing ability and cartilage injuries often evolve to osteoarthritis. Cell-based strategies aiming to engineer cartilaginous tissue through the combination of biocompatible scaffolds and articular chondrocytes represent an alternative to standard surgical techniques. In this context, perfusion bioreactors have been introduced to enhance cellular access to oxygen and nutrients, hence overcoming the limitations of static culture and improving matrix deposition. Here, we combined an optimized cocktail of soluble factors, the BIT (BMP-2, Insulin, Thyroxin), and clinical-grade collagen sponges with a bidirectional perfusion bioreactor, namely the oscillating perfusion bioreactor (OPB), to engineer in vitro articular cartilage by human articular chondrocytes (HACs) obtained from osteoarthritic patients. After amplification, HACs were seeded and cultivated in collagen sponges either in static or dynamic conditions. Chondrocyte phenotype and the nature of the matrix synthesized by HACs were assessed using western blotting and immunohistochemistry analyses. Finally, the stability of the cartilaginous tissue produced by HACs was evaluated in vivo by subcutaneous implantation in nude mice. Our results showed that perfusion improved the distribution and quality of cartilaginous matrix deposited within the sponges, compared to static conditions. Specifically, dynamic culture in the OPB, in combination with the BIT cocktail, resulted in the homogeneous production of extracellular matrix rich in type II collagen. Remarkably, the production of type I collagen, a marker of fibrous tissues, was also inhibited, indicating that the association of the OPB with the BIT cocktail limits fibrocartilage formation, favoring the reconstruction of hyaline cartilage.	[Mayer, Nathalie; Pasdeloup, Marielle; Mallein-Gerin, Frederic] Univ Lyon 1, Lab Tissue Biol & Therapeut Engn, CNRS, UMR 5305, Lyon, France; [Mayer, Nathalie; Pasdeloup, Marielle; Mallein-Gerin, Frederic] Univ Lyon, Inst Biol & Chem Prot, Lyon, France; [Lopa, Silvia; Talo, Giuseppe; Lovati, Arianna B.; Moretti, Matteo] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Riboldi, Stefania A.] Bioengn Labs Srl, Meda, Italy; [Moretti, Matteo] EOC, Regenerat Med Technol Lab, Lugano, Switzerland; [Moretti, Matteo] SIRM, Lugano, Switzerland; [Moretti, Matteo] Fdn Cardiocentro Ticino, Lugano, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; IRCCS Istituto Ortopedico Galeazzi	Mallein-Gerin, F (corresponding author), Univ Lyon 1, Lab Tissue Biol & Therapeut Engn, CNRS, UMR 5305, Lyon, France.; Mallein-Gerin, F (corresponding author), Univ Lyon, Inst Biol & Chem Prot, Lyon, France.	f.mallein-gerin@ibcp.fr	Moretti, Matteo/AIC-6221-2022; Lopa, Silvia/G-3455-2015; Lovati, Arianna Barbara/J-8213-2016; Talo, Giuseppe/K-6361-2016	Moretti, Matteo/0000-0002-7301-1208; Lopa, Silvia/0000-0003-0410-5814; Lovati, Arianna Barbara/0000-0002-5230-9718; Mayer, Nathalie/0000-0002-6123-8990; Talo, Giuseppe/0000-0003-1976-5073	Rhone-Alpes Region; French National Centre for Scientific Research (CNRS); Universite Claude Bernard Lyon 1; Italian Ministry of Health; Bioengineering Laboratories S.r.l.	Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); French National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; Italian Ministry of Health(Ministry of Health, Italy); Bioengineering Laboratories S.r.l.	NM held a CMIRA Explora' doc 2011 fellowship from the Rhone-Alpes Region (en.rhonealpes.fr). This work was financially supported by the French National Centre for Scientific Research (CNRS, www.cnrs.fr), the Universite Claude Bernard Lyon 1 (www.univ-lyon1.fr) and by the Italian Ministry of Health (www.salute.gov.it). The CNRS provided support in the form of salary for FMG and MP and the CNRS and the Universite Claude Bernard Lyon 1 provided support in the form of research materials. The Italian Ministry of Health provided support in the form of salaries for SL, GT, ABL, and MM and of research materials. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioengineering Laboratories S.r.l. provided support in the form of salary for SR, but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Asawa Y, 2009, TISSUE ENG PT A, V15, P1109, DOI 10.1089/ten.tea.2007.0218; Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Cheng M, 2009, TISSUE ENG PT A, V15, P645, DOI 10.1089/ten.tea.2008.0077; Claus S, 2012, TISSUE ENG PART C-ME, V18, P104, DOI [10.1089/ten.TEC.2011.0259, 10.1089/ten.tec.2011.0259]; Colombini A, 2015, TISSUE ENG PT A, V21, P793, DOI [10.1089/ten.tea.2014.0279, 10.1089/ten.TEA.2014.0279]; Davisson T, 2002, TISSUE ENG, V8, P807, DOI 10.1089/10763270260424169; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; Gouttenoire M, 2004, BIORHEOLOGY, V41, P535; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004; Hautier A, 2008, GROWTH FACTORS, V26, P201, DOI 10.1080/08977190802242488; Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001; Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001; Lafont JE, 2016, OSTEOARTHR CARTILAGE, V24, P856, DOI 10.1016/j.joca.2015.11.017; Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695, DOI 10.1007/BF00158202; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Lopa S, 2015, BIOTECHNOL BIOENG, V112, P1457, DOI 10.1002/bit.25557; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Moretti M, 2008, BIO-MED MATER ENG, V18, P273, DOI 10.3233/BME-2008-0536; Moretti MG, 2010, PUB, Patent No. US2010/ 0297233 A1; Oliveira JT, 2009, J TISSUE ENG REGEN M, V3, P493, DOI 10.1002/term.184; Ollitrault D, 2015, TISSUE ENG PART C-ME, V21, P133, DOI [10.1089/ten.TEC.2013.0724, 10.1089/ten.tec.2013.0724]; Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; Raimondi MT, 2011, BIOMECH MODEL MECHAN, V10, P259, DOI 10.1007/s10237-010-0232-8; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Sabatino MA, 2015, J TISSUE ENG REGEN M, V9, P1394, DOI 10.1002/term.1661; Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009; Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wendt D, 2006, BIORHEOLOGY, V43, P481; Yamaoka H, 2010, J BIOMED MATER RES A, V93A, P123, DOI 10.1002/jbm.a.32509; Yang KGA, 2006, OSTEOARTHR CARTILAGE, V14, P561, DOI 10.1016/j.joca.2005.12.002	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161479	10.1371/journal.pone.0161479	http://dx.doi.org/10.1371/journal.pone.0161479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584727	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600033
J	Oldham, M; Yoon, P; Fathi, Z; Beyer, WF; Adamson, J; Liu, LH; Alcorta, D; Xia, WL; Osada, T; Liu, CX; Yang, XY; Dodd, RD; Herndon, JE; Meng, BY; Kirsch, DG; Lyerly, HK; Dewhirst, MW; Fecci, P; Walder, H; Spector, NL				Oldham, Mark; Yoon, Paul; Fathi, Zak; Beyer, Wayne F.; Adamson, Justus; Liu, Leihua; Alcorta, David; Xia, Wenle; Osada, Takuya; Liu, Congxiao; Yang, Xiao Y.; Dodd, Rebecca D.; Herndon, James E., II; Meng, Boyu; Kirsch, David G.; Lyerly, H. Kim; Dewhirst, Mark W.; Fecci, Peter; Walder, Harold; Spector, Neil L.			X-Ray Psoralen Activated Cancer Therapy (X-PACT)	PLOS ONE			English	Article							T-CELL LYMPHOMA; TERM-FOLLOW-UP; EXTRACORPOREAL PHOTOCHEMOTHERAPY; PUVA; TRANSIMMUNIZATION; APOPTOSIS; PSORIASIS; PHOTOBIOLOGY; MONOCYTE	This work investigates X-PACT (X-ray Psoralen Activated Cancer Therapy): a new approach for the treatment of solid cancer. X-PACT utilizes psoralen, a potent anti-cancer therapeutic with current application to proliferative disease and extracorporeal photopheresis (ECP) of cutaneous T Cell Lymphoma. An immunogenic role for light-activated psoralen has been reported, contributing to long-term clinical responses. Psoralen therapies have to-date been limited to superficial or extracorporeal scenarios due to the requirement for psoralen activation by UVA light, which has limited penetration in tissue. X-PACT solves this challenge by activating psoralen with UV light emitted from novel non-tethered phosphors (co-incubated with psoralen) that absorb x-rays and re-radiate (phosphoresce) at UV wavelengths. The efficacy of X-PACT was evaluated in both in-vitro and in-vivo settings. In-vitro studies utilized breast (4T1), glioma (CT2A) and sarcoma (KP-B) cell lines. Cells were exposed to X-PACT treatments where the concentrations of drug (psoralen and phosphor) and radiation parameters (energy, dose, and dose rate) were varied. Efficacy was evaluated primarily using flow cell cytometry in combination with complimentary assays, and the in-vivo mouse study. In an in-vitro study, we show that X-PACT induces significant tumor cell apoptosis and cytotoxicity, unlike psoralen or phosphor alone (p<0.0001). We also show that apoptosis increases as doses of phosphor, psoralen, or radiation increase. Finally, in an in-vivo pilot study of BALBc mice with syngeneic 4T1 tumors, we show that the rate of tumor growth is slower with X-PACT than with saline or AMT + X-ray (p<0.0001). Overall these studies demonstrate a potential therapeutic effect for X-PACT, and provide a foundation and rationale for future studies. In summary, X-PACT represents a novel treatment approach in which well-tolerated low doses of x-ray radiation are delivered to a specific tumor site to generate UVA light which in-turn unleashes both short- and potentially long-term antitumor activity of photo-active therapeutics like psoralen.	[Oldham, Mark; Yoon, Paul; Adamson, Justus; Dodd, Rebecca D.; Meng, Boyu; Kirsch, David G.; Dewhirst, Mark W.; Walder, Harold] Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC USA; [Fathi, Zak] Immunolight LLC, Detroit, MI USA; [Beyer, Wayne F.] QNS Grp LLC, Bahama, NC USA; [Liu, Leihua; Alcorta, David; Xia, Wenle; Spector, Neil L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Osada, Takuya; Liu, Congxiao; Yang, Xiao Y.; Lyerly, H. Kim] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Herndon, James E., II] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Fecci, Peter] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Oldham, M (corresponding author), Duke Univ, Dept Radiat Oncol, Med Ctr, Durham, NC USA.	Mark.Oldham@Duke.edu	Lyerly, Herbert Kim/AAX-4925-2020; Lyerly, Herbert K/B-6528-2014; Adamson, Justus/AAM-5335-2021; Dewhirst, Mark/Q-1302-2019	Lyerly, Herbert Kim/0000-0002-0063-4770; Lyerly, Herbert K/0000-0002-0063-4770; Dewhirst, Mark/0000-0003-3459-6546; Fecci, Peter/0000-0002-2912-8695; Yoon, Suk Whan "Paul"/0000-0002-0313-8131; Adamson, Justus/0000-0002-7868-5631; Dodd, Rebecca/0000-0001-7295-1882	Duke University, Immunolight LLC [P50 CA190991]; Duke SPORE in Brain Cancer [P50 CA190991]; NATIONAL CANCER INSTITUTE [P50CA190991] Funding Source: NIH RePORTER	Duke University, Immunolight LLC; Duke SPORE in Brain Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MO received Brainspore funding from Duke University P50 CA190991, Immunolight LLC funding was provided to MO MD NS and KL. Immunolight personnel (HW ZF WB) provided the energy converters and psoralen.; Funding support was received from P50 CA190991-Duke SPORE in Brain Cancer. We are very grateful to Dr Kathleen Ashcraft and Dr Kelly Lee for discussions and technical assistance arising from related work to that presented here.	Berger CL, 2002, TRANSFUS APHER SCI, V26, P205, DOI 10.1016/S1473-0502(02)00014-9; Bethea D, 1999, J DERMATOL SCI, V19, P78, DOI 10.1016/S0923-1811(98)00064-4; Bourke FA, 2014, US Patent Number, Patent No. [US20140323946 A1, 20140323946]; Bourke FA, 2014, US Patent Number, Patent No. [US20140272030 A1, 20140272030]; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; Edelson RL, 2014, TRANSFUS APHER SCI, V50, P322, DOI 10.1016/j.transci.2013.07.031; El-Domyati M, 2013, PHOTODERMATOL PHOTO, V29, P18, DOI 10.1111/phpp.12012; Gasparro F P, 1997, Recent Results Cancer Res, V143, P101; Girardi M, 2003, HEMATOL ONCOL CLIN N, V17, P1391, DOI 10.1016/S0889-8588(03)00106-0; Girardi M, 2002, TRANSFUS APHER SCI, V26, P181, DOI 10.1016/S1473-0502(02)00011-3; Girardi M, 2006, LEUKEMIA LYMPHOMA, V47, P1495, DOI 10.1080/10428190600581419; Gonzalez AL, 2014, CLIN EXP IMMUNOL, V175, P449, DOI 10.1111/cei.12231; HERRMANN JJ, 1995, J AM ACAD DERMATOL, V33, P234, DOI 10.1016/0190-9622(95)90241-4; Holtick U, 2012, TRANSPLANTATION, V94, pE31, DOI 10.1097/TP.0b013e31825f4454; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Knobler R, 2012, PHOTODERMATOL PHOTO, V28, P250, DOI 10.1111/j.1600-0781.2012.00689.x; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Maves RC, 2011, VACCINE, V29, P2691, DOI 10.1016/j.vaccine.2011.01.077; Morse MA, 2010, INT J CANCER, V126, P2893, DOI 10.1002/ijc.24995; Panno ML, 2014, WORLD J CLIN ONCOL, V5, P348, DOI 10.5306/wjco.v5.i3.348; Sachdeva M, 2014, J CLIN INVEST, V124, P4305, DOI 10.1172/JCI77116; Scaffidi JP, 2011, ACS NANO, V5, P4679, DOI 10.1021/nn200511m; SCHMITT IM, 1995, J PHOTOCH PHOTOBIO B, V27, P101, DOI 10.1016/1011-1344(94)07101-S; Shenoi SD, 2014, INDIAN J DERMATOL VE, V80, P497, DOI 10.4103/0378-6323.144143; Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122; Valbuena MC, 2007, PHOTODERMATOL PHOTO, V23, P126, DOI 10.1111/j.1600-0781.2007.00294.x; Wang Y, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen087; Xia WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088983	29	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162078	10.1371/journal.pone.0162078	http://dx.doi.org/10.1371/journal.pone.0162078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583569	Green Published, gold			2022-12-27	WOS:000382855600099
J	Tilgner, J; von Trotha, KT; Gombert, A; Jacobs, MJ; Drechsler, M; Doring, Y; Soehnlein, O; Grommes, J				Tilgner, Jessica; von Trotha, Klaus Thilo; Gombert, Alexander; Jacobs, Michael J.; Drechsler, Maik; Doering, Yvonne; Soehnlein, Oliver; Grommes, Jochen			Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury	PLOS ONE			English	Article							NEUTROPHILS	Background Treatment of acute lung injury (ALI) remains an unsolved problem in intensive care medicine. Recruitment of neutrophils into the lungs, regarded as a key mechanism in progression of ALI, depends on signaling between neutrophils and platelets. Consequently we explored the effect of platelet-targeted aspirin and tirofiban treatment in endotoxin induced acute lung injury Methods C57Bl/6 mice were exposed to aerosolized LPS (500 mu g/ml) for 30min and treated with Aspirin (100 mu g/g bodyweight via intraperitoneal injection, 30 min before or 1 hour after LPS inhalation) or Tirofiban (0.5 mu g/g bodyweight via tail vein injection 30 min before or 1 hour after LPS inhalation). The count of alveolar, interstitial, and intravascular neutrophils was assessed 4h later by flow cytometry. Lung permeability changes were assessed by FITC-dextran clearance and protein content in the BAL fluid. Results Aspirin both before and after LPS inhalation reduced neutrophil influx into the lung and lung permeability indicating the protective role of Aspirin in ALI. Tirofiban, however, did not alter neutrophil recruitment after LPS inhalation. Release of platelet-derived chemokines CCL5 and PF4 and neutrophil extracellular traps was reduced by Aspirin but not by Tirofiban. Conclusion Aspirin, but not Tirofiban reduces neutrophil recruitment and displays protective effects during endotoxin induced lung injury.	[Tilgner, Jessica; von Trotha, Klaus Thilo; Gombert, Alexander; Jacobs, Michael J.; Grommes, Jochen] Rhenish Westphalian Tech Univ Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany; [Jacobs, Michael J.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Drechsler, Maik; Doering, Yvonne; Soehnlein, Oliver; Grommes, Jochen] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] Univ Amsterdam, Dept Pathol, Amsterdam, Netherlands; [Drechsler, Maik; Doering, Yvonne; Soehnlein, Oliver] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany	Maastricht University; RWTH Aachen University; Maastricht University; University of Munich; University of Amsterdam; German Centre for Cardiovascular Research; Munich Heart Alliance	Grommes, J (corresponding author), Rhenish Westphalian Tech Univ Aachen, European Vasc Ctr Aachen Maastricht, Aachen, Germany.; Grommes, J (corresponding author), Univ Munich, Inst Cardiovasc Prevent, Munich, Germany.	jgrommes@ukaachen.de	Doring, Yvonne/E-1796-2013; Drechsler, Maik/C-3829-2008; Döring, Yvonne/E-9414-2017; Döring, Yvonne/AAA-3018-2022	Döring, Yvonne/0000-0001-9307-3396; Grommes, Jochen/0000-0002-6419-6802	Else-Kroner-Fresenius Stiftung; B. Braun Foundation	Else-Kroner-Fresenius Stiftung; B. Braun Foundation	This study was supported by the Else-Kroner-Fresenius Stiftung and the B. Braun Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge Patricia Lemnitzer, Carmen Schaller and Zohreh Packsereshtmogharab for excellent technical assistance. This study was supported by the Else-Kroner-Fresenius Stiftung and the B. Braun Foundation.	Bdeir K, 2010, AM J RESP CRIT CARE, V181, P935, DOI 10.1164/rccm.200907-1128OC; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; DOERSCHUK CM, 1987, J APPL PHYSIOL, V63, P1806, DOI 10.1152/jappl.1987.63.5.1806; Doerschuk CM, 2001, MICROCIRCULATION, V8, P71, DOI 10.1038/sj.mn.7300151; Doerschuk CM, 2000, AM J RESP CELL MOL, V23, P133, DOI 10.1165/ajrcmb.23.2.f193; Folkesson HG, 1997, J APPL PHYSIOL, V82, P1743, DOI 10.1152/jappl.1997.82.6.1743; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Grommes J, 2014, J INNATE IMMUN, V6, P111, DOI 10.1159/000353229; Grommes J, 2012, EUR RESPIR J, V40, P416, DOI 10.1183/09031936.00091011; Grommes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038917; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Massberg S, 2010, NAT MED; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rossaint J, 2015, CARDIOVASC RES; Rossaint J, 2014, BLOOD, V123, P2573, DOI 10.1182/blood-2013-07-516484; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; von Hundelshausen P, 2007, THROMB HAEMOSTASIS, V97, P704, DOI 10.1160/TH07-01-0066; Von Hundelshausen P, 2009, MICROCIRCULATION, V16, P84, DOI 10.1080/10739680802564787; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161218	10.1371/journal.pone.0161218	http://dx.doi.org/10.1371/journal.pone.0161218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583400	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600015
J	Gao, YS; Wang, B; Gao, SG				Gao, Yushun; Wang, Bing; Gao, Shugeng			BRD7 Acts as a Tumor Suppressor Gene in Lung Adenocarcinoma	PLOS ONE			English	Article							PROGNOSTIC CLASSIFIER; EXPRESSION; BROMODOMAIN; COMBINATION; RELEVANCE; CARCINOMA; MICRORNA; TARGET	Lung cancer is one of the most malignant tumors and the leading cause of cancer-related deaths worldwide. Among lung cancers, 40% are diagnosed as adenocarcinoma. Bromodomain containing 7 (BRD7) is a member of bromodomain-containing protein family. It was proved to be downregulated in various cancers. However, the role of BRD7 in lung adenocarcinoma is still unknown. Western blot and qRT-PCR was performed to measure the BRD7 expression in lung adenocarcinoma tissues and cells. CCK8 and migration assay was done to detect the functional role of BRD7 in lung adenocarcinoma. In this study, we showed that the expression of BRD7 was downregulated in lung adenocarcinoma tissues and cells. The lower of BRD7 levels in patients with lung adenocarcinoma was associated with shortened disease-free survival. Furthermore, overexpression of BRD7 inhibited lung adenocarcinoma cell proliferation and migration. Inhibition of BRD7 expression promoted cell proliferation and migration by activating ERK phosphorylation. Overexpression of BRD7 inhibited cyclin D and myc expression. Our findings are consistent with a tumor suppressor role for BRD7 in lung adenocarcinoma tumorigenesis.	[Gao, Yushun; Wang, Bing; Gao, Shugeng] Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst Hosp, Dept Thorac Surg Oncol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Gao, SG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Canc Inst Hosp, Dept Thorac Surg Oncol, Beijing 100021, Peoples R China.	yushun1gao@163.com						Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Feng J, 2014, ONCOTARGET, V5, P9689, DOI 10.18632/oncotarget.2103; Ge XJ, 2015, MOL MED REP, V11, P333, DOI 10.3892/mmr.2014.2757; Ho CS, 2014, LUNG CANCER, V83, P154, DOI 10.1016/j.lungcan.2013.11.024; Hu KS, 2014, ONCOTARGET, V5, P3088, DOI 10.18632/oncotarget.1816; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Li D, 2015, INT J CLIN EXP PATHO, V8, P14693; Liu HY, 2008, J HISTOCHEM CYTOCHEM, V56, P531, DOI 10.1369/jhc.7A7340.2007; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Liu HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-253; Maquilan G, 2018, AM J CLIN ONCOL-CANC, V41, P391, DOI 10.1097/COC.0000000000000288; Pal S, 2016, CANCER MICROENVIRON, V9, P77, DOI 10.1007/s12307-016-0184-3; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Park YA, 2014, CLIN CANCER RES, V20, P565, DOI 10.1158/1078-0432.CCR-13-1271; Park YA, 2012, GYNECOL ONCOL, V124, P125, DOI 10.1016/j.ygyno.2011.09.026; Pern F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047993; Robles AI, 2015, J THORAC ONCOL, V10, P1037, DOI 10.1097/JTO.0000000000000560; Schliekelman MJ, 2015, CANCER RES, V75, P1789, DOI 10.1158/0008-5472.CAN-14-2535; Song XY, 2016, DRUG DES DEV THER, V10, P1345, DOI 10.2147/DDDT.S96766; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; Sun Y, 2015, ONCOTARGET; Tejero R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101899; Van de Vijver P, 2012, CHEM COMMUN, V48, P9403, DOI 10.1039/c2cc34956f; Wu WJ, 2013, EUR J CLIN INVEST, V43, P131, DOI 10.1111/eci.12024; Xu P, 2015, INT J CLIN EXP PATHO, V8, P15887; Yan GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0203-5; Yang WB, 2014, ONCOTARGET, V5, P740, DOI 10.18632/oncotarget.1608; Yarchoan M, 2015, CUREUS, V7, DOI 10.7759/cureus.409; Zhang ZY, 2015, ONCOTARGET, V6, P1462, DOI 10.18632/oncotarget.2808; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0156701	10.1371/journal.pone.0156701	http://dx.doi.org/10.1371/journal.pone.0156701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580131	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877400001
J	Kuehne, A; Tiffany, A; Lasry, E; Janssens, M; Besse, C; Okonta, C; Larbi, K; Pah, AC; Danis, K; Porten, K				Kuehne, Anna; Tiffany, Amanda; Lasry, Estrella; Janssens, Michel; Besse, Clement; Okonta, Chibuzo; Larbi, Kwabena; Pah, Alfred C.; Danis, Kostas; Porten, Klaudia			Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; FIXED-DOSE COMBINATIONS; ARTESUNATE-AMODIAQUINE; NIMBA COUNTY; OPEN-LABEL; TRIAL	Background In October 2014, during the Ebola outbreak in Liberia healthcare services were limited while malaria transmission continued. Medecins Sans Frontieres (MSF) implemented a mass drug administration (MDA) of malaria chemoprevention (CP) in Monrovia to reduce malaria-associated morbidity. In order to inform future interventions, we described the scale of the MDA, evaluated its acceptance and estimated the effectiveness. Methods MSF carried out two rounds of MDA with artesunate/amodiaquine (ASAQ) targeting four neighbourhoods of Monrovia (October to December 2014). We systematically selected households in the distribution area and administered standardized questionnaires. We calculated incidence ratios (IR) of side effects using poisson regression and compared self-reported fever risk differences (RD) pre- and post-MDA using a z-test. Findings In total, 1,259,699 courses of ASAQ-CP were distributed. All households surveyed (n = 222; 1233 household members) attended the MDA in round 1 (r1) and 96% in round 2 (r2) (212/222 households; 1,154 household members). 52% (643/1233) initiated ASAQ-CP in r1 and 22% (256/1154) in r2. Of those not initiating ASAQ-CP, 29% (172/590) saved it for later in r1, 47% (423/898) in r2. Experiencing side effects in r1 was not associated with ASAQ-CP initiation in r2 (IR 1.0, 95% CI 0.49-2.1). The incidence of self-reported fever decreased from 4.2% (52/1229) in the month prior to r1 to 1.5% (18/1229) after r1 (p<0.001) and decrease was larger among household members completing ASAQ-CP (RD = 4.9%) compared to those not initiating ASAQ-CP (RD = 0.6%) in r1 (p<0.001). Conclusions The reduction in self-reported fever cases following the intervention suggests that MDAs may be effective in reducing cases of fever during Ebola outbreaks. Despite high coverage, initiation of ASAQ-CP was low. Combining MDAs with longer term interventions to prevent malaria and to improve access to healthcare may reduce both the incidence of malaria and the proportion of respondents saving their treatment for future malaria episodes.	[Kuehne, Anna] Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany; [Kuehne, Anna; Danis, Kostas] ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden; [Kuehne, Anna; Porten, Klaudia] Epictr, Paris, France; [Tiffany, Amanda] Epictr, Geneva, Switzerland; [Lasry, Estrella] Med Sans Frontieres, Operat Ctr Paris, Trop Med, New York, NY USA; [Janssens, Michel; Besse, Clement] Med Sans Frontieres, Operat Ctr Paris, Monrovia Project, Monrovia, Liberia; [Okonta, Chibuzo] Med Sans Frontieres, Operat Ctr Paris, Desk Urgence, Paris, France; [Larbi, Kwabena; Pah, Alfred C.] Minist Hlth, Liberian Natl Malaria Control Programme, Monrovia, Liberia; [Danis, Kostas] Inst Veille Sanitaire, Paris, France	Robert Koch Institute; European Centre for Disease Prevention & Control; Doctors Without Borders; Institute of Public Health Surveillance	Kuehne, A (corresponding author), Robert Koch Inst, Postgrad Training Appl Epidemiol, Berlin, Germany.; Kuehne, A (corresponding author), ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden.; Kuehne, A (corresponding author), Epictr, Paris, France.; Tiffany, A (corresponding author), Epictr, Geneva, Switzerland.	KuehneAn@rki.de; Amanda.Tiffany@geneva.msf.org	Danis, Kostas/ABD-7357-2020; Kuehne, Anna/AAD-7816-2022	Kuehne, Anna/0000-0002-8578-0362	Medecins sans Frontieres	Medecins sans Frontieres	Epicentre (AT, KP) received core funding from Medecins sans Frontieres to conduct this research.	Alba S, 2011, INT J EPIDEMIOL, V40, P405, DOI 10.1093/ije/dyq240; [Anonymous], 2015, 2014 ANN REP; [Anonymous], 2010, NAT MAL STRAT PLAN 2; Kuehne A, 2015, TROP MED INT HEALTH, V20, P43; Ministry of Health and Social Welfare (MOHSW) [Liberia], 2014, LIB EB DAIL SITR 202; National Malaria Control Program (NMCP) [Liberia] Ministry of Health and Social Welfare (MOHSW) Liberia Institute of Statistics and Geo-information Services (LISGIS) and ICF International, 2012, LIB MAL IND SURV 201; Newby G, 2015, AM J TROP MED HYG, V93, P125, DOI 10.4269/ajtmh.14-0254; Poirot E, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008846.pub2; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-250; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-251; Song JP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-57; von Seidlein L, 2003, T ROY SOC TROP MED H, V97, P217, DOI 10.1016/S0035-9203(03)90125-8; von Seidlein L, 2003, TRENDS PARASITOL, V19, P452, DOI 10.1016/j.pt.2003.08.003; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6; WHO, 2015, EB SIT REP; World Health Organisation (WHO), 2015, GUID TEMP MAL CONTR	17	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161311	10.1371/journal.pone.0161311	http://dx.doi.org/10.1371/journal.pone.0161311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580098	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400023
J	Brannstrom, J; Svedhem, V; Marrone, G; Andersson, O; Azimi, F; Blaxhult, A; Sonnerborg, A				Brannstrom, Johanna; Svedhem, Veronica; Marrone, Gaetano; Andersson, Orjan; Azimi, Farshad; Blaxhult, Anders; Sonnerborg, Anders			Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study	PLOS ONE			English	Article							INFECTION; OPPORTUNITIES; TRANSMISSION; THERAPY; UNAWARE; DISEASE; AUDIT	Objectives One quarter of HIV-1 positive individuals in Sweden present for care with HIV or AIDS associated conditions without an HIV test (missed presentations) and 16% report neglect of such symptoms. The objective of this study was to identify risk factors for these missed opportunities of HIV-1 diagnosis. Methods A national study, recruiting 409 newly diagnosed HIV-1 infected adults over a 2.5-year period, was performed. Logistic regression models tested the relationship between missed presentation and patient's neglect versus socio-demographic and behavioural risk factors. Additionally the initiator of the HIV test was assessed. Results The odds for a missed presentation was lower for migrants (from East Europe, Asia, and Pacific (East): OR 0.4 (0.2-0.8); Sub-Saharan Africa (SSA): 0.3 (0.2-0.6); other: 0.5 (0.2-1.0)), compared to patients born in Sweden, just as symptoms neglected by the patient (East (0.3 (0.1-1.0); SSA (0.4 (0.2-0.8)). The latter was also lower for men who have sex with men (0.5 (0.2-1.0)), compared to patients infected heterosexually. Patients infected in the East, with present/previous substance use or a previous negative HIV test were more likely to take the initiative to test on their own, whereas those >50 years and with a previously missed presentation had significantly reduced odds, p<0.05. Conclusions Individuals without epidemiological indicators of HIV are more likely to have a history of missed presentations, to neglect symptoms and are less prone to take an initiative to test for HIV themselves. It is important to further implement testing to include all patients with symptoms and conditions indicative of HIV.	[Brannstrom, Johanna; Svedhem, Veronica; Sonnerborg, Anders] Karolinska Inst, Dept Med, Infect Dis Unit, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Brannstrom, Johanna; Svedhem, Veronica; Marrone, Gaetano; Sonnerborg, Anders] Karolinska Univ Hosp Huddinge, Dept Infect Dis, Stockholm, Sweden; [Andersson, Orjan] Sundsvall Cty Hosp, Dept Infect Dis, Sundsvall, Sweden; [Azimi, Farshad] Gavle Cty Hosp, Dept Infect Dis, Gavle, Sweden; [Blaxhult, Anders] Stockholm South Gen Hosp, Dept Clin Sci & Educ, Stockholm, Sweden; [Sonnerborg, Anders] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Brannstrom, J (corresponding author), Karolinska Inst, Dept Med, Infect Dis Unit, Karolinska Univ Hosp Huddinge, Stockholm, Sweden.; Brannstrom, J (corresponding author), Karolinska Univ Hosp Huddinge, Dept Infect Dis, Stockholm, Sweden.	johanna.brannstrom@karolinska.se	Sönnerborg, Anders/W-2011-2019	Sönnerborg, Anders/0000-0001-8928-3374; Marrone, Gaetano/0000-0002-2991-1663; Brannstrom, Johanna/0000-0001-7684-8591	Swedish Board of Health and Welfare; Public Health Agency of Sweden; Karolinska Institutet; Swedish Physicians against AIDS Foundation; Gilead Science Nordic: Gilead Nordic Fellow program	Swedish Board of Health and Welfare; Public Health Agency of Sweden; Karolinska Institutet(Karolinska Institutet); Swedish Physicians against AIDS Foundation; Gilead Science Nordic: Gilead Nordic Fellow program	The study is funded by The Swedish Board of Health and Welfare (AS) and Public Health Agency of Sweden (AS) www.folkhalsomyndigheten.se/about-folkhalsomyndigheten-the-public-health-agency-ofsweden/, Karolinska Institutet (JB) https://internwebben.ki.se/sv/beslut-om-tilldelning-av-kid-medel, Swedish Physicians against AIDS Foundation (JB) http://www.aidsfond.se/beviljade-projekt-24785244 and Gilead Science Nordic: Gilead Nordic Fellow program. www.Gilead.com (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation. of the manuscript. JB had full access to the data and responsibility for the submission.	[Anonymous], 1993, JAMA, V269, P729; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Brannstrom J, 2005, INT J STD AIDS, V16, P702, DOI 10.1258/095646205774357262; Brannstrom J, 2016, HIV MED, V17, P425, DOI 10.1111/hiv.12321; Brawley D, 2013, SCOT MED J, V58, P173, DOI 10.1177/0036933013496965; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; Champenois K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-200; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Elmahdi R, 2014, SEX TRANSM INFECT, V90, P119, DOI 10.1136/sextrans-2013-051312; GAIL MH, 1990, J ACQ IMMUN DEF SYND, V3, P296; Gazzard B, 2008, HIV MED, V9, P34, DOI 10.1111/j.1468-1293.2008.00592.x; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Helleberg M, 2011, SCAND J INFECT DIS; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Lazarus J, 2013, HIV MED; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Monforte AD, 2011, ANTIVIR THER, V16, P1103, DOI 10.3851/IMP1883; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Ndiaye B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-11; Scognamiglio P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-473; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845; Vives N, 2012, INT J STD AIDS, V23, P475, DOI 10.1258/ijsa.2011.011280; Wohlgemut J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-72	28	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162503	10.1371/journal.pone.0162503	http://dx.doi.org/10.1371/journal.pone.0162503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603207	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200071
J	Chen, WL; Liao, BL; Hu, FY; Nie, JM; Lan, Y; Li, HQ; Lu, RC; Gao, Y; Song, YX; Zhao, QX; Zheng, YH; Tang, XP; Cai, WP				Chen, Weilie; Liao, Baolin; Hu, Fengyu; Nie, Jingmin; Lan, Yun; Li, Huiqin; Lu, Ruichao; Gao, Yanqing; Song, Yuxia; Zhao, Qingxia; Zheng, Yuhuang; Tang, Xiaoping; Cai, Weiping			Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China	PLOS ONE			English	Article							RANDOMIZED-TRIAL; PLUS RIBAVIRIN; INFECTION; PREVALENCE; THERAPY; UPDATE	Background Co-infection with hepatitis C virus (HCV) has become the most common cause of death in human immunodeficiency virus (HIV) infected patients on antiretroviral therapy. The distribution of HCV genotypes varies with geographical regions and time, and limited studies have focused on the HCV genotype in HIV/HCV co-infection. Methods The distribution of HCV genotypes was evaluated in 414 patients with HIV/HCV co-infection in three regions (South, Central and Northwest) of China from 2008 to 2010. The NS5B region of HCV was characterized using nested reverse transcription polymerase chain reaction. Nucleotide sequences obtained were subjected to phylogenetic analysis, and genotypes were assigned using published reference genotypes. Results Genotype 3 was the most prevalent HCV strain (36.2%), followed by genotype 6 (30.0%), genotype 1 (28.5%), genotype 2 (5.1%), and genotype 5 (0.2%). The distribution varied geographically. Genotype 6 (37.6%) was the predominant strain while genotype 1 (20.2%) was less common in the South compared to the Central and Northwest regions (all P < 0.001). The distribution also varied temporally. There was no significant difference in genotype distribution in Guangdong (a province in the South region), between patient cohorts from 2005-2008 and 2009-2010. However, outside Guangdong, genotypes 3 and 6a became significantly more prevalent (22.4% vs. 42.2%, P<0.001; 8.0% vs. 19.8%, P = 0.004), and genotype 1 less prevalent (54.4% vs. 26.6%, P<0.001) over time. Conclusion The most dramatic shift in genotypic distribution was the movement of HCV genotypes 3 and 6a outside of Guangdong in HIV/HCV co-infected patients. This movement appeared closely associated with transmission via injected drug use.	[Chen, Weilie; Liao, Baolin; Hu, Fengyu; Nie, Jingmin; Lan, Yun; Tang, Xiaoping; Cai, Weiping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Li, Huiqin] Yunnan Prov Infect Dis Hosp, Dept Infect Dis, Kunming, Yunnan, Peoples R China; [Lu, Ruichao] Guangxi Zhuang Autonomous Reg Longtan Hosp, Dept Infect Dis, Guangxi, Peoples R China; [Gao, Yanqing] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Song, Yuxia] Xinjiang 6 Peoples Hosp, Dept Infect Dis, Xinjiang, Peoples R China; [Zhao, Qingxia] Zhenzhou 6 Peoples Hosp, Dept Infect Dis, Zhenzhou, Peoples R China; [Zheng, Yuhuang] Zhongnan Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Hunan, Peoples R China	Guangzhou Medical University; Capital Medical University; Central South University	Tang, XP; Cai, WP (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	xtang@21cn.com; gz8hcwp@126.com			Chinese National Key Technologies R&D Program for the 12th Five-year Plan [2012ZX10001003-003]; Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau [201300000092, 2014Y2-00149]; National Natural Science Foundation of China [81201286]	Chinese National Key Technologies R&D Program for the 12th Five-year Plan; Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Chinese National Key Technologies R&D Program for the 12th Five-year Plan (2012ZX10001003-003), the Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau (201300000092 and 2014Y2-00149) and National Natural Science Foundation of China (81201286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Ju W, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0341-1; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Piroth L, 2015, CLIN INFECT DIS, V61, P817, DOI 10.1093/cid/civ381; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Rong X, 2014, ARCH VIROL, V159, P3231, DOI 10.1007/s00705-014-2185-1; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2012, LIVER INT, V32, P129, DOI 10.1111/j.1478-3231.2011.02719.x; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608	22	8	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161844	10.1371/journal.pone.0161844	http://dx.doi.org/10.1371/journal.pone.0161844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603929	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200027
J	Jin, YL; Chen, PY; Zhang, YF; Tian, G; Feng, HQ; Hou, YM				Jin, Yinli; Chen, Peiyu; Zhang, Yanfang; Tian, Guo; Feng, Hongqiang; Hou, Youming			Effect of Water on Survival and Development of Diapausing Eggs of Apolygus lucorum (Hemiptera: Miridae)	PLOS ONE			English	Article							MULTIPLE CROPS; BT COTTON; TERMINATION; TEMPERATURE; PHOTOPERIOD; MOISTURE; BEETLE; LIFE; BUG	The green mirid bug Apolygus lucorum is a regional pest of multiple crops in northern China, and the survival and development of diapausing eggs during winter plays an important role in the population dynamics of this species. The effect of water on the survival and development of A. lucorum eggs was investigated using laboratory-induced diapause. Diapausing eggs were exposed to various humidity regimes under three conditions: (1) termination of diapause with exposure to warm long-day (WLD) conditions (i.e., 26 +/- 1 degrees C and 75 +/- 5% relative humidity (RH) under a photoperiod of 16 hours light and 8 hours dark), (2) termination of diapause by chilling at 4 degrees C, or (3) during the post-diapause stage, i.e., from transfer to WLD conditions after chilling, until the hatching of nymphs. The results indicate that water availability is crucial for the post-diapause resumption of development of A. lucorum. However, exposure to excessive moisture was detrimental, as indicated by a decrease in diapause termination rate and a prolonged pre-hatching period of diapausing eggs, compared to limited moisture conditions. This implies that both too dry and too humid environmental conditions would suppress survival and postpone hatching of overwintered A. lucorum eggs, and might explain why this pest has not caused severe damage in either southern or western China where the respective climates are very humid or dry.	[Jin, Yinli; Hou, Youming] Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou 350002, Fujian, Peoples R China; [Jin, Yinli; Chen, Peiyu; Zhang, Yanfang; Tian, Guo; Feng, Hongqiang] Henan Acad Agr Sci, Henan Key Lab Crop Pest Control,Inst Plant Protec, Key Lab Integrated Pest Management Crops Southern, Int Joint Res Lab Crop Protect Henan,Biol Pestici, Zhengzhou 450002, Henan, Peoples R China; [Chen, Peiyu] Nanyang Acad Agr Sci, Nanyang 473008, Henan, Peoples R China	Fujian Agriculture & Forestry University; Henan Academy of Agricultural Sciences	Hou, YM (corresponding author), Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou 350002, Fujian, Peoples R China.; Feng, HQ (corresponding author), Henan Acad Agr Sci, Henan Key Lab Crop Pest Control,Inst Plant Protec, Key Lab Integrated Pest Management Crops Southern, Int Joint Res Lab Crop Protect Henan,Biol Pestici, Zhengzhou 450002, Henan, Peoples R China.	feng_hq@163.com; ymhou@fafu.edu.cn		Hou, Youming/0000-0001-7984-9688; jin, yinli/0000-0002-5889-2166; Feng, Hongqiang/0000-0002-1171-248X	Special Fund for Agro-Scientific Research in the Public Interest [201103012-7]; Chinese Ministry of Agriculture [2014ZX08012-004]	Special Fund for Agro-Scientific Research in the Public Interest; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This work was financially supported by the Special Fund for Agro-Scientific Research in the Public Interest (201103012-7) and the Chinese Ministry of Agriculture (2014ZX08012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1972, Applied Entomology and Zoology, V7, P142; Barns HF, 1943, J ANIM ECOL, V12, P137, DOI 10.2307/1373; [陈培育 CHEN Pei-yu], 2010, [河南农业大学学报, Journal of Henan Agricultural University], V44, P83; Chen PY, 2010, THESIS; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Feng HQ, 2012, J ECON ENTOMOL, V105, P1921, DOI 10.1603/EC12193; Feng HQ, 2012, ENVIRON ENTOMOL, V41, P1606, DOI 10.1603/EN12099; Higaki M, 2012, J INSECT PHYSIOL, V58, P56, DOI 10.1016/j.jinsphys.2011.09.014; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1325, DOI 10.1016/j.jinsphys.2010.04.016; [金银利 Jin Yinli], 2015, [植物保护, Plant Protection], V41, P179; [金银利 Jin Yinli], 2015, [植物保护, Plant Protection], V41, P149; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; KRYSAN JL, 1978, J INSECT PHYSIOL, V24, P535, DOI 10.1016/0022-1910(78)90055-0; Li GP, 2011, CROP PROT, V30, P1573, DOI 10.1016/j.cropro.2011.08.015; Lu Y. H., 2008, ACTA PHYTOPHYLACICA, V35, P215; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, APPL ENTOMOL ZOOL, V45, P387, DOI 10.1303/aez.2010.387; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu YH, 2008, BIOL CONTROL MIRIDS, P151; Nahrung HF, 1999, ENTOMOL EXP APPL, V93, P201, DOI 10.1023/A:1003878911300; National Bureau of Statistics of China, NAT DAT; Pan HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094190; R Core Team, 2012, R LANG ENV STAT COMP; Ritz C, 2008, USE R, P1; TAUBER MJ, 1976, ANNU REV ENTOMOL, V21, P81, DOI 10.1146/annurev.en.21.010176.000501; Terao M, 2012, J INSECT PHYSIOL, V58, P737, DOI 10.1016/j.jinsphys.2012.02.009; [田彩红 Tian Caihong], 2013, [植物保护, Plant Protection], V39, P56; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhuo De-Gan, 2011, Acta Entomologica Sinica, V54, P136	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161657	10.1371/journal.pone.0161657	http://dx.doi.org/10.1371/journal.pone.0161657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603210	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255200021
J	Lin, GG; Zhang, K; Yi, L; Han, YX; Xie, JH; Li, JM				Lin, Guigao; Zhang, Kuo; Yi, Lang; Han, Yanxi; Xie, Jiehong; Li, Jinming			National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China	PLOS ONE			English	Article							CYP2D6; ASSOCIATION; METABOLITE; PHENOTYPE; SURVIVAL; VKORC1; IMPACT	Tamoxifen has been successfully used for treating breast cancer and preventing cancer recurrence. Cytochrome P450 2D6 (CYP2D6) plays a key role in the process of metabolizing tamoxifen to its active moiety, endoxifen. Patients with variants of the CYP2D6 gene may not receive the full benefit of tamoxifen treatment. The CYP2D6* 10 variant (the most common variant in Asians) was analyzed to optimize the prescription of tamoxifen in China. To ensure referring clinicians have accurate information for genotype-guided tamoxifen treatment, the Chinese National Center for Clinical Laboratories (NCCL) organized a national proficiency testing (PT) to evaluate the performance of laboratories providing CYP2D6* 10 genotyping. Ten genomic DNA samples with CYP2D6 wild-type or CYP2D6* 10 variants were validated by PCR-sequencing and sent to 28 participant laboratories. The genotyping results and pharmacogenomic test reports were submitted and evaluated by NCCL experts. Additional information regarding the number of samples tested, the accreditation/certification status, and detecting technology was also requested. Thirty-one data sets were received, with a corresponding analytical sensitivity of 98.2%(548/558 challenges; 95% confidence interval: 96.7-99.1%) and an analytic specificity of 96.5% (675/682; 95% confidence interval: 97.9-99.5%). Overall, 25/28 participants correctly identified CYP2D6* 10 status in 10 samples; however, two laboratories made serious genotyping errors. Most of the essential information was included in the 20 submitted CYP2D6* 10 test reports. The majority of Chinese laboratories are reliable for detecting the CYP2D6* 10 variant; however, several issues revealed in this study underline the importance of PT schemes in continued external assessment and provision of guidelines.	[Lin, Guigao; Zhang, Kuo; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Gerontol, Beijing, Peoples R China; [Lin, Guigao; Zhang, Kuo; Yi, Lang; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Lin, Guigao; Zhang, Kuo; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China; [Yi, Lang] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China	Beijing Hospital; Beijing Hospital; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Gerontol, Beijing, Peoples R China.; Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.; Li, JM (corresponding author), Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China.	jmli@nccl.org.cn			Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China [201402018]; Beijing Natural Science Foundation [7164295]	Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China (No. 201402018) and Beijing Natural Science Foundation (7164295).	Garcia-Sepulveda CA, 2010, MOL BIOL REP, V37, P1883, DOI 10.1007/s11033-009-9624-1; ALLEN KE, 1980, BRIT J PHARMACOL, V71, P83, DOI 10.1111/j.1476-5381.1980.tb10912.x; Beck JC, 2001, CANCER EPIDEM BIOMAR, V10, P551; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Jordan VC, 2003, NAT REV DRUG DISCOV, DOI [10.1016/S0140-6736(11)60993-8, DOI 10.1016/S0140-6736(11)60993-8]; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Kiyotani K, 2012, BREAST CANCER RES TR, V131, P137, DOI 10.1007/s10549-011-1777-7; Lin GG, 2015, J CARDIOVASC PHARM, V66, P129, DOI 10.1097/FJC.0000000000000254; Lin GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134174; Madlensky L, 2011, CLIN PHARMACOL THER, V89, P718, DOI 10.1038/clpt.2011.32; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Qian JC, 2013, PHARMACOGENOMICS, V14, P1731, DOI 10.2217/pgs.13.160; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Tang KF, 2015, J ZHEJIANG UNIV-SC B, V16, P191, DOI 10.1631/jzus.B1400282; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155; Yi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148081	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162361	10.1371/journal.pone.0162361	http://dx.doi.org/10.1371/journal.pone.0162361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603206	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200061
J	Ouellette, SB; Noel, BM; Parker, LL				Ouellette, Steven B.; Noel, Brett M.; Parker, Laurie L.			A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; DIFFERENTIAL SENSITIVITY; PEPTIDE BIOSENSOR; DRUG DISCOVERY; ABL ACTIVITY; FOLLOW-UP; IMATINIB; NILOTINIB; CANCER; PHOSPHORYLATION	Kinase enzymes are an important class of drug targets, particularly in cancer. Cell-based kinase assays are needed to understand how potential kinase inhibitors act on their targets in a physiologically relevant context. Current cell-based kinase assays rely on antibody-based detection of endogenous substrates, inaccurate disease models, or indirect measurements of drug action. Here we expand on previous work from our lab to introduce a 96-well plate compatible approach for measuring cell-based kinase activity in disease-relevant human chronic myeloid leukemia cell lines using an exogenously added, multi-functional peptide substrate. Our cellular models natively express the BcrAbl oncogene and are either sensitive or have acquired resistance to well-characterized BcrAbl tyrosine kinase inhibitors. This approach measures IC50 values comparable to established methods of assessing drug potency, and its robustness indicates that it can be employed in drug discovery applications. This medium-throughput assay could bridge the gap between single target focused, high-throughput in vitro assays and lower-throughput cell-based follow-up experiments.	[Ouellette, Steven B.; Noel, Brett M.; Parker, Laurie L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Ouellette, Steven B.; Noel, Brett M.] KinaSense LLC, W Lafayette, IN 47901 USA; [Parker, Laurie L.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Mason Canc Ctr, Minneapolis, MN 55455 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities	Ouellette, SB; Parker, LL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA.; Ouellette, SB (corresponding author), KinaSense LLC, W Lafayette, IN 47901 USA.; Parker, LL (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Mason Canc Ctr, Minneapolis, MN 55455 USA.	souellette@kinasense.com; llparker@umn.edu	Parker, Laurie L/C-1510-2010	Parker, Laurie L/0000-0002-6234-3346	National Institutes of Health [R00CA127161, R21CA160129]; NATIONAL CANCER INSTITUTE [R00CA127161, R21CA160129, R01CA182543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health through grants R00CA127161 and R21CA160129, nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health through grants R00CA127161 and R21CA160129. The authors would like to thank Matthew Martin and Broxton Davis for assisting in experimental procedures.	[Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.04.002; Boros K, 2015, ONCOTARGET, V6, P25575, DOI 10.18632/oncotarget.4669; Brummendorf TH, 2015, BRIT J HAEMATOL, V168, P69, DOI 10.1111/bjh.13108; Cassuto O, 2012, ONCOTARGET, V3, P1557; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Cui W, 2015, CHEM COMMUN, V51, P362, DOI 10.1039/c4cc07453j; Drew AE, 2011, J BIOMOL SCREEN, V16, P164, DOI 10.1177/1087057110394657; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Eadie LN, 2014, CLIN PHARMACOL THER, V95, P294, DOI 10.1038/clpt.2013.208; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Frietsch JJ, 2014, ONCOTARGET, V5, P5257, DOI 10.18632/oncotarget.2072; Gioia R, 2011, BLOOD, V118, P2211, DOI 10.1182/blood-2010-10-313692; Hsu J, 2013, J BIOMOL SCREEN, V18, P890, DOI 10.1177/1087057113489881; Iversen PW, 2004, ASSAY GUIDANCE MANUA; Jabbour E, 2014, AM J HEMATOL, V89, P547, DOI 10.1002/ajh.23691; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kim SH, 2014, HAEMATOLOGICA, V99, P1191, DOI 10.3324/haematol.2013.096776; Kim Yeo-Kyeoung, 2014, Chonnam Med J, V50, P102, DOI 10.4068/cmj.2014.50.3.102; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Li H, 2004, BIOCHEMISTRY-US, V43, P1599, DOI 10.1021/bi035597k; Lipchik AM, 2015, J AM CHEM SOC, V137, P2484, DOI 10.1021/ja507164a; Lipchik AM, 2012, BIOCHEMISTRY-US, V51, P7515, DOI 10.1021/bi300970h; Lu LH, 2009, BIOCHEMISTRY-US, V48, P3600, DOI 10.1021/bi8020923; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mand MR, 2010, J BIOMOL SCREEN, V15, P434, DOI 10.1177/1087057110363307; Mathrubutham MF, 2009, PROCEEDINGS OF THE 1; Mizutani T, 2010, CLIN CANCER RES, V16, P3964, DOI 10.1158/1078-0432.CCR-10-0548; Morris MC, 2013, BBA-PROTEINS PROTEOM, V1834, P1387, DOI 10.1016/j.bbapap.2013.01.025; Okabe S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-32; Pan XY, 2015, ORG BIOMOL CHEM, V13, P7050, DOI 10.1039/c5ob00430f; Peled N, 2013, CELL ONCOL, V36, P277, DOI 10.1007/s13402-013-0133-9; Placzek EA, 2010, ANAL BIOCHEM, V397, P73, DOI 10.1016/j.ab.2009.09.048; Rezende Vinícius Marcondes, 2013, Rev. Bras. Hematol. Hemoter., V35, P103, DOI 10.5581/1516-8484.20130030; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Smith AL, 2009, J MED CHEM, V52, P6189, DOI 10.1021/jm901081g; Tang C, 2011, LEUKEMIA LYMPHOMA, V52, P2139, DOI 10.3109/10428194.2011.591013; Tang JB, 2012, CHEMBIOCHEM, V13, P665, DOI 10.1002/cbic.201100763; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; White D, 2007, J CLIN ONCOL, V25, P4445, DOI 10.1200/JCO.2006.09.9499; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Xu WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048867; Yang TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056627; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	46	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161748	10.1371/journal.pone.0161748	http://dx.doi.org/10.1371/journal.pone.0161748			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598410	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800019
J	Cho, YS; Kim, BS; Sim, CK; Kim, I; Lee, MS				Cho, Yeon Sook; Kim, Byung Soo; Sim, Chan Kyu; Kim, Inki; Lee, Myeong Sup			Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating Chemicals	PLOS ONE			English	Article							EPITHELIAL-CELLS; DNA METHYLATION; IN-VIVO; INTERLEUKIN-7; BIOLOGY; MICE; RNA; IDENTIFICATION; HOMEOSTASIS; TARGET	Interleukin-7 (IL-7) is a cytokine essential for T cell homeostasis, and is clinically important. However, the regulatory mechanism of IL-7 gene expression is not well known, and a systematic approach to screen chemicals that regulate IL-7 expression has not yet been developed. In this study, we attempted to develop human reporter cell lines using CRISPR/Cas9-mediated genome editing technology. For this purpose, we designed donor DNA that contains an enhanced green fluorescent protein (eGFP) gene, drug selection cassette, and modified homologous arms which are considered to enhance the translation of the eGFP reporter transcript, and also a highly efficient single-guide RNA with a minimal off-target effect to target the IL-7 start codon region. By applying this system, we established IL-7 eGFP reporter cell lines that could report IL-7 gene transcription based on the eGFP protein signal. Furthermore, we utilized the cells to run a pilot screen campaign for IL-7-upregulating chemicals in a high-throughput format, and identified a chemical that can up-regulate IL-7 gene transcription. Collectively, these results suggest that our IL-7 reporter system can be utilized in large-scale chemical library screening to reveal novel IL-7 regulatory pathways and to identify potential drugs for development of new treatments in immunodeficiency disease.	[Cho, Yeon Sook; Kim, Byung Soo; Sim, Chan Kyu; Lee, Myeong Sup] Univ Ulsan, Coll Med, Asan Med Ctr, Lab Mol Immunol & Med MoIM,Dept Biomed Sci, Seoul 05505, South Korea; [Kim, Inki] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Convergence Med, Seoul 05505, South Korea	University of Ulsan; University of Ulsan	Lee, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Lab Mol Immunol & Med MoIM,Dept Biomed Sci, Seoul 05505, South Korea.	myeong@amc.seoul.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C2449]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare	This study was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare [granted to MSL; grant number HI14C2449]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan AD, 2013, J BIOMOL SCREEN, V18, P180, DOI 10.1177/1087057112459901; Baker M, 2014, NAT BIOTECHNOL, V32, P309, DOI 10.1038/nbt.2863; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Ceredig R, 2012, SEMIN IMMUNOL, V24, P159, DOI 10.1016/j.smim.2012.02.004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dansithong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136930; Gao JB, 2015, INT J MOL SCI, V16, P10267, DOI 10.3390/ijms160510267; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Hasson SA, 2015, ACS CHEM BIOL, V10, P1188, DOI 10.1021/cb5010417; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hrabeta J, 2015, INT J ONCOL, V47, P971, DOI 10.3892/ijo.2015.3066; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Kim JY, 2011, TOXICOLOGY, V289, P91, DOI 10.1016/j.tox.2011.07.014; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; McCamish M, 2011, MABS-AUSTIN, V3, P209, DOI 10.4161/mabs.3.2.15005; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Morre M, 2012, TARGET ONCOL, V7, P55, DOI 10.1007/s11523-012-0210-4; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Petrilli AM, 2014, AM J TRANSL RES, V6, P471; Ribeiro AR, 2013, J IMMUNOL, V191, P1200, DOI 10.4049/jimmunol.1203042; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sekai M, 2013, MOL IMMUNOL, V54, P378, DOI 10.1016/j.molimm.2013.01.002; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sim CK, 2016, CANCER IMMUNOL IMMUN, V65, P663, DOI 10.1007/s00262-016-1830-9; Song H, 2007, INT J IMMUNOGENET, V34, P107, DOI 10.1111/j.1744-313X.2007.00658.x; Stiborova M, 2011, BBA-PROTEINS PROTEOM, V1814, P175, DOI 10.1016/j.bbapap.2010.05.016; Wang XQ, 2004, NUCLEIC ACIDS RES, V32, P1382, DOI 10.1093/nar/gkh305; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161899	10.1371/journal.pone.0161899	http://dx.doi.org/10.1371/journal.pone.0161899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589392	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800023
J	Huh, CW; Youn, YH; Jung, DH; Park, JJ; Kim, JH; Park, H				Huh, Cheal Wung; Youn, Young Hoon; Jung, Da Hyun; Park, Jae Jun; Kim, Jie-Hyun; Park, Hyojin			Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRIPLE THERAPY; ANTIMICROBIAL RESISTANCE; SUBMUCOSAL DISSECTION; REVISED EDITION; PATIENT FACTORS; CANCER; ULCER; INFECTION; OMEPRAZOLE	Purpose After endoscopic resection (ER) of gastric tumors, eradication of Helicobacter pylori (H. pylori) infection is advised to reduce metachronous recurrence. Optimal timing of such therapy (yet to be established) was investigated herein, examining early active and late scarring stages of post-ER iatrogenic ulcers. Materials and Methods Analysis included 514 patients who received proton-pump inhibitor (PPI)-based triple therapy for H. pylori eradication after ER for gastric neoplasms between January 2008 and June 2015. Clinicopathologic characteristics, particularly the timing of triple therapy, were used to compare eradication rates, assigning patients to early-(<= 2 weeks), intermediate( 2-8 weeks), and late-phase (>= 8 weeks) treatment groups. Results H. pylori eradication rates differed significantly by timing of triple therapy after ER (early, 90.0%; intermediate, 76.2%, late, 72.4%; p < .001). However, eradication success rates were not significantly affected by age, smoking, alcohol consumption, preexisting comorbidity, method of ER, size and location of iatrogenic ulcer, and duration of therapeutic regimen. Early initiation of H. pylori eradication was also identified as a significant independent predictor of eradication success in multivariate analysis (Odds ratio = 3.67, 95% CI 2.18-6.16; p < .001). Conclusion In patients undergoing ER of gastric tumors, early post-ER attempts at eradication of H. pylori offer the best chance of eradication success.	[Huh, Cheal Wung; Youn, Young Hoon; Jung, Da Hyun; Park, Jae Jun; Kim, Jie-Hyun; Park, Hyojin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Youn, YH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea.	dryoun@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Huh, Cheal Wung/0000-0001-7327-8503; Youn, Young Hoon/0000-0002-0071-229X; park, hyojin/0000-0003-4814-8330; Jung, Da Hyun/0000-0001-6668-3113				Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; BLAIR AJ, 1987, J CLIN INVEST, V79, P582, DOI 10.1172/JCI112850; Cheon JH, 2008, HELICOBACTER, V13, P564, DOI 10.1111/j.1523-5378.2008.00647.x; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Choi KS, 2011, GASTROINTEST ENDOSC, V73, P942, DOI 10.1016/j.gie.2010.12.032; CUTLER AF, 1993, AM J GASTROENTEROL, V88, P505; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Gisbert JP, 2001, EUR J GASTROEN HEPAT, V13, P1303, DOI 10.1097/00042737-200111000-00007; GRAHAM DY, 1992, GASTROENTEROLOGY, V102, P493, DOI 10.1016/0016-5085(92)90095-G; Jung DH, 2015, ENDOSCOPY, V47, P1119, DOI 10.1055/s-0034-1392537; Jung DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124725; Kakushima N, 2004, GASTROINTEST ENDOSC, V59, pAB90; Kakushima N, 2006, J GASTROEN HEPATOL, V21, P1586, DOI 10.1111/j.1440-1746.2006.04321.x; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Kim SG, 2014, J GASTROEN HEPATOL, V29, P1371, DOI 10.1111/jgh.12607; Kim SG, 2011, J GASTRIC CANCER, V11, P146, DOI 10.5230/jgc.2011.11.3.146; LABENZ J, 1994, SCAND J GASTROENTERO, V29, P1070, DOI 10.3109/00365529409094890; Lee JY, 2014, DIGEST DIS SCI, V59, P1235, DOI 10.1007/s10620-014-3093-7; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Lee SH, 2012, DIGEST DIS SCI, V57, P429, DOI 10.1007/s10620-011-1941-2; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Malfertheiner P, 1999, ALIMENT PHARM THERAP, V13, P703, DOI 10.1046/j.1365-2036.1999.00535.x; Moayyedi P, 1997, J GASTROENTEROL, V32, P24, DOI 10.1007/BF01213292; SAKITA T, 1971, GASTROENTEROLOGY, V60, P835; Seo SI, 2015, HELICOBACTER, V20, P424, DOI 10.1111/hel.12221; Shin WG, 2016, HELICOBACTER, V21, P266, DOI 10.1111/hel.12279; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yazbek PB, 2015, DIGEST DIS SCI, V60, P2901, DOI 10.1007/s10620-015-3712-y; Yuan YH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008337.pub2	34	6	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162258	10.1371/journal.pone.0162258	http://dx.doi.org/10.1371/journal.pone.0162258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588679	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877800044
J	Juszczak, GR; Miller, M				Juszczak, Grzegorz R.; Miller, Michal			Detour Behavior of Mice Trained with Transparent, Semitransparent and Opaque Barriers	PLOS ONE			English	Article							STRESS-INDUCED ANALGESIA; OBJECT RETRIEVAL; COGNITIVE DEFICITS; EXECUTIVE FUNCTION; RECEPTOR AGONIST; RHESUS-MONKEYS; MOTOR DEFICITS; REACHING TASK; PERFORMANCE; PHENCYCLIDINE	Detour tasks are commonly used to study problem solving skills and inhibitory control in canids and primates. However, there is no comparable detour test designed for rodents despite its significance for studying the development of executive skills. Furthermore, mice offer research opportunities that are not currently possible to achieve when primates are used. Therefore, the aim of the study was to translate the classic detour task to mice and to compare obtained data with key findings obtained previously in other mammals. The experiment was performed with V-shaped barriers and was based on the water escape paradigm. The study showed that an apparently simple task requiring mice to move around a small barrier constituted in fact a challenge that was strongly affected by the visibility of the target. The most difficult task involved a completely transparent barrier, which forced the mice to resolve a conflict between vision and tactile perception. The performance depended both on the inhibitory skills and on previous experiences. Additionally, all mice displayed a preference for one side of the barrier and most of them relied on the egocentric strategy. Obtained results show for the first time that the behavior of mice subjected to the detour task is comparable to the behavior of other mammals tested previously with free-standing barriers. This detailed characterization of the detour behavior of mice constitutes the first step toward the substitution of rodents for primates in laboratory experiments employing the detour task.	[Juszczak, Grzegorz R.; Miller, Michal] Inst Genet & Anim Breeding, Dept Anim Behav, Jastrzebiec, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences	Juszczak, GR (corresponding author), Inst Genet & Anim Breeding, Dept Anim Behav, Jastrzebiec, Poland.	g.juszczak@ighz.pl	Juszczak, Grzegorz R/A-1339-2008	Miller, Michal/0000-0001-7445-8100; Juszczak, Grzegorz/0000-0002-0976-6905	S.VI.2 intramural grant, Institute of Genetics and Animal Breeding	S.VI.2 intramural grant, Institute of Genetics and Animal Breeding	This work was supported by an S.VI.2 intramural grant, Institute of Genetics and Animal Breeding, http://www.ighz.edu.pl/(GRJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvernhe A, 2008, J NEUROSCI, V28, P7324, DOI 10.1523/JNEUROSCI.1909-08.2008; Berthouex P. M., 2002, STAT ENV ENG; Cannon CE, 2013, NEUROPHARMACOLOGY, V64, P191, DOI 10.1016/j.neuropharm.2012.05.003; CHAPUIS N, 1987, ANIM LEARN BEHAV, V15, P174, DOI 10.3758/BF03204960; CHAPUIS N, 1983, Q J EXP PSYCHOL-B, V35, P213, DOI 10.1080/14640748308400906; CHAPUIS N, 1987, Q J EXP PSYCHOL-B, V39, P49; Chapuis N, 1987, COGNITIVE PROCESS, P97, DOI DOI 10.1007/978-94-009-3531-0_7; Dettmer AM, 2015, DEV PSYCHOBIOL, V57, P349, DOI 10.1002/dev.21285; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Edgin JO, 2008, J INT NEUROPSYCH SOC, V14, P90, DOI 10.1017/S1355617708080053; Elsworth JD, 2012, NEUROPHARMACOLOGY, V62, P1442, DOI 10.1016/j.neuropharm.2011.08.026; Ersche KD, 2011, BIOL PSYCHIAT, V70, P754, DOI 10.1016/j.biopsych.2011.06.033; Etienne AS, 1998, NATURE, V396, P161, DOI 10.1038/24151; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; Gray RA, 2006, AIDS RES HUM RETROV, V22, P1031, DOI 10.1089/aid.2006.22.1031; Grieves RM, 2013, LEARN MOTIV, V44, P81, DOI 10.1016/j.lmot.2012.08.001; HUGHES C, 1993, DEV PSYCHOL, V29, P498, DOI 10.1037/0012-1649.29.3.498; Igloi K, 2009, HIPPOCAMPUS, V19, P1199, DOI 10.1002/hipo.20595; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jentsch JD, 1997, SCIENCE, V277, P953, DOI 10.1126/science.277.5328.953; Jentsch JD, 1999, NEUROSCIENCE, V90, P823, DOI 10.1016/S0306-4522(98)00481-3; Jentsch JD, 2000, BIOL PSYCHIAT, V48, P415, DOI 10.1016/S0006-3223(00)00926-4; Jovalekic A, 2011, BEHAV BRAIN RES, V222, P279, DOI 10.1016/j.bbr.2011.02.035; Juszczak GR, 2008, PHYSIOL BEHAV, V95, P400, DOI 10.1016/j.physbeh.2008.07.003; Kohler W., 1925, MENTALITY APES; LOCKMAN JJ, 1984, CHILD DEV, V55, P482; Lockman JJ, 1987, COGNITIVE PROCESS, P250; Mogil JS, 1996, P NATL ACAD SCI USA, V93, P3048, DOI 10.1073/pnas.93.7.3048; Murai T, 2014, BEHAV BRAIN RES, V261, P26, DOI 10.1016/j.bbr.2013.11.036; Murai T, 2013, BEHAV BRAIN RES, V246, P125, DOI 10.1016/j.bbr.2013.02.019; Nakazawa S, 2015, PSYCHOPHARMACOLOGY B; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Osthaus B, 2010, ANIM COGN, V13, P881, DOI 10.1007/s10071-010-0331-z; PANOCKA I, 1986, BRAIN RES, V397, P156, DOI 10.1016/0006-8993(86)91380-6; Pongracz P, 2001, ANIM BEHAV, V62, P1109, DOI 10.1006/anbe.2001.1866; POUCET B, 1983, ANIM BEHAV, V31, P594, DOI 10.1016/S0003-3472(83)80083-9; Pryce CR, 2004, ANN NY ACAD SCI, V1032, P245, DOI 10.1196/annals.1314.030; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Richter SH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00154; Roberts WA, 2007, J EXP PSYCHOL-ANIM B, V33, P79, DOI 10.1037/0097-7403.33.2.79; Roitberg BZ, 2002, NEUROSURGERY, V50, P137, DOI 10.1097/00006123-200201000-00022; Santos LR, 1999, J COMP PSYCHOL, V113, P186; Smith BP, 2010, ANIM BEHAV, V80, P155, DOI 10.1016/j.anbehav.2010.04.017; Smith SM, 2013, NEUROPHARMACOLOGY, V64, P215, DOI 10.1016/j.neuropharm.2012.06.013; Spiers HJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00125; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; TAYLOR JR, 1990, BEHAV NEUROSCI, V104, P564, DOI 10.1037/0735-7044.104.4.564; TAYLOR JR, 1990, BRAIN, V113, P617, DOI 10.1093/brain/113.3.617; Tunur T, 2010, LEARN MEMORY, V17, P328, DOI 10.1101/lm.1818410; Uslaner JM, 2013, PSYCHOPHARMACOLOGY, V225, P21, DOI 10.1007/s00213-012-2788-8; van Meer PJK, 2015, EUR J PHARMACOL, V759, P3, DOI 10.1016/j.ejphar.2015.02.055; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Walker SC, 2006, EUR J NEUROSCI, V23, P3119, DOI 10.1111/j.1460-9568.2006.04826.x; Wallis JD, 2001, EUR J NEUROSCI, V13, P1797, DOI 10.1046/j.0953-816x.2001.01546.x; Wynne CDL, 2004, BEHAV PROCESS, V67, P281, DOI 10.1016/j.beproc.2004.04.007; Zentall TR, 2002, J GEN PSYCHOL, V129, P328, DOI 10.1080/00221300209602102; Zentall TR, 2001, BEHAV PROCESS, V54, P65, DOI 10.1016/S0376-6357(01)00150-4; Zucca P, 2005, ANIM COGN, V8, P122, DOI 10.1007/s10071-004-0243-x	60	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162018	10.1371/journal.pone.0162018	http://dx.doi.org/10.1371/journal.pone.0162018			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588753	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800027
J	Pietan, LL; Spradling, TA; Demastes, JW				Pietan, Lucas L.; Spradling, Theresa A.; Demastes, James W.			The Mitochondrial Cytochrome Oxidase Subunit I Gene Occurs on a Minichromosome with Extensive Heteroplasmy in Two Species of Chewing Lice, Geomydoecus aurei and Thomomydoecus minor	PLOS ONE			English	Article							POCKET GOPHER HOSTS; HUMAN-BODY LOUSE; GENOME; SEQUENCE; DNA; TRICHODECTIDAE; PHTHIRAPTERA; MALLOPHAGA; EVOLUTION; PRIMERS	In animals, mitochondrial DNA (mtDNA) typically occurs as a single circular chromosome with 13 protein-coding genes and 22 tRNA genes. The various species of lice examined previously, however, have shown mitochondrial genome rearrangements with a range of chromosome sizes and numbers. Our research demonstrates that the mitochondrial genomes of two species of chewing lice found on pocket gophers, Geomydoecus aurei and Thomomydoecus minor, are fragmented with the 1,536 base-pair (bp) cytochrome-oxidase subunit I (cox1) gene occurring as the only protein-coding gene on a 1,916-1,964 bp mini-circular chromosome in the two species, respectively. The cox1 gene of T. minor begins with an atypical start codon, while that of G. aurei does not. Components of the non-protein coding sequence of G. aurei and T. minor include a tRNA (isoleucine) gene, inverted repeat sequences consistent with origins of replication, and an additional non-coding region that is smaller than the non-coding sequence of other lice with such fragmented mitochondrial genomes. Sequences of cox1 minichromosome clones for each species reveal extensive length and sequence heteroplasmy in both coding and noncoding regions. The highly variable non-gene regions of G. aurei and T. minor have little sequence similarity with one another except for a 19-bp region of phylogenetically conserved sequence with unknown function.	[Pietan, Lucas L.; Spradling, Theresa A.; Demastes, James W.] Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA	University of Northern Iowa	Demastes, JW (corresponding author), Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA.	Jim.Demastes@uni.edu			National Science Foundation [DEB 1445708]; Dr. Dave Swanson Genetics Research Award; Division Of Environmental Biology [1445708] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Dr. Dave Swanson Genetics Research Award; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by National Science Foundation award DEB 1445708 to JWD, TAS. LLP received research support via The Dr. Dave Swanson Genetics Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aphasizhev R, 2014, BIOCHIMIE, V100, P125, DOI 10.1016/j.biochi.2014.01.003; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Demastes JW, 2012, J PARASITOL, V98, P262, DOI 10.1645/GE-2904.1; Dong WG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-751; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EMERSON K C, 1981, Miscellaneous Publications of the Entomological Society of America, V12, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOX TD, 1987, ANNU REV GENET, V21, P67, DOI 10.1146/annurev.ge.21.120187.000435; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HELLENTHAL RA, 1984, J MED ENTOMOL, V21, P432, DOI 10.1093/jmedent/21.4.432; Herd K., 2012, The Open Genomics Journal, V5, P14, DOI 10.2174/1875693X01205010014; Johansson ML, 2012, MOL BIOL REP, V39, P9009, DOI 10.1007/s11033-012-1772-z; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundberg KS, 1991, GENE, P108; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Lyal C.H.C., 1985, Bulletin of the British Museum (Natural History) Entomology, V51, P187; NADLER SA, 1989, ANN ENTOMOL SOC AM, V82, P109, DOI 10.1093/aesa/82.1.109; PAGE RDM, 1995, SYST ENTOMOL, V20, P129, DOI 10.1111/j.1365-3113.1995.tb00087.x; Price R.D., 2003, ILL NAT HIS SURV SPE; Ramesh A, 2012, MOL BIOCHEM PARASIT, V183, P32, DOI 10.1016/j.molbiopara.2012.01.004; Reed DL, 2000, J PARASITOL, V86, P951, DOI 10.1645/0022-3395(2000)086[0951:SPOHHB]2.0.CO;2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shao R, 2015, SCI REP, P5; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wong RG, 2015, MITOCHONDRION, V25, P76, DOI 10.1016/j.mito.2015.10.006; Xiong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073329; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162248	10.1371/journal.pone.0162248	http://dx.doi.org/10.1371/journal.pone.0162248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589589	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800042
J	Song, DL; Xi, XY; Huang, SM; Liang, GQ; Sun, JW; Zhou, W; Wang, XB				Song, Dali; Xi, Xiangyin; Huang, Shaomin; Liang, Guoqing; Sun, Jingwen; Zhou, Wei; Wang, Xiubin			Short-Term Responses of Soil Respiration and C-Cycle Enzyme Activities to Additions of Biochar and Urea in a Calcareous Soil	PLOS ONE			English	Article							SANDY LOAM SOIL; CARBON MINERALIZATION; NITROGEN-FERTILIZATION; AGRONOMIC PERFORMANCE; PLANT PRODUCTIVITY; ORGANIC-CARBON; WATER; DECOMPOSITION; DYNAMICS; LITTER	Biochar (BC) addition to soil is a proposed strategy to enhance soil fertility and crop productivity. However, there is limited knowledge regarding responses of soil respiration and C-cycle enzyme activities to BC and nitrogen (N) additions in a calcareous soil. A 56-day incubation experiment was conducted to investigate the combined effects of BC addition rates (0, 0.5, 1.0, 2.5 and 5.0% by mass) and urea (U) application on soil nutrients, soil respiration and C-cycle enzyme activities in a calcareous soil in the North China Plain. Our results showed soil pH values in both U-only and U plus BC treatments significantly decreased within the first 14 days and then stabilized, and CO(2)emission rate in all U plus BC soils decreased exponentially, while there was no significant difference in the contents of soil total organic carbon (TOC), dissolved organic carbon (DOC), total nitrogen (TN), and C/N ratio in each treatment over time. At each incubation time, soil pH, electrical conductivity (EC), TOC, TN, C/N ratio, DOC and cumulative CO2 emission significantly increased with increasing BC addition rate, while soil potential activities of the four hydrolytic enzymes increased first and then decreased with increasing BC addition rate, with the largest values in the U + 1.0% BC treatment. However, phenol oxidase activity in all U plus BC soils showed a decreasing trend with the increase of BC addition rate. Our results suggest that U plus BC application at a rate of 1% promotes increases in hydrolytic enzymes, does not highly increase C/N and C mineralization, and can improve in soil fertility.	[Song, Dali; Liang, Guoqing; Sun, Jingwen; Zhou, Wei; Wang, Xiubin] Chinese Acad Agr Sci, Inst Agr Resource & Reg Planning, Minist Agr, Key Lab Plant Nutr & Nutrient Cycling, Beijing 100081, Peoples R China; [Song, Dali; Xi, Xiangyin] Southwest Univ, Chongqing 400715, Peoples R China; [Huang, Shaomin] Henan Acad Agr Sci, Inst Plant Nutrient & Environm Resources, Zhengzhou 450002, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Southwest University - China; Henan Academy of Agricultural Sciences	Wang, XB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resource & Reg Planning, Minist Agr, Key Lab Plant Nutr & Nutrient Cycling, Beijing 100081, Peoples R China.	wangxiubin@caas.cn			National Natural Science Foundation of China [31372135]; National Basic Research Program of China [2013CB127405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work has been funded by the National Natural Science Foundation of China (No. 31372135) and the National Basic Research Program of China (2013CB127405) (website: http://www.973.gov.cn/AreaAppl.aspx). The funders had a role in study design, data collection and analysis, decision to publish.	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Bailey VL, 2011, SOIL BIOL BIOCHEM, V43, P296, DOI 10.1016/j.soilbio.2010.10.014; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Beesley L, 2011, SOIL BIOL BIOCHEM, V43, P188, DOI 10.1016/j.soilbio.2010.09.035; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Bruun S, 2014, EUR J SOIL SCI, V65, P52, DOI 10.1111/ejss.12073; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Cely P, 2014, SOLID EARTH, V5, P585, DOI 10.5194/se-5-585-2014; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Cullen D., 1996, Biochemistry and molecular biology III., P295; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Czimczik CI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002798; Dai ZM, 2013, J SOIL SEDIMENT, V13, P989, DOI 10.1007/s11368-013-0698-y; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; El-Mahrouky M, 2015, PEDOSPHERE, V25, P46, DOI 10.1016/S1002-0160(14)60075-8; El-Naggar AH, 2015, CHEMOSPHERE, V138, P67, DOI 10.1016/j.chemosphere.2015.05.052; Fan FL, 2012, SOIL BIOL BIOCHEM, V55, P70, DOI 10.1016/j.soilbio.2012.06.008; Fang YY, 2015, SOIL BIOL BIOCHEM, V80, P136, DOI 10.1016/j.soilbio.2014.10.006; Garland JL, 2010, APPL SOIL ECOL, V44, P262, DOI 10.1016/j.apsoil.2010.01.003; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Helfrich M, 2008, SOIL BIOL BIOCHEM, V40, P1823, DOI 10.1016/j.soilbio.2008.03.006; IBI, 2012, STANDARDIZED PRODUCT; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Keith A, 2015, SOIL BIOL BIOCHEM, V88, P372, DOI 10.1016/j.soilbio.2015.06.007; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Laird DA, 2010, GEODERMA, V158, P443, DOI 10.1016/j.geoderma.2010.05.013; Lammirato C, 2011, SOIL BIOL BIOCHEM, V43, P1936, DOI 10.1016/j.soilbio.2011.05.021; Lee KH, 2003, FOREST ECOL MANAG, V185, P263, DOI 10.1016/S0378-1127(03)00164-6; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lesturgez G, 2006, AGR ECOSYST ENVIRON, V114, P239, DOI 10.1016/j.agee.2005.10.020; Lin Y, 2012, CHEMOSPHERE, V87, P151, DOI 10.1016/j.chemosphere.2011.12.007; Lu WW, 2014, SOIL BIOL BIOCHEM, V76, P12, DOI 10.1016/j.soilbio.2014.04.029; Masto RE, 2013, ECOL ENG, V58, P314, DOI 10.1016/j.ecoleng.2013.07.011; McBeath AV, 2009, ORG GEOCHEM, V40, P1161, DOI 10.1016/j.orggeochem.2009.09.006; Mukherjee A, 2014, SCI TOTAL ENVIRON, V487, P26, DOI 10.1016/j.scitotenv.2014.03.141; Nguyen BT, 2009, ORG GEOCHEM, V40, P846, DOI 10.1016/j.orggeochem.2009.05.004; Ni K, 2012, J SOIL SEDIMENT, V12, P1007, DOI 10.1007/s11368-012-0529-6; Ouyang L, 2014, SOIL RES, V52, P46, DOI 10.1071/SR13186; Paz-Ferreiro J, 2014, J SOIL SEDIMENT, V14, P483, DOI 10.1007/s11368-013-0806-z; Piotrowska A, 2012, GEODERMA, V189, P72, DOI 10.1016/j.geoderma.2012.04.018; Prayogo C, 2014, BIOL FERT SOILS, V50, P695, DOI 10.1007/s00374-013-0884-5; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smider B, 2014, AGR ECOSYST ENVIRON, V191, P99, DOI 10.1016/j.agee.2014.01.024; Song YY, 2014, EUR J SOIL BIOL, V61, P72, DOI 10.1016/j.ejsobi.2014.02.001; Spokas KA, 2011, CHEMOSPHERE, V85, P869, DOI 10.1016/j.chemosphere.2011.06.108; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Sui YH, 2016, SCI TOTAL ENVIRON, V544, P203, DOI 10.1016/j.scitotenv.2015.11.079; Tammeorg P, 2014, AGR ECOSYST ENVIRON, V191, P108, DOI 10.1016/j.agee.2014.01.007; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Wang JY, 2012, CATENA, V96, P83, DOI 10.1016/j.catena.2012.03.009; Wang RZ, 2015, SOIL BIOL BIOCHEM, V81, P159, DOI 10.1016/j.soilbio.2014.11.015; Wang XB, 2015, APPL SOIL ECOL, V96, P265, DOI 10.1016/j.apsoil.2015.08.018; Zhang AF, 2012, PLANT SOIL, V351, P263, DOI 10.1007/s11104-011-0957-x; Zhou XB, 2012, SOIL BIOL BIOCHEM, V47, P67, DOI 10.1016/j.soilbio.2011.05.012; Zibilske LM, 2007, SOIL SCI SOC AM J, V71, P133, DOI 10.2136/sssaj2006.0167; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	64	11	15	11	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161694	10.1371/journal.pone.0161694	http://dx.doi.org/10.1371/journal.pone.0161694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589265	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800013
J	Al-Allawi, N; Mohammad, AM; Jamal, S				Al-Allawi, Nasir; Mohammad, Ameen M.; Jamal, Shakir			Doppler-Defined Pulmonary Hypertension in Sickle Cell Anemia in Kurdistan, Iraq	PLOS ONE			English	Article							EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; DISEASE PATIENTS; RISK-FACTORS; RIGHT HEART; CHILDREN; ECHOCARDIOGRAPHY; ADULTS; PREVALENCE; DEATH	To determine the frequency, clinical and laboratory associations of pulmonary hypertension in Iraqi Kurds with sickle cell anemia, a total of ninety four such patients attending a major hemoglobinopathy center in Iraqi Kurdistan were enrolled. All patients were re-evaluated clinically and had their blood counts, HbF, serum ferritin, LDH, renal and liver function assessed. Transthoracic Doppler echocardiography with measurement of tricuspid valve regurgitant jet velocity (TRV) was performed. A TRV in excess of 2.8 m/s was considered for the purposes of this study as indicative of pulmonary hypertension (PH). The prevalence of TRV in excess of 2.8m/s was 10.6%. By univariate analysis: significantly higher reticulocyte count, more frequent blood transfusions and pain episodes were encountered in the PH group as compared to the non-PH group (p = 0.001, 0.045 and 0.02 respectively). Moreover, PH patients had significantly higher mean right atrial area, left atrial size, E wave/A wave ratio and ejection fraction by echocardiography (p = 0.027, 0.037, <0.001 and 0.008 respectively). Except for reticulocyte count none of the other parameters remained significant by multivariate analysis (p = 0.024). In conclusion the current study revealed that pulmonary hypertension is rather frequent among Iraqi Kurds with sickle cell anemia, and identified reticulocyte count as an independently associated parameter with PH in this population. Future prospective studies including right heart catheterization and appropriate medical intervention are warranted.	[Al-Allawi, Nasir] Univ Duhok, Dept Pathol, Coll Med, Duhok, Kurdistan, Iraq; [Mohammad, Ameen M.] Univ Duhok, Dept Med, Coll Med, Duhok, Kurdistan, Iraq; [Jamal, Shakir] Azadi Teaching Hosp, Dept Hematol, Duhok, Kurdistan, Iraq	University of Duhok; University of Duhok	Mohammad, AM (corresponding author), Univ Duhok, Dept Med, Coll Med, Duhok, Kurdistan, Iraq.	doctoramb@yahoo.com						Al-Allawi NAS, 2012, HEMOGLOBIN, V36, P333, DOI 10.3109/03630269.2012.692344; Aliyu ZY, 2008, AM J HEMATOL, V83, P485, DOI 10.1002/ajh.21162; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Ballas SK, 2011, HEMOGLOBIN, V35, P511, DOI 10.3109/03630269.2011.610477; Caughey MC, 2015, BRIT J HAEMATOL, V170, P416, DOI 10.1111/bjh.13447; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; Fonseca GHH, 2012, EUR RESPIR J, V39, P112, DOI 10.1183/09031936.00134410; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hagar RW, 2008, BRIT J HAEMATOL, V140, P104, DOI 10.1111/j.1365-2141.2007.06822.x; Hamamy HA, 2013, J COMMUN GENET, V4, P147, DOI 10.1007/s12687-012-0127-8; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, PEDIATR HEMAT ONCOL, V24, P159, DOI 10.1080/08880010601185892; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; Machado RF, 2007, BRIT J HAEMATOL, V136, P319, DOI 10.1111/j.1365-2141.2006.06417.x; Marouf R, 2014, MED PRIN PRACT, V23, P212, DOI 10.1159/000362126; Mehari A, 2013, AM J RESP CRIT CARE, V187, P840, DOI 10.1164/rccm.201207-1222OC; Mehari A, 2012, JAMA-J AM MED ASSOC, V307, P1254, DOI 10.1001/jama.2012.358; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nef HM, 2010, HEART, V96, P552, DOI 10.1136/hrt.2008.156299; Nelson SC, 2007, J PEDIAT HEMATOL ONC, V29, P334, DOI 10.1097/MPH.0b013e31805d8f32; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; SUTTON LL, 1994, AM J CARDIOL, V74, P626, DOI 10.1016/0002-9149(94)90760-9	29	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162036	10.1371/journal.pone.0162036	http://dx.doi.org/10.1371/journal.pone.0162036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583566	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600090
J	Borghi, SM; Pinho-Ribeiro, FA; Fattori, V; Bussmann, AJC; Vignoli, JA; Camilios-Neto, D; Casagrande, R; Verri, WA				Borghi, Sergio M.; Pinho-Ribeiro, Felipe A.; Fattori, Victor; Bussmann, Allan J. C.; Vignoli, Josiane A.; Camilios-Neto, Doumit; Casagrande, Rubia; Verri, Waldiceu A., Jr.			Quercetin Inhibits Peripheral and Spinal Cord Nociceptive Mechanisms to Reduce Intense Acute Swimming-Induced Muscle Pain in Mice	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED OXIDATIVE STRESS; INDUCED INFLAMMATION; NRF2 EXPRESSION; TNF-ALPHA; HYPERALGESIA; EXERCISE; SUPEROXIDE; SUPPLEMENTATION; ACTIVATION	The present study aimed to evaluate the effects of the flavonoid quercetin (3,3', 4', 5,7-pen-tahydroxyflavone) in a mice model of intense acute swimming-induced muscle pain, which resembles delayed onset muscle soreness. Quercetin intraperitoneal (i.p.) treatment dose-dependently reduced muscle mechanical hyperalgesia. Quercetin inhibited myelo-peroxidase (MPO) and N-acetyl-beta-D-glucosaminidase (NAG) activities, cytokine production, oxidative stress, cyclooxygenase-2 (COX-2) and gp91(phox) mRNA expression and muscle injury (creatinine kinase [CK] blood levels and myoblast determination protein [MyoD] mRNA expression) as well as inhibited NF kappa B activation and induced Nrf2 and HO-1 mRNA expression in the soleus muscle. Beyond inhibiting those peripheral effects, quercetin also inhibited spinal cord cytokine production, oxidative stress and glial cells activation (glial fibrillary acidic protein [GFAP] and ionized calcium-binding adapter molecule 1 [Iba-1] mRNA expression). Concluding, the present data demonstrate that quercetin is a potential molecule for the treatment of muscle pain conditions related to unaccustomed exercise.	[Borghi, Sergio M.; Pinho-Ribeiro, Felipe A.; Fattori, Victor; Verri, Waldiceu A., Jr.] Univ Estadual Londrina, Dept Ciencias Patol, Ctr Ciencias Biol, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil; [Bussmann, Allan J. C.] Univ Estadual Londrina, Lab Anat Patol, Ctr Ciencias Saude, Univ Hosp, Ave Robert Koch 60, BR-86039440 Londrina, Parana, Brazil; [Vignoli, Josiane A.; Camilios-Neto, Doumit] Univ Estadual Londrina, Dept Bioquim & Biotecnol, Ctr Ciencias Exatas, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil; [Casagrande, Rubia] Univ Estadual Londrina, Dept Ciencias Farmaceut, Ctr Ciencias Exatas, Univ Hosp, Ave Robert Koch 60, BR-86039440 Londrina, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina; Universidade Estadual de Londrina	Verri, WA (corresponding author), Univ Estadual Londrina, Dept Ciencias Patol, Ctr Ciencias Biol, Rodovia Celso Garcia Cid,Km 380,PR445, BR-86057970 Londrina, Parana, Brazil.	waverri@uel.br	Fattori, Victor/C-2745-2016; Borghi, Sergio M/H-7137-2017; WA, Verri/I-1330-2013; Vignoli, Josiane/AFQ-1790-2022; de Pinho Ribeiro, Felipe Almeida/AAI-8107-2020; Casagrande, Rubia/I-1377-2013; Neto, Doumit Camilios/H-3688-2013; Casagrande, Rubia/U-6019-2019	Fattori, Victor/0000-0002-4565-7706; Borghi, Sergio M/0000-0002-6978-7505; WA, Verri/0000-0003-2756-9283; Vignoli, Josiane/0000-0002-8615-8161; de Pinho Ribeiro, Felipe Almeida/0000-0003-4264-9839; Neto, Doumit Camilios/0000-0002-1986-658X; Casagrande, Rubia/0000-0002-2296-1668	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria; Parana State Government; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Parana State Government; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian grants from Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Araucaria, Parana State Government and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work received financial support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Araucaria, Parana State Government and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). It is noteworthy to mention that this manuscript has been read and approved by all the authors, which contributed substantially to the work. The authors declare no conflict of interest.	Akram M, 2015, J ETHNOPHARMACOL, V174, P322, DOI 10.1016/j.jep.2015.08.028; Anjaneyulu M, 2003, PROG NEURO-PSYCHOPH, V27, P1001, DOI 10.1016/S0278-5846(03)00160-X; Askari G, 2012, J RES MED SCI, V17, P637; Azevedo MI, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-53; Bagul PK, 2015, J NUTR BIOCHEM, V26, P1298, DOI 10.1016/j.jnutbio.2015.06.006; Borghi SM, 2015, EXP PHYSIOL, V100, P531, DOI 10.1113/EP085026; Borghi SM, 2014, J PHARM PHARMACOL, V66, P1009, DOI 10.1111/jphp.12226; Borghi SM, 2014, PHYSIOL BEHAV, V128, P277, DOI 10.1016/j.physbeh.2014.01.023; Calixto-Campos C, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/285708; Carvalho TT, 2015, EUR J PHARMACOL, V749, P62, DOI 10.1016/j.ejphar.2014.12.023; Chacur M, 2009, EUR J PAIN, V13, P915, DOI 10.1016/j.ejpain.2008.11.008; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Cleto LS, 2011, BRAZ J MED BIOL RES, V44, P546, DOI 10.1590/S0100-879X2011007500050; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Diaz-Ruiz A, 2009, NEUROSCI LETT, V452, P56, DOI 10.1016/j.neulet.2009.01.020; Ding Y, 2014, CHINESE MED J-PEKING, V127, P3265, DOI 10.3760/cma.j.issn.0366-6999.20141191; FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298; Faria A, 2014, FOOD CHEM, V149, P190, DOI 10.1016/j.foodchem.2013.10.095; Fattori V, 2015, INFLAMM RES, V64, P993, DOI 10.1007/s00011-015-0885-y; Gao C, 2014, EUR J APPL PHYSIOL, V114, P695, DOI 10.1007/s00421-013-2802-9; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gao Z, 2014, BIOCHEM PHARMACOL, V91, P474, DOI 10.1016/j.bcp.2014.08.009; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grau JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00100; Graven-Nielsen Thomas, 2003, Curr Pain Headache Rep, V7, P443, DOI 10.1007/s11916-003-0060-y; Guazelli CFS, 2013, J NAT PROD, V76, P200, DOI 10.1021/np300670w; Guedes RP, 2009, BRAIN RES BULL, V80, P422, DOI 10.1016/j.brainresbull.2009.08.007; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hohmann MSN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627046; Hsu CC, 2013, BIOCHEM PHARMACOL, V85, P385, DOI 10.1016/j.bcp.2012.11.002; Huang JQ, 2012, J PHARM PHARMACOL, V64, P1119, DOI 10.1111/j.2042-7158.2012.01504.x; Jang M, 2016, J PAIN, V17, P282, DOI 10.1016/j.jpain.2015.10.007; Kang JS, 2010, CURR OPIN CLIN NUTR, V13, P243, DOI 10.1097/MCO.0b013e328336ea98; Kiyomoto M, 2013, J NEUROSCI, V33, P7667, DOI 10.1523/JNEUROSCI.4968-12.2013; Konrad M, 2011, INT J SPORT NUTR EXE, V21, P338, DOI 10.1123/ijsnem.21.4.338; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu XD, 2009, ARCH ORAL BIOL, V54, P1143, DOI 10.1016/j.archoralbio.2009.09.006; Maioli NA, 2015, BRAZ J MED BIOL RES, V48, P321, DOI [10.1590/1414-431X20144187, 10.1590/1414-431x20144187]; Marina R, 2015, MOL MED REP, V11, P539, DOI 10.3892/mmr.2014.2741; McAnulty SR, 2008, APPL PHYSIOL NUTR ME, V33, P254, DOI 10.1139/H07-177; Murase S, 2013, J PHYSIOL-LONDON, V591, P3035, DOI 10.1113/jphysiol.2012.249235; Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000; Nieman DC, 2007, J APPL PHYSIOL, V103, P1728, DOI 10.1152/japplphysiol.00707.2007; Nieman DC, 2009, MED SCI SPORT EXER, V41, P1467, DOI 10.1249/MSS.0b013e318199491f; O'Fallon KS, 2012, INT J SPORT NUTR EXE, V22, P430, DOI 10.1123/ijsnem.22.6.430; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pinho-Ribeiro FA, 2016, NEUROPHARMACOLOGY, V105, P508, DOI 10.1016/j.neuropharm.2016.02.019; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ramyaa P, 2014, BBA-GEN SUBJECTS, V1840, P681, DOI 10.1016/j.bbagen.2013.10.024; Ruiz-Miyazawa KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118942; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Tenschert S, 2004, NEUROSCI LETT, V361, P196, DOI 10.1016/j.neulet.2003.12.003; Testa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096795; Valerio DA, 2009, J NAT PROD, V72, P1975, DOI 10.1021/np900259y; Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001; Verri WA, 2012, STUD NAT PROD CHEM, V36, P297, DOI 10.1016/B978-0-444-53836-9.00026-8; Vicentini FTMC, 2011, J DERMATOL SCI, V61, P162, DOI 10.1016/j.jdermsci.2011.01.002; Wang DM, 2014, EUR J PHARMACOL, V728, P59, DOI 10.1016/j.ejphar.2014.01.057; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Wiczkowski W, 2015, MOL NUTR FOOD RES, V59, P1088, DOI 10.1002/mnfr.201400567; Willain A, 2008, ARCH PHARM RES, V31, P713, DOI 10.1007/s12272-001-1217-2; Xu X, 2015, MEDIAT INFLAMM, V2015, DOI [10.1155/2015/810798, 10.1155/2015/380218]; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146; Zhao YJ, 2015, PHYSIOL BEHAV, V142, P57, DOI 10.1016/j.physbeh.2015.02.005	70	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162267	10.1371/journal.pone.0162267	http://dx.doi.org/10.1371/journal.pone.0162267			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583449	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600126
J	Park, SM; Shin, SY; Cho, KH				Park, Sang-Min; Shin, Sung-Young; Cho, Kwang-Hyun			A Regulated Double-Negative Feedback Decodes the Temporal Gradient of Input Stimulation in a Cell Signaling Network	PLOS ONE			English	Article							SYSTEMS BIOLOGY; DYNAMICS; FATE; TRANSDUCTION; INFORMATION; BISTABILITY; SENSITIVITY; COORDINATE; MOTIFS; KINASE	Revealing the hidden mechanism of how cells sense and react to environmental signals has been a central question in cell biology. We focused on the rate of increase of stimulation, or temporal gradient, known to cause different responses of cells. We have investigated all possible three-node enzymatic networks and identified a network motif that robustly generates a transient or sustained response by acute or gradual stimulation, respectively. We also found that a regulated double-negative feedback within the motif is essential for the temporal gradient-sensitive switching. Our analysis highlights the essential structure and mechanism enabling cells to properly respond to dynamic environmental changes.	[Park, Sang-Min; Shin, Sung-Young; Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea; [Shin, Sung-Young] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Shin, Sung-Young] Monash Univ, Biomed Discovery Inst, Clayton, Vic 3800, Australia	Korea Advanced Institute of Science & Technology (KAIST); Monash University; Monash University	Cho, KH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	ckh@kaist.ac.kr	Cho, Kwang-Hyun/C-1684-2011; Shin, Sungyoung/B-7336-2018	Shin, Sungyoung/0000-0002-1447-9687	National Research Foundation of Korea (NRF) - Korea Government, Ministry of Science, ICT & Future Planning [2015M3A9A7067220, 2014R1A2A1A10052404, 2013M3A9A7046303]; KUSTAR-KAIST Institute, Korea under the RD program; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C2162]; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning	National Research Foundation of Korea (NRF) - Korea Government, Ministry of Science, ICT & Future Planning; KUSTAR-KAIST Institute, Korea under the RD program; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2015M3A9A7067220, 2014R1A2A1A10052404 and 2013M3A9A7046303). This work was also supported by the KUSTAR-KAIST Institute, Korea, under the R&D program supervised by the KAIST, the grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C2162), and the KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagha A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00426; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Ashwin P, 2012, PHILOS T R SOC A, V370, P1166, DOI 10.1098/rsta.2011.0306; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bergmann S, 2007, PLOS BIOL, V5, P232, DOI 10.1371/journal.pbio.0050046; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Cullen PJ, 2003, CURR BIOL, V13, pR699, DOI 10.1016/j.cub.2003.08.041; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Dovzhenok A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042811; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hoare A, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-4; IZHIKEVICH EM, 2007, DYNAMICAL SYSTEMS IN; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Meng XY, 2012, DISCRETE CONT DYN-A, V32, P2729, DOI 10.3934/dcds.2012.32.2729; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nene NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040085; Nene NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032779; Nguyen LK, 2015, CELL CYCLE, V14, P189, DOI 10.4161/15384101.2014.973743; Perryman C, 2014, P ROY SOC A-MATH PHY, V470, DOI 10.1098/rspa.2014.0226; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Purvis JE, 2012, SCIENCE, V336, P1440, DOI 10.1126/science.1218351; Ratte S, 2013, NEURON, V78, P758, DOI 10.1016/j.neuron.2013.05.030; Saka Y, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-47; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sauro HM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.3; Schneider A, 2012, BIOESSAYS, V34, P542, DOI 10.1002/bies.201100172; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Sokolowski TR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002654; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Wolkenhauer O, 2005, MOL BIOSYST, V1, P14, DOI 10.1039/b502088n; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110	47	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162153	10.1371/journal.pone.0162153	http://dx.doi.org/10.1371/journal.pone.0162153			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584002	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600113
J	Patel, P; Kato, T; Ujiie, H; Wada, H; Lee, D; Hu, HP; Hirohashi, K; Ahn, JY; Zheng, JZ; Yasufuku, K				Patel, Priya; Kato, Tatsuya; Ujiie, Hideki; Wada, Hironobu; Lee, Daiyoon; Hu, Hsin-pei; Hirohashi, Kentaro; Ahn, Jin Young; Zheng, Jinzi; Yasufuku, Kazuhiro			Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer	PLOS ONE			English	Article							CONTRAST AGENT; CT; LOCALIZATION; TELOMERASE; GFP	Background Investigation of CF800, a novel PEGylated nano-liposomal imaging agent containing indocyanine green (ICG) and iohexol, for real-time near infrared (NIR) fluorescence and computed tomography (CT) image-guided surgery in an orthotopic lung cancer model in nude mice. Methods CF800 was intravenously administered into 13 mice bearing the H460 orthotopic human lung cancer. At 48 h post-injection (peak imaging agent accumulation time point), ex vivo NIR and CT imaging was performed. A clinical NIR imaging system (SPY (R), Novadaq) was used to measure fluorescence intensity of tumor and lung. Tumor-to-background-ratios (TBR) were calculated in inflated and deflated states. The mean Hounsfield unit (HU) of lung tumor was quantified using the CT data set and a semi-automated threshold-based method. Histological evaluation using H&E, the macrophage marker F4/80 and the endothelial cell marker CD31, was performed, and compared to the liposomal fluorescence signal obtained from adjacent tissue sections Results The fluorescence TBR measured when the lung is in the inflated state (2.0 +/- 0.58) was significantly greater than in the deflated state (1.42 +/- 0.380 (n = 7, p<0.003). Mean fluorescent signal in tumor was highly variable across samples, (49.0 +/- 18.8 AU). CT image analysis revealed greater contrast enhancement in lung tumors (a mean increase of 110 +/- 57 HU) when CF800 is administered compared to the no contrast enhanced tumors (p = 0.0002). Conclusion Preliminary data suggests that the high fluorescence TBR and CT tumor contrast enhancement provided by CF800 may have clinical utility in localization of lung cancer during CT and NIR image-guided surgery.	[Patel, Priya; Kato, Tatsuya; Ujiie, Hideki; Wada, Hironobu; Lee, Daiyoon; Hu, Hsin-pei; Hirohashi, Kentaro; Ahn, Jin Young; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada; [Zheng, Jinzi; Yasufuku, Kazuhiro] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Yasufuku, K (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.; Zheng, JZ; Yasufuku, K (corresponding author), Univ Hlth Network, TECHNA Inst, Toronto, ON, Canada.; Zheng, JZ; Yasufuku, K (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.	jinzi.zheng@rmp.uhn.on.ca; kazuhiro.yasufuku@uhn.ca	Ujiie, Hideki/I-1939-2019	Ujiie, Hideki/0000-0001-6119-8776; Zheng, Jinzi/0000-0002-7650-3910; Patel, Priya/0000-0002-5886-8481	Canadian Cancer Society Research Institute (CCSRI) Innovation Grant; Princess Margaret Cancer Foundation; Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program	Canadian Cancer Society Research Institute (CCSRI) Innovation Grant; Princess Margaret Cancer Foundation(University of Toronto); Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program	The authors would like to thank Novadaq Inc. for providing the PINPOINT (R) system for our studies. We are grateful to the funding agencies and following grants for supporting the work and staff involved in this research: Canadian Cancer Society Research Institute (CCSRI) Innovation Grant, Princess Margaret Cancer Foundation, Spatio-Temporal Targeting and Amplification of Radiation Response (STTARR) program and its affiliated funding agencies. We would also like to acknowledge Dr. Trevor McKee for histology image analysis, Ms. Linyu Fan for liposome preparation, and Ms. Maria Bisa for animal technical services.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Buseman CM, 2012, MUTAT RES-FUND MOL M, V730, P90, DOI 10.1016/j.mrfmmm.2011.07.006; Dunne M, 2011, J CONTROL RELEASE, V154, P298, DOI 10.1016/j.jconrel.2011.05.022; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Ichinose J, 2013, ANN THORAC SURG, V96, P1203, DOI 10.1016/j.athoracsur.2013.05.026; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Kunhachan S, 2014, NANO LETT, V14, P972, DOI [10.1021/nl404391r, DOI 10.1021/NL404391R]; Mayo JR, 2009, RADIOLOGY, V250, P576, DOI 10.1148/radiol.2502080442; Nakajima T, 2014, ANN THORAC SURG, V97, P1771, DOI 10.1016/j.athoracsur.2014.01.048; O'Shannessy DJ, 2012, ONCOTARGET, V3, P414; Silverman JD, 2009, MED PHYS, V36, P1700, DOI 10.1118/1.3112363; Takizawa H, 2014, J THORAC CARDIOV SUR, V147, pE50, DOI 10.1016/j.jtcvs.2013.12.058; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Yano S, 2016, PLOS ONE, V11; Yano S, 2015, ONCOTARGET, V6, P13133, DOI 10.18632/oncotarget.3811; Zheng JZ, 2007, PHARM RES-DORDR, V24, P1193, DOI 10.1007/s11095-006-9220-1; Zheng JZ, 2015, BIOMATERIALS, V67, P160, DOI 10.1016/j.biomaterials.2015.07.010; Zheng JZ, 2010, CONTRAST MEDIA MOL I, V5, P147, DOI 10.1002/cmmi.378; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	23	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161991	10.1371/journal.pone.0161991	http://dx.doi.org/10.1371/journal.pone.0161991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584018	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600082
J	Rachakonda, V; Borhani, AA; Dunn, MA; Andrzejewski, M; Martin, K; Behari, J				Rachakonda, Vikrant; Borhani, Amir A.; Dunn, Michael A.; Andrzejewski, Margaret; Martin, Kelly; Behari, Jaideep			Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis	PLOS ONE			English	Article							STAGE LIVER-DISEASE; SEVERE MUSCLE DEPLETION; NUTRITIONAL-STATUS; SURVIVAL; MASS; TRANSPLANTATION; PREVALENCE; SARCOPENIA; GHRELIN; MODEL	Background and Aims Malnutrition is a leading cause of morbidity and mortality in cirrhosis. There is no consensus as to the optimal approach for identifying malnutrition in end-stage liver disease. The aim of this study was to measure biochemical, serologic, hormonal, radiographic, and anthropometric features in a cohort of hospitalized cirrhotic patients to characterize biomarkers for identification of malnutrition. Design In this prospective observational cohort study, 52 hospitalized cirrhotic patients were classified as malnourished (42.3%) or nourished (57.7%) based on mid-arm muscle circumference < 23 cm and dominant handgrip strength < 30 kg. Anthropometric measurements were obtained. Appetite was assessed using the Simplified Nutrition Appetite Questionnaire (SNAQ) score. Fasting levels of serum adipokines, cytokines, and hormones were determined using Luminex assays. Logistic regression analysis was used to determine features independently associated with malnutrition. Results Subjects with and without malnutrition differed in several key features of metabolic phenotype including wet and dry BMI, skeletal muscle index, visceral fat index and HOMA-IR. Serum leptin levels were lower and INR was higher in malnourished subjects. Serum leptin was significantly correlated with HOMA-IR, wet and dry BMI, mid-arm muscle circumference, skeletal muscle index, and visceral fat index. Logistic regression analysis revealed that INR and log-transformed leptin were independently associated with malnutrition. Conclusions Low serum leptin and elevated INR are associated with malnutrition in hospitalized patients with end-stage liver disease.	[Rachakonda, Vikrant; Dunn, Michael A.; Andrzejewski, Margaret; Martin, Kelly; Behari, Jaideep] Univ Pittsburgh, Div Gastroenterol, Dept Med, Pittsburgh, PA 15213 USA; [Rachakonda, Vikrant; Dunn, Michael A.; Andrzejewski, Margaret; Martin, Kelly; Behari, Jaideep] Univ Pittsburgh, Div Hepatol, Dept Med, Pittsburgh, PA 15213 USA; [Rachakonda, Vikrant; Dunn, Michael A.; Andrzejewski, Margaret; Martin, Kelly; Behari, Jaideep] Univ Pittsburgh, Div Nutr, Dept Med, Pittsburgh, PA 15213 USA; [Borhani, Amir A.] Univ Pittsburgh, Dept Radiol, Sch Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Behari, J (corresponding author), Univ Pittsburgh, Div Gastroenterol, Dept Med, Pittsburgh, PA 15213 USA.; Behari, J (corresponding author), Univ Pittsburgh, Div Hepatol, Dept Med, Pittsburgh, PA 15213 USA.; Behari, J (corresponding author), Univ Pittsburgh, Div Nutr, Dept Med, Pittsburgh, PA 15213 USA.	beharij@upmc.edu			National Institutes of Health Institutional Training Grant [5T32DK063922]; NIH [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	National Institutes of Health Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by a National Institutes of Health Institutional Training Grant 5T32DK063922 (PI: Whitcomb) to VR. This project used the University of Pittsburgh Cancer Institute (UPCI) Biomarkers Facility Luminex Core Laboratory which is supported by NIH award P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addeman BT, 2015, J MAGN RESON IMAGING, V41, P233, DOI 10.1002/jmri.24526; Alberino F, 2001, NUTRITION, V17, P445, DOI 10.1016/S0899-9007(01)00521-4; Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; Cabre E, 1998, Curr Opin Clin Nutr Metab Care, V1, P423, DOI 10.1097/00075197-199809000-00010; CAPOCACCIA L, 1994, J HEPATOL, V21, P317; Caregaro L, 1996, AM J CLIN NUTR, V63, P602, DOI 10.1093/ajcn/63.4.602; Chen CY, 2010, J CHIN MED ASSOC, V73, P225, DOI 10.1016/S1726-4901(10)70048-4; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; Diker-Cohen T, 2015, J CLIN ENDOCR METAB, V100, P1802, DOI 10.1210/jc.2014-4491; Engineer Diana R, 2012, Int J Pept, V2012, P287457, DOI 10.1155/2012/287457; Figueiredo FA, 2000, LIVER TRANSPLANT, V6, P575, DOI 10.1053/jlts.2000.9736; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Grosfeld A, 2002, J BIOL CHEM, V277, P42953, DOI 10.1074/jbc.M206775200; Hanai T, 2015, NUTRITION, V31, P193, DOI 10.1016/j.nut.2014.07.005; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Holecek M, 2015, NUTRITION, V31, P14, DOI 10.1016/j.nut.2014.03.016; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kondrup J, 2006, BEST PRACT RES CL GA, V20, P547, DOI 10.1016/j.bpg.2006.02.001; Montano-Loza AJ, 2014, LIVER TRANSPLANT, V20, P640, DOI 10.1002/lt.23863; Montano-Loza AJ, 2012, CLIN GASTROENTEROL H, V10, P166, DOI 10.1016/j.cgh.2011.08.028; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Norman K, 2006, WORLD J GASTROENTERO, V12, P3380, DOI 10.3748/wjg.v12.i21.3385; O'Brien A, 2008, GASTROENTEROLOGY, V134, P1729, DOI 10.1053/j.gastro.2008.02.001; Pirlich M, 1996, HEPATOLOGY, V24, P1422, DOI 10.1053/jhep.1996.v24.pm0008938174; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Santolaria F, 2003, ALCOHOL ALCOHOLISM, V38, P60, DOI 10.1093/alcalc/agg015; Sheriff S, 2014, PEPTIDES, V60, P1, DOI 10.1016/j.peptides.2014.07.010; Singal AK, 2013, TRANSPL INT, V26, P788, DOI 10.1111/tri.12123; Smiechowska J, 2010, J INVEST MED, V58, P554, DOI 10.231/JIM.0b013e3181cf91ca; Song MY, 2004, AM J CLIN NUTR, V79, P874; Takabatake N, 2001, AM J RESP CRIT CARE, V163, P1314, DOI 10.1164/ajrccm.163.6.2004175; Tandon P, 2012, LIVER TRANSPLANT, V18, P1209, DOI 10.1002/lt.23495; Testa R, 2000, J HEPATOL, V33, P33, DOI 10.1016/S0168-8278(00)80156-7; Wallace AM, 2002, NUTR CANCER, V44, P156, DOI 10.1207/S15327914NC4402_06; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074	36	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0159142	10.1371/journal.pone.0159142	http://dx.doi.org/10.1371/journal.pone.0159142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583675	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600001
J	Sengupta, T; Manoj, N				Sengupta, Tanusree; Manoj, Narayanan			Phosphatidylserine and Phosphatidylethanolamine Bind to Protein Z Cooperatively and with Equal Affinity	PLOS ONE			English	Article							FACTOR X-A; KINETIC CHARACTERIZATION; MOLECULAR DETERMINANTS; PROTHROMBINASE COMPLEX; FACTOR-VIII; INHIBITOR; COAGULATION; ACTIVATION; DOMAIN; MEMBRANES	Protein Z (PZ) is an anticoagulant that binds with high affinity to Protein Z-dependent protease inhibitor (ZPI) and accelerates the rate of ZPI-mediated inhibition of factor Xa (fXa) by more than 1000-fold in the presence of Ca2+ and phospholipids. PZ promotion of the ZPI-fXa interaction results from the anchoring of the Gla domain of PZ onto phospholipid surfaces and positioning the bound ZPI in close proximity to the Gla-anchored fXa, forming a ternary complex of PZ/ZPI/fXa. Although interaction of PZ with phospholipid membrane appears to be absolutely crucial for its cofactor activity, little is known about the binding of different phospholipids to PZ. The present study was conceived to understand the interaction of different phospholipids with PZ. Experiments with both soluble lipids and model membranes revealed that PZ binds to phosphatidylserine (PS) and phosphatidylethanolamine (PE) with equal affinity (K-d similar to 48 mu M); further, PS and PE bound to PZ synergistically. Equilibrium dialysis experiments revealed two lipid-binding sites for both PS and PE. PZ binds with weaker affinity to other phospholipids, e.g., phosphatidic acid, phosphatidylglycerol, phosphatidylcholine and binding of these lipids is not synergistic with respect to PS. Both PS and PE -containing membranes supported the formation of a fXa-PZ complex. PZ protection of fXa from antithrombin inhibition were also shown to be comparable in presence of both PS: PC and PE: PC membranes. These findings are particularly important and intriguing since they suggest a special affinity of PZ, in vivo, towards activated platelets, the primary membrane involved in blood coagulation process.	[Sengupta, Tanusree; Manoj, Narayanan] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Sengupta, T (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	tanusree@imail.iitm.ac.in	S, Tanusree/AAI-8680-2021; Manoj, Narayanan/W-2301-2019	S, Tanusree/0000-0002-6828-667X; Manoj, Narayanan/0000-0002-8144-1566	Department of Biotechnology (DBT); Ministry of Science and Technology, Government of India (GoI) [BT/BIO-CARE/01/88/2011-12]; Bio-CARe scheme of the DBT, GoI	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ministry of Science and Technology, Government of India (GoI); Bio-CARe scheme of the DBT, GoI	This work received funding from the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (GoI) and was supported by grant number BT/BIO-CARE/01/88/2011-12. TS is supported by funding from the Bio-CARe scheme of the DBT, GoI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandari S, 2014, CHEM PHYS LIPIDS, V184, P25, DOI 10.1016/j.chemphyslip.2014.09.001; Banerjee M, 2002, SPECIFICITY SOLUBLE, P7751; BROZE GJ, 1984, J CLIN INVEST, V73, P933, DOI 10.1172/JCI111317; Chattopadhyay R, 2012, ARTERIOSCL THROM VAS, V32, P2387, DOI 10.1161/ATVBAHA.112.250928; Clark SR, 2013, P NATL ACAD SCI USA, V110, P5875, DOI 10.1073/pnas.1222419110; Dayer Mohammad Reza, 2012, ISRN Hematol, V2012, P762728, DOI 10.5402/2012/762728; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2015, J BIOL CHEM, V290, P9906, DOI 10.1074/jbc.M114.633479; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; ICHINOSE A, 1990, BIOCHEM BIOPH RES CO, V172, P1139, DOI 10.1016/0006-291X(90)91566-B; JONES ME, 1985, THROMB RES, V39, P711, DOI 10.1016/0049-3848(85)90255-5; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Karimi Z, 2012, BIOINFORMATION, V8, P407, DOI 10.6026/97320630008407; Majumder R, 2005, BIOCHEMISTRY-US, V44, P16998, DOI 10.1021/bi051469f; Majumder R, 2003, BIOPHYS J, V84, P1238, DOI 10.1016/S0006-3495(03)74939-X; Majumder R, 2008, BLOOD, V112, P2795, DOI 10.1182/blood-2008-02-138941; Majumder R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100006; Majumder R, 2011, J BIOL CHEM, V286, P35535, DOI 10.1074/jbc.M111.260141; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P5120, DOI 10.1021/bi9626160; Morrissey JH, 2008, THROMB RES, V122, pS23, DOI 10.1016/S0049-3848(08)70014-8; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Okajima K, 2001, IMMUNOL REV, V184, P258, DOI 10.1034/j.1600-065x.2001.1840123.x; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; Qureshi SH, 2014, BBA-PROTEINS PROTEOM, V1844, P1631, DOI 10.1016/j.bbapap.2014.06.011; RAWALASHEIKH R, 1992, BLOOD, V79, P398; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; SHAW MC, 1971, ANAL BIOCHEM, V44, P288, DOI 10.1016/0003-2697(71)90371-X; SMIRNOV MD, 1994, J BIOL CHEM, V269, P816; Srivastava A, 2002, J BIOL CHEM, V277, P1855, DOI 10.1074/jbc.M105697200; Tavoosi N, 2013, BIOCHEMISTRY-US, V52, P5545, DOI 10.1021/bi4006368; Tavoosi N, 2011, J BIOL CHEM, V286, P23247, DOI 10.1074/jbc.M111.251769; Vasse M, 2011, HAMOSTASEOLOGIE, V31, P155, DOI 10.5482/ha-1161; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yegneswaran S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135025; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhai X, 2002, BIOCHEMISTRY-US, V41, P5675, DOI 10.1021/bi011844d	39	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161896	10.1371/journal.pone.0161896	http://dx.doi.org/10.1371/journal.pone.0161896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584039	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600072
J	Aravantinou, M; Frank, I; Hallor, M; Singer, R; Tharinger, H; Kenney, J; Gettie, A; Grasperge, B; Blanchard, J; Salazar, A; Piatak, M; Lifson, JD; Robbiani, M; Derby, N				Aravantinou, Meropi; Frank, Ines; Hallor, Magnus; Singer, Rachel; Tharinger, Hugo; Kenney, Jessica; Gettie, Agegnehu; Grasperge, Brooke; Blanchard, James; Salazar, Andres; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Robbiani, Melissa; Derby, Nina			PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; POLYINOSINIC-POLYCYTIDYLIC ACID; IMMATURE DENDRITIC CELLS; NONHUMAN-PRIMATES; RHESUS MACAQUES; SIV INFECTION; DISEASE PROGRESSION; TARGETED VACCINE; IMMUNE-RESPONSES; L-LYSINE	Myeloid dendritic cells (mDCs) contribute to both HIV pathogenesis and elicitation of antiviral immunity. Understanding how mDC responses to stimuli shape HIV infection outcomes will inform HIV prevention and treatment strategies. The long double-stranded RNA (dsRNA) viral mimic, polyinosinic polycytidylic acid (polyIC, PIC) potently stimulates DCs to focus Th1 responses, triggers direct antiviral activity in vitro, and boosts anti-HIV responses in vivo. Stabilized polyICLC (PICLC) is being developed for vaccine adjuvant applications in humans, making it critical to understand how mDC sensing of PICLC influences HIV infection. Using the monocyte-derived DC (moDC) model, we sought to describe how PICLC (vs. other dsRNAs) impacts HIV infection within DCs and DC-T cell mixtures. We extended this work to in vivo macaque rectal transmission studies by administering PICLC with or before rectal SIVmac239 (SIVwt) or SIVmac239 Delta Nef (SIV Delta Nef) challenge. Like PIC, PICLC activated DCs and T cells, increased expression of alpha(4)beta(7) and CD169, and induced type IIFN responses in vitro. The type of dsRNA and timing of dsRNA exposure differentially impacted in vitro DC-driven HIV infection. Rectal PICLC treatment similarly induced DC and T cell activation and pro-and anti-HIV factors locally and systemically. Importantly, this did not enhance SIV transmission in vivo. Instead, SIV acquisition was marginally reduced after a single high dose challenge. Interestingly, in the PICLC-treated, SIV Delta Nef-infected animals, SIV Delta Nef viremia was higher, in line with the importance of DC and T cell activation in SIV Delta Nef replication. In the right combination anti-HIV strategy, PICLC has the potential to limit HIV infection and boost HIV immunity.	[Aravantinou, Meropi; Frank, Ines; Hallor, Magnus; Singer, Rachel; Tharinger, Hugo; Kenney, Jessica; Robbiani, Melissa; Derby, Nina] Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA; [Hallor, Magnus] Linkoping Univ, Linkoping, Sweden; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Grasperge, Brooke; Blanchard, James] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Salazar, Andres] Oncovir Inc, Washington, DC USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD USA	Population Council; Linkoping University; Rockefeller University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Derby, N (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	nderby@popcouncil.org			National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R37 AI040877, R01 AI040877-19]; National Cancer Institute, NIH [HHSN261200800001E]; Tulane National Primate Research Center [P51OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040877, U24AI126683] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011124] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tulane National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants R37 AI040877 to MR and R01 AI040877-19 to ND and in part with federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Partial support was also provided to the Tulane National Primate Research Center by base Grant P51OD011104.	Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; [Anonymous], 2011, GUIDE CARE USE LAB A; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Avril T, 2009, J IMMUNOTHER, V32, P353, DOI 10.1097/CJI.0b013e31819d29bf; BLACK PL, 1992, INT J IMMUNOPHARMACO, V14, P1341, DOI 10.1016/0192-0561(92)90005-6; Blanchet FP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-6; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cline AN, 2005, J MED PRIMATOL, V34, P303; Conforti R, 2010, CANCER RES, V70, P490, DOI 10.1158/0008-5472.CAN-09-1890; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; Derby N, 2011, CURR OPIN HIV AIDS, V6, P379, DOI 10.1097/COH.0b013e3283499d63; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Gesuete R, 2016, STROKE, V47, P262, DOI 10.1161/STROKEAHA.115.010329; Goode D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097767; Gowen BB, 2007, J IMMUNOL, V178, P5200, DOI 10.4049/jimmunol.178.8.5200; Guerra-Perez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149491; Guerra-Perez N, 2015, J IMMUNOL, V194, P2415, DOI 10.4049/jimmunol.1402623; Gummuluru S, 2014, J INFECT DIS, V210, pS641, DOI 10.1093/infdis/jiu442; Hartman LLR, 2014, J PEDIAT HEMATOL ONC, V36, P451, DOI 10.1097/MPH.0000000000000047; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hu W, 2015, P NATL ACAD SCI USA, V112, P13994, DOI 10.1073/pnas.1510760112; Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Jaroenpool J, 2007, CELL IMMUNOL, V250, P91, DOI 10.1016/j.cellimm.2008.01.009; Jasny E, 2012, JAIDS-J ACQ IMM DEF, V61, P425, DOI 10.1097/QAI.0b013e318266be53; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim WK, 2015, AIDS RES HUM RETROV, V31, P696, DOI [10.1089/aid.2015.0003, 10.1089/AID.2015.0003]; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; LEVY HB, 1975, J INFECT DIS, V132, P434, DOI 10.1093/infdis/132.4.434; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Martin-Gayo E., 2016, C RETR OPP INF BOST; Martinelli E, 2013, JAIDS J ACQUIRED IMM; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; Martins KA, 2015, EXPERT REV VACCINES, V14, P447, DOI 10.1586/14760584.2015.966085; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Messmer D, 2000, J VIROL, V74, P2406, DOI 10.1128/JVI.74.5.2406-2413.2000; Miller EA, 2016, C RETR OPP INF BOST; Morse MA, 2011, CLIN CANCER RES, V17, P4844, DOI 10.1158/1078-0432.CCR-11-0891; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nicodemus CF, 2010, IMMUNOTHERAPY-UK, V2, P137, DOI 10.2217/IMT.10.8; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Paijo J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005546; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Peretti S, 2005, BLOOD, V106, P1305, DOI 10.1182/blood-2004-12-4899; Petit C, 2001, VIROLOGY, V286, P225, DOI 10.1006/viro.2001.0984; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Rodriguez-Plata MT, 2012, J IMMUNOL, V188, P6036, DOI 10.4049/jimmunol.1200267; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Saulle I, 2016, AIDS RES HUM RETROV, V32, P129, DOI [10.1089/AID.2015.0019, 10.1089/aid.2015.0019]; Shey MS, 2015, INNATE IMMUN-LONDON, V21, P99, DOI 10.1177/1753425913513815; Sloan DD, 2015, C RETR OPP INF BOST; St Gelais C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034521; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; TALMADGE JE, 1985, CANCER RES, V45, P1058; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Thompson EA, 2015, J IMMUNOL, V195, P1015, DOI 10.4049/jimmunol.1500078; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Vagenas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012891; Vagenas P, 2009, JAIDS-J ACQ IMM DEF, V52, P433, DOI 10.1097/QAI.0b013e3181b880f3; van der Kuyl AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000257; Wang LL, 2002, J CLIN INVEST, V110, P1175, DOI 10.1172/JCI200215536; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Whitney JB, 2015, C RETR OPP INF BOST; Whitney JB, 2016, C RETR OPP INF BOST; Wonderlich ER, 2012, VIRULENCE, V3, P647, DOI 10.4161/viru.22491; Wong JP, 2009, CURR PHARM DESIGN, V15, P1269, DOI 10.2174/138161209787846775; Wong JP, 2005, VACCINE, V23, P2266, DOI 10.1016/j.vaccine.2005.01.037; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	101	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161730	10.1371/journal.pone.0161730	http://dx.doi.org/10.1371/journal.pone.0161730			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603520	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200023
J	Belmont, TFD; Palmeira, DK; da Silva, AS; Vilar, KD; Medeiros, FS; Vasconcelos, LRS; dos Anjos, ACM; Hatzlhofer, BLD; Pitta, MGD; Bezerra, MAC; Araujo, AD; Rego, MJBD; Moura, P; Cavalcanti, MDM				de Mendonca Belmont, Taciana Furtado; Palmeira, Kleyton do O.; da Silva, Andreia Soares; Vilar, Kamila de Melo; Medeiros, Fernanda Silva; Silva Vasconcelos, Luydson Richardson; Mendona dos Anjos, Ana Claudia; Domingues Hatzlhofer, Betania Lucena; da Rocha Pitta, Maira Galdino; Cavalcanti Bezerra, Marcos Andre; Araujo, Aderson da Silva; Barreto de Melo Rego, Moacyr Jesus; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro			Single Nucleotide Polymorphisms at+191 and+292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia	PLOS ONE			English	Article							INFLAMMATION; SECRETION; RELEASE; FAMILY; INJURY	Introduction Patients with sickle cell anemia (SCA) may present chronic hemolytic anemia, vaso-occlusion and respiratory tract infection (RTI) episodes. Galectin-3 (GAL-3) is a multifunctional protein involved in inflammation, apoptosis, adhesion and resistance to reactive oxygen species. Studies point to a dual role for GAL-3 as both a circulation damage-associated molecular pattern and a cell membrane associated pattern recognition receptor. Objective To investigate associations between the SNPs of GAL-3 gene (LGALS3) and serum levels with RTI and vaso-occlusive crisis (VOC) in children with SCA. Materials and Methods SNPs +191 and +292 in LGALS3 were studied using the TaqMan real-time PCR system; GAL-3 serum levels were measured by ELISA. The study included 79 children with SCA ranging from 2 to 12 years old. Results GAL-3 serum levels were associated with LGALS3 +191 and +292 genotypes (p < 0.0001; p = 0.0169, respectively). LGALS3 +191, AA genotype was associated with low and CC with higher levels of GAL-3. For LGALS3 +292, the CC genotype was associated with lower GAL-3 and AA with higher levels. Patients with Frequency of RTI (FRTI) >= 1 presented higher frequency of +191AA (p = 0.0263) and +292AC/CC genotypes (p = 0.0320). SNP +292 was associated with Frequency of VOC (FVOC) (p = 0.0347), whereas no association was shown with SNP + 191 and FVOC. However, CA/AC and AA/CC genotypes with lower GAL-3 levels showed a higher frequency in patients with FRTI >= 1 (p = 0.0170; p = 0.0138, respectively). Also, patients with FVOC >= 1 presented association with CA/AC (p = 0.0228). LGALS3 +191 and +292 combined genotypes related to low (p = 0.0263) and intermediate expression (p = 0.0245) were associated with FRTI >= 1. Lower GAL-3 serum levels were associated with FRTI >= 1 (p = 0.0426) and FVOC >= 1 (p = 0.0012). Conclusion Variation of GAL-3 serum levels related to SNPs at +191 and +292 may constitute a susceptibility factor for RTI and VOC frequency.	[de Mendonca Belmont, Taciana Furtado; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro] Rede Nordeste Biotecnol, Programa Doutorado, Recife, PE, Brazil; [Palmeira, Kleyton do O.; da Silva, Andreia Soares; Medeiros, Fernanda Silva; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil; [Palmeira, Kleyton do O.; da Silva, Andreia Soares; Medeiros, Fernanda Silva; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil; [Vilar, Kamila de Melo; da Rocha Pitta, Maira Galdino; Barreto de Melo Rego, Moacyr Jesus] Univ Fed Pernambuco, LINAT, Recife, PE, Brazil; [Silva Vasconcelos, Luydson Richardson] CPqAM FIOCRUZ PE, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil; [Mendona dos Anjos, Ana Claudia; Araujo, Aderson da Silva] Fundacao Hematol & Hemoterapia Pernambuco HEMOPE, Recife, PE, Brazil; [Domingues Hatzlhofer, Betania Lucena; Cavalcanti Bezerra, Marcos Andre] Univ Fed Pernambuco, Dept Ciencias Biol, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco	Moura, P (corresponding author), Rede Nordeste Biotecnol, Programa Doutorado, Recife, PE, Brazil.; Moura, P (corresponding author), Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.; Moura, P (corresponding author), Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.	patricia.moura@upe.br	Pitta, Maira G R/H-8433-2013; Moura, Patricia M M F/H-7233-2018; Vasconcelos, Luydson/AAC-4907-2020; Rêgo, Moacyr/I-6782-2013	Vasconcelos, Luydson/0000-0002-1625-3358; Rêgo, Moacyr/0000-0002-1883-6012; Moura, Patricia/0000-0003-4259-388X; Soares da Silva, Andreia/0000-0003-1600-6899	National Council for Scientific and Technological Development (CNPq); Higher Education Personnel Training Coordination (Capes); Foundation for Science and Technology of the State of Pernambuco (FACEPE)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Higher Education Personnel Training Coordination (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Science and Technology of the State of Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was supported by the National Council for Scientific and Technological Development (CNPq), the Higher Education Personnel Training Coordination (Capes) and the Foundation for Science and Technology of the State of Pernambuco (FACEPE). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aslan M, 2000, ANN NY ACAD SCI, V899, P375; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Chen HJ, 2012, NEUROSCI LETT, V518, P1, DOI 10.1016/j.neulet.2012.02.065; Davis LG, 1986, BASIC METHODS MOL BI, P338; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dover G, 2003, HEMATOLOGY INFANCY C, P790; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hoppe CC, 2014, HEMATOL ONCOL CLIN N, V28, P265, DOI 10.1016/j.hoc.2013.11.006; Hu CY, 2011, CLIN RHEUMATOL, V30, P1227, DOI 10.1007/s10067-011-1741-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ipek G, 2015, CARDIOLOGY, V132, P105, DOI 10.1159/000431354; Kadrofske MM, 1998, ARCH BIOCHEM BIOPHYS, V349, P7, DOI 10.1006/abbi.1997.0447; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; Madrigal-Matute J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000785; Mehul B, 1997, J CELL SCI, V110, P1169; Mendonca TF, 2010, BLOOD CELL MOL DIS, V44, P224, DOI 10.1016/j.bcmd.2010.02.004; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Quinn CT, 2016, EXP BIOL MED MAYWOOD; Raimond J, 1997, MAMM GENOME, V8, P706, DOI 10.1007/s003359900548; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; ten Oever J, 2013, EUR J CLIN MICROBIOL, V32, P1605, DOI 10.1007/s10096-013-1919-4; Torres LD, 2016, CYTOKINE, V80, P18, DOI 10.1016/j.cyto.2016.02.012; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; ZUBERI RI, 1994, CELL IMMUNOL, V156, P1, DOI 10.1006/cimm.1994.1148	34	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162297	10.1371/journal.pone.0162297	http://dx.doi.org/10.1371/journal.pone.0162297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603703	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200055
J	Li, ZZ; Zhang, TT; Lin, ZC; Hou, CZ; Zhang, J; Men, YQ; Li, HS; Gao, JG				Li, Zhenzu; Zhang, Tingting; Lin, Zhuchun; Hou, Congzhe; Zhang, Jian; Men, Yuqin; Li, Huashun; Gao, Jiangang			Lgl1 Is Required for Olfaction and Development of Olfactory Bulb in Mice	PLOS ONE			English	Article							ROSTRAL MIGRATORY STREAM; GANGLIONIC EMINENCE; POLARITY COMPLEX; KNOCKOUT MICE; NULL MICE; NEURONS; BRAIN; GENE; DIFFERENTIATION; EXPRESSION	Lethal giant larvae 1 (Lgl1) was initially identified as a tumor suppressor in Drosophila and functioned as a key regulator of epithelial polarity and asymmetric cell division. In this study, we generated Lgl1 conditional knockout mice mediated by Pax2-Cre, which is expressed in olfactory bulb (OB). Next, we examined the effects of Lgl1 loss in the OB. First, we determined the expression patterns of Lgl1 in the neurogenic regions of the embryonic dorsal region of the LGE (dLGE) and postnatal OB. Furthermore, the Lgl1 conditional mutants exhibited abnormal morphological characteristics of the OB. Our behavioral analysis exhibited greatly impaired olfaction in Lgl1 mutant mice. To elucidate the possible mechanisms of impaired olfaction in Lgl1 mutant mice, we investigated the development of the OB. Interestingly, reduced thickness of the MCL and decreased density of mitral cells (MCs) were observed in Lgl1 mutant mice. Additionally, we observed a dramatic loss in SP8(+) interneurons (e.g. calretinin and GABAergic/non-dopaminergic interneurons) in the GL of the OB. Our results demonstrate that Lgl1 is required for the development of the OB and the deletion of Lgl1 results in impaired olfaction in mice.	[Li, Zhenzu; Zhang, Tingting; Zhang, Jian; Men, Yuqin; Gao, Jiangang] Shandong Univ, Inst Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Lin, Zhuchun] Jinan First Peoples Hosp, Jinan 250011, Shandong, Peoples R China; [Hou, Congzhe] Shandong Univ, Hosp 2, Jinan 250000, Shandong, Peoples R China; [Li, Huashun] Tongji Univ, Shanghai East Hosp, Adv Inst Translat Med, Sch Med,SARITEX Ctr Stem Cell Engn Translat Med, Shanghai 200123, Peoples R China; [Li, Huashun] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Stem Cell&Nanomed, Shanghai 200123, Peoples R China; [Li, Huashun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Shenzhen 518000, Guangdong, Peoples R China	Shandong University; Shandong University; Tongji University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Gao, JG (corresponding author), Shandong Univ, Inst Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.; Li, HS (corresponding author), Tongji Univ, Shanghai East Hosp, Adv Inst Translat Med, Sch Med,SARITEX Ctr Stem Cell Engn Translat Med, Shanghai 200123, Peoples R China.; Li, HS (corresponding author), Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Stem Cell&Nanomed, Shanghai 200123, Peoples R China.; Li, HS (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Shenzhen 518000, Guangdong, Peoples R China.	huashunli@tongji.edu.cn; jggao@sdu.edu.cn		Zhang, Jian/0000-0001-6231-0301	National Basic Research Program (973) of China [2014CB541703]; National Natural Science Foundation of China [30871436, 30973297, 31171194]; Shandong Provincial Science and Technology Key Program [2009GG10002039]; Shenzhen Committee for Technological Renovation [ZDSY20120617112838879]; Shenzhen Peacock Plan [KQCX20130628112914292]; Shandong Provincial Natural Science Foundation of China [ZR2013CQ041]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science and Technology Key Program; Shenzhen Committee for Technological Renovation; Shenzhen Peacock Plan; Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Basic Research Program (973) of China (2014CB541703); the National Natural Science Foundation of China (30871436, 30973297 and 31171194); Shandong Provincial Science and Technology Key Program (2009GG10002039); Shenzhen Committee for Technological Renovation (ZDSY20120617112838879) and Shenzhen Peacock Plan (KQCX20130628112914292); and Shandong Provincial Natural Science Foundation of China (ZR2013CQ041).	Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Capilla-Gonzalez V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00147; Congzhe H, 2014, DEV BIOL, V395, P167, DOI [10.1016/j.ydbio.2014.07.007, DOI 10.1016/J.YDBIO.2014.07.007]; Dahan I, 2012, MOL BIOL CELL, V23, P591, DOI 10.1091/mbc.E11-01-0015; EDWARDS DA, 1972, BEHAV BIOL, V7, P823, DOI 10.1016/S0091-6773(72)80174-3; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; Kosaka T, 2012, NEUROSCI RES, V73, P24, DOI 10.1016/j.neures.2012.02.013; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lopez-Mascaraque L, 2002, CELL DEATH DIFFER, V9, P1279, DOI 10.1038/sj.cdd.4401076; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Nagayama S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00098; Nathan BP, 2004, BEHAV BRAIN RES, V150, P1, DOI 10.1016/S0166-4328(03)00219-5; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Pencea V, 2003, J COMP NEUROL, V463, P402, DOI 10.1002/cne.10746; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Prosser HM, 2007, EUR J NEUROSCI, V26, P3339, DOI 10.1111/j.1460-9568.2007.05958.x; Schablitzky S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00045; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Schmouth JF, 2012, MOL CELL BIOL, V32, P1296, DOI 10.1128/MCB.06016-11; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stenman J, 2003, J NEUROSCI, V23, P167; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yun K, 2001, DEVELOPMENT, V128, P193; Zarnescu DC, 2005, DEV CELL, V8, P43, DOI 10.1016/j.devcel.2004.10.020	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162126	10.1371/journal.pone.0162126	http://dx.doi.org/10.1371/journal.pone.0162126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603780	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200046
J	Oliver, JF; Rafecas, M				Oliver, Josep F.; Rafecas, M.			Modelling Random Coincidences in Positron Emission Tomography by Using Singles and Prompts: A Comparison Study	PLOS ONE			English	Article							WHOLE-BODY PET; ACCIDENTAL COINCIDENCES; IMAGE-RECONSTRUCTION; 3D PET; COUNT RATE; SCANNER; NOISE; OPTIMIZATION; VARIANCE; SCATTER	Random coincidences degrade the image in Positron Emission Tomography, PET. To compensate for their degradation effects, the rate of random coincidences should be estimated. Under certain circumstances, current estimation methods fail to provide accurate results. We propose a novel method, "Singles-Prompts" (SP), that includes the information conveyed by prompt coincidences and models the pile-up. The SP method has the same structure than the well-known "Singles Rate" (SR) approach. Hence, SP can straightforwardly replace SR. In this work, the SP method has been extensively assessed and compared to two conventional methods, SR and the delayed window (DW) method, in a preclinical PET scenario using Monte-Carlo simulations. SP offers accurate estimates for the randoms rates, while SR and DW tend to overestimate the rates (similar to 10%, and 5%, respectively). With pile-up, the SP method is more robust than SR (but less than DW). At the image level, the contrast is overestimated in SR-corrected images, + 16%, while SP produces the correct value. Spill-over is slightly reduced using SP instead of SR. The DW images values are similar to those of SP except for low-statistic scenarios, where DW behaves as if randoms were not compensated for. In particular, the contrast is reduced, -16%. In general, the better estimations of SP translate into better image quality.	[Oliver, Josep F.; Rafecas, M.] Inst Fis Corpuscular IFIC UV CSIC, Valencia, Spain; [Rafecas, M.] Univ Lubeck, Lubeck, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Lubeck	Oliver, JF (corresponding author), Inst Fis Corpuscular IFIC UV CSIC, Valencia, Spain.	josep.f.oliver@uv.es	Rafecas, Magdalena/L-5816-2014; Oliver, Josep F/I-4830-2012	Rafecas, Magdalena/0000-0001-5691-7756; Oliver, Josep F/0000-0002-8585-9345	Spanish Ministry of Science and Innovation [FPA2010-14891]; Generalitat Valenciana [GVISIC/2012/020]; Universitat zu Lubeck	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Universitat zu Lubeck	This work was supported by the Spanish Ministry of Science and Innovation under grant FPA2010-14891 and the Generalitat Valenciana under grant GVISIC/2012/020. The work was also supported by Universitat zu Lubeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Badawi RD, 1999, PHYS MED BIOL, V44, P941, DOI 10.1088/0031-9155/44/4/010; Badawi RD, 1996, PHYS MED BIOL, V41, P1755, DOI 10.1088/0031-9155/41/9/014; Beltrame P, 2011, NUCL INSTRUM METH A, V654, P546, DOI 10.1016/j.nima.2011.06.059; Brasse D, 2005, J NUCL MED, V46, P859; Chang TT, 2012, MED PHYS, V39, P5891, DOI 10.1118/1.4750053; DEFRISE M, 1991, PHYS MED BIOL, V36, P939, DOI 10.1088/0031-9155/36/7/003; Evans R., 1955, ATOMIC NUCL, DOI 10.1063/1.3059850; Goertzen AL, 2012, J NUCL MED, V53, P1300, DOI 10.2967/jnumed.111.099382; Goldschmidt B, 2013, IEEE T NUCL SCI, V60, P1550, DOI 10.1109/TNS.2013.2252193; HOFFMAN EJ, 1981, J COMPUT ASSIST TOMO, V5, P391, DOI 10.1097/00004728-198106000-00015; Knoll GF, 1955, RAD DETECTION MEASUR; McElroy DP, 2005, PHYS MED BIOL, V50, P3323, DOI 10.1088/0031-9155/50/14/009; Moskal P, 2014, NUCL INSTRUM METH A, V764, P317, DOI 10.1016/j.nima.2014.07.052; Njejimana L, 2013, IEEE T NUCL SCI, V60, P3633, DOI 10.1109/TNS.2013.2250307; Oliver JF, 2008, IEEE NUCL SCI S C, P4732; Oliver JF, 2015, ACTA PHYS POL, V127, P5; Oliver JF, 2011, P SOC PHOTO-OPT INS, V7961; Oliver JF, 2013, IEEE T NUCL SCI, V60, P3399, DOI 10.1109/TNS.2013.2274702; Oliver JF, 2012, IEEE NUCL SCI CONF R, P2995; Oliver JF, 2010, PHYS MED BIOL, V55, P6951, DOI 10.1088/0031-9155/55/22/022; OpenGATE C, 2006, GATE US GUID VERS 3; POLITTE DG, 1991, IEEE T MED IMAGING, V10, P82, DOI 10.1109/42.75614; Poon JK, 2012, PHYS MED BIOL, V57, P4077, DOI 10.1088/0031-9155/57/13/4077; Pratx G, 2009, PHYS MED BIOL, V54, P5073, DOI 10.1088/0031-9155/54/17/001; Rafecas M, 2007, NUCL INSTRUM METH A, V571, P285, DOI 10.1016/j.nima.2006.10.084; Rahmim A, 2009, MED PHYS, V36, P3654, DOI 10.1118/1.3160108; Rey M, 2005, IEEE NUCL SCI CONF R, P2070; Rokitta O, 2000, NUCL SCI S C REC, V3, p17/37; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Stearns CW, 2004, IEEE NUCL SCI CONF R, P3067, DOI 10.1109/NSSMIC.2003.1352545; STROTHER SC, 1990, IEEE T NUCL SCI, V37, P783, DOI 10.1109/23.106715; Tetrault MA, 2010, IEEE T NUCL SCI, V57, P117, DOI 10.1109/TNS.2009.2038055; Tetrault MA, 2005, IEEE NUCL SCI CONF R, P2849; Tong S, 2010, PHYS MED BIOL, V55, P1453, DOI 10.1088/0031-9155/55/5/013; Torres-Espallardo I, 2008, PHYS MED BIOL, V53, P2391, DOI 10.1088/0031-9155/53/9/012; VARDI Y, 1985, J AM STAT ASSOC, V80, P8, DOI 10.2307/2288030; Walker MD, 2009, J NUCL MED, V50, P1409, DOI 10.2967/jnumed.109.062679; Wang YC, 2006, J NUCL MED, V47, P1891; Watson CC, 2005, J NUCL MED, V46, P1825; Yang YF, 2006, IEEE T NUCL SCI, V53, P127, DOI 10.1109/TNS.2006.870177; Yu DF, 2002, NUCL INSTRUM METH A, V488, P362, DOI 10.1016/S0168-9002(02)00460-6	42	10	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162096	10.1371/journal.pone.0162096	http://dx.doi.org/10.1371/journal.pone.0162096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603143	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200040
J	Stevenson, KT; Peterson, MN; Bradshaw, A				Stevenson, Kathryn T.; Peterson, M. Nils; Bradshaw, Amy			How Climate Change Beliefs among US Teachers Do and Do Not Translate to Students	PLOS ONE			English	Article							CHANGE KNOWLEDGE; EDUCATION; SKEPTICISM; PERCEPTIONS; ADOLESCENTS; RISK	Research suggests climate change beliefs among science teachers mirror those of the general public, raising questions of whether teachers may be perpetuating polarization of public opinion through their classrooms. We began answering these questions with a survey of middle school science teachers (n = 24) and their students (n = 369) in North Carolina, USA. Similar to previous studies, we found that though nearly all (92.1%) of students had teachers who believe that global warming is happening, few (12%) are in classrooms with teachers who recognize that global warming is anthropogenic. We found that teacher beliefs that global warming is happening and student climate change knowledge were the strongest predictors of student belief that global warming is happening and human caused. Conversely, teacher beliefs about human causes of global warming had no relationship with student beliefs, suggesting that science teachers' low recognition of the causes of global warming is not necessarily problematic in terms of student outcomes. These findings may be explained by previous research suggesting adolescents interpret scientific information relatively independently of ideological constraints. Though teacher polarization may be problematic in its own right, it appears that as long as climate change information is presented in classrooms, students deduce anthropogenic causes.	[Stevenson, Kathryn T.; Peterson, M. Nils] North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Bradshaw, Amy] NC State Univ, Dept Zool, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Stevenson, KT (corresponding author), North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	kathryn_stevenson@ncsu.edu		Stevenson, Kathryn/0000-0002-5577-5861; Peterson, Nils/0000-0002-4246-1206	North Carolina Sea Grant [2012-R/12-HCE-5]	North Carolina Sea Grant	North Carolina Sea Grant for funded this work (Project # 2012-R/12-HCE-5): https://ncseagrant.ncsu.edu/ in a grant awarded to MNP and KTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HE, 2009, J ENVIRON EDUC, V40, P27, DOI 10.3200/JOEE.40.3.27-36; Bedford D, 2015, J GEOG, V115, P1; Blandford C, 2009, CLIMATE CHANGE PERCE; Capstick S, 2015, WIRES CLIM CHANGE, V6, P35, DOI 10.1002/wcc.321; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Corner A, 2015, WIRES CLIM CHANGE, V6, P523, DOI 10.1002/wcc.353; Desimone LM, 2004, EDUC EVAL POLICY AN, V26, P1, DOI 10.3102/01623737026001001; Flora JA, 2014, CLIMATIC CHANGE, V127, P419, DOI 10.1007/s10584-014-1274-1; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Harish Alon, 2012, ABCNEWS 0802; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Howe PD, 2015, NAT CLIM CHANGE, V5, P596, DOI 10.1038/nclimate2583; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2012, HDB RISK THEORY EPIS, V1; Leiserowitz A, 2011, AM TEENSKNOWLEDGE CL, P2; Leiserowitz A., 2010, RACE ETHNICITY PUBLI; McBeth B., 2008, NATL ENV LITERACY AS; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; Mead E, 2012, ATL J COMMUN, V20, P31, DOI 10.1080/15456870.2012.637027; Moser SC, 2011, OXFORD HDB CLIMATE C, P161; Ojala M, 2015, J YOUTH STUD, V18, P1135, DOI 10.1080/13676261.2015.1020927; Ojala M, 2013, SUSTAINABILITY-BASEL, V5, P2191, DOI 10.3390/su5052191; Pew Research Center, 2014, CLIM CHANG KEY DAT P; Plutzer E, 2016, SCIENCE, V351, P664, DOI 10.1126/science.aab3907; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Shi J, 2016, NAT CLIM CHANGE, V6, P759, DOI [10.1038/NCLIMATE2997, 10.1038/nclimate2997]; Shi J, 2015, RISK ANAL, V35, P2183, DOI 10.1111/risa.12406; Sina M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147201; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Stevenson KT, 2014, CLIMATIC CHANGE, V126, P293, DOI 10.1007/s10584-014-1228-7; Taber F., 2009, International Journal of Environmental & Science Education, V4, P97; Tobler C, 2012, CLIMATIC CHANGE, V114, P189, DOI 10.1007/s10584-011-0393-1; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017	35	25	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161462	10.1371/journal.pone.0161462	http://dx.doi.org/10.1371/journal.pone.0161462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603667	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200014
J	Kinyua, AW; Yang, DJ; Chang, I; Kim, KW				Kinyua, Ann W.; Yang, Dong Joo; Chang, Inik; Kim, Ki Woo			Steroidogenic Factor 1 in the Ventromedial Nucleus of the Hypothalamus Regulates Age-Dependent Obesity	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; BROWN ADIPOSE-TISSUE; SYMPATHETIC ACTIVITY; FEEDING-BEHAVIOR; BODY-WEIGHT; LEPTIN; RATS; HOMEOSTASIS; NEURONS; LESIONS	The ventromedial nucleus of the hypothalamus (VMH) is important for the regulation of whole body energy homeostasis and lesions in the VMH are reported to result in massive weight gain. The nuclear receptor steroidogenic factor 1 (SF-1) is a known VMH marker as it is exclusively expressed in the VMH region of the brain. SF-1 plays a critical role not only in the development of VMH but also in its physiological functions. In this study, we generated prenatal VMH-specific SF-1 KO mice and investigated age-dependent energy homeostasis regulation by SF-1. Deletion of SF-1 in the VMH resulted in dysregulated insulin and leptin homeostasis and late onset obesity due to increased food intake under normal chow and high fat diet conditions. In addition, SF-1 ablation was accompanied by a marked reduction in energy expenditure and physical activity and this effect was significantly pronounced in the aged mice. Taken together, our data indicates that SF-1 is a key component in the VMH-mediated regulation of energy homeostasis and implies that SF-1 plays a protective role against metabolic stressors including aging and high fat diet.	[Kinyua, Ann W.; Yang, Dong Joo; Kim, Ki Woo] Yonsei Univ, Wonju Coll Med, Dept Pharmacol, Wonju 26426, South Korea; [Kinyua, Ann W.; Yang, Dong Joo; Kim, Ki Woo] Yonsei Univ, Wonju Coll Med, Dept Global Med Sci, Wonju 26426, South Korea; [Chang, Inik] Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul 03722, South Korea; [Kim, Ki Woo] UT Southwestern Med Ctr, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Kim, Ki Woo] UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, KW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Pharmacol, Wonju 26426, South Korea.; Kim, KW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Global Med Sci, Wonju 26426, South Korea.; Kim, KW (corresponding author), UT Southwestern Med Ctr, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.; Kim, KW (corresponding author), UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	kiwoo@yonsei.ac.kr	Kim, Ki Woo Woo/AAW-9645-2021	Kim, Ki Woo Woo/0000-0002-7790-1515	Small and Medium Business Administration (Technological Innovation RD Program) [S2178403]; National Research Foundation [2016R1C1B3012748, 2014K1A3A1A19066980, 2016R1A5A2008630]; Global PhD Fellowship [NRF-2015H1A2A1032009]	Small and Medium Business Administration (Technological Innovation RD Program); National Research Foundation; Global PhD Fellowship	This work was supported by Small and Medium Business Administration (Technological Innovation R&D Program S2178403), National Research Foundation (2016R1C1B3012748 and 2014K1A3A1A19066980 for K.W.K. and 2016R1A5A2008630 for I. C.), and Global PhD Fellowship (NRF-2015H1A2A1032009 for D. J. Y.).	Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2012, CURR OPIN LIPIDOL, V23, P190, DOI 10.1097/MOL.0b013e328352dcef; BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307; BERTHOUD HR, 1979, ENDOCRINOLOGY, V105, P146, DOI 10.1210/endo-105-1-146; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Gu ZY, 2012, AGE, V34, P1393, DOI 10.1007/s11357-011-9312-7; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; Kim KW, 2011, P NATL ACAD SCI USA, V108, P10673, DOI 10.1073/pnas.1102364108; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Martin-Gronert Malgorzata S, 2013, Med Wieku Rozwoj, V17, P7; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Muller DC, 1996, SEMIN NEPHROL, V16, P289; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Parker KL, 1998, MOL CELL ENDOCRINOL, V145, P15, DOI 10.1016/S0303-7207(98)00164-6; SAKAGUCHI T, 1988, INT J OBESITY, V12, P285; SAKAGUCHI T, 1988, BRAIN RES BULL, V20, P461, DOI 10.1016/0361-9230(88)90135-9; SHIMAZU T, 1991, BRAIN RES BULL, V27, P501, DOI 10.1016/0361-9230(91)90149-E; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Xu Y, 2010, CELL METAB, V12, P88, DOI 10.1016/j.cmet.2010.05.002; Zhao LP, 2008, MOL ENDOCRINOL, V22, P1403, DOI 10.1210/me.2008-0034; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	34	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162352	10.1371/journal.pone.0162352	http://dx.doi.org/10.1371/journal.pone.0162352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598259	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800056
J	Weinberger, O; Winter, L; Dieringer, MA; Els, A; Oezerdem, C; Rieger, J; Kuehne, A; Cassara, AM; Pfeiffer, H; Wetterling, F; Niendorf, T				Weinberger, Oliver; Winter, Lukas; Dieringer, Matthias A.; Els, Antje; Oezerdem, Celal; Rieger, Jan; Kuehne, Andre; Cassara, Antonino M.; Pfeiffer, Harald; Wetterling, Friedrich; Niendorf, Thoralf			Local Multi-Channel RF Surface Coil versus Body RF Coil Transmission for Cardiac Magnetic Resonance at 3 Tesla: Which Configuration Is Winning the Game?	PLOS ONE			English	Article							PARALLEL TRANSMISSION; ABSORPTION RATE; CMR PROTOCOLS; MRI; EXCITATION; ARRAY; SYNCHRONIZATION; SIMULATIONS; TEMPERATURE; HOMOGENEITY	Introduction The purpose of this study was to demonstrate the feasibility and efficiency of cardiac MR at 3 Tesla using local four-channel RF coil transmission and benchmark it against large volume body RF coil excitation. Methods Electromagnetic field simulations are conducted to detail RF power deposition, transmission field uniformity and efficiency for local and body RF coil transmission. For both excitation regimes transmission field maps are acquired in a human torso phantom. For each transmission regime flip angle distributions and blood-myocardium contrast are examined in a volunteer study of 12 subjects. The feasibility of the local transceiver RF coil array for cardiac chamber quantification at 3 Tesla is demonstrated. Results Our simulations and experiments demonstrate that cardiac MR at 3 Tesla using four-channel surface RF coil transmission is competitive versus current clinical CMR practice of large volume body RF coil transmission. The efficiency advantage of the 4TX/4RX setup facilitates shorter repetition times governed by local SAR limits versus body RF coil transmission at whole-body SAR limit. No statistically significant difference was found for cardiac chamber quantification derived with body RF coil versus four-channel surface RF coil transmission. Our simulation also show that the body RF coil exceeds local SAR limits by a factor of similar to 2 when driven at maximum applicable input power to reach the whole-body SAR limit. Conclusion Pursuing local surface RF coil arrays for transmission in cardiac MR is a conceptually appealing alternative to body RF coil transmission, especially for patients with implants.	[Weinberger, Oliver; Winter, Lukas; Dieringer, Matthias A.; Els, Antje; Oezerdem, Celal; Niendorf, Thoralf] Helmholtz Assoc, Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany; [Weinberger, Oliver; Dieringer, Matthias A.; Niendorf, Thoralf] ECRC, Berlin, Germany; [Oezerdem, Celal] German Ctr Cardiovasc Res DZHK, Berlin, Germany; [Rieger, Jan; Kuehne, Andre; Niendorf, Thoralf] MRI TOOLS GmbH, Berlin, Germany; [Cassara, Antonino M.; Pfeiffer, Harald] PTB, Med Metrol Dept, Braunschweig, Germany; [Cassara, Antonino M.; Pfeiffer, Harald] PTB, Med Metrol Dept, Berlin, Germany; [Wetterling, Friedrich] Trinity Coll Dublin, Inst Neurosci, Dublin, Ireland; [Dieringer, Matthias A.] Siemens Healthcare GmbH, Berlin, Germany; [Cassara, Antonino M.] ITIS Fdn Res Informat Technol Soc, Zurich, Switzerland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; German Centre for Cardiovascular Research; Physikalisch-Technische Bundesanstalt (PTB); Physikalisch-Technische Bundesanstalt (PTB); Trinity College Dublin; Siemens AG	Niendorf, T (corresponding author), Helmholtz Assoc, Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany.; Niendorf, T (corresponding author), ECRC, Berlin, Germany.; Niendorf, T (corresponding author), MRI TOOLS GmbH, Berlin, Germany.	Thoralf.Niendorf@mdc-berlin.de	Cassara, Antonino Mario/AAG-8649-2020	Cassara, Antonino Mario/0000-0003-3375-7440; Winter, Lukas/0000-0002-4381-275X; Kuehne, Andre/0000-0002-4133-5056	DZHK (German Centre for Cardiovascular Research) [BER 601]; EUROSTARS program (heaRT_4_EU) [E!9340]; BMBF (Federal Ministry of Education and Research, Germany) [FKZ 01QE1501B]; Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association [1210251]	DZHK (German Centre for Cardiovascular Research); EUROSTARS program (heaRT_4_EU); BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association	This work was supported (in part, C.O.) by the DZHK (German Centre for Cardiovascular Research, BER 601) and by the BMBF (Federal Ministry of Education and Research, Germany). This work was funded (in part, A. K.) by the EUROSTARS program (heaRT_4_EU, E!9340) and the BMBF (Federal Ministry of Education and Research, Germany, FKZ 01QE1501B). This work was funded (in part, T.N.) by the Helmholtz Alliance ICEMED-Imaging and Curing Environmental Metabolic Diseases, through the Initiative and Network Fund of the Helmholtz Association (ICEMED-Project 1210251). The funders provided support in the form of salaries (in part, C.O., J. R., A.K.), but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Andre Kuehne and Jan Rieger are employees of MRI. TOOLS GmbH, Berlin, Germany. Thoralf Niendorf is founder and CEO of MRI. TOOLS GmbH, Berlin. Germany. The funder provided support in the form of salaries for authors A. K. and J. R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2013, DECL HELS ETH PRINC; [Anonymous], 2008, C953 IEEE; Becker M, 2010, EUR RADIOL, V20, P1344, DOI 10.1007/s00330-009-1676-z; Carinci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057982; Childs AS, 2013, MAGN RESON MATER PHY, V26, P401, DOI 10.1007/s10334-012-0360-5; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Deniz CM, 2016, MAGN RESON MED, V75, P423, DOI 10.1002/mrm.25646; Dieringer MA, 2011, J MAGN RESON IMAGING, V33, P736, DOI 10.1002/jmri.22451; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Eichfelder G, 2011, MAGN RESON MED, V66, P1468, DOI 10.1002/mrm.22927; Eryaman Y, 2011, MAGN RESON MED, V65, P1305, DOI 10.1002/mrm.22724; Etezadi-Amoli M, 2015, MAGN RESON MED, V74, P1790, DOI 10.1002/mrm.25543; Frauenrath T, 2012, P ISMRM, P2803; Frauenrath T, 2008, ACTA ACUST UNITED AC, V94, P148, DOI 10.3813/AAA.918017; Frauenrath T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-67; Frauenrath T, 2009, INVEST RADIOL, V44, P539, DOI 10.1097/RLI.0b013e3181b4c15e; Graessl A, 2014, MAGN RESON MED, V72, P276, DOI 10.1002/mrm.24903; Graesslin I, 2012, MAGN RESON MED, V68, P1664, DOI 10.1002/mrm.24138; Guerin B, 2015, MAGN RESON MED, V73, P1137, DOI 10.1002/mrm.25243; International Electrotechnical Commission (IEC), 2015, MED EL EQ 2; Katscher U, 2003, MAGNET RESON MED, V49, P144, DOI 10.1002/mrm.10353; Kramer CM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-91; Kramer CM, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-35; Kraus O, 2014, P ISMRM, P0947; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Krishnamurthy N, 2014, J MAGN RESON IMAGING, V39, P475, DOI 10.1002/jmri.24152; Krishnamurthy R, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-68; Kumar A, 2009, MAGN RESON MED, V61, P1201, DOI 10.1002/mrm.21948; Lattanzi R, 2009, MAGN RESON MED, V61, P315, DOI 10.1002/mrm.21782; Meltzer AJ, 2013, SURGERY, V153, P683, DOI 10.1016/j.surg.2012.11.005; Mueller A, 2012, RADIOLOGY, V263, P77, DOI 10.1148/radiol.11110347; Niendorf T, 2013, J MAGN RESON, V229, P208, DOI 10.1016/j.jmr.2012.11.015; Oezerdem C, 2016, MAGN RESON MED, V75, P2553, DOI 10.1002/mrm.25840; Park DJ, 2013, PHYS MED BIOL, V58, P5673, DOI 10.1088/0031-9155/58/16/5673; Rajiah P, 2014, RADIOGRAPHICS, V34, P1612, DOI 10.1148/rg.346140048; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Saekho S, 2006, MAGN RESON MED, V55, P719, DOI 10.1002/mrm.20840; Schar M, 2004, MAGN RESON MED, V51, P799, DOI 10.1002/mrm.20024; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Snyder CJ, 2009, MAGN RESON MED, V61, P517, DOI 10.1002/mrm.21895; Spence DK, 2007, CONCEPT MAGN RESON B, V31B, P86, DOI 10.1002/cmr.b.20088; Thalhammer C, 2012, J MAGN RESON IMAGING, V36, P847, DOI 10.1002/jmri.23724; Ullmann P, 2005, MAGNET RESON MED, V54, P994, DOI 10.1002/mrm.20646; Vernickel P, 2007, MAGN RESON MED, V58, P381, DOI 10.1002/mrm.21294; Wang J., 1996, P ISMRM, V14, P1434, DOI [10.1002/jmri.24152, DOI 10.1002/JMRI.24152]; Wang ZW, 2007, J MAGN RESON IMAGING, V26, P437, DOI 10.1002/jmri.20977; Weinberger O, 2016, P ISMRM, P2324; Winter L, 2015, MAGN RESON MED, V74, P999, DOI 10.1002/mrm.25483; Winter L, 2012, EUR RADIOL, V22, P2211, DOI 10.1007/s00330-012-2487-1; Wu XP, 2015, NMR BIOMED, V28, P1332, DOI 10.1002/nbm.3378; Yeo DTB, 2011, J MAGN RESON IMAGING, V33, P1209, DOI 10.1002/jmri.22544; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011; Zilberti L, 2015, MAGN RESON MED, V74, P272, DOI 10.1002/mrm.25687	53	17	17	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161863	10.1371/journal.pone.0161863	http://dx.doi.org/10.1371/journal.pone.0161863			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598923	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000383254800023
J	Xin, C; Johnstone, M; Wang, NL; Wang, RKK				Xin, Chen; Johnstone, Murray; Wang, Ningli; Wang, Ruikang K.			OCT Study of Mechanical Properties Associated with Trabecular Meshwork and Collector Channel Motion in Human Eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; AQUEOUS OUTFLOW SYSTEM; OPEN-ANGLE GLAUCOMA; PRESSURE-DEPENDENT CHANGES; INTRAOCULAR-PRESSURE; SUBSTRATUM STIFFNESS; LATRUNCULIN B; GRADED-LEVELS; MECHANOTRANSDUCERS YAP; EXTRACELLULAR-MATRIX	We report the use of a high-resolution optical coherence tomography (OCT) imaging platform to identify and quantify pressure-dependent aqueous outflow system (AOS) tissue relationships and to infer mechanical stiffness through examination of tissue properties in ex vivo human eyes. Five enucleated human eyes are included in this study, with each eye prepared with four equal-sized quadrants, each encompassing 90 degrees of the limbal circumference. In radial limbal segments perfusion pressure within Schlemm's canal (SC) is controlled by means of a perfusion cannula inserted into the canal lumen, while the other end of the cannula leads to a reservoir at a height that can control the pressure in the cannula. The OCT system images the sample with a spatial resolution of about 5 mu m from the trabecular meshwork (TM) surface. Geometric parameters are quantified from the 2D OCT images acquired from the sample subjected to controlled changes in perfusion pressures; parameters include area and height of the lumen of SC, collector channel entrances (CCE) and intrascleral collector channels (ISCC). We show that 3D OCT imaging permits the identification of 3-D relationships of the SC, CCE and ISCC lumen dimensions. Collagen flaps or leaflets are found at CCE that are attached or hinged at only one end, whilst the flaps are connected to the TM by cylindrical structures spanning SC. Increasing static SC pressures resulted in SC lumen enlargement with corresponding enlargement of the CCE and ISCC lumen. Pressure-dependent SC lumen area and height changes are significant at the 0.01 levels for ANOVA, and at the 0.05 for both polynomial curves and Tukey paired comparisons. Dynamic measurements demonstrate a synchronous increase in SC, CCE and ISCC lumen height in response to pressure changes from 0 to 10, 30 or 50 mm Hg, respectively, and the response time is within the 50-millisecond range. From the measured SC volume and corresponding IOP values, we demonstrate that an elastance curve can be developed to infer the mechanical stiffness of the TM by means of quantifying pressure-dependent SC volume changes over a 2 mm radial region of SC. Our study finds pressure-dependent motion of the TM that corresponds to collagen leaflet configuration motion at CCE; the synchronous tissue motion also corresponds with synchrony of SC and CCE lumen dimension changes.	[Xin, Chen; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Johnstone, Murray; Wang, Ruikang K.] Univ Washington, Dept Ophthalmol, Seattle, WA 98104 USA; [Xin, Chen; Wang, Ningli] Capital Med Univ, Beijing TongRen Hosp, Beijing TongRen Eye Ctr, Beijing 100730, Peoples R China; [Xin, Chen] Capital Med Univ, Beijing AnZhen Hosp, Dept Ophthalmol, Beijing 100029, Peoples R China	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Capital Medical University; Capital Medical University	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Wang, RKK (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98104 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019; Johnstone, Murray/ABG-3511-2020	Wang, Ruikang/0000-0001-5169-8822; Johnstone, Murray/0000-0003-2136-2433	National Eye Institute [R01EY024158-01]; W.H. Coulter Foundation Translational Research Partnership Program; NATIONAL EYE INSTITUTE [R01EY024158] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); W.H. Coulter Foundation Translational Research Partnership Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Eye Institute (R01EY024158-01), W.H. Coulter Foundation Translational Research Partnership Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1988, INVEST OPHTH VIS SCI, V29, P90; Ascher KW, 1961, AMERICAN LECTURE SER; Ascher KW, 1942, AM J OPHTHALMOL, V25, P31; Asher K.W., 1942, AM J OPHTHALMOL, V25, P1301; ASHTON N, 1952, BRIT J OPHTHALMOL, V36, P265, DOI 10.1136/bjo.36.5.265; Bentley MD, 2016, INVEST OPHTH VIS SCI, V57, P1153, DOI 10.1167/iovs.15-17753; Bradley JMB, 2003, INVEST OPHTH VIS SCI, V44, P5174, DOI 10.1167/iovs.03-0213; Clark AF, 2012, INVEST OPHTH VIS SCI, V53, P2473, DOI 10.1167/iovs.12-9483g; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Dong R, BIOENG C 2004 P IEEE, P188; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; FRIBERG TR, 1985, JAMA-J AM MED ASSOC, V253, P1755, DOI 10.1001/jama.253.12.1755; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; Gelman S, 2008, ANESTHESIOLOGY, V108, P735, DOI 10.1097/ALN.0b013e3181672607; Gonzalez JM, 2014, CLIN EXP OPHTHALMOL, V42, P502, DOI 10.1111/ceo.12255; Gonzalez JM, 2013, INVEST OPHTH VIS SCI, V54, P1039, DOI 10.1167/iovs.12-10479; GRIERSON I, 1975, EXP EYE RES, V20, P523, DOI 10.1016/0014-4835(75)90219-5; GRIERSON I, 1974, EXP EYE RES, V19, P21, DOI 10.1016/0014-4835(74)90068-2; GRIERSON I, 1975, EXP EYE RES, V20, P505, DOI 10.1016/0014-4835(75)90218-3; GRIERSON I, 1975, AM J OPHTHALMOL, V80, P863, DOI 10.1016/0002-9394(75)90284-6; Grieshaber MC, 2010, EYE, V24, P1220, DOI 10.1038/eye.2009.317; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Hann CR, 2014, INVEST OPHTH VIS SCI, V55, P5834, DOI 10.1167/iovs.14-14128; Hann CR, 2011, EXP EYE RES, V92, P104, DOI 10.1016/j.exer.2010.12.010; Hariri S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106013; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; JOHNSTONE M, 1980, INVEST OPHTH VIS SCI, V19, P835; Johnstone M, 2016, GLAUCOMA RES CLIN AD; JOHNSTONE MA, 1973, AM J OPHTHALMOL, V75, P365, DOI 10.1016/0002-9394(73)91145-8; JOHNSTONE MA, 1979, INVEST OPHTH VIS SCI, V18, P44; Johnstone MA, 1994, AM J OPHTHALMOL, V78, P630; Johnstone M, 2011, EXP EYE RES, V92, P318, DOI 10.1016/j.exer.2011.03.011; Johnstone M, 2010, GLAUCOMA BOOK: A PRACTICAL, EVIDENCE-BASED APPROACH TO PATIENT CARE, P65, DOI 10.1007/978-0-387-76700-0_7; Johnstone MA, 2014, J OCUL PHARMACOL TH, V30, P88, DOI 10.1089/jop.2013.0224; Jung SM, 2013, AM J PHYSIOL-HEART C, V305, pH803, DOI 10.1152/ajpheart.00103.2013; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Kagemann L, 2014, INVEST OPHTH VIS SCI, V55, P1805, DOI 10.1167/iovs.13-13264; Kagemann L, 2010, INVEST OPHTH VIS SCI, V51, P4054, DOI 10.1167/iovs.09-4559; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Li GR, 2014, INVEST OPHTH VIS SCI, V55, P3737, DOI 10.1167/iovs.13-13700; Li P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046013; Li P, 2013, BIOMED OPT EXPRESS, V4, P2051, DOI 10.1364/BOE.4.002051; Li P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016012; Li P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076026; Li P, 2011, BIOMED OPT EXPRESS, V2, P3109, DOI 10.1364/BOE.2.003109; Liton PB, 2005, BIOCHEM BIOPH RES CO, P337; Luna C, 2009, INVEST OPHTH VIS SCI, V50, P5805, DOI 10.1167/iovs.09-3796; Morgan JT, 2015, ONCOTARGET, V6, P15362, DOI 10.18632/oncotarget.3798; Morgan JT, 2015, EXP EYE RES, V132, P174, DOI 10.1016/j.exer.2015.01.025; PEDERSON JE, 1978, INVEST OPHTH VIS SCI, V17, P377; PHELPS CD, 1982, AM J OPHTHALMOL, V93, P423, DOI 10.1016/0002-9394(82)90132-5; PHELPS CD, 1978, OPHTHALMOLOGY, V85, P276; Quick CM, 2008, AM J PHYSIOL-HEART C, V294, pH2144, DOI 10.1152/ajpheart.00781.2007; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raghunathan VK, 2015, INVEST OPHTH VIS SCI, V56, P4447, DOI 10.1167/iovs.15-16739; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V176, P309, DOI 10.1007/BF00421587; ROHEN JW, 1993, EXP EYE RES, V56, P683, DOI 10.1006/exer.1993.1085; Santhanam L, 2010, CIRC RES, V107, P117, DOI 10.1161/CIRCRESAHA.109.215228; SCHIRMER KE, 1971, ARCH OPHTHALMOL-CHIC, V85, P263, DOI 10.1001/archopht.1971.00990050265001; SCHIRMER KE, 1969, CAN J OPHTHALMOLOGY, V4, P40; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Shi GH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016016; Song SZ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121505; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Sun YC, 2015, QUANT IMAGING MED SU, V5, P171, DOI 10.3978/j.issn.2223-4292.2014.11.15; Susanna R, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.1; SUSON EB, 1969, ARCH OPHTHALMOL-CHIC, V81, P808, DOI 10.1001/archopht.1969.00990010810010; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Thomasy SM, 2012, INVEST OPHTH VIS SCI, V53, P952, DOI 10.1167/iovs.11-8526; Tovar-Vidales T, 2008, INVEST OPHTH VIS SCI, V49, P622, DOI 10.1167/iovs.07-0835; Tumminia SJ, 1998, INVEST OPHTH VIS SCI, V39, P1361; VANBUSKIRK EM, 1982, INVEST OPHTH VIS SCI, V22, P625; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Wang F, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116008; WEINREB RN, 1984, AM J OPHTHALMOL, V98, P784, DOI 10.1016/0002-9394(84)90698-6; Wood JA, 2011, INVEST OPHTH VIS SCI, V52, P9298, DOI 10.1167/iovs.11-7857; Xue W, 2007, INVEST OPHTH VIS SCI, V48, P3184, DOI 10.1167/iovs.06-1403; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zhong L, 2006, P I MECH ENG H, V220, P647, DOI 10.1243/09544119JEIM123	85	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162048	10.1371/journal.pone.0162048	http://dx.doi.org/10.1371/journal.pone.0162048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598990	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800034
J	Akimova, A; Nunez-Riboni, I; Kempf, A; Taylor, MH				Akimova, Anna; Nunez-Riboni, Ismael; Kempf, Alexander; Taylor, Marc H.			Spatially-Resolved Influence of Temperature and Salinity on Stock and Recruitment Variability of Commercially Important Fishes in the North Sea	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; COD GADUS-MORHUA; PLAICE PLEURONECTES-PLATESSA; SPRAT SPRATTUS-SPRATTUS; LONG-TERM TRENDS; ATLANTIC COD; SPAWNING STOCK; CLASS STRENGTH; REGIME SHIFTS; POPULATION-STRUCTURE	Understanding of the processes affecting recruitment of commercially important fish species is one of the major challenges in fisheries science. Towards this aim, we investigated the relation between North Sea hydrography (temperature and salinity) and fish stock variables (recruitment, spawning stock biomass and pre-recruitment survival index) for 9 commercially important fishes using spatially-resolved cross-correlation analysis. We used high-resolution (0.2 degrees x 0.2 degrees) hydrographic data fields matching the maximal temporal extent of the fish population assessments (1948-2013). Our approach allowed for the identification of regions in the North Sea where environmental variables seem to be more influential on the fish stocks, as well as the regions of a lesser or nil influence. Our results confirmed previously demonstrated negative correlations between temperature and recruitment of cod and plaice and identified regions of the strongest correlations (German Bight for plaice and north-western North Sea for cod). We also revealed a positive correlation between herring spawning stock biomass and temperature in the Orkney-Shetland area, as well as a negative correlation between sole pre-recruitment survival index and temperature in the German Bight. A strong positive correlation between sprat stock variables and salinity in the central North Sea was also found. To our knowledge the results concerning correlations between North Sea hydrography and stocks' dynamics of herring, sole and sprat are novel. The new information about spatial distribution of the correlation provides an additional help to identify mechanisms underlying these correlations. As an illustration of the utility of these results for fishery management, an example is provided that incorporates the identified environmental covariates in stock-recruitment models.	[Akimova, Anna; Nunez-Riboni, Ismael; Kempf, Alexander; Taylor, Marc H.] Thunen Inst Sea Fisheries, Hamburg, Germany	Johann Heinrich von Thunen Institute	Akimova, A (corresponding author), Thunen Inst Sea Fisheries, Hamburg, Germany.	anna.akimova@thuenen.de	Nunez-Riboni, Ismael/HGB-9167-2022; Taylor, Marc/AAI-6598-2021	Taylor, Marc/0000-0001-9730-6994; Akimova, Anna/0000-0003-4161-4140				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Algen A, 1980, DISTRIBUTION ABUNDAN, V1980; Alheit J, 2014, J MARINE SYST, V131, P21, DOI 10.1016/j.jmarsys.2013.11.002; Aschan M, 2009, DEEP-SEA RES PT II, V56, P2012, DOI 10.1016/j.dsr2.2008.11.012; Bannister R.C.A., 1974, EARLY LIFE HIST FISH, P21; Baumann H, 2009, J SEA RES, V61, P234, DOI 10.1016/j.seares.2009.01.004; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Becker G.A., 1997, DTSCH HYDROGR Z, V49, P135; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Brander KM, 2005, ICES J MAR SCI, V62, P339, DOI 10.1016/j.icesjms.2004.07.029; Brunel T, 2007, FISH OCEANOGR, V16, P336, DOI 10.1111/j.1365-2419.2007.00435.x; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cook RM, 2005, ICES J MAR SCI, V62, P1322, DOI 10.1016/j.icesjms.2005.04.023; CORTEN A, 1992, ICES MAR SC, V195, P402; CORTEN A, 1990, NETH J SEA RES, V25, P227, DOI 10.1016/0077-7579(90)90024-B; Corten A, 2003, PROG OCEANOGR, V58, P285, DOI 10.1016/j.pocean.2003.08.008; Corten A, 1999, J SEA RES, V42, P191, DOI 10.1016/S1385-1101(99)00030-1; Corten A, 2013, ICES J MAR SCI, V70, P1, DOI 10.1093/icesjms/fss187; Curry RG, 2001, J PHYS OCEANOGR, V31, P3374, DOI 10.1175/1520-0485(2001)031<3374:OGCCAW>2.0.CO;2; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cushing D.H., 1982, CLIMATE FISHERIES; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Daewel U, 2011, CAN J FISH AQUAT SCI, V68, P426, DOI 10.1139/F10-164; DESILVA SS, 1973, MAR BIOL, V20, P282, DOI 10.1007/BF00354272; Dethlefsen V, 1996, ICES J MAR SCI, V53, P1024, DOI 10.1006/jmsc.1996.0128; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Dickson R. R., 1971, DTSCH HYDROGR Z, V24, P97; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Emery W. J., 2004, DATA ANAL METHODS PH, V2nd; Engelhard GH, 2014, ICES J MAR SCI, V71, P90, DOI 10.1093/icesjms/fst087; Fonds M., 1995, EFFECT WINTER TEMPER; Fox CJ, 2000, J SEA RES, V44, P159, DOI 10.1016/S1385-1101(00)00039-3; Gladics AJ, 2015, J MARINE SYST, V146, P72, DOI 10.1016/j.jmarsys.2014.06.015; Glantz M. H., 1992, CLIMATE VARIABILITY; Groger JP, 2010, ICES J MAR SCI, V67, P454, DOI 10.1093/icesjms/fsp259; Gulev SK, 2013, NATURE, V499, P464, DOI 10.1038/nature12268; Hart P.J., 2002, HDB FISH BIOL FISHER; HAWG, 2015, REP HERR ASS WORK GR; Heath M, 1997, J SEA RES, V38, P413, DOI 10.1016/S1385-1101(97)00045-2; Heath MR, 2008, FISH RES, V93, P92, DOI 10.1016/j.fishres.2008.02.014; Heath MR, 2005, ICES J MAR SCI, V62, P847, DOI 10.1016/j.icesjms.2005.01.023; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; Heyen H, 1998, TELLUS A, V50, P545, DOI 10.1034/j.1600-0870.1998.00012.x; Hirata FE, 2013, GEOPHYS RES LETT, V40, P3337, DOI 10.1002/grl.50632; Hjermann DO, 2013, MAR ECOL PROG SER, V480, P263, DOI 10.3354/meps10315; Hjollo SS, 2009, J MARINE SYST, V78, P180, DOI 10.1016/j.jmarsys.2009.06.001; Houde E.D., 1987, American Fisheries Society Symposium, P17; Hufnagl M, 2015, PROG OCEANOGR, V138, P486, DOI 10.1016/j.pocean.2014.04.029; Hufnagl M, 2013, J SEA RES, V84, P26, DOI 10.1016/j.seares.2012.10.007; ICES, 1990, SPRAT BIOL WORKSH CO; ICES, 2014, 2013ACOM48 ICES CM; ICES, 2015, STOCK ASS; ILES TC, 1994, NETH J SEA RES, V32, P399, DOI 10.1016/0077-7579(94)90017-5; Iles TC, 1998, J SEA RES, V39, P41, DOI 10.1016/S1385-1101(97)00022-1; Kempf A, 2013, FISH OCEANOGR, V22, P174, DOI 10.1111/fog.12013; Kempf A, 2009, CAN J FISH AQUAT SCI, V66, P633, DOI 10.1139/F09-022; Kirtman B., 2013, CLIMATE CHANGE 2013, P953; Lacroix G, 2013, J SEA RES, V84, P13, DOI 10.1016/j.seares.2012.07.010; LAST JM, 1987, J CONSEIL, V44, P73; Lee A.J., 1980, ELSEVIER OCEANOG SER, V24, P467, DOI DOI 10.1016/S0422-9894(08)71359-X; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Levi D, 2003, SCI MAR, V67, P259, DOI 10.3989/scimar.2003.67s1259; LIVEZEY RE, 1983, MON WEATHER REV, V111, P46, DOI 10.1175/1520-0493(1983)111<0046:SFSAID>2.0.CO;2; Locarnini R. A., 2010, NOAA ATLAS NESDIS, V68, P1; MARAVELIAS CD, 1995, SCI MAR, V59, P427; Maravelias CD, 1997, MAR ECOL PROG SER, V159, P151, DOI 10.3354/meps159151; Margonski P, 2010, PROG OCEANOGR, V87, P277, DOI 10.1016/j.pocean.2010.08.003; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; Matei D, 2012, SCIENCE, V335, P76, DOI 10.1126/science.1210299; Meyer EMI, 2011, J MARINE SYST, V86, P35, DOI 10.1016/j.jmarsys.2011.02.001; Montero-Serra I, 2015, GLOBAL CHANGE BIOL, V21, P144, DOI 10.1111/gcb.12747; MUNK P, 1993, MAR ECOL PROG SER, V99, P17, DOI 10.3354/meps099017; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Nash RDM, 2005, FISH OCEANOGR, V14, P279, DOI 10.1111/j.1365-2419.2005.00336.x; Nash RDM, 2012, J MARINE SYST, V93, P58, DOI 10.1016/j.jmarsys.2011.09.009; Neat FC, 2014, J APPL ECOL, V51, P1564, DOI 10.1111/1365-2664.12343; Nicolas D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088447; Nielsen EE, 2009, MAR ECOL PROG SER, V376, P213, DOI 10.3354/meps07798; Nissling A, 2014, HYDROBIOLOGIA, V514; Nunez I, 2016, AHOI V18 11 FIGSHARE; Nunez-Riboni I, 2015, J MARINE SYST, V151, P15, DOI 10.1016/j.jmarsys.2015.06.003; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Ojaveer E, 2010, REV FISH BIOL FISHER, V20, P203, DOI 10.1007/s11160-009-9130-5; Olsen EM, 2011, P ROY SOC B-BIOL SCI, V278, P504, DOI 10.1098/rspb.2010.1465; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; Ottersen G, 2013, MAR ECOL PROG SER, V480, P205, DOI 10.3354/meps10249; Payne MR, 2010, ICES J MAR SCI, V67, P1939, DOI 10.1093/icesjms/fsq036; Payne MR, 2009, ICES J MAR SCI, V66, P272, DOI 10.1093/icesjms/fsn211; Peck MA, 2012, J MARINE SYST, V93, P77, DOI 10.1016/j.jmarsys.2011.08.005; Pecuchet L, 2014, ICEJ MARINE SCI J, V72, P1323; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Phillips ID, 2002, INT J CLIMATOL, V22, P197, DOI 10.1002/joc.726; Planque B, 2003, SCI MAR, V67, P211, DOI 10.3989/scimar.2003.67s1211; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Poulsen NA, 2011, MAR ECOL PROG SER, V436, P231, DOI 10.3354/meps09246; Punt AE, 2014, ICES J MAR SCI, V71, P2208, DOI 10.1093/icesjms/fst057; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Raab K, 2012, MAR ECOL PROG SER, V470, P101, DOI 10.3354/meps09919; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Righton D, 2007, J MAR BIOL ASSOC UK, V87, P599, DOI 10.1017/S0025315407054641; Rijnsdorp AD, 1996, ICES J MAR SCI, V53, P1199, DOI 10.1006/jmsc.1996.0145; RIJNSDORP AD, 1992, NETH J SEA RES, V29, P173, DOI 10.1016/0077-7579(92)90018-A; Rijnsdorp AD, 1995, NETH J SEA RES, V34, P237, DOI 10.1016/0077-7579(95)90031-4; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rogers S., 2001, N SEA FISH FISHERIES; Schott F, 1966, ERGANZUNGSHEFT DTSCH, P58; Segers FHID, 2007, ICES J MAR SCI, V64, P60, DOI 10.1093/icesjms/fsl002; Shepherd J.G., 1984, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V185, P255; Skern-Mauritzen M, 2016, FISH FISH, V17, P165, DOI 10.1111/faf.12111; Sparrevohn CR, 2013, FISH OCEANOGR, V22, P400, DOI 10.1111/fog.12030; Speirs DC, 2010, FISH RES, V106, P474, DOI 10.1016/j.fishres.2010.09.023; Stenseth N., 2004, MARINE ECOSYSTEMS CL; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Subbey S, 2014, ICES J MAR SCI, V71, P2307, DOI 10.1093/icesjms/fsu148; Teal LR, 2008, MAR ECOL PROG SER, V358, P219, DOI 10.3354/meps07367; Tortonese E., 1986, FISHES NE ATLANTIC M, V2; Turrell WR, 1996, ICES J MAR SCI, V53, P899, DOI 10.1006/jmsc.1996.0112; van der Veer HW, 1999, MAR ECOL PROG SER, V184, P245, DOI 10.3354/meps184245; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANDERLAND MA, 1991, NETH J SEA RES, V27, P277, DOI 10.1016/0077-7579(91)90030-5; VANDERVEER HW, 1990, MAR ECOL PROG SER, V64, P1, DOI 10.3354/meps064001; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; Voss R, 2011, ICES J MAR SCI, V68, P1379, DOI 10.1093/icesjms/fsr061; WALTERS CJ, 1988, CAN J FISH AQUAT SCI, V45, P1848, DOI 10.1139/f88-217; WGMIXFISH, 2015, 2015ACOM21 WGMIXFISH; WGNSSK, 2015, 2015ACOM13 WGNSSK IC; WKNSEA, 2015, BENCHM WORKSH N SEA; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008; Wu BY, 2015, J CLIMATE, V28, P6841, DOI 10.1175/JCLI-D-14-00274.1	134	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161917	10.1371/journal.pone.0161917	http://dx.doi.org/10.1371/journal.pone.0161917			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584155	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600073
J	Chung, S; Shah, B; Storey, P; Iqbal, S; Slater, J; Axel, L				Chung, Sohae; Shah, Binita; Storey, Pippa; Iqbal, Sohah; Slater, James; Axel, Leon			Quantitative Perfusion Analysis of First-Pass Contrast Enhancement Kinetics: Application to MRI of Myocardial Perfusion in Coronary Artery Disease	PLOS ONE			English	Article							TISSUE HOMOGENEITY MODEL; BLOOD-FLOW; ADIABATIC APPROXIMATION; COMPUTED-TOMOGRAPHY; WATER EXCHANGE; GD-DTPA; QUANTIFICATION; DECONVOLUTION; RESOLUTION; VOLUMES	Purpose Perfusion analysis from first-pass contrast enhancement kinetics requires modeling tissue contrast exchange. This study presents a new approach for numerical implementation of the tissue homogeneity model, incorporating flexible distance steps along the capillary (NTHf). Methods The proposed NTHf model considers contrast exchange in fluid packets flowing along the capillary, incorporating flexible distance steps, thus allowing more efficient and stable calculations of the transit of tracer through the tissue. We prospectively studied 8 patients (62 +/- 13 years old) with suspected CAD, who underwent first-pass perfusion CMR imaging at rest and stress prior to angiography. Myocardial blood flow (MBF) and myocardial perfusion reserve index (MPRI) were estimated using both the NTHf and the conventional adiabatic approximation of the TH models. Coronary artery lesions detected at angiography were clinically assigned to one of three categories of stenosis severity ('insignificant', 'mild to moderate' and 'severe') and related to corresponding myocardial territories. Results The mean MBF (ml/g/min) at rest/stress and MPRI were 0.80 +/- 0.33/1.25 +/- 0.45 and 1.68 +/- 0.54 in the insignificant regions, 0.74 +/- 0.21/1.09 +/- 0.28 and 1.54 +/- 0.46 in the mild to moderate regions, and 0.79 +/- 0.28/0.63 +/- 0.34 and 0.85 +/- 0.48 in the severe regions, respectively. The correlation coefficients of MBFs at rest/stress and MPRI between the NTHf and AATH models were r = 0.97/0.93 and r = 0.91, respectively. Conclusions The proposed NTHf model allows efficient quantitative analysis of the transit of tracer through tissue, particularly at higher flow. Results of initial application to MRI of myocardial perfusion in CAD are encouraging.	[Chung, Sohae; Storey, Pippa; Axel, Leon] NYU, Sch Med, CAI2R, New York, NY 10016 USA; [Chung, Sohae; Storey, Pippa; Axel, Leon] NYU, Sch Med, Dept Radiol, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY 10016 USA; [Shah, Binita; Iqbal, Sohah; Slater, James] NYU, Sch Med, Dept Med, Div Cardiol, New York, NY 10016 USA	New York University; New York University; New York University	Chung, S (corresponding author), NYU, Sch Med, CAI2R, New York, NY 10016 USA.; Chung, S (corresponding author), NYU, Sch Med, Dept Radiol, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY 10016 USA.	sohae.chung@nyumc.org	Chung, Sohae/S-9249-2019	Slater, James/0000-0003-3888-0317; Storey, Pippa/0000-0003-1915-7860; Chung, Sohae/0000-0002-1132-900X; Shah, Binita/0000-0001-8872-8001; Axel, Leon/0000-0003-0608-4690	NIH [R01 HL083309]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000053, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001074] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by NIH Grant R01 HL083309.	AXEL L, 1983, INVEST RADIOL, V18, P94, DOI 10.1097/00004424-198301000-00018; AXEL L, 1980, RADIOLOGY, V137, P679, DOI 10.1148/radiology.137.3.7003648; BASSINGT.JB, 1966, CIRC RES, V18, P398, DOI 10.1161/01.RES.18.4.398; Bhave NM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-89; Breton E, 2011, J MAGN RESON IMAGING, V34, P676, DOI 10.1002/jmri.22647; Cernicanu A, 2006, ACAD RADIOL, V13, P686, DOI 10.1016/j.acra.2006.02.040; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; CZERNIN J, 1993, CIRCULATION, V88, P62, DOI 10.1161/01.CIR.88.1.62; DIESBOURG LD, 1992, MAGNET RESON MED, V23, P239, DOI 10.1002/mrm.1910230205; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; GONZALEZ F, 1990, AM J PHYSIOL, V258, pH1012, DOI 10.1152/ajpheart.1990.258.4.H1012; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAASE A, 1990, MAGN RESON MED, V13, P77, DOI 10.1002/mrm.1910130109; Jerosch-Herold M, 1998, MED PHYS, V25, P73, DOI 10.1118/1.598163; JOHNSON JA, 1966, AM J PHYSIOL, V210, P1299, DOI 10.1152/ajplegacy.1966.210.6.1299; Kershaw LE, 2010, MAGN RESON MED, V64, P1772, DOI 10.1002/mrm.22573; Larsson HBW, 1996, MAGN RESON MED, V35, P716, DOI 10.1002/mrm.1910350513; MANNING WJ, 1991, J AM COLL CARDIOL, V18, P959, DOI 10.1016/0735-1097(91)90754-W; Nagel E, 2003, CIRCULATION, V108, P432, DOI 10.1161/01.CIR.0000080915.35024.A9; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Pack NA, 2010, MAGN RESON MED, V64, P125, DOI 10.1002/mrm.22282; St Lawrence KS, 1998, J CEREBR BLOOD F MET, V18, P1365, DOI 10.1097/00004647-199812000-00011; St Lawrence KS, 1998, J CEREBR BLOOD F MET, V18, P1378; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162067	10.1371/journal.pone.0162067	http://dx.doi.org/10.1371/journal.pone.0162067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583385	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600095
J	Stillman, CM; Watt, JC; Grove, GA; Wollam, ME; Uyar, F; Mataro, M; Cohen, NJ; Howard, DV; Howard, JH; Erickson, KI				Stillman, Chelsea M.; Watt, Jennifer C.; Grove, George A., Jr.; Wollam, Mariegold E.; Uyar, Fatma; Mataro, Maria; Cohen, Neal J.; Howard, Darlene V.; Howard, James H., Jr.; Erickson, Kirk I.			Physical Activity Is Associated with Reduced Implicit Learning but Enhanced Relational Memory and Executive Functioning in Young Adults	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MILD COGNITIVE IMPAIRMENT; AEROBIC EXERCISE; DRUG-ADDICTION; OLDER-ADULTS; AGE-DIFFERENCES; FITNESS; BRAIN; MOTOR; NEUROGENESIS	Accumulating evidence suggests that physical activity improves explicit memory and executive cognitive functioning at the extreme ends of the lifespan (i.e., in older adults and children). However, it is unknown whether these associations hold for younger adults who are considered to be in their cognitive prime, or for implicit cognitive functions that do not depend on motor sequencing. Here we report the results of a study in which we examine the relationship between objectively measured physical activity and (1) explicit relational memory, (2) executive control, and (3) implicit probabilistic sequence learning in a sample of healthy, college-aged adults. The main finding was that physical activity was positively associated with explicit relational memory and executive control (replicating previous research), but negatively associated with implicit learning, particularly in females. These results raise the intriguing possibility that physical activity upregulates some cognitive processes, but downregulates others. Possible implications of this pattern of results for physical health and health habits are discussed.	[Stillman, Chelsea M.; Erickson, Kirk I.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Watt, Jennifer C.; Grove, George A., Jr.; Wollam, Mariegold E.; Uyar, Fatma; Erickson, Kirk I.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Mataro, Maria] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Cohen, Neal J.] Univ Illinois, Beckman Inst, Urbana, IL USA; [Howard, Darlene V.] Georgetown Univ, Dept Psychol, Washington, DC 20057 USA; [Howard, James H., Jr.] Catholic Univ Amer, Dept Psychol, Washington, DC 20064 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Barcelona; University of Illinois System; University of Illinois Urbana-Champaign; Georgetown University; Catholic University of America	Stillman, CM (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.	cms289@pitt.edu	Mataro, Maria/B-4524-2011; Stillman, Chelsea/ABF-2587-2020	Mataro, Maria/0000-0002-9946-2656; Stillman, Chelsea/0000-0003-2672-7374	National Institute of Diabetes and Digestive and Kidney Diseases [RO1DK095172]; National Institute of Mental Health [T32 MH109986]; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funding from National Institute of Diabetes and Digestive and Kidney Diseases (http://www.niddk.nih.gov/Pages/default.aspx) grant number RO1DK095172 to KIE. CMS was supported by National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml) grant T32 MH109986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bennett Ilana J, 2011, Neurobiol Aging, V32, DOI 10.1016/j.neurobiolaging.2010.03.017; Berchtold NC, 2001, EUR J NEUROSCI, V14, P1992, DOI 10.1046/j.0953-816x.2001.01825.x; Bergstrom JCR, 2012, APPL COGNITIVE PSYCH, V26, P91, DOI 10.1002/acp.1800; Boyer M, 2005, PSYCHOL RES-PSYCH FO, V69, P383, DOI 10.1007/s00426-004-0207-4; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Drollette ES, 2016, DEVELOPMENTAL SCI, V19, P90, DOI 10.1111/desc.12291; Duchesne C, 2015, BRAIN COGNITION, V99, P68, DOI 10.1016/j.bandc.2015.07.005; DUSTMAN RE, 1984, NEUROBIOL AGING, V5, P35, DOI 10.1016/0197-4580(84)90083-6; Erickson KI, 2007, NEUROBIOL AGING, V28, P179, DOI 10.1016/j.neurobiolaging.2005.11.016; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Gamble KR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00563; Gheysen F, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00137; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Gujral S, 2014, PSYCHIAT RES, V218, P93, DOI 10.1016/j.psychres.2014.03.028; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Howard DV, 2001, PSYCHON B REV, V8, P798, DOI 10.3758/BF03196220; Howard JH, 2008, J EXP PSYCHOL LEARN, V34, P1139, DOI 10.1037/a0012797; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Janacsek K, 2012, INT J PSYCHOPHYSIOL, V83, P213, DOI 10.1016/j.ijpsycho.2011.11.012; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Korol DL, 2004, NEUROBIOL LEARN MEM, V82, P309, DOI 10.1016/j.nlm.2004.07.006; Korol DL, 2013, HIPPOCAMPUS, V23, P1125, DOI 10.1002/hipo.22197; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; LEWICKI P, 1987, J EXP PSYCHOL LEARN, V13, P523, DOI 10.1037/0278-7393.13.4.523; Lungu OV, 2004, EXP BRAIN RES, V159, P135, DOI 10.1007/s00221-004-1945-7; Lynch WJ, 2013, NEUROSCI BIOBEHAV R, V37, P1622, DOI 10.1016/j.neubiorev.2013.06.011; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mang CS, 2014, J APPL PHYSIOL, V117, P1325, DOI 10.1152/japplphysiol.00498.2014; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Monti JM, 2015, J COGNITIVE NEUROSCI, V27, P234, DOI 10.1162/jocn_a_00717; Monti JM, 2012, HIPPOCAMPUS, V22, P1876, DOI 10.1002/hipo.22023; Nemeth D, 2013, CEREB CORTEX, V23, P801, DOI 10.1093/cercor/bhs068; Niemann C, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00170; Poldrack RA, 2003, NEURON, V37, P891, DOI 10.1016/S0896-6273(03)00159-4; Rieckmann A, 2010, NEUROIMAGE, V50, P1303, DOI 10.1016/j.neuroimage.2010.01.015; Roig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044594; Rose M, 2002, NEURON, V36, P1221, DOI 10.1016/S0896-6273(02)01105-4; Schendan HE, 2013, BEHAV NEUROSCI, V127, P204, DOI 10.1037/a0032012; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Simon JR, 2012, J COGNITIVE NEUROSCI, V24, P451, DOI 10.1162/jocn_a_00116; Simon JR, 2011, J GERONTOL B-PSYCHOL, V66, P32, DOI 10.1093/geronb/gbq066; Simon JR, 2011, BEHAV BRAIN RES, V216, P452, DOI 10.1016/j.bbr.2010.08.043; Smith JC, 2013, J ALZHEIMERS DIS, V37, P197, DOI 10.3233/JAD-130467; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; SPIRDUSO WW, 1978, J GERONTOL, V33, P26, DOI 10.1093/geronj/33.1.26; Statton MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141393; Stillman CM, 2016, J GERONTOL B-PSYCHOL, V71, P212, DOI 10.1093/geronb/gbu135; Stillman CM, 2014, CONSCIOUS COGN, V28, P141, DOI 10.1016/j.concog.2014.07.002; Stillman CM, 2013, BRAIN CONNECT, V3, P601, DOI 10.1089/brain.2013.0169; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061483; ten Brinke LF, 2015, BRIT J SPORT MED, V49, P248, DOI 10.1136/bjsports-2013-093184; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Watson PD, 2013, HIPPOCAMPUS, V23, P570, DOI 10.1002/hipo.22115; Winker R, 2010, WIEN KLIN WOCHENSCHR, V122, P704, DOI 10.1007/s00508-010-1485-z; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4; Zhou YH, 2016, FRONT NEUROENDOCRIN, V40, P24, DOI 10.1016/j.yfrne.2015.07.001; Zhou YH, 2014, J SPORT HEALTH SCI, V3, P163, DOI 10.1016/j.jshs.2014.04.005	72	13	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162100	10.1371/journal.pone.0162100	http://dx.doi.org/10.1371/journal.pone.0162100			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584059	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600102
J	Riccadonna, C; Maroun, CY; de Silly, RV; Boehler, M; Tardon, MC; Jueliger, S; Taverna, P; Barba, L; Marinari, E; Pellegatta, S; Bassoy, EY; Martinvalet, D; Dietrich, PY; Walker, PR				Riccadonna, Cristina; Maroun, Celine Yacoub; de Silly, Romain Vuillefroy; Boehler, Margaux; Tardon, Marta Calvo; Jueliger, Simone; Taverna, Pietro; Barba, Leticia; Marinari, Eliana; Pellegatta, Serena; Bassoy, Esen Yonca; Martinvalet, Denis; Dietrich, Pierre-Yves; Walker, Paul R.			Decitabine Treatment of Glioma-Initiating Cells Enhances Immune Recognition and Killing	PLOS ONE			English	Article							HUMAN-LEUKOCYTE ANTIGEN; CANCER-TESTIS ANTIGENS; CLASS-I ANTIGENS; STEM-LIKE CELLS; CD8(+) T-CELLS; DNA METHYLATION; HUMAN GLIOBLASTOMA; IMMUNOTHERAPEUTIC IMPLICATIONS; MALIGNANT GLIOMAS; UP-REGULATION	Malignant gliomas are aggressive brain tumours with very poor prognosis. The majority of glioma cells are differentiated (glioma-differentiated cells: GDCs), whereas the smaller population (glioma-initiating cells, GICs) is undifferentiated and resistant to conventional therapies. Therefore, to better target this pool of heterogeneous cells, a combination of diverse therapeutic approaches is envisaged. Here we investigated whether the immunosensitising properties of the hypomethylating agent decitabine can be extended to GICs. Using the murine GL261 cell line, we demonstrate that decitabine augments the expression of the death receptor FAS both on GDCs and GICs. Interestingly, it had a higher impact on GICs and correlated with an enhanced sensitivity to FASL-mediated cell death. Moreover, the expression of other critical molecules involved in cognate recognition by cytotoxic T lymphocytes, MHCI and ICAM-1, was upregulated by decitabine treatment. Consequently, T-cell mediated killing of both GDCs and GICs was enhanced, as was T cell proliferation after reactivation. Overall, although GICs are described to resist classical therapies, our study shows that hypomethylating agents have the potential to enhance glioma cell recognition and subsequent destruction by immune cells, regardless of their differentiation status. These results support the development of combinatorial treatment modalities including epigenetic modulation together with immunotherapy in order to treat heterogenous malignancies such as glioblastoma.	[Riccadonna, Cristina; Maroun, Celine Yacoub; de Silly, Romain Vuillefroy; Boehler, Margaux; Tardon, Marta Calvo; Barba, Leticia; Marinari, Eliana; Dietrich, Pierre-Yves; Walker, Paul R.] Univ Hosp Geneva, Ctr Oncol, Geneva, Switzerland; [Riccadonna, Cristina; Maroun, Celine Yacoub; de Silly, Romain Vuillefroy; Boehler, Margaux; Tardon, Marta Calvo; Barba, Leticia; Marinari, Eliana; Dietrich, Pierre-Yves; Walker, Paul R.] Univ Geneva, Geneva, Switzerland; [Jueliger, Simone] Astex Pharmaceut, Cambridge Sci Pk, Cambridge, England; [Taverna, Pietro] Astex Pharmaceut, Pleasanton, CA USA; [Pellegatta, Serena] Fdn IRCCS Ist Neurol C Besta, Unit Mol Neurooncol, Milan, Italy; [Bassoy, Esen Yonca; Martinvalet, Denis] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	University of Geneva; University of Geneva; Astex Pharmaceuticals; IRCCS Istituto Neurologico Besta; University of Geneva	Walker, PR (corresponding author), Univ Hosp Geneva, Ctr Oncol, Geneva, Switzerland.; Walker, PR (corresponding author), Univ Geneva, Geneva, Switzerland.	Paul.Walker@hcuge.ch	Pellegatta, Serena/AAL-3693-2021; de Silly, Romain Vuillefroy/N-7978-2013	Pellegatta, Serena/0000-0001-7804-9486; de Silly, Romain Vuillefroy/0000-0001-6573-9752; Bassoy, Esen Yonca/0000-0001-8870-7040	Geneva Cancer League; Ernst and Lucie Schmidheiny Foundation	Geneva Cancer League; Ernst and Lucie Schmidheiny Foundation	This investigation was supported by a grant from the Geneva Cancer League (http://www.lgc.ch/) to PRW and by the Ernst and Lucie Schmidheiny Foundation (http://www.fondation-schmidheiny.ch/) to CR. SJ and PT are employees of Astex Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair SJ, 2009, CANCER IMMUNOL IMMUN, V58, P589, DOI 10.1007/s00262-008-0582-6; Alizadeh D, 2014, CANCER RES, V74, P2663, DOI 10.1158/0008-5472.CAN-14-0301; Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Auffinger B, 2015, EXPERT REV NEUROTHER, V15, P741, DOI 10.1586/14737175.2015.1051968; Avril T, 2012, BRAIN PATHOL, V22, P159, DOI 10.1111/j.1750-3639.2011.00515.x; Bao L, 2011, CANCER IMMUNOL IMMUN, V60, P1299, DOI 10.1007/s00262-011-1037-z; Bassoy EY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153433; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Cashen AF, 2008, CANCER CHEMOTH PHARM, V61, P759, DOI 10.1007/s00280-007-0531-7; CHABOT GG, 1983, CANCER RES, V43, P592; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chu SH, 2012, MOL MED REP, V5, P138, DOI 10.3892/mmr.2011.620; Coral S, 2002, CLIN CANCER RES, V8, P2690; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; de Silly RV, 2015, EUR J IMMUNOL, V45, P2263, DOI 10.1002/eji.201445284; Drachsler M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.102; Eisele G, 2013, ANTICANCER RES, V33, P3563; Eisele G, 2011, NEURO-ONCOLOGY, V13, P155, DOI 10.1093/neuonc/noq176; Eramo A, 2005, CANCER RES, V65, P11469, DOI 10.1158/0008-5472.CAN-05-1724; Everson RG, 2016, NEURO-ONCOLOGY, V18, P368, DOI 10.1093/neuonc/nov153; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; He JS, 2010, J IMMUNOL, V184, P555, DOI 10.4049/jimmunol.0902465; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Joo KM, 2012, CANCER RES, V72, P3828, DOI 10.1158/0008-5472.CAN-11-3760; Kataoka T, 1996, J IMMUNOL, V156, P3678; Kim TY, 2006, CANCER RES, V66, P7490, DOI 10.1158/0008-5472.CAN-05-4552; Konkankit VV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-192; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Licht JD, 2015, CELL, V162, P938, DOI 10.1016/j.cell.2015.08.005; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Masson F, 2007, J IMMUNOL, V179, P845, DOI 10.4049/jimmunol.179.2.845; Moen EL, 2014, MOL CANCER THER, V13, P1334, DOI 10.1158/1535-7163.MCT-13-0924; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Poon C, 2016, NEUROPHARMACOLOGY; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Seki N, 2002, J IMMUNOL, V168, P3484, DOI 10.4049/jimmunol.168.7.3484; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Shin DY, 2013, BIOMED PHARMACOTHER, V67, P305, DOI 10.1016/j.biopha.2013.01.004; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; VANGROENINGEN CJ, 1986, CANCER RES, V46, P4831; Walker PR, 2002, IMMUNOLOGY, V107, P28, DOI 10.1046/j.1365-2567.2002.01507.x; WEBER J, 1994, CANCER RES, V54, P1766; Weintraub K, 2016, NAT MED, V22, P8, DOI 10.1038/nm0116-8; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Zhang QM, 2014, ASIAN PAC J CANCER P, V15, P3495, DOI 10.7314/APJCP.2014.15.8.3495; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	59	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162105	10.1371/journal.pone.0162105	http://dx.doi.org/10.1371/journal.pone.0162105			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579489	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400058
J	Pareek, CS; Smoczynski, R; Kadarmideen, HN; Dziuba, P; Blaszczyk, P; Sikora, M; Walendzik, P; Grzybowski, T; Pierzchala, M; Horbanczuk, J; Szostak, A; Ogluszka, M; Zwierzchowski, L; Czarnik, U; Fraser, L; Sobiech, P; Wasowicz, K; Gelfand, B; Feng, YP; Kumar, D				Pareek, Chandra Shekhar; Smoczynski, Rafal; Kadarmideen, Haja N.; Dziuba, Piotr; Blaszczyk, Pawel; Sikora, Marcin; Walendzik, Paulina; Grzybowski, Tomasz; Pierzchala, Mariusz; Horbanczuk, Jaroslaw; Szostak, Agnieszka; Ogluszka, Magdalena; Zwierzchowski, Lech; Czarnik, Urszula; Fraser, Leyland; Sobiech, Przemyslaw; Wasowicz, Krzysztof; Gelfand, Brian; Feng, Yaping; Kumar, Dibyendu			Single Nucleotide Polymorphism Discovery in Bovine Pituitary Gland Using RNA-Seq Technology	PLOS ONE			English	Article							GENOME; CATTLE; ASSOCIATION; SEQUENCE; GROWTH; IDENTIFICATION; LIVESTOCK; GENOTYPE; PROGRESS; TRAITS	Examination of bovine pituitary gland transcriptome by strand-specific RNA-seq allows detection of putative single nucleotide polymorphisms (SNPs) within potential candidate genes (CGs) or QTLs regions as well as to understand the genomics variations that contribute to economic trait. Here we report a breed-specific model to successfully perform the detection of SNPs in the pituitary gland of young growing bulls representing Polish Holstein-Friesian (HF), Polish Red, and Hereford breeds at three developmental ages viz., six months, nine months, and twelve months. A total of 18 bovine pituitary gland polyA transcriptome libraries were prepared and sequenced using the Illumina NextSeq 500 platform. Sequenced FastQ databases of all 18 young bulls were submitted to NCBI-SRA database with NCBI-SRA accession numbers SRS1296732. For the investigated young bulls, a total of 113,882,3098 raw paired-end reads with a length of 156 bases were obtained, resulting in an approximately 63 million paired-end reads per library. Breed-wise, a total of 515.38, 215.39, and 408.04 million paired-end reads were obtained for Polish HF, Polish Red, and Hereford breeds, respectively. Burrows-Wheeler Aligner (BWA) read alignments showed 93.04%, 94.39%, and 83.46% of the mapped sequencing reads were properly paired to the Polish HF, Polish Red, and Hereford breeds, respectively. Constructed breed-specific SNP-db of three cattle breeds yielded at 13,775,885 SNPs. On an average 765,326 breed-specific SNPs per young bull were identified. Using two stringent filtering parameters, i.e., a minimum 10 SNP reads per base with an accuracy >= 90% and a minimum 10 SNP reads per base with an accuracy = 100%, SNP-db records were trimmed to construct a highly reliable SNP-db. This resulted in a reduction of 95,7% and 96,4% cut-off mark of constructed raw SNP-db. Finally, SNP discoveries using RNA-Seq data were validated by KASP (TM) SNP genotyping assay. The comprehensive QTLs/CGs analysis of 76 QTLs/CGs with RNA-seq data identified KCNIP4, CCSER1, DPP6, MAP3K5 and GHR CGs with highest SNPs hit loci in all three breeds and developmental ages. However, CAST CG with more than 100 SNPs hits were observed only in Polish HF and Hereford breeds. These findings are important for identification and construction of novel tissue specific SNP-db and breed specific SNP-db dataset by screening of putative SNPs according to QTL db and candidate genes for bovine growth and reproduction traits, one can develop genomic selection strategies for growth and reproductive traits.	[Pareek, Chandra Shekhar; Smoczynski, Rafal; Dziuba, Piotr; Blaszczyk, Pawel; Sikora, Marcin; Walendzik, Paulina] Nicolaus Copernicus Univ, Div Funct Genom Biol & Biomed Res, Ctr Modern Interdisciplinary Technol, Torun, Poland; [Kadarmideen, Haja N.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Copenhagen, Denmark; [Grzybowski, Tomasz] Nicolaus Copernicus Univ, Inst Forens Med, Dept Mol & Forens Genet, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Pierzchala, Mariusz; Horbanczuk, Jaroslaw; Szostak, Agnieszka; Ogluszka, Magdalena; Zwierzchowski, Lech] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland; [Czarnik, Urszula; Fraser, Leyland] Univ Warmia & Mazury, Fac Anim Bioengn, Olsztyn, Poland; [Sobiech, Przemyslaw; Wasowicz, Krzysztof] Univ Warmia & Mazury, Fac Vet Med, Olsztyn, Poland; [Gelfand, Brian; Feng, Yaping; Kumar, Dibyendu] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA	Nicolaus Copernicus University; University of Copenhagen; Nicolaus Copernicus University; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Warmia & Mazury; University of Warmia & Mazury; Rutgers State University New Brunswick	Pareek, CS (corresponding author), Nicolaus Copernicus Univ, Div Funct Genom Biol & Biomed Res, Ctr Modern Interdisciplinary Technol, Torun, Poland.	pareekcs@umk.pl	pareek, chandra/M-2751-2014; Grzybowski, Tomasz/A-1676-2015; Horbanczuk, Jaroslaw/ABD-8389-2021; Pierzchala, Mariusz/G-1052-2013	pareek, chandra/0000-0002-0329-787X; Grzybowski, Tomasz/0000-0001-6228-6460; Pierzchala, Mariusz/0000-0001-7001-1336; Sikora, Marcin/0000-0003-2022-4434; Czarnik, Urszula/0000-0002-9065-2197; Kadarmideen, Haja/0000-0001-6294-382X; Szostak, Agnieszka/0000-0003-3578-0492; Fraser, Leyland/0000-0002-2997-9991; Horbanczuk, Jaroslaw Olav/0000-0002-7561-0941; Wasowicz, Krzysztof/0000-0002-9496-3144	National Science Centre, Krakow, Poland [2012/05/B/NZ2/01629]; entitled "Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji"	National Science Centre, Krakow, Poland; entitled "Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji"	This research paper was financially supported by National Science Centre, Krakow, Poland, Project No. 2012/05/B/NZ2/01629; entitled "Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji".	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bai YS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-8; Baldwin RL VI, 2012, GENE REGUL SYST BIO, V6, P67, DOI 10.4137/GRSB.S9687; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Djari A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-307; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fortes MRS, 2012, J ANIM SCI, V90, P2894, DOI 10.2527/jas.2011-4601; GEORGES M, 1995, GENETICS, V139, P907; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Henshall JM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-12; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Huang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030244; KBioscience, 2009, PRIMERPICKER LIT KAS; Koringa PG, 2013, GENE, V530, P119, DOI 10.1016/j.gene.2013.07.061; Kumar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-684; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Li C, 2004, J ANIM SCI, V82, P1; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Martin M, 2011, EMBNET J, V17; Morsci NS, 2006, ANIM GENET, V37, P554, DOI 10.1111/j.1365-2052.2006.01528.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pareek CS, 2011, BRIEF FUNCT GENOMICS, V10, P165, DOI 10.1093/bfgp/elr019; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Pareek CS, 2016, P PAG; Pauciullo A, 2015, ANIM GENET, V46, P122, DOI 10.1111/age.12261; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Tan AC, 2008, CANCER BIOL THER, V7, P137, DOI 10.4161/cbt.7.1.5199; Villanueva B, 2004, J ANIM SCI, V82, P1305; Wang WX, 2011, SCI REP-UK, V1, DOI 10.1038/srep00055; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113881; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	44	14	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161370	10.1371/journal.pone.0161370	http://dx.doi.org/10.1371/journal.pone.0161370			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606429	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600006
J	El Azami, M; Hammers, A; Jung, JL; Costes, N; Bouet, R; Lartizien, C				El Azami, Meriem; Hammers, Alexander; Jung, Julien; Costes, Nicolas; Bouet, Romain; Lartizien, Carole			Detection of Lesions Underlying Intractable Epilepsy on T1-Weighted MRI as an Outlier Detection Problem	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; VOXEL-BASED MORPHOMETRY; HUMAN BRAIN; AUTOMATED DETECTION; IMPROVES DETECTION; CLASSIFICATION; MATTER; ATLAS	Pattern recognition methods, such as computer aided diagnosis (CAD) systems, can help clinicians in their diagnosis by marking abnormal regions in an image. We propose a machine learning system based on a one-class support vector machine (OC-SVM) classifier for the detection of abnormalities in magnetic resonance images (MRI) applied to patients with intractable epilepsy. The system learns the features associated with healthy control subjects, allowing a voxelwise assessment of the deviation of a test subject pattern from the learned patterns. While any number of various features can be chosen and learned, here we focus on two texture parameters capturing image patterns associated with epileptogenic lesions on T1-weighted brain MRI e.g. heterotopia and blurred junction between the grey and white matter. The CAD output consists of patient specific 3D maps locating clusters of suspicious voxels ranked by size and degree of deviation from control patterns. System performance was evaluated using realistic simulations of challenging detection tasks as well as clinical data of 77 healthy control subjects and of eleven patients (13 lesions). It was compared to that of a mass univariate statistical parametric mapping (SPM) single subject analysis based on the same set of features. For all simulations, OC-SVM yielded significantly higher values of the area under the ROC curve (AUC) and higher sensitivity at low false positive rate. For the clinical data, both OC-SVM and SPM successfully detected 100% of the lesions in the MRI positive cases (3/13). For the MRI negative cases (10/13), OC-SVM detected 7/10 lesions and SPM analysis detected 5/10 lesions. In all experiments, OC-SVM produced fewer false positive detections than SPM. OC-SVM may be a versatile system for unbiased lesion detection.	[El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, CREATIS, F-69622 Villeurbanne, France; [El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, CNRS, UMR5220, F-69622 Villeurbanne, France; [El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, INSERM, U1206, F-69622 Villeurbanne, France; [El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, INSA Lyon, F-69622 Villeurbanne, France; [Hammers, Alexander] Neurodis Fdn, Lyon, France; [Hammers, Alexander] Kings Coll London, Div Imaging Sci & Biomed Engn, PET Ctr, London, England; [Jung, Julien; Bouet, Romain] Lyon Neurosci Res Ctr, INSERM, CNRS, U1028,UMR5292, Lyon, France; [Costes, Nicolas] CERMEP Imagerie Vivant, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	El Azami, M (corresponding author), Univ Lyon 1, CREATIS, F-69622 Villeurbanne, France.; El Azami, M (corresponding author), Univ Lyon 1, CNRS, UMR5220, F-69622 Villeurbanne, France.; El Azami, M (corresponding author), Univ Lyon 1, INSERM, U1206, F-69622 Villeurbanne, France.; El Azami, M (corresponding author), Univ Lyon 1, INSA Lyon, F-69622 Villeurbanne, France.	meriem.elazami@creatis.insa-lyon.fr	Costes, Nicolas/D-4452-2013; Lartizien, Carole/H-4447-2014; Lachaux, Jean-Philippe/K-1681-2017; Lartizien, Carole/M-6991-2019; Hammers, Alexander/D-9982-2015	Costes, Nicolas/0000-0002-2954-9262; Lartizien, Carole/0000-0001-7594-4231; Jung, Julien/0000-0002-9274-0086; Bouet, Romain/0000-0002-3690-2976; Hammers, Alexander/0000-0001-9530-4848	LABEX PRIMES of Universite de Lyon within the program "Investissements d'Avenir" [ANR-11-LABX-0063, ANR-11-IDEX-0007]	LABEX PRIMES of Universite de Lyon within the program "Investissements d'Avenir"(French National Research Agency (ANR))	This work was supported by the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs Jean Isnard and Genevieve Demarquay from the Hospices Civils de Lyon for permission to use the imaging data from patients under their care; and Sandrine Bouvard and Phillipe Ryvlin from Lyon Neuroscience Research Center for providing the data for normal control subjects. This work was supported by the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR).	Ahmed B, 2015, EPILEPSY BEHAV, V48, P21, DOI 10.1016/j.yebeh.2015.04.055; [Anonymous], MRI NEGATIVE EPILEPS; Antel SB, 2003, NEUROIMAGE, V19, P1748, DOI 10.1016/S1053-8119(03)00226-X; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barkovich AJ, 1996, J CLIN NEUROPHYSIOL, V13, P481, DOI 10.1097/00004691-199611000-00003; Bernasconi A, 2011, NAT REV NEUROL, V7, P99, DOI 10.1038/nrneurol.2010.199; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bowman A.W., 1997, OXFORD STAT SCI SERI; Bruggemann JM, 2007, EPILEPSY RES, V77, P93, DOI 10.1016/j.eplepsyres.2007.09.004; Cantor-Rivera D, 2015, COMPUT MED IMAG GRAP, V41, P14, DOI 10.1016/j.compmedimag.2014.07.002; Colliot O, 2006, NEUROIMAGE, V29, P162, DOI 10.1016/j.neuroimage.2005.07.021; Duchesne S, 2006, NEUROIMAGE, V29, P557, DOI 10.1016/j.neuroimage.2005.07.052; El Azami M, 2013, INT WORKSHOP PATTERN, P90, DOI 10.1109/PRNI.2013.32; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Focke NK, 2012, NEUROIMAGE, V59, P356, DOI 10.1016/j.neuroimage.2011.07.068; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Guigue V., 2005, PERCEPTION SYSTMES I; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Hammers, 2015, MRI NEGATIVE EPILEPS, P28; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Huppertz HJ, 2009, EPILEPSIA, V50, P155, DOI 10.1111/j.1528-1167.2008.01734.x; Huppertz HJ, 2005, EPILEPSY RES, V67, P35, DOI 10.1016/j.eplepsyres.2005.07.009; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033096; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Manly BFJ, 2006, CHAPMAN HALL TEXTS S; Markou M, 2003, SIGNAL PROCESS, V83, P2499, DOI 10.1016/j.sigpro.2003.07.019; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meagher D, 1980, OCTREE ENCODING NEW; Mourao-Miranda J, 2011, NEUROIMAGE, V58, P793, DOI 10.1016/j.neuroimage.2011.06.042; Petrick N, 2013, MED PHYS, V40, DOI 10.1118/1.4816310; Sato JR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00178; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Srivastava S, 2005, NEUROIMAGE, V27, P253, DOI 10.1016/j.neuroimage.2005.03.045; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Thesen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016430; Vapnik V., 1998, STAT LEARNING THEORY; Wagner J, 2011, BRAIN, V134, P2844, DOI 10.1093/brain/awr204	46	22	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161498	10.1371/journal.pone.0161498	http://dx.doi.org/10.1371/journal.pone.0161498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603778	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200016
J	Frank, ASK; Carthey, AJR; Banks, PB				Frank, Anke S. K.; Carthey, Alexandra J. R.; Banks, Peter B.			Does Historical Coexistence with Dingoes Explain Current Avoidance of Domestic Dogs? Island Bandicoots Are Naive to Dogs, unlike Their Mainland Counterparts	PLOS ONE			English	Article							PREDATOR-RECOGNITION; TOXOPLASMA-GONDII; PERAMELES GUNNII; CATS; CONSERVATION; MANAGEMENT; AUSTRALIA; TASMANIA; WILDLIFE; IMPACTS	Introduced predators have a global reputation for causing declines and extinctions of native species. Native prey naivete towards novel predators is thought to be a key reason for predator impacts. However, naivete is not necessarily forever: where coexistence establishes, it is likely that naivete will be reduced through adaptation, and the once alien predator will eventually become recognised by prey. For example, native marsupial bandicoots in Sydney avoid backyards with domestic dogs (C. lupus familiaris), but not domestic cats (Felis catus), even though cats and dogs were both introduced about 200 years ago (Carthey and Banks 2012). The authors attributed bandicoots' recognition of dogs to long-term exposure to a close relative of dogs, dingoes that arrived in Australia 4000 years ago. Here, we test a prediction of this hypothesis by taking the study to Tasmania, where dingoes have never been present but where domestic dogs also arrived about 200 years ago. We use a similar survey design to that of Carthey and Banks (2012): asking Hobart residents to report on pet-ownership, bandicoot sightings and scats within their backyards, as well as an array of yard characteristic control variables. We predicted that if long term experience with dingoes enabled mainland bandicoots to recognise domestic dogs, then Tasmanian bandicoots, which are inexperienced with dingoes, would not recognise domestic dogs. Our results indicate that Tasmanian bandicoots are naive to both dogs and cats after only 200 years of coexistence, supporting our hypothesis and the notion that naivete in native prey towards alien predators (as observed on the mainland) may eventually be overcome.	[Frank, Anke S. K.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Frank, Anke S. K.] Univ Cologne, Inst Bot, Cologne, Germany; [Carthey, Alexandra J. R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Banks, Peter B.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Tasmania; University of Cologne; Macquarie University; University of Sydney	Frank, ASK (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.; Frank, ASK (corresponding author), Univ Cologne, Inst Bot, Cologne, Germany.	anke.frank@utas.edu.au	Frank, Anke S. K./J-7789-2014	Frank, Anke S. K./0000-0002-0177-4898; Banks, Peter/0000-0002-4340-6495; Carthey, Alexandra Jane Repin/0000-0002-0472-2217	ARC Discovery Grant [DP140104413]	ARC Discovery Grant(Australian Research Council)	This work was supported by (http://www.hobartcity.com.au/Environment/Dr_Edward_Hall_Environment_Grants) (AF) and ARC Discovery Grant DP140104413 (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; Balme J, 2016, J ARCHAEOLO IN PRESS; Banks PB, 1998, J MAMMAL, V79, P1260, DOI 10.2307/1383017; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Bilney R, 2015, WILDLIFE AUSTR, V52, P28; Bilney RJ, 2011, ANIM BIOL, V61, P29, DOI 10.1163/157075511X554400; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; BLACKHALL S, 1980, AUST WILDLIFE RES, V7, P191, DOI 10.1071/WR9800191; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; Blumstein DT, 2002, ANIM CONSERV, V5, P87, DOI 10.1017/S1367943002002123; Blumstein DT, 1996, OIKOS, V77, P569, DOI 10.2307/3545948; Bonnaud E, 2011, BIOL INVASIONS, V13, P581, DOI 10.1007/s10530-010-9851-3; Boyce J, 2006, ENVIRON HIST-US, V11, P102, DOI 10.1093/envhis/11.1.102; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Calver MC, 2011, BIOL CONSERV, V144, P1895, DOI 10.1016/j.biocon.2011.04.015; Carthey AJR, 2015, OIKOS, V89, P932; Carthey AJR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031804; Committee TSS, 2008, EPBC ACT LIST THREAT; Cox GW, 2004, ALIEN SPECIES EVOLUT; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Daniels GD, 2011, BIODIVERS CONSERV, V20, P3517, DOI 10.1007/s10531-011-0139-4; Denny E., 2010, REV CAT ECOLOGY MANA; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; Dowle M, 2009, EUR J WILDLIFE RES, V55, P45, DOI 10.1007/s10344-008-0212-9; Driessen MM, 1996, WILDLIFE RES, V23, P721, DOI 10.1071/WR9960721; Gerard A, 2014, NATURWISSENSCHAFTEN, V101, P921, DOI 10.1007/s00114-014-1233-8; GUILER E R, 1970, Australian Journal of Zoology, V18, P49, DOI 10.1071/ZO9700049; HIATT B, 1967, OCEANIA, V38, P99, DOI 10.1002/j.1834-4461.1967.tb00947.x; Hocking Gregory J., 1996, Records of the Queen Victoria Museum, V103, P163; Holderness-Roddam B, 2014, AUSTRALAS J ENV MAN, V21, P441, DOI 10.1080/14486563.2014.952787; Hudgens BR, 2011, OECOLOGIA, V165, P699, DOI 10.1007/s00442-010-1761-7; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Hughes NK, 2012, ECOL LETT, V15, P1326, DOI 10.1111/j.1461-0248.2012.01856.x; HUTCHISON WM, 1969, BMJ-BRIT MED J, V4, P806, DOI 10.1136/bmj.4.5686.806-b; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; Jose Danielle P., 2002, Australian Mammalogy, V24, P213; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; KRUUK H, 1981, J APPL ECOL, V18, P197, DOI 10.2307/2402489; McArthur M, 2000, ASIA PAC J CLIN NUTR, V9, P215, DOI 10.1046/j.1440-6047.2000.00192.x; McLean IG, 1996, BIOL CONSERV, V75, P51, DOI 10.1016/0006-3207(95)00038-0; McLean IG, 1999, BIOL CONSERV, V87, P123, DOI 10.1016/S0006-3207(98)00024-X; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Morley CG, 2006, CONSERVATION EVIDENC, V3, P3; Nogales M, 2013, BIOSCIENCE, V63, P804, DOI 10.1525/bio.2013.63.10.7; Obendorf DL, 1996, J WILDLIFE DIS, V32, P623, DOI 10.7589/0090-3558-32.4.623; Oskarsson MCR, 2011, P ROYAL SOC LONDON B; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Taborsky M., 1988, Notornis, V35, P197; Tambling CJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1153, DOI 10.1007/s00265-015-1929-6; Tchabovsky AV, 2001, J ETHOL, V19, P105, DOI 10.1007/s101640170006; Villemey A, 2013, BIOL CONSERV, V158, P147, DOI 10.1016/j.biocon.2012.08.007; WEAVERS B W, 1989, Australian Zoologist, V25, P83	61	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161447	10.1371/journal.pone.0161447	http://dx.doi.org/10.1371/journal.pone.0161447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603517	Green Published, gold			2022-12-27	WOS:000383255200013
J	Lu, MK; Chen, CM; Duann, JR; Ziemann, U; Chen, JC; Chiou, SM; Tsai, CH				Lu, Ming-Kuei; Chen, Chun-Ming; Duann, Jeng-Ren; Ziemann, Ulf; Chen, Jui-Cheng; Chiou, Shang-Ming; Tsai, Chon-Haw			Investigation of Motor Cortical Plasticity and Corticospinal Tract Diffusion Tensor Imaging in Patients with Parkinsons Disease and Essential Tremor	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TIMING-DEPENDENT PLASTICITY; WHITE-MATTER INVOLVEMENT; THETA-BURST STIMULATION; INTRACORTICAL INHIBITION; CORTICOCORTICAL INHIBITION; CORTEX EXCITABILITY; RESTING TREMOR; FACILITATION; DYSFUNCTION	Parkinson's disease (PD) and essential tremor (ET) are characterized with motor dysfunctions. Motor circuit dysfunctions can be complementarily investigated by paired associative stimulation (PAS)-induced long-term potentiation (LTP)-like plasticity and diffusion tensor imaging (DTI) of the corticospinal tract (CST). Three groups of twelve subjects with moderate severity PD, ET with intention tremor and healthy controls (HC) were studied. The primary motor cortex (M1) excitability, measured by motor evoked potential (MEP) amplitude and by short-interval and long-interval intracortical inhibition (SICI and LICI) was compared between the three groups before and after PAS. The DTI measures of fractional anisotropy (FA) and mean diffusivity (MD) were acquired. PAS effects and DTI data were simultaneously examined between groups. PAS increased MEP amplitude in HC but not in PD and ET. SICI and LICI were significantly reduced after PAS irrespective of groups. No significant differences of the mean FA and MD were found between groups. There was no significant correlation between the PAS effects and the DTI measures. Findings suggest that both PD and ET with intention tremor have impairment of the associative LTP-like corticospinal excitability change in M1. The microstructure of the CST is not relevant to the deficiency of M1 associative plasticity in PD and ET.	[Lu, Ming-Kuei; Chen, Jui-Cheng; Tsai, Chon-Haw] China Med Univ Hosp, Dept Neurol, Neurosci Lab, Taichung, Taiwan; [Lu, Ming-Kuei; Chen, Jui-Cheng; Chiou, Shang-Ming; Tsai, Chon-Haw] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Lu, Ming-Kuei; Chen, Chun-Ming; Chen, Jui-Cheng; Tsai, Chon-Haw] China Med Univ, Grad Inst Neural & Cognit Sci, Coll Med, Taichung, Taiwan; [Chen, Chun-Ming] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Duann, Jeng-Ren] Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taiwan; [Duann, Jeng-Ren] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Ziemann, Ulf] Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Ziemann, Ulf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Chiou, Shang-Ming] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Central University; University of California System; University of California San Diego; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lu, MK; Tsai, CH (corresponding author), China Med Univ Hosp, Dept Neurol, Neurosci Lab, Taichung, Taiwan.; Lu, MK; Tsai, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Lu, MK; Tsai, CH (corresponding author), China Med Univ, Grad Inst Neural & Cognit Sci, Coll Med, Taichung, Taiwan.	d4297@mail.cmuh.org.tw; d8079@mail.cmuh.org.tw	Lu, Ming-Kuei/AAF-3338-2020; Ziemann, Ulf/AAY-9125-2020; Lu, Ming-Kuei/M-2435-2013	Lu, Ming-Kuei/0000-0002-2768-4399; Lu, Ming-Kuei/0000-0002-2768-4399	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; National Science Council [NSC99-2314-B-039-017-MY2, 102-2320-B-039-001]; Ministry of Science and Technology [MOST103-2314-B-039-032-MY2]; "Aim for the Top University Plan" of the China Medical University and Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); "Aim for the Top University Plan" of the China Medical University and Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and by grants from the National Science Council (NSC99-2314-B-039-017-MY2 and 102-2320-B-039-001), the Ministry of Science and Technology (MOST103-2314-B-039-032-MY2) and "Aim for the Top University Plan" of the China Medical University and Ministry of Education, Taiwan.	Berardelli A, 1996, BRAIN, V119, P71, DOI 10.1093/brain/119.1.71; Carson RG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00823; Chu J, 2009, NEUROLOGY, V72, P842, DOI 10.1212/01.wnl.0000343881.27524.e8; Chuang WL, 2014, MOVEMENT DISORD, V29, P501, DOI 10.1002/mds.25809; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Deuschl G, 2000, BRAIN, V123, P1568, DOI 10.1093/brain/123.8.1568; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Florian J, 2007, EUR J NEUROSCI, V25, P3461, DOI 10.1111/j.1460-9568.2007.05603.x; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Hallett Mark, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS85, DOI 10.1016/S1353-8020(11)70027-X; Hamada M, 2014, J NEUROSCI, V34, P12837, DOI 10.1523/JNEUROSCI.1960-14.2014; Hanajima R, 2000, BRAIN DEV-JPN, V22, pS132; Hanajima R, 1996, J NEUROL SCI, V140, P109, DOI 10.1016/0022-510X(96)00100-1; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubers A, 2012, BRAIN STIMUL, V5, P297, DOI 10.1016/j.brs.2011.03.008; Kishore A, 2014, CEREB CORTEX, V24, P2055, DOI 10.1093/cercor/bht058; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Kojovic M, 2015, MOVEMENT DISORD, V30, P1098, DOI 10.1002/mds.26167; Krivanekova L, 2011, EUR J NEUROSCI, V34, P1292, DOI 10.1111/j.1460-9568.2011.07849.x; Kujirai K, 2006, J NEUROPHYSIOL, V96, P1337, DOI 10.1152/jn.01140.2005; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lefaucheur JP, 2005, CLIN NEUROPHYSIOL, V116, P244, DOI 10.1016/j.clinph.2004.11.017; Lin CC, 2013, EUR J RADIOL, V82, pE610, DOI 10.1016/j.ejrad.2013.06.016; Lindenbach D, 2013, NEUROSCI BIOBEHAV R, V37, P2737, DOI 10.1016/j.neubiorev.2013.09.008; Lu MK, 2015, CLIN NEUROPHYSIOL, V126, P2330, DOI 10.1016/j.clinph.2015.02.010; Lu MK, 2015, 1 INT BRAIN STIM C S, P342; MacKinnon CD, 2005, ANN NEUROL, V58, P516, DOI 10.1002/ana.20599; Meunier S, 2012, EUR J NEUROSCI, V35, P975, DOI 10.1111/j.1460-9568.2012.08034.x; Morgante F, 2006, BRAIN, V129, P1059, DOI 10.1093/brain/awl031; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Muller-Dahlhaus Florian, 2010, Front Synaptic Neurosci, V2, P34, DOI 10.3389/fnsyn.2010.00034; Ni Z, 2013, NEUROLOGY, V80, P1746, DOI 10.1212/WNL.0b013e3182919029; Pasquereau B, 2016, BRAIN, V139, P127, DOI 10.1093/brain/awv312; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; Romeo S, 1998, MUSCLE NERVE, V21, P1304, DOI 10.1002/(SICI)1097-4598(199810)21:10<1304::AID-MUS9>3.0.CO;2-F; Rosenkranz K, 2006, EUR J NEUROSCI, V23, P822, DOI 10.1111/j.1460-9568.2006.04605.x; Russmann H, 2009, CLIN NEUROPHYSIOL, V120, P1204, DOI 10.1016/j.clinph.2009.04.005; Saini J, 2012, PARKINSONISM RELAT D, V18, P477, DOI 10.1016/j.parkreldis.2012.01.006; Schwingenschuh P, 2010, MOVEMENT DISORD, V25, P560, DOI 10.1002/mds.23019; Shahed J, 2007, PARKINSONISM RELAT D, V13, P67, DOI 10.1016/j.parkreldis.2006.05.033; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Udupa K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00128; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; Worker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112638; Zamir O, 2012, CLIN NEUROPHYSIOL, V123, P815, DOI 10.1016/j.clinph.2011.07.051; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	52	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162265	10.1371/journal.pone.0162265	http://dx.doi.org/10.1371/journal.pone.0162265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603204	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200051
J	Frickmann, H; Wiemer, D; Frey, C; Hagen, RM; Hinz, R; Podbielski, A; Koller, T; Warnke, P				Frickmann, Hagen; Wiemer, Dorothea; Frey, Claudia; Hagen, Ralf Matthias; Hinz, Rebecca; Podbielski, Andreas; Koeller, Thomas; Warnke, Philipp			Low Enteric Colonization with Multidrug-Resistant Pathogens in Soldiers Returning from Deployments-Experience from the Years 2007-2015	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; CLINICAL ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; STAPHYLOCOCCUS-AUREUS; CHROMOGENIC MEDIUM; FECAL CARRIAGE; ANTIBIOTIC-RESISTANCE; INFECTION; RISK	This assessment describes the enteric colonization of German soldiers 8-12 weeks after returning from mostly but not exclusively subtropical or tropical deployment sites with third-generation cephalosporin-resistant Enterobacteriaceae, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). Between 2007 and 2015, 828 stool samples from returning soldiers were enriched in nonselective broth and incubated on selective agars for Enterobacteriaceae expressing extended-spectrum beta-lactamases (ESBL), VRE and MRSA. Identification and resistance testing of suspicious colonies was performed using MALDI-TOF-MS, VITEK-II and agar diffusion gradient testing (bioMerieux, Marcy-l'Etoile, France). Isolates with suspicion of ESBL were characterized by ESBL/ampC disc-(ABCD)-testing and molecular approaches (PCR, Sanger sequencing). Among the returnees, E. coli with resistance against third-generation cephalosporins (37 ESBL, 1 ESBL + ampC, 1 uncertain mechanism) were found in 39 instances (4.7%). Associated quinolone resistance was found in 46.2% of these isolates. Beta-lactamases of the bla(CTX-M) group 1 predominated among the ESBL mechanisms, followed by the blaCTX-M group 9, and bla(SHV). VRE of vanA-type was isolated from one returnee (0.12%). MRSA was not isolated at all. There was no clear trend regarding the distribution of resistant isolates during the assessment period. Compared with colonization with resistant bacteria described in civilians returning from the tropics, the colonization in returned soldiers is surprisingly low and stable. This finding, together with high colonization rates found in previous screenings on deployment, suggests a loss of colonization during the 8- to 12-week period between returning from the deployments and assessment.	[Frickmann, Hagen; Wiemer, Dorothea; Frey, Claudia; Hinz, Rebecca] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Frickmann, Hagen; Podbielski, Andreas; Koeller, Thomas; Warnke, Philipp] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Hagen, Ralf Matthias] NATO Ctr Excellence Mil Med, Deployment Hlth Surveillance Capabil, Munich, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; NATO (North Atlantic Treaty Organisation)	Frickmann, H (corresponding author), German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany.; Frickmann, H (corresponding author), Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	Frickmann@bnitm.de	Hagen, Ralf Matthias/AAA-1723-2021					Alabi AS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-455; Barguigua A, 2013, MICROB PATHOGENESIS, V61-62, P16, DOI 10.1016/j.micpath.2013.04.010; Bercion R, 2009, J INFECT DEV COUNTR, V3, P187, DOI 10.3855/jidc.34; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bossaer JB, 2011, SUPPORT CARE CANCER, V19, P231, DOI 10.1007/s00520-009-0808-y; Cullik A, 2010, J MED MICROBIOL, V59, P580, DOI 10.1099/jmm.0.016188-0; Diederen B, 2005, J CLIN MICROBIOL, V43, P1925, DOI 10.1128/JCM.43.4.1925-1927.2005; Frickmann H., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/573904; Girlich D, 2014, CLIN MICROBIOL INFEC, V20, P350, DOI 10.1111/1469-0691.12325; Gurnee EA, 2015, J INFECT DIS, V212, P1862, DOI 10.1093/infdis/jiv278; Haas EJ, 2010, INFECT CONT HOSP EP, V31, P1038, DOI 10.1086/655464; Habeeb MA, 2013, PAK J MED SCI, V29, P540, DOI 10.12669/pjms.292.3144; Hagen RM, 2015, EUR J MICROBIOL IMMU, V5, P281, DOI 10.1556/1886.2015.00037; Helm F., 2013, WEHRMED WEHRPHARM, V1, P40; Hovhannisyan G, 2015, MIKROBIOLOGIE, V25, P5; Huang TD, 2010, J CLIN MICROBIOL, V48, P2091, DOI 10.1128/JCM.02342-09; Ingram PR, 2011, J MED MICROBIOL, V60, P715, DOI 10.1099/jmm.0.029140-0; Jazmati N, 2016, J CLIN MICROBIOL, V54, P467, DOI 10.1128/JCM.02926-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Jones SL, 2006, TROP MED INT HEALTH, V11, P1725, DOI 10.1111/j.1365-3156.2006.01731.x; Kalra L, 2013, AM J INFECT CONTROL, V41, P1253, DOI 10.1016/j.ajic.2013.05.021; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957; Karami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083030; Klare I, 2012, DIAGN MICR INFEC DIS, V74, P171, DOI 10.1016/j.diagmicrobio.2012.06.020; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Loulergue J, 2006, EUR J CLIN MICROBIOL, V25, P407, DOI 10.1007/s10096-006-0144-9; Lubbert C, 2015, INT J MED MICROBIOL, V305, P148, DOI 10.1016/j.ijmm.2014.12.001; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Matar MJ, 2006, CLIN INFECT DIS, V42, P1506, DOI 10.1086/503675; Murk JLAN, 2009, J CLIN MICROBIOL, V47, P1885, DOI 10.1128/JCM.01406-08; Obeng-Nkrumah N, 2013, AM J TROP MED HYG, V89, P960, DOI 10.4269/ajtmh.12-0642; Ongut G, 2014, CLIN LAB, V60, P1213, DOI 10.7754/Clin.Lab.2013.130812; Ongut G, 2013, J MED MICROBIOL, V62, P661, DOI 10.1099/jmm.0.052845-0; Paltansing S, 2013, EMERG INFECT DIS, V19, P1206, DOI [10.3201/eid1908.130257, 10.3201/eid.1908.130257]; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Pitout JDD, 2004, J CLIN MICROBIOL, V42, P5715, DOI 10.1128/JCM.42.12.5715-5721.2004; Rahbar Mohammad, 2008, Pak J Biol Sci, V11, P496, DOI 10.3923/pjbs.2008.496.498; Raji MA, 2013, J INFECT PUBLIC HEAL, V6, P431, DOI 10.1016/j.jiph.2013.05.002; Rieg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1225-0; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Seid J, 2005, ACTA TROP, V95, P143, DOI 10.1016/j.actatropica.2005.05.009; Seni Jeremiah, 2013, BMC Res Notes, V6, P298, DOI 10.1186/1756-0500-6-298; Severin JA, 2012, TROP MED INT HEALTH, V17, P455, DOI 10.1111/j.1365-3156.2011.02949.x; Severin JA, 2010, J ANTIMICROB CHEMOTH, V65, P465, DOI 10.1093/jac/dkp471; Sire JM, 2007, J INFECT DEV COUNTR, V1, P263, DOI 10.3855/jidc.362; Tsu JHL, 2015, UROLOGY, V85, P15, DOI 10.1016/j.urology.2014.07.078; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vandersee S., 2011, Hygiene Medizin, V36, P384; Weinstock DM, 2007, BIOL BLOOD MARROW TR, V13, P615, DOI 10.1016/j.bbmt.2007.01.078; Zhang H, 2014, CHINESE MED J-PEKING, V127, P2429, DOI 10.3760/cma.j.issn.0366-6999.20131538	52	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162129	10.1371/journal.pone.0162129	http://dx.doi.org/10.1371/journal.pone.0162129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598775	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800042
J	He, F; Zhang, W; Zhang, GQ				He, Feng; Zhang, Wei; Zhang, Guoqiang			A Differential Evolution Algorithm Based on Nikaido-Isoda Function for Solving Nash Equilibrium in Nonlinear Continuous Games	PLOS ONE			English	Article							STRATEGY; MARKETS; MODELS	A differential evolution algorithm for solving Nash equilibrium in nonlinear continuous games is presented in this paper, called NIDE (Nikaido-Isoda differential evolution). At each generation, parent and child strategy profiles are compared one by one pairwisely, adapting Nikaido-Isoda function as fitness function. In practice, the NE of nonlinear game model with cubic cost function and quadratic demand function is solved, and this method could also be applied to non-concave payoff functions. Moreover, the NIDE is compared with the existing Nash Domination Evolutionary Multiplayer Optimization (NDEMO), the result showed that NIDE was significantly better than NDEMO with less iterations and shorter running time. These numerical examples suggested that the NIDE method is potentially useful.	[He, Feng; Zhang, Wei; Zhang, Guoqiang] Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China; [Zhang, Guoqiang] Xuchang Univ, Xuchang, Peoples R China	Tianjin University; Xuchang University	Zhang, GQ (corresponding author), Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China.; Zhang, GQ (corresponding author), Xuchang Univ, Xuchang, Peoples R China.	zgq@tju.edu.cn	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	National Natural Science Foundation of China [71320107003, 71532009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This manuscript is supported by National Natural Science Foundation of China (71320107003, 71532009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldick R., 2000, LINEAR SUPPLY FUNCTI; Baldick R., 2001, CAPACITY CONSTRAINED; Eaves BC, 1999, J ECON DYN CONTROL, V23, P1249, DOI 10.1016/S0165-1889(98)00073-6; Hajimirsadeghi Hossein, 2009, Proceedings of the 2009 World Congress on Nature & Biologically Inspired Computing (NaBIC 2009), P1532, DOI 10.1109/NABIC.2009.5393669; Koh A, 2012, APPL SOFT COMPUT, V12, P161, DOI 10.1016/j.asoc.2011.08.056; Latorre MD, 2003, IEEE T POWER SYST, V18, P611, DOI 10.1109/TPWRS.2003.810900; Lee KH, 2003, IEEE T POWER SYST, V18, P830, DOI 10.1109/TPWRS.2002.807067; McKelvey R., 1992, TECHNICAL REPORT; Moitre D, 2002, ELECTR POW SYST RES, V60, P153, DOI 10.1016/S0378-7796(01)00174-2; Nikaido H., 1955, PAC J MATH, V5, P807, DOI DOI 10.2140/PJM.1955.5.807; Park JB, 2001, IEEE T POWER SYST, V16, P847, DOI 10.1109/59.962436; Peydayesh M., 2010, P IEEE POW EN SOC GE, P1, DOI [10.1109/PES.2010.5589876, DOI 10.1109/PES.2010.5589876]; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Pu XS, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500533; Sahraei-Ardakani M, 2008, 2008 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND GAMES, P276, DOI 10.1109/CIG.2008.5035650; Son YS, 2004, IEEE T EVOLUT COMPUT, V8, P305, DOI 10.1109/TEVC.2004.832862; Song YQ, 2003, ELECTR POW SYST RES, V67, P45, DOI 10.1016/S0378-7796(03)00042-7; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Storn R.M., 1995, DIFFERENTIAL EVOLUTI, V23; Wang X, 2004, IEEE T POWER SYST, V19, P1348, DOI 10.1109/TPWRS.2004.831237; Weber J. D., 1999, 1999 IEEE Power Engineering Society Summer Meeting. Conference Proceedings (Cat. No. 99CH36364), P682, DOI 10.1109/PESS.1999.787399; Wei JY, 1999, OPER RES, V47, P102, DOI 10.1287/opre.47.1.102; Wen FS, 2001, POWER ENG REV IEEE, V21, P24; Zhang Yu-bo, 2003, Proceedings of the CSEE, V23, P80	25	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161634	10.1371/journal.pone.0161634	http://dx.doi.org/10.1371/journal.pone.0161634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589229	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800012
J	Min, YW; Hong, YS; Ko, EJ; Lee, JY; Ahn, KD; Bae, JM; Rhee, PL				Min, Yang Won; Hong, Yun Soo; Ko, Eun-Ju; Lee, Ji-Yeon; Ahn, Ki Duck; Bae, Je Moon; Rhee, Poong-Lyul			Nitrergic Pathway Is the Main Contributing Mechanism in the Human Gastric Fundus Relaxation: An In Vitro Study	PLOS ONE			English	Article							NONADRENERGIC NONCHOLINERGIC RELAXATION; VASOACTIVE INTESTINAL POLYPEPTIDE; NITRIC-OXIDE SYNTHASE; FUNCTIONAL DYSPEPSIA; SMOOTH-MUSCLE; NEUROTRANSMITTER; TRANSMISSION; STOMACH; PEPTIDE; ACCOMMODATION	Background Human gastric fundus relaxation is mediated by intrinsic inhibitory pathway. We investigated the roles of nitrergic and purinergic pathways, two known inhibitory factors in gastric motility, on spontaneous and nerve-evoked contractions in human gastric fundus muscles. Methods Gastric fundus muscle strips (12 circular and 13 longitudinal) were obtained from patients without previous gastrointestinal motility disorder who underwent gastrectomy for stomach cancer. Using these specimens, we examined basal tone, peak, amplitude, and frequency of spontaneous contractions, and peak and nadir values under electrical field stimulation (EFS, 150 V, 0.3 ms, 10 Hz, 20 s). To examine responses to purinergic and nitrergic inhibition without cholinergic innervation, atropine (muscarinic antagonist, 1 mu M), MRS2500 (a purinergic P2Y1 receptor antagonist, 1 mu M), and N-nitro-L-arginine (L-NNA, a nitric oxide synthase inhibitor, 100 mu M) were added sequentially for spontaneous and electrically-stimulated contractions. Tetrodotoxin was used to confirm any neuronal involvement. Results In spontaneous contraction, L-NNA increased basal tone and peak in both muscle layers, while amplitude and frequency were unaffected. EFS (up to 10 Hz) uniformly induced initial contraction and subsequent relaxation in a frequency-dependent manner. Atropine abolished initial on-contraction and induced only relaxation during EFS. While MRS2500 showed no additional influence, L-NNA reversed relaxation (p = 0.012 in circular muscle, and p = 0.006 in longitudinal muscle). Tetrodotoxin abolished any EFS-induced motor response. Conclusions The relaxation of human gastric fundus muscle is reduced by nitrergic inhibition. Hence, nitrergic pathway appears to be the main mechanism for the human gastric fundus relaxation.	[Min, Yang Won; Hong, Yun Soo; Rhee, Poong-Lyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Ko, Eun-Ju; Lee, Ji-Yeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biomed Res Inst, Seoul, South Korea; [Ahn, Ki Duck; Bae, Je Moon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, PL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	plrhee@skku.edu		Rhee, Poong-Lyul/0000-0003-0495-5296				Andrews CN, 2007, AM J PHYSIOL-GASTR L, V292, pG1359, DOI 10.1152/ajpgi.00403.2006; Baccari MC, 2001, REGUL PEPTIDES, V98, P27, DOI 10.1016/S0167-0115(00)00225-1; BEREZIN I, 1994, AM J PHYSIOL, V266, pC981, DOI 10.1152/ajpcell.1994.266.4.C981; Boeckxstaens GE, 1997, COMP BIOCHEM PHYS A, V118, P925, DOI 10.1016/S0300-9629(97)00022-4; BOECKXSTAENS GE, 1992, ARCH INT PHARMACOD T, V318, P107; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; BURNSTOCK G, 1972, BRIT J PHARMACOL, V46, P234, DOI 10.1111/j.1476-5381.1972.tb06868.x; BURNSTOCK G, 1963, NATURE, V200, P581, DOI 10.1038/200581a0; BURNSTOCK G, 1986, ARCH INT PHARMACOD T, V280, P1; Curro D, 2004, BRIT J PHARMACOL, V143, P785, DOI 10.1038/sj.bjp.0705993; Curro D, 2002, N-S ARCH PHARMACOL, V366, P578, DOI 10.1007/s00210-002-0633-z; DAMATO M, 1992, J AUTONOM NERV SYST, V37, P175, DOI 10.1016/0165-1838(92)90039-J; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; DESAI KM, 1994, BRIT J PHARMACOL, V113, P1197, DOI 10.1111/j.1476-5381.1994.tb17124.x; FAHRENKRUG J, 1993, PHARMACOL TOXICOL, V72, P354, DOI 10.1111/j.1600-0773.1993.tb01344.x; Jenkinson KM, 2000, BRIT J PHARMACOL, V130, P1627, DOI 10.1038/sj.bjp.0703481; Kuiken SD, 2002, GUT, V51, P212, DOI 10.1136/gut.51.2.212; LEFEBVRE RA, 1992, BRIT J PHARMACOL, V106, P173, DOI 10.1111/j.1476-5381.1992.tb14311.x; LEFEBVRE RA, 1995, BRIT J PHARMACOL, V116, P2017, DOI 10.1111/j.1476-5381.1995.tb16406.x; LEFEBVRE RA, 1993, GEN PHARMACOL, V24, P257, DOI 10.1016/0306-3623(93)90301-D; LI CG, 1990, EUR J PHARMACOL, V191, P303; Min YW, 2014, J NEUROGASTROENTEROL, V20, P318, DOI 10.5056/jnm13098; Nan JF, 2015, J NEUROGASTROENTEROL, V21, P103, DOI 10.5056/jnm14096; RAND MJ, 1992, CLIN EXP PHARMACOL P, V19, P147, DOI 10.1111/j.1440-1681.1992.tb00433.x; SHUTTLEWORTH CWR, 1995, REGUL PEPTIDES, V56, P101, DOI 10.1016/0167-0115(95)00013-2; Sinn DH, 2010, AM J PHYSIOL-GASTR L, V299, pG1198, DOI 10.1152/ajpgi.00523.2009; Tack J, 2004, GASTROENTEROLOGY, V127, P1239, DOI 10.1053/j.gastro.2004.05.030; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Tack J, 2002, GUT, V51, P219, DOI 10.1136/gut.51.2.219; Toda N, 2005, PHARMACOL REV, V57, P315, DOI 10.1124/pr.57.3.4; Tonini M, 2000, BRIT J PHARMACOL, V129, P12, DOI 10.1038/sj.bjp.0702977; WARD SM, 1994, CELL TISSUE RES, V275, P513, DOI 10.1007/BF00318820	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162146	10.1371/journal.pone.0162146	http://dx.doi.org/10.1371/journal.pone.0162146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589594	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800033
J	Okuchi, Y; Imajo, M; Mizuno, R; Kamioka, Y; Miyoshi, H; Taketo, MM; Nagayama, S; Sakai, Y; Matsuda, M				Okuchi, Yoshihisa; Imajo, Masamichi; Mizuno, Rei; Kamioka, Yuji; Miyoshi, Hiroyuki; Taketo, Makoto Mark; Nagayama, Satoshi; Sakai, Yoshiharu; Matsuda, Michiyuki			Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; COLORECTAL-CANCER; EPIGENETIC DRIFT; ABERRANT CRYPTS; MURINE COLON; APC GENE; IN-VIVO; METHYLATION; NEOPLASIA; DISEASE	Aging-associated alterations of cellular functions have been implicated in various disorders including cancers. Due to difficulties in identifying aging cells in living tissues, most studies have focused on aging-associated changes in whole tissues or certain cell pools. Thus, it remains unclear what kinds of alterations accumulate in each cell during aging. While analyzing several mouse lines expressing fluorescent proteins (FPs), we found that expression of FPs is gradually silenced in the intestinal epithelium during aging in units of single crypt composed of clonal stem cell progeny. The cells with low FP expression retained the wildtype Apc allele and the tissues composed of them did not exhibit any histological abnormality. Notably, the silencing of FPs was also observed in intestinal adenomas and the surrounding normal mucosae of Apc-mutant mice, and mediated by DNA methylation of the upstream promoter. Our genome-wide analysis then showed that the silencing of FPs reflects specific gene expression alterations during aging, and that these alterations occur in not only mouse adenomas but also human sporadic and hereditary (familial adenomatous polyposis) adenomas. Importantly, pharmacological inhibition of DNA methylation, which suppresses adenoma development in Apc-mutant mice, reverted the aging-associated silencing of FPs and gene expression alterations. These results identify aging-associated gene expression signatures that are heterogeneously induced by DNA methylation and precede intestinal tumorigenesis triggered by Apc inactivation, and suggest that pharmacological inhibition of the signature genes could be a novel strategy for the prevention and treatment of intestinal tumors.	[Okuchi, Yoshihisa; Mizuno, Rei; Kamioka, Yuji; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol, Kyoto, Japan; [Okuchi, Yoshihisa; Mizuno, Rei; Kamioka, Yuji; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Biol Dis, Kyoto, Japan; [Okuchi, Yoshihisa; Mizuno, Rei] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Imajo, Masamichi; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Kyoto, Japan; [Kamioka, Yuji] Kyoto Univ, Innovat Technohub Integrated Med Bioimaging, Kyoto, Japan; [Miyoshi, Hiroyuki; Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Nagayama, Satoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japanese Foundation for Cancer Research	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol, Kyoto, Japan.; Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Dis, Kyoto, Japan.; Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Kyoto, Japan.	matsuda.michiyuki.2c@kyoto-u.ac.jp	Imajo, Masamichi/O-2140-2018	Imajo, Masamichi/0000-0003-0115-5840; Miyoshi, Hiroyuki/0000-0001-7400-0714; Matsuda, Michiyuki/0000-0002-5876-9969; Okuchi, Yoshihisa/0000-0003-3009-6990	Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, and Science (MEXT); Japan Agency for Medical Research and Development (AMED); MEXT; Naito Foundation;  [25870363]; Grants-in-Aid for Scientific Research [15H05949] Funding Source: KAKEN	Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, and Science (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YO and MM were supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, and Science (MEXT) and the Japan Agency for Medical Research and Development (AMED) (http://www.jst.go.jp/EN/index.html), and by a Grant-in-Aid for Scientific Research on Innovative Areas "Resonance Biology" of MEXT (https://kaken.nii.ac.jp/grant/KAKENHI-PLANNED-15H05949/). MM was also supported by the Naito Foundation (https://www.naito-f.or.jp/en/). MI was supported by a Grant-in-Aid for Young Scientists (B) (25870363) (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25870363/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cesari M, 2006, ANTIOXID REDOX SIGN, V8, P609, DOI 10.1089/ars.2006.8.609; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Cracowski JL, 2002, TRENDS PHARMACOL SCI, V23, P360, DOI 10.1016/S0165-6147(02)02053-9; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Kamioka Y, 2012, CELL STRUCT FUNCT, V37, P65, DOI 10.1247/csf.11045; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Luo YX, 2014, GASTROENTEROL REP, V2, P16, DOI 10.1093/gastro/got039; MCLELLAN EA, 1988, CANCER RES, V48, P6187; MEHTALI M, 1990, GENE, V91, P179, DOI 10.1016/0378-1119(90)90086-7; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Mizuno R, 2014, J EXP MED, V211, P1123, DOI 10.1084/jem.20132112; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shibata D, 2009, J PATHOL, V217, P199, DOI 10.1002/path.2461; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162300	10.1371/journal.pone.0162300	http://dx.doi.org/10.1371/journal.pone.0162300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589228	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800048
J	Jung, MG; Kim, SS; Yu, JH; Shin, KS				Jung, Mun-Gu; Kim, Sung Su; Yu, Jae-Hyuk; Shin, Kwang-Soo			Characterization of gprK Encoding a Putative Hybrid G-Protein-Coupled Receptor in Aspergillus fumigatus	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; YEAST SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGUS; CANDIDA-ALBICANS; SUPEROXIDE-DISMUTASE; GLIOTOXIN PRODUCTION; GALLERIA-MELLONELLA; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA; NIDULANS	The G-protein-coupled receptor (GPCR) family represents the largest and most varied collection of membrane embedded proteins that are sensitized by ligand binding and interact with heterotrimeric G proteins. Despite their presumed critical roles in fungal biology, the functions of the GPCR family members in the opportunistic human pathogen Aspergillus fumigatus are largely unknown, as only two (GprC and GprD) of the 15 predicted GPCRs have been studied. Here, we characterize the gprK gene, which is predicted to encode a hybrid GPCR with both 7-transmembrane and regulator of G-protein signaling (RGS) domains. The deletion of gprK causes severely impaired asexual development coupled with reduced expression of key developmental activators. Moreover, Delta gprK results in hyper-activation of germination even in the absence of carbon source, and elevated expression and activity of the protein kinase A PkaC1. Furthermore, proliferation of the Delta gprK mutant is restricted on the medium when pentose is the sole carbon source, suggesting that GprK may function in external carbon source sensing. Notably, the absence of gprK results in reduced tolerance to oxidative stress and significantly lowered mRNA levels of the stress-response associated genes sakA and atfA. Activities of catalases and SODs are severely decreased in the Delta gprK mutant, indicating that GprK may function in proper activation of general stress response. The Delta gprK mutant is also defective in gliotoxin (GT) production and slightly less virulent toward the greater wax moth, Galleria mellonella. Transcriptomic studies reveal that a majority of transporters are down-regulated by Delta gprK. In summary, GprK is necessary for proper development, GT production, and oxidative stress response, and functions in down-regulating the PKA-germination pathway.	[Jung, Mun-Gu; Shin, Kwang-Soo] Daejeon Univ, Dept Life Sci, Daejeon, South Korea; [Kim, Sung Su] Daejeon Univ, Dept Biomed Lab Sci, Daejeon, South Korea; [Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	Daejeon University; Daejeon University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shin, KS (corresponding author), Daejeon Univ, Dept Life Sci, Daejeon, South Korea.; Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Yu, JH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jyu1@wisc.edu; shinks@dju.kr	Yu, Jae-Hyuk/A-2343-2008; Shin, Kwang-Soo/W-3001-2019	Yu, Jae-Hyuk/0000-0002-6530-8407	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A1A2057724]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology	This work was primarily supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2057724) to K.S. Shin. The work at UW was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955) grants to J.H. Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affeldt KJ, 2014, MBIO, V5, DOI 10.1128/mBio.01501-14; Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; Akhtar N, 2015, MICROBIOL-SGM, V161, P1435, DOI 10.1099/mic.0.000088; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Cabrera IE, 2015, G3-GENES GENOM GENET, V5, P2729, DOI 10.1534/g3.115.020974; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chung KS, 2001, J BIOL CHEM, V276, P40190, DOI 10.1074/jbc.M100341200; Cockrill BA, 1999, ANNU REV MED, V50, P303, DOI 10.1146/annurev.med.50.1.303; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; DOWNEY RJ, 1994, MICROBIOS, V78, P35; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Fillinger S, 2002, MOL MICROBIOL, V44, P1001, DOI 10.1046/j.1365-2958.2002.02933.x; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gehrke A, 2010, APPL ENVIRON MICROB, V76, P3989, DOI 10.1128/AEM.00052-10; Gruber S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-108; Han KH, 2004, MOL MICROBIOL, V51, P1333, DOI 10.1111/j.1365-2958.2003.03940.x; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Karpichev IV, 2002, J BIOL CHEM, V277, P19609, DOI 10.1074/jbc.M202045200; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li LD, 2006, EUKARYOT CELL, V5, P1287, DOI 10.1128/EC.00109-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 2000, GENETICS, V154, P609; Lyons TJ, 2004, P NATL ACAD SCI USA, V101, P5506, DOI 10.1073/pnas.0306324101; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Miller TL, 1999, ENDOCRINOLOGY, V140, P4152, DOI 10.1210/en.140.9.4152; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Paris S, 2003, APPL ENVIRON MICROB, V69, P1581, DOI 10.1128/AEM.69.3.1581-1588.2003; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Scharf DH, 2012, APPL MICROBIOL BIOT, V93, P467, DOI 10.1007/s00253-011-3689-1; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; Shin KS, 2015, BIOCHEM BIOPH RES CO, V463, P428, DOI 10.1016/j.bbrc.2015.05.090; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; Unkles SE, 2001, EMBO J, V20, P6246, DOI 10.1093/emboj/20.22.6246; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yu JH, 2006, J MICROBIOL, V44, P145; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun CW, 1998, BIOCHEM BIOPH RES CO, V252, P29, DOI 10.1006/bbrc.1998.9600	69	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161312	10.1371/journal.pone.0161312	http://dx.doi.org/10.1371/journal.pone.0161312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584150	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600020
J	Marien, KM; Croons, V; Waumans, Y; Sluydts, E; De Schepper, S; Andries, L; Waelput, W; Fransen, E; Vermeulen, PB; Kockx, MM; De Meyer, GRY				Marien, Koen M.; Croons, Valerie; Waumans, Yannick; Sluydts, Ellen; De Schepper, Stefanie; Andries, Luc; Waelput, Wim; Fransen, Erik; Vermeulen, Peter B.; Kockx, Mark M.; De Meyer, Guido R. Y.			Development and Validation of a Histological Method to Measure Microvessel Density in Whole-Slide Images of Cancer Tissue	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VON-WILLEBRAND-FACTOR; RENAL-CELL CARCINOMA; TUMOR ANGIOGENESIS; MICROVASCULAR DENSITY; IMMUNOHISTOCHEMICAL EXPRESSION; INTERNATIONAL CONSENSUS; PROGNOSTIC-SIGNIFICANCE; QUANTITATIVE-ANALYSIS; VASCULAR PATTERNS	Despite all efforts made to develop predictive biomarkers for antiangiogenic therapies, no unambiguous markers have been identified so far. This is due to among others the lack of standardized tests. This study presents an improved microvessel density quantification method in tumor tissue based on stereological principles and using whole-slide images. Vessels in tissue sections of different cancer types were stained for CD31 by an automated and validated immunohistochemical staining method. The stained slides were digitized with a digital slide scanner. Systematic, uniform, random sampling of the regions of interest on the whole-slide images was performed semi-automatically with the previously published applications AutoTag and AutoSnap. Subsequently, an unbiased counting grid was combined with the images generated with these scripts. Up to six independent observers counted microvessels in up to four cancer types: colorectal carcinoma, glioblastoma multi-forme, ovarian carcinoma and renal cell carcinoma. At first, inter-observer variability was found to be unacceptable. However, after a series of consensus training sessions and interim statistical analysis, counting rules were modified and inter-observer concordance improved considerably. Every CD31-positive object was counted, with exclusion of suspected CD31-positive monocytes, macrophages and tumor cells. Furthermore, if interconnected, stained objects were considered a single vessel. Ten regions of interest were sufficient for accurate microvessel density measurements. Intra-observer and inter-observer variability were low (intraclass correlation coefficient > 0.7) if the observers were adequately trained.	[Marien, Koen M.; De Meyer, Guido R. Y.] Univ Antwerp, Div Physiopharmacol, Antwerp, Belgium; [Marien, Koen M.; Croons, Valerie; Waumans, Yannick; Sluydts, Ellen; De Schepper, Stefanie; Andries, Luc; Kockx, Mark M.] HistoGeneX NV, Antwerp, Belgium; [Waelput, Wim] Univ Hosp Brussels UZ Brussel, Dept Pathol, Brussels, Belgium; [Fransen, Erik] Univ Antwerp, StatUa Ctr Stat, Antwerp, Belgium; [Vermeulen, Peter B.] Univ Antwerp, Fac Med & Hlth Sci, CORE, Translat Canc Res Unit,GZA Hosp, Antwerp, Belgium	University of Antwerp; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University Hospital Brussels; University of Antwerp; University of Antwerp	Marien, KM (corresponding author), Univ Antwerp, Div Physiopharmacol, Antwerp, Belgium.; Marien, KM (corresponding author), HistoGeneX NV, Antwerp, Belgium.	koen.marien@uantwerpen.be	Fransen, Erik/C-4102-2015; De Meyer, Guido/R-8129-2016	Fransen, Erik/0000-0001-7785-4790; De Meyer, Guido/0000-0003-3848-8702; Marien, Koen/0000-0001-7212-7682; Waelput, Wim/0000-0002-4433-5852	HistoGeneX NV	HistoGeneX NV	The author(s) received no specific funding for this work. HistoGeneX NV provided support in the form of salaries for authors KMM, VC, YW, ES, SDS, LA and MMK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pathomation BVBA did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acikalin MF, 2005, DIGEST LIVER DIS, V37, P162, DOI 10.1016/j.dld.2004.09.028; Ahmed MM, 2010, INDIAN J PATHOL MICR, V53, P439, DOI 10.4103/0377-4929.68268; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Birner P, 2003, BRAIN PATHOL, V13, P133, DOI 10.1111/j.1750-3639.2003.tb00013.x; Birrer MJ, 2015, ASCO ANN M; BOSSI P, 1995, CANCER RES, V55, P5049; Boxer GM, 2005, TUMOR BIOL, V26, P1, DOI 10.1159/000084180; Cao Y, 2013, CANCER-AM CANCER SOC, V119, P313, DOI 10.1002/cncr.27746; Cartana T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052815; Chappell JC, 2012, CELLS TISSUES ORGANS, V195, P94, DOI 10.1159/000331398; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Duff SE, 2007, COLORECTAL DIS, V9, P793, DOI 10.1111/j.1463-1318.2006.01199.x; Edeline J, 2012, HUM PATHOL, V43, P1982, DOI 10.1016/j.humpath.2012.01.023; Ferrero A, 2011, GYNECOL ONCOL, V123, P301, DOI 10.1016/j.ygyno.2011.07.026; Foernzler D, 2010, GASTROINTESTINAL CAN; Fox SB, 2004, APMIS, V112, P413, DOI 10.1111/j.1600-0463.2004.apm11207-0803.x; Gao J, 2009, DIGEST LIVER DIS, V41, P116, DOI 10.1016/j.dld.2008.07.315; Griffioen AW, 2012, CLIN CANCER RES, V18, P3961, DOI 10.1158/1078-0432.CCR-12-0002; Grizzi F, 2007, APPL IMMUNOHISTO M M, V15, P134, DOI 10.1097/01.pai.0000213105.18569.fa; Gulubova M, 2009, J GASTROEN HEPATOL, V24, P1265, DOI 10.1111/j.1440-1746.2007.05009.x; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Han ES, 2010, GYNECOL ONCOL, V119, P484, DOI 10.1016/j.ygyno.2010.08.016; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hansen S, 1998, LAB INVEST, V78, P1563; Harjes U, 2012, BRIT J CANCER, V107, P1207, DOI 10.1038/bjc.2012.398; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Imao T, 2004, INT J UROL, V11, P948, DOI 10.1111/j.1442-2042.2004.00931.x; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Labiche A, 2009, HISTOL HISTOPATHOL, V24, P425, DOI 10.14670/HH-24.425; Landriscina M, 2006, J NEURO-ONCOL, V80, P251, DOI 10.1007/s11060-006-9189-y; Liang JT, 2004, BRIT J SURG, V91, P355, DOI 10.1002/bjs.4447; Liu YL, 2012, J CANCER RES CLIN, V138, P647, DOI 10.1007/s00432-011-1099-5; Lokmic Z, 2011, HISTOL HISTOPATHOL, V26, P781, DOI 10.14670/HH-26.781; MACLENNAN GT, 1995, UROLOGY, V46, P27, DOI 10.1016/S0090-4295(99)80153-8; Mahzouni P, 2010, INDIAN J PATHOL MICR, V53, P605, DOI 10.4103/0377-4929.71996; Marien KM, 2015, METHODSX, V2, P272, DOI 10.1016/j.mex.2015.05.002; Marien KM, 2015, EXPERT REV MOL DIAGN, V15, P399, DOI 10.1586/14737159.2015.993972; Martini M, 2013, CANCER-AM CANCER SOC, V119, P1004, DOI 10.1002/cncr.27821; Moreira LR, 2009, BRAZ J MED BIOL RES, V42, P593, DOI 10.1590/S0100-879X2009005000004; Nadkarni NJ, 2013, CANCER LETT, V331, P99, DOI 10.1016/j.canlet.2012.12.016; Nagy JA, 2009, BRIT J CANCER, V100, P865, DOI 10.1038/sj.bjc.6604929; Nagy JA, 2010, SEMIN THROMB HEMOST, V36, P321, DOI 10.1055/s-0030-1253454; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; Ning H, 2012, CHINESE MED J-PEKING, V125, P2120, DOI 10.3760/cma.j.issn.0366-6999.2012.12.008; Offersen BV, 2002, APMIS, V110, P177, DOI 10.1034/j.1600-0463.2002.100209.x; Onguru O, 2008, NEUROPATHOLOGY, V28, P29, DOI 10.1111/j.1440-1789.2007.00828.x; Pansrikaew P, 2010, ASIAN PAC J CANCER P, V11, P623; Pantanowitz L, 2013, ARCH PATHOL LAB MED, V137, P1710, DOI 10.5858/arpa.2013-0093-CP; Perryman LA, 2006, BIOCHEM BIOPH RES CO, V345, P1207, DOI 10.1016/j.bbrc.2006.05.020; Preusser M, 2006, CANCER-AM CANCER SOC, V107, P162, DOI 10.1002/cncr.21973; PROTOPAPA E, 1993, EUR J CANCER, V29A, P1391, DOI 10.1016/0959-8049(93)90008-4; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; R Core Team, 2021, R LANGUAGE ENV STAT; Ren JC, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-158; Romanenko AM, 2012, VIRCHOWS ARCH, V460, P611, DOI 10.1007/s00428-012-1243-x; Saad RS, 2006, MODERN PATHOL, V19, P1317, DOI 10.1038/modpathol.3800651; Sandlund J, 2007, TUMOR BIOL, V28, P158, DOI 10.1159/000102980; Sato S, 2011, HISTOL HISTOPATHOL, V26, P497, DOI 10.14670/HH-26.497; Semaan A, 2011, GYNECOL ONCOL, V121, P181, DOI 10.1016/j.ygyno.2010.11.019; Sharma S, 2005, HISTOPATHOLOGY, V46, P481, DOI 10.1111/j.1365-2559.2005.02142.x; Sica G, 2011, INT J ONCOL, V38, P41, DOI 10.3892/ijo_00000822; Sie M, 2010, NEUROPATH APPL NEURO, V36, P636, DOI 10.1111/j.1365-2990.2010.01113.x; Smith NR, 2013, CLIN CANCER RES, V19, P6943, DOI 10.1158/1078-0432.CCR-13-1637; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; St Croix B, 2000, SCIENCE, V289, P1197; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Tonar Z, 2008, MICROSC RES TECHNIQ, V71, P760, DOI 10.1002/jemt.20619; Vermeulen PB, 1999, BRIT J CANCER, V79, P316, DOI 10.1038/sj.bjc.6690051; Vermeulen PB, 1996, EUR J CANCER, V32A, P2474, DOI 10.1016/S0959-8049(96)00379-6; Vermeulen PB, 2002, EUR J CANCER, V38, P1564, DOI 10.1016/S0959-8049(02)00094-1; Wang JY, 2011, INT J BIOL SCI, V7, P600, DOI 10.7150/ijbs.7.600; Wang YX, 2012, REGUL PEPTIDES, V178, P36, DOI 10.1016/j.regpep.2012.06.005; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P1389, DOI 10.1037/0096-1523.33.6.1389; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wesseling P, 1998, HUM PATHOL, V29, P352, DOI 10.1016/S0046-8177(98)90115-0; Yan G, 2008, WORLD J GASTROENTERO, V14, P101, DOI 10.3748/wjg.14.101; Zhan HL, 2012, ASIAN PAC J CANCER P, V13, P867, DOI 10.7314/APJCP.2012.13.3.867; Zhang YA, 2011, CANCER LETT, V303, P47, DOI 10.1016/j.canlet.2011.01.011; Zhao GN, 2012, MED ONCOL, V29, P3325, DOI 10.1007/s12032-012-0313-x; Zhao YY, 2012, J THORAC ONCOL, V7, P71, DOI 10.1097/JTO.0b013e31823085f4	85	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161496	10.1371/journal.pone.0161496	http://dx.doi.org/10.1371/journal.pone.0161496			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583442	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600034
J	Pfefferle, D; Hammerschmidt, K; Mundry, R; Ruiz-Lambides, AV; Fischer, J; Widdig, A				Pfefferle, Dana; Hammerschmidt, Kurt; Mundry, Roger; Ruiz-Lambides, Angelina V.; Fischer, Julia; Widdig, Anja			Does the Structure of Female Rhesus Macaque Coo Calls Reflect Relatedness and/or Familiarity?	PLOS ONE			English	Article							MATRILINEAL SIGNATURES; PLAYBACK EXPERIMENTS; SOCIAL RELATIONSHIPS; BARBARY MACAQUES; PATERNAL KIN; AGE; SUPPORT; MONKEYS; KINSHIP; VOICE	In social animals, kin relations strongly shape the social structure of a group. In female-bonded species, maternal relatedness is likely to be mediated via familiarity, but evidence is accumulating that non-human primates are able to recognize kin that they are not familiar with and adjust their behavior accordingly. In playback experiments, female rhesus macaques showed increased interest in 'coo' calls produced by unfamiliar paternal half-sisters compared to 'coo' calls produced by unfamiliar unrelated females, suggesting that these calls should have some common structural characteristics that facilitate the discrimination of kin from non-kin. Here we analyzed 'coo' calls of 67 adult female rhesus macaques from four groups and seven matrilines living on the island of Cayo Santiago (Puerto Rico). We tested whether the call structure of closely maternal and/or paternal related females, as determined from extensive pedigree data, differed from the call structure of unrelated females, while controlling for familiarity (i.e., group-matrilineal membership and age difference) of subjects. In contrast to our expectation, kinship did not predict similarities in 'coo' call structure, whereas 'coo' structure was more similar when produced by females of similar age as well as by females with higher familiarity, suggesting that experience is more decisive than genetic background. The high number of individuals in the analysis and the high accuracy of the assignment of calls to individuals render a lack of power as an unlikely explanation. Thus, based on the results of this study, kin recognition in rhesus monkeys does neither appear to be based on the assessment of self-similarity, nor on the comparison among related subjects (i.e., acoustic phenotype matching), but appears to be mediated by different or multiple cues. Furthermore, the results support the notion that frequent social interactions result in increasing acoustic similarity within largely innate call types ('vocal accommodation').	[Pfefferle, Dana; Widdig, Anja] Univ Leipzig, Inst Biol, Behav Ecol Res Grp, Leipzig, Germany; [Pfefferle, Dana; Ruiz-Lambides, Angelina V.] Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Dept Primatol, Leipzig, Germany; [Pfefferle, Dana] German Primate Ctr, Cognit Neurosci Lab, Gottingen, Germany; [Pfefferle, Dana; Fischer, Julia] German Primate Ctr, Leibniz Sci Campus Primate Cognit, Gottingen, Germany; [Pfefferle, Dana; Fischer, Julia] Univ Gottingen, Gottingen, Germany; [Hammerschmidt, Kurt; Fischer, Julia] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Mundry, Roger] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Ruiz-Lambides, Angelina V.] Univ Puerto Rico, Caribbean Primate Res Ctr Cayo Santiago, San Juan, PR 00936 USA	Leipzig University; Max Planck Society; Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); University of Gottingen; Deutsches Primatenzentrum (DPZ); Max Planck Society; University of Puerto Rico	Pfefferle, D (corresponding author), Univ Leipzig, Inst Biol, Behav Ecol Res Grp, Leipzig, Germany.; Pfefferle, D (corresponding author), Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Dept Primatol, Leipzig, Germany.; Pfefferle, D (corresponding author), German Primate Ctr, Cognit Neurosci Lab, Gottingen, Germany.; Pfefferle, D (corresponding author), German Primate Ctr, Leibniz Sci Campus Primate Cognit, Gottingen, Germany.; Pfefferle, D (corresponding author), Univ Gottingen, Gottingen, Germany.	dpfefferle@dpz.eu	Fischer, Julia/B-6674-2008	Fischer, Julia/0000-0002-5807-0074; Pfefferle, Dana/0000-0003-4827-0360	Deutsche Forschungsgemeinschaft [PF 659/3-1, WI 1808/3-1, WI 1808/5-1]; National Institutes of Health [2P40OD012217]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD012217] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Deutsche Forschungsgemeinschaft, www.dfg.de, PF 659/3-1 to DP, WI 1808/3-1 and WI 1808/5-1 to AW and conducted within the Emmy-Noether Group of 'Primate Kin Selection' awarded to AW; Maintenance of the Cayo Santiago population is currently supported by the University of Puerto Rico (UPR) and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health (https://www.nih.gov/, grant number 2P40OD012217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol J, 1999, J VOICE, V13, P424, DOI 10.1016/S0892-1997(99)80048-4; Ackermann H, 2014, BEHAV BRAIN SCI, V37, DOI 10.1017/S0140525X1400003X; Aiken L. S., 1991, MULTIPLE REGRESSION; Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bercovitch FB, 2003, NATURWISSENSCHAFTEN, V90, P309, DOI 10.1007/s00114-003-0436-1; Boulet MJ, 1996, MATURITAS, V23, P15, DOI 10.1016/0378-5122(95)00947-7; Caruso S, 2000, FERTIL STERIL, V74, P1073, DOI 10.1016/S0015-0282(00)01582-X; Casper JK, 2006, UNDERSTANDING VOICE; da Silva PT, 2011, J VOICE, V25, P411, DOI 10.1016/j.jvoice.2010.04.002; Egnor SER, 2004, TRENDS NEUROSCI, V27, P649, DOI 10.1016/j.tins.2004.08.009; Ferrand CT, 2002, J VOICE, V16, P480, DOI 10.1016/S0892-1997(02)00123-6; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Fischer J, 1998, ANIM BEHAV, V56, P623, DOI 10.1006/anbe.1998.0796; Fischer J., 2008, LEARNING MEMORY COMP, P299, DOI [10.1016/B978-012370509-9.00055-3, DOI 10.1016/B978-012370509-9.00055-3]; Fischer J, 2013, AM J PRIMATOL, V75, P643, DOI 10.1002/ajp.22153; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Fox J., 2018, R COMPANION APPL REG, VThird; GERRITSMA EJ, 1994, CLIN OTOLARYNGOL, V19, P79, DOI 10.1111/j.1365-2273.1994.tb01153.x; GOUZOULES H, 1990, BEHAVIOUR, V115, P327, DOI 10.1163/156853990X00635; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerschmidt K, 1998, PRIMATES, V39, P231, DOI 10.1007/BF02557735; Hammerschmidt K., 2008, EVOLUTION COMMUNICAT, P93; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; HAUSER MD, 1991, ETHOLOGY, V89, P29; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; JANUS M, 1992, AM J PRIMATOL, V26, P291, DOI 10.1002/ajp.1350260406; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kessler SE, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-14; Koda H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071432; KUESTER J, 1994, ANIM BEHAV, V48, P1183, DOI 10.1006/anbe.1994.1350; Lemasson A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-362; Levrero F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8609; Lindholm P, 1997, MATURITAS, V28, P47, DOI 10.1016/S0378-5122(97)00062-5; Locke JL, 1995, THE CHILDS PATH TO S; Meyer D, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-16; MITANI JC, 1992, AM J PRIMATOL, V27, P233, DOI 10.1002/ajp.1350270402; Naguib M, 2001, ETHOLOGY, V107, P341, DOI 10.1046/j.1439-0310.2001.00669.x; Penn DJ, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P55; PEREIRA ME, 1988, ANIM BEHAV, V36, P184, DOI 10.1016/S0003-3472(88)80262-8; Pfefferle D, 2014, CURR BIOL, V24, P1806, DOI 10.1016/j.cub.2014.06.058; Pfefferle D, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1628; Quinn G.P., 2002, EXPT DESIGN DATA ANA; References Seyfarth RM, 2012, KNOWLEDGE SOCIAL REL, P628; Rendall D, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P295; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; Sato K, 2002, ANN OTO RHINOL LARYN, V111, P15, DOI 10.1177/000348940211100103; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schrader Lars, 1997, Bioacoustics, V7, P247; Schulke O, 2012, EVOLUTION PRIMATE SO, P193; SHERMAN PW, 1980, AM NAT, V116, P604, DOI 10.1086/283652; SILK J, 1993, INT J PRIMATOL, V14, P95, DOI 10.1007/BF02196505; Snowdon CT, 1999, ETHOLOGY, V105, P893, DOI 10.1046/j.1439-0310.1999.00483.x; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Van Horn RC, 2008, ANIM BEHAV, V75, P1173, DOI 10.1016/j.anbehav.2007.08.027; Thinh VN, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-36; Watson SK, 2015, CURR BIOL, V25, P495, DOI 10.1016/j.cub.2014.12.032; Weiss BM, BEHAV ECOL IN PRESS; Widdig A, 2001, P NATL ACAD SCI USA, V98, P13769, DOI 10.1073/pnas.241210198; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x; Widdig A, 2016, AM J PRIMATOL, V78, P44, DOI 10.1002/ajp.22424; Zuur Alain F., 2009, P1	66	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161133	10.1371/journal.pone.0161133	http://dx.doi.org/10.1371/journal.pone.0161133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579491	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400018
J	Roberto, G; Leal, I; Sattar, N; Loomis, AK; Avillach, P; Egger, P; van Wijngaarden, R; Ansell, D; Reisberg, S; Tammesoo, ML; Alavere, H; Pasqua, A; Pedersen, L; Cunningham, J; Tramontan, L; Mayer, MA; Herings, R; Coloma, P; Lapi, F; Sturkenboom, M; van der Lei, J; Schuemie, MJ; Rijnbeek, P; Gini, R				Roberto, Giuseppe; Leal, Ingrid; Sattar, Naveed; Loomis, A. Katrina; Avillach, Paul; Egger, Peter; van Wijngaarden, Rients; Ansell, David; Reisberg, Sulev; Tammesoo, Mari-Liis; Alavere, Helene; Pasqua, Alessandro; Pedersen, Lars; Cunningham, James; Tramontan, Lara; Mayer, Miguel A.; Herings, Ron; Coloma, Preciosa; Lapi, Francesco; Sturkenboom, Miriam; van der Lei, Johan; Schuemie, Martijn J.; Rijnbeek, Peter; Gini, Rosa			Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project	PLOS ONE			English	Article							HEALTH-CARE DATABASES; DRUG; PREVALENCE; VALIDATION; EXPERIENCE; RECORDS; RISK	Due to the heterogeneity of existing European sources of observational healthcare data, data source-tailored choices are needed to execute multi-data source, multi-national epidemiological studies. This makes transparent documentation paramount. In this proof-of-concept study, a novel standard data derivation procedure was tested in a set of heterogeneous data sources. Identification of subjects with type 2 diabetes (T2DM) was the test case. We included three primary care data sources (PCDs), three record linkage of administrative and/or registry data sources (RLDs), one hospital and one biobank. Overall, data from 12 million subjects from six European countries were extracted. Based on a shared event definition, sixteeen standard algorithms (components) useful to identify T2DM cases were generated through a top-down/bottom-up iterative approach. Each component was based on one single data domain among diagnoses, drugs, diagnostic test utilization and laboratory results. Diagnoses-based components were subclassified considering the healthcare setting (primary, secondary, inpatient care). The Unified Medical Language System was used for semantic harmonization within data domains. Individual components were extracted and proportion of population identified was compared across data sources. Drug-based components performed similarly in RLDs and PCDs, unlike diagnoses-based components. Using components as building blocks, logical combinations with AND, OR, AND NOT were tested and local experts recommended their preferred data source-tailored combination. The population identified per data sources by resulting algorithms varied from 3.5% to 15.7%, however, age-specific results were fairly comparable. The impact of individual components was assessed: diagnoses-based components identified the majority of cases in PCDs (93-100%), while drug-based components were the main contributors in RLDs (81-100%). The proposed data derivation procedure allowed the generation of data source-tailored case-finding algorithms in a standardized fashion, facilitated transparent documentation of the process and benchmarking of data sources, and provided bases for interpretation of possible inter-data source inconsistency of findings in future studies.	[Roberto, Giuseppe; Lapi, Francesco; Gini, Rosa] Reg Agcy Healthcare Serv Tuscany, Epidemiol Unit, Florence, Italy; [Leal, Ingrid; Avillach, Paul; Coloma, Preciosa; Sturkenboom, Miriam; van der Lei, Johan; Rijnbeek, Peter] Erasmus Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Sattar, Naveed] Univ Glasgow, British Heart Fdn Glasgow, Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Loomis, A. Katrina] Pfizer Worldwide Res & Dev, Groton, CT USA; [Avillach, Paul] Harvard Med Sch, Dept Biomed Informat, Boston, MA USA; [Avillach, Paul] Boston Childrens Hosp, Childrens Hosp Informat Program, Boston, MA USA; [Egger, Peter] GlaxoSmithKline, Worldwide Epidemiol GSK, Stockley Pk West, Uxbridge, Middx, England; [van Wijngaarden, Rients; Herings, Ron] PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands; [Ansell, David] Cegedim Strateg Data Med Res Ltd, Hlth Improvement Network, London, England; [Reisberg, Sulev] Univ Tartu, Software Technol & Applicat Competence Ctr, Quretec, Tartu, Estonia; [Tammesoo, Mari-Liis; Alavere, Helene] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Tammesoo, Mari-Liis; Alavere, Helene] Tartu Univ Hosp, Tartu, Estonia; [Pasqua, Alessandro] Italian Coll Gen Practitioners & Primary Care, Hlth Search, Florence, Italy; [Pedersen, Lars] Aarhus Univ Hosptial, Dept Clin Epidemiol, Aarhus, Denmark; [Cunningham, James] Univ Manchester, Manchester, Lancs, England; [Tramontan, Lara] Arsenal IT Consortium, Venetos Res Ctr eHlth Innovat, Treviso, Italy; [Mayer, Miguel A.] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Mayer, Miguel A.] Univ Pompeu Fabra, Barcelona, Spain; [Schuemie, Martijn J.] Janssen Res & Dev, Epidemiol, Titusville, NJ USA; [Schuemie, Martijn J.] Observat Hlth Data Sci & Informat, New York, NY USA	Erasmus University Rotterdam; Erasmus MC; University of Glasgow; Pfizer; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; GlaxoSmithKline; University of Tartu; University of Tartu; Aarhus University; University of Manchester; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Johnson & Johnson; Janssen Pharmaceuticals	Roberto, G (corresponding author), Reg Agcy Healthcare Serv Tuscany, Epidemiol Unit, Florence, Italy.	giuseppe.roberto@ars.toscana.it	Roberto, Giuseppe/AAR-4498-2020; Mayer, Miguel Angel/AAL-2810-2021; Mayer, Miguel Angel/K-5255-2014; Herings, Ron/AAE-4096-2021	Roberto, Giuseppe/0000-0001-6478-6442; Mayer, Miguel Angel/0000-0003-0362-6298; Mayer, Miguel Angel/0000-0003-0362-6298; Herings, Ron/0000-0002-2561-8734; Gini, Rosa/0000-0002-6250-877X; Reisberg, Sulev/0000-0001-6835-9632; Schuemie, Martijn/0000-0002-0817-5361; Ansell, David/0000-0001-9575-1509; Sturkenboom, Miriam/0000-0003-1360-2388	Innovative Medicines Initiative Joint Undertaking under European Medical Information Framework grant [115372]; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Association companies'; Pfizer Worldwide Research and Development; GlaxoSmithKline; Cegedim Strategic Data Medical Research Ltd; Janssen	Innovative Medicines Initiative Joint Undertaking under European Medical Information Framework grant; European Union's Seventh Framework Programme (FP7); European Federation of Pharmaceutical Industries and Association companies'; Pfizer Worldwide Research and Development; GlaxoSmithKline(GlaxoSmithKline); Cegedim Strategic Data Medical Research Ltd; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking (http://www.imi.europa.eu/) under European Medical Information Framework grant agreement no. 115372, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Association companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer Worldwide Research and Development, GlaxoSmithKline, Cegedim Strategic Data Medical Research Ltd and Janssen provided support in the form of salaries for AKL, PE, DA and MJS, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, PREV EST DIAB AD AG; Avillach P, 2013, J AM MED INFORM ASSN, V20, P184, DOI 10.1136/amiajnl-2012-000933; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Blak Betina T, 2011, Inform Prim Care, V19, P251; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Conway Mike, 2011, AMIA Annu Symp Proc, V2011, P274; Gini R, 2015, PHARMACOEPIDEM DR S, V24, P1; Gini Rosa, 2016, EGEMS (Wash DC), V4, P1189, DOI 10.13063/2327-9214.1189; Gini R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-15; Hernan MA, 2011, EPIDEMIOLOGY, V22, P290, DOI 10.1097/EDE.0b013e3182114039; Hripcsak G, 2013, J AM MED INFORM ASSN, V20, P117, DOI 10.1136/amiajnl-2012-001145; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P303, DOI 10.2147/CLEP.S37587; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Mayer MA, 2015, STUD HEALTH TECHNOL, V210, P224, DOI 10.3233/978-1-61499-512-8-224; Morley KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110900; Nexo BA, 2013, EPIDEMIOLOGY, V24, P331, DOI 10.1097/EDE.0b013e318281e48a; Overby CL, 2013, J AM MED INFORM ASSN, V20, pE243, DOI 10.1136/amiajnl-2013-001930; Pathak J, 2013, J AM MED INFORM ASSN, V20, pE206, DOI 10.1136/amiajnl-2013-002428; Richesson R L, 2014, Yearb Med Inform, V9, P215, DOI 10.15265/IY-2014-0009; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE319, DOI 10.1136/amiajnl-2013-001952; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sancho JJ, 1998, ST HEAL T, V56, P35; Trifiro G, 2014, J INTERN MED, V275, P551, DOI 10.1111/joim.12159; Valkhoff VE, 2014, J CLIN EPIDEMIOL, V67, P921, DOI 10.1016/j.jclinepi.2014.02.020; van Herk-Sukel MPP, 2012, PHARMACOEPIDEM DR S, V21, P94, DOI 10.1002/pds.2205; Vlug AE, 1999, METHOD INFORM MED, V38, P339; World Health Organization, 1999, WHONCDNCS992	29	19	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160648	10.1371/journal.pone.0160648	http://dx.doi.org/10.1371/journal.pone.0160648			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27580049	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000382877400008
J	Skov, V; Burton, M; Thomassen, M; Larsen, TS; Riley, CH; Madelung, AB; Kjaer, L; Bondo, H; Stamp, I; Ehinger, M; Dahl-Sorensen, R; Brochmann, N; Nielsen, K; Thiele, J; Jensen, MK; Bjerrum, OW; Kruse, TA; Hasselbalch, HC				Skov, Vibe; Burton, Mark; Thomassen, Mads; Larsen, Thomas Stauffer; Riley, Caroline H.; Madelung, Ann Brinch; Kjaer, Lasse; Bondo, Henrik; Stamp, Inger; Ehinger, Mats; Dahl-Sorensen, Rasmus; Brochmann, Nana; Nielsen, Karsten; Thiele, Juergen; Jensen, Morten K.; Bjerrum, Ole Weis; Kruse, Torben A.; Hasselbalch, Hans Carl			A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis	PLOS ONE			English	Article							ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; IDIOPATHIC MYELOFIBROSIS; GENE-EXPRESSION; CD34(+) CELLS; PANCREATIC ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CHRONIC INFLAMMATION; DIAGNOSIS; DISEASE	Recent studies have shown that a large proportion of patients classified as essential thrombocythemia (ET) actually have early primary prefibrotic myelofibrosis (prePMF), which implies an inferior prognosis as compared to patients being diagnosed with so-called genuine or true ET. According to the World Health Organization (WHO) 2008 classification, bone marrow histology is a major component in the distinction between these disease entities. However, the differential diagnosis between them may be challenging and several studies have not been able to distinguish between them. Most lately, it has been argued that simple blood tests, including the leukocyte count and plasma lactate dehydrogenase (LDH) may be useful tools to separate genuine ET from prePMF, the latter disease entity more often being featured by anemia, leukocytosis and elevated LDH. Whole blood gene expression profiling was performed in 17 and 9 patients diagnosed with ET and PMF, respectively. Using elevated LDH obtained at the time of diagnosis as a marker of prePMF, a 7-gene signature was identified which correctly predicted the prePMF group with a sensitivity of 100% and a specificity of 89%. The 7 genes included MPO, CEACAM8, CRISP3, MS4A3, CEACAM6, HEMGN, and MMP8, which are genes known to be involved in inflammation, cell adhesion, differentiation and proliferation. Evaluation of bone marrow biopsies and the 7-gene signature showed a concordance rate of 71%, 79%, 62%, and 38%. Our 7-gene signature may be a useful tool to differentiate between genuine ET and prePMF but needs to be validated in a larger cohort of "ET" patients.	[Skov, Vibe; Riley, Caroline H.; Kjaer, Lasse; Dahl-Sorensen, Rasmus; Brochmann, Nana; Jensen, Morten K.; Hasselbalch, Hans Carl] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark; [Burton, Mark; Thomassen, Mads; Kruse, Torben A.] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark; [Larsen, Thomas Stauffer] Odense Univ Hosp, Dept Hematol 10, Odense, Denmark; [Madelung, Ann Brinch; Bondo, Henrik; Stamp, Inger] Naestved Hosp, Dept Pathol, Naestved, Denmark; [Ehinger, Mats] Univ Lund Hosp, Dept Pathol, Lund, Sweden; [Nielsen, Karsten] Univ Aarhus, Dept Pathol, Aarhus, Denmark; [Thiele, Juergen] Univ Cologne, Inst Pathol, Cologne, Germany; [Bjerrum, Ole Weis] Univ Copenhagen, Dept Hematol L, Rigshosp, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Naestved Hospital; Lund University; Skane University Hospital; Aarhus University; University of Cologne; Rigshospitalet; University of Copenhagen	Hasselbalch, HC (corresponding author), Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark.	hans.hasselbalch@gmail.com	Bjerrum, Ole Weis/AAF-9999-2019; Hasselbalch, Hans/H-2217-2017	Hasselbalch, Hans/0000-0003-3936-8032; Larsen, Thomas Stauffer/0000-0002-8418-6708	Danish Council for independent Research Medical Sciences	Danish Council for independent Research Medical Sciences(Det Frie Forskningsrad (DFF))	The study has received grants from The Danish Council for independent Research Medical Sciences (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-sundhed-og-sygdom).	Aumann K, 2013, BLOOD, V122, P93, DOI 10.1182/blood-2012-11-463257; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barbui T, 2013, LEUKEMIA, V27, P1953, DOI 10.1038/leu.2013.74; Barbui T, 2012, BLOOD, V120, P569, DOI 10.1182/blood-2012-01-407981; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barcellini W, 2013, LEUKEMIA RES, V37, P1509, DOI 10.1016/j.leukres.2013.09.001; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2014, CURR HEMATOL MALIG R, V9, P331, DOI 10.1007/s11899-014-0227-0; Barosi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035631; Barosi G, 2010, LEUKEMIA RES, V34, P1119, DOI 10.1016/j.leukres.2010.05.010; Beer PA, 2010, HAEMATOL-HEMATOL J, V95, P1960, DOI 10.3324/haematol.2010.026708; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Berkofsky-Fessler W, 2010, CLIN CANCER RES, V16, P4339, DOI 10.1158/1078-0432.CCR-10-1092; Borregaard N, 2001, CURR OPIN HEMATOL, V8, P23, DOI 10.1097/00062752-200101000-00005; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brousseau M, 2010, HISTOPATHOLOGY, V56, P758, DOI 10.1111/j.1365-2559.2010.03545.x; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Carobbio A, 2012, AM J HEMATOL, V87, P203, DOI 10.1002/ajh.22241; Donato JL, 2002, J CLIN INVEST, V109, P51, DOI 10.1172/JCI14025; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Ester A, 1981, Sangre (Barc), V26, P567; Finazzi G, 2012, LEUKEMIA, V26, P716, DOI 10.1038/leu.2011.258; Gnatenko DV, 2010, BLOOD, V115, P7, DOI 10.1182/blood-2009-05-224477; GORDON BR, 1981, BLOOD, V58, P904; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Hager M, 2010, J INTERN MED, V268, P25, DOI 10.1111/j.1365-2796.2010.02237.x; HASSELBALCH H, 1985, SCAND J HAEMATOL, V34, P177; HASSELBALCH H, 1984, SCAND J HAEMATOL, V32, P179; HASSELBALCH H, 1990, AM J HEMATOL, V34, P291, DOI 10.1002/ajh.2830340411; Hasselbalch HC, 2014, LEUKEMIA RES, V38, P263, DOI 10.1016/j.leukres.2013.07.002; Hasselbalch HC, 2013, CYTOKINE GROWTH F R, V24, P133, DOI 10.1016/j.cytogfr.2013.01.004; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112786; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085567; Hasselbalch HC, 2013, LEUKEMIA RES, V37, P214, DOI 10.1016/j.leukres.2012.10.020; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hasselbalch HC, 2011, LEUKEMIA RES, V35, P1330, DOI 10.1016/j.leukres.2011.03.013; Hasselbalch HC, 2009, LEUKEMIA RES, V33, P11, DOI 10.1016/j.leukres.2008.06.002; Hermouet S, 2011, HAEMATOL-HEMATOL J, V96, P1575, DOI 10.3324/haematol.2011.055392; Hussein K, 2009, EXP HEMATOL, V37, P1186, DOI 10.1016/j.exphem.2009.07.005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang J, 2010, BLOOD, V116, P711, DOI 10.1182/blood-2009-07-235341; Koschmieder S, 2016, LEUKEMIA, V30, P1018, DOI 10.1038/leu.2016.12; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kvasnicka HM, 2006, SEMIN THROMB HEMOST, V32, P362, DOI 10.1055/s-2006-942757; Lataillade JJ, 2008, BLOOD, V112, P3026, DOI 10.1182/blood-2008-06-158386; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Maraqa L, 2008, CLIN CANCER RES, V14, P405, DOI 10.1158/1078-0432.CCR-07-1363; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Rotunno G, 2014, BLOOD, V123, P1552, DOI 10.1182/blood-2013-11-538983; Rupoli S, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0269-1; Skov V, 2013, LEUKEMIA LYMPHOMA, V54, P2269, DOI 10.3109/10428194.2013.764417; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Skov V, 2012, LEUKEMIA LYMPHOMA, V53, P123, DOI 10.3109/10428194.2011.597905; Skov V, 2011, EUR J HAEMATOL, V87, P54, DOI 10.1111/j.1600-0609.2011.01618.x; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tefferi A, 2000, NEW ENGL J MED, V342, P1255, DOI 10.1056/NEJM200004273421706; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; Thiele J, 2002, LEUKEMIA LYMPHOMA, V43, P1035, DOI 10.1080/10428190290021542; Thiele J, 2001, ANN HEMATOL, V80, P160, DOI 10.1007/s002770000278; Thiele J, 2000, HAEMATOLOGICA, V85, P1126; Thiele J, 2011, BLOOD, V117, P5710, DOI 10.1182/blood-2010-07-293761; Thiele Juergen, 2009, Curr Hematol Malig Rep, V4, P33, DOI 10.1007/s11899-009-0005-6; VELLENGA E, 1982, CLIN LAB HAEMATOL, V4, P239; Visekruna A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/239368; Wilkins BS, 2008, BLOOD, V111, P60, DOI 10.1182/blood-2007-05-091850; Xu M, 2005, BLOOD, V105, P4805; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8	70	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161570	10.1371/journal.pone.0161570	http://dx.doi.org/10.1371/journal.pone.0161570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579896	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400028
J	Gonzalez-Alvaro, I; Castrejon, I; Ortiz, AM; Toledano, E; Castaneda, S; Garcia-Vadillo, A; Carmona, L				Gonzalez-Alvaro, Isidoro; Castrejon, Isabel; Ortiz, Ana M.; Toledano, Esther; Castaneda, Santos; Garcia-Vadillo, Alberto; Carmona, Loreto		EMECAR Study Grp	Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACTIVITY SCORE; SEDIMENTATION-RATE; VALIDATION; THERAPIES; REMISSION; CONSENSUS; SOCIETY; GENDER; VALUES	Objective To estimate cut-off points and to establish response criteria for the Hospital Universitario La Princesa Index (HUPI) in patients with chronic polyarthritis. Methods Two cohorts, one of early arthritis (Princesa Early Arthritis Register Longitudinal [PEARL] study) and other of long-term rheumatoid arthritis (Estudio de la Morbilidad y Expresion Clinica de la Artritis Reumatoide [EMECAR]) including altogether 1200 patients were used to determine cut-off values for remission, and for low, moderate and high activity through receiver operating curve (ROC) analysis. The areas under ROC (AUC) were compared to those of validated indexes (SDAI, CDAI, DAS28). ROC analysis was also applied to establish minimal and relevant clinical improvement for HUPI. Results The best cut-off points for HUPI are 2, 5 and 9, classifying RA activity as remission if <= 2, low disease activity if > 2 and <= 5), moderate if > 5 and < 9 and high if >= 9. HUPI's AUC to discriminate between low-moderate activity was 0.909 and between moderate-high activity 0.887. DAS28's AUCs were 0.887 and 0.846, respectively; both indices had higher accuracy than SDAI (AUCs: 0.832 and 0.756) and CDAI (AUCs: 0.789 and 0.728). HUPI discriminates remission better than DAS28-ESR in early arthritis, but similarly to SDAI. The HUPI cut-off for minimal clinical improvement was established at 2 and for relevant clinical improvement at 4. Response criteria were established based on these cut-off values. Conclusions The cut-offs proposed for HUPI perform adequately in patients with either early or long term arthritis.	[Gonzalez-Alvaro, Isidoro; Ortiz, Ana M.; Castaneda, Santos; Garcia-Vadillo, Alberto] Hosp Univ Princesa, IIS IP, Dept Rheumatol, Madrid, Spain; [Castrejon, Isabel] Rush Univ, Med Ctr, Div Rheumatol, Chicago, IL 60612 USA; [Toledano, Esther] Hosp Clin San Carlos, Dept Rheumatol, IdISSC, Madrid, Spain; [Carmona, Loreto] Inst Salud Musculoesquelet, Madrid, Spain	Rush University; Hospital Clinico San Carlos	Gonzalez-Alvaro, I (corresponding author), Hosp Univ Princesa, IIS IP, Dept Rheumatol, Madrid, Spain.	isidoro.ga@ser.es	Castrejon, Isabel/ABH-5293-2020; Hernandez, Antonio Naranjo/E-7910-2010; Carmona, Loreto/A-2748-2014; Sanmarti, Raimon/M-4434-2017	Hernandez, Antonio Naranjo/0000-0002-2013-6664; Carmona, Loreto/0000-0002-4401-2551; Casado, Enrique/0000-0001-8839-6430; Garcia Vadillo, Alberto/0000-0003-3262-8364; Castrejon, MD, PhD, Isabel/0000-0003-1811-2417; Sanmarti, Raimon/0000-0002-8864-3806; Gratacos, Jordi/0000-0003-4007-4103; BELMONTE-SERRANO, MIGUEL ANGEL/0000-0002-4874-0433	Ministerio de Economia y Competitividad (Instituto de Salud Carlos III) [RD12/0009/0017, PI14/00442]; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Society of Rheumatology; Spanish Foundation of Rheumatology; Aventis	Ministerio de Economia y Competitividad (Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Spanish Society of Rheumatology; Spanish Foundation of Rheumatology; Aventis(Sanofi-Aventis)	Support was provided by grants RD12/0009/0017 and PI14/00442 to IG-A from the Ministerio de Economia y Competitividad (Instituto de Salud Carlos III) and co-funded by Fondo Europeo de Desarrollo Regional (FEDER). The EMECAR study was funded by the Spanish Society of Rheumatology, the Spanish Foundation of Rheumatology, and by an independent research grant from Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlmen M, 2010, ANN RHEUM DIS, V69, P230, DOI 10.1136/ard.2008.102244; Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Fernandez IC, 2010, REUMATOL CLIN, V6, P33, DOI 10.1016/j.reuma.2009.12.003; Castrejon I, 2008, CLIN EXP RHEUMATOL, V26, P769; Castrejon I, 2013, ARTHRIT CARE RES, V65, P518, DOI 10.1002/acr.21854; Castrejon I, 2010, J RHEUMATOL, V37, P1439, DOI 10.3899/jrheum.091333; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Gonzalez-Alvaro I, 2015, RHEUMATOLOGY, V54, P1200, DOI 10.1093/rheumatology/keu461; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Gonzalez-Alvaro I, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2561; Hallert E, 2003, ANN RHEUM DIS, V62, P667, DOI 10.1136/ard.62.7.667; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Leeb BF, 2007, J RHEUMATOL, V34, P2382; PINALS RS, 1981, ARTHRITIS RHEUM, V24, P1308, DOI 10.1002/art.1780241012; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radovits BJ, 2008, ANN RHEUM DIS, V67, P1127, DOI 10.1136/ard.2007.079913; Saleem B, 2006, CLIN EXP RHEUMATOL, V24, pS33; Sanmarti R, 2015, REUMATOL CLIN, V11, P279, DOI [10.1016/J.REUMA.2015.05.001, 10.1016/j.reuma.2015.05.001]; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B	23	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161727	10.1371/journal.pone.0161727	http://dx.doi.org/10.1371/journal.pone.0161727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603313	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200022
J	Ibinda, F; Zarnack, HC; Newton, CR				Ibinda, Fredrick; Zarnack, Hans-Christoph; Newton, Charles R.			Sodium Disturbances in Children Admitted to a Kenyan Hospital: Magnitude, Outcome and Associated Factors	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE SYSTEM; SEVERE FALCIPARUM-MALARIA; KILIFI HEALTH; HYPONATREMIA; HYPERNATREMIA; DEHYDRATION; VASOPRESSIN; PREVALENCE; SEIZURES; DEATH	Background Perturbations of blood sodium are the most frequently encountered electrolyte disorder in sick children, and may influence fluid therapy. We examined the frequency of blood sodium perturbations, and factors and outcomes associated with hyponatremia in children admitted to a rural Kenyan hospital and investigated the risk factors associated with deaths in hyponatremic children. Methods Plasma sodium levels and other laboratory parameters were measured in children admitted to a rural Kenyan hospital. Clinical measurements were collected using standard forms and entered into a computer database. The proportion of children admitted with hyponatremia was determined. Logistic regression models were used to investigate factors associated with hyponatremia, and death in those with hyponatremia. Results Abnormal plasma sodium occurred in 46.6%(95% confidence interval (95% CI) 43.5-49.6%) of 1026 pediatric admissions. Hyponatremia occurred in 44.4% (95% CI 41.4-47.5%) and hypernatremia in 2.1% (95% CI 1.3-3.0%). Malaria (40.8%) was the most common underlying primary diagnosis in hyponatremic children. Malaria, hyperglycemia, wasting, high creatinine levels and preserved consciousness were associated with hyponatremia. Pallor and seizures were associated with increased mortality in hyponatremic children. Conclusions Sodium disturbances are common in pediatric admissions to a County hospital in rural Kenya. Seizures and pallor were predictors of mortality in hyponatremic children.	[Ibinda, Fredrick; Zarnack, Hans-Christoph; Newton, Charles R.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford	Newton, CR (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya.; Newton, CR (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	cnewton@kemri-wellcome.org	Newton, Charles RJC/B-7578-2014	Newton, Charles RJC/0000-0002-6999-5507	Wellcome Trust Senior Clinical Fellowship [083744]; Wellcome Trust masters training fellowship [101140]	Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Wellcome Trust masters training fellowship	This study was supported by the Wellcome Trust Senior Clinical Fellowship to Professor Charles Newton (No. 083744). Fredrick Ibinda was supported by the Wellcome Trust masters training fellowship (101140).	ANDERSON RJ, 1985, ANN INTERN MED, V102, P164, DOI 10.7326/0003-4819-102-2-164; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Ayus JC, 2008, AM J PHYSIOL-RENAL, V295, pF619, DOI 10.1152/ajprenal.00502.2007; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dunn K, 1997, J PAEDIATR CHILD H, V33, P26, DOI 10.1111/j.1440-1754.1997.tb00986.x; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; English MC, 1996, ARCH DIS CHILD, V74, P201, DOI 10.1136/adc.74.3.201; FINBERG L, 1955, PEDIATRICS, V16, P1; Foster BA, 2014, J PEDIATR-US, V165, P163, DOI 10.1016/j.jpeds.2014.01.040; GORDILLO G, 1957, PEDIATRICS, V20, P303; Halawa I, 2011, EPILEPSIA, V52, P410, DOI 10.1111/j.1528-1167.2010.02939.x; Hanson J, 2009, AM J TROP MED HYG, V80, P141, DOI 10.4269/ajtmh.2009.80.141; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Ibinda F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122606; Kariuki SM, 2015, NEUROLOGY, V84, P1838, DOI 10.1212/WNL.0000000000001542; Kariuki SM, 2011, BRAIN, V134, P1519, DOI 10.1093/brain/awr051; KATZ MA, 1973, NEW ENGL J MED, V289, P843, DOI 10.1056/NEJM197310182891607; MACAULAY D, 1961, ARCH DIS CHILD, V36, P543, DOI 10.1136/adc.36.189.543; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mcnab S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009457.pub2; Mcnab S, 2015, LANCET, V385, P1190, DOI 10.1016/S0140-6736(14)61459-8; MILLER LH, 1967, ANN TROP MED PARASIT, V61, P265, DOI 10.1080/00034983.1967.11686487; Mishra SK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-24; Moritz ML, 1999, PEDIATRICS, V104, P435, DOI 10.1542/peds.104.3.435; Mung'Ala-Odera V, 2004, AM J TROP MED HYG, V71, P64, DOI 10.4269/ajtmh.2004.71.64; Ndila C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25593; R Core Team, 2021, R LANGUAGE ENV STAT; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Sharf R E, 1993, Arch Fam Med, V2, P647, DOI 10.1001/archfami.2.6.647; Sodarangani M, 2008, LANCET NEUROL, V7, P145, DOI [10.1016/SI474-4422(07)70331-9, 10.1016/S1474-4422(07)70331-9]; Sowunmi A, 2000, J TROP PEDIATRICS, V46, P195, DOI 10.1093/tropej/46.4.195; Thwaites CL, 2015, LANCET, V385, P362, DOI 10.1016/S0140-6736(14)60236-1; WHO, 2013, GUID MAN COMM CHILDH; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161320	10.1371/journal.pone.0161320	http://dx.doi.org/10.1371/journal.pone.0161320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603309	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200012
J	Jing, QH; Tang, YT; Qian, DJ; Lu, Y; Jiang, YX				Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang			Posterior Corneal Characteristics of Cataract Patients with High Myopia	PLOS ONE			English	Article							REFRACTIVE ERROR; AXIAL LENGTH; ASTIGMATISM; ANTERIOR; AGE; CHINESE	Purpose To evaluate the characteristics of the posterior corneal surface in patients with high myopia before cataract surgery. Methods We performed a cross-sectional study at the Eye and ENT Hospital of Fudan University, Shanghai, China. Corneal astigmatism and axial length were measured with a rotating Scheimpflug camera (Pentacam) and partial coherence interferometry (IOLMaster) in a high-myopia study group of 167 eyes (axial length >= 26 mm) and a control group of 150 eyes (axial length > 20 mm and < 25 mm). Results Total corneal astigmatism and anterior corneal astigmatism values were higher in the high-myopia group than in the control group. There was no significant difference in posterior corneal astigmatism between the high-myopia study group and the control group. In the study group, the mean posterior corneal astigmatism (range 0 - -0.9 diopters) was -0.29 diopters (D) +/- 0.17 standard deviations (SD). The steep corneal meridian was aligned vertically (60 degrees-120 degrees) in 87.43% of eyes for the posterior corneal surface, and did not change with increasing age. There was a significant correlation (r = 0.235, p = 0.002) between posterior corneal astigmatism and anterior corneal astigmatism, especially when the anterior corneal surface showed with-the-rule (WTR) astigmatism(r = 0.452, p = 0.000). There was a weak negative correlation between posterior corneal astigmatism and age (r = -0.15, p = 0.053) in the high-myopia group. Compared with total corneal astigmatism values, the anterior corneal measurements alone overestimated WTR astigmatism by a mean of 0.27 +/- 0.18 D in 68.75% of eyes, underestimated against-the-rule (ATR) astigmatism by a mean of 0.41 +/- 0.28 D in 88.89% of eyes, and underestimated oblique astigmatism by a mean of 0.24 +/- 0.13 D in 63.64% of eyes. Conclusions Posterior corneal astigmatism decreased with age and remained as ATR astigmatism in most cases of high myopia. There was a significant correlation between posterior corneal astigmatism and anterior corneal astigmatism when anterior corneal astigmatism was WTR. If posterior corneal astigmatism is not accounted for when selecting toric intraocular lenses for high-myopia patients, the use of anterior corneal astigmatism measurements alone will lead to overestimation of WTR astigmatism and underestimation of ATR and oblique astigmatism.	[Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai, Peoples R China; [Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang] State Hlth Minist, Key Lab Myopia, Shanghai, Peoples R China; [Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang] Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China	Fudan University	Jiang, YX (corresponding author), Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai, Peoples R China.; Jiang, YX (corresponding author), State Hlth Minist, Key Lab Myopia, Shanghai, Peoples R China.; Jiang, YX (corresponding author), Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China.	yongxiang_jiang@163.com			Nature Science Foundation of China [81270989]; Nature Science Foundation of Xinjiang Uygur Autonomous Region [2015211C225]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Xinjiang Uygur Autonomous Region	Nature Science Foundation of China grant: 81270989 recipient: Yi Lu (the funder had a role in study design and decision to publish the manuscript). Nature Science Foundation of Xinjiang Uygur Autonomous Region grant: 2015211C225 recipient: Yongxiang Jiang (the funder had a role in study design and decision to publish the manuscript).	Carney LG, 1997, INVEST OPHTH VIS SCI, V38, P311; Goggin M, 2015, J REFRACT SURG, V31, P98, DOI 10.3928/1081597X-20150122-04; GOH WSH, 1994, OPHTHAL PHYSL OPT, V14, P378, DOI 10.1111/j.1475-1313.1994.tb00128.x; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Kaye SB, 1997, J CATARACT REFR SURG, V23, P1496, DOI 10.1016/S0886-3350(97)80020-X; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Kohnen T, 2013, J CATARACT REFR SURG, V39, P1795, DOI 10.1016/j.jcrs.2013.10.017; Konstantopoulos A, 2007, BRIT J OPHTHALMOL, V91, P551, DOI 10.1136/bjo.2006.103408; Leo SW, 2011, J AAPOS, V15, P181, DOI 10.1016/j.jaapos.2010.09.020; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Mencucci R, 2014, CLIN OUTCOMES ROTATI; Miyake T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117194; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Nemeth G, 2014, CORNEA, V33, P1214, DOI 10.1097/ICO.0000000000000238; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Qian X, 2013, CHIN J PRACT OPHTHAL, V31, P557; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Tonn B, 2015, INVEST OPHTH VIS SCI, V56, P291, DOI 10.1167/iovs.14-15659; Tuft SJ, 2004, J CATARACT REFR SURG, V30, P1045, DOI 10.1016/j.jcrs.2003.09.053; Ueno Y, 2014, J REFRACT SURG, V30, P192, DOI 10.3928/1081597X-20140218-01; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Yang J, 2015, PLOS ONE, V10; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172	24	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162012	10.1371/journal.pone.0162012	http://dx.doi.org/10.1371/journal.pone.0162012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603713	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200035
J	Kasbaoui, N; Cooper, J; Mills, DS; Burman, O				Kasbaoui, Naima; Cooper, Jonathan; Mills, Daniel S.; Burman, Oliver			Effects of Long-Term Exposure to an Electronic Containment System on the Behaviour and Welfare of Domestic Cats	PLOS ONE			English	Article							COGNITIVE BIAS; FELIS-CATUS; VIRTUAL FENCES; ANXIETY; STRESS; JUDGMENT; HORSES; RISK; CLASSIFICATION; VOCALIZATIONS	Free-roaming cats are exposed to a variety of risks, including involvement in road traffic accidents. One way of mitigating these risks is to contain cats, for example using an electronic boundary fence system that delivers an electric 'correction' via a collar if a cat ignores a warning cue and attempts to cross the boundary. However, concerns have been expressed over the welfare impact of such systems. Our aim was to determine if long-term exposure to an electronic containment system was associated with reduced cat welfare. We compared 46 owned domestic cats: 23 cats that had been contained by an electronic containment system for more than 12 months (AF group); and 23 cats with no containment system that were able to roam more widely (C group). We assessed the cats' behavioural responses and welfare via four behavioural tests (unfamiliar person test; novel object test; sudden noise test; cognitive bias test) and an owner questionnaire. In the unfamiliar person test, C group lip-licked more than the AF group, whilst the AF group looked at, explored and interacted more with the unfamiliar person than C group. In the novel object test, the AF group looked at and explored the object more than C group. No significant differences were found between AF and C groups for the sudden noise or cognitive bias tests. Regarding the questionnaire, C group owners thought their cats showed more irritable behaviour and AF owners thought that their cats toileted inappropriately more often than C owners. Overall, AF cats were less neophobic than C cats and there was no evidence of significant differences between the populations in general affective state. These findings indicate that an electronic boundary fence with clear pre-warning cues does not impair the long term quality of life of cats.	[Kasbaoui, Naima; Cooper, Jonathan; Mills, Daniel S.; Burman, Oliver] Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln LN6 7DL, Lincs, England	University of Lincoln	Kasbaoui, N (corresponding author), Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln LN6 7DL, Lincs, England.	nkasbaoui@lincoln.ac.uk		Cooper, Jonathan/0000-0002-9014-4395	University of Lincoln	University of Lincoln	This work was funded partly from a charitable donation provided to the University of Lincoln by Feline Friends (Derbyshire) for the purposes of research into the welfare of cats and partly by the University of Lincoln. The donor had no influence on the specific use of the donation, the design, execution or interpretation of the work undertaken, but we are grateful to them for supplying funds to address this contentious issue in cat welfare.	Ainsworth M., 1978, PATTERNS ATTACHMENT; Amat M, 2009, APPL ANIM BEHAV SCI, V121, P134, DOI 10.1016/j.applanim.2009.09.012; Appukuttan D, 2014, J ORAL SCI, V56, P151, DOI 10.2334/josnusd.56.151; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Berny P, 2010, VET J, V183, P255, DOI 10.1016/j.tvjl.2009.03.034; Briefer EF, 2013, APPL ANIM BEHAV SCI, V146, P45, DOI 10.1016/j.applanim.2013.03.007; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Buffington CAT, 2006, JAVMA-J AM VET MED A, V228, P722, DOI 10.2460/javma.228.5.722; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; CARLSTEAD K, 1993, ZOO BIOL, V12, P321, DOI 10.1002/zoo.1430120403; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Companion Animal Welfare Council , 2012, US EL PULS TRAIN AID; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; Dehasse J, 1997, APPL ANIM BEHAV SCI, V52, P365, DOI 10.1016/S0168-1591(96)01135-5; Destrez A, 2014, APPL ANIM BEHAV SCI, V154, P30, DOI 10.1016/j.applanim.2014.01.005; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Dickman CR, 2015, APPL ANIM BEHAV SCI, V173, P76, DOI 10.1016/j.applanim.2014.09.021; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Duhautois B, 2010, B ACAD VET FRANCE, V163, P167; Ellis SLH, 2015, ANTHROZOOS, V28, P625, DOI 10.1080/08927936.2015.1070005; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Finka LR, 2015, THESIS; Fitzgerald KT, 2010, TOP COMPANION ANIM M, V25, P213, DOI 10.1053/j.tcam.2010.09.006; Freymond SB, 2014, APPL ANIM BEHAV SCI, V158, P34, DOI 10.1016/j.applanim.2014.06.006; Ghirlanda S, 2003, ANIM BEHAV, V66, P15, DOI 10.1006/anbe.2003.2174; Grigg EK, 2012, J FELINE MED SURG; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Gunaseelan S, 2013, ANTHROZOOS, V26, P199, DOI 10.2752/175303713X13636846944123; Guy NC, 2014, J VET BEHAV, V9, P78, DOI 10.1016/j.jveb.2013.11.001; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hillmann E, 2003, APPL ANIM BEHAV SCI, V81, P99, DOI 10.1016/S0168-1591(02)00254-X; Horwitz DF, 1997, APPL ANIM BEHAV SCI, V52, P129, DOI 10.1016/S0168-1591(96)01073-8; Huynh TN, 2011, BEHAV BRAIN RES, V222, P212, DOI 10.1016/j.bbr.2011.03.038; Jouven M, 2012, RANGELAND J, V34, P111, DOI 10.1071/RJ11044; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; Karagiannis CI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0373-1; Kendall K, 2008, J VET BEHAV, V3, P244, DOI 10.1016/j.jveb.2008.03.001; Kitts-Morgan SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120513; Lansade L, 2012, BEHAV PROCESS, V91, P94, DOI 10.1016/j.beproc.2012.06.003; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lee C, 2009, APPL ANIM BEHAV SCI, V119, P15, DOI 10.1016/j.applanim.2009.03.010; Lepczyk CA, 2015, APPL ANIM BEHAV SCI, V173, P29, DOI 10.1016/j.applanim.2015.07.002; Levine E, 2005, APPL ANIM BEHAV SCI, V90, P325, DOI 10.1016/j.applanim.2004.07.006; MCCUNE S, 1995, APPL ANIM BEHAV SCI, V45, P109, DOI 10.1016/0168-1591(95)00603-P; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mertens C., 1991, Anthrozoos, V4, P214, DOI 10.2752/089279391787057062; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Mills DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018448; Moretti L, 2015, ANIM BEHAV, V107, P159, DOI 10.1016/j.anbehav.2015.06.008; Neilson J, 2004, J FELINE MED SURG, V6, P5, DOI 10.1016/j.jfms.2003.09.008; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V31, P119, DOI 10.1016/0168-1591(91)90159-U; Potter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135109; RESCORLA RA, 1979, J EXP PSYCHOL ANIM B, V5, P152, DOI 10.1037/0097-7403.5.2.152; Rochlitz I, 2003, VET REC, V153, P549, DOI 10.1136/vr.153.18.549; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Schwartz S, 2002, J AM VET MED ASSOC, V220, P1028, DOI 10.2460/javma.2002.220.1028; Seksel K, 1998, AUST VET J, V76, P317, DOI 10.1111/j.1751-0813.1998.tb12353.x; Shrestha B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018046; Stanton LA, 2015, APPL ANIM BEHAV SCI, V173, P3, DOI 10.1016/j.applanim.2015.04.001; Stella JL, 2011, JAVMA-J AM VET MED A, V238, P67, DOI 10.2460/javma.238.1.67; Sung W, 2006, AM J VET RES, V67, P1500, DOI 10.2460/ajvr.67.9.1500; Tami G, 2011, ANIM WELFARE, V20, P185; Thomas RL, 2014, URBAN ECOSYST, V17, P911, DOI 10.1007/s11252-014-0360-5; Tibbs TM, 1995, INFLUENCE ELECT DIVE; Tiedemann AR, 1999, USDA FOR SERV PNW RE, pU1; Toukhsati SR, 2012, ANTHROZOOS, V25, P61, DOI 10.2752/175303712X13240472427195; Umstatter C, 2015, RANGELAND ECOL MANAG, V68, P100, DOI 10.1016/j.rama.2014.12.004; Umstatter C, 2011, COMPUT ELECTRON AGR, V75, P10, DOI 10.1016/j.compag.2010.10.005; van den Bos R, 1998, APPL ANIM BEHAV SCI, V59, P323, DOI 10.1016/S0168-1591(98)00147-6; WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195	77	9	9	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162073	10.1371/journal.pone.0162073	http://dx.doi.org/10.1371/journal.pone.0162073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27602572	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000383255200038
J	Kim, J; Choi, GH; Ko, KH; Kim, JO; Oh, SH; Park, YS; Kim, OJ; Kim, NK				Kim, Jinkwon; Choi, Gun Ho; Ko, Ki Han; Kim, Jung Oh; Oh, Seung Hun; Park, Young Seok; Kim, Ok Joon; Kim, Nam Keun			Association of the Single Nucleotide Polymorphisms in microRNAs 130b, 200b, and 495 with Ischemic Stroke Susceptibility and Post-Stroke Mortality	PLOS ONE			English	Article							HUMAN PLATELET MICRORNA; CARDIOVASCULAR-DISEASE; EXPRESSION; MEGAKARYOCYTOPOIESIS; INFLAMMATION; BIOGENESIS; ACTIVATION; MIR-196A2; NETWORKS; MIR-146A	The microRNA (miRNA) is a small non-coding RNA molecule that modulates gene expression at the posttranscriptional level. Platelets have a crucial role in both hemostasis and thrombosis, a condition that can occlude a cerebral artery and cause ischemic stroke. miR-130b, miR-200b, and miR-495 are potential genetic modulators involving platelet production and activation. We hypothesized that single nucleotide polymorphisms (SNPs) in these miRNAs might potentially contribute to the susceptibility to ischemic stroke and post-stroke mortality. This study included 523 ischemic stroke patients and 400 control subjects. We investigated the association of three miRNA SNPs (miR-130bT>C, miR-200bT>C, and miR-495A>C) with ischemic stroke prevalence and post-stroke mortality. In the multivariate logistic regression, there was no statistically significant difference in the distribution of miR-130bT>C, miR-200bT>C, or miR-495A>C between the ischemic stroke and control groups. In the subgroup analysis based on ischemic stroke subtype, the miR-200b CC genotype was less frequently found in the large-artery atherosclerosis stroke subtype compared with controls (TT+CT vs CC; adjusted odds ratio for CC, 0.506; 95% confidence interval, 0.265-0.965). During a mean follow-up period of 4.80 +/- 2.11 years after stroke onset, there were 106 all-cause deaths among the 523 stroke patients. Multivariate Cox regression analysis did not find a significant association between post-stroke mortality and three miRNA SNPs. Our findings suggest that the functional SNP of miR-200b might be responsible for the susceptibility to large-artery atherosclerotic stroke.	[Kim, Jinkwon; Oh, Seung Hun; Kim, Ok Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 13496, South Korea; [Choi, Gun Ho; Ko, Ki Han; Kim, Jung Oh; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 13496, South Korea; [Park, Young Seok] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Neurosurg, Cheongju 28644, South Korea; [Kim, Nam Keun] CHA Univ, Coll Life Sci, Dept Biomed Sci, 335 Pangyo Ro, Songnam 13488, South Korea	Pochon Cha University; Pochon Cha University; Chungbuk National University; Chungbuk National University Hospital; Pochon Cha University	Kim, OJ (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 13496, South Korea.; Kim, NK (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 13496, South Korea.; Kim, NK (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, 335 Pangyo Ro, Songnam 13488, South Korea.	okjun77@cha.ac.kr; nkkim@cha.ac.kr	Kim, Jinkwon/N-1878-2018; Kim, Jinkwon/AAR-6729-2021	Kim, Jinkwon/0000-0003-0156-9736; Kim, Jinkwon/0000-0003-0156-9736; Kim, Jung Oh/0000-0002-4171-2034	grant of the Korea Healthcare technology RD Project [HI15C1972010015, HI16C1559]; Ministry for Health, Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea [2014R1A1A1002067, 2015R1D1A1A09057432]	grant of the Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea	This study was partly supported by a grant of the Korea Healthcare technology R&D Project (HI15C1972010015 and HI16C1559), Ministry for Health, Welfare & Family Affairs, Republic of Korea and by Basic Science Research Program through National Research Foundation of Korea Grants funded by the Korean Government (2014R1A1A1002067, 2015R1D1A1A09057432), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Bray PF, 2007, HEMATOL ONCOL CLIN N, V21, P633, DOI 10.1016/j.hoc.2007.06.002; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998; Cui L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089019; Dangwal S, 2012, THROMB HAEMOSTASIS, V108, P599, DOI 10.1160/TH12-03-0211; Duan XM, 2014, J DIABETES COMPLICAT, V28, P705, DOI 10.1016/j.jdiacomp.2014.04.012; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fuentes E, 2015, LIFE SCI, V133, P29, DOI 10.1016/j.lfs.2015.04.016; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gatsiou A, 2012, CURR VASC PHARMACOL, V10, P524, DOI 10.2174/157016112801784611; Harker LA, 1998, SEMIN HEMATOL, V35, P241; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Huan TX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7601; Huang SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117007; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; IWAMOTO T, 1995, STROKE, V26, P52, DOI 10.1161/01.STR.26.1.52; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Li HY, 2011, BRIT J HAEMATOL, V155, P298, DOI 10.1111/j.1365-2141.2011.08859.x; McManus DD, 2015, NAT REV CARDIOL, V12, P711, DOI 10.1038/nrcardio.2015.101; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Obsteter J, 2015, MOL GENET GENOM MED, V3, P30, DOI 10.1002/mgg3.110; Opalinska JB, 2010, BLOOD, V116, pE128, DOI 10.1182/blood-2010-06-292920; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Rieger JK, 2015, DRUG METAB DISPOS, V43, P884, DOI 10.1124/dmd.114.062844; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Stakos DA, 2013, PLATELETS, V24, P579, DOI 10.3109/09537104.2012.724483; Suresh S, 2011, J CELL COMMUN SIGNAL, V5, P183, DOI 10.1007/s12079-011-0139-x; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Yu TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1031-5; Zhang ZZ, 2017, MOL NEUROBIOL, V54, P2776, DOI 10.1007/s12035-016-9865-7; Zhu RX, 2014, NEUROCHEM RES, V39, P1709, DOI 10.1007/s11064-014-1364-5	44	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162519	10.1371/journal.pone.0162519	http://dx.doi.org/10.1371/journal.pone.0162519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603512	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200073
J	Mandel, JR; Ramsey, AJ; Iorizzo, M; Simon, PW				Mandel, Jennifer R.; Ramsey, Adam J.; Iorizzo, Massimo; Simon, Philipp W.			Patterns of Gene Flow between Crop and Wild Carrot, Daucus carota (Apiaceae) in the United States	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NATURAL-POPULATIONS; CULTIVATED CARROTS; INHERITANCE; DIVERSITY; CHLOROPLAST; EVOLUTION; TRANSGENE; RECOMBINATION; INTROGRESSION	Studies of gene flow between crops and their wild relatives have implications for both management practices for cultivation and understanding the risk of transgene escape. These types of studies may also yield insight into population dynamics and the evolutionary consequences of gene flow for wild relatives of crop species. Moreover, the comparison of genetic markers with different modes of inheritance, or transmission, such as those of the nuclear and chloroplast genomes, can inform the relative risk of transgene escape via pollen versus seed. Here we investigate patterns of gene flow between crop and wild carrot, Daucus carota (Apiaceae) in two regions of the United States. We employed 15 nuclear simple sequence repeat (SSR) markers and one polymorphic chloroplast marker. Further, we utilized both conventional population genetic metrics along with Shannon diversity indices as the latter have been proposed to be more sensitive to allele frequency changes and differentiation. We found that populations in both regions that were proximal to crop fields showed lower levels of differentiation to the crops than populations that were located farther away. We also found that Shannon measures were more sensitive to differences in both genetic diversity and differentiation in our study. Finally, we found indirect evidence of paternal transmission of chloroplast DNA and accompanying lower than expected levels of chloroplast genetic structure amongst populations as might be expected if chloroplast DNA genes flow through both seed and pollen. Our findings of substantial gene flow for both nuclear and chloroplast markers demonstrate the efficiency of both pollen and seed to transfer genetic information amongst populations of carrot.	[Mandel, Jennifer R.; Ramsey, Adam J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Mandel, Jennifer R.] Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA; [Iorizzo, Massimo] North Carolina State Univ, Plants Human Hlth Inst, Dept Hort Sci, Kannapolis, NC USA; [Simon, Philipp W.] Univ Wisconsin Madison, Vegetable Crops Unit, USDA ARS, Madison, WI USA	University of Memphis; University of Memphis; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Mandel, JR (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.; Mandel, JR (corresponding author), Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA.	jmandel@memphis.edu	Iorizzo, Massimo/AAJ-3952-2020; Ramsey, Adam/AAB-2376-2021	Iorizzo, Massimo/0000-0002-0032-8247; Simon, Philipp/0000-0001-6978-6062; Mandel, Jennifer/0000-0003-3539-2991	United States Department of Agriculture-National Institute of Food and Agriculture Award [2014-33522-21826]; Nantucket Biodiversity Initiative Grant; W. Harry Feinstone Center for Genomic Research equipment support; ARS [ARS-0425034] Funding Source: Federal RePORTER	United States Department of Agriculture-National Institute of Food and Agriculture Award; Nantucket Biodiversity Initiative Grant; W. Harry Feinstone Center for Genomic Research equipment support; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture-National Institute of Food and Agriculture Award 2014-33522-21826 to JRM; Nantucket Biodiversity Initiative Grant to AJR; and the W. Harry Feinstone Center for Genomic Research equipment support to JRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M. S., 2010, GENE FLOW CROPS THEI; [Anonymous], 2016, GENETICALLY ENG CROP, DOI [10.17226/23395, DOI 10.17226/23395]; Baranski R., 2008, TRANSGENIC PLANT J, V2, P18; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Bartsch D, 1999, MOL ECOL, V8, P1733, DOI 10.1046/j.1365-294x.1999.00769.x; Bartsch D, 2004, INTROGRESSION GENETI; BOBLENZ K, 1990, MOL GEN GENET, V220, P489, DOI 10.1007/BF00391760; Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090; Burt A, 2006, GENES CONFLICT BIOL; Campbell LG, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500114; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Davidar P, 2015, AM J BOT, V102, P129, DOI 10.3732/ajb.1400404; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; DEWET JMJ, 1975, ECON BOT, V29, P99, DOI 10.1007/BF02863309; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellis JR, 2008, HEREDITY, V100, P574, DOI 10.1038/hdy.2008.11; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Ellstrand NC, 2010, EVOL APPL, V3, P494, DOI 10.1111/j.1752-4571.2010.00140.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Gressel J, 2015, PEST MANAG SCI, V71, P658, DOI 10.1002/ps.3850; Hamilton MB, 1999, MOL ECOL, V8, P521; HARRIS SA, 1991, TAXON, V40, P393, DOI 10.2307/1223218; Hauser TP, 2002, CONSERV GENET, V3, P75; Hauser TP, 2001, GENET RESOUR CROP EV, V48, P499, DOI 10.1023/A:1012051731933; HEYWOOD VH, 1983, ISRAEL J BOT, V32, P51; Iorizzo M, 2016, NAT GENET, V48, P657, DOI 10.1038/ng.3565; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kwit C, 2011, TRENDS BIOTECHNOL, V29, P284, DOI 10.1016/j.tibtech.2011.02.003; LACEY EP, 1982, OIKOS, V39, P83, DOI 10.2307/3544535; Mandel JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136303; Mandel JR, 2013, CONSERV GENET, V14, P31, DOI 10.1007/s10592-012-0421-3; Mandel JR, 2012, J HERED, V103, P418, DOI 10.1093/jhered/esr142; McCauley DE, 2013, NEW PHYTOL, V200, P966, DOI 10.1111/nph.12431; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Nassar Nagib M. A., 2002, Genetics and Molecular Research, V1, P298; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pritchard JK, 2000, GENETICS, V155, P945; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Rohr Heike, 1999, Progress in Botany, V60, P39; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; RONFORT J, 1995, THEOR APPL GENET, V91, P150, DOI 10.1007/BF00220872; Rong J, 2010, ANN BOT-LONDON, V106, P285, DOI 10.1093/aob/mcq108; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2015, MOL ECOL RESOUR, V15, P1259, DOI 10.1111/1755-0998.12458; Simon Philipp W., 2008, P327, DOI 10.1007/978-0-387-74110-9_8; Smouse PE, 2015, MOL ECOL RESOUR, V15, P1375, DOI 10.1111/1755-0998.12422; Snow AA, 2010, NEW PHYTOL, V186, P537, DOI 10.1111/j.1469-8137.2009.03172.x; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; STEINBORN R, 1995, THEOR APPL GENET, V91, P632, DOI 10.1007/BF00223290; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Szklarczyk M, 2014, THEOR APPL GENET, V127, P1689, DOI 10.1007/s00122-014-2331-x; UMEHARA M, 2005, PLANT BIOTECHOL, V22, P497, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.22.497; Vivek BS, 1999, THEOR APPL GENET, V98, P669, DOI 10.1007/s001220051119; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Wang W, 2014, NEW PHYTOL, V202, P679, DOI 10.1111/nph.12428; Warwick SI, 2005, CROP FERALITY AND VOLUNTEERISM, P9; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wiel C. van de, 2003, EUCARPIA leafy vegetables 2003. Proceedings of the EUCARPIA Meeting on Leafy Vegetables Genetics and Breeding, Noordwijkerhout, Netherlands, 19-21 March 2003, P111; WIJNHEIJMER EHM, 1989, EUPHYTICA, V40, P147, DOI 10.1007/BF00023309; Wilson GA, 2003, GENETICS, V163, P1177; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu JP, 2005, GENOME, V48, P951, DOI [10.1139/g05-082, 10.1139/G05-082]; [No title captured]	74	14	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161971	10.1371/journal.pone.0161971	http://dx.doi.org/10.1371/journal.pone.0161971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603516	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200033
J	Spector, J; Kodippili, GC; Ritchie, K; Low, PS				Spector, Jeff; Kodippili, Gayani C.; Ritchie, Ken; Low, Philip S.			Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes	PLOS ONE			English	Article							HEINZ BODIES; MEMBRANE SKELETON; HEMOGLOBIN; DEFORMABILITY; GLYCOPHORIN; SENESCENT; TRACKING; ANKYRIN; BINDING; DISEASE	Sickle cell disease (SCD) is caused by an inherited mutation in hemoglobin that leads to sickle hemoglobin (HbS) polymerization and premature HbS denaturation. Previous publications have shown that HbS denaturation is followed by binding of denatured HbS (a.k.a. hemichromes) to band 3, the consequent clustering of band 3 in the plane of the erythrocyte membrane that in turn promotes binding of autologous antibodies to the clustered band 3, and removal of the antibody-coated erythrocytes from circulation. Although each step of the above process has been individually demonstrated, the fraction of band 3 that is altered by association with denatured HbS has never been determined. For this purpose, we evaluated the lateral diffusion of band 3 in normal cells, reversibly sickled cells (RSC), irreversibly sickled cells (ISC), and hemoglobin SC erythrocytes (HbSC) in order to estimate the fraction of band 3 that was diffusing more slowly due to hemichrome-induced clustering. We labeled fewer than ten band 3 molecules per intact erythrocyte with a quantum dot to avoid perturbing membrane structure and we then monitored band 3 lateral diffusion by single particle tracking. We report here that the size of the slowly diffusing population of band 3 increases in the sequence: normal cells<HbSC<RSC<ISC. We also demonstrate that the size of the compartment in which band 3 is free to diffuse decreases roughly in the same order, with band 3 diffusing in two compartments of sizes 35 and 71 nm in normal cells, but only a single compartment in HbSC cells (58 nm), RSC (45 nm) and ISC (36 nm). These data suggest that the mobility of band 3 is increasingly constrained during SCD progression, suggesting a global impact of the mutated hemoglobin on erythrocyte membrane properties.	[Spector, Jeff; Ritchie, Ken] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Kodippili, Gayani C.; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	plow@purdue.edu		Low, Philip/0000-0001-9042-5528	National Institutes of Health [GM24417-36]; National Science Foundation [0646633]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	PSL acknowledges funding from the National Institutes of Health (GM24417-36) and use of shared Purdue Cancer Center facilities supported by P30 CA023168. KR acknowledges funding from the National Science Foundation (Grant #0646633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; CORBETT JD, 1993, J CLIN INVEST, V91, P208, DOI 10.1172/JCI116172; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HAVELL TC, 1978, AM J HEMATOL, V4, P9, DOI 10.1002/ajh.2830040103; Huang Z, 2003, BIOPHYS J, V85, P2374, DOI 10.1016/S0006-3495(03)74661-X; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; KAY MMB, 1983, P NATL ACAD SCI-BIOL, V80, P1631, DOI 10.1073/pnas.80.6.1631; Kodippili GC, 2012, J BIOL CHEM, V287, P4129, DOI 10.1074/jbc.M111.294439; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; Liu SC, 1996, J CLIN INVEST, V97, P29, DOI 10.1172/JCI118402; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; LUTZ HU, 1987, P NATL ACAD SCI USA, V84, P7368, DOI 10.1073/pnas.84.21.7368; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; SCHLUTER K, 1986, P NATL ACAD SCI USA, V83, P6137, DOI 10.1073/pnas.83.16.6137; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Tomishige M, 1999, MOL BIOL CELL, V10, P2475, DOI 10.1091/mbc.10.8.2475; WALDER JA, 1984, J BIOL CHEM, V259, P238; WAUGH SM, 1985, BIOCHEMISTRY-US, V24, P34, DOI 10.1021/bi00322a006; WAUGH SM, 1986, J CLIN INVEST, V78, P1155, DOI 10.1172/JCI112696	22	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162514	10.1371/journal.pone.0162514	http://dx.doi.org/10.1371/journal.pone.0162514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598991	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800074
J	Yamashita, Y; Wang, LQ; Nanba, F; Ito, C; Toda, T; Ashida, H				Yamashita, Yoko; Wang, Liuqing; Nanba, Fumio; Ito, Chiaki; Toda, Toshiya; Ashida, Hitoshi			Procyanidin Promotes Translocation of Glucose Transporter 4 in Muscle of Mice through Activation of Insulin and AMPK Signaling Pathways	PLOS ONE			English	Article							MODEL DB/DB MICE; GLUCOSE-UPTAKE; ALPHA-GLUCOSIDASE; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; DIETARY POLYPHENOLS; PLASMA-MEMBRANE; PROTEIN-KINASE; BLOOD-GLUCOSE; IN-VITRO	Procyanidins are the oligomeric or polymeric forms of epicatechin and catechin. In this study, we isolated and purified dimer to tetramer procyanidins from black soybean seed coat and investigated the anti-hyperglycemic effects by focusing on glucose transporter 4 (GLUT4) translocation and the underlying molecular mechanism in skeletal muscle of mice. The anti-hyperglycemic effects of procyanidins were also compared with those of monomer (-)-epicatechin (EC) and major anthocyanin, cyanidin-3-O-beta-glucoside (C3G). To investigate GLUT4 translocation and its related signaling pathways, ICR mice were orally given procyanidins, EC and C3G in water at 10 mu g/kg body weight. The mice were sacrificed 60 min after the dose of polyphenols, and soleus muscle was extracted from the hind legs. The results showed that trimeric and tetrameric procyanidins activated both insulin-and AMPK-signaling pathways to induce GLUT4 translocation in muscle of ICR mice. We confirmed that procyanidins suppressed acute hyperglycemia with an oral glucose tolerance test in a dose-dependent manner. Of these beneficial effects, cinnamtannin A2, one of the tetramers, was the most effective. In conclusion, procyanidins, especially cinnamtannin A2, significantly ameliorate postprandial hyperglycemia at least in part by promoting GLUT4 translocation to the plasma membrane by activating both insulin-and AMPK-signaling pathways.	[Yamashita, Yoko; Wang, Liuqing; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan; [Nanba, Fumio; Ito, Chiaki; Toda, Toshiya] Fujicco Co Ltd, Res Dev, Kobe, Hyogo 6508558, Japan	Kobe University	Ashida, H (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.	ashida@kobe-u.ac.jp			Cross-ministerial Strategic Innovation Promotion Program by Cabinet Office, Government of Japan; JSPS KAKENHI [26850082]; Fujicco Co. Ltd.	Cross-ministerial Strategic Innovation Promotion Program by Cabinet Office, Government of Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fujicco Co. Ltd.	This work was supported by Cross-ministerial Strategic Innovation Promotion Program by Cabinet Office, Government of Japan, and JSPS KAKENHI Grant-in-Aid for Young Scientists (B) Grant Number 26850082 (YY). Fujicco Co. Ltd. partly funded the investigations described in the present manuscript. Fujicco Co. Ltd. provided support in the form of salaries for authors [FN, CI, TT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe Y, 2008, TETRAHEDRON LETT, V49, P6413, DOI 10.1016/j.tetlet.2008.08.087; Adisakwattana S, 2010, INT J FOOD SCI NUTR, V61, P295, DOI 10.3109/09637480903455963; Beecher GR, 2004, PHARM BIOL, V42, P2, DOI 10.3109/13880200490893474; Benalla W, 2010, CURR DIABETES REV, V6, P247, DOI 10.2174/157339910791658826; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Claussnitzer M, 2011, MOL NUTR FOOD RES, V55, pS26, DOI 10.1002/mnfr.201000372; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Dao TMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020700; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Garber AJ, 2012, HEART FAIL CLIN, V8, P563, DOI 10.1016/j.hfc.2012.06.004; Gonzalez-Abuin N, 2015, CURR MED CHEM, V22, P39; Gonzalez-Abuin N, 2012, J AGR FOOD CHEM, V60, P9055, DOI 10.1021/jf3010349; Habtemariam S, 2014, CURR PHARM BIOTECHNO, V15, P391, DOI 10.2174/1389201015666140617104643; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166; Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p; Kang C, 2010, FOOD CHEM TOXICOL, V48, P2366, DOI 10.1016/j.fct.2010.05.073; Kawabata K, 2011, MOL NUTR FOOD RES, V55, P467, DOI 10.1002/mnfr.201000267; Kim JS, 2000, BIOSCI BIOTECH BIOCH, V64, P2458, DOI 10.1271/bbb.64.2458; Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lin CL, 2008, MOL NUTR FOOD RES, V52, P930, DOI 10.1002/mnfr.200700437; Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; Mohankumar SK, 2013, J NUTR BIOCHEM, V24, P445, DOI 10.1016/j.jnutbio.2012.01.006; Nilsson Peter M, 2012, Lakartidningen, V109, P1549; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Nishiumi S, 2010, J AGR FOOD CHEM, V58, P12916, DOI 10.1021/jf102840w; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Pereira DF, 2011, NUTRITION, V27, P1161, DOI 10.1016/j.nut.2011.01.008; Pinent M, 2012, CRIT REV FOOD SCI, V52, P569, DOI 10.1080/10408398.2010.501533; Schafer A, 2007, DIABETES RES CLIN PR, V77, P41, DOI 10.1016/j.diabres.2006.10.011; Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741; Shabrova EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024634; Sheena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025747; Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128; Ueda M, 2013, BIOFACTORS, V39, P457, DOI 10.1002/biof.1085; Vu V, 2013, J MOL ENDOCRINOL, V51, P155, DOI 10.1530/JME-13-0059; Wu ZX, 2015, NAT PROD RES, V29, P988, DOI 10.1080/14786419.2014.965165; Yamamoto N, 2011, PHYTOTHER RES, V25, P1218, DOI 10.1002/ptr.3416; Yamashita Y, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.2; Yamashita Y, 2013, BIOSCI BIOTECH BIOCH, V77, P888, DOI 10.1271/bbb.130095; Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018; Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007	57	40	42	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161704	10.1371/journal.pone.0161704	http://dx.doi.org/10.1371/journal.pone.0161704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598258	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800016
J	Stanton, C; Clune, J				Stanton, Christopher; Clune, Jeff			Curiosity Search: Producing Generalists by Encouraging Individuals to Continually Explore and Acquire Skills throughout Their Lifetime	PLOS ONE			English	Article							MOTIVATION; DIVERSITY; ROBOTS; WILD	Natural animals are renowned for their ability to acquire a diverse and general skill set over the course of their lifetime. However, research in artificial intelligence has yet to produce agents that acquire all or even most of the available skills in non-trivial environments. One candidate algorithm for encouraging the production of such individuals is Novelty Search, which pressures organisms to exhibit different behaviors from other individuals. However, we hypothesized that Novelty Search would produce sub-populations of specialists, in which each individual possesses a subset of skills, but no one organism acquires all or most of the skills. In this paper, we propose a new algorithm called Curiosity Search, which is designed to produce individuals that acquire as many skills as possible during their lifetime. We show that in a multiple-skill maze environment, Curiosity Search does produce individuals that explore their entire domain, while a traditional implementation of Novelty Search produces specialists. However, we reveal that when modified to encourage intra-life behavioral diversity, Novelty Search can produce organisms that explore almost as much of their environment as Curiosity Search, although Curiosity Search retains a significant performance edge. Finally, we show that Curiosity Search is a useful helper objective when combined with Novelty Search, producing individuals that acquire significantly more skills than either algorithm alone.	[Stanton, Christopher; Clune, Jeff] Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA	University of Wyoming	Stanton, C (corresponding author), Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA.	cstanto3@uwyo.edu						Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; Clune J, 2015, PREPRINT; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Delarboulas P, 2010, PPSN 11, pXI; Dewsbury R, 2012, DAILY MAIL ONLIN JUN; Griffin AS, 2014, ANIM BEHAV, V92, P221, DOI 10.1016/j.anbehav.2014.04.009; Hornby Gregory S., 2006, AUTOMATED ANTENNA DE; Hornby GS, 2005, IEEE T ROBOT, V21, P402, DOI 10.1109/TRO.2004.839222; Ngo H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00833; Kakade S, 2000, NEUROSCIENCE, V96, P651; Kohler W., 1924, MENTALITY APES; Koza J. R., 2003, GENETIC PROGRAMMING; Krulwich R., 2013, 60 WILD COYOTES PATR; Lee S., 2013, LNCS, V7835, P540, DOI DOI 10.1007/978-3-642-37192-954; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Mouret J.-B., 2010, WCCI 2010 IEEE WORLD, P4079; Nguyen A., 2015, P GEN EV COMP C; Pape Leo, 2012, Front Neurorobot, V6, P6, DOI 10.3389/fnbot.2012.00006; Patrick Matthew, 2010, 2010 IEEE Information Theory Workshop (ITW 2010), P249, DOI 10.1109/ITW.2010.5593348; Salge C, 2013, CORR; Schmidhuber J., 1991, P INT C SIM AD BEH A, P222; Soltoggio A, 2009, GEN EV COMP C; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Toffolo A, 2003, EVOL COMPUT, V11, P151, DOI 10.1162/106365603766646816; Velez R, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P737, DOI 10.1145/2576768.2598225; Weng JY, 2001, SCIENCE, V291, P599, DOI 10.1126/science.291.5504.599; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; Woolley B, 2011, GEN EV COMP C; Zhang G, 2014, COUPLING EVOLUTION I, P852	37	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162235	10.1371/journal.pone.0162235	http://dx.doi.org/10.1371/journal.pone.0162235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589267	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800040
J	Sushames, A; Edwards, A; Thompson, F; McDermott, R; Gebel, K				Sushames, Ashleigh; Edwards, Andrew; Thompson, Fintan; McDermott, Robyn; Gebel, Klaus			Validity and Reliability of Fitbit Flex for Step Count, Moderate to Vigorous Physical Activity and Activity Energy Expenditure	PLOS ONE			English	Article							ACTIVITY MONITORS; ACCELEROMETER; CALIBRATION; VALIDATION	Objectives To examine the validity and reliability of the Fitbit Flex against direct observation for measuring steps in the laboratory and against the Actigraph for step counts in free-living conditions and for moderate-to-vigorous physical activity (MVPA) and activity energy expenditure (AEE) overall. Methods Twenty-five adults (12 females, 13 males) wore a Fitbit Flex and an Actigraph GT3X+ during a laboratory based protocol (including walking, incline walking, running and stepping) and free-living conditions during a single day period to examine measurement of steps, AEE and MVPA. Twenty-four of the participants attended a second session using the same protocol. Results Intraclass correlations (ICC) for test-retest reliability of the Fitbit Flex were strong for walking (ICC = 0.57), moderate for stair stepping (ICC = 0.34), and weak for incline walking (ICC = 0.22) and jogging (ICC = 0.26). The Fitbit significantly undercounted walking steps in the laboratory (absolute proportional difference: 21.2%, 95%CI 13.0-29.4%), but it was more accurate, despite slightly over counting, for both jogging (6.4%, 95%CI 3.7-9.0%) and stair stepping (15.5%, 95%CI 10.1-20.9%). The Fitbit had higher coefficients of variation (C-v) for step counts compared to direct observation and the Actigraph. In free-living conditions, the average MVPA minutes were lower in the Fitbit (35.4 minutes) compared to the Actigraph (54.6 minutes), but AEE was greater from the Fitbit (808.1 calories) versus the Actigraph (538.9 calories). The coefficients of variation were similar for AEE for the Actigraph (C-v = 36.0) and Fitbit (C-v = 35.0), but lower in the Actigraph (C-v = 25.5) for MVPA against the Fitbit (C-v = 32.7). Conclusion The Fitbit Flex has moderate validity for measuring physical activity relative to direct observation and the Actigraph. Test-rest reliability of the Fitbit was dependant on activity type and had greater variation between sessions compared to the Actigraph. Physical activity surveillance studies using the Fitbit Flex should consider the potential effect of measurement reactivity and undercounting of steps.	[Sushames, Ashleigh; Edwards, Andrew] James Cook Univ, Coll Healthcare Sci, Cairns, Qld, Australia; [Sushames, Ashleigh; Thompson, Fintan; McDermott, Robyn; Gebel, Klaus] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Ctr Chron Dis Prevent, Cairns, Qld, Australia; [Edwards, Andrew] Univ St Mark & St John, Fac Sport & Hlth Sci, Plymouth, Devon, England; [Gebel, Klaus] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW, Australia	James Cook University; James Cook University; University of Sydney	Sushames, A (corresponding author), James Cook Univ, Coll Healthcare Sci, Cairns, Qld, Australia.; Sushames, A (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Ctr Chron Dis Prevent, Cairns, Qld, Australia.	ashleigh.sushames@my.jcu.edu.au	Gebel, Klaus/W-5681-2019; Gebel, Klaus/J-5280-2014	Gebel, Klaus/0000-0003-0330-7756; Gebel, Klaus/0000-0003-0330-7756	Research Infrastructure Block Grant (RIBG) through College of Public Health, Medical and Veterinary Sciences at James Cook University	Research Infrastructure Block Grant (RIBG) through College of Public Health, Medical and Veterinary Sciences at James Cook University	A Research Infrastructure Block Grant (RIBG) was received by KG and AS through the College of Public Health, Medical and Veterinary Sciences at James Cook University. This funding was used to purchase the Actigraph and Fitbit Flex devices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV PHYS; Borg G., 1998, BORGS PERCEIVED EXER; Bouchard C., 2012, PHYS ACTIVITY HLTH; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Conroy MB, 2011, MED SCI SPORT EXER, V43, P1568, DOI 10.1249/MSS.0b013e31820b9395; Dengel DR, 2014, OPEN SPORTS MED J, V8, P11, DOI DOI 10.2174/1874387001408010011; Department of Health, 2014, PHYS ACT SED BEH GUI; Dierker KE, 2014, MED SCI SPORT EXER, V46, P792, DOI 10.1249/01.mss.0000495877.54448.6c; Dontje Manon L., 2015, Journal of Medical Engineering & Technology, V39, P286, DOI 10.3109/03091902.2015.1050125; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Lee JA, 2015, J SPORT SCI, V33, P991, DOI 10.1080/02640414.2014.981848; Lee JA, 2015, J EXERC SCI FIT, V13, P16, DOI 10.1016/j.jesf.2014.11.002; Maher CA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2952; Noah AJ SD, 2013, J MED ENG TECHNOL, V37, P465; Paul S.S., 2015, BMJ OPEN SPORT EXERC, V1, DOI [DOI 10.1136/BMJSEM-2015-000013, 10.1136/bmjsem-2015-000013]; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Sushames AJ, 2015, PUBLIC HEALTH, V129, P1656, DOI 10.1016/j.puhe.2015.07.024; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Van Hoye K, 2015, INT J ENV RES PUB HE, V12, P6561, DOI 10.3390/ijerph120606561; Vanhelst Jeremy, 2012, BMC Res Notes, V5, P187, DOI 10.1186/1756-0500-5-187; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	32	78	81	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161224	10.1371/journal.pone.0161224	http://dx.doi.org/10.1371/journal.pone.0161224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589592	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000382877800006
J	Ellen, Y; Flecknell, P; Leach, M				Ellen, Yvette; Flecknell, Paul; Leach, Matt			Evaluation of Using Behavioural Changes to Assess Post-Operative Pain in the Guinea Pig (Cavia porcellus)	PLOS ONE			English	Article							FACIAL EXPRESSIONS; LABORATORY MOUSE; RAT; BUPRENORPHINE; RABBITS; LAPAROTOMY; NOCICEPTION; MODULATION; MANAGEMENT; MELOXICAM	To manage pain effectively in people and animals, it is essential to recognise when pain is present and to assess its intensity. Currently there is very little information regarding the signs of post-surgical pain or its management in guinea pigs. Studies from other rodent species indicate that behaviour-based scoring systems can be used successfully to detect pain and evaluate analgesic efficacy. This preliminary study aimed to establish whether behaviour-based scoring systems could be developed to assess post-surgical pain in guinea pigs. This prospective, randomised, placebo-controlled study used 16 guinea pigs, and evaluated changes in behaviour following either anaesthesia alone or anaesthesia and orchiectomy. Behaviour was assessed using a combination of manual and automated scoring of remotely obtained video footage. A small number of behaviours were identified that appeared to have high specificity for pain caused by orchiectomy. However, the behaviours were displayed infrequently. The most common was a change in posture from standing to recumbency, sometimes with one hind leg extended either to the side or behind the body. A composite behaviour score incorporating these abnormal behaviours differentiated between the effects of surgery and anaesthesia alone (p<0.0001), and between animals that received analgesia post-operatively compared to an untreated group (p<0.0001). Although behavioural changes occurred in these guinea pigs after orchiectomy, the changes were relatively subtle and the individual specific pain-related behaviours occurred infrequently. However, it may prove possible to develop a behaviour-based scoring system for routine use in this species using a combination of pain-related behaviours.	[Ellen, Yvette] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Flecknell, Paul] Newcastle Univ, Inst Neurosci, Newcastle, NSW, Australia; [Leach, Matt] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle, NSW, Australia	QIMR Berghofer Medical Research Institute; University of Newcastle; University of Newcastle	Flecknell, P (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle, NSW, Australia.	paul.flecknell@ncl.ac.uk		Flecknell, Paul/0000-0002-1075-1129	Wellcome Trust; Newcastle University	Wellcome Trust(Wellcome TrustEuropean Commission); Newcastle University	Yvette Ellen was supported by the Wellcome Trust. The cost of the project was funded by Newcastle University.	Arras Margarete, 2007, BMC Vet Res, V3, P16, DOI 10.1186/1746-6148-3-16; Aung HH, 2004, LIFE SCI, V74, P2685, DOI 10.1016/j.lfs.2003.08.047; Clark JA, 1997, LAB ANIM SCI, V47, P300; COLLIER HO, 1961, BRIT J PHARM CHEMOTH, V17, P28, DOI 10.1111/j.1476-5381.1961.tb01101.x; COLLIER HOJ, 1963, BRIT J PHARM CHEMOTH, V21, P155, DOI 10.1111/j.1476-5381.1963.tb01511.x; da Silva LFS, 2006, PHYSIOL BEHAV, V87, P821, DOI 10.1016/j.physbeh.2006.01.019; Dunbar ML, 2016, J AM ASSOC LAB ANIM, V55, P29; Farnworth MJ, 2011, ANIM WELFARE, V20, P225; Mendes LAF, 2008, LIFE SCI, V83, P644, DOI 10.1016/j.lfs.2008.09.006; Flecknell P, 2015, LAB ANIMAL ANAESTHES; Gebhart GF, 2009, REC ALL PAIN LAB AN; Glass G.V., 1972, REV ED RES, V42, P288; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.2307/1165127; Hawkins MG, 2006, J EXOT PET MED, V15, P177, DOI 10.1053/j.jepm.2006.06.004; Home Office, 2014, GREAT BRIT 2014; Jirkof P, 2012, LAB ANIM-UK, V46, P325, DOI 10.1258/la.2012.012027; Kaiser S., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P380, DOI 10.1002/9781444318777.ch27; Keating SCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044437; Keown AJ, 2011, NEW ZEAL VET J, V59, P305, DOI 10.1080/00480169.2011.609477; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; LILES JH, 1992, LAB ANIM, V26, P241, DOI 10.1258/002367792780745706; Liles JH, 1998, LAB ANIM, V32, P149, DOI 10.1258/002367798780600025; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Miller AL, 2011, APPL ANIM BEHAV SCI, V131, P138, DOI 10.1016/j.applanim.2011.02.007; MITCHELL D, 1977, PHYSIOL BEHAV, V18, P125, DOI 10.1016/0031-9384(77)90103-2; MORRISEY J, 2012, FERRETS RABBITS RODE; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Pet Food Manufacturer's Association, 2015, PET POP 2015; Rehbinder C, 1996, LAB ANIM, V30, P193, DOI 10.1258/002367796780684881; Reinert J., 2012, ASSESSMENT PAIN BEHA; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2002, LAB ANIM-UK, V36, P322, DOI 10.1258/002367702320162423; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Thompson AC, 2004, COMPARATIVE MED, V54, P293; Turner PV, 2006, COMPARATIVE MED, V56, P63; Whittaker A. L., 2013, APPL ANIMAL BEHAV SC; Wright-Williams SL, 2007, PAIN, V130, P108, DOI 10.1016/j.pain.2006.11.003	41	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161941	10.1371/journal.pone.0161941	http://dx.doi.org/10.1371/journal.pone.0161941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583446	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600076
J	Dror, DM; Hossain, SAS; Majumdar, A; Koehlmoos, TLP; John, D; Panda, PK				Dror, David Mark; Hossain, S. A. Shahed; Majumdar, Atanu; Koehlmoos, Tracey Lynn Perez; John, Denny; Panda, Pradeep Kumar			What Factors Affect Voluntary Uptake of Community-Based Health Insurance Schemes in Low-and Middle-Income Countries? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							WILLINGNESS-TO-PAY; DROP-OUT; ENROLLMENT; FEASIBILITY; PREFERENCES; AFRICA; DEMAND; IMPACT; UGANDA; FUNDS	Introduction This research article reports on factors influencing initial voluntary uptake of community-based health insurance (CBHI) schemes in low-and middle-income countries (LMIC), and renewal decisions. Methods Following PRISMA protocol, we conducted a comprehensive search of academic and gray literature, including academic databases in social science, economics and medical sciences (e.g., Econlit, Global health, Medline, Proquest) and other electronic resources (e.g., Eldis and Google scholar). Search strategies were developed using the thesaurus or index terms (e.g., MeSH) specific to the databases, combined with free text terms related to CBHI or health insurance. Searches were conducted from May 2013 to November 2013 in English, French, German, and Spanish. From the initial search yield of 15,770 hits, 54 relevant studies were retained for analysis of factors influencing enrolment and renewal decisions. The quantitative synthesis (informed by meta-analysis) and the qualitative analysis (informed by thematic synthesis) were compared to gain insight for an overall synthesis of findings/statements. Results Meta-analysis suggests that enrolments in CBHI were positively associated with household income, education and age of the household head (HHH), household size, female-headed household, married HHH and chronic illness episodes in the household. The thematic synthesis suggests the following factors as enablers for enrolment: (a) knowledge and understanding of insurance and CBHI, (b) quality of healthcare, (c) trust in scheme management. Factors found to be barriers to enrolment include: (a) inappropriate benefits package, (b) cultural beliefs, (c) affordability, (d) distance to healthcare facility, (e) lack of adequate legal and policy frameworks to support CBHI, and (f) stringent rules of some CBHI schemes. HHH education, household size and trust in the scheme management were positively associated with member renewal decisions. Other motivators were: (a) knowledge and understanding of insurance and CBHI, (b) healthcare quality, (c) trust in scheme management, and (d) receipt of an insurance payout the previous year. The barriers to renewal decisions were: (a) stringent rules of some CBHI schemes, (b) inadequate legal and policy frameworks to support CBHI and (c) inappropriate benefits package. Conclusion and Policy Implications The demand-side factors positively affecting enrolment in CBHI include education, age, female household heads, and the socioeconomic status of households. Moreover, when individuals understand how their CBHI functions they are more likely to enroll and when people have a positive claims experience, they are more likely to renew. A higher prevalence of chronic conditions or the perception that healthcare is of good quality and nearby act as factors enhancing enrolment. The perception that services are distant or deficient leads to lower enrolments. The second insight is that trust in the scheme enables enrolment. Thirdly, clarity about the legal or policy framework acts as a factor influencing enrolments. This is significant, as it points to hitherto unpublished evidence that governments can effectively broaden their outreach to grassroots groups that are excluded from social protection by formulating supportive regulatory and policy provisions even if they cannot fund such schemes in full, by leveraging people's willingness to exercise voluntary and contributory enrolment in a community-based health insurance.	[Dror, David Mark; Majumdar, Atanu] Micro Insurance Acad, New Delhi, India; [Dror, David Mark] Erasmus Univ, Rotterdam, Netherlands; [Hossain, S. A. Shahed] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Koehlmoos, Tracey Lynn Perez] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [John, Denny] Peoples Open Access Educ Initiat Peoples Uni, Delhi, India; [Panda, Pradeep Kumar] Int Inst Hlth Management Res, Delhi, India; [Dror, David Mark] 86 Okhla Ind Estate Phase 3, New Delhi 110020, India	Erasmus University Rotterdam; International Centre for Diarrhoeal Disease Research (ICDDR); Uniformed Services University of the Health Sciences - USA	Dror, DM (corresponding author), Micro Insurance Acad, New Delhi, India.; Dror, DM (corresponding author), Erasmus Univ, Rotterdam, Netherlands.; Dror, DM (corresponding author), 86 Okhla Ind Estate Phase 3, New Delhi 110020, India.	daviddror@socialre.org	Dror, David/I-6021-2013; John, Denny/J-7815-2017	Dror, David/0000-0002-8757-4239; John, Denny/0000-0002-4486-632X	3ie [SR4/1009]	3ie	Grant from 3ie and Grant No. SR4/1009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo EF, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1179-3; Aggarwal A, 2010, DISCUSSION PAPER SER; Akotey OJ, 2011, J RISK FINANC, V12, P182, DOI 10.1108/15265941111136932; Alatinga K., 2011, Journal of Sustainable Development, V4, P125, DOI 10.5539/jsd.v4n5p125; [Anonymous], 2013, 7251 IZA; [Anonymous], 2007, 20060702 IIMA; Atim C, 2000, 50 ABT ASS INC PARTN; Bai A., 2012, QUALITY ASSESSMENT T; Bank World, 2009, WE CLASS COUNTRIES; Basaza R, 2008, HEALTH POLICY, V87, P172, DOI 10.1016/j.healthpol.2007.12.008; Basaza R, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-105; Basaza RK, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-33; Bendig M., 2011, ENROLMENT MICROLIFE; Bhat R, 2007, INT J EQUITY HEALTH, P11; Bonan J, 2012, 14 INT LAB OFF MICR; Chankova S, 2008, HEALTH POLICY PLANN, V23, P264, DOI 10.1093/heapol/czn011; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Criel B, 2003, SOC SCI MED, V57, P1205, DOI 10.1016/S0277-9536(02)00495-1; Criel B, 1998, TROP MED INT HEALTH, V3, P640, DOI 10.1046/j.1365-3156.1998.00286.x; Critical Appraisal Skills Programme, 2013, 12 QUEST HELP YOU MA; Critical Appraisal Skills Programmer, 2006, 10 QUEST HELP YOU MA; De Allegri M, 2006, SOC SCI MED, V62, P1520, DOI 10.1016/j.socscimed.2005.07.036; De Allegri M, 2006, HEALTH POLICY, V76, P58, DOI 10.1016/j.healthpol.2005.04.010; De Allegri M, 2006, B WORLD HEALTH ORGAN, V84, P852; Donfouet HPP, 2012, 11 INT WORKSH SPAT E; Dong HJ, 2009, HEALTH POLICY, V92, P174, DOI 10.1016/j.healthpol.2009.03.013; Dong HJ, 2004, HEALTH POLICY, V69, P45, DOI 10.1016/j.healthpol.2003.12.001; Dong HJ, 2005, HEALTH POLICY, V72, P149, DOI 10.1016/j.healthpol.2004.02.014; Dror D.M., 2014, ENCY HLTH EC, V1, P412; Dror D.M., 1999, INT SOCIAL SECURITY, V52, P71, DOI [DOI 10.1111/1468-246X.00034, 10.1111/1468-246X.00034]; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Dror DM, 2010, GLOB RISK FOR GRF DA; Dror DM, 2016, MICROINSURANCE BUSIN; Eckhardt M, 2011, REV PANAM SALUD PUBL, V29, P177; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; Fonta WM., 2010, AFRICAN REV MONEY FI, P109; Gnawali DP, 2009, HEALTH POLICY, V90, P214, DOI 10.1016/j.healthpol.2008.09.015; Gottret P. E., 2006, HLTH FINANCING REVIS; Gumber, 2001, HNP DISCUSSION PAPER; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Ito S, 2009, WHY IS TAKE UP MICRO; Jutting J, 2003, WORKING PAPERS, V204; Kuwawenaruwa A, 2011, East Afr Med J, V88, P54; Kyomugisha E, 2009, AFR HEALTH SCI, V9, P59; Lammers J, 2010, AIID RES SERIES; Mathiyazhagan K, 1998, INT J HEALTH PLAN M, V13, P47, DOI 10.1002/(SICI)1099-1751(199801/03)13:1&lt;47::AID-HPM495&gt;3.0.CO;2-I; Mladovsky P, 2014, SOC SCI MED, V107, P78, DOI 10.1016/j.socscimed.2014.02.008; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Msuya J, 2004, ZEF DISCUSSION PAPER, P82; Msuya JM, 2007, INT J PUBLIC ADMIN, V30, P813, DOI 10.1080/01900690701227263; Noubiap JJN, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.17.2279; Nsiah-Boateng Eric, 2013, Value Health Reg Issues, V2, P300, DOI 10.1016/j.vhri.2013.06.005; Onwujekwe O, 2011, AFRICAN J HLTH EC, V1, P1; Onwujekwe O, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-162; Onwujekwe O, 2009, HEALTH POLICY, V92, P96, DOI 10.1016/j.healthpol.2009.02.007; Oriakhi HO, 2012, STUD ETHNO-MED, V6, P95, DOI 10.1080/09735070.2012.11886425; Ozawa S, 2009, ADV HEALTH ECON HEAL, V21, P107, DOI 10.1108/S0731-2199(2009)0000021008; Panda P, 2015, SYSTEMATIC REV METAA, DOI [10.1093/heapol/czs034, DOI 10.1093/HEAPOL/CZS034]; Panda P, 2013, WHAT FACTORS AFFECT; Panda P, 2014, HEALTH POLICY PLANN, V29, P960, DOI 10.1093/heapol/czt077; Poletti T, 2007, OPTIONS SCALING COMM; Ranson MK, 2001, HNP DISCUSSION PAPER; Rao KD, 2009, HEALTH POLICY PLANN, V24, P301, DOI 10.1093/heapol/czp018; Robyn PJ, 2013, HEALTH POLICY PLANN, V28, P111, DOI 10.1093/heapol/czs034; Sakthivel Selvaraj, 2012, Economic and Political Weekly, V47, P60; Schneider P, 2005, SOC SCI MED, V61, P1430, DOI 10.1016/j.socscimed.2004.11.074; Schneider P, 2001, SYNOPSIS RESULTS IMP; Shafie AA, 2013, SOC SCI MED, V96, P272, DOI 10.1016/j.socscimed.2013.02.045; Sinha T, 2006, UNDERSTANDING MEMBER; Stuckler D, 2010, POLITICAL EC UNIVERS; Tabor S., 2005, SOCIAL PROTECTION DI, V0503; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Uzochukwu B, 2009, COMMUNITY BASED HLTH; Waddington H, 2012, PROTOCOL FARMER FIEL; Wang H, 2005, HEALTH POLICY PLANN, V20, P366, DOI 10.1093/heapol/czi045; Zhang LC, 2006, HEALTH POLICY, V76, P233, DOI 10.1016/j.healthpol.2005.06.001	76	70	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160479	10.1371/journal.pone.0160479	http://dx.doi.org/10.1371/journal.pone.0160479			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579731	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400005
J	Melese, E; Peterson, JR; Feldman, RM; Baker, LA; Bell, NP; Chuang, AZ; Blieden, LS				Melese, Ephrem; Peterson, Jeffrey R.; Feldman, Robert M.; Baker, Laura A.; Bell, Nicholas P.; Chuang, Alice Z.; Blieden, Lauren S.			Comparing Laser Peripheral Iridotomy to Cataract Extraction in Narrow Angle Eyes Using Anterior Segment Optical Coherence Tomography	PLOS ONE			English	Article							PROSPECTIVE CASE SERIES; CLOSURE GLAUCOMA PACG; CLINICAL-OUTCOMES; CHAMBER ANGLE; COEXISTING CATARACT; LENS IMPLANTATION; PHACOEMULSIFICATION; CONFIGURATION; POPULATION; PREVALENCE	Purpose To evaluate the changes in anterior chamber angle (ACA) parameters in primary angle closure (PAC) spectrum eyes before and after cataract extraction (CE) and compare to the changes after laser peripheral iridotomy (LPI) using anterior segment optical coherence tomography (ASOCT). Methods Twenty-eight PAC spectrum eyes of 18 participants who underwent CE and 34 PAC spectrum eyes of 21 participants who underwent LPI were included. ASOCT images with 3-dimensional mode angle analysis scans were taken with the CASIA SS-1000 (Tomey Corp., Nagoya, Japan) before and after CE or LPI. Mixed-effect model analysis was used to 1) compare best-corrected visual acuity, intraocular pressure, and ACA parameters before and after CE; 2) identify and estimate the effects of potential contributing factors affecting changes in ACA parameters; and 3) compare CE and LPI treatment groups. Results The increase in average angle parameters (TISA750 and TICV750) was significantly greater after CE than LPI. TICV750 increased by 102% (2.114 [+/- 1.203] mu L) after LPI and by 174% (4.546 [+/- 1.582] mu L) after CE (P < 0.001). Change of TICV750 in the CE group was significantly affected by age (P = 0.002), race (P = 0.006), and intraocular lens power (P = 0.037). Conclusions CE results in greater anatomic changes in the ACA than LPI in PAC spectrum eyes. ASOCT may be used to follow anatomic changes in the angle after intervention.	[Melese, Ephrem; Peterson, Jeffrey R.; Feldman, Robert M.; Baker, Laura A.; Bell, Nicholas P.; Blieden, Lauren S.] Robert Cizik Eye Clin, Houston, TX 77030 USA; [Peterson, Jeffrey R.; Feldman, Robert M.; Bell, Nicholas P.; Chuang, Alice Z.; Blieden, Lauren S.] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Blieden, LS (corresponding author), Robert Cizik Eye Clin, Houston, TX 77030 USA.; Blieden, LS (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Ruiz Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA.	lblieden@cizikeye.org		Feldman, Robert/0000-0001-8586-6345	Alcon (Fort Worth, TX, USA); National Eye Institute Vision Core Grant (Bethesda, MD, USA) [P30EY010608]; Challenge Grant rom Research to Prevent Blindness (New York, NY); Hermann Eye Fund (Houston, TX)	Alcon (Fort Worth, TX, USA); National Eye Institute Vision Core Grant (Bethesda, MD, USA); Challenge Grant rom Research to Prevent Blindness (New York, NY); Hermann Eye Fund (Houston, TX)	This work was supported by Alcon (Fort Worth, TX, USA; alcon.com), National Eye Institute Vision Core Grant P30EY010608 (Bethesda, MD, USA; nei.nih.gov), a Challenge Grant to McGovern Medical School from Research to Prevent Blindness (New York, NY; rpbusa.org), and the Hermann Eye Fund (Houston, TX; cizikeye.org/philanthropy/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2005, SHIELDS TXB GLAUCOMA, P217; Allingham RR, 2005, SHIELDS TXB GLAUCOMA, P303; Blieden LS, 2015, INVEST OPHTH VIS SCI, V56, P2842, DOI 10.1167/iovs.14-15883; Congdon NG, 2002, BRIT J OPHTHALMOL, V86, P18, DOI 10.1136/bjo.86.1.18; Cumba Ricardo J, 2013, ISRN Ophthalmol, V2013, P828972, DOI 10.1155/2013/828972; Cumba RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/487309; Dias-Santos A, 2015, INT OPHTHALMOL, V35, P173, DOI 10.1007/s10792-014-9926-8; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gazzard G, 2003, OPHTHALMOLOGY, V110, P630, DOI 10.1016/S0161-6420(02)01893-6; Hayashi K, 2000, OPHTHALMOLOGY, V107, P698, DOI 10.1016/S0161-6420(00)00007-5; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; How AC, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.019; Kansara S, 2016, J GLAUCOMA, V25, pE469, DOI 10.1097/IJG.0000000000000293; Kim Martha, 2012, Korean J Ophthalmol, V26, P97, DOI 10.3341/kjo.2012.26.2.97; Kim Martha, 2011, Korean J Ophthalmol, V25, P77, DOI 10.3341/kjo.2011.25.2.77; Kucumen RB, 2008, J CATARACT REFR SURG, V34, P1694, DOI 10.1016/j.jcrs.2008.05.049; Lai JSM, 2006, J GLAUCOMA, V15, P47, DOI 10.1097/01.ijg.0000196619.34368.0a; Lee RY, 2014, OPHTHALMOLOGY, V121, P1194, DOI 10.1016/j.ophtha.2013.12.027; Lim LS, 2004, OPHTHALMOLOGY, V111, P1470, DOI 10.1016/j.ophtha.2004.01.036; LOWE RF, 1969, AM J OPHTHALMOL, V67, P87, DOI 10.1016/0002-9394(69)90012-9; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; Melese EK, 2016, AM J OPHTHALMOL, V169, P208, DOI 10.1016/j.ajo.2016.06.032; Memarzadeh F, 2007, AM J OPHTHALMOL, V144, P464, DOI 10.1016/j.ajo.2007.04.009; Nolan WP, 2008, J GLAUCOMA, V17, P455, DOI 10.1097/IJG.0b013e3181650f31; Prum Bruce E Jr, 2016, Ophthalmology, V123, pP1, DOI 10.1016/j.ophtha.2015.10.049; Rigi M, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/590978; Rosman M, 2002, OPHTHALMOLOGY, V109, P2227, DOI 10.1016/S0161-6420(02)01275-7; Shams PN, 2012, J GLAUCOMA, V21, P545, DOI 10.1097/IJG.0b013e31821db1db; Spaeth G L, 1995, Trans Am Ophthalmol Soc, V93, P337; Spaeth G L, 1971, Trans Ophthalmol Soc U K, V91, P709; Spaeth GL, 2006, J GLAUCOMA, V15, P346, DOI 10.1097/01.ijg.0000212267.42606.73; Tai MC, 2010, J CATARACT REFR SURG, V36, P1758, DOI 10.1016/j.jcrs.2010.05.011; Tarongoy P, 2009, SURV OPHTHALMOL, V54, P211, DOI 10.1016/j.survophthal.2008.12.002; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thomas R, 2003, BRIT J OPHTHALMOL, V87, P450, DOI 10.1136/bjo.87.4.450	35	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162283	10.1371/journal.pone.0162283	http://dx.doi.org/10.1371/journal.pone.0162283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606482	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600036
J	Carrere-Kremer, S; Rubbo, PA; Pisoni, A; Bendriss, S; Marin, G; Peries, M; Bollore, K; Terru, D; Godreuil, S; Bourdin, A; Van de Perre, P; Tuaillon, E				Carrere-Kremer, Severine; Rubbo, Pierre-Alain; Pisoni, Amandine; Bendriss, Sophie; Marin, Gregory; Peries, Marianne; Bollore, Karine; Terru, Dominique; Godreuil, Sylvain; Bourdin, Arnaud; Van de Perre, Philippe; Tuaillon, Edouard			High IFN-gamma Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; LATENT TUBERCULOSIS; DIAGNOSIS; ASSAYS; INFECTION; CD4(+); VACCINE; ADULTS; TOOL	Interferon gamma (IFN-gamma) release assays (IGRAs) detect Mycobacterium tuberculosis (Mtb) infection regardless of the active (ATB) or latent (LTBI) forms of tuberculosis (TB). In this study, Mtb-specific T cell response against region of deletion 1 (RD1) antigens were explored by a microbead multiplex assay performed in T-SPOT TB assay (T-SPOT) supernatants from 35 patients with ATB and 115 patients with LTBI. T-SPOT is positive when over 7 IFN-gamma secreting cells (SC)/250 000 peripheral blood mononuclear cells (PBMC) are enumerated. However, over 100 IFN-gamma SC /250 000 PBMC were more frequently observed in the ATB group compared to the LTBI group. By contrast, lower cytokine concentrations and lower cytokine productions relative to IFN-gamma secretion were observed for IL 4, IL-12, TNF-alpha, GM-CSF, Eotaxin and IFN-alpha when compared to LTBI. Thus, high IFN-gamma release and low cytokine secretions in relation with IFN-gamma production appeared as signatures of ATB, corroborating that multicytokine Mtb-specific response against RD1 antigens reflects host capacity to contain TB reactivation. In this way, testing cytokine profile in IGRA supernatants would be helpful to improve ATB screening strategy including immunologic tests.	[Carrere-Kremer, Severine; Rubbo, Pierre-Alain; Pisoni, Amandine; Peries, Marianne; Bollore, Karine; Van de Perre, Philippe; Tuaillon, Edouard] Univ Montpellier, UMR1058, INSERM, EFS, Montpellier, France; [Carrere-Kremer, Severine; Rubbo, Pierre-Alain; Bollore, Karine; Van de Perre, Philippe; Tuaillon, Edouard] Univ Montpellier, Montpellier, France; [Pisoni, Amandine; Bendriss, Sophie; Terru, Dominique; Godreuil, Sylvain; Van de Perre, Philippe; Tuaillon, Edouard] CHRU Montpellier, Dept Bacteriol Virol, Montpellier, France; [Bourdin, Arnaud] CHRU Montpellier, Dept Pneumol, Montpellier, France; [Marin, Gregory] CHRU Montpellier, Dept Med Informat, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Carrere-Kremer, S; Tuaillon, E (corresponding author), Univ Montpellier, UMR1058, INSERM, EFS, Montpellier, France.; Carrere-Kremer, S; Tuaillon, E (corresponding author), Univ Montpellier, Montpellier, France.; Tuaillon, E (corresponding author), CHRU Montpellier, Dept Bacteriol Virol, Montpellier, France.	severine.kremer@yahoo.fr; e-tuaillon@chu-montpellier.fr	Van de Perre, Philippe/B-9692-2008	Van de Perre, Philippe/0000-0002-3912-0427; godreuil, sylvain/0000-0003-3436-0082; Tuaillon, Edouard/0000-0001-5866-9530	INSERM DHOS (AFSSAPS) [2010-A00422-37]; CHRU Montpellier; Fondation de France	INSERM DHOS (AFSSAPS); CHRU Montpellier; Fondation de France(Fondation de France)	This work was supported by the INSERM DHOS grant (AFSSAPS no 2010-A00422-37) and by CHRU Montpellier. SCK was funded by the Fondation de France. The INSERM DHOS grant (AFSSAPS no 2010-A00422-37) did not provide any support in the form of salaries for authors, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Fondation de France provided support in the form of salaries for SCK.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Biraro IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146098; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144705; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Geldenhuys H, 2015, VACCINE, V33, P3592, DOI 10.1016/j.vaccine.2015.05.036; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jenum S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101224; Kim S, 2015, J MOL DIAGN, V17, P90, DOI 10.1016/j.jmoldx.2014.08.005; Kobashi Y, 2010, LUNG, V188, P283, DOI 10.1007/s00408-010-9238-3; Lavender TW, 2013, CLIN MICROBIOL INFEC, V19, P1078, DOI 10.1111/1469-0691.12129; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Little KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124525; Mamishi S, 2014, EUR J CLIN MICROBIOL, V33, P2111, DOI 10.1007/s10096-014-2190-z; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Ritz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037535; Rozot V, 2015, CLIN INFECT DIS, V60, P432, DOI 10.1093/cid/ciu795; Rubbo PA, 2012, J CLIN MICROBIOL, V50, P1711, DOI 10.1128/JCM.00117-12; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Suter-Riniker F, 2011, CLIN VACCINE IMMUNOL, V18, P1395, DOI 10.1128/CVI.05013-11; Tebruegge M, 2015, AM J RESP CRIT CARE, V192, P485, DOI 10.1164/rccm.201501-0059OC; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051338; WHO, 2014, GLOB TUB REP 2014; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	35	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162137	10.1371/journal.pone.0162137	http://dx.doi.org/10.1371/journal.pone.0162137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603919	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200047
J	Maffey, L; Vega, CG; Mino, S; Garaicoechea, L; Parreno, V				Maffey, Lucia; Vega, Celina G.; Mino, Samuel; Garaicoechea, Lorena; Parreno, Viviana			Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODY; LACTOBACILLUS-RHAMNOSUS GG; INDUCED DIARRHEA; MONOCLONAL-ANTIBODIES; IN-VITRO; PASSIVE PROTECTION; CONFER PROTECTION; CONTROLLED-TRIAL; FRAGMENTS; RESPONSES	Species A Rotaviruses (RVA) remain a leading cause of mortality in children under 5 years of age. Current treatment options are limited. We assessed the efficacy of two VP6-specific llama-derived heavy chain antibody fragments (VHH) -2KD1 and 3B2- as an oral prophylactic and therapeutic treatment against RVA-induced diarrhea in a neonatal mouse model inoculated with virulent murine RVA (ECw, G16P[16]I7). Joint therapeutic administration of 2KD1+3B2 (200 mu g/dose) successfully reduced diarrhea duration, RVA infection severity and virus shedding in feces. While the same dose of 2KD1 or 3B2 (200 mu g) significantly reduced duration of RVA-induced diarrhea, 2KD1 was more effective in diminishing the severity of intestinal infection and RVA shedding in feces, perhaps because 2KD1 presented higher binding affinity for RVA particles than 3B2. Neither prophylactic nor therapeutic administration of the VHH interfered with the host's humoral immune response against RVA. When 2KD1 (200 mu g) was administered after diarrhea development, it also significantly reduced RVA intestinal infection and fecal shedding. Host antibody responses against the oral VHH treatment were not detected, nor did viral escape mutants. Our findings show that oral administration of anti-VP6 VHH constitute, not only an effective prophylactic treatment against RVA-associated diarrhea, but also a safe therapeutic tool against RVA infection, even once diarrhea is present. Anti-VP6 VHH could be used complementary to ongoing vaccination, especially in populations that have shown lower immunization efficacy. These VHH could also be scaled-up to develop pediatric medication or functional food like infant milk formulas that might help treat RVA diarrhea.	[Maffey, Lucia; Vega, Celina G.; Mino, Samuel; Garaicoechea, Lorena; Parreno, Viviana] INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet & Agron, Buenos Aires, DF, Argentina; [Maffey, Lucia; Vega, Celina G.; Garaicoechea, Lorena; Parreno, Viviana] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Parreno, V (corresponding author), INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet & Agron, Buenos Aires, DF, Argentina.; Parreno, V (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	parreno.viviana@inta.gob.ar		Mino, Samuel/0000-0003-1048-8532; Vega, Celina/0000-0002-0644-7263; parreno, viviana/0000-0003-0385-5592; Maffey, Lucia/0000-0002-1411-8355	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto Investigacion Cientifica y Tecnologica [328-10]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto INTABIO AF [03-2010]; Convocatoria Alimentos Funcionales, Fondo Argentino Sectorial (FONARSEC) through the Proyecto Nacional de Salud Animal [1115053]; Instituto Nacional de Tecnologia Agropecuaria through the Programa Nacional de Biotecnologia [1131032]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto Investigacion Cientifica y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto INTABIO AF; Convocatoria Alimentos Funcionales, Fondo Argentino Sectorial (FONARSEC) through the Proyecto Nacional de Salud Animal; Instituto Nacional de Tecnologia Agropecuaria through the Programa Nacional de Biotecnologia	This work received support from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the following grants: Proyecto Investigacion Cientifica y Tecnologica No 328-10, Proyecto INTABIO AF No 03-2010. Convocatoria Alimentos Funcionales, Fondo Argentino Sectorial (FONARSEC) and from Instituto Nacional de Tecnologia Agropecuaria through the following grants: Proyecto Nacional de Salud Animal No 1115053 and Programa Nacional de Biotecnologia No 1131032.; We would like to thank Dr. Ulrich Desselberger for his kind help with the manuscript and his valuable suggestions. We are very grateful for the technical assistance of Fatima Torales for caring for the animals and Dr. Marina Bok and M.Sci. Josefina Baztarrica for useful assistance throughout the experimental procedures. We would also like to thank Dr. Osvaldo Zabal and Diego Compaired for technical support. We are thankful to Dr. Alejandro Castello for providing ECw RVA strains used in this work. VP, CGV and LLG are members of CONICET Scientist Carrier, Argentina. LM has a PhD scholarship from CONICET, Argentina.	Aladin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032949; Arbabi-ghahroudi M, 2005, PROKARYOTIC EXPRESSI, P501; Bae EA, 2000, BIOL PHARM BULL, V23, P1122, DOI 10.1248/bpb.23.1122; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Cornaglia E, 1989, REV LATINOAM MICROBI, P59; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; COULSON BS, 1990, J CLIN MICROBIOL, V28, P1367, DOI 10.1128/JCM.28.6.1367-1374.1990; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Estes MK, 2001, FIELDS VIROLOGY, P1347; Feng NG, 2013, J VIROL, V87, P8307, DOI 10.1128/JVI.00619-13; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gomez-Sebastian S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-59; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Gunaydin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096409; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hodgins DC, 1999, J VIROL, V73, P186, DOI 10.1128/JVI.73.1.186-197.1999; Inagaki M, 2010, BIOSCI BIOTECH BIOCH, V74, P680, DOI 10.1271/bbb.90862; Ismaili A, 2007, BIOTECHNOL APPL BIOC, V47, P11, DOI 10.1042/BA20060071; Kim DH, 2000, BIOL PHARM BULL, V23, P356, DOI 10.1248/bpb.23.356; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lentz EM, 2012, PLANTA, V236, P703, DOI 10.1007/s00425-012-1642-x; LITTLE LM, 1982, INFECT IMMUN, V38, P755, DOI 10.1128/IAI.38.2.755-763.1982; Maffey L, 2015, REV ARGENT MICROBIOL, V47, P368, DOI 10.1016/j.ram.2015.09.005; MATSUI SM, 1989, J CLIN MICROBIOL, V27, P780, DOI 10.1128/JCM.27.4.780-782.1989; Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198; Mino S, 2013, VET MICROBIOL, V161, P239, DOI 10.1016/j.vetmic.2012.07.033; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; OFFIT PA, 1986, J VIROL, V58, P700, DOI 10.1128/JVI.58.2.700-703.1986; Pant N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-86; Pant N, 2006, J INFECT DIS, V194, P1580, DOI 10.1086/508747; Pant N, 2011, FUTURE MICROBIOL, V6, P583, DOI [10.2217/fmb.11.32, 10.2217/FMB.11.32]; Parashar UD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7204; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; Pellis M, 2012, ARCH BIOCHEM BIOPHYS, V526, P114, DOI 10.1016/j.abb.2012.04.023; Preidis GA, 2012, J PEDIATR GASTR NUTR, V55, P299, DOI 10.1097/MPG.0b013e31824d2548; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Sarker SA, 1998, PEDIATR INFECT DIS J, V17, P1149, DOI 10.1097/00006454-199812000-00010; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Sarker SA, 2007, J HEALTH POPUL NUTR, V25, P465; Sarker SA, 2013, GASTROENTEROLOGY, V145, P740, DOI 10.1053/j.gastro.2013.06.053; SVENSSON L, 1987, J GEN VIROL, V68, P1993, DOI 10.1099/0022-1317-68-7-1993; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Teran CG, 2009, INT J INFECT DIS, V13, P518, DOI 10.1016/j.ijid.2008.09.014; Tokuhara D, 2013, J CLIN INVEST, V123, P3829, DOI 10.1172/JCI70266; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Vega C, 2011, VET IMMUNOL IMMUNOP, V142, P156, DOI 10.1016/j.vetimm.2011.05.003; Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334; Vega CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042788; VESIKARI T, 1985, J PEDIATR-US, V107, P189, DOI 10.1016/S0022-3476(85)80123-2; Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16; *WHO UNICEF, 2006, IMPL NEW REC CLIN MA; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zhang Z, 2013, PATHOG DIS, V67, P184, DOI 10.1111/2049-632X.12030	66	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162351	10.1371/journal.pone.0162351	http://dx.doi.org/10.1371/journal.pone.0162351			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603013	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200059
J	Bahler, C; Signorell, A; Reich, O				Bahler, Caroline; Signorell, Andri; Reich, Oliver			Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland	PLOS ONE			English	Article							SMALL-AREA ANALYSIS; OLDER-PEOPLE; RETROSPECTIVE ANALYSIS; END; PLACE; DEATH; PATIENT; HOSPITALIZATIONS; PREFERENCES; POPULATION	Background Many efforts are undertaken in Switzerland to enable older and/or chronically ill patients to stay home longer at the end-of-life. One of the consequences might be an increased need for hospitalisations at the end-of-life, which goes along with burdensome transitions for patients and higher health care costs for the society. Aim We aimed to examine the health care utilisation in the last six months of life, including transitions between health care settings, in a Swiss adult population. Methods The study population consisted of 11'310 decedents of 2014 who were insured at the Helsana Group, the leading health insurance in Switzerland. Descriptive statistics were used to analyse the health care utilisation by age group, taking into account individual and regional factors. Zero-inflated Poisson regression model was used to predict the number of transitions. Results Mean age was 78.1 in men and 83.8 in women. In the last six months of life, 94.7% of the decedents had at least one consultation; 61.6% were hospitalised at least once, with a mean length of stay of 28.3 days; and nursing home stays were seen in 47.4% of the decedents. Over the same time period, 64.5% were transferred at least once, and 12.9% experienced at least one burdensome transition. Main predictors for transitions were age, sex and chronic conditions. A high density of home care nurses was associated with a decrease, whereas a high density of ambulatory care physicians was associated with an increase in the number of transitions. Conclusions Health care utilisation was high in the last six months of life and a considerable number of decedents were being transferred. Advance care planning might prevent patients from numerous and particularly from burdensome transitions.	[Bahler, Caroline; Signorell, Andri; Reich, Oliver] Helsana Insurance Grp, Dept Hlth Sci, CH-8081 Zurich, Switzerland		Reich, O (corresponding author), Helsana Insurance Grp, Dept Hlth Sci, CH-8081 Zurich, Switzerland.	oliver.reich@helsana.ch			Helsana Group	Helsana Group	Helsana Group provided support in the form of salaries for authors [CB, OR, AS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abarshi E, 2010, PALLIATIVE MED, V24, P166, DOI 10.1177/0269216309351381; Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Berlin C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-289; Bundesamt fur Gesundheit und Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren, 2012, NAT STRAT PALL CAR 2; Bundesamt fur Statistik [Swiss Federal Statistical Office], 2013, STAT HILF PFLEG HAUS; Bundesamt fur Statistik [Swiss Federal Statistical Office], 2015, NOM RAUML GLIED; Bundesamt fur Statistik [Swiss Federal Statistical Office], 2013, STAT SOZ I SOMED; Burge Frederick I, 2005, BMC Palliat Care, V4, P3, DOI 10.1186/1472-684X-4-3; Chitnis XA, 2013, BMJ SUPPORT PALLIAT, V3, P422, DOI 10.1136/bmjspcare-2012-000424; Dowling-Castronovo A, 2002, GERONTOLOGIST, V42, P82, DOI 10.1093/geront/42.suppl_3.54; Evans G, 2011, J EVAL CLIN PRACT, V17, P1045, DOI 10.1111/j.1365-2753.2010.01471.x; FMH [Swiss Medical Association], 2013, ARZTESTATISTIK; Fried TR, 1999, ANN INTERN MED, V131, P109, DOI 10.7326/0003-4819-131-2-199907200-00006; Gielen B, 2010, HEALTH POLICY, V97, P53, DOI 10.1016/j.healthpol.2010.03.002; Gomez-Batiste X, 2007, J PAIN SYMPTOM MANAG, V33, P584, DOI 10.1016/j.jpainsymman.2007.02.019; Hedinger D, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0111-3; Hedinger D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113236; Hollander MJ, 2007, CAN J AGING, V26, P149, DOI 10.3138/cja.26.suppl_1.149; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; JACOB JA, 2015, JAMA J AM MED ASSOC, V314, P761; Kardamanidis K, 2007, MED J AUSTRALIA, V187, P383, DOI 10.5694/j.1326-5377.2007.tb01306.x; Kaspers PJ, 2013, PALLIATIVE MED, V27, P544, DOI 10.1177/0269216312457212; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Klinkenberg M, 2005, HEALTH SOC CARE COMM, V13, P420, DOI 10.1111/j.1365-2524.2005.00567.x; Ko W, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-960; Lawson Beverley, 2006, BMC Palliat Care, V5, P4, DOI 10.1186/1472-684X-5-4; Matter-Walstra K, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-119; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Organisation for Economic Co-operation and Development (OECD), 2013, LIF EXP BIRTH; Perrels AJ, 2014, PALLIATIVE MED, V28, P220, DOI 10.1177/0269216313510341; Pollock K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4855; Reich O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-116; Simoens S, 2010, J PALLIAT MED, V13, P1365, DOI 10.1089/jpm.2010.0212; Switzerland GfK, 2009, BEV PALL CAR; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Van den Block L, 2007, JAMA-J AM MED ASSOC, V298, P1638, DOI 10.1001/jama.298.14.1638; Van den Block Lieve, 2007, BMC Palliat Care, V6, P6; van den Block L, 2015, EUR J PUBLIC HEALTH, V25, P569, DOI 10.1093/eurpub/ckv039; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0160932	10.1371/journal.pone.0160932	http://dx.doi.org/10.1371/journal.pone.0160932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IT	27598939	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800004
J	Fernandes, FF; de Oliveira, LL; Landgraf, TN; Peron, G; Costa, MV; Coelho-Castelo, AAM; Bonato, VLD; Roque-Barreira, MC; Panunto-Castelo, A				Fernandes, Fabr-Cio Freitas; de Oliveira, Leandro Licursi; Landgraf, Taise Natali; Peron, Gabriela; Costa, Marcelo Vieira; Coelho-Castelo, Arlete A. M.; Bonato, Vania L. D.; Roque-Barreira, Maria-Cristina; Panunto-Castelo, Ademilson			Detrimental Effect of Fungal 60-kDa Heat Shock Protein on Experimental Paracoccidioides brasiliensis Infection	PLOS ONE			English	Article							ANTIINFLAMMATORY CYTOKINES; GLYCOPROTEIN GP43; IMMUNE-RESPONSE; HUMAN MONOCYTES; EXPRESSION; GENE; PATHOGENESIS; PURIFICATION; PROTECTION; SPECIATION	The genus Paracoccidioides comprises species of dimorphic fungi that cause paracocci-dioidomycosis (PCM), a systemic disease prevalent in Latin America. Here, we investigated whether administration of native 60-kDa heat shock protein of P. brasiliensis (nPbHsp60) or its recombinant counterpart (rPbHsp60) affected the course of experimental PCM. Mice were subcutaneously injected with nPbHsp60 or rPbHsp60 emulsified in complete's Freund Adjuvant (CFA) at three weeks after intravenous injection of P. brasiliensis yeasts. Infected control mice were injected with CFA or isotonic saline solution alone. Thirty days after the nPbHsp60 or rPbHsp60 administration, mice showed remarkably increased fungal load, tissue inflammation, and granulomas in the lungs, liver, and spleen compared with control mice. Further, rPbHsp60 treatment (i) decreased the known protective effect of CFA against PCM and (ii) increased the concentrations of IL-17, TNF-alpha, IL-12, IFN-gamma, IL-4, IL-10, and TGF-beta in the lungs. Together, our results indicated that PbHsp60 induced a harmful immune response, exacerbated inflammation, and promoted fungal dissemination. Therefore, we propose that PbHsp60 contributes to the fungal pathogenesis.	[Fernandes, Fabr-Cio Freitas; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cellular & Mol Biol, Ribeirao Preto, SP, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Landgraf, Taise Natali; Coelho-Castelo, Arlete A. M.; Bonato, Vania L. D.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil; [Peron, Gabriela] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Costa, Marcelo Vieira; Panunto-Castelo, Ademilson] Univ Sao Paulo, Ribeirao Preto Fac Philosophy Sci & Letters, Dept Biol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Panunto-Castelo, A (corresponding author), Univ Sao Paulo, Ribeirao Preto Fac Philosophy Sci & Letters, Dept Biol, Ribeirao Preto, SP, Brazil.	apcastelo@usp.br	Bonato, Vania LD/C-3509-2015; Landgraf, Taise/H-7145-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; de Oliveira, Leandro Licursi/D-3616-2009; Castelo, Ademilson Panunto/C-8501-2012	Bonato, Vania LD/0000-0003-4189-2685; Landgraf, Taise/0000-0003-2084-7340; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Castelo, Ademilson Panunto/0000-0003-0148-0133; Peron, Gabriela/0000-0002-9863-7565	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/14777-1, 2013/12278-3, 2009/03235-3, 2012/08552-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	APC (Grant #2009/14777-1, and #2013/12278-3), FFF (# 2009/03235-3), and TNL (# 2012/08552-0) were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva MG, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1303, DOI 10.1134/S0006297915100119; Soares RDA, 2008, INFECT IMMUN, V76, P4214, DOI 10.1128/IAI.00753-07; Bethlem E P, 1999, Curr Opin Pulm Med, V5, P319, DOI 10.1097/00063198-199909000-00010; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; Bolhassani A, 2008, EXPERT REV VACCINES, V7, P1185, DOI 10.1586/14760584.7.8.1185; Bonfim CV, 2009, MED MYCOL, V47, P722, DOI 10.3109/13693780802641425; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Cunha DA, 2002, CLIN DIAGN LAB IMMUN, V9, P374, DOI 10.1128/CDLI.9.2.374-377.2002; de Brito T, 1994, Rev Inst Med Trop Sao Paulo, V36, P185, DOI 10.1590/S0036-46651994000200016; de Oliveira LL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000183; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Falkowska-Podstawka M., 2003, Polish Journal of Veterinary Sciences, V6, P61; Fernandes VC, 2011, MICROBES INFECT, V13, P1062, DOI 10.1016/j.micinf.2011.06.004; Fernandes VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017885; Hernandez O, 2011, YEAST, V28, P771, DOI 10.1002/yea.1902; Izacc SMS, 2001, MED MYCOL, V39, P445, DOI 10.1080/714031053; Junger WG, 1996, J TRAUMA, V40, P702, DOI 10.1097/00005373-199605000-00004; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kurokawa CS, 2007, MICROBIOL IMMUNOL, V51, P421, DOI 10.1111/j.1348-0421.2007.tb03929.x; Kurokawa Cilmery Suemi, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P125, DOI 10.1590/S0036-46651998000300001; LOPES JD, 1994, BRAZ J MED BIOL RES, V27, P2309; Martinez R, 2015, REV INST MED TROP SP, V57, P11, DOI 10.1590/S0036-46652015000700004; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Moingeon P, 2003, CURR OPIN MICROBIOL, V6, P462, DOI 10.1016/j.mib.2003.08.002; Nicola AM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-158; Alegre-Maller ACP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003317; Peracoli MTS, 2003, MICROBES INFECT, V5, P413, DOI 10.1016/S1286-4579(03)00040-6; Reis BS, 2008, VACCINE, V26, P5461, DOI 10.1016/j.vaccine.2008.07.097; Restrepo A, 2015, REV INST MED TROP SP, V57, P5, DOI 10.1590/S0036-46652015000700003; Ribeiro AM, 2010, VACCINE, V28, P1528, DOI 10.1016/j.vaccine.2009.11.062; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; ROBLEDO MA, 1982, AM REV RESPIR DIS, V125, P563, DOI 10.1164/arrd.1982.125.5.563; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SANBLAS G, 1977, MYCOPATHOLOGIA, V62, P77, DOI 10.1007/BF01259396; SEVERO LC, 1979, MYCOPATHOLOGIA, V67, P115; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; UEDA AK, 1987, MYCOPATHOLOGIA, V98, P27, DOI 10.1007/BF00431014; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; VICENTINI AP, 1994, INFECT IMMUN, V62, P1465, DOI 10.1128/IAI.62.4.1465-1469.1994; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162486	10.1371/journal.pone.0162486	http://dx.doi.org/10.1371/journal.pone.0162486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598463	gold, Green Submitted, Green Published			2022-12-27	WOS:000383254800070
J	Kim, JS; Choi, J; Hahn, HJ; Lee, YB; Yu, DS; Kim, JW				Kim, Jung Soo; Choi, Jinyoung; Hahn, Hyung-Jin; Lee, Young-Bok; Yu, Dong-Soo; Kim, Jin-Wou			Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; MIF PROMOTER POLYMORPHISMS; TOTAL SERUM IGE; FACTOR GENE; REGION POLYMORPHISM; ASTHMA; ONSET; SUSCEPTIBILITY; EPIDEMIOLOGY; POPULATION	The macrophage migration inhibitory factor (MIF) gene is located on human chromosome 22q11.2 and is linked to atopic phenotypes. Plasma MIF and log [total IgE] levels are significantly elevated in atopic dermatitis (AD) patients. The aim of this study was to evaluate the relationship between two MIF polymorphisms, -173 G to C and -794 CATT(5-8), and total plasma IgE levels in AD patients in Korea. We performed PCR-RFLP analysis in 178 AD patients and 80 control subjects to determine whether MIF SNPs are associated with susceptibility to AD. Plasma total IgE and MIF levels were determined, and then logistic regression analyses were performed to determine the associations between a SNP or haplotype and plasma total IgE or MIF levels. The -173 G/C polymorphism, located in the MIF promoter, was significantly associated with AD; the odds ratios (ORs) for the CC homozygotes and GC heterozygotes were 9.3 and 2.5, respectively. The MIF C/5-CATT and the MIF C/7-CATT haplotypes were significantly associated with AD; the ORs for the MIF C/5-CATT and MIF C/7-CATT haplotypes were 9.7 and 4.5, respectively. Log [total IgE] levels were highly associated with the MIF -794 7-CATT polymorphism. Notably, the MIF C/7-CATT haplotype was associated with a decrease in plasma log [total IgE] levels in a gene dose-dependent manner. Although log [MIF] levels were not associated with the MIF polymorphisms, the frequencies of the MIF C/5-CATT haplotype-containing genotypes decreased in order of MIF levels. Our results demonstrate that MIF promoter polymorphisms in the -173 C allele and the MIF C/5-CATT and C/7-CATT haplotypes were significantly associated with an increased risk for AD. In particular, the -794 7-CATT locus and the MIF C/7-CATT haplotype were significantly associated with decreased total IgE levels in the plasma, suggesting that these polymorphisms might be a marker for intrinsic AD rather than extrinsic AD that shows high total IgE levels and presence of allergen-specific IgE.	[Kim, Jung Soo; Choi, Jinyoung; Hahn, Hyung-Jin; Lee, Young-Bok; Yu, Dong-Soo; Kim, Jin-Wou] Catholic Univ Korea, Dept Dermatol, Coll Med, Uijongbu City, Kyonggi Do, South Korea	Catholic University of Korea	Kim, JW (corresponding author), Catholic Univ Korea, Dept Dermatol, Coll Med, Uijongbu City, Kyonggi Do, South Korea.	jwkim52@catholic.ac.kr	LEE, YOUNG BOK/AAZ-6426-2021	Choi, Jin Young/0000-0002-3641-2504	Korea Health 21 R&D Project, Ministry of Health Welfare, Korea [01-PJ3-PG6-01GN09-003]	Korea Health 21 R&D Project, Ministry of Health Welfare, Korea	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare (http://english.mohw.go.kr/front_eng/index.jsp), Korea (01-PJ3-PG6-01GN09-003) to JWK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1999, J INVEST DERMATOL, V113, P628, DOI 10.1046/j.1523-1747.1999.00720.x; Barton A, 2003, GENES IMMUN, V4, P487, DOI 10.1038/sj.gene.6364014; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; De Benedetti F, 2003, ARTHRITIS RHEUM, V48, P1398, DOI 10.1002/art.10882; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donn RP, 2004, J INVEST DERMATOL, V123, P484, DOI 10.1111/j.0022-202X.2004.23314.x; Donn RP, 2001, ARTHRITIS RHEUM-US, V44, P1782, DOI 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hizawa N, 2004, AM J RESP CRIT CARE, V169, P1014, DOI 10.1164/rccm.200307-933OC; ISHIZAKA K, 1984, ANNU REV IMMUNOL, V2, P159, DOI 10.1146/annurev.immunol.2.1.159; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Lee YB, 2008, KOREAN J ASTHMA ALLE, V28, P53; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Ma L, 2014, INT J DERMATOL, V53, pE75, DOI 10.1111/j.1365-4632.2012.05597.x; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; Melotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114274; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Miyagaki T, 2015, J DERMATOL SCI, V78, P89, DOI 10.1016/j.jdermsci.2015.02.010; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morales-Zambrano R, 2014, INT J CLIN EXP MED, V7, P2605; Nagata Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115593; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sanchez E, 2006, GENES IMMUN, V7, P433, DOI 10.1038/sj.gene.6364310; Schmid P, 2001, ALLERGY, V56, P841, DOI 10.1034/j.1398-9995.2001.00144.x; Shimizu T, 2005, GENES IMMUN, V6, P285, DOI 10.1038/sj.gene.6364191; Shimizu T, 1999, J ALLERGY CLIN IMMUN, V104, P659, DOI 10.1016/S0091-6749(99)70339-8; Shimizu T, 1997, BIOCHEM BIOPH RES CO, V240, P173, DOI 10.1006/bbrc.1997.7633; Shin HD, 2005, ALLERGY, V60, P1146, DOI 10.1111/j.1398-9995.2005.00839.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Watarai H, 2000, P NATL ACAD SCI USA, V97, P13251, DOI 10.1073/pnas.230445397; Wollenberg A, 2000, ALLERGY, V55, P205, DOI 10.1034/j.1398-9995.2000.00115.x; Wu J, 2009, TISSUE ANTIGENS, V73, P302, DOI 10.1111/j.1399-0039.2008.01206.x; Wu J, 2009, J DERMATOL SCI, V53, P212, DOI 10.1016/j.jdermsci.2008.11.002; Wuthrich B, 2003, J INVEST ALLERG CLIN, V13, P1	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162477	10.1371/journal.pone.0162477	http://dx.doi.org/10.1371/journal.pone.0162477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598332	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800068
J	Meneton, P; Lemogne, C; Herquelot, E; Bonenfant, S; Larson, MG; Vasan, RS; Menard, J; Goldberg, M; Zins, M				Meneton, Pierre; Lemogne, Cedric; Herquelot, Eleonore; Bonenfant, Sebastien; Larson, Martin G.; Vasan, Ramachandran S.; Menard, Joel; Goldberg, Marcel; Zins, Marie			A Global View of the Relationships between the Main Behavioural and Clinical Cardiovascular Risk Factors in the GAZEL Prospective Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OBSTRUCTIVE SLEEP-APNEA; BODY-MASS INDEX; PHYSICAL-ACTIVITY; METAANALYSIS; STROKE; ASSOCIATION; DEPRESSION; COUNTRIES; OUTCOMES	Although it has been recognized for a long time that the predisposition to cardiovascular diseases (CVD) is determined by many risk factors and despite the common use of algorithms incorporating several of these factors to predict the overall risk, there has yet been no global description of the complex way in which CVD risk factors interact with each other. This is the aim of the present study which investigated all existing relationships between the main CVD risk factors in a well-characterized occupational cohort. Prospective associations between 12 behavioural and clinical risk factors (gender, age, parental history of CVD, non-moderate alcohol consumption, smoking, physical inactivity, obesity, hypertension, dyslipidemia, diabetes, sleep disorder, depression) were systematically tested using Cox regression in 10,736 middle-aged individuals free of CVD at baseline and followed over 20 years. In addition to independently predicting CVD risk (HRs from 1.18 to 1.97 in multivariable models), these factors form a vast network of associations where each factor predicts, and/or is predicted by, several other factors (n = 47 with p<0.05, n = 37 with p<0.01, n = 28 with p<0.001, n = 22 with p<0.0001). Both the number of factors associated with a given factor (1 to 9) and the strength of the associations (HRs from 1.10 to 6.12 in multivariable models) are very variable, suggesting that all the factors do not have the same influence within this network. These results show that there is a remarkably extensive network of relationships between the main CVD risk factors which may have not been sufficiently taken into account, notably in preventive strategies aiming to lower CVD risk.	[Meneton, Pierre] Univ Paris 13, Univ Paris 06, Sorbonne Univ, INSERM,U1142,LIMICS,UMR S 1142, Paris, France; [Lemogne, Cedric] Univ Paris 05, Hop Univ Paris Ouest, AP HP, Ctr Psychiat & Neurosci,INSERM,U894, Paris, France; [Herquelot, Eleonore; Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] UVSQ, INSERM, UMS 011, Villejuif, France; [Herquelot, Eleonore; Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] VIMA, UMR S 1168, Villejuif, France; [Larson, Martin G.] Boston Univ, Dept Biostat, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Boston Univ, Dept Med, Framingham Heart Study, Boston, MA 02215 USA; [Menard, Joel] Univ Paris 05, Hop Univ Paris Ouest, AP HP, INSERM,CIC1418, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Boston University; Boston University; Framingham Heart Study; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Meneton, P (corresponding author), Univ Paris 13, Univ Paris 06, Sorbonne Univ, INSERM,U1142,LIMICS,UMR S 1142, Paris, France.	pierre.meneton@spim.jussieu.fr	Zins, Marie/AAX-6551-2021; Goldberg, Marcel/I-7834-2012; Lemogne, Cédric/Q-6091-2019; Ramachandran, Vasan/Y-2527-2019; Meneton, Pierre/T-1216-2019	Goldberg, Marcel/0000-0002-6161-5880; Ramachandran, Vasan/0000-0001-7357-5970; Lemogne, Cedric/0000-0002-3487-4721	EDF-GDF; Institut National pour la Sante et la Recherche Medicale (INSERM); Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Association Robert Debre pour la Recherche Medicale; INSERM	EDF-GDF; Institut National pour la Sante et la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Association Robert Debre pour la Recherche Medicale; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The GAZEL Cohort Study was funded by EDF-GDF and the Institut National pour la Sante et la Recherche Medicale (INSERM), and received grants from the Cohortes Sante TGIR Program, Agence nationale de la recherche (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET). The present analyses were funded by the Association Robert Debre pour la Recherche Medicale and by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P., 2001, SAGE U PAPER SERIES, V7136; Angelakopoulou A, 2012, EUR HEART J, V33, P393, DOI 10.1093/eurheartj/ehr225; Anthony David, 2014, FP Essent, V421, P11; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; CASTELLI WP, 1983, AM HEART J, V106, P1191, DOI 10.1016/0002-8703(83)90174-6; De Backer G, 2012, EUR J PREV CARDIOL, V19, P14, DOI 10.1177/2047487312448988; Dong JY, 2013, ATHEROSCLEROSIS, V229, P489, DOI 10.1016/j.atherosclerosis.2013.04.026; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Fiedorowicz JG, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0492-6; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Geleijnse JM, 2004, EUR J PUBLIC HEALTH, V14, P235, DOI 10.1093/eurpub/14.3.235; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Hopkins P N, 1986, Cardiol Clin, V4, P3; Kannel WB, 2004, AM HEART J, V148, P16, DOI 10.1016/j.ahj.2003.10.022; Kannel William B, 2002, J Gend Specif Med, V5, P27; Kannel WB, 2009, AM J CARDIOL, V103, P426, DOI 10.1016/j.amjcard.2008.09.098; Kashani M, 2013, J CARDIOVASC NURS, V28, pE18, DOI 10.1097/JCN.0b013e318294b206; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147, DOI 10.1007/BF03404221; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Li J, 2013, CURR OPIN CARDIOL, V28, P575, DOI 10.1097/HCO.0b013e328364289c; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; Metzger MH, 2002, J CLIN EPIDEMIOL, V55, P48, DOI 10.1016/S0895-4356(01)00409-7; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Payne RA, 2012, BRIT J CLIN PHARMACO, V74, P396, DOI 10.1111/j.1365-2125.2012.04219.x; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Peters SAE, 2013, STROKE, V44, P2394, DOI 10.1161/STROKEAHA.113.001624; Price JF, 1997, EPIDEMIOLOGY, V8, P584, DOI 10.1097/00001648-199709000-00018; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Tamers SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087653; Tuomilehto J, 2004, ATHEROSCLEROSIS SUPP, V5, P9, DOI 10.1016/j.atherosclerosissup.2004.03.006; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; WALLACE RB, 1987, EPIDEMIOL REV, V9, P95, DOI 10.1093/oxfordjournals.epirev.a036310; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Willis A, 2012, J ROY SOC MED, V105, P348, DOI 10.1258/jrsm.2012.110193; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zins M, 2009, ADV LIFE COURSE RES, V14, P135, DOI 10.1016/j.alcr.2010.02.003	47	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162386	10.1371/journal.pone.0162386	http://dx.doi.org/10.1371/journal.pone.0162386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598908	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800063
J	Randall, K; Henderson, N; Reens, J; Eckersley, S; Nystrom, AC; South, MC; Balendran, CA; Bottcher, G; Hughes, G; Price, SA				Randall, Kevin; Henderson, Neil; Reens, Jaimini; Eckersley, Sonia; Nystrom, Ann-Christin; South, Marie C.; Balendran, Clare A.; Bottcher, Gerhard; Hughes, Glen; Price, Sally A.			Claudin-2 Expression Levels in Ulcerative Colitis: Development and Validation of an In-Situ Hybridisation Assay for Therapeutic Studies	PLOS ONE			English	Article							TIGHT JUNCTIONS; ANTIBODY VALIDATION; EPITHELIAL-CELLS; CROHNS-DISEASE; IMMUNOHISTOCHEMISTRY; HETEROGENEITY; DISCOVERY	Ulcerative colitis is a chronic inflammatory disease affecting the colon and is characterized by epithelial damage and barrier dysfunction. Upregulation of the tight junction protein claudin-2 by cytokines is hypothesized to contribute to the dysregulation of the epithelial barrier. New therapeutic agents which block the action of cytokines are being investigated in patients with ulcerative colitis. In order to understand the potential of these therapies, it is important to have reliable assays that can assess downstream endpoints that reflect drug mechanism of action. The aim of the current study was therefore to establish & validate an assay to reproducibly assess the expression and distribution of claudin-2 in human colon biopsy samples. Initially, the potential to measure claudin-2 protein by immunohistochemistry (IHC) was investigated. To identify suitable reagents to develop an IHC assay, preestablished criteria were used to screen five commercial antibodies by Western blotting, immunofluorescence and immunohistochemistry on claudin-2 positive and negative cells and healthy and ulcerative colitis colon tissue. Despite some of these antibodies specifically detecting claudin-2 using some of these techniques, none of the antibodies showed the expected specific staining pattern in formalin fixed human colon samples. As an alternative method to detect claudin-2 expression and distribution in formalin fixed biopsy sections, an in situ hybridization assay was developed. This assay underwent a novel tiered approach of validation to establish that it was fit-for-purpose, and suitable for clinical deployment. In addition, to understand the possible relationship of claudin-2 in the context of disease severity, expression was compared to the Geboes score. Overall, the microscopical Geboes score correlated with the claudin-2 biomarker score for samples that retained crypt morphology; samples with the highest Geboes score were not specifically distinguished, probably due to crypt destruction. In summary, we have applied a strategy for identifying target-specific antibodies in formalin fixed biopsy samples and highlighted that (published) antibodies may not correctly identify the intended antigen in tissues fixed using this method. Furthermore, we have developed and, for the first time, validated an in situ hybridization assay for detection of claudin-2 mRNA, suitable for use as a supportative method in clinical trials. Using our validated assay, we have demonstrated that increased claudin-2 expression correlates with the severity of ulcerative colitis, where crypt destruction is not seen.	[Randall, Kevin; Reens, Jaimini; Eckersley, Sonia; South, Marie C.; Hughes, Glen; Price, Sally A.] AstraZeneca R&D, Alderley Pk, Macclesfield, Cheshire, England; [Henderson, Neil; Nystrom, Ann-Christin; Balendran, Clare A.; Bottcher, Gerhard] AstraZeneca R&D, Molndal, Sweden	AstraZeneca; AstraZeneca	Henderson, N (corresponding author), AstraZeneca R&D, Molndal, Sweden.	neil.henderson@astrazeneca.com		Price, Sally/0000-0002-5722-8458				Agency E. M., 2011, GUID BIOAN METH VAL; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Das P, 2012, VIRCHOWS ARCH, V460, P261, DOI 10.1007/s00428-012-1195-1; Dhani NC, 2015, BRIT J CANCER, V113, P864, DOI 10.1038/bjc.2015.284; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Everit B, 1992, ANAL CONTINGENCY TAB; Fogh J, 1975, NEW HUMAN TUMOR CELL; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Howat WJ, 2014, METHODS, V70, P34, DOI 10.1016/j.ymeth.2014.01.018; Kaarteenaho-Wiik R, 2009, J HISTOCHEM CYTOCHEM, V57, P187, DOI 10.1369/jhc.2008.951566; Lee JW, 2006, PHARM RES, V23, P312, DOI 10.1007/s11095-005-9045-3; Li JH, 2013, J BIOL CHEM, V288, P22790, DOI 10.1074/jbc.M113.484238; Marsden CJ, 2014, J BIOMOL SCREEN, V19, P829, DOI 10.1177/1087057114527770; Mosli MH, 2014, GUT; MURAKAMI H, 1980, P NATL ACAD SCI-BIOL, V77, P3464, DOI 10.1073/pnas.77.6.3464; Nemeth Z, 2009, J HISTOCHEM CYTOCHEM, V57, P113, DOI 10.1369/jhc.2008.952291; Oshima T, 2008, J GASTROEN HEPATOL, V23, pS146, DOI 10.1111/j.1440-1746.2008.05405.x; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; Rosen MJ, 2011, INFLAMM BOWEL DIS, V17, P2224, DOI 10.1002/ibd.21628; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Timmerman P, 2012, BIOANALYSIS, V4, P1883, DOI [10.4155/BIO.12.164, 10.4155/bio.12.164]; US Department of Health and Human Services UF Center for Drug Evaluation and Research Center for Veterinary Medicine, 2014, GUID IND AN IN PRESS; US Department of Health and Human Services UF Center for Drug Evaluation and Research Center for Veterinary Medicine, 2011, GUID IND US IN PRESS; Van Itallie CM, 2012, J CELL SCI, V125, P4902, DOI 10.1242/jcs.111237; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162076	10.1371/journal.pone.0162076	http://dx.doi.org/10.1371/journal.pone.0162076			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598247	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800036
J	Tschudin-Sutter, S; Braissant, O; Erb, S; Stranden, A; Bonkat, G; Frei, R; Widmer, AF				Tschudin-Sutter, Sarah; Braissant, Olivier; Erb, Stefan; Stranden, Anne; Bonkat, Gernot; Frei, Reno; Widmer, Andreas F.			Growth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study	PLOS ONE			English	Article							SEVERE INFECTION; RIBOTYPE; MORTALITY; DIARRHEA; DEATH	A broad spectrum of symptoms has been associated with C. difficile infection (CDI). Several studies indicate that toxin-production correlates with growth rates of C. difficile. This study aimed to correlate growth rates of C. difficile with disease severity and strain characteristics. From 01/2003 to 10/2011, strains from a prospective cohort of all inpatients with CDI at the University Hospital Basel, Switzerland were analyzed regarding binary toxin, presence of the tcdC deletion and ribotype. Isothermal microcalorimetry was performed to determine growth rates, quantified by the Gompertz function. Ordered logistic regression models were used to correlate disease severity with strain features and clinical characteristics. Among 199 patients, 31 (16%) were infected with binary toxin-producing strains, of which the tcdC gene-deletion nt117 was detected in 9 (4%). Disease severity was classified as mild in 130 patients (65.3%), as severe in 59 patients (29.7%) and as severe/complicated in 10 patients (5.0%). Growth rates were inversely associated with disease severity in univariable (OR 0.514, 95% CI 0.29-0.91, p = 0.023) and multivariable analyses (OR 0.51, 95% CI 0.26-0.97, p = 0.040). While none of the strain characteristics such as presence of the tcdC gene deletion or binary toxin predicted CDI severity, growth rates were inversely correlated with disease severity. Further investigations are needed to analyze growth-regulators and respective correlations with the level of toxin production in C. difficile, which may be important determinants of disease severity.	[Tschudin-Sutter, Sarah; Erb, Stefan; Stranden, Anne; Widmer, Andreas F.] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Braissant, Olivier] Univ Basel, Lab Biomech & Biocalorimetry, Basel, Switzerland; [Bonkat, Gernot] Univ Basel Hosp, Dept Urol, Basel, Switzerland; [Frei, Reno] Univ Basel Hosp, Div Clin Microbiol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Tschudin-Sutter, S (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland.	Sarah.Tschudin@uhbs.ch	Braissant, Olivier/AAO-2371-2020; Tschudin-Sutter, Sarah/K-2212-2019	Braissant, Olivier/0000-0003-0659-755X; Tschudin-Sutter, Sarah/0000-0003-4875-5368	"Antibacterial Europe ASPIRE Research awards" by Pfizer International Operations; Swiss National Science Foundation grant [PBBSP3-134499]	"Antibacterial Europe ASPIRE Research awards" by Pfizer International Operations; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF))	This study was supported by an unrestricted educational grant "Antibacterial Europe ASPIRE Research awards 2011" by Pfizer International Operations. S. Tschudin-Sutter is the recipient of a Swiss National Science Foundation grant (PBBSP3-134499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by an unrestricted educational grant "Antibacterial Europe ASPIRE Research awards 2011" by Pfizer International Operations. S. Tschudin-Sutter is the recipient of a Swiss National Science Foundation grant (PBBSP3-134499).	Bacci S, 2011, EMERG INFECT DIS, V17, P976, DOI [10.3201/eid1706.101483, 10.3201/eid/1706.101483]; Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Braissant O, 2015, METHODS, V76, P27, DOI 10.1016/j.ymeth.2014.10.009; Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Fenner L, 2008, J CLIN MICROBIOL, V46, P328, DOI 10.1128/JCM.01503-07; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Rao K, 2015, CLIN INFECT DIS, V61, P233, DOI 10.1093/cid/civ254; See I, 2014, CLIN INFECT DIS; Sirard S, 2011, J CLIN MICROBIOL, V49, P4040, DOI 10.1128/JCM.05053-11; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1	25	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161711	10.1371/journal.pone.0161711	http://dx.doi.org/10.1371/journal.pone.0161711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598309	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800017
J	Orini, M; Taggart, P; Srinivasan, N; Hayward, M; Lambiase, PD				Orini, Michele; Taggart, Peter; Srinivasan, Neil; Hayward, Martin; Lambiase, Pier D.			Interactions between Activation and Repolarization Restitution Properties in the Intact Human Heart: In-Vivo Whole-Heart Data and Mathematical Description	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; CONDUCTION-VELOCITY RESTITUTION; T-WAVE ALTERNANS; SHORT-TERM-MEMORY; VENTRICULAR-FIBRILLATION; ADRENERGIC-STIMULATION; SPATIAL-DISPERSION; MECHANISMS; INDUCTION; CLASSIFICATION	Background The restitution of the action potential duration (APDR) and conduction velocity (CVR) are mechanisms whereby cardiac excitation and repolarization adapt to changes in heart rate. They modulate the vulnerability to dangerous arrhythmia, but the mechanistic link between restitution and arrhythmogenesis remains only partially understood. Methods This paper provides an experimental and theoretical study of repolarization and excitation restitution properties and their interactions in the intact human epicardium. The interdependence between excitation and repolarization dynamic is studied in 8 patients (14 restitution protocols, 1722 restitution curves) undergoing global epicardial mapping with multi-electrode socks before open heart surgery. A mathematical description of the contribution of both repolarization and conduction dynamics to the steepness of the APDR slope is proposed. Results This study demonstrates that the APDR slope is a function of both activation and repolarization dynamics. At short cycle length, conduction delay significantly increases the APDR slope by interacting with the diastolic interval. As predicted by the proposed mathematical formulation, the APDR slope was more sensitive to activation time prolongation than to the simultaneous shortening of repolarization time. A steep APDR slope was frequently identified, with 61% of all cardiac sites exhibiting an APDR slope >1, suggesting that a slope >1 may not necessarily promote electrical instability in the human epicardium. APDR slope did not change for different activation or repolarization times, and it was not a function of local baseline APD. However, it was affected by the spatial organization of electrical excitation, suggesting that in tissue APDR is not a unique function of local electrophysiological properties. Spatial heterogeneity in both activation and repolarization restitution contributed to the increase in the modulated dispersion of repolarization, which for short cycle length was as high as 250 ms. Heterogeneity in conduction velocity restitution can translate into both activation and repolarization dispersion and increase cardiac instability. The proposed mathematical formulation shows an excellent agreement with the experimental data (correlation coefficient r = 0.94) and provides a useful tool for the understanding of the complex interactions between activation and repolarization restitution properties as well as between their measurements.	[Orini, Michele; Taggart, Peter; Srinivasan, Neil; Lambiase, Pier D.] UCL, Inst Cardiovasc Sci, London, England; [Orini, Michele; Srinivasan, Neil; Lambiase, Pier D.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Hayward, Martin] Univ Coll London Hosp, Heart Hosp, London, England	University of London; University College London; University of London; Queen Mary University London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Orini, M (corresponding author), UCL, Inst Cardiovasc Sci, London, England.; Orini, M (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, London, England.	m.orini@ucl.ac.uk	Lambiase, Pier/L-8534-2019; Orini, Michele/ABF-6272-2020; Orini, Michele/H-3937-2015	Lambiase, Pier/0000-0002-9055-9267; Orini, Michele/0000-0001-5773-0344; Orini, Michele/0000-0001-5773-0344; Srinivasan, Neil/0000-0002-4423-6547	Marie Curie Intra-European Fellowships for Career Development (IEF), FP7-PEOPLE-IEF; British Heart Foundation Fellowship; University College London Hospital Biomedicine NIHR Grant; MRC [G0901819] Funding Source: UKRI; Medical Research Council [G0901819] Funding Source: researchfish	Marie Curie Intra-European Fellowships for Career Development (IEF), FP7-PEOPLE-IEF; British Heart Foundation Fellowship(British Heart Foundation); University College London Hospital Biomedicine NIHR Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Marie Curie Intra-European Fellowships for Career Development (IEF), call identifier FP7-PEOPLE-2013-IEF: MO; British Heart Foundation Fellowship: NS; and University College London Hospital Biomedicine NIHR Grant: PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banville I, 2002, J CARDIOVASC ELECTR, V13, P1141, DOI 10.1046/j.1540-8167.2002.01141.x; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Child N, 2015, HEART RHYTHM, V12, P1644, DOI 10.1016/j.hrthm.2015.04.013; Chinushi M, 2003, J CARDIOVASC ELECTR, V14, P632, DOI 10.1046/j.1540-8167.2003.03028.x; Coronel R, 2006, HEART RHYTHM, V3, P1043, DOI 10.1016/j.hrthm.2006.05.027; Coronel R, 2009, HEART RHYTHM, V6, P537, DOI 10.1016/j.hrthm.2009.01.013; Dorenkamp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054768; Echebarria B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051911; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Finlay MC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00213; Fox JJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.138101; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Franz MR, 2003, J CARDIOVASC ELECTR, V14, pS140, DOI 10.1046/j.1540.8167.90303.x; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Hanson B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00414; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Ideker RE, 2002, J CARDIOVASC ELECTR, V13, P1173, DOI 10.1046/j.1540-8167.2002.01173.x; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Laurita KR, 1998, CIRCULATION, V98, P2774, DOI 10.1161/01.CIR.98.24.2774; Mironov S, 2008, CIRCULATION, V118, P17, DOI 10.1161/CIRCULATIONAHA.107.737254; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Orini M, 2015, COMPUT CARDIOL CONF, V42, P545, DOI 10.1109/CIC.2015.7410968; Orini M, 2015, ENG MED BIOL SOC EMB, DOI [10.1016/j.pbiomolbio.2014.06.004, DOI 10.1016/J.PBIOMOLBIO.2014.06.004]; Orini M, 2014, IEEE T BIO-MED ENG, V61, P308, DOI 10.1109/TBME.2013.2289304; Otani NF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021910; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Potse M, 2009, AM J PHYSIOL-HEART C, V297, pH792, DOI 10.1152/ajpheart.00064.2009; Pueyo E, 2016, J MOL CELL CARDIOL, V97, P93, DOI 10.1016/j.yjmcc.2016.05.003; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Ramirez J, 2015, J ELECTROCARDIOL, V48, P551, DOI 10.1016/j.jelectrocard.2015.04.002; Scacchi S, 2009, MATH BIOSCI, V219, P113, DOI 10.1016/j.mbs.2009.03.004; Srinivasan NT, 2016, AM J PHYSL HEART CIR; Stevenson WG, 2005, J CARDIOVASC ELECTR, V16, P1017, DOI 10.1111/j.1540-8167.2005.50155.x; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Taggart P, 2014, PROG BIOPHYS MOL BIO, V115, P252, DOI 10.1016/j.pbiomolbio.2014.06.004; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; van Duijvenboden S, 2015, AM J PHYSIOL-HEART C, V309, pH2108, DOI 10.1152/ajpheart.00560.2015; van Duijvenboden S, 2015, IEEE ENG MED BIO, P76, DOI 10.1109/EMBC.2015.7318304; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x; Wei N, 2015, J THEOR BIOL, V367, P21, DOI 10.1016/j.jtbi.2014.11.014; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Weiss JN, 2015, J MOL CELL CARDIOL, V82, P136, DOI 10.1016/j.yjmcc.2015.02.017; Wyatt R. F., 1980, IEEE 1980 Frontiers of Engineering in Health Care, P22; Zhou X, 2015, CIRCULATION, V132	50	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161765	10.1371/journal.pone.0161765	http://dx.doi.org/10.1371/journal.pone.0161765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588688	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800017
J	Yan, Q; Cui, XX; Lin, S; Gan, SP; Xing, H; Dou, DL				Yan, Qiang; Cui, Xiaoxia; Lin, Shuai; Gan, Shuping; Xing, Han; Dou, Daolong			GmCYP82A3, a Soybean Cytochrome P450 Family Gene Involved in the Jasmonic Acid and Ethylene Signaling Pathway, Enhances Plant Resistance to Biotic and Abiotic Stresses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHYTOPHTHORA ROOT-ROT; FUNCTIONAL GENOMICS; NICOTIANA-TABACUM; CELL-DEATH; SOJAE; ARABIDOPSIS; DEFENSE; EXPRESSION; TOLERANCE	The cytochrome P450 monooxygenases (P450s) represent a large and important enzyme superfamily in plants. They catalyze numerous monooxygenation/hydroxylation reactions in biochemical pathways, P450s are involved in a variety of metabolic pathways and participate in the homeostasis of phytohormones. The CYP82 family genes specifically reside in dicots and are usually induced by distinct environmental stresses. However, their functions are largely unknown, especially in soybean (Glycine max L.). Here, we report the function of GmCYP82A3, a gene from soybean CYP82 family. Its expression was induced by Phytophthora sojae infection, salinity and drought stresses, and treatment with methyl jasmonate (MeJA) or ethephon (ETH). Its expression levels were consistently high in resistant cultivars. Transgenic Nicotiana benthamiana plants overexpressing GmCYP82A3 exhibited strong resistance to Botrytis cinerea and Phytophthora parasitica, and enhanced tolerance to salinity and drought stresses. Furthermore, transgenic plants were less sensitive to jasmonic acid (JA), and the enhanced resistance was accompanied with increased expression of the JA/ET signaling pathway-related genes.	[Yan, Qiang; Lin, Shuai; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Cui, Xiaoxia; Gan, Shuping; Xing, Han] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642; Yan, Qiang/0000-0003-2461-5133	National Science and Technology Major Projects [2014ZX0800910B]; National Natural Science Foundation of China [31171831]; Jiangsu Planned Projects for Postdoctoral Research Funds [1501046A]	National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Planned Projects for Postdoctoral Research Funds	This work was supported by grants from National Science and Technology Major Projects (2014ZX0800910B), Daolong Dou, http://www.nmp.gov.cn/; National Natural Science Foundation of China (31171831), Daolong Dou, http://www.nsfc.gov.cn/nsfc/cen/2016sqsl/index.html; Jiangsu Planned Projects for Postdoctoral Research Funds (1501046A), Qiang Yan, http://bsh.jshrss.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berim A, 2013, J BIOL CHEM, V288, P1795, DOI 10.1074/jbc.M112.420448; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Burnham KD, 2003, CROP SCI, V43, P1610, DOI 10.2135/cropsci2003.1610; Chai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067670; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; CORBINEAU F, 1988, PLANT GROWTH REGUL, V7, P157; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Frank MR, 1996, PLANT PHYSIOL, V110, P1035, DOI 10.1104/pp.110.3.1035; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Garcia-Abellan JO, 2015, PHYSIOL PLANTARUM, V155, P296, DOI 10.1111/ppl.12320; Guttikonda SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-243; Han YP, 2008, EUPHYTICA, V162, P231, DOI 10.1007/s10681-007-9558-4; Hoagland D. R., 1950, CALIF AES C, V347, P357; HORSCH RB, 1985, COLD SPRING HARB SYM, V50, P433, DOI 10.1101/SQB.1985.050.01.054; Hua W, 2014, PLANT SCI, V232, P1, DOI [10.1016/j.plantsci.2014.12.010, DOI 10.1016/J.PLANTSCI.2014.12.010]; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Kruse T, 2008, CHEM BIOL, V15, P149, DOI 10.1016/j.chembiol.2008.01.008; Lee S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-65; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Lee S, 2014, THEOR APPL GENET, V127, P429, DOI 10.1007/s00122-013-2229-z; Lee S, 2013, THEOR APPL GENET, V126, P1121, DOI 10.1007/s00122-013-2040-x; Liu F, 2010, CELL RES, V20, P539, DOI 10.1038/cr.2010.36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mideros S, 2007, PHYTOPATHOLOGY, V97, P655, DOI 10.1094/PHYTO-97-5-0655; Mizutani M, 2012, BIOL PHARM BULL, V35, P824, DOI 10.1248/bpb.35.824; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Murgia I, 2011, J PLANT PHYSIOL, V168, P894, DOI 10.1016/j.jplph.2010.11.020; Mushrush GW, 2006, J ENVIRON SCI HEAL A, V41, P2495, DOI 10.1080/10934520600927591; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Peng JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004664; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Rajcan I, 2005, J CROP IMPROV, V14, P145, DOI 10.1300/J411v14n01_07; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Ranathunge K, 2008, PHYTOPATHOLOGY, V98, P1179, DOI 10.1094/PHYTO-98-11-1179; Schmitthenner AF, 1994, 143 OH AGR RES DEV C; Schopfer CR, 1998, MOL GEN GENET, V258, P315, DOI 10.1007/s004380050736; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Sugimoto T, 2011, BREEDING SCI, V61, P511, DOI 10.1270/jsbbs.61.511; Sun LQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6372; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomas R, 2007, PLANT PHYSIOL, V144, P299, DOI 10.1104/pp.106.091090; TOOLEY PW, 1984, PHYTOPATHOLOGY, V74, P1209, DOI 10.1094/Phyto-74-1209; Tucker DM, 2010, CROP SCI, V50, P628, DOI 10.2135/cropsci2009.03.0161; Tyler BM, 2008, STADLER GEN, P67, DOI 10.1007/978-0-387-76723-9_6; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Van der Ent S, 2009, NEW PHYTOL, V183, P419, DOI 10.1111/j.1469-8137.2009.02851.x; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; WALKER AK, 1984, CROP SCI, V24, P490, DOI 10.2135/cropsci1984.0011183X002400030014x; Wang HH, 2012, CROP SCI, V52, P609, DOI 10.2135/cropsci2011.06.0336; Wang HH, 2010, PLANT GENOME-US, V3, P23, DOI 10.3835/plantgenome2009.12.0029; Wen C.-K, 2015, ETHYLENE IN PLANTS, P73, DOI [10.1007/978-94-017-9484-8, DOI 10.1007/978-94-017-9484-8]; Weng CR, 2007, EUPHYTICA, V158, P81, DOI 10.1007/s10681-007-9428-0; Wu X, 2011, PLANT BREEDING, V130, P144, DOI 10.1111/j.1439-0523.2010.01799.x; Zeng WenTao, 2015, Journal of Nanjing Agricultural University, V38, P787; Zhao Y, 2014, PLANT PHYSIOL, V164, P1068, DOI 10.1104/pp.113.227595; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49	71	60	63	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162253	10.1371/journal.pone.0162253	http://dx.doi.org/10.1371/journal.pone.0162253			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588421	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800043
J	Abdi, S; Bahloul, A; Behlouli, A; Hardelin, JP; Makrelouf, M; Boudjelida, K; Louha, M; Cheknene, A; Belouni, R; Rous, Y; Merad, Z; Selmane, D; Hasbelaoui, M; Bonnet, C; Zenati, A; Petit, C				Abdi, Samia; Bahloul, Amel; Behlouli, Asma; Hardelin, Jean-Pierre; Makrelouf, Mohamed; Boudjelida, Kamel; Louha, Malek; Cheknene, Ahmed; Belouni, Rachid; Rous, Yahia; Merad, Zahida; Selmane, Djamel; Hasbelaoui, Mokhtar; Bonnet, Crystel; Zenati, Akila; Petit, Christine			Diversity of the Genes Implicated in Algerian Patients Affected by Usher Syndrome	PLOS ONE			English	Article							RETINITIS-PIGMENTOSA; MOLECULAR DIAGNOSIS; LONG ISOFORM; HAIR-CELLS; MUTATIONS; PROTEIN; DEAFNESS; PREVALENCE; PATHOGENESIS; FREQUENCY	Usher syndrome (USH) is an autosomal recessive disorder characterized by a dual sensory impairment affecting hearing and vision. USH is clinically and genetically heterogeneous. Ten different causal genes have been reported. We studied the molecular bases of the disease in 18 unrelated Algerian patients by targeted-exome sequencing, and identified the causal biallelic mutations in all of them: 16 patients carried the mutations at the homozygous state and 2 at the compound heterozygous state. Nine of the 17 different mutations detected in MYO7A (1 of 5 mutations), CDH23 (4 of 7 mutations), PCDH15 (1 mutation), USH1C (1 mutation), USH1G (1 mutation), and USH2A (1 of 2 mutations), had not been previously reported. The deleterious consequences of a missense mutation of CDH23 (p. Asp1501Asn) and the in-frame single codon deletion in USH1G (p. Ala397del) on the corresponding proteins were predicted from the solved 3D-structures of extracellular cadherin (EC) domains of cadherin-23 and the sterile alpha motif (SAM) domain of USH1G/sans, respectively. In addition, we were able to show that the USH1G mutation is likely to affect the binding interface between the SAM domain and USH1C/harmonin. This should spur the use of 3D-structures, not only of isolated protein domains, but also of protein-protein interaction interfaces, to predict the functional impact of mutations detected in the USH genes.	[Abdi, Samia; Behlouli, Asma; Makrelouf, Mohamed; Zenati, Akila] Univ Alger 1, Lab Biochim Genet, Serv Biol CHU Bab El Oued, Algiers 16, Algeria; [Abdi, Samia; Belouni, Rachid] CHU Frantz Fanon, Lab Cent Biol, Blida 09, Algeria; [Abdi, Samia; Boudjelida, Kamel; Cheknene, Ahmed; Belouni, Rachid; Rous, Yahia; Merad, Zahida] Univ Saad Dahleb, Fac Med, Blida 09, Algeria; [Bahloul, Amel; Hardelin, Jean-Pierre; Petit, Christine] Inst Pasteur, INSERM, UMRS1120, Unite Genet & Physiol Audit, F-75015 Paris, France; [Behlouli, Asma] Univ Sci & Technol Houari Boumediene, Fac Sci Biol, Algiers 16, Algeria; [Boudjelida, Kamel; Merad, Zahida] CHU Frantz Fanon, Serv Ophtalmol, Blida 09, Algeria; [Louha, Malek] Hop Armand Trousseau, AP HP, Serv Biochim & Biol Mol, F-75012 Paris, France; [Cheknene, Ahmed; Rous, Yahia] CHU Frantz Fanon, Serv ORL, Blida 09, Algeria; [Selmane, Djamel] CHU Bab El Oued, Serv ORL, Algiers 16, Algeria; [Hasbelaoui, Mokhtar] CHU Tizi Ouzou, Serv ORL, Tizi Ouzou 15, Algeria; [Bonnet, Crystel; Petit, Christine] Univ Paris 06, Inst Vis, INSERM, UMRS 1120, F-75005 Paris, France; [Petit, Christine] Coll France, F-75005 Paris, France	Universite Saad Dahlab de Blida; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University Science & Technology Houari Boumediene; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; UDICE-French Research Universities; PSL Research University Paris; College de France	Petit, C (corresponding author), Univ Paris 06, Inst Vis, INSERM, UMRS 1120, F-75005 Paris, France.; Petit, C (corresponding author), Coll France, F-75005 Paris, France.	christine.petit@pasteur.fr	Bonnet, Crystel/AAN-5950-2021	Bonnet, Crystel/0000-0002-1916-9119; Petit, Christine/0000-0002-9069-002X; BAHLOUL, Amel/0000-0001-7042-4616	Tassili Project; Algerian government; BNP Paribas Foundation; ERC grant "Hair bundle" [ERC-2011-AdG 294570]; French LABEX LIFESENSES grant [ANR-10-LABX-65]; ERC grant "Hair bundle" (LIGHT4DEAF) [ANR-15-RHUS-001]	Tassili Project; Algerian government; BNP Paribas Foundation; ERC grant "Hair bundle"; French LABEX LIFESENSES grant; ERC grant "Hair bundle" (LIGHT4DEAF)	This work was supported by grants from the Tassili Project, the Algerian government, the BNP Paribas Foundation, the ERC grant "Hair bundle" (ERC-2011-AdG 294570), ANR-15-RHUS-001 (LIGHT4DEAF), and the French LABEX LIFESENSES grant [reference ANR-10-LABX-65].; We thank all the family members for their participation in the study. We also thank Luce Smagghe for technical assistance. This work was supported by grants from the Tassili Project, the Algerian government, the BNP Paribas Foundation, the ERC grant "Hair bundle" (ERC-2011-AdG 294570), ANR-15-RHUS-001 (LIGHT4DEAF), and the French LABEX LIFE-SENSES grant [reference ANR-10-LABX-65].	Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Aller E, 2010, EUR J HUM GENET, V18, P788, DOI 10.1038/ejhg.2010.14; Ammar-Khodja F, 2015, MOL GENET GENOM MED, V3, P189, DOI 10.1002/mgg3.131; Ammar-Khodja F, 2009, EUR J MED GENET, V52, P174, DOI 10.1016/j.ejmg.2009.03.018; Aparisi MJ, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0168-7; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Besnard T, 2014, MOL GENET GENOM MED, V2, P30, DOI 10.1002/mgg3.25; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bonnet C, 2016, EUR J HUM GENET, V24, P1730, DOI 10.1038/ejhg.2016.99; Bonnet C, 2012, CURR OPIN NEUROL, V25, P42, DOI 10.1097/WCO.0b013e32834ef8b2; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Ebermann I, 2007, HUM GENET, V121, P203, DOI 10.1007/s00439-006-0304-0; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kimberling WJ, 2010, GENET MED, V12, P512, DOI 10.1097/GIM.0b013e3181e5afb8; Lenarduzzi S, 2015, HEARING RES, V320, P18, DOI 10.1016/j.heares.2014.12.006; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; Oshima A, 2008, Hum Mutat, V29, pE37, DOI 10.1002/humu.20761; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Riahi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120584; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Roux AF, 2006, J MED GENET, V43, P763, DOI 10.1136/jmg.2006.041954; SMITH RJH, 1994, AM J MED GENET, V50, P32, DOI 10.1002/ajmg.1320500107; Sotomayor M, 2012, NATURE, V492, P128, DOI 10.1038/nature11590; Spandau UHM, 2002, GRAEF ARCH CLIN EXP, V240, P495, DOI 10.1007/s00417-002-0485-8; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Weston MD, 1996, AM J HUM GENET, V59, P1074; Yan J, 2010, P NATL ACAD SCI USA, V107, P4040, DOI 10.1073/pnas.0911385107	40	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161893	10.1371/journal.pone.0161893	http://dx.doi.org/10.1371/journal.pone.0161893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583663	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600070
J	Gershman, SJ; Gerstenberg, T; Baker, CL; Cushman, FA				Gershman, Samuel J.; Gerstenberg, Tobias; Baker, Chris L.; Cushman, Fiery A.			Plans, Habits, and Theory of Mind	PLOS ONE			English	Article							RATIONAL ACTION; TIME PRESSURE; 2 SYSTEMS; MODEL; PUNISHMENT; HUMANS; INFORMATION; JUDGMENT; BEHAVIOR; BELIEFS	Human success and even survival depends on our ability to predict what others will do by guessing what they are thinking. If I accelerate, will he yield? If I propose, will she accept? If I confess, will they forgive? Psychologists call this capacity "theory of mind." According to current theories, we solve this problem by assuming that others are rational actors. That is, we assume that others design and execute efficient plans to achieve their goals, given their knowledge. But if this view is correct, then our theory of mind is startlingly incomplete. Human action is not always a product of rational planning, and we would be mistaken to always interpret others' behaviors as such. A wealth of evidence indicates that we often act habitually-a form of behavioral control that depends not on rational planning, but rather on a history of reinforcement. We aim to test whether the human theory of mind includes a theory of habitual action and to assess when and how it is deployed. In a series of studies, we show that human theory of mind is sensitive to factors influencing the balance between habitual and planned behavior.	[Gershman, Samuel J.; Cushman, Fiery A.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Gerstenberg, Tobias; Baker, Chris L.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Gershman, SJ (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gershman@fas.harvard.edu						ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; Alexander L, 2009, CAMB INTROD PHILOS L, P1, DOI 10.1017/CBO9780511804595; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baird JA, 2004, NEW DIR CHILD ADOLES, V103, P37, DOI 10.1002/cd.96; Baker CL, 2009, COGNITION, V113, P329, DOI 10.1016/j.cognition.2009.07.005; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bartsch K., 1995, CHILDREN TALK MIND; Bernacer J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00883; Betsch T, 1998, EUR J SOC PSYCHOL, V28, P861, DOI 10.1002/(SICI)1099-0992(1998110)28:6<861::AID-EJSP899>3.0.CO;2-D; Chambon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017133; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Critcher CR, 2013, SOC PSYCHOL PERS SCI, V4, P308, DOI 10.1177/1948550612457688; Cushman F, 2015, P NATL ACAD SCI USA, V112, P13817, DOI 10.1073/pnas.1506367112; Cushman F, 2015, PHILOS COMPASS, V10, P117, DOI 10.1111/phc3.12192; Cushman F, 2013, PERS SOC PSYCHOL REV, V17, P273, DOI 10.1177/1088868313495594; Darley JM, 2000, LAW HUMAN BEHAV, V24, P659, DOI 10.1023/A:1005552203727; Daw ND, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0478; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2014, COGN AFFECT BEHAV NE, V14, P473, DOI 10.3758/s13415-014-0277-8; Dennett Daniel C., 1987, INTENTIONAL STANCE; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Dolan RJ, 2013, NEURON, V80, P312, DOI 10.1016/j.neuron.2013.09.007; Fudenberg D, 2015, ARXIV150503342; Gendler TS, 2008, J PHILOS, V105, P634, DOI 10.5840/jphil20081051025; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Gershman SJ, 2017, PSYCHON B REV, V24, P557, DOI 10.3758/s13423-016-1110-x; Gershman SJ, 2014, J EXP PSYCHOL GEN, V143, P182, DOI 10.1037/a0030844; Gerstenberg T., 2014, P 36 ANN C COGN SCI; GILBERT DT, 1995, PSYCHOL BULL, V117, P21, DOI 10.1037/0033-2909.117.1.21; Hamlin JK, 2013, COGNITION, V128, P451, DOI 10.1016/j.cognition.2013.04.004; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Jacquet PO, 2012, PLOS ONE, V7, DOI [0.1371/journal.pone.0039629, DOI 10.1371/J0URNAL.P0NE.0039629]; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Jara-Ettinger J, 2015, PSYCHOL SCI, V26, P633, DOI 10.1177/0956797615572806; Jara-Ettinger J, 2015, COGNITION, V140, P14, DOI 10.1016/j.cognition.2015.03.006; Jern A, 2015, COGNITION, V142, P12, DOI 10.1016/j.cognition.2015.05.006; Ji MF, 2007, J CONSUM PSYCHOL, V17, P261, DOI 10.1016/S1057-7408(07)70037-2; Johnson SGB, 2015, COGNITIVE PSYCHOL, V77, P42, DOI 10.1016/j.cogpsych.2015.01.003; Kahneman D., 2011, THINKING FAST SLOW; Kelemen D, 2004, PSYCHOL SCI, V15, P295, DOI 10.1111/j.0956-7976.2004.00672.x; Keramati M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002055; Killen M, 2011, COGNITION, V119, P197, DOI 10.1016/j.cognition.2011.01.006; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Knobe J, 2011, OXFORD HDB FREE WILL, P530; Malle B.F., 2011, THEORIES SOCIAL PSYC, P72; Malle BF, 2014, PSYCHOL INQ, V25, P147, DOI 10.1080/1047840X.2014.877340; Malle BF, 1997, J EXP SOC PSYCHOL, V33, P101, DOI 10.1006/jesp.1996.1314; Marchette SA, 2011, J NEUROSCI, V31, P15264, DOI 10.1523/JNEUROSCI.3634-11.2011; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Morse SJ, 2004, U ILLINOIS LAW REV, P363; Neal DT, 2012, J EXP SOC PSYCHOL, V48, P492, DOI 10.1016/j.jesp.2011.10.011; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Otto AR, 2015, J COGNITIVE NEUROSCI, V27, P319, DOI 10.1162/jocn_a_00709; Otto AR, 2013, P NATL ACAD SCI USA, V110, P20941, DOI 10.1073/pnas.1312011110; Otto AR, 2013, PSYCHOL SCI, V24, P751, DOI 10.1177/0956797612463080; Piaget J, 1929, CHILDS CONCEPTION WO, P213; Pollard B, 2006, AM PHILOS QUART, V43, P57; Schad DJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01450; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P701, DOI 10.1017/S0140525X00623439; Summerfield C, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00070; Tenenbaum, 2011, P 32 ANN C COGN SCI, V33, P2469, DOI DOI 10.1093/BRAIN/AWW287; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Thrailkill EA, 2015, J EXP PSYCHOL-ANIM L, V41, P69, DOI 10.1037/xan0000045; Ullman T.D., 2009, 22 INT C NEUR INF PR, P1874; Van de Calseyde PPFM, 2014, ORGAN BEHAV HUM DEC, V125, P113, DOI 10.1016/j.obhdp.2014.07.001; Vierkant Tillman, 2005, ETHICAL THEORY MORAL, V8, P507, DOI [DOI 10.1007/S10677-005-5990-5, 10.1007/s10677-005-5990-5]; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Yaffe G, 2012, ROUTL PHILOS COMPAN, P174	76	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162246	10.1371/journal.pone.0162246	http://dx.doi.org/10.1371/journal.pone.0162246			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584041	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600122
J	Nakao, M; Aso, S; Imai, Y; Ueda, N; Hatanaka, T; Shiba, M; Kirita, T; Matsuda, T				Nakao, Megumi; Aso, Shimpei; Imai, Yuichiro; Ueda, Nobuhiro; Hatanaka, Toshihide; Shiba, Mao; Kirita, Tadaaki; Matsuda, Tetsuya			Statistical Analysis of Interactive Surgical Planning Using Shape Descriptors in Mandibular Reconstruction with Fibular Segments	PLOS ONE			English	Article							COMPUTER-AIDED-DESIGN; VIRTUAL SURGERY; FLAP; STEREOLITHOGRAPHY; SIMULATION; OSTEOTOMY; ACCURACY	This study was performed to quantitatively analyze medical knowledge of, and experience with, decision-making in preoperative virtual planning of mandibular reconstruction. Three shape descriptors were designed to evaluate local differences between reconstructed mandibles and patients' original mandibles. We targeted an asymmetrical, wide range of cutting areas including the mandibular sidepiece, and defined a unique three-dimensional coordinate system for each mandibular image. The generalized algorithms for computing the shape descriptors were integrated into interactive planning software, where the user can refine the preoperative plan using the spatial map of the local shape distance as a visual guide. A retrospective study was conducted with two oral surgeons and two dental technicians using the developed software. The obtained 120 reconstruction plans show that the participants preferred a moderate shape distance rather than optimization to the smallest. We observed that a visually plausible shape could be obtained when considering specific anatomical features (e.g., mental foramen. mandibular midline). The proposed descriptors can be used to multilaterally evaluate reconstruction plans and systematically learn surgical procedures.	[Nakao, Megumi; Aso, Shimpei; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Kyoto, Japan; [Imai, Yuichiro] Rakuwakai Otowa Hosp, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Ueda, Nobuhiro; Hatanaka, Toshihide; Shiba, Mao; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Nara, Japan	Kyoto University; Nara Medical University	Nakao, M (corresponding author), Kyoto Univ, Grad Sch Informat, Kyoto, Japan.	megumi@i.kyoto-u.ac.jp		Nakao, Megumi/0000-0002-5508-4366	JSPS [15H03032]; Center of Innovation (COI) Program of Japan Science and Technology Agency (JST); Center of Innovation (COI) Program from Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [16H03167] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation (COI) Program of Japan Science and Technology Agency (JST); Center of Innovation (COI) Program from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the JSPS Grant-in-Aid for Scientific Research (B) (15H03032). This work was also supported by the Center of Innovation (COI) Program of Japan Science and Technology Agency (JST).; This research was supported by a JSPS Grant-in-Aid for Scientific Research (B) (15H03032) and the Center of Innovation (COI) Program from the Japan Science and Technology Agency (JST).	Antony AK, 2011, PLAST RECONSTR SURG, V128, P1080, DOI 10.1097/PRS.0b013e31822b6723; Ciocca L, 2015, J CRANIO MAXILL SURG, V43, P28, DOI 10.1016/j.jcms.2014.10.005; FLEMMING AFS, 1990, BRIT J PLAST SURG, V43, P403, DOI 10.1016/0007-1226(90)90003-I; Foley BD, 2013, J ORAL MAXIL SURG, V71, pE111, DOI 10.1016/j.joms.2012.08.022; Foster RD, 1999, HEAD NECK-J SCI SPEC, V21, P66, DOI 10.1002/(SICI)1097-0347(199901)21:1<66::AID-HED9>3.3.CO;2-Q; Hirsch DL, 2009, J ORAL MAXIL SURG, V67, P2115, DOI 10.1016/j.joms.2009.02.007; Imanishi K, 2010, INT J COMPUT ASS RAD, V5, P461, DOI 10.1007/s11548-010-0413-z; Infante-Cossio P, 2012, OR SURG OR MED OR PA, V113, P712, DOI 10.1016/j.oooo.2011.11.033; Juergens P, 2009, J ORAL MAXIL SURG, V67, P2167, DOI 10.1016/j.joms.2009.04.104; Khalifa GA, 2015, J ORAL MAXILLOFAC SU, V74, P621, DOI [10.1016/j.joms.2015.09.036, DOI 10.1016/J.J0MS.2015.09.036]; Kimsal J, 2011, J ORAL MAXIL SURG, V69, P3010, DOI 10.1016/j.joms.2010.12.042; Kumta S, 2015, INDIAN J PLAST SURG, V48, P263, DOI 10.4103/0970-0358.173123; Metzler P, 2014, J ORAL MAXIL SURG, V72, P2601, DOI 10.1016/j.joms.2014.07.024; Nakao M, 2015, IEEE J BIOMED HEALTH, V19, P581, DOI 10.1109/JBHI.2014.2320720; Nakao M, 2013, IEEE ENG MED BIO, P3367, DOI 10.1109/EMBC.2013.6610263; Olsson P, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000447; Rohner D, 2013, J CRANIO MAXILL SURG, V41, P382, DOI 10.1016/j.jcms.2012.10.021; Roser SM, 2010, J ORAL MAXIL SURG, V68, P2824, DOI 10.1016/j.joms.2010.06.177; Shen Y, 2012, OR SURG OR MED OR PA, V114, P175, DOI 10.1016/j.tripleo.2011.06.030; Sink J, 2012, J RECONSTR MICROSURG, V28, P395, DOI 10.1055/s-0032-1315762; Smolka K, 2008, ORAL ONCOL, V44, P571, DOI 10.1016/j.oraloncology.2007.07.005; Steinbacher DM, 2015, J ORAL MAXIL SURG, V73, pS40, DOI 10.1016/j.joms.2015.04.038; Tepper O, 2012, PLAST RECONSTR SURG, V130, p192E, DOI 10.1097/PRS.0b013e318254fbf6; Wang WH, 2012, J CRANIO MAXILL SURG, V40, P599, DOI 10.1016/j.jcms.2011.10.017; Yamanaka Y, 2010, J PLAST RECONSTR AES, V63, P1751, DOI 10.1016/j.bjps.2010.03.001; Zhao LP, 2012, ARCH PLAST SURG-APS, V39, P309, DOI 10.5999/aps.2012.39.4.309	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161524	10.1371/journal.pone.0161524	http://dx.doi.org/10.1371/journal.pone.0161524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583465	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600036
J	Cagney, KA; Sterrett, D; Benz, J; Tompson, T				Cagney, Kathleen A.; Sterrett, David; Benz, Jennifer; Tompson, Trevor			Social Resources and Community Resilience in the Wake of Superstorm Sandy	PLOS ONE			English	Article							COLLECTIVE EFFICACY; VIOLENT CRIME; DISASTER; RECOVERY; PREPAREDNESS; PARADOX	Recovery efforts after natural disasters typically focus on physical infrastructure. In general less attention is paid to the social infrastructure that might impact the capacity of the community to rebuild. We examine perceptions of preparedness and recovery (markers of resilience at the community level) in the wake of Superstorm Sandy with a novel data set that includes a multi-mode survey of twelve neighborhoods severely affected by the storm. With these data, we suggest that social resources are associated with beliefs about neighborhood resilience. People who live in communities with higher social cohesion (coefficient = .73, p < .001), informal social control (coefficient = .53, p < .001), and social exchange (coefficient = .69, p < .001) are more likely to believe their neighborhoods are well prepared for a disaster. Likewise, people living in communities with higher social cohesion (coefficient = .35, p < .01), informal social control (coefficient = .27, p < .05), and social exchange (coefficient = .42, p < .001) are more likely to be confident their neighborhoods will recover quickly from a disaster. However, the effects of social resources on beliefs about resilience vary based on neighborhood socioeconomic status (SES) and the impact of the storm. Informal social control and social exchange lead to a greater increase in confidence in recovery in low, as compared to high, SES neighborhoods. Social resources tend to have more impact on perceptions of recovery in communities less affected by the storm. In sum, these findings suggest the potential value of various forms of social intervention to better equip communities to respond when disaster strikes.	[Cagney, Kathleen A.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA; [Sterrett, David; Benz, Jennifer; Tompson, Trevor] Univ Chicago, NORC, Associated Press NORC Ctr Publ Affairs Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Cagney, KA (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	kacagney@uchicago.edu			Rockefeller Foundation	Rockefeller Foundation	This study was funded by the Rockefeller Foundation (rockefellerfoundation.org) and awarded to TT and KC. The funder commented on the study design. The funder had no role in data collection, data analysis, decision to publish or preparation of the manuscript.; We would like to thank the many researchers and journalists from across NORC, the University of Chicago, and the Associated Press who provided critical support to this project. From NORC, we thank Dan Malato, Rebecca Reimer, Matthew Courser (now at PIRE), Emily Dooley (now at Newsday), and Emily Alvarez for extensive support of the data collection and analysis, as well Mike Meit for his early contributions to the study design. We also thank NORC statisticians Ned English, Becki Curtis, Wei Zeng, and Jie Zhao for informing the neighborhood selection and leading the survey sampling and weighting. We especially thank the staff of NORC's Telephone Survey and Support Operations and Field Operations who collected the data for their invaluable contribution to the study. From AP, we thank Karen Testa, Evan Berland, James Martinez, and Amanda Barrett for their insights into the affected region, as well as Jennifer Agiesta (now at CNN) for her contributions to the analysis and report. We thank The Rockefeller Foundation for supporting our work and for contributing their expertise. In particular we acknowledge Nancy Kete, Neill Coleman, Sundaa Bridgett-Jones, and Sam Carter. We also thank the other Rockefeller grantees for input throughout the project period, including the participants of the workshop on Measuring, Assessing and Profiling Human Resilience at the Bellagio Center. We note that University of Chicago colleagues shared advice on the research design and subsequent analysis. We thank Christopher Browning from The Ohio State University for his help constructing the neighborhood-level measures and Wendy Fleischer from the NYC Housing and Neighborhood Recovery Donor Collaborative for her insights during the neighborhood selection process.	Abramson DM, 2015, J BEHAV HEALTH SER R, V42, P42, DOI 10.1007/s11414-014-9410-2; Aldrich DP, 2014, AM BEHAV SCI; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; AP-NORC Center for Public Affairs Research, 2013, 2 YEARS SUP SAND EXP; Bandura A., 1986, SOCIAL FDN THOUGHT A; Berkes F, 2013, SOC NATUR RESOUR, V26, P5, DOI 10.1080/08941920.2012.736605; Bhandari RB, 2014, DISASTER PREV MANAG, V23, P314, DOI 10.1108/DPM-06-2013-0105; Bihari M, 2012, LANDSCAPE URBAN PLAN, V106, P253, DOI 10.1016/j.landurbplan.2012.03.011; Browning CR, 2006, AM SOCIOL REV, V71, P661, DOI 10.1177/000312240607100407; Browning CR, 2004, SOC FORCES, V83, P503, DOI 10.1353/sof.2005.0006; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; Browning CR, 2002, J MARRIAGE FAM, V64, P833, DOI 10.1111/j.1741-3737.2002.00833.x; Burayidi M., 2013, RESILIENT DOWNTOWNS; Burton I, 2015, INT J DISAST RISK RE, V12, P1, DOI 10.1016/j.ijdrr.2014.08.006; Cagney KA, 2007, AM J PUBLIC HEALTH, V97, P919, DOI 10.2105/AJPH.2005.071472; Chamlee-Wright E, 2011, SOCIOL REV, V59, P266, DOI 10.1111/j.1467-954X.2011.02008.x; Cox RS, 2011, AM J COMMUN PSYCHOL, V48, P395, DOI 10.1007/s10464-011-9427-0; House J.S., 1988, SCIENCE, V29, P241; Jacobs J, 1961, LIFE DEATH GREAT AM; Madsen W, 2016, J COMMUNITY PSYCHOL, V44, P277, DOI 10.1002/jcop.21764; McCreight R, 2010, J HOMEL SECUR EMERG, V7; Mukherji A, 2014, J CIV SOC, V10, P119, DOI 10.1080/17448689.2014.885787; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Park Robert E., 1925, CITY; PORTES A., 1998, ANN REV SOCIOLOGY; Rae Douglas W., 2003, CITY URBANISM ITS EN; Rahill GJ, 2014, DISASTERS, V38, pS73, DOI 10.1111/disa.12051; Reininger BM, 2013, SOC SCI MED, V83, P50, DOI 10.1016/j.socscimed.2013.01.037; Rich MA, 2013, J URBAN AFF, V35, P365, DOI 10.1111/j.1467-9906.2012.00639.x; Sampson R. J., 2012, GREAT AMERICAN CITY; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Shaw C. R., 1969, CLASSICS ENV CRIMINO; Silver E, 2004, CRIMINOLOGY, V42, P551, DOI 10.1111/j.1745-9125.2004.tb00529.x; Subaiya S, 2014, AM J PUBLIC HEALTH, V104, P632, DOI 10.2105/AJPH.2013.301668; United Nations International Strategy for Disaster Reduction, 2005, HYOG FRAM ACT 2005 2; Walker B., 2012, RESILIENCE PRACTICE; Wirth L, 1938, AM J SOCIOL, V44, P1, DOI 10.1086/217913	37	42	43	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160824	10.1371/journal.pone.0160824	http://dx.doi.org/10.1371/journal.pone.0160824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579482	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400010
J	Chiu, WC; Chiou, TJ; Chung, MJ; Chiang, AN				Chiu, Wen-Chin; Chiou, Tzeon-Jye; Chung, Meng-Ju; Chiang, An-Na			beta(2)-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							CELL MIGRATION; STIMULATES ANGIOGENESIS; GLYCOPROTEIN-I; VEGF; BETA-2-GLYCOPROTEIN-I; NEOVASCULARIZATION; PROLIFERATION; PROGRESSION; EXPRESSION; CARCINOMA	Angiogenesis is the process of new blood vessel formation, and it plays a key role in various physiological and pathological conditions. The beta(2)-glycoprotein I (beta(2)-GPI) is a plasma glycoprotein with multiple biological functions, some of which remain to be elucidated. This study aimed to identify the contribution of beta(2)-GPI on the angiogenesis induced by vascular endothelial growth factor (VEGF), a pro-angiogenic factor that may regulate endothelial remodeling, and its underlying mechanism. Our results revealed that beta(2)-GPI dose-dependently decreased the VEGF-induced increase in endothelial cell proliferation, using the 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) and the bromodeoxyuridine (BrdU) incorporation assays. Furthermore, incubation with both beta(2)-GPI and deglycosylated beta(2)-GPI inhibited the VEGF-induced tube formation. Our results suggest that the carbohydrate residues of beta(2)-GPI do not participate in the function of anti-angiogenesis. Using in vivo Matrigel plug and angioreactor assays, we show that beta(2)-GPI remarkably inhibited the VEGF-induced angiogenesis at a physiological concentration. Moreover, beta(2)-GPI inhibited the VEGF-induced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), Akt, and endothelial nitric oxide synthase (eNOS). In summary, our in vitro and in vivo data reveal for the first time that beta(2)-GPI inhibits the VEGF-induced angiogenesis and highlights the potential for beta(2)-GPI in anti-angiogenic therapy.	[Chiu, Wen-Chin; Chung, Meng-Ju; Chiang, An-Na] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Chiu, Wen-Chin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Thorac Surg, Kaohsiung, Taiwan; [Chiou, Tzeon-Jye] Taipei Vet Gen Hosp, Dept Med, Div Transfus Med, Taipei, Taiwan; [Chiou, Tzeon-Jye] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chiang, AN (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan.	anchia@ym.edu.tw			Ministry of Education, Aiming for the Top University Plan; National Science Council [NSC 102-2320-B-010-025]; Ministry of Science and Technology, Taiwan, ROC [MOST 103-2320-B-010-024-MY3]	Ministry of Education, Aiming for the Top University Plan; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from a grant from Ministry of Education, Aiming for the Top University Plan; the National Science Council (grant number NSC 102-2320-B-010-025); and the Ministry of Science and Technology (grant number MOST 103-2320-B-010-024-MY3), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard JE, 2010, J IMMUNOL, V185, P1550, DOI 10.4049/jimmunol.1000526; Beecken WDC, 2006, ANN SURG ONCOL, V13, P1241, DOI 10.1245/s10434-006-9009-9; Beecken WDC, 2010, CANCER LETT, V296, P160, DOI 10.1016/j.canlet.2010.04.010; Bekhite MM, 2011, J CELL SCI, V124, P1819, DOI 10.1242/jcs.077594; Belotti D, 2011, INT J BIOCHEM CELL B, V43, P1674, DOI 10.1016/j.biocel.2011.08.012; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Bronneke S, 2015, ANGIOGENESIS, V18, P361, DOI 10.1007/s10456-015-9472-7; CAI G, 1995, BBA-MOL CELL RES, V1269, P13, DOI 10.1016/0167-4889(95)00091-6; Cao ZF, 2013, BBA-REV CANCER, V1836, P273, DOI 10.1016/j.bbcan.2013.08.001; Carpini JD, 2010, ANGIOGENESIS, V13, P43, DOI 10.1007/s10456-010-9163-3; Chistiakov DA, 2015, ACTA PHYSIOL, V213, P539, DOI 10.1111/apha.12438; Chiu WC, 2013, MOL CELL BIOCHEM, V372, P9, DOI 10.1007/s11010-012-1440-6; Chiu WC, 2012, BIOCHEM J, V445, P125, DOI 10.1042/BJ20111383; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Ding Q, 2015, WORLD J GASTROENTERO, V21, P9566, DOI 10.3748/wjg.v21.i32.9566; Elshabrawy HA, 2015, ANGIOGENESIS, V18, P433, DOI 10.1007/s10456-015-9477-2; Esposito E, 2015, STROKE, V46, P2691, DOI 10.1161/STROKEAHA.115.009070; Eswarappa SM, 2015, CANCER RES, V75, P2765, DOI 10.1158/0008-5472.CAN-14-3805; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gately S, 1997, P NATL ACAD SCI USA, V94, P10868, DOI 10.1073/pnas.94.20.10868; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; HUNT JE, 1993, P NATL ACAD SCI USA, V90, P2141, DOI 10.1073/pnas.90.6.2141; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Itoh Y, 2000, J BIOCHEM-TOKYO, V128, P1017, DOI 10.1093/oxfordjournals.jbchem.a022829; Iyer AKV, 2015, J CELL BIOCHEM, V116, P2484, DOI 10.1002/jcb.25192; Jeong DE, 2015, ONCOTARGET, V6, P33046, DOI 10.18632/oncotarget.5422; Kassaar O, 2014, BLOOD, V123, P1948, DOI 10.1182/blood-2013-11-535963; KATO H, 1991, BIOCHEMISTRY-US, V30, P11687, DOI 10.1021/bi00114a012; Kim BR, 2015, ONCOTARGET, V6, P31830, DOI 10.18632/oncotarget.5570; Kondo J, 2011, J BONE MINER METAB, V29, P23, DOI 10.1007/s00774-010-0193-0; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Lin KY, 2005, J CELL BIOCHEM, V94, P485, DOI 10.1002/jcb.20314; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mai JT, 2014, INFLAMMATION, V37, P858, DOI 10.1007/s10753-013-9806-9; Miyakis S, 2004, THROMB RES, V114, P335, DOI 10.1016/j.thromres.2004.07.017; Morbidelli L, 1996, AM J PHYSIOL-HEART C, V270, pH411, DOI 10.1152/ajpheart.1996.270.1.H411; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nakagawa H, 2009, BLOOD, V114, P2553, DOI 10.1182/blood-2008-12-190629; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; Passam FH, 2010, J AUTOIMMUN, V35, P232, DOI 10.1016/j.jaut.2010.06.013; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; Radziwon-Balicka A, 2012, CAN J PHYSIOL PHARM, V90, P679, DOI [10.1139/Y2012-036, 10.1139/y2012-036]; Rivera JC, 2015, INVEST OPHTH VIS SCI, V56, P7897, DOI 10.1167/iovs.15-17146; Ruan GX, 2012, CELL CYCLE, V11, P2047, DOI 10.4161/cc.20535; Sakai T, 2007, AM J PATHOL, V171, P1659, DOI 10.2353/ajpath.2007.070146; Santos IC, 2010, CANCER SCI, V101, P453, DOI 10.1111/j.1349-7006.2009.01403.x; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schuermann A, 2015, ANGIOGENESIS, V18, P463, DOI 10.1007/s10456-015-9473-6; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Takeuchi R, 2000, BLOOD, V96, P1594, DOI 10.1182/blood.V96.4.1594.h8001594_1594_1595; Tian RH, 2015, CELLS TISSUES ORGANS, V201, P1, DOI 10.1159/000440949; Tong QY, 2014, TOXICOL APPL PHARM, V281, P166, DOI 10.1016/j.taap.2014.07.026; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031195; Wang SX, 1998, BIOCHEM J, V335, P225, DOI 10.1042/bj3350225; Xu J, 2015, MOL MED REP, V12, P4708, DOI 10.3892/mmr.2015.3975; Yasuda S, 2000, ATHEROSCLEROSIS, V152, P337, DOI 10.1016/S0021-9150(99)00496-7; Yu P, 2008, J THROMB HAEMOST, V6, P1215, DOI 10.1111/j.1538-7836.2008.03000.x; ZABRENETZKY V, 1994, INT J CANCER, V59, P191, DOI 10.1002/ijc.2910590209; Zhang Y, 2015, DRUG DES DEV THER, V9, P3413, DOI 10.2147/DDDT.S87920	61	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161950	10.1371/journal.pone.0161950	http://dx.doi.org/10.1371/journal.pone.0161950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579889	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400047
J	Contandriopoulos, D; Duhoux, A; Larouche, C; Perroux, M				Contandriopoulos, Damien; Duhoux, Arnaud; Larouche, Catherine; Perroux, Melanie			The Impact of a Researcher's Structural Position on Scientific Performance: An Empirical Analysis	PLOS ONE			English	Article							RESEARCH COLLABORATION; SOCIAL NETWORKS; H-INDEX; PRODUCTIVITY; SCIENCE; INDIVIDUALS; INTEGRATION; CENTRALITY; PATTERNS; SCOPUS	This article discusses the nature and structure of scientific collaboration as well as the association between academic collaboration networks and scientific productivity. Based on empirical data gathered from the CVs of 73 researchers affiliated with an academic research network in Canada, this study used social network analysis (SNA) to examine the association between researchers' structural position in the network and their scientific performance. With reference to Granovetter's and Burt's theories on weak ties and structural holes, we argue it is the bridging position a researcher holds in a scientific network that matters most to improve scientific performance. The results of correlation scores between network centrality and two different indicators of scientific performance indicate there is a robust association between researchers' structural position in collaboration networks and their scientific performance. We believe this finding, and the method we have developed, could have implications for the way research networks are managed and researchers are supported.	[Contandriopoulos, Damien; Duhoux, Arnaud; Perroux, Melanie] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Contandriopoulos, Damien; Larouche, Catherine; Perroux, Melanie] Univ Montreal, Publ Hlth Res Inst IRSPUM, Montreal, PQ, Canada; [Duhoux, Arnaud] Charles Le Moyne Hosp, Res Ctr, Longueuil, PQ, Canada; [Larouche, Catherine] McGill Univ, Dept Anthropol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Contandriopoulos, D (corresponding author), Univ Montreal, Fac Nursing, Montreal, PQ, Canada.; Contandriopoulos, D (corresponding author), Univ Montreal, Publ Hlth Res Inst IRSPUM, Montreal, PQ, Canada.	damien.contandriopoulos@umontreal.ca	Perroux, Mélanie/GXV-7542-2022		Quebec Nursing Intervention Research Network; Canadian Institutes of Health Research (CIHR)	Quebec Nursing Intervention Research Network; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The authors wish to acknowledge the financial support of the Quebec Nursing Intervention Research Network for this research. DC also benefited from a Canadian Institutes of Health Research (CIHR) funded Applied Public Health research chair (www.pocosa.ca).; The authors wish to acknowledge the support of the Quebec Nursing Intervention Research Network for this research. DC also benefited from a Canadian Institutes of Health Research (CIHR) funded Applied Public Health research chair (www.pocosa.ca).	Abbasi A, 2014, LIBR INFORM SCI RES, V36, P66, DOI 10.1016/j.lisr.2013.08.001; Abbasi A, 2012, INFORM PROCESS MANAG, V48, P671, DOI 10.1016/j.ipm.2011.09.001; Abramo G, 2009, HIGH EDUC, V57, P155, DOI 10.1007/s10734-008-9139-z; Andrews SB, 1999, NETWORKS ORG; Barjak F., 2008, SOCIAL GEOGRAPHY DIS, V3, P23, DOI [10.5194/sg-3-23-2008, DOI 10.5194/SGD-3-121-2007]; Boardman PC, 2008, RES POLICY, V37, P900, DOI 10.1016/j.respol.2008.01.012; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Borgatti SP, 2011, ORGAN SCI, V22, P1168, DOI 10.1287/orsc.1100.0641; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Bourdieu P., 1992, INVITATION REFLEXIVE; Bourdieu P., 1990, REPROD ED SOC CULTUR, V2nd ed.; Bourdieu Pierre, 1984, ACTES RECHERCHE SCI, V52, P3; Bourdieu Pierre, 1980, SENS PRATIQUE; Burt RS, 1992, STRUCTURAL HOLES SOC; Carpenter DP, 2004, J POLIT, V66, P224, DOI 10.1046/j.1468-2508.2004.00149.x; Carrington P. J., 2005, MODELS METHODS SOCIA; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Crane D., 1972, INVISIBLE COLL DIFFU; Cross R, 2002, CALIF MANAGE REV, V44, P25, DOI 10.2307/41166121; De Groote SL, 2012, NURS OUTLOOK, V60, P391, DOI 10.1016/j.outlook.2012.04.007; Defazio D, 2009, RES POLICY, V38, P293, DOI 10.1016/j.respol.2008.11.008; Dundar H, 1998, RES HIGH EDUC, V39, P607, DOI 10.1023/A:1018705823763; Duque RB, 2005, SOC STUD SCI, V35, P755, DOI 10.1177/0306312705053048; Ebadi A, 2015, J INFORMETR, V9, P809, DOI 10.1016/j.joi.2015.08.002; Ebadi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133061; Frank O., 2005, MODELS METHODS SOCIA, P31; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; Hagstrom W., 1965, SCI COMMUNITY; Harzing A.W., 2010, PUBLISH PERISH BOOK; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hoekman J, 2010, RES POLICY, V39, P662, DOI 10.1016/j.respol.2010.01.012; Ioannidis JPA, 2016, J CLIN EPIDEMIOL, V73, P82, DOI 10.1016/j.jclinepi.2016.02.012; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Kilduff M, 2010, ACAD MANAG ANN, V4, P317, DOI 10.1080/19416520.2010.494827; Lakitan B, 2012, TECHNOL SOC, V34, P227, DOI 10.1016/j.techsoc.2012.06.001; Lamont M, 2002, ANNU REV SOCIOL, V28, P167, DOI 10.1146/annurev.soc.28.110601.141107; Landry R, 1996, HIGH EDUC, V32, P283, DOI 10.1007/BF00138868; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Leydesdorff L, 2008, J INFORMETR, V2, P317, DOI 10.1016/j.joi.2008.07.003; Martin-Sempere MJ, 2008, SCIENTOMETRICS, V76, P457, DOI 10.1007/s11192-007-1866-x; Meho LI, 2007, J AM SOC INF SCI TEC, V58, P2105, DOI 10.1002/asi.20677; Melin G, 2000, RES POLICY, V29, P31, DOI 10.1016/S0048-7333(99)00031-1; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Milard B, 2014, J ASSOC INF SCI TECH, V65, P2459, DOI 10.1002/asi.23149; Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501; NELSON RE, 1989, ACAD MANAGE J, V32, P377, DOI 10.2307/256367; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Ponomariov BL, 2010, RES POLICY, V39, P613, DOI 10.1016/j.respol.2010.02.013; Prell C., 2012, SOCIAL NETWORK ANAL; SCOTT J., 1991, SOCIAL NETWORK ANAL; Scott J., 2011, SAGE HDB SOCIAL NETW; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snijders TA, 2005, MODELS LONGITUDINAL, P215; Sonnenwald DH, 2007, ANNU REV INFORM SCI, V41, P643, DOI 10.1002/aris.2007.1440410121; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Vieira ES, 2009, SCIENTOMETRICS, V81, P587, DOI 10.1007/s11192-009-2178-0; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Ynalvez MA, 2011, RES POLICY, V40, P204, DOI 10.1016/j.respol.2010.10.004	63	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161281	10.1371/journal.pone.0161281	http://dx.doi.org/10.1371/journal.pone.0161281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579954	Green Published, gold			2022-12-27	WOS:000382877400022
J	Kerkhofs, J; Leijten, J; Bolander, J; Luyten, FP; Post, JN; Geris, L				Kerkhofs, Johan; Leijten, Jeroen; Bolander, Johanna; Luyten, Frank P.; Post, Janine N.; Geris, Liesbet			A Qualitative Model of the Differentiation Network in Chondrocyte Maturation: A Holistic View of Chondrocyte Hypertrophy	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEIN; SIGNAL-TRANSDUCTION NETWORKS; CARTILAGE IN-VIVO; GROWTH-FACTOR-I; ENDOCHONDRAL OSSIFICATION; TRANSCRIPTION FACTOR; OSTEOARTHRITIC CARTILAGE; GENE-EXPRESSION	Differentiation of chondrocytes towards hypertrophy is a natural process whose control is essential in endochondral bone formation. It is additionally thought to play a role in several pathophysiological processes, with osteoarthritis being a prominent example. We perform a dynamic analysis of a qualitative mathematical model of the regulatory network that directs this phenotypic switch to investigate the influence of the individual factors holistically. To estimate the stability of a SOX9 positive state (associated with resting/proliferation chondrocytes) versus a RUNX2 positive one (associated with hypertrophy) we employ two measures. The robustness of the state in canalisation (size of the attractor basin) is assessed by a Monte Carlo analysis and the sensitivity to perturbations is assessed by a perturbational analysis of the attractor. Through qualitative predictions, these measures allow for an in silico screening of the effect of the modelled factors on chondrocyte maintenance and hypertrophy. We show how discrepancies between experimental data and the model's results can be resolved by evaluating the dynamic plausibility of alternative network topologies. The findings are further supported by a literature study of proposed therapeutic targets in the case of osteoarthritis.	[Kerkhofs, Johan; Geris, Liesbet] Univ Liege, Biomech Res Unit, Liege, Belgium; [Kerkhofs, Johan; Geris, Liesbet] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium; [Kerkhofs, Johan; Leijten, Jeroen; Bolander, Johanna; Luyten, Frank P.; Geris, Liesbet] Katholieke Univ Leuven, Prometheus, Leuven, Belgium; [Leijten, Jeroen; Bolander, Johanna; Luyten, Frank P.] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Leuven, Belgium; [Post, Janine N.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dev BioEngn, Enschede, Netherlands	University of Liege; KU Leuven; KU Leuven; KU Leuven; University of Twente	Geris, L (corresponding author), Univ Liege, Biomech Res Unit, Liege, Belgium.; Geris, L (corresponding author), Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium.; Geris, L (corresponding author), Katholieke Univ Leuven, Prometheus, Leuven, Belgium.	liesbet.geris@ulg.ac.be	Luyten, Frank/GPS-7793-2022; Post, Janine N./E-9983-2011; Leijten, Jeroen/G-5311-2011; Bolander, Johanna/AAB-3461-2021; geris, liesbet/D-2343-2016	Post, Janine N./0000-0002-6645-6583; Leijten, Jeroen/0000-0002-8063-207X; geris, liesbet/0000-0002-8180-1445; Bolander, Johanna/0000-0002-6915-9509	Research Foundation Flanders (FWO-Vlaanderen); European Research Council under the European Union's Seventh Framework Programme/ERC [279100, 294191]; Special Research Council (KU Leuven) [GOA/13/016]	Research Foundation Flanders (FWO-Vlaanderen)(FWO); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC)); Special Research Council (KU Leuven)	JK acknowledges scholarship funding from the Research Foundation Flanders (FWO-Vlaanderen). JL is a postdoctoral fellow of the Research Foundation Flanders (FWO-Vlaanderen) and received a F+ fellowship (GOA/13/016). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC (Grant Agreement n. 279100 and 294191) and from the Special Research Council (KU Leuven-GOA/13/016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is part of Prometheus, the KU Leuven R&D division for skeletal tissue engineering (http://www.kuleuven.be/prometheus).	Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Andrade AC, 2011, ENDOCR DEV, V21, P52, DOI 10.1159/000328127; [Anonymous], 2014, R LANG ENV STAT COMP; Araldi E, 2011, NAT MED, V17, P25, DOI 10.1038/nm0111-25; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Bauge C, 2008, ARTHRITIS RHEUM, V58, P221, DOI 10.1002/art.23154; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Brown KK, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-22; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Chen JZ, 2013, J CELL BIOCHEM, V114, P245, DOI 10.1002/jcb.24362; Chia SL, 2009, ARTHRITIS RHEUM-US, V60, P2019, DOI 10.1002/art.24654; Christensen C, 2007, IET SYST BIOL, V1, P61, DOI 10.1049/iet-syb:20060071; Daoud G, 2014, DEVELOPMENT, V141, P3978, DOI 10.1242/dev.111906; Daouti S, 2005, OSTEOARTHR CARTILAGE, V13, P508, DOI 10.1016/j.joca.2005.02.003; Davies OG, 2015, CALCIFIED TISSUE INT, V97, P432, DOI 10.1007/s00223-015-0034-1; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Delorme B, 2009, STEM CELLS, V27, P1142, DOI 10.1002/stem.34; Ding M, 2012, J CELL PHYSIOL, V227, P3446, DOI 10.1002/jcp.24045; Dodig M, 1999, DEV BIOL, V209, P298, DOI 10.1006/dbio.1999.9258; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Eberhard Voit, 2012, 1 COURSE SYSTEMS BIO; Edda Klipp, 2009, SYSTEMS BIOL; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fosang AJ, 2011, BEST PRACT RES CL RH, V25, P751, DOI 10.1016/j.berh.2011.11.010; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Funck-Brentano T, 2014, ARTHRITIS RHEUMATOL, V66, P3028, DOI 10.1002/art.38799; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; HARRISON ET, 1991, EXP CELL RES, V192, P340, DOI 10.1016/0014-4827(91)90050-5; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Jeffries MA, 2014, ARTHRITIS RHEUMATOL, V66, P2804, DOI 10.1002/art.38762; Johnson ME, 2014, CALCIFIED TISSUE INT, V94, P396, DOI 10.1007/s00223-013-9824-5; Kaiser M, 2004, ARTHRITIS RHEUM-US, V50, P3535, DOI 10.1002/art.20750; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kerkhofs J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130033; Kerkhofs J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034729; Khan FM, 2014, BBA-PROTEINS PROTEOM, V1844, P289, DOI 10.1016/j.bbapap.2013.05.007; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kitagaki J, 2003, OSTEOARTHR CARTILAGE, V11, P36, DOI 10.1053/joca.2002.0863; Kobayashi H, 2013, OARSI 2013; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krumsiek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022649; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Lammens J, 2012, ACTA ORTHOP BELG, V78, P569; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Leijten JCH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4306; Leijten JCH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049896; Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI 10.1089/ten.TEB.2008.0575; Li DL, 2012, RHEUMATOL INT, V32, P2017, DOI 10.1007/s00296-011-1929-4; Li WJ, 2014, STEROIDS, V89, P20, DOI 10.1016/j.steroids.2014.07.011; Luo JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036010; Ma B, 2013, OSTEOARTHR CARTILAGE, V21, P599, DOI 10.1016/j.joca.2013.01.014; Ma B, 2013, J BIOL CHEM, V288, P17552, DOI 10.1074/jbc.M113.453985; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Melas IN, 2014, OSTEOARTHR CARTILAGE, V22, P509, DOI 10.1016/j.joca.2014.01.001; Miclea RL, 2011, OSTEOARTHR CARTILAGE, V19, P1363, DOI 10.1016/j.joca.2011.07.014; Mori Y, 2014, J BIOL CHEM, V289, P10192, DOI 10.1074/jbc.M113.524090; Oh JH, 2012, BIOCHEM BIOPH RES CO, V418, P634, DOI 10.1016/j.bbrc.2012.01.064; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; Pap T, 2015, NAT REV RHEUMATOL, V11, P606, DOI 10.1038/nrrheum.2015.95; Peterson H, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00303; Piera-Velazquez S, 2007, EXP CELL RES, V313, P1069, DOI 10.1016/j.yexcr.2007.01.001; Qiao M, 2004, J BIOL CHEM, V279, P42709, DOI 10.1074/jbc.M404480200; Reynard LN, 2013, NAT REV RHEUMATOL, V9, P573, DOI 10.1038/nrrheum.2013.121; Roberts SJ, 2015, BONE, V70, P10, DOI 10.1016/j.bone.2014.08.007; Rue P, 2010, CHAOS, V20, DOI 10.1063/1.3524908; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Saadatpour A, 2010, J THEOR BIOL, V266, P641, DOI 10.1016/j.jtbi.2010.07.022; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Scharstuhl A, 2003, ARTHRITIS RHEUM-US, V48, P3442, DOI 10.1002/art.11328; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Selvamurugan N, 2009, FEBS LETT, V583, P1141, DOI 10.1016/j.febslet.2009.02.040; Shirakabe K, 2001, GENES CELLS, V6, P851, DOI 10.1046/j.1365-2443.2001.00466.x; Singhania R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001077; Smeets B, 2013, COMPUT METHOD BIOMEC, V16, P1071, DOI 10.1080/10255842.2013.829461; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Sun MMG, 2014, BIRTH DEFECTS RES C, V102, P74, DOI 10.1002/bdrc.21062; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; Thompson EM, 2015, J TISSUE ENG REGEN M, V9, P889, DOI 10.1002/term.1918; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Ullah M, 2010, WIRES SYST BIOL MED, V2, P385, DOI 10.1002/wsbm.78; Veliz-Cuba A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-221; Verdicchio MP, 2011, BIOCOMPUT-PAC SYM, P350; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wang BL, 2014, ARTHRITIS RHEUMATOL, V66, P107, DOI 10.1002/art.38195; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Weng TJ, 2012, ARTHRITIS RHEUM-US, V64, P3982, DOI 10.1002/art.34645; Wu L, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/752150; Wu QQ, 2010, ANN NY ACAD SCI, V1192, P344, DOI 10.1111/j.1749-6632.2009.05212.x; Wu SF, 2008, J BIOL CHEM, V283, P34037, DOI 10.1074/jbc.M803754200; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xing WR, 2014, J BONE MINER RES, V29, P2262, DOI 10.1002/jbmr.2256; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002; Zhang M, 2009, J CELL SCI, V122, P1382, DOI 10.1242/jcs.040709; Zhong LL, 2015, INT J MOL SCI, V16, P19225, DOI 10.3390/ijms160819225; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103; Zhou JX, 2016, BIOSYSTEMS, V142, P15, DOI 10.1016/j.biosystems.2016.03.002; Zhou X, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/809579; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	128	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162052	10.1371/journal.pone.0162052	http://dx.doi.org/10.1371/journal.pone.0162052			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579819	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400054
J	Limsreng, S; Marcy, O; Ly, S; Ouk, V; Chanroeurn, H; Thavary, S; Boroath, B; Canestri, A; Viretto, G; Delfraissy, JF; Segeral, O				Limsreng, Setha; Marcy, Olivier; Ly, Sowath; Ouk, Vara; Chanroeurn, Hak; Thavary, Saem; Boroath, Ban; Canestri, Ana; Viretto, Gerald; Delfraissy, Jean-Francois; Segeral, Olivier			Dyslipidemias and Elevated Cardiovascular Risk on Lopinavir-Based Antiretroviral Therapy in Cambodia	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; MYOCARDIAL-INFARCTION; DATA-COLLECTION; MANAGEMENT; DISEASE; LOPINAVIR/RITONAVIR; LIPOPROTEIN	Background Lopinavir/ritonavir (LPV/r) is widely used in Cambodia with high efficacy but scarce data exist on long-term metabolic toxicity. Methods We carried out a cross-sectional and retrospective study evaluating metabolic disorders and cardiovascular risk in Cambodian patients on LPV/r-based antiretroviral therapy (ART) for >1 year followed in Calmette Hospital, Phnom Penh. Data collected included cardiovascular risk factors, fasting blood lipids and glucose, and retrospective collection of bioclinical data. We estimated the 10-year risks of coronary heart disease with the Framingham, Ramathibodi-Electricity Generating Authority of Thailand (Rama-EGAT), and the Data Collection on Adverse Effects of Anti-HIV Drugs (D:A:D) risk equations. We identified patients with LDL above targets defined by the French expert group on HIV and by the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group (IDSA-AACTG). Results Of 115 patients enrolled-mean age 40.9 years, 69.2% male, mean time on LPV/r 3.8 years -40 (34.8%) had hypercholesterolemia (> 2.40 g/L), and 69 (60.0%) had low HDL cholesterol (< 0.40 g/L). Twelve (10.5%), 28 (24%) and 9 (7.7%) patients had a 10-year risk of coronary heart disease >= 10% according to the Framingham, D:A:D, and Rama-EGAT score, respectively. Fifty one (44.4%) and 36 (31.3%) patients had not reached their LDL target according to IDSA-AACTG and French recommendations, respectively. Conclusion Prevalence of dyslipidemia was high in this cohort of HIV-infected Cambodian patients on LPV/r. Roughly one third had high LDL levels requiring specific intervention.	[Limsreng, Setha; Ouk, Vara; Chanroeurn, Hak; Thavary, Saem; Boroath, Ban] Hop Calmette, Phnom Penh, Cambodia; [Marcy, Olivier] ESTHER Cambodia, Phnom Penh, Cambodia; [Marcy, Olivier; Ly, Sowath] Inst Pasteur Cambodia, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia; [Viretto, Gerald] ESTHER, Paris, France; [Canestri, Ana; Delfraissy, Jean-Francois; Segeral, Olivier] Bicetre Hosp, Dept Internal Med, Le Kremlin Bicetre, France; [Marcy, Olivier] Univ Bordeaux, Ctr INSERM U1219, Bordeaux Popula Hlth, Bordeaux, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Limsreng, S (corresponding author), Hop Calmette, Phnom Penh, Cambodia.	sethamd@gmail.com	Marcy, Olivier/T-3299-2019	Marcy, Olivier/0000-0003-3350-112X	ESTHER, Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, Paris, France; Pfizer; Phnom Penh; Cambodia	ESTHER, Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, Paris, France; Pfizer(Pfizer); Phnom Penh; Cambodia	This study was founded by Calmette Hospital with support by ESTHER, Ensemble pour une Solidarite Therapeutique Hospitaliere En Reseau, Paris, France, http://www.esther.fr/en/, and the participation of Pfizer, Phnom Penh, Cambodia, http://www.dksh.com.kh/, and Servier, Phnom Penh, Cambodia. These funding organizations had no role in study design, data collection and analysis, or decision to publish this manuscript.	Aboud M, 2010, INT J CLIN PRACT, V64, P1252, DOI 10.1111/j.1742-1241.2010.02424.x; Anastos K, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-34; Association WM, 2008, DECL HELS ETH PRINC; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cotter AG, 2011, AIDS, V25, P867, DOI 10.1097/QAD.0b013e32834507f0; Domingo P, 2008, J ANTIMICROB CHEMOTH, V61, P1348, DOI 10.1093/jac/dkn121; Dube MP, 2003, CLIN INFECT DIS, V37, P613, DOI 10.1086/378131; Edwards-Jackson N, 2011, HIV MED, V12, P510, DOI 10.1111/j.1468-1293.2011.00916.x; Joseph E, 2006, LANCET, V368, P476, DOI 10.1016/S0140-6736(06)69155-1; European AIDS Clinical Society, 2011, EUR AIDS CLIN SOC GU; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Ferradini L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-14; Fourie CMT, 2010, LIPIDS, V45, P73, DOI 10.1007/s11745-009-3369-4; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044098; Hiransuthikul Narin, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P69; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Lake JE, 2013, LANCET INFECT DIS, V13, P964, DOI 10.1016/S1473-3099(13)70271-8; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Mendis S., 2011, GLOB ATL CARD DIS PR; Meynard Jean-Luc, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P311, DOI 10.1177/1545109708326088; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Morineau G, 2009, AIDS PATIENT CARE ST, V23, P669, DOI 10.1089/apc.2008.0241; Oum S, 2010, PHNOM PENH; Pongchaiyakul Chatlert, 2006, Journal of the Medical Association of Thailand, V89, P1835; Rose H, 2006, METABOLISM, V55, P90, DOI 10.1016/j.metabol.2005.07.012; Saves M, 2002, CLIN INFECT DIS, V34, P1396, DOI 10.1086/339866; Segeral O, 2011, AIDS RES HUM RETROV, V27, P597, DOI [10.1089/AID.2010.0125, 10.1089/aid.2010.0125]; Stein JH, 2008, J CLIN LIPIDOL, V2, P464, DOI 10.1016/j.jacl.2008.08.442; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yeni P, 2010, PRISE CHARGE MED PER	34	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160306	10.1371/journal.pone.0160306	http://dx.doi.org/10.1371/journal.pone.0160306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579612	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400003
J	Liu, Y; Jiang, L; Yang, DP; Liu, H				Liu, Yuan; Jiang, Li; Yang, Dapeng; Liu, Hong			Analysis of Hand and Wrist Postural Synergies in Tolerance Grasping of Various Objects	PLOS ONE			English	Article							DIFFERENT FINGER MUSCLES; MECHANICAL IMPLEMENTATION; MYOELECTRIC CONTROL; JUNCTURAE-TENDINUM; DESIGN; CONSTRAINTS; MOVEMENTS; REACH; TOOL	Human can successfully grasp various objects in different acceptable relative positions between human hand and objects. This grasp functionality can be described as the grasp tolerance of human hand, which is a significant functionality of human grasp. To understand the motor control of human hand completely, an analysis of hand and wrist postural synergies in tolerance grasping of various objects is needed. Ten healthy right-handed subjects were asked to perform the tolerance grasping with right hand using 6 objects of different shapes, sizes and relative positions between human hand and objects. Subjects were wearing CyberGlove attaching motion tracker on right hand, allowing a measurement of the hand and wrist postures. Correlation analysis of joints and inter-joint/inter-finger modules were carried on to explore the coordination between joints or modules. As the correlation between hand and wrist module is not obvious in tolerance grasping, individual analysis of wrist synergies would be more practical. In this case, postural synergies of hand and wrist were then presented separately through principal component analysis (PCA), expressed through the principal component (PC) information transmitted ratio, PC elements distribution and reconstructed angle error of joints. Results on correlation comparison of different module movements can be well explained by the influence factors of the joint movement correlation. Moreover, correlation analysis of joints and modules showed the wrist module had the lowest correlation among all inter-finger and inter-joint modules. Hand and wrist postures were both sufficient to be described by a few principal components. In terms of the PC elements distribution of hand postures, compared with previous investigations, there was a greater proportion of movement in the thumb joints especially the interphalangeal (IP) and opposition rotation (ROT) joint. The research could serve to a complete understanding of hand grasp, and the design, control of the anthropomorphic hand and wrist.	[Liu, Yuan; Jiang, Li; Yang, Dapeng; Liu, Hong] Harbin Inst Technol, State Key Lab Robot & Syst, Harbin, Heilongjiang, Peoples R China	Harbin Institute of Technology	Yang, DP (corresponding author), Harbin Inst Technol, State Key Lab Robot & Syst, Harbin, Heilongjiang, Peoples R China.	yangdapeng@hit.edu.cn	Yang, Dapeng/S-5454-2017; Yang, Dapeng/AGE-4955-2022	Yang, Dapeng/0000-0003-2884-3854; Yang, Dapeng/0000-0003-2884-3854; Liu, Yuan/0000-0002-9703-7357	National Basic Research Program (973 Program) of China [2011CB013306]; National Natural Science Foundation of China [51205080]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the National Basic Research Program (973 Program) of China (Grant No. 2011CB013306) and National Natural Science Foundation of China (51205080).	[Anonymous], 2012, P IEEE EMBS; Bandara DSV, 2014, P IEEE RAS-EMBS INT, P1039, DOI 10.1109/BIOROB.2014.6913917; BREMNER FD, 1991, J PHYSIOL-LONDON, V432, P355, DOI 10.1113/jphysiol.1991.sp018389; BREMNER FD, 1991, J PHYSIOL-LONDON, V432, P381, DOI 10.1113/jphysiol.1991.sp018390; Brown CY, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P2883; Bullock IM, 2013, IEEE INT CONF ROBOT, P1068, DOI 10.1109/ICRA.2013.6630705; Bullock IM, 2013, IEEE T HAPTICS, V6, P296, DOI 10.1109/TOH.2013.6; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Chalon M, 2014, INT J HUM ROBOT, V11, DOI 10.1142/S0219843614500194; Chalon M, 2010, IEEE INT C INT ROBOT, P5886, DOI 10.1109/IROS.2010.5650454; Chen WR, 2014, IEEE INT CONF ROBOT, P403, DOI 10.1109/ICRA.2014.6906888; Controzzi M, 2010, IEEE ENG MED BIO, P499, DOI 10.1109/IEMBS.2010.5627148; CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Fahrer M, 1981, INTERDEPENDENT INDEP, P399; Feix T., 2009, P ROB SCI SYST C WOR; Feix T, 2014, IEEE T HAPTICS, V7, P430, DOI 10.1109/TOH.2014.2326867; Feix T, 2014, IEEE T HAPTICS, V7, P311, DOI 10.1109/TOH.2014.2326871; Grinyagin IV, 2005, J NEUROPHYSIOL, V94, P2284, DOI 10.1152/jn.01310.2004; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Hairong Wang, 2012, 2012 IEEE International Conference on Mechatronics and Automation (ICMA), P777, DOI 10.1109/ICMA.2012.6283241; Huenerfauth M., 2009, CITY U NEW YORK, V4, P22; Jarrasse N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-113; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jiang L, 2015, LECT NOTES ARTIF INT, V9244, P269, DOI 10.1007/978-3-319-22879-2_25; KAMAKURA N, 1980, AM J OCCUP THER, V34, P437, DOI 10.5014/ajot.34.7.437; Keen D, 1999, SOC NEUR ABSTR; Keen DA, 2003, MUSCLE NERVE, V28, P614, DOI 10.1002/mus.10481; KILBREATH SL, 1994, J PHYSIOL-LONDON, V479, P487, DOI 10.1113/jphysiol.1994.sp020312; Kochan A, 2005, IND ROBOT, V32, P15, DOI 10.1108/01439910510573237; Li SC, 2014, IND ROBOT, V41, P447, DOI 10.1108/IR-03-2014-0312; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Liu Y, 2015, IEEE ASME INT C ADV, P877, DOI 10.1109/AIM.2015.7222649; Lovchik CS, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P907, DOI 10.1109/ROBOT.1999.772420; Ma JX, 2015, IEEE T HUM-MACH SYST, V45, P74, DOI 10.1109/THMS.2014.2358634; Martin J, 2014, INT J ROBOT RES, V33, P783, DOI 10.1177/0278364913511677; Mason CR, 2001, J NEUROPHYSIOL, V86, P2896, DOI 10.1152/jn.2001.86.6.2896; Mouri T., 2002, P INT C CONTR AUT SY, P1288; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Pan LZ, 2015, IEEE T BIO-MED ENG, V62, P1927, DOI 10.1109/TBME.2015.2407491; Reilly KT, 2003, J NEUROPHYSIOL, V90, P2560, DOI 10.1152/jn.00287.2003; Rosmarin JB, 2008, IEEE INT CONF ROBOT, P773, DOI 10.1109/ROBOT.2008.4543299; Saliba MA, 2013, INT J HUM ROBOT, V10, DOI 10.1142/S0219843613500011; Santello M, 1998, J NEUROSCI, V18, P10105; Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Schlesinger IG., 1919, MECH AUFBAU KUNSTLIC, P321; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Sun BY, 2014, IEEE ENG MED BIO, P6215, DOI 10.1109/EMBC.2014.6945049; Takeda H, 2009, IEEE ENG MED BIO, P5048, DOI 10.1109/IEMBS.2009.5333668; Touvet F, 2014, EXP BRAIN RES, V232, P3055, DOI 10.1007/s00221-014-3990-1; Vinjamuri R, 2007, P ANN INT IEEE EMBS, P4846, DOI 10.1109/IEMBS.2007.4353425; Vinjamuri R, 2010, IEEE T INF TECHNOL B, V14, P986, DOI 10.1109/TITB.2009.2038907; Vinjamuri R, 2010, IEEE T BIO-MED ENG, V57, P284, DOI 10.1109/TBME.2009.2032532; VONSCHROEDER HP, 1990, J HAND SURG-AM, V15A, P595, DOI 10.1016/S0363-5023(09)90021-1; VONSCHROEDER HP, 1993, J HAND SURG-AM, V18A, P641, DOI 10.1016/0363-5023(93)90309-Q; Xu K, 2014, IEEE INT CONF ROBOT, P1348, DOI 10.1109/ICRA.2014.6907027; Xu K, 2014, ADV ROBOTICS, V28, P1459, DOI 10.1080/01691864.2014.958534; Yang DP, 2014, ADV ROBOTICS, V28, P1533, DOI 10.1080/01691864.2014.957723; Zheng Joshua Z., 2011, IEEE International Conference on Robotics and Automation, P4169; Zinck A, 2012, APPL BIONICS BIOMECH, V9, P117, DOI 10.1155/2012/463245	62	10	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161772	10.1371/journal.pone.0161772	http://dx.doi.org/10.1371/journal.pone.0161772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580298	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400041
J	Ross, RE; Nimmo-Smith, WAM; Howell, KL				Ross, Rebecca E.; Nimmo-Smith, W. Alex M.; Howell, Kerry L.			Increasing the Depth of Current Understanding: Sensitivity Testing of Deep-Sea Larval Dispersal Models for Ecologists	PLOS ONE			English	Article							ROCKALL TROUGH; OCEAN MODEL; WATER; CONNECTIVITY; TRAJECTORIES; SIMULATIONS; CIRCULATION; POPULATIONS; TRANSPORT; PATTERNS	Larval dispersal is an important ecological process of great interest to conservation and the establishment of marine protected areas. Increasing numbers of studies are turning to biophysical models to simulate dispersal patterns, including in the deep-sea, but for many ecologists unassisted by a physical oceanographer, a model can present as a black box. Sensitivity testing offers a means to test the models' abilities and limitations and is a starting point for all modelling efforts. The aim of this study is to illustrate a sensitivity testing process for the unassisted ecologist, through a deep-sea case study example, and demonstrate how sensitivity testing can be used to determine optimal model settings, assess model adequacy, and inform ecological interpretation of model outputs. Five input parameters are tested (timestep of particle simulator (TS), horizontal (HS) and vertical separation (VS) of release points, release frequency (RF), and temporal range (TR) of simulations) using a commonly employed pairing of models. The procedures used are relevant to all marine larval dispersal models. It is shown how the results of these tests can inform the future set up and interpretation of ecological studies in this area. For example, an optimal arrangement of release locations spanning a release area could be deduced; the increased depth range spanned in deep-sea studies may necessitate the stratification of dispersal simulations with different numbers of release locations at different depths; no fewer than 52 releases per year should be used unless biologically informed; three years of simulations chosen based on climatic extremes may provide results with 90% similarity to five years of simulation; and this model setup is not appropriate for simulating rare dispersal events. A step-by-step process, summarising advice on the sensitivity testing procedure, is provided to inform all future unassisted ecologists looking to run a larval dispersal simulation.	[Ross, Rebecca E.; Nimmo-Smith, W. Alex M.; Howell, Kerry L.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth, Devon, England	University of Plymouth	Ross, RE (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Plymouth, Devon, England.	Rebecca.Ross@plymouth.ac.uk	Ross, Rebecca E./AAQ-6980-2020; Smith, William AM Nimmo/D-3344-2009	Ross, Rebecca E./0000-0002-5395-1219; Howell, Kerry/0000-0003-3359-1778	Natural Environment Research Council [NE/K501104/1]; Natural Environment Research Council [1220472] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council as a PhD grant (NE/K501104/1) awarded to RER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly-Bechet M, 2008, J THEOR BIOL, V255, P320, DOI 10.1016/j.jtbi.2008.08.016; Blanke B, 2012, DYNAM ATMOS OCEANS, V55-56, P22, DOI 10.1016/j.dynatmoce.2012.04.003; Bonhommeau S, 2009, FISH OCEANOGR, V18, P371, DOI 10.1111/j.1365-2419.2009.00517.x; Booth DA, 1987, J CONS INT EXPLORATI, V39, P175; Bradbury IR, 2008, P ROY SOC B-BIOL SCI, V275, P1803, DOI 10.1098/rspb.2008.0216; Brickman D, 2002, J ATMOS OCEAN TECH, V19, P83, DOI 10.1175/1520-0426(2002)019<0083:LSMICO>2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Carson HS, 2010, CURR BIOL, V20, P1926, DOI 10.1016/j.cub.2010.09.057; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; ELLETT DJ, 1986, P ROY SOC EDINB B, V88, P61, DOI 10.1017/S0269727000004474; Etter RJ, 2015, DEEP-SEA RES, VI, DOI [10.1016/j.dsr.2015.6.009, DOI 10.1016/J.DSR.2015.6.009]; Etter RJ, 2011, MOL ECOL, V20, P829, DOI 10.1111/j.1365-294X.2010.04978.x; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Foster NL, 2012, MOL ECOL, V21, P1143, DOI 10.1111/j.1365-294X.2012.05455.x; Hardy SM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0193; Harris PT, 2014, MAR GEOL, V353, P169, DOI 10.1016/j.margeo.2014.03.023; Hilario A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00006; Holliday NP, 2000, DEEP-SEA RES PT I, V47, P1303, DOI 10.1016/S0967-0637(99)00109-0; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Kough AS, 2015, CORAL REEFS, V34, P753, DOI 10.1007/s00338-015-1311-1; Kough AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064970; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; Matthysen E, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P3; McClain CR, 2010, P ROY SOC B-BIOL SCI, V277, P3533, DOI 10.1098/rspb.2010.1057; McGrath T, 2012, DEEP-SEA RES PT I, V61, P57, DOI 10.1016/j.dsr.2011.11.007; Mercier A, 2011, J BIOL RHYTHM, V26, P82, DOI 10.1177/0748730410391948; Mercier A, 2008, MAR BIOL, V156, P205, DOI 10.1007/s00227-008-1077-x; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; Mullineaux Lauren S., 1994, P201; Mullineaux LS, 2002, CAH BIOL MAR, V43, P281; New AL, 2001, CONT SHELF RES, V21, P777, DOI 10.1016/S0278-4343(00)00113-8; North E.W., 2009, 295 ICES COOP RES; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Peck MA, 2012, J MARINE SYST, V93, P77, DOI 10.1016/j.jmarsys.2011.08.005; Putman NF, 2014, J EXP MAR BIOL ECOL, V450, P98, DOI 10.1016/j.jembe.2013.10.026; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Sandwell DT, 2014, SCIENCE, V346, P65, DOI 10.1126/science.1258213; Sherwin TJ, 2015, OCEAN SCI, V11, P343, DOI 10.5194/os-11-343-2015; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Simons RD, 2013, J MARINE SYST, V119, P19, DOI 10.1016/j.jmarsys.2013.03.004; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Tian RC, 2009, FISH OCEANOGR, V18, P173, DOI 10.1111/j.1365-2419.2009.00506.x; Ullgren JE, 2010, DEEP-SEA RES PT I, V57, P248, DOI 10.1016/j.dsr.2009.11.005; von Storch JS, 2010, OCEAN DYNAM, V60, P759, DOI 10.1007/s10236-010-0303-5; Waller RG, 2005, CORAL REEFS, V24, P514, DOI 10.1007/s00338-005-0501-7; Werner FE, 2007, OCEANOGRAPHY, V20, P54, DOI 10.5670/oceanog.2007.29; Wood S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1, DOI 10.1111/geb.12101; Yearsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023063; Young CM, 2012, INTEGR COMP BIOL, V52, P483, DOI 10.1093/icb/ics090	53	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161220	10.1371/journal.pone.0161220	http://dx.doi.org/10.1371/journal.pone.0161220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575625	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877200018
J	Yu, YH; Liao, PR; Guo, CJ; Chen, CH; Mochly-Rosen, D; Chuang, LM				Yu, Yu-Hsiang; Liao, Pei-Ru; Guo, Chien-Jung; Chen, Che-Hong; Mochly-Rosen, Daria; Chuang, Lee-Ming			PKC-ALDH2 Pathway Plays a Novel Role in Adipocyte Differentiation	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 2; CARDIAC PROTECTION; METABOLIC SYNDROME; OXIDATIVE STRESS; PPAR-GAMMA; PROTEIN; OBESITY; CARBONYLATION; ACTIVATION; EXPRESSION	The ALDH2 gene encodes the mitochondrial aldehyde dehydrogenase 2 (ALDH2), a critical enzyme involved in ethanol clearance through acetaldehyde metabolism. ALDH2 also catalyzes the metabolism of other bioreactive aldehydes, including propionaldehyde, butyraldehyde, and 4-hydroxykenals (4-HNE). Increased levels of 4-HNE in adipose tissue positively correlate with obesity and insulin resistance. However, it remains unclear whether ALDH2 is involved in regulation of adipocyte differentiation. Here, we found that ALDH2 protein levels were lower in white adipose tissue of high-fat diet-fed mice and ob/ob mice relative to lean mice. Knockdown of ALDH2 expression in 3T3-L1 preadipocytes caused an increase in intracellular 4-HNE, thereby attenuated adipocyte differentiation. By contrast, an ALDH2 activator, Alda-1, significantly accelerated adipogenesis, which was accompanied by an increase in adipogenic gene expression. Consistently, adipogenesis was reduced when protein kinase C epsilon (PKC epsilon), an ALDH2 phosphorylating activator, was silenced in 3T3-L1 preadipocytes, whereas treatment with a PKCe agonist in 3T3-L1 preadipocytes enhanced adipogenesis. Whole-genome microarray profiling of Alda-1-treated cells demonstrated several upregulated transcripts encoding proteins involved in metabolism and the majority of these transcripts are for proteins involved in PPAR signaling pathways. Furthermore, PKC epsilon-ALDH2 interaction alleviates 4-HNE induced aberrant PPAR. regulation on adipogenesis. Taken together, these results demonstrate that ALDH2 activation enhances adipogenesis and signaling pathways involving PPAR gamma. Thus, activation of PKC epsilon-ALDH2 regulatory axis may be a therapeutic target for treating obesity and type 2 diabetes.	[Yu, Yu-Hsiang] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Liao, Pei-Ru; Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Guo, Chien-Jung; Chuang, Lee-Ming] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei, Taiwan; [Chen, Che-Hong; Mochly-Rosen, Daria] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Chuang, Lee-Ming] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan	National Ilan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Stanford University; National Taiwan University	Chuang, LM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei, Taiwan.; Chuang, LM (corresponding author), Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei, Taiwan.	leeming@ntu.edu.tw	Chuang, Lee-Ming/AAF-3324-2019; Yu, Yu-Hsiang/J-4424-2019	Yu, Yu-Hsiang/0000-0001-9629-8478; Mochly-Rosen, Daria/0000-0002-6691-8733; CHUANG, LEE-MING/0000-0003-0978-2662	Ministry of Science and Technology in Taiwan [MOST 101-2314-B-002-158-MY3]; Ministry of Science and Technology in the US [NIAAA11147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147] Funding Source: NIH RePORTER	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology in the US; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Ministry of Science and Technology MOST 101-2314-B-002-158-MY3 to LMC in Taiwan and NIAAA11147 to DMR in the US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Budas GR, 2009, TRENDS CARDIOVAS MED, V19, P158, DOI 10.1016/j.tcm.2009.09.003; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Churchill EN, 2009, J MOL CELL CARDIOL, V46, P278, DOI 10.1016/j.yjmcc.2008.09.713; Crabb DW, 2001, ALCOHOL CLIN EXP RES, V25, P945, DOI 10.1097/00000374-200107000-00001; Dasuri K, 2013, FREE RADICAL RES, V47, P8, DOI 10.3109/10715762.2012.733003; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Guo JM, 2013, CELL RES, V23, P915, DOI 10.1038/cr.2013.69; Mattson MP, 2009, EXP GERONTOL, V44, P625, DOI 10.1016/j.exger.2009.07.003; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Soares AF, 2005, FREE RADICAL BIO MED, V38, P882, DOI 10.1016/j.freeradbiomed.2004.12.010; Wang JT, 2013, OCEAN ENG, V63, P8, DOI 10.1016/j.oceaneng.2013.01.028; Wang ZG, 2012, MOL CELL ENDOCRINOL, V349, P222, DOI 10.1016/j.mce.2011.10.027; Webb PR, 2003, CELL MOL LIFE SCI, V60, P1504, DOI 10.1007/s00018-003-2337-z; Weber D, 2013, REDOX BIOL, V1, P226, DOI 10.1016/j.redox.2013.01.012; Zambelli VO, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009539	22	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161993	10.1371/journal.pone.0161993	http://dx.doi.org/10.1371/journal.pone.0161993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575855	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877200052
J	Baese-Berk, MM; Dilley, LC; Schmidt, S; Morrill, TH; Pitt, MA				Baese-Berk, Melissa M.; Dilley, Laura C.; Schmidt, Stephanie; Morrill, Tuuli H.; Pitt, Mark A.			Revisiting Neil Armstrongs Moon-Landing Quote: Implications for Speech Perception, Function Word Reduction, and Acoustic Ambiguity	PLOS ONE			English	Article							RECOGNITION; HYPOTHESIS; HEAR	Neil Armstrong insisted that his quote upon landing on the moon was misheard, and that he had said one small step for a man, instead of one small step for man. What he said is unclear in part because function words like a can be reduced and spectrally indistinguishable from the preceding context. Therefore, their presence can be ambiguous, and they may disappear perceptually depending on the rate of surrounding speech. Two experiments are presented examining production and perception of reduced tokens of for and for a in spontaneous speech. Experiment 1 investigates the distributions of several acoustic features of for and for a. The results suggest that the distributions of for and for a overlap substantially, both in terms of temporal and spectral characteristics. Experiment 2 examines perception of these same tokens when the context speaking rate differs. The perceptibility of the function word a varies as a function of this context speaking rate. These results demonstrate that substantial ambiguity exists in the original quote from Armstrong, and that this ambiguity may be understood through context speaking rate.	[Baese-Berk, Melissa M.] Univ Oregon, Dept Linguist, Eugene, OR 97403 USA; [Dilley, Laura C.; Schmidt, Stephanie] Michigan State Univ, Dept Commun Sci & Disorders, E Lansing, MI 48824 USA; [Morrill, Tuuli H.] George Mason Univ, Program Linguist, Dept English, Fairfax, VA 22030 USA; [Pitt, Mark A.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	University of Oregon; Michigan State University; George Mason University; University System of Ohio; Ohio State University	Dilley, LC (corresponding author), Michigan State Univ, Dept Commun Sci & Disorders, E Lansing, MI 48824 USA.	ldilley@msu.edu		Baese-Berk, Melissa/0000-0002-4855-9319	National Science Foundation [0847653, 1431063]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (0847653 and 1431063) to LD, http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON AS, 1968, J ACOUST SOC AM, V44, P377, DOI 10.1121/1.1970569; [Anonymous], 2006, BBC NEWS; Baese-Berk MM, 2014, PSYCHOL SCI, V25, P1546, DOI 10.1177/0956797614533705; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bell A, 2003, J ACOUST SOC AM, V113, P1001, DOI 10.1121/1.1534836; Boersma P., 2015, PRAAT; Cole RA, 1979, PERCEPTION PRODUCTIO; Collingridge DS, 2013, J MIX METHOD RES, V7, P81, DOI 10.1177/1558689812454457; Crouch I, 2012, NEW YORKER NEWS DESK; Dilley LC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01002; Dilley LC, 2010, PSYCHOL SCI, V21, P1664, DOI 10.1177/0956797610384743; Dilley LC, 2010, J MEM LANG, V63, P274, DOI 10.1016/j.jml.2010.06.003; Ernestus M, 2002, BRAIN LANG, V81, P162, DOI 10.1006/brln.2001.2514; Ernestus M, 2011, J PHONETICS, V39, P253, DOI 10.1016/S0095-4470(11)00055-6; Heffner CC, 2013, LANG COGNITIVE PROC, V28, P1275, DOI 10.1080/01690965.2012.672229; Johnson Keith., 2004, SPONTANEOUS SPEECH D, P29; Jones E. M., 1995, APOLLO 11 LUNAR SURF; LEHISTE I, 1972, J ACOUST SOC AM, V51, P2018, DOI 10.1121/1.1913062; Mattys SL, 2007, J EXP PSYCHOL HUMAN, V33, P960, DOI 10.1037/0096-1523.33.4.960; Mitterer H, 2008, J MEM LANG, V59, P133, DOI 10.1016/j.jml.2008.02.004; Morrill T, 2015, PSYCHON B REV, V22, P1451, DOI 10.3758/s13423-015-0820-9; Morrill TH, 2014, COGNITION, V131, P69, DOI 10.1016/j.cognition.2013.12.006; Shockey L., 2008, SOUND PATTERNS SPOKE; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0155975	10.1371/journal.pone.0155975	http://dx.doi.org/10.1371/journal.pone.0155975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603209	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200001
J	Fisher, JT; Heim, N; Code, S; Paczkowski, J				Fisher, Jason T.; Heim, Nicole; Code, Sandra; Paczkowski, John			Grizzly Bear Noninvasive Genetic Tagging Surveys: Estimating the Magnitude of Missed Detections	PLOS ONE			English	Article							MARK-RECAPTURE POPULATION; URSUS-ARCTOS; OCCUPANCY ESTIMATION; BIODIVERSITY LOSS; NATIONAL-PARK; DENSITY; BIAS; HETEROGENEITY; CONSERVATION; CARNIVORES	Sound wildlife conservation decisions require sound information, and scientists increasingly rely on remotely collected data over large spatial scales, such as noninvasive genetic tagging (NGT). Grizzly bears (Ursus arctos), for example, are difficult to study at population scales except with noninvasive data, and NGT via hair trapping informs management over much of grizzly bears' range. Considerable statistical effort has gone into estimating sources of heterogeneity, but detection error-arising when a visiting bear fails to leave a hair sample-has not been independently estimated. We used camera traps to survey grizzly bear occurrence at fixed hair traps and multi-method hierarchical occupancy models to estimate the probability that a visiting bear actually leaves a hair sample with viable DNA. We surveyed grizzly bears via hair trapping and camera trapping for 8 monthly surveys at 50 (2012) and 76 (2013) sites in the Rocky Mountains of Alberta, Canada. We used multimethod occupancy models to estimate site occupancy, probability of detection, and conditional occupancy at a hair trap. We tested the prediction that detection error in NGT studies could be induced by temporal variability within season, leading to underestimation of occupancy. NGT via hair trapping consistently underestimated grizzly bear occupancy at a site when compared to camera trapping. At best occupancy was underestimated by 50%; at worst, by 95%. Probability of false absence was reduced through successive surveys, but this mainly accounts for error imparted by movement among repeated surveys, not necessarily missed detections by extant bears. The implications of missed detections and biased occupancy estimates for density estimation-which form the crux of management plans-require consideration. We suggest hair-trap NGT studies should estimate and correct detection error using independent survey methods such as cameras, to ensure the reliability of the data upon which species management and conservation actions are based.	[Fisher, Jason T.; Heim, Nicole] Alberta Innovates Technol Futures, Ecosyst Management Unit, 3,4476 Markham St, Victoria, BC V8Z 7X8, Canada; [Fisher, Jason T.; Heim, Nicole] Univ Victoria, Sch Environm Studies, STN CSC, POB 3060, Victoria, BC V8W 3R4, Canada; [Code, Sandra; Paczkowski, John] Alberta Environm & Pk, Pk Div, Suite 201,800 Railway Ave, Canmore, AB T1W 1P1, Canada	Alberta Innovates; University of Victoria	Fisher, JT (corresponding author), Alberta Innovates Technol Futures, Ecosyst Management Unit, 3,4476 Markham St, Victoria, BC V8Z 7X8, Canada.; Fisher, JT (corresponding author), Univ Victoria, Sch Environm Studies, STN CSC, POB 3060, Victoria, BC V8W 3R4, Canada.	Jason.fisher@albertainnovates.ca			Alberta Environment and Parks; Alberta Innovates-Technology Futures; Natural Sciences and Engineering Research Council of Canada; Yellowstone	Alberta Environment and Parks; Alberta Innovates-Technology Futures; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Yellowstone	This work was primarily funded by Alberta Environment and Parks and Alberta Innovates-Technology Futures under the grant title "East Slopes Predators Project." Scholarship funding was granted to Nicole Heim by Natural Sciences and Engineering Research Council of Canada and Yellowstone to Yukon to Conservation Initiative. Alberta Innovates-Technology Futures provided support in the form of salaries for authors JTF and NH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alberta Environment and Parks provided support in the form of salaries for authors SC and JP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Benn B, 2002, URSUS, V13, P213; Boulanger J, 2004, J MAMMAL, V85, P618, DOI 10.1644/BRB-134; Boulanger J, 2004, J WILDLIFE MANAGE, V68, P457, DOI 10.2193/0022-541X(2004)068[0457:SDABID]2.0.CO;2; Boulanger J, 2002, URSUS, V13, P137; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Campbell Lori A., 2008, P223; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Efford MG, 2014, ECOLOGY, V95, P1341, DOI 10.1890/13-1497.1; Efford MG, 2014, METHODS ECOL EVOL, V5, P599, DOI 10.1111/2041-210X.12169; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Festa- Bianchet M., 2010, STATUS GRIZZLY BEAR; Fisher JT, 2013, CAN J ZOOL, V91, P706, DOI 10.1139/cjz-2013-0022; Fisher JT, 2014, CONSERV BIOL, V28, P1249, DOI 10.1111/cobi.12302; Fisher JT, 2014, J WILDLIFE MANAGE, V78, P1087, DOI 10.1002/jwmg.750; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Heim N.A., 2015, COMPLEX EFFECTS HUMA; Hines JE., 2006, PRESENCESOFTWARE EST; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall WL, 2013, ECOLOGY, V94, P610, DOI 10.1890/12-1720.1; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Long RA, 2008, NONINVASIVE SURVEY M; Long Robert A., 2008, P8; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P453, DOI 10.2193/0022-541X(2004)068[0453:PRAAGC]2.0.CO;2; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P439, DOI 10.2193/0022-541X(2004)068[0439:GEAWPE]2.0.CO;2; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mooers AO, 2010, BIOSCIENCE, V60, P843, DOI 10.1525/bio.2010.60.10.11; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Paetkau D, 2004, J WILDLIFE MANAGE, V68, P449, DOI 10.2193/0022-541X(2004)068[0449:TONOMI]2.0.CO;2; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Poole KG, 2001, WILDLIFE BIOL, V7, P105, DOI 10.2981/wlb.2001.014; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Roon DA, 2003, MOL ECOL NOTES, V3, P163, DOI 10.1046/j.1471-8286.2003.00358.x; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Rovang S, 2015, WILDLIFE BIOL, V21, P68, DOI 10.2981/wlb.00033; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz Charles C., 2003, Ursus (Knoxville), V14, P109; Stetz JB, 2015, J FISH WILDL MANAG, V6, P191, DOI 10.3996/122013-JFWM-085; Stewart FEC, 2016, ECOL EVOL, V6, P1493, DOI 10.1002/ece3.1921; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Whittington J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134446; Zedrosser A, 2009, OECOLOGIA, V160, P847, DOI 10.1007/s00442-009-1343-8	67	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161055	10.1371/journal.pone.0161055	http://dx.doi.org/10.1371/journal.pone.0161055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603134	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200010
J	Guan, F; Zhai, XF; Duan, JZ; Zhang, MX; Hou, BR				Guan, Fang; Zhai, Xiaofan; Duan, Jizhou; Zhang, Meixia; Hou, Baorong			Influence of Sulfate-Reducing Bacteria on the Corrosion Behavior of High Strength Steel EQ70 under Cathodic Polarization	PLOS ONE			English	Article							PROTECTED HIGH-STRENGTH; DIRECT ELECTRON UPTAKE; LOW-ALLOY STEELS; CARBON-STEEL; HYDROGEN EMBRITTLEMENT; SEAWATER; IRON; BIOFILMS; BIOCORROSION; SULFIDE	Certain species of sulfate- reducing bacteria (SRB) use cathodes as electron donors for metabolism, and this electron transfer process may influence the proper protection potential choice for structures. The interaction between SRB and polarized electrodes had been the focus of numerous investigations. In this paper, the impact of cathodic protection (CP) on Desulfovibrio caledoniens metabolic activity and its influence on highs trength steel EQ70 were studied by bacterial analyses and electrochemical measurements. The results showed that EQ70 under -0.85 V-SCE CP had a higher corrosion rate than that without CP, while EQ70 with -1.05 V-SCE had a lower corrosion rate. The enhanced SRB metabolic activity at -0.85 V-SCE was most probably caused by the direct electron transfer from the electrode polarized at -0.85 V-SCE. This direct electron transfer pathway was unavailable in -1.05 V-SCE. In addition, the application of cathodic protection led to the transformation of sulfide rusts into carbonates rusts. These observations have been employed to provide updated recommendations for the optimum CP potential for steel structures in the presence of SRB.	[Guan, Fang; Zhai, Xiaofan; Duan, Jizhou; Zhang, Meixia; Hou, Baorong] Chinese Acad Sci, Inst Oceanol, Marine Corros & Protect Ctr, 7 Nanhai Rd, Qingdao 266071, Peoples R China; [Guan, Fang; Zhang, Meixia] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, JZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Marine Corros & Protect Ctr, 7 Nanhai Rd, Qingdao 266071, Peoples R China.	duanjz@qdio.ac.cn			National Basic Research Program of China (973 Program) [2014CB643304]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The present work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2014CB643304). JD received the funding.	AWagner P., 1993, INTERRELATIONSHIP MA; Bai PP, 2015, CORROS SCI, V93, P109, DOI 10.1016/j.corsci.2015.01.024; Bao Q, 2012, CORROS SCI, V65, P405, DOI 10.1016/j.corsci.2012.08.044; Batt C, 2002, BRIT CORROS J, V37, P194, DOI 10.1179/000705902225006606; Beese-Vasbender PF, 2015, ELECTROCHIM ACTA, V167, P321, DOI 10.1016/j.electacta.2015.03.184; Cao C.N., 2002, ELECTROCHEMICAL IMPE; Chen X., CORROSION SCI, V101, P1; Cordas CM, 2008, ELECTROCHIM ACTA, V54, P29, DOI 10.1016/j.electacta.2008.02.041; Dawn E. H, 2004, APPL ENVIRON MICROB, V70, P1234; de Romero M., 2009, CATHODIC PROTECTION; de Romero M. F., 2008, CORROSION 2008; deSaravia SGG, 1997, BIOFOULING, V11, P1, DOI 10.1080/08927019709378317; Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Geelhoed JS, 2011, ENVIRON SCI TECHNOL, V45, P815, DOI 10.1021/es102842p; Guezennec J, 1988, 1 EUR FED CORR WORKS, P256; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hernandez G, 1994, CORROS REV, V1-2, P29; Kajiyama F, 1999, CORROSION, V55, P74, DOI 10.5006/1.3283968; Kim JG, 2001, CORROS SCI, V43, P2011, DOI 10.1016/S0010-938X(01)00015-4; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Li FS, 2012, ADV MATER RES-SWITZ, V368-373, P42, DOI 10.4028/www.scientific.net/AMR.368-373.42; Little B., 1995, MAT SCI FORUM; Lojou E, 2002, ELECTROANAL, V14, P913, DOI 10.1002/1521-4109(200207)14:13<913::AID-ELAN913>3.0.CO;2-N; Malard E, 2008, ELECTROCHIM ACTA, V54, P8, DOI 10.1016/j.electacta.2008.05.075; Mehanna M, 2008, ELECTROCHIM ACTA, V54, P140, DOI 10.1016/j.electacta.2008.02.101; Miranda E, 2006, CORROS SCI, V48, P2417, DOI 10.1016/j.corsci.2005.09.005; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Niu LN, 2012, APPL MECH MATER, V117-119, P1905, DOI 10.4028/www.scientific.net/AMM.117-119.1905; Pineau S, 2008, CORROS SCI, V50, P1099, DOI 10.1016/j.corsci.2007.11.029; Refait P, 2013, CORROS SCI, V71, P32, DOI 10.1016/j.corsci.2013.01.042; ROBINSON MJ, 1994, CORROSION, V50, P626, DOI 10.5006/1.3293536; Rosenbaum M, 2011, BIORESOURCE TECHNOL, V102, P324, DOI 10.1016/j.biortech.2010.07.008; Sherar BWA, 2011, CORROS SCI, V53, P955, DOI 10.1016/j.corsci.2010.11.027; Starosvetsky D, 2010, CORROS SCI, V52, P1536, DOI 10.1016/j.corsci.2010.01.013; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Villano M, 2011, BIORESOURCE TECHNOL, V102, P3193, DOI 10.1016/j.biortech.2010.10.146; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Voordeckers JW, 2010, APPL ENVIRON MICROB, V76, P2371, DOI 10.1128/AEM.02250-09; Wan Y, 2010, ELECTROCHIM ACTA, V55, P1528, DOI 10.1016/j.electacta.2009.10.009; Wang XH, 2014, INT J ELECTROCHEM SC, V9, P8199; Wei JC, 2010, ENVIRON SCI TECHNOL, V44, P3187, DOI 10.1021/es903758m; Xu DK, 2016, BIOELECTROCHEMISTRY, V110, P52, DOI 10.1016/j.bioelechem.2016.03.003; Xu D, 2014, INT BIODETER BIODEGR, V91, P74, DOI 10.1016/j.ibiod.2014.03.014; Xu DK, 2013, CORROS SCI, V77, P385, DOI 10.1016/j.corsci.2013.07.044; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004; Yu L, 2013, ELECTROCHEM COMMUN, V26, P101, DOI 10.1016/j.elecom.2012.10.022; Yu L, 2011, ELECTROCHIM ACTA, V56, P9041, DOI 10.1016/j.electacta.2011.05.086; Yuan SJ, 2013, CORROS SCI, V74, P353, DOI 10.1016/j.corsci.2013.04.058; Zhang JX, 2010, ANTI-CORROS METHOD M, V57, P249, DOI [10.1108/000355910110758961, 10.1108/00035591011075896]; Zhang L, 2012, CORROSION, V68, P713, DOI 10.5006/0521; Zhao X., 2007, SULFATE REDUCING BAC; Zhu Y, 2007, MATER CORROS, V58, P447, DOI 10.1002/maco.200604030	52	43	51	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162315	10.1371/journal.pone.0162315	http://dx.doi.org/10.1371/journal.pone.0162315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603928	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200057
J	Hammami, P; Lancelot, R; Lesnoff, M				Hammami, Pachka; Lancelot, Renaud; Lesnoff, Matthieu			Modelling the Dynamics of Post-Vaccination Immunity Rate in a Population of Sahelian Sheep after a Vaccination Campaign against Peste des Petits Ruminants Virus	PLOS ONE			English	Article							BIRTH SEX-RATIOS; ANTIBODIES; COLOSTRUM; LIVESTOCK; DISEASES; GOATS	Background Peste des petits ruminants (PPR) is an acute infectious viral disease affecting domestic small ruminants (sheep and goats) and some wild ruminant species in Africa, the Middle East and Asia. A global PPR control strategy based on mass vaccination-in regions where PPR is endemic-was recently designed and launched by international organizations. Sahelian Africa is one of the most challenging endemic regions for PPR control. Indeed, strong seasonal and annual variations in mating, mortality and offtake rates result in a complex population dynamics which might in turn alter the population post-vaccination immunity rate (PIR), and thus be important to consider for the implementation of vaccination campaigns. Methods In a context of preventive vaccination in epidemiological units without PPR virus transmission, we developed a predictive, dynamic model based on a seasonal matrix population model to simulate PIR dynamics. This model was mostly calibrated with demographic and epidemiological parameters estimated from a long-term follow-up survey of small ruminant herds. We used it to simulate the PIR dynamics following a single PPR vaccination campaign in a Sahelian sheep population, and to assess the effects of (i) changes in offtake rate related to the Tabaski (a Muslim feast following the lunar calendar), and (ii) the date of implementation of the vaccination campaigns. Results The persistence of PIR was not influenced by the Tabaski date. Decreasing the vaccination coverage from 100 to 80% had limited effects on PIR. However, lower vaccination coverage did not provide sufficient immunity rates (PIR < 70%). As a trade-off between model predictions and other considerations like animal physiological status, and suitability for livestock farmers, we would suggest to implement vaccination campaigns in September-October. This model is a first step towards better decision support for animal health authorities. It might be adapted to other species, livestock farming systems or diseases.	[Hammami, Pachka; Lancelot, Renaud] Ctr Cooperat Int Rech Agron Dev Cirad, UMR Controle Malad Anim Exot & Emergentes Cmaee, Campus Int Baillarguet, F-34398 Montpellier, France; [Hammami, Pachka; Lancelot, Renaud] INRA, UMR Cmaee 1309, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] Cirad, UMR Syst Elevage Mediterraneens & Trop Selmet, F-34398 Montpellier, France; [Lesnoff, Matthieu] INRA, UMR Selmet, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] Montpellier Supagro, UMR Selmet, Campus Int Baillarguet, F-34398 Montpellier, France	CIRAD; INRAE; CIRAD; INRAE; Institut Agro; Montpellier SupAgro	Hammami, P (corresponding author), Ctr Cooperat Int Rech Agron Dev Cirad, UMR Controle Malad Anim Exot & Emergentes Cmaee, Campus Int Baillarguet, F-34398 Montpellier, France.; Hammami, P (corresponding author), INRA, UMR Cmaee 1309, Campus Int Baillarguet, F-34398 Montpellier, France.	pachka.hammami@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; Hammami, Pachka/0000-0002-7490-6257	Bill and Melinda Gates Foundation; OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	This study was conducted in the frame of the project "Vaccine Standard and Pilot Approach for the Progressive Control and Eradication of PPR in Africa" (VSPA), funded by the Bill and Melinda Gates Foundation, the OIE World Animal Health and Welfare Fund, and Cirad. Sheep demographic data were collected during the joint research programme "Pathologie et Productivite des Petits Ruminants" co-funded by the Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal), the Directorate of Veterinary Services (DSV, Dakar, Senegal), and Cirad.	Adams W, 2005, WORKING THE SAHEL; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Albina E, 2013, VET MICROBIOL, V165, P38, DOI 10.1016/j.vetmic.2012.12.013; ALSABBAGH TA, 1995, J ANIM SCI, V73, P2860; Alves AC, 2015, J DAIRY SCI, V98, P3706, DOI 10.3168/jds.2014-7992; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; [Anonymous], 2006, CARBON LAND WATER GL; [Anonymous], 2012, UNDP CLIMATE CHANGE; ATA FA, 1989, VET REC, V124, P590, DOI 10.1136/vr.124.22.590; Awa DN, 2002, PREV VET MED, V55, P265, DOI 10.1016/S0167-5877(02)00013-2; Bacaer N, 2009, B MATH BIOL, V71, P1781, DOI 10.1007/s11538-009-9426-6; Balamurugan Vinayagamurthy, 2012, Virologica Sinica, V27, P228, DOI 10.1007/s12250-012-3249-6; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Berg C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3985; Bidjeh Kebkiba, 1999, Cahiers Agricultures, V8, P219; Bodjo S.C., 2006, BIOKEMISTRI, V18, P99, DOI DOI 10.4314/BI0KEM.V18I2.56408; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caswell, 2000, MATRIX POPULATION MO; Collett D, 2003, C&H TEXT STAT SCI, P45; Coward C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004359; Davis CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059465; Delville PL, 2002, SOC NATURE SAHEL; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; Diallo A., 2003, VVolume 114, P113; El Arbi AS, 2014, EMERG INFECT DIS, V20, P334, DOI 10.3201/eid2002.131345; El-Yuguda AD, 2013, VET WORLD, V6, P807, DOI 10.14202/vetworld.2013.807-811; Ettair M, 2012, REMESA ATELIER CONJO; Farougou S, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.544; Faugere O, 1990, REV ELEV MED VET PAY, V43; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Haight R.G, 1989, POPULATION HARVESTIN, V27; Hashemi M, 2008, SMALL RUMINANT RES, V75, P204, DOI 10.1016/j.smallrumres.2007.11.002; Jones BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149982; KENT JP, 1995, BEHAV ECOL SOCIOBIOL, V36, P101, DOI 10.1007/BF00170714; KENT JP, 1992, BEHAV ECOL SOCIOBIOL, V30, P151, DOI 10.1007/BF00166697; Kihu SM, 2015, PASTORALISM, V5, DOI 10.1186/s13570-015-0029-6; Kihu SM, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0401-1; Kivaria FM, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.593; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; Lancelot R., 1998, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V51, P135; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lesnoff M, 1999, AGR SYST, V61, P207, DOI 10.1016/S0308-521X(99)00053-0; Lesnoff M, 2000, PREV VET MED, V46, P113, DOI 10.1016/S0167-5877(00)00139-2; Lesnoff M, 2015, ANIMAL, V9, P1888, DOI 10.1017/S175173111500124X; Lesnoff M, 2004, PREV VET MED, V62, P101, DOI 10.1016/j.prevetmed.2003.11.009; Lesnoff M, 2003, MATH COMPUT MODEL, V37, P945, DOI 10.1016/S0895-7177(03)00110-9; Lesnoff M, 2009, EPIDEMIOL INFECT, V137, P1405, DOI 10.1017/S0950268809002453; Lesnoff M, 2001, REV ELEV MED VET PAY, V54; Lesnoff M, 2014, CALCULATION DEMOGRAP, P41; Lesnoff M, 2000, THESIS; Lesnoff M, 2011, QUAE; Lesnoff M, 2010, TROP ANIM HEALTH PRO, V42, P1155, DOI 10.1007/s11250-010-9540-3; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Matser A, 2009, ECOL LETT, V12, P1298, DOI 10.1111/j.1461-0248.2009.01378.x; McCullagh P, 1989, GEN LINEAR MODELS; Mopate L. Y., 2014, Open Journal of Animal Sciences, V4, P175; Moulin CH, 1993, THESIS; Nantoume H., 2011, Livestock Research for Rural Development, V23, P110; NAPIER KM, 1974, J REPROD FERTIL, V39, P391, DOI 10.1530/jrf.0.0390391; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Nowak R, 2006, REPROD NUTR DEV, V46, P431, DOI 10.1051/rnd:2006023; Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997; OIE FAO, 2015, GLOB STRAT CONTR ERR; PLOWRIGHT W, 1969, RES VET SCI, V10, P373; Roeder P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0139; Rousseau R, 1954, INFORM GEOGRAPHIQUE, V18, P68, DOI [10.3406/ingeo.1954.1368, DOI 10.3406/INGEO.1954.1368]; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Sarr J, 1994, RES COORD M FAO AEA, P195; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Sow A, 2008, REV ELEV MED VET PAY, V61; STEM C, 1993, PREV VET MED, V16, P141, DOI 10.1016/0167-5877(93)90084-7; Texeira M, 2008, ECOL MODEL, V217, P197, DOI 10.1016/j.ecolmodel.2008.06.027; The R Core Team, 2015, R LANG ENV STAT COMP, P3366; Thombare N.N., 2009, AGR EC RES REV, V22, P319, DOI 10.22004/ag.econ.57469; Trabucco A, 2009, CGIAR CONSORT SPATIA; Tuljapurkar S., 1997, STRUCTURED POPULATIO, V18; Zahur AB, 2009, PAK VET J, V29, P174; Zahur A.B., 2014, J BIOSCI MED, V2, P27, DOI DOI 10.4236/JBM.2014.26005	81	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161769	10.1371/journal.pone.0161769	http://dx.doi.org/10.1371/journal.pone.0161769			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603710	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200025
J	Zhai, HC; Gong, WK; Tan, YN; Liu, AY; Song, WW; Li, JW; Deng, ZY; Kong, LL; Gong, JW; Shang, HH; Chen, TT; Ge, Q; Shi, YZ; Yuan, YL				Zhai, Huanchen; Gong, Wankui; Tan, Yunna; Liu, Aiying; Song, Weiwu; Li, Junwen; Deng, Zhuying; Kong, Linglei; Gong, Juwu; Shang, Haihong; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu			Identification of Chromosome Segment Substitution Lines of Gossypium barbadense Introgressed in G. hirsutum and Quantitative Trait Locus Mapping for Fiber Quality and Yield Traits	PLOS ONE			English	Article							UPLAND COTTON CULTIVARS; DENSITY LINKAGE MAP; QTL ANALYSIS; LYCOPERSICON PENNELLII; MORPHOLOGICAL TRAITS; GENOME SEQUENCE; L.; CONSTRUCTION; IMPROVEMENT; POPULATION	Chromosome segment substitution lines MBI9804, MBI9855, MBI9752, and MBI9134, which were obtained by advanced backcrossing and continuously inbreeding from an interspecific cross between CCRI36, a cultivar of upland cotton (Gossypium hirsutum) as the recurrent parent, and Hai1, a cultivar of sea island cotton (G. barbadense) as the donor parent, were used to construct a multiple parent population of (MBI9804xMBI9855)x(M-BI9752xMBI9134). The segregating generations of double-crossed F-1 and F-2 and F-2:3 were used to map the quantitative trait locus (QTL) for fiber quality and yield-related traits. The recovery rate of the recurrent parent CCRI36 in the four parental lines was from 94.3%-96.9%. Each of the parental lines harbored 12-20 introgressed segments from Hai1across 21 chromosomes. The number of introgressed segments ranged from 1 to 27 for the individuals in the three generations, mostly from 9 to 18, which represented a genetic length of between 126 cM and 246 cM. A total of 24 QTLs controlling fiber quality and 11 QTLs controlling yield traits were detected using the three segregating generations. These QTLs were distributed across 11 chromosomes and could collectively explain 1.78%-20.27% of the observed phenotypic variations. Sixteen QTLs were consistently detected in two or more generations, four of them were for fiber yield traits and 12 were for fiber quality traits. One introgressed segment could significantly reduce both lint percentage and fiber micronaire. This study provides useful information for gene cloning and marker-assisted breeding for excellent fiber quality.	[Zhai, Huanchen; Gong, Wankui; Tan, Yunna; Liu, Aiying; Song, Weiwu; Li, Junwen; Deng, Zhuying; Kong, Linglei; Gong, Juwu; Shang, Haihong; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton, Inst Cotton Res,Minist Agr, Anyang, Henan, Peoples R China; [Zhai, Huanchen] Henan Univ Technol, Coll Bioengn, Zhengzhou, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Henan University of Technology	Shi, YZ; Yuan, YL (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton, Inst Cotton Res,Minist Agr, Anyang, Henan, Peoples R China.	shiyzmb@126.com; youluyuan@hotmail.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31101188]; National High Technology Research and Development Program of China [2012AA101108]; National Basic Research Program of China (973 Project) [2010CB126000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Project)(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (31101188) to YZS, the National High Technology Research and Development Program of China (2012AA101108) to YLY, and the National Basic Research Program of China (973 Project) (2010CB126000) to YLY.	Cao ZB, 2014, THEOR APPL GENET, V127, P587, DOI 10.1007/s00122-013-2241-3; Clement JD, 2012, FIELD CROP RES, V128, P1, DOI 10.1016/j.fcr.2011.12.002; ESHED Y, 1995, GENETICS, V141, P1147; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; He Rui, 2014, Acta Agronomica Sinica, V40, P457; Jenkins JN, 2006, CROP SCI, V46, P1169, DOI 10.2135/cropsci2005.08-0269; Jenkins JN, 2007, CROP SCI, V47, P561, DOI 10.2135/cropsci2006.06.0396; Jenkins JN, 2012, EUPHYTICA, V187, P161, DOI 10.1007/s10681-011-0580-1; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2005, J HERED, V96, P441, DOI 10.1093/jhered/esi052; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li L, 2008, THESIS; Li XN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00432; Liang Yan, 2010, Molecular Plant Breeding, V8, P221; Liu JY, 2000, ACTA BOT SIN, V42, P991; Liu QM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127938; Ma LiuJun, 2013, Cotton Science, V25, P486; McCarty JC, 2006, EUPHYTICA, V152, P99, DOI 10.1007/s10681-006-9183-7; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Percy RG, 2006, CROP SCI, V46, P1311, DOI 10.2135/cropsci2005.08-0284; REINISCH AJ, 1994, GENETICS, V138, P829; Saha S, 2008, PLANT BREEDING, V127, P612, DOI 10.1111/j.1439-0523.2008.01532.x; Saha S, 2006, GENETICS, V172, P1927, DOI 10.1534/genetics.105.053371; Saha S, 2010, THEOR APPL GENET, V120, P1193, DOI 10.1007/s00122-009-1247-3; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Smith CW, 1997, CROP SCI, V37, P1775, DOI 10.2135/cropsci1997.0011183X003700060019x; Song XL, 2005, GENOME, V48, P378, DOI 10.1139/G04-126; Stelly DM, 2005, CROP SCI, V45, P2663, DOI 10.2135/cropsci2004.0642; Sun QA, 2010, MOL BIOL REP, V37, P3319, DOI 10.1007/s11033-009-9918-3; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan XY, 2008, GENETICS, V179, P2239, DOI 10.1534/genetics.108.089862; Wang B, 2012, THEOR APPL GENET, V125, P1263, DOI 10.1007/s00122-012-1911-x; Wang HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130742; Wang JK, 2006, GENET RES, V88, P93, DOI 10.1017/S0016672306008408; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; [王为 WANG Wei], 2009, [棉花学报, Cotton Science], V21, P394; Xu ZZ, 2015, PLANT CELL REP, V34, P1177, DOI 10.1007/s00299-015-1776-y; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JZ, 2014, MOL GENET GENOMICS, V289, P1347, DOI 10.1007/s00438-014-0930-5; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; Zhang JF, 2014, EUPHYTICA, V198, P1, DOI 10.1007/s10681-014-1094-4; [张金凤 Zhang Jinfeng], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P773; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhu Y, 2010, J NANOMATER, V2010, P8	58	24	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0159101	10.1371/journal.pone.0159101	http://dx.doi.org/10.1371/journal.pone.0159101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603312	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200002
J	Zhao, W; Yao, F; Zhang, MC; Jing, T; Zhang, S; Hou, L; Zou, XY				Zhao, Wei; Yao, Feng; Zhang, Mengchen; Jing, Ting; Zhang, Shuang; Hou, Lin; Zou, Xiangyang			The Potential Roles of the G1LEA and G3LEA Proteins in Early Embryo Development and in Response to Low Temperature and High Salinity in Artemia sinica	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; LEA PROTEINS; DESICCATION TOLERANCE; BRINE SHRIMP; GENE; STRESS; MITOCHONDRIA; EXPRESSION; MOTIF; ACTS	Late embryogenesis abundant proteins (LEA) are stress resistance-related proteins that play crucial roles in protecting against desiccation, cold and high salinity in a variety of animals and plants. However, the expression pattern, distribution and functions of LEA proteins in the post-diapause period of Artemia sinica, and under high salinity and low temperature stresses, remain unknown. In this study, the complete cDNA sequences of the group 1 LEA (As-g1lea) and group 3 LEA (As-g3lea) genes from A. sinica were cloned. The expression patterns and location of As-G1LEA and As-G1LEA were investigated. The protein abundances of As-G1LEA, As-G3LEA and Trehalase were analyzed during different developmental stages of the embryo and under low temperature and high salinity stresses in A. sinica. The full-length cDNA of As-g1lea was 960 bp, encoding a 182 amino acid protein, and As-g3lea was 2089 bp, encoding a 364 amino acid protein. As-g1lea and As-g3lea showed their highest expressions at 0 h of embryonic development and both showed higher relative expression in embryonic, rather than adult, development stages. The abundances of As-G1LEA, As-G3LEA and trehalose were upregulated under low temperature and downregulated under high salinity stress. These two genes did not show any tissue or organ specific expression. Our results suggested that these LEA proteins might play a pivotal role in stress tolerance in A. sinica	[Zhao, Wei; Yao, Feng; Zhang, Mengchen; Jing, Ting; Zhang, Shuang; Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China; [Zou, Xiangyang] Dalian Med Univ, Dept Biol, Dalian, Peoples R China	Liaoning Normal University; Dalian Medical University	Hou, L (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China.; Zou, XY (corresponding author), Dalian Med Univ, Dept Biol, Dalian, Peoples R China.	houlin@lnnu.edu.cn; zouxiangyang@126.com			National Natural Science Foundation of China [31272644, 31572607]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (31272644, 31572607).; This work was supported by grants from the National Natural Science Foundation of China [grant numbers 31272644, 31572607].	ANDERSON E, 1970, J ULTRA MOL STRUCT R, V32, P497, DOI 10.1016/S0022-5320(70)80025-9; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Chu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085343; Clegg James S., 2002, P129; Conte FP, 2007, INT REV CYTOL, V91, P46; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Eom JW, 1996, PLANT SCI, V115, P17, DOI 10.1016/0168-9452(96)04332-4; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hatanaka R, 2013, INSECT BIOCHEM MOLEC, V43, P1055, DOI 10.1016/j.ibmb.2013.08.004; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; Jiang LJ, 2007, ACTA BIOCH BIOPH SIN, V39, P351, DOI 10.1111/j.1745-7270.2007.00287.x; Kuenen D. J., 1938, Zoologische Mededeelingen Leiden, V20, P222; Liu Yun, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P569; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Manfre AJ, 2006, PLANT PHYSIOL, V140, P140, DOI 10.1104/pp.105.072967; Menze Michael A., 2009, Communicative & Integrative Biology, V2, P428; Menze MA, 2009, J BIOL CHEM, V284, P10714, DOI 10.1074/jbc.C900001200; Moore DS, 2016, CRYOBIOLOGY, V73, P240, DOI 10.1016/j.cryobiol.2016.07.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Tompa K, 2012, Methods Mol Biol, V895, P167, DOI 10.1007/978-1-61779-927-3_13; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Wolkers WF, 2011, BIOCHIM BIOPHYS ACTA, V1544, P196	39	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162272	10.1371/journal.pone.0162272	http://dx.doi.org/10.1371/journal.pone.0162272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603306	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255200052
J	Boudreault, S; Martenon-Brodeur, C; Caron, M; Garant, JM; Tremblay, MP; Armero, VES; Durand, M; Lapointe, E; Thibault, P; Tremblay-Letourneau, M; Perreault, JP; Scott, MS; Lemay, G; Bisaillon, M				Boudreault, Simon; Martenon-Brodeur, Camille; Caron, Marie; Garant, Jean-Michel; Tremblay, Marie-Pier; Armero, Victoria E. S.; Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Lemay, Guy; Bisaillon, Martin			Global Profiling of the Cellular Alternative RNA Splicing Landscape during Virus-Host Interactions	PLOS ONE			English	Article							REOVIRUS REPLICATION; GENE-EXPRESSION; NUCLEAR EXPORT; PROTEIN; IDENTIFICATION; INHIBITION; APOPTOSIS; ICP27; CYCLE; TRANSCRIPTOME	Alternative splicing (AS) is a central mechanism of genetic regulation which modifies the sequence of RNA transcripts in higher eukaryotes. AS has been shown to increase both the variability and diversity of the cellular proteome by changing the composition of resulting proteins through differential choice of exons to be included in mature mRNAs. In the present study, alterations to the global RNA splicing landscape of cellular genes upon viral infection were investigated using mammalian reovirus as a model. Our study provides the first comprehensive portrait of global changes in the RNA splicing signatures that occur in eukaryotic cells following infection with a human virus. We identify 240 modified alternative splicing events upon infection which belong to transcripts frequently involved in the regulation of gene expression and RNA metabolism. Using mass spectrometry, we also confirm modifications to transcript-specific peptides resulting from AS in virus-infected cells. These findings provide additional insights into the complexity of virus-host interactions as these splice variants expand proteome diversity and function during viral infection.	[Boudreault, Simon; Martenon-Brodeur, Camille; Caron, Marie; Garant, Jean-Michel; Tremblay, Marie-Pier; Armero, Victoria E. S.; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Bisaillon, Martin] Univ Sherbrooke, Fac Med Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada; [Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe] Univ Sherbrooke, Lab Genom Fonct, Sherbrooke, PQ J1E 4K8, Canada; [Lemay, Guy] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Montreal	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada.	Martin.Bisaillon@USherbrooke.ca	Garant, Jean-Michel/AAA-1692-2019	Garant, Jean-Michel/0000-0002-0559-5598	Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada; FRQ-S; Universite de Sherbrooke Research Chair in Structure and Genomic RNA	Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); FRQ-S; Universite de Sherbrooke Research Chair in Structure and Genomic RNA	This work was supported by grants from the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (MB and JPP), the Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke (MB and JPP), and the Natural Sciences and Engineering Research Council of Canada (GL). JPP holds the Universite de Sherbrooke Research Chair in Structure and Genomic RNA. MB is a Chercheur-boursier Senior from the Fonds de recherche du Quebec-Sante (FRQ-S), and SB holds graduate training awards from the FRQ-S and Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akusjarvi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5006, DOI 10.2741/3059; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Alvarez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073723; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauman John A, 2011, Bioeng Bugs, V2, P125; Bergeron J, 1998, VIROLOGY, V246, P199, DOI 10.1006/viro.1998.9188; Biamonti G, 2014, SEMIN CELL DEV BIOL, V32, P30, DOI 10.1016/j.semcdb.2014.03.016; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boehme KW, 2013, J VIROL, V87, P12967, DOI 10.1128/JVI.02080-13; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brosseau JP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1287; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Chakrabarty R, 2015, INVEST NEW DRUG, V33, P761, DOI 10.1007/s10637-015-0216-8; Clements D, 2014, ONCOLYTIC VIROTHER, V3, P69, DOI 10.2147/OV.S51321; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DANIS C, 1993, BIOCHEM CELL BIOL, V71, P81, DOI 10.1139/o93-012; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Germann S, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/269570; Gong J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00167; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hoyt CC, 2004, J VIROL, V78, P6360, DOI 10.1128/JVI.78.12.6360-6369.2004; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; Kohl C, 2015, BATS VIRUSES NEW FRO, P203; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301; Lu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059092; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; McCormick AL, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P324; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Okoro Danielle R, 2012, Genes Cancer, V3, P311, DOI 10.1177/1947601912455323; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Ooms LS, 2012, J VIROL, V86, P10979, DOI 10.1128/JVI.01172-12; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Pimienta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124638; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; REISSIG M, 1956, J EXP MED, V104, P289, DOI 10.1084/jem.104.3.289; Rudd P, 2005, J GEN VIROL, V86, P1489, DOI 10.1099/vir.0.80628-0; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sandekian V, 2015, VIROLOGY, V483, P229, DOI 10.1016/j.virol.2015.04.020; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43; Tyler KL, 2001, TRENDS MICROBIOL, V9, P560, DOI 10.1016/S0966-842X(01)02103-5; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Yang D., 2009, RNA VIRUSES HOST GEN; Yue ZY, 1996, J VIROL, V70, P3497, DOI 10.1128/JVI.70.6.3497-3501.1996; Zhu YF, 2014, MOL CELL PROTEOMICS, V13, P1552, DOI 10.1074/mcp.M113.031203; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	85	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161914	10.1371/journal.pone.0161914	http://dx.doi.org/10.1371/journal.pone.0161914			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598998	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800024
J	Goemans, NM; Tulinius, M; van den Hauwe, M; Kroksmark, AK; Buyse, G; Wilson, RJ; van Deutekom, JC; de Kimpe, SJ; Lourbakos, A; Campion, G				Goemans, Nathalie M.; Tulinius, Mar; van den Hauwe, Marleen; Kroksmark, Anna-Karin; Buyse, Gunnar; Wilson, Rosamund J.; van Deutekom, Judith C.; de Kimpe, Sjef J.; Lourbakos, Afrodite; Campion, Giles			Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study	PLOS ONE			English	Article							6-MINUTE WALK TEST; ANTISENSE OLIGONUCLEOTIDE; DISEASE PROGRESSION; EXPRESSION; DELETIONS; CHILDREN	Background Drisapersen induces exon 51 skipping during dystrophin pre-mRNA splicing and allows synthesis of partially functional dystrophin in Duchenne muscular dystrophy (DMD) patients with amenable mutations. Methods This 188-week open-label extension of the dose-escalation study assessed the long-term efficacy, safety, and pharmacokinetics of drisapersen (PRO051/GSK2402968), 6 mg/kg subcutaneously, in 12 DMD subjects. Dosing was once weekly for 72 weeks. All subjects had a planned treatment interruption (weeks 73-80), followed by intermittent dosing (weeks 81-188). Results Subjects received a median (range) total dose of 5.93 (5.10 to 6.02) mg/kg drisapersen. After 177 weeks (last efficacy assessment), median (mean [SD]) six-minute walk distance (6MWD) improved by 8 (-24.5 [161]) meters for the 10 subjects able to complete the 6MWD at baseline (mean age [SD]: 9.5 [1.9] years). These statistics include 2 subjects unable to complete the test at later visits and who scored "zero". When only the 8 ambulant subjects at week 177 were taken into account, a median (mean [SD]) increase of 64 (33 [121]) meters in 6MWD was observed. Of 7 subjects walking >= 330 m at extension baseline, 5 walked farther at week 177. Of 3 subjects walking <330 m, 2 lost ambulation, while 1 declined overall but walked farther at some visits. Over the 188 weeks, the most common adverse events were injection-site reactions, raised urinary alpha(1)-microglobulin and proteinuria. Dystrophin expression was detected in all muscle biopsies obtained at week 68 or 72. Conclusion Drisapersen was generally well tolerated over 188 weeks. Possible renal effects, thrombocytopenia and injection-site reactions warrant continued monitoring. Improvements in the 6MWD at 12 weeks were sustained after 3.4 years of dosing for most patients. For a small, uncontrolled study, the outcomes are encouraging, as natural history studies would anticipate a decline of over 100 meters over a 3-year period in a comparable cohort.	[Goemans, Nathalie M.; van den Hauwe, Marleen; Buyse, Gunnar] Univ Hosp Leuven, Leuven, Belgium; [Tulinius, Mar; Kroksmark, Anna-Karin] Univ Gothenburg, Gothenburg, Sweden; [Wilson, Rosamund J.] Spica Consultants Ltd, Marlborough, Wilts, England; [van Deutekom, Judith C.; de Kimpe, Sjef J.; Lourbakos, Afrodite; Campion, Giles] BioMarin Pharmaceut Inc, Leiden, Netherlands	KU Leuven; University Hospital Leuven; University of Gothenburg	Goemans, NM (corresponding author), Univ Hosp Leuven, Leuven, Belgium.	nathalie.goemans@uzleuven.be			Prosensa Therapeutics BV, Leiden, Netherlands; GlaxoSmithKline, Middlesex, UK; Prosensa Therapeuics BV; GlaxoSmithKline; BioMarin Pharmaceutical Inc., Leiden, The Netherlands; Spica Consultants Ltd, Marlborough, UK	Prosensa Therapeutics BV, Leiden, Netherlands; GlaxoSmithKline, Middlesex, UK(GlaxoSmithKline); Prosensa Therapeuics BV; GlaxoSmithKline(GlaxoSmithKline); BioMarin Pharmaceutical Inc., Leiden, The Netherlands(Netherlands Government); Spica Consultants Ltd, Marlborough, UK	This study was sponsored by Prosensa Therapeutics BV, Leiden, Netherlands until 21 July 2011; subsequently, GlaxoSmithKline, Middlesex, UK, sponsored the study until the data cut reported here. This work was performed collaboratively by University Hospitals Leuven, University of Gothenburg, and Prosensa Therapeutics BV, GlaxoSmithKline and BioMarin Pharmaceutical Inc. researchers. None of the contributing authors listed on this paper were affiliated with GlaxoSmithKline at the time of the study. Prosensa Therapeuics BV provided support in the form of salaries and/or research materials for authors (JCvD, SJdK, AL, GVC, NMG), the study design, data collection, data analysis and in the preparation of the manuscript. GlaxoSmithKline provided support in the form of salaries and/or research materials for non-author collaborators (stated in the acknowledgements), the study design, data collection, data analysis and in the preparation of the manuscript. BioMarin Pharmaceutical Inc., Leiden, The Netherlands, provided support in the form of salaries and/or research materials for authors (JCvD, SJdK, AL, GVC), the data collection and analysis, and in the decision to publish, or preparation of the manuscript. Spica Consultants Ltd, Marlborough, UK, provided support in the form of salaries (RJW) and data analysis and preparation of the manuscript, but did not play a role in the study design and data collection. The specific roles of these authors are articulated in the "Author Contributions" section.; This study was supported by Prosensa Therapeutics BV, Leiden, Netherlands and GlaxoSmithkline, GSK House, Brentford, UK. We take full responsibility for the content of the paper but thank Caudex Medical, Oxford, UK, supported by Prosensa Therapeutics BV for assistance in preparing the outline and initial draft of the manuscript. The authors would like to thank all non-author collaborators including John E. Kraus (GlaxoSmithKline, London, UK), Pauline Bedwell (Prosensa Therapeutics BV), Ad Sitsen (Prosensa Therapeutics BV) and Allison Morgan (Prosensa Therapeutics BV). The authors also wish to acknowledge Shaun Jones and Claire Wardell (Prosensa Therapeutics BV) for critical review of the manuscript, and Padraig Wright (formerly of GlaxoSmithKline) for critical review of earlier drafts of this manuscript. Gunnar Buyse is Senior Clinical Investigator of the Research Foundation-Flanders (FWO Vlaanderen, Belgium). We would like to thank Ismar Healthcare for their support with editing of the manuscript, which was funded by BioMarin Pharmaceutical Inc.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; Braun S, 2000, GENE THER, V7, P1447, DOI 10.1038/sj.gt.3301261; Brolin Camilla, 2011, Artif DNA PNA XNA, V2, P6; Bushby Kate, 2011, Clin Investig (Lond), V1, P1217; Buyse GM, 2015, LANCET, V385, P1748, DOI 10.1016/S0140-6736(15)60025-3; Domenech-Clar R, 2003, PEDIATR PULM, V35, P126, DOI 10.1002/ppul.10217; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Ellis JA, 2013, NEUROMUSCULAR DISORD, V23, P682, DOI 10.1016/j.nmd.2013.05.008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Goemans N, 2013, NEUROMUSCULAR DISORD, V23, P618, DOI 10.1016/j.nmd.2013.05.006; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Hammond SM, 2010, CURR OPIN MOL THER, V12, P478; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013; Henricson E, 2013, PLOS CURR, V5; Henricson Erik, 2012, PLoS Curr, V3, pRRN1297, DOI 10.1371/currents.RRN1297; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Khirani S, 2014, PEDIATR PULM, V49, P473, DOI 10.1002/ppul.22847; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mayer OH, 2015, PEDIATR PULM, V50, P487, DOI 10.1002/ppul.23172; Mazzone E, 2011, NEUROLOGY, V77, P250, DOI 10.1212/WNL.0b013e318225ab2e; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; Mcdonald CM, 2013, MUSCLE NERVE, V48, P343, DOI 10.1002/mus.23902; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mendell JR, 2013, MUSCLE NERVE, V48, P21, DOI 10.1002/mus.23810; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Pane M, 2014, NEUROMUSCULAR DISORD, V24, P201, DOI 10.1016/j.nmd.2013.11.014; QUANJER PH, 1989, EUR RESPIR J, V2, pS184; Roberto R, 2011, SPINE, V36, pE1009, DOI 10.1097/BRS.0b013e3181fea1ed; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Ommen GJ, 2008, CURR OPIN MOL THER, V10, P140; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Wu B, 2014, GENE THER, V21, P785, DOI 10.1038/gt.2014.53	42	75	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161955	10.1371/journal.pone.0161955	http://dx.doi.org/10.1371/journal.pone.0161955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588424	Green Published, gold			2022-12-27	WOS:000382877800025
J	Burley, SD; Whittingham-Dowd, J; Allen, J; Grosset, JF; Onambele-Pearson, GL				Burley, Simon D.; Whittingham-Dowd, Jayde; Allen, Jeremy; Grosset, Jean-Francois; Onambele-Pearson, Gladys L.			The Differential Hormonal Milieu of Morning versus Evening May Have an Impact on Muscle Hypertrophic Potential	PLOS ONE			English	Article							HEAVY-RESISTANCE EXERCISE; FACTOR BINDING PROTEIN-3; CIRCADIAN-RHYTHMS; SKELETAL-MUSCLE; NUTRITIONAL SUPPLEMENTATION; MUSCULAR PERFORMANCE; BODY-TEMPERATURE; IGF-I; RESPONSES; GROWTH	Substantial gains in muscle strength and hypertrophy are clearly associated with the routine performance of resistance training. What is less evident is the optimal timing of the resistance training stimulus to elicit these significant functional and structural skeletal muscle changes. Therefore, this investigation determined the impact of a single bout of resistance training performed either in the morning or evening upon acute anabolic signalling (insulinlike growth factor-binding protein-3 (IGFBP-3), myogenic index and differentiation) and catabolic processes (cortisol). Twenty-four male participants (age 21.4 +/- 1.9yrs, mass 83.7 +/- 13.7kg) with no sustained resistance training experience were allocated to a resistance exercise group (REP). Sixteen of the 24 participants were randomly selected to perform an additional non-exercising control group (CP) protocol. REP performed two bouts of resistance exercise (80% 1RM) in the morning (AM: 0800 hrs) and evening (PM: 1800 hrs), with the sessions separated by a minimum of 72 hours. Venous blood was collected immediately prior to, and 5 min after, each resistance exercise and control sessions. Serum cortisol and IGFBP-3 levels, myogenic index, myotube width, were determined at each sampling period. All data are reported as mean +/- SEM, statistical significance was set at P <= 0.05. As expected a significant reduction in evening cortisol concentration was observed at pre (AM: 98.4 +/- 10.5, PM: 49.8 +/- 4.4 ng/ml, P<0.001) and post (AM: 98.0 +/- 9.0, PM: 52.7 +/- 6.0 ng/ml, P<0.001) exercise. Interestingly, individual cortisol differences pre vs post exercise indicate a time-of-day effect (AM difference:-2 +/- 2.6%, PM difference: 14.0 +/- 6.7%, P = 0.03). A time-of-day related elevation in serum IGFBP-3 (AM: 3274.9 +/- 345.2, PM: 3605.1 +/- 367.5, p = 0.032) was also evident. Pre exercise myogenic index (AM: 8.0 +/- 0.6%, PM: 16.8 +/- 1.1%) and myotube width (AM: 48.0 +/- 3.0, PM: 71.6 +/- 1.9 mu m) were significantly elevated (P<0.001) in the evening. Post exercise myogenic index was greater AM (11.5 +/- 1.6%) compared with PM (4.6 +/- 0.9%). No difference was observed in myotube width (AM: 48.5 +/- 1.5, PM: 47.8 +/- 1.8 mu m) (P> 0.05). Timing of resistance training regimen in the evening appears to augment some markers of hypertrophic potential, with elevated IGFBP-3, suppressed cortisol and a superior cellular environment. Further investigation, to further elucidate the time course of peak anabolic signalling in morning vs evening training conditions, are timely.	[Burley, Simon D.; Grosset, Jean-Francois; Onambele-Pearson, Gladys L.] Manchester Metropolitan Univ, HEAL Res Ctr, Exercise & Sport Sci, Crewe Green Rd, Crewe CW1 5DU, England; [Whittingham-Dowd, Jayde] Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Allen, Jeremy] Univ Salford, Sch Hlth Sport & Rehabil Sci, Salford M5 4WT, Greater Manches, England; [Grosset, Jean-Francois] Univ Technol Compiegne, Biomecan & Bioingn, CNRS, UMR 7338, F-60205 Compiegne, France	Manchester Metropolitan University; University of Manchester; University of Salford; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Picardie Universites; Universite de Technologie de Compiegne	Onambele-Pearson, GL (corresponding author), Manchester Metropolitan Univ, HEAL Res Ctr, Exercise & Sport Sci, Crewe Green Rd, Crewe CW1 5DU, England.	g.pearson@mmu.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Grosset, Jean-Francois/AFY-2470-2022	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Whittingham-Dowd, Jayde/0000-0002-7939-6081; Grosset, Jean-Francois/0000-0003-4509-0778				Ahtiainen JP, 2003, EUR J APPL PHYSIOL, V89, P555, DOI 10.1007/s00421-003-0833-3; ATKINSON G, 1993, ERGONOMICS, V36, P273, DOI 10.1080/00140139308967882; Bermon S, 1999, ACTA PHYSIOL SCAND, V165, P51; Bird SP, 2004, CHRONOBIOL INT, V21, P131, DOI 10.1081/CBI-120027987; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2003, J PHYSIOL-LONDON, V553, P213, DOI 10.1113/jphysiol.2003.047019; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Callard D, 2000, CHRONOBIOL INT, V17, P693, DOI 10.1081/CBI-100101075; Carrier J, 2000, CHRONOBIOL INT, V17, P719, DOI 10.1081/CBI-100102108; DINNEEN S, 1993, J CLIN INVEST, V92, P2283, DOI 10.1172/JCI116832; Dreyer HC, 2006, J PHYSIOL-LONDON, V576, P613, DOI 10.1113/jphysiol.2006.113175; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forsling ML, 1998, EXP PHYSIOL, V83, P409, DOI 10.1113/expphysiol.1998.sp004124; Foulstone EJ, 2003, J CELL PHYSIOL, V195, P70, DOI 10.1002/jcp.10227; Gauthier A, 1996, CHRONOBIOL INT, V13, P135, DOI 10.3109/07420529609037077; HACK CE, 1989, BLOOD, V74, P1704; Hawley JA, 2004, EXERC SPORT SCI REV, V32, P4, DOI 10.1097/00003677-200401000-00002; Hayes LD, 2010, CHRONOBIOL INT, V27, P675, DOI 10.3109/07420521003778773; Juul A, 1998, J CLIN ENDOCR METAB, V83, P4408, DOI 10.1210/jc.83.12.4408; Kahn SM, 2002, J ENDOCRINOL, V175, P113, DOI 10.1677/joe.0.1750113; Komi PV, 2000, J BIOMECH, V33, P1197, DOI 10.1016/S0021-9290(00)00064-6; Koziris LP, 1999, J APPL PHYSIOL, V86, P1436, DOI 10.1152/jappl.1999.86.4.1436; KRAEMER RR, 1993, J SPORT MED PHYS FIT, V33, P246; Kraemer WJ, 2004, MED SCI SPORT EXER, V36, P674, DOI 10.1249/01.MSS.0000121945.36635.61; Kraemer WJ, 2003, J STRENGTH COND RES, V17, P455; KRAEMER WJ, 1993, J APPL PHYSIOL, V75, P594, DOI 10.1152/jappl.1993.75.2.594; KRAEMER WJ, 1990, J APPL PHYSIOL, V69, P1442, DOI 10.1152/jappl.1990.69.4.1442; Kraemer WJ, 1998, J APPL PHYSIOL, V85, P1544, DOI 10.1152/jappl.1998.85.4.1544; KRIEGER DT, 1971, J CLIN ENDOCR METAB, V32, P266, DOI 10.1210/jcem-32-2-266; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; MELHIM AF, 1993, INT J SPORTS MED, V14, P303, DOI 10.1055/s-2007-1021182; Nindl BC, 2001, J APPL PHYSIOL, V90, P1319, DOI 10.1152/jappl.2001.90.4.1319; Pearson SJ, 2005, CHRONOBIOL INT, V22, P1013, DOI 10.1080/07420520500397900; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Pledge D, 2011, CYTOKINE, V55, P318, DOI 10.1016/j.cyto.2011.05.005; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Reilly T, 1983, Br J Sports Med, V17, P128; REILLY T, 1990, CHRONOBIOL INT, V7, P59, DOI 10.3109/07420529009056955; Reilly T, 1982, BRIT J SPORTS MED, V16, P115; Reilly T, 2009, EUR J APPL PHYSIOL, V106, P321, DOI 10.1007/s00421-009-1066-x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; RUDOLF MCJ, 1991, AM J DIS CHILD, V145, P769; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sedliak M, 2008, J SPORT SCI, V26, P1005, DOI 10.1080/02640410801930150; Sedliak M, 2009, J STRENGTH COND RES, V23, P2451, DOI 10.1519/JSC.0b013e3181bb7388; Smilios I, 2003, MED SCI SPORT EXER, V35, P644, DOI 10.1249/01.MSS.0000058366.04460.5F; Souissi N, 2002, J SPORT SCI, V20, P929, DOI 10.1080/026404102320761813; STEPHENSON LA, 1989, EUR J APPL PHYSIOL O, V58, P756, DOI 10.1007/BF00637388; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Uchida MC, 2009, J STRENGTH COND RES, V23, P2003, DOI 10.1519/JSC.0b013e3181b73bf7; West DWD, 2010, INT J BIOCHEM CELL B, V42, P1371, DOI 10.1016/j.biocel.2010.05.012; West DWD, 2013, MED SCI SPORTS EXERC, P2044; Williams AG, 2002, EUR J APPL PHYSIOL, V86, P315, DOI 10.1007/s00421-001-0536-6; WYSE JP, 1994, BRIT J SPORT MED, V28, P167, DOI 10.1136/bjsm.28.3.167; Zafeiridis A, 2003, J APPL PHYSIOL, V94, P591, DOI 10.1152/japplphysiol.00330.2002	58	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161500	10.1371/journal.pone.0161500	http://dx.doi.org/10.1371/journal.pone.0161500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583459	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000382855600035
J	Chen, GM; Lix, L; Tu, K; Hemmelgarn, BR; Campbell, NRC; McAlister, FA; Quan, H				Chen, Guanmin; Lix, Lisa; Tu, Karen; Hemmelgarn, Brenda R.; Campbell, Norm R. C.; McAlister, Finlay A.; Quan, Hude		Hypertension Outcome Surveillance	Influence of Using Different Databases and 'Look Back' Intervals to Define Comorbidity Profiles for Patients with Newly Diagnosed Hypertension: Implications for Health Services Researchers	PLOS ONE			English	Article							ICD-10 ADMINISTRATIVE DATA; CHRONIC DISEASE SCORE; MEDICARE CLAIMS; RISK; PERFORMANCE; ADJUSTMENT; CHARLSON; ELIXHAUSER; MORTALITY; VALIDITY	Objective To determine the data sources and 'look back' intervals to define comorbidities. Data Sources Hospital discharge abstracts database (DAD), physician claims, population registry and death registry from April 1, 1994 to March 31, 2010 in Alberta, Canada. Study Design Newly-diagnosed hypertension cases from 1997 to 2008 fiscal years were identified and followed up to 12 years. We defined comorbidities using data sources and duration of retrospective observation (6 months, 1 year, 2 years, and 3 years). The C-statistics for logistic regression and concordance index (CI) for Cox model of mortality and cardiovascular disease hospitalization were used to evaluate discrimination performance for each approach of defining comorbidities. Principal Findings The comorbidities prevalence became higher with a longer duration. Using DAD alone underestimated the prevalence by about 75%, compared to using both DAD and physicianclaims. The C-statistic and CI were highest when both DAD and physician claims were used, and model performance improved when observation duration increased from 6 months to one year or longer. Conclusion The comorbidities prevalence is greatly impacted by the data source and duration of retrospective observation. A combination of DAD and physicians claims with at least one year observation duration improves predictions for cardiovascular disease and one-year mortality outcome model performance.	[Chen, Guanmin; Hemmelgarn, Brenda R.; Campbell, Norm R. C.; Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Chen, Guanmin; Hemmelgarn, Brenda R.; Quan, Hude] Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada; [Lix, Lisa] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Tu, Karen] Univ Toronto, Dept Family & Community Med, ICES, Toronto, ON, Canada; [Hemmelgarn, Brenda R.; Campbell, Norm R. C.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Campbell, Norm R. C.] Univ Calgary, Dept Pharmacol & Therapeut, Calgary, AB, Canada; [McAlister, Finlay A.] Univ Alberta, Div Gen Internal Med, Edmonton, ON, Canada; [Chen, Guanmin] Alberta Hlth Serv, Res Facilitat, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Manitoba; University of Toronto; University of Calgary; University of Calgary; University of Alberta; Alberta Health Services (AHS); University of Calgary	Chen, GM (corresponding author), Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada.; Chen, GM (corresponding author), Univ Calgary, Inst Publ Hlth, Calgary, AB, Canada.; Chen, GM (corresponding author), Alberta Hlth Serv, Res Facilitat, Calgary, AB, Canada.	guchen@ucalgary.ca	Chen, Guanmin/AAN-4510-2020; McAlister, Finlay/C-4151-2013	Quan, Hude/0000-0002-7848-7256; McAlister, Finlay/0000-0001-7435-3341; Tu, Karen/0000-0003-0883-4934	Canadian Institutes of Health Research (CIHR) [MOP-125977]; Alberta Innovates - Health Solutions; Canadian Institute for Health Research; Roy and Vi Baay Chair in Kidney Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Roy and Vi Baay Chair in Kidney Research	This project was funded by Canadian Institutes of Health Research (CIHR, funding reference number: MOP-125977). H.Q. and F.M. salary support is from Alberta Innovates - Health Solutions. F.M. holds the University of Alberta Chair in Cardiac Outcomes Research. K.T. is supported by a Fellowship in Primary Care Research by the Canadian Institute for Health Research. N.C. holds the Heart and Stroke Foundation of Canada CIHR Chair in Hypertension Prevention and Control. B.H. is supported by the Roy and Vi Baay Chair in Kidney Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.Q. and F.M. salary support is from Alberta Innovates-Health Solutions, FM holds the University of Alberta Chair in Cardiac Outcomes Research, K.T. is supported from a Fellowship in Primary Care Research by the Canadian Institute for Health Research, N.C. holds the Heart and Stroke Foundation of Canada CIHR Chair in Hypertension Prevention and Control. B.H is supported by the Roy and Vi Baay Chair in Kidney Research.	Austin PC, 2012, ANN EPIDEMIOL, V22, P881, DOI 10.1016/j.annepidem.2012.09.011; CLARK DO, 1995, MED CARE, V33, P783, DOI 10.1097/00005650-199508000-00004; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; JOHNSON RE, 1994, J CLIN EPIDEMIOL, V47, P1191, DOI 10.1016/0895-4356(94)90106-6; Klabunde CN, 2006, MED CARE, V44, P921, DOI 10.1097/01.mlr.0000223480.52713.b9; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Leal JR, 2010, CLIN MICROBIOL INFEC, V16, P715, DOI 10.1111/j.1469-0691.2009.02867.x; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Lix LM, 2011, OSTEOPOROSIS INT, V22, P2633, DOI 10.1007/s00198-010-1516-7; Perkins AJ, 2004, J CLIN EPIDEMIOL, V57, P1040, DOI 10.1016/j.jclinepi.2004.03.002; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Quan HD, 2013, CAN J CARDIOL, V29, P592, DOI 10.1016/j.cjca.2012.12.016; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Radley DC, 2008, J CLIN EPIDEMIOL, V61, P580, DOI 10.1016/j.jclinepi.2007.08.001; Schneeweiss S, 2004, J GEN INTERN MED, V19, P444, DOI 10.1111/j.1525-1497.2004.30109.x; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Wang PS, 2000, J CLIN EPIDEMIOL, V53, P571, DOI 10.1016/S0895-4356(00)00222-5; Yan Y, 2005, MED CARE, V43, P1073, DOI 10.1097/01.mlr.0000182477.29129.86; Zhang JX, 1999, MED CARE, V37, P1128, DOI 10.1097/00005650-199911000-00005	28	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162074	10.1371/journal.pone.0162074	http://dx.doi.org/10.1371/journal.pone.0162074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583532	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600098
J	Mantwill, S; Schulz, PJ				Mantwill, Sarah; Schulz, Peter J.			Causal Attribution and Coping Maxims Differences between Immigrants and Non-Immigrants Suffering from Back Pain in Switzerland	PLOS ONE			English	Article							COMMON-SENSE MODEL; PERCEPTION QUESTIONNAIRE; RHEUMATOID-ARTHRITIS; AFRICAN-AMERICAN; BREAST-CANCER; HEALTH; ILLNESS; WOMEN; REPRESENTATION; ADJUSTMENT	Objectives This study aimed at investigating the relationship between causal attributions and coping maxims in people suffering from back pain. Further, it aimed at identifying in how far causal attributions and related coping maxims would defer between immigrants and non-immigrants in Switzerland. Methods Data for this study came from a larger survey study that was conducted among immigrant populations in the German-and Italian-speaking part of Switzerland. Included in the analyses were native Swiss participants, as well as Albanian-and Serbian-speaking immigrants, who had indicated to have suffered from back pain within the last 12 months prior to the study. Data was analyzed for overall 495 participants. Items for causal attributions and coping maxims were subject to factor analyses. Cultural differences were assessed with ANOVA and regression analyses. Interaction terms were included to investigate whether the relationship between causal attributions and coping maxims would differ with cultural affiliation. Results For both immigrant groups the physician's influence on the course of their back pain was more important than for Swiss participants (p < .05). With regard to coping, both immigrant groups were more likely to agree with maxims that were related to the improvement of the back pain, as well as the acceptance of the current situation (p < .05). The only consistent interaction effect that was found indicated that being Albanian-speaking negatively moderated the relationship between physical activity as an attributed cause of back pain and all three identified coping maxims. Conclusion The study shows that differences in causal attribution and coping maxims between immigrants and non-immigrants exist. Further, the results support the assumption of an association between causal attribution and coping maxims. However cultural affiliation did not considerably moderate this relationship.	[Mantwill, Sarah; Schulz, Peter J.] Univ Lugano, Inst Commun & Hlth, Lugano, Switzerland	Universita della Svizzera Italiana	Mantwill, S (corresponding author), Univ Lugano, Inst Commun & Hlth, Lugano, Switzerland.	Sarah.Mantwill@usi.ch	Schulz, Peter/AAM-9816-2020; Schulz, Peter/GQQ-1290-2022	Schulz, Peter/0000-0003-4281-489X; Schulz, Peter/0000-0003-4281-489X	Swiss public sector insurer (SUVA)	Swiss public sector insurer (SUVA)	The authors received funding from a Swiss public sector insurer (SUVA). Funding was provided for (1.) one research assistant, (2.) assistants who recruited participants for the study and the (3.) prize draw that participants were eligible to participate in. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	AFFLECK G, 1987, J CONSULT CLIN PSYCH, V55, P29, DOI 10.1037/0022-006X.55.1.29; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bischoff A., 2009, DIVERSITY HLTH CARE, V6, P159; Bischoff A, 2008, J IMMIGR MINOR HEALT, V10, P325, DOI 10.1007/s10903-007-9089-z; Bischoff A, 2009, EUR J PUBLIC HEALTH, V19, P59, DOI 10.1093/eurpub/ckn113; Bundesamt fur Gesundheit (BAG) (Swiss Federal Office of Public Health (SFOPH)), 2010, GES MIGR MIGR SCHWEI; Bundesamt fur Gesundheit (BAG) (Swiss Federal Office of Public Health (SFOPH)), 2007, WIE GES SIND MIGR MI; Bundesamt fur Statistik (BFS) (Swiss Federal Statistical Office (SFSO)), 2015, MIGR INT IND BEV MIG; Bundesamt fur Statistik (BFS) (Swiss Federal Statistical Office (SFSO)), 2014, GESUNDHEITSSTATISTIK; Bundesamt fur Statistik (BFS) (Swiss Federal Statistical Office (SFSO)), 2014, MIGR INT IND AUSL BE; Burri Sharani B., 2010, KOSOVARISCHE BEVOLKE; Camerini AL, 2016, PATIENT EDUC COUNS, V99, P462, DOI 10.1016/j.pec.2015.10.018; Campbell CM, 2012, PAIN MANAG, V2, P219, DOI 10.2217/PMT.12.7; Cano A, 2006, J PAIN, V7, P459, DOI 10.1016/j.jpain.2006.01.445; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; EDWARDS LC, 1992, PAIN, V51, P267, DOI 10.1016/0304-3959(92)90209-T; Edwards RR, 2005, PAIN MED, V6, P88, DOI 10.1111/j.1526-4637.2005.05007.x; Fontana M, 2008, SWISS MED WKLY, V138, P752, DOI 2008/49/smw-12328; Geiger-Brown J. M., 2012, HDB OCCUPATIONAL HLT, P297; Graham-Engeland JE, 2016, ANN BEHAV MED, V50, P12, DOI 10.1007/s12160-015-9723-2; Grossmann FF, 2011, PUBLIC HEALTH NURS, V28, P129, DOI 10.1111/j.1525-1446.2010.00896.x; Grzywacz JG, 2007, J OCCUP ENVIRON MED, V49, P1302, DOI 10.1097/JOM.0b013e31815ae9bc; Guggisberg J, 2011, GESUNDHEITSMONITORIN; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hoffmann TC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-7; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jordan MS, 1998, ARTHRIT CARE RES, V11, P80, DOI 10.1002/art.1790110203; Kellner U, 2013, CLIN RHEUMATOL, V32, P189, DOI 10.1007/s10067-012-2099-9; Kivimaki M, 2001, WORK STRESS, V15, P3, DOI 10.1080/02678370118685; Kneckt MC, 2000, J CLIN PERIODONTOL, V27, P205, DOI 10.1034/j.1600-051x.2000.027003205.x; KRAAIMAAT FW, 1988, J BEHAV MED, V11, P293, DOI 10.1007/BF00844434; Lavery JF, 1996, CANCER NURS, V19, P20, DOI 10.1097/00002820-199602000-00003; Leventhal H, 1998, PSYCHOL HEALTH, V13, P717, DOI 10.1080/08870449808407425; Leventhal H, 2003, SELF REGULATION HLTH, P77; Leventhal H, 1980, CONTRIBUTIONS MED PS, V2, P7; Leventhal H., 1997, PERCEPTIONS HLTH ILL, V2, P19; Leventhal H, 2011, ANN BEHAV MED, V41, P152, DOI 10.1007/s12160-010-9246-9; Linton SJ, 2011, SCAND J PAIN, V2, P47, DOI 10.1016/j.sjpain.2011.01.005; Macfarlane GJ, 1997, SPINE, V22, P1143, DOI 10.1097/00007632-199705150-00015; Marques-Vidal P, 2011, PUBLIC HEALTH NUTR, V14, P1148, DOI 10.1017/S1368980011000103; McAndrew LM, 2008, BRIT J HEALTH PSYCH, V13, P195, DOI 10.1348/135910708X295604; Meints SM, 2016, J PAIN, V17, P642, DOI 10.1016/j.jpain.2015.12.017; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Murgic L, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0059-z; Osborne J. W, 2015, PRACTICAL ASSESSMENT, V20, P2, DOI [DOI 10.7275/HB2G-M060, 10.7275/hb2g-m060]; Reid GJ, 1998, PAIN, V76, P83, DOI 10.1016/S0304-3959(98)00029-3; Roesch SC, 2001, J PSYCHOSOM RES, V50, P205, DOI 10.1016/S0022-3999(01)00188-X; Rutter CL, 2002, BRIT J HEALTH PSYCH, V7, P377, DOI 10.1348/135910702320645372; SCHIAFFINO KM, 1992, PERS SOC PSYCHOL B, V18, P709, DOI 10.1177/0146167292186007; Schulz PJ, 2006, PATIENT EDUC COUNS, V64, P294, DOI 10.1016/j.pec.2006.03.009; Schulz PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078029; SnowTurek AL, 1996, PAIN, V64, P455, DOI 10.1016/0304-3959(95)00190-5; Soares JJF, 1999, SCAND J CARING SCI, V13, P254, DOI 10.1080/02839319950162453; SWANSON GM, 1995, J NATL CANCER I, V87, P1747, DOI 10.1093/jnci/87.23.1747; TENNEN H, 1984, BASIC APPL SOC PSYCH, V5, P131, DOI 10.1207/s15324834basp0502_6; Vyshka G, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-12; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; Weinman J, 2000, BRIT J HEALTH PSYCH, V5, P263, DOI 10.1348/135910700168900; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Wimmer A, 2004, ETHNIC RACIAL STUD, V27, P1, DOI 10.1080/0141987032000147922; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113	62	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161758	10.1371/journal.pone.0161758	http://dx.doi.org/10.1371/journal.pone.0161758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583445	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600056
J	Mendez-Villanueva, A; Suarez-Arrones, L; Rodas, G; Fernandez-Gonzalo, R; Tesch, P; Linnehan, R; Kreider, R; Di Salvo, V				Mendez-Villanueva, Alberto; Suarez-Arrones, Luis; Rodas, Gil; Fernandez-Gonzalo, Rodrigo; Tesch, Per; Linnehan, Richard; Kreider, Richard; Di Salvo, Valter			MRI-Based Regional Muscle Use during Hamstring Strengthening Exercises in Elite Soccer Players	PLOS ONE			English	Article							MEDICAL-RESEARCH PROGRAM; PROFESSIONAL FOOTBALL; NONUNIFORM CHANGES; INJURIES; MECHANICS; STRAINS; RETURN; AUDIT	The present study examined site-specific hamstring muscles use with functional magnetic resonance imaging (MRI) in elite soccer players during strength training. Thirty-six players were randomized into four groups, each performing either Nordic hamstring, flywheel legcurl, Russian belt or the hip-extension conic-pulley exercise. The transverse relaxation time (T-2) shift from pre-to post-MRI were calculated for the biceps femoris long (BFI) and short (BFs) heads, semitendinosus (ST) and semimembranosus (SM) muscles at proximal, middle and distal areas of the muscle length. T-2 values increased substantially after flywheel leg-curl in all regions of the BFI (from 9 +/- 8 to 16 +/- 8%), BFs (41 +/- 6-71 +/- 11%), and ST (60 +/- 1-69 +/- 7%). Nordic hamstring induced a substantial T2 increase in all regions of the BFs (13 +/- 8-16 +/- 5%) and ST (15 +/- 7-17 +/- 5%). T-2 values after the Russian belt deadlift substantially increased in all regions of the BFI (6 +/- 4-7 +/- 5%), ST (8 +/- 3-11 +/- 2%), SM (6 +/- 4-10 +/- 4%), and proximal and distal regions of BFs (6 +/- 6-8 +/- 5%). T-2 values substantially increased after hip-extension conic-pulley only in proximal and middle regions of BFI (11 +/- 5-7 +/- 5%) and ST (7 +/- 3-12 +/- 4%). The relevance of such MRI-based inter-and intra-muscle use in designing more effective resistance training for improving hamstring function and preventing hamstring injuries in elite soccer players should be explored with more mechanistic studies.	[Mendez-Villanueva, Alberto; Suarez-Arrones, Luis; Di Salvo, Valter] ASPIRE Acad, Football Performance & Sci Dept, Doha, Qatar; [Suarez-Arrones, Luis] Pablo de Olavide Univ, Sports Dept, Seville, Spain; [Rodas, Gil] Futbol Club Barcelona, Dept Med, Barcelona, Spain; [Fernandez-Gonzalo, Rodrigo; Tesch, Per] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Linnehan, Richard] Johnson Space Ctr, Natl Aeronaut & Space Adm, Houston, TX USA; [Kreider, Richard] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA; [Di Salvo, Valter] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy	Aspire Academy for Sports Excellence; Universidad Pablo de Olavide; Karolinska Institutet; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Texas A&M University System; Texas A&M University College Station; Foro Italico University of Rome	Mendez-Villanueva, A (corresponding author), ASPIRE Acad, Football Performance & Sci Dept, Doha, Qatar.	jose.villanueva@aspire.qa	Rodas, Gil/B-7235-2019; Kreider, Richard/O-1804-2014	Rodas, Gil/0000-0002-8060-3914; Suarez Moreno-Arrones, Luis Jesus/0000-0002-5432-4786; Kreider, Richard/0000-0002-3906-1658; Fernandez-Gonzalo, Rodrigo/0000-0003-2816-9855	NPRP grant from the Qatar National Research Fund [NPRP 6-1526-3-363]	NPRP grant from the Qatar National Research Fund(Qatar National Research Fund (QNRF))	This study was made possible by NPRP grant #NPRP 6-1526-3-363 from the Qatar National Research Fund (a member of Qatar Foundation). The funder provided support in the form of salaries for authors LSA, RFG and PT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arnason A, 2008, SCAND J MED SCI SPOR, V18, P40, DOI 10.1111/j.1600-0838.2006.00634.x; Askling C, 2003, SCAND J MED SCI SPOR, V13, P244, DOI 10.1034/j.1600-0838.2003.00312.x; Askling CM, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2013-092165; Chleboun GS, 2001, CELLS TISSUES ORGANS, V169, P401, DOI 10.1159/000047908; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Ekstrand J, 2012, BRIT J SPORT MED, V46, P112, DOI 10.1136/bjsports-2011-090155; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; Fernandez-Gonzalo R, 2016, INT J SPORTS MED, V37, P559, DOI 10.1055/s-0042-100290; Hallen A, 2014, J SPORT SCI, V32, P1229, DOI 10.1080/02640414.2014.905695; Hedayatpour N, 2012, J ELECTROMYOGR KINES, V22, P329, DOI 10.1016/j.jelekin.2011.11.010; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kubota J, 2007, EUR J APPL PHYSIOL, V101, P713, DOI 10.1007/s00421-007-0549-x; Malliaropoulos N, 2012, BRIT J SPORT MED, V46, P846, DOI 10.1136/bjsports-2011-090474; Mendiguchia J, 2013, J STRENGTH COND RES, V27, P3426, DOI 10.1519/JSC.0b013e31828fd3e7; Mendiguchia J, 2013, J STRENGTH COND RES, V27, P574, DOI 10.1519/JSC.0b013e31825c2f38; Mjolsnes R, 2004, SCAND J MED SCI SPOR, V14, P311, DOI 10.1046/j.1600-0838.2003.367.x; Ono T, 2011, RES SPORTS MED, V19, P42, DOI 10.1080/15438627.2011.535769; Ono T, 2010, RES SPORTS MED, V18, P188, DOI 10.1080/15438627.2010.490185; Opar DA, 2015, MED SCI SPORT EXER, V47, P857, DOI 10.1249/MSS.0000000000000465; Petersen J, 2014, AM J SPORT MED, V42, P399, DOI 10.1177/0363546513512779; Roberts TJ, 2011, J EXP BIOL, V214, P353, DOI 10.1242/jeb.038588; Schache AG, 2012, MED SCI SPORT EXER, V44, P647, DOI 10.1249/MSS.0b013e318236a3d2; Sherry MA, 2011, STRENGTH COND J, V33, P56, DOI 10.1519/SSC.0b013e31821e2f71; Silder A, 2008, SKELETAL RADIOL, V37, P1101, DOI 10.1007/s00256-008-0546-0; Suarez-Arrones L, 2014, INT J SPORT PHYSIOL, V9, P316, DOI [10.1123/ijspp.2013-0069, 10.1123/IJSPP.2013-0069]; Thelen DG, 2005, MED SCI SPORT EXER, V37, P1931, DOI 10.1249/01.mss.0000176674.42929.de; Timmins RG, 2015, MED SCI SPORT EXER, V47, P905, DOI 10.1249/MSS.0000000000000507; Tous-Fajardo J, 2006, INTJ SPORT PHYSIOL, V1, P293, DOI 10.1123/ijspp.1.3.293; Wakahara T, 2013, MED SCI SPORT EXER, V45, P2158, DOI 10.1249/MSS.0b013e3182995349; Woods C, 2004, BRIT J SPORT MED, V38, P36, DOI 10.1136/bjsm.2002.002352; Woods C, 2002, BRIT J SPORT MED, V36, P436, DOI 10.1136/bjsm.36.6.436	31	41	41	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161356	10.1371/journal.pone.0161356	http://dx.doi.org/10.1371/journal.pone.0161356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583444	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600024
J	Nair, D; Rajshekhar, N; Klinton, JS; Watson, B; Velayutham, B; Tripathy, JP; Jawahar, MS; Swaminathan, S				Nair, Dina; Rajshekhar, Nandita; Klinton, Joel Shyam; Watson, Basilea; Velayutham, Banurekha; Tripathy, Jaya Prasad; Jawahar, Mohideen Shaheed; Swaminathan, Soumya			Household Contact Screening and Yield of Tuberculosis Cases-A Clinic Based Study in Chennai, South India	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; SUSCEPTIBILITY; INFECTION; DISEASE	Background Contact investigation is an active case finding strategy to increase detection of Tuberculosis (TB) and a key component of TB control programs. The household contacts are at a higher risk of exposure than members of the general population. The information on the value and yield of household contact screening and the approaches used in high incidence settings like India is limited. Objective To evaluate the yield of active case finding in household contacts of newly diagnosed smear positive TB patients and the factors associated with increased yield. Method Retrospective record review of the household contacts of newly diagnosed sputum smear positive patients (index case) enrolled in a clinical trial at National Institute of Research in Tuberculosis, Chennai during the period 2007-2014. A sequential screening algorithm with chest x-ray followed by symptom screen was employed to identify presumptive TB patients. Results 643 household contacts of 280 index TB patients were identified out of which 544 (85%) consented for screening. 71/544 (13%) patients had an abnormal chest radiograph and out of them 70% were symptomatic. A total of 29/544 (5.3%) contacts were found to have TB among whom 23/29 (79%) were sputum smear positive. The number needed to screen (NNS) to identify a new TB case among all household contacts was 19 and among those with an abnormal CXR was 02. Age group > 44 years, male gender and siblings of the index case was associated with abnormal chest radiograph whereas age group between 15-44 was significantly associated with developing TB disease among household contacts. Conclusion Active screening among household contacts is an effective way to improve TB case detection. The yield for new TB cases among contacts with abnormal x-ray was high in this study and the use of Chest X-rays in combination with symptom screen is recommended.	[Nair, Dina; Klinton, Joel Shyam; Watson, Basilea; Velayutham, Banurekha; Jawahar, Mohideen Shaheed] Natl Inst Res TB, Madras, Tamil Nadu, India; [Rajshekhar, Nandita] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Tripathy, Jaya Prasad] Union South East Asia Off, Int Union TB & Lung Dis, New Delhi, India; [Swaminathan, Soumya] Indian Council Med Res, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Columbia University; Indian Council of Medical Research (ICMR)	Nair, D (corresponding author), Natl Inst Res TB, Madras, Tamil Nadu, India.	dinanair73@yahoo.co.in	Watson, Basilea/AGH-6965-2022					Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Central TB Division, 2005, TECHN OP GUID TUB CO; Duarte R, 2011, REV PORT PNEUMOL, V17, P15; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Gonzalez-Ochoa E, 2009, TROP MED INT HEALTH, V14, P131, DOI 10.1111/j.1365-3156.2008.02201.x; Greenaway C, 2003, INT J TUBERC LUNG D, V7, pS479; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Hsu YH, 2006, J FORMOS MED ASSOC, V105, P363, DOI 10.1016/S0929-6646(09)60131-5; Jia ZW, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-64; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Khaparde Kshitij, 2015, Tuberc Res Treat, V2015, P670167, DOI 10.1155/2015/670167; Kuaban C, 1996, Med Trop (Mars), V56, P156; Lee KW, 2000, RADIOLOGY, V214, P831, DOI 10.1148/radiology.214.3.r00mr05831; Lienhardt C, 2003, PEDIATRICS, V111, pE608, DOI 10.1542/peds.111.5.e608; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Liu EY, 2010, J PUBLIC HEALTH-UK, V32, P461, DOI 10.1093/pubmed/fdq032; Rieder HL, 2003, INT J TUBERC LUNG D, V7, pS333; Suggaravetsiri P, 2003, INT J TUBERC LUNG D, V7, pS424; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; WHO, 2015, ANTIMICROBIAL RESIST; WHO/APOC/MG/12.2, 2012, WHOAPOCMG122 AOPC, P28; World Health Organisation, END TB STRAT GLOB ST; World Health Organization, 2013, SYST SCREEN ACT TUB; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	26	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162090	10.1371/journal.pone.0162090	http://dx.doi.org/10.1371/journal.pone.0162090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583974	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000382855600101
J	Rodriguez-Andres, D; Juan, MC; Mendez-Lopez, M; Perez-Hernandez, E; Lluch, J				Rodriguez-Andres, David; Juan, M. -Carmen; Mendez-Lopez, Magdalena; Perez-Hernandez, Elena; Lluch, Javier			MnemoCity Task: Assessment of Childrens Spatial Memory Using Stereoscopy and Virtual Environments	PLOS ONE			English	Article							AUGMENTED REALITY SYSTEM; GENDER-DIFFERENCES; SEARCH BEHAVIOR; WORKING-MEMORY; ORIENTATION; NAVIGATION; REPRESENTATIONS; MODELS; RATS	This paper presents the MnemoCity task, which is a 3D application that introduces the user into a totally 3D virtual environment to evaluate spatial short-term memory. A study has been carried out to validate the MnemoCity task for the assessment of spatial short-term memory in children, by comparing the children's performance in the developed task with current approaches. A total of 160 children participated in the study. The task incorporates two types of interaction: one based on standard interaction and another one based on natural interaction involving physical movement by the user. There were no statistically significant differences in the results of the task using the two types of interaction. Furthermore, statistically significant differences were not found in relation to gender. The correlations between scores were obtained using the MnemoCity task and a traditional procedure for assessing spatial short-term memory. Those results revealed that the type of interaction used did not affect the performance of children in the MnemoCity task.	[Rodriguez-Andres, David; Juan, M. -Carmen; Lluch, Javier] Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Camino Vera S-N, E-46022 Valencia, Spain; [Mendez-Lopez, Magdalena] Univ Zaragoza, Dept Psicol & Sociol, Zaragoza, Spain; [Perez-Hernandez, Elena] Univ Autonoma Madrid, Dept Psicol Evolut & Educ, Madrid, Spain	Universitat Politecnica de Valencia; University of Zaragoza; Autonomous University of Madrid	Juan, MC (corresponding author), Univ Politecn Valencia, Inst Univ Automat & Informat Ind, Camino Vera S-N, E-46022 Valencia, Spain.	mcarmen@dsic.upv.es	LLUCH, JAVIER/L-1424-2018; Méndez-López, Magdalena/D-3059-2011; Juan, M.-Carmen/I-3585-2015; Perez-Hernandez, Elena/H-5619-2015	LLUCH, JAVIER/0000-0002-4317-0806; Méndez-López, Magdalena/0000-0002-4249-602X; Juan, M.-Carmen/0000-0002-8764-1470; Perez-Hernandez, Elena/0000-0001-8822-6423	Spanish Ministry of Economy and Competitiveness (MINECO) through the CHILDMNEMOS project [TIN2012-37381-C02-01]; European Regional Development Fund (FEDER); Gobierno de Aragon (Departamento de Industria e Innovacion); Fondo Social Europeo for Aragon	Spanish Ministry of Economy and Competitiveness (MINECO) through the CHILDMNEMOS project; European Regional Development Fund (FEDER)(European Commission); Gobierno de Aragon (Departamento de Industria e Innovacion); Fondo Social Europeo for Aragon	This work was funded mainly by the Spanish Ministry of Economy and Competitiveness (MINECO) through the CHILDMNEMOS project (TIN2012-37381-C02-01) and confinanced by the European Regional Development Fund (FEDER). Other financial support was received from the Gobierno de Aragon (Departamento de Industria e Innovacion), and Fondo Social Europeo for Aragon.	Alloway T. P., 2012, AUTOMATED WORKING ME; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Alloway TP, 2010, J EXP CHILD PSYCHOL, V106, P20, DOI 10.1016/j.jecp.2009.11.003; [Anonymous], 2001, BINOCUL VIS STRABISM, V16, P91; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Burgess N, 2005, TRENDS COGN SCI, V9, P535, DOI 10.1016/j.tics.2005.09.011; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Canovas R, 2008, BEHAV BRAIN RES, V190, P112, DOI 10.1016/j.bbr.2008.02.024; Canovas R, 2011, BEHAV BRAIN RES, V216, P116, DOI 10.1016/j.bbr.2010.07.026; Cantoni V, 2004, J VISUAL LANG COMPUT, V15, P333, DOI 10.1016/j.jvlc.2003.10.002; Juan MC, 2011, INT J HUM-COMPUT INT, V27, P436, DOI 10.1080/10447318.2011.552059; Castanes Maria S, 2003, Binocul Vis Strabismus Q, V18, P217; Cimadevilla JM, 2014, J CLIN EXP NEUROPSYC, V36, P1002, DOI 10.1080/13803395.2014.963520; Cimadevilla JM, 2011, J NEUROSCI METH, V196, P45, DOI 10.1016/j.jneumeth.2010.12.026; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; Dodgson NA, 2004, PROC SPIE, V5291, P36, DOI 10.1117/12.529999; Foreman, 2010, THEMES SCI TECHNOL E, V2, P225; Grantcharov TP, 2004, BRIT J SURG, V91, P146, DOI 10.1002/bjs.4407; Hamilton DA, 2003, BEHAV BRAIN RES, V143, P85, DOI 10.1016/S0166-4328(03)00028-7; Hamilton DA, 2002, BEHAV BRAIN RES, V129, P159, DOI 10.1016/S0166-4328(01)00343-6; Hartley T, 2004, COGNITION, V94, P39, DOI 10.1016/j.cognition.2003.12.001; Hill-Briggs F, 2007, ARCH CLIN NEUROPSYCH, V22, P389, DOI 10.1016/j.acn.2007.01.013; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Juan MC, 2006, PRESENCE-VIRTUAL AUG, V15, P393, DOI 10.1162/pres.15.4.393; Juan MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113751; Juan MC, 2005, IEEE COMPUT GRAPH, V25, P31, DOI 10.1109/MCG.2005.143; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; KOENIG S, 2011, INT J DES INNOV RES, V6, P1; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; lacolina SA, 2011, P 9 ACM SIGCHI IT CH, P118, DOI 10.1145/2037296.2037326; LANG J, 1983, INT OPHTHALMOL, V6, P33, DOI 10.1007/BF00137371; Leon I, 2014, NEUROPSYCHOLOGY, V28, P485, DOI 10.1037/neu0000054; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Loomis JM, 1999, BEHAV RES METH INS C, V31, P557, DOI 10.3758/BF03200735; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin-SanJose JF, 2013, SPAN COMP GRAPH C CE, P177; Martin-SanJose JF, 2017, INTERACT LEARN ENVIR, V25, P17, DOI 10.1080/10494820.2015.1090455; Martin-SanJose JF, 2014, J AMB INTEL SMART EN, V6, P295, DOI 10.3233/AIS-140257; McComas J, 1998, ST HEAL T, V58, P161; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; OADES RD, 1978, BEHAV BIOL, V24, P327, DOI 10.1016/S0091-6773(79)90184-6; Piccardi L, 2014, CLIN NEUROPSYCHOL, V28, P84, DOI 10.1080/13854046.2013.863976; Piccardi L, 2013, NEUROL SCI, V34, P971, DOI 10.1007/s10072-012-1175-x; Rauterberg M, 1997, ADV HUM FACT ERGON, V21, P253; Reis, 2011, 6 IB C INF SYST TECH, P1; Reynolds Cecil R, 2001, TOMAL TEST OF MEMORY; Roskos-Ewoldsen B, 1998, J EXP PSYCHOL LEARN, V24, P215, DOI 10.1037/0278-7393.24.1.215; Shelton AL, 1997, PSYCHON B REV, V4, P102, DOI 10.3758/BF03210780; Smith AD, 2005, PERCEPTION, V34, P1221, DOI 10.1068/p5270; Stanton D, 1998, ST HEAL T, V58, P219; Sturz BR, 2010, PSYCHOL RES-PSYCH FO, V74, P560, DOI 10.1007/s00426-010-0277-4; VANDERSTAAY FJ, 1990, BEHAV NEURAL BIOL, V53, P356, DOI 10.1016/0163-1047(90)90226-V; Wang RXF, 2000, COGNITION, V77, P215, DOI 10.1016/S0010-0277(00)00105-0; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686; Xie L., 2008, P 2 INT C TANG EMB I, p191 , DOI [10.1145/1347390.1347433, DOI 10.1145/1347390.1347433]; Zhang H, 2014, MEM COGNITION, V42, P1106, DOI 10.3758/s13421-014-0418-x	58	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161858	10.1371/journal.pone.0161858	http://dx.doi.org/10.1371/journal.pone.0161858			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579715	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400045
J	Sujon, MK; Alam, MK; Rahman, SA				Sujon, Mamun Khan; Alam, Mohammad Khursheed; Rahman, Shaifulizan Abdul			Prevalence of Third Molar Agenesis: Associated Dental Anomalies in Non-Syndromic 5923 Patients	PLOS ONE			English	Article							3RD-MOLAR AGENESIS; HYPODONTIA; TEETH; REDUCTION; DENTITION; ABSENCE; PATTERN; GROWTH; PEOPLE; SIZE	The aim of this study was to investigate the prevalence of third molar agenesis and other associated dental anomalies in Bangladeshi population and to investigate the relationship of other dental anomalies with the third molar presence/agenesis. A retrospective study was performed using panoramic radiographs of 5923 patients, who ranged in age from 10 to 50 years. All radiographs were analyzed by Planmeca Romexis (R) 3.0 software (Planmeca Oy, Helsinki, Finland). Pearson chi-square and one way ANOVA (Post Hoc) test were conducted. The prevalence of third molar agenesis was 38.4%. The frequency of third molar agenesis was significantly higher in females than males (p < 0.025). Third molar agenesis was significantly more prevalent in maxilla as compared to mandible (p < 0.007). The prevalence of other dental anomalies was 6.5%, among them hypodontia was 3.1%. Prevalence of third molar agenesis varies in different geographic region. Among the other dental anomalies hypodontia was more prevalent.	[Sujon, Mamun Khan; Alam, Mohammad Khursheed] Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia; [Rahman, Shaifulizan Abdul] Univ Sains Malaysia, Oral & Maxillofacial Surg, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Alam, MK (corresponding author), Univ Sains Malaysia, Orthodont Unit, Sch Dent Sci, Kota Baharu 16150, Kelantan, Malaysia.	dralam@gmail.com	SUJON, MAMUN KHAN/AAD-8637-2019; alam, mohammed/GXH-3645-2022; Alam, Mohammad Khursheed/D-3062-2012; Alam, Mohammad/GQR-2648-2022	Alam, Mohammad Khursheed/0000-0001-7131-1752; Sujon, Mamun Khan/0000-0002-4159-9692	USM Grant (RU-Grant) by Universiti Sains Malaysia [1001/PPSG/812154]	USM Grant (RU-Grant) by Universiti Sains Malaysia	Sujon Mamun Khan has been awarded USM fellowship and is thankful for the financial support provided throughout his studies and we also grateful to USM Grant (RU-Grant 1001/PPSG/812154) by Universiti Sains Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed GS, 2007, ARCH ORAL BIOL, V52, P1018, DOI 10.1016/j.archoralbio.2007.05.008; Alam MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101157; Baba-Kawano S, 2002, ANGLE ORTHOD, V72, P112; Bianchi FJ, 2007, J APPL ORAL SCI, V15, P382, DOI 10.1590/S1678-77572007000500002; BISHARA SE, 1983, AM J ORTHOD DENTOFAC, V83, P131, DOI 10.1016/S0002-9416(83)90298-1; Cameron J, 1996, AUST DENT J, V41, P1, DOI 10.1111/j.1834-7819.1996.tb05645.x; Carter K, 2015, J DENT RES, V94, P886, DOI 10.1177/0022034515581644; Celikoglu M, 2011, AM J ORTHOD DENTOFAC, V140, P856, DOI 10.1016/j.ajodo.2011.05.021; Celikoglu M, 2010, J ORAL MAXIL SURG, V68, P990, DOI 10.1016/j.joms.2009.07.063; ENDO Y, 1994, PHYSIOL BEHAV, V56, P629, DOI 10.1016/0031-9384(94)90217-8; Garcia-Hernandez F, 2008, INT J MORPHOL, V26, P825, DOI 10.4067/S0717-95022008000400008; Garib DG, 2009, ANGLE ORTHOD, V79, P436, DOI 10.2319/021308-87.1; GARN SM, 1962, J DENT RES, V41, P717, DOI 10.1177/00220345620410033001; GARN SM, 1970, ANGLE ORTHOD, V40, P51; Gravely J F, 1965, Br Dent J, V119, P397; Hamasha AA, 2002, INT ENDOD J, V35, P910, DOI 10.1046/j.1365-2591.2002.00593.x; Harris EF, 2008, AM J ORTHOD DENTOFAC, V134, P761, DOI 10.1016/j.ajodo.2006.12.019; John J, 2012, J DENT SCI, V7, P211, DOI 10.1016/j.jds.2012.05.002; KEENE HJ, 1964, AM J ORTHOD DENTOFAC, V50, P445, DOI 10.1016/0002-9416(64)90207-6; Kiliaridis S, 2006, SEMIN ORTHOD, V12, P110, DOI DOI 10.1053/J.SODO.2006.01.004; Leco Berrocal MI, 2007, MED ORAL PATOL ORAL, V12, P134; Lee SH, 2009, FORENSIC SCI INT, V188, P107, DOI 10.1016/j.forsciint.2009.03.033; Massier M, 1941, AM J DIS CHILD, V62, P33; Mok Y. Y., 1996, Annals Academy of Medicine Singapore, V25, P828; Mostowska A, 2003, EUR J ORAL SCI, V111, P365, DOI 10.1034/j.1600-0722.2003.00069.x; NANDA RS, 1954, AM J ORTHOD DENTOFAC, V40, P698, DOI 10.1016/0002-9416(54)90058-5; Nomura R, 2003, J DENT RES, V82, P786, DOI 10.1177/154405910308201005; Ochoa BK, 2004, AM J ORTHOD DENTOFAC, V125, P148, DOI 10.1016/j.ajodo.2003.03.008; Poulsen S, 2013, PEDIAT DENT CLIN APP, P191; Rozkovcova E, 2004, Prague Med Rep, V105, P35; Sandhu S, 2005, J ORAL MAXIL SURG, V63, P640, DOI 10.1016/j.joms.2004.12.014; SHAH RM, 1979, J DENT RES, V58, P544, DOI 10.1177/00220345790580012201; Shinn D L, 1976, J Dent, V4, P42, DOI 10.1016/0300-5712(76)90069-5; Silvestri AR, 2004, J AM DENT ASSOC, V135, P1397, DOI 10.14219/jada.archive.2004.0049; YAMADA K, 1991, ARCH ORAL BIOL, V36, P129, DOI 10.1016/0003-9969(91)90075-6	35	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162070	10.1371/journal.pone.0162070	http://dx.doi.org/10.1371/journal.pone.0162070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580050	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400056
J	Humanes, A; Noonan, SHC; Willis, BL; Fabricius, KE; Negri, AP				Humanes, Adriana; Noonan, Sam H. C.; Willis, Bette L.; Fabricius, Katharina E.; Negri, Andrew P.			Cumulative Effects of Nutrient Enrichment and Elevated Temperature Compromise the Early Life History Stages of the Coral Acropora tenuis	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORAL; SUSPENDED SEDIMENTS; WATER-QUALITY; FERTILIZATION SUCCESS; REDUCES SURVIVORSHIP; MILLEPORA EHRENBERG; LARVAL DEVELOPMENT; CLIMATE-CHANGE; HEAT-STRESS	Inshore coral reefs are experiencing the combined pressures of excess nutrient availability associated with coastal activities and warming seawater temperatures. Both pressures are known to have detrimental effects on the early life history stages of hard corals, but studies of their combined effects on early demographic stages are lacking. We conducted a series of experiments to test the combined effects of nutrient enrichment (three levels) and elevated seawater temperature (up to five levels) on early life history stages of the inshore coral Acropora tenuis, a common species in the Indo-Pacific and Red Sea. Gamete fertilization, larval survivorship and larval settlement were all significantly reduced as temperature increased, but only fertilization was further affected by simultaneous nutrient enrichment. Combined high temperatures and nutrient enrichment affected fertilization in an additive manner, whereas embryo abnormalities increased synergistically. Higher than normal temperatures (32 degrees C) increased coral juvenile growth rates 1.6-fold, but mortality also increased by 50%. The co-occurrence of nutrient enrichment with high temperatures reduced juvenile mortality to 36%, ameliorating temperature stress (antagonistic interaction). Overall, the types of effect (additive vs synergistic or antagonistic) and their magnitude varied among life stages. Gamete and embryo stages were more affected by temperature stress and, in some cases, also by nutrient enrichment than juveniles. The data suggest that coastal runoff events might exacerbate the impacts of warming temperatures on fertilization if these events co-occur during corals spawning. The cumulative impacts of simultaneous exposure to nutrient enrichment and elevated temperatures over all early life history stages increases the likelihood for failure of larval supply and recruitment for this coral species. Our results suggest that improving the water quality of river discharges into coastal areas might help to enhance the thermal tolerances of early life history stages in this common coral species.	[Humanes, Adriana; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Humanes, Adriana; Willis, Bette L.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia; [Humanes, Adriana; Noonan, Sam H. C.; Fabricius, Katharina E.; Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Humanes, A (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.; Humanes, A (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld, Australia.; Humanes, A (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	adrihumanes@gmail.com	Negri, Andrew P/G-9909-2017; Fabricius, Katharina/F-1759-2010	Negri, Andrew P/0000-0003-1388-7395; Noonan, Sam/0000-0002-0392-6197; Fabricius, Katharina/0000-0001-7671-4358	Australian Institute of Marine Science the Australian Government's National Environmental Research Program; Australian Government's National Environmental Science Programme; AIMS@JCU; Australian Research Council through AusAID	Australian Institute of Marine Science the Australian Government's National Environmental Research Program; Australian Government's National Environmental Science Programme(Australian Government); AIMS@JCU; Australian Research Council through AusAID(Australian Research Council)	This study was funded by the Australian Institute of Marine Science the Australian Government's National Environmental Research Program and the Australian Government's National Environmental Science Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adriana Humanes also expresses gratitude for financial support from AIMS@JCU and to the Australian Research Council for support through AusAID.; We would like to thank Paul O'Brien, Manuela Giammusso and Cesar Herrera for assistance with experimental work. This study was funded by the Australian Institute of Marine Science the Australian Government's National Environmental Research Program and the Australian Government's National Environmental Science Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Adriana Humanes also expresses gratitude for financial support from AIMS@JCU and to the Australian Research Council for support through AusAID. The authors also acknowledge the contribution by C. Orejas and three anonymous referee, whose helpful reviews improved the manuscript.	Angly FE, 2016, PEERJ, V4, DOI 10.7717/peerj.1511; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Arrigo KR, 2005, NATURE, V5, P437; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Ball EE, 2002, INT J DEV BIOL, V46, P671; Ban SS, 2014, EVIDENCE MULTIPLE ST; Bartolini F, 2013, GLOBAL CHANGE BIOL, V19, P373, DOI 10.1111/gcb.12050; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Bassim KM, 2002, MAR BIOL, V140, P479, DOI 10.1007/s00227-001-0722-4; Berkelmans R, 1999, SEASONAL LOCAL SPATI; Bongiorni L, 2003, MAR ECOL PROG SER, V253, P137, DOI 10.3354/meps253137; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bryson S, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00027-15; Burke J, 2011, GUARDIAN 0228; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Caldwell GS, 2005, MAR ENVIRON RES, V59, P405, DOI 10.1016/j.marenvres.2004.06.005; Chua CM, 2013, MAR ECOL PROG SER, V475, P85, DOI 10.3354/meps10077; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cunning R, 2015, CORAL REEFS, V34, P155, DOI 10.1007/s00338-014-1216-4; Cunning R, 2013, NAT CLIM CHANGE, V3, P259, DOI [10.1038/NCLIMATE1711, 10.1038/nclimate1711]; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; Devlin M, 2001, GBRMPA RES PUBLICATI, V68; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Edmunds PJ, 2011, J EXP BIOL, V214, P2783, DOI 10.1242/jeb.055343; Edmunds PJ, 2005, OECOLOGIA, V146, P350, DOI 10.1007/s00442-005-0210-5; Edmunds PJ, 2004, MAR ECOL PROG SER, V269, P111, DOI 10.3354/meps269111; Edmunds PJ, 2001, MAR BIOL, V139, P981; Fabricius K, 2005, MAR POLLUT BULL, V51, P384, DOI 10.1016/j.marpolbul.2004.10.041; Fabricius KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054399; Fabricius KE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P493, DOI 10.1007/978-94-007-0114-4_28; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fabricius KE, 2003, ESTUAR COAST SHELF S, V57, P613, DOI 10.1016/S0272-7714(02)00400-6; Fabricius KE, 2014, EFFECTS RIVER RUN OF; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Figueiredo J, 2014, NAT CLIM CHANGE, V4, P498, DOI 10.1038/NCLIMATE2210; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Furnas M., 2003, CATCHMENTS CORALS TE; GESAMP, 2001, PROT OC LAND BAS ACT; Grossart HP, 2001, LIMNOL OCEANOGR, V46, P267, DOI 10.4319/lo.2001.46.2.0267; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Harrison P.L., 2000, 9 INT COR REEF S, V1, P409; Harrison PL, 2001, MAR BIOL, V139, P1057; Heyward AJ, 2010, CORAL REEFS, V29, P631, DOI 10.1007/s00338-009-0578-5; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Jones Alison M., 2011, Journal of Marine Biology, V2011, P1; Jones RJ, 1999, MAR POLLUT BULL, V38, P864, DOI 10.1016/S0025-326X(98)90160-6; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keith SA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0011; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Lam EKY, 2015, CORAL REEFS, V34, P837, DOI 10.1007/s00338-015-1317-8; Lincoln R.J., 1998, DICT ECOLOGY EVOLUTI, V2nd ed; Marshall DJ, 2006, MAR POLLUT BULL, V52, P734, DOI 10.1016/j.marpolbul.2006.05.005; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCulloch M, 2003, NATURE, V421, P727, DOI 10.1038/nature01361; Meissner KJ, 2012, CORAL REEFS, V31, P309, DOI 10.1007/s00338-011-0866-8; Michalek-Wagner K, 2001, CORAL REEFS, V19, P231, DOI 10.1007/s003380170003; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Negri AP, 2000, MAR POLLUT BULL, V41, P420, DOI 10.1016/S0025-326X(00)00139-9; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Omori M, 2001, LIMNOL OCEANOGR, V46, P704, DOI 10.4319/lo.2001.46.3.0704; Portune KJ, 2010, MAR GENOM, V3, P51, DOI 10.1016/j.margen.2010.03.002; Ralph P. J., 2007, Toxicological and Environmental Chemistry, V89, P589, DOI 10.1080/02772240701561593; Randall CJ, 2009, CORAL REEFS, V28, P537, DOI 10.1007/s00338-009-0482-z; Ricardo GF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18084; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; Sawall Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039951; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schnitzler CE, 2012, MAR BIOL, V159, P633, DOI 10.1007/s00227-011-1842-0; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Thiyagarajan V, 2003, J EXP MAR BIOL ECOL, V287, P223, DOI 10.1016/S0022-0981(02)00570-1; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Waters D.K., 2014, TECHNICAL REPORT; Weber M, 2012, P NATL ACAD SCI USA, V109, pE1558, DOI 10.1073/pnas.1100715109; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Wieczorek SK, 1998, BIOFOULING, V12, P81, DOI 10.1080/08927019809378348; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Willis BL, 1997, CORAL REEFS, V16, pS53, DOI 10.1007/s003380050242; Woolsey ES, 2015, CORAL REEFS, V34, P471, DOI 10.1007/s00338-014-1253-z	95	36	37	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161616	10.1371/journal.pone.0161616	http://dx.doi.org/10.1371/journal.pone.0161616			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575699	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000382877200030
J	Shlyueva, D; Meireles, ACA; Pagani, M; Stark, A				Shlyueva, Daria; Meireles-Filho, Antonio C. A.; Pagani, Michaela; Stark, Alexander			Genome-Wide Ultrabithorax Binding Analysis Reveals Highly Targeted Genomic Loci at Developmental Regulators and a Potential Connection to Polycomb-Mediated Regulation	PLOS ONE			English	Article							HOMEOTIC GENE-CONTROL; CELL-CYCLE; TRANSCRIPTION FACTORS; RESPONSE ELEMENTS; GROUP PROTEINS; ENDS-OUT; DROSOPHILA; HOX; EXPRESSION; COMPLEX	Hox homeodomain transcription factors are key regulators of animal development. They specify the identity of segments along the anterior-posterior body axis in metazoans by controlling the expression of diverse downstream targets, including transcription factors and signaling pathway components. The Drosophila melanogaster Hox factor Ultrabithorax (Ubx) directs the development of thoracic and abdominal segments and appendages, and loss of Ubx function can lead for example to the transformation of third thoracic segment appendages (e.g. halters) into second thoracic segment appendages (e.g. wings), resulting in a characteristic four-wing phenotype. Here we present a Drosophila melanogaster strain with a V5-epitope tagged Ubx allele, which we employed to obtain a high quality genome-wide map of Ubx binding sites using ChIP-seq. We confirm the sensitivity of the V5 ChIP-seq by recovering 7/8 of well-studied Ubx-dependent cis-regulatory regions. Moreover, we show that Ubx binding is predictive of enhancer activity as suggested by comparison with a genome-scale resource of in vivo tested enhancer candidates. We observed densely clustered Ubx binding sites at 12 extended genomic loci that included ANTP-C, BX-C, Polycomb complex genes, and other regulators and the clustered binding sites were frequently active enhancers. Furthermore, Ubx binding was detected at known Polycomb response elements (PREs) and was associated with significant enrichments of Pc and Pho ChIP signals in contrast to binding sites of other developmental TFs. Together, our results show that Ubx targets developmental regulators via strongly clustered binding sites and allow us to hypothesize that regulation by Ubx might involve Polycomb group proteins to maintain specific regulatory states in cooperative or mutually exclusive fashion, an attractive model that combines two groups of proteins with prominent gene regulatory roles during animal development.	[Shlyueva, Daria; Meireles-Filho, Antonio C. A.; Pagani, Michaela; Stark, Alexander] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Shlyueva, Daria] Univ Copenhagen, Biotech Res & Innovat Ctr, Fac Hlth & Med Sci, Copenhagen, Denmark; [Meireles-Filho, Antonio C. A.] Ecole Polytech Fed Lausanne, Lab Syst Biol & Genet, Lausanne, Switzerland	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Copenhagen; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Stark, A (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012; Meireles-Filho, Antonio/E-5550-2014	Stark, Alexander/0000-0003-2611-0841; Meireles-Filho, Antonio/0000-0001-5853-9197; Shlyueva, Daria/0000-0002-8990-0843	Boehringer Ingelheim; Austrian Research Promotion Agency (FFG); Austrian Science Fund (FWF) [F4303-B09]; European Research Council (ERC) [242922]	Boehringer Ingelheim(Boehringer Ingelheim); Austrian Research Promotion Agency (FFG); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC))	Research in the laboratory of AS is supported by Boehringer Ingelheim (www.boehringer-ingelheim.com), the Austrian Research Promotion Agency (FFG, www.ffg.at) and the Austrian Science Fund (FWF, F4303-B09, www.fwf.ac.at). DS was supported by a European Research Council starting grant (ERC, no. 242922, www.erc.europa.eu) awarded to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CD, 2013, GENOME WIDE QUANTITA; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Bardet AF, 2013, BIOINFORMATICS, V29, P2705, DOI 10.1093/bioinformatics/btt470; Beck S, 2010, ADV EXP MED BIOL, V689, P41; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; BIENZ M, 1988, CELL, V53, P567, DOI 10.1016/0092-8674(88)90573-9; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bonn S, 2012, NAT PROTOC, V7, P978, DOI 10.1038/nprot.2012.049; BOULET AM, 1988, GENE DEV, V2, P1600, DOI 10.1101/gad.2.12a.1600; Calgaro S, 2002, GENETICS, V160, P547; CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2; Choo SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014778; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; Galant R, 2002, DEVELOPMENT, V129, P3115; Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; GOULD AP, 1990, NATURE, V348, P308, DOI 10.1038/348308a0; GOULD AP, 1992, DEVELOPMENT, V116, P1163; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Gutierrez L, 2003, DEVELOPMENT, V130, P343, DOI 10.1242/dev.00222; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HINZ U, 1992, DEVELOPMENT, V116, P543; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; KAUFMAN TC, 1980, GENETICS, V94, P115; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuhnlein RP, 1997, MECH DEVELOP, V66, P107, DOI 10.1016/S0925-4773(97)00103-2; Kurant E, 1998, DEVELOPMENT, V125, P1037; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Langmead B., 2009, GENOME BIOL; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; MCCORMICK AM, 1995, DEVELOPMENT, V121, P2799; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meireles ACA, 2014, CURR BIOL, V24, P1, DOI 10.1016/j.cub.2013.11.017; Mohit P, 2006, DEV BIOL, V291, P356, DOI 10.1016/j.ydbio.2005.12.022; MULLER J, 1989, EMBO J, V8, P4143, DOI 10.1002/j.1460-2075.1989.tb08599.x; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Park D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083506; Pavlopoulos A, 2011, P NATL ACAD SCI USA, V108, P2855, DOI 10.1073/pnas.1015077108; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Scuderi A, 2006, DEV BIOL, V291, P110, DOI 10.1016/j.ydbio.2005.12.014; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Sorge S, 2012, EMBO J; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Strubbe G, 2011, P NATL ACAD SCI USA, V108, P5572, DOI 10.1073/pnas.1007916108; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; Struhl G., 1981, HOMOEOTIC MUTATION T; STRUTT DI, 1994, MECH DEVELOP, V46, P27, DOI 10.1016/0925-4773(94)90035-3; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tseng ASK, 2002, GENETICS, V162, P229; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Weihe U, 2004, DEVELOPMENT, V131, P767, DOI 10.1242/dev.00979; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; Yanez-Cuna JO, 2012, GENOME RES, V22, P2018, DOI 10.1101/gr.132811.111; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	84	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161997	10.1371/journal.pone.0161997	http://dx.doi.org/10.1371/journal.pone.0161997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575958	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877200053
J	Frontalini, F; Curzi, D; Cesarini, E; Canonico, B; Giordano, FM; De Matteis, R; Bernhard, JM; Pieretti, N; Gu, B; Eskelsen, JR; Jubb, AM; Zhao, L; Pierce, EM; Gobbi, P; Papa, S; Coccioni, R				Frontalini, Fabrizio; Curzi, Davide; Cesarini, Erica; Canonico, Barbara; Giordano, Francesco M.; De Matteis, Rita; Bernhard, Joan M.; Pieretti, Nadia; Gu, Baohua; Eskelsen, Jeremy R.; Jubb, Aaron M.; Zhao, Linduo; Pierce, Eric M.; Gobbi, Pietro; Papa, Stefano; Coccioni, Rodolfo			Mercury-Pollution Induction of Intracellular Lipid Accumulation and Lysosomal Compartment Amplification in the Benthic Foraminifer Ammonia parkinsoniana	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; NILE-RED; GENE-EXPRESSION; ACRIDINE-ORANGE; IN-SITU; BIOMARKERS; RESPONSES; DROPLETS; CELLS; INDICATORS	Heavy metals such as mercury (Hg) pose a significant health hazard through bioaccumulation and biomagnification. By penetrating cell membranes, heavy metal ions may lead to pathological conditions. Here we examined the responses of Ammonia parkinsoniana, a benthic foraminiferan, to different concentrations of Hg in the artificial sea water. Confocal images of untreated and treated specimens using fluorescent probes (Nile Red and Acridine Orange) provided an opportunity for visualizing the intracellular lipid accumulation and acidic compartment regulation. With increased Hg over time, we observed an increased number of lipid droplets, which may have acted as a detoxifying organelle where Hg is sequestered and biologically inactivated. Further, Hg seems to promote the proliferation of lysosomes both in terms of number and dimension that, at the highest level of Hg, resulted in cell death. We report, for the first time, the presence of Hg within the foraminiferal cell: at the basal part of pores, in the organic linings of the foramen/septa, and as cytoplasmic accumulations.	[Frontalini, Fabrizio; Pieretti, Nadia; Coccioni, Rodolfo] Univ Urbino, Dept Pure & Appl Sci, Urbino, Italy; [Curzi, Davide; Cesarini, Erica; Canonico, Barbara; Giordano, Francesco M.; De Matteis, Rita; Gobbi, Pietro; Papa, Stefano] Univ Urbino, Dept Biomol Sci, Urbino, Italy; [Bernhard, Joan M.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Gu, Baohua; Eskelsen, Jeremy R.; Jubb, Aaron M.; Zhao, Linduo; Pierce, Eric M.] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA	University of Urbino; University of Urbino; Woods Hole Oceanographic Institution; United States Department of Energy (DOE); Oak Ridge National Laboratory	Frontalini, F (corresponding author), Univ Urbino, Dept Pure & Appl Sci, Urbino, Italy.	fabrizio.frontalini@uniurb.it	Gobbi, Pietro/J-2566-2012; Jubb, Aaron/G-4538-2013; De+Matteis, Rita/AAG-6904-2019; Eskelsen, Jeremy/S-5927-2016; Frontalini, Fabrizio/C-4819-2008; Pierce, Eric M/G-1615-2011; Jubb, Aaron/CAA-2223-2022; Bernhard, Joan/M-3260-2013	Gobbi, Pietro/0000-0003-4705-0833; Jubb, Aaron/0000-0001-6875-1079; Eskelsen, Jeremy/0000-0003-2828-9099; Frontalini, Fabrizio/0000-0002-0425-9306; Pierce, Eric M/0000-0002-4951-1931; Jubb, Aaron/0000-0001-6875-1079; DE MATTEIS, Rita/0000-0003-4665-4547; Bernhard, Joan/0000-0003-2121-625X; Canonico, Barbara/0000-0003-3383-715X	PRIN Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (protocollo RMTLYR); Investment in Science Fund at WHOI; Office of Biological and Environmental Research, US Department of Energy (DOE) as part of the Mercury Science Focus Area at Oak Ridge National Laboratory; DOE [DE-AC05-00OR22725]	PRIN Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (protocollo RMTLYR); Investment in Science Fund at WHOI; Office of Biological and Environmental Research, US Department of Energy (DOE) as part of the Mercury Science Focus Area at Oak Ridge National Laboratory(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	The research for this paper was partially made possible by the financial support from the PRIN 2010-2011 Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (protocollo 2010RMTLYR) to RC. JMB acknowledges support from The Investment in Science Fund at WHOI. BG, JRE, AJ, LZ, and EMP were supported in part by the Office of Biological and Environmental Research, US Department of Energy (DOE) as part of the Mercury Science Focus Area at Oak Ridge National Laboratory, which is managed by UT-Battelle LLC for the DOE under contract DE-AC05-00OR22725.	ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; Anderson O.R., 1991, BIOL FORAMINIFERA, P335; Artal MC, 2013, ENVIRON TOXICOL CHEM, V32, P908, DOI 10.1002/etc.2128; Braeckman B, 1999, TISSUE CELL, V31, P223, DOI 10.1054/tice.1999.0021; BRESLER V, 1995, J FORAMIN RES, V25, P267, DOI 10.2113/gsjfr.25.3.267; Ciacci C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036937; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; DELNOMDEDIEU M, 1992, CHEM-BIOL INTERACT, V81, P243, DOI 10.1016/0009-2797(92)90081-U; Diaz G, 2007, EUR J HISTOCHEM, V51, P213; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Dondero F, 2006, COMP BIOCHEM PHYS C, V143, P150, DOI 10.1016/j.cbpc.2006.01.005; Eisler R, 2006, MERCURY HAZARDS LIVI; Frontalini F, 2008, ESTUAR COAST SHELF S, V76, P404, DOI 10.1016/j.ecss.2007.07.024; Frontalini F, 2015, EUR J HISTOCHEM, V59, P1, DOI 10.4081/ejh.2015.2460; Frontalini Fabrizio, 2011, Revue de Micropaleontologie, V54, P115, DOI 10.1016/j.revmic.2011.03.001; Gentes S, 2015, ENVIRON SCI TECHNOL, V49, P14560, DOI 10.1021/acs.est.5b03586; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Gomiero A, 2013, SCI TOTAL ENVIRON, V442, P534, DOI 10.1016/j.scitotenv.2012.10.023; Grasselli E, 2013, CHEMOSPHERE, V91, P1123, DOI 10.1016/j.chemosphere.2013.01.016; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gu B, 2014, BIOGEOSCIENCES, V11, P5259, DOI 10.5194/bg-11-5259-2014; Gu BH, 2011, P NATL ACAD SCI USA, V108, P1479, DOI 10.1073/pnas.1008747108; GUTKNECHT J, 1981, J MEMBRANE BIOL, V61, P61, DOI 10.1007/BF01870753; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Le Cadre V, 2006, ENVIRON POLLUT, V143, P304, DOI 10.1016/j.envpol.2005.11.033; Lee J.J., 1991, BIOL FORAMINIFERA; Loumbourdis NS, 2004, ENVIRON POLLUT, V129, P299, DOI 10.1016/j.envpol.2003.10.010; Marigomez I, 1996, ARCH ENVIRON CON TOX, V31, P54, DOI 10.1007/BF00203907; Mascotti K, 2000, TRANSFUSION, V40, P693, DOI 10.1046/j.1537-2995.2000.40060693.x; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; Mok WJ, 2014, FOOD CHEM, V147, P340, DOI 10.1016/j.foodchem.2013.09.157; Moore MN, 2006, AUTOPHAGY, V2, P217, DOI 10.4161/auto.2663; Moore MN, 2006, MAR ENVIRON RES, V61, P278, DOI 10.1016/j.marenvres.2005.10.005; Morvan J, 2004, AQUAT LIVING RESOUR, V17, P317, DOI 10.1051/alr:2004034; Munoz L, 2015, ECOTOX ENVIRON SAFE, V113, P241, DOI 10.1016/j.ecoenv.2014.11.036; Murphy G, 2008, AM J RESP CELL MOL, V38, P532, DOI 10.1165/rcmb.2007-0204OC; Nicholson S, 2003, CHEMOSPHERE, V52, P1147, DOI 10.1016/S0045-6535(03)00328-X; Nigam R, 2009, MAR POLLUT BULL, V59, P362, DOI 10.1016/j.marpolbul.2009.08.014; Paoli L, 2015, ENVIRON SCI POLLUT R, V22, P15891, DOI 10.1007/s11356-015-4807-x; PREVOT P, 1986, J PROTOZOOL, V33, P42, DOI 10.1111/j.1550-7408.1986.tb05553.x; Raspanti E, 2009, CHEMOSPHERE, V76, P48, DOI 10.1016/j.chemosphere.2009.02.030; Reed S.J.B, 2005, ELECT MICROPROBE ANA; Rowan-Carroll A, 2013, ENVIRON MOL MUTAGEN, V54, P240, DOI 10.1002/em.21768; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; Salucci S, 2010, MICRON, V41, P966, DOI 10.1016/j.micron.2010.07.002; Saraswat R, 2004, MAR POLLUT BULL, V48, P91, DOI 10.1016/S0025-326X(03)00330-8; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Sen Gupta BL, 1999, MODERN FORAMINIFERA, P3; Stankovic S, 2013, ENV CHEM SUSTAINABLE, P151; Stankovic S, 2014, ENVIRON CHEM LETT, V12, P63, DOI 10.1007/s10311-013-0430-6; Sun LB, 2013, AQUAT TOXICOL, V126, P148, DOI 10.1016/j.aquatox.2012.11.002; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Vasanthi LA, 2013, CHEMOSPHERE, V91, P1156, DOI 10.1016/j.chemosphere.2013.01.021; Yanko V, 1998, J FORAMIN RES, V28, P177; Yanko V, 1999, MODERN FORAMINIFERA, P217; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	61	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162401	10.1371/journal.pone.0162401	http://dx.doi.org/10.1371/journal.pone.0162401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603511	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200063
J	Laleg, K; Cassan, D; Barron, C; Prabhasankar, P; Micard, V				Laleg, Karima; Cassan, Denis; Barron, Cecile; Prabhasankar, Pichan; Micard, Valerie			Structural, Culinary, Nutritional and Anti-Nutritional Properties of High Protein, Gluten Free, 100% Legume Pasta	PLOS ONE			English	Article							ANTINUTRITIONAL FACTORS; STARCH DIGESTIBILITY; GLYCEMIC RESPONSE; PHYTIC ACID; CELIAC-DISEASE; FREE SPAGHETTI; DIETARY FIBER; QUALITY; WHEAT; CHICKPEA	Wheat pasta has a compact structure built by a gluten network entrapping starch granules resulting in a low glycemic index, but is nevertheless unsuitable for gluten-intolerant people. High protein gluten-free legume flours, rich in fibers, resistant starch and minerals are thus a good alternative for gluten-free pasta production. In this study, gluten-free pasta was produced exclusively from faba, lentil or black-gram flours. The relationship between their structure, their cooking and Rheological properties and their in-vitro starch digestion was analyzed and compared to cereal gluten-free commercial pasta. Trypsin inhibitory activity, phytic acid and a-galactosides were determined in flours and in cooked pasta. All legume pasta were rich in protein, resistant starch and fibers. They had a thick but weak protein network, which is built during the pasta cooking step. This particular structure altered pasta springiness and increased cooking losses. Black-gram pasta, which is especially rich in soluble fibers, differed from faba and lentil pasta, with high springiness (0.85 vs. 0.75) and less loss during cooking. In comparison to a commercial cereal gluten-free pasta, all the legume pasta lost less material during cooking but was less cohesive and springy. Interestingly, due to their particular composition and structure, lentil and faba pasta released their starch more slowly than the commercial gluten-free pasta during the in-vitro digestion process. Anti-nutritional factors in legumes, such as trypsin inhibitory activity and a-galactosides were reduced by up to 82% and 73%, respectively, by pasta processing and cooking. However, these processing steps had a minor effect on phytic acid. This study demonstrates the advantages of using legumes for the production of gluten-free pasta with a low glycemic index and high nutritional quality.	[Laleg, Karima; Cassan, Denis; Barron, Cecile; Micard, Valerie] Univ Montpellier, UMR IATE, CIRAD, INRA,Montpellier SupAgro, Montpellier, France; [Laleg, Karima] INRA, CRNH Auvergne, UNH, UMR 1019, Clermont Ferrand, France; [Prabhasankar, Pichan] Cent Food Technol Res Inst, CSIR, Mysore, Karnataka, India	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Micard, V (corresponding author), Univ Montpellier, UMR IATE, CIRAD, INRA,Montpellier SupAgro, Montpellier, France.	valerie.micard@supagro.fr		MICARD, VALERIE/0000-0002-5193-9136	"Qualiment Institute Carnot" as part of the "VEGAGE" project; INRA, Clermont-Ferrand, France; INRA	"Qualiment Institute Carnot" as part of the "VEGAGE" project; INRA, Clermont-Ferrand, France; INRA	This work was carried out with the financial support of "Qualiment Institute Carnot" as part of the "VEGAGE" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful to P. K. Shetty H (Pondicherry University, Pondicherry, India), GEMEF industries (Aix-en-Provence, France) and Celnat (Saint-Germain-Laprade, France) for kindly providing black-gram, faba bean and lentil flours, respectively. The authors thank S. Walrand (INRA, Clermont-Ferrand, France) coordinator of VEGAGE project, financial support of this work, for helpful discussion. The authors also thank C. Cherbut (INRA, Paris) and E. Rock (INRA, Clermont) for initiating the collaborative project "Improvement of plant proteins-based staple foods" funded by INRA between INRA and CSIR-CFTRI (India) which gave some preliminary results on black gram, initiating the present work. Authors are indebted to L. Saulnier (INRA, BIA, Nantes, France) and G. Conejero (INRA, Montpellier, France) for sugar analysis and PHIV access facilities, respectively. The authors would like to thank J. Bonicel, T-M. Lasserre and A. Putois (UMR IATE, Montpellier, France) for their technical assistance.	Asif M, 2013, CRIT REV FOOD SCI, V53, P1168, DOI 10.1080/10408398.2011.574804; Bjorck I, 2000, BRIT J NUTR, V83, pS149; Bock JE, 2015, CEREAL CHEM, V92, P460, DOI 10.1094/CCHEM-07-14-0152-R; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; Brijesh T, 2012, PULSE CHEM TECHNOLOG; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Campion B, 2009, THEOR APPL GENET, V118, P1211, DOI 10.1007/s00122-009-0975-8; DESHPANDE SS, 1984, J FOOD SCI, V49, P516, DOI 10.1111/j.1365-2621.1984.tb12456.x; Elli L, 2015, WORLD J GASTROENTERO, V21, P7110, DOI 10.3748/wjg.v21.i23.7110; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; ENGLYST HN, 1988, J ASSOC OFF ANA CHEM, V71, P808; Englyst KN, 1999, AM J CLIN NUTR, V69, P448; *FAO, 1970, FAO NUTR STUD, V24; Flores-Silva PC, 2014, INT J FOOD SCI TECH, V49, P1985, DOI 10.1111/ijfs.12529; Frias J, 1997, Z LEBENSM UNTERS F A, V204, P66, DOI 10.1007/s002170050039; Gallegos-Infante JA, 2010, FOOD CHEM, V119, P1544, DOI 10.1016/j.foodchem.2009.09.040; Girigowda K, 2005, PLANT FOOD HUM NUTR, V60, P173, DOI 10.1007/s11130-005-9552-3; Giuberti G, 2015, FOOD CHEM, V175, P43, DOI 10.1016/j.foodchem.2014.11.127; Goni I, 2003, FOOD CHEM, V81, P511, DOI 10.1016/S0308-8146(02)00480-6; Greffeuille V, 2015, FOOD FUNCT, V6, P2996, DOI [10.1039/c5fo00382b, 10.1039/C5FO00382B]; Guillon F, 2002, BRIT J NUTR, V88, pS293, DOI 10.1079/BJN2002720; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Honke J, 1998, Z LEBENSM UNTERS F A, V206, P279, DOI 10.1007/s002170050257; HOOVER R, 1985, STARKE, V37, P181, DOI 10.1002/star.19850370602; Hou A, 2009, INT J AGRON, V2009, DOI 10.1155/2009/484571; HOVE EL, 1979, NEW ZEAL J AGR RES, V22, P41, DOI 10.1080/00288233.1979.10420841; JENKINS DJA, 1987, AM J CLIN NUTR, V45, P946, DOI 10.1093/ajcn/45.5.946; JENKINS DJA, 1983, DIABETES CARE, V6, P155, DOI 10.2337/diacare.6.2.155; Laleg K, 2016, FOOD FUNCT, V7, P1196, DOI [10.1039/C5FO01231G, 10.1039/c5fo01231g]; LATTA M, 1980, J AGR FOOD CHEM, V28, P1313, DOI 10.1021/jf60232a049; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; Ma Z, 2011, FOOD RES INT, V44, P2534, DOI 10.1016/j.foodres.2010.12.017; MacGregor E. A, 1980, POLYM IN NATURE; Mansueto P, 2014, J AM COLL NUTR, V33, P39, DOI 10.1080/07315724.2014.869996; Marengo M, 2015, LWT-FOOD SCI TECHNOL, V63, P511, DOI 10.1016/j.lwt.2015.03.070; Marti A, 2013, TRENDS FOOD SCI TECH, V31, P63, DOI 10.1016/j.tifs.2013.03.001; Martinez-Villaluenga C, 2008, CRIT REV FOOD SCI, V48, P301, DOI 10.1080/10408390701326243; Midorikawa K, 2001, BIOCHEM BIOPH RES CO, V288, P552, DOI 10.1006/bbrc.2001.5808; Molvig L, 1997, P NATL ACAD SCI USA, V94, P8393, DOI 10.1073/pnas.94.16.8393; Morel MH, 2000, CEREAL CHEM, V77, P685, DOI 10.1094/CCHEM.2000.77.5.685; Multari S, 2015, COMPR REV FOOD SCI F, V14, P511, DOI 10.1111/1541-4337.12146; Padalino L, 2015, INT J FOOD SCI NUTR, V66, P148, DOI 10.3109/09637486.2014.959897; Pastor-Cavada E, 2014, FOOD CHEM, V163, P97, DOI 10.1016/j.foodchem.2014.04.078; Petitot M, 2010, FOOD BIOPHYS, V5, P284, DOI 10.1007/s11483-010-9170-3; Petitot M, 2010, FOOD BIOPHYS, V5, P309, DOI 10.1007/s11483-010-9180-1; Petitot M, 2010, FOOD RES INT, V43, P634, DOI 10.1016/j.foodres.2009.07.020; Petitot M, 2009, TRENDS FOOD SCI TECH, V20, P521, DOI 10.1016/j.tifs.2009.06.005; Petitot M, 2009, FOOD CHEM, V116, P401, DOI 10.1016/j.foodchem.2009.01.001; Piecyk M, 2012, FOOD CHEM, V135, P1057, DOI 10.1016/j.foodchem.2012.05.051; Rosa-Sibakov N, 2016, LWT-FOOD SCI TECHNOL, V67, P27, DOI 10.1016/j.lwt.2015.11.032; Sanchez-Chino X, 2015, NUTR CANCER, V67, P401, DOI 10.1080/01635581.2015.1004729; Sandhu KS, 2008, CARBOHYD POLYM, V71, P245, DOI 10.1016/j.carbpol.2007.05.036; SAULNIER L, 1995, CARBOHYD POLYM, V26, P279, DOI 10.1016/0144-8617(95)00020-8; Simopoulos AP, 2003, OMEGA 6 OMEGA 3 ESSE; Sozer N, 2009, FOOD HYDROCOLLOID, V23, P849, DOI 10.1016/j.foodhyd.2008.03.016; Suneja Y, 2011, FOOD RES INT, V44, P621, DOI 10.1016/j.foodres.2010.12.020; SUSHEELAMMA NS, 1974, J SCI FOOD AGR, V25, P665, DOI 10.1002/jsfa.2740250608; Takeoka GR, 1997, J AGR FOOD CHEM, V45, P3395, DOI 10.1021/jf970264d; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; THOMPSON LU, 1984, J FOOD SCI, V49, P1228, DOI 10.1111/j.1365-2621.1984.tb10443.x; Torres A, 2007, FOOD CHEM, V101, P202, DOI 10.1016/j.foodchem.2006.01.018; Torres A, 2006, J AGR FOOD CHEM, V54, P6685, DOI 10.1021/jf0606095; Troccoli A, 2000, J CEREAL SCI, V32, P99, DOI 10.1006/jcrs.2000.0322; Vasagam KPK, 2011, AQUACULT NUTR, V17, pE188, DOI 10.1111/j.1365-2095.2009.00748.x; Vidal-Valverde C, 1998, Z LEBENSM UNTERS F A, V207, P140, DOI 10.1007/s002170050308; Wang N, 2009, LWT-FOOD SCI TECHNOL, V42, P842, DOI 10.1016/j.lwt.2008.10.007; WHO, 2007, WHO TECH REP SER, V935, P1; Wu JHY, 2015, BRIT J NUTR, V114, P448, DOI 10.1017/S0007114515002056; Zhao YH, 2005, J FOOD SCI, V70, pS371, DOI 10.1111/j.1365-2621.2005.tb11458.x	70	64	64	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160721	10.1371/journal.pone.0160721	http://dx.doi.org/10.1371/journal.pone.0160721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603917	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200007
J	Park, H; Konda, KA; Roberts, CP; Maguina, JL; Leon, SR; Clark, JL; Coates, TJ; Caceres, CF; Klausner, JD				Park, Hayoung; Konda, Kelika A.; Roberts, Chelsea P.; Maguina, Jorge L.; Leon, Segundo R.; Clark, Jesse L.; Coates, Thomas J.; Caceres, Carlos F.; Klausner, Jeffrey D.			Risk Factors Associated with Incident Syphilis in a Cohort of High-Risk Men in Peru	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; MALE SEX PARTNERS; HIV-INFECTION; GAY; TRANSMISSION; NOTIFICATION; PREVALENCE; PREVENTION; REDUCE; WOMEN	Background Syphilis is concentrated among high-risk groups, but the epidemiology of syphilis reinfection is poorly understood. We characterized factors associated with syphilis incidence, including reinfection, in a high-risk cohort in Peru. Methods Participants in the NIMH CPOL trial were assessed at baseline and 2 annual visits with HIV/STI testing and behavioral surveys. Participants diagnosed with syphilis also attended 4- and 9-month visits. All participants underwent syphilis testing with RPR screening and TPPA confirmation. Antibiotic treatment was provided according to CDC guidelines. Reinfection was defined as a 4-fold titer increase or recurrence of seroreactivity after successful treatment with subsequent negative RPR titers. The longitudinal analysis used a Possion generalized estimating equations model with backward selection of variables in the final model (criteria P <0.02). Results Of 2,709 participants, 191 (7.05%) were RPR-reactive (median 1:8, range 1:1-1:1024) with TPPA confirmation. There were 119 total cases of incident syphilis, which included both reinfection and first-time incident cases. In the bivariate analysis, the oldest 2 quartiles of age (incidence ratio (IR) 3.84; P <0.001 and IR 8.15; P <0.001) and being MSM/TW (IR 6.48; P <0.001) were associated with higher risk of incident syphilis infection. Of the sexual risk behaviors, older age of sexual debut (IR 12.53; P <0.001), not being in a stable partnership (IR 1.56, P = 0.035), higher number of sex partners (IR 3.01; P <0.001), unprotected sex in the past 3 months (IR 0.56; P = 0.003), HIV infection at baseline (IR 3.98; P <0.001) and incident HIV infection during the study period (IR 6.26; P = 0.003) were all associated with incident syphilis. In the multivariable analysis, older age group (adjusted incidence ratio (aIR) 6.18; P <0.001), men reporting having sex with a man (aIR 4.63; P <0.001), and incident HIV infection (aIR 4.48; P = 0.008) were significantly associated. Conclusions We report a high rate of syphilis reinfection among high-risk men who have evidence of previous syphilis infection. Our findings highlight the close relationship between HIV incidence with both incident syphilis and syphilis reinfection. Further studies on syphilis reinfection are needed to understand patterns of syphilis reinfection and new strategies beyond periodic testing of high-risk individuals based on HIV status are needed.	[Park, Hayoung; Konda, Kelika A.; Roberts, Chelsea P.; Clark, Jesse L.; Coates, Thomas J.; Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA; [Konda, Kelika A.; Leon, Segundo R.; Caceres, Carlos F.] Univ Peruana Cayetano Heredia, Unidad Salud Sexualidad & Desarrollo Humano, Lima, Peru; [Maguina, Jorge L.] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; Universidad Peruana de Ciencias Aplicadas (UPC)	Klausner, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA.	JDKlausner@mednet.ucla.edu	Maguiña, Jorge L./AGQ-6299-2022; Leon, Segundo Ramos/J-3058-2019; Oliveira, Claudia DL/G-8618-2011	Maguiña, Jorge L./0000-0002-4136-7795; Leon, Segundo Ramos/0000-0002-5630-5714; Caceres, Carlos F./0000-0002-8101-0790; Park, Hayoung/0000-0001-8703-5764; Clark, Jesse/0000-0001-5862-6530	National Institute of Health [U10MH61536, R25MH087222]; South America Program in HIV Research (SAPHIR) [NIH R25 MH087222];  [U10 MH61536]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH087222, U10MH061536] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South America Program in HIV Research (SAPHIR); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant number U10MH61536 from the National Institute of Health supported KAK, JLM, SRL, JLC, TJC, and CFC. Grant number R25MH087222 for the South America Program in HIV Research by the National Institute of Health supported HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study participants and study staff of the National Institute of Mental Health (NIMH) Collaborative HIV/STI Prevention Trial in Peru, funded by Grant number U10 MH61536. HP was supported by the South America Program in HIV Research (SAPHIR), NIH R25 MH087222.	Caceres CF, 2007, AIDS, V21, pS59; Callegari FM, 2014, AIDS BEHAV, V18, pS104, DOI 10.1007/s10461-013-0533-x; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Clark JL, 2007, SEX TRANSM DIS, V34, P309, DOI 10.1097/01.olq.0000240289.84094.93; Clark JL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-65; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Down I, 2012, SEX HEALTH, V9, P472, DOI 10.1071/SH12023; Ehlman DC, 2010, SEX TRANSM DIS, V37, P478, DOI 10.1097/OLQ.0b013e3181e212cb; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Klausner JD, 1998, J INFECT DIS, V177, P1766, DOI 10.1086/517442; Klausner JD, 2004, AIDS CARE, V16, P964, DOI 10.1080/09540120412331292471; Konda KA, 2013, SEX TRANSM DIS, V40, P569, DOI 10.1097/OLQ.0b013e3182956eeb; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Long CM, 2006, SEX TRANSM DIS, V33, P151, DOI 10.1097/01.olq.0000204506.06551.5f; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Magro CM, 1996, HUM PATHOL, V27, P1066, DOI 10.1016/S0046-8177(96)90285-3; NIMH Collaborative HIV/STD Prevention Trial Group, 2007, AIDS, V21 Suppl 2, pS29; Ogilvie GS, 2009, CLIN INFECT DIS, V48, P1554, DOI 10.1086/598997; Pathela P, 2015, CLIN INFECT DIS, V61, P281, DOI 10.1093/cid/civ289; Peeling RW, 2004, LANCET, V364, P1561, DOI 10.1016/S0140-6736(04)17327-3; Phipps W, 2009, SEX TRANSM DIS, V36, P331, DOI 10.1097/OLQ.0b013e3181990c85; Snowden JM, 2010, SEX TRANSM DIS, V37, P75, DOI 10.1097/OLQ.0b013e3181c03434; Solomon MM, 2014, CLIN INFECT DIS, V59, P1020, DOI 10.1093/cid/ciu450; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Taylor MM, 2010, SEX TRANSM DIS, V37, P767, DOI 10.1097/OLQ.0b013e3181e65e8b	27	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162156	10.1371/journal.pone.0162156	http://dx.doi.org/10.1371/journal.pone.0162156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602569	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200048
J	Wang, FH; Lu, JM; Wen, J; Ebihara, A; Li, DZ				Wang, Fan-Hong; Lu, Jin-Mei; Wen, Jun; Ebihara, Atsushi; Li, De-Zhu			Applying DNA Barcodes to Identify Closely Related Species of Ferns: A Case Study of the Chinese Adiantum (Pteridaceae)	PLOS ONE			English	Article							RETICULATE EVOLUTION; MEISHANIANUM PTERIDACEAE; MOLECULAR EVIDENCE; CHLOROPLAST DNA; HYBRID ORIGIN; LAND PLANTS; NUCLEAR-DNA; PRIMER SETS; TRNL-F; IDENTIFICATION	DNA barcoding is a fast-developing technique to identify species by using short and standard DNA sequences. Universal selection of DNA barcodes in ferns remains unresolved. In this study, five plastid regions (rbcL, matK, trnH-psbA, trnL-F and rps4-trnS) and eight nuclear regions (ITS, pgiC, gapC, LEAFY, ITS2, IBR3_2, DET1, and SQD1_1) were screened and evaluated in the fern genus Adiantum from China and neighboring areas. Due to low primer universality (matK) and/or the existence of multiple copies (ITS), the commonly used barcodes matK and ITS were not appropriate for Adiantum. The PCR amplification rate was extremely low in all nuclear genes except for IBR3_2. rbcL had the highest PCR amplification rate (94.33%) and sequencing success rate (90.78%), while trnH-psbA had the highest species identification rate (75%). With the consideration of discriminatory power, cost-efficiency and effort, the two-barcode combination of rbcL + trnH-psbA seems to be the best choice for barcoding Adiantum, and perhaps basal polypod ferns in general. The nuclear IBR3_2 showed 100% PCR amplification success rate in Adiantum, however, it seemed that only diploid species could acquire clean sequences without cloning. With cloning, IBR3_2 can successfully distinguish cryptic species and hybrid species from their related species. Because hybridization and allopolyploidy are common in ferns, we argue for including a selected group of nuclear loci as barcodes, especially via the next-generation sequencing, as it is much more efficient to obtain single-copy nuclear loci without the cloning procedure.	[Wang, Fan-Hong; Lu, Jin-Mei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Wang, Fan-Hong] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; National Museum of Nature and Science	Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.; Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Key Basic Research Program of China [2014CB954100]; Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]; Applied Fundmental Research Foundation of Yunnan Province [2014GA003, 2014FB168]; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]; National Natural Science Foundation of China [31070199]	National Key Basic Research Program of China(National Basic Research Program of China); Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Applied Fundmental Research Foundation of Yunnan Province; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by The National Key Basic Research Program of China (Grant No. 2014CB954100), the Project of Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-EW-J-24), and the Applied Fundmental Research Foundation of Yunnan Province (Grants No. 2014GA003, 2014FB168), and the Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences (Grant No. 2009-LSF-GBOWS-01), the National Natural Science Foundation of China (Grant No. 31070199).	Adjie B, 2007, J PLANT RES, V120, P129, DOI 10.1007/s10265-006-0032-5; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARRINGTON DS, 1989, AM FERN J, V79, P55, DOI 10.2307/1547160; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Chang HM, 2009, AM FERN J, V99, P61, DOI 10.1640/0002-8444-99.2.61; Chao YS, 2012, INT J MOL SCI, V13, P4523, DOI 10.3390/ijms13044523; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen CW, 2013, ANN BOT-LONDON, V111, P663, DOI 10.1093/aob/mct004; Chen CW, 2012, AM J BOT, V99, pE223, DOI 10.3732/ajb.1100498; Ching RC, 1983, B BOT RES, V3, P2; Ching RC, 1957, ACTA PHYTOTAX SINICA, V6, P301; Ching RC, 1940, SUNYATSENIA, V5, P201; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dyer RJ, 2012, ANN BOT-LONDON, V110, P1515, DOI 10.1093/aob/mcs202; Ebihara A, 2005, AM J BOT, V92, P1535, DOI 10.3732/ajb.92.9.1535; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; Jaruwattanaphan T, 2013, SYST BOT, V38, P15, DOI 10.1600/036364413X661980; Juslen A, 2011, TAXON, V60, P1284, DOI 10.1002/tax.605005; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lave A, 1977, J CRAMER; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Lin Y.X., 1990, FLORA REIPUBLICAE PO, V3, P173; Lin YX, 1980, ACTA PHYTOTAX SINICA, V18, P101; Lin YX, 2013, FLORA CHINA, V2-3, P238; Liu YC, 2009, NOVON, V19, P59, DOI 10.3417/2007055; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Manton I., 1950, PROBLEMS CYTOLOGY EV; Mao Xing-Xing, 2014, Plant Diversity and Resources, V36, P453, DOI 10.7677/ynzwyj201414012; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; NEUHAUS H, 1987, CURR GENET, V11, P251, DOI 10.1007/BF00355398; Nitta JH, 2011, AM J BOT, V98, P1782, DOI 10.3732/ajb.1000484; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Pham Van The, 2013, Taiwania, V58, P151, DOI 10.6165/tai.2013.58.151; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Qian Y. Y., 1992, Acta Botanica Austro Sinica, P37; Reid JD, 2006, INT J PLANT SCI, V167, P529, DOI 10.1086/501071; Rothfels CJ, 2014, SYST BIOL, V63, P31, DOI 10.1093/sysbio/syt058; Rothfels CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076957; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Schneider H, 2013, J SYST EVOL, V51, P142, DOI 10.1111/j.1759-6831.2012.00226.x; Schuettpelz E, 2008, SYST BOT, V33, P621, DOI 10.1600/036364408786500127; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Sessa EB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-104; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V49, P240, DOI 10.1016/j.ympev.2008.06.015; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Spooner DM, 2016, J SYST EVOL, V54, P191, DOI 10.1111/jse.12203; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tryon R.M., 1990, FAMILIES GENERA VASC, V1, P230, DOI DOI 10.1007/978-3-662-02604-5_42; Wang L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-158; Wang Y, 2015, PHYTOTAXA, V236, P266, DOI 10.11646/phytotaxa.236.3.7; [王莹 Wang Ying], 2015, [科学通报, Chinese Science Bulletin], V60, P922; Wen J, 2015, J SYST EVOL, V53, P477, DOI 10.1111/jse.12181; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Xiang JY, 2015, J SYST EVOL, V53, P2, DOI 10.1111/jse.12141; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Zhang GF, 2006, FLORA YUNNANICA, V20, P308; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zhang WY, 2014, SYST BOT, V39, P1034, DOI 10.1600/036364414X682616	85	91	96	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160611	10.1371/journal.pone.0160611	http://dx.doi.org/10.1371/journal.pone.0160611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603700	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200005
J	Du, SH; Li, ZD; Chen, C; Tan, WK; Chi, ZX; Kwang, TW; Xu, XH; Wang, S				Du, Shou-Hui; Li, Zhendong; Chen, Can; Tan, Wee-Kiat; Chi, Zhixia; Kwang, Timothy Weixin; Xu, Xue-Hu; Wang, Shu			Co-Expansion of Cytokine-Induced Killer Cells and V.9V delta 2 T Cells for CAR T-Cell Therapy	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; GAMMA; IMMUNOTHERAPY; RECEPTOR; LYMPHOCYTES; SPECIFICITY; ACTIVATION; EXPRESSION	Gamma delta (gamma delta) T cells and cytokine-induced killer (CIK) cells, which are a heterogeneous population of T lymphocytes and natural killer T (NKT) cells, have been separately expanded ex vivo and shown to be capable of targeting and mediating cytotoxicity against various tumor cells in a major histocompatibility complex-unrestricted manner. However, the co-expansion and co-administration of these immune cells have not been explored. In this study we describe an efficient method to expand simultaneously both CIK and V gamma 9V delta 2 T cells, termed as CIKZ cells, from human peripheral blood mononuclear cells (PBMCs) using Zometa, interferon-gamma (IFN-gamma), interleukin 2 (IL-2), anti-CD3 antibody and engineered K562 feeder cells expressing CD64, CD137L and CD86. A 21-day culture of PBMCs with this method yielded nearly 20,000-fold expansion of CIKZ cells with gamma delta T cells making up over 20% of the expanded population. The expanded CIKZ cells exhibited antitumor cytotoxicity and could be modified to express anti-CD19 chimeric antigen receptor (CAR), anti-CEA CAR, and anti-HER2 CAR to enhance their specificity and cytotoxicity against CD19-, CEA-, or HER2-positive tumor cells. The tumor inhibitory activity of anti-CD19 CAR-modified CIKZ cells was further demonstrated in vivo in a Raji tumor mouse model. The findings herein substantiate the feasibility of co-expanding CIK and gamma delta cells for adoptive cellular immunotherapy applications such as CAR T-cell therapy against cancer.	[Du, Shou-Hui; Li, Zhendong; Tan, Wee-Kiat; Chi, Zhixia; Wang, Shu] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Tan, Wee-Kiat; Wang, Shu] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore; [Chen, Can; Kwang, Timothy Weixin] Tessa Therapeut Pte Ltd, Singapore 239351, Singapore; [Xu, Xue-Hu] Guangzhou Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); Guangzhou Medical University	Wang, S (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Wang, S (corresponding author), Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.	dbsws@nus.edu.sg	wang, shu/H-6744-2012	Kwang, Timothy/0000-0003-4029-3533	National Medical Research Council [NMRC/CIRG/1367/2013, NMRC/CIRG/1406/2014]; Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore); Tessa Therapeutics, Pte Ltd. Singapore; Singapore Ministry of Health's National Medical Research Council [NMRC/CIRG/1367/2013, NMRC/CIRG/1406/2014]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR)); Tessa Therapeutics, Pte Ltd. Singapore; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	Funding that supported this study was provided to SW from the National Medical Research Council - NMRC/CIRG/1367/2013, NMRC/CIRG/1406/2014 (http://www.nmrc.gov.sg/index.html), Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore; http://www.ibn.a-star.edu.sg/), and Tessa Therapeutics, Pte Ltd. Singapore (http://www.tessatherapeutics.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Singapore Ministry of Health's National Medical Research Council (NMRC/CIRG/1367/2013; NMRC/CIRG/1406/2014), Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore), and Tessa Therapeutics, Pte Ltd. Singapore.	Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Bonanno G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-129; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Deniger DC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00636; Deniger DC, 2014, CLIN CANCER RES, V20, P5708, DOI 10.1158/1078-0432.CCR-13-3451; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dotti G, 2014, IMMUNOL REV, V257, P107, DOI 10.1111/imr.12131; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Gogoi D, 2013, INDIAN J MED RES, V138, P755; Hombach AA, 2013, MOL THER, V21, P2268, DOI 10.1038/mt.2013.192; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kondo M, 2011, JOVE-J VIS EXP, DOI 10.3791/3182; Krug C, 2014, CANCER IMMUNOL IMMUN, V63, P999, DOI 10.1007/s00262-014-1572-5; Legut M, 2015, CELL MOL IMMUNOL, V12, P656, DOI 10.1038/cmi.2015.28; Li YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-104; Linn YC, 2002, BRIT J HAEMATOL, V116, P78, DOI 10.1046/j.1365-2141.2002.03247.x; Lopez RD, 2001, CANCER IMMUNOL IMMUN, V49, P629, DOI 10.1007/s002620000148; Marin V, 2010, HAEMATOL-HEMATOL J, V95, P2144, DOI 10.3324/haematol.2010.026310; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Rischer M, 2004, BRIT J HAEMATOL, V126, P583, DOI 10.1111/j.1365-2141.2004.05077.x; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Shirasu N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/292436; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sluijter BJR, 2010, CLIN IMMUNOL, V137, P221, DOI 10.1016/j.clim.2010.07.009; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wada I, 2014, CANCER MED-US, V3, P362, DOI 10.1002/cam4.196; Wang QJ, 2011, J IMMUNOL METHODS, V366, P43, DOI 10.1016/j.jim.2011.01.002; Wongkajornsilp A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078980; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; Zhang JY, 2012, J CANCER RES CLIN, V138, P1057, DOI 10.1007/s00432-012-1179-1	37	34	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161820	10.1371/journal.pone.0161820	http://dx.doi.org/10.1371/journal.pone.0161820			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598655	Green Submitted, gold, Green Published			2022-12-27	WOS:000383254800021
J	Edinger, N; Lebendiker, M; Klein, S; Zigler, M; Langut, Y; Levitzki, A				Edinger, Nufar; Lebendiker, Mario; Klein, Shoshana; Zigler, Maya; Langut, Yael; Levitzki, Alexander			Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; CANCER-CELLS; I INTERFERONS; TUMOR-CELLS; KINASE PKR; APOPTOSIS; TLR3	Selective delivery of drugs to tumor cells can increase potency and reduce toxicity. In this study, we describe a novel recombinant chimeric protein, dsRBEC, which can bind polyIC and deliver it selectively into EGFR over-expressing tumor cells. dsRBEC, comprises the dsRNA binding domain (dsRBD) of human PKR (hPKR), which serves as the polyIC binding moiety, fused to human EGF (hEGF), the targeting moiety. dsRBEC shows high affinity towards EGFR and triggers ligand-induced endocytosis of the receptor, thus leading to the selective internalization of polyIC into EGFR over-expressing tumor cells. The targeted delivery of polyIC by dsRBEC induced cellular apoptosis and the secretion of IFN-beta and other pro-inflammatory cytokines. dsRBEC-delivered polyIC is much more potent than naked polyIC and is expected to reduce the toxicity caused by systemic delivery of polyIC.	[Edinger, Nufar; Klein, Shoshana; Zigler, Maya; Langut, Yael; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Jerusalem, Israel; [Lebendiker, Mario] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Prot Purificat Unit, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Jerusalem, Israel.	alex.levitzki@mail.huji.ac.il			European Research Council (ERC) [249898]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by European Research Council (ERC) Advanced Grant No. 249898 (A.L.) [https://erc.europa.eu/funding-andgrants].	Abourbeh G, 2012, IUBMB LIFE, V64, P324, DOI 10.1002/iub.1002; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; Bekisz J, 2010, PHARMACEUTICALS, V3, P994, DOI 10.3390/ph3040994; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; BURGESS RR, 1991, METHOD ENZYMOL, V208, P3; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180; CONNOR J, 1985, J CELL BIOL, V101, P582, DOI 10.1083/jcb.101.2.582; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5; Galli R, 2010, J IMMUNOL, V184, P6658, DOI 10.4049/jimmunol.0902401; Gambara G, 2015, J CELL MOL MED, V19, P327, DOI 10.1111/jcmm.12379; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Hertzog PJ, 2012, IMMUNOL CELL BIOL, V90, P471, DOI 10.1038/icb.2012.15; HOMAN ER, 1972, TOXICOL APPL PHARM, V23, P579, DOI 10.1016/0041-008X(72)90098-1; Hutchinson MH, 2006, J CHROMATOGR A, V1128, P125, DOI 10.1016/j.chroma.2006.06.050; Jiang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-12; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Joubran S, 2014, BIOCONJUGATE CHEM, V25, P1644, DOI 10.1021/bc500252a; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kang J, 2007, ANAL BIOCHEM, V365, P147, DOI 10.1016/j.ab.2007.03.003; KROWN SE, 1985, J BIOL RESP MODIF, V4, P640; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li M, 2004, PROTEIN EXPRES PURIF, V33, P1, DOI 10.1016/j.pep.2003.08.023; Marenchino M, 2009, PROTEIN EXPRES PURIF, V63, P112, DOI 10.1016/j.pep.2008.09.010; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mellert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052473; Moiseeva EP, 2007, CARCINOGENESIS, V28, P435, DOI 10.1093/carcin/bgl171; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Orita T, 2013, CURR EYE RES, V38, P53, DOI 10.3109/02713683.2012.721044; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; PELLETIER B, 1988, J BIOCHEM BIOPH METH, V16, P63, DOI 10.1016/0165-022X(88)90104-2; Pohar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092391; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaffert D, 2011, PHARM RES-DORDR, V28, P731, DOI 10.1007/s11095-010-0225-4; Shir A, 2011, CLIN CANCER RES, V17, P1033, DOI 10.1158/1078-0432.CCR-10-1140; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takahashi Hirokazu, 2014, PLoS One, V9, pe82624, DOI 10.1371/journal.pone.0082624; Thomas T, 1999, J CELL PHYSIOL, V179, P257, DOI 10.1002/(SICI)1097-4652(199906)179:3<257::AID-JCP3>3.0.CO;2-4; Tsai SY, 2015, J IMMUNOL, V195, P4426, DOI 10.4049/jimmunol.1500378; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vitale G, 2007, ANN SURG, V246, P259, DOI 10.1097/01.sla.0000261460.07110.f2; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Yamaguchi S, 2013, BIOTECHNOL J, V8, P17, DOI 10.1002/biot.201200025; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; ZABRISKIE DW, 1988, BIOTECHNOL BIOENG, V32, P100, DOI 10.1002/bit.260320114; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804; Zigler M, 2016, CANC IMMUNOL R UNPUB	55	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162321	10.1371/journal.pone.0162321	http://dx.doi.org/10.1371/journal.pone.0162321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598772	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800052
J	Quigley, AS; Veres, SP; Kreplak, L				Quigley, Andrew S.; Veres, Samuel P.; Kreplak, Laurent			Bowstring Stretching and Quantitative Imaging of Single Collagen Fibrils via Atomic Force Microscopy	PLOS ONE			English	Article							DESMIN INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; DISCRETE PLASTICITY; TENSILE PROPERTIES; I FIBRILS; FIBERS; TENDON; MUTATIONS; MOLECULES; PACKING	Collagen is the primary structural protein in animals. Serving as nanoscale biological ropes, collagen fibrils are responsible for providing strength to a variety of connective tissues such as tendon, skin, and bone. Understanding structure-function relationships in collagenous tissues requires the ability to conduct a variety of mechanical experiments on single collagen fibrils. Though significant advances have been made, certain tests are not possible using the techniques currently available. In this report we present a new atomic force microscopy (AFM) based method for tensile manipulation and subsequent nanoscale structural assessment of single collagen fibrils. While the method documented here cannot currently capture force data during loading, it offers the great advantage of allowing structural assessment after subrupture loading. To demonstrate the utility of this technique, we describe the results of 23 tensile experiments in which collagen fibrils were loaded to varying levels of strain and subsequently imaged in both the hydrated and dehydrated states. We show that following a dehydration-rehydration cycle (necessary for sample preparation), fibrils experience an increase in height and decrease in radial modulus in response to one loading-unloading cycle to strain <5%. This change is not altered by a second cycle to strain >5%. In fibril segments that ruptured during their second loading cycle, we show that the fibril structure is affected away from the rupture site in the form of discrete permanent deformations. By comparing the severity of select damage sites in both hydrated and dehydrated conditions, we demonstrate that dehydration masks damage features, leading to an underestimate of the degree of structural disruption. Overall, the method shows promise as a powerful tool for the investigation of structure-function relationships in nanoscale fibrous materials.	[Quigley, Andrew S.; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Veres, Samuel P.; Kreplak, Laurent] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada; [Veres, Samuel P.] St Marys Univ, Div Engn, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Saint Marys University - Canada	Kreplak, L (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.; Kreplak, L (corresponding author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.	kreplak@dal.ca		Veres, Samuel/0000-0001-6308-4836; kreplak, laurent/0000-0001-9370-9809	National Science and Engineering Research Council of Canada [355291]; Canadian Graduate Scholarship from the National Science and Engineering Research Council of Canada; Nova Scotia Graduate Scholarship from the Nova Scotia Government	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Graduate Scholarship from the National Science and Engineering Research Council of Canada; Nova Scotia Graduate Scholarship from the Nova Scotia Government	Discovery grant number 355291 from the National Science and Engineering Research Council of Canada (LK). This work was supported by a Canadian Graduate Scholarship from the National Science and Engineering Research Council of Canada (AQ), and a Nova Scotia Graduate Scholarship from the Nova Scotia Government (AQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin SJ, 2016, J MECH BEHAV BIOMED, V60, P356, DOI 10.1016/j.jmbbm.2016.02.004; Baldwin SJ, 2014, BIOPHYS J, V107, P1794, DOI 10.1016/j.bpj.2014.09.003; BOULIGAND Y, 1985, BIOL CELL, V54, P143, DOI 10.1111/j.1768-322X.1985.tb00389.x; Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704; Carlisle CR, 2010, ACTA BIOMATER, V6, P2997, DOI 10.1016/j.actbio.2010.02.050; Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006; COOPER A, 1969, BIOCHEM J, V112, P515, DOI 10.1042/bj1120515; Dutov P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145711; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Gautieri A, 2009, J MECH BEHAV BIOMED, V2, P130, DOI 10.1016/j.jmbbm.2008.03.001; Grant CA, 2009, BIOPHYS J, V97, P2985, DOI 10.1016/j.bpj.2009.09.010; HODGE AJ, 1960, P NATL ACAD SCI USA, V46, P186, DOI 10.1073/pnas.46.2.186; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; LILLIE JH, 1977, J ULTRA MOL STRUCT R, V58, P134, DOI 10.1016/S0022-5320(77)90025-9; Liu W, 2010, J THROMB HAEMOST, V8, P1030, DOI 10.1111/j.1538-7836.2010.03745.x; Liu YH, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0080; Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Streeter I, 2011, SOFT MATTER, V7, P3373, DOI 10.1039/c0sm01192d; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Svensson RB, 2012, J APPL PHYSIOL, V112, P419, DOI 10.1152/japplphysiol.01172.2011; Svensson RB, 2010, BIOPHYS J, V99, P4020, DOI 10.1016/j.bpj.2010.11.018; Svensson RB, 2010, J MECH BEHAV BIOMED, V3, P112, DOI 10.1016/j.jmbbm.2009.01.005; Veres SP, 2014, MATRIX BIOL, V33, P54, DOI 10.1016/j.matbio.2013.07.003; Veres SP, 2013, J ORTHOP RES, V31, P731, DOI 10.1002/jor.22292; Veres SP, 2012, BIOPHYS J, V102, P2876, DOI 10.1016/j.bpj.2012.05.022; Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008	35	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161951	10.1371/journal.pone.0161951	http://dx.doi.org/10.1371/journal.pone.0161951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598334	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800028
J	Wang, MY; Fu, P; Yin, YH; He, M; Liu, Y				Wang, Meiyu; Fu, Ping; Yin, Yonghua; He, Miao; Liu, Yu			Acute, Recent and Past HEV Infection among Voluntary Blood Donors in China: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEPATITIS-E VIRUS; SEROPREVALENCE; EPIDEMIOLOGY; PREVALENCE; ANTIBODIES	Introduction Hepatitis E virus is one of new threats to blood safety which was usually considered to be transmitted via fecal-oral route. China is one of the hyperendemic regions where frequent outbreaks of hepatitis E are noted. However, the overall prevalence of HEV infection among mainland Chinese blood donors is not clear until now. Method The peer-reviewed literatures reporting the prevalence of HEV in Chinese blood donors were identified by systematic searching of five electronic databases. The systematic review and meta-analysis were conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement issued in 2009. Data manipulation and statistical analyses were performed by Stata 12.0. Results Fourteen eligible articles involving 22 independent studies were included. Pooled prevalence of HEV infection biomarkers (anti-HEV IgG, anti-HEV IgM, RNA and antigen) among mainland Chinese blood donors were 29.2%, 1.1%, 0.1% and 0.1%, respectively which were higher than the data reported in other countries. The analysis of HEV genotypes indicated that the most prevalent strains in Chinese blood donors were genotype 1 and 4. Conclusions Mainland China is indicated with a relatively higher risk of transmission of hepatitis E through transfusion and the screening of blood donors for HEV RNA, especially in HEV-endemic areas, might reduce the potential risk of HEV infection via transfusion.	[Wang, Meiyu; Fu, Ping; Yin, Yonghua; He, Miao; Liu, Yu] Chinese Acad Med Sci, Inst Blood Transfus, HuaCai Rd 26 Hao,Dong San Huan Rd ErDuan, Chengdu, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS	He, M; Liu, Y (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, HuaCai Rd 26 Hao,Dong San Huan Rd ErDuan, Chengdu, Sichuan, Peoples R China.	messa1022@126.com; 21615620@qq.com	He, Miao/AAB-6972-2020; He, Miao/AAA-2953-2020	He, Miao/0000-0002-2815-1690	Science and Technology Support Program of Sichuan Province [2014SZ0239]	Science and Technology Support Program of Sichuan Province	Grant sponsor: Science and Technology Support Program of Sichuan Province, Grant number: 2014SZ0239 URL: http://www.scst.gov.cn/zhuzhan/gs/20140208/5965.html Authors who received the funding: YU LIU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2000, LANCET, V356, P1081, DOI 10.1016/S0140-6736(00)02737-9; Aggarwal R, 2013, J CLIN EXP HEPATOL, V3, P125, DOI 10.1016/j.jceh.2013.05.010; Aminiafshar S, 2014, IRANIAN J PUBLIC HLT, V33; Banks GC, 2012, INT J SELECT ASSESS, V20, P182, DOI 10.1111/j.1468-2389.2012.00591.x; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Cheng W, 2006, CHINESE J MICOCIRCUL, P85; Gajjar Maitrey D, 2014, Asian J Transfus Sci, V8, P29, DOI 10.4103/0973-6247.126685; Gallian P, 2014, EMERG INFECT DIS, V20, P1914, DOI 10.3201/eid2011.140516; Gao DY, 2004, CHINESE J VIROL, P322; Guo QS, 2010, J CLIN MICROBIOL, V48, P317, DOI 10.1128/JCM.01466-09; Gupta E, 2013, J CLIN VIROL, V58, P374, DOI 10.1016/j.jcv.2013.07.019; [黄国永 HUANG Guo-Yong], 2009, [北京医学, Beijing Medical Journal], V31, P366; Jia Y, 2004, J HIGH ALTITIDE MED, V14, P53; Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x; Liu XG, 2007, CHINESE FRONTIER QUA, V30, P273; Liu XG, 2008, CHINESE J NATURE MED, V10, P321; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Matsubayashi K, 2011, ISBT SCI SER, V6, P344, DOI DOI 10.1111/J.1751-2824.2011.01512.X; Moher D, 2015, CULT MED PSYCHIAT, V4, DOI DOI 10.1023/B:MEDI.0000005484.26741.79; Petrovic T, 2014, J INFECT DEV COUNTR, V8, P1322, DOI 10.3855/jidc.4369; Purcell RH, 2013, EMERG MICROBES INFEC, V2, DOI [10.1038/emi2013.9, 10.1038/emi.2013.9]; Ren FR, 2014, TRANSFUSION, V54, P910, DOI 10.1111/trf.12530; Ruggeri FM, 2013, DIAGNOSIS HEPATITIS, P53; Ruggeri FM, 2013, EPIDEMIOLOGY HUMAN H, P11; Sang Lie-yong, 2007, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V21, P29; Sauleda S, 2015, TRANSFUSION, V55, P972, DOI 10.1111/trf.12929; Schmid CH, 2004, J CLIN EPIDEMIOL, V57, P683, DOI 10.1016/j.jclinepi.2003.12.001; Slot E, 2013, EUROSURVEILLANCE, V18, P23, DOI 10.2807/1560-7917.ES2013.18.31.20550; Stanley T.D, 1989, J ECON SURV, V3, P161, DOI DOI 10.1111/J.1467-6419.1989.TB00064.X; Tendulkar Anita A, 2015, Asian J Transfus Sci, V9, P82, DOI 10.4103/0973-6247.150959; Wang HL, 2005, J SHENYANG ARMY MED, V2, P97; Wang L, 2013, CHINESE J BLOOD TRAN, P1237; Wang XB, 2009, J CLIN TRANSFUSION, V11, P148; World Health Organization, HEP E; Wormser GP, 2014, CLIN INFECT DIS, P59; Xu CY, 2013, TRANSFUSION, V53, P2505, DOI 10.1111/trf.12326; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; ZHUANG H, 1991, GASTROENTEROL JPN, V26, P135; Zhuang WC, 2014, INT J INFECT DIS, V26, P9, DOI 10.1016/j.ijid.2014.04.022; 黄旭颖, 2012, [中国输血杂志, Chinese Journal of Blood Transfusion], V25, P870; 黄国永, 2009, [中国输血杂志, Chinese Journal of Blood Transfusion], V22, P314	43	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161089	10.1371/journal.pone.0161089	http://dx.doi.org/10.1371/journal.pone.0161089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597991	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800005
J	Zhong, HJ; Yuan, Y; Xie, WR; Chen, MH; He, XX				Zhong, Hao-Jie; Yuan, Yu; Xie, Wen-Rui; Chen, Mei-Hui; He, Xing-Xiang			Type 2 Diabetes Mellitus Is Associated with More Serious Small Intestinal Mucosal Injuries	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL OVERGROWTH; INFLAMMATION; PREVALENCE; TRANSIT; RATS	Background Clinical and experimental research has revealed that diabetes mellitus (DM) is characterized by intestinal hypomotility, gut microbial dysbiosis, increased gut permeability, microcirculation disorders, circulatory changes, and dysfunction of intestinal stem cells, which may be linked to inflammation of intestinal mucosa. However, the relationship between type 2 DM (T2DM) and macroscopic small intestinal mucosal injuries is still unclear. Therefore, we retrospectively studied capsule endoscopy data to determine the relationship between T2DM and small intestinal mucosal injuries. Materials and Methods We compared the records of 38 T2DM patients with those of 152 non-DM patients for small intestinal mucosal injuries. Different types of mucosal injuries and Lewis scores were compared between T2DM and non-DM patients. The relationships between patients with or without different types of diabetic complications and the Lewis score was assessed. Moreover, the relationships between insulin resistance and Lewis score, between HbA1c and Lewis score, were also both assessed. Results The prevalence of a villous edema in subjects with T2DM was significantly higher than in those without DM (P < 0.001), but incidence of ulcers was not different (P = 1.000). With T2DM, the Lewis score was also significantly higher (P = 0.002). In addition, subjects with diabetic nephropathy showed significantly higher Lewis scores than patients without diabetic nephropathy (P = 0.033). In Pearson's correlation tests, the homeostasis model assessment of insulin resistance (HOMA-IR) value was correlated positively with the Lewis score (gamma = 0.175, P = 0.015), but no statistical correlation was found between HbA1c level and Lewis score (gamma = 0.039, P = 0.697). Conclusions Subjects with T2DM, especially those with diabetic nephropathy, have higher Lewis scores and more serious small intestinal mucosal lesions.	[Zhong, Hao-Jie; Yuan, Yu; Xie, Wen-Rui; Chen, Mei-Hui; He, Xing-Xiang] Guangdong Pharmaceut Univ, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University	He, XX (corresponding author), Guangdong Pharmaceut Univ, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	hexingxiangtongxun@126.com		Zhong, Hao-Jie/0000-0001-6586-756X				American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caunedo-Alvarez A, 2010, REV ESP ENFERM DIG, V102, P80, DOI 10.4321/s1130-01082010000200002; D'Addio F, 2015, CELL STEM CELL, V17, P486, DOI 10.1016/j.stem.2015.07.010; Endo H, 2014, GASTROINTEST ENDOSC, V80, P826, DOI 10.1016/j.gie.2014.03.024; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fu RG, 2011, RENAL FAILURE, V33, P615, DOI 10.3109/0886022X.2011.581404; Gralnev IM, 2008, ALIMENT PHARM THERAP, V27, P146, DOI 10.1111/j.1365-2036.2007.03556.x; Harsch IA, 2003, EUR J PHARMACOL, V481, P249, DOI 10.1016/j.ejphar.2003.09.019; Horton F, 2014, DIABETIC MED, V31, P559, DOI 10.1111/dme.12360; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lewis BS, 2005, ENDOSCOPY, V37, P960, DOI 10.1055/s-2005-870353; MAGNUSSON M, 1991, GUT, V32, P754, DOI 10.1136/gut.32.7.754; Moreno-Navarrete JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037160; Matsushita Y, 2013, J GASTROENTEROL, V48, P633, DOI 10.1007/s00535-012-0660-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MOGENSEN CE, 1987, KIDNEY INT, V31, P673, DOI 10.1038/ki.1987.50; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Ojetti V, 2009, EUR REV MED PHARMACO, V13, P419; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rana S, 2011, DIABETES TECHNOL THE, V13, P1115, DOI 10.1089/dia.2011.0078; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Song SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134321; Takeuchi K, 1997, J PHARMACOL EXP THER, V281, P200; Thomas Hugh, 2015, Nat Rev Endocrinol, V11, P688, DOI 10.1038/nrendo.2015.184; Toyry JP, 1996, DIABETES, V45, P308, DOI 10.2337/diabetes.45.3.308; Virally-Monod M, 1998, DIABETES METAB, V24, P530; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Yamamoto Yasuhiko, 2013, Front Endocrinol (Lausanne), V4, P105, DOI 10.3389/fendo.2013.00105; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100	38	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162354	10.1371/journal.pone.0162354	http://dx.doi.org/10.1371/journal.pone.0162354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598308	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800057
J	Fa, JE; Olivero, J; Farfan, MA; Lewis, J; Yasuoka, H; Noss, A; Hattori, S; Hirai, M; Kamgaing, TOW; Carpaneto, G; Germi, F; Marquez, AL; Duarte, J; Duda, R; Gallois, S; Riddell, M; Nasi, R				Fa, John E.; Olivero, Jesus; Angel Farfan, Miguel; Lewis, Jerome; Yasuoka, Hirokazu; Noss, Andrew; Hattori, Shiho; Hirai, Masaaki; Kamgaing, Towa O. W.; Carpaneto, Giuseppe; Germi, Francesco; Luz Marquez, Ana; Duarte, Jesus; Duda, Romain; Gallois, Sandrine; Riddell, Michael; Nasi, Robert			Differences between Pygmy and Non-Pygmy Hunting in Congo Basin Forests	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; BUSHMEAT; WILDLIFE; IMPACTS; CHOICE; MARKET; TRADE; GAME	We use data on game harvest from 60 Pygmy and non-Pygmy settlements in the Congo Basin forests to examine whether hunting patterns and prey profiles differ between the two hunter groups. For each group, we calculate hunted animal numbers and biomass available per inhabitant, P, per year (harvest rates) and killed per hunter, H, per year (extraction rates). We assess the impact of hunting of both hunter groups from estimates of numbers and biomass of prey species killed per square kilometre, and by examining the proportion of hunted taxa of low, medium and high population growth rates as a measure of their vulnerability to overhunting. We then map harvested biomass (kg(-1)P(-1)Yr(-1)) of bushmeat by Pygmies and non-Pygmies throughout the Congo Basin. Hunting patterns differ between Pygmies and non-Pygmies; Pygmies take larger and different prey and non-Pygmies sell more for profit. We show that non-Pygmies have a potentially more severe impact on prey populations than Pygmies. This is because non-Pygmies hunt a wider range of species, and twice as many animals are taken per square kilometre. Moreover, in non-Pygmy settlements there was a larger proportion of game taken of low population growth rate. Our harvest map shows that the non-Pygmy population may be responsible for 27 times more animals harvested than the Pygmy population. Such differences indicate that the intense competition that may arise from the more widespread commercial hunting by non-Pygmies is a far more important constraint and source of conflict than are protected areas.	[Fa, John E.] Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M1 5GD, Lancs, England; [Fa, John E.] CIFOR Headquarters, Ctr Int Forestry Res CIFOR, Bogor 16115, Indonesia; [Olivero, Jesus; Angel Farfan, Miguel; Luz Marquez, Ana] Univ Malaga, Fac Ciencias, Dept Biol Anim, Grp Biogeog Diversidad & Conservac, Campus Teatinos S-N, E-29071 Malaga, Spain; [Lewis, Jerome] UCL, Dept Anthropol, 14 Taviton St, London WC1H 0BW, England; [Yasuoka, Hirokazu; Kamgaing, Towa O. W.] Kyoto Univ, Ctr African Area Studies, Sakyo Ku, 46 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan; [Noss, Andrew] Univ Florida, Dept Geog, 3141 Turlington Hall, Gainesville, FL 32611 USA; [Hattori, Shiho] Tenri Univ, Fac Int Studies, 1050 Somanouchi, Tenri, Nara 6328510, Japan; [Hirai, Masaaki] Japan Forest Technol Assoc, Chiyoda Ku, 7 Rokubancho, Tokyo 1020085, Japan; [Kamgaing, Towa O. W.] Minist Forestry & Wildlife, POB 14794, Yaounde, Cameroon; [Carpaneto, Giuseppe; Germi, Francesco] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Duarte, Jesus] Ofitecma, Calle Colombia 5, Ronda 29400, Spain; [Duda, Romain; Gallois, Sandrine] Univ Autonoma Barcelona, Ethnoecol Lab, E-08193 Barcelona, Spain; [Duda, Romain; Gallois, Sandrine] MNHN Musee Homme, Dept Hommes, Nat, Soc, 17 Pl Trocadero, F-75116 Paris, France; [Riddell, Michael] UN House, Bioclimate Res & Dev, 4 Hunter Sq, Edinburgh EH1 1QW, Midlothian, Scotland; [Nasi, Robert] CIFOR Headquarters, Consultat Grp Int Agr Res, Jalan CIFOR, Bogor 16115, Indonesia; [Germi, Francesco] 46 2F2 Elm Row, Edinburgh EH7 4AH, Midlothian, Scotland	Manchester Metropolitan University; CGIAR; Center for International Forestry Research (CIFOR); Universidad de Malaga; University of London; University College London; Kyoto University; State University System of Florida; University of Florida; Roma Tre University; Autonomous University of Barcelona; Museum National d'Histoire Naturelle (MNHN); CGIAR; Center for International Forestry Research (CIFOR)	Fa, JE (corresponding author), Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M1 5GD, Lancs, England.; Fa, JE (corresponding author), CIFOR Headquarters, Ctr Int Forestry Res CIFOR, Bogor 16115, Indonesia.	jfa949@gmail.com	Duarte, Jesus/ABE-3009-2020; Gallois, Sandrine/AAG-4964-2019; Kamgaing, Towa O. William/U-6301-2019; Duda, Romain/ABD-9678-2020; Márquez, Ana Luz/K-8345-2014; Nasi, Robert/P-2382-2019; Olivero, Jesús/K-8727-2014; Farfan Aguilar, Miguel Angel/K-8783-2014	Gallois, Sandrine/0000-0002-4354-7685; Kamgaing, Towa O. William/0000-0002-5653-9019; Márquez, Ana Luz/0000-0001-5586-9334; Nasi, Robert/0000-0001-9739-3135; Olivero, Jesús/0000-0003-1714-0360; YASUOKA, Hirokazu/0000-0001-5066-1534; DUARTE DUARTE, JESUS/0000-0002-4952-154X; Fa, Julia E./0000-0002-3611-8487; FA, Julia Elizabeth/0000-0002-1572-9828; Farfan Aguilar, Miguel Angel/0000-0002-4617-6517; CARPANETO, Giuseppe Maria/0000-0002-6874-3463	Department for International Development (DFID); United States Agency for International Development (USAID); Leverhulme Trust [RP2011-R-045]; European Union's Seventh Framework Programme (FP7) / ERC [FP7-261971-LEK]; USAID; UKAID; CGIAR Fund; Grants-in-Aid for Scientific Research [16H05661, 15H02598] Funding Source: KAKEN	Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Leverhulme Trust(Leverhulme Trust); European Union's Seventh Framework Programme (FP7) / ERC; USAID(United States Agency for International Development (USAID)); UKAID(CGIAR); CGIAR Fund(CGIAR); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Department for International Development (DFID), the United States Agency for International Development (USAID), and the Leverhulme Trust (grant RP2011-R-045).; We are grateful to Roger Fotso, Allard Blom, Jacob Willie, David Wilkie, Nikki Tagg and Mark Infield for providing us with additional information on study sites. Data supplied by Romain Duda and Sandrine Gallois were collected under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement nr. FP7-261971-LEK to Reyes-Garcia. We thank USAID, UKAID, the CGIAR Fund and the Leverhulme Trust (grant RP2011-R-045) for providing core financial support for this study. This work was also part of and was conducted as part of the CGIAR Research Program on Forests, Trees and Agroforestry.	Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; [Anonymous], 2014, WORLD URB PROSP 2014; Arambiza E, 2006, HUM ORGAN, V65, P20, DOI 10.17730/humo.65.1.86y8rem7ugf8497u; BAHUCHET S, 1993, MAN BIOSPH, V13, P37; Bahuchet S., 1985, ETHNOS, V1, P6; Beltran J., 2000, BEST PRACT PROTECT A, V4; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Bennett EL., 2000, HUNTING WILDLIFE TRO; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Bikaba D, 2010, INDIGENOUS PEOPLES C, P49; Bobo Kadiri S., 2015, African Study Monographs Supplementary Issue, V51, P119; Bobo Kadiri S., 2011, Human Dimensions of Wildlife, V16, P445, DOI 10.1080/10871209.2011.608219; BODMER RE, 1995, ECOL APPL, V5, P872, DOI 10.2307/2269338; Brechin S., 2003, CONTESTED NATURE PRO; Brockington Dan, 2002, FORTRESS CONSERVATIO; Carpaneto G.M., 1989, Hystrix, V1, P1; CONSERVATION INTERNATIONAL, IND PEOPL CONS INT P; Counsell, 2016, PROTECTED AREAS CONG; Curran B., 2009, CONSERV SOC, V7, P30, DOI [10.4103/0972-4923.54795, DOI 10.4103/0972-4923.54795]; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2015, CONSERV BIOL, V29, P805, DOI 10.1111/cobi.12441; Fa JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112367; Fa John E., 2001, Conservation Biology Series (Cambridge), V6, P203; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; HARAKO R, 1976, Kyoto University African Studies, V10, P37; Hart JA, 2000, BIOL RESOURCE MANAGE, P106; HART JA, 1978, HUM ECOL, V6, P325, DOI 10.1007/BF00889029; HAWKES K, 1982, AM ETHNOL, V9, P379, DOI 10.1525/ae.1982.9.2.02a00100; Hoare AL, 2007, RESOURCE RIGHTS TIMB; Ichikawa M, 1983, AFR STUDY MONOGR, V4, P55, DOI [10.14989/68001, DOI 10.14989/68001]; Ingram DJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07823-200340; IUCN, IUCN RED LIST THREAT; IUCN W. UNEP, 1980, WORLD CONS STRAT; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kingdon J., 2013, MAMMALS AFRICA; Kitanishi K., 1995, AFR STUDY MONOGR, V16, P73, DOI [DOI 10.14989/68133, 10.14989/68133]; Kumpel NF, 2007, CONSERV SCI PRACT, V2, P73; Lewis Jerome, 2014, SOCIAL ORIGINS LANGU, P77, DOI [10.1093/acprof:oso/9780199665327.003.0007, DOI 10.1093/ACPROF:OSO/9780199665327.003.0007]; Lupo KD, 2005, J ANTHROPOL ARCHAEOL, V24, P335, DOI 10.1016/j.jaa.2005.02.002; Mavah GA, 2015, THESIS; Mbomio Ngomo D, 2009, PLAN MANEJO RIO CAMP; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Nelson J., 2003, INDIGENOUS PEOPLES P; Noss A, 2000, BIOL RESOURCE MANAGE, P282; Olivero J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144499; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Redford K., 1996, TRADITIONAL PEOPLES; Redford K. H., 2007, 29 WILDL CONS SOC; Redford K. H., 2006, 25 WCS; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; Riddell M, 2011, THESIS; Riddell M, 2013, CONSERV SOC, V11, P199, DOI 10.4103/0972-4923.121002; Robinson J., 2000, HUNTING SUSTAINABILI; Roe D., 2009, COMMUNITY MANAGEMENT; Sarkar S, 2011, BIOL CONSERV, V144, P979, DOI 10.1016/j.biocon.2010.03.008; Schmidt-Soltau K, 2005, PLAN DEV PEUPLES AUT; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Takeuchi K, 1995, ZOOARCHAEOLOGY, V4, P27; TANNO T, 1976, Kyoto University African Studies, V10, P101; Terashima H., 1983, AFRICAN STUDY MONOGR, V3, P71; Usongo L, 2004, INT J SUST DEV WORLD, V11, P119, DOI 10.1080/13504500409469816; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; VANSINA J, 1995, J AFR HIST, V36, P173, DOI 10.1017/S0021853700034101; Vickers W. T., 1980, WORKING PAPERS S AM, V2, P7; White F, 1983, SERIES NATURAL RESOU, VXX; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wilshusen PR, CONTESTED NATURE PRO, P41; WWF, 1996, IND PEOPL CONS WWF S; Yasuoka H., 2014, AFR STUDY MONOGR SUP, V49, P115, DOI 10.14989/189625; Yasuoka Hirokazu, 2006, African Study Monographs Supplementary Issue, V33, P95	75	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161703	10.1371/journal.pone.0161703	http://dx.doi.org/10.1371/journal.pone.0161703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589384	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800014
J	Flood, D; Mux, S; Martinez, B; Garcia, P; Douglas, K; Goldberg, V; Lopez, W; Rohloff, P				Flood, David; Mux, Sandy; Martinez, Boris; Garcia, Pablo; Douglas, Kate; Goldberg, Vera; Lopez, Waleska; Rohloff, Peter			Implementation and Outcomes of a Comprehensive Type 2 Diabetes Program in Rural Guatemala	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHRONIC DISEASE; CENTRAL-AMERICA; HEALTH; CARE; MANAGEMENT; PREVALENCE; PREVENTION; GLUCOSE; HYPERTENSION	Background The burden of chronic, non-communicable diseases such as diabetes is growing rapidly in low-and middle-income countries. Implementing management programs for diabetes and other chronic diseases for underserved populations is thus a critical global health priority. However, there is a notable dearth of shared programmatic and outcomes data from diabetes treatment programs in these settings. Program Description We describe our experiences as a non-governmental organization designing and implementing a type 2 diabetes program serving Maya indigenous people in rural Guatemala. We detail the practical challenges and solutions we have developed to build and sustain diabetes programming in this setting. Methods We conduct a retrospective chart review from our electronic medical record to evaluate our program's performance. We generate a cohort profile, assess cross-sectional indicators using a framework adapted from the literature, and report on clinical longitudinal outcomes. Results A total of 142 patients were identified for the chart review. The cohort showed a decrease in hemoglobin A1C from a mean of 9.2% to 8.1% over an average of 2.1 years of follow-up (p < 0.001). The proportions of patients meeting glycemic targets were 53% for hemoglobin A1C < 8% and 32% for the stricter target of hemoglobin A1C < 7%. Conclusion We first offer programmatic experiences to address a gap in resources relating to the practical issues of designing and implementing global diabetes management interventions. We then present clinical data suggesting that favorable diabetes outcomes can be attained in poor areas of rural Guatemala.	[Flood, David; Mux, Sandy; Martinez, Boris; Garcia, Pablo; Douglas, Kate; Goldberg, Vera; Lopez, Waleska; Rohloff, Peter] Wuqu Kawoq, Maya Hlth Alliance, Santiago Sacatepequez, Sacatepequez, Guatemala; [Flood, David] Univ Minnesota, Med Pediat Residency Program, Minneapolis, MN USA; [Garcia, Pablo] St Peters Univ Hosp, Internal Med Residency Program, New Brunswick, NJ USA; [Goldberg, Vera] Harvard Med Sch, Boston, MA USA; [Rohloff, Peter] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; Saint Peter's University Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Rohloff, P (corresponding author), Wuqu Kawoq, Maya Hlth Alliance, Santiago Sacatepequez, Sacatepequez, Guatemala.; Rohloff, P (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	peter@wuqukawoq.org	Rohloff, Peter/P-8722-2017; Garcia, Pablo/AAU-7506-2020	Rohloff, Peter/0000-0001-7274-8315; Douglas, Katherine/0000-0002-7331-3716; Flood, David/0000-0002-4372-7387				[Anonymous], 2015, DIABETES CARE, V38, pS4, DOI 10.2337/dc15-S003; [Anonymous], 2013, IDF DIABETES ATLAS; Aschner P, 2014, DIABETES RES CLIN PR, V103, P238, DOI 10.1016/j.diabres.2013.11.010; Balcazar H, 2011, J AMBUL CARE MANAG, V34, P362, DOI 10.1097/JAC.0b013e31822cbd0b; Barcelo A, 2010, CENTRAL AMERICA DIAB; Barcelo A, 2012, DIABETES CARE, V35, P738, DOI 10.2337/dc11-1614; Barcelo A, 2010, PRIM CARE DIABETES, V4, P145, DOI 10.1016/j.pcd.2010.04.005; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beran D, 2016, LANCET DIABETES ENDO, V4, P275, DOI 10.1016/S2213-8587(15)00521-5; Bukhman G, 2011, THE PIH GUIDE TO CHR; Chary A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-476; Clinical Guidelines Task Force, 2012, GLOBAL GUIDELINE FOR; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Dagaenis GR, 2016, DIABETES CARE; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dube L, 2015, DIABETES EDUCATOR, V41, P69, DOI 10.1177/0145721714558305; Esterson YB, 2014, J HEALTH CARE POOR U, V25, P72, DOI 10.1353/hpu.2014.0037; Flood D, 2015, PRIVATIZATION AND TH; Flores W, 2008, ANALYSIS OF POLITICS; Garcia Caal ER, 2015, NATIONAL HEALTH CALC; Gaziano T, 2015, HEALTH AFFAIR, V34, P1538, DOI 10.1377/hlthaff.2015.0349; Gaziano TA, 2015, LANCET GLOB HEALTH, V3, pE556, DOI 10.1016/S2214-109X(15)00143-6; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gherman A, 2011, PRACT DIABETES INT, V28, P125, DOI DOI 10.1002/PDI.1574; Gill GV, 2008, DIABETIC MED, V25, P606, DOI 10.1111/j.1464-5491.2008.02421.x; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Greiner M, 2012, HEART HEALTH RAXNAQI; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Instituto Nacional de Estadistica, 2011, MAPS OF RURAL POVERT; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Katz I, 2009, PRIM CARE DIABETES, V3, P157, DOI 10.1016/j.pcd.2009.06.007; Kengne AP, 2009, PRIM CARE DIABETES, V3, P181, DOI 10.1016/j.pcd.2009.08.005; Kronick R, 2015, 2014 NATIONAL HEALTH; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Labhardt ND, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-339; Lekoubou A, 2010, INT J ENV RES PUB HE, V7, P353, DOI 10.3390/ijerph7020353; Liu SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1043; Mamo Y, 2007, CLIN MED, V7, P228, DOI 10.7861/clinmedicine.7-3-228; Maronsky HS, 2012, HEALTH IN THE AMERIC; Moreira Diaz JP, 2014, REV GUATEM CARDIOL, V24, pS34; MSPAS, 2011, GUIDES FOR THE PREVE; Pastakia SD, 2011, ANN PHARMACOTHER, V45, P721, DOI 10.1345/aph.1P779; Perez-Cuevas R, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-50; Price C, 2011, QJM-INT J MED, V104, P571, DOI 10.1093/qjmed/hcr005; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Rawal LB, 2012, INT J BEHAV MED, V19, P121, DOI 10.1007/s12529-011-9162-9; Roglic G, 2010, DIABETES RES CLIN PR, V87, P15, DOI 10.1016/j.diabres.2009.10.006; Guzman JR, 2010, REV PANAM SALUD PUBL, V28, P463, DOI 10.1590/S1020-49892010001200008; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Universidad Rafael Landivar, 2009, STUDY INFORMATION AB; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, 2012, PREVENTION CONTROL N; Zabetian A, 2014, DIABETES RES CLIN PR, V104, P206, DOI 10.1016/j.diabres.2014.01.005	54	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161152	10.1371/journal.pone.0161152	http://dx.doi.org/10.1371/journal.pone.0161152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583362	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600014
J	McFarlane, SE; Sirkia, PM; Alund, M; Qvarnstrom, A				McFarlane, S. Eryn; Sirkia, Paivi M.; Alund, Murielle; Qvarnstrom, Anna			Hybrid Dysfunction Expressed as Elevated Metabolic Rate in Male Ficedula Flycatchers	PLOS ONE			English	Article							CLIMATE-CHANGE; DARWINS COROLLARY; MITOCHONDRIAL; EVOLUTION; HYBRIDIZATION; PERFORMANCE; SPECIATION; STERILITY; SURVIVAL; GENES	Studies of ecological speciation are often biased towards extrinsic sources of selection against hybrids, resulting from intermediate hybrid morphology, but the knowledge of how genetic incompatibilities accumulate over time under natural conditions is limited. Here we focus on a physiological trait, metabolic rate, which is central to life history strategies and thermoregulation but is also likely to be sensitive to mismatched mitonuclear interactions. We measured the resting metabolic rate of male collared, and pied flycatchers as well as of naturally occurring F1 hybrid males, in a recent hybrid zone. We found that hybrid males had a higher rather than intermediate metabolic rate, which is indicative of hybrid physiological dysfunction. Fitness costs associated with elevated metabolic rate are typically environmentally dependent and exaggerated under harsh conditions. By focusing on male hybrid dysfunction in an eco-physiological trait, our results contribute to the general understanding of how combined extrinsic and intrinsic sources of hybrid dysfunction build up under natural conditions.	[McFarlane, S. Eryn; Alund, Murielle; Qvarnstrom, Anna] Dept Ecol & Genet, Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden; [Sirkia, Paivi M.] Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland; [Sirkia, Paivi M.] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland	University of Helsinki; University of Turku	McFarlane, SE (corresponding author), Dept Ecol & Genet, Anim Ecol, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	eryn.mcfarlane@ebc.uu.se	Ålund, Murielle/Q-2996-2019	Ålund, Murielle/0000-0003-2861-9721; Sirkia, Paivi Maria/0000-0003-0346-6298	Swedish Research Council [621-2012-3722]; Natural Sciences and Engineering Research Council; Stiftelsen for Zoologisk Forskning; Academy of Finland [267430]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Stiftelsen for Zoologisk Forskning; Academy of Finland(Academy of Finland)	This work was supported by funding from the Swedish Research Council (AQ 621-2012-3722), the Natural Sciences and Engineering Research Council (SEM PGS-D), Stiftelsen for Zoologisk Forskning (SEM and MA) and the Academy of Finland (PMS 267430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alund M, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0169; Arnqvist G, 2010, EVOLUTION, V64, P3354, DOI 10.1111/j.1558-5646.2010.01135.x; Bates D, LME4 LINEAR MIXED EF; Becker M, 2013, NAT CLIM CHANGE, V3, P1039, DOI 10.1038/NCLIMATE2027; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Blackmer AL, 2005, BEHAV ECOL, V16, P906, DOI 10.1093/beheco/ari069; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Deerenberg C, 1998, J COMP PHYSIOL B, V168, P507, DOI 10.1007/s003600050171; Dieckmann U., 2004, ADAPTIVE SPECIATION; Dobzhansky T, 1936, GENETICS, V21, P113; Ellison CK, 2008, J EVOLUTION BIOL, V21, P1844, DOI 10.1111/j.1420-9101.2008.01608.x; Fishman L, 2001, EVOLUTION, V55, P1932, DOI 10.1111/j.0014-3820.2001.tb01311.x; FORD WCL, 1981, J REPROD FERTIL, V63, P271; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Gomendio M, 2011, P ROY SOC LOND B BIO; HALANGK W, 1985, BIOCHIM BIOPHYS ACTA, V808, P316, DOI 10.1016/0005-2728(85)90014-3; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Hoekstra LA, 2013, GENETICS, V195, P1129, DOI 10.1534/genetics.113.154914; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hothorn T, 2008, BIOMETRICAL J, V50, P346; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huxley J, 1940, NEW SYSTEMATICS, P185; Johnson NA, 2010, TRENDS GENET, V26, P317, DOI 10.1016/j.tig.2010.04.005; Kawakami T, 2014, MOL ECOLOGY RESOURCE; Klaassen M, 2004, COMP BIOCHEM PHYS A, V137, P639, DOI 10.1016/j.cbpb.2003.12.004; Krol E, 2003, J EXP BIOL, V206, P4283, DOI 10.1242/jeb.00676; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Larivee ML, 2010, FUNCT ECOL, V24, P597, DOI 10.1111/j.1365-2435.2009.01680.x; LASIEWSKI R. C., 1964, CONDOR, V66, P212, DOI 10.2307/1365646; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lundberg A, 1992, PIED FLYCATCHER; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; MANI GS, 1990, PROC R SOC SER B-BIO, V240, P29, DOI 10.1098/rspb.1990.0025; Muhlfeld CC, 2014, NATURE CLIMATE CHANG; Nadachowska-Brzyska K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003942; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Olson JR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P263, DOI 10.1086/648395; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Qvarnstrom A, 2005, BIOL LETTERS, V1, P68, DOI 10.1098/rsbl.2004.0265; Qvarnstrom A, 2015, EVOLUTIONARY APPL; Qvarnstrom A, 2010, PHILOS T R SOC B, V365, P1841, DOI 10.1098/rstb.2009.0306; Qvarnstrom A, 2009, ECOLOGY, V90, P1948, DOI 10.1890/08-0494.1; R Core Team, 2021, R LANGUAGE ENV STAT; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saetre GP, 1997, NATURE, V387, P589; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Skibiel AL, 2013, FUNCT ECOL, V27, P1382, DOI 10.1111/1365-2435.12130; Svedin N, 2008, P ROY SOC B-BIOL SCI, V275, P735, DOI 10.1098/rspb.2007.0967; Tieleman BI, 2009, P ROY SOC B-BIOL SCI, V276, P1685, DOI 10.1098/rspb.2008.1946; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Trier CN, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004075; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979	60	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161547	10.1371/journal.pone.0161547	http://dx.doi.org/10.1371/journal.pone.0161547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583553	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600038
J	Nakao, M; Endo, S; Nakao, S; Yoshida, M; Matsuda, T				Nakao, Megumi; Endo, Shota; Nakao, Shinichi; Yoshida, Munehito; Matsuda, Tetsuya			Augmented Endoscopic Images Overlaying Shape Changes in Bone Cutting Procedures	PLOS ONE			English	Article							SPINAL NAVIGATION; MICROENDOSCOPIC DISKECTOMY; TUMOR SURGERY; REGISTRATION; ACCURACY; FUTURE	In microendoscopic discectomy for spinal disorders, bone cutting procedures are performed in tight spaces while observing a small portion of the target structures. Although optical tracking systems are able to measure the tip of the surgical tool during surgery, the poor shape information available during surgery makes accurate cutting difficult, even if preoperative computed tomography and magnetic resonance images are used for reference. Shape estimation and visualization of the target structures are essential for accurate cutting. However, time-varying shape changes during cutting procedures are still challenging issues for intraoperative navigation. This paper introduces a concept of endoscopic image augmentation that overlays shape changes to support bone cutting procedures. This framework handles the history of the location of the measured drill tip as a volume label and visualizes the remains to be cut overlaid on the endoscopic image in real time. A cutting experiment was performed with volunteers, and the feasibility of this concept was examined using a clinical navigation system. The efficacy of the cutting aid was evaluated with respect to the shape similarity, total moved distance of a cutting tool, and required cutting time. The results of the experiments showed that cutting performance was significantly improved by the proposed framework.	[Nakao, Megumi; Endo, Shota; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Nakao, Shinichi; Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan	Kyoto University; Wakayama Medical University	Nakao, M (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	megumi@i.kyoto-u.ac.jp		Nakao, Megumi/0000-0002-5508-4366	JSPS [15H03032]; Center of Innovation (COI) Program from Japan Science and Technology Agency (JST)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation (COI) Program from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This research was supported by the JSPS Grant-in-Aid for Scientific Research (B) (15H03032); URL: https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the JSPS Grant-in-Aid for Scientific Research (B) (15H03032). This work was also supported by the Center of Innovation (COI) Program from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Keiho Imanishi, Tomoaki Takemura, Kotaro Minato, and Takashi Takahashi for participating in a valuable discussion on the system design and experiments.	Agus M, 2013, PRESENCE, V12, P110; Bichlmeier C, 2009, IEEE T MED IMAGING, V28, P1498, DOI 10.1109/TMI.2009.2018622; Cartiaux O, 2014, ANN BIOMED ENG, V42, P205, DOI 10.1007/s10439-013-0890-7; Cartiaux O, 2013, COMPUT AIDED SURG, V18, P19, DOI 10.3109/10929088.2012.744096; Edwards PJ, 2000, IEEE T MED IMAGING, V19, P1082, DOI 10.1109/42.896784; Foley K.T., 1997, TECH NEUROSURG, V3, P301; Haouchine N, 2015, IEEE T VIS COMPUT GR, V21, P584, DOI 10.1109/TVCG.2014.2377772; Helm PA, 2015, IEEE T MED IMAGING, V34, P1738, DOI 10.1109/TMI.2015.2391200; Imanishi K, 2013, INT J COMPUT ASS RAD, V5, P461; Johnson JP, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13532; Kockro RA, 2009, NEUROSURGERY, V65, P795, DOI 10.1227/01.NEU.0000349918.36700.1C; Liao HE, 2010, IEEE T BIO-MED ENG, V57, P1476, DOI 10.1109/TBME.2010.2040278; Luan S, 2012, COMPUT METH PROG BIO, V108, P151, DOI 10.1016/j.cmpb.2012.02.007; Mori M, 2010, INT J COMPUT ASS RAD, V5, pS414; Morris D, 2006, IEEE COMPUT GRAPH, V26, P48, DOI 10.1109/MCG.2006.140; Nakagawa H, 2005, INT J SPINE SURG, P2; Nakao M, 2015, IEEE INT S MIX AUG R, P176; Park P, 2015, OPER NEUROSURG, V11, P259, DOI 10.1227/NEU.0000000000000726; Rahmathulla G, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13516; Righesso O, 2007, NEUROSURGERY, V61, P545, DOI 10.1227/01.NEU.0000290901.00320.F5; Schouten R, 2012, J CLIN NEUROSCI, V19, P1137, DOI 10.1016/j.jocn.2012.01.020; Smith N, 2013, EUR SPINE J, V22, P2458, DOI 10.1007/s00586-013-2848-8; Tjardes T, 2010, EUR SPINE J, V19, P25, DOI 10.1007/s00586-009-1091-9; Vankipuram M, 2010, J BIOMED INFORM, V43, P661, DOI 10.1016/j.jbi.2010.05.016; Wang JC, 2014, IEEE T BIO-MED ENG, V61, P1295, DOI 10.1109/TBME.2014.2301191; Wang XW, 2010, IEEE T MED IMAGING, V29, P1213, DOI 10.1109/TMI.2009.2028341; Wen R, 2013, INT J COMPUT ASS RAD, V8, P1015, DOI 10.1007/s11548-013-0897-4	27	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161815	10.1371/journal.pone.0161815	http://dx.doi.org/10.1371/journal.pone.0161815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584732	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600063
J	Wolkewitz, M; Schumacher, M				Wolkewitz, Martin; Schumacher, Martin			Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data	PLOS ONE			English	Article							CLINICAL-STUDY REPORTS; REAL-WORLD DATA; VIRUS-INFECTION; COMPETING RISK; IMMORTAL TIME; ADULTS; BIAS; METAANALYSIS; OSELTAMIVIR; CHILDREN	Background Observational studies claimed reducing effects of neuraminidase inhibitors (NI) on hospital mortality in patients with H1N1 influenza A. It has been criticized that such findings are prone to common and serious survival biases. Methods With observational data from the FLU-CIN study group, multi-state and dynamic prediction models have been used to avoid such biases. The data included 1391 patients with confirmed pandemic influenza A/H1N1 infection collected during 2009-2010 in the UK. Due to their close relationship, the main outcome measures were hospital death and length of hospital stay. Findings There is no direct effect of NI on the hospital death rate; the hazard ratio (HR) of NI was 1.03 (95%-CI: 0.64-1.66). The discharge rate is increased for NI patients (HR = 1.89 (95%-CI: 1.65-2.16)) indicating that NI-treated patients stay shorter in hospital than NI-untreated patients, on average 3.10 days (95%-CI: 2.07-4.14). We also showed that the initiation timing of NI treatment (<= 2 days versus > 2 days after onset) made no difference on the effects on the hospital death and discharge hazards. The hazard ratios remain stable after adjusting for potential confounders measured at admission (such as comorbidities and influenza-related clinical symptoms). Conclusions The potential beneficial effect of NI on hospitalized patients in the UK is rather a reduction of the length of hospital stay than a reduction of the mortality rate. There seems to be no confounding by indication and no differences if NI is given early or late. Different effects could be present in other populations (such as non-hospitalized individuals) or countries. Careful interpretation of the effect on length of hospital stay is needed due to potentially different discharge policies of NI-treated and NI-untreated patients.	[Wolkewitz, Martin; Schumacher, Martin] Univ Freiburg, Inst Med Biometry & Stat, Ctr Med Biometry & Med Informat, Med Ctr, Freiburg, Germany	University of Freiburg	Wolkewitz, M (corresponding author), Univ Freiburg, Inst Med Biometry & Stat, Ctr Med Biometry & Med Informat, Med Ctr, Freiburg, Germany.	wolke@imbi.uni-freiburg.de		Wolkewitz, Martin/0000-0002-1268-5057	German Research Foundation (Deutsche Forschungsgemeinschaft) [WO 1746/1-2]	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	MW received funding from the German Research Foundation (Deutsche Forschungsgemeinschaft) (grant No WO 1746/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisasmito W, 2010, J INFECT DIS, V202, P1154, DOI 10.1086/656316; [Anonymous], 2015, LANCET, V386, P1510, DOI [10.1016/S0140-6736(15)00523-1, DOI 10.1016/S0140-6736(15)00523-1]; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Beyersmann J, 2006, INFECT CONT HOSP EP, V27, P493, DOI 10.1086/503375; Beyersmann J, 2011, COMPETING RISKS MULT; Cortese G, 2010, BIOMETRICAL J, V52, P138, DOI 10.1002/bimj.200900076; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Freemantle N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2371; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Hanley JA, 2014, INT J EPIDEMIOL, V43, P949, DOI 10.1093/ije/dyu105; Heneghan CJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2547; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; JONES M, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G3001; Jones Mark, 2014, Lancet Respir Med, V2, pe9, DOI 10.1016/S2213-2600(14)70126-2; Lange T, 2014, INT J EPIDEMIOL, V43, P971, DOI 10.1093/ije/dyu100; Leibovici L, 2014, CLIN MICROBIOL INFEC, V20, pO979, DOI 10.1111/1469-0691.12708; Antes Gerd, 2014, Lancet Respir Med, V2, pe10, DOI [10.1016/S2213-2600(14)70137-7, 10.1016/S2213-2600(14)70127-4]; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Michiels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060348; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Schumacher M, 2013, INT J EPIDEMIOL, V42, P1502, DOI 10.1093/ije/dyt111; van Houwelingen H., 2011, DYNAMIC PREDICTION C; van Walraven C, 2016, J CLIN EPIDEMIOL, V69, P170, DOI 10.1016/j.jclinepi.2015.07.006; Wiysonge CS, 2014, INT J EPIDEMIOL, V43, P1691, DOI 10.1093/ije/dyu219; Wolkewitz M, 2014, LANCET RESP MED, V2, P8, DOI [10.1016/S2213-, DOI 10.1016/S2213-]; Wolkewitz M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5060; Wolkewitz M, 2012, J CLIN EPIDEMIOL, V65, P1171, DOI 10.1016/j.jclinepi.2012.04.008; Wolkewitz M, 2011, J ANTIMICROB CHEMOTH, V66, P381, DOI 10.1093/jac/dkq424; Wong JY, 2015, AM J EPIDEMIOL, V182, P294, DOI 10.1093/aje/kwv054; Yu HJ, 2011, CLIN INFECT DIS, V52, P457, DOI 10.1093/cid/ciq144	35	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160430	10.1371/journal.pone.0160430	http://dx.doi.org/10.1371/journal.pone.0160430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583403	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600005
J	Xu, J; Han, R; Kim, DW; Mo, JH; Jin, YD; Rha, KS; Kim, YM				Xu, Jun; Han, Ruining; Kim, Dae Woo; Mo, Ji-Hun; Jin, Yongde; Rha, Ki-Sang; Kim, Yong Min			Role of Interleukin-10 on Nasal Polypogenesis in Patients with Chronic Rhinosinusitis with Nasal Polyps	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CELL-ACTIVATING FACTOR; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; PROTEIN-A; T-CELLS; EXPRESSION; INFLAMMATION; IL-10; PATHOGENESIS	Background and Objectives Interleukin 10 (IL-10) is a potent anti-inflammatory cytokine. The dysregulation of IL-10 is associated with an enhanced immunopathologic response to infection, as well as with an increased risk for developing numerous autoimmune diseases. In this study, we investigated IL-10 expression in chronic rhinosinusitis with nasal polyps (CRSwNP) and assessed the possible role of IL-10 in the pathogenesis of CRSwNP. Materials and Methods Thirty-five patients with CRSwNP, 12 patients with chronic rhinosinusitis without NP (CRSsNP) and 10 control subjects were enrolled in this study. NP tissues and uncinated tissues (UT) were collected for analysis. Dispersed NP cells (DNPCs) were cultured in the presence or absence of IL-25 and IL-10, and a flow cytometric assay was performed to identify the constitutive cell populations of the DNPCs. Murine NP (n = 18) models were used for the in vivo experiments. Real-time PCR, immunohistochemistry, western blotting analysis and ELISA were performed to measure the expression levels of the selected inflammatory cytokines and inflammation-associated molecules. Results The mRNA expression levels of IL-10, IL-5, IL-17A, IL-25 and interferon gamma (IFN-gamma) were significantly higher in the NP tissues than in the UT tissues. Strong positive correlations were observed between IL-10 and a variety of inflammatory cytokines (IL-5, IL-17A, IL-25, IFN-gamma) and inflammation-associated molecules (B-cell activating factor; BAFF, CD19). Other than the IL-25 to IL-10 ratio, the expression ratios of the other measured inflammatory cytokines to IL-10 were significantly lower in the CRSwNP group than in the CRSsNP or control groups. Administrating IL-25 into the cultured DNPCs significantly increased the production of IL-10, but administrating IL-10 had no effect on the production of IL-25. Conclusion Increased expression of IL-10, IL-10 related inflammatory cytokine, and IL-10 related B cell activation indicated that IL-10, a potent anti-inflammatory cytokine, has a pivotal role in the pathogenesis of CRSwNPs.	[Xu, Jun; Han, Ruining; Rha, Ki-Sang; Kim, Yong Min] Chungnam Natl Univ, Res Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Daejeon, South Korea; [Kim, Dae Woo] Seoul Natl Univ, Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Mo, Ji-Hun] Dankook Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Cheonan, South Korea; [Xu, Jun; Han, Ruining; Jin, Yongde] Yanbian Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Yanji, Peoples R China	Chungnam National University; Seoul National University (SNU); Seoul National University Hospital; Dankook University; Yanbian University	Kim, YM (corresponding author), Chungnam Natl Univ, Res Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Daejeon, South Korea.	entkym@cnu.ac.kr	; Mo, Ji-Hun/E-5586-2011	Rha, Ki-Sang/0000-0001-9981-057X; Kim, Yong Min/0000-0001-5414-8332; Mo, Ji-Hun/0000-0003-1331-364X	research fund of Chungnam National University	research fund of Chungnam National University	This work was supported by research fund of Chungnam National University 2014.	Ba L, 2015, ALLERGY ASTHMA IMMUN, V7, P346, DOI 10.4168/aair.2015.7.4.346; Baba S, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0100-2; Bachert C, 1997, J ALLERGY CLIN IMMUN, V99, P837, DOI 10.1016/S0091-6749(97)80019-X; BUELENS C, 1995, EUR J IMMUNOL, V25, P2668, DOI 10.1002/eji.1830250940; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Esmaeilzadeh H, 2015, CLIN IMMUNOL, V160, P349, DOI 10.1016/j.clim.2015.05.012; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Frodermann V, 2011, J INFECT DIS, V204, P253, DOI 10.1093/infdis/jir276; Gong J, 2013, AM J OTOLARYNG, V34, P183, DOI 10.1016/j.amjoto.2012.10.003; Higaki T, 2012, CLIN EXP ALLERGY, V42, P1217, DOI 10.1111/j.1365-2222.2012.04015.x; Hunter CA, 1997, J IMMUNOL, V158, P3311; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jin J, 2014, LARYNGOSCOPE, V124, pE151, DOI 10.1002/lary.24472; Jin J, 2014, EUR ARCH OTO-RHINO-L, V271, P1097, DOI 10.1007/s00405-013-2683-x; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kim DW, 2016, LARYNGOSCOPE, V126, pE265, DOI 10.1002/lary.26004; Kim DW, 2011, AM J RHINOL ALLERGY, V25, pE255, DOI 10.2500/ajra.2011.25.3727; Konig K, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0123-3; Krysko O, 2011, ALLERGY, V66, P396, DOI 10.1111/j.1398-9995.2010.02498.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007589; Liu Z, 2009, ALLERGY, V64, P149, DOI 10.1111/j.1398-9995.2008.01847.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malagutti N, 2008, AM J RHINOL, V22, P468, DOI 10.2500/ajr.2008.22.3210; de Castro MCM, 2013, AM J RHINOL ALLERGY, V27, pE32, DOI 10.2500/ajra.2013.27.3868; Ndishimye Pacifique, 2015, Clujul Med, V88, P164, DOI 10.15386/cjmed-459; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Okano M, 2016, ALLERGOL INT, V65, P96, DOI 10.1016/j.alit.2015.08.005; Okano M, 2015, J ALLERGY CLIN IMMUN, V136, P343, DOI 10.1016/j.jaci.2014.10.058; Okano M, 2014, ALLERGOL INT, V63, P563, DOI 10.2332/allergolint.14-OA-0703; Okano M, 2009, J ALLERGY CLIN IMMUN, V123, P868, DOI 10.1016/j.jaci.2009.01.047; Othieno C, 1999, INFECT IMMUN, V67, P5730, DOI 10.1128/IAI.67.11.5730-5735.1999; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ozkara S, 2012, EUR ARCH OTO-RHINO-L, V269, P2519, DOI 10.1007/s00405-012-1967-x; Park SJ, 2013, J ALLERGY CLIN IMMUN, V131, P772, DOI 10.1016/j.jaci.2012.12.671; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Peric A, 2012, B-ENT, V8, P25; Peric A, 2011, ALLERGOL IMMUNOPATH, V39, P133, DOI 10.1016/j.aller.2010.05.001; Peric A, 2013, INDIAN J OTOLARYNGOL, V65, pS295, DOI 10.1007/s12070-011-0447-8; Peric A, 2010, ACTA CLIN CROAT, V49, P395; Peric Aleksandar, 2010, Kulak Burun Bogaz Ihtis Derg, V20, P111; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Sachse F, 2006, CLIN EXP IMMUNOL, V144, P534, DOI 10.1111/j.1365-2249.2006.03089.x; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Shen Y, 2011, SCAND J IMMUNOL, V74, P176, DOI 10.1111/j.1365-3083.2011.02546.x; Shen Y, 2014, ASIAN PAC J ALLERGY, V32, P300, DOI 10.12932/AP0469.32.4.2014; Shi J, 2009, J INVEST ALLERG CLIN, V19, P276; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; Wu DW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002998; Yang X, 2000, EUR J IMMUNOL, V30, P382, DOI 10.1002/1521-4141(200002)30:2<382::AID-IMMU382>3.0.CO;2-L; Yoon YH, 2014, RHINOLOGY, V52, P390, DOI [10.4193/Rhin13.154, 10.4193/Rhino13.154]; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang Q, 2013, ACTA OTO-LARYNGOL, V133, P165, DOI 10.3109/00016489.2012.717713	58	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161013	10.1371/journal.pone.0161013	http://dx.doi.org/10.1371/journal.pone.0161013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584662	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600012
J	Rangel, LI; Henkels, MD; Shaffer, BT; Walker, FL; Davis, EW; Stockwell, VO; Bruck, D; Taylor, BJ; Loper, JE				Rangel, Lorena I.; Henkels, Marcella D.; Shaffer, Brenda T.; Walker, Francesca L.; Davis, Edward W., II; Stockwell, Virginia O.; Bruck, Denny; Taylor, Barbara J.; Loper, Joyce E.			Characterization of Toxin Complex Gene Clusters and Insect Toxicity of Bacteria Representing Four Subgroups of Pseudomonas fluorescens	PLOS ONE			English	Article							CATERPILLARS-FLOPPY MCF; BIOLOGICAL-CONTROL; PHOTORHABDUS; COLONIZATION; SPP.; IDENTIFICATION; PHENOLOXIDASE; RHIZOSPHERE; SEQUENCE; DISEASE	Ten strains representing four lineages of the Pseudomonas fluorescens group (P. chlororaphis, P. corrugata, P. koreensis, and P. fluorescens subgroups) were evaluated for toxicity to the tobacco hornworm Manduca sexta and the common fruit fly Drosophila melanogaster. The three strains within the P. chlororaphis subgroup exhibited both oral and injectable toxicity to the lepidopteran M. sexta. All three strains have the gene cluster encoding the FitD insect toxin and a Delta fitD mutant of P. protegens strain Pf-5 exhibited diminished oral toxicity compared to the wildtype strain. Only one of the three strains, P. protegens Pf-5, exhibited substantial levels of oral toxicity against the dipteran D. melanogaster. Three strains in the P. fluorescens subgroup, which lack fitD, consistently showed significant levels of injectable toxicity against M. sexta. In contrast, the oral toxicity of these strains against D. melanogaster was variable between experiments, with only one strain, Pseudomonas sp. BG33R, causing significant levels of mortality in repeated experiments. Toxin complex (Tc) gene clusters, which encode insecticidal properties in Photorhabdus luminescens, were identified in the genomes of seven of the ten strains evaluated in this study. Within those seven genomes, six types of Tc gene clusters were identified, distinguished by gene content, organization and genomic location, but no correlation was observed between the presence of Tc genes and insect toxicity of the evaluated strains. Our results demonstrate that members of the P. fluorescens group have the capacity to kill insects by both FitD-dependent and independent mechanisms.	[Rangel, Lorena I.; Henkels, Marcella D.; Stockwell, Virginia O.; Loper, Joyce E.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Henkels, Marcella D.; Shaffer, Brenda T.; Davis, Edward W., II; Stockwell, Virginia O.; Bruck, Denny; Loper, Joyce E.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR 97333 USA; [Walker, Francesca L.; Taylor, Barbara J.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Rangel, Lorena I.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Bruck, Denny] DuPont Pioneer, Johnston, IA USA	Oregon State University; United States Department of Agriculture (USDA); Oregon State University; University of California System; University of California Davis; DuPont; Pioneer Hi-Bred International, Inc.	Loper, JE (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.; Loper, JE (corresponding author), ARS, USDA, Hort Crops Res Lab, Corvallis, OR 97333 USA.	loperj@science.oregonstate.edu		Rangel, Lorena/0000-0002-9081-5275; Davis, Edward/0000-0003-1229-4272; Loper, Joyce/0000-0003-3501-5969	Oregon State University; United States Department of Agriculture National Institute of Food and Agriculture [2008-35600-18770, 2011-67019-30192]	Oregon State University; United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	LIR was supported by a Provost's Distinguished Graduate Fellowship from Oregon State University. This work was supported by Agriculture and Food Research Initiative Competitive Grant 2008-35600-18770 and 2011-67019-30192 from the United States Department of Agriculture National Institute of Food and Agriculture.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bidla G, 2009, J INNATE IMMUN, V1, P301, DOI 10.1159/000168009; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen WJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004288; Commare RR, 2002, CROP PROT, V21, P671, DOI 10.1016/S0261-2194(02)00020-0; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Defago G., 1990, SOIL BIOCH, P249; Dowling AJ, 2004, CELL MICROBIOL, V6, P345, DOI 10.1046/j.1462-5822.2003.00357.x; Ffrench-Constant R, 2006, ADV APPL MICROBIOL, V58, P169, DOI 10.1016/S0065-2164(06)58005-5; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Flury P, 2016, ISME J, V10, P2527, DOI 10.1038/ismej.2016.5; Fuchs TM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-214; Garrido-Sanz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150183; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Gross H, 2007, CHEM BIOL, V14, P53, DOI 10.1016/j.chembiol.2006.11.007; Guiney DG, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00129; Gupta S, 2003, MOL CELL BIOCHEM, V253, P41, DOI 10.1023/A:1026045100219; Henkels MD, 2014, MOL PLANT MICROBE IN, V27, P733, DOI 10.1094/MPMI-10-13-0311-R; Hinchliffe SJ, 2010, OPEN TOXINOL J, V3, P17, DOI [10.2174/1875414701003010083, DOI 10.2174/1875414701003010101]; Hofte M, 2010, RES MICROBIOL, V161, P464, DOI 10.1016/j.resmic.2010.04.007; HOWELL CR, 1979, PHYTOPATHOLOGY, V69, P480, DOI 10.1094/Phyto-69-480; Hurst MRH, 2011, J BACTERIOL, V193, P1966, DOI 10.1128/JB.01044-10; Jang JY, 2013, J AGR FOOD CHEM, V61, P6786, DOI 10.1021/jf401218w; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim MS, 2004, PLANT BIOLOGY, V6, P105, DOI 10.1055/s-2004-817803; KING EO, 1954, J LAB CLIN MED, V44, P301; KLUEPFEL DA, 1993, PHYTOPATHOLOGY, V83, P1240, DOI 10.1094/Phyto-83-1240; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; Lee PJ, 2004, BIOCHEM BIOPH RES CO, V319, P1110, DOI 10.1016/j.bbrc.2004.04.203; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Liu JR, 2010, J AGR FOOD CHEM, V58, P12343, DOI 10.1021/jf103604r; Loper JE, 2016, ENVIRON MICROBIOL, V18, P3509, DOI 10.1111/1462-2920.13369; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Ma ZW, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00382; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MAZZOLA M, 2007, PHYTOPATHOLOGY S, V97, pS72; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Olcott MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012504; Olorunleke FE, 2015, ENV MICROBIOL REP, V7, P774, DOI 10.1111/1758-2229.12310; Otsu Y, 2004, BIOCONTROL SCI TECHN, V14, P427, DOI 10.1080/09583150410001683538; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Puntener W, 1981, MANUAL FIELD TRIALS, P68; Raaijmakers JM, 1998, MOL PLANT MICROBE IN, V11, P144, DOI 10.1094/MPMI.1998.11.2.144; Ruffner B, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1763-2; Ruffner B, 2013, ENVIRON MICROBIOL, V15, P751, DOI 10.1111/j.1462-2920.2012.02884.x; Seaton SC, 2013, APPL ENVIRON MICROB, V79, P5405, DOI 10.1128/AEM.00819-13; Shrestha YK, 2011, J ASIA-PAC ENTOMOL, V14, P127, DOI 10.1016/j.aspen.2010.10.007; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stockwell VO, 2007, PHYTOPATHOLOGY, V97, P244, DOI 10.1094/PHYTO-97-2-0244; Tang HP, 2009, FLY, V3, P105, DOI 10.4161/fly.3.1.7747; THOMASHOW LS, 1990, APPL ENVIRON MICROB, V56, P908, DOI 10.1128/AEM.56.4.908-912.1990; Tran H, 2007, NEW PHYTOL, V175, P731, DOI 10.1111/j.1469-8137.2007.02138.x; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; VINCENT MN, 1991, APPL ENVIRON MICROB, V57, P2928, DOI 10.1128/AEM.57.10.2928-2934.1991; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Waterfield NR, 2003, FEMS MICROBIOL LETT, V229, P265, DOI 10.1016/S0378-1097(03)00846-2; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; WILSON M, 1993, PHYTOPATHOLOGY, V83, P117, DOI 10.1094/Phyto-83-117; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006	64	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161120	10.1371/journal.pone.0161120	http://dx.doi.org/10.1371/journal.pone.0161120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580176	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877400017
J	Wang, WQ; Hao, QQ; Tian, FX; Li, QX; Wang, W				Wang, Wenqiang; Hao, Qunqun; Tian, Fengxia; Li, Qinxue; Wang, Wei			Cytokinin-Regulated Sucrose Metabolism in Stay-Green Wheat Phenotype	PLOS ONE			English	Article							EXTRACELLULAR INVERTASE; PHOSPHATE SYNTHASE; CHENOPODIUM-RUBRUM; MUTANT TASG1; INDUCTION; SINK; EXPRESSION; GLUCOSE; PROTEIN; SHOOTS	A wheat stay-green mutant, tasg1, was observed to exhibit significantly delayed senescence in the late developmental stage. The photosynthetic capacity of the flag leaf was greater in tasg1 than in wild type (WT) plants. In addition, the grain volume of tasg1 was significantly higher than that of WT at the early filling stage. The content of various cytokinins (CKs) in the grain was significantly higher in tasg1 than in WT and was accompanied by an upregulated expression of some cell cycle-related genes. Examination of the metabolism of soluble sugars in tasg1 and WT revealed that the concentrations of glucose (Glu), fructose (Fru), and sucrose (Suc) were higher in the flag leaves and grains of tasg1 than in WT plants. The activities of sucrose-phosphate synthase (SPS), sucrose synthase (SuSy), and cell wall invertase (CW-invertase) were higher in tasg1, suggesting an altered metabolism and transport of soluble sugars. Furthermore, when tasg1 was treated with the CK inhibitor lovastatin, the activity of invertase was inhibited and was associated with premature senescence phenotype. However, the activity of invertase was partially recovered in tasg1 when treated with 6-benzylaminopurine (BAP). The trend of change in the concentrations of Glu, Fru, and Suc was similar to that of invertase. Our results suggest that CKs might regulate the stay-green phenotype of tasg1 by regulating the invertase activity involved in Suc remobilization.	[Wang, Wenqiang; Hao, Qunqun; Li, Qinxue; Wang, Wei] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Tian, Fengxia] Nanyang Normal Univ, Coll Life Sci & Technol, Nanyang 473061, Henan, Peoples R China	Shandong Agricultural University; Nanyang Normal College	Wang, W (corresponding author), Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.	wangw@sdau.edu.cn			National Natural Science Foundation of China [31370304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (no. 31370304).	Brenner Mark L., 1995, P649; Degenhardt B, 2000, PLANT SOIL, V225, P83, DOI 10.1023/A:1026539311358; Dekkers JCM, 2002, NAT REV GENET, V3, P22, DOI 10.1038/nrg701; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Ehness R, 1997, PLANT J, V11, P539, DOI 10.1046/j.1365-313X.1997.11030539.x; FLORES S, 1988, PLANT MOL BIOL, V11, P409, DOI 10.1007/BF00039021; Goetz M, 2001, P NATL ACAD SCI USA, V98, P6522, DOI 10.1073/pnas.091097998; Hauch S, 1998, PLANTA, V207, P266, DOI 10.1007/s004250050482; HUBER SC, 1989, PLANT CELL PHYSIOL, V30, P277, DOI 10.1093/oxfordjournals.pcp.a077740; HUBER SC, 1982, PLANT PHYSIOL, V69, P691, DOI 10.1104/pp.69.3.691; Hui Z, 2012, PLANT CELL REP, V31, P1073, DOI 10.1007/s00299-012-1226-z; JACQMARD A, 1994, CYTOKININS CHEM ACTI, P197; Joran V, 2013, PLANT CELL PHYSL, V2, P1; Kebrom TH, 2012, PLANT PHYSIOL, V160, P308, DOI 10.1104/pp.112.197954; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koonjul PK, 2005, J EXP BOT, V56, P179, DOI 10.1093/jxb/eri018; KUIPER D, 1993, PLANT CELL ENVIRON, V16, P1025, DOI 10.1111/j.1365-3040.1996.tb02052.x; Lara MEB, 2004, PLANT CELL, V16, P1276, DOI 10.1105/tpc.018929; LEFEBVRE R, 1992, CAN J BOT, V70, P1897, DOI 10.1139/b92-235; LERBS S, 1984, PLANTA, V162, P289, DOI 10.1007/BF00396739; Mok MC., 1994, CYTOKININS CHEM ACTI, P155, DOI DOI 10.1201/9781351071284; Mustroph A, 2006, PLANTA, V225, P103, DOI 10.1007/s00425-006-0333-x; POZUETAROMERO J, 1991, FEBS LETT, V291, P233, DOI 10.1016/0014-5793(91)81292-G; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; ROITSCH T, 1995, PLANT PHYSIOL, V108, P285, DOI 10.1104/pp.108.1.285; Roitsch T, 2000, PLANT GROWTH REGUL, V32, P359, DOI 10.1023/A:1010781500705; Spano G, 2003, J EXP BOT, V54, P1415, DOI 10.1093/jxb/erg150; Stitt M, 1988, PLANTA, V177, P116; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Wang WQ, 2016, PLANT CELL REP, V35, P585, DOI 10.1007/s00299-015-1905-7; Werner T, 2008, J EXP BOT, V59, P2659, DOI 10.1093/jxb/ern134; Zheng HJ, 2009, PLANT BREEDING, V128, P54, DOI 10.1111/j.1439-0523.2008.01529.x	34	20	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161351	10.1371/journal.pone.0161351	http://dx.doi.org/10.1371/journal.pone.0161351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580166	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400024
J	Kim, SY; Sim, CK; Zhang, QY; Tang, H; Brunmeir, R; Pan, H; Karnani, N; Han, WP; Zhang, KL; Xu, F				Kim, Sun-Yee; Sim, Choon Kiat; Zhang, Qiongyi; Tang, Hui; Brunmeir, Reinhard; Pan, Hong; Karnani, Neerja; Han, Weiping; Zhang, Kangling; Xu, Feng			An Alternative Strategy for Pan-acetyl-lysine Antibody Generation	PLOS ONE			English	Article							ENRICHMENT; METABOLISM; TARGETS	Lysine acetylation is an important post-translational modification in cell signaling. In acetylome studies, a high-quality pan-acetyl-lysine antibody is key to successful enrichment of acetylated peptides for subsequent mass spectrometry analysis. Here we show an alternative method to generate polyclonal pan-acetyl-lysine antibodies using a synthesized random library of acetylated peptides as the antigen. Our antibodies are tested to be specific for acetyl-lysine peptides/proteins via ELISA and dot blot. When pooled, five of our antibodies show broad reactivity to acetyl-lysine peptides, complementing a commercial antibody in terms of peptide coverage. The consensus sequence of peptides bound by our antibody cocktail differs slightly from that of the commercial antibody. Lastly, our antibodies are tested in a proof-of-concept to analyze the acetylome of HEK293 cells. In total we identified 1557 acetylated peptides from 416 proteins. We thus demonstrated that our antibodies are well-qualified for acetylome studies and can complement existing commercial antibodies.	[Kim, Sun-Yee; Sim, Choon Kiat; Zhang, Qiongyi; Brunmeir, Reinhard; Pan, Hong; Karnani, Neerja; Xu, Feng] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Tang, Hui; Zhang, Kangling] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Han, Weiping] Agcy Sci Technol & Res, Lab Metab Med, Singapore Bioimaging Consortium, Singapore, Singapore; [Han, Weiping; Xu, Feng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Han, Weiping; Xu, Feng] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Texas System; University of Texas Medical Branch Galveston; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore	Xu, F (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.; Zhang, KL (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Zhang, KL; Xu, F (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Xu, F (corresponding author), Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore.	kazhang@utmb.edu; xu_feng@sics.a-star.edu.sg	Sim, Choon Kiat/B-1820-2014	Sim, Choon Kiat/0000-0002-7871-2134; Brunmeir, Reinhard/0000-0001-7545-2819; KIM, Sun-Yee/0000-0002-8061-2271; Karnani, Neerja/0000-0002-5301-409X; Xu, Feng/0000-0003-2016-7521	Agency for Science, Technology and Research (A*STAR) of Singapore; A*STAR of Singapore	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the intramural funding from the Agency for Science, Technology and Research (A*STAR) of Singapore to FX. Funding for the open-access charge was provided by A*STAR of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Franzel B, 2015, PROTEOMICS, V15, P44, DOI 10.1002/pmic.201400015; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh Mai-Loan, 2009, V519, P507, DOI 10.1007/978-1-59745-281-6_34; Kim SY, 2016, ARCH BIOCHEM BIOPHYS, V598, P1, DOI 10.1016/j.abb.2016.03.025; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140619; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133448; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Qiang LP, 2005, J IMMUNOASS IMMUNOCH, V26, P13, DOI 10.1081/IAS-200041153; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Svinkina T, 2015, MOL CELL PROTEOMICS, V14, P2429, DOI 10.1074/mcp.O114.047555; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Winter D, 2015, METHODS MOL BIOL, V1295, P259, DOI 10.1007/978-1-4939-2550-6_20; Xu Wei, 2013, Methods Mol Biol, V981, P137, DOI 10.1007/978-1-62703-305-3_11; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162528	10.1371/journal.pone.0162528	http://dx.doi.org/10.1371/journal.pone.0162528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606599	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600057
J	Divino, F; Corado, ADG; Naveca, FG; Stefani, MMA; Bello, G				Divino, Flavia; Guerra Corado, Andre de Lima; Naveca, Felipe Gomes; Stefani, Mariane M. A.; Bello, Gonzalo			High Prevalence and Onward Transmission of Non-Pandemic HIV-1 Subtype B Clades in Northern and Northeastern Brazilian Regions	PLOS ONE			English	Article							POPULATION-DYNAMICS; GENETIC DIVERSITY; DRUG-RESISTANCE; ALGORITHMS	The Human immunodeficiency virus type-1 (HIV-1) epidemic in Brazil is mainly driven by the subtype B pandemic lineage (B-PANDEMIC), while Caribbean non-pandemic subtype B clades (B-CAR) seem to account for a very low fraction of HIV-infections in this country. The molecular characteristics of the HIV-1 subtype B strains disseminated in the Northern and Northeastern Brazilian regions, however, have not been explored so far. In this study, we estimate the prevalence of the HIV-1 B-PANDEMIC and B-CAR clades across different Brazilian regions and we reconstruct the spatiotemporal dynamics of dissemination of the major Brazilian B-CAR clades. A total of 2,682 HIV-1 subtype B pol sequences collected from 21 different Brazilian states from the five country regions between 1998 and 2013 were analyzed. Maximum Likelihood phylogenetic analyses revealed that the B-CAR strains reached 16 out 21 Brazilian states here analyzed. The B-CAR clades comprise a low fraction (< 10%) of subtype B infections in most Brazilian states analyzed, with exception of Roraima (41%), Amazonas (14%) and Maranhao (14%). Bayesian phylogeographic analyses indicate that B-CAR strains originally from the Hispaniola and Trinidad and Tobago were introduced at multiple times into different states from all Brazilian regions and a few of those strains, probably introduced into Roraima, Maranhao and Sao Paulo between the late 1970s and the early 1980s, established secondary outbreaks in the Brazilian population. These results support that the HIV-1 subtype B epidemics in some Brazilian states from the Northern and Northeastern regions display a unique molecular pattern characterized by the high prevalence of B-CAR lineages, which probably reflects a strong epidemiological link with the HIV-1 epidemics in the Caribbean region.	[Divino, Flavia; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil; [Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Stefani, Mariane M. A.] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Goias	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.	gbellobr@gmail.com	Naveca, Felipe/H-1130-2012; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Naveca, Felipe/0000-0002-2888-1060; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Public Health Service from the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro" (FAPERJ) [E-26/110.439/2014]; "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) [472896/2012-1]; Instituto Oswaldo Cruz-FIOCRUZ	Public Health Service from the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro" (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Oswaldo Cruz-FIOCRUZ	GB was supported by Public Health Service grants E-26/110.439/2014 from the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro" (FAPERJ) and 472896/2012-1 from the "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq). FD was funded by a fellowship from Instituto Oswaldo Cruz- FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral EF, 2005, ONLINE J MIGRATION P; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arouck R, 2000, LUSOTOPIE, P67; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Brazilian (2015) Ministry of Health, 2015, AIDS EP B; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Cabello M, 2015, AIDS, V29, P483, DOI 10.1097/QAD.0000000000000552; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Chen J.J., 2011, MODEL SIMUL ENG, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0025286; Corbin H.P, 2007, BRAZILIAN MIGRATION; da Costa CM, 2016, AIDS RES HUM RETROVI; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Diniz A.M.A., 2005, CAD GEOGRAFIA, V15, P23; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heemskerk M, 2009, EUROPEAN REV LATIN A, P5; Heemskerk Marieke, 2015, SURINAME MIGRATION P; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Leonardi V., 2000, FRONTEIRAS AMAZONICA; Martins CC, 2011, AN 3 S POS GRAD REL; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360; Pereira Mariana Cunha, 2006, Estud. av., V20, P209; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER V1 6; Rambaut A., 2014, FIGTREE V14 TREE FIG; Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]; Soares CL, 2011, PRACS REV HUMANIDADE, V4, P129; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vale Ana Lia Farias, 2006, Estud. av., V20, P255; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162112	10.1371/journal.pone.0162112	http://dx.doi.org/10.1371/journal.pone.0162112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603317	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200042
J	Ichimura, K; Matoba, T; Nakano, K; Tokutome, M; Honda, K; Koga, J; Egashira, K				Ichimura, Kenzo; Matoba, Tetsuya; Nakano, Kaku; Tokutome, Masaki; Honda, Katsuya; Koga, Jun-ichiro; Egashira, Kensuke			A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model	PLOS ONE			English	Article								Background There is an unmet need to develop an innovative cardioprotective modality for acute myocardial infarction, for which interventional reperfusion therapy is hampered by ischemiareperfusion (IR) injury. We recently reported that bioabsorbable poly(lactic acid/glycolic acid) (PLGA) nanoparticle-mediated treatment with pitavastatin (pitavastatin-NP) exerts a cardioprotective effect in a rat IR injury model by activating the PI3K-Akt pathway and inhibiting inflammation. To obtain preclinical proof-of-concept evidence, in this study, we examined the effect of pitavastatin-NP on myocardial IR injury in conscious and anesthetized pig models. Methods and Results Eighty-four Bama mini-pigs were surgically implanted with a pneumatic cuff occluder at the left circumflex coronary artery (LCx) and telemetry transmitters to continuously monitor electrocardiogram as well as to monitor arterial blood pressure and heart rate. The LCx was occluded for 60 minutes, followed by 24 hours of reperfusion under conscious conditions. Intravenous administration of pitavastatin-NP containing >= 8 mg/body of pitavastatin 5 minutes before reperfusion significantly reduced infarct size; by contrast, pitavastatin alone (8 mg/body) showed no therapeutic effects. Pitavastatin-NP produced anti-apoptotic effects on cultured cardiomyocytes in vitro. Cardiac magnetic resonance imaging performed 4 weeks after IR injury revealed that pitavastatin-NP reduced the extent of left ventricle remodeling. Importantly, pitavastatin-NP exerted no significant effects on blood pressure, heart rate, or serum biochemistry. Exploratory examinations in anesthetized pigs showed pharmacokinetic analysis and the effects of pitavastatin-NP on no-reflow phenomenon. Conclusions NP-mediated delivery of pitavastatin to IR-injured myocardium exerts cardioprotective effects on IR injury without apparent adverse side effects in a preclinical conscious pig model. Thus, pitavastatin-NP represents a novel therapeutic modality for IR injury in acute myocardial infarction.	[Ichimura, Kenzo; Matoba, Tetsuya; Tokutome, Masaki; Honda, Katsuya] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Japan; [Nakano, Kaku; Koga, Jun-ichiro; Egashira, Kensuke] Kyushu Univ, Dept Cardiovasc Res Dev & Translat Med, Ctr Cardiovasc Disrupt Innovat, Fukuoka, Japan	Kyushu University; Kyushu University	Egashira, K (corresponding author), Kyushu Univ, Dept Cardiovasc Res Dev & Translat Med, Ctr Cardiovasc Disrupt Innovat, Fukuoka, Japan.	egashira@cardiol.med.kyushu-u.ac.jp	MIZEKA, PANU/A-3952-2017; Ichimura, Kenzo/AAC-9485-2020	Ichimura, Kenzo/0000-0002-5734-335X; Matoba, Tetsuya/0000-0003-4563-304X	Ministry of Education, Science, and Culture, Tokyo, Japan [26461131, 25461135, 25293185]; Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Intractable diseases overcome research project from Japan Agency for Medical Research and development	Ministry of Education, Science, and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Intractable diseases overcome research project from Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED))	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Tokyo, Japan, under grant numbers 26461131 (K. Nakano), 25461135 (T. Matoba) and 25293185 (K. Egashira), by Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan (K. Egashira), and by the Intractable diseases overcome research project from Japan Agency for Medical Research and development (K. Egashira).	Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; BARDAJI A, 1990, CARDIOVASC RES, V24, P227, DOI 10.1093/cvr/24.3.227; Bodi V, 2014, INT J CARDIOL, V175, P138, DOI 10.1016/j.ijcard.2014.05.003; Bune LT, 2013, PHYSIOL REP, V1, DOI [10.1002/PHY2.3, 10.1002/phy2.3]; Chen L, 2011, HYPERTENSION, V57, P343, DOI 10.1161/HYPERTENSIONAHA.110.157032; FLETCHER PJ, 1981, CIRC RES, V49, P618, DOI 10.1161/01.RES.49.3.618; Fujino T, 2012, MITOCHONDRION, V12, P449, DOI 10.1016/j.mito.2012.06.002; Heusch G, 2011, J MOL CELL CARDIOL, V50, P951, DOI 10.1016/j.yjmcc.2011.02.016; Ikeda G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20467; Ishikita A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003872; Kapur NK, 2013, CIRCULATION, V128, P328, DOI 10.1161/CIRCULATIONAHA.112.000029; Katsuki S, 2014, CIRCULATION, V129, P896, DOI 10.1161/CIRCULATIONAHA.113.002870; Kehl F, 2002, ANESTHESIOLOGY, V96, P675, DOI 10.1097/00000542-200203000-00025; Kimura S, 2008, CIRCULATION, V118, pS65, DOI 10.1161/CIRCULATIONAHA.107.740613; Kubo M, 2009, ARTERIOSCL THROM VAS, V29, P796, DOI 10.1161/ATVBAHA.108.182584; Liu Y, 2008, COMPARATIVE MED, V58, P580; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nagaoka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132451; Nakano Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29601; Nakashiro S, 2016, ARTERIOSCL THROM VAS, V36, P491, DOI 10.1161/ATVBAHA.115.307057; Oda S, 2010, J VASC SURG, V52, P412, DOI 10.1016/j.jvs.2010.03.020; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; Qi HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065147; Saxena V, 2006, INT J PHARMACEUT, V308, P200, DOI 10.1016/j.ijpharm.2005.11.003; Stone GW, 2016, J AM COLL CARDIOL, V67, P1674, DOI 10.1016/j.jacc.2016.01.069; Suzuki Y, 2008, CATHETER CARDIO INTE, V71, P100, DOI 10.1002/ccd.21329; Suzuki Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/195483; Van Allen NR, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-22; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	34	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162425	10.1371/journal.pone.0162425	http://dx.doi.org/10.1371/journal.pone.0162425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603665	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200064
J	Wichert, A				Wichert, Andreas			The Quantum Binding Problem in the Context of Associative Memory	PLOS ONE			English	Article							SIMILARITY; MODEL	We present a method to solve the binding problem by using a quantum algorithm for the retrieval of associations from associative memory during visual scene analysis. The problem is solved by mapping the information representing different objects into superposition by using entanglement and Grover's amplification algorithm.	[Wichert, Andreas] Univ Lisbon, INESC ID, Dept Comp Sci & Engn, Oporto, Portugal; [Wichert, Andreas] Univ Lisbon, Inst Super Tecn, Oporto, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Wichert, A (corresponding author), Univ Lisbon, INESC ID, Dept Comp Sci & Engn, Oporto, Portugal.; Wichert, A (corresponding author), Univ Lisbon, Inst Super Tecn, Oporto, Portugal.	andreas.wichert@tecnico.ulisboa.pt	Wichert, Andreas/E-2494-2012	Wichert, Andreas/0000-0002-2179-4378	Fundacao para a Ciencia e a Tecnologia (FCT) [UID/CEC/50021/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by national funds through Fundacao para a Ciencia e a Tecnologia (FCT) with reference UID/CEC/50021/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson S, 2015, NAT PHYS, V11, P291, DOI 10.1038/nphys3272; Aimeur E, 2013, MACH LEARN, V90, P261, DOI 10.1007/s10994-012-5316-5; Brassard G, 1998, QUANTUM COUNTING; Giovannetti V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160501; Gross C. G., 1977, LATERALIZATION NERVO, P109; Grover L. K., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P53, DOI 10.1145/276698.276712; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Grover LK, 1998, PHYS REV LETT, V80, P4329, DOI 10.1103/PhysRevLett.80.4329; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Harrow AW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.150502; Hecht-Nielsen R, 1989, NEUR NETW 1989 IJCNN; Islam M. S., 2009, Information Technology Journal, V8, P208, DOI 10.3923/itj.2009.208.213; Kosko B., 1992, NEURAL NETWORKS FUZZ; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; OSHERSON DN, 1987, J MATH PSYCHOL, V31, P93, DOI 10.1016/0022-2496(87)90038-1; Palm G., 1982, NEURAL ASSEMBLIES AL; Palm G., 1997, ASS PROCESSING PROCE, P307; Palm G, 1990, GEHIRN KOGNITION, P164; Posner M. I., 1994, IMAGES MIND; Rosenbaum D, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052310; Sacramento J, 2012, BIOL CYBERN, V106, P123, DOI 10.1007/s00422-012-0488-4; STEINBUCH K, 1961, KYBERNETIK, V1, P36, DOI 10.1007/BF00293853; Tapp, 2000, ARXIVQUANTPH0005055; Tay N, 2010, COGN COMPUT, P1; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Ventura D, 1999, FOUND PHYS LETT, V12, P547, DOI 10.1023/A:1021695125245; Ventura D, 2000, INFORM SCIENCES, V124, P273, DOI 10.1016/S0020-0255(99)00101-2; Ventura D, 1988, NEUR NETW P 1998 IEE, V1, P509; Wichert A, 2002, NEUROCOMPUTING, V48, P741, DOI 10.1016/S0925-2312(01)00671-3; Wichert A, 2001, CONNECT SCI, V13, P1, DOI 10.1080/05940090010022693; Wichert A, 2008, NEUROCOMPUTING, V71, P2806, DOI 10.1016/j.neucom.2007.08.019; Wichert A, 2013, J LOGIC COMPUT, V23, P627, DOI 10.1093/logcom/exs010; Wichert A, 2009, COGN COMPUT, V1, P342, DOI 10.1007/s12559-009-9027-6; Wichert A, 2011, COGN COMPUT, V3, P311, DOI 10.1007/s12559-010-9064-1; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wittek P, 2014, QUANTUM MACHINE LEARNING: WHAT QUANTUM COMPUTING MEANS TO DATA MINING, P1	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162312	10.1371/journal.pone.0162312	http://dx.doi.org/10.1371/journal.pone.0162312			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603782	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200056
J	Hansen, VL; Schilkey, FD; Miller, RD				Hansen, Victoria Leigh; Schilkey, Faye Dorothy; Miller, Robert David			Transcriptomic Changes Associated with Pregnancy in a Marsupial, the Gray Short-Tailed Opossum Monodelphis domestica	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; OXYTOCIN RECEPTOR; GENE-EXPRESSION; SMINTHOPSIS-CRASSICAUDATA; SPATIOTEMPORAL EXPRESSION; CONVERGENT EVOLUTION; HOUSEKEEPING GENES; ESTROGEN-RECEPTORS; PLACENTA; PROGESTERONE	Live birth has emerged as a reproductive strategy many times across vertebrate evolution; however, mammals account for the majority of viviparous vertebrates. Marsupials are a mammalian lineage that last shared a common ancestor with eutherians (placental mammals) over 148 million years ago. Marsupials are noted for giving birth to highly altricial young after a short gestation, and represent humans' most distant viviparous mammalian relatives. Here we ask what insight can be gained into the evolution of viviparity in mammals specifically and vertebrates in general by analyzing the global uterine transcriptome in a marsupial. Transcriptome analyses were performed using NextGen sequencing of uterine RNA samples from the gray short-tailed opossum, Monodelphis domestica. Samples were collected from late stage pregnant, virgin, and non-pregnant experienced breeders. Three different algorithms were used to determine differential expression, and results were confirmed by quantitative PCR. Over 900 opossum gene transcripts were found to be significantly more abundant in the pregnant uterus than non-pregnant, and over 1400 less so. Most with increased abundance were genes related to metabolism, immune systems processes, and transport. This is the first study to characterize the transcriptomic differences between pregnant, non-pregnant breeders, and virgin marsupial uteruses and helps to establish a set of pregnancy-associated genes in the opossum. These observations allowed for comparative analyses of the differentially transcribed genes with other mammalian and non-mammalian viviparous species, revealing similarities in pregnancy related gene expression over 300 million years of amniote evolution.	[Hansen, Victoria Leigh; Miller, Robert David] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA; [Schilkey, Faye Dorothy] New Mexico IDeA Networks Biomed Res Excellence, Natl Ctr Genome Resources, Santa Fe, NM USA; [Hansen, Victoria Leigh] Natl Sci Fdn, Div Integrat Organismal Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA	University of New Mexico; National Center for Genome Resources (NCGR); National Science Foundation (NSF)	Hansen, VL (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.; Hansen, VL (corresponding author), Natl Sci Fdn, Div Integrat Organismal Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA.	vhansen@unm.edu		Miller, Robert/0000-0002-8479-8819	National Science Foundation [IOS-1353123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110907] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Science Foundation funded this research under grant number IOS-1353123 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1353123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asahina T, 1998, HORM RES, V50, P37, DOI 10.1159/000053122; Baardman ME, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.102442; Baker Michelle L., 2004, Journal of Mammalian Evolution, V11, P1, DOI 10.1023/B:JOMM.0000029143.39776.ec; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Brandley MC, 2012, GENOME BIOL EVOL, V4, P394, DOI 10.1093/gbe/evs013; Carter AM, 2013, ANNU REV ANIM BIOSCI, V1, P443, DOI 10.1146/annurev-animal-031412-103653; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chern SR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-106; Chern SR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-127; CORSO G, 1988, Archivio Italiano di Anatomia e di Embriologia, V93, P237; Corso G, 2000, J MORPHOL, V243, P153, DOI 10.1002/(SICI)1097-4687(200002)243:2<153::AID-JMOR4>3.0.CO;2-Q; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Drewlo S, 2012, PLACENTA, V33, P952, DOI 10.1016/j.placenta.2012.09.007; Elliot MG, 2009, PLACENTA, V30, P949, DOI 10.1016/j.placenta.2009.08.004; Enders AC, 2012, PLACENTA, V33, P319, DOI 10.1016/j.placenta.2012.02.008; Freyer C, 2007, PLACENTA, V28, P249, DOI 10.1016/j.placenta.2006.03.007; Freyer C, 2003, J EXP ZOOL PART A, V299A, P59, DOI 10.1002/jez.a.10291; Freyer C, 2002, J ANAT, V201, P101, DOI 10.1046/j.1469-7580.2002.00084.x; Freyer C, 2009, J EXP ZOOL PART B, V312B, P545, DOI 10.1002/jez.b.21239; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Garratt M, 2013, P NATL ACAD SCI USA, V110, P7760, DOI 10.1073/pnas.1305018110; Goff LA, 2012, ANALYSIS EXPLORATION; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; KEYS JL, 1988, BIOL REPROD, V39, P473, DOI 10.1095/biolreprod39.2.473; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; Kimura T, 1996, ENDOCRINOLOGY, V137, P780, DOI 10.1210/en.137.2.780; Kin K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115139; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Laird MK, 2014, J MORPHOL, V275, P1081, DOI 10.1002/jmor.20282; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Maiti K, 2011, ENDOCRINOLOGY, V152, P2448, DOI 10.1210/en.2010-0979; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; MOLL R, 1983, LAB INVEST, V49, P599; Mossman HW, 1987, VERTEBRATE FETAL MEM; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Okumu LA, 2010, REPRODUCTION, V140, P143, DOI 10.1530/REP-10-0113; PADYKULA HA, 1982, J REPROD FERTIL, P95; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RENFREE MB, 1994, J REPROD FERTIL, V102, P433; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; ROBERTS CT, 1994, J REPROD FERTIL, V100, P105; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875, DOI 10.1530/jrf.0.0820875; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose R, 2000, HORM BEHAV, V37, P163, DOI 10.1006/hbeh.1999.1568; Samborski A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112177; Shaw G, 1999, BIOL REPROD, V60, P611, DOI 10.1095/biolreprod60.3.611; Spencer TE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1879, DOI 10.2741/spencer; SPENCER TE, 1995, BIOL REPROD, V53, P1527, DOI 10.1095/biolreprod53.6.1527; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; STONEROOK MJ, 1992, BIOL REPROD, V46, P290, DOI 10.1095/biolreprod46.2.290; Terzidou V, 2005, J CLIN ENDOCR METAB, V90, P237, DOI 10.1210/jc.2004-0277; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tyndale-Biscoe H, 1987, REPROD PHYSL MAMMALS; Umylny B, 2011, TAG BASED NEXT GENER, P449; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; VandeBerg John L., 1997, ILAR J, V38, P4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wathes DC, 1999, J ENDOCRINOL, V161, P143, DOI 10.1677/joe.0.1610143; Whittington CM, 2015, MOL BIOL EVOL, V32, P3114, DOI 10.1093/molbev/msv177; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Yamashita K, 2013, MOL PHYLOGENET EVOL, V67, P520, DOI 10.1016/j.ympev.2013.02.017	75	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161608	10.1371/journal.pone.0161608	http://dx.doi.org/10.1371/journal.pone.0161608			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598793	gold, Green Submitted, Green Published			2022-12-27	WOS:000383254800013
J	Kong, PL; Looi, LM; Lau, TP; Cheah, PL				Kong, Po-Lian; Looi, Lai-Meng; Lau, Tze-Pheng; Cheah, Phaik-Leng			Assessment of Telomere Length in Archived Formalin-Fixed, Paraffinized Human Tissue Is Confounded by Chronological Age and Storage Duration	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DIPLOID CELL STRAINS; COLORECTAL-CANCER; EMBEDDED TISSUE; DNA EXTRACTION; CIGARETTE-SMOKING; HUMAN FIBROBLASTS; BIOMARKER; INSTABILITY; ATTRITION	Telomeres shorten with physiological aging but undergo substantial restoration during cancer immortalization. Increasingly, cancer studies utilize the archive of formalin-fixed, paraffin-embedded (FFPE) tissues in diagnostic pathology departments. Conceptually, such studies would be confounded by physiological telomere attrition and loss of DNA integrity from prolonged tissue storage. Our study aimed to investigate these two confounding factors. 145 FFPE tissues of surgically-resected, non-diseased appendixes were retrieved from our pathology archive, from years 2008 to 2014. Cases from 2013 to 2014 were categorized by patient chronological age (0-20 years, 21-40 years, 41-60 years, >60 years). Telomere lengths of age categories were depicted by telomere/chromosome 2 centromere intensity ratio (TCR) revealed by quantitative fluorescence in situ hybridization. Material from individuals aged 0-20 years from years 2013/2014, 2011/2012, 2009/2010, and 2008 were compared for storage effect. Telomere integrity was assessed by telomere fluorescence intensity (TFI). Epithelial TCRs (mean +/- SD) for the respective age groups were 4.84 +/- 2.08, 3.64 +/- 1.21, 2.03 +/- 0.37, and 1.93 +/- 0.45, whereas corresponding stromal TCRs were 5.16 +/- 2.55, 3.84 +/- 1.36, 2.49 +/- 1.20, and 2.93 +/- 1.24. A trend of inverse correlation with age in both epithelial and stromal tissues is supported by r = -0.69, p < 0.001 and r = -0.42, p < 0.001 respectively. Epithelial TFIs (mean +/- SD) of years 2013/2014, 2011/2012, 2009/2010 and 2008 were 852.60 +/- 432.46, 353.04 +/- 127.12, 209.24 +/- 55.57 and 429.22 +/- 188.75 respectively. Generally, TFIs reduced with storage duration (r = -0.42, p < 0.001). Our findings agree that age-related telomere attrition occurs in normal somatic tissues, and suggest that an age-based reference can be established for telomere studies on FFPE tissues. We also showed that FFPE tissues archived beyond 2 years are suboptimal for telomere analysis.	[Kong, Po-Lian; Looi, Lai-Meng; Lau, Tze-Pheng; Cheah, Phaik-Leng] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Federal Te, Malaysia	Universiti Malaya	Looi, LM (corresponding author), Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Federal Te, Malaysia.	looilm@ummc.edu.my	Looi, Lai Meng/AAB-9403-2019; Lau, Tzepheng/AAE-2843-2022; Looi, Lai Meng/A-3382-2009	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant [UM.0000017/HIR.C1]; University of Malaya Research Grant (UMRG) [RP016D-13HTM]; Unit	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant; University of Malaya Research Grant (UMRG); Unit	This study was funded by University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant (Grant number: UM.0000017/HIR.C1) and University of Malaya Research Grant (UMRG) (Grant number: RP016D-13HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Unit for Research Support and Education (PURSuE), Department of Pathology, Faculty of Medicine, University of Malaya for assistance in retrieval of archived FFPE tissues and provision of unstained FFPE tissue sections.	ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Augustine TA, 2015, BRIT J CANCER, V112, P313, DOI 10.1038/bjc.2014.561; Bass BP, 2014, ARCH PATHOL LAB MED, V138, P1520, DOI 10.5858/arpa.2013-0691-RA; Bekaert S, 2005, ANTICANCER RES, V25, P3011; Bekaert S, 2004, DEV BIOL, V274, P15, DOI 10.1016/j.ydbio.2004.06.023; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; DUBEAU L, 1986, CANCER RES, V46, P2964; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Furugori E, 2000, J CANCER RES CLIN, V126, P481, DOI 10.1007/s004320000137; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Gnanapragasam VJ, 2010, BJU INT, V105, P274, DOI 10.1111/j.1464-410X.2009.08665.x; GREER CE, 1994, PCR METH APPL, V3, pS113; Guan JZ, 2007, MOL CELL BIOCHEM, V304, P353, DOI 10.1007/s11010-007-9518-2; HAMMOND DW, 1994, J CLIN PATHOL, V47, P508, DOI 10.1136/jcp.47.6.508; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heaphy CM, 2011, J CELL MOL MED, V15, P1227, DOI 10.1111/j.1582-4934.2011.01284.x; Hou LF, 2015, EBIOMEDICINE, V2, P591, DOI 10.1016/j.ebiom.2015.04.008; Hung NA, 2016, MODERN PATHOL, V29, P212, DOI 10.1038/modpathol.2015.156; Jenkins EC, 2012, AM J MED GENET A, V158A, P1060, DOI 10.1002/ajmg.a.35275; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Merkelbach S, 1997, AM J PATHOL, V150, P1537; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8; Narath R, 2005, CYTOM PART A, V68A, P113, DOI 10.1002/cyto.a.20190; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Rane JK, 2016, EUR UROL, V69, P551, DOI 10.1016/j.eururo.2015.09.039; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shen YQ, 2011, LABMEDICINE, V42, P478, DOI 10.1309/LM030FHMRRUWKQWH; Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6; Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Wang JH, 2013, NEUROSCI BULL, V29, P649, DOI 10.1007/s12264-013-1379-y; Xie R, 2011, J HISTOCHEM CYTOCHEM, V59, P356, DOI 10.1369/0022155411398488; Zhang CA, 2015, HUM MOL GENET, V24, P5356, DOI 10.1093/hmg/ddv252	54	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161720	10.1371/journal.pone.0161720	http://dx.doi.org/10.1371/journal.pone.0161720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598341	gold, Green Submitted, Green Published			2022-12-27	WOS:000383254800018
J	Strickland, BA; Vilella, FJ; Belant, JL				Strickland, Bradley A.; Vilella, Francisco J.; Belant, Jerrold L.			Scale-Dependent Habitat Selection and Size-Based Dominance in Adult Male American Alligators	PLOS ONE			English	Article							HOME-RANGE; BODY-SIZE; POPULATION; MOVEMENTS; ECOLOGY; RIVER; PREY	Habitat selection is an active behavioral process that may vary across spatial and temporal scales. Animals choose an area of primary utilization (i.e., home range) then make decisions focused on resource needs within patches. Dominance may affect the spatial distribution of conspecifics and concomitant habitat selection. Size-dependent social dominance hierarchies have been documented in captive alligators, but evidence is lacking from wild populations. We studied habitat selection for adult male American alligators (Alligator mississippiensis; n = 17) on the Pearl River in central Mississippi, USA, to test whether habitat selection was scale-dependent and individual resource selectivity was a function of conspecific body size. We used K-select analysis to quantify selection at the home range scale and patches within the home range to determine selection congruency and important habitat variables. In addition, we used linear models to determine if body size was related to selection patterns and strengths. Our results indicated habitat selection of adult male alligators was a scale-dependent process. Alligators demonstrated greater overall selection for habitat variables at the patch level and less at the home range level, suggesting resources may not be limited when selecting a home range for animals in our study area. Further, diurnal habitat selection patterns may depend on thermoregulatory needs. There was no relationship between resource selection or home range size and body size, suggesting size-dependent dominance hierarchies may not have influenced alligator resource selection or space use in our sample. Though apparent habitat suitability and low alligator density did not manifest in an observed dominance hierarchy, we hypothesize that a change in either could increase intraspecific interactions, facilitating a dominance hierarchy. Due to the broad and diverse ecological roles of alligators, understanding the factors that influence their social dominance and space use can provide great insight into their functional role in the ecosystem.	[Strickland, Bradley A.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Vilella, Francisco J.] Mississippi State Univ, US Geol Survey, Mississippi Cooperat Fish & Wildlife Res Unit, Mississippi State, MS 39762 USA; [Belant, Jerrold L.] Mississippi State Univ, Carnivore Ecol Lab, Forest & Wildlife Res Ctr, Mississippi State, MS 39762 USA; [Strickland, Bradley A.] Florida Int Univ, Dept Biol Sci, Marine Sci Program, Miami, FL 33199 USA	Mississippi State University; Mississippi State University; United States Department of the Interior; United States Geological Survey; Mississippi State University; State University System of Florida; Florida International University	Strickland, BA (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.; Strickland, BA (corresponding author), Florida Int Univ, Dept Biol Sci, Marine Sci Program, Miami, FL 33199 USA.	bstri007@fiu.edu	Belant, Jerrold/HDM-7749-2022	Strickland, Bradley/0000-0001-6443-7672	Mississippi Department of Wildlife, Fisheries and Parks [14-16-0009-1543]; Berryman Institute [10-7400-0471-CA]; Institutional Animal Care and Use Committee of Mississippi State University [12-016]	Mississippi Department of Wildlife, Fisheries and Parks; Berryman Institute; Institutional Animal Care and Use Committee of Mississippi State University	Funding by Mississippi Department of Wildlife, Fisheries and Parks (award number 14-16-0009-1543) and Berryman Institute (award number 10-7400-0471-CA) was instrumental in data collection.r Funding was provided by Mississippi Department of Wildlife, Fisheries and Parks (award number 14-16-0009-1543) and Berryman Institute (award number 10-7400-0471-CA). We are grateful to R. Flynt, C. Hunt, and S. Edwards of MDWFP for project support and coordination. We thank B. Leopold and R. Iglay for comments to an earlier version of this manuscript and suggestions for analysis. We also appreciate the thoughtful comments of anonymous reviewers to improve the manuscript. A. Smith and S. Godfrey provided valuable assistance in the field. Thanks to C. Kochanny and A. Rosenblatt for radio design and attachment. Animal capture and handling procedures were conducted under the auspices of protocol 12-016 from the Institutional Animal Care and Use Committee of Mississippi State University. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Beacham JL, 2003, BEHAVIOUR, V140, P1275, DOI 10.1163/156853903771980594; Belant JL, 2010, POLAR BIOL, V33, P31, DOI 10.1007/s00300-009-0682-6; Bondavalli C, 1999, ECOSYSTEMS, V2, P49, DOI 10.1007/s100219900057; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Calenge C, 2007, J STAT SOFTW, V22, P1; Calsbeek R, 2002, J ANIM ECOL, V71, P513, DOI 10.1046/j.1365-2656.2002.00619.x; Chabreck, 1963, P SE ASS GAME FISH C, V17, P47; Chabreck RH, 1965, P SE ASS GAME FISH C, V19, P102; COOPER CM, 1985, HYDROBIOLOGIA, V126, P193, DOI 10.1007/BF00007496; Cox MC, 2011, ESTIMATION ALLIGATOR, V5045, P1; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; DREWS C, 1990, HERPETOL J, V1, P514; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; FRETWELL S D, 1972, P217; Garrick L. D., 1978, B AM MUS NAT HIST, V160, P153; GILES LW, 1949, J WILDLIFE MANAGE, V13, P16, DOI 10.2307/3796122; GOODWIN TM, 1979, J HERPETOL, V13, P157, DOI 10.2307/1563922; Grant PBC, 2010, HERPETOL CONSERV BIO, V5, P456; HUTTON J, 1989, AM ZOOL, V29, P1033; JOANEN T., 1972, P ANN C SE ASS GAME, V26, P252; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kaminski, 2005, GAYLORD MEMORIAL LAB, P93; KAUFMANN JH, 1983, BIOL REV, V58, P1, DOI 10.1111/j.1469-185X.1983.tb00379.x; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; KENNEDY M, 1993, OIKOS, V68, P158, DOI 10.2307/3545322; Lang J.W., 1987, P273; Lehtinen RM, 1997, ENVIRON BIOL FISH, V49, P7, DOI 10.1023/A:1007346430221; Lewis JD, 2014, SOUTHEAST NAT, V13, P261, DOI 10.1656/058.013.0208; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Mazzotti FJ, 2009, ECOL INDIC, V9, pS137, DOI 10.1016/j.ecolind.2008.06.008; MCILHENNY EA, 1935, ALLIGATORS LIFE HIST; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Murphy TM, 1977, DISTRIBUTION MOVEMEN; Nifong JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083953; Nifong JC, 2013, J EXP MAR BIOL ECOL, V440, P185, DOI 10.1016/j.jembe.2013.01.002; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Piller KR, 2004, T AM FISH SOC, V133, P1004, DOI 10.1577/T03-047.1; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rosenblatt AE, 2013, ESTUAR COAST SHELF S, V135, P182, DOI 10.1016/j.ecss.2013.10.008; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Ryberg WA, 2002, J EXP ZOOL, V294, P325, DOI 10.1002/jez.10207; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Sartain BT, 2013, R BARNETT BACKWATER, V5056, P1; Sartain BT, 2013, AQUATIC PLANT COMMUN, V5057, P1; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111&lt;255:PIBLBA&gt;2.0.CO;2; SPRINGER JT, 1979, J WILDLIFE MANAGE, V43, P926, DOI 10.2307/3808276; Staton M.A., 1975, Memoria Soc Cienc nat La Salle, VNo. 101, P237; Strickland BA, 2015, SPATIAL ECOLOGY POPU; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Tucker AD, 1997, WILDLIFE RES, V24, P379, DOI 10.1071/WR95073; USDA, 2012, NAT AGR IM PROGR; VLIET KA, 1989, AM ZOOL, V29, P1019; Watanabe YY, 2013, AQUAT BIOL, V18, P1, DOI 10.3354/ab00489; Webb KK, 2009, J WILDLIFE MANAGE, V73, P566, DOI 10.2193/2006-294; Wersal R.M., 2006, GEORESOUR I REP, V5003, P1; White G.C., 1990, ANAL WILDLIFE RADIO; Wilson RR, 2012, WILDLIFE BIOL, V18, P424, DOI 10.2981/12-044; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	67	6	6	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161814	10.1371/journal.pone.0161814	http://dx.doi.org/10.1371/journal.pone.0161814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588947	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800019
J	Terry, L; Cassels, N; Lu, K; Acton, JH; Margrain, TH; North, RV; Fergusson, J; White, N; Wood, A				Terry, Louise; Cassels, Nicola; Lu, Kelly; Acton, Jennifer H.; Margrain, Tom H.; North, Rachel V.; Fergusson, James; White, Nick; Wood, Ashley			Automated Retinal Layer Segmentation Using Spectral Domain Optical Coherence Tomography: Evaluation of Inter-Session Repeatability and Agreement between Devices	PLOS ONE			English	Article							MACULAR THICKNESS MEASUREMENTS; NERVE-FIBER; SD-OCT; IMAGE-ANALYSIS; REPRODUCIBILITY; DEGENERATION; EYES; CLASSIFICATION; FUNDUS; SIZE	Retinal and intra-retinal layer thicknesses are routinely generated from optical coherence tomography (OCT) images, but on-board software capabilities and image scaling assumptions are not consistent across devices. This study evaluates the device-independent Iowa Reference Algorithms ( Iowa Institute for Biomedical Imaging) for automated intra-retinal layer segmentation and image scaling for three OCT systems. Healthy participants (n = 25) underwent macular volume scans using a Cirrus HD-OCT (Zeiss), 3D-OCT 1000 (Topcon), and a non-commercial long-wavelength (1040nm) OCT on two occasions. Mean thickness of 10 intra-retinal layers was measured in three ETDRS subfields ( fovea, inner ring and outer ring) using the Iowa Reference Algorithms. Where available, total retinal thicknesses were measured using on-board software. Measured axial eye length (AEL)-dependent scaling was used throughout, with a comparison made to the system-specific fixed-AEL scaling. Inter-session repeatability and agreement between OCT systems and segmentation methods was assessed. Inter-session coefficient of repeatability (CoR) for the foveal subfield total retinal thickness was 3.43 mu m, 4.76 mu m, and 5.98 mu m for the Zeiss, Topcon, and long-wavelength images respectively. For the commercial software, CoR was 4.63 mu m (Zeiss) and 7.63 mu m (Topcon). The Iowa Reference Algorithms demonstrated higher repeatability than the on-board software and, in addition, reliably segmented all 10 intra-retinal layers. With fixed-AEL scaling, the algorithm produced significantly different thickness values for the three OCT devices (P<0.05), with these discrepancies generally characterized by an overall offset (bias) and correlations with axial eye length for the foveal subfield and outer ring (P<0.05). This correlation was reduced to an insignificant level in all cases when AEL-dependent scaling was used. Overall, the Iowa Reference Algorithms are viable for clinical and research use in healthy eyes imaged with these devices, however ocular biometry is required for accurate quantification of OCT images.	[Terry, Louise; Cassels, Nicola; Lu, Kelly; Acton, Jennifer H.; Margrain, Tom H.; North, Rachel V.; Fergusson, James; White, Nick; Wood, Ashley] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Fergusson, James; White, Nick] Cardiff Univ, Vis Sci Bioimaging Labs, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Wood, A (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.	wooda2@cardiff.ac.uk	Acton, Jennifer/AAU-3307-2021	Acton, Jennifer/0000-0002-0347-7651; North, Rachel Valerie/0000-0002-6657-5099; Terry, Louise/0000-0002-6200-8230	Cardiff University; Medical Research Council; School of Optometry and Vision Sciences	Cardiff University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); School of Optometry and Vision Sciences	This work was funded by Cardiff University. VSBL acknowledges the Medical Research Council and School of Optometry and Vision Sciences for support.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; ANSI, 2000, Z136 ANSI ORL LAS I, V168; Antony B, 2011, BIOMED OPT EXPRESS, V2, P2403, DOI 10.1364/BOE.2.002403; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boey PY, 2014, CAN J OPHTHALMOL, V49, P489, DOI 10.1016/j.jcjo.2014.06.013; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Buchser NM, 2012, INVEST OPHTH VIS SCI, V53, P3742, DOI 10.1167/iovs.11-8432; Bussel II, 2014, BRIT J OPHTHALMOL, V98, P15, DOI 10.1136/bjophthalmol-2013-304326; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Chopovska Y, 2011, OPHTHALMOLOGICA, V225, P27, DOI 10.1159/000316693; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Farsiu S, 2014, OPHTHALMOLOGY, V121, P162, DOI 10.1016/j.ophtha.2013.07.013; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Garcia-Martin E, 2012, RETINA-J RET VIT DIS, V32, P1581, DOI 10.1097/IAE.0b013e318242b838; Garcia-Martin E, 2011, ACTA OPHTHALMOL, V89, pE23, DOI 10.1111/j.1755-3768.2010.02045.x; Garvin MK, 2013, INVEST OPHTH VIS SCI, V54, P6998, DOI 10.1167/iovs.13-12131; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Giani A, 2010, AM J OPHTHALMOL, V150, P815, DOI 10.1016/j.ajo.2010.06.025; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hee MR, 1996, OPHTHALMOLOGY, V103, P1260, DOI 10.1016/S0161-6420(96)30512-5; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Kotera Y, 2011, INVEST OPHTH VIS SCI, V52, P1412, DOI 10.1167/iovs.10-5572; Lee K, 2010, AUTOMATED INTRARETIN; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martinez-de-la-Casa JM, 2012, INVEST OPHTH VIS SCI, V53, P6214, DOI 10.1167/iovs.12-9875; Parravano M, 2010, INVEST OPHTH VIS SCI, V51, P4788, DOI 10.1167/iovs.09-4976; Povazay B, 2003, OPT EXPRESS, V11, P1980, DOI 10.1364/OE.11.001980; Povazay B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2773728; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Rashid A, 2014, REPORODUCIBILITY TOT; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sohn EH, 2013, INVEST OPHTH VIS SCI, V54, P4184, DOI 10.1167/iovs.12-10420; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Wood A, 2011, AM J OPHTHALMOL, V152, P1030, DOI 10.1016/j.ajo.2011.05.021	45	40	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162001	10.1371/journal.pone.0162001	http://dx.doi.org/10.1371/journal.pone.0162001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588683	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000382877800026
J	Basir, A; Grundeman, P; Moll, F; van Herwaarden, J; Pasterkamp, G; Nijland, R				Basir, Amir; Grundeman, Paul; Moll, Frans; van Herwaarden, Joost; Pasterkamp, Gerard; Nijland, Reindert			Adherence of Staphylococcus aureus to Dyneema Purity (R) Patches and to Clinically Used Cardiovascular Prostheses	PLOS ONE			English	Article							BACTERIAL BIOFILMS; VALVE ENDOCARDITIS	Various materials that are used for vascular and heart valve prostheses carry drawbacks: some require anticoagulant drugs or have moderate durability; others are not suitable for endovascular treatment. These prostheses are associated with bacterial infections. A material potentially suitable for prostheses is Dyneema Purity (R), made of ultra-high-molecular-weight polyethylene. Dyneema Purity (R) fibers are very thin, flexible, resistant to fatigue and abrasion, and have high strength. S. aureus adherence to Dyneema Purity (R) was tested and compared with currently used cardiovascular prostheses. We compared adhesion of S. aureus to Dyneema Purity (R) (1 membrane-based and 1 yarn-composed patch) with 5 clinically used yarn-composed polyester and membrane-based expanded polytetrafluoroethylene patches. Patches were contaminated with S. aureus bacteria and bacterial adherence was quantified. S. aureus adherence was also visualized in flow conditions. Overall, bacterial adherence was higher on yarn-composed prosthesis materials, with a rough surface, than on the membrane-based materials, with a smooth surface. Adherence to Dyneema Purity (R) materials was non-inferior to the currently used materials. Therefore, patches of Dyneema Purity (R) might be attractive for use in cardiovascular applications such as catheter-based heart valves and endovascular prostheses by their good mechanical properties combined with their noninferiority regarding bacterial adhesion.	[Basir, Amir; Grundeman, Paul; Pasterkamp, Gerard] UMC Utrecht, Dept Expt Cardiol, Utrecht, Netherlands; [Moll, Frans; van Herwaarden, Joost] UMC Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Nijland, Reindert] UMC Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Nijland, Reindert] Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wageningen University & Research	Basir, A (corresponding author), UMC Utrecht, Dept Expt Cardiol, Utrecht, Netherlands.; Nijland, R (corresponding author), UMC Utrecht, Dept Med Microbiol, Utrecht, Netherlands.; Nijland, R (corresponding author), Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands.	amirbasir@hotmail.com; reindert.nijland@wur.nl	Nijland, Reindert/B-8206-2008	Nijland, Reindert/0000-0003-0049-3768; van Herwaarden, Joost/0000-0003-1165-5179	University Medical Center Utrecht; DSM	University Medical Center Utrecht; DSM	University Medical Center Utrecht has a collaboration agreement with DSM, whereby DSM contributes its Dyneema Purity (R) fiber technology to enable UMC Utrecht to develop and evaluate a prototype of a non-biological supportive scaffold for the minimally invasive treatment of valvular and vascular diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas J, 2013, MOL MICROBIOL, V87, P254, DOI 10.1111/mmi.12097; Aydinuraz K, 2009, J SURG RES, V157, pE79, DOI 10.1016/j.jss.2009.04.008; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Basir Amir, 2015, Innovations (Phila), V10, P195, DOI 10.1097/IMI.0000000000000163; Begun J, 2007, PLOS PATHOG, V3, P526, DOI 10.1371/journal.ppat.0030057; Cornwett JL., RUTHERFORDS VASCULAR; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Dingenen JLJv, 2001, HIGH PERFORMANCE FIB, P329; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hasse B, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13754; Hurwit D, 2014, ARTHROSCOPY, V30, P1406, DOI 10.1016/j.arthro.2014.05.030; Joseph R, 2009, J MATER SCI-MATER M, V20, P153, DOI 10.1007/s10856-008-3502-6; Kim J, 2012, MOLECULES, V17, P9818, DOI 10.3390/molecules17089818; Kurtz SM, 2011, CLIN ORTHOP RELAT R, V469, P2262, DOI 10.1007/s11999-011-1872-4; Leroy O, 2012, CURR OPIN INFECT DIS, V25, P154, DOI 10.1097/QCO.0b013e3283501853; Nadell CD, 2009, FEMS MICROBIOL REV, V33, P206, DOI 10.1111/j.1574-6976.2008.00150.x; Naylor AR, 2001, EUR J VASC ENDOVASC, V21, P289, DOI 10.1053/ejvs.2001.1311; Peck M, 2012, CELLS TISSUES ORGANS, V195, P144, DOI 10.1159/000331406; Ricco JB, 2011, SEMIN VASC SURG, V24, P234, DOI 10.1053/j.semvascsurg.2011.10.006; Starakis Ioannis, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P249; Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x; TORNOS P, 1992, CHEST, V101, P37, DOI 10.1378/chest.101.1.37; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354; Wust DM, 2006, ARTHROSCOPY, V22, P1146, DOI 10.1016/j.arthro.2006.06.013	26	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162216	10.1371/journal.pone.0162216	http://dx.doi.org/10.1371/journal.pone.0162216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583703	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600120
J	Girsault, A; Lukes, T; Sharipov, A; Geissbuehler, S; Leutenegger, M; Vandenberg, W; Dedecker, P; Hofkens, J; Lasser, T				Girsault, Arik; Lukes, Tomas; Sharipov, Azat; Geissbuehler, Stefan; Leutenegger, Marcel; Vandenberg, Wim; Dedecker, Peter; Hofkens, Johan; Lasser, Theo			SOFI Simulation Tool: A Software Package for Simulating and Testing Super-Resolution Optical Fluctuation Imaging	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; STORM; RECONSTRUCTION; RESOLUTION; LIMIT	Super-resolution optical fluctuation imaging (SOFI) allows one to perform sub-diffraction fluorescence microscopy of living cells. By analyzing the acquired image sequence with an advanced correlation method, i.e. a high-order cross-cumulant analysis, super-resolution in all three spatial dimensions can be achieved. Here we introduce a software tool for a simple qualitative comparison of SOFI images under simulated conditions considering parameters of the microscope setup and essential properties of the biological sample. This tool incorporates SOFI and STORM algorithms, displays and describes the SOFI image processing steps in a tutorial-like fashion. Fast testing of various parameters simplifies the parameter optimization prior to experimental work. The performance of the simulation tool is demonstrated by comparing simulated results with experimentally acquired data.	[Girsault, Arik; Lukes, Tomas; Sharipov, Azat; Geissbuehler, Stefan; Leutenegger, Marcel; Lasser, Theo] Ecole Polytech Fed Lausanne, Lab Opt Biomed, Lausanne, Switzerland; [Vandenberg, Wim; Dedecker, Peter; Hofkens, Johan] Univ Leuven, Dept Chem, Celestijnenlaan, Heverlee, Belgium; [Lukes, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Radioelect, Prague, Czech Republic; [Leutenegger, Marcel] Max Planck Inst Biophys Chem, Abt NanoBiophoton, Gottingen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; KU Leuven; Czech Technical University Prague; Max Planck Society	Lasser, T (corresponding author), Ecole Polytech Fed Lausanne, Lab Opt Biomed, Lausanne, Switzerland.	theo.lasser@epfl.ch	Hofkens, Johan/AAP-9255-2020; Geissbühler, Stefan/AAY-8299-2021; Vandenberg, Wim/D-2124-2012; Hofkens, Johan/AAL-4204-2020; Hofkens, Johan/D-4284-2017	Vandenberg, Wim/0000-0002-5888-9100; Hofkens, Johan/0000-0002-9101-0567; Dedecker, Peter/0000-0002-1882-2075	Swiss National Science Foundation (SNSF) [200020-159945/1, 205321-138305/1]; SCIEX scholarship [13.183]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SCIEX scholarship	This research was supported by the Swiss National Science Foundation (SNSF, http://www.snf.ch/en) under grants 200020-159945/1 and 205321-138305/1. Tomas Lukes acknowledges a SCIEX scholarship (13.183).	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Dertinger T, 2010, OPT EXPRESS, V18, P18875, DOI 10.1364/OE.18.018875; Geissbuehler S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6830; Geissbuehler S, 2011, BIOMED OPT EXPRESS, V2, P408, DOI 10.1364/BOE.2.000408; Geissbueler S., 2012, OPT NANOSCOPY, V1, P4, DOI DOI 10.1186/2192-2853-1-4; Girsault A, 2016, MATLAB CODES SOFI OP; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Lukes T, 2014, PROC SPIE, V9129, DOI 10.1117/12.2052621; MENDEL JM, 1991, P IEEE, V79, P278, DOI 10.1109/5.75086; Min JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04577; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Patterson G, 2013, AMNU REV PHYS CHEM, P345; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Sonka M., 1998, IMAGE PROCESSING ANA; Vandenberg W, 2015, CELL TISSUE RES, V360, P151, DOI 10.1007/s00441-014-2109-0	22	24	24	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161602	10.1371/journal.pone.0161602	http://dx.doi.org/10.1371/journal.pone.0161602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583365	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000382855600044
J	Perez, M; Ladero, V; Redruello, B; del Rio, B; Fernandez, L; Rodriguez, JM; Martin, M; Fernandez, M; Alvarez, MA				Perez, Marta; Ladero, Victor; Redruello, Begoma; del Rio, Beatriz; Fernandez, Leonides; Miguel Rodriguez, Juan; Cruz Martin, Ma; Fernandez, Maria; Alvarez, Miguel A.			Mastitis Modifies the Biogenic Amines Profile in Human Milk, with Significant Changes in the Presence of Histamine, Putrescine and Spermine	PLOS ONE			English	Article							BREAST-MILK; SYNTHETIC POLYAMINES; RAT MILK; ACIDS; PRETERM; MOTHERS; ORIGIN	Biogenic amines (BAs) are low molecular weight nitrogenous organic compounds with different biological activities. Putrescine, spermidine and spermine are essential for the development of the gut and immune system of newborns, and are all found in human milk. Little is known, however, about the role of histamine, tyramine or cadaverine in breast milk. Nor is it known whether mastitis alters the BA composition of milk. The BA profile of human milk, and the influence of mastitis on BA concentrations, were therefore investigated. Putrescine, spermidine and spermine were the main BAs detected. In mastitis-affected milk, the concentrations of putrescine, spermine and histamine were higher.	[Perez, Marta; Ladero, Victor; Redruello, Begoma; del Rio, Beatriz; Cruz Martin, Ma; Fernandez, Maria; Alvarez, Miguel A.] IPLA CSIC, Inst Prod Lacteos Asturias, Paseo Rio Linares S-N, Villaviciosa 33300, Spain; [Fernandez, Leonides; Miguel Rodriguez, Juan] Univ Complutense Madrid, Dept Nutr Bromatol & Tecnol Alimentos, Avda Puerta de Hierro, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); Complutense University of Madrid	Fernandez, M (corresponding author), IPLA CSIC, Inst Prod Lacteos Asturias, Paseo Rio Linares S-N, Villaviciosa 33300, Spain.	mfernandez@ipla.csic.es	Martin, Maria Cruz/F-2152-2013; Alvarez, Miguel A./F-2535-2013; Martín, María/HDL-9512-2022; Rodriguez, Juan Miguel/ABB-6650-2020; Arias-Alvarez, M/L-6169-2014; Perez, Marta/A-6239-2015; Ladero, Victor/B-6807-2008; Redruello, Begoña/A-2204-2016; Fernández, Leonides/N-7521-2019; del Rio, Beatriz/L-3082-2014	Martin, Maria Cruz/0000-0003-1975-6775; Alvarez, Miguel A./0000-0001-9607-7480; Rodriguez, Juan Miguel/0000-0002-1285-9686; Arias-Alvarez, M/0000-0001-7907-7454; Perez, Marta/0000-0002-1059-3677; Ladero, Victor/0000-0002-7613-3745; Fernández, Leonides/0000-0003-2380-0767; Redruello, Begona/0000-0003-1787-5594; del Rio, Beatriz/0000-0001-8107-1975	Spanish Ministry of Economy and Competitiveness [AGL2013-45431-R, AGL2013-41980P]; Plan for Science, Technology and Innovation of the Principality of Asturias [GRUPIN14-137]; European Regional Development Funds [GRUPIN14-137]; FPU (Programa de Formacion del Profesorado Universitario) fellowship from the Spanish Ministry of Education, Culture and Sport	Spanish Ministry of Economy and Competitiveness(Spanish Government); Plan for Science, Technology and Innovation of the Principality of Asturias; European Regional Development Funds(European Commission); FPU (Programa de Formacion del Profesorado Universitario) fellowship from the Spanish Ministry of Education, Culture and Sport	This work was performed with the financial support of the Spanish Ministry of Economy and Competitiveness (AGL2013-45431-R and AGL2013-41980P) and the GRUPIN14-137 project (which is co-financed by the Plan for Science, Technology and Innovation of the Principality of Asturias 2014-2017 and the European Regional Development Funds). M.P. was the recipient of an FPU (Programa de Formacion del Profesorado Universitario) fellowship from the Spanish Ministry of Education, Culture and Sport.	Ali MA, 2014, J HUM NUTR DIET, V27, P459, DOI 10.1111/jhn.12156; Ali MA, 2013, J HUM NUTR DIET, V26, P164, DOI 10.1111/jhn.12097; Aryeetey RNO, 2009, BREASTFEED MED, V4, P161, DOI 10.1089/bfm.2008.0131; AURAND LW, 1980, J ANIM SCI, V50, P783, DOI 10.2527/jas1980.505783x; BUTS JP, 1995, J PEDIATR GASTR NUTR, V21, P44, DOI 10.1097/00005176-199507000-00007; Chanphai P, 2016, INT J BIOL MACROMOL, V92, P515, DOI [10.1016/j.ijbiomac.2016.07.049, DOI 10.1016/J.IJBI0MAC.2016.07.049]; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Correa MF, 2015, CHEM BIOL DRUG DES, V85, P461, DOI 10.1111/cbdd.12431; D'Agostino L, 2006, IUBMB LIFE, V58, P75, DOI 10.1080/15216540600662525; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Essemine J, 2011, INT J BIOL MACROMOL, V49, P201, DOI 10.1016/j.ijbiomac.2011.04.016; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fetherston CM, 2006, BREASTFEED MED, V1, P136, DOI 10.1089/bfm.2006.1.136; Fiechter G, 2013, J CHROMATOGR B, V927, P191, DOI 10.1016/j.jchromb.2012.12.006; Gomez-Gallego C, 2013, BR J NUTR, V11, P1; Gregory KE, 2013, CURR PEDIAT REP, V1; Hettinga KA, 2009, VET MICROBIOL, V137, P384, DOI 10.1016/j.vetmic.2009.01.016; Hunt KM, 2013, BREASTFEED MED, V8, P105, DOI 10.1089/bfm.2011.0141; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Jimenez E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-288; Ladero V, 2010, CURR NUTR FOOD SCI, V6, P145, DOI 10.2174/157340110791233256; Linares DM, 2011, CRIT REV FOOD SCI, V51, P691, DOI 10.1080/10408398.2011.582813; Mizuno K, 2012, J HUM LACT, V28, P529, DOI 10.1177/0890334412455946; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Plaza-Zamora J, 2013, BRIT J NUTR, V110, P524, DOI 10.1017/S0007114512005284; Ploszaj T, 1997, COMP BIOCHEM PHYS B, V118, P45, DOI 10.1016/S0305-0491(97)00018-7; POLLACK PF, 1992, AM J CLIN NUTR, V56, P371, DOI 10.1093/ajcn/56.2.371; Redruello B, 2013, FOOD CHEM, V139, P1029, DOI 10.1016/j.foodchem.2013.01.071; ROMAIN N, 1992, PEDIATR RES, V32, P58, DOI 10.1203/00006450-199207000-00011; Sabater-Molina M, 2009, NUTRITION, V25, P940, DOI 10.1016/j.nut.2009.01.017; Shahid M, 2010, BIOMEDICAL ASPECTS OF HISTAMINE: CURRENT PERSPECTIVES, P3, DOI 10.1007/978-90-481-9349-3_1; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; ZIA S, 1987, AM J VET RES, V48, P1617	34	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162426	10.1371/journal.pone.0162426	http://dx.doi.org/10.1371/journal.pone.0162426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584695	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600132
J	Pramono, RXA; Imtiaz, SA; Rodriguez-Villegas, E				Pramono, Renard Xaviero Adhi; Imtiaz, Syed Anas; Rodriguez-Villegas, Esther			A Cough-Based Algorithm for Automatic Diagnosis of Pertussis	PLOS ONE			English	Article							SOUND; RECORDINGS	Pertussis is a contagious respiratory disease which mainly affects young children and can be fatal if left untreated. The World Health Organization estimates 16 million pertussis cases annually worldwide resulting in over 200,000 deaths. It is prevalent mainly in developing countries where it is difficult to diagnose due to the lack of healthcare facilities and medical professionals. Hence, a low-cost, quick and easily accessible solution is needed to provide pertussis diagnosis in such areas to contain an outbreak. In this paper we present an algorithm for automated diagnosis of pertussis using audio signals by analyzing cough and whoop sounds. The algorithm consists of three main blocks to perform automatic cough detection, cough classification and whooping sound detection. Each of these extract relevant features from the audio signal and subsequently classify them using a logistic regression model. The output from these blocks is collated to provide a pertussis likelihood diagnosis. The performance of the proposed algorithm is evaluated using audio recordings from 38 patients. The algorithm is able to diagnose all pertussis successfully from all audio recordings without any false diagnosis. It can also automatically detect individual cough sounds with 92% accuracy and PPV of 97%. The low complexity of the proposed algorithm coupled with its high accuracy demonstrates that it can be readily deployed using smartphones and can be extremely useful for quick identification or early screening of pertussis and for infection outbreaks control.	[Pramono, Renard Xaviero Adhi; Imtiaz, Syed Anas; Rodriguez-Villegas, Esther] Imperial Coll London, Dept Elect & Elect Engn, London, England	Imperial College London	Pramono, RXA (corresponding author), Imperial Coll London, Dept Elect & Elect Engn, London, England.	renard.pramono14@imperial.ac.uk		Pramono, Renard Xaviero Adhi/0000-0002-4731-2752; Imtiaz, Syed Anas/0000-0001-9017-8977				Abeyratne UR, 2013, IEEE ENG MED BIO, P5216, DOI 10.1109/EMBC.2013.6610724; Al-khassaweneh Mahmood, 2013, Journal of Medical Engineering & Technology, V37, P165, DOI 10.3109/03091902.2012.758322; Amrulloh YA, 2015, BIOMED SIGNAL PROCES, V21, P126, DOI 10.1016/j.bspc.2015.05.001; Barry Samantha J, 2006, Cough, V2, P8, DOI 10.1186/1745-9974-2-8; Brookes M., 2014, VOICEBOX SPEECH PROC; Chatrzarrin H., 2011, PROC IEEE 719 INT S, P162, DOI [10.1109/MeMeA.2011.5966670, DOI 10.1109/MEMEA.2011.5966670]; Chung KF, 2009, PULM PHARMACOL THER, V22, P139, DOI 10.1016/j.pupt.2008.12.008; Doherty MJ, 1997, EUR RESPIR J, V10, P202, DOI 10.1183/09031936.97.10010202; Gillet O, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL IV, PROCEEDINGS, P269; Hankins RQ, 2014, INT CONF ELECTRO INF, P567, DOI 10.1109/EIT.2014.6871826; Jia-Ming Liu, 2013, 2013 IEEE China Summit and International Conference on Signal and Information Processing (ChinaSIP), P160, DOI 10.1109/ChinaSIP.2013.6625319; Korpas J, 1996, PULM PHARMACOL THER, V9, P261, DOI 10.1006/pulp.1996.0034; Kosasih K, 2012, IEEE ENG MED BIO, P5654, DOI 10.1109/EMBC.2012.6347277; Kosasih K, 2015, IEEE T BIO-MED ENG, V62, P1185, DOI 10.1109/TBME.2014.2381214; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Larson EC, 2011, UBICOMP'11: PROCEEDINGS OF THE 2011 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P375, DOI 10.1145/2030112.2030163; Lucio C, 2014, 2014 7TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2014), P405, DOI 10.1109/BMEI.2014.7002808; Martinek J, 2008, J PHYSIOL PHARMACOL, V59, P433; MathWorks, 2016, MATLAB SIM TECHN COM; Matos S, 2006, IEEE T BIO-MED ENG, V53, P1078, DOI 10.1109/TBME.2006.873548; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; NHS, 2014, WHOOP COUGH SYMPT; Parker D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082971; Peeters G., 2004, LARGE AUDIO FEATURES; Pew Research Center, 2016, SMARTPH OWN INT US C; Public Health Agency of Canada, 2016, PERT WHOOP COUGH; Rabiner L., 1993, FUNDAMENTALS OF SPEE; Scheirer E, 1997, INT CONF ACOUST SPEE, P1331, DOI 10.1109/ICASSP.1997.596192; Swarnkar V, 2013, IEEE ENG MED BIO, P1764, DOI 10.1109/EMBC.2013.6609862; Swarnkar V, 2012, IEEE ENG MED BIO, P3147, DOI 10.1109/EMBC.2012.6346632; Swarnkar V, 2013, ANN BIOMED ENG, V41, P1016, DOI 10.1007/s10439-013-0741-6; Thorpe W, 2001, ANZIIS 2001: PROCEEDINGS OF THE SEVENTH AUSTRALIAN AND NEW ZEALAND INTELLIGENT INFORMATION SYSTEMS CONFERENCE, P391; Tracey BH, 2011, IEEE ENG MED BIO, P6017, DOI 10.1109/IEMBS.2011.6091487; World Health Organization, 2016, PERT	34	64	69	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162128	10.1371/journal.pone.0162128	http://dx.doi.org/10.1371/journal.pone.0162128			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583523	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600109
J	Kothur, K; Wienholt, L; Mohammad, SS; Tantsis, EM; Pillai, S; Britton, PN; Jones, CA; Angiti, RR; Barnes, EH; Schlub, T; Bandodkar, S; Brilot, F; Dale, RC				Kothur, Kavitha; Wienholt, Louise; Mohammad, Shekeeb S.; Tantsis, Esther M.; Pillai, Sekhar; Britton, Philip N.; Jones, Cheryl A.; Angiti, Rajeshwar R.; Barnes, Elizabeth H.; Schlub, Timothy; Bandodkar, Sushil; Brilot, Fabienne; Dale, Russell C.			Utility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral Encephalitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID NEOPTERIN; CELL-ACTIVATING FACTOR; T-CELLS; TH17 CELLS; CHEMOKINE; CXCL13; BRAIN; CYTOKINE; BLOOD	Background Despite the discovery of CSF and serum diagnostic autoantibodies in autoimmune encephalitis, there are still very limited CSF biomarkers for diagnostic and monitoring purposes in children with inflammatory or autoimmune brain disease. The cause of encephalitis is unknown in up to a third of encephalitis cohorts, and it is important to differentiate infective from autoimmune encephalitis given the therapeutic implications. Aim To study CSF cytokines and chemokines as diagnostic biomarkers of active neuroinflammation, and assess their role in differentiating demyelinating, autoimmune, and viral encephalitis. Methods We measured and compared 32 cytokine/chemokines using multiplex immunoassay and APRIL and BAFF using ELISA in CSF collected prior to commencing treatment from paediatric patients with confirmed acute disseminated encephalomyelitis (ADEM, n = 16), anti-NMDAR encephalitis (anti-NMDAR E, n = 11), and enteroviral encephalitis (EVE, n = 16). We generated normative data using CSF from 20 non-inflammatory neurological controls. The sensitivity of CSF cytokine/chemokines to diagnose encephalitis cases was calculated using 95th centile of control values as cut off. We correlated CSF cytokine/chemokines with disease severity and follow up outcome based on modified Rankin scale. One-way hierarchical correlational cluster analysis of molecules was performed in different encephalitis and outcome groups. Results In descending order, CSF TNF-alpha, IL-10, IFN-alpha, IL-6, CXCL13 and CXCL10 had the best sensitivity (>79.1%) when all encephalitis patients were included. The combination of IL-6 and IFN-alpha was most predictive of inflammation on multiple logistic regression with area under the ROC curve 0.99 (CI 0.97-1.00). There were no differences in CSF cytokine concentrations between EVE and anti-NMDAR E, whereas ADEM showed more pronounced elevation of Th17 related (IL-17, IL-21) and Th2 (IL-4, CCL17) related cytokine/chemokines. Unlike EVE, heat map analysis showed similar clustering of cytokine/chemokine molecules in immune mediated encephalitis (ADEM and anti-NMDAR E). Th1 and B cell (CXCL13 and CXCL10) molecules clustered together in patients with severe encephalopathy at admission and worse disability at follow up in all encephalitis. There was no correlation between CSF neopterin and IFN-gamma or IFN-alpha. Conclusion A combination panel of cytokine/chemokines consisting of CSF TNF-alpha, IL-10, IFN-alpha, IL-6, CXCL13 and CXCL10 measured using multiplex immunoassay may be used to diagnose and monitor intrathecal inflammation in the brain. Given their association with worse outcome, certain key chemokines (CXCL13, CXCL10) could represent potential therapeutic targets in encephalitis.	[Kothur, Kavitha; Mohammad, Shekeeb S.; Tantsis, Esther M.; Pillai, Sekhar; Brilot, Fabienne; Dale, Russell C.] Univ Sydney, Brain Autoimmun Grp, Inst Neurosci & Muscle Res, Childrens Hosp Westmead, Sydney, NSW, Australia; [Wienholt, Louise] Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia; [Britton, Philip N.; Jones, Cheryl A.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Britton, Philip N.; Jones, Cheryl A.] Childrens Hosp Westmead, Sydney, NSW, Australia; [Angiti, Rajeshwar R.] Univ Sydney, Nepean Hosp, Dept Neonatol, Sydney, NSW, Australia; [Barnes, Elizabeth H.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Schlub, Timothy] Univ Sydney, Sydney Sch Publ Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Bandodkar, Sushil] Childrens Hosp Westmead, Dept Biochem, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Nepean Hospital; University of Sydney; University of Sydney; University of Sydney; University of Sydney	Dale, RC (corresponding author), Univ Sydney, Brain Autoimmun Grp, Inst Neurosci & Muscle Res, Childrens Hosp Westmead, Sydney, NSW, Australia.	russell.dale@health.nsw.gov.au	Britton, Philip/ABD-2084-2020; Britton, Philip/ABD-2085-2020; Mohammad, Shekeeb/AAD-1282-2022; Brilot, Fabienne/AAT-3138-2020; Angiti, Rajeshwar/ABI-2595-2020; Mohammad, Shekeeb/Q-6928-2019; kothur, kavitha/M-3330-2018	Britton, Philip/0000-0002-2993-6000; Britton, Philip/0000-0002-2993-6000; Mohammad, Shekeeb/0000-0003-1219-4781; Brilot, Fabienne/0000-0002-7025-2276; Angiti, Rajeshwar/0000-0003-2059-4128; kothur, kavitha/0000-0002-0109-8877; Wienholt, Louise/0000-0002-5618-4772; Schlub, Timothy/0000-0001-7746-9649; Bandodkar, Sushil/0000-0001-5000-4518	Petre Foundation; Australian Postgraduate award; Multiple Sclerosis Research Australia	Petre Foundation; Australian Postgraduate award(Australian Government); Multiple Sclerosis Research Australia	This work was supported by a scholarship from the Petre Foundation, Australian Postgraduate award, Multiple Sclerosis Research Australia, and donations in the memory of Ewan Murray. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by scholarship from Petre Foundation, Australian Postgraduate award, Multiple Sclerosis Research Australia and donations in the memory of Ewan Murray.	Bagaeva LV, 2006, J IMMUNOL, V176, P7676, DOI 10.4049/jimmunol.176.12.7676; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Banks WA, 2005, CURR PHARM DESIGN, V11, P973, DOI 10.2174/1381612053381684; Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; BREW BJ, 1990, ANN NEUROL, V28, P556, DOI 10.1002/ana.410280413; Britton PN, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2848; Camdessanche JP, 2011, EUR J NEUROL, V18, P929, DOI 10.1111/j.1468-1331.2010.03180.x; Carr DJJ, 2003, J VIROL, V77, P10037, DOI 10.1128/JVI.77.18.10037-10046.2003; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Dale RC, 2003, NEUROPEDIATRICS, V34, P141; Dale RC, 2010, CURR OPIN PEDIATR, V22, P718, DOI 10.1097/MOP.0b013e3283402b71; Dale RC, 2009, DEV MED CHILD NEUROL, V51, P317, DOI 10.1111/j.1469-8749.2008.03225.x; Delves Peter J., 2011, ROITTS ESSENTIAL IMM; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Granerod J, 2010, EPIDEMIOL INFECT, V138, P783, DOI 10.1017/S0950268810000725; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Hacohen Y, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000010; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huber AK, 2015, ADV NEUROIMMUNE BIOL, V6, P1, DOI 10.3233/NIB-150101; Ichiyama T, 2008, CYTOKINE, V44, P149, DOI 10.1016/j.cyto.2008.07.002; Ishizu T, 2006, J NEUROIMMUNOL, V175, P52, DOI 10.1016/j.jneuroim.2006.03.020; Ittah M, 2011, J INNATE IMMUN, V3, P200, DOI 10.1159/000321194; Kimura A, 2015, J NEUROL SCI, V352, P79, DOI 10.1016/j.jns.2015.03.036; Klimatcheva E, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0068-1; Kothur K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149411; Kothur K, 2016, CYTOKINE, V77, P227, DOI 10.1016/j.cyto.2015.10.001; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leypoldt F., 2014, JAMA NEUROL; Liba Z, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0507-9; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Martinez-Hernandez E, 2011, NEUROLOGY, V77, P589, DOI 10.1212/WNL.0b013e318228c136; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Michael BD, 2015, J INFECT DIS; Michael BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146288; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Molero-Luis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083237; Momcilovic M, 2012, IMMUNOL RES, V52, P53, DOI 10.1007/s12026-012-8282-x; Moraes-Fontes Maria Francisca, 2012, ISRN Rheumatol, V2012, P989218, DOI 10.5402/2012/989218; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Phares TW, 2011, J VIROL, V85, P2589, DOI 10.1128/JVI.02260-10; Piazza F, 2010, J NEUROIMMUNOL, V220, P104, DOI 10.1016/j.jneuroim.2010.01.011; Pillai SC, 2015, PEDIATRICS, V135, pE974, DOI 10.1542/peds.2014-2702; Pranzatelli MR, 2013, J INTERF CYTOK RES, V33, P523, DOI 10.1089/jir.2012.0132; Rainey-Barger EK, 2011, BRAIN BEHAV IMMUN, V25, P922, DOI 10.1016/j.bbi.2010.10.002; Rantalaiho T, 2001, J NEUROL SCI, V184, P169, DOI 10.1016/S0022-510X(01)00441-5; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Roberts WK, 2015, ANN NEUROL, V78, P619, DOI 10.1002/ana.24494; Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002; Rubenstein JL, 2013, BLOOD, V121, P4740, DOI 10.1182/blood-2013-01-476333; SCHOEDON G, 1986, J INTERFERON RES, V6, P697, DOI 10.1089/jir.1986.6.697; Senel M, 2010, J NEUROL NEUROSUR PS, V81, P929, DOI 10.1136/jnnp.2009.195438; Sghiri R, 2005, CLIN DIAGN LAB IMMUN, V12, P1437, DOI 10.1128/CDLI.12.12.1437-1441.2005; Sinclair AJ, 2013, DEV MED CHILD NEUROL, V55, P71, DOI 10.1111/j.1469-8749.2012.04443.x; Tuzun E, 2009, ACTA NEUROPATHOL, V118, P737, DOI 10.1007/s00401-009-0582-4; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458; Wang SM, 2008, J INFECT DIS, V198, P1002, DOI 10.1086/591462; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Wirleitner B, 2002, J LEUKOCYTE BIOL, V72, P1148	68	73	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161656	10.1371/journal.pone.0161656	http://dx.doi.org/10.1371/journal.pone.0161656			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575749	Green Published, gold			2022-12-27	WOS:000382877200031
J	Baumann, JH; Townsend, JE; Courtney, TA; Aichelman, HE; Davies, SW; Lima, FP; Castillo, KD				Baumann, Justin H.; Townsend, Joseph E.; Courtney, Travis A.; Aichelman, Hannah E.; Davies, Sarah W.; Lima, Fernando P.; Castillo, Karl D.			Temperature Regimes Impact Coral Assemblages along Environmental Gradients on Lagoonal Reefs in Belize	PLOS ONE			English	Article							CLIMATE-CHANGE; BLEACHING EVENT; LIFE-HISTORIES; RESILIENCE; EUTROPHICATION; DECLINE; MODEL; CIRCULATION; ADAPTATION; STRESSORS	Coral reefs are increasingly threatened by global and local anthropogenic stressors such as rising seawater temperature, nutrient enrichment, sedimentation, and overfishing. Although many studies have investigated the impacts of local and global stressors on coral reefs, we still do not fully understand how these stressors influence coral community structure, particularly across environmental gradients on a reef system. Here, we investigate coral community composition across three different temperature and productivity regimes along a nearshore-offshore gradient on lagoonal reefs of the Belize Mesoamerican Barrier Reef System (MBRS). A novel metric was developed using ultra-high-resolution satellite-derived estimates of sea surface temperatures (SST) to classify reefs as exposed to low (low(TP)), moderate (mod(TP)), or high (high(TP)) temperature parameters over 10 years (2003 to 2012). Coral species richness, abundance, diversity, density, and percent cover were lower at high(TP) sites relative to low(TP) and mod(TP) sites, but these coral community traits did not differ significantly between low(TP) and mod(TP) sites. Analysis of coral life history strategies revealed that high(TP) sites were dominated by hardy stress-tolerant and fast-growing weedy coral species, while low(TP) and mod(TP) sites consisted of competitive, generalist, weedy, and stress-tolerant coral species. Satellite-derived estimates of Chlorophyll-a (chl-a) were obtained for 13-years (2003-2015) as a proxy for primary production. Chl-a concentrations were highest at high(TP) sites, medial at mod(TP) sites, and lowest at low(TP) sites. Notably, thermal parameters correlated better with coral community traits between site types than productivity, suggesting that temperature (specifically number of days above the thermal bleaching threshold) played a greater role in defining coral community structure than productivity on the MBRS. Dominance of weedy and stress-tolerant genera at high(TP) sites suggests that corals utilizing these two life history strategies may be better suited to cope with warmer oceans and thus may warrant protective status under climate change.	[Baumann, Justin H.; Townsend, Joseph E.; Courtney, Travis A.; Aichelman, Hannah E.; Davies, Sarah W.; Castillo, Karl D.] Univ N Carolina, Dept Marine Sci, 3202 Murray & Venable Halls, Chapel Hill, NC 27599 USA; [Courtney, Travis A.; Davies, Sarah W.] Northeastern Univ, Dept Marine & Environm Sci, 430 Nahant Rd, Nahant, MA USA; [Courtney, Travis A.] Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Lima, Fernando P.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Campus Agr Vairao, Vairao, Portugal	University of North Carolina; University of North Carolina Chapel Hill; Northeastern University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidade do Porto	Baumann, JH (corresponding author), Univ N Carolina, Dept Marine Sci, 3202 Murray & Venable Halls, Chapel Hill, NC 27599 USA.	baumannj@live.unc.edu	Lima, Fernando P./C-1398-2008	Lima, Fernando P./0000-0001-9575-9834; Baumann, Justin/0000-0003-0113-0491; Courtney, Travis/0000-0002-1868-9630	Rufford Foundation [15802-1]; National Science Foundation [OCE 1459522]; Department of Defense NDSEG fellowship; Directorate For Geosciences [1459522] Funding Source: National Science Foundation	Rufford Foundation; National Science Foundation(National Science Foundation (NSF)); Department of Defense NDSEG fellowship(United States Department of Defense); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Rufford Foundation (http://www.rufford.org) Small Grant to JHB (15802-1); National Science Foundation (Oceanography) (nsf.gov) to KDC (OCE 1459522); Department of Defense NDSEG fellowship to JHB.	Alvarez-Filip L, 2009, P ROY SOC LOND B BIO; Alvarez-Filip L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03486; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Andrefouet S, 2002, CORAL REEFS, V21, P43, DOI 10.1007/s00338-001-0199-0; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bell PRF, 2014, AMBIO, V43, P361, DOI 10.1007/s13280-013-0443-1; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Buglass S, 2016, MAR POLLUT BULL, V104, P198, DOI 10.1016/j.marpolbul.2016.01.038; Burke L., 2004, REEFS RISK CARIBBEAN; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carrillo L, 2015, CONT SHELF RES, V109, P164, DOI 10.1016/j.csr.2015.09.014; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Chin TM, 2013, ALGORITHM THEORETICA, V1, P13; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cortes J., 1990, CORAL REEFS GOLFO DU; Cramer K, 2010, P 2010 AGU OC SCI M; Cramer KL, 2015, MAR POLLUT BULL, V96, P176, DOI 10.1016/j.marpolbul.2015.05.031; Cramer KL, 2012, ECOL LETT, V15, P561, DOI 10.1111/j.1461-0248.2012.01768.x; D'Croz L, 2001, B MAR SCI, V69, P203; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fine M, 2013, GLOBAL CHANGE BIOL, V19, P3640, DOI 10.1111/gcb.12356; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Ginsburg R, 2003, ATOLL RES B, V496; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUNTE W, 1992, MAR BIOL, V114, P625, DOI 10.1007/BF00357259; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Lirman D, 2007, MAR POLLUT BULL, V54, P779, DOI 10.1016/j.marpolbul.2006.12.014; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; McClanahan TR, 2008, MAR BIOL, V153, P755, DOI 10.1007/s00227-007-0844-4; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; Moberg F, 1999, ECOL ECON, V29, P2151; Polonia ARM, 2015, SCI TOTAL ENVIRON, V537, P139, DOI 10.1016/j.scitotenv.2015.07.102; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254, P20; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Paris CB, 2008, CORAL REEFS, V27, P773, DOI 10.1007/s00338-008-0396-1; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Pineda J, 2013, LIMNOL OCEANOGR, V58, P1531, DOI 10.4319/lo.2013.58.5.1531; Prouty NG, 2008, CORAL REEFS, V27, P727, DOI 10.1007/s00338-008-0413-4; Sheng JY, 2004, OCEAN DYNAM, V54, P232, DOI 10.1007/s10236-003-0074-3; Sheng JY, 2003, J PHYS OCEANOGR, V33, P2049, DOI 10.1175/1520-0485(2003)033<2049:ANSOCI>2.0.CO;2; Simons RA, 2011, ERDDAP ENV RES DIVIS; Soto I, 2011, J MARINE BIOL, V2011; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Tang LQ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002930; Team RC, 2012, R LANG ENV STAT COMP; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Torres JL, 2002, CARIBB J SCI, V38, P222; van Hooidonk R, 2015, GLOBAL CHANGE BIOL, V21, P3389, DOI 10.1111/gcb.12901; van Woesik R, 1999, MAR FRESHWATER RES, V50, P427, DOI 10.1071/MF97046; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; West K, 2001, MAR POLLUT BULL, V42, P864, DOI 10.1016/S0025-326X(01)00040-6; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wooldridge S, 2005, MAR ECOL PROG SER, V295, P157, DOI 10.3354/meps295157; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833	85	18	18	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162098	10.1371/journal.pone.0162098	http://dx.doi.org/10.1371/journal.pone.0162098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606598	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600017
J	Adam, AP; Lowery, AM; Martino, N; Alsaffar, H; Vincent, PA				Adam, Alejandro P.; Lowery, Anthony M.; Martino, Nina; Alsaffar, Hiba; Vincent, Peter A.			Src Family Kinases Modulate the Loss of Endothelial Barrier Function in Response to TNF-alpha: Crosstalk with p38 Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TYROSINE PHOSPHORYLATION; VE-CADHERIN; VASCULAR-PERMEABILITY; PARACELLULAR PATHWAY; SEVERE SEPSIS; SERUM-LEVELS; KAPPA-B; ACTIVATION; MOUSE	Activation of Src Family Kinase (SFK) signaling is required for the increase in endothelial permeability induced by a variety of cytokines and growth factors. However, we previously demonstrated that activation of endogenous SFKs by expression of dominant negative C-terminal Src Kinase (DN-Csk) is not sufficient to decrease endothelial adherens junction integrity. Basal SFK activity has been observed in normal venular endothelia and was not associated with increased basal permeability. The basal SFK activity however was found to contribute to increased sensitivity of the venular endothelium to inflammatory mediator-induced leakage. How SFK activation achieves this is still not well understood. Here, we show that SFK activation renders human dermal microvascular endothelial cells susceptible to low doses of TNF-alpha. Treatment of DN-Csk-expressing cells with 50 pg/ml TNF-alpha induced a loss of TEER as well as drastic changes in the actin cytoskeleton and focal adhesion proteins. This synergistic effect was independent of ROCK or NF-kappa B activity. TNF-alpha induced p38 signaling was required for the synergistic effect on barrier function, and activation of the p38 MAPK alone was also able to induce changes in permeability only in monolayers with active SFKs. These results suggest that the activation of endogenous levels of SFK renders the endothelial barrier more susceptible to low, physiologic doses of TNF-alpha through activation of p38 which leads to a loss of endothelial tight junctions.	[Adam, Alejandro P.; Lowery, Anthony M.; Martino, Nina; Alsaffar, Hiba; Vincent, Peter A.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Adam, Alejandro P.] Albany Med Coll, Dept Ophthalmol, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Adam, AP; Vincent, PA (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.; Adam, AP (corresponding author), Albany Med Coll, Dept Ophthalmol, Albany, NY 12208 USA.	adama1@mail.amc.edu; vincenp@mail.amc.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235	American Heart Association [13SDG17100110]; NIH [R01 HL77870]	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a American Heart Association grant 13SDG17100110 to APA and NIH R01 HL77870 to PAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Adam AP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272858; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; BRAVERMAN IM, 1986, J INVEST DERMATOL, V86, P577, DOI 10.1111/1523-1747.ep12355222; BULL RH, 1992, BRIT J DERMATOL, V126, P436, DOI 10.1111/j.1365-2133.1992.tb11815.x; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; Clauss M, 2001, BLOOD, V97, P1321, DOI 10.1182/blood.V97.5.1321; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Garcia-Ponce A, 2015, THROMB HAEMOSTASIS, V113, P20, DOI 10.1160/TH14-04-0298; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Han JY, 2013, BLOOD, V122, P4140, DOI 10.1182/blood-2013-03-491423; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuppers V, 2014, CELL TISSUE RES, V355, P577, DOI 10.1007/s00441-014-1812-1; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Young HL, 2007, AM J RESP CELL MOL, V37, P485, DOI 10.1165/rcmb.2006-0439OC; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1996, BLOOD, V87, P1780; Lula JF, 2009, EUR J HEART FAIL, V11, P825, DOI 10.1093/eurjhf/hfp105; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; MILLAR AB, 1989, LANCET, V2, P712, DOI 10.1016/S0140-6736(89)90772-1; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Oldenburg J, 2014, CELL TISSUE RES, V355, P545, DOI 10.1007/s00441-013-1792-6; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Piegeler T, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-57; Piegeler T, 2014, ANESTHESIOLOGY, V120, P1414, DOI 10.1097/ALN.0000000000000174; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; ROTEN R, 1991, AM REV RESPIR DIS, V143, P590, DOI 10.1164/ajrccm/143.3.590; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001; Shivanna M, 2010, INVEST OPHTH VIS SCI, V51, P1575, DOI 10.1167/iovs.09-4343; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH448, DOI 10.1152/ajpheart.00773.2013; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH455, DOI 10.1152/ajpheart.00774.2013; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Sun CX, 2012, ARTERIOSCL THROM VAS, V32, P2444, DOI 10.1161/ATVBAHA.112.252205; Takatsuka A, 2008, DEV BIOL, V315, P474, DOI 10.1016/j.ydbio.2008.01.004; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trani M, 2015, CURR OPIN HEMATOL, V22, P267, DOI 10.1097/MOH.0000000000000137; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Yang Guang, 2010, J Cardiovasc Dis Res, V1, P29, DOI 10.4103/0975-3583.59983; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393	70	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161975	10.1371/journal.pone.0161975	http://dx.doi.org/10.1371/journal.pone.0161975			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603666	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200034
J	Ardalan, A; Keleh, MK; Saberinia, A; Khorasani-Zavareh, D; Khankeh, H; Miadfar, J; Maleknia, S; Mobini, A; Mehranamin, S				Ardalan, Ali; Keleh, Maryam Kandi; Saberinia, Amin; Khorasani-Zavareh, Davoud; Khankeh, Hamidreza; Miadfar, Jafar; Maleknia, Samaneh; Mobini, Atieh; Mehranamin, Sara			2015 Estimation of Hospitals Safety from Disasters in IRIran: The Results from the Assessment of 421 Hospitals	PLOS ONE			English	Article								Background and Objective Iran's health system has developed a Farsi edition of the Hospital Safety Index (HSI) and has integrated the related assessment program into the health information system. This article presents the results of the 2015 estimation of hospital safety from disasters in I.R.Iran using HSI. Methods We analyzed data from 421 hospitals that had submitted a complete HSI assessment form on the Ministry of Health and Medical Education Portal System. Data collection was based on the self-assessments of the hospital disaster committees. HSI includes 145 items categorized in three components including, structural, non-structural and functional capacity. For each item, safety status was categorized into three levels: not safe (0), average safety (1) and high safety (2). A normalized scoring scheme on a 100-point scale was developed. Hospitals were classified to three safety classes according to their normalized total score: low (<= 34.0), average (34.01-66.0) and high (>66.0). Results The average score of all safety components were 43.0 out of 100 (+/- 11.0). Eighty-two hospitals (19.4%) were classified as not safe, and 339 hospitals (80.6%) were classified in the average safety category. No hospital was placed in the high safety category. Average safety scores were 41.0, 47.0, and 42.0 for functional capacity, non-structural safety, and structural safety respectively. The average safety score increased between 2012 and 2015, from 34.0 to 43.0. Conclusions Hospital safety in the event of disasters has improved in Iran in recent years and more hospitals have joined the HSI program. This is a result of continuous efforts invested in capacity building programs and promotion of the 2012 HSI estimation. The HSI should be maintained to monitor the progress of Iran's health system in regards to hospital safety in the case of disasters. It is recommended that WHO continue advocacy of HSI, establish a HSI monitoring system, and add it to country profiles on WHO website.	[Ardalan, Ali; Keleh, Maryam Kandi] Univ Tehran Med Sci, Natl Inst Hlth Res, Dept Disaster & Emergency Hlth, Tehran, Iran; [Ardalan, Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Disaster Publ Hlth, Tehran, Iran; [Ardalan, Ali] Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Saberinia, Amin; Khankeh, Hamidreza; Miadfar, Jafar; Maleknia, Samaneh; Mobini, Atieh; Mehranamin, Sara] Minist Hlth & Med Educ, Disaster & Emergency Management Ctr, Tehran, Iran; [Khorasani-Zavareh, Davoud] Shahid Beheshti Univ Med Sci, Sch HSE, Dept Hlth Disaster & Emergency, Tehran, Iran; [Khorasani-Zavareh, Davoud] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sodersjukhuset, Sweden	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Harvard University; Ministry of Health & Medical Education (MOHME); Shahid Beheshti University Medical Sciences; Karolinska Institutet; Sodersjukhuset Hospital	Ardalan, A (corresponding author), Univ Tehran Med Sci, Natl Inst Hlth Res, Dept Disaster & Emergency Hlth, Tehran, Iran.; Ardalan, A (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Disaster Publ Hlth, Tehran, Iran.; Ardalan, A (corresponding author), Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	aardalan@tums.ac.ir	Khankeh, Hamidreza/AAF-4581-2021; Khankeh, Hamidreza/C-9974-2017; Saberinia, Amin/AAH-9948-2021; Maleknia, Samaneh/ABF-8552-2020	Saberinia, Amin/0000-0001-8612-4319; Maleknia, Samaneh/0000-0002-0691-4722				[Anonymous], 2008, HOSP SAF IND GUID EV; Ardalan A, 2014, PLOS CURRENTS DISAST, P6; Ardalan A, GOOD PRACTICE INTEGR; Ardalan Ali, 2012, PLoS Curr, V4, pe4f93005fbcb34, DOI 10.1371/4f93005fbcb34; Ingrassia PL, 2016, MINERVA ANESTESIOL; Jagnarine SH, 2014, SAFE HOSP CARIBBEAN; Pisla M, 2010, REPUBLIC MALDOVA HOS; Radovic V, 2012, INT J ENV RES PUB HE, V9, P1677, DOI 10.3390/ijerph9051677; Rockenschaub Gerald, 2013, World Hosp Health Serv, V49, P28; UNDRR, 2015, AUST J EMERG MANAG; United Nations International Strategy for Disaster Reduction, 2009 INT DAY DIS RED; World Health Organization, 2015, HOSP SAF IND GUID EV	12	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161542	10.1371/journal.pone.0161542	http://dx.doi.org/10.1371/journal.pone.0161542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602564	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200018
J	Chiu, HC; Huang, WR; Liao, TL; Wu, HY; Munir, M; Shih, WL; Liu, HJ				Chiu, Hung-Chuan; Huang, Wei-Ru; Liao, Tsai-Ling; Wu, Hung-Yi; Munir, Muhammad; Shih, Wing-Ling; Liu, Hung-Jen			Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle	PLOS ONE			English	Article							AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; MOUTH-DISEASE VIRUS; POLO-LIKE KINASE-1; DNA-DAMAGE; NONSTRUCTURAL PROTEIN; INTERPHASE REQUIRES; CHECKPOINT PATHWAY; ACTIVATION; EXPRESSION; ARREST	The p17 protein of avian reovirus (ARV) causes cell cycle retardation in a variety of cell lines; however, the underlying mechanism(s) by which p17 regulates the cell cycle remains largely unknown. We demonstrate for the first time that p17 interacts with CDK1 and vimentin as revealed by reciprocal co-immunoprecipitation and GST pull-down assays. Both in vitro and in vivo studies indicated that direct interaction of p17 and CDK1/vimentin was mapped within the amino terminus (aa 1-60) of p17 and central region (aa 27-118) of CDK1/vimentin. Furthermore, p17 was found to occupy the Plk1-binding site within the vimentin, thereby blocking Plk1 recruitment to CDK1-induced vimentin phosphorylation at Ser 56. Interaction of p17 to CDK1 or vimentin interferes with CDK1-catalyzed phosphorylation of vimentin at Ser 56 and subsequently vimentin phosphorylation at Ser 82 by Plk1. Furthermore, we have identified upstream signaling pathways and cellular factor(s) targeted by p17 and found that p17 regulates inhibitory phosphorylation of CDK1 and blocks vimentin phosphorylation at Ser 56 and Ser 82. The p17-mediated inactivation of CDK1 is dependent on several mechanisms, which include direct interaction with CDK1, p17-mediated suppression of Plk1 by activating the Tpr/p53 and ATM/Chk1/PP2A pathways, and p17-mediated cdc25C degradation via an ubiquitin-proteasome pathway. Additionally, depletion of p53 with a shRNA as well as inhibition of ATM and vimentin by inhibitors diminished virus yield while Tpr and CDK1 knockdown increased virus yield. Taken together, results demonstrate that p17 suppresses both CDK1 and Plk1functions, disrupts vimentin phosphorylation, causes G2/M cell cycle arrest and thus benefits virus replication.	[Chiu, Hung-Chuan; Huang, Wei-Ru; Liu, Hung-Jen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan; [Liao, Tsai-Ling] Taichung Vet Gen Hosp, Dept Med Res, Taichung 402, Taiwan; [Wu, Hung-Yi] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung 912, Taiwan; [Munir, Muhammad] Pirbright Inst, Pirbright, England; [Shih, Wing-Ling] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung 912, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; National Pingtung University Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Pingtung University Science & Technology	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.; Liu, HJ (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw	Munir, Muhammad/T-4965-2019	Munir, Muhammad/0000-0002-7889-1398; Munir, Muhammad/0000-0003-4038-0370; Huang, Wei-Ru/0000-0002-2508-8374; chiu, hung-chuan/0000-0001-6219-4937; Liu, Hung-Jen/0000-0002-1460-1494	Taichung Veterans General Hospital [TCVGHNCHU1047602, TCVGH-NCHU1057603]; National Chung Hsing University [TCVGHNCHU1047602, TCVGH-NCHU1057603]; Ministry of Science and Technology of Taiwan [MOST 102-2321-B-005-012]; Ministry of Education of Taiwan under the Aiming for Top University (ATU) plan; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001852] Funding Source: researchfish; BBSRC [BBS/E/I/00001852] Funding Source: UKRI	Taichung Veterans General Hospital; National Chung Hsing University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan under the Aiming for Top University (ATU) plan; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Taichung Veterans General Hospital (TCVGHNCHU1047602 & TCVGH-NCHU1057603), National Chung Hsing University (TCVGHNCHU1047602 & TCVGH-NCHU1057603), the Ministry of Science and Technology of Taiwan (MOST 102-2321-B-005-012), and the Ministry of Education of Taiwan, under the Aiming for Top University (ATU) plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SJ, 2000, P NATL ACAD SCI USA, V97, P10996, DOI 10.1073/pnas.200375297; Advani SJ, 2000, J VIROL, V74, P8, DOI 10.1128/JVI.74.1.8-15.2000; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Belyavskyi M, 1998, P NATL ACAD SCI USA, V95, P11205, DOI 10.1073/pnas.95.19.11205; Bhattacharya B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-7; Braunagel SC, 1998, VIROLOGY, V244, P195, DOI 10.1006/viro.1998.9097; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Du N, 2014, J VIROL, V88, P5816, DOI 10.1128/JVI.03826-13; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Fournier N, 1999, ONCOGENE, V18, P4015, DOI 10.1038/sj.onc.1202775; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Funasaka T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00878; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Ghosh S, 2011, J VIRAL HEPATITIS, V18, pE568, DOI 10.1111/j.1365-2893.2011.01487.x; Gladue DP, 2013, J VIROL, V87, P6794, DOI 10.1128/JVI.00448-13; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrimech M, 2000, EMBO J, V19, P3956, DOI 10.1093/emboj/19.15.3956; Huang WR, 2011, J BIOL CHEM, V286, P30780, DOI 10.1074/jbc.M111.257154; Huang WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133699; Jackman MR, 1997, CANCER SURV, V29, P47; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kitay MK, 1996, J VIROL, V70, P7885, DOI 10.1128/JVI.70.11.7885-7893.1996; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Li SY, 2009, J VIROL, V83, P8340, DOI 10.1128/JVI.00711-09; Lin PY, 2011, ARCH VIROL, V156, P1917, DOI 10.1007/s00705-011-1063-3; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Palii SS, 2013, CELL CYCLE, V12, P1105, DOI 10.4161/cc.24127; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Plummer EM, 2012, NANOMEDICINE-UK, V7, P877, DOI [10.2217/nnm.11.185, 10.2217/NNM.11.185]; Poggioli GJ, 2001, J VIROL, V75, P7429, DOI 10.1128/JVI.75.16.7429-7434.2001; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shmulevitz M, 2002, J VIROL, V76, P609, DOI 10.1128/JVI.76.2.609-618.2002; SPANDIDOS DA, 1976, J VIROL, V19, P968, DOI 10.1128/JVI.19.3.968-976.1976; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; Vazquez-Iglesias L, 2009, J VIROL, V83, P10163, DOI 10.1128/JVI.01080-09; Wang XH, 2011, J MICROBIOL BIOTECHN, V21, P366, DOI 10.4014/jmb.1010.10003; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Ye M, 1999, J VIROL, V73, P1320, DOI 10.1128/JVI.73.2.1320-1330.1999; Yu JT, 2004, J CELL BIOL, V164, P487, DOI 10.1083/JCB.200310059; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279	61	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162356	10.1371/journal.pone.0162356	http://dx.doi.org/10.1371/journal.pone.0162356			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603133	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200060
J	Daubenspeck, JM; Liu, RH; Dybvig, K				Daubenspeck, James M.; Liu, Runhua; Dybvig, Kevin			Rhamnose Links Moonlighting Proteins to Membrane Phospholipid in Mycoplasmas	PLOS ONE			English	Article							ELONGATION-FACTOR TU; ALPHA-ENOLASE; MASS-SPECTROMETRY; CELL-SURFACE; AUTOANTIBODIES; IDENTIFICATION; PLASMODIUM; PNEUMONIAE; AUTOIMMUNE; ADHERENCE	Many proteins that have a primary function as a cytoplasmic protein are known to have the ability to moonlight on the surface of nearly all organisms. An example is the glycolytic enzyme enolase, which can be found on the surface of many types of cells from bacteria to human. Surface enolase is not enzymatic because it is monomeric and oligomerization is required for glycolytic activity. It can bind various molecules and activate plasminogen. Enolase lacks a signal peptide and the mechanism by which it attaches to the surface is unknown. We found that treatment of whole cells of the murine pathogen Mycoplasma pulmonis with phospholipase D released enolase and other common moonlighting proteins. Glycostaining suggested that the released proteins were glycosylated. Cytoplasmic and membrane-bound enolase was isolated by immunoprecipitation. No post-translational modification was detected on cytoplasmic enolase, but membrane enolase was associated with lipid, phosphate and rhamnose. Treatment with phospholipase released the lipid and phosphate from enolase but not the rhamnose. The site of rhamnosylation was identified as a glutamine residue near the C-terminus of the protein. Rhamnose has been found in all species of mycoplasma examined but its function was previously unknown. Mycoplasmas are small bacteria with have no peptidoglycan, and rhamnose in these organisms is also not associated with polysaccharide. We suggest that rhamnose has a central role in anchoring proteins to the membrane by linkage to phospholipid, which may be a general mechanism for the membrane association of moonlighting proteins in mycoplasmas and perhaps other bacteria.	[Daubenspeck, James M.; Liu, Runhua; Dybvig, Kevin] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Dybvig, K (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.	dybvig@uab.edu	Liu, Runhua/K-2388-2019	Liu, Runhua/0000-0002-0892-6946	National Institutes of Health [AI63909]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI63909) to KD. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Arfi Y, 2016, P NATL ACAD SCI USA, V113, P5406, DOI 10.1073/pnas.1600546113; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; Bao SJ, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0223-6; Bolland JR, 2012, FEMS MICROBIOL LETT, V331, P25, DOI 10.1111/j.1574-6968.2012.02551.x; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Daubenspeck JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143362; Daubenspeck JM, 2009, MOL MICROBIOL, V72, P1235, DOI 10.1111/j.1365-2958.2009.06720.x; Decker BL, 2006, J BIOL CHEM, V281, P14523, DOI 10.1074/jbc.M600911200; EDER K, 1992, J CHROMATOGR, V607, P55, DOI 10.1016/0021-9673(92)87054-C; FERRANTE G, 1986, J BIOL CHEM, V261, P7062; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Ghosh AK, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000900011; Godier A, 2013, J THROMB HAEMOST, V11, P26, DOI 10.1111/jth.12064; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hoelzle LE, 2007, FEMS IMMUNOL MED MIC, V49, P215, DOI 10.1111/j.1574-695X.2006.00184.x; Jordan DS, 2013, MOL MICROBIOL, V90, P1046, DOI 10.1111/mmi.12415; Jordan DS, 2013, MOL MICROBIOL, V89, P918, DOI 10.1111/mmi.12320; KOCHETKO.NK, 1965, TETRAHEDRON, V21, P2029, DOI 10.1016/S0040-4020(01)98342-5; Kornspan JD, 2012, J LIPIDS, V2012, DOI 10.1155/2012/640762; LAWSON AM, 1971, J AM CHEM SOC, V93, P1014; Layh-Schmitt G, 2000, MICROBIOL-UK, V146, P741, DOI 10.1099/00221287-146-3-741; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; Peng B, 2013, J PROTEOME RES, V12, P1789, DOI 10.1021/pr3011342; RAZIN S, 1963, J GEN MICROBIOL, V33, P471, DOI 10.1099/00221287-33-3-471; Ren GY, 2004, J AUTOIMMUN, V23, P161, DOI 10.1016/j.jaut.2004.06.003; Robinson MW, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130017; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Shaw BM, 2012, INFECT IMMUN, V80, P704, DOI 10.1128/IAI.06009-11; Simmons WL, 2007, J BACTERIOL, V189, P1905, DOI 10.1128/JB.01512-06; Song Z, 2012, PLOS ONE, V7; Vega-Rodriguez J, 2014, P NATL ACAD SCI USA, V111, pE492, DOI 10.1073/pnas.1315517111; Wang WF, 2016, MOL BIOSYST, V12, P1420, DOI 10.1039/c5mb00550g; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07; ZINBO M, 1970, J AM CHEM SOC, V92, P2105, DOI 10.1021/ja00710a052	43	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162505	10.1371/journal.pone.0162505	http://dx.doi.org/10.1371/journal.pone.0162505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603308	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200072
J	Gonzalez, C; Esteban, R; Canals, C; Muniz-Diaz, E; Nogues, N				Gonzalez, Cecilia; Esteban, Rosa; Canals, Carme; Muniz-Diaz, Eduardo; Nogues, Nuria			Stabilization of Transfected Cells Expressing Low-Incidence Blood Group Antigens: Novel Methods Facilitating Their Use as Reagent-Cells	PLOS ONE			English	Article							HUMAN PLATELET ANTIBODIES; INTRACELLULAR TREHALOSE; MEMBRANE STABILITY; MAMMALIAN-CELLS; MOLECULAR-BASIS; FLOW-CYTOMETRY; K562 CELLS; PRESERVATION; LINES; TRANSDUCTION	Background The identification of erythrocyte antibodies in the serum of patients rely on panels of human red blood cells (RBCs), which coexpress many antigens and are not easily available for low-incidence blood group phenotypes. These problems have been addressed by generating cell lines expressing unique blood group antigens, which may be used as an alternative to human RBCs. However, the use of cell lines implies several drawbacks, like the requirement of cell culture facilities and the high cost of cryopreservation. The application of cell stabilization methods could facilitate their use as reagent cells in clinical laboratories. Methods We generated stably-transfected cells expressing low-incidence blood group antigens (Di(a) and Lu-a). High-expresser clones were used to assess the effect of TransFix (R) treatment and lyophilization as cell preservation methods. Cells were kept at 4 degrees C and cell morphology, membrane permeability and antigenic properties were evaluated at several time-points after treatment. Results TransFix (R) addition to cell suspensions allows cell stabilization and proper antigen detection for at least 120 days, despite an increase in membrane permeability and a reduction in antigen expression levels. Lyophilized cells showed minor morphological changes and antigen expression levels were rather conserved at days 1, 15 and 120, indicating a high stability of the freeze-dried product. These stabilized cells have been proved to react specifically with human sera containing alloantibodies. Conclusions Both stabilization methods allow long-term preservation of the transfected cells antigenic properties and may facilitate their distribution and use as reagent-cells expressing low-incidence antigens, overcoming the limited availability of such rare RBCs.	[Gonzalez, Cecilia; Esteban, Rosa; Canals, Carme; Muniz-Diaz, Eduardo; Nogues, Nuria] Banc Sang & Teixits, Immunohematol Lab, Barcelona, Spain		Nogues, N (corresponding author), Banc Sang & Teixits, Immunohematol Lab, Barcelona, Spain.	nnogues@bst.cat			Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, Spain [PI020749]; Diagnostic Grifols; Ministerio de Ciencia e Innovacion (MICINN)-Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, within the TRACE program, Spain [TRA2009_0331]	Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, Spain(Instituto de Salud Carlos III); Diagnostic Grifols; Ministerio de Ciencia e Innovacion (MICINN)-Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, within the TRACE program, Spain(Ministry of Science and Innovation, Spain (MICINN))	This project was supported in part by a grant from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (grant number: PI020749), Spain, URL:(http://www.eng.isciii.es/ISCIII/es/general/index.shtml). Additional funding was provided by Diagnostic Grifols and the Ministerio de Ciencia e Innovacion (MICINN)-Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011, in a collaborative agreement within the TRACE program (grant number: TRA2009_0331), Spain. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Diagnostic Grifols agreed with the publication of these data.	Albertorio F, 2007, J AM CHEM SOC, V129, P10567, DOI 10.1021/ja0731266; Barnett D, 1996, CYTOMETRY, V26, P216, DOI 10.1002/(SICI)1097-0320(19960915)26:3<216::AID-CYTO6>3.0.CO;2-C; Barnett D, 2000, BRIT J HAEMATOL, V108, P784, DOI 10.1046/j.1365-2141.2000.01932.x; Barnett D, 1998, BRIT J HAEMATOL, V102, P553; Barnett D, 1999, CYTOMETRY, V38, P88; Beckmann R, 1998, BLOOD, V92, P4428, DOI 10.1182/blood.V92.11.4428.423k15_4428_4438; Bikoue A, 2002, J IMMUNOL METHODS, V266, P19, DOI 10.1016/S0022-1759(02)00094-7; Buchanan SS, 2010, PLOS ONE, V5; CALDWELL CW, 1994, CYTOMETRY, V16, P243, DOI 10.1002/cyto.990160308; Canonico B, 2004, J IMMUNOL METHODS, V295, P67, DOI 10.1016/j.jim.2004.09.013; Canonico B, 2010, CYTOM PART B-CLIN CY, V78B, P267, DOI 10.1002/cyto.b.20510; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1983, ARCH BIOCHEM BIOPHYS, V220, P477, DOI 10.1016/0003-9861(83)90438-1; CROWE LM, 1984, BIOCHIM BIOPHYS ACTA, V769, P141, DOI 10.1016/0005-2736(84)90017-8; CROWE LM, 1988, BIOCHIM BIOPHYS ACTA, V946, P193, DOI 10.1016/0005-2736(88)90392-6; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Esteban R, 2004, VOX SANGUINIS S3, V87, P38; Foxcroft Z, 2007, VOX SANG, V93, P300, DOI 10.1111/j.1423-0410.2007.00951.x; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Hayashi T, 2011, TRANSFUSION MED, V21, P199, DOI 10.1111/j.1365-3148.2010.01064.x; Hayashi T, 2014, BLOOD TRANSFUS-ITALY, V12, pS273, DOI 10.2450/2012.0126-12; Hildinger M, 1999, J VIROL, V73, P4083, DOI 10.1128/JVI.73.5.4083-4089.1999; Iwamoto S, 1998, INT J HEMATOL, V68, P257; Jani IV, 2001, J IMMUNOL METHODS, V257, P145; Janossy G, 2006, Patent No. [WO/ 2006/ 090096, 2006090096]; Kanias T, 2006, CELL PRESERV TECHNOL, V4, P253, DOI 10.1089/cpt.2006.9996; Laroche V, 2005, TRANSFUSION, V45, P1909, DOI 10.1111/j.1537-2995.2005.00638.x; Lopez GH, 2012, VOX SANG, V102, P171, DOI 10.1111/j.1423-0410.2011.01532.x; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Parsons SF, 1997, BLOOD, V89, P4219, DOI 10.1182/blood.V89.11.4219; Puig T, 2002, GENE THER, V9, P1472, DOI 10.1038/sj.gt.3301826; Rigal D., 2005, Vox Sanguinis, V89, P23; Rindler V, 1999, CRYOBIOLOGY, V38, P2, DOI 10.1006/cryo.1998.2143; Rindler V, 1999, CRYOBIOLOGY, V39, P228, DOI 10.1006/cryo.1999.2204; RUSSO DCW, 1994, BLOOD, V84, P3518; Sidoux-Walter F, 2000, BLOOD, V96, P1566, DOI 10.1182/blood.V96.4.1566.h8001566_1566_1573; Smythe JS, 1996, BLOOD, V87, P2968, DOI 10.1182/blood.V87.7.2968.bloodjournal8772968; Stoll C, 2011, TRANSFUS MED HEMOTH, V38, P89, DOI 10.1159/000326900; Wang LL, 2012, CYTOM PART A, V81A, P567, DOI 10.1002/cyto.a.22060; Wozniak MJ, 2012, TRANSFUSION, V52, P1458, DOI 10.1111/j.1537-2995.2011.03490.x; Yazdanbakhsh K, 2000, AM J HEMATOL, V63, P114, DOI 10.1002/(SICI)1096-8652(200003)63:3<114::AID-AJH2>3.0.CO;2-Z; Zhang SZ, 2010, J ZHEJIANG UNIV-SC B, V11, P889, DOI 10.1631/jzus.B1000184; Zhou XL, 2010, CRYOLETTERS, V31, P147	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161968	10.1371/journal.pone.0161968	http://dx.doi.org/10.1371/journal.pone.0161968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603310	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200032
J	Saltychev, M; Vastamaki, H; Mattie, R; McCormick, Z; Vastamaki, M; Laimi, K				Saltychev, Mikhail; Vastamaki, Heidi; Mattie, Ryan; McCormick, Zachary; Vastamaki, Martti; Laimi, Katri			Psychometric Properties of the Pain Numeric Rating Scale When Applied to Multiple Body Regions among Professional Musicians	PLOS ONE			English	Article							VISUAL ANALOG SCALE; RELIABILITY; INTENSITY	Background Despite the broad popularity of a numeric rating scale (NRS) its psychometric properties are not well known. The objective was to determine if there is any difference in the discrimination ability of the NRS when used for measuring pain severity separately in different body regions. Methods Cross-sectional survey study of 630 professional musicians. Item Response Theory (IRT) was used to define the psychometric properties of the NRS. Results The discrimination ability of the pain NRS was dependent on the body area to which it was applied. The discrimination was low 0.5 (95% CI 0.4. to 0.7) for the hand region and perfect for the shoulder and upper part of the neck-3.2 (95% CI 1.2 to 5.2) and 10.5 (95% CI 10.0 to 10.9), respectively. Both shoulder and neck NRSs showed a great shift towards higher levels of pain severity meaning that the ability of the NRS to discriminate low levels of pain is poor. NRS scores obtained from all other regions did not demonstrate any discrimination ability. Conclusions The pain NRS might have different psychometric properties depending on the body area to which it is applied. Overall, the modest discrimination ability of the pain NRS implies that it should be used in screening questionnaires with some reservations.	[Saltychev, Mikhail; Laimi, Katri] Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland; [Saltychev, Mikhail; Laimi, Katri] Univ Turku, Turku, Finland; [Vastamaki, Heidi; Vastamaki, Martti] Orton Fdn, Orton Res Inst, Helsinki, Finland; [Mattie, Ryan] Stanford Univ Hosp & Clin, Dept Orthoped Surg Phys Med & Rehabil, Stanford, CA USA; [McCormick, Zachary] Northwestern McGaw Med Ctr, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL USA	University of Turku; University of Turku; Stanford University; Shirley Ryan AbilityLab	Saltychev, M (corresponding author), Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland.	mikhail.saltychev@gmail.com			Finnish Social Insurance Institution [9752]	Finnish Social Insurance Institution	This work was supported by Finnish Social Insurance Institution, grant 9752.	Baker F., 2001, BASICS ITEM RESPONSE; Becker J, 2007, PAIN MED, V8, pS129, DOI 10.1111/j.1526-4637.2007.00377.x; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Edelen MO, 2010, J GERONTOL A-BIOL, V65, P778, DOI 10.1093/gerona/glp215; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kersten P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099485; KREMER E, 1981, PAIN, V10, P241, DOI 10.1016/0304-3959(81)90199-8; Milojevic KG, 2004, AM J EMERG MED, V22, P238, DOI 10.1016/j.ajem.2004.02.022; Schroeder J, 2007, J PAIN S, V8, pS66; THOMEE R, 1995, SCAND J REHABIL MED, V27, P145; Yu CH, 2013, SIMPLE GUIDE ITEM RE	14	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161874	10.1371/journal.pone.0161874	http://dx.doi.org/10.1371/journal.pone.0161874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603011	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200029
J	Xiao, Y; Liu, JS; Peng, Y; Xiong, X; Huang, L; Yang, HX; Zhang, J; Tao, LJ				Xiao, Yun; Liu, Jishi; Peng, Yu; Xiong, Xuan; Huang, Ling; Yang, Huixiang; Zhang, Jian; Tao, Lijian			GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression	PLOS ONE			English	Article							TUBULOINTERSTITIAL FIBROSIS; OXIDATIVE STRESS; MYOFIBROBLASTS; TRANSCRIPTION; ACTIVATION; INSIGHTS; KIDNEY	Tubular epithelial-mesenchymal transition (EMT) has been widely accepted as the underlying mechanisms of renal interstitial fibrosis (RIF). The production of reactive oxygen species (ROS) plays a vital role in tubular EMT process. The purpose of this study was to investigate the involved molecular mechanisms in TGF-beta-induced EMT and identify the potential role of glutathione S-transferase alpha 3 (GSTA3) in this process. The iTRAQ screening was performed to identify protein alterations of the rats underwent unilateral-ureteral obstruction (UUO). Protein expression of GSTA3 in patients with obstructive nephropathy and UUO rats was detected by immunohistochemistry. Protein and mRNA expression of GSTA3 in UUO rats and NRK-52E cells were determined by Western blot and RT-PCR. siRNA and overexpression plasmid were transfected specifically to assess the role of GSTA3 in RIF. The generation of ROS was measured by dichlorofluorescein fluorescence analysis. GSTA3 protein and mRNA expression was significantly reduced in UUO rats. Immunohistochemical analysis revealed that GSTA3 expression was reduced in renal cortex in UUO rats and patients with obstructive nephropathy. Treating with TGF-beta 1 down-regulated GSTA3 expression in NRK-52E cells, which have been found to be correlated with the decreased expression in E-cadherin and megalin and increased expression in alpha-smooth muscle actin. Furthermore, knocking down GSTA3 in NRK-52 cells led to increased production of ROS and tubular EMT, whereas overexpressing GSTA3 ameliorated ROS production and prevented the occurrence of tubular EMT. GSTA3 plays a protective role against tubular EMT in renal fibrosis, suggesting GSTA3 is a potential therapeutic target for RIF.	[Xiao, Yun; Liu, Jishi; Peng, Yu; Xiong, Xuan; Huang, Ling; Tao, Lijian] Cent S Univ, Xiangya Hosp, Div Nephrol, Changsha 410078, Peoples R China; [Xiao, Yun] Guangzhou Med Univ, Div Nephrol, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China; [Tao, Lijian] Cent S Univ, State Key Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; [Yang, Huixiang] Cent S Univ, Div Digest Med, Xiangya Hosp, Changsha 410078, Hunan, Peoples R China; [Zhang, Jian] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Central South University; Guangzhou Medical University; Central South University; Central South University; University System of Ohio; Ohio State University	Tao, LJ (corresponding author), Cent S Univ, Xiangya Hosp, Div Nephrol, Changsha 410078, Peoples R China.; Tao, LJ (corresponding author), Cent S Univ, State Key Lab Med Genet China, Changsha 410078, Hunan, Peoples R China.	lijiantt_tao@sina.com	TAO, Li/HIR-4254-2022	Zhang, Jian/0000-0002-9523-5296	National Natural Science Foundation of China [81370547]; CHINA-CANADA Joint Health Research Initiative Foundation [81061120524/H07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CHINA-CANADA Joint Health Research Initiative Foundation	This work was supported by the National Natural Science Foundation of China (Grants NO. 81370547), and the CHINA-CANADA Joint Health Research Initiative Foundation (Grants NO. 81061120524/H07).; This work was supported by the National Natural Science Foundation of China (Grants NO. 81370547), and the CHINA-CANADA Joint Health Research Initiative Foundation (Grants NO. 81061120524/H07). We thank Dr. Jian Zhang (The Ohio State University) for his critical reading and editing of our manuscript.	Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Djamali A, 2005, AM J TRANSPLANT, V5, P500, DOI 10.1111/j.1600-6143.2004.00713.x; Djamali A, 2007, AM J PHYSIOL-RENAL, V293, pF445, DOI 10.1152/ajprenal.00037.2007; Fotouhi-Ardakani N, 1999, BIOCHEM J, V339, P685, DOI 10.1042/0264-6021:3390685; Gonzalez J, 2013, BIOCHEM BIOPH RES CO, V438, P257, DOI 10.1016/j.bbrc.2013.07.025; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Il Gum S, 2007, J ETHNOPHARMACOL, V112, P568, DOI 10.1016/j.jep.2007.05.014; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim SK, 2003, J PHARMACOL EXP THER, V305, P353, DOI 10.1124/jpet.102.045153; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Li Q, 2012, J CELL BIOCHEM, V11, P415; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu QJ, 2011, AM J NEPHROL, V34, P142, DOI 10.1159/000329325; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Vaziri ND, 2003, KIDNEY INT, V63, P186, DOI 10.1046/j.1523-1755.2003.00711.x; YAMADA T, 1992, CYTOGENET CELL GENET, V61, P125, DOI 10.1159/000133388; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002; Zhang XL, 2015, INT J MOL MED, V35, P1747, DOI 10.3892/ijmm.2015.2170	30	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160855	10.1371/journal.pone.0160855	http://dx.doi.org/10.1371/journal.pone.0160855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602565	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200008
J	Zoicas, I; Reichel, M; Gulbins, E; Kornhuber, J				Zoicas, Iulia; Reichel, Martin; Gulbins, Erich; Kornhuber, Johannes			Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory	PLOS ONE			English	Article							INDUCED AVOIDANCE IMPAIRMENT; MICE; AMITRIPTYLINE; PIRACETAM; DEPRESSION; RATS; INHIBITION; DISEASE; DRUGS	Major depressive disorder is often associated with deficits in social and cognitive functioning. Mice transgenic for acid sphingomyelinase (t-ASM) were previously shown to have a depressive-like phenotype, which could be normalized by antidepressant treatment. Here, we investigated whether t-ASM mice show deficits in social behavior and memory performance, and whether these possible deficits might be normalized by amitriptyline treatment. Our results revealed that ASM overexpression altered the behavior of mice in a sex-dependent manner. As such, t-ASM female, but not male, mice showed an impaired social preference and a depressive-and anxiogenic-like phenotype, which could be normalized by amitriptyline treatment. Both male and female t-ASM mice showed unaltered preference for social novelty, novel object recognition, and social and object discrimination abilities. Amitriptyline treatment impaired novel object recognition and object discrimination abilities in female, but not in male, wild-type mice, while female t-ASM mice showed unaltered novel object recognition and object discrimination abilities. This study suggests that female t-ASM mice represent a model of depression with comorbid anxiety and social deficits, without memory impairments. It further suggests that ASM overexpression has a protective role against the detrimental effects of amitriptyline on female, but not on male, non-social (object) memory.	[Zoicas, Iulia; Reichel, Martin; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Univ Hosp, Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	University of Erlangen Nuremberg; University of Duisburg Essen	Zoicas, I (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Univ Hosp, Erlangen, Germany.	iulia.zoicas@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Reichel, Martin/0000-0001-7886-2784; Zoicas, Iulia/0000-0001-7187-3181	BMBF [01EE1401G/OptiMD]	BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by BMBF grant 01EE1401G/OptiMD to JK and EG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank Juliana Monti for technical assistance. This study was supported by BMBF grant 01EE1401G/OptiMD to JK and EG.	ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Avota E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001290; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Carvalho AF, 2014, CNS NEUROL DISORD-DR, V13, P1819; Christoffersen GRJ, 1998, PROG NEURO-PSYCHOPH, V22, P211, DOI 10.1016/S0278-5846(97)00104-8; Damoiseaux VA, 2014, CLIN PHARMACOKINET, V53, P509, DOI 10.1007/s40262-014-0145-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Everss E, 2005, BEHAV BRAIN RES, V159, P235, DOI 10.1016/j.bbr.2004.11.004; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Lukas M, 2013, PSYCHONEUROENDOCRINO, V38, P916, DOI 10.1016/j.psyneuen.2012.09.018; Marisco PC, 2013, NEUROCHEM RES, V38, P1704, DOI 10.1007/s11064-013-1072-6; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Orsetti M, 2007, INT J NEUROPSYCHOPH, V10, P345, DOI 10.1017/S1461145706006705; Parra A, 2002, NEUROSCI RES COMMUN, V31, P135, DOI 10.1002/nrc.10046; Pavone F, 1997, BEHAV BRAIN RES, V89, P229, DOI 10.1016/S0166-4328(97)00066-1; Quillin RC, 2015, HEPATOL RES, V45, P305, DOI 10.1111/hepr.12352; Sansone M, 1999, PHARMACOL BIOCHEM BE, V62, P613, DOI 10.1016/S0091-3057(98)00202-0; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tse WS, 2004, J NERV MENT DIS, V192, P260, DOI 10.1097/01.nmd.0000120884.60002.2b; Wang YL, 2016, EUR J PHARMACOL, V779, P59, DOI 10.1016/j.ejphar.2016.03.013; Wegner MS, 2014, BIOCHEM PHARMACOL, V92, P577, DOI 10.1016/j.bcp.2014.10.007; Zoicas I, 2016, BEHAV BRAIN RES, V297, P323, DOI 10.1016/j.bbr.2015.10.034	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162498	10.1371/journal.pone.0162498	http://dx.doi.org/10.1371/journal.pone.0162498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598773	gold, Green Submitted, Green Published			2022-12-27	WOS:000383254800072
J	Iqbal, S; Hoque, MT				Iqbal, Sumaiya; Hoque, Md Tamjidul			Estimation of Position Specific Energy as a Feature of Protein Residues from Sequence Alone for Structural Classification	PLOS ONE			English	Article							BACKBONE TORSION ANGLES; ACCESSIBLE SURFACE-AREA; SECONDARY STRUCTURE; INTRINSIC DISORDER; STRUCTURE PREDICTION; REGIONS; RECOGNITION; ACCURATE; BINDING	A set of features computed from the primary amino acid sequence of proteins, is crucial in the process of inducing a machine learning model that is capable of accurately predicting three-dimensional protein structures. Solutions for existing protein structure prediction problems are in need of features that can capture the complexity of molecular level interactions. With a view to this, we propose a novel approach to estimate position specific estimated energy (PSEE) of a residue using contact energy and predicted relative solvent accessibility (RSA). Furthermore, we demonstrate PSEE can be reasonably estimated based on sequence information alone. PSEE is useful in identifying the structured as well as unstructured or, intrinsically disordered region of a protein by computing favorable and unfavorable energy respectively, characterized by appropriate threshold. The most intriguing finding, verified empirically, is the indication that the PSEE feature can effectively classify disorder versus ordered residues and can segregate different secondary structure type residues by computing the constituent energies. PSEE values for each amino acid strongly correlate with the hydrophobicity value of the corresponding amino acid. Further, PSEE can be used to detect the existence of critical binding regions that essentially undergo disorder-to-order transitions to perform crucial biological functions. Towards an application of disorder prediction using the PSEE feature, we have rigorously tested and found that a support vector machine model informed by a set of features including PSEE consistently outperforms a model with an identical set of features with PSEE removed. In addition, the new disorder predictor, DisPredict2, shows competitive performance in predicting protein disorder when compared with six existing disordered protein predictors.	[Iqbal, Sumaiya; Hoque, Md Tamjidul] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA	University of Louisiana System; University of New Orleans	Hoque, MT (corresponding author), Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA.	thoque@uno.edu		Iqbal, Sumaiya/0000-0001-7700-4374	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF [(2013-16)-RD-A-19]	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF	Both the authors gratefully acknowledge the Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF (2013-16)-RD-A-19.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Berman HM, 1999, NUCLEIC ACIDS RES, V28, P135; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eickholt J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-88; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Hoque MT, 2016, J COMPUT CHEM, V37, P1119, DOI 10.1002/jcc.24298; Iqbal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141551; Iqbal S, 2015, J THEOR BIOL, V380, P380, DOI 10.1016/j.jtbi.2015.06.012; Iqbal S, 2014, 2014 17TH INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY (ICCIT), P110, DOI 10.1109/ICCITechn.2014.7073113; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Islam MN, 2016, J THEOR BIOL, V389, P60, DOI 10.1016/j.jtbi.2015.10.015; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Mizianty Marcin J, 2013, Intrinsically Disord Proteins, V1, pe24428, DOI 10.4161/idp.24428; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; Petsko G., 2004, PROTEIN STRUCTURE FU; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sing T., 2009, VISUALIZING PERFORMA; Sirota FL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S15; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang T, 2010, PROTEINS, V78, P3353, DOI 10.1002/prot.22842	52	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161452	10.1371/journal.pone.0161452	http://dx.doi.org/10.1371/journal.pone.0161452			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588752	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800009
J	Stacey, W; Bhave, S; Uht, RM				Stacey, Winfred; Bhave, Shreyas; Uht, Rosalie M.			Mechanisms by Which 17 beta-Estradiol (E2) Suppress Neuronal cox-2 Gene Expression	PLOS ONE			English	Article							NF-KAPPA-B; ESTROGEN-RECEPTOR-ALPHA; HISTONE H4 ACETYLATION; TRANSCRIPTIONAL REPRESSION; ALZHEIMERS-DISEASE; BETA; BRAIN; CYCLOOXYGENASE-2; RECRUITMENT; PROMOTER	E2 attenuates inflammatory responses by suppressing expression of pro-inflammatory genes. Given that inflammation is increasingly being associated with neurodegenerative and psychiatric processes, we sought to elucidate mechanisms by which E2 down-regulates a component of an inflammatory response, cyclooxygenase-2 (COX-2) expression. Although inflammatory processes in the brain are usually associated with microglia and astrocytes, we found that the COX-2 gene (cox-2) was expressed in a neuronal context, specifically in an amygdalar cell line (AR-5). Given that COX-2 has been reported to be in neurons in the brain, and that the amygdala is a site involved in neurodegenerative and neuropsychiatric processes, we investigated mechanisms by which E2 could down-regulate cox-2 expression in the AR-5 line. These cells express estrogen receptors alpha (ER alpha) and beta (ER beta), and as shown here cox-2. At the level of RNA, E2 and the ER beta selective ligand diarylpropionitrile (DPN) both attenuated gene expression, whereas the ERa selective ligand propyl pyrazole triol (PPT) had no effect. Neither ligand increased ER beta at the cox-2 promoter. Rather, DPN decreased promoter occupancy of NF-kappa B p65 and histone 4 (H4) acetylation. Treatment with the non-specific HDAC inhibitor Trichostatin A (TSA) counteracted DPN's repressive effects on cox-2 expression. In keeping with the TSA effect, E2 and DPN increased histone deacetylase one (HDAC1) and switch-independent 3A (Sin3A) promoter occupancy. Lastly, even though E2 increased CpG methylation, DPN did not. Taken together, the pharmacological data indicate that ER beta contributes to neuronal cox-2 expression, as measured by RNA levels. Furthermore, ER ligands lead to increased recruitment of HDAC1, Sin3A and a concomitant reduction of p65 occupancy and Ac-H4 levels. None of the events, however, are associated with a significant recruitment of ER beta at the promoter. Thus, ER beta directs recruitment to the cox-2 promoter, but does so in the absence of being recruited itself.	[Stacey, Winfred; Bhave, Shreyas; Uht, Rosalie M.] Univ North Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Ft Worth, TX 76107 USA; [Stacey, Winfred; Bhave, Shreyas; Uht, Rosalie M.] Univ North Texas Hlth Sci Ctr, Inst Hlth Aging, Ctr Alzheimers & Neurodegenerat Dis Res, Ft Worth, TX 76107 USA; [Stacey, Winfred] US Army, Inst Surg Res, 3698 Chambers Pass,BHT 1, Jbsa Ft Sam Houston, TX 78234 USA		Uht, RM (corresponding author), Univ North Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Ft Worth, TX 76107 USA.; Uht, RM (corresponding author), Univ North Texas Hlth Sci Ctr, Inst Hlth Aging, Ctr Alzheimers & Neurodegenerat Dis Res, Ft Worth, TX 76107 USA.	rosalie.uht@unthsc.edu	Bhave, Shreyas/N-1309-2019		National Institutes of Health [R01-MH082900]; RMU University of North Texas Health Science Center; Doctoral Student Bridge Grant; Neurobiology of Aging Predoctoral Training Grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RMU University of North Texas Health Science Center; Doctoral Student Bridge Grant; Neurobiology of Aging Predoctoral Training Grant	This work was supported by National Institutes of Health, R01-MH082900, RMU University of North Texas Health Science Center, Doctoral Student Bridge Grant, WS and Neurobiology of Aging Predoctoral Training Grant - Associate Fellow, WS.	Andreasson KI, 2001, J NEUROSCI, V21, P8198; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Brown CM, 2010, ENDOCRINOLOGY, V151, P4916, DOI 10.1210/en.2010-0371; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hewett SJ, 2006, PHARMACOL THERAPEUT, V112, P335, DOI 10.1016/j.pharmthera.2005.04.011; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hur K, 2003, BIOCHEM BIOPH RES CO, V310, P844, DOI 10.1016/j.bbrc.2003.09.095; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Jadhav RR, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0045-9; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lalmansingh AS, 2008, ENDOCRINOLOGY, V149, P346, DOI 10.1210/en.2007-0372; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li R, 2005, FRONT BIOSCI-LANDMRK, V10, P257, DOI 10.2741/1525; Li R, 2014, MOL CELL ENDOCRINOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques M, 2013, NUCLEIC ACIDS RES, V41, P8094, DOI 10.1093/nar/gkt595; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mulchahey JJ, 1999, ENDOCRINOLOGY, V140, P251, DOI 10.1210/en.140.1.251; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Pozzi S, 2006, ANN NY ACAD SCI, V1089, P302, DOI 10.1196/annals.1386.035; Rao JS, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.27; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT SA, 1991, NEUROLOGY, V41, P351, DOI 10.1212/WNL.41.3.351; Sharma D, 2012, ENDOCRINOLOGY, V153, P2353, DOI 10.1210/en.2011-1002; Song SH, 2001, CANCER RES, V61, P4628; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Sunday L, 2006, AM J PHYSIOL-ENDOC M, V291, pE261, DOI 10.1152/ajpendo.00550.2005; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vegeto E, 2002, MOL PSYCHIATR, V7, P236, DOI 10.1038/sj.mp.4001007; Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035; Wang DB, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-12; Xing DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036890; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zhao YC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010626; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	57	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161430	10.1371/journal.pone.0161430	http://dx.doi.org/10.1371/journal.pone.0161430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588681	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800008
J	Hanif, A; Edin, ML; Zeldin, DC; Morisseau, C; Nayeem, MA				Hanif, Ahmad; Edin, Matthew L.; Zeldin, Darryl C.; Morisseau, Christophe; Nayeem, Mohammed A.			Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPAR gamma	PLOS ONE			English	Article							LOWERS BLOOD-PRESSURE; EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; ENDOTHELIAL-CELLS; LINOLEIC-ACID; LIPOXYGENASE PRODUCTS; POTENTIAL ROLE; METABOLISM; INHIBITION; EXPRESSION	Coronary reactive hyperemia (CRH) is a physiological response to ischemic insult that prevents the potential harm associated with an interruption of blood supply. The relationship between the pharmacologic inhibition of soluble epoxide hydrolase (sEH) and CRH response to a brief ischemia is not known. sEH is involved in the main catabolic pathway of epoxyeicosatrienoic acids (EETs), which are converted into dihydroxyeicosatrienoic acids (DHETs). EETs protect against ischemia/reperfusion injury and have numerous beneficial physiological effects. We hypothesized that inhibition of sEH by t-AUCB enhances CRH in isolated mouse hearts through changing the oxylipin profiles, including an increase in EETs/DHETs ratio. Compared to controls, t-AUCB-treated mice had increased CRH, including repayment volume (RV), repayment duration, and repayment/debt ratio (p < 0.05). Treatment with t-AUCB significantly changed oxylipin profiles, including an increase in EET/DHET ratio, increase in EpOME/DiHOME ratio, increase in the levels of HODEs, decrease in the levels of mid-chain HETEs, and decrease in prostanoids (p < 0.05). Treatment with MS-PPOH (CYP epoxygenase inhibitor) reduced CRH, including RV (p < 0.05). Involvement of PPAR gamma in the modulation of CRH was demonstrated using a PPAR gamma-antagonist (T0070907) and a PPAR gamma-agonist (rosiglitazone). T0070907 reduced CRH (p < 0.05), whereas rosiglitazone enhanced CRH (p < 0.05) in isolated mouse hearts compared to the non-treated. These data demonstrate that sEH inhibition enhances, whereas CYP epoxy-genases- inhibition attenuates CRH, PPAR gamma mediate CRH downstream of the CYP epoxy-genases-EET pathway, and the changes in oxylipin profiles associated with sEH-inhibition collectively contributed to the enhanced CRH.	[Hanif, Ahmad; Nayeem, Mohammed A.] West Virginia Univ, Ctr Basic & Translat Stroke Res, Sch Pharm, Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Morisseau, Christophe] Univ Calif Davis, One Shields Ave, Davis, CA 95616 USA	West Virginia University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of California System; University of California Davis	Nayeem, MA (corresponding author), West Virginia Univ, Ctr Basic & Translat Stroke Res, Sch Pharm, Basic Pharmaceut Sci, Morgantown, WV 26506 USA.	mnayeem@hsc.wvu.edu	Nayeem, Mohammed A/A-3949-2017; Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019	Nayeem, Mohammed A/0000-0002-7827-4760; Zeldin, Darryl C/0000-0002-2087-7307; Edin, Matthew/0000-0002-7042-500X	National Institutes of Health / National Heart, Lung, and Blood Institute [HL-114559]; Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences [Z01 ES025034]; NIGMS of the National Institutes of Health [U54GM104942]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES025034, ZIAES025034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Institutes of Health / National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health / National Heart, Lung, and Blood Institute grant (HL-114559) to M. A. Nayeem (http://www.nhlbi.nih.gov) and the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES025034 to D. C. Zeldin) (http://www.niehs.nih.gov).; This work was supported by National Institutes of Health Grant (HL-114559) to M. A. Nayeem and the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034 to D. C. Zeldin). We thank Brandi Talkington, PhD, and the West Virginia Clinical and Translational Science Institute (WVCTSI) for editorial support. The WVCTSI is supported by the NIGMS of the National Institutes of Health under award number U54GM104942. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann R, 2007, BIOCHEM PHARMACOL, V74, P612, DOI 10.1016/j.bcp.2007.05.027; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Berwick ZC, 2010, MICROCIRCULATION, V17, P600, DOI 10.1111/j.1549-8719.2010.00054.x; Borbouse L, 2010, AM J PHYSIOL-HEART C, V298, P29; BRINKMAN HJM, 1990, THROMB HAEMOSTASIS, V63, P291; BURHOP KE, 1988, CIRC RES, V62, P687, DOI 10.1161/01.RES.62.4.687; Cai ZJ, 2013, J LIPID RES, V54, P1448, DOI 10.1194/jlr.M036533; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; COFFMAN JD, 1960, AM J PHYSIOL, V199, P1143, DOI 10.1152/ajplegacy.1960.199.6.1143; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; DEMEYER GRY, 1992, BRIT J PHARMACOL, V107, P597; Dolegowska B, 2009, PLATELETS, V20, P242, DOI 10.1080/09537100902849836; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Emerson MR, 2004, BRAIN RES, V1021, P140, DOI 10.1016/j.brainres.2004.06.045; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fleming I, 2014, PHARMACOL REV, V66, P1106, DOI 10.1124/pr.113.007781; Fritsche KL, 2008, PROSTAG LEUKOTR ESS, V79, P173, DOI 10.1016/j.plefa.2008.09.019; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; Gilroy DW, 2016, P NATL ACAD SCI USA, V25; Hattori T, 2008, J INVEST DERMATOL, V128, P1123, DOI 10.1038/sj.jid.5701172; Honda HM, 1999, ARTERIOSCL THROM VAS, V19, P680, DOI 10.1161/01.ATV.19.3.680; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Kingsbury MP, 2000, J MOL CELL CARDIOL, V32, P527, DOI 10.1006/jmcc.1999.1097; KITAKAZE M, 1992, CIRC RES, V71, P558, DOI 10.1161/01.RES.71.3.558; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lee JW, 2012, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2012-7; Li LM, 2014, PLOS ONE, V9, pe8433; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; MA YH, 1991, AM J PHYSIOL, V261, pH451, DOI 10.1152/ajpheart.1991.261.2.H451; Maayah ZH, 2016, ARCH TOXICOL, V90, P359, DOI 10.1007/s00204-014-1419-z; Mitchell Lex A, 2002, Cardiovasc Toxicol, V2, P219; Moghaddam MF, 1997, NAT MED, V3, P562, DOI 10.1038/nm0597-562; Moran JH, 1997, TOXICOL APPL PHARM, V146, P53, DOI 10.1006/taap.1997.8197; NAKAO J, 1982, ATHEROSCLEROSIS, V44, P339, DOI 10.1016/0021-9150(82)90008-9; Nayeem MA, 2013, AM J PHYSIOL-REG I, V304, P14; Nayeem MA, 2010, AM J PHYSIOL-REG I, V299, P28; Nayeem MA, 2011, MOL CELL BIOCHEM, V350, P101, DOI 10.1007/s11010-010-0686-0; Nowak G, 2004, TOXICOL LETT, V147, P161, DOI 10.1016/j.toxlet.2003.11.002; Obinata H, 2009, PROSTAG OTH LIPID M, V89, P66, DOI 10.1016/j.prostaglandins.2008.11.002; Park S, 2008, YONSEI MED J, V49, P592, DOI 10.3349/ymj.2008.49.4.592; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; Ponnoth DS, 2012, AM J PHYSIOL-REG I, V303, P26; Pradhan I, 2015, MOL CELL BIOCHEM, V5, P5; PROCTOR KG, 1987, CIRC RES, V60, P50, DOI 10.1161/01.RES.60.1.50; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Sha WX, 2012, IMMUNOBIOLOGY, V217, P1225, DOI 10.1016/j.imbio.2012.05.001; Sharifi-Sanjani M, 2013, AM J PHYSIOL-HEART C, V304, P22; Shim CY, 2014, AM J PHYSIOL-ENDOC M, V307, P21; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; STERN N, 1993, ENDOCRINOLOGY, V133, P843, DOI 10.1210/en.133.2.843; STERN N, 1989, ENDOCRINOLOGY, V125, P3090, DOI 10.1210/endo-125-6-3090; STOLL LL, 1994, AM J PHYSIOL, V266, pC990, DOI 10.1152/ajpcell.1994.266.4.C990; SUGIYAMA S, 1987, LIFE SCI, V40, P225, DOI 10.1016/0024-3205(87)90336-5; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; TANG DG, 1995, BIOCHEM BIOPH RES CO, V211, P462, DOI 10.1006/bbrc.1995.1836; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Wen YS, 1996, AM J PHYSIOL-CELL PH, V271, pC1212, DOI 10.1152/ajpcell.1996.271.4.C1212; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhao X, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-3; Zhou X, 2013, AM J PHYSIOL-HEART C, V305, P16	73	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162147	10.1371/journal.pone.0162147	http://dx.doi.org/10.1371/journal.pone.0162147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583776	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600112
J	Niemietz, CJ; Sauer, V; Stella, J; Fleischhauer, L; Chandhok, G; Guttmann, S; Avsar, Y; Guo, SL; Ackermann, EJ; Gollob, J; Monia, BP; Zibert, A; Schmidt, HHJ				Niemietz, Christoph J.; Sauer, Vanessa; Stella, Jacqueline; Fleischhauer, Lutz; Chandhok, Gursimran; Guttmann, Sarah; Avsar, Yesim; Guo, Shuling; Ackermann, Elizabeth J.; Gollob, Jared; Monia, Brett P.; Zibert, Andree; Schmidt, Hartmut H. -J.			Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LIVER-TRANSPLANTATION; RNA INTERFERENCE; TRANSTHYRETIN; GENERATION; ANTISENSE; URINE; TAFAMIDIS; DISEASE; DIFFERENTIATION	Familial amyloid polyneuropathy (FAP) is caused by mutations of the transthyretin (TTR) gene, predominantly expressed in the liver. Two compounds that knockdown TTR, comprising a small interfering RNA (siRNA; ALN-TTR-02) and an antisense oligonucleotide (ASO; IONIS-TTRRx), are currently being evaluated in clinical trials. Since primary hepatocytes from FAP patients are rarely available for molecular analysis and commercial tissue culture cells or animal models lack the patient-specific genetic background, this study uses primary cells derived from urine of FAP patients. Urine-derived cells were reprogrammed to induced pluripotent stem cells (iPSCs) with high efficiency. Hepatocyte-like cells (HLCs) showing typical hepatic marker expression were obtained from iPSCs of the FAP patients. TTR mRNA expression of FAP HLCs almost reached levels measured in human hepatocytes. To assess TTR knockdown, siTTR1 and TTR-ASO were introduced to HLCs. A significant downregulation (>80%) of TTR mRNA was induced in the HLCs by both oligonucleotides. TTR protein present in the cell culture supernatant of HLCs was similarly downregulated. Gene expression of other hepatic markers was not affected by the therapeutic oligonucleotides. Our data indicate that urine cells (UCs) after reprogramming and hepatic differentiation represent excellent primary human target cells to assess the efficacy and specificity of novel compounds.	[Niemietz, Christoph J.; Sauer, Vanessa; Stella, Jacqueline; Fleischhauer, Lutz; Chandhok, Gursimran; Guttmann, Sarah; Avsar, Yesim; Zibert, Andree; Schmidt, Hartmut H. -J.] Univ Klinikum Munster, Klin Transplantat Med, Albert Schweitzer Campus 1,Gebaude A14, D-48149 Munster, Germany; [Guo, Shuling; Ackermann, Elizabeth J.; Monia, Brett P.] Ionis Pharmaceut Inc, 2855 Gazelle Ct, Carlsbad, CA 92010 USA; [Gollob, Jared] Alnylam Pharmaceut Inc, 300 Third St 3, Cambridge, MA 02142 USA	Ionis Pharmaceuticals, Inc.	Schmidt, HHJ (corresponding author), Univ Klinikum Munster, Klin Transplantat Med, Albert Schweitzer Campus 1,Gebaude A14, D-48149 Munster, Germany.	hepar@ukmuenster.de		Zibert, Andree/0000-0002-5188-450X; Niemietz, Christoph/0000-0002-9393-8748; Fleischhauer, Lutz/0000-0002-0234-5446; Schmidt, Hartmut/0000-0002-2402-7764	Forderwettbewerb Translationale Stammzellforschung des Landes NRW [w1403ts011a]; grant of the " Innovative Medizinische Forschung" (IMF); Ionis Pharmaceuticals; Alnylam Pharmaceuticals	Forderwettbewerb Translationale Stammzellforschung des Landes NRW; grant of the " Innovative Medizinische Forschung" (IMF); Ionis Pharmaceuticals; Alnylam Pharmaceuticals	Part of the work was supported by the "Forderwettbewerb Translationale Stammzellforschung des Landes NRW (w1403ts011a)" and a grant of the " Innovative Medizinische Forschung" (IMF) dedicated to Y. Avsar. In addition, Ionis Pharmaceuticals and Alnylam Pharmaceuticals provided support in the form of salaries for authors S. Guo, EA, BM (Ionis Pharmaceuticals, Inc.) and JG (Alnylam Pharmaceuticals, Inc.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Both funders supported research materials. The specific roles of these authors are articulated in the 'author contributions' section.; We are grateful to O. Nadzemova for excellent technical assistance. Part of the work was supported by the "Forderwettbewerb Translationale Stammzellforschung des Landes NRW (w1403ts011a)" and a grant of the " Innovative Medizinische Forschung" (IMF) dedicated to Y. Avsar. All authors reviewed and approved the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Ackermann EJ, 2012, AMYLOID, V19, P43, DOI 10.3109/13506129.2012.673140; Afzal MZ, 2015, JOVE-J VIS EXP, DOI 10.3791/52032; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Benson MD, 2006, MUSCLE NERVE, V33, P609, DOI 10.1002/mus.20503; Butler JS, 2016, AMYLOID, V23, P109, DOI 10.3109/13506129.2016.1160882; Chen Y, 2015, STEM CELL REP, V5, P22, DOI 10.1016/j.stemcr.2015.04.017; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Guan X, 2014, STEM CELL RES, V12, P467, DOI 10.1016/j.scr.2013.12.004; Isono K, 2014, STEM CELL RES, V12, P574, DOI 10.1016/j.scr.2014.01.004; JACOBSON DR, 1990, AM J HUM GENET, V47, P127; Jia B, 2014, LIFE SCI, V108, P22, DOI 10.1016/j.lfs.2014.05.004; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kurosawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1012, DOI 10.1016/j.bbrc.2005.09.142; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lee SH, 2013, EUR J PHARM BIOPHARM, V85, P5, DOI 10.1016/j.ejpb.2013.03.021; Leung A, 2013, STEM CELL REP, V1, P451, DOI 10.1016/j.stemcr.2013.10.003; Li D, 2016, STEM CELL REP, V6, P717, DOI 10.1016/j.stemcr.2016.04.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lorenzer C, 2015, J CONTROL RELEASE, V203, P1, DOI 10.1016/j.jconrel.2015.02.003; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Merlini G, 2013, J CARDIOVASC TRANSL, V6, P1011, DOI 10.1007/s12265-013-9512-x; Niemietz C, 2015, MOLECULES, V20, P17944, DOI 10.3390/molecules201017944; Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015; Plante-Bordeneuve V, 2013, HAND CLINIC, V115, P643, DOI 10.1016/B978-0-444-52902-2.00038-2; Pomfret EA, 1998, TRANSPLANTATION, V65, P918, DOI 10.1097/00007890-199804150-00010; Propsting MJ, 2000, BIOCHEM BIOPH RES CO, V279, P970, DOI 10.1006/bbrc.2000.4048; Propsting MJ, 1999, BIOCHEM BIOPH RES CO, V260, P313, DOI 10.1006/bbrc.1999.0906; Quarta CC, 2012, JACC-CARDIOVASC IMAG, V5, P755, DOI 10.1016/j.jcmg.2012.02.015; Sauer V, 2016, CELL TRANSP IN PRESS; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Sehgal A, 2013, J HEPATOL, V59, P1354, DOI 10.1016/j.jhep.2013.05.045; Si-Tayeb K, 2016, DIS MODEL MECH, V9, P81, DOI 10.1242/dmm.022277; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Slamecka J, 2016, CELL CYCLE, V15, P234, DOI 10.1080/15384101.2015.1121332; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Suhr OB, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0326-6; Tsankov AM, 2015, NAT BIOTECHNOL, V33, P1182, DOI 10.1038/nbt.3387; Wang C.W., 2016, IEEE J SEL AREA COMM, V30, P2016, DOI DOI 10.1089/CELL.2015.0015; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161455	10.1371/journal.pone.0161455	http://dx.doi.org/10.1371/journal.pone.0161455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584576	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600031
J	Won, EY; Lee, SO; Lee, DH; Lee, D; Bae, KH; Lee, SC; Kim, SJ; Chi, SW				Won, Eun-Young; Lee, Sang-Ok; Lee, Dong-Hwa; Lee, Daeyoup; Bae, Kwang-Hee; Lee, Sang Chul; Kim, Seung Jun; Chi, Seung-Wook			Structural Insight into the Critical Role of the N-Terminal Region in the Catalytic Activity of Dual-Specificity Phosphatase 26	PLOS ONE			English	Article							CHROMOSOME ARM 8P; CRYSTAL-STRUCTURE; PROTEIN PHOSPHATASE; P53 RESTORATION; DUSP26; SUPPRESSION; ACTIVATION; PATHWAY; GROWTH	Human dual-specificity phosphatase 26 (DUSP26) is a novel target for anticancer therapy because its dephosphorylation of the p53 tumor suppressor regulates the apoptosis of cancer cells. DUSP26 inhibition results in neuroblastoma cell cytotoxicity through p53-mediated apoptosis. Despite the previous structural studies of DUSP26 catalytic domain (residues 61-211, DUSP26-C), the high-resolution structure of its catalytically active form has not been resolved. In this study, we determined the crystal structure of a catalytically active form of DUSP26 (residues 39-211, DUSP26-N) with an additional N-terminal region at 2.0 angstrom resolution. Unlike the C-terminal domain-swapped dimeric structure of DUSP26-C, the DUSP26-N (C152S) monomer adopts a fold-back conformation of the C-terminal alpha 8-helix and has an additional alpha 1-helix in the N-terminal region. Consistent with the canonically active conformation of its protein tyrosine phosphate-binding loop (PTP loop) observed in the structure, the phosphatase assay results demonstrated that DUSP26-N has significantly higher catalytic activity than DUSP26-C. Furthermore, size exclusion chromatography-multiangle laser scattering (SEC-MALS) measurements showed that DUSP26-N (C152S) exists as a monomer in solution. Notably, the crystal structure of DUSP26-N (C152S) revealed that the N-terminal region of DUSP26-N (C152S) serves a scaffolding role by positioning the surrounding alpha 7-alpha 8 loop for interaction with the PTP-loop through formation of an extensive hydrogen bond network, which seems to be critical in making the PTP-loop conformation competent for phosphatase activity. Our study provides the first high-resolution structure of a catalytically active form of DUSP26, which will contribute to the structure-based rational design of novel DUSP26-targeting anticancer therapeutics.	[Won, Eun-Young; Lee, Sang-Ok; Lee, Dong-Hwa; Kim, Seung Jun; Chi, Seung-Wook] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Bae, Kwang-Hee; Lee, Sang Chul] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Daejeon, South Korea; [Won, Eun-Young; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST)	Kim, SJ; Chi, SW (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.	ksj@kribb.re.kr; swchi@kribb.re.kr	Lee, Daeyoup/C-1653-2011; Kim, Seung Jun/N-5248-2019	Lee, Daeyoup/0000-0003-2006-1823; Kim, Seung Jun/0000-0002-6913-6358; Bae, Kwang-Hee/0000-0002-5868-2556	National Research Foundation of Korea(NRF) grants - Korea government(MEST) [2011-0030027, NRF-2012M3C1A3671508, NRF-2014R1A2A2A05002961]; Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2015M3A9C4076320]; KRIBB Research Initiative Program	National Research Foundation of Korea(NRF) grants - Korea government(MEST); Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation; KRIBB Research Initiative Program	This work was supported by the National Research Foundation of Korea(NRF) grants funded by the Korea government(MEST) (2011-0030027; to SJK, NRF-2012M3C1A3671508 and NRF-2014R1A2A2A05002961; to SWC) and by the Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation (NRF-2015M3A9C4076320; to SWC). This work was also supported by the KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Armes JE, 2004, ONCOGENE, V23, P5697, DOI 10.1038/sj.onc.1207740; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chi SW, 2014, BMB REP, V47, P167, DOI 10.5483/BMBRep.2014.47.3.261; EMMERTBUCK MR, 1995, CANCER RES, V55, DOI DOI 10.1038/35042675; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Jeong MS, 2012, CHEM COMMUN, V48, P6553, DOI 10.1039/c2cc31377d; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4351; Kim SJ, 2007, PROTEINS, V66, P239, DOI 10.1002/prot.21197; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lokareddy RK, 2013, BIOCHEMISTRY-US, V52, P938, DOI 10.1021/bi301476m; Lountos GT, 2011, ACTA CRYSTALLOGR D, V67, P471, DOI 10.1107/S090744491100970X; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Minton AP, 2016, ANAL BIOCHEM, V501, P4, DOI 10.1016/j.ab.2016.02.007; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pribill I, 2001, CANCER GENET CYTOGEN, V129, P23, DOI 10.1016/S0165-4608(01)00419-8; Shang X, 2010, ONCOGENE, V29, P4938, DOI 10.1038/onc.2010.244; Shi Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.207; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Tanuma N, 2009, ONCOGENE, V28, P752, DOI 10.1038/onc.2008.431; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang JY, 2006, J NEUROCHEM, V98, P89, DOI 10.1111/j.1471-4159.2006.03852.x; Wang JY, 2008, J NEUROCHEM, V107, P1544, DOI 10.1111/j.1471-4159.2008.05714.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2013, ACTA CRYSTALLOGR D, V69, P1160, DOI 10.1107/S0907444913004770; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu W, 2007, ONCOGENE, V26, P1178, DOI 10.1038/sj.onc.1209899; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	44	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162115	10.1371/journal.pone.0162115	http://dx.doi.org/10.1371/journal.pone.0162115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583453	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600107
J	Wu, XL; Xu, JQ; Feng, GF; Wiggans, GR; Taylor, JF; He, J; Qian, CS; Qiu, JS; Simpson, B; Walker, J; Bauck, S				Wu, Xiao-Lin; Xu, Jiaqi; Feng, Guofei; Wiggans, George R.; Taylor, Jeremy F.; He, Jun; Qian, Changsong; Qiu, Jiansheng; Simpson, Barry; Walker, Jeremy; Bauck, Stewart			Optimal Design of Low-Density SNP Arrays for Genomic Prediction: Algorithm and Applications	PLOS ONE			English	Article							GENOTYPING ARRAY; MARKER PANELS; IMPUTATION; VALUES; CATTLE; ACCURACY; SUBSETS; CHIPS	Low-density (LD) single nucleotide polymorphism (SNP) arrays provide a cost-effective solution for genomic prediction and selection, but algorithms and computational tools are needed for the optimal design of LD SNP chips. A multiple-objective, local optimization (MOLO) algorithm was developed for design of optimal LD SNP chips that can be imputed accurately to medium-density (MD) or high-density (HD) SNP genotypes for genomic prediction. The objective function facilitates maximization of non-gap map length and system information for the SNP chip, and the latter is computed either as locus-averaged (LASE) or haplotype-averaged Shannon entropy (HASE) and adjusted for uniformity of the SNP distribution. HASE performed better than LASE with <= 1,000 SNPs, but required considerably more computing time. Nevertheless, the differences diminished when >5,000 SNPs were selected. Optimization was accomplished conditionally on the presence of SNPs that were obligated to each chromosome. The frame location of SNPs on a chip can be either uniform (evenly spaced) or non-uniform. For the latter design, a tunable empirical Beta distribution was used to guide location distribution of frame SNPs such that both ends of each chromosome were enriched with SNPs. The SNP distribution on each chromosome was finalized through the objective function that was locally and empirically maximized. This MOLO algorithm was capable of selecting a set of approximately evenly-spaced and highly-informative SNPs, which in turn led to increased imputation accuracy compared with selection solely of evenly-spaced SNPs. Imputation accuracy increased with LD chip size, and imputation error rate was extremely low for chips with >= 3,000 SNPs. Assuming that genotyping or imputation error occurs at random, imputation error rate can be viewed as the upper limit for genomic prediction error. Our results show that about 25% of imputation error rate was propagated to genomic prediction in an Angus population. The utility of this MOLO algorithm was also demonstrated in a real application, in which a 6K SNP panel was optimized	[Wu, Xiao-Lin; Xu, Jiaqi; Feng, Guofei; Qiu, Jiansheng; Simpson, Barry; Walker, Jeremy; Bauck, Stewart] GeneSeek, Bioinformat & Biostat, Lincoln, NE USA; [Xu, Jiaqi; Feng, Guofei] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Wiggans, George R.] USDA ARS, Anim Genom & Improvement Lab, Beltsville, MD USA; [Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [He, Jun] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Hunan, Peoples R China; [Qian, Changsong] Neogen Biosci Technol Shanghai Co Ltd, Mkt & Business Dev, Shanghai, Peoples R China	University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Hunan Agricultural University	Wu, XL (corresponding author), GeneSeek, Bioinformat & Biostat, Lincoln, NE USA.	NWu@neogen.com	Wu, Xiaolin/GPX-5124-2022	Wu, Xiaolin/0000-0002-5604-9220	GeneSeek (a Neogen Company); Neogen Bio-Scientific Technology (Shanghai) Company Ltd.; visiting scholar program of University of Nebraska-Lincoln; Hundred-Talents Program of Hunan Province, China; "Improving Genetic Predictions in Dairy Animals Using Phenotypic and Genomic Information" of the Agricultural Research Service of the United States Department of Agriculture [8042-31000-101-00]; Neogen RD fund; GeneSeek; Neogen company	GeneSeek (a Neogen Company); Neogen Bio-Scientific Technology (Shanghai) Company Ltd.; visiting scholar program of University of Nebraska-Lincoln; Hundred-Talents Program of Hunan Province, China; "Improving Genetic Predictions in Dairy Animals Using Phenotypic and Genomic Information" of the Agricultural Research Service of the United States Department of Agriculture; Neogen RD fund; GeneSeek; Neogen company	GeneSeek (a Neogen Company) and Neogen Bio-Scientific Technology (Shanghai) Company Ltd. provided support in the form of salaries for XW, CQ, BS, JW and SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funding by Neogen to this research does not alter our adherence to PLOS ONE policies on sharing data and materials. JH was supported partially by the visiting scholar program of University of Nebraska-Lincoln and by the Hundred-Talents Program of Hunan Province, China. GRW was supported by appropriated project 8042-31000-101-00, "Improving Genetic Predictions in Dairy Animals Using Phenotypic and Genomic Information" of the Agricultural Research Service of the United States Department of Agriculture. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture. USDA is an equal opportunity provider and employer.; This research was financially supported by Neogen R&D fund. JX and GF acknowledge the internship financial support by GeneSeek, an Neogen company. Adam McQuistan and Anna Fuller at GeneSeek are thanked for help in preparing and cleaning the data. Thanks also goes to Suzanne Hubbard at USDA (Beltsville, MD) for her technical assistance in preparing this manuscript.	[Anonymous], 2010, BOV GEN BEADCH; Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Bolormaa S, 2015, ANIM GENET, V46, P544, DOI 10.1111/age.12340; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Corbin LJ, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-9; Dassonneville R, 2011, J DAIRY SCI, V94, P3679, DOI 10.3168/jds.2011-4299; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Harris BL, 2009, INTERBULL B, V44, P3; Houston RD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-90; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Moser G, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-37; Neogen, 2016, GENESEEK LAUNCH IMPR; Ha NT, 2014, EUR J HUM GENET, V22, P1124, DOI 10.1038/ejhg.2013.304; Okut H, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-34; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Rincon G, 2011, J DAIRY SCI, V94, P6116, DOI 10.3168/jds.2011-4764; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Weigel KA, 2009, J DAIRY SCI, V92, P5248, DOI 10.3168/jds.2009-2092; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2012, J DAIRY SCI, V95, P1552, DOI 10.3168/jds.2011-4985; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501	23	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161719	10.1371/journal.pone.0161719	http://dx.doi.org/10.1371/journal.pone.0161719			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583971	Green Published, gold			2022-12-27	WOS:000382855600052
J	Torrado, B; Grana, M; Badano, JL; Irigoin, F				Torrado, Belen; Grana, Martin; Badano, Jose L.; Irigoin, Florencia			Ciliary Entry of the Hedgehog Transcriptional Activator Gli2 Is Mediated by the Nuclear Import Machinery but Differs from Nuclear Transport in Being Imp-alpha/beta 1-Independent	PLOS ONE			English	Article							RAN-DEPENDENT NUCLEAR; PRIMARY CILIUM; PROTEIN FUNCTION; SIGNALING CENTER; PORE COMPLEX; IN-VITRO; LOCALIZATION; MECHANISMS; SUPPRESSOR; EXPORT	Gli2 is the primary transcriptional activator of Hedgehog signalling in mammals. Upon stimulation of the pathway, Gli2 moves into the cilium before reaching the nucleus. However, the mechanisms underlying its entry into the cilium are not completely understood. Since several similarities have been reported between nuclear and ciliary import, we investigated if the nuclear import machinery participates in Gli2 ciliary entry. Here we show that while two conserved classical nuclear localization signals mediate Gli2 nuclear localization via importin (Imp)-alpha/beta 1, these sequences are not required for Gli2 ciliary import. However, blocking Imp-mediated transport through overexpression of GTP-locked Ran reduced the percentage of Gli2 positive cilia, an effect that was not explained by increased CRM1-dependent export of Gli2 from the cilium. We explored the participation of Imp-beta 2 in Gli2 ciliary traffic and observed that this transporter is involved in moving Gli2 into the cilium, as has been described for other ciliary proteins. In addition, our data indicate that Imp-beta 2 might also collaborate in Gli2 nuclear entry. How does Imp-beta 2 determine the final destination of a protein that can localize to two distinct subcellular compartments remains an open question. Therefore, our data shows that the nuclear-cytoplasmic shuttling machinery plays a critical role mediating the subcellular distribution of Gli2 and the activation of the pathway, but distinct importins likely play a differential role mediating its ciliary and nuclear translocation.	[Torrado, Belen; Badano, Jose L.; Irigoin, Florencia] Inst Pasteur Montevideo, Human Mol Genet Lab, Mataojo 2020, Montevideo 11400, Uruguay; [Grana, Martin] Inst Pasteur Montevideo, Bioinformat Unit, Mataojo 2020, Montevideo 11400, Uruguay; [Irigoin, Florencia] Univ Republica, Fac Med, Dept Histol & Embriol, Gral Flores 2125, Montevideo 11800, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay	Irigoin, F (corresponding author), Inst Pasteur Montevideo, Human Mol Genet Lab, Mataojo 2020, Montevideo 11400, Uruguay.; Irigoin, F (corresponding author), Univ Republica, Fac Med, Dept Histol & Embriol, Gral Flores 2125, Montevideo 11800, Uruguay.	firigoin@gmail.com	Irigoin, Florencia/HCH-3798-2022	Grana, Martin/0000-0003-1182-8236; Torrado, Belen/0000-0002-0679-3422; Badano, Jose/0000-0002-0706-8652	Interdisciplinary Grant from the Institut Pasteur de Montevideo; Agencia Nacional de Investigacion e Innovacion (ANII)-Programa Innova; MERCOSUR Structural Convergence Fund (FOCEM) [COF 03/11]; Agencia Nacional de Investigacion e Innovacion; Comision Academica de Posgrado, Universidad de la Republica (CAP); Programa para el Desarrollo de las Ciencias Basicas (PEDECIBA)	Interdisciplinary Grant from the Institut Pasteur de Montevideo; Agencia Nacional de Investigacion e Innovacion (ANII)-Programa Innova; MERCOSUR Structural Convergence Fund (FOCEM); Agencia Nacional de Investigacion e Innovacion; Comision Academica de Posgrado, Universidad de la Republica (CAP); Programa para el Desarrollo de las Ciencias Basicas (PEDECIBA)	This work was supported by an Interdisciplinary Grant from the Institut Pasteur de Montevideo (www.pasteur.edu.uy) to FI, Agencia Nacional de Investigacion e Innovacion (ANII, www.anii.org.uy)-Programa Innova to JLB and partially funded by MERCOSUR Structural Convergence Fund (FOCEM, COF 03/11). BT was supported with scholarships from the Agencia Nacional de Investigacion e Innovacion and the Comision Academica de Posgrado, Universidad de la Republica (CAP, www.posgrados.udelar.edu.uy). MG, JLB and FI are supported by the Agencia Nacional de Investigacion e Innovacion and the Programa para el Desarrollo de las Ciencias Basicas (PEDECIBA, www.pedeciba.edu.uy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Fan SL, 2011, ORGANOGENESIS, V7, P147, DOI 10.4161/org.7.3.17084; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Garcia-Gonzalo FR, 2012, J CELL BIOL, V197, P697, DOI 10.1083/jcb.201111146; Gascue C, 2012, J CELL SCI, V125, P362, DOI 10.1242/jcs.089375; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Ishiguro K, 2007, EUR J IMMUNOL, V37, P2309, DOI 10.1002/eji.200737180; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Kee H Lynn, 2013, Cilia, V2, P11, DOI 10.1186/2046-2530-2-11; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu JL, 2015, DEVELOPMENT, V142, P1651, DOI 10.1242/dev.119669; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834, DOI 10.1074/jbc.271.51.32834; Maia TM, 2014, BIOL OPEN, V3, P138, DOI 10.1242/bio.20146577; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; Pagano M., 2018, PRINCIPLES BIOSTATIS; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Santos N, 2014, J CELL SCI, V127, P1500, DOI 10.1242/jcs.139253; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Sheng T, 2006, J BIOL CHEM, V281, P9, DOI 10.1074/jbc.C500300200; Shi Q, 2014, J CELL SCI, V127, P1092, DOI 10.1242/jcs.142828; Soderholm JF, 2011, ACS CHEM BIOL, V6, P700, DOI 10.1021/cb2000296; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Szczepny A, 2014, BIOCHEM J, V461, P469, DOI 10.1042/BJ20130709; Takao D, 2014, CURR BIOL, V24, P2288, DOI 10.1016/j.cub.2014.08.012; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544; Zeng HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015900; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	70	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162033	10.1371/journal.pone.0162033	http://dx.doi.org/10.1371/journal.pone.0162033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579771	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400053
J	Xia, MF; Yki-Jarvinen, H; Bian, H; Lin, HD; Yan, HM; Chang, XX; Zhou, Y; Gao, X				Xia, Ming-Feng; Yki-Jarvinen, Hannele; Bian, Hua; Lin, Huan-Dong; Yan, Hong-Mei; Chang, Xin-Xia; Zhou, You; Gao, Xin			Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CIRCULATING TRIACYLGLYCEROL SIGNATURES; HEPATIC STEATOSIS; CONFERS SUSCEPTIBILITY; I148M VARIANT; PNPLA3; ASSOCIATION; ULTRASOUND; MANAGEMENT; DIAGNOSIS; NAFLD	Objectives Presence of non-alcoholic fatty liver disease (NAFLD) can predict risks for diabetes, cardiovascular disease and advanced liver disease in the general population. We aimed to establish a non-invasive score for prediction of NAFLD in Han Chinese, the largest ethnic group in the world, and detect whether ethnicity influences the accuracy of such a score. Methods Liver fat content (LFAT) was measured by quantitative ultrasound in 3548 subjects in the Shanghai Changfeng Community and a Chinese score was created using multivariate logistic regression analyses. This new score was internally validated in Chinese and externally in Finns. Its diagnostic performance was compared to the NAFLD liver fat score, fatty liver index (FLI) and hepatic steatosis index (HSI) developed in Finns, Italians and Koreans. We also analyzed how obesity related to LFAT measured by H-1-MRS in 79 Finns and 118 Chinese with type 2 diabetes (T2D). Results The metabolic syndrome and T2D, fasting serum insulin, body mass index (BMI) and AST/ALT ratio were independent predictors of NAFLD in Chinese. The AUROC in the Chinese validation cohort was 0.76 (0.73-0.78) and in Finns 0.73 (0.68-0.78) (p<0.0001). 43%, 27%, 32% and 42% of Chinese had NAFLD when determined by the Chinese score, NAFLD liver fat score (p<0.001 vs. Chinese score), FLI (p<0.001) and HSI (NS). For any given BMI and waist circumference, the Chinese had a markedly higher LFAT than the Finns. Conclusion The predictors of NAFLD in Han Chinese are as in Europids but the Chinese have more LFAT for any given degree of obesity than Europids. Ethnicity needs to be considered when NAFLD is predicted using risk scores.	[Xia, Ming-Feng; Bian, Hua; Lin, Huan-Dong; Yan, Hong-Mei; Chang, Xin-Xia; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Xia, Ming-Feng; Bian, Hua; Lin, Huan-Dong; Yan, Hong-Mei; Chang, Xin-Xia; Gao, Xin] Fudan Unvers, Inst Chron Metab Dis, Shanghai, Peoples R China; [Yki-Jarvinen, Hannele; Zhou, You] Univ Helsinki, Dept Med, Helsinki, Finland; [Yki-Jarvinen, Hannele; Zhou, You] Minerva Fdn, Helsinki, Finland	Fudan University; Fudan University; University of Helsinki	Gao, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.; Gao, X (corresponding author), Fudan Unvers, Inst Chron Metab Dis, Shanghai, Peoples R China.	zhongshan_endo@126.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796; ZHOU, YOU/0000-0002-1743-1291; Bian, Hua/0000-0001-8449-0665	National Key Basic Research Program of China [2012CB524906]; Shanghai municipal health project grant [2013ZYJB0802]; Shanghai Municipal Science and Technology Fund [13441900303]; Shanghai Health and Family Planning Commission Foundation [12GWZX0103, 2013SY005]; National Ministry of Education Program [985III-YFX0302]; Shanghai Hospital Development Center Foundation [SHDC12012201]; National Natural Science Foundation of China for Young Scholar [81300682]; Orion-Farmos Research Foundation; Clinical Chemistry Research Foundation; Paulo Foundation; Finnish Cultural Foundation	National Key Basic Research Program of China(National Basic Research Program of China); Shanghai municipal health project grant; Shanghai Municipal Science and Technology Fund; Shanghai Health and Family Planning Commission Foundation; National Ministry of Education Program; Shanghai Hospital Development Center Foundation; National Natural Science Foundation of China for Young Scholar; Orion-Farmos Research Foundation; Clinical Chemistry Research Foundation; Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by grants from the National Key Basic Research Program of China (Grant No. 2012CB524906 to XG), the Shanghai municipal health project grant (Grant No. 2013ZYJB0802 to XG), the Shanghai Municipal Science and Technology Fund (Grant No. 13441900303 to HB), the Shanghai Health and Family Planning Commission Foundation (Grant Nos. 12GWZX0103 and 2013SY005 to XG), the National Ministry of Education Program (Grant No. 985III-YFX0302 to XG), Shanghai Hospital Development Center Foundation (Grant No. SHDC12012201 to XG), and National Natural Science Foundation of China for Young Scholar (Grant No. 81300682 to MX). This study was also supported in part by The Orion-Farmos Research Foundation (to YZ), the Clinical Chemistry Research Foundation (to YZ), the Paulo Foundation (to YZ) and the Finnish Cultural Foundation (to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bian H, 2011, DIABETES TECHNOL THE, V13, P149, DOI 10.1089/dia.2010.0101; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dongiovanni P, 2015, HEPATOLOGY, V61, P506, DOI 10.1002/hep.27490; ETLER DA, 1992, HUM BIOL, V64, P567; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gao X, 2013, J DIABETES, V5, P406, DOI 10.1111/1753-0407.12056; Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Li XM, 2012, ATHEROSCLEROSIS, V224, P480, DOI 10.1016/j.atherosclerosis.2012.07.002; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Peng XE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050256; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Wang XL, 2015, J HEPATOL, V62, P1438, DOI 10.1016/j.jhep.2015.01.040; Xia MF, 2016, ALIMENT PHARM THER, V43, P631, DOI 10.1111/apt.13521; Xia MF, 2012, OBESITY, V20, P444, DOI 10.1038/oby.2011.302; Xia MF, 2011, CLIN EXP PHARMACOL P, V38, P373, DOI 10.1111/j.1440-1681.2011.05519.x; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhou Y, 2015, J HEPATOL, V62, P657, DOI 10.1016/j.jhep.2014.10.010	36	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160526	10.1371/journal.pone.0160526	http://dx.doi.org/10.1371/journal.pone.0160526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579785	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000382877400006
J	Weber, EM; Hultgren, J; Algers, B; Olsson, IAS				Weber, Elin M.; Hultgren, Jan; Algers, Bo; Olsson, I. Anna S.			Do Laboratory Mouse Females that Lose Their Litters Behave Differently around Parturition?	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; MATERNAL-BEHAVIOR; BREEDING PERFORMANCE; PERINATAL-MORTALITY; NESTING MATERIAL; MUS-MUSCULUS; HOUSE MICE; CAGE SIZE; C57BL/6J; SYSTEMS	Efficiency in laboratory mouse breeding is hampered by poor reproductive performance, including the loss of entire litters shortly after birth. However, the underlying mechanisms are not yet fully understood and establishing the cause of death in laboratory mouse pups can be complicated. Newborn mouse pups are generally hidden in nests, dead pups are often eaten by the female, and the widespread practice of leaving periparturient females undisturbed complicates inspection, which may delay the discovery of pup loss. In order to efficiently prevent problems with litter loss, it is important to find key factors for survival. We investigated differences in periparturient behavior between female laboratory mice whose pups survived until weaning and females whose entire litters were lost. Video recordings of 82 primiparous females of the C57BL/6 strain or knockouts with C57BL/6 background were used. The mice were observed from 24 h before until 24 h after parturition and female behaviors coded using a pre-established ethogram. The relationship between behavior and survival was analyzed using logistic models, where litter survival was regressed on the proportion of 30-s observations with at least one occurrence of the behavior. We found that females with surviving litters performed more nest building behavior during the last 24 h before parturition (p = 0.004) and spent less time outside the nest during the entire observation period (p = 0.001). Increased litter survival was also associated with more passive maternal behaviors and the female ignoring still pups less. Females that lost their litters performed more parturition-related behaviors, suggesting prolonged labor. The results indicate that maternal behavior plays a significant role in laboratory mouse pup survival. Complications at parturition also contribute to litter mortality.	[Weber, Elin M.; Hultgren, Jan; Algers, Bo] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden; [Weber, Elin M.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Olsson, I. Anna S.] Univ Porto, I3S Inst Invest & Inovacao Saude, Oporto, Portugal; [Weber, Elin M.; Olsson, I. Anna S.] Univ Porto, IBMC Inst Biol Mol & Celular, Lab Anim Sci, Oporto, Portugal	Swedish University of Agricultural Sciences; Stanford University; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Weber, EM (corresponding author), Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden.; Weber, EM (corresponding author), Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.; Weber, EM (corresponding author), Univ Porto, IBMC Inst Biol Mol & Celular, Lab Anim Sci, Oporto, Portugal.	elin.weber@slu.se	Olsson, Anna/C-1792-2008	Olsson, Anna/0000-0002-4369-8723; Hultgren, Jan/0000-0001-9164-2321	Swedish Board of Agriculture [Dnr 31-4343/09]; Swedish Research Council [K2010-79X-21370-01-3]; Fundacao para a Ciencia e a Tecnologia (FCT), Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal [POCTI/NSE/45352/2002]	Swedish Board of Agriculture; Swedish Research Council(Swedish Research CouncilEuropean Commission); Fundacao para a Ciencia e a Tecnologia (FCT), Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal(Portuguese Foundation for Science and Technology)	This project was funded by Swedish Board of Agriculture, Dnr 31-4343/09, http://www.jordbruksverket.se/. IASO received this funding. It was also funded by Swedish Research Council, K2010-79X-21370-01-3, http://www.vr.se/. BA received this funding. The experimental study in which video recordings were made was funded by research grant POCTI/NSE/45352/2002 from the Fundacao para a Ciencia e a Tecnologia (FCT), Ministerio da Ciencia, Tecnologia e Ensino Superior, Portugal, http://www.fct.pt/. IASO and EMW received this funding.	Bond TLY, 2002, PHYSIOL BEHAV, V75, P551, DOI 10.1016/S0031-9384(02)00659-5; Borges VF, 2005, PREV VET MED, V70, P165, DOI 10.1016/j.prevetmed.2005.03.003; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; BROWN RZ, 1953, ECOL MONOGR, V23, P217, DOI 10.2307/1943592; Carvalho AFU, 2009, BRAZ J BIOL, V69, P153, DOI 10.1590/S1519-69842009000100020; Cooper JC, 2007, BIOL REPROD, V77, P274, DOI 10.1095/biolreprod.106.057125; Edwards SA, 2002, LIVEST PROD SCI, V78, P3, DOI 10.1016/S0301-6226(02)00180-X; EHRET G, 1984, Z TIERPSYCHOL, V65, P25; Eskola S, 1999, LAB ANIM-UK, V33, P122, DOI 10.1258/002367799780578354; European Commission, 2013, COM2013859FINAL EUR; Ewer RF., 1968, ETHOLOGY MAMMALS, P234; Gaskill BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074153; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; GUASTAVINO JM, 1984, PHYSIOL BEHAV, V32, P225, DOI 10.1016/0031-9384(84)90134-3; HAUSCHKA TS, 1952, J HERED, V43, P117, DOI 10.1093/oxfordjournals.jhered.a106283; ITURRIAN WB, 1968, LAB ANIM CARE, V18, P160; KONIG B, 1987, BEHAV ECOL SOCIOBIOL, V20, P1, DOI 10.1007/BF00292161; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Malmkvist J, 2007, APPL ANIM BEHAV SCI, V107, P120, DOI 10.1016/j.applanim.2006.09.018; MARTINO PE, 1990, VET RES COMMUN, V14, P199, DOI 10.1007/BF00347738; Mellor DJ, 2004, VET J, V168, P118, DOI 10.1016/j.tvjl.2003.08.004; Offenbacher S, 2005, J PERIODONTOL, V76, P2133, DOI 10.1902/jop.2005.76.11-S.2133; Porto G, 2007, IRON OVERLOAD IMMUNI; Potgieter FJ, 1997, J S AFR VET ASSOC, V68, P8; Rasmussen S, 2009, J AM ASSOC LAB ANIM, V48, P363; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Rodrigues P, 2006, INT J EXP PATHOL, V87, P317, DOI 10.1111/j.1365-2613.2006.00491.x; Shoji H, 2006, PHYSIOL BEHAV, V89, P320, DOI 10.1016/j.physbeh.2006.06.012; Singh J, 2006, BIRTH DEFECTS RES B, V77, P216, DOI 10.1002/bdrb.20077; Spangenberg EMF, 2014, LAB ANIM-UK, V48, P193, DOI 10.1177/0023677214531569; Tsai PP, 2003, LAB ANIM-UK, V37, P44, DOI 10.1258/002367703762226683; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Weaver SR, 2015, USE RATLOFT DECREASE; Weber EM, 2013, REPROD DOMEST ANIM, V48, P292, DOI 10.1111/j.1439-0531.2012.02147.x; Weber EM, 2008, APPL ANIM BEHAV SCI, V114, P1, DOI 10.1016/j.applanim.2008.06.006; Weber EM, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-83; Wettschureck N, 2004, MOL CELL BIOL, V24, P8048, DOI 10.1128/MCB.24.18.8048-8054.2004; Whitaker J, 2007, LAB ANIMAL, V36, P32, DOI 10.1038/laban1107-32; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161238	10.1371/journal.pone.0161238	http://dx.doi.org/10.1371/journal.pone.0161238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575720	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877200019
J	Geng, C; Chen, X; Pan, XH; Li, JY				Geng, Chong; Chen, Xiao; Pan, Xiaohua; Li, Jiyu			The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SURGICAL ADJUVANT BREAST; PREOPERATIVE CHEMOTHERAPY; AXILLARY DISSECTION; IDENTIFICATION RATE; AMERICAN-SOCIETY; CARCINOMA; MANAGEMENT; MORBIDITY; LYMPHADENECTOMY; METASTASIS	Background With the increased use of neoadjuvant chemotherapy (NAC) in breast cancer, the timing of sentinel lymph node biopsy (SLNB) has become increasingly important. In this study, we aimed to evaluate the feasibility and accuracy of SLNB for initially clinically node-negative breast cancer after NAC by conducting a systematic review and meta-analysis. Methods We searched PubMed, Embase, and the Cochrane Library from January 1, 1993 to November 30, 2015 for studies on initially clinically node-negative breast cancer patients who underwent SLNB after NAC followed by axillary lymph node dissection (ALND). Results A total of 1,456 patients from 16 studies were included in this review. The pooled identification rate (IR) for SLNB was 96% [95% confidence interval (CI): 95%-97%], and the false negative rate (FNR) was 6% (95% CI: 3%-8%). The pooled sensitivity, negative predictive value (NPV) and accuracy rate (AR) were 94% (95% CI: 92%-97%, I-2 = 27.5%), 98% (95% CI: 98%-99%, I-2 = 42.7%) and 99% (95% CI: 99%-100%, I-2 = 32.6%), respectively. In the subgroup analysis, no significant differences were found in either the IR of an SLNB when different mapping methods were used (P = 0.180) or in the FNR between studies with and without immunohistochemistry (IHC) staining (P = 0.241). Conclusion Based on current evidence, SLNB is technically feasible and accurate enough for axillary staging in initially clinically node-negative breast cancer patients after NAC.	[Geng, Chong; Chen, Xiao; Pan, Xiaohua; Li, Jiyu] Shandong Univ, Shandong Prov Hosp, Dept Breast & Thyroid Surg, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, JY (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Breast & Thyroid Surg, Jinan, Shandong, Peoples R China.	bigli2004@163.com			Key Research and Development Program of Shandong Province [2015GSF118023]; Projects of Medical and Health Technology Development Program in Shandong Province [2014WS0349]	Key Research and Development Program of Shandong Province; Projects of Medical and Health Technology Development Program in Shandong Province	This work was supported by the Key Research and Development Program of Shandong Province (no. 2015GSF118023, recipient: JL) and the Projects of Medical and Health Technology Development Program in Shandong Province (no. 2014WS0349, recipient: JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hilli Z, 2015, ANN SURG ONCOL, V22, P3369, DOI 10.1245/s10434-015-4718-6; Boileau JF, 2015, J CLIN ONCOL, V33, P258, DOI 10.1200/JCO.2014.55.7827; BONADONNA G, 1990, J NATL CANCER I, V82, P1539, DOI 10.1093/jnci/82.19.1539; Botteri E, 2010, ANN ONCOL, V21, P723, DOI 10.1093/annonc/mdp386; Boughey JC, 2015, ANN SURG, V261, P547, DOI 10.1097/SLA.0000000000000551; Chu KU, 1999, ANN SURG ONCOL, V6, P756, DOI 10.1007/s10434-999-0756-2; Classe JM, 2009, J CLIN ONCOL, V27, P726, DOI 10.1200/JCO.2008.18.3228; Co M, 2015, WORLD J SURG, V39, P1438, DOI 10.1007/s00268-015-2984-x; Cote RJ, 1999, LANCET, V354, P896, DOI 10.1016/S0140-6736(98)11104-2; Czerniecki BJ, 1999, CANCER, V85, P1098, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1098::AID-CNCR13>3.0.CO;2-N; Dalus K, 2011, NUKLEARMED-NUCL MED, V50, P33, DOI 10.3413/nukmed-0320-10-05; Del Bianco P, 2008, EJSO-EUR J SURG ONC, V34, P508, DOI 10.1016/j.ejso.2007.05.017; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; Fisher ER, 2002, CANCER-AM CANCER SOC, V95, P681, DOI 10.1002/cncr.10741; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Fraile M, 2000, ANN ONCOL, V11, P701, DOI 10.1023/A:1008377910967; Fu JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105316; Gannan E, 2016, BREAST J, V22, P413, DOI 10.1111/tbj.12595; Gimbergues P, 2008, ANN SURG ONCOL, V15, P1316, DOI 10.1245/s10434-007-9759-z; GIULIANO AE, 1994, ANN SURG, V220, P391, DOI 10.1097/00000658-199409000-00015; Hack TF, 1999, J CLIN ONCOL, V17, P143, DOI 10.1200/JCO.1999.17.1.143; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hunt KK, 2009, ANN SURG, V250, P558, DOI 10.1097/SLA.0b013e3181b8fd5e; IVENS D, 1992, BRIT J CANCER, V66, P136, DOI 10.1038/bjc.1992.230; Jinno H, 2008, BREAST J, V14, P551, DOI 10.1111/j.1524-4741.2008.00646.x; Kamath VJ, 2001, ARCH SURG-CHICAGO, V136, P688, DOI 10.1001/archsurg.136.6.688; Kelly AM, 2009, ACAD RADIOL, V16, P551, DOI 10.1016/j.acra.2009.01.026; Kida K, 2015, EJSO-EUR J SURG ONC, V41, P566, DOI 10.1016/j.ejso.2014.10.066; Kim JY, 2015, J BREAST CANCER, V18, P22, DOI [10.4048/jbc.2015.18.1.22, 10.5293/kfma.2015.18.4.022]; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Kinoshita Takayuki, 2007, Breast Cancer, V14, P10, DOI 10.2325/jbcs.14.10; KOYAMA H, 1975, CANCER, V36, P1603, DOI 10.1002/1097-0142(197511)36:5<1603::AID-CNCR2820360512>3.0.CO;2-4; Krag DN, 2007, LANCET ONCOL, V8, P881, DOI 10.1016/S1470-2045(07)70278-4; Krag DN, 2010, LANCET ONCOL, V11, P927, DOI 10.1016/S1470-2045(10)70207-2; Lyman GH, 2015, J CLIN ONCOL, V33, P232, DOI 10.1200/JCO.2014.58.9838; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; MAMOUNAS EP, 1995, J CLIN ONCOL, V13, P537, DOI 10.1200/JCO.1995.13.3.537; Mocellin S, 2016, INT J CANCER, V138, P472, DOI 10.1002/ijc.29644; Moskovitz AH, 2001, AM J SURG, V181, P434, DOI 10.1016/S0002-9610(01)00602-X; Nason KS, 2000, CANCER-AM CANCER SOC, V89, P2187, DOI 10.1002/1097-0142(20001201)89:11<2187::AID-CNCR6>3.3.CO;2-R; Papa MZ, 2008, J SURG ONCOL, V98, P403, DOI 10.1002/jso.21128; Pecha V, 2011, CANCER-AM CANCER SOC, V117, P4606, DOI 10.1002/cncr.26102; Piato JRM, 2003, EUR J SURG ONCOL, V29, P118, DOI 10.1053/ejso.2002.1349; Pinero-Madrona A, 2015, CIR ESPAN, V93, P23, DOI 10.1016/j.ciresp.2014.01.004; Rebollo-Aguirre AC, 2012, REV ESP MED NUCL IMA, V31, P117, DOI 10.1016/j.remn.2011.04.007; Samphao S, 2008, ANN SURG ONCOL, V15, P1282, DOI 10.1245/s10434-008-9863-8; Santa-Maria CA, 2015, ONCOLOGY-NY, V29, P828; Sharkey FE, 1996, MODERN PATHOL, V9, P893; Tafra L, 2001, AM J SURG, V182, P312, DOI 10.1016/S0002-9610(01)00718-8; Takahashi M, 2012, WORLD J SURG, V36, P2847, DOI 10.1007/s00268-012-1704-z; Tan VKM, 2011, J SURG ONCOL, V104, P97, DOI 10.1002/jso.21911; Tanaka Y, 2006, ONCOL REP, V15, P927; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; van der Heiden-van der Loo M, 2015, EUR J CANCER, V51, P915, DOI 10.1016/j.ejca.2015.03.014; van Deurzen CHM, 2009, EUR J CANCER, V45, P3124, DOI 10.1016/j.ejca.2009.08.001; van Nijnatten TJA, 2015, EJSO-EUR J SURG ONC, V41, P1278, DOI 10.1016/j.ejso.2015.07.020; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xing Y, 2006, BRIT J SURG, V93, P539, DOI 10.1002/bjs.5209; Yin K, 2015, ONCOTARGETS THER, V8, P2665, DOI 10.2147/OTT.S88216; Yu JC, 2007, ANN SURG ONCOL, V14, P174, DOI 10.1245/s10434-006-9132-7	62	58	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162605	10.1371/journal.pone.0162605	http://dx.doi.org/10.1371/journal.pone.0162605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606623	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255600068
J	Miguel, RDV; Calla, NEQ; Pavelko, SD; Cherpes, TL				Miguel, Rodolfo D. Vicetti; Calla, Nirk E. Quispe; Pavelko, Stephen D.; Cherpes, Thomas L.			Intravaginal Chlamydia trachomatis Challenge Infection Elicits T(H)1 and T(H)17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage	PLOS ONE			English	Article							CD4(+) T-CELLS; DISEASE TOLERANCE; VACCINE; STRAINS; MOUSE; SUSCEPTIBILITY; REINFECTION; RESISTANCE; MODELS	While ascension of Chlamydia trachomatis into the upper genital tract of women can cause pelvic inflammatory disease and Fallopian tube damage, most infections elicit no symptoms or overt upper genital tract pathology. Consistent with this asymptomatic clinical presentation, genital C. trachomatis infection of women generates robust T(H)2 immunity. As an animal model that modeled this response would be invaluable for delineating bacterial pathogenesis and human host defenses, herein we explored if pathogen-specific T(H)2 immunity is similarly elicited by intravaginal (ivag) infection of mice with oculogenital C. trachomatis serovars. Analogous to clinical infection, ascension of primary C. trachomatis infection into the mouse upper genital tract produced no obvious tissue damage. Clearance of ivag challenge infection was mediated by interferon (IFN)-gamma-producing CD4(+) T cells, while IFN-gamma signaling blockade concomitant with a single ivag challenge promoted tissue damage by enhancing Chlamydia-specific T(H)17 immunity. Likewise, IFN-gamma and IL-17 signaling blockade or CD4(+) T cell depletion eliminated the genital pathology produced in untreated controls by multiple ivag challenge infections. Conversely, we were unable to detect formation of pathogen-specific T(H)2 immunity in C. trachomatis-infected mice. Together, our work revealed C. trachomatis infection of mice generates T(H)1 and T(H)17 immune responses that promote pathogen clearance and immunopathological tissue damage. Absence of Chlamydia-specific T(H)2 immunity in these mice newly highlights the need to identify experimental models of C. trachomatis genital infection that more closely recapitulate the human host response.	[Miguel, Rodolfo D. Vicetti; Calla, Nirk E. Quispe; Pavelko, Stephen D.; Cherpes, Thomas L.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Cherpes, Thomas L.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Miguel, RDV (corresponding author), Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	vicettimiguel.1@osu.edu	Miguel, Rodolfo D Vicetti/H-8651-2019; Quispe Calla, Nirk/B-8621-2018	Miguel, Rodolfo D Vicetti/0000-0002-2494-8184; Quispe Calla, Nirk/0000-0001-8829-4549	Ohio State University College of Medicine; NIH/NCI [P30 CA016058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Ohio State University College of Medicine(Ohio State University); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by The Ohio State University College of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors appreciate support provided by The Ohio State University's Comparative Pathology and Mouse Phenotyping Shared Resource (supported by grant P30 CA016058 from the NIH/NCI), Micro-imaging Lab (a component of the Wright Center of Innovation in Biomedical Imaging), and University Laboratory Animal Resources, the financial support provided by The Ohio State University College of Medicine, and the professional guidance provided by Ann E. Thompson.	Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Batteiger B. E., 2014, MANDELL DOUGLAS BENN, P2154; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2015, SCIENCE, V348, P1322, DOI 10.1126/science.aac6528; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Cochrane M, 2010, FUTURE MICROBIOL, V5, P1833, DOI [10.2217/fmb.10.148, 10.2217/FMB.10.148]; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Dong XH, 2014, INFECT IMMUN, V82, P1833, DOI 10.1128/IAI.01668-13; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; ITO JI, 1984, J INFECT DIS, V150, P577, DOI 10.1093/infdis/150.4.577; Lena S, 2005, J INFECT DIS, V191, pS78, DOI 10.1086/425289; Lyons Joseph M., 2005, Journal of Microbiology Immunology and Infection, V38, P383; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miguel RDV, 2015, J MICROBIOL METH, V119, P79, DOI 10.1016/j.mimet.2015.10.003; Miguel RDV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058565; Miguel RDV, 2012, MED HYPOTHESES, V79, P713, DOI 10.1016/j.mehy.2012.07.032; Miguel RDV, 2012, AM J REPROD IMMUNOL, V68, P499, DOI 10.1111/aji.12008; Miguel RDV, 2012, J IMMUNOL METHODS, V384, P191, DOI 10.1016/j.jim.2012.07.018; Miguel RDV, 2012, J IMMUNOL, V189, P3449, DOI 10.4049/jimmunol.1103054; Morre SA, 2000, INFECT IMMUN, V68, P7209, DOI 10.1128/IAI.68.12.7209-7211.2000; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Olsen AW, 2015, J INFECT DIS; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; VanVoorhis WC, 1997, INFECT IMMUN, V65, P2175, DOI 10.1128/IAI.65.6.2175-2182.1997; Vasilevsky S, 2014, CLIN MICROBIOL REV, V27, P346, DOI 10.1128/CMR.00105-13; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; Yu H, 2014, VACCINE, V32, P4672, DOI 10.1016/j.vaccine.2014.06.002; Yu H, 2011, J IMMUNOL, V186, P3615, DOI 10.4049/jimmunol.1002952	42	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162445	10.1371/journal.pone.0162445	http://dx.doi.org/10.1371/journal.pone.0162445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606424	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255600046
J	Park, SI; Bisgin, H; Ding, HJ; Semey, HG; Langley, DA; Tong, WD; Xu, JS				Park, Su Inn; Bisgin, Halil; Ding, Hongjian; Semey, Howard G.; Langley, Darryl A.; Tong, Weida; Xu, Joshua			Species Identification of Food Contaminating Beetles by Recognizing Patterns in Microscopic Images of Elytra Fragments (vol 11, e0157940, 2016)	PLOS ONE			English	Correction									[Bisgin, Halil] Univ Michigan, Dept Comp Sci Engn & Phys, Flint, MI 48503 USA	University of Michigan System; University of Michigan; University of Michigan Flint	Bisgin, H (corresponding author), Univ Michigan, Dept Comp Sci Engn & Phys, Flint, MI 48503 USA.							Park SI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157940	1	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162757	10.1371/journal.pone.0162757	http://dx.doi.org/10.1371/journal.pone.0162757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603930	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200077
J	Tanaka, A; Furubayashi, T; Matsushita, A; Inoue, D; Kimura, S; Katsumi, H; Sakane, T; Yamamoto, A				Tanaka, Akiko; Furubayashi, Tomoyuki; Matsushita, Akifumi; Inoue, Daisuke; Kimura, Shunsuke; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira			Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption	PLOS ONE			English	Article							IN-VITRO EVALUATION; DRUG-DELIVERY; INSULIN; MUCOADHESIVE; IMPROVEMENT; SUSPENSION	The nasal absorption of macromolecules from powder formulations and the effect of sodium carboxymethyl cellulose (CMC-Na) as a pharmaceutical excipient on their absorption were studied. Model macromolecules were fluorescein isothiocyanate-labeled dextran (average molecular weight of 4.4kDa, FD4) and insulin. The plasma concentration of FD4 after application of the powder containing 50% starch (control) was higher than that after application of the solution, and the absorption from 50% starch powder was enhanced by the substitution of starch with CMC-Na. The fractional absorption of FD4 after administration of the CMC-Na powder formulation was 30% and 40% higher than that after administration from the solution and the starch powder, respectively. The nasal absorption of insulin from the powder and the effect of CMC-Na were similar with those of FD4. The effective absorption of FD4 and insulin after application of powder with CMC-Na could be due to the increase in the nasal residence of FD4 and insulin. No damage in the nasal mucosa or dysfunction of the mucociliary clearance was observed after application of the drug powder and CMC-Na. The present findings indicate that nasal delivery of powder formulations with the addition of CMC-Na as an excipient is a promising approach for improving the nasal absorption of macromolecules.	[Tanaka, Akiko; Matsushita, Akifumi; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina, Kyoto 6078414, Japan; [Furubayashi, Tomoyuki; Inoue, Daisuke] Shujitsu Univ, Sch Pharm, Kita Ku, Nishikawara, Okayama 7038516, Japan; [Kimura, Shunsuke] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kyotanabe, Kyoto 6100395, Japan; [Sakane, Toshiyasu] Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada Ku, Motoyamakita Machi 4-19-1, Kobe, Hyogo 6588558, Japan	Kyoto Pharmaceutical University; Kobe Pharmaceutical University	Sakane, T (corresponding author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina, Kyoto 6078414, Japan.; Sakane, T (corresponding author), Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada Ku, Motoyamakita Machi 4-19-1, Kobe, Hyogo 6588558, Japan.	sakane@mb.kyoto-phu.ac.jp		Inoue, Daisuke/0000-0003-0219-4331				Dong ZQ, 2011, J PHARM SCI-US, V100, P1866, DOI 10.1002/jps.22428; du Plessis LH, 2010, INT J PHARMACEUT, V385, P181, DOI 10.1016/j.ijpharm.2009.10.031; Fetih G, 2005, J CONTROL RELEASE, V106, P287, DOI 10.1016/j.jconrel.2005.05.017; Harris AS, 1993, J DRUG TARGET, V1, P101, DOI 10.3109/10611869308996066; He L, 2007, J CONTROL RELEASE, V122, P94, DOI 10.1016/j.jconrel.2007.06.017; HIRAI S, 1981, INT J PHARM, V7, P317; HUSSAIN AA, 1979, J PHARM SCI, V68, P1196, DOI 10.1002/jps.2600680942; Inoue D, 2013, BIOL PHARM BULL, V36, P966, DOI 10.1248/bpb.b12-01076; Irifune M, 1999, Auris Nasus Larynx, V26, P49, DOI 10.1016/S0385-8146(98)00062-5; Ishikawa F, 2002, PHARM RES-DORDR, V19, P1097, DOI 10.1023/A:1019881706159; Ishikawa F, 2001, INT J PHARM, V224, P105, DOI 10.1016/S0378-5173(01)00736-0; Krug N, 2005, ALLERGY, V60, P354, DOI 10.1111/j.1398-9995.2005.00703.x; Li M, 2016, MOL PHARMACEUT, V13, P885, DOI 10.1021/acs.molpharmaceut.5b00802; LIU FY, 1993, PHARMACEUT RES, V10, P228, DOI 10.1023/A:1018934810512; Lu HT, 2011, XENOBIOTICA, V41, P567, DOI 10.3109/00498254.2011.563877; Makidon PE, 2010, J AEROSOL MED PULM D, V23, P77, DOI 10.1089/jamp.2009.0766; Marttin E, 1998, ADV DRUG DELIVER REV, V29, P13, DOI 10.1016/S0169-409X(97)00059-8; Merchant HA, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070378; OKUDA M, 1986, Rhinology (Utrecht), V24, P113; Pennington J, 2008, DRUG DEV IND PHARM, V34, P923, DOI [10.1080/03639040802149046, 10.1080/03639040802149046 ]; Rajendran NN, 2011, INT J PHARM SCI RES, V2, P3136; SATIR P, 1990, ANNU REV PHYSIOL, V52, P137, DOI 10.1146/annurev.ph.52.030190.001033; SCHIPPER NGM, 1991, PHARMACEUT RES, V8, P807, DOI 10.1023/A:1015830907632; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; Wang YX, 2014, NANOMEDICINE-UK, V9, P451, DOI [10.2217/nnm.13.102, 10.2217/NNM.13.102]; YAMAMOTO A, 1994, PHARMACEUT RES, V11, P1496, DOI 10.1023/A:1018968611962	28	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0159150	10.1371/journal.pone.0159150	http://dx.doi.org/10.1371/journal.pone.0159150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598527	Green Submitted, gold, Green Published			2022-12-27	WOS:000383254800001
J	Vasco, G; Gazzellini, S; Petrarca, M; Lispi, ML; Pisano, A; Zazza, M; Della Bella, G; Castelli, E; Bertini, E				Vasco, Gessica; Gazzellini, Simone; Petrarca, Maurizio; Lispi, Maria Luisa; Pisano, Alessandra; Zazza, Marco; Della Bella, Gessica; Castelli, Enrico; Bertini, Enrico			Functional and Gait Assessment in Children and Adolescents Affected by Friedreich's Ataxia: A One-Year Longitudinal Study	PLOS ONE			English	Article							CLINICAL-FEATURES; DISEASE SEVERITY; PROGRESSION; VARIABILITY; IDEBENONE; HYPERTROPHY; PARAMETERS; BALANCE; SCALE	Friedreich's ataxia is the most common autosomal recessive form of neurodegenerative ataxia. We present a longitudinal study on the gait pattern of children and adolescents affected by Friedreich's ataxia using Gait Analysis and the Scale for the Assessment and Rating of Ataxia (SARA). We assessed the spectrum of changes over 12 months of the gait characteristics and the relationship between clinical and instrumental evaluations. We enrolled 11 genetically confirmed patients affected by Friedreich's ataxia in this study together with 13 normally developing age-matched subjects. Eight patients completed a 12-month follow-up under the same protocol. By comparing the gait parameters of Friedreich's ataxia with the control group, we found significant differences for some relevant indexes. In particular, the increased knee and ankle extension in stance revealed a peculiar bio-mechanical pattern, which correlated reliably with SARA Total, Gait and Sitting scores. The knee pattern showed its consistency also at the follow-up: Knee extension increased from 6.8 +/- 3.5 degrees to -0.5 +/- 3.7 degrees and was significantly correlated with the SARA total score. This feature anticipated the loss of the locomotor function in two patients. In conclusion, our findings demonstrate that the selective and segmental analysis of kinetic/kinematic features of ataxic gait, in particular the behavior of the knee, provides sensitive measures to detect specific longitudinal and functional alterations, more than the SARA scale, which however has proved to be a reliable and practical assessment tool. Functional outcomes measures integrated by instrumental evaluation increase their sensitivity, reliability and suitability for the follow-up of the disease progression and for the application in clinical trials and in rehabilitative programs.	[Vasco, Gessica; Gazzellini, Simone; Petrarca, Maurizio; Lispi, Maria Luisa; Pisano, Alessandra; Della Bella, Gessica; Castelli, Enrico] IRCCS Bambino Gesu Childrens Hosp, Movement Anal & Robot Lab MARLab, Neurorehabil Unit, Dept Neurosci, Rome, Italy; [Vasco, Gessica; Bertini, Enrico] IRCCS Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Zazza, Marco] Bambino Gesu Pediat Hosp, IRCCS, Dept Neurosci, Neurol Unit, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Vasco, G (corresponding author), IRCCS Bambino Gesu Childrens Hosp, Movement Anal & Robot Lab MARLab, Neurorehabil Unit, Dept Neurosci, Rome, Italy.; Vasco, G (corresponding author), IRCCS Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy.	gessica.vasco@opbg.net	Petrarca, Maurizio/B-4181-2019; Gazzellini, Simone/AAC-2721-2019; Bertini, Enrico/ABG-1278-2020; bella, gessica della/AAA-8011-2020; Petrarca, Maurizio/GWZ-3714-2022; Bertini, Enrico/A-2284-2014	bella, gessica della/0000-0002-7160-0092; Petrarca, Maurizio/0000-0002-7330-3569; Bertini, Enrico/0000-0001-9276-4590	Italian Ministry of Health [201501X003626]	Italian Ministry of Health(Ministry of Health, Italy)	MP reports research funding from the Italian Ministry of Health (Grant number 201501X003626). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; BECK RJ, 1981, J BONE JOINT SURG AM, V63, P1452, DOI 10.2106/00004623-198163090-00012; Bell KJ, 2002, J PEDIATR ORTHOPED, V22, P677, DOI 10.1097/00004694-200209000-00020; Brandsma R, 2014, DEV MED CHILD NEUROL, V56, P556, DOI 10.1111/dmcn.12369; Burk K, 2013, J NEUROCHEM, V126, P118, DOI 10.1111/jnc.12318; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Croarkin E, 2009, J NEUROL PHYS THER, V33, P144, DOI 10.1097/NPT.0b013e3181b5112e; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Delatycki MB, 2009, J NEUROL, V256, P36, DOI 10.1007/s00415-009-1007-y; Friedman LS, 2010, MOVEMENT DISORD, V25, P426, DOI 10.1002/mds.22912; Gouelle A, 2013, GAIT POSTURE, V38, P461, DOI 10.1016/j.gaitpost.2013.01.013; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; Klopstock T, 1999, ACTA NEUROPATHOL, V97, P139, DOI 10.1007/s004010050966; Koeppen AH, 2013, J NEUROPATH EXP NEUR, V72, P78, DOI 10.1097/NEN.0b013e31827e5762; Marelli C, 2012, MOVEMENT DISORD, V27, P135, DOI 10.1002/mds.23879; Milne SC, 2014, CEREBELLUM, V13, P677, DOI 10.1007/s12311-014-0583-2; Mitoma H, 2000, J NEUROL SCI, V174, P22, DOI 10.1016/S0022-510X(99)00329-9; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2010, MOVEMENT DISORD, V25, P1944, DOI 10.1002/mds.23169; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Parkinson MH, 2013, J NEUROCHEM, V126, P103, DOI 10.1111/jnc.12317; Patla AE, 2003, IEEE ENG MED BIOL, V22, P48, DOI 10.1109/MEMB.2003.1195695; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Pineda M, 2008, EUR J PAEDIATR NEURO, V12, P470, DOI 10.1016/j.ejpn.2007.11.006; Rustin P, 2002, FREE RADICAL RES, V36, P467, DOI 10.1080/10715760290021333; Schiff M, 2016, BRAIN, V139, DOI 10.1093/brain/aww085; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schniepp R, 2014, J NEUROL, V261, P213, DOI 10.1007/s00415-013-7189-3; Schniepp R, 2012, MOVEMENT DISORD, V27, P125, DOI 10.1002/mds.23978; Serrao M, 2012, CEREBELLUM, V11, P194, DOI 10.1007/s12311-011-0296-8; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Tai G, 2015, J NEUROL NEUROSUR PS, V86, P660, DOI 10.1136/jnnp-2014-308022	36	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162463	10.1371/journal.pone.0162463	http://dx.doi.org/10.1371/journal.pone.0162463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598307	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800067
J	Kim, HS; Jung, M; Choi, SK; Moon, WK; Kim, SJ				Kim, Hoe Suk; Jung, Minji; Choi, Sul Ki; Moon, Woo Kyung; Kim, Seung Ja			Different Biological Action of Oleic Acid in ALDH(high) and ALDH(low) Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer	PLOS ONE			English	Article							FATTY-ACID; STEM-CELLS; PROLIFERATION; ACTIVATION; MARKERS; PROGRESSION; LIPOGENESIS; METABOLISM; EXPRESSION; APOPTOSIS	The mechanisms underlying breast cancer progression of ductal carcinoma in situ (DCIS) associated with fatty acids are largely unknown. In the present study, we compared the action of oleic acid (OA) on two human DCIS cell lines, MCF10DCIS. COM (ER/PR/HER2-negative) and SUM225 (HER2 overexpressed). OA led to a significant increase in proliferation, migration, lipid accumulation and the expression of lipogenic proteins, such as SREBP-1, FAS and ACC-1, in MCF10DCIS. COM cells but not SUM225 cells. The ALDH(high) subpopulation analyzed by the ALDEFLUOR assay was approximately 39.2 +/- 5.3% of MCF10DCIS. COM cells but was small (3.11 +/- 0.9%) in SUM225 cells. We further investigated the different biological action of OA in the distinct ALDH(low) and ALDH(high) subpopulations of MCF10DCIS. COM cells. OA led to an increase in the expression of ALDH1A1, ALDH1A2 and ALDH1A3 in MCF10DCIS. COM cells. SREBP-1 and ACC-1 were highly expressed in ALDH(high) cells relative to ALDH(low) cells, whereas FAS was higher in ALDH(low) cells. In the presence of OA, ALDH(high) cells were more likely to proliferate and migrate and displayed significantly high levels of SREBP-1 and FAS and strong phosphorylation of FAK and AKT relative to ALDH(low) cells. This study suggests that OA could be a critical risk factor to promote the proliferation and migration of ALDH(high) cells in DCIS, leading to breast cancer progression.	[Kim, Hoe Suk; Jung, Minji; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul, South Korea; [Choi, Sul Ki; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, 101 Daehak Ro, Seoul, South Korea; [Kim, Seung Ja] Sheikh Khalifa Specialty Hosp, Dept Radiol, Abu Dhabi, U Arab Emirates	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul, South Korea.; Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 101 Daehak Ro, Seoul, South Korea.; Kim, SJ (corresponding author), Sheikh Khalifa Specialty Hosp, Dept Radiol, Abu Dhabi, U Arab Emirates.	moonwk@snu.ac.kr; winnerkim89@gmail.com			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2009043]; SNUH Research Fund [03-2013-0060]; Brain Korea 21 (BK21) program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; SNUH Research Fund; Brain Korea 21 (BK21) program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology (2013R1A1A2009043) and partly supported by grant no. 03-2013-0060 from the SNUH Research Fund (http://www.snuh.org/). Suk Ki Choi is the recipient of a fellowship from the Brain Korea 21 (BK21) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballehaninna UK, 2011, J CLIN ONCOL, V29, pE97, DOI 10.1200/JCO.2010.32.6850; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Currie MJ, 2013, HUM PATHOL, V44, P402, DOI 10.1016/j.humpath.2012.06.004; Fay MP, 1997, CANCER RES, V57, P3979; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; Knudsen ES, 2013, CELL CYCLE, V12, P2042, DOI 10.4161/cc.25065; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Lee MM, 2000, ANNU REV NUTR, V20, P221, DOI 10.1146/annurev.nutr.20.1.221; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097330; Liu ZH, 2013, ONCOL LETT, V5, P1395, DOI 10.3892/ol.2013.1160; MacLennan M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2646; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Navarro-Tito N, 2010, INT J BIOCHEM CELL B, V42, P306, DOI 10.1016/j.biocel.2009.11.010; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pala V, 2001, J NATL CANCER I, V93, P1088, DOI 10.1093/jnci/93.14.1088; Pandey PR, 2013, ONCOGENE, V32, P5111, DOI 10.1038/onc.2012.519; Pape-Zambito D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100488; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Porter D, 2003, MOL CANCER RES, V1, P362; Shekhar MPV, 2013, ONCOTARGET, V4, P231, DOI 10.18632/oncotarget.818; Soto-Guzman A, 2008, MOL CELL ENDOCRINOL, V294, P81, DOI 10.1016/j.mce.2008.08.003; Soto-Guzman A, 2013, PROSTAG LEUKOTR ESS, V88, P243, DOI 10.1016/j.plefa.2012.12.003; Soto-Guzman A, 2010, CLIN EXP METASTAS, V27, P505, DOI 10.1007/s10585-010-9340-1; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Tsukabe M, 2013, ONCOLOGY-BASEL, V85, P248, DOI 10.1159/000355476; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Zhong Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-60	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0160835	10.1371/journal.pone.0160835	http://dx.doi.org/10.1371/journal.pone.0160835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589390	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877800005
J	Lu, ZM; Li, XF				Lu, Zhe-Ming; Li, Xin-Feng			Attack Vulnerability of Network Controllability	PLOS ONE			English	Article							COMPLEX NETWORKS; RANDOM-WALKS; SYNCHRONIZATION; DYNAMICS; ROBUSTNESS; EVOLUTION	Controllability of complex networks has attracted much attention, and understanding the robustness of network controllability against potential attacks and failures is of practical significance. In this paper, we systematically investigate the attack vulnerability of network controllability for the canonical model networks as well as the real-world networks subject to attacks on nodes and edges. The attack strategies are selected based on degree and betweenness centralities calculated for either the initial network or the current network during the removal, among which random failure is as a comparison. It is found that the node-based strategies are often more harmful to the network controllability than the edge-based ones, and so are the recalculated strategies than their counterparts. The Barabasi-Albert scale-free model, which has a highly biased structure, proves to be the most vulnerable of the tested model networks. In contrast, the Erdos-Renyi random model, which lacks structural bias, exhibits much better robustness to both node-based and edge-based attacks. We also survey the control robustness of 25 real-world networks, and the numerical results show that most real networks are control robust to random node failures, which has not been observed in the model networks. And the recalculated betweenness-based strategy is the most efficient way to harm the controllability of real-world networks. Besides, we find that the edge degree is not a good quantity to measure the importance of an edge in terms of network controllability.	[Lu, Zhe-Ming; Li, Xin-Feng] Zhejiang Univ, Sch Aeronaut & Astronaut, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Lu, ZM (corresponding author), Zhejiang Univ, Sch Aeronaut & Astronaut, Hangzhou, Zhejiang, Peoples R China.	zheminglu@zju.edu.cn						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; [Anonymous], 1991, APPL NONLINEAR CONTR; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee SJ, 2012, ARXIV12093737; Batagelj V., 2006, PAJEK DATASETS; Bechhoefer J, 2005, REV MOD PHYS, V77, P783, DOI 10.1103/RevModPhys.77.783; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.047104; Brandes U, 2007, INT J BIFURCAT CHAOS, V17, P2303, DOI 10.1142/S0218127407018403; Caldarelli G., 2007, SCALE FREE NETWORKS; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Cross R., 2004, HIDDEN POWER SOCIAL; Dorogovtsev S. N., 2013, EVOLUTION NETWORKS B; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; ERDOS P, 1960, B INT STATIST INST, V38, P343; GABOW HN, 1976, J ACM, V23, P221, DOI 10.1145/321941.321942; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; HAUTUS MLJ, 1969, P K NED AKAD A MATH, V72, P443; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu B, 2008, IEEE T AUTOMAT CONTR, V53, P1009, DOI 10.1109/TAC.2008.919548; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lombardi A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056110; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Nie S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089066; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; NORLEN K, 2002, P INT TEL SOC 14 BIE; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Porfiri M, 2010, PHYSICA D, V239, P454, DOI 10.1016/j.physd.2010.01.012; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Pu CL, 2012, PHYSICA A, V391, P4420, DOI 10.1016/j.physa.2012.04.019; Rahman A, 2009, SIAM J CONTROL OPTIM, V48, P162, DOI 10.1137/060674909; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rugh W, 1996, LINEAR SYSTEM THEORY, V2; Shmulevich I., 2010, PROB BOOL NETW; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Tu YH, 2000, NATURE, V406, P353, DOI 10.1038/35019222; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Wang WX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026115; Wang XF, 2002, IEEE T CIRCUITS-I, V49, P54, DOI 10.1109/81.974874; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; [No title captured]	61	21	26	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162289	10.1371/journal.pone.0162289	http://dx.doi.org/10.1371/journal.pone.0162289			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588941	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800046
J	Matthews, FE; Bennett, H; Wittenberg, R; Jagger, C; Dening, T; Brayne, C				Matthews, Fiona E.; Bennett, Holly; Wittenberg, Raphael; Jagger, Carol; Dening, Tom; Brayne, Carol		Cognitive Function Ageing Studies	Who Lives Where and Does It Matter? Changes in the Health Profiles of Older People Living in Long Term Care and the Community over Two Decades in a High Income Country	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE FUNCTION; RISK-FACTORS; ALZHEIMERS-DISEASE; HOME RESIDENTS; DEMENTIA; PREVALENCE; POPULATION; DEPRESSION; ENGLAND	Background There have been fundamental shifts in the attitude towards, access to and nature of long term care in high income countries. The proportion and profile of the older population living in such settings varies according to social, cultural, and economic characteristics as well as governmental policies. Changes in the profiles of people in different settings are important for policy makers and care providers. Although details will differ, how change occurs across time is important to all, including lower and middle income countries developing policies themselves. Here change is examined across two decades in England. Methods and Findings Using the two Cognitive Function and Ageing Studies (CFAS I: 77% response, CFAS II: 56% response), two population based studies of older people carried out in the same areas conducted two decades apart, the study diagnosis of dementia using the Automated Geriatric Examination for Computer Assisted Taxonomy, health and wellbeing were examined, focusing on long term care. The proportion of individuals with three or more health conditions increased for everyone living in long term care between CFAS I (47.6%, 95% CI: 42.3-53.1) and CFAS II (62.7%, 95% CI: 54.8-70.0) and was consistently higher in those without dementia compared to those with dementia in both studies. Functional impairment measured by activities of daily living increased in assisted living facilities from 48% (95% CI: 44%-52%) to 67% (95% CI: 62%-71%). Conclusions Health profiles of residents in long term care have changed dramatically over time. Dementia prevalence and reporting multiple health conditions have increased. Receiving care in the community puts pressure on unpaid carers and formal services; these results have implications for policies about supporting people at home as well as for service provision within long term care including quality of care, health management, cost, and the development of a skilled, caring, and informed workforce.	[Matthews, Fiona E.] Cambridge Inst Publ Hlth, Cambridge Biomed Campus, Biostat Unit, MRC, Forvie Site,Robinson Way, Cambridge, England; [Matthews, Fiona E.; Jagger, Carol] Newcastle Univ, Inst Hlth & Soc, Edwardson Bldg,Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Bennett, Holly; Brayne, Carol] Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Wittenberg, Raphael] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, Houghton St, London, England; [Dening, Tom] Univ Nottingham, Inst Mental Hlth, Triumph Rd, Nottingham, England	MRC Biostatistics Unit; University of Cambridge; Newcastle University - UK; University of Cambridge; University of London; London School Economics & Political Science; University of Nottingham	Brayne, C (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	cb105@medschl.cam.ac.uk	Matthews, Fiona/O-6932-2015; Brayne, Carol/AAA-4285-2020; Dening, Tom/E-1335-2013; Morris, Josephine D./F-3366-2018	Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; Dening, Tom/0000-0003-3387-4241; Morris, Josephine D./0000-0001-9404-5602; Jagger, Carol/0000-0002-6377-9926	Medical Research Council [G0601022, G9901400]; MRC [G9901400, MC_U105292687, G0601022] Funding Source: UKRI; Medical Research Council [MC_U105292687] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CFAS II has been funded through a grant from the Medical Research Council (grant number G0601022). CFAS I was also funded through the Medical Research Council (grant number G9901400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2007, AM J GERIAT PSYCHIAT, V15, P497, DOI 10.1097/JGP.0b013e31802e21d8; Arfken CL, 2011, PSYCHOTHER PSYCHOSOM, V80, P325, DOI 10.1159/000324795; Bolton M., 2012, CAMPAIGN END LONELIN; Bowman C, 2004, AGE AGEING, V33, P561, DOI 10.1093/ageing/afh177; Caffrey C, 2012, NCHS DATA BRIEF, V91; Campbell Stern M, 1993, BRIT MED J, V306; CFAS, COGN FUNCT AG STUD C; Darton R, 2012, HEALTH SOC CARE COMM, V20, P87, DOI 10.1111/j.1365-2524.2011.01022.x; DCLG, LAYING FDN HOUS STRA; DH/SCLG&CP/SCPI/SR, LIV WELL DEM NAT DEM; England N, NHS 5 YEAR FORW VIEW; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gordon AL, 2014, AGE AGEING, V43, P97, DOI 10.1093/ageing/aft077; Hajek A, 2016, J AM MED DIR ASSOC, V17, P300, DOI 10.1016/j.jamda.2015.10.015; Jagger C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-21; Kendig H, 2010, AGE AGEING, V39, P342, DOI 10.1093/ageing/afq016; KIYAK HA, 1994, GERONTOLOGIST, V34, P324, DOI 10.1093/geront/34.3.324; Laukkanen P, 2001, AGE AGEING, V30, P489, DOI 10.1093/ageing/30.6.489; Lithgow S, 2012, INT J GERIATR PSYCH, V27, P785, DOI 10.1002/gps.2784; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Mann AH, 2000, INT J GERIATR PSYCH, V15, P1105, DOI 10.1002/1099-1166(200012)15:12<1105::AID-GPS252>3.0.CO;2-W; Martin-Garcia S, 2013, INT PSYCHOGERIATR, V25, P1077, DOI 10.1017/S1041610213000458; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; ONS, 2013, WHAT DOES 2011 CENS; Prince M., 2013, WORLD ALZHEIMER REPO; Rafnsson SB, 2017, AGING MENT HEALTH, V21, P104, DOI 10.1080/13607863.2015.1088510; Ready RE, 2004, INT J GERIATR PSYCH, V19, P256, DOI 10.1002/gps.1075; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Spiers NA, 2005, J GERONTOL A-BIOL, V60, P248, DOI 10.1093/gerona/60.2.248; Stewart R, 2014, AGE AGEING, V43, P562, DOI 10.1093/ageing/afu062; van der Lee J, 2015, AGING MENT HEALTH, P1, DOI [10.1080/13607863.2015.1102196, DOI 10.1080/13607863.2015.1102196]; Victor CR, 2005, AGEING SOC, V25, P357, DOI 10.1017/S0144686X04003332	34	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161705	10.1371/journal.pone.0161705	http://dx.doi.org/10.1371/journal.pone.0161705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589586	Green Published, Green Accepted, gold			2022-12-27	WOS:000382877800015
J	Sartorius, T; Hennige, AM; Fritsche, A; Haring, HU				Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich			Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion	PLOS ONE			English	Article							PEOPLE	Aims Recent studies have identified unique brain effects of insulin detemir (Levemir (R)). Due to its pharmacologic properties, insulin detemir may reach higher concentrations in the brain than regular insulin. This might explain the observed increased brain stimulation after acute insulin detemir application but it remained unclear whether chronic insulin detemir treatment causes alterations in brain activity as a consequence of overstimulation. Methods In mice, we examined insulin detemir's prolonged brain exposure by continuous subcutaneous (s.c.) application using either micro-osmotic pumps or daily s.c. injections and performed continuous radiotelemetric electrocorticography and locomotion recordings. Results Acute intracerebroventricular injection of insulin detemir activated cortical and locomotor activity significantly more than regular insulin in equimolar doses (0.94 and 5.63mU in total), suggesting an enhanced acute impact on brain networks. However, given continuously s.c., insulin detemir significantly reduced cortical activity (theta: 21.3 +/- 6.1% vs. 73.0 +/- 8.1%, P<0.001) and failed tomaintain locomotion, while regular insulin resulted in an increase of both parameters. Conclusions The data suggest that permanently-increased insulin detemir levels in the brain convert its hyperstimulatory effects and finally mediate impairments in brain activity and locomotion. This observation might be considered when human studies with insulin detemir are designed to target the brain in order to optimize treatment regimens.	[Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich] Univ Tubingen, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Dept Internal Med, Tubingen, Germany; [Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich] German Ctr Diabet Res DZD, Tubingen, Germany; [Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich] Univ Tuebingen IDM, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Sartorius, T (corresponding author), Univ Tubingen, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Dept Internal Med, Tubingen, Germany.; Sartorius, T (corresponding author), German Ctr Diabet Res DZD, Tubingen, Germany.; Sartorius, T (corresponding author), Univ Tuebingen IDM, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany.	tina.sartorius@med.uni-tuebingen.de			Novo Nordisk (Bagsvaerd, Denmark); Deutsche Forschungsgemeinschaft [HE 3653/3-1]; German Federal Ministry of Education and Research (BMBF) [DLR01GI0925]; Open Access Publishing Fund of University of Tuebingen	Novo Nordisk (Bagsvaerd, Denmark)(Novo Nordisk); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Open Access Publishing Fund of University of Tuebingen	This study was supported by grants from Novo Nordisk (Bagsvaerd, Denmark) to Hans-Ulrich Haring and the Deutsche Forschungsgemeinschaft to Anita M. Hennige (HE 3653/3-1). We further acknowledge support by the German Federal Ministry of Education and Research (BMBF; DLR01GI0925) to the German Center for Diabetes Research (DZD e.V.) and support by Open Access Publishing Fund of University of Tuebingen.	Begg DP, 2015, DIABETES, V64, P2457, DOI 10.2337/db14-1364; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Cesarovic N, 2011, JOVE-J VIS EXP, DOI 10.3791/3260; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Hallschmid M, 2010, DIABETES, V59, P1101, DOI 10.2337/db09-1493; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Hennige AM, 2006, DIABETOLOGIA, V49, P1274, DOI 10.1007/s00125-006-0192-9; Herring RA, 2015, DIABETES OBES METAB, V17, P459, DOI 10.1111/dom.12434; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; MARSHALL S, 1984, J BIOL CHEM, V259, P6376; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x; Rossetti P, 2008, DIABETES, V57, P746, DOI 10.2337/db07-1433; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Sartorius T, 2012, FASEB J, V26, P1799, DOI 10.1096/fj.11-191023; Tschritter O, 2012, DIABETOLOGIA, V55, P175, DOI 10.1007/s00125-011-2309-z; Tschritter O, 2009, DIABETES OBES METAB, V11, P1017, DOI 10.1111/j.1463-1326.2009.01085.x; Tschritter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001196; Tschritter O, 2009, J CLIN ENDOCR METAB, V94, P4600, DOI 10.1210/jc.2009-0469; van Golen LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094483	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162124	10.1371/journal.pone.0162124	http://dx.doi.org/10.1371/journal.pone.0162124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589235	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800030
J	Li, Y; Liu, HH; Xia, MD; Gong, HP				Li, Yang; Liu, Huihui; Xia, Mengdie; Gong, Haipeng			Lysine and the Na+/K+ Selectivity in Mammalian Voltage-Gated Sodium Channels	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ION SELECTIVITY; EEEE MOTIF; PORE; MODEL; CA2+; PERMEATION; CONDUCTION	Voltage-gated sodium (Na-v) channels are critical in the generation and transmission of neuronal signals in mammals. The crystal structures of several prokaryotic Na-v channels determined in recent years inspire the mechanistic studies on their selection upon the permeable cations (especially between Na+ and K+ ions), a property that is proposed to be mainly determined by residues in the selectivity filter. However, the mechanism of cation selection in mammalian Na-v channels lacks direct explanation at atomic level due to the difference in amino acid sequences between mammalian and prokaryotic Na-v homologues, especially at the constriction site where the DEKA motif has been identified to determine the Na+/K+ selectivity in mammalian Na-v channels but is completely absent in the prokaryotic counter-parts. Among the DEKA residues, Lys is of the most importance since its mutation to Arg abolishes the Na+/K+ selectivity. In this work, we modeled the pore domain of mammalian Na-v channels by mutating the four residues at the constriction site of a prokaryotic Na-v channel (NavRh) to DEKA, and then mechanistically investigated the contribution of Lys in cation selection using molecular dynamics simulations. The DERA mutant was generated as a comparison to understand the loss of ion selectivity caused by the K-to-R mutation. Simulations and free energy calculations on the mutants indicate that Lys facilitates Na+/K+ selection by electrostatically repelling the cation to a highly Na+-selective location sand-wiched by the carboxylate groups of Asp and Glu at the constriction site. In contrast, the electrostatic repulsion is substantially weakened when Lys is mutated to Arg, because of two intrinsic properties of the Arg side chain: the planar geometric design and the sparse charge distribution of the guanidine group.	[Li, Yang; Liu, Huihui; Xia, Mengdie; Gong, Haipeng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Gong, HP (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	hgong@tsinghua.edu.cn		Liu, Huihui/0000-0003-3181-8289	Ministry of Science and Technology of China [2015CB910100]; National Natural Science Foundation of China [31470033]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Ministry of Science and Technology of China (#2015CB910100) and by the National Natural Science Foundation of China (#31470033, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam SS, 2010, J MOL LIQ, V153, P95, DOI 10.1016/j.molliq.2010.01.005; Boda D, 2007, BIOPHYS J, V93, P1960, DOI 10.1529/biophysj.107.105478; Boiteux C, 2014, P NATL ACAD SCI USA, V111, P3454, DOI 10.1073/pnas.1320907111; Carnevale V, 2011, J PHYS CHEM LETT, V2, P2504, DOI 10.1021/jz2011379; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Charalambous K, 2011, BIOCHEMISTRY-US, V50, P6742, DOI 10.1021/bi200942y; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093267; Corry B, 2012, J AM CHEM SOC, V134, P1840, DOI 10.1021/ja210020h; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Csanyi E, 2012, BBA-BIOMEMBRANES, V1818, P592, DOI 10.1016/j.bbamem.2011.10.029; Dudev T, 2014, J AM CHEM SOC, V136, P3553, DOI 10.1021/ja4121132; Dudev T, 2012, J PHYS CHEM B, V116, P10703, DOI 10.1021/jp304925a; Dudev T, 2012, PHYS CHEM CHEM PHYS, V14, P12451, DOI 10.1039/c2cp00036a; Dudev T, 2010, J AM CHEM SOC, V132, P2321, DOI 10.1021/ja909280g; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furini S, 2014, BIOPHYS J, V106, P2175, DOI 10.1016/j.bpj.2014.04.005; Furini S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002476; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Korkosh VS, 2014, J GEN PHYSIOL, V144, P231, DOI 10.1085/jgp.201411226; Li Y, 2015, PROTEIN CELL, V6, P413, DOI 10.1007/s13238-015-0152-6; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell Jr AD, EXTENDING TREATMENT, DOI [10.1002/jcc.20065, DOI 10.1002/JCC.20065]; Mahdavi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133000; Mahdavi S, 2014, TOXINS, V6, P3454, DOI 10.3390/toxins6123454; Mahdavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105300; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Payandeh J, 2012, NATURE; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; ZWANZIG RW, 1955, J CHEM PHYS, V23, P1915, DOI 10.1063/1.1740604	58	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162413	10.1371/journal.pone.0162413	http://dx.doi.org/10.1371/journal.pone.0162413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584582	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600131
J	Nemes, A; Fortmann, T; Poeschke, S; Greve, B; Prevedello, D; Santacroce, A; Stummer, W; Senner, V; Ewelt, C				Nemes, Andrei; Fortmann, Thomas; Poeschke, Stephan; Greve, Burkhard; Prevedello, Daniel; Santacroce, Antonio; Stummer, Walter; Senner, Volker; Ewelt, Christian			5-ALA Fluorescence in Native Pituitary Adenoma Cell Lines: Resection Control and Basis for Photodynamic Therapy (PDT)?	PLOS ONE			English	Article							INDUCED PROTOPORPHYRIN-IX; TRANS-SPHENOIDAL MICROSURGERY; FOLLOW-UP; MITOCHONDRIAL; GLIOMA; LIGHT; EXCISION; SURGERY	Objective: Pituitary adenomas (PA), especially invasive ones, are often not completely resectable. Usage of 5-aminolevulinic acid (5-ALA) for fluorescence guided surgery could improve the rate of total resection and, additionally, open the doors for photodynamic therapy (PDT) in case of unresectable or partially resected PAs. The aim of this study was to investigate the uptake of 5-ALA and the effect of 5-ALA based PDT in cell lines. Methods: GH3 and AtT-20 cell lines were incubated with different concentrations of 5-ALA, protoporphyrin IX (PPIX) fluorescence was measured by flow cytometry and fluorescencespectrometry. WST-1 assays were performed to determine the surviving fraction of cells after PDT. PPIX fluorescence intensities and PDT effect of the pituitary adenoma cells were compared to U373MG, a well-known glioblastoma cell line. Results: Both cell lines showed a 5-ALA dependent intracellular PPIX fluorescence. Significant differences after 24hrs of incubation were observed in AtT-20 cells in comparison to GH3. Regardless of the incubation or metabolism time, there was a proliferation inhibiting effect after PDT, with no statistical significance. Conclusion: Since GH3 cells showed a heterogenous uptake of 5-ALA in the flow cytometry profile, but not constantly high concentrations they might have a 5-ALA efflux mechanism, which still needs to be determined. In the case of AtT-20, the cells might need a longer time for the uptake due to their size or slow metabolism. We showed that the different cell lines have different uptake and metabolism mechanisms, which needs to be further investigated. The general uptake of 5-ALA allows the possibility of resection control and PDT for pituitary adenomas. But, the role of PDT for unresectable pituitary adenomas deserves further investigations.	[Nemes, Andrei; Poeschke, Stephan; Senner, Volker] Univ Hosp Muenster, Inst Neuropathol, Munster, Germany; [Fortmann, Thomas; Stummer, Walter; Ewelt, Christian] Univ Hosp Muenster, Dept Neurosurg, Munster, Germany; [Greve, Burkhard] Univ Hosp Muenster, Dept Radiotherapy Radiooncol, Munster, Germany; [Prevedello, Daniel] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Santacroce, Antonio] Univ Hosp Tuebingen, Dept Neurosurg, Tubingen, Germany	University of Munster; University of Munster; University of Munster; University System of Ohio; Ohio State University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Ewelt, C (corresponding author), Univ Hosp Muenster, Dept Neurosurg, Munster, Germany.	christian.ewelt@ukmuenster.de	Stummer, Walter/AAF-9043-2019; Stummer, Walter/AAA-3319-2020					Buchfelder M, 1991, Acta Neurochir Suppl (Wien), V53, P72; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Choi MC, 2013, INT J GYNECOL CANCER, V23, P698, DOI 10.1097/IGC.0b013e31828b5ba2; CIRIC I, 1983, J NEUROSURG, V59, P395, DOI 10.3171/jns.1983.59.3.0395; de Vijlder HC, 2012, ACTA DERM-VENEREOL, V92, P641, DOI 10.2340/00015555-1448; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eljamel MS, 2009, J NEURO-ONCOL, V92, P417, DOI 10.1007/s11060-009-9820-9; Etminan N, 2011, J NEUROSURG, V115, P281, DOI 10.3171/2011.3.JNS10434; Farrell WE, 2000, FRONT NEUROENDOCRIN, V21, P174, DOI 10.1006/frne.1999.0195; Fernandez-Miranda JC, 2010, ACTA NEUROCHIR, V152, P1281, DOI 10.1007/s00701-009-0487-y; Gopalan R, 2011, NEUROSURGERY, V69, P284, DOI 10.1227/NEU.0b013e31821bc44e; Grebenova D, 2003, J PHOTOCH PHOTOBIO B, V69, P71, DOI 10.1016/S1011-1344(02)00410-4; HARDY J, 1979, HOSP PRACT, V14, P81, DOI 10.1080/21548331.1979.11707562; Higgins TS, 2008, AM J RHINOL, V22, P649, DOI 10.2500/ajr.2008.22.3246; Jain AK, 2007, BRIT J NEUROSURG, V21, P328, DOI 10.1080/02688690701395447; Kawamata T, 2002, NEUROL RES, V24, P259, DOI 10.1179/016164102101199882; Kriska T, 2005, ARCH BIOCHEM BIOPHYS, V433, P435, DOI 10.1016/j.abb.2004.09.025; Li F, 2011, J CELL BIOCHEM, V112, P3035, DOI 10.1002/jcb.23228; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Nadeau V, 2004, PHOTODERMATOL PHOTO, V20, P170, DOI 10.1111/j.1600-0781.2004.00100.x; Onuki J, 2004, ARCH BIOCHEM BIOPHYS, V432, P178, DOI 10.1016/j.abb.2004.09.030; Oruckaptan HH, 2000, SURG NEUROL, V53, P211, DOI 10.1016/S0090-3019(00)00171-3; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; REGULA J, 1995, GUT, V36, P67, DOI 10.1136/gut.36.1.67; Robinson DJ, 1998, PHOTOCHEM PHOTOBIOL, V67, P140, DOI 10.1562/0031-8655(1998)067<0140:FPOAIP>2.3.CO;2; Rotenberg B, 2010, LARYNGOSCOPE, V120, P1292, DOI 10.1002/lary.20949; Saeger Wolfgang, 2005, Endocrine, V28, P57, DOI 10.1385/ENDO:28:1:057; Sailer R, 2007, PHOTOCH PHOTOBIO SCI, V6, P145, DOI 10.1039/b611715e; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharwani A, 2014, Gulf J Oncolog, V1, P79; Sherlock M, 2011, NAT REV ENDOCRINOL, V7, P291, DOI 10.1038/nrendo.2011.42; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Stummer W, 1998, NEUROSURGERY, V42, P518, DOI 10.1097/00006123-199803000-00017; Stummer W, 1998, ACTA NEUROCHIR, V140, P995, DOI 10.1007/s007010050206; Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006; Wild PJ, 2005, MOL CANCER THER, V4, P516, DOI 10.1158/1535-7163.MCT-04-0141	36	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161364	10.1371/journal.pone.0161364	http://dx.doi.org/10.1371/journal.pone.0161364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583461	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600025
J	Song, J; Xue, C; Preisser, JS; Cramer, DW; Houck, KL; Liu, G; Folsom, AR; Couper, D; Yu, FL; Dong, JF				Song, Jaewoo; Xue, Cheng; Preisser, John S.; Cramer, Drake W.; Houck, Katie L.; Liu, Guo; Folsom, Aaron R.; Couper, David; Yu, Fuli; Dong, Jing-Fei			Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; HUMAN VONWILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; PLASMA FACTOR-VIII; BLOOD-GROUP-A; ASIALOGLYCOPROTEIN RECEPTOR; SIALIC-ACID; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; GROUP-B	VWF is extensively glycosylated with biantennary core fucosylated glycans. Most N-linked and O-linked glycans on VWF are sialylated. FVIII is also glycosylated, with a glycan structure similar to that of VWF. ST3GAL sialyltransferases catalyze the transfer of sialic acids in the alpha 2,3 linkage to termini of N- and O-glycans. This sialic acid modification is critical for VWF synthesis and activity. We analyzed genetic and phenotypic data from the Atherosclerosis Risk in Communities (ARIC) study for the association of single nucleotide polymorphisms (SNPs) in the ST3GAL4 gene with plasma VWF levels and FVIII activity in 12,117 subjects. We also analyzed ST3GAL4 SNPs found in 2,535 subjects of 26 ethnicities from the 1000 Genomes (1000G) project for ethnic diversity, SNP imputation, and ST3GAL4 haplotypes. We identified 14 and 1,714 ST3GAL4 variants in the ARIC GWAS and 1000G data-bases respectively, with 46% being ethnically diverse in their allele frequencies. Among the 14 ST3GAL4 SNPs found in ARIC GWAS, the intronic rs2186717, rs7928391, and rs11220465 were associated with VWF levels and with FVIII activity after adjustment for age, BMI, hypertension, diabetes, ever-smoking status, and ABO. This study illustrates the power of next-generation sequencing in the discovery of new genetic variants and a significant ethnic diversity in the ST3GAL4 gene. We discuss potential mechanisms through which these intronic SNPs regulate ST3GAL4 biosynthesis and the activity that affects VWF and FVIII.	[Song, Jaewoo; Cramer, Drake W.; Houck, Katie L.; Dong, Jing-Fei] BloodWorks Northwest Res Inst, Seattle, WA 98104 USA; [Song, Jaewoo] Yonsei Univ, Dept Lab Med, Coll Med, Seoul, South Korea; [Xue, Cheng; Yu, Fuli] Baylor Coll Med, Mol & Human Genet Dept, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Preisser, John S.; Couper, David] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liu, Guo] Sichuan Univ, Dept Otolaryngol Head & Neck Surg, West China Hosp, Chengdu, Peoples R China; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Yu, Fuli] Tianjin Med Univ Gen Hosp, Inst Neurol, Tianjin 300052, Peoples R China; [Dong, Jing-Fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	Yonsei University; Yonsei University Health System; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Sichuan University; University of Minnesota System; University of Minnesota Twin Cities; Tianjin Medical University; University of Washington; University of Washington Seattle	Dong, JF (corresponding author), BloodWorks Northwest Res Inst, Seattle, WA 98104 USA.; Yu, FL (corresponding author), Baylor Coll Med, Mol & Human Genet Dept, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Yu, FL (corresponding author), Tianjin Med Univ Gen Hosp, Inst Neurol, Tianjin 300052, Peoples R China.; Dong, JF (corresponding author), Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA.	fyu@bcm.edu; jfdong@bloodworksnw.org		Song, Jaewoo/0000-0002-1877-5731; Couper, David/0000-0002-4313-9235	Atherosclerosis Risk in Communities research contracts (ARIC consortium) [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Heart, Lung, and Blood Institute [HL71895, HL85769]; National Heart, Lung, and Blood Institute contracts [HL71895, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694, HL085769]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C]; National Institutes of Health and NIH Roadmap for Medical Research [UL1RR025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL085769, R01HL071895, R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	Atherosclerosis Risk in Communities research contracts (ARIC consortium); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute contracts; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by Atherosclerosis Risk in Communities research contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022 (ARIC consortium); and research grants HL71895 (JFD) and HL85769 (JFD) from the National Heart, Lung, and Blood Institute. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, R01HL086694; HL71895 and HL085769; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BASTIDA E, 1988, THROMB HAEMOSTASIS, V60, P30; Bellissimo DB, 2012, BLOOD, V119, P2135, DOI 10.1182/blood-2011-10-384610; Bovenschen N, 2005, J THROMB HAEMOST, V3, P1257, DOI 10.1111/j.1538-7836.2005.01389.x; Campos M, 2012, BLOOD, V119, P1929, DOI 10.1182/blood-2011-10-383661; Campos M, 2011, BLOOD, V117, P5224, DOI 10.1182/blood-2010-08-300152; Canis K, 2012, BIOCHEM J, V447, P217, DOI 10.1042/BJ20120810; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; DEBEIRE P, 1983, FEBS LETT, V151, P22, DOI 10.1016/0014-5793(83)80334-2; DEMARCO L, 1981, J CLIN INVEST, V68, P321, DOI 10.1172/JCI110259; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FEDERICI AB, 1988, BLOOD, V71, P947; FOLSOM AR, 1993, ARTERIOSCLER THROMB, V13, P1829, DOI 10.1161/01.ATV.13.12.1829; Grahn A, 2001, GLYCOCONJUGATE J, V18, P759, DOI 10.1023/A:1021199300718; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HIRONAKA T, 1992, J BIOL CHEM, V267, P8012; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Kamphuisen PW, 1998, THROMB HAEMOSTASIS, V79, P323; Kitagawa H, 1996, J BIOL CHEM, V271, P931, DOI 10.1074/jbc.271.2.931; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Lenting PJ, 2010, HAEMOPHILIA, V16, P194, DOI 10.1111/j.1365-2516.2010.02320.x; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Lopes AA, 2000, THROMB HAEMOSTASIS, V83, P683; MATSUI T, 1992, J BIOL CHEM, V267, P8723; McGrath RT, 2010, BLOOD, V115, P2666, DOI 10.1182/blood-2009-09-241547; Morange PE, 2005, BRIT J HAEMATOL, V128, P91, DOI 10.1111/j.1365-2141.2004.05275.x; PAPP AC, 1989, THROMB HAEMOSTASIS, V61, P15; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SAMOR B, 1989, GLYCOCONJUGATE J, V6, P263, DOI 10.1007/BF01047846; Schilow WF, 2004, THROMB HAEMOSTASIS, V92, P427; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Seitz EM, 2006, NUCLEIC ACIDS RES, V34, P2847, DOI 10.1093/nar/gkl355; SODETZ JM, 1977, J BIOL CHEM, V252, P5538; SODETZ JM, 1979, J BIOL CHEM, V254, P754; Taniguchi A, 2001, GLYCOBIOLOGY, V11, P241, DOI 10.1093/glycob/11.3.241; Taniguchi A, 2001, BIOCHEM BIOPH RES CO, V287, P1148, DOI 10.1006/bbrc.2001.5709; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WAGNER DD, 1987, BLOOD, V69, P27; Wang QY, 2013, J THROMB HAEMOST, V11, P261, DOI 10.1111/jth.12093; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	48	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160757	10.1371/journal.pone.0160757	http://dx.doi.org/10.1371/journal.pone.0160757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584569	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600011
J	Chooi, WH; Chan, SCW; Gantenbein, B; Chan, BP				Chooi, Wai Hon; Chan, Samantha Chun Wai; Gantenbein, Benjamin; Chan, Barbara Pui			Loading-Induced Heat-Shock Response in Bovine Intervertebral Disc Organ Culture	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SMOOTH-MUSCLE-CELLS; HYDROSTATIC-PRESSURE; IN-VITRO; ARTICULAR CHONDROCYTES; MECHANICAL-STRESS; DEGENERATION; HEAT-SHOCK-PROTEIN-70; COMPRESSION; VIVO	Mechanical loading has been shown to affect cell viability and matrix maintenance in the intervertebral disc (IVD) but there is no investigation on how cells survive mechanical stress and whether the IVD cells perceive mechanical loading as stress and respond by expression of heat shock proteins. This study investigates the stress response in the IVD in response to compressive loading. Bovine caudal disc organ culture was used to study the effect of physiological range static loading and dynamic loading. Cell activity, gene expression and immunofluorescence staining were used to analyze the cell response. Cell activity and cytoskeleton of the cells did not change significantly after loading. In gene expression analysis, significant up-regulation of heat shock protein-70 (HSP70) was observed in nucleus pulposus after two hours of loading. However, the expression of the matrix remodeling genes did not change significantly after loading. Similarly, expressions of stress response and matrix remodeling genes changed with application and removal of the dynamic loading. The results suggest that stress response was induced by physiological range loading without significantly changing cell activity and upregulating matrix remodeling. This study provides direct evidence on loading induced stress response in IVD cells and contributes to our understanding in the mechanoregulation of intervertebral disc cells.	[Chooi, Wai Hon; Chan, Barbara Pui] Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China; [Chan, Samantha Chun Wai; Gantenbein, Benjamin] Univ Bern, Inst Surg Technol & Biomech, Tissue & Organ Mechanobiol, Bern, Switzerland; [Chan, Samantha Chun Wai] Empa, Biointerfaces, Swiss Fed Labs Mat Sci & Technol, St Gallen, Switzerland	University of Hong Kong; University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Chan, BP (corresponding author), Univ Hong Kong, Dept Mech Engn, Tissue Engn Lab, Hong Kong, Hong Kong, Peoples R China.	bpchan@hku.hk	Chan, Barbara Pui/AAM-7767-2020; Gantenbein, Benjamin/H-9302-2019	Gantenbein, Benjamin/0000-0002-9005-0655; Chan, BP/0000-0001-5419-2472; Chooi, Wai Hon/0000-0003-0268-0938	AOSpine award [SRN_2011_14]; Theme-Based Research Scheme [T12-708/12-N]; AOSpine Spine Research Network Grant; Swiss National Science Foundation Project [310030_153411]	AOSpine award; Theme-Based Research Scheme; AOSpine Spine Research Network Grant; Swiss National Science Foundation Project(Swiss National Science Foundation (SNSF))	This study was partially supported by an AOSpine award (SRN_2011_14) (https://aospine.aofoundation.org/Structure/Pages/default.aspx) and a Theme-Based Research Scheme (T12-708/12-N) (http://www.ugc.edu.hk/eng/rgc/theme/theme.htm) to BP, an AOSpine Spine Research Network Grant to WH (https://aospine.aofoundation.org/Structure/Pages/default.aspx), and a Swiss National Science Foundation Project (#310030_153411) (http://www.snf.ch/en/funding/projects/Pages/default.aspx) to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 1997, J RHEUMATOL, V24, P1787; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Chan D, 2006, EUR SPINE J, V15, pS317, DOI 10.1007/s00586-006-0171-3; Chan SCW, 2012, JOVE-J VIS EXP, DOI 10.3791/3490; Chan SCW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072489; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Chang J, 2001, CIRCULATION, V104, P209, DOI 10.1161/01.CIR.104.2.209; Enokiya Yasunobu, 2010, Bull Tokyo Dent Coll, V51, P129; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Fujita S, 2012, J ORTHOP RES, V30, P401, DOI 10.1002/jor.21535; Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002; Gantenbein B, 2015, CURR STEM CELL RES T, V10, P339, DOI 10.2174/1574888X10666150312102948; Gruber HE, 1998, SPINE, V23, P751, DOI 10.1097/00007632-199804010-00001; HASKIN CL, 1993, BIOCHEM CELL BIOL, V71, P361, DOI 10.1139/o93-054; Iatridis JC, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.01407; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Jagodzinski M, 2006, EUR J APPL PHYSIOL, V96, P249, DOI 10.1007/s00421-005-0071-y; Kaarniranta K, 1998, P NATL ACAD SCI USA, V95, P2319, DOI 10.1073/pnas.95.5.2319; Kaarniranta K, 2001, OSTEOARTHR CARTILAGE, V9, P7, DOI 10.1053/joca.2000.0354; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kippenberger S, 1999, PIGM CELL RES, V12, P246, DOI 10.1111/j.1600-0749.1999.tb00757.x; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Kuperman DI, 1997, BRAIN RES, V771, P221, DOI 10.1016/S0006-8993(97)00710-5; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; LIPSON SJ, 1981, ARTHRITIS RHEUM-US, V24, P12; Lomas C, 2011, EUR CELLS MATER, V22, P178, DOI 10.22203/eCM.v022a14; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Luna C, 2009, MOL VIS, V15, P534; Luo SS, 2007, ACTA HISTOCHEM CYTOC, V40, P9, DOI 10.1267/ahc.06011; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; MacLean JJ, 2008, J ORTHOP RES, V26, P579, DOI 10.1002/jor.20560; McCann MR, 2013, ARTHRITIS RHEUM-US, V65, P1853, DOI 10.1002/art.37979; Morimoto R, 2002, ENCY MOL BIOL; Nakamura S, 2006, J ORTHOP RES, V24, P733, DOI 10.1002/jor.20077; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Schmocker A, 2016, BIOMATERIALS, V88, P110, DOI 10.1016/j.biomaterials.2016.02.015; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Sharp CA, 2009, EUR SPINE J, V18, P1587, DOI 10.1007/s00586-009-1053-2; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Takahashi K, 1997, J ORTHOPAED RES, V15, P150, DOI 10.1002/jor.1100150122; Takao T, 2002, SPINE, V27, P361, DOI 10.1097/00007632-200202150-00007; Tsuchida S, 2014, J ORTHOP RES, V32, P975, DOI 10.1002/jor.22623; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Walser J, 2012, REPLACING ANIMAL MOD, V89; Xiao J, 2010, APPL BIOCHEM BIOTECH, V162, P1996, DOI 10.1007/s12010-010-8975-3; Xu QB, 2000, CIRC RES, V86, P1122	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161615	10.1371/journal.pone.0161615	http://dx.doi.org/10.1371/journal.pone.0161615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580124	Green Published, gold			2022-12-27	WOS:000382877400031
J	Glastras, SJ; Chen, H; Teh, R; McGrath, RT; Chen, J; Pollock, CA; Wong, MG; Saad, S				Glastras, Sarah J.; Chen, Hui; Teh, Rachel; McGrath, Rachel T.; Chen, Jason; Pollock, Carol A.; Wong, Muh Geot; Saad, Sonia			Mouse Models of Diabetes, Obesity and Related Kidney Disease	PLOS ONE			English	Article							RENAL LIPID-ACCUMULATION; DIET-INDUCED OBESITY; ANIMAL-MODELS; STREPTOZOTOCIN; METABOLISM; MELLITUS; ALLOXAN; GLUCOSE; HEALTH; TYPE-1	Multiple rodent models have been used to study diabetic kidney disease (DKD). The purpose of the present study was to compare models of diabetes and obesity-induced metabolic syndrome and determine differences in renal outcomes. C57BL/6 male mice were fed either normal chow or high fat diet (HFD). At postnatal week 8, chow-fed mice were randomly assigned to low-dose streptozotocin (STZ, 55 mg/kg/day, five consecutive days) or vehicle control, whereas HFD-fed mice were given either one high-dose of STZ (100 mg/kg) or vehicle control. Intraperitoneal glucose tolerance tests were performed at Week 14, 20 and 30. Urinary albumin to creatinine ratio (ACR) and serum creatinine were measured, and renal structure was assessed using Periodic Acid Schiff (PAS) staining at Week 32. Results showed that chow-fed mice exposed to five doses of STZ resembled type 1 diabetes mellitus with a lean phenotype, hyperglycaemia, microalbuminuria and increased serum creatinine levels. Their kidneys demonstrated moderate tubular injury with evidence of tubular dilatation and glycogenated nuclear inclusion bodies. HFD-fed mice resembled metabolic syndrome as they were obese with dyslipidaemia, insulin resistance, and significantly impaired glucose tolerance. One dose STZ, in addition to HFD, did not worsen metabolic features (including fasting glucose, non esterified fatty acid, and triglyceride levels). There were significant increases in urinary ACR and serum creatinine levels, and renal structural changes were predominantly related to interstitial vacuolation and tubular dilatation in HFD-fed mice.	[Glastras, Sarah J.; Teh, Rachel; Pollock, Carol A.; Wong, Muh Geot; Saad, Sonia] Univ Sydney, Dept Med, Kolling Inst, Sydney, NSW, Australia; [Glastras, Sarah J.; McGrath, Rachel T.] Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, St Leonards, NSW 2065, Australia; [Chen, Hui] Univ Technol Sydney, Sch Life Sci, Fac Sci, Sydney, NSW, Australia; [Chen, Jason] Royal North Shore Hosp, Dept Anat Pathol, St Leonards, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Technology Sydney; Royal North Shore Hospital	Glastras, SJ (corresponding author), Univ Sydney, Dept Med, Kolling Inst, Sydney, NSW, Australia.; Glastras, SJ (corresponding author), Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, St Leonards, NSW 2065, Australia.	sarah.glastras@sydney.edu.au	Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014; Glastras, Sarah J./AAL-2541-2020	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Glastras, Sarah J./0000-0002-9317-1348; Saad, Sonia/0000-0001-8067-8046; McGrath, Rachel/0000-0003-3453-058X	Diabetes Australia; Diabetes Australia Research Trust grant [Y15G-POLC]	Diabetes Australia; Diabetes Australia Research Trust grant	This study was funded by Diabetes Australia; Diabetes Australia Research Trust grant Y15G-POLC awarded to S.J.G., C.A.P., and S.S.	ABRAHAM S, 1994, HUM PATHOL, V25, P1063, DOI 10.1016/0046-8177(94)90066-3; Alicic RZ, 2013, ADV CHRONIC KIDNEY D, V20, P121, DOI 10.1053/j.ackd.2012.12.006; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Cao X, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0083-8; Chen T, 2015, MED J AUSTRALIA, V203, P1, DOI 10.5694/mja15.00241; Chow Bryna S M, 2015, Curr Protoc Mouse Biol, V5, P85, DOI 10.1002/9780470942390.mo140192; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Decleves AE, 2014, KIDNEY INT, V85, P611, DOI 10.1038/ki.2013.462; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Gabbay E, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0137-y; Gilbert ER, 2011, EXP DIABETES RES, DOI 10.1155/2011/416254; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Glastras SJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0032-3; Han BG, 2008, AM J PHYSIOL-ENDOC M, V295, pE981, DOI 10.1152/ajpendo.90283.2008; Herman-Edelstein M, 2014, J LIPID RES, V55, P561, DOI 10.1194/jlr.P040501; Inoue E, 2012, J ENDOCRINOL, V213, P285, DOI 10.1530/JOE-12-0014; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kang J, 2005, ACTA DIABETOL, V42, P110, DOI 10.1007/s00592-005-0188-9; Kharroubi AT, 2015, WORLD J DIABETES, V6, P850, DOI 10.4239/wjd.v6.i6.850; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Ma LJ, 2011, AM J PHYSIOL-RENAL, V300, pF1203, DOI 10.1152/ajprenal.00468.2010; Mathew AV, 2011, CURR DIABETES REV, V7, P41, DOI 10.2174/157339911794273928; Mount P, 2015, METABOLITES, V5, P720, DOI 10.3390/metabo5040720; Nakamura A, 2013, INT J MOL SCI, V14, P21240, DOI 10.3390/ijms141121240; Nannipieri M, 2001, NEPHRON, V87, P50, DOI 10.1159/000045884; Organisation WH, 2014, GLOB HLTH OBS GHO DA; Panwar B, 2015, KIDNEY INT, V87, P1216, DOI 10.1038/ki.2014.384; Podrini C, 2013, MAMM GENOME, V24, P240, DOI 10.1007/s00335-013-9456-0; Radenkovic M, 2016, J PHARMACOL TOX MET, V78, P13, DOI 10.1016/j.vascn.2015.11.004; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Shao ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092574; Sharma SG, 2013, CLIN J AM SOC NEPHRO, V8, P1718, DOI 10.2215/CJN.02510213; Speakman J, 2007, OBES REV, V8, P55, DOI 10.1111/j.1467-789X.2007.00319.x; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tesch GH, 2007, NEPHROLOGY, V12, P261, DOI 10.1111/j.1440-1797.2007.00796.x; Thakur P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099872; Tsuboi N, 2013, NEPHROL DIAL TRANSPL, V28, P108, DOI 10.1093/ndt/gft258; Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.1053/j.ajkd.2014.08.001, 10.2337/dc14-1296]; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Yamahara K, 2013, J AM SOC NEPHROL, V24, P1769, DOI 10.1681/ASN.2012111080; Zaccardi F, 2016, POSTGRAD MED J, V92, P63, DOI 10.1136/postgradmedj-2015-133281; Zhang J., 2015, ADV MATER SCI ENG, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0116888	48	85	89	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162131	10.1371/journal.pone.0162131	http://dx.doi.org/10.1371/journal.pone.0162131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579698	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400060
J	Yoneyama, T; Ohtsuki, S; Honda, K; Kobayashi, M; Iwasaki, M; Uchida, Y; Okusaka, T; Nakamori, S; Shimahara, M; Ueno, T; Tsuchida, A; Sata, N; Ioka, T; Yasunami, Y; Kosuge, T; Kaneda, T; Kato, T; Yagihara, K; Fujita, S; Huang, W; Yamada, T; Tachikawa, M; Terasaki, T				Yoneyama, Toshihiro; Ohtsuki, Sumio; Honda, Kazufumi; Kobayashi, Makoto; Iwasaki, Motoki; Uchida, Yasuo; Okusaka, Takuji; Nakamori, Shoji; Shimahara, Masashi; Ueno, Takaaki; Tsuchida, Akihiko; Sata, Naohiro; Ioka, Tatsuya; Yasunami, Yohichi; Kosuge, Tomoo; Kaneda, Takashi; Kato, Takao; Yagihara, Kazuhiro; Fujita, Shigeyuki; Huang, Wilber; Yamada, Tesshi; Tachikawa, Masanori; Terasaki, Tetsuya			Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics	PLOS ONE			English	Article							BINDING-PROTEINS; PLASMA BIOMARKER; INSULIN; SERUM; RISK; DISCOVERY; QUANTITATION; FLUIDS; ASSAY; PATH	Pancreatic cancer is one of the most lethal tumors, and reliable detection of early-stage pancreatic cancer and risk diseases for pancreatic cancer is essential to improve the prognosis. As 260 genes were previously reported to be upregulated in invasive ductal adenocarcinoma of pancreas (IDACP) cells, quantification of the corresponding proteins in plasma might be useful for IDACP diagnosis. Therefore, the purpose of the present study was to identify plasma biomarkers for early detection of IDACP by using two proteomics strategies: antibody-based proteomics and liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics. Among the 260 genes, we focused on 130 encoded proteins with known function for which antibodies were available. Twenty-three proteins showed values of the area under the curve (AUC) of more than 0.8 in receiver operating characteristic (ROC) analysis of reverse-phase protein array (RPPA) data of IDACP patients compared with healthy controls, and these proteins were selected as biomarker candidates. We then used our high-throughput selected reaction monitoring or multiple reaction monitoring (SRM/MRM) methodology, together with an automated sample preparation system, micro LC and auto analysis system, to quantify these candidate proteins in plasma from healthy controls and IDACP patients on a large scale. The results revealed that insulin-like growth factor- binding protein (IGFBP) 2 and IGFBP3 have the ability to discriminate IDACP patients at an early stage from healthy controls, and IGFBP2 appeared to be increased in risk diseases of pancreatic malignancy, such as intraductal papillary mucinous neoplasms (IPMNs). Furthermore, diagnosis of IDACP using the combination of carbohydrate antigen 19-9 (CA19-9), IGFBP2 and IGFBP3 is significantly more effective than CA19-9 alone. This suggests that IGFBP2 and IGFBP3 may serve as compensatory biomarkers for CA19-9. Early diagnosis with this marker combination may improve the prognosis of IDACP patients.	[Yoneyama, Toshihiro; Uchida, Yasuo; Tachikawa, Masanori; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi, Japan; [Ohtsuki, Sumio] Kumamoto Univ, Dept Pharmaceut Microbiol, Fac Life Sci, Kumamoto, Japan; [Honda, Kazufumi; Kobayashi, Makoto; Yamada, Tesshi] Natl Canc Ctr, Div Chemotherapy & Clin Res, Res Inst, Tokyo, Japan; [Ohtsuki, Sumio; Honda, Kazufumi] Japan Agcy Med Res & Dev AMED CREST, Tokyo, Japan; [Iwasaki, Motoki] Natl Canc Ctr, Div Epidemiol, Res Ctr Canc Prevent & Screening, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan; [Nakamori, Shoji] Natl Hosp Org, Osaka Natl Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan; [Shimahara, Masashi; Ueno, Takaaki] Osaka Med Coll, Dept Oral Surg, Osaka, Japan; [Tsuchida, Akihiko] Tokyo Med Univ, Dept Gastrointestinal & Pediat Surg, Tokyo, Japan; [Sata, Naohiro] Jichi Med Univ, Dept Surg, Shimotsuke, Tochigi, Japan; [Ioka, Tatsuya] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan; [Yasunami, Yohichi] Fukuoka Univ, Islet Inst, Fukuoka, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Tokyo, Japan; [Kaneda, Takashi] Nihon Univ, Sch Dent Matsudo, Dept Radiol, Chiba, Japan; [Kato, Takao] Nihon Univ, Sch Dent Matsudo, Dept Oral Implant, Chiba, Japan; [Yagihara, Kazuhiro] Saitama Canc Ctr, Dept Oral Surg, Saitama, Japan; [Fujita, Shigeyuki] Wakayama Med Univ, Dept Oral & Maxillofacial Surg, Wakayama, Japan; [Huang, Wilber] Abnova, Taipei, Taiwan	Tohoku University; Kumamoto University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Osaka National Hospital; Osaka Medical College; Tokyo Medical University; Jichi Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Fukuoka University; National Cancer Center - Japan; Nihon University; Nihon University; Wakayama Medical University	Ohtsuki, S (corresponding author), Kumamoto Univ, Dept Pharmaceut Microbiol, Fac Life Sci, Kumamoto, Japan.; Ohtsuki, S (corresponding author), Japan Agcy Med Res & Dev AMED CREST, Tokyo, Japan.	sohtsuki@kumamoto-u.ac.jp	Terasaki, Tetsuya/K-6730-2012; Ohtsuki, Sumio/S-4360-2016	Terasaki, Tetsuya/0000-0002-6332-7575; Ohtsuki, Sumio/0000-0003-4634-7133; Kobayashi, Makoto/0000-0001-7176-7207	Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) [14089014]; Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS KAKENHI [14J05219, 15K15751, 23390469]; Industrial Technology Research Grant Program of the New Energy and the Industrial Technology Development Organization of Japan [P00041]; Cabinet Office, Government of Japan [LS005]; Third-Term Comprehensive Control Research for Cancer, Research on Biological Markers for New Drug Development and Health Labour Sciences Research; Applied Research for Innovative Treatment of Cancer grant by the Ministry of Health, Labour and Welfare of Japan; Practical Research for Innovation Cancer Control [15ck0106101h0002]; AMED-CREST by Japan Agency for Medical Research and Development [10801082]; Grants-in-Aid for Scientific Research [15H04913] Funding Source: KAKEN	Project for Development of Innovative Research on Cancer Therapeutics (P-Direct); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Industrial Technology Research Grant Program of the New Energy and the Industrial Technology Development Organization of Japan; Cabinet Office, Government of Japan; Third-Term Comprehensive Control Research for Cancer, Research on Biological Markers for New Drug Development and Health Labour Sciences Research; Applied Research for Innovative Treatment of Cancer grant by the Ministry of Health, Labour and Welfare of Japan; Practical Research for Innovation Cancer Control; AMED-CREST by Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was performed as a research program in the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct, 14089014), Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp). This study was also supported in part by JSPS KAKENHI Grant Numbers 14J05219, 15K15751, 23390469, and by the Industrial Technology Research Grant Program of the New Energy and the Industrial Technology Development Organization of Japan (P00041), and the Funding Program for Next Generation World-Leading Researchers (LS005) by the Cabinet Office, Government of Japan (http://www.cao.go.jp/index-e.html), and the Third-Term Comprehensive Control Research for Cancer, Research on Biological Markers for New Drug Development and Health Labour Sciences Research, and Applied Research for Innovative Treatment of Cancer grant by the Ministry of Health, Labour and Welfare of Japan, and Practical Research for Innovation Cancer Control (15ck0106101h0002), and AMED-CREST (10801082) by Japan Agency for Medical Research and Development (http://www.amed.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of our authors, W.H., is a CEO of a commercial company: Abnova. The funder provided support in the form of salaries for W.H. and research materials (antibodies for RPPA), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Azar WJ, 2014, ONCOGENE, V33, P578, DOI 10.1038/onc.2012.630; Azar WJ, 2011, ENDOCRINOLOGY, V152, P3332, DOI 10.1210/en.2011-1121; Ballehaninna UK, 2011, INDIA J SURG ONCOL, V2, P88, DOI 10.1007/s13193-011-0042-1; BAXTER RC, 1993, TRENDS ENDOCRIN MET, V4, P91, DOI 10.1016/1043-2760(93)90085-S; BAXTER RC, 1990, J CLIN ENDOCR METAB, V70, P1347, DOI 10.1210/jcem-70-5-1347; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; BENTLEY DR, 1986, BIOCHEM J, V239, P339, DOI 10.1042/bj2390339; Brock R, 2012, AM J CANCER RES, V2, P598; CARRIAGA MT, 1995, CANCER-AM CANCER SOC, V75, P171, DOI 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2; Chang MC, 2014, WORLD J GASTROENTERO, V20, P2358, DOI 10.3748/wjg.v20.i9.2358; Chen R, 2007, MOL CELL PROTEOMICS, V6, P1331, DOI 10.1074/mcp.M700072-MCP200; Chen R, 2006, PROTEOMICS, V6, P3871, DOI 10.1002/pmic.200500702; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Domanski D, 2012, PROTEOMICS, V12, P1222, DOI 10.1002/pmic.201100568; Evans JD, 1997, INT J PANCREATOL, V22, P95; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Food Administration D, 2001, GUID IND BIOAN METH, V22; Hoeflich A, 2001, CANCER RES, V61, P8601; Honda K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15921; Honda K, 2013, JPN J CLIN ONCOL, V43, P103, DOI 10.1093/jjco/hys200; Humphery-Smith I, 2004, PROTEOMICS, V4, P2519, DOI 10.1002/pmic.200400866; Iwasaki M, 2015, EUR J CANC PREV; Kamiie J, 2008, PHARM RES-DORDR, V25, P1469, DOI 10.1007/s11095-008-9532-4; Kannagi Reiji, 2007, Chang Gung Med J, V30, P189; Karna E, 2002, INT J EXP PATHOL, V83, P239, DOI 10.1046/j.1365-2613.2002.00237.x; Kaur S, 2012, BIOMARK MED, V6, P597, DOI [10.2217/BMM.12.69, 10.2217/bmm.12.69]; Kendrick ZW, 2014, HPB, V16, P670, DOI 10.1111/hpb.12199; Kim Y, 2015, J PROTEOME RES; Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P2195, DOI 10.1158/1055-9965.EPI-11-0400; Matsubara J, 2010, MOL CELL PROTEOMICS, V9, P695, DOI 10.1074/mcp.M900234-MCP200; Murakoshi Y, 2011, CANCER SCI, V102, P630, DOI 10.1111/j.1349-7006.2010.01818.x; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Ohtsuki S, 2011, J PHARM SCI-US, V100, P3547, DOI 10.1002/jps.22612; Ono M, 2009, J BIOL CHEM, V284, P29041, DOI 10.1074/jbc.M109.041749; Otani T, 2006, CANCER CAUSE CONTROL, V17, P1245, DOI 10.1007/s10552-006-0065-z; Pan S, 2015, PROTEOMICS, V15, P2705, DOI 10.1002/pmic.201400476; Pan S, 2012, J PROTEOME RES, V11, P1937, DOI 10.1021/pr201117w; Parker CE, 2014, MOL ONCOL, V8, P840, DOI 10.1016/j.molonc.2014.03.006; Percy AJ, 2013, J PROTEOMICS, V95, P66, DOI 10.1016/j.jprot.2013.07.026; Percy AJ, 2013, PROTEOMICS, V13, P2202, DOI 10.1002/pmic.201200316; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rohrmann S, 2012, BRIT J CANCER, V106, P1004, DOI 10.1038/bjc.2012.19; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sinclair J, 2011, METHODS, V54, P361, DOI 10.1016/j.ymeth.2011.03.004; Solier C, 2014, PROTEOMICS, V14, P774, DOI 10.1002/pmic.201300334; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Uchida Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-21; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; Yamaji T, 2012, INT J OBESITY, V36, P440, DOI 10.1038/ijo.2011.114; Yamaji T, 2010, CANCER RES, V70, P5430, DOI 10.1158/0008-5472.CAN-10-0178; Yamaji T, 2009, AM J EPIDEMIOL, V170, P1502, DOI 10.1093/aje/kwp311; Yoneyama T, 2013, J PROTEOME RES, V12, P753, DOI 10.1021/pr3008144; Zhou C, 2012, J PROTEOME RES, V11, P2103, DOI 10.1021/pr200636x	56	61	68	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161009	10.1371/journal.pone.0161009	http://dx.doi.org/10.1371/journal.pone.0161009			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579675	Green Published, gold			2022-12-27	WOS:000382877400012
J	Yonezawa, T; Uchida, M; Tomioka, M; Matsuki, N				Yonezawa, Tomohiro; Uchida, Mona; Tomioka, Michiko; Matsuki, Naoaki			Lunar Cycle Influences Spontaneous Delivery in Cows	PLOS ONE			English	Article							ATMOSPHERIC CONDITIONS; BAROMETRIC-PRESSURE; BIRTH-RATE; PHASE; PARTURITION; MELATONIN; LABOR; MOON	There is a popular belief that the lunar cycle influences spontaneous delivery in both humans and cattle. To assess this relationship, we investigated the synodic distribution of spontaneous deliveries in domestic Holstein cows. We used retrospective data from 428 spontaneous, full-term deliveries within a three-year period derived from the calving records of a private farm in Hokkaido, Japan. Spontaneous birth frequency increased uniformly from the new moon to the full moon phase and decreased until the waning crescent phase. There was a statistically significant peak between the waxing gibbous and full moon phases compared with those between the last quarter and the waning crescent. These changes were clearly observed in deliveries among multiparous cows, whereas they were not evident in deliveries among nulliparous cows. These data suggest the utility of dairy cows as models for bio-meteorological studies, and indicate that monitoring lunar phases may facilitate comprehensive understanding of parturition.	[Yonezawa, Tomohiro; Uchida, Mona; Matsuki, Naoaki] Univ Tokyo, Dept Vet Med Sci, Tokyo, Japan; [Tomioka, Michiko] Kitasato Univ, Sch Vet Med, Aomori, Japan	University of Tokyo; Kitasato University	Yonezawa, T (corresponding author), Univ Tokyo, Dept Vet Med Sci, Tokyo, Japan.	ayone@mail.ecc.u-tokyo.ac.jp	Uchida, Mona/AAK-1828-2021		Grants-in-Aid for Scientific Research [16K15045] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Arliss JM, 2005, AM J OBSTET GYNECOL, V192, P1462, DOI 10.1016/j.ajog.2004.12.034; Cajochen C, 2013, CURR BIOL, V23, P1485, DOI 10.1016/j.cub.2013.06.029; Carlhall S, 2013, EUR J OBSTET GYN R B, V171, P49, DOI 10.1016/j.ejogrb.2013.08.021; CUTLER WB, 1980, AM J OBSTET GYNECOL, V137, P834, DOI 10.1016/0002-9378(80)90895-9; Ghiandoni G, 1998, EUR J OBSTET GYN R B, V77, P47, DOI 10.1016/S0301-2115(97)00226-1; Hirsch E, 2011, INT J BIOMETEOROL, V55, P265, DOI 10.1007/s00484-010-0332-2; KELLY IW, 1994, PSYCHOL REP, V75, P507, DOI 10.2466/pr0.1994.75.1.507; King EA, 1997, J NURSE-MIDWIFERY, V42, P32, DOI 10.1016/S0091-2182(96)00101-2; Kuss O, 2008, ACTA OBSTET GYN SCAN, V87, P1378, DOI 10.1080/00016340802478174; Leonard P, 1987, D DUNLAP DOINGS, V20, P7; MARTENS R, 1988, PSYCHOL REP, V63, P923, DOI 10.2466/pr0.1988.63.3.923; Maudet C, 2002, J ANIM SCI, V80, P942; MIYAOKA E, 1989, CAN J STAT, V17, P123, DOI 10.2307/3314843; Morton-Pradhan S, 2005, AM J OBSTET GYNECOL, V192, P1970, DOI 10.1016/j.ajog.2005.02.066; Nakamura Y, 2001, J PINEAL RES, V30, P29, DOI 10.1034/j.1600-079X.2001.300104.x; Ochiai AM, 2012, INT J BIOMETEOROL, V56, P661, DOI 10.1007/s00484-011-0465-y; Olcese J, 2013, REPROD SCI, V20, P168, DOI 10.1177/1933719112442244; RIPPMANN ET, 1957, AM J OBSTET GYNECOL, V74, P148, DOI 10.1016/S0002-9378(16)37014-4; SIEBER M, 1989, J DAIRY SCI, V72, P2402, DOI 10.3168/jds.S0022-0302(89)79373-5; Stocker SD, 2004, AM J PHYSIOL-REG I, V287, pR127, DOI 10.1152/ajpregu.00526.2003; TRAP R, 1989, GYNECOL OBSTET INVES, V28, P14, DOI 10.1159/000293490; Troxel TR, 2012, J ANIM SCI, V90, P1583, DOI 10.2527/jas.2011-4088; Widjaja D, 2015, EUR J APPL PHYSIOL, V115, P1205, DOI 10.1007/s00421-015-3118-8; WITTER FR, 1983, AM J OBSTET GYNECOL, V145, P637, DOI 10.1016/0002-9378(83)91212-7	24	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161735	10.1371/journal.pone.0161735	http://dx.doi.org/10.1371/journal.pone.0161735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580019	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400038
J	Wu, HL; Feng, JY; Lv, WT; Huang, QL; Fu, MS; Cai, MX; He, QQ; Shang, J				Wu, Huali; Feng, Junyi; Lv, Wenting; Huang, Qiaoling; Fu, Mengsi; Cai, Minxuan; He, Qiangqiang; Shang, Jing			Developmental Neurotoxic Effects of Percutaneous Drug Delivery: Behavior and Neurochemical Studies in C57BL/6 Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; 5-HT1A RECEPTOR; TACROLIMUS OINTMENT; TOPICAL APPLICATION; ATOPIC-DERMATITIS; RETINOIC ACID; SKIN; SYSTEM; BRAIN; HYDROQUINONE	Dermatosis often as a chronic disease requires effective long-term treatment; a comprehensive evaluation of mental health of dermatology drug does not receive enough attention. An interaction between dermatology and psychiatry has been increasingly described. Substantial evidence has accumulated that psychological stress can be associated with pigmentation, endocrine and immune systems in skin to create the optimal responses against pathogens and other physicochemical stressors to maintain or restore internal homeostasis. Additionally, given the common ectodermal origin shared by the brain and skin, we are interested in assessing how disruption of skin systems (pigmentary, endocrine and immune systems) may play a key role in brain functions. Thus, we selected three drugs (hydroquinone, isotretinoin, tacrolimus) with percutaneous excessive delivery to respectively intervene in these systems and then evaluate the potential neurotoxic effects. Firstly, C57BL/6 mice were administrated a dermal dose of hydroquinone cream, isotretinoin gel or tacrolimus ointment (2%, 0.05%, 0.1%, respectively, 5 times of the clinical dose). Behavioral testing was performed and levels of proteins were measured in the hippocampus. It was found that mice treated with isotretinoin or tacrolimus, presented a lower activity in open-field test and obvious depressive-like behavior in tail suspension test. Besides, they damaged cytoarchitecture, reduced the level of 5-HT-5-HT1A/1B system and increased the expression of apoptosis-related proteins in the hippocampus. To enable sensitive monitoring the dose-response characteristics of the consecutive neurobehavioral disorders, mice received gradient concentrations of hydroquinone (2%, 4%, 6%). Subsequently, hydroquinone induced behavioral disorders and hippocampal dysfunction in a dose-dependent response. When doses were high as 6% which was 3 times higher than 2% dose, then 100% of mice exhibited depressive-like behavior. Certainly, 6% hydroquinone exposure elicited the most serious impairment of hippocampal structure and survival. The fact that higher doses of hydroquinone are associated with a greater risk of depression is further indication that hydroquinone is responsible for the development of depression. These above data demonstrated that chronic administration of different dermatology drugs contributed into common mental distress. This surprising discovery of chemical stressors stimulating the hippocampal dysfunction, paves the way for exciting areas of study on the cross-talk between the skin and the brain, as well as is suggesting how to develop effective and safe usage of dermatological drugs in daily practice.	[Wu, Huali; Feng, Junyi; Lv, Wenting; Huang, Qiaoling; Fu, Mengsi; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wu, Huali; Feng, Junyi; Lv, Wenting; Huang, Qiaoling; Fu, Mengsi; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Jiangsu, Peoples R China; [He, Qiangqiang] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining, Qinghai Provinc, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences	Shang, J (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.; Shang, J (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Jiangsu, Peoples R China.	shangjing21cn@163.com			National Science and Technology Infrastructure Program of China [2012BAI30B001]; One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province [Y229461211]; Science and Technology Plan Projects in Qinghai Province [2015-ZJ-733]	National Science and Technology Infrastructure Program of China; One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province; Science and Technology Plan Projects in Qinghai Province	This study was supported by (1) National Science and Technology Infrastructure Program of China (2012BAI30B001) Prof Jing Shang, (2) One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province (Y229461211) Prof Jing Shang, and (3) Science and Technology Plan Projects in Qinghai Province (2015-ZJ-733) Prof Jing Shang.	Akhavan A, 2003, AM J CLIN DERMATOL, V4, P473, DOI 10.2165/00128071-200304070-00004; Alenina N, 2015, BEHAV BRAIN RES, V277, P49, DOI 10.1016/j.bbr.2014.07.038; Alikhan FS, 2011, CUTAN OCUL TOXICOL, V30, P175, DOI 10.3109/15569527.2011.560914; ANGEL A, 1972, TOXICOL APPL PHARM, V21, P214, DOI 10.1016/0041-008X(72)90064-6; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Borovaya A, 2013, INT J DERMATOL, V52, P1040, DOI 10.1111/ijd.12169; Bremner JD, 2012, J CLIN PSYCHIAT, V73, P37, DOI 10.4088/JCP.10r05993; Claudet I, 2015, PEDIATR EMERG CARE, V31, P44, DOI 10.1097/PEC.0000000000000301; CloezTayarani I, 1997, P NATL ACAD SCI USA, V94, P9899, DOI 10.1073/pnas.94.18.9899; Draelos ZD, 2010, CUTIS, V86, P153; English JC, 2005, FOOD CHEM TOXICOL, V43, P483, DOI 10.1016/j.fct.2004.11.015; Ganceviciene R, 2009, BRIT J DERMATOL, V160, P345, DOI 10.1111/j.1365-2133.2008.08959.x; Harada M, 2000, Ryoikibetsu Shokogun Shirizu, P86; Hategan A, 2015, J NEUROPSYCH CLIN N, V27, pE140, DOI 10.1176/appi.neuropsych.14010011; Hazama Y, 2016, BIOL PHARM BULL, V39, P343, DOI 10.1248/bpb.b15-00727; Hiramoto K, 2011, CLIN EXP DERMATOL, V36, P52, DOI 10.1111/j.1365-2230.2010.03777.x; Jaako-Movits K, 2005, EUR J NEUROSCI, V22, P2871, DOI 10.1111/j.1460-9568.2005.04481.x; Jiang S, 2016, EVID-BASED COMPL ALT, V2047412, P25; Korabel Hanna, 2008, Przegl Lek, V65, P244; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lee WS, 2016, KOREAN J INTERN MED, V31, P779, DOI 10.3904/kjim.2015.066; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Mielke H, 2011, TOXICOL LETT, V204, P190, DOI 10.1016/j.toxlet.2011.04.032; Mitchell A, 1919, BRIT MED J, V1919, P465, DOI 10.1136/bmj.2.3067.465; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Palchaudhuri M, 2005, CELL TISSUE RES, V321, P159, DOI 10.1007/s00441-005-1112-x; Panhans-Gross A, 2001, J ALLERGY CLIN IMMUN, V107, P345, DOI 10.1067/mai.2001.112600; Paterson LM, 2013, MED RES REV, V33, P54, DOI 10.1002/med.20245; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; Popova NK, 2013, REV NEUROSCIENCE, V24, P191, DOI 10.1515/revneuro-2012-0082; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schuller E, 2004, J ALLERGY CLIN IMMUN, V114, P137, DOI 10.1016/j.jaci.2004.03.021; Seo DH, 2012, APPL MICROBIOL BIOT, V95, P1417, DOI 10.1007/s00253-012-4297-4; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, DERMATOLOGY, V211, P199, DOI 10.1159/000087012; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tobin DJ, 2006, CHEM SOC REV, V35, P52, DOI 10.1039/b505793k; Topping DC, 2007, FOOD CHEM TOXICOL, V45, P70, DOI 10.1016/j.fct.2006.07.019; Undre NA, 2009, BRIT J DERMATOL, V160, P665, DOI 10.1111/j.1365-2133.2008.08974.x; VANE F M, 1988, Skin Pharmacology, V1, P237; Wijdicks EFM, 2001, LIVER TRANSPLANT, V7, P937, DOI 10.1053/jlts.2001.27475; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu H, 2014, SCI WORLD J, DOI 10.1155/2014/237356; Wu HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089663; Zhou J, 2014, J DERMATOL SCI, V73, P110, DOI 10.1016/j.jdermsci.2013.09.005	52	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162570	10.1371/journal.pone.0162570	http://dx.doi.org/10.1371/journal.pone.0162570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606422	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600066
J	Cai, SR; Qiu, AQ; Broekman, BFP; Wong, EQ; Gluckman, PD; Godfrey, KM; Saw, SM; Soh, SE; Kwek, K; Chong, YS; Meaney, MJ; Kramer, MS; Rifkin-Graboi, A				Cai, Shirong; Qiu, Anqi; Broekman, Birit F. P.; Wong, Eric Qinlong; Gluckman, Peter D.; Godfrey, Keith M.; Saw, Seang Mei; Soh, Shu-E; Kwek, Kenneth; Chong, Yap-Seng; Meaney, Michael J.; Kramer, Michael S.; Rifkin-Graboi, Anne		GUSTO Study Grp	The Influence of Gestational Diabetes on Neurodevelopment of Children in the First Two Years of Life: A Prospective Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; IRON-DEFICIENCY ALTERS; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EXPLICIT MEMORY PERFORMANCE; AUDITORY RECOGNITION MEMORY; MISMATCH NEGATIVITY MMN; NEUROCOGNITIVE-DEVELOPMENT; NEWBORN-INFANTS; SCHOOL-AGE; LONG-TERM	Objective Analyze the relation of gestational diabetes and maternal blood glucose levels to early cognitive functions in the first two years of life. Methods In a prospective Singaporean birth cohort study, pregnant women were screened for gestational diabetes at 26-28 weeks gestation using a 75-g oral glucose tolerance test. Four hundred and seventy three children (n = 74 and n = 399 born to mothers with and without gestational diabetes respectively) underwent neurocognitive assessments at 6, 18, and/or 24 month, including electrophysiology during an attentional task and behavioral measures of attention, memory and cognition. Results Gestational diabetes is related to left hemisphere EPmax amplitude differences (oddball versus standard) at both six (P = 0.039) and eighteen months (P = 0.039), with mean amplitudes suggesting offspring of mothers with gestational diabetes exhibit greater neuronal activity to standard stimuli and less to oddball stimuli. Associations between 2-hour maternal glucose levels and the difference in EPmax amplitude were marginal at 6 months [adjusted beta = -0.19 (95% CI: -0.42 to +0.04) mu V, P = 0.100] and significant at 18 months [adjusted beta = -0.27 (95% CI: -0.49 to -0.06) mu V, P = 0.014], and the EPmax amplitude difference (oddball-standard) associated with the Bayley Scales of Infant and toddler Development-III cognitive score at 24 months [beta = 0.598 (95% CI: 0.158 to 1.038), P = 0.008]. Conclusion Gestational diabetes and maternal blood glucose levels are associated with offspring neuronal activity during an attentional task at both six and eighteen months. Such electrophysiological differences are likely functionally important, having been previously linked to attention problems later in life.	[Cai, Shirong; Chong, Yap-Seng; Kramer, Michael S.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Qiu, Anqi; Broekman, Birit F. P.; Wong, Eric Qinlong; Gluckman, Peter D.; Soh, Shu-E; Chong, Yap-Seng; Meaney, Michael J.; Rifkin-Graboi, Anne] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore, Singapore; [Broekman, Birit F. P.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Godfrey, Keith M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Soh, Shu-E] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pediat, Singapore, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal & Fetal Med, Singapore, Singapore; [Meaney, Michael J.] McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ, Canada	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; National University of Singapore; University of Auckland; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; McGill University; McGill University; McGill University	Rifkin-Graboi, A (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	anne_rifkin@sics.a-star.edu.sg	Meaney, Michael/N-5931-2019; Qiu, Anqi/H-2267-2011; Rifkin-Graboi, Anne/AFM-0959-2022; Rifkin-Graboi, Anne/AAH-3658-2022	Qiu, Anqi/0000-0002-0215-6338; Rifkin-Graboi, Anne/0000-0002-7641-4678; SOH, SHU E/0000-0002-0790-4200; Chong, Yap Seng/0000-0002-7232-8473; Godfrey, Keith/0000-0002-4643-0618; Cai, Shirong/0000-0002-0650-2234	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program; Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore [NMRC/TCR/004-NUS/2008, NMRC/TCR/012-NUHS/2014]; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; Abbott Nutrition Research and Development Asia-Pacific Center; MRC [MC_UP_A620_1017, MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10042] Funding Source: researchfish	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program; Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; Abbott Nutrition Research and Development Asia-Pacific Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore- NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore and Abbott Nutrition Research and Development Asia-Pacific Center. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; Bayley N., 2019, BAYLEY SCALES INFANT; Bell R, 2008, BJOG-INT J OBSTET GY, V115, P445, DOI 10.1111/j.1471-0528.2007.01644.x; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Cai SR, 2015, AM J CLIN NUTR, V101, P326, DOI 10.3945/ajcn.114.095414; Chee CYI, 2005, J AFFECT DISORDERS, V89, P157, DOI 10.1016/j.jad.2005.09.004; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039; deReginer RA, 2000, J PEDIATR-US, V137, P777, DOI 10.1067/mpd.2000.109149; Deregnier RA, 2007, DEV NEUROPSYCHOL, V31, P379, DOI 10.1080/87565640701229524; Dionne G, 2008, PEDIATRICS, V122, pE1073, DOI 10.1542/peds.2007-3028; Fellman V, 2004, PEDIATR RES, V56, P291, DOI 10.1203/01.PDR.0000132750.97066.B9; Franken IHA, 2005, BIOL PSYCHOL, V70, P161, DOI 10.1016/j.biopsycho.2005.01.007; Fraser A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0489-x; Fraser A, 2014, DIABETOLOGIA, V57, P102, DOI 10.1007/s00125-013-3065-z; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Hay WW, 2012, CURR DIABETES REP, V12, P4, DOI 10.1007/s11892-011-0243-6; Ibanez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135849; JACOBSON SW, 1992, CHILD DEV, V63, P711; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jing HK, 2006, BRAIN DEV-JPN, V28, P247, DOI 10.1016/j.braindev.2005.09.002; Jing H, 2007, DEV NEUROPSYCHOL, V31, P349, DOI 10.1080/87565640701229227; Jorgenson LA, 2003, DEV NEUROSCI-BASEL, V25, P412, DOI 10.1159/000075667; Koschack J, 2003, PSYCHOL MED, V33, P481, DOI 10.1017/S0033291702007067; Kushnerenko EV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00595; Linder K, 2015, J CLIN ENDOCRINOLOGY; Nelson CA, 2000, BEHAV NEUROSCI, V114, P950, DOI 10.1037//0735-7044.114.5.950; Nelson CA, 2003, J PEDIATR-US, V142, P575, DOI 10.1067/mpd.2003.210; Nelson CA, 2008, J AM ACAD CHILD PSY, V47, P1252, DOI 10.1097/CHI.0b013e318185a6d8; Nold JL, 2004, PEDIATR CLIN N AM, V51, P619, DOI 10.1016/j.pcl.2004.01.003; Nomura Y, 2012, ARCH PEDIAT ADOL MED, V166, P337, DOI 10.1001/archpediatrics.2011.784; Oades RD, 1996, BIOL PSYCHOL, V43, P163, DOI 10.1016/0301-0511(96)05189-7; Ornoy A, 1999, ARCH DIS CHILD-FETAL, V81, pF10, DOI 10.1136/fn.81.1.F10; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; Rao R, 2003, J NUTR, V133, P3215, DOI 10.1093/jn/133.10.3215; Riggins T, 2010, ADV CHILD DEV BEHAV, V38, P73; Riggins T, 2009, DEV NEUROPSYCHOL, V34, P762, DOI 10.1080/87565640903265145; RIZZO TA, 1994, AM J OBSTET GYNECOL, V171, P706, DOI 10.1016/0002-9378(94)90086-8; Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005; Sheese Brad E, 2009, Cogn Neuropsychiatry, V14, P332, DOI 10.1080/13546800902844064; Siddappa AM, 2004, PEDIATR RES, V55, P1034, DOI 10.1203/01.pdr.0000127021.38207.62; Soh SE, 2013, INT J EPIDEMIOL; Stenninger E, 1998, ARCH DIS CHILD-FETAL, V79, pF174, DOI 10.1136/fn.79.3.F174; Thiagayson P, 2013, GEN HOSP PSYCHIAT, V35, P112, DOI 10.1016/j.genhosppsych.2012.11.006; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; van den Heuvel MI, 2015, SOC COGN AFFECT NEUR, V10, P453, DOI 10.1093/scan/nsu075; Veena SR, 2010, ARCH DIS CHILD, V95, P347, DOI 10.1136/adc.2009.165159; Wong L., 2001, SMJ Singapore Medical Journal, V42, P517; Yoncheva Y, 2014, NEUROIMAGE, V97, P262, DOI 10.1016/j.neuroimage.2014.04.006	51	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162113	10.1371/journal.pone.0162113	http://dx.doi.org/10.1371/journal.pone.0162113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603522	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200043
J	Han, JM; Guo, RH; Li, JQ; Guan, C; Chen, Y; Zhao, W				Han, Jimin; Guo, Ronghui; Li, Jiaqi; Guan, Chen; Chen, Yu; Zhao, Wei			Organ Mass Variation in a Toad Headed Lizard Phrynocephalus vlangalii in Response to Hypoxia and Low Temperature in the Qinghai-Tibet Plateau, China	PLOS ONE			English	Article							HIGH-ALTITUDE; PHENOTYPIC PLASTICITY; BREATHING PATTERN; ADAPTATION; TOLERANCE; VERTEBRATES; DIVERGENCE; QUATERNARY; GRADIENT; HISTORY	Hypoxia and low temperature at high altitudes are the main environmental pressures for alpine animals, inducing phenotypic plasticity at several levels. To investigate the effect of these variables on the organ mass of Phrynocephalus vlangalii, 138 individuals belonging to four populations living along an altitudinal gradient in the Qinghai-Tibet Plateau (China) were dissected to remove heart, lungs, stomach, and intestinal tract. Organ dry mass, individuals' sex, and body mass, as well as mean annual temperature and average air pressure (calculated from a 30-year-data series obtained from the National Climatic Data Center) were subjected to two-way analyses of covariance and generalized linear mixed models (GLMMs). Except for the heart, organ mass varied significantly among populations, although only lung and stomach mass increased significantly with increasing altitude. Males' heart and lung mass was higher than that of females, which might be due to their different behavior and reproductive efforts. GLMM analyses indicated that air pressure had a positive effect on heart, lung and intestinal tract mass, whereas temperature had a negative effect on these three organs. In order to explain the effect of hypoxia and low temperature on P. vlangalii's organ mass, further rigorous study on respiration, energy budget and food intake was encouraged.	[Han, Jimin; Guo, Ronghui; Guan, Chen; Chen, Yu; Zhao, Wei] Lanzhou Univ, Sch Life Sci, Lanzhou, Gansu, Peoples R China; [Li, Jiaqi] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Lanzhou University	Zhao, W (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou, Gansu, Peoples R China.	zhaowei@lzu.edu.cn			Fundamental Research Funds for the Central Universities [lzujbky-2014-93]; National Nature grants [31200287, 31471988]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature grants	The Fundamental Research Funds for the Central Universities, W Zhao (lzujbky-2014-93, http://kyc.lzu.edu.cn/lzupage/B20100520025646.html); National Nature grants W Zhao (31200287, http://www.nsfc.gov.cn/Portal0/default152.htm); National Nature grants, Liu NF (31471988, http://www.nsfc.gov.cn/Portal0/default152.htm).	Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fonseca EM, 2012, COMP BIOCHEM PHYS A, V162, P281, DOI 10.1016/j.cbpa.2012.03.020; Hammond KA, 2001, J EXP BIOL, V204, P1991; He JZ, 2013, COMP BIOCHEM PHYS A, V165, P207, DOI 10.1016/j.cbpa.2013.03.007; He JZ, 2013, J EXP ZOOL PART A, V319A, P117, DOI 10.1002/jez.1776; Hicks JW, 1999, AM J PHYSIOL-REG I, V277, pR18, DOI 10.1152/ajpregu.1999.277.1.R18; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Jin YT, 2013, MOL PHYLOGENET EVOL, V68, P259, DOI 10.1016/j.ympev.2013.03.022; Jin YT, 2014, MOL PHYLOGENET EVOL, V71, P288, DOI 10.1016/j.ympev.2013.11.004; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; Lei FM, 2014, CURR ZOOL, V60, P149, DOI 10.1093/czoolo/60.2.149; Li JQ, 2014, HERPETOL J, V24, P17; Liao JC, 2010, MAMM BIOL, V75, P381, DOI 10.1016/j.mambio.2009.11.003; Lu SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125751; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mingji C, 2015, HEART, V101, P1054, DOI 10.1136/heartjnl-2014-307158; Mortola JP, 2000, ANNU REV PHYSIOL, V62, P847, DOI 10.1146/annurev.physiol.62.1.847; Munns SL, 1998, PHYSIOL ZOOL, V71, P267, DOI 10.1086/515913; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Qi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041130; Qi Y, 2011, ASIAN HERPETOL RES, V2, P110, DOI 10.3724/SP.J.1245.2011.00110; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Wang Shuo-guo, 2004, Sichuan Daxue Xuebao (Ziran Kexueban), V41, P403; Wang Z, 2014, OECOLOGIA, V174, P639, DOI 10.1007/s00442-013-2811-8; Wang Z, 2013, ASIAN HERPETOL RES, V4, P214, DOI 10.3724/SP.J.1245.2013.00214; Wu YY, 2015, ECOL EVOL, V5, P5138, DOI 10.1002/ece3.1783; Xin Y, 2015, COMP BIOCHEM PHYS B, V188, P31, DOI 10.1016/j.cbpb.2015.06.004; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Y, 2015, COMP BIOCHEM PHYS A, V190, P9, DOI 10.1016/j.cbpa.2015.08.013; Zhao KT, 1979, J INNER MONGOLIA U, V2, P111	32	8	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162572	10.1371/journal.pone.0162572	http://dx.doi.org/10.1371/journal.pone.0162572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603795	Green Submitted, gold, Green Published			2022-12-27	WOS:000383255200076
J	Ciappuccini, R; Aide, N; Blanchard, D; Rame, JP; de Raucourt, D; Michels, JJ; Babin, E; Bardet, S				Ciappuccini, Renaud; Aide, Nicolas; Blanchard, David; Rame, Jean-Pierre; de Raucourt, Dominique; Michels, Jean-Jacques; Babin, Emmanuel; Bardet, Stephane			Incremental Value of a Dedicated Head and Neck Acquisition during F-18-FDG PET/CT in Patients with Differentiated Thyroid Cancer	PLOS ONE			English	Article							POINT-SPREAD FUNCTION; HIGH-RESOLUTION HEAD; TIME-OF-FLIGHT; LYMPH-NODE; TOMOGRAPHY/COMPUTED TOMOGRAPHY; PROGNOSTIC VALUE; FDG-PET/CT; RECURRENT; CARCINOMA; IMPACT	Objectives F-18-FDG-PET/CT is a useful tool used to evidence persistent/recurrent disease (PRD) in patients with differentiated thyroid cancer and iodine-refractory lesions. The aim of this study was to compare the diagnostic value at the cervical level of the routine whole-body (WB) acquisition and that of a complementary head and neck (HN) acquisition, performed successively during the same PET/CT study. Methods PET/CT studies combining WB and HN acquisitions performed in 85 consecutive patients were retrospectively reviewed by two nuclear medicine physicians. F-18-FDG uptake in cervical lymph nodes (LN) or in the thyroid bed was assessed. Among the 85 patients, the PET/CT results of the 26 who subsequently underwent neck surgery were compared with surgical and pathological reports. The size of each largest nodal metastasis was assessed by a pathologist. Results In the 85 patients, inter-observer agreement was excellent for both WB and HN PET/CT interpretation. Of the 26 patients who underwent surgery, 25 had pathology proven PRD in the neck. Of these 25 patients, 15 displayed FDG uptake on either WB or HN PET. In these 15 patients, HN PET detected more malignant lesions than WB PET did (21/27 = 78% vs. 12/27 = 44%, P = 0.006). Node/background ratios were significantly higher on HN than on WB PET (P<0.0001). Three false-negative studies (20%) on WB PET were upstaged as true-positive on HN PET. The mean size of the largest LN metastasis was 3 mm for the LN detected neither on WB nor on HN PET, 7 mm for the metastasis detected on HN but not WB PET, and 13 mm for those detected on both acquisitions (P = 0.0004). Receiver-Operating Characteristic analysis showed that area under the curve was higher for HN PET than for WB PET (0.97 [95% CI, 0.90-0.99] vs 0.88 [95% CI, 0.78-0.95], P = 0.009). Conclusions HN acquisition improves the ability to detect PRD in the neck compared with WB acquisition alone. We recommend systematically adding an HN acquisition when PET/CT is performed to detect PRD in the neck.	[Ciappuccini, Renaud; Aide, Nicolas; Bardet, Stephane] Francois Baclesse Canc Ctr, Dept Nucl Med, Caen, France; [Ciappuccini, Renaud; Aide, Nicolas; Bardet, Stephane] Francois Baclesse Canc Ctr, Thyroid Unit, Caen, France; [Ciappuccini, Renaud; Babin, Emmanuel] Normandie Univ, INSERM, Canc & Prevent U1086, Caen, France; [Aide, Nicolas] Francois Baclesse Canc Ctr, INSERM, BioTICLA Unit, U1199, Caen, France; [Aide, Nicolas] Normandie Univ, Caen, France; [Aide, Nicolas] Univ Hosp, Dept Nucl Med, Caen, France; [Blanchard, David; Rame, Jean-Pierre; de Raucourt, Dominique] Francois Baclesse Canc Ctr, Dept Head & Neck Surg, Caen, France; [Michels, Jean-Jacques] Francois Baclesse Canc Ctr, Dept Pathol, Caen, France; [Babin, Emmanuel] Univ Hosp, Dept Head & Neck Surg, Caen, France	UNICANCER; Centre Francois Baclesse; UNICANCER; Centre Francois Baclesse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE; UNICANCER; Centre Francois Baclesse; UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE	Ciappuccini, R (corresponding author), Francois Baclesse Canc Ctr, Dept Nucl Med, Caen, France.; Ciappuccini, R (corresponding author), Francois Baclesse Canc Ctr, Thyroid Unit, Caen, France.; Ciappuccini, R (corresponding author), Normandie Univ, INSERM, Canc & Prevent U1086, Caen, France.	r.ciappuccini@baclesse.unicancer.fr	Marie-José, Lucas/ABE-1443-2020; Ciappuccini, Renaud/ABD-8805-2020; AIDE, Nicolas/K-6547-2015	Ciappuccini, Renaud/0000-0002-5181-8182; AIDE, Nicolas/0000-0001-9207-0847; Babin, Emmanuel/0000-0002-3568-8955				Aide N, 2009, J CLIN ENDOCR METAB, V94, P2075, DOI 10.1210/jc.2008-2313; Avram AM, 2015, J CLIN ENDOCR METAB, V100, P1895, DOI 10.1210/jc.2014-4043; Bardet S, 2015, J CLIN ENDOCR METAB, V100, P132, DOI 10.1210/jc.2014-1199; Bellevre D, 2014, EUR J NUCL MED MOL I, V41, P1103, DOI 10.1007/s00259-014-2689-7; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Chatziioannou SN, 2014, ACAD RADIOL, V21, P58, DOI 10.1016/j.acra.2013.09.017; Cheng G, 2013, EUR J NUCL MED MOL I, V40, P779, DOI 10.1007/s00259-013-2343-9; Choi JS, 2009, AM J ROENTGENOL, V193, P871, DOI 10.2214/AJR.09.2386; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davison JM, 2008, CLIN NUCL MED, V33, P464, DOI 10.1097/RLU.0b013e31817792c9; Durante C, 2013, ENDOCR-RELAT CANCER, V20, pR141, DOI 10.1530/ERC-13-0066; Freudenberg LS, 2007, EUR RADIOL, V17, P3139, DOI 10.1007/s00330-007-0682-2; Grunwald F, 1999, EUR J NUCL MED, V26, P1547, DOI 10.1007/s002590050493; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hughes DT, 2012, ANN SURG ONCOL, V19, P2951, DOI 10.1245/s10434-012-2380-9; Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227; Kadrmas DJ, 2009, J NUCL MED, V50, P1315, DOI 10.2967/jnumed.109.063016; Kunawudhi A, 2012, CLIN NUCL MED, V37, P561, DOI 10.1097/RLU.0b013e318252d30e; Lasnon C, 2012, CLIN NUCL MED, V37, P971, DOI 10.1097/RLU.0b013e318251e3d1; Leboulleux S, 2009, J CLIN ENDOCR METAB, V94, P1310, DOI 10.1210/jc.2008-1747; PACINI F, 1992, J CLIN ENDOCR METAB, V74, P1401, DOI 10.1210/jc.74.6.1401; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Rodrigues RS, 2009, J NUCL MED, V50, P1205, DOI 10.2967/jnumed.109.062075; Rogasch JMM, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0111-5; Schluter B, 2001, J NUCL MED, V42, P71; Teoh EJ, 2016, EUR RADIOL, V26, P576, DOI 10.1007/s00330-015-3832-y; Travagli JP, 1998, J CLIN ENDOCR METAB, V83, P2675, DOI 10.1210/jc.83.8.2675; Wang WP, 2000, J CLIN ENDOCR METAB, V85, P1107, DOI 10.1210/jc.85.3.1107; Weber T, 2012, HORM METAB RES, V44, P904, DOI 10.1055/s-0032-1316351; Yim JH, 2011, J CLIN ENDOCR METAB, V96, P2049, DOI 10.1210/jc.2010-2298	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162482	10.1371/journal.pone.0162482	http://dx.doi.org/10.1371/journal.pone.0162482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598385	Green Submitted, gold, Green Published			2022-12-27	WOS:000383254800069
J	Kim, E; Kim, Y				Kim, Eunseong; Kim, Yonggyun			Translational Control of Host Gene Expression by a Cys-Motif Protein Encoded in a Bracovirus	PLOS ONE			English	Article							COTESIA-PLUTELLAE BRACOVIRUS; CAMPOLETIS-SONORENSIS ICHNOVIRUS; INHIBITORY FACTOR; DIAMONDBACK MOTH; IMMUNOSUPPRESSIVE ROLE; HEMOCYTE POPULATION; CHELONUS-INANITUS; PARASITIC WASP; POLYDNAVIRUS; IDENTIFICATION	Translational control is a strategy that various viruses use to manipulate their hosts to suppress acute antiviral response. Polydnaviruses, a group of insect double-stranded DNA viruses symbiotic to some endoparasitoid wasps, are divided into two genera: ichnovirus (IV) and bracovirus (BV). In IV, some Cys-motif genes are known as host translation-inhibitory factors (HTIF). The genome of endoparasitoid wasp Cotesia plutellae contains a Cys-motif gene (Cp-TSP13) homologous to an HTIF known as teratocyte-secretory protein 14 (TSP14) of Microplitis croceipes. Cp-TSP13 consists of 129 amino acid residues with a predicted molecular weight of 13.987 kDa and pI value of 7.928. Genomic DNA region encoding its open reading frame has three introns. Cp-TSP13 possesses six conserved cysteine residues as other Cys-motif genes functioning as HTIF. Cp-TSP13 was expressed in Plutella xylostella larvae parasitized by C. plutellae. C. plutellae bracovirus (CpBV) was purified and injected into non-parasitized P. xylostella that expressed Cp-TSP13. Cp-TSP13 was cloned into a eukaryotic expression vector and used to infect Sf9 cells to transiently express Cp-TSP13. The synthesized Cp-TSP13 protein was detected in culture broth. An overlaying experiment showed that the purified Cp-TSP13 entered hemocytes. It was localized in the cytosol. Recombinant Cp-TSP13 significantly inhibited protein synthesis of secretory proteins when it was added to in vitro cultured fat body. In addition, the recombinant Cp-TSP13 directly inhibited the translation of fat body mRNAs in in vitro translation assay using rabbit reticulocyte lysate. Moreover, the recombinant Cp-TSP13 significantly suppressed cellular immune responses by inhibiting hemocyte-spreading behavior. It also exhibited significant insecticidal activities by both injection and feeding routes. These results indicate that Cp-TSP13 is a viral HTIF.	[Kim, Eunseong; Kim, Yonggyun] Andong Natl Univ, Dept Bioresource Sci, Andong 36729, South Korea	Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong 36729, South Korea.	hosanna@andong.ac.kr			framework of international cooperation program [2014K2A2A2000441]	framework of international cooperation program	This study was supported by a grant (2014K2A2A2000441) under the framework of international cooperation program managed by National Research Foundation of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MR, 2015, INSECT MOL BIOL, V24, P13, DOI 10.1111/imb.12132; Armitage SAO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-53; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Barandoc KP, 2010, COMP BIOCHEM PHYS B, V156, P129, DOI 10.1016/j.cbpb.2010.03.001; Barandoc KP, 2009, COMP BIOCHEM PHYS D, V4, P218, DOI 10.1016/j.cbd.2009.03.003; Basio NAM, 2003, PHYSIOL ENTOMOL, V31, P341; Beliveau C, 2015, J VIROL, V89, P8909, DOI 10.1128/JVI.01001-15; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0047; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke GR, 2015, J VIROL, V89, P9511, DOI 10.1128/JVI.01388-15; Burke GR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004660; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Burke GR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003348; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Chevignon G, 2015, INSECT BIOCHEM MOLEC, V62, P86, DOI 10.1016/j.ibmb.2014.12.008; Chevignon G, 2014, J VIROL, V88, P8795, DOI 10.1128/JVI.00209-14; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; Consoli FL, 2004, COMP BIOCHEM PHYS B, V137, P463, DOI 10.1016/j.cbpc.2004.02.001; Cui LW, 1997, ARCH INSECT BIOCHEM, V36, P251, DOI 10.1002/(SICI)1520-6327(1997)36:4<251::AID-ARCH2>3.0.CO;2-V; Dahlman DL, 2003, INSECT MOL BIOL, V12, P527, DOI 10.1046/j.1365-2583.2003.00439.x; Dahlman DL, 1991, BIOL CONTROL, V1, P118, DOI 10.1016/1049-9644(91)90110-L; Einerwold J, 2001, BIOCHEMISTRY-US, V40, P14404, DOI 10.1021/bi011499s; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; FLEMING JAGW, 1991, P NATL ACAD SCI USA, V88, P9770, DOI 10.1073/pnas.88.21.9770; Furihata S, 2014, J INVERTEBR PATHOL, V115, P26, DOI 10.1016/j.jip.2013.10.013; Gill TA, 2013, INSECT MOL BIOL, V22, P341, DOI 10.1111/imb.12022; Hanington PC, 2008, INSECT BIOCHEM MOLEC, V38, P596, DOI 10.1016/j.ibmb.2008.02.002; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hepat R, 2013, J INVERTEBR PATHOL, V114, P34, DOI 10.1016/j.jip.2013.05.004; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; Ibrahim AMA, 2007, DEV COMP IMMUNOL, V31, P978, DOI 10.1016/j.dci.2006.11.005; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Kaeslin M, 2005, J INSECT PHYSIOL, V51, P1330, DOI 10.1016/j.jinsphys.2005.08.003; Kim Y, 2005, ARCH INSECT BIOCHEM, V59, P230, DOI 10.1002/arch.20074; Kim Yonggyun, 2006, Journal of Asia-Pacific Entomology, V9, P37, DOI 10.1016/S1226-8615(08)60273-3; Kim Yonggyun, 2007, Journal of Asia-Pacific Entomology, V10, P181, DOI 10.1016/S1226-8615(08)60351-9; Kumar S, 2016, DEV COMP IMMUNOL, V54, P97, DOI 10.1016/j.dci.2015.09.003; Kumar S, 2014, COMP BIOCHEM PHYS A, V177, P27, DOI 10.1016/j.cbpa.2014.07.017; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Lee S, 2008, ARCH INSECT BIOCHEM, V67, P157, DOI 10.1002/arch.20218; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis F, 2013, J VIROL, V87, P9649, DOI 10.1128/JVI.00886-13; Nalini M, 2007, J INSECT PHYSIOL, V53, P1283, DOI 10.1016/j.jinsphys.2007.07.004; Ng TH, 2014, DEV COMP IMMUNOL, V46, P129, DOI 10.1016/j.dci.2014.04.002; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Park B, 2011, BMB REP, V44, P393, DOI 10.5483/BMBRep.2011.44.6.393; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pohl M, 2013, BIOSYSTEMS, V114, P31, DOI 10.1016/j.biosystems.2013.07.003; Prasad SV, 2014, DEV COMP IMMUNOL, V44, P152, DOI 10.1016/j.dci.2013.12.001; Ragan EJ, 2010, J BIOL CHEM, V285, P29642, DOI 10.1074/jbc.M110.125419; Rana RL, 2002, INSECT BIOCHEM MOLEC, V32, P1507, DOI 10.1016/S0965-1748(02)00071-1; Ribeiro C, 1999, J INSECT PHYSIOL, V45, P677, DOI 10.1016/S0022-1910(99)00043-8; SAS Institute, 1989, SAS STAT US GUID REL; Savary S, 1999, INSECT MOL BIOL, V8, P319, DOI 10.1046/j.1365-2583.1999.83130.x; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; SHELBY KS, 1994, J GEN VIROL, V75, P2285, DOI 10.1099/0022-1317-75-9-2285; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; Strand MR, 2013, CURR OPIN VIROL, V3, P587, DOI 10.1016/j.coviro.2013.06.004; Strand MR, 2010, INSECT VIROLOGY, P171; Surakasi VP, 2011, INSECT MOL BIOL, V20, P609, DOI 10.1111/j.1365-2583.2011.01091.x; Svitkin YV, 2001, RNA, V7, P1743; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valzania L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095104; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; WEBB BA, 1994, ARCH INSECT BIOCHEM, V26, P147, DOI 10.1002/arch.940260208; Wyler T, 2003, J GEN VIROL, V84, P1151, DOI 10.1099/vir.0.18830-0; Yeh Jennifer E, 2015, Genes Cancer, V6, P153; Yu RX, 2007, J INSECT PHYSIOL, V53, P22, DOI 10.1016/j.jinsphys.2006.09.011	79	3	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161661	10.1371/journal.pone.0161661	http://dx.doi.org/10.1371/journal.pone.0161661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598941	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800014
J	Xu, JS; He, Q; Ma, ZG; Li, T; Zhang, XY; Debrunner-Vossbrinck, BA; Zhou, ZY; Vossbrinck, CR				Xu, Jinshan; He, Qiang; Ma, Zhenggang; Li, Tian; Zhang, Xiaoyan; Debrunner-Vossbrinck, Bettina A.; Zhou, Zeyang; Vossbrinck, Charles R.			The Genome of Nosema sp Isolate YNPr: A Comparative Analysis of Genome Evolution within the Nosema/Vairimorpha Clade	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; HOST-SPECIFICITY; ENCEPHALITOZOON-CUNICULI; COMPLETE SEQUENCE; PREDATORY MITE; MICROSPORIDIA; PARASITE; ORGANIZATION; PHYLOGENY; IDENTIFICATION	The microsporidian parasite designated here as Nosema sp. Isolate YNPr was isolated from the cabbage butterfly Pieris rapae collected in Honghe Prefecture, Yunnan Province, China. The genome was sequenced by Illumina sequencing and compared to those of two related members of the Nosema/Vairimorpha clade, Nosema ceranae and Nosema apis. Based upon assembly statistics, the Nosema sp. YNPr genome is 3.36 x 10(6)bp with a G+C content of 23.18% and 2,075 protein coding sequences. An "ACCCTT" motif is present approximately 50-bp upstream of the start codon, as reported from other members of the clade and from Encephalitozoon cuniculi, a sister taxon. Comparative small subunit ribosomal DNA (SSU rDNA) analysis as well as genome-wide phylogenetic analysis confirms a closer relationship between N. ceranae and Nosema sp. YNPr than between the two honey-bee parasites N. ceranae and N. apis. The more closely related N. ceranae and Nosema sp. YNPr show similarities in a number of structural characteristics such as gene synteny, gene length, gene number, transposon composition and gene reduction. Based on transposable element content of the assemblies, the transposon content of Nosema sp. YNPr is 4.8%, that of N. ceranae is 3.7%, and that of N. apis is 2.5%, with large differences in the types of transposons present among these 3 species. Gene function annotation indicates that the number of genes participating in most metabolic activities is similar in all three species. However, the number of genes in the transcription, general function, and cysteine protease categories is greater in N. apis than in the other two species. Our studies further characterize the evolution of the Nosema/Vairimorpha clade of microsporidia. These organisms maintain variable but very reduced genomes. We are interested in understanding the effects of genetic drift versus natural selection on genome size in the microsporidia and in developing a testable hypothesis for further studies on the genomic ecology of this group.	[Xu, Jinshan; Ma, Zhenggang; Zhang, Xiaoyan; Zhou, Zeyang] Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China; [He, Qiang; Li, Tian; Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Debrunner-Vossbrinck, Bettina A.] Gateway Community Coll, Dept Math Sci, 20 Church St, New Haven, CT 06510 USA; [Vossbrinck, Charles R.] Connecticut Agr Expt Stn, Dept Environm Sci, 123 Huntington St, New Haven, CT 06511 USA	Chongqing Normal University; Southwest University - China; Connecticut Agricultural Experiment Station	Xu, JS (corresponding author), Chongqing Normal Univ, Coll Life Sci, Chongqing, Peoples R China.	xujinshan2003@aliyun.com			National High-tech R&D Program (863 Program) [2013AA102507]; National Natural Science Foundation of China [31270138, 31302037, 31402142, 31001037]; Natural Science Foundation Project of Chongqing Science & technology Commission [cstc2015jcyjA80020]	National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing Science & technology Commission	This study is supported by National High-tech R&D Program (863 Program, No. 2013AA102507), National Natural Science Foundation of China (No. 31270138, 31302037, 31402142, 31001037), Natural Science Foundation Project of Chongqing Science & technology Commission (No. cstc2015jcyjA80020).	ANDREADIS TG, 1994, J INVERTEBR PATHOL, V64, P46, DOI 10.1006/jipa.1994.1067; ANDREADIS TG, 1985, P NATL ACAD SCI USA, V82, P5574, DOI 10.1073/pnas.82.16.5574; ANDREADIS TG, 1989, J MED ENTOMOL, V26, P140, DOI 10.1093/jmedent/26.3.140; Becnel JJ, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P671; Becnel JJ, 2002, J INVERTEBR PATHOL, V79, P163, DOI 10.1016/S0022-2011(02)00032-0; Bhat SA, 2009, AFR J AGR RES, V4, P1519; Bjornson S, 1999, BIOL CONTROL, V15, P153, DOI 10.1006/bcon.1999.0712; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Bruchhaus I, 2003, EUKARYOT CELL, V2, P501, DOI 10.1128/EC.2.3.501-509.2003; Chen DR, 2012, PARASITOL RES, V111, P263, DOI 10.1007/s00436-012-2829-6; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Choi J, 2009, GENES GENOM, V31, P443, DOI 10.1007/BF03191858; Choi Y, 2011, J INVERTEBR PATHOL, V107, P86, DOI 10.1016/j.jip.2011.02.005; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001277; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; EAKIN AE, 1992, J BIOL CHEM, V267, P7411; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Hayasaka S, 1999, JARQ-JPN AGR RES Q, V33, P65; He Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123170; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Huang WF, 2004, FUNGAL GENET BIOL, V41, P473, DOI 10.1016/j.fgb.2003.12.005; Kashkarova L, 1979, PARAZITOLOGIIA, V14, P164; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kawarabata Takeshi, 2003, Journal of Insect Biotechnology and Sericology, V72, P1; Keeling PJ, 2010, GENOME BIOL EVOL, V2, P304, DOI 10.1093/gbe/evq022; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Kent ML, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P493; Keohane EM, 1998, FOLIA PARASIT, V45, P117; Kingsolver JG, 2000, PHYSIOL BIOCHEM ZOOL, V73, P621, DOI 10.1086/317758; KUDO R. R., 1940, JOUR PARASITOL, V26, P123, DOI 10.2307/3272378; Kyei-Poku G, 2008, J EUKARYOT MICROBIOL, V55, P51, DOI 10.1111/j.1550-7408.2007.00302.x; LOM JII, 1963, ACTA PROTOZOOLOGICA, V1, P81; NAGELI KW, 1857, BOT Z, V15, P760; Nakjang S, 2013, GENOME BIOL EVOL, V5, P2285, DOI 10.1093/gbe/evt184; Natsopoulou ME, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1896; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Peyretaillade E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2156; Pombert JF, 2012, P NATL ACAD SCI USA, V109, P12638, DOI 10.1073/pnas.1205020109; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Sabath N, 2013, GENOME BIOL EVOL, V5, P966, DOI 10.1093/gbe/evt050; Selman M, 2011, CURR BIOL, V21, pR576, DOI 10.1016/j.cub.2011.06.017; Shaw Ross W., 1999, P418; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Smit AF, 1996, OPEN, V3, P1996; Solter LF, 1998, J INVERTEBR PATHOL, V71, P207, DOI 10.1006/jipa.1997.4740; Solter LF, 1997, J INVERTEBR PATHOL, V69, P135, DOI 10.1006/jipa.1996.4650; Solter LF, 2000, BIOL CONTROL, V19, P48, DOI 10.1006/bcon.2000.0845; Sprague V., 1977, Comparative pathobiology. Volume 2. Systematics of the Microsporidia., P1; SWEENEY AW, 1991, PARASITOL TODAY, V7, P217, DOI 10.1016/0169-4758(91)90147-G; SWEENEY AW, 1985, J INVERTEBR PATHOL, V46, P98, DOI 10.1016/0022-2011(85)90133-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TANADA Y, 1959, ANNU REV ENTOMOL, V4, P277, DOI 10.1146/annurev.en.04.010159.001425; Tsai SJ, 2005, J EUKARYOT MICROBIOL, V52, P52, DOI 10.1111/j.1550-7408.2005.3291rr.x; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Vossbrinck CR, 2005, FOLIA PARASIT, V52, P131, DOI 10.14411/fp.2005.017; Watanabe H, 1974, APPL ENTOMOL ZOOL, V3, P133; WEIDNER E, 1972, Z PARASITENKD, V40, P227; Williams BAP, 2005, P NATL ACAD SCI USA, V102, P10936, DOI 10.1073/pnas.0501321102; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	69	9	10	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162336	10.1371/journal.pone.0162336	http://dx.doi.org/10.1371/journal.pone.0162336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598992	Green Submitted, gold, Green Published			2022-12-27	WOS:000383254800054
J	Pacheco, LL; Jonzon, R; Hurtig, AK				Pacheco, Lubin Lobo; Jonzon, Robert; Hurtig, Anna-Karin			Health Assessment and the Right to Health in Sweden: Asylum Seekers' Perspectives	PLOS ONE			English	Article							PERCEIVED DISCRIMINATION; CARE; MIGRATION; SERVICES; ISSUES	Background Swedish law entitles asylum seekers to a voluntary health assessment and to "health care that cannot be postponed". The last expression suggests, however, restrictions on the entitlement, and what it may or may not include remains ultimately a decision for health professionals in the specific case. Indeed, the health assessment constitutes the sole active effort from Swedish authorities to fulfill this right. This study was therefore aimed at assessing how the information, procedures and services related to the health assessment are accessible and acceptable to fulfill the right to health of asylum seekers, from their own perspective. Methods The study has a cross-sectional design. A questionnaire was administrated in 16 language schools for immigrants, in four counties of Sweden. Three hundred eighty-six individuals fulfilled the inclusion criteria. The frequency of their answers was tabulated to estimate how the information, procedures and services related to the health assessment correspond to the criteria for accessibility and acceptability regarding the right to health. Findings Forty-eight (12.4%) respondents did not undergo the health assessment. Thirty-one of them did not even receive the invitation letter. They said they lost the opportunity to know their health status, to obtain treatment for or advice about their health problems. Additionally, 55.2% of those who attended the health assessment indicated that their needs were overlooked, particularly when these were of a psychological nature. Two in three participants also considered the health assessment to be a communicable disease control, rather than an effort to take care of their health needs. Nevertheless, the respondents had a positive attitude towards the health assessment as such. Conclusions Although being an important contribution, the health assessment does not suffice to fulfill the right to health of asylum seekers because there are shortcomings regarding the accessibility and acceptability of the information, procedures and services that it includes.	[Pacheco, Lubin Lobo; Jonzon, Robert; Hurtig, Anna-Karin] Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden; [Jonzon, Robert] Publ Hlth Agcy Sweden, Solna, Sweden	Umea University; Public Health Agency of Sweden	Pacheco, LL (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden.	lubinlobo1@gmail.com			European Refugee Fund [E85-292:51-2011-12792]	European Refugee Fund	The European Refugee Fund (Grant number E85-292:51-2011-12792) http://ec.europa.eu/dgs/home-affairs/financing/fundings/migrationasylum-borders/refugee-fund/index_en.htm RJ received the funding. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredstrom A, 2008, SAFE SEX UNSAFE IDEN; Brune Y, 1990, RADD OKANDA HIV AIDS; de Beco G, 2013, J HUM RIGHTS PRACT, V5, P380, DOI 10.1093/jhuman/hut003; Duvell F, 2010, POPUL SPACE PLACE, V16, P227, DOI 10.1002/psp.590; Ebeling A, 2011, ATT FORSTA BLI FORST; Hausmann LRM, 2008, MED CARE, V46, P905, DOI 10.1097/MLR.0b013e3181792562; Hjern A, 1997, SCAND J SOC MED, V25, P207, DOI 10.1177/140349489702500310; Jonzon R., 2014, 5 EUPHA EUR C MIGR E; Jonzon R, 2015, SCAND J PUBLIC HEALT, V43, P548, DOI 10.1177/1403494815576786; Kalengayi FKN, 2012, J IMMIGR MINOR HEALT, V14, P39, DOI 10.1007/s10903-011-9509-y; Laban CJ, 2008, SOC PSYCH PSYCH EPID, V43, P507, DOI 10.1007/s00127-008-0333-1; Lahman MKE, 2011, HISPANIC J BEHAV SCI, V33, P304, DOI 10.1177/0739986311414162; Lindkvist P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1333-6; Marks Stephen P., 2013, ADV HUMAN RIGHT HLTH, P1; Nkulu FKK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-349; Norredam M, 2009, EUROPEAN J PUBLIC HL, P1; Sorkin DH, 2010, J GEN INTERN MED, V25, P390, DOI 10.1007/s11606-010-1257-5; Stalgren M., 2008, EXPLORATIVE STUDY PR; Steel Z, 2004, INT J LAW PSYCHIAT, V27, P511, DOI 10.1016/j.ijlp.2004.08.006; Stevens D., 2010, NO IRELAND LEGAL Q, V61, P363; Suurmond J, 2013, PUBLIC HEALTH, V127, P668, DOI 10.1016/j.puhe.2013.04.004; Svenberg K, 2011, J REFUG STUD, V24, P1; Swedish government, 200649 SOU SWED GOV; Swedish government, NAT STRAT MOT HIV AI; The National Board of Health and Welfare, 2014, VARD PAPP; The Swedish Association of Local Authorities and Regions, 2014, HALS SJUK AS 2013; The Swedish Association of Local Authorities and Regions, 2008, SJUKV AS OMF KOSTN 2; The Swedish Association of Local Authorities and Regions, 2011, HALS SJUKV AS 2010; The Swedish Migration Agency, APPL AS REC 2015; The Swedish Migration Agency, 2007, UTV IN MOTT AS FRAN; UNHCR, CONV PROT REL STAT R; Union European, 2009, MIN STAND REC APPL A; United Nations High Commissioner for Refugees (UNHCR), 2015, MID TRENDS; Wamala S, 2007, J EPIDEMIOL COMMUN H, V61, P409, DOI 10.1136/jech.2006.049999; Westin M, 2004, HEALTH POLICY, V68, P333, DOI 10.1016/j.healthpol.2003.10.008	35	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161842	10.1371/journal.pone.0161842	http://dx.doi.org/10.1371/journal.pone.0161842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589238	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800021
J	Atanelishvili, I; Shirai, Y; Akter, T; Noguchi, A; Ash, KT; Misra, S; Ghatak, S; Silver, RM; Bogatkevich, GS				Atanelishvili, Ilia; Shirai, Yuichiro; Akter, Tanjina; Noguchi, Atsushi; Ash, Kurt T.; Misra, Suniti; Ghatak, Sibnath; Silver, Richard M.; Bogatkevich, Galina S.			D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts	PLOS ONE			English	Article							TYROSINE KINASE RECEPTOR; SYSTEMIC-SCLEROSIS; C-MET; CASPASE CLEAVAGE; GENE-TRANSFER; FIBROSIS; APOPTOSIS; EXPRESSION; PROTOONCOGENE; AMERICAN	Pulmonary fibrosis represents the terminal stage of a diverse group of lung diseases including scleroderma associated interstitial lung disease. The molecular mechanisms underlying the pathogenesis of lung fibrosis are not well understood and there is a great need for more effective treatment for this lethal disease. We recently discovered a small fragment of hepatocyte growth factor (HGF) receptor MET as a peptide designated "M10," with strong antifi-brotic properties. Furthermore, we showed that aspartic acid at position 1398 of MET is essential for M10 generation. The current study was undertaken to investigate the D1398G variant of MET in which aspartic acid at position 1398 was mutated to glycine resulting in loss of M10. We demonstrate that lung fibroblasts, A549, and primary alveolar epithelial cells (AEC) expressing D1398G MET exhibit reduced auto-phosphorylation on tyrosine residues and reduced activation of Ras and MAPK. HGF treatment of scleroderma lung fibroblasts as well as HGF treatment of TGF beta-treated normal lung fibroblasts transfected with wild type MET is associated with decreased collagen, connective tissue growth factor (CTGF, CCN2) and smooth muscle alpha-actin (SMA). However, HGF has no such effects in cells transfected with MET D1398G. Cisplatin- and FasL-induced apoptosis is significantly reduced in AEC transfected with MET wild type, but not in AEC transfected with MET D1398G. We conclude that the D1398G variant of MET is associated with compromised phosphorylation and impaired HGF signaling in lung fibroblasts and AEC, two cell types implicated in the pathogenesis of pulmonary fibrosis associated with scleroderma. Ongoing studies will explore the frequency of this variant and its relationship to pulmonary outcomes in scleroderma patients.	[Atanelishvili, Ilia; Shirai, Yuichiro; Akter, Tanjina; Noguchi, Atsushi; Ash, Kurt T.; Silver, Richard M.; Bogatkevich, Galina S.] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Shirai, Yuichiro] Nippon Med Sch, Dept Allergy & Rheumatol, Tokyo, Japan; [Misra, Suniti; Ghatak, Sibnath] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC USA	Medical University of South Carolina; Nippon Medical School; Medical University of South Carolina	Bogatkevich, GS (corresponding author), Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	bogatkev@musc.edu		Ash, Kurt/0000-0002-4460-9673	Clinical Research Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [P60 AR062755]; Scleroderma Foundation; South Carolina COBRE for Developmentally Based Cardiovascular Diseases (NIH-NIGMS) [P30 GM103342]	Clinical Research Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Scleroderma Foundation; South Carolina COBRE for Developmentally Based Cardiovascular Diseases (NIH-NIGMS)	This study was funded by the Multidisciplinary Clinical Research Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60 AR062755 to GSB and RMS) and by Scleroderma Foundation (to GSB). Imaging core was supported by South Carolina COBRE for Developmentally Based Cardiovascular Diseases (NIH-NIGMS P30 GM103342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter T, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0411-1; Atanelishvili I, 2016, TRANSL RES, V170, P99, DOI 10.1016/j.trsl.2015.12.009; Atanelishvili I, 2014, AM J RESP CELL MOL, V50, P893, DOI 10.1165/rcmb.2013-0317OC; Bhogal RK, 2005, J CLIN IMMUNOL, V25, P592, DOI 10.1007/s10875-005-7827-3; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P2432, DOI 10.1002/art.22713; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Bogatkevich GS, 2012, RHEUMATOL CURR RES S, VS1, pe001; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; Dohi M, 2000, AM J RESP CRIT CARE, V162, P2302, DOI 10.1164/ajrccm.162.6.9908097; Foveau B, 2007, CELL DEATH DIFFER, V14, P752, DOI 10.1038/sj.cdd.4402080; GALIMI F, 1993, STEM CELLS, V11, P22; Gazdhar A, 2013, HUM GENE THER, V24, P105, DOI 10.1089/hum.2012.098; Greidinger EL, 1998, CHEST, V114, P801, DOI 10.1378/chest.114.3.801; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Inoue H, 2003, FASEB J, V17, pA468; Kawaguchi Y, 2002, J RHEUMATOL, V29, P1877; Krishnan E, 2005, EUR J EPIDEMIOL, V20, P855, DOI 10.1007/s10654-005-2210-5; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Lee YH, 2008, AM J PHYSIOL-LUNG C, V294, pL778, DOI 10.1152/ajplung.00410.2007; Lefebvre J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.377; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; LONGATI P, 1994, ONCOGENE, V9, P49; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; McNearney TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P318, DOI 10.1002/art.22532; Mizuno S, 2005, FASEB J, V19, P580, DOI 10.1096/fj.04-1535fje; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; NAKAMURA T, 1991, Progress in Growth Factor Research, V3, P67, DOI 10.1016/0955-2235(91)90014-U; NALDINI L, 1991, ONCOGENE, V6, P501; Nietert PJ, 2005, J RHEUMATOL, V32, P1888; Okazaki S, 2010, RHEUMATOL INT, V30, P871, DOI 10.1007/s00296-009-1068-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodrigues G A, 1993, EXS, V65, P167; Schoenfeld SR, 2015, RHEUM DIS CLIN N AM, V41, P237, DOI 10.1016/j.rdc.2014.12.005; Silver RM, 2012, CURR OPIN RHEUMATOL, V24, P642, DOI 10.1097/BOR.0b013e328356d9dc; Steen V, 2012, ARTHRITIS RHEUM-US, V64, P2986, DOI 10.1002/art.34482; Thomason P, 2000, J CELL SCI, V113, P3141; Tulasne D, 2004, MOL CELL BIOL, V24, P10328, DOI 10.1128/MCB.24.23.10328-10339.2004; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Varga JA, 2008, RHEUM DIS CLIN N AM, V34, P115, DOI 10.1016/j.rdc.2007.11.002; VIGNA E, 1994, CELL MOL BIOL, V40, P597; Watanabe M, 2005, MOL THER, V12, P58, DOI 10.1016/j.ymthe.2005.02.019; YANAGITA K, 1993, J BIOL CHEM, V268, P21212; Zimmer Y, 2010, CANCER LETT, V289, P228, DOI 10.1016/j.canlet.2009.08.017	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162357	10.1371/journal.pone.0162357	http://dx.doi.org/10.1371/journal.pone.0162357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584154	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600130
J	Hani, Y; Ghuloum, S; Mahfoud, Z; Opler, M; Khan, A; Yehya, A; Abdulhakam, A; Hammoudeh, S; Al-Mujalli, A; Elsherbiny, R; Al-Amin, H				Hani, Yahya; Ghuloum, Suhaila; Mahfoud, Ziyad; Opler, Mark; Khan, Anzalee; Yehya, Arij; Abdulhakam, Abdulmoneim; Hammoudeh, Samer; Al-Mujalli, Azza; Elsherbiny, Reem; Al-Amin, Hassen			Validation of the Arabic Version of Calgary Depression Scale for Schizophrenia	PLOS ONE			English	Article							RATING-SCALE; GENDER DIFFERENCES; VALIDITY; RELIABILITY; POPULATION; ADAPTATION; SYMPTOMS	Background Patients with schizophrenia commonly show both depressive and negative symptoms that can differentially affect the prognosis and course of treatment. The Calgary Depression Scale for Schizophrenia (CDSS) was designed to distinguish between depression and negative symptoms in patients with schizophrenia. The purpose of this study is to validate an Arabic version of the CDSS among patients with schizophrenia. Methods The diagnosis of schizophrenia was confirmed using the Arabic Mini International Neuropsychiatric Interview 6 (MINI 6). A standardized translation back-translation process was adopted. One rater administered the Arabic CDSS to subjects with schizophrenia as well as to a control group who should not have any psychiatric disorder except for depression. Another rater, blinded to the results administered the already validated Arabic version of Beck Depression Inventory-II (BDI-II). Results We recruited 102 patients and 102 controls subjects. The CDSS showed good internal consistency in the active group (Cronbach's alpha = 0.82). The Intraclass Coefficient correlations (ICC) for the inter-rater reliability (n = 21) was 0.90, p<0.05 and test-retest reliability (n = 19) was 0.85, p<0.001. When compared to the BDI-II, the cutoff score of 5 on the Arabic CDSS showed reasonable sensitivity and specificity of 72.75% and 67.95% respectively. Conclusions The psychometric properties of the Arabic version of CDSS demonstrate that it is a valid tool to assess the depressive symptoms in the Arab patients with schizophrenia.	[Hani, Yahya; Ghuloum, Suhaila; Abdulhakam, Abdulmoneim] Hamad Med Corp, Rumailah Hosp, Dept Psychiat, Doha, Qatar; [Mahfoud, Ziyad] Weill Cornell Med Qatar, Dept Hlth Policy & Res, Doha, Qatar; [Opler, Mark; Khan, Anzalee] Prophase LLC, New York, NY USA; [Yehya, Arij; Hammoudeh, Samer; Elsherbiny, Reem] Weill Cornell Med Qatar, Dept Res, Doha, Qatar; [Al-Mujalli, Azza] Primary Hlth Care Corp, Doha, Qatar; [Al-Amin, Hassen] Weill Cornell Med Qatar, Dept Psychiat, Doha, Qatar	Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Primary Health Care Corporation (PHCC); Qatar Foundation (QF); Weill Cornell Medical College Qatar	Al-Amin, H (corresponding author), Weill Cornell Med Qatar, Dept Psychiat, Doha, Qatar.	haa2019@qatar-med.cornell.edu	Opler, Mark/U-7075-2019; Al-Amin, Hassen/ABC-3650-2020	Al-Amin, Hassen/0000-0001-6358-1541; Mahfoud, Ziyad/0000-0003-4098-6401; Hammoudeh, Samer/0000-0003-0805-8111; Yehya, Arij/0000-0001-6669-8470; Hani, Yahya/0000-0002-6617-8675	Qatar National Research Fund (QNRF) [NPRP 4-268-3-086]	Qatar National Research Fund (QNRF)(National Research Foundation of KoreaQatar National Research Fund (QNRF))	This study was part of a larger project funded solely by Qatar National Research Fund (QNRF) (www.qnrf.org) granted to Dr. Hassen Al-Amin (NPRP 4-268-3-086). QNRF did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Khalek AM, 1998, PSYCHOL REP, V82, P264, DOI 10.2466/PR0.82.1.264-266; ADDINGTON D, 1992, SCHIZOPHR RES, V6, P201, DOI 10.1016/0920-9964(92)90003-N; Addington D, 1996, SCHIZOPHR RES, V19, P205, DOI 10.1016/0920-9964(95)00070-4; ADDINGTON D, 1994, SCHIZOPHR RES, V11, P239, DOI 10.1016/0920-9964(94)90017-5; ADDINGTON D, 1990, SCHIZOPHR RES, V3, P247, DOI 10.1016/0920-9964(90)90005-R; Al-Musawi N M, 2001, J Pers Assess, V77, P568, DOI 10.1207/S15327752JPA7703_13; ANGERMEYER MC, 1989, PSYCHOL MED, V19, P365, DOI 10.1017/S0033291700012411; Bernard D, 1998, ACTA PSYCHIAT SCAND, V97, P36, DOI 10.1111/j.1600-0447.1998.tb09960.x; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Bosanac P, 2013, MED J AUSTRALIA, V199, P36, DOI 10.5694/mjao12.10516; Bressan RA, 1998, SCHIZOPHR RES, V32, P41; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Ghuloum S, 2011, J PAK MED ASSOC, V61, P216; GOLDSTEIN JM, 1988, AM J PSYCHIAT, V145, P684; Hafner H, 2005, SCHIZOPHR RES, V77, P11, DOI 10.1016/j.schres.2005.01.004; HIRSCH SR, 1989, SCHIZOPHR RES, V2, P259, DOI 10.1016/0920-9964(89)90002-9; Kadri N, 2005, EUR PSYCHIAT, V20, P193, DOI 10.1016/j.eurpsy.2004.11.007; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kaneda Y, 2000, No To Shinkei, V52, P163; Kim SW, 2006, PSYCHIAT RES, V144, P57, DOI 10.1016/j.psychres.2005.10.002; Kontaxakis VP, 2000, PSYCHIAT RES, V94, P163, DOI 10.1016/S0165-1781(00)00137-2; Lako IM, 2012, J AFFECT DISORDERS, V140, P38, DOI 10.1016/j.jad.2011.10.014; Lancon C, 1999, PSYCHIAT RES, V89, P123, DOI 10.1016/S0165-1781(99)00097-9; Maggini C, 2006, EUR PSYCHIAT, V21, P227, DOI 10.1016/j.eurpsy.2005.07.001; Mulholland C, 2000, ADV PSYCHIAT TREAT, V6, P169, DOI [10.1192/apt.6.3.169, DOI 10.1192/APT.6.3.169]; Muller MJ, 1999, J PSYCHIATR RES, V33, P433, DOI 10.1016/S0022-3956(99)00018-7; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; (QSA) QSA, 2010, CENSUS 2010, DOI [10.1016/j.eurpsy.2004.11.007, DOI 10.1016/J.EURPSY.2004.11.007]; Sarro S, 2004, SCHIZOPHR RES, V68, P349, DOI 10.1016/S0920-9964(02)00490-5; Siris SG, 2001, CLIN PRAC, P31; Suttajit S, 2013, NEUROPSYCH DIS TREAT, V9, P113, DOI 10.2147/NDT.S40292; WHO, 2004, GBD WHO REP 2004UPDA; Xiao WD, 2009, AUST NZ J PSYCHIAT, V43, P548, DOI 10.1080/00048670902873672; Yehya A, 2015, 4 QAT INT PSYCH C	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162304	10.1371/journal.pone.0162304	http://dx.doi.org/10.1371/journal.pone.0162304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583831	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600128
J	Gemmati, D; Burini, F; Talarico, A; Fabbri, M; Bertocco, C; Vigliano, M; Moratelli, S; Cuneo, A; Serino, ML; Avato, FM; Tisato, V; Gaudio, RM				Gemmati, Donato; Burini, Francesco; Talarico, Anna; Fabbri, Matteo; Bertocco, Cesare; Vigliano, Marco; Moratelli, Stefano; Cuneo, Antonio; Serino, Maria Luisa; Avato, Francesco Maria; Tisato, Veronica; Gaudio, Rosa Maria			The Active Metabolite of Warfarin (3 '-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study	PLOS ONE			English	Article							VKORC1 GENOTYPES; GENE VARIANTS; HUMAN PLASMA; CYP2C9; POLYMORPHISMS; VALIDATION; GUIDELINES; ASSAYS; OLD; LC	Objectives Warfarin oral anticoagulant therapy (OAT) requires regular and frequent drug adjustment monitored by INR. Interindividual variability, drug and diet interferences, and genetics (VKORC1 and CYP2C9) make the maintenance/reaching of stable INR a not so easy task. HPLC assessment of warfarin/enantiomers was suggested as a valid monitoring-tool along with INR, but definite results are still lacking. We evaluated possible correlations between INR, warfarin/3'-hydroxywarfarin, and drug weekly dosage aimed at searching novel alternatives to OAT monitoring. VKORC1/CYP2C9 pharmacogenetics investigation was performed to account for the known influence on warfarin homeostasis. Methods 133 OAT patients were recruited and assessed for warfarin/3'-hydroxywarfarin serum levels (HPLC), INR, and VKORC1 and CYP2C9 genotypes. A subgroup of 52 patients were monitored in detail (5 consecutive controls; c0-c4) till the target INR was reached. Correlation analyses were performed in both groups Results In the whole OAT group both warfarin and 3'-hydroxywarfarin correlate with INR at comparable degree (r(2) = 0.0388 and 0.0362 respectively). Conversely, warfarin weekly dosage better correlates with warfarin than with 3'-hydroxywarfarin (r(2) = 0.0975 and r(2) = 0.0381 respectively), but considering together warfarin plus 3'-hydroxywarfarin the correlation strongly increased (r(2) = 0.1114; p<0.0001). Interestingly, 3'-hydroxywarfarin reached a strong correlation at c4 respect to warfarin (r(2) = 0.2157 and r(2) = 0.0549; p = 0.0005 and p = 0.0944 respectively) seeming less affected by drug adjustments in the subgroup of 52 patients who started OAT. The multivariate analyses aimed at estimating the true contribution of 3'-hydroxywarfarin on INR value ascribed it the unique significant value (p = 0.0021) in spite of warfarin who lost association. The pharmacogenetics studies confirmed that patients carrying the VKORC1 variant-allele required lower warfarin maintenance dosage and that the combination of VKORC1 and CYP2C9 yielded a warfarin responsive index (WRI) inversely related to the number variant alleles Conclusion Our results overall suggest that 3'-hydroxywarfarin monitoring could be of great advantage in INR monitoring respect to classical warfarin assessment showing significant contribution also in multivariate analysis. Therefore, additional active metabolites should be recognized and investigated as novel useful indicators.	[Gemmati, Donato; Burini, Francesco; Vigliano, Marco; Moratelli, Stefano; Cuneo, Antonio; Serino, Maria Luisa] Univ Ferrara, Dept Biomed & Specialty Surg Sci, Sect Med Biochem Mol Biol & Genet, Ctr Haemostasis & Thrombosis, Ferrara, Italy; [Talarico, Anna; Fabbri, Matteo; Bertocco, Cesare; Avato, Francesco Maria; Gaudio, Rosa Maria] Univ Ferrara, Sect Med & Publ Hlth, Dept Med Sci, Ferrara, Italy; [Tisato, Veronica] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Tisato, Veronica] Univ Ferrara, LTTA Ctr, Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Gemmati, D (corresponding author), Univ Ferrara, Dept Biomed & Specialty Surg Sci, Sect Med Biochem Mol Biol & Genet, Ctr Haemostasis & Thrombosis, Ferrara, Italy.	d.gemmati@unife.if	Tisato, Veronica/K-4525-2016; Serino, Maria Luisa/AAC-7368-2022; Cuneo, Antonio/K-7617-2016; Fabri, Matteo/AAH-4639-2020	Fabri, Matteo/0000-0001-6343-3944; Gemmati, Donato/0000-0001-6213-6120; Tisato, Veronica/0000-0001-8448-066X				Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Benmira Sihame, 2010, Recent Pat Cardiovasc Drug Discov, V5, P120; Borkowski Andrew A, 2014, Recent Pat Biotechnol, V8, P110, DOI 10.2174/1872208309666140904112003; Dahal K, 2016, CHEST, V149, P951, DOI 10.1378/chest.15-1719; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Gemmati D, 2004, WOUND REPAIR REGEN, V12, P512, DOI 10.1111/j.1067-1927.2004.012503.x; Gemmati D, 2006, J VASC SURG, V44, P554, DOI 10.1016/j.jvs.2006.05.011; Gemmati D, 2009, J VASC SURG, V50, P1444, DOI 10.1016/j.jvs.2009.07.103; Harbrecht U, 2011, HAMOSTASEOLOGIE, V31, P21, DOI 10.5482/ha-1149; John JM, 2006, FUTUR CARDIOL, V2, P29, DOI 10.2217/14796678.2.1.29; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Johnson JA, 2015, TRENDS CARDIOVAS MED, V25, P33, DOI 10.1016/j.tcm.2014.09.001; Jones DR, 2011, J CHROMATOGR B, V879, P1056, DOI 10.1016/j.jchromb.2011.03.022; Jorgensen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044064; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Langley MR, 2009, J MOL DIAGN, V11, P216, DOI 10.2353/jmoldx.2009.080123; Lee K, 2015, CLIN PHARMACOKINET, V54, P517, DOI 10.1007/s40262-014-0219-1; Li JZ, 2015, NUTR METAB CARDIOVAS, V25, P706, DOI 10.1016/j.numecd.2015.03.013; Liu HQ, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0959-3; Marsalek P, 2015, ANAL BIOANAL CHEM, V407, P7849, DOI 10.1007/s00216-015-8954-1; Mazzaccara C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071505; Miyagata Y, 2011, INT HEART J, V52, P44, DOI 10.1536/ihj.52.44; Mushiroda T, 2006, J HUM GENET, V51, P249, DOI 10.1007/s10038-005-0354-5; Obayashi K, 2006, CLIN PHARMACOL THER, V80, P169, DOI 10.1016/j.clpt.2006.04.010; Osman A, 2005, J CHROMATOGR B, V826, P75, DOI 10.1016/j.jchromb.2005.08.011; Perez-Andreu V, 2009, CURR DRUG METAB, V10, P632, DOI 10.2174/138920009789375432; Ring PR, 2000, J PHARMACEUT BIOMED, V22, P573, DOI 10.1016/S0731-7085(00)00232-6; Schulman S, 2012, BLOOD, V119, P3016, DOI 10.1182/blood-2011-10-378950; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; Shaik AN, 2016, J CHROMATOGR B, V1008, P164, DOI 10.1016/j.jchromb.2015.11.036; Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191; Timson DJ, 2015, CURRENT DRUG TARGETS; Tisato V, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/423407; Tognazzo S, 2006, J VASC SURG, V44, P815, DOI 10.1016/j.jvs.2006.06.006; White Pamela J, 2010, J Pharm Pract, V23, P194, DOI 10.1177/0897190010362177; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003; Wittkowsky Ann K, 2003, Semin Vasc Med, V3, P221; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; Zuo Z, 2010, J PHARMACEUT BIOMED, V52, P305, DOI 10.1016/j.jpba.2010.01.005	39	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162084	10.1371/journal.pone.0162084	http://dx.doi.org/10.1371/journal.pone.0162084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606428	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600016
J	Kaliyappan, R; Viswanathan, S; Suthanthiram, B; Subbaraya, U; Somasundram, SM; Muthu, M				Kaliyappan, Raja; Viswanathan, Sriram; Suthanthiram, Backiyarani; Subbaraya, Uma; Somasundram, Saraswathi Marimuthu; Muthu, Mayilvaganan			Evolutionary Expansion of WRKY Gene Family in Banana and Its Expression Profile during the Infection of Root Lesion Nematode, Pratylenchus coffeae	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; KNOT NEMATODE; ARABIDOPSIS; DEFENSE; RESISTANCE; IMMUNITY; RICE	The WRKY family of transcription factors orchestrate the reprogrammed expression of the complex network of defense genes at various biotic and abiotic stresses. Within the last 96 million years, three rounds of Musa polyploidization events had occurred from selective pressure causing duplication of MusaWRKYs with new activities. Here, we identified a total of 153 WRKY transcription factors available from the DH Pahang genome. Based on their phylogenetic relationship, the MusaWRKYs available with complete gene sequence were classified into the seven common WRKY sub-groups. Synteny analyses data revealed paralogous relationships, with 17 MusaWRKY gene pairs originating from the duplication events that had occurred within the Musa lineage. We also found 15 other MusaWRKY gene pairs originating from much older duplication events that had occurred along Arecales and Poales lineage of commelinids. Based on the synonymous and nonsynonymous substitution rates, the fate of duplicated MusaWRKY genes was predicted to have undergone sub-functionalization in which the duplicated gene copies retain a subset of the ancestral gene function. Also, to understand the regulatory roles of MusaWRKY during a biotic stress, Illumina sequencing was performed on resistant and susceptible cultivars during the infection of root lesion nematode, Pratylenchus coffeae. The differential WRKY gene expression analysis in nematode resistant and susceptible cultivars during challenged and unchallenged conditions had distinguished: 1) MusaWRKYs participating in general banana defense mechanism against P.coffeae common to both susceptible and resistant cultivars, 2) MusaWRKYs that may aid in the pathogen survival as suppressors of plant triggered immunity, 3) MusaWRKYs that may aid in the host defense as activators of plant triggered immunity and 4) cultivar specific MusaWRKY regulation. Mainly, MusaWRKY52, -69 and -92 are found to be P.coffeae specific and can act as activators or repressors in a defense pathway. Overall, this preliminary study in Musa provides the basis for understanding the evolution and regulatory mechanism of MusaWRKY during nematode stress.	[Kaliyappan, Raja; Viswanathan, Sriram; Suthanthiram, Backiyarani; Subbaraya, Uma; Somasundram, Saraswathi Marimuthu; Muthu, Mayilvaganan] ICAR Natl Res Ctr Banana, Crop Improvement Div, Tiruchirappalli, Tamil Nadu, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Banana	Suthanthiram, B (corresponding author), ICAR Natl Res Ctr Banana, Crop Improvement Div, Tiruchirappalli, Tamil Nadu, India.	backiyarani@gmail.com			Indian Council for Agricultural Research [2000711005]	Indian Council for Agricultural Research	This work was supported by the Indian Council for Agricultural Research, grant no. 2000711005.	Adachi H, 2015, PLANT CELL; Ali MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102360; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Backiyarani S, 2014, PHYSIOL MOL PLANT P, V86, P11, DOI 10.1016/j.pmpp.2014.02.002; Bauters L, 2014, MOL PLANT PATHOL, V15, P352, DOI 10.1111/mpp.12098; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Food and Agriculture Organization of the United Nations, 2014, FAOSTAT DAT 2013; Grunewald W, 2008, PLANT PHYSIOL, V148, P358, DOI 10.1104/pp.108.119131; Grunewald W, 2013, EMBO REP, V14, P1136, DOI 10.1038/embor.2013.169; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Huh SU, 2015, SCI REP-UK, V5, DOI 10.1038/srep07981; Hurst LD, TRENDS GENETICS, V18, P486; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Kyndt T, 2012, NEW PHYTOL, V196, P887, DOI 10.1111/j.1469-8137.2012.04311.x; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Meng Y, 2012, MOL PLANT MICROBE IN, V25, P1492, DOI 10.1094/MPMI-04-12-0082-R; Olivier Garsmeur, 2013, POLYPLOIDE CYTOGENET, P16; Petitot AS, 2008, TREE GENET GENOMES, V4, P379, DOI 10.1007/s11295-007-0117-x; Nguyen PV, 2014, RICE, V7, DOI 10.1186/s12284-014-0023-4; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Smant G, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P273, DOI 10.1007/978-94-007-0434-3_13; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-270; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Wang YY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0076-3; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523	38	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162013	10.1371/journal.pone.0162013	http://dx.doi.org/10.1371/journal.pone.0162013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603787	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200036
J	Zhang, XH; Li, M; Zhang, BC; Chen, KM; He, KW				Zhang, Xuehan; Li, Meng; Zhang, Bicheng; Chen, Kangming; He, Kongwang			Development of a Sandwich ELISA for EHEC O157:H7 Intimin gamma 1	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; REAL-TIME PCR; EPEC; IDENTIFICATION; ANTIBODIES; O157-H7; GENES; CELLS	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a zoonotic pathogen of worldwide importance that causes foodborne infections in humans. Intimin gamma 1 (intimin gamma 1) is one of the most important outer membrane proteins required for EHEC's intimate adhesion to epithelial cells. Here, we generated a polyclonal antibody (pAb) and a monoclonal antibody (mAb) against intimin gamma 1 to develop a double antibody sandwich ELISA (DAS-ELISA) with increased sensitivity and specificity for measuring EHEC O157: H7. To achieve this goal, a rabbit pAb was used as a capture antibody, and a mouse mAb was a detection antibody. No cross-reactivity was observed with the other genera of pathogenic bacteria tested with the DAS-ELISA, which included Salmonella enteritidis, Shigella flexneri type 2, Listeria monocytogenes, Streptococcus suis type 2, and other 18 serotype E. coli. Detection limits of the DAS-ELISA were 1 x 10(3) CFU/mL for EHEC O157:H7 cultures, 1 x 10(4) CFU/g before enrichment, and 1 x 10(2) CFU/g after enrichment of contaminated samples. Field samples (n = 498) were tested using a previously established duplex-PCR method and compared to our DAS-ELISA. The DAS-ELISA had a specificity of 94.4%, a sensitivity of 91.5% and accuracy of 94.0% compared with duplex-PCR. The DAS-ELISA developed here can be applied to EHEC O157:H7 quantification in food, animal, and environmental samples.	[Zhang, Xuehan; Li, Meng; Zhang, Bicheng; He, Kongwang] Jiangsu Acad Agr Sci, Inst Vet Med, Natl Ctr Engn Res Vet Bioprod, Key Lab Engn Res Vet Bioprod,Agr Minist, Nanjing 210014, Jiangsu, Peoples R China; [Zhang, Xuehan; Li, Meng; Zhang, Bicheng; He, Kongwang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Xuehan; Li, Meng; Zhang, Bicheng; He, Kongwang] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Province, Nanjing 210014, Jiangsu, Peoples R China; [Chen, Kangming] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Jiangsu Academy of Agricultural Sciences; Kansas State University	Zhang, XH; He, KW (corresponding author), Jiangsu Acad Agr Sci, Inst Vet Med, Natl Ctr Engn Res Vet Bioprod, Key Lab Engn Res Vet Bioprod,Agr Minist, Nanjing 210014, Jiangsu, Peoples R China.; Zhang, XH; He, KW (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.; Zhang, XH; He, KW (corresponding author), State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Province, Nanjing 210014, Jiangsu, Peoples R China.	liuxuehan1996@hotmail.com; kwh2003@263.net		zhang, xuehan/0000-0002-0647-2266	Jiangsu province agricultural science and technology independent innovation funds [CX(16)1028]; National Natural Science Foundation of China [31572503]	Jiangsu province agricultural science and technology independent innovation funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Jiangsu province agricultural science and technology independent innovation funds (CX(16)1028) and the National Natural Science Foundation of China (31572503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidar-Ugrinovich L, 2007, INT J FOOD MICROBIOL, V115, P297, DOI 10.1016/j.ijfoodmicro.2006.10.046; Barletta F, 2009, J CLIN MICROBIOL, V47, P1915, DOI 10.1128/JCM.00608-09; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Blanco M, 2006, J MED MICROBIOL, V55, P1165, DOI 10.1099/jmm.0.46518-0; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096366; Deisingh AK, 2004, J APPL MICROBIOL, V96, P419, DOI 10.1111/j.1365-2672.2003.02170.x; Desmarchelier PM, 1998, J CLIN MICROBIOL, V36, P1801, DOI 10.1128/JCM.36.6.1801-1804.1998; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; GANNON VPJ, 1992, APPL ENVIRON MICROB, V58, P3809, DOI 10.1128/AEM.58.12.3809-3815.1992; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Kerr P, 2001, J APPL MICROBIOL, V90, P543, DOI 10.1046/j.1365-2672.2001.01281.x; Kim Seong-Hee, 2005, J Vet Sci, V6, P41; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Li BG, 2012, APPL ENVIRON MICROB, V78, P5297, DOI 10.1128/AEM.00794-12; Li BG, 1997, MOL CELL PROBE, V11, P397, DOI 10.1006/mcpr.1997.0132; Li L, 2011, ACTA AGRI BOREALI SI, V26, P58, DOI [10.7668/hbnxb.2011.06.012, DOI 10.7668/HBNXB.2011.06.012]; Li Y, 2004, J FOOD PROTECT, V67, P27, DOI 10.4315/0362-028X-67.1.27; Luo L, 2014, HUBEI AGR SCI, V53, DOI [10.1371/journal.pone.0091632, DOI 10.1371/JOURNAL.PONE.0091632]; Mohammed HO, 2015, J FOOD PROTECT, V78, P1812, DOI 10.4315/0362-028X.JFP-14-596; Rabinovitz BC, 2012, J DAIRY SCI, V95, P3318, DOI 10.3168/jds.2011-5093; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; ROGER V, 1992, CURR MICROBIOL, V25, P197, DOI 10.1007/BF01570719; SCHMIDT H, 1994, MED MICROBIOL IMMUN, V183, P23; Shen ZQ, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-14; Son WG, 2002, CLIN DIAGN LAB IMMUN, V9, P46, DOI 10.1128/CDLI.9.1.46-53.2002; Vandekerchove DGF, 2002, VET MICROBIOL, V88, P351, DOI 10.1016/S0378-1135(02)00125-6; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	33	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162274	10.1371/journal.pone.0162274	http://dx.doi.org/10.1371/journal.pone.0162274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603508	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200053
J	Multini, LC; Wilke, ABB; Suesdek, L; Marrelli, MT				Multini, Laura Cristina; Bruno Wilke, Andre Barretto; Suesdek, Lincoln; Marrelli, Mauro Toledo			Population Genetic Structure of Aedes fluviatilis (Diptera: Culicidae)	PLOS ONE			English	Article							IMMATURE MOSQUITOS DIPTERA; COLOMBIAN ATLANTIC COAST; SAO-PAULO; MUNICIPAL PARKS; MICROSATELLITE MARKERS; ECOLOGICAL ASPECTS; 1ST REPORT; CITY; EXPANSION; SOFTWARE	Although Aedes fluviatilis is an anthropophilic mosquito found abundantly in urban environments, its biology, epidemiological potential and genetic characteristics are poorly understood. Climate change and urbanization processes that result in environmental modifications benefit certain anthropophilic mosquito species such as Ae. fluviatilis, greatly increasing their abundance in urban areas. To gain a better understanding of whether urbanization processes modulate the genetic structure of this species in the city of Sao Paulo, we used eight microsatellite loci to genetically characterize Ae. fluviatilis populations collected in nine urban parks in the city of Sao Paulo. Our results show that there is high gene flow among the populations of this species, heterozygosity deficiency and low genetic structure and that the species may have undergone a recent population expansion. There are two main hypotheses to explain these findings: (i) Ae. fluviatilis populations have undergone a population expansion as a result of urbanization; and (ii) as urbanization of the city of Sao Paulo occurred recently and was quite intense, the structuring of these populations cannot be observed yet, apart from in the populations of Ibirapuera and Piqueri parks, where the first signs of structuring have appeared. We believe that the expansion found in Ae. fluviatilis populations is probably correlated with the unplanned urbanization of the city of Sao Paulo, which transformed green areas into urbanized areas, as well as the increasing population density in the city.	[Multini, Laura Cristina; Bruno Wilke, Andre Barretto; Marrelli, Mauro Toledo] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, SP, Brazil; [Multini, Laura Cristina; Suesdek, Lincoln; Marrelli, Mauro Toledo] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil; [Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan	Wilke, ABB (corresponding author), Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, SP, Brazil.	andrewilke@usp.br	Suesdek, Lincoln/C-7943-2013; Marrelli, Mauro/H-2568-2013; Wilke, Andre B B/J-9973-2014	Suesdek, Lincoln/0000-0001-6829-738X; Marrelli, Mauro/0000-0002-0312-8777; Wilke, Andre B B/0000-0002-6629-7666; Multini, Laura Cristina/0000-0002-1322-9889	State of Sao Paulo Research Foundation (FAPESP) [2013/15313-4]; FAPESP [2013/22347-2, 2012/19117-2]; CNPq [311805/2014-0]	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the State of Sao Paulo Research Foundation (FAPESP) for providing financial support (grant 2013/15313-4, www.fapesp.br). LCM was the recipient of a fellowship from FAPESP (2013/22347-2, www.fapesp.br), and ABBW was the recipient of a postdoctoral fellowship from FAPESP (2012/19117-2, www.fapesp.br). LS is the recipient of a CNPq grant (311805/2014-0, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Belisario CJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0879-1; Bello F, 2009, GENET MOL RES, V8, P1179, DOI 10.4238/vol8-3gmr652; Bello FJ, 2014, GENET MOL RES, V13, P4110, DOI 10.4238/2014.May.30.6; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102; Ceretti W, 2015, J AM MOSQUITO CONTR, V31, P172, DOI 10.2987/14-6457R; Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Cornuet JM, 1996, GENETICS, V144, P2001; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Edillo FE, 2007, J MED ENTOMOL, V44, P145, DOI 10.1603/0022-2585(2007)44[145:ASOBAM]2.0.CO;2; Edman J.D., 1988, Miscellaneous Publications of the Entomological Society of America, P43; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284; Forattini OP, 2002, CULICIDOLOGIA MED; GOMES AD, 1985, REV SAUDE PUBL, V19, P190, DOI 10.1590/S0034-89101985000200009; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515; Ibanez-Justicia A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0865-7; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kasai N, 1979, THESIS; LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487; Laporta GZ, 2006, REV BRAS ENTOMOL, V50, P125, DOI 10.1590/S0085-56262006000100019; Levy MZ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1003; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; McGaughran A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087317; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Michel AP, 2006, GENETICS, V173, P1389, DOI 10.1534/genetics.106.059667; Mirabello L, 2006, HEREDITY, V97, P438, DOI 10.1038/sj.hdy.6800913; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Multini LC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1256-9; NASCI RS, 1981, MOSQ NEWS, V41, P808; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; PATTON D R, 1975, Wildlife Society Bulletin, V3, P171; Porretta D, 2005, MOL ECOL NOTES, V5, P48, DOI 10.1111/j.1471-8286.2004.00826.x; Pudovkin AI, 1996, GENETICS, V144, P383; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131; StatSoft I., 2004, STAT DAT AN SOFTW SY; Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002; Tason de Camargo M.V., 1983, Memorias do Instituto Oswaldo Cruz, V78, P83; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Tchouassi DP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003364; Urbinatti PR, 2001, REV SAUDE PUBL, V35, P461, DOI 10.1590/S0034-89102001000500009; Piccinali RV, 2015, INFECT GENET EVOL, V34, P143, DOI 10.1016/j.meegid.2015.05.030; Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x; Vezzani D, 2006, VET PARASITOL, V136, P259, DOI 10.1016/j.vetpar.2005.10.026; WRBU, 2015, SYST CAT CUL; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093	67	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162328	10.1371/journal.pone.0162328	http://dx.doi.org/10.1371/journal.pone.0162328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598889	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800053
J	Ogiso, H; Ito, H; Ando, T; Arioka, Y; Kanbe, A; Ando, K; Ishikawa, T; Saito, K; Hara, A; Moriwaki, H; Shimizu, M; Seishima, M				Ogiso, Hideyuki; Ito, Hiroyasu; Ando, Tatsuya; Arioka, Yuko; Kanbe, Ayumu; Ando, Kazuki; Ishikawa, Tetsuya; Saito, Kuniaki; Hara, Akira; Moriwaki, Hisataka; Shimizu, Masahito; Seishima, Mitsuru			The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice	PLOS ONE			English	Article							INDUCED HEPATITIS MODEL; REGULATORY T-CELLS; CARBON-TETRACHLORIDE; DENDRITIC CELLS; RAT-LIVER; FULMINANT-HEPATITIS; KUPFFER CELLS; TNF-ALPHA; TRYPTOPHAN; INJURY	In the present study, we examined the role of indoleamine 2,3-dioxygenase (IDO) in the development of CCl4-induced hepatic fibrosis. The liver fibrosis induced by repetitive administration with CCl4 was aggravated in IDO-KO mice compared to WT mice. In IDO-KO mice treated with CCl4, the number of several inflammatory cells and the expression of pro-inflammatory cytokines increased in the liver. In the results, activated hepatic stellate cells (HSCs) and fibrogenic factors on HSCs increased after repetitive CCl4 administration in IDO-KO mice compared to WT mice. Moreover, the treatment with L-tryptophan aggravated the CCl4-induced hepatic fibrosis in WT mice. Our findings demonstrated that the IDO deficiency enhanced the inflammation in the liver and aggravated liver fibrosis in repetitive CCl4-treated mice.	[Ogiso, Hideyuki; Ito, Hiroyasu; Ando, Tatsuya; Arioka, Yuko; Kanbe, Ayumu; Ando, Kazuki; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Japan; [Moriwaki, Hisataka; Shimizu, Masahito] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan; [Ishikawa, Tetsuya] Nagoya Univ, Dept Med Technol, Sch Hlth Sci, Nagoya, Aichi, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Saito, Kuniaki] Fac Med, Kyoto, Japan; [Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan	Gifu University; Gifu University; Nagoya University; Kyoto University; Gifu University	Ito, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Japan.	hito@gifu-u.ac.jp		Arioka, Yuko/0000-0002-1792-8812				Abu-Tair L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082571; Bahcecioglu IH, 2004, CELL BIOCHEM FUNCT, V22, P359, DOI 10.1002/cbf.1114; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; CHATAMRA K, 1981, BRIT J EXP PATHOL, V62, P283; Chi Victor, 2007, J Vis Exp, P308, DOI 10.3791/308; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Dai Y, 1995, J PHARMACOL EXP THER, V275, P1614; Fan XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082190; Feng Yibin, 2010, Chin Med, V5, P33, DOI 10.1186/1749-8546-5-33; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; GEERTS A, 1988, J HEPATOL, V6, P50, DOI 10.1016/S0168-8278(88)80461-6; GRESSNER AM, 1992, HEPATOLOGY, V16, P1250; Gressner AM, 1996, KIDNEY INT, V49, pS39; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hoshi M, 2009, LEUKEMIA RES, V33, P39, DOI 10.1016/j.leukres.2008.05.023; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Ito H, 2014, IMMUNOLOGY; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Ito H, 2009, J IMMUNOL, V182, P391, DOI 10.4049/jimmunol.182.1.391; Iwamoto N, 2009, LIVER INT, V29, P277, DOI 10.1111/j.1478-3231.2008.01748.x; Kuales MA, 2011, HISTOL HISTOPATHOL, V26, P997, DOI 10.14670/HH-26.997; Li D, 2012, CELL BIOCHEM FUNCT, V30, P309, DOI 10.1002/cbf.2803; Lim HJ, 2011, MOL CELLS, V31, P123, DOI 10.1007/s10059-011-0016-8; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Murakami Y, 2012, CYTOKINE, V59, P245, DOI 10.1016/j.cyto.2012.04.022; Murata S, 2014, INT J MOL SCI, V15, P5412, DOI 10.3390/ijms15045412; Ogawa K, 2012, CANCER SCI, V103, P951, DOI 10.1111/j.1349-7006.2012.02237.x; Ohtaki H, 2014, BBA-MOL BASIS DIS, V1842, P1464, DOI 10.1016/j.bbadis.2014.04.015; Sakaida I, 1998, J HEPATOL, V28, P298, DOI 10.1016/0168-8278(88)80017-5; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schmidt SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063301; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Tarao K, 2013, SCAND J GASTROENTERO, V48, P729, DOI 10.3109/00365521.2013.782064; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TOMASI A, 1987, BIOCHEM J, V246, P313, DOI 10.1042/bj2460313; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zhang X, 2004, WORLD J GASTROENTERO, V10, P610, DOI 10.3748/wjg.v10.i4.610	40	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162183	10.1371/journal.pone.0162183	http://dx.doi.org/10.1371/journal.pone.0162183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598994	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800044
J	Okpeku, M; Esmailizadeh, A; Adeola, AC; Shu, LP; Zhang, YS; Wang, YZ; Sanni, TM; Imumorin, IG; Peters, SO; Zhang, JJ; Dong, Y; Wang, W				Okpeku, Moses; Esmailizadeh, Ali; Adeola, Adeniyi C.; Shu, Liping; Zhang, Yesheng; Wang, Yangzi; Sanni, Timothy M.; Imumorin, Ikhide G.; Peters, Sunday O.; Zhang, Jiajin; Dong, Yang; Wang, Wen			Genetic Variation of Goat Interferon Regulatory Factor 3 Gene and Its Implication in Goat Evolution	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; POSITIVE SELECTION; FACTOR FAMILY; EXPRESSION; IRF3	The immune systems are fundamentally vital for evolution and survival of species; as such, selection patterns in innate immune loci are of special interest in molecular evolutionary research. The interferon regulatory factor (IRF) gene family control many different aspects of the innate and adaptive immune responses in vertebrates. Among these, IRF3 is known to take active part in very many biological processes. We assembled and evaluated 1356 base pairs of the IRF3 gene coding region in domesticated goats from Africa (Nigeria, Ethiopia and South Africa) and Asia (Iran and China) and the wild goat (Capra aegagrus). Five segregating sites with. value of 0.0009 for this gene demonstrated a low diversity across the goats' populations. Fu and Li tests were significantly positive but Tajima's D test was significantly negative, suggesting its deviation from neutrality. Neighbor joining tree of IRF3 gene in domesticated goats, wild goat and sheep showed that all domesticated goats have a closer relationship than with the wild goat and sheep. Maximum likelihood tree of the gene showed that different domesticated goats share a common ancestor and suggest single origin. Four unique haplotypes were observed across all the sequences, of which, one was particularly common to African goats (MOCH-K14-0425, Poitou and WAD). In assessing the evolution mode of the gene, we found that the codon model d(N)/d(S) ratio for all goats was greater than one. Phylogenetic Analysis by Maximum Likelihood (PAML) gave a omega(0) (d(N)/d(S)) value of 0.067 with LnL value of -6900.3 for the first Model (M1) while omega 2 = 1.667 in model M2 with LnL value of -6900.3 with positive selection inferred in 3 codon sites. Mechanistic empirical combination (MEC) model for evaluating adaptive selection pressure on particular codons also confirmed adaptive selection pressure in three codons (207, 358 and 408) in IRF3 gene. Positive diversifying selection inferred with recent evolutionary changes in domesticated goat IRF3 led us to conclude that the gene evolution may have been influenced by domestication processes in goats.	[Okpeku, Moses; Esmailizadeh, Ali; Adeola, Adeniyi C.; Shu, Liping; Zhang, Yesheng; Wang, Yangzi; Dong, Yang; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Okpeku, Moses] Niger Delta Univ, Dept Anim Sci, Ammassoma, Bayelsa State, Nigeria; [Zhang, Jiajin] Yunnan Agr Univ, Sch Sci & Informat Engn, Kunming 650201, Peoples R China; [Dong, Yang] Kunming Univ Sci & Technol, Coll Life Sci, Lab Appl Genom & Synthet Biol, Kunming 650500, Peoples R China; [Sanni, Timothy M.] Fed Univ Agr, Dept Anim Breeding & Genet, Abeokuta, Ogun State, Nigeria; [Esmailizadeh, Ali] Shahid Bahonar Univ Kerman, Dept Anim Sci, PB 76169-133, Kerman, Iran; [Imumorin, Ikhide G.] Cornell Univ, Coll Agr & Life Sci, Anim Genet & Genom Lab, Off Int Programs, Ithaca, NY 14853 USA; [Peters, Sunday O.] Berry Coll, Dept Anim Sci, Mt Berry, GA USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan Agricultural University; Kunming University of Science & Technology; University of Agriculture, Abeokuta; Shahid Bahonar University of Kerman (SBUK); Cornell University	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.	wwang@mail.kiz.ac.cn	Peters, Sunday/AAE-9683-2021; Okpeku, Moses/T-8184-2019; Esmailizadeh, Ali/N-9005-2016; Esmailizadeh, Ali K./D-7252-2011; Wang, Wen/AAP-9873-2020; Adeola, Adeniyi Charles/GQH-3891-2022	Okpeku, Moses/0000-0002-8337-6294; Esmailizadeh, Ali/0000-0003-0986-6639; Esmailizadeh, Ali K./0000-0003-0986-6639; Adeola, Adeniyi Charles/0000-0001-5171-7878; Peters, Sunday/0000-0002-0216-926X	Chinese Academy of Sciences Fellowship [Y302851081]; Education Trust Fund (TETFUND), Nigeria [NDU/TETFUND/2013/0004]; "973" project [2013CB835200]; Chinese Academy of Sciences (CAS) International Post-doctoral Fellowship	Chinese Academy of Sciences Fellowship; Education Trust Fund (TETFUND), Nigeria; "973" project(National Basic Research Program of China); Chinese Academy of Sciences (CAS) International Post-doctoral Fellowship	This work was supported by the Chinese Academy of Sciences Fellowship for Postdoctoral and Visiting Scholars from Developing Countries, Grant Number Y302851081, awarded to Dr. Moses Okpeku; Education Trust Fund (TETFUND), Nigeria, Grant Number NDU/TETFUND/2013/0004, awarded to Dr. Moses Okpeku; and "973" project (Grant No. 2013CB835200) to Dr. Wen Wang.; We thank Dr. Wei Chen and Dr. Xueyan Li for their valuable comments and suggestions and proof reading of the manuscript. Kunming Institute of Zoology (KIZ), Kunming China is appreciated for hosting Dr. Moses Okpeku for the Chinese Academy of Sciences (CAS) International Post-doctoral Fellowship for Visiting Scholars from Developing Countries. All members of the Wen Wang Team in KIZ are appreciated for the warm support given to Dr. Moses Okpeku and his family.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agrafioti I, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-23; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Aziz M. A., 2010, Lohmann Information, V45, P42; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Boulila M, 2013, J GENET, V92, P11, DOI 10.1007/s12041-013-0211-9; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; de Lendonck LY, 2014, CELL MOL LIFE SCI, V71, P3873, DOI 10.1007/s00018-014-1653-9; de Lendonck LY, 2013, P NATL ACAD SCI USA, V110, pE3189, DOI 10.1073/pnas.1219221110; Di Paolo NC, 2013, CELL REP, V3, P1840, DOI 10.1016/j.celrep.2013.05.025; Dong Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1606-1; Ijaz N, 2015, PAK J AGR SCI, V52, P1113; Jann OC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-216; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kimball J. W., 2012, HAPLOTYPES; LEE YH, 1995, MOL BIOL EVOL, V12, P231; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Olson-Manning CF, 2013, MOL BIOL EVOL, V30, P14, DOI 10.1093/molbev/mss204; Pal C, 2001, GENETICS, V158, P927; Rabo JS, 1996, SMALL RUMINANT RES, V21, P161, DOI 10.1016/0921-4488(96)00855-3; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Rausher MD, 2013, EVOLUTION, V67, P34, DOI 10.1111/j.1558-5646.2012.01771.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; The International HapMap Consortium, 2003, INT HAPMAP PROJ, P789; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; Wright KM, 2010, GENETICS, V184, P483, DOI 10.1534/genetics.109.110411; Yang JR, 2012, P NATL ACAD SCI USA, V109, pE831, DOI 10.1073/pnas.1117408109; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161962	10.1371/journal.pone.0161962	http://dx.doi.org/10.1371/journal.pone.0161962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598391	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800029
J	Nisa-Martinez, R; Molina-Sanchez, MD; Toro, N				Nisa-Martinez, Rafael; Dolores Molina-Sanchez, Mara; Toro, Nicolas			Host Factors Influencing the Retrohoming Pathway of Group II Intron RmInt1, Which Has an Intron-Encoded Protein Naturally Devoid of Endonuclease Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-LEGUMINOSARUM; RIBOZYME CORE; RNASE H2; REPAIR; IDENTIFICATION; RETROMOBILITY; FLUORESCENCE; MUTAGENESIS	Bacterial group II introns are self-splicing catalytic RNAs and mobile retroelements that have an open reading frame encoding an intron-encoded protein (IEP) with reverse transcriptase (RT) and RNA splicing or maturase activity. Some IEPs carry a DNA endonuclease (En) domain, which is required to cleave the bottom strand downstream from the intron-insertion site for target DNA-primed reverse transcription (TPRT) of the inserted intron RNA. Host factors complete the insertion of the intron. By contrast, the major retrohoming pathway of introns with IEPs naturally lacking endonuclease activity, like the Sinorhizobium meliloti intron RmInt1, is thought to involve insertion of the intron RNA into the template for lagging strand DNA synthesis ahead of the replication fork, with possible use of the nascent strand to prime reverse transcription of the intron RNA. The host factors influencing the retrohoming pathway of such introns have not yet been described. Here, we identify key candidates likely to be involved in early and late steps of RmInt1 retrohoming. Some of these host factors are common to En(+) group II intron retrohoming, but some have different functions. Our results also suggest that the retrohoming process of RmInt1 may be less dependent on the intracellular free Mg2+ concentration than those of other group II introns.	[Nisa-Martinez, Rafael; Dolores Molina-Sanchez, Mara; Toro, Nicolas] CSIC, Struct Dynam & Funct Rhizobacterial Genomes, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, Calle Prof Albareda 1, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Struct Dynam & Funct Rhizobacterial Genomes, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, Calle Prof Albareda 1, E-18008 Granada, Spain.	nicolas.toro@eez.csic.es	Molina-Sánchez, Maria Dolores/J-1925-2016; Toro, Nicolas/K-4909-2014	Molina-Sánchez, Maria Dolores/0000-0002-3627-9360; Toro, Nicolas/0000-0002-3614-807X	 [BIO2014-51953-P]		This work was funded by BIO2014-51953-P (https://sede.micinn.gob.es/).	Baker-Austin C, 2005, MICROBIOL-SGM, V151, P2637, DOI 10.1099/mic.0.28076-0; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Becker A, 2009, J BIOTECHNOL, V140, P45, DOI 10.1016/j.jbiotec.2008.11.006; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chillon I, 2014, RNA, V20, P2000, DOI 10.1261/rna.047407.114; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Cooper DL, 2015, MOL MICROBIOL, V95, P769, DOI 10.1111/mmi.12899; Coros CJ, 2009, MOL CELL, V34, P250, DOI 10.1016/j.molcel.2009.03.014; Coros CJ, 2008, RNA, V14, P2634, DOI 10.1261/rna.1247608; Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416; Enyeart PJ, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-2; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Gregan J, 2001, GENE DEV, V15, P2229, DOI 10.1101/gad.201301; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lambowitz AM, 2010, COLD SPRING HARB PER, V3, DOI [DOI 10.1101/CSHPERSPECT.A003616, 10.1101/cshperspect.a003616]; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; Martinez-Abarca F, 2004, NUCLEIC ACIDS RES, V32, P2880, DOI 10.1093/nar/gkh616; Martinez-Abarca F, 2000, MOL MICROBIOL, V38, P917, DOI 10.1046/j.1365-2958.2000.02197.x; Massoni SC, 2012, J BACTERIOL, V194, P5325, DOI 10.1128/JB.00674-12; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Molina-Sanchez MD, 2015, GENOMIC ELEMENTS HLT, P195; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; Nisa-Martinez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084056; Pobigaylo N, 2008, MOL PLANT MICROBE IN, V21, P219, DOI 10.1094/MPMI-21-2-0219; Pobigaylo N, 2006, APPL ENVIRON MICROB, V72, P4329, DOI 10.1128/AEM.03072-05; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; PYLE AM, 2008, THE ROYAL SOCIETY OF, P201; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sambrook, 1989, MOL CLONING LAB MANU, P68; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Smith D, 2005, GENE DEV, V19, P2477, DOI 10.1101/gad.1345105; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Truong DM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005422; Truong DM, 2013, P NATL ACAD SCI USA, V110, pE3800, DOI 10.1073/pnas.1315742110; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; VILLADAS PJ, 1995, FEMS MICROBIOL ECOL, V17, P161, DOI 10.1111/j.1574-6941.1995.tb00139.x; Wais RJ, 2002, MOL PLANT MICROBE IN, V15, P1245, DOI 10.1094/MPMI.2002.15.12.1245; Yao J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003469	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162275	10.1371/journal.pone.0162275	http://dx.doi.org/10.1371/journal.pone.0162275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588750	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800045
J	Salminger, S; Sturma, A; Roche, AD; Hruby, LA; Paternostro-Sluga, T; Kumnig, M; Ninkovic, M; Pierer, G; Schneeberger, S; Gabl, M; Chelmonski, A; Jablecki, J; Aszmann, OC				Salminger, Stefan; Sturma, Agnes; Roche, Aidan D.; Hruby, Laura A.; Paternostro-Sluga, Tatjana; Kumnig, Martin; Ninkovic, Marina; Pierer, Gerhard; Schneeberger, Stefan; Gabl, Markus; Chelmonski, Adam; Jablecki, Jerzy; Aszmann, Oskar C.			Functional and Psychosocial Outcomes of Hand Transplantation Compared with Prosthetic Fitting in Below-Elbow Amputees: A Multicenter Cohort Study	PLOS ONE			English	Article							UPPER EXTREMITY; FOREARM TRANSPLANTATION; LIMB TRANSPLANTATION; WORLD EXPERIENCE; UPDATE; ALLOTRANSPLANTATION; ARM; IMMUNOSUPPRESSION; REHABILITATION; REPLANTATION	Background Hand-transplantation and improvements in the field of prostheses opened new frontiers in restoring hand function in below-elbow amputees. Both concepts aim at restoring reliable hand function, however, the indications, advantages and limitations for each treatment must be carefully considered depending on level and extent of amputation. Here we report our findings of a multi-center cohort study comparing hand function and quality-of-life of people with transplanted versus prosthetic hands. Methods Hand function in amputees with either transplant or prostheses was tested with Action Research Arm Test (ARAT), Southampton Hand Assessment Procedure (SHAP) and the Disabilities of the Arm, Shoulder and Hand measure (DASH). Quality-of-life was compared with the Short-Form 36 (SF-36). Results Transplanted patients (n = 5) achieved a mean ARAT score of 40.86 +/- 8.07 and an average SHAP score of 75.00 +/- 11.06. Prosthetic patients (n = 7) achieved a mean ARAT score of 39.00 +/- 3.61 and an average SHAP score of 75.43 +/- 10.81. There was no significant difference between transplanted and prosthetic hands in ARAT, SHAP or DASH. While qualityof- life metrics were equivocal for four scales of the SF-36, transplanted patients reported significantly higher scores in "role-physical" (p = 0.006), "vitality" (p = 0.008), "role-emotional" (p = 0.035) and "mental-health" (p = 0.003). Conclusions The indications for hand transplantation or prosthetic fitting in below-elbow amputees require careful consideration. As functional outcomes were not significantly different between groups, patient's best interests and the route of least harm should guide treatment. Due to the immunosuppressive side-effects, the indication for allotransplantation must still be restrictive, the best being bilateral amputees.	[Salminger, Stefan; Aszmann, Oskar C.] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria; [Salminger, Stefan; Sturma, Agnes; Roche, Aidan D.; Hruby, Laura A.; Aszmann, Oskar C.] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Christian Doppler Lab Restorat Extrem Funct, Vienna, Austria; [Sturma, Agnes; Hruby, Laura A.; Paternostro-Sluga, Tatjana] Med Univ Vienna, Dept Phys Med & Rehabil, Vienna, Austria; [Paternostro-Sluga, Tatjana] Danube Hosp Vienna, Dept Phys Med & Rehabil, Vienna, Austria; [Kumnig, Martin] Med Univ Innsbruck, Ctr Adv Psychol Plast & Transplant Surg, Dept Med Psychol, Innsbruck, Austria; [Ninkovic, Marina] Med Univ Innsbruck, Dept Phys Med & Rehabil, Innsbruck, Austria; [Pierer, Gerhard] Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, Innsbruck, Austria; [Schneeberger, Stefan] Med Univ Innsbruck, Dept Gen, Innsbruck, Austria; [Schneeberger, Stefan] Med Univ Innsbruck, Dept Transplant Surg, Innsbruck, Austria; [Gabl, Markus] Med Univ Innsbruck, Dept Traumatol, Innsbruck, Austria; [Chelmonski, Adam; Jablecki, Jerzy] St Hedwigss Hosp Trzebnica, Hand Trauma Ctr, Subdept Replantat Limbs, Trzebnica, Poland; [Jablecki, Jerzy] State Higher Med Profess Sch, Opole, Poland	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Donauspital; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Aszmann, OC (corresponding author), Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria.; Aszmann, OC (corresponding author), Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Christian Doppler Lab Restorat Extrem Funct, Vienna, Austria.	oskar.aszmann@meduniwien.ac.at	Schneeberger, Stefan/S-9329-2019; Sturma, Agnes/AAO-1489-2021; Roche, Aidan/AAC-5695-2019	Schneeberger, Stefan/0000-0002-2619-8639; Sturma, Agnes/0000-0003-2066-1394; Salminger, Stefan/0000-0002-1992-7354; Gabl, Markus/0000-0001-7459-2756; jablecki, jerzy/0000-0002-9498-1051; Roche, Aidan/0000-0002-8892-5053	Christian Doppler Research Foundation a subdivision of the Austrian Federal Ministry of Economy, Family and Youth; Austrian Council for Research and Technology Development	Christian Doppler Research Foundation a subdivision of the Austrian Federal Ministry of Economy, Family and Youth; Austrian Council for Research and Technology Development	This work was supported by the Christian Doppler Research Foundation a subdivision of the Austrian Federal Ministry of Economy, Family and Youth, the Austrian Council for Research and Technology Development.	Agnew SP, 2012, J RECONSTR MICROSURG, V28, P63, DOI 10.1055/s-0031-1281522; Aszmann OC, 2015, LANCET, V385, P2183, DOI 10.1016/S0140-6736(14)61776-1; Benatar D, 2002, BMJ-BRIT MED J, V324, P971, DOI 10.1136/bmj.324.7343.971; Bernardon L, 2015, J PLAST RECONSTR AES, V68, P1171, DOI 10.1016/j.bjps.2015.07.007; Bhaskaranand K, 2003, ARCH ORTHOP TRAUM SU, V123, P363, DOI 10.1007/s00402-003-0546-4; Biddiss E, 2007, AM J PHYS MED REHAB, V86, P977, DOI 10.1097/PHM.0b013e3181587f6c; Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Breidenbach WC, 2002, J HAND SURG-AM, V27A, P760, DOI 10.1053/jhsu.2002.35306; Brenner MJ, 2002, J BONE JOINT SURG AM, V84A, P1861, DOI 10.2106/00004623-200210000-00020; Brugger U., 2013, HTAI C SEOUL; Carty MJ, 2013, PLAST RECONSTR SURG, V132, P423, DOI 10.1097/PRS.0b013e318295883d; Chang J, 2011, HAND CLIN, V27, P553, DOI 10.1016/j.hcl.2011.07.006; Chelmonski A, 2015, ANN TRANSPL, V20, P639; Chung Kevin C, 2010, Plast Reconstr Surg, V125, P589, DOI 10.1097/PRS.0b013e3181c82eb6; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Farina D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010453; Gilbert R, 1964, MED TRIB MED NEWS, V5; Graham B, 1998, J HAND SURG-AM, V23A, P783, DOI 10.1016/S0363-5023(98)80151-2; Hautz T, 2011, HAND CLIN, V27, P423, DOI 10.1016/j.hcl.2011.07.004; Herndon JH, 2000, NEW ENGL J MED, V343, P503, DOI 10.1056/NEJM200008173430710; Hettiaratchy S, 2003, BRIT MED J, V326, P1226, DOI 10.1136/bmj.326.7401.1226; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jablecki J, 2009, TRANSPL P, V41, P513, DOI 10.1016/j.transproceed.2009.01.006; Jablecki J, 2011, HAND CLIN, V27, P433, DOI 10.1016/j.hcl.2011.08.003; Jones NF, 2002, J HAND SURG-AM, V27A, P771, DOI 10.1053/jhsu.2002.34373; Kanitakis J, 2003, TRANSPLANTATION, V76, P688, DOI 10.1097/01.TP.0000079458.81970.9A; Kay S, 2013, J PLAST RECONSTR AES, V66, P1456, DOI 10.1016/j.bjps.2013.04.065; Kumnig M, 2012, TRANSPL INT, V25, P573, DOI 10.1111/j.1432-2277.2012.01463.x; Kyberd PJ, 2009, BRIT J OCCUP THER, V72, P212, DOI 10.1177/030802260907200506; Lanzetta M, 2001, J HAND SURG-BRIT EUR, V26, P511, DOI 10.1054/jhsb.2001.0635; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; Mathes DW, 2009, J HAND SURG-AM, V34A, P808, DOI 10.1016/j.jhsa.2009.01.021; Meyer TM, 2003, HAND CLIN, V19, P41, DOI 10.1016/S0749-0712(02)00056-2; Ninkovic M, 2011, HAND CLIN, V27, P455, DOI 10.1016/j.hcl.2011.08.005; PEACOCK K, 1987, CLIN ORTHOP RELAT R, P153; Petruzzo Palmina, 2011, Clin Transpl, P247; Pinzur M S, 1999, Chir Narzadow Ruchu Ortop Pol, V64, P571; Piza-Katzer H, 2001, J HAND SURG-BRIT EUR, V26, P518, DOI 10.1054/jhsb.2001.0672; Piza-Katzer H, 2002, J HAND SURG-BRIT EUR, V27B, P385, DOI 10.1054/jhsb.2002.0759; Piza-Katzer H, 2009, HANDCHIR MIKROCHIR P, V41, P210, DOI 10.1055/s-0029-1225628; Roche AD, 2014, CURR SURG REP, V2, DOI 10.1007/s40137-013-0044-8; Salminger S, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0128-3; Salminger S, 2015, ORTHOPADE, V44, P413, DOI 10.1007/s00132-015-3113-0; Schneeberger S, 2007, AM J TRANSPLANT, V7, P1753, DOI 10.1111/j.1600-6143.2007.01837.x; Schneeberger S, 2011, TRANSPL INT, V24, P760, DOI 10.1111/j.1432-2277.2011.01261.x; Schuind F, 2007, J HAND SURG-BRIT EUR, V32E, P2, DOI 10.1016/j.jhsb.2006.09.008; Shores JT, 2015, PLAST RECONSTR SURG, V135, p351E, DOI 10.1097/PRS.0000000000000892; Simmons PD, 2000, MICROSURG, V20, P458, DOI 10.1002/1098-2752(2000)20:8<458::AID-MICR19>3.0.CO;2-G; Szajerka T, ANN TRANSPLANT, V16, P83; Turner-Bowker DM, 2002, SF 36 HLTH SURVEY SF; Unger L, 2014, COURIER J; Vilkki SK, 2007, J PLAST RECONSTR AES, V60, P835, DOI 10.1016/j.bjps.2007.02.018; Ware J., 1993, SF 36 HLTH SURVEY MA; Weissenbacher A, 2014, VCA, V1, P11, DOI DOI 10.4161/23723505.2014.973798; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	55	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162507	10.1371/journal.pone.0162507	http://dx.doi.org/10.1371/journal.pone.0162507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589057	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800065
J	Wang, WC; Chen, SY; Zhang, XZ				Wang, Wen-Cai; Chen, Si-Yun; Zhang, Xian-Zhi			Chloroplast Genome Evolution in Actinidiaceae: clpP Loss, Heterogenous Divergence and Phylogenomic Practice	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PLASTID GENOMES; INDEPENDENT TRANSFERS; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; GENE LOSSES; ANGIOSPERMS; REPEAT; CAMPANULACEAE; BIOGEOGRAPHY	Actinidiaceae is a well-known economically important plant family in asterids. To elucidate the chloroplast (cp) genome evolution within this family, here we present complete genomes of three species from two sister genera (Clematoclethra and Actinidia) in the Actinidiaceae via genome skimming technique. Comparative analyses revealed that the genome structure and content were rather conservative in three cp genomes in spite of different inheritance pattern, i.e. paternal in Actinidia and maternal in Clematoclethra. The clpP gene was lacked in all the three sequenced cp genomes examined here indicating that the clpP gene loss is likely a conspicuous synapomorphic characteristic during the cp genome evolution of Actinidiaceae. Comprehensive sequence comparisons in Actinidiaceae cp genomes uncovered that there were apparently heterogenous divergence patterns among the cpDNA regions, suggesting a preferred data-partitioned analysis for cp phylogenomics. Twenty non-coding cpDNA loci with fast evolutionary rates are further identified as potential molecular markers for systematics studies of Actinidiaceae. Moreover, the cp phylogenomic analyses including 31 angiosperm plastomes strongly supported the monophyly of Actinidia, being sister to Clematoclethra in Actinidiaceae which locates in the basal asterids, Ericales.	[Zhang, Xian-Zhi] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Wang, Wen-Cai] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England; [Chen, Si-Yun] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China	Northwest A&F University - China; University of London; Queen Mary University London; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, XZ (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	zhangxianzhi@nwsuaf.edu.cn		chen (CHEN), si yun (Si-Yun)/0000-0002-1730-5420	Northwest AF University [2452016052, Z109021509]	Northwest AF University	This study was funded by the Basic Science Fund (grant no. 2452016052) and Doctor Startup Fund (grant no. Z109021509) from Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barrett CF, 2016, NEW PHYTOL, V209, P855, DOI 10.1111/nph.13617; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chat J, 2004, AM J BOT, V91, P736, DOI 10.3732/ajb.91.5.736; Chat J, 1999, THEOR APPL GENET, V99, P314, DOI 10.1007/s001220051238; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cusimano N, 2016, NEW PHYTOL, V210, P680, DOI 10.1111/nph.13784; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dodsworth S, 2014, SYST BIOL, P1; Dodsworth S, 2015, TRENDS PLANT SCI, V20, P525, DOI 10.1016/j.tplants.2015.06.012; Dong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077965; Downie SR, 2015, SYST BOT, V40, P336, DOI 10.1600/036364415X686620; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fajardo D, 2013, TREE GENET GENOMES, V9, P489, DOI 10.1007/s11295-012-0573-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Givnish TJ, 2016, CLADISTICS, V32, P581, DOI 10.1111/cla.12153; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Hao WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108291; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Huang HW, 2013, ACTINIDIA TAXONOMY R; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Jiang W, 2014, MOL PHYLOGENET EVOL, V80, P308, DOI 10.1016/j.ympev.2014.08.006; Jones SS, 2014, PLANT SYST EVOL, V300, P1421, DOI 10.1007/s00606-013-0971-y; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Knox EB, 2014, P NATL ACAD SCI USA, V111, P11097, DOI 10.1073/pnas.1403363111; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Li JQ, 2002, SYST BOT, V27, P408; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Ma PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11608; Ma PF, 2014, SYST BIOL, V63, P933, DOI 10.1093/sysbio/syu054; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Miller M.A., 2010, P GAT COMP ENV WORKS; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Raubeson LA, 2007, PLANT DIVERSITY EVOL, P45; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Sloan DB, 2014, MOL PHYLOGENET EVOL, V72, P82, DOI 10.1016/j.ympev.2013.12.004; Sloan DB, 2012, GENOME BIOL EVOL, V4, P294, DOI 10.1093/gbe/evs006; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Streicher JW, 2016, SYST BIOL, V65, P128, DOI 10.1093/sysbio/syv058; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ueda M, 2007, GENE, V402, P51, DOI 10.1016/j.gene.2007.07.019; Weitemier K, 2015, PEERJ, V2, DOI 10.7717/peerj.718; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; Wicke S, 2015, REGNUM VEG, V158, P9; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wu CS, 2015, GENOME BIOL EVOL, V7, P2000, DOI 10.1093/gbe/evv125; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053939, 10.1371/journal.pone.0073053]; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144701; Zhang XZ, 2016, MOL PHYLOGENET EVOL, V96, P118, DOI 10.1016/j.ympev.2015.11.025; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao H, 2015, SCI REPORTS, V5, P5018	84	34	35	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162324	10.1371/journal.pone.0162324	http://dx.doi.org/10.1371/journal.pone.0162324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589600	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877800051
J	Bazyar, S; Ramalho, J; Eldeniz, C; An, HY; Lee, YZ				Bazyar, Soha; Ramalho, Joana; Eldeniz, Cihat; An, Hongyu; Lee, Yueh Z.			Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; MAGNETIC-RESONANCE PERFUSION; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; MICROVASCULAR PERMEABILITY; QUANTITATIVE MEASUREMENT; VASCULAR-PERMEABILITY; CLINICAL-APPLICATIONS; BARRIER PERMEABILITY; RECIRCULATION PHASE	Purpose Plasma volume and blood volume are imaging-derived parameters that are often used to evaluation intracranial tumors. Physiologically, these parameters are directly related, but their two different methods of measurements, T1-dynamic contrast enhanced (DCE)-and T2-dynamic susceptibility contrast (DSC)-MR utilize different model assumptions and approaches. This poses the question of whether the interchangeable use of T1-DCE-MRI derived fractionated plasma volume (vp) and relative cerebral blood volume (rCBV) assessed using DSC-MRI, particularly in glioblastoma, is reliable, and if this relationship can be generalized to other types of brain tumors. Our goal was to examine the hypothetical correlation between these parameters in three most common intracranial tumor types. Methods Twenty-four newly diagnosed, treatment naive brain tumor patients, who had undergone DCE- and DSC-MRI, were classified in three histologically proven groups: glioblastoma (n = 7), meningioma (n = 9), and intraparenchymal metastases (n = 8). The rCBV was obtained from DSC after normalization with the normal-appearing anatomically symmetrical contralateral white matter. Correlations between these parameters were evaluated using Pearson (r), Spearman's (rho) and Kendall's tau-b (tau(B)) rank correlation coefficient. Results The Pearson, Spearman and Kendall's correlation between vp with rCBV were r = 0.193, rho= 0.253 and tau(B) = 0.33 (p-(Pearson) = 0.326, p-(Spearman) = 0.814 and p-(Kendall) = 0.823) in glioblastoma, r = -0.007,. = 0.051 and tau(B) = 0.135 (p-(Pearson) = 0.970, p-(Spearman) = 0.765 and p-(Kendall) = 0.358) in meningiomas, and r = 0.289, rho = 0.228 and tau(B) = 0.239 (p-(Pearson) = 0.109, p-(Spearman) = 0.210 and p-(Kendall) = 0.095) in metastasis. Conclusion Results indicate that no correlation exists between vp with rCBV in glioblastomas, meningiomas and intraparenchymal metastatic lesions. Consequently, these parameters, as calculated in this study, should not be used interchangeably in either research or clinical practice.	[Bazyar, Soha; Lee, Yueh Z.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA; [Ramalho, Joana] Ctr Hosp Lisboa Cent, Lisbon, Portugal; [Eldeniz, Cihat; An, Hongyu] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO USA; [An, Hongyu] Washington Univ, Ctr Clin Imaging Res, St Louis, MO USA; [Lee, Yueh Z.] Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA; [Lee, Yueh Z.] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA; [Lee, Yueh Z.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; Centro Hospitalar de Lisboa Central, EPE; Universidade de Lisboa; Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bazyar, S; Lee, YZ (corresponding author), Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27599 USA.; Lee, YZ (corresponding author), Univ N Carolina, Dept Radiol, Chapel Hill, NC 27599 USA.; Lee, YZ (corresponding author), Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27599 USA.; Lee, YZ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	sbazyar@ncsu.edu; leey@med.unc.edu	Lee, Yueh/AAF-1430-2021	Lee, Yueh/0000-0003-1846-7680; Bazyar, Soha/0000-0002-8425-8281; Eldeniz, Cihat/0000-0002-4457-0916	NCI NIH HHS [P30 CA016086] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcaide-Leon P, 2015, AM J NEURORADIOL, V36, P871, DOI 10.3174/ajnr.A4231; ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Bergamino M, 2014, CLIN IMAG, V38, P808, DOI 10.1016/j.clinimag.2014.07.008; Bhujwalla Z M, 1999, Top Magn Reson Imaging, V10, P92, DOI 10.1097/00002142-199904000-00002; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Bruening R, 1996, AM J NEURORADIOL, V17, P831; Buckley DL, 2002, MAGN RESON MED, V47, P601, DOI 10.1002/mrm.10080; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2006, AM J NEURORADIOL, V27, P409; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Covarrubias DJ, 2004, ONCOLOGIST, V9, P528, DOI 10.1634/theoncologist.9-5-528; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Gahramanov S, 2011, INT J RADIAT ONCOL, V79, P514, DOI 10.1016/j.ijrobp.2009.10.072; Haroon HA, 2007, BRIT J RADIOL, V80, P161, DOI 10.1259/bjr/17112059; Harrer JU, 2004, J MAGN RESON IMAGING, V20, P748, DOI 10.1002/jmri.20182; Hu LS, 2010, AM J NEURORADIOL, V31, P40, DOI 10.3174/ajnr.A1787; Jackson A, 2002, AM J NEURORADIOL, V23, P7; Johnson G, 2002, P 10 ANN M ISMRM HON, P2123; Jung BC, 2016, J NEUROIMAGING, V26, P240, DOI 10.1111/jon.12281; Kassner A, 2000, J MAGN RESON IMAGING, V11, P103, DOI 10.1002/(SICI)1522-2586(200002)11:2<103::AID-JMRI5>3.0.CO;2-Z; Kety Seymour S., 1995, P201; Knopp EA, 1999, RADIOLOGY, V211, P791, DOI 10.1148/radiology.211.3.r99jn46791; Lacerda S, 2009, NEUROIMAG CLIN N AM, V19, P527, DOI 10.1016/j.nic.2009.08.007; Larsen VA, 2013, NEURORADIOLOGY, V55, P361, DOI 10.1007/s00234-012-1127-4; Law M, 2004, AM J NEURORADIOL, V25, P746; Law M., 2009, CLIN MR NEUROIMAGING, P341; Lev MH, 1999, NEUROIMAG CLIN N AM, V9, P309; Li K L, 2000, J Magn Reson Imaging, V12, P347, DOI 10.1002/1522-2586(200008)12:2<347::AID-JMRI19>3.0.CO;2-7; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Ludemann L, 2005, MAGN RESON IMAGING, V23, P833, DOI 10.1016/j.mri.2005.06.007; Ludemann L, 2009, EUR J RADIOL, V70, P465, DOI 10.1016/j.ejrad.2008.02.012; Mouthuy N, 2012, J NEURORADIOLOGY, V39, P301, DOI 10.1016/j.neurad.2011.11.002; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Provenzale JM, 2002, AM J ROENTGENOL, V178, P711, DOI 10.2214/ajr.178.3.1780711; Roberts HC, 2000, AM J NEURORADIOL, V21, P891; Santarosa C, 2016, EUR J RADIOL, V85, P1147, DOI 10.1016/j.ejrad.2016.03.020; Server A, 2011, NEURORADIOLOGY, V53, P319, DOI 10.1007/s00234-010-0740-3; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; WEINMANN HJ, 1984, PHYSIOL CHEM PHYS ME, V16, P167; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161807	10.1371/journal.pone.0161807	http://dx.doi.org/10.1371/journal.pone.0161807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584684	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600062
J	Bradshaw, D; Raghwani, J; Jacka, B; Sacks-Davis, R; Lamoury, F; Down, I; Prestage, G; Applegate, TL; Hellard, M; Sasadeusz, J; Dore, GJ; Pybus, OG; Matthews, GV; Danta, M				Bradshaw, Daniel; Raghwani, Jayna; Jacka, Brendan; Sacks-Davis, Rachel; Lamoury, Francois; Down, Ian; Prestage, Garrett; Applegate, Tanya L.; Hellard, Margaret; Sasadeusz, Joe; Dore, Gregory J.; Pybus, Oliver G.; Matthews, Gail V.; Danta, Mark			Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men	PLOS ONE			English	Article							HEPATITIS-C VIRUS; POSITIVE MEN; PHYLOGENETIC ANALYSIS; SEQUENCE-ANALYSIS; RISK-FACTORS; SEX; PREVALENCE; SYDNEY; COHORT; RNA	Background This study aimed to investigate the potential influence of venue-based networks on HCV transmission in HIV-positive gay and bisexual men (GBM). Methods This was a prospectively recruited cohort of HIV-infected GBM with recently-acquired HCV infection resident in Melbourne and Sydney. Clinical and demographic data were collected together with blood samples for HCV sequencing. Phylogenies were inferred and clusters of individuals infected with HCV with genetic sequence homology were identified. Venues used for sourcing sexual partners were identified; sourcing partners from the same venue was considered a potential social link. Using the Jaccard similarity coefficient, associations were identified between the network of sites where men sourced sex partners and transmission relationships as defined by phylogenetic clustering. Results Forty individuals were recruited, of whom 62.5% were considered to have sexually-and 37.5% IDU-acquired HCV. Venue use was consistent with men being members of a more sexually adventurous gay community subculture. Six phylogenetically-determined pairs or clusters were identified, comprising fifteen (15/28, 53.6%) individuals. Participants belonging to phylogenetic clusters were observed within the same networks. There was a significant correlation between the network and phylogenetic clustering when both cities were considered simultaneously (p = 0.005), raising the possibility that social connections may be important for HCV transmissions. Conclusions Venue-based network elicitation is a promising approach for elucidating HCV transmissions amongst HIV-infected GBM. Public health approaches targeting individuals and venues prominent within networks may reduce onward HCV transmission.	[Bradshaw, Daniel; Jacka, Brendan; Lamoury, Francois; Down, Ian; Prestage, Garrett; Applegate, Tanya L.; Dore, Gregory J.; Matthews, Gail V.] UNSW Australia, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Bradshaw, Daniel] Brighton & Sussex Univ Hosp NHS Trust, Dept HIV GU Med, Brighton, E Sussex, England; [Raghwani, Jayna; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England; [Sacks-Davis, Rachel; Hellard, Margaret] Univ Melbourne, Burnet Inst, Melbourne, Vic, Australia; [Sasadeusz, Joe] Royal Melbourne Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Danta, Mark] UNSW Australia, St Vincents Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Oxford; Burnet Institute; University of Melbourne; Royal Melbourne Hospital; University of New South Wales Sydney	Bradshaw, D (corresponding author), UNSW Australia, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.; Bradshaw, D (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Dept HIV GU Med, Brighton, E Sussex, England.	daniel.bradshaw@bsuh.nhs.uk	Sacks-Davis, Rachel/H-3277-2019; matthews, gail/AAG-8626-2022; matthews, gail/AFL-8501-2022; Dore, Gregory John/ABD-5665-2021; Jacka, Brendan/T-3553-2018; Pybus, Oliver G/B-2640-2012	Dore, Gregory John/0000-0002-4741-2622; Jacka, Brendan/0000-0002-5910-853X; Pybus, Oliver G/0000-0002-8797-2667; Applegate, Tanya/0000-0002-8657-4261; Matthews, Gail/0000-0002-1048-6396; Down, Ian/0000-0001-9275-8692; Prestage, Garrett/0000-0003-3917-8992; Bradshaw, Daniel/0000-0001-7186-2482; Sacks-Davis, Rachel/0000-0003-0860-2762; Raghwani, Jayna/0000-0001-8538-4995	Australian National Health and Medical Research Council Project Grant [568859]	Australian National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by Australian National Health and Medical Research Council Project Grant [Grant no 568859]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2008, AIDS EDUC PREV, V20, P420, DOI 10.1521/aeap.2008.20.5.420; Bradshaw D, 2015, J INFECT DIS, V211, P736, DOI 10.1093/infdis/jiu550; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fierer D, 2011, C RETR OPP INF BOSTO; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Green A.I., 2014, SEXUAL FIELDS SOCIOL; Hagan H, 2015, AIDS, V29, P2335, DOI 10.1097/QAD.0000000000000834; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Jacka B, 2014, HEPATOLOGY, V60, P1571, DOI 10.1002/hep.27310; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Kippax S, 1998, AIDS CARE, V10, P677, DOI 10.1080/09540129848307; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lamoury FMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131437; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; Meng SA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-117; Miller M, 2010, P GAT COMP ENV WOKRS; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nishijima T, 2014, JAIDS-J ACQ IMM DEF, V65, P213, DOI 10.1097/QAI.0000000000000044; Osmond DH, 2007, AM J PUBLIC HEALTH, V97, P1677, DOI 10.2105/AJPH.2005.062851; Phang CW, 2008, SEX TRANSM INFECT, V84, P217, DOI 10.1136/sti.2007.028787; Prestage G, 2015, AIDS BEHAV, V19, P2224, DOI 10.1007/s10461-015-1027-9; Prestage G, 2015, AIDS BEHAV, V19, P1905, DOI 10.1007/s10461-015-1032-z; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Simpson W, STATA USERGROUP 1ST; Sun HY, 2012, J CLIN MICROBIOL, V50, P781, DOI 10.1128/JCM.06014-11; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Vanhommerig JW, 2014, JAIDS-J ACQ IMM DEF, V66, pE111, DOI 10.1097/QAI.0000000000000208; Vogel M, 2010, LIVER INT, V30, P1169, DOI 10.1111/j.1478-3231.2010.02305.x; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; Wylie JL, 2007, HEALTH PLACE, V13, P617, DOI 10.1016/j.healthplace.2006.09.002	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162002	10.1371/journal.pone.0162002	http://dx.doi.org/10.1371/journal.pone.0162002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584149	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600083
J	Ji, MD; Lu, YL; Zhao, CH; Gao, WX; He, FX; Zhang, J; Zhao, D; Qiu, W; Wang, YW				Ji, Mingde; Lu, Yanlai; Zhao, Chenhui; Gao, Wenxing; He, Fengxia; Zhang, Jing; Zhao, Dan; Qiu, Wen; Wang, Yingwei			C5a Induces the Synthesis of IL-6 and TNF-alpha in Rat Glomerular Mesangial Cells through MAPK Signaling Pathways	PLOS ONE			English	Article							SUBLYTIC C5B-9 COMPLEXES; IGA NEPHROPATHY; THY-1 NEPHRITIS; EPITHELIAL-CELLS; OXIDATIVE STRESS; RENAL INJURY; APOPTOSIS; ACTIVATION; RECEPTOR; GLOMERULONEPHRITIS	Inflammatory response has been reported to contribute to the renal lesions in rat Thy-1 nephritis (Thy-1N) as an animal model of human mesangioproliferative glomerulonephritis (MsPGN). Besides C5b-9 complex, C5a is also a potent pro-inflammatory mediator and correlated to severity of various nephritic diseases. However, the role of C5a in mediating pro-inflammatory cytokine production in rats with Thy-1N is poorly defined. In the present studies, the levels of C5a, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were first determined in the renal tissues of rats with Thy-1N. Then, the expression of IL-6 and TNF-alpha was detected in rat glomerular mesangial cells (GMC) stimulated with our recombinant rat C5a in vitro. Subsequently, the activation of mitogen-activated protein kinase (MAPK) signaling pathways (p38 MAPK, ERK1/2 and JNK) and their roles in the regulation of IL-6 and TNF-alpha production were examined in the GMC induced by C5a. The results showed that the levels of C5a, IL-6 and TNF-alpha were markedly increased in the renal tissues of Thy-1N rats. Rat C5a stimulation in vitro could up-regulate the expression of IL-6 and TNF-alpha in rat GMC, and the activation of MAPK signaling pathways was involved in the induction of IL-6 and TNF-alpha. Mechanically, p38 MAPK activation promoted IL-6 production, while either ERK1/2 or JNK activation promoted TNF-alpha production in the GMC with exposure to C5a. Taken together, these data implicate that C5a induces the synthesis of IL-6 and TNF-a in rat GMC through the activation of MAPK signaling pathways.	[Ji, Mingde; Lu, Yanlai; He, Fengxia; Zhang, Jing; Zhao, Dan; Qiu, Wen; Wang, Yingwei] Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China; [Ji, Mingde] Nanjing Univ Tradit Chinese Med, Dept Lab Med, Affiliated Hosp, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Chenhui] Nanjing Med Univ, Dept Med, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China; [Gao, Wenxing] Nanjing Med Univ, Basic Med Sci Basic Med Coll, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing Medical University	Qiu, W (corresponding author), Nanjing Med Univ, Dept Immunol, Nanjing 211166, Jiangsu, Peoples R China.	qiuwen@njmu.edu.cn		He, Fengxia/0000-0002-1695-3127	National Natural Science Foundations of China [81273333, 81471626, 31470853]; Natural Science Foundations of Jiangsu Province in China [BK20131386]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Excellent Young or Middle-aged Teachers Project of Nanjing Medical University	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundations of Jiangsu Province in China; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; Excellent Young or Middle-aged Teachers Project of Nanjing Medical University	This work was supported by National Natural Science Foundations of China (81273333, 81471626, https://isisn.nsfc.gov.cn/egrantweb/), YWW; National Natural Science Foundations of China (31470853, https://isisn.nsfc.gov.cn/egrantweb/), WQ; Natural Science Foundations of Jiangsu Province in China (BK20131386, http://www.jstd.gov.cn/), WQ; the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; and Excellent Young or Middle-aged Teachers Project of Nanjing Medical University, WQ.; The study was supported by the grants from National Natural Science Foundations of China (81273333, 81471626 and 31470853) and the grant from Natural Science Foundations of Jiangsu Province in China (BK20131386). The study was also supported by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions and Excellent Young or Middle-aged Teachers Project of Nanjing Medical University.	Aizawa K, 2014, J NEPHROL, V27, P395, DOI 10.1007/s40620-014-0099-3; Alexander JJ, 2012, KIDNEY INT, V82, P961, DOI 10.1038/ki.2012.249; An LL, 2014, EUR J IMMUNOL, V44, P3669, DOI 10.1002/eji.201444560; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Bao LH, 2005, EUR J IMMUNOL, V35, P2496, DOI 10.1002/eji.200526327; Bao R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098636; Cao Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1731, DOI 10.1152/ajpcell.00213.2011; Chihara Y, 2006, CLIN NEPHROL, V65, P385; Choi SJ, 2015, INT J NANOMED, V10, P3217, DOI 10.2147/IJN.S82061; Cina DP, 2011, AM J PHYSIOL-RENAL, V300, pF488, DOI 10.1152/ajprenal.00214.2010; Clemente MG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/697238; Cove-Smith A, 2013, AM J PATHOL, V183, P391, DOI 10.1016/j.ajpath.2013.04.029; CUI LX, 1994, PROTEIN SCI, V3, P1169, DOI 10.1002/pro.5560030803; Fehr S, 2015, CELL PHYSIOL BIOCHEM, V36, P2237, DOI 10.1159/000430188; Guo RF, 2004, FASEB J, V18, pA560; Hao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038317; HASLETT C, 1985, AM J PATHOL, V119, P101; Huang FX, 2001, J CLIN LAB ANAL, V15, P30, DOI 10.1002/1098-2825(2001)15:1<30::AID-JCLA6>3.0.CO;2-X; Jain U, 2015, J IMMUNOL, V194, P3414, DOI 10.4049/jimmunol.1401814; Liang Y, 2015, CELL PHYSIOL BIOCHEM, V36, P1793, DOI 10.1159/000430151; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Liu XL, 2011, CELL PHYSIOL BIOCHEM, V27, P391, DOI 10.1159/000327966; Ma R, 2013, J CLIN IMMUNOL, V33, P172, DOI 10.1007/s10875-012-9772-2; Maeda Y, 2015, ONCOL REP, V33, P1844, DOI 10.3892/or.2015.3800; Mima A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017929; Nagai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066759; Qin DP, 2013, J NEPHROL, V26, P199, DOI 10.5301/jn.5000125; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153; Qiu W, 2012, J PATHOL, V226, P619, DOI 10.1002/path.3011; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Rampino T, 2011, CLIN SCI, V120, P25, DOI 10.1042/CS20100147; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Sadakane C, 2011, CLIN EXP NEPHROL, V15, P14, DOI 10.1007/s10157-010-0342-8; Schaeffer V, 2007, SHOCK, V27, P623, DOI 10.1097/SHK.0b013e31802fa0bd; Shimizu A, 2000, NEPHRON, V86, P152, DOI 10.1159/000045734; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Vaivoda R, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/250456; Wang YH, 2016, CLIN EXP MED, V16, P183, DOI 10.1007/s10238-015-0351-8; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143; Xu JH, 2006, CELL TISSUE RES, V326, P159, DOI 10.1007/s00441-006-0214-4; Yang JB, 2015, KOREAN J PARASITOL, V53, P371, DOI 10.3347/kjp.2015.53.4.371; Zhang JX, 2016, J APPL TOXICOL, V36, P271, DOI 10.1002/jat.3179; Zhang J, 2014, FASEB J, V28, P1511, DOI 10.1096/fj.13-242693; Zhao Y, 2014, MOL MED REP, V10, P45, DOI 10.3892/mmr.2014.2176; Zhu Y, 2015, MOL VIS, V21, P1122	47	17	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161867	10.1371/journal.pone.0161867	http://dx.doi.org/10.1371/journal.pone.0161867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583546	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600068
J	Lee, MTG; Lee, CC; Wang, HM; Chou, TH; Wu, MC; Hsueh, KL; Chen, SC				Lee, Meng-Tse Gabriel; Lee, Chien-Chang; Wang, Hsuan-Mao; Chou, Tzung-Hsin; Wu, Meng-Che; Hsueh, Kuang-Lung; Chen, Shyr-Chyr			Hypothermia Increases Tissue Plasminogen Activator Expression and Decreases Post-Operative Intra-Abdominal Adhesion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PERITONEAL ADHESIONS; FIBRINOLYTIC-ACTIVITY; MODERATE HYPOTHERMIA; ABDOMINAL-SURGERY; PELVIC-SURGERY; PREVENTION; METALLOPROTEINASES; PATHOPHYSIOLOGY; TEMPERATURE	Background Therapeutic hypothermia during operation decreases postoperative intra-abdominal adhesion formation. We sought to determine the most appropriate duration of hypothermia, and whether hypothermia affects the expression of tissue plasminogen activator (tPA). Methods 80 male BALB/c mice weighing 25-30 g are randomized into one of five groups: adhesion model with infusion of 15 degrees C saline for 15 minutes (A); 30 minutes (B); 45 minute (C); adhesion model without infusion of cold saline (D); and sham operation without infusion of cold saline (E). Adhesion scores and tPA levels in the peritoneum fluid levels were analyzed on postoperative days 1, 7, and 14. Results On day 14, the cold saline infusion groups (A, B, and C) had lower adhesion scores than the without infusion of cold saline group (D). However, only group B (cold saline infusion for 30 minutes) had a significantly lower adhesion scores than group D. Also, group B was found to have 3.4 fold, 2.3 fold, and 2.2 fold higher levels of tPA than group D on days 1, 7, and 14 respectively. Conclusions Our results suggest that cold saline infusion for 30 minutes was the optimum duration to decrease postoperative intra-abdominal adhesion formation. The decrease in the adhesion formations could be partly due to an increase in the level of tPA.	[Lee, Meng-Tse Gabriel; Lee, Chien-Chang; Wang, Hsuan-Mao; Chou, Tzung-Hsin; Wu, Meng-Che; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lee, Meng-Tse Gabriel; Lee, Chien-Chang; Wang, Hsuan-Mao; Chou, Tzung-Hsin; Wu, Meng-Che; Chen, Shyr-Chyr] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Emergency Med, Yunlin Branch, Touliu, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Dept Gen Med, Yunlin Branch, Touliu, Taiwan; [Hsueh, Kuang-Lung] China Med Univ, Res Dept, China Med Univ Hosp, Res Ctr Tumor Med Sci, Taichung, Taiwan; [Hsueh, Kuang-Lung] China Med Univ, Ctr Chinese Med & Acupuncture, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Chen, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, SC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	scchen@ntu.edu.tw	Lee, Chien-Chang/HHM-5986-2022; Wang, Hsuan Mao/AAG-3017-2021	WU, MENG-CHE/0000-0002-9584-3486; CHEN, SHYR-CHYR/0000-0002-5858-3013; LEE, CHIEN-CHANG/0000-0002-1243-2463; Lee, Meng-tse/0000-0002-2648-1522	Taiwan National Science Foundation [NSC 101-2314-B-002 -055-MY3]; Taiwan National Ministry of Science and Technology [MOST 104-2314-B-002-028, MOST 104-2811-B-002 -060]	Taiwan National Science Foundation; Taiwan National Ministry of Science and Technology	This work is supported by Taiwan National Science Foundation grant NSC 101-2314-B-002 -055-MY3, and Taiwan National Ministry of Science and Technology grants MOST 104-2314-B-002-028 and MOST 104-2811-B-002 -060. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Fertil Steril, V55, P700; Arung W, 2011, WORLD J GASTROENTERO, V17, P4545, DOI 10.3748/wjg.v17.i41.4545; Badjatia N, 2004, NEUROCRIT CARE, V1, P201, DOI 10.1385/NCC:1:2:201; Binda MM, 2006, FERTIL STERIL, V86, P166, DOI 10.1016/j.fertnstert.2005.11.079; Binda MM, 2004, HUM REPROD, V19, P2626, DOI 10.1093/humrep/deh495; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Brokelman WJA, 2009, J SURG RES, V151, P89, DOI 10.1016/j.jss.2008.01.005; DIAMOND MP, 1994, FERTIL STERIL, V62, P984; diZerega GS, 1997, EUR J SURG, V163, P10; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Ellis H, 1997, EUR J SURG, V163, P5; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; EVANS DM, 1993, AM J SURG, V165, P229, DOI 10.1016/S0002-9610(05)80516-1; Fang CC, 2010, WORLD J SURG, V34, P721, DOI 10.1007/s00268-009-0378-7; GEHLBACH DL, 1994, INT J FERTIL MENOP S, V39, P172; Gonzalez-Ibarra Fernando Pavel, 2011, Front Neurol, V2, P4, DOI 10.3389/fneur.2011.00004; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7; HERSHLAG A, 1991, CLIN OBSTET GYNECOL, V34, P395, DOI 10.1097/00003081-199106000-00023; HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236; Holmdahl L, 1997, EUR J SURG, V163, P24; Kato A, 2002, AM J PHYSIOL-GASTR L, V282, pG608, DOI 10.1152/ajpgi.00454.2001; Lai HS, 1998, J FORMOS MED ASSOC, V97, P323; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149; Lin HF, 2014, AM J SURG, V208, P419, DOI 10.1016/j.amjsurg.2013.10.028; Luijendijk RW, 1996, ANN SURG, V223, P242, DOI 10.1097/00000658-199603000-00003; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; MENZIES D, 1989, J ROY SOC MED, V82, P534, DOI 10.1177/014107688908200909; Oncel M, 2001, J SURG RES, V101, P52, DOI 10.1006/jsre.2001.6245; Patel S, 2000, J AM COLL SURGEONS, V191, P650, DOI 10.1016/S1072-7515(00)00736-5; SCOTTCOOMBES D, 1995, BRIT J SURG, V82, P414, DOI 10.1002/bjs.1800820346; ten Broek RPG, 2014, LANCET, V383, P48, DOI 10.1016/S0140-6736(13)61687-6; ten Broek RPG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5588; THOMPSON JN, 1989, BRIT J SURG, V76, P382, DOI 10.1002/bjs.1800760422; Tjarnstrom J, 1999, EUR J SURG, V165, P834; VIPOND MN, 1990, LANCET, V335, P1120, DOI 10.1016/0140-6736(90)91125-T; VIPOND MN, 1994, ANN ROY COLL SURG, V76, P412; Wagner S, 2003, BRAIN RES, V984, P63, DOI 10.1016/S0006-8993(03)03088-9; Watts DD, 1998, J TRAUMA, V44, P846, DOI 10.1097/00005373-199805000-00017; WEIBEL MA, 1973, AM J SURG, V126, P345, DOI 10.1016/S0002-9610(73)80123-0	42	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160627	10.1371/journal.pone.0160627	http://dx.doi.org/10.1371/journal.pone.0160627			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583464	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600007
J	Mishra, DK; Veena, U; Kaliki, S; Kethiri, AR; Sangwan, VS; Ali, MH; Naik, MN; Singh, V				Mishra, Dilip Kumar; Veena, Uppala; Kaliki, Swathi; Kethiri, Abhinav Reddy; Sangwan, Virender S.; Ali, Mohammed Hasnat; Naik, Milind N.; Singh, Vivek			Differential Expression of Stem Cell Markers in Ocular Surface Squamous Neoplasia	PLOS ONE			English	Article							CANCER; CARCINOMA; CORNEAL; CONJUNCTIVAL; MEMBRANE; CD117; HEAD; NECK; P63	Ocular Surface Squamous Neoplasm (OSSN) is the neoplasia arising from the conjunctiva, cornea and limbus. OSSN ranges from mild, moderate, severe dysplasia, carcinoma in situ (CIS) to squamous cell carcinoma (SCC). Recent findings on cancer stem cells theory indicate that population of stem-like cell as in neoplasia determines its heterogeneity and complexity leading to varying tumor development of metastatic behavior and recurrence. Cancer stem cell markers are not much explored in the cases of OSSN. In the present study, we aim to evaluate the expression of stem cells using stem cell markers mainly p63, ABCG2, c-KIT (CD117) and CD44 in OSSN tissue, which could have prognostic significance. The present study tries for the first time to explore expression of these stem markers in the cases of OSSN. These cases are subdivided into two groups. One group comprises of carcinoma in situ (n = 6) and the second group comprises of invasive carcinoma (n = 6). The mean age at presentation was 52 years; with 53 years for CIS group and 52 years for SCC group. From each group section from the paraffin block were taken for the IHC staining of p63, c-Kit, ABCG2 and CD44. Our experiments show high expression of P63 and CD44 in the cases of CIN and SCC. Both CIS and SCC displayed positive staining with p63, with more than 80% cells staining positive. However minimal expression of c-kit in both CIN and SCC. But surprisingly we got high expression of ABCG2 in cases of carcinoma in situ as compared to that of invasive squamous cell carcinoma. More than 50% of cells showed CD44 positivity in both CIS and SCC groups. Our results show for the first time that these four stem cells especially the limbal epithelium stem cells play a vital role in the genesis of OSSN but we need to explore more cases before establishing its clinical and biological significance.	[Mishra, Dilip Kumar; Veena, Uppala] LV Prasad Eye Inst, Ophthalm Pathol Lab, Hyderabad, Telangana, India; [Kaliki, Swathi; Naik, Milind N.] LV Prasad Eye Inst, Operat Eyesight Universal Inst Eye Canc, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Champalimaud Translat Ctr Eye Res, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India; [Ali, Mohammed Hasnat] LV Prasad Eye Inst, Clin Epidemiol & Biostat, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Singh, Vivek] Manipal Univ, Manipal, Karnataka, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Manipal Academy of Higher Education (MAHE)	Mishra, DK (corresponding author), LV Prasad Eye Inst, Ophthalm Pathol Lab, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Champalimaud Translat Ctr Eye Res, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India.; Singh, V (corresponding author), Manipal Univ, Manipal, Karnataka, India.	dilip@lvpei.org; viveksingh@lvpei.org	Kaliki, Swathi/C-2529-2018; Singh, Vivek/C-4574-2013; Sangwan, Virender Singh/AAA-1091-2022	Singh, Vivek/0000-0003-3958-5635; Sangwan, Virender Singh/0000-0002-8229-4158; Kethiri, Abhinav Reddy/0000-0001-9286-4591	Hyderabad Eye Research Foundation in Hyderabad, India; Operation Eyesight Universal Institute for Eye cancer in Hyderabad, India; Champalimaud Foundation in Lisbon, Portugal; Champalimaud foundation; Research Grant by SERB [SERB/LS-599/2013]	Hyderabad Eye Research Foundation in Hyderabad, India; Operation Eyesight Universal Institute for Eye cancer in Hyderabad, India; Champalimaud Foundation in Lisbon, Portugal; Champalimaud foundation; Research Grant by SERB	This work was supported by the Hyderabad Eye Research Foundation in Hyderabad, India, the Operation Eyesight Universal Institute for Eye cancer in Hyderabad, India, the Champalimaud Foundation in Lisbon, Portugal, and the Champalimaud foundation and Research Grant by SERB (Vivek Singh: SERB/LS-599/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina A, 2013, LANCET ONCOL, V14, pE152, DOI 10.1016/S1470-2045(12)70598-3; Bancroft JD, 2008, THEORY AND PRACTICE; Basu Sayan, 2015, OPHTHALMOLOGY; Bhagwandin VJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148807; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Botchkarev VA, 2014, P53 P63 P73 EPIDERMI; Chauhan S, 2014, ARCH PATHOL LAB MED, V138, P1488, DOI 10.5858/arpa.2013-0353-OA; Chen JS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-7; Chui J, 2011, AM J PATHOL, V178, P817, DOI 10.1016/j.ajpath.2010.10.037; Kobayashi NCC, 2015, REV ASSOC MED BRAS, V61, P86, DOI 10.1590/1806-9282.61.01.086; Emanuel P, 2005, MODERN PATHOL, V18, P645, DOI 10.1038/modpathol.3800329; ERIE JC, 1986, OPHTHALMOLOGY, V93, P176; Fan HJ, 2013, HISTOPATHOLOGY, V62, P1028, DOI 10.1111/his.12111; FURNER BB, 1989, ARCH DERMATOL, V125, P287; Gonfloni S, 2015, INT J DEV BIOL, V59, P87, DOI 10.1387/ijdb.150045sg; Kamal S, 2015, OPHTHALMOLOGY, V122, P1688, DOI 10.1016/j.ophtha.2015.04.027; Kim BH, 2013, GRAEF ARCH CLIN EXP, V251, P2569, DOI 10.1007/s00417-013-2450-0; KONO M, 1990, J THORAC IMAG, V5, P61, DOI 10.1097/00005382-199001000-00010; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Lee GA, 1997, AUST NZ J OPHTHALMOL, V25, P269, DOI 10.1111/j.1442-9071.1997.tb01514.x; LEE GA, 1995, SURV OPHTHALMOL, V39, P429, DOI 10.1016/S0039-6257(05)80054-2; LEE GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P525, DOI 10.1001/archopht.1992.01080160103042; Li XT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13157; Margaritescu C, 2011, ROM J MORPHOL; Mittal R, 2013, SAUDI J OPHTHALMOL, V27, P177, DOI 10.1016/j.sjopt.2013.07.002; Nagata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093164; Qian X, 2015, CRIT REV ONCOL HEMAT, V95, P337, DOI 10.1016/j.critrevonc.2015.03.009; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Salcedo-Hernandez RA, 2016, G ITAL DERMATOL VENE; Sudha B, 2008, INDIAN J MED RES, V128, P149; TABBARA KF, 1988, OPHTHALMOLOGY, V95, P318; Tabin G, 1997, OPHTHALMOLOGY, V104, P485, DOI 10.1016/S0161-6420(97)30287-5; Ujevic I, 1973, ROSTR ZENTRALBL BAKT, V128, P173; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Xie J, 2014, AM J CANCER RES, V4, P698; Yang J, 1997, INT OPHTHALMOL CLIN, V37, P73, DOI 10.1097/00004397-199703740-00007; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856; Youssef NS, 2014, INT J CLIN EXP PATHO, V7, P5725	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161800	10.1371/journal.pone.0161800	http://dx.doi.org/10.1371/journal.pone.0161800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584160	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600060
J	Reissig, F; Mamat, C; Steinbach, J; Pietzsch, HJ; Freudenberg, R; Navarro-Retamal, C; Caballero, J; Kotzerke, J; Wunderlich, G				Reissig, Falco; Mamat, Constantin; Steinbach, Joerg; Pietzsch, Hans-Juergen; Freudenberg, Robert; Navarro-Retamal, Carlos; Caballero, Julio; Kotzerke, Joerg; Wunderlich, Gerd			Direct and Auger Electron-Induced, Single- and Double-Strand Breaks on Plasmid DNA Caused by Tc-99m-Labeled Pyrene Derivatives and the Effect of Bonding Distance	PLOS ONE			English	Article							IN-VIVO; COMPLEXES; LIGANDS; BINDING; RADIONUCLIDES; BIOMOLECULES; EMITTERS; THERAPY; TC-99M; I-125	It is evident that Tc-99m causes radical-mediated DNA damage due to Auger electrons, which were emitted simultaneously with the known gamma-emission of Tc-99m. We have synthesized a series of new Tc-99m-labeled pyrene derivatives with varied distances between the pyrene moiety and the radionuclide. The pyrene motif is a common DNA intercalator and allowed us to test the influence of the radionuclide distance on damages of the DNA helix. In general, pUC 19 plasmid DNA enables the investigation of the unprotected interactions between the radiotracers and DNA that results in single-strand breaks (SSB) or double-strand breaks (DSB). The resulting DNA fragments were separated by gel electrophoresis and quantified by fluorescent staining. Direct DNA damage and radical-induced indirect DNA damage by radiolysis products of water were evaluated in the presence or absence of the radical scavenger DMSO. We demonstrated that Auger electrons directly induced both SSB and DSB in high efficiency when Tc-99m was tightly bound to the plasmid DNA and this damage could not be completely prevented by DMSO, a free radical scavenger. For the first time, we were able to minimize this effect by increasing the carbon chain lengths between the pyrene moiety and the Tc-99m nuclide. However, a critical distance between the Tc-99m atom and the DNA helix could not be determined due to the significantly lowered DSB generation resulting from the interaction which is dependent on the type of the Tc-99m binding motif. The effect of variable DNA damage caused by the different chain length between the pyrene residue and the Tc-core as well as the possible conformations of the applied Tc-complexes was supplemented with molecular dynamics (MD) calculations. The effectiveness of the DNA-binding Tc-99m-labeled pyrene derivatives was demonstrated by comparison to non-DNA- binding (TcO4-)-Tc-99m, since nearly all DNA damage caused by (TcO4-)-Tc-99m was prevented by incubating with DMSO.	[Reissig, Falco; Freudenberg, Robert; Kotzerke, Joerg; Wunderlich, Gerd] Tech Univ Dresden, Univ Hosp, Fac Med Carl Gustav Carus, Dept Nucl Med, Dresden, Germany; [Mamat, Constantin; Steinbach, Joerg; Pietzsch, Hans-Juergen] Inst Radiopharmaceut Canc Res, Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Navarro-Retamal, Carlos; Caballero, Julio] Univ Talca, Ctr Bioinformat & Simulac Mol, Fac Ingn, 2 Norte 685,Casilla 721, Talca, Chile	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Universidad de Talca	Reissig, F; Wunderlich, G (corresponding author), Tech Univ Dresden, Univ Hosp, Fac Med Carl Gustav Carus, Dept Nucl Med, Dresden, Germany.	Falco.Reissig@uniklinikum-dresden.de; Gerd.Wunderlich@uniklinikum-dresden.de	Mamat, Constantin/V-9398-2017; Caballero, Julio/G-3654-2014; Steinbach, Joerg/B-5940-2015	Mamat, Constantin/0000-0003-1906-3186; Caballero, Julio/0000-0003-0182-1444; Steinbach, Joerg/0000-0002-1708-6440; Navarro-Retamal, Carlos/0000-0001-9581-0206; Reissig, Falco/0000-0002-5203-0776				Alberto R, 1998, J AM CHEM SOC, V120, P7987, DOI 10.1021/ja980745t; Alberto R, 2001, J AM CHEM SOC, V123, P3135, DOI 10.1021/ja003932b; Ardes-Guisot N, 2011, ORG BIOMOL CHEM, V9, P5373, DOI 10.1039/c1ob05119a; Balagurumoorthy P, 2008, RADIAT RES, V170, P70, DOI 10.1667/RR1072.1; Balagurumoorthy P, 2012, INT J RADIAT BIOL, V88, P998, DOI 10.3109/09553002.2012.706360; BLOOMER WD, 1977, NATURE, V265, P620, DOI 10.1038/265620a0; Chung WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108162; Cornelissen B, 2014, J LABELLED COMPD RAD, V57, P310, DOI 10.1002/jlcr.3152; Costantini DL, 2007, J NUCL MED, V48, P1357, DOI 10.2967/jnumed.106.037937; DeSombre ER, 2000, ACTA ONCOL, V39, P659, DOI 10.1080/028418600750063695; Goddu SM, 1996, ACTA ONCOL, V35, P901, DOI 10.3109/02841869609104044; Haefliger P, 2005, BIOCONJUGATE CHEM, V16, P582, DOI 10.1021/bc0500084; Hafliger P, 2005, CHEMBIOCHEM, V6, P414, DOI 10.1002/cbic.200400210; HOWELL RW, 1992, MED PHYS, V19, P1371, DOI 10.1118/1.596927; Jimenez-Mancilla N, 2013, J LABELLED COMPD RAD, V56, P663, DOI 10.1002/jlcr.3087; Kassis AI, 2000, ACTA ONCOL, V39, P721, DOI 10.1080/028418600750063785; Kassis AI, 2004, INT J RADIAT BIOL, V80, P789, DOI 10.1080/09553000400017663; Kotzerke J, 2012, NUKLEARMED-NUCL MED, V51, P170, DOI 10.3413/Nukmed-0506-12-05; Kotzerke J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104653; Lobachevsky PN, 2008, INT J RADIAT BIOL, V84, P991, DOI 10.1080/09553000802478091; Lobachevsky PN, 2004, INT J RADIAT BIOL, V80, P915, DOI 10.1080/09553000400017754; Pomplun E, 2004, INT J RADIAT BIOL, V80, P855, DOI 10.1080/09553000400017614; Pretze M, 2013, J FLUORINE CHEM, V150, P25, DOI 10.1016/j.jfluchem.2013.02.028; Schibli R, 2000, BIOCONJUGATE CHEM, V11, P345, DOI 10.1021/bc990127h; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Taborda A, 2015, MED PHYS, V42, P3661, DOI 10.1118/1.4925888; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P3103, DOI 10.1021/bi00127a010; Xu Z, 2011, CHEM-ASIAN J, V6, P2113, DOI 10.1002/asia.201100120; Zobi F, 2005, CHEMBIOCHEM, V6, P1397, DOI 10.1002/cbic.200400453	29	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161973	10.1371/journal.pone.0161973	http://dx.doi.org/10.1371/journal.pone.0161973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583677	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600080
J	Zhang, J; Zhou, Y; Wei, N; Yang, B; Wang, AX; Zhou, H; Zhao, XQ; Wang, YJ; Liu, LP; Ouyoung, M; Villegas, B; Groher, M				Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhou, Hai; Zhao, Xingquan; Wang, Yongjun; Liu, Liping; Ouyoung, Melody; Villegas, Brenda; Groher, Michael			Laryngeal Elevation Velocity and Aspiration in Acute Ischemic Stroke Patients	PLOS ONE			English	Article							DEGLUTITION LITERATURE; PREDICTING ASPIRATION; VARIABILITY; STIMULATION; IMPAIRMENTS; KINEMATICS; DYSPHAGIA; BOLUS	Objectives Aspiration after stroke has been associated with aspiration pneumonia, which contributes to increased mortality of stroke. Laryngeal elevation is a core mechanism for protection from aspiration. Few studies have explored the predictive value of laryngeal elevation velocity for aspiration after stroke. This study aimed to explore the ability of laryngeal elevation velocity to predict aspiration in patients with acute ischemic stroke. Methods This was a prospective cohort study that included consecutive acute ischemic stroke patients treated at a teaching hospital during a 10-month period. Patients underwent magnetic resonance imaging (MRI) to confirm the diagnosis of acute ischemic stroke. Patients who were at risk of aspiration and could swallow 5 ml of diluted barium (40%, w/v) for a videofluoroscopic swallowing (VFS) study were included. The association between abnormal indices in the oral and pharyngeal phase of the VFS study and aspiration was examined using univariate analyses. These indices included the lip closure, tongue movement and control, laryngeal elevation velocity and range, the latency of pharyngeal swallowing, pharyngeal transit time (PTT), abnormal epiglottis tilt, residual barium in the pharynx, and the duration of upper esophageal sphincter (UES) opening. The laryngeal elevation velocity (%/s) was calculated as the range of laryngeal elevation (%) from the resting position to the maximum superior position or to the position where the laryngeal vestibule is fully closed divided by the corresponding duration of laryngeal elevation. The range of laryngeal elevation (%) was the percentage calculated as the distance between the resting laryngeal position and the maximum superior excursion position or position where the laryngeal vestibule is fully closed divided by the distance between the resting laryngeal position and the lowest edge of the mandible. A logistic regression analysis was used to determine the predictive value for aspiration secondary to reduced laryngeal elevation velocity after adjusting for the effects of other indices. Intrarater and interrater reliability were calculated using Pearson's correlation coefficients. Results Data from 89 patients were analyzed. This cohort included 71 males and 18 females with a mean age of 59.31 +/- 11.46 years. The mean time from stroke onset to the VFS study was 3 days (1-7). Twenty one (23%) patients aspirated while swallowing 5 ml of diluted barium (40%, w/v). Aspiration was associated with age, the velocity (%/s) of laryngeal elevation and duration, delayed pharyngeal phase, pharyngeal transit time, abnormal epiglottic tilt, and invalid laryngeal elevation before true swallowing, and duration of upper esophageal sphincter (UES) opening. After adjusting for the effects of the indices mentioned above, logistic regression analysis revealed that a reduced of laryngeal elevation velocity before vestibule closure was predictive of aspiration independently (OR, 0.993; 95% CI, 0.987-1.000). Discussions Reduced laryngeal elevation velocity for laryngeal elevated to position where laryngeal vestibule is fully closed was an independent predictor of aspiration in patients with acute ischemic stroke. This may be related to a decreased contraction velocity of the muscles involved in hyolaryngeal elevation. Therapeutic methods aimed at improving laryngeal elevation velocity may decrease aspiration events and pneumonias after stroke.	[Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] Beijing Inst Brain Disorders, Stroke Ctr, Beijing, Peoples R China; [Zhang, Jing; Zhou, Yun; Wei, Na; Yang, Bo; Wang, Anxin; Zhao, Xingquan; Wang, Yongjun; Liu, Liping] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Zhou, Hai] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China; [Ouyoung, Melody] Univ Southern Calif, Keck Hosp, Dept Speech Pathol, Los Angeles, CA USA; [Villegas, Brenda] Univ Southern Calif, Dept Otolaryngol Head & Neck Surg, Los Angeles, CA USA; [Groher, Michael] Univ Redlands, Dept Commun Disorders, Redlands, CA 92373 USA	Capital Medical University; Capital Medical University; University of Southern California; University of Southern California Keck Hospital; University of Southern California	Liu, LP (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.; Liu, LP (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Liu, LP (corresponding author), Beijing Inst Brain Disorders, Stroke Ctr, Beijing, Peoples R China.; Liu, LP (corresponding author), Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China.	liping_sister@163.com			Ministry of Science and Technology; Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project [2006BAI01A11, 2011BAI08B01, 2011BAI08B02]; National Science and Technology Major Project of China [2008ZX09312-008]; State Key Development Program for Basic Research of China [2009CB521905]; Beijing Municipal Science and Technology Commission [D101107049310005, Z12110000551 2016]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03]; Beijing Institute for Brain Disorders [BIBD-PXM2013_014226_07_000084]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; National 11th & 12th Five-year S & T Major Project; National Science and Technology Major Project of China; State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Beijing Institute for Brain Disorders	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China. Individual grants include the National 11th & 12th Five-year S & T Major Project (2006BAI01A11, 2011BAI08B01, 2011BAI08B02), the National Science and Technology Major Project of China (2008ZX09312-008), the State Key Development Program for Basic Research of China (2009CB521905), the Beijing Municipal Science and Technology Commission (D101107049310005, Z12110000551 2016), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03), and Beijing Institute for Brain Disorders (BIBD-PXM2013_014226_07_000084). The funding institutions had no role in the study design, data collection or analysis, or in the decision to publish or preparation of the manuscript for publication.	Bernard R., 2002, DYSPHAGIA, V17, P57; Broniatowski M, 1999, OTOLARYNG HEAD NECK, V120, P464, DOI 10.1053/hn.1999.v120.a93228; Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Cohen DL, 2016, INT J STROKE, V11, P399, DOI 10.1177/1747493016639057; Cvejic L, 2011, RESPIROLOGY, V16, P269, DOI 10.1111/j.1440-1843.2010.01875.x; Ertekin C, 2003, CLIN NEUROPHYSIOL, V114, P2226, DOI 10.1016/S1388-2457(03)00237-2; Gleeson DCL, 1999, J COMMUN DISORD, V32, P373, DOI 10.1016/S0021-9924(99)00017-9; Gonzalez-Fernandez Marlis, 2013, Curr Phys Med Rehabil Rep, V1, P187; Hadley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046013; Hammond CAS, 2009, CHEST, V135, P769, DOI 10.1378/chest.08-1122; Hart TR, 2001, ARCH PHYS MED REHAB, V82, P677, DOI 10.1053/apmr.2001.21939; Humbert IA, 2015, AM J SPEECH-LANG PAT, V24, P72, DOI 10.1044/2014_AJSLP-14-0045; Kahrilas PJ, 1997, GASTROENTEROLOGY, V113, P1457, DOI 10.1053/gast.1997.v113.pm9352847; Kim Y, 2010, DYSPHAGIA, V25, P20, DOI 10.1007/s00455-009-9224-1; Kuhl V, 2003, J NEUROL, V250, P333, DOI 10.1007/s00415-003-1007-2; LeBrasseur NK, 2006, PHYS THER, V86, P1342, DOI 10.2522/ptj.20050162; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079746; Logemann JA, 2000, J SPEECH LANG HEAR R, V43, P1264, DOI 10.1044/jslhr.4305.1264; Martin-Harris B, 2008, PHYS MED REH CLIN N, V19, P769, DOI 10.1016/j.pmr.2008.06.004; Molfenter SM, 2012, DYSPHAGIA, V27, P162, DOI 10.1007/s00455-012-9397-x; Molfenter SM, 2011, DYSPHAGIA, V26, P67, DOI 10.1007/s00455-010-9309-x; Morad Khosh M, 1997, OPERAT TECH OTOLARYN, V8, P182; Nagy A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/738971; Oommen ER, 2011, DYSPHAGIA, V26, P318, DOI 10.1007/s00455-010-9314-0; Paik NJ, 2008, J ELECTROMYOGR KINES, V18, P329, DOI 10.1016/j.jelekin.2006.09.011; Palmer JB, 2000, AM FAM PHYSICIAN, V61, P2453; Park T, 2013, AM J PHYS MED REHAB, V92, P320, DOI 10.1097/PHM.0b013e318269d935; Park T, 2010, DYSPHAGIA, V25, P177, DOI 10.1007/s00455-009-9237-9; Perlman A L, 1994, Dysphagia, V9, P90; Power ML, 2009, DYSPHAGIA, V24, P257, DOI 10.1007/s00455-008-9198-4; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Steele CM, 2011, CLIN OTOLARYNGOL, V36, P30, DOI 10.1111/j.1749-4486.2010.02219.x; Steele CM, 2014, DYSPHAGIA, V29, P295, DOI 10.1007/s00455-014-9516-y; van der Kruis JGJ, 2011, DYSPHAGIA, V26, P171, DOI 10.1007/s00455-010-9318-9	34	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162257	10.1371/journal.pone.0162257	http://dx.doi.org/10.1371/journal.pone.0162257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583413	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600125
J	Ziros, P; Zagoriti, Z; Lagoumintzis, G; Kyriazopoulou, V; Iskrenova, RP; Habeos, EI; Sykiotis, GP; Chartoumpekis, DV; Habeos, IG				Ziros, Panos; Zagoriti, Zoi; Lagoumintzis, George; Kyriazopoulou, Venetsana; Iskrenova, Ralitsa P.; Habeos, Evagelia I.; Sykiotis, Gerasimos P.; Chartoumpekis, Dionysios V.; Habeos, Ioannis G.			Hepatic Fgf21 Expression Is Repressed after Simvastatin Treatment in Mice	PLOS ONE			English	Article							GROWTH-FACTOR 21; UNFOLDED PROTEIN RESPONSE; PPAR-ALPHA; INSULIN-RESISTANCE; CROSS-TALK; ANTIDIABETIC ACTIONS; INDUCED INHIBITION; CIRCULATING FGF21; LIPID-METABOLISM; STATINS	Fibroblast growth factor 21 (Fgf21) is a hormone with emerging beneficial roles in glucose and lipid homeostasis. The interest in Fgf21 as a potential antidiabetic drug and the factors that regulate its production and secretion is growing. Statins are the most widely prescribed drug for the treatment of dyslipidemia. However, the function of statins is not limited to the lowering of cholesterol as they are associated with pleiotropic actions such as antioxidant, anti-inflammatory and cytoprotective effects. The recently described effect of statins on mitochondrial function and the induction of Fgf21 by mitochondrial stress prompted us to investigate the effect of statin treatment on Fgf21 expression in the liver. To this end, C57BL6J male mice and primary mouse hepatocytes were treated with simvastatin, and Fgf21 expression was subsequently assessed by immunoblotting and quantitative real-time PCR. Hepatic Fgf21 protein and mRNA and circulating levels of FGF21significantly decreased in mice that had received simvastatin in their food (0.1% w/w) for 1 week. This effect was also observed with simvastatin doses as low as 0.01% w/w for 1 week or following 2 intraperitoneal injections within a single day. The reduction in Fgf21 mRNA levels was further verified in primary mouse hepatocytes, indicating that the effect of simvastatin is cell autonomous. In conclusion, simvastatin treatment reduced the circulating and hepatic Fgf21 levels and this effect warrants further investigation with reference to its role in metabolism.	[Ziros, Panos; Kyriazopoulou, Venetsana; Iskrenova, Ralitsa P.; Habeos, Evagelia I.; Sykiotis, Gerasimos P.; Chartoumpekis, Dionysios V.; Habeos, Ioannis G.] Univ Patras, Sch Med, Div Endocrinol, Dept Internal Med, Patras, Greece; [Zagoriti, Zoi; Lagoumintzis, George] Univ Patras, Dept Pharm, Patras, Greece; [Ziros, Panos; Sykiotis, Gerasimos P.] Univ Lausanne Hosp, Lausanne, Switzerland	University of Patras; University of Patras; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Habeos, IG (corresponding author), Univ Patras, Sch Med, Div Endocrinol, Dept Internal Med, Patras, Greece.	ihabeos@med.upatras.gr	Sykiotis, Gerasimos P/E-7407-2017; Chartoumpekis, Dionysios/L-8071-2017	Habeos, Evagelia Eva/0000-0001-5124-0942; Chartoumpekis, Dionysios/0000-0002-6139-6067; Lagoumintzis, George/0000-0002-0441-9023; Sykiotis, Gerasimos/0000-0002-9565-4941	Basic Research Program K. Karatheodori (University of Patras); Marie Curie (7th European Community Framework Programme) [PIOF-GA-2012-329442]	Basic Research Program K. Karatheodori (University of Patras); Marie Curie (7th European Community Framework Programme)	This work was partially supported by the Basic Research Program K. Karatheodori (University of Patras). DVC is supported by Marie Curie PIOF-GA-2012-329442 (7th European Community Framework Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Basic Research Program K. Karatheodori (University of Patras). DVC is supported by Marie Curie PIOF-GA-2012-329442 (7th European Community Framework Programme). The funders played no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript.	Adams AC, 2013, MOL METAB, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Andreux PA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05285; Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bae KH, 2014, ENDOCRINOL METAB, V29, P105, DOI 10.3803/EnM.2014.29.2.105; Bouitbir J, 2012, EUR HEART J, V33, P1397, DOI 10.1093/eurheartj/ehr224; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chartoumpekis D, 2010, BIOCHEM BIOPH RES CO, V396, P463, DOI 10.1016/j.bbrc.2010.04.117; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Chen JC, 2008, CARDIOVASC RES, V80, P138, DOI 10.1093/cvr/cvn160; Cheng XG, 2014, TOXICOL APPL PHARM, V278, P65, DOI 10.1016/j.taap.2014.04.013; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Emanuelli B, 2014, J CLIN INVEST, V124, P515, DOI 10.1172/JCI67353; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gimeno RE, 2014, TRENDS ENDOCRIN MET, V25, P303, DOI 10.1016/j.tem.2014.03.001; Guridi M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3715; Helmers AJ, 2009, AM J TROP MED HYG, V81, P631, DOI 10.4269/ajtmh.2009.09-0204; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2015, TRENDS ENDOCRIN MET, V26, P608, DOI 10.1016/j.tem.2015.09.007; Kim H, 2015, MOL CELL BIOL, V35, P4121, DOI 10.1128/MCB.00665-15; Kim KH, 2014, DIABETES METAB J, V38, P245, DOI 10.4093/dmj.2014.38.4.245; Kim KH, 2013, BIOCHEM BIOPH RES CO, V440, P76, DOI 10.1016/j.bbrc.2013.09.026; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Kim SH, 2015, DIABETOLOGIA, V58, P809, DOI 10.1007/s00125-014-3475-6; Kosters A, 2003, J HEPATOL, V38, P710, DOI 10.1016/S0168-8278(03)00093-X; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Lee MS, 2015, ANN NY ACAD SCI, V1350, P61, DOI 10.1111/nyas.12822; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Liao JK, 2012, EUR HEART J, V33, P1299, DOI 10.1093/eurheartj/ehr287; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu TF, 2012, CELL METAB, V16, P213, DOI 10.1016/j.cmet.2012.06.014; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Luo Yongde, 2013, Front Endocrinol (Lausanne), V4, P194, DOI 10.3389/fendo.2013.00194; Markan KR, 2016, SEMIN CELL DEV BIOL, V53, P85, DOI 10.1016/j.semcdb.2015.09.021; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451; Miyake M, 2016, FASEB J, V30, P798, DOI 10.1096/fj.15-275990; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Niknejad N, 2007, J BIOL CHEM, V282, P29748, DOI 10.1074/jbc.M705859200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Ranji P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100033; Roy A, 2015, CELL METAB, V22, P253, DOI 10.1016/j.cmet.2015.05.022; Slocum SL, 2016, ARCH BIOCHEM BIOPHYS, V591, P57, DOI 10.1016/j.abb.2015.11.040; So WY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.80; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Tricarico PM, 2015, INT J MOL SCI, V16, P16067, DOI 10.3390/ijms160716067; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010; Wagner RJ, 2010, AM J PHYSIOL-CELL PH, V299, pC119, DOI 10.1152/ajpcell.00429.2009; Yang ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048392; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Yokoyama M, 2007, J LIPID RES, V48, P646, DOI 10.1194/jlr.M600301-JLR200; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003	76	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162024	10.1371/journal.pone.0162024	http://dx.doi.org/10.1371/journal.pone.0162024			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583452	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600087
J	Rabin, J; Houser, B; Talbert, C; Patel, R				Rabin, Jeff; Houser, Brook; Talbert, Carolyn; Patel, Ruh			Blue-Black or White-Gold? Early Stage Processing and the Color of 'The Dress'	PLOS ONE			English	Article							ASYMMETRIES; PERCEPTION; VISION	Purpose In Feb 2015 an image of a dress posted on Tumblr triggered an internet phenomenon: Is the Dress blue and black (BB) or white and gold (WG)? Many claim BB and others insist WG while the true colors are BB. The prevailing theory is that assumptions about the illuminant govern perception of the Dress with WG due to bluish lighting and BB due to yellowish. Our purpose was to determine if early stage optical, retinal and/or neural factors also impact perception of the Dress. Methods Thirty-nine subjects were categorized as BB or WG based on their initial perception of the Dress and their perception reported when viewing the Dress on iPhone 5, iPad, and 22 '' LCD displays. Macular pigment optical density (MPOD) measured with the QuantifEye (TM) MPS II and visual brainwaves (VEPs) in response to brief presentations of a transparency of the Dress illuminated by a flashing light were measured on each subject and compared between BB and WG groups. Additionally, CIE chromaticity (color) and luminance (brightness) were measured from multiple areas of the Dress image to determine cone stimulation and contrast. Results Mean MPOD was higher in the WG group (0.49) vs. the BB (0.41, p = 0.04) and median values were higher as well (WG = 0.46, BB = 0.36, p = 0.03). There was no difference in VEP amplitude between groups (p > 0.85) but mean VEP latency was longer in WG (130 msec.) vs. the BB group (107 msec., p = 0.0005). Colorimetry of the Dress showed significantly greater stimulation of blue cones (contrast = 73%) vs. red and green sensitive cones (contrast = 13%). Conclusions Our findings indicate that observers with denser MPOD may be predisposed to perceive the Dress as WG due to great absorption of blue light by the macular pigment. Moreover, the novel, substantial stimulation of blue cones by the Dress may contribute to ambiguity and dichotomous perception since the blue cones are so sparse in the retina. Finally, the delayed WG VEPs indicate distinct neural processing in perception of the consistent with fMRI evidence that the WG percept is processed at higher cortical levels than the BB. These results do not fully explain the dichotomous perception of the Dress but do exemplify the need to consider early stage processing when elucidating ambiguous percepts and figures.	[Rabin, Jeff; Houser, Brook; Talbert, Carolyn; Patel, Ruh] Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX 78209 USA		Rabin, J (corresponding author), Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX 78209 USA.	rabin@uiwtx.edu						Bach M, 2015, OPHTHALMOLOGE, V112, P512, DOI 10.1007/s00347-015-0064-0; Beatty S, 2004, ARCH BIOCHEM BIOPHYS, V430, P70, DOI 10.1016/j.abb.2004.03.015; Bernstein PS, 2014, PROG RETIN EYE RES; COLE GR, 1992, BEHAV RES METH INSTR, V24, P22, DOI 10.3758/BF03203465; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Gegenfurtner KR, 2015, CURR BIOL, V25, pR543, DOI 10.1016/j.cub.2015.04.043; KRAUSKOPF J, 1982, VISION RES, V22, P1123, DOI 10.1016/0042-6989(82)90077-3; Lafer-Sousa R, 2015, CURR BIOL, V25, pR545, DOI 10.1016/j.cub.2015.04.053; Makridaki M, 2009, OPHTHAL PHYSL OPT, V29, P338, DOI 10.1111/j.1475-1313.2009.00667.x; Rabin J, 2011, INVEST OPHTH VIS SCI, V52, P816, DOI 10.1167/iovs.10-6283; Schlaffke L, 2015, CORTEX, V73, P271, DOI 10.1016/j.cortex.2015.08.017; Shevell SK, 2008, ANNU REV PSYCHOL, V59, P143, DOI 10.1146/annurev.psych.59.103006.093619; SMITH VC, 1975, VISION RES, V15, P161, DOI 10.1016/0042-6989(75)90203-5; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; Vemuri K, 2016, J OPT SOC AM, V1, P37; Vingrys AJ, 1998, VISION RES, V38, P1085, DOI 10.1016/S0042-6989(97)00250-2; Werner A, 2014, VISION RES, V104, P80, DOI 10.1016/j.visres.2014.10.005; Winkler AD, 2015, CURR BIOL, V25, pR547, DOI 10.1016/j.cub.2015.05.004; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	20	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161090	10.1371/journal.pone.0161090	http://dx.doi.org/10.1371/journal.pone.0161090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580077	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877400015
J	Mistry, H; Sharma, P; Mahato, S; Saravanan, R; Kumar, PA; Bhandari, V				Mistry, Hiral; Sharma, Paresh; Mahato, Sudipta; Saravanan, R.; Kumar, P. Anand; Bhandari, Vasundhra			Prevalence and Characterization of Oxacillin Susceptible mecA-Positive Clinical Isolates of Staphylococcus aureus Causing Bovine Mastitis in India	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL SUSCEPTIBILITY; PCR ASSAY; MRSA; STRAINS; EMERGENCE; INFECTIONS; HOMOLOG; CLONE	Bovine mastitis caused by multidrug resistant Staphylococcus aureus is a huge problem reported worldwide, resulting in prolonged antibiotic treatment and death of livestock. The current study is focused on surveillance of antibiotic susceptibility along with genotypic and phenotypic characterization of the pathogenic S. aureus strains causing mastitis in India. One hundred and sixty seven milk samples were collected from mastitis-affected cows from different farms in India resulting in thirty nine isolated S. aureus strains. Antibiotic sensitivity profiling revealed the majority of the strains (n = 24) to be multidrug resistant and eleven strains showed reduced susceptibility to vancomycin (MICs = 2 mu g/ml). All strains were oxacillin sensitive, but 19 strains were positive for the mecA gene, which revealed the occurrence of oxacillin susceptible mecA positive strains (OS-MRSA) for the first time from India. Additionally, 32 strains were positive for the pvl gene, a virulence determinant; of these 17 were also OS-MRSA strains. Molecular characterization based on multilocus sequence typing (MLST), spa typing, agr typing and SCCmec classification revealed strains belonging to different groups. Moreover, strains showed spa types (t2526, t9602) and MLST sequence types, ST-72, ST-88 and ST-239 which have been earlier reported in human infections. The prevalence of OS-MRSA strains indicates the importance of including both the genetic and phenotypic tests in characterizing S. aureus strains. Increased genotypic variability with strain related to human infections and pvl positive isolates indicates a worrisome situation with the possibility of bilateral transfer.	[Mistry, Hiral; Sharma, Paresh; Mahato, Sudipta; Bhandari, Vasundhra] Natl Inst Anim Biotechnol DBT, Hyderabad, Andhra Pradesh, India; [Saravanan, R.] Breeding Vet Coll & Res Inst, Dept Anim Genet & Breeding, Namakkal, Tamil Nadu, India; [Kumar, P. Anand] SVVU, Dept Vet Microbiol, NTR Coll Vet Sci, Gannavaram, Andhra Pradesh, India; [Bhandari, Vasundhra] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Tamil Nadu Veterinary & Animal Sciences University; Sri Venkateswara Veterinary University; University of Hyderabad	Bhandari, V (corresponding author), Natl Inst Anim Biotechnol DBT, Hyderabad, Andhra Pradesh, India.; Bhandari, V (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, Andhra Pradesh, India.	vasundhra23@gmail.com	Ramasamy, Saravanan/ADW-8513-2022	Ramasamy, Saravanan/0000-0003-2409-0357; BHANDARI, VASUNDHRA/0000-0002-1930-1722	National Institute of Animal Biotechnology Hyderabad; Department of Biotechnology, India [BT/PR8856/ADV/90/157/2013]; Fast Track Young Scientist Grant Science and Engineering Research Board, India [SERB/LS173/2014]	National Institute of Animal Biotechnology Hyderabad; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Fast Track Young Scientist Grant Science and Engineering Research Board, India	Funded by Intramural funds from National Institute of Animal Biotechnology Hyderabad and extramural funding by Department of Biotechnology, India project (BT/PR8856/ADV/90/157/2013) and Fast Track Young Scientist Grant Science and Engineering Research Board, India (SERB/LS173/2014).	Awandkar SP., 2013, BIOLIFE, V1, P139; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bouchiat C., 2015, New Microbes and New Infections, V7, P15, DOI 10.1016/j.nmni.2015.05.003; Chadwick SG, 2013, J CLIN MICROBIOL, V51, P2541, DOI 10.1128/JCM.00417-13; Chandrasekaran D., 2014, Journal of Applied and Natural Science, V6, P786; Conceicao T, 2015, J ANTIMICROB CHEMOTH, V70, P3200, DOI 10.1093/jac/dkv261; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Ebert MD, 2009, EMERG RADIOL, V16, P159, DOI 10.1007/s10140-008-0706-5; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Haran KP, 2012, J CLIN MICROBIOL, V50, P688, DOI 10.1128/JCM.05214-11; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Hososaka Yasuko, 2007, Journal of Infection and Chemotherapy, V13, P79, DOI 10.1007/s10156-006-0502-7; Huber H, 2010, EUROSURVEILLANCE, V15, P7; Kaliwal BB, 2011, VET WORLD, V4, P158; Kumar R, 2011, J BIOSCIENCES, V36, P175, DOI 10.1007/s12038-011-9004-6; Kumar VA, 2013, J CLIN MICROBIOL, V51, P318, DOI 10.1128/JCM.01040-12; Kutar K., 2015, Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, V36, P22, DOI 10.5958/0974-0147.2015.00005.7; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116699; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Liu CL, 2015, J MICROBIOL IMMUNOL, V48, P490, DOI 10.1016/j.jmii.2014.03.003; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mubarack HM, 2012, VET WORLD, V5, P352, DOI 10.5455/vetworld.2012.352-355; Nam HM, 2011, FOODBORNE PATHOG DIS, V8, P231, DOI 10.1089/fpd.2010.0661; Okolie CE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0490-9; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Park KH, 2015, J ANTIMICROB CHEMOTH, V70, P1185, DOI 10.1093/jac/dku475; Pournaras S, 2013, FUTURE MICROBIOL, V8, P1365, DOI 10.2217/fmb.13.118; Prashanth K, 2011, J GLOB INFECT DIS, V3, P115, DOI 10.4103/0974-777X.81686; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Radostits OM, 2007, VET MED-US, V9th, P174; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sharff KA, 2012, J CLIN MICROBIOL, V50, P4151, DOI 10.1128/JCM.01564-12; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Sudhan N. A., 2005, Indian Journal of Animal Research, V39, P127; Sumathi BR, 2008, VET WORLD, V1, P37; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wang DF, 2015, INFECT GENET EVOL, V31, P9, DOI 10.1016/j.meegid.2014.12.039; Wayne P., 2014, M100S24 CLSI, V34, P50; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	47	41	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162256	10.1371/journal.pone.0162256	http://dx.doi.org/10.1371/journal.pone.0162256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603123	Green Published, gold			2022-12-27	WOS:000383255200050
J	Hassoun, E; Safrin, M; Ziv, H; Pri-Chen, S; Kessler, E				Hassoun, Eyal; Safrin, Mary; Ziv, Hana; Pri-Chen, Sarah; Kessler, Efrat			Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Plasma Marker of Muscle and Liver Fibrosis in Mice (vol 11, e0159606, 2016)	PLOS ONE			English	Correction																		Hassoun E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159606	1	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162747	10.1371/journal.pone.0162747	http://dx.doi.org/10.1371/journal.pone.0162747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598301	Green Published, gold			2022-12-27	WOS:000383254800077
J	Turner, RJ; Eikmans, M; Bajema, IM; Bruijn, JA; Baelde, HJ				Turner, R. J.; Eikmans, M.; Bajema, I. M.; Bruijn, J. A.; Baelde, H. J.			Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIABETIC-NEPHROPATHY; LUPUS NEPHRITIS; EXPRESSION; PODOCYTES; OVEREXPRESSION; GLOMERULI; INDUCTION; REJECTION; ISOFORMS	Vascular endothelial growth factor A (VEGF-A) is essential for maintaining the glomerular filtration barrier. Absolute renal levels of VEGF-A change in patients with diabetic nephropathy and inflammatory kidney diseases, but whether changes in the renal splicing patterns of VEGF-A play a role remains unclear. In this study, we investigated mRNA splicing patterns of pro-angiogenic isoforms of VEGF-A in glomeruli and whole kidney samples from human patients with kidney disease and from mouse models of kidney disease. Kidney biopsies were obtained from patients with acute rejection following kidney transplantation, patients with diabetic nephropathy, and control subjects. In addition, kidney samples were obtained from mice with lupus nephritis, mice with diabetes mellitus, and control mice. The relative expression of each VEGF-A splice variant was measured using RT-PCR followed by quantitative fragment analysis. The pattern of renal VEGF-A splice variants was unchanged in diabetic nephropathy and lupus nephritis and was stable throughout disease progression in acute transplant rejection and diabetic nephropathy; these results suggest renal VEGF-A splicing stability during kidney disease. The splicing patterns were species-specific; in the control human kidney samples, VEGF-A 121 was the dominant isoform, whereas VEGF-A 164 was the dominant isoform measured in the mouse kidney samples.	[Turner, R. J.; Bajema, I. M.; Bruijn, J. A.; Baelde, H. J.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Eikmans, M.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Turner, RJ (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	r.j.turner@lumc.nl		baelde, Hans/0000-0002-1214-500X	Dutch National Science Academy (KNAW)	Dutch National Science Academy (KNAW)	We thank Pascal Bus for his help with the animal experiments. We thank the Dutch National Science Academy (KNAW) for awarding this study the Van Walree award for presentation on an international scientific conference.	Avihingsanon Y, 2009, KIDNEY INT, V75, P1340, DOI 10.1038/ki.2009.75; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Bates DO, 2006, CLIN SCI, V110, P575, DOI 10.1042/CS20050292; Bertuccio C, 2011, J BIOL CHEM, V286, P39933, DOI 10.1074/jbc.M111.241620; Bortoloso E, 2004, EUR J ENDOCRINOL, V150, P799, DOI 10.1530/eje.0.1500799; Botermans JM, 2011, CLIN J AM SOC NEPHRO, V6, P1207, DOI 10.2215/CJN.07820910; BRUIJN JA, 1988, AM J PATHOL, V130, P639; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Esquibies AE, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-32; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kitagawa N, 2006, DIABETES RES CLIN PR, V73, P150, DOI 10.1016/j.diabres.2005.12.008; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Navarro C, 2002, LUPUS, V11, P21, DOI 10.1191/0961203302lu131oa; Oltean S, 2015, J AM SOC NEPHROL, V26, P1889, DOI 10.1681/ASN.2014040350; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rintala SE, 2006, TRANSPLANT P, V38, P3236, DOI 10.1016/j.transproceed.2006.10.049; ROBERTS WG, 1995, J CELL SCI, V108, P2369; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Thilo F, 2012, NEPHROL DIAL TRANSPL, V27, P921, DOI 10.1093/ndt/gfr457; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; Van Vliet AI, 2001, J PATHOL, V193, P256; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wang HH, 2015, J AM SOC NEPHROL, V26, P314, DOI 10.1681/ASN.2013090985; Wang LY, 2015, INT J BIOCHEM CELL B, V58, P17, DOI 10.1016/j.biocel.2014.10.030; Whittle C, 1999, CLIN SCI, V97, P303, DOI 10.1042/CS19990016; Woolard J, 2009, MICROCIRCULATION, V16, P572, DOI 10.1080/10739680902997333	31	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162166	10.1371/journal.pone.0162166	http://dx.doi.org/10.1371/journal.pone.0162166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598902	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800043
J	Zhao, HY; Wang, DD; Chen, L; Liu, XY; Yan, H				Zhao, Hongya; Wang, Debby D.; Chen, Long; Liu, Xinyu; Yan, Hong			Identifying Multi-Dimensional Co-Clusters in Tensors Based on Hyperplane Detection in Singular Vector Spaces	PLOS ONE			English	Article							GENE-EXPRESSION DATA; GEOMETRIC BICLUSTERING ALGORITHM; VALUE DECOMPOSITION; MICROARRAY DATA; CAENORHABDITIS-ELEGANS; INTEGRATIVE ANALYSIS; MULTIPLE-SCLEROSIS; MATRIX	Co-clustering, often called biclustering for two-dimensional data, has found many applications, such as gene expression data analysis and text mining. Nowadays, a variety of multidimensional arrays (tensors) frequently occur in data analysis tasks, and co-clustering techniques play a key role in dealing with such datasets. Co-clusters represent coherent patterns and exhibit important properties along all the modes. Development of robust co-clustering techniques is important for the detection and analysis of these patterns. In this paper, a co-clustering method based on hyperplane detection in singular vector spaces (HDSVS) is proposed. Specifically in this method, higher-order singular value decomposition (HOSVD) transforms a tensor into a core part and a singular vector matrix along each mode, whose row vectors can be clustered by a linear grouping algorithm (LGA). Meanwhile, hyperplanar patterns are extracted and successfully supported the identification of multi-dimensional co-clusters. To validate HDSVS, a number of synthetic and biological tensors were adopted. The synthetic tensors attested a favorable performance of this algorithm on noisy or overlapped data. Experiments with gene expression data and lineage data of embryonic cells further verified the reliability of HDSVS to practical problems. Moreover, the detected co-clusters are well consistent with important genetic pathways and gene ontology annotations. Finally, a series of comparisons between HDSVS and state-of-the-art methods on synthetic tensors and a yeast gene expression tensor were implemented, verifying the robust and stable performance of our method.	[Zhao, Hongya] Shenzhen Polytech, Ind Ctr, Shenzhen, Peoples R China; [Wang, Debby D.; Chen, Long; Liu, Xinyu; Yan, Hong] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Wang, Debby D.] Caritas Inst Higher Educ, Hong Kong, Hong Kong, Peoples R China	ShenZhen Polytechnic; City University of Hong Kong	Chen, L (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.	ee.chenlong@my.cityu.edu.hk			Hong Kong Research Grants Council (Project CityU) [11214814]; National Natural Science Funds of China [31100958]	Hong Kong Research Grants Council (Project CityU); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Hong Kong Research Grants Council (Project CityU 11214814) and the National Natural Science Funds of China (Project No. 31100958).	An JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042431; [Anonymous], [No title captured]; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Chen HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071680; Cheng KO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-210; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Comon P, 2014, IEEE SIGNAL PROC MAG, V31, P44, DOI 10.1109/MSP.2014.2298533; Dhillon I. S., 2003, Journal of Machine Learning Research, V3, P1265, DOI 10.1162/153244303322753661; Dhillon I. S., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P269, DOI 10.1145/502512.502550; Du Z, 2014, CELL, V156, P359, DOI 10.1016/j.cell.2013.11.046; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Gan XC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-209; Garcia-Escudero LA, 2009, J R STAT SOC B, V71, P301, DOI 10.1111/j.1467-9868.2008.00682.x; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Hecker M, 2013, MOL NEUROBIOL, V48, P737, DOI 10.1007/s12035-013-8463-1; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H., 2008, P 14 ACM SIGKDD INT, P327; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lam BSY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041906; Lenstra A.K., 1982, ANN DISCRETE MATH, V16, P201, DOI [10.1016/S0304-0208(08)72452-6, DOI 10.1016/S0304-0208(08)72452-6]; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Moore JL, 2013, DEVELOPMENT, V140, P3266, DOI 10.1242/dev.096040; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Pascual-Montano A, 2006, IEEE T PATTERN ANAL, V28, P403, DOI 10.1109/TPAMI.2006.60; Pison G, 2006, COMPSTAT 2006: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P43, DOI 10.1007/978-3-7908-1709-6_4; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Pontes B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115497; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Shao JF, 2013, J BIOL CHEM, V288, P33411, DOI 10.1074/jbc.M113.487975; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; Van Aelst S, 2006, COMPUT STAT DATA AN, V50, P1287, DOI 10.1016/j.csda.2004.11.011; Wang DZ, 2013, J THEOR BIOL, V317, P200, DOI 10.1016/j.jtbi.2012.10.012; Weiland S, 2010, IEEE T SIGNAL PROCES, V58, P1171, DOI 10.1109/TSP.2009.2034308; Wu T., 2016, ARXIV160300395; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Yang WH, 2011, IEEE T KNOWL DATA EN, V23, P568, DOI 10.1109/TKDE.2010.150; Zhao HY, 2008, J THEOR BIOL, V251, P264, DOI 10.1016/j.jtbi.2007.11.030; Zhao HY, 2012, CURR BIOINFORM, V7, P43, DOI 10.2174/157489312799304413; Zhao HY, 2009, PATTERN RECOGN, V42, P2578, DOI 10.1016/j.patcog.2009.03.016; Zhao L, 2005, P 2005 ACM SIGMOD IN, P694	50	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162293	10.1371/journal.pone.0162293	http://dx.doi.org/10.1371/journal.pone.0162293			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598575	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800051
J	Ando, Y; Oku, T; Tsuji, T				Ando, Yusuke; Oku, Teruaki; Tsuji, Tsutomu			Platelet Supernatant Suppresses LPS-Induced Nitric Oxide Production from Macrophages Accompanied by Inhibition of NF-kappa B Signaling and Increased Arginase-1 Expression	PLOS ONE			English	Article							IN-VIVO; SYNTHASE; METABOLISM; INDUCTION; INJURY; CYTOKINES; PATTERN; ROLES	We previously reported that mouse bone marrow-derived macrophages (BMDMs) that had been co-cultured with platelets exhibited lower susceptibility to bacterial lipopolysaccharide (LPS) and produced lower levels of nitric oxide (NO) and inflammatory cytokines including TNF-alpha and IL-6. The suppression of macrophage responses was mediated, at least in part, by platelet supernatant. In the present study, we assessed phenotypic changes of BMDMs induced by incubation with the supernatant from thrombin-activated platelets (PLT-sup) and found that BMDMs cultured with PLT-sup (PLT-BMDMs) expressed a lower level of inducible NO synthase (iNOS) and a higher level of arginase-1, both of which are involved in the L-arginine metabolism, upon stimulation with LPS or zymosan. We also examined possible modulation of the NF-kappa B signaling pathway and observed suppression of I kappa B alpha phosphorylation and a decrease of NF-kappa B p65 expression in LPS-stimulated PLT-BMDMs. These results suggest that PLT-sup suppresses inflammatory responses of BMDMs via negative regulation of NF-kappa B signaling leading to lowered expression of iNOS and enhanced L-arginine catabolism by arginase-1.	[Ando, Yusuke; Oku, Teruaki; Tsuji, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Tokyo, Japan	Hoshi University	Tsuji, T (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Tokyo, Japan.	tsuji@hoshi.ac.jp		Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED); Hoshi University Otani Research Grants	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hoshi University Otani Research Grants	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Japan Agency for Medical Research and Development (AMED), and by Hoshi University Otani Research Grants.	Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ando Y, 2016, PLATELETS, V27, P344, DOI 10.3109/09537104.2015.1103369; Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Garcia-Bonilla L, 2014, J IMMUNOL, V193, P2531, DOI 10.4049/jimmunol.1400918; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Griscavage JM, 1996, P NATL ACAD SCI USA, V93, P3308, DOI 10.1073/pnas.93.8.3308; He LZ, 2013, AM J PATHOL, V182, P2407, DOI 10.1016/j.ajpath.2013.02.032; Heemskerk S, 2009, NAT REV NEPHROL, V5, P629, DOI 10.1038/nrneph.2009.155; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Numata M, 1998, J IMMUNOL, V160, P3031; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sonoki T, 1997, J BIOL CHEM, V272, P3689, DOI 10.1074/jbc.272.6.3689; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133	47	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162208	10.1371/journal.pone.0162208	http://dx.doi.org/10.1371/journal.pone.0162208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588757	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800036
J	Liu, CF; Sun, JF; Lu, Y; Bo, YC				Liu, Changfeng; Sun, Jinfeng; Lu, Yan; Bo, Yacong			Effects of Anthocyanin on Serum Lipids in Dyslipidemia Patients: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ESTER TRANSFER PROTEIN; RISK-FACTORS; DOUBLE-BLIND; CHOLESTEROL; EXTRACT; WOMEN	Background Dyslipidemia was present in most of the patients with coronary heart disease. Epidemiological evidence suggests that anthocyanin has some effects on the serum lipid. However, these results are controversial. This study aimed at collecting current clinical evidence and evaluating the effects of anthocyanin supplementation on total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) in dialysis patients. Methods The search included PubMed, Web of Science, MEDLINE, Cochrane Library, China National Knowledge Infrastructure, Wanfang Database (up to July 2015) to identify randomized controlled trials (RCTs) on the association between anthocyanin and serum lipids. Rev-Man (version 5.2) was used for Meta-analysis. Meta-regression analysis, sensitivity analysis and Egger's weighted regression tests were performed by using STATA software (version 12.0; StatCorp, College Station, TX, USA). Results Six studies (seven arms) involving 586 subjects were included in this meta-analysis. The results showed that anthocyanin supplementation has significant effects on TC [MD = -24.06, 95% CI(-45.58 to -2.64) mg/dL, I-2 = 93%], TG [MD = -26.14, 95% CI(-40.20 to -3.08) mg/dL, I-2 = 66% 1], LDL-C [MD = -22.10, 95% CI (-34.36 to -9.85) mg/dL, I-2 = 61%], and HDL-C(MD = 5.58, 95% CI (1.02 to 10.14) mg/dL; I-2 = 90%). Conclusion Anthocyanin supplementation significantly reduces serum TC, TG, and LDL-C levels in patients with dyslipidemia, and increases HDL-C. Further rigorously designed RCTs with larger sample sizes are needed to confirm the effectiveness of anthocyanin supplementation for dyslipidemia, especially hypo high density lipoprotein cholesterolemia.	[Liu, Changfeng] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Sun, Jinfeng] Zhengzhou Univ, Coll Publ Hlth, Dept Social Med & Hlth Serv Management, Zhengzhou 450001, Peoples R China; [Lu, Yan] Ninth Peoples Hosp Shanghai City, North Hosp, Shanghai 201999, Peoples R China; [Bo, Yacong] Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou 450001, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Liu, CF (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China.	1324058728@qq.com	SUN, JIN/GPX-9641-2022	Bo, Yacong/0000-0001-7306-9971	Zhengzhou Scientific and technical Bureau [153PRKXF232]	Zhengzhou Scientific and technical Bureau	This work was supported by Zhengzhou Scientific and technical Bureau (No. 153PRKXF232).	Abdel-Maksoud M, 2008, J CARDIOVASC PHARM, V51, P331, DOI 10.1097/FJC.0b013e318165e2e7; Afford S, 2000, J CLIN PATHOL-MOL PA, V53, P55, DOI 10.1136/mp.53.2.55; [Anonymous], 1993, MINERVA CHIR, V48, pXIII; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Cao GH, 2001, AM J CLIN NUTR, V73, P920; de Souza MO, 2012, NUTR RES, V32, P976, DOI 10.1016/j.nutres.2012.10.001; GSe HJPT, 2011, COCHRANE HDB SYSTEMA; Hassellund SS, 2013, J HUM HYPERTENS, V27, P100, DOI 10.1038/jhh.2012.4; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001; Kianbakht S, 2014, PHYTOTHER RES, V28, P432, DOI 10.1002/ptr.5011; Li D, 2015, J NUTR, V145, P742, DOI 10.3945/jn.114.205674; Liang YT, 2013, EUR J NUTR, V52, P869, DOI 10.1007/s00394-012-0393-6; [牟海英 Mu Haiying], 2010, [营养学报, Acta Nutrimenta Sinica], V32, P551; Padala S, 2012, ATHEROSCLEROSIS, V222, P15, DOI 10.1016/j.atherosclerosis.2011.11.005; [秦玉 QIN Yu], 2008, [食品科学, Food Science], V29, P540; Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814; Rinkuniene E, 2009, MEDICINA-LITHUANIA, V45, P140, DOI 10.3390/medicina45020018; Shim SH, 2012, J MED FOOD, V15, P818, DOI 10.1089/jmf.2012.2241; Soltani R, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/217451; Wang Y, 2016, J SCI FOOD AGR, V96, P2494, DOI 10.1002/jsfa.7370; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zhu Y, 2013, NUTR METAB CARDIOVAS, V23, P843, DOI 10.1016/j.numecd.2012.06.005	25	60	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162089	10.1371/journal.pone.0162089	http://dx.doi.org/10.1371/journal.pone.0162089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589062	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800029
J	Kao, JH; Lin, SH; Lai, CF; Lin, YC; Kong, ZL; Wong, CS				Kao, Jen-Hsin; Lin, Sheng-Hsiung; Lai, Chun-Fu; Lin, Yu-Chieh; Kong, Zwe-Ling; Wong, Chih-Shung			Shea Nut Oil Triterpene Concentrate Attenuates Knee Osteoarthritis Development in Rats: Evidence from Knee Joint Histology	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; ADJUVANT-INDUCED ARTHRITIS; NURVALA STEM BARK; SUBCHONDRAL BONE; ANTIINFLAMMATORY ACTIVITY; INTRAARTICULAR INJECTION; ARTICULAR-CARTILAGE; LUPEOL LINOLEATE; GLUCOSAMINE; CHONDROITIN	Background Shea nut oil triterpene concentrate is considered to have anti-inflammatory and antioxidant properties. Traditionally, it has been used to treat arthritic conditions in humans. This study aimed to investigate the effect of attenuating osteoarthritis (OA)-induced pain and joint destruction in rats by administering shea nut oil triterpene concentrate (SheaFlex75, which is more than 50% triterpenes). Methods An anterior cruciate ligament transaction (ACLT) with medial meniscectomy (MMx) was used to induce OA in male Wistar rats. Different doses of SheaFlex75 (111.6 mg/kg, 223.2 mg/kg, and 446.4 mg/kg) were then intragastrically administered daily for 12 weeks after surgery. Body weight and the width of the knee joint were measured weekly. Additionally, incapacitance tests were performed at weeks 2, 4, 6, 8, 10 and 12 to measure the weight bearing of the hind limbs, and the morphology and histopathology of the medial femoral condyles were examined and were evaluated using the Osteoarthritis Research Society International (OARSI) scoring system. Results This study showed that SheaFlex75 reduced the swelling of the knee joint with OA and rectified its weight bearing after ACLT plus MMx surgery in rats. Treatment with SheaFlex75 also decreased ACLT plus MMx surgery-induced knee joint matrix loss and cartilage degeneration. Conclusion SheaFlex75 relieves the symptoms of OA and protects cartilage from degeneration. SheaFlex75 thus has the potential to be an ideal nutraceutical supplement for joint protection, particularly for injured knee joints.	[Kao, Jen-Hsin] Cathay Gen Hosp, Dept Med Res, Taipei, Taiwan; [Lin, Sheng-Hsiung; Wong, Chih-Shung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Chun-Fu] Natl Def Med Ctr, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Lai, Chun-Fu] Triserv Gen Hosp, Songshan Branch, Dept Family Med, Taipei, Taiwan; [Lin, Yu-Chieh] Natl Def Med Ctr, Dept Pathol, Triserv Gen Hosp, Taipei, Taiwan; [Lin, Yu-Chieh] Taoyuan Armed Forces Gen Hosp, Dept Pathol, Taoyuan, Taiwan; [Lin, Yu-Chieh] Natl Def Med Ctr, Taipei, Taiwan; [Kong, Zwe-Ling] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Wong, Chih-Shung] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Kao, Jen-Hsin] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan	Cathay General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Taiwan Ocean University; Cathay General Hospital; National Defense Medical Center	Wong, CS (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Wong, CS (corresponding author), Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.	w82556@gmail.com	Kong, Zwe-Ling/AAB-5261-2019; Kong, Zwe-Ling/E-8763-2013; Kong, Zwe-Ling/AAB-5328-2019	Kong, Zwe-Ling/0000-0002-4877-6524; Kong, Zwe-Ling/0000-0002-4877-6524; LAI, CHUN-FU/0000-0003-2109-1522	Universal Integrated Corp., Taipei, Taiwan	Universal Integrated Corp., Taipei, Taiwan	This study received financial support in the form of a contract from Universal Integrated Corp., Taipei, Taiwan, a commercial company. Universal Integrated Corp. was not involved in any part of the study design or conduct, data collection or data analysis, or manuscript writing.; The SheaFlex75 was provided by Universal Integrated CORP., Taipei, Taiwan. This study was supported by Universal Integrated CORP., Taipei, Taiwan. Financial disclosure statements have been submitted, and no conflict of interest has been reported by the authors.	Akihisa T, 1996, PHYTOCHEMISTRY, V43, P1255, DOI 10.1016/S0031-9422(96)00343-3; Akihisa T, 2010, J OLEO SCI, V59, P273, DOI 10.5650/jos.59.273; Ameye LG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2016; Azebaze AGB, 2009, PLANTA MED, V75, P243, DOI 10.1055/s-0028-1088375; Banno N, 2006, J ETHNOPHARMACOL, V107, P249, DOI 10.1016/j.jep.2006.03.006; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363; Bove SE, 2006, OSTEOARTHR CARTILAGE, V14, P1041, DOI 10.1016/j.joca.2006.05.001; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Chen SP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/147163; Cheras PA, 2010, PHYTOTHER RES, V24, P1126, DOI 10.1002/ptr.3075; Chou MM, 2005, EXP BIOL MED, V230, P255; Creamer P, 2000, CURR OPIN RHEUMATOL, V12, P450, DOI 10.1097/00002281-200009000-00019; Ernst E, 2003, CLIN RHEUMATOL, V22, P285, DOI 10.1007/s10067-003-0731-4; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Fransen M, 2015, ANN RHEUM DIS, V74, P851, DOI 10.1136/annrheumdis-2013-203954; Geetha T, 2001, J ETHNOPHARMACOL, V76, P77, DOI 10.1016/S0378-8741(01)00175-1; Geetha T, 1999, MOL CELL BIOCHEM, V201, P83, DOI 10.1023/A:1007056300503; Geetha T, 1999, GEN PHARMACOL-VASC S, V32, P495, DOI 10.1016/S0306-3623(98)00212-2; Geetha T, 1998, PHARMACOL RES, V37, P191, DOI 10.1006/phrs.1997.0278; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007; Hayami T, 2004, ARTHRITIS RHEUM-US, V50, P1193, DOI 10.1002/art.20124; Henrotin YE, 1998, CLIN RHEUMATOL, V17, P31, DOI 10.1007/BF01450955; Honfo FG, 2014, CRIT REV FOOD SCI, V54, P673, DOI 10.1080/10408398.2011.604142; ITOH T, 1975, LIPIDS, V10, P808, DOI 10.1007/BF02532325; Janusz MJ, 2002, OSTEOARTHR CARTILAGE, V10, P785, DOI 10.1053/joca.2002.0823; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; KWEIFIOOKAI G, 1995, J ETHNOPHARMACOL, V46, P7, DOI 10.1016/0378-8741(95)01222-Y; KWEIFIOOKAI G, 1994, RES COMMUN MOL PATH, V85, P45; Lozoya KAA, 2000, PATHOL RES PRACT, V196, P729; PEERS KE, 1977, J SCI FOOD AGR, V28, P1000, DOI 10.1002/jsfa.2740281109; de Andrade MAP, 2015, ARTHROSCOPY, V31, P785, DOI 10.1016/j.arthro.2014.11.021; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Tsai WY, 2013, CONNECT TISSUE RES, V54, P49, DOI 10.3109/03008207.2012.734877; Van Vijven JPJ, 2012, OSTEOARTHR CARTILAGE, V20, P809, DOI 10.1016/j.joca.2012.04.008; Yang SB, 2015, ARTHRITIS RHEUMATOL, V67, P714, DOI 10.1002/art.38932; Yorimitsu M, 2008, OSTEOARTHR CARTILAGE, V16, P764, DOI 10.1016/j.joca.2007.11.006; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	44	17	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162022	10.1371/journal.pone.0162022	http://dx.doi.org/10.1371/journal.pone.0162022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583436	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600086
J	May, M; Relich, RF				May, Meghan; Relich, Ryan F.			A Comprehensive Systems Biology Approach to Studying Zika Virus	PLOS ONE			English	Article							TRANSMISSION; INFECTION; SERVER; SELECTON	Zika virus (ZIKV) is responsible for an ongoing and intensifying epidemic in the Western Hemisphere. We examined the complete predicted proteomes, glycomes, and selectomes of 33 ZIKV strains representing temporally diverse members of the African lineage, the Asian lineage, and the current outbreak in the Americas. Derivation of the complete selectome is an 'omics' approach to identify distinct evolutionary pressures acting on different features of an organism. Employment of the M8 model did not show evidence of global diversifying selection acting on the ZIKV polyprotein; however, a mixed effect model of evolution showed strong evidence (P<0.05) for episodic diversifying selection acting on specific sites. Single nucleotide polymorphisms (SNPs) were predictably frequent across strains relative to the derived consensus sequence. None of the 9 published detection procedures utilize targets that share 100% identity across the 33 strains examined, indicating that ZIKV escape from molecular detection is predictable. The predicted O-linked glycome showed marked diversity across strains; however, the N-linked glycome was highly stable. All Asian and American strains examined were predicted to include glycosylation of E protein ASN(154), a modification proposed to mediate neurotropism, whereas the modification was not predicted for African strains. SNP diversity, episodic diversifying selection, and differential glycosylation, particularly of ASN(154), may have major biological implications for ZIKV disease. Taken together, the systems biology perspective of ZIKV indicates: a.) The recently emergent Asian/American N-glycotype is mediating the new and emerging neuropathogenic potential of ZIKV; and b.) further divergence at specific sites is predictable as endemnicity is established in the Americas.	[May, Meghan] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA; [May, Meghan] Seacoast Biomed Sci Inst, York, ME 03911 USA; [Relich, Ryan F.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of New England - Maine; Indiana University System; Indiana University Bloomington	May, M (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.; May, M (corresponding author), Seacoast Biomed Sci Inst, York, ME 03911 USA.	mmay3@une.edu			sbsi-innovation-fund/parny	sbsi-innovation-fund/parny	This work was supported by the following source of funding: http://www.seacoastbiomedicalscience.org/#!sbsi-innovation-fund/parny (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182; Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934; Ayres CFJ, 2016, LANCET, V16; Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Beasley DWC, 2005, CURR MOL MED, V5, P835, DOI 10.2174/156652405774962272; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607; Besnard M, 2014, Euro Surveill, V19; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Cunha MS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00032-16; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dirlikov E, 2016, MMWR MORB MORTAL WKL; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Favoretto S, 2016, 1 DETECTION IN PRESS; Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15; Gardner LM, 2016, LANCET INFECT DIS; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; May M, 2008, MICROB PATHOGENESIS, V45, P38, DOI 10.1016/j.micpath.2008.02.002; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Olabode AS, 2015, VIROLOGY, V482, P202, DOI 10.1016/j.virol.2015.03.029; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Robinson O, 2016, MOL BIOL EVOLUTION; Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685; Thiery G, 2016, INTENSIVE CARE MED; Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16; WOLFE MS, 1982, LANCET, V2, P1306; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; World Health Organization, ZIK VIR FACT SHEET; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48	68	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161355	10.1371/journal.pone.0161355	http://dx.doi.org/10.1371/journal.pone.0161355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584813	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600023
J	Morineau, C; Gissot, L; Bellec, Y; Hematy, K; Tellier, F; Renne, C; Haslam, R; Beaudoin, F; Napier, J; Faure, JD				Morineau, Celine; Gissot, Lionel; Bellec, Yannick; Hematy, Kian; Tellier, Frederique; Renne, Charlotte; Haslam, Richard; Beaudoin, Frederic; Napier, Johnathan; Faure, Jean-Denis			Dual Fatty Acid Elongase Complex Interactions in Arabidopsis	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID SYNTHESIS; CELL-PROLIFERATION; SECRETORY PATHWAY; PASTICCINO GENES; PLASMA-MEMBRANE; PLANT; THALIANA; REDUCTASE; DIVISION	Very long chain fatty acids (VLCFAs) are involved in plant development and particularly in several cellular processes such as membrane trafficking, cell division and cell differentiation. However, the precise role of VLCFAs in these different cellular processes is still poorly understood in plants. In order to identify new factors associated with the biosynthesis or function of VLCFAs, a yeast multicopy suppressor screen was carried out in a yeast mutant strain defective for fatty acid elongation. Loss of function of the elongase 3 hydroxyacyl-CoA dehydratase PHS1 in yeast and PASTICCINO2 in plants prevents growth and induces cytokinesis defects. PROTEIN TYROSIN PHOSPHATASE-LIKE (PTPLA) previously characterized as an inactive dehydratase was able to restore yeast phs1 growth and VLCFAs elongation but not the plant pas2-1 defects. PTPLA interacted with elongase subunits in the Endoplasmic Reticulum (ER) and its absence induced the accumulation of 3-hydroxyacyl-CoA as expected from a dehydratase involved in fatty acid (FA) elongation. However, loss of PTPLA function increased VLCFA levels, an effect that was dependent on the presence of PAS2 indicating that PTPLA activity repressed FA elongation. The two dehydratases have specific expression profiles in the root with PAS2, mostly restricted to the endodermis, while PTPLA was confined in the vascular tissue and pericycle cells. Comparative ectopic expression of PTPLA and PAS2 in their respective domains confirmed the existence of two independent elongase complexes based on PAS2 or PTPLA dehydratase that are functionally interacting.	[Morineau, Celine; Gissot, Lionel; Bellec, Yannick; Hematy, Kian; Tellier, Frederique; Renne, Charlotte; Faure, Jean-Denis] Univ Paris Saclay, Inst Jean Pierre Bourgin, INRA, AgroParisTech,CNRS, Versailles, France; [Morineau, Celine] Univ Paris Saclay, Univ Paris 11, Orsay, France; [Haslam, Richard; Beaudoin, Frederic; Napier, Johnathan] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden, Herts, England	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Faure, JD (corresponding author), Univ Paris Saclay, Inst Jean Pierre Bourgin, INRA, AgroParisTech,CNRS, Versailles, France.	jean-denis.faure@versailles.inra.fr	Hématy, Kian/AAD-8989-2021	Hematy, Kian/0000-0002-3933-3852; Haslam, Richard/0000-0001-6226-5643; Napier, Johnathan/0000-0003-3580-3607; Faure, Jean-Denis/0000-0001-6867-6021	Ministere de l'Enseignement Superieur et de la Recherche (France); LabEx Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]; BBSRC [BBS/E/C/00005207] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005207] Funding Source: researchfish	Ministere de l'Enseignement Superieur et de la Recherche (France); LabEx Saclay Plant Sciences-SPS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Ministere de l'Enseignement Superieur et de la Recherche (France) (doctoral fellowship to CM).; We thank the Plant Observatory imaging platform of the IJPB institute for providing microscopy technical support and the chemistry platform for the FAMES analysis. We thank also Frederic Beaudoin (Departement of Biological Chemistry and Crop Protection; Rothamsted Research; UK), Jerome Joubes (Laboratoire de Biogenese membranaire; CNRS UMR 5200, France) Ljerka Kunst (Department of Botany; University of British Columbia; Canada) and Sebastien Baud (IJPB, INRA, Versailles, France) for providing seeds and DNA as well as the European Arabidopsis Stock Center for providing Arabidopsis T-DNA insertion mutant. This work was funded by the Ministere de l'Enseignement Superieur et de la Recherche (France) (doctoral fellowship to C.M.). The IJPB benefits from the support of the LabEx Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS).	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; Bach L, 2011, J CELL SCI, V124, P3223, DOI 10.1242/jcs.074575; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bellec Y, 2002, PLANT J, V32, P713, DOI 10.1046/j.1365-313X.2002.01456.x; Blacklock BJ, 2006, BIOCHEM BIOPH RES CO, V346, P583, DOI 10.1016/j.bbrc.2006.05.162; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Faure JD, 1998, DEVELOPMENT, V125, P909; Franke RB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00004; Gable K, 2004, J EXP BOT, V55, P543, DOI 10.1093/jxb/erh061; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Harrar Y, 2003, PLANT PHYSIOL, V132, P1217, DOI 10.1104/pp.102.019026; Haslam TM, 2013, PLANT SCI, V210, P93, DOI 10.1016/j.plantsci.2013.05.008; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; Ianiri G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105147; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joubes J, 2008, PLANT MOL BIOL, V67, P547, DOI 10.1007/s11103-008-9339-z; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Lee SB, 2009, PLANT J, V60, P462, DOI 10.1111/j.1365-313X.2009.03973.x; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; Markham JE, 2011, PLANT CELL, V23, P2362, DOI 10.1105/tpc.110.080473; Millar AA, 1998, PLANT CELL, V10, P1889, DOI 10.1105/tpc.10.11.1889; Millar AA, 1997, PLANT J, V12, P121, DOI 10.1046/j.1365-313X.1997.12010121.x; MINET M, 1992, PLANT J, V2, P417; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Molino D, 2014, BBA-MOL CELL BIOL L, V1841, P1422, DOI 10.1016/j.bbalip.2014.06.014; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nobusawa T, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001531; Nobusawa T, 2012, GENES CELLS, V17, P709, DOI 10.1111/j.1365-2443.2012.01619.x; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Park JA, 2005, FEBS LETT, V579, P4459, DOI 10.1016/j.febslet.2005.07.013; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pruitt RE, 2000, P NATL ACAD SCI USA, V97, P1311, DOI 10.1073/pnas.97.3.1311; Reina-Pinto JJ, 2009, PLANT CELL, V21, P1252, DOI 10.1105/tpc.109.065565; Roudier F, 2010, PLANT CELL, V22, P364, DOI 10.1105/tpc.109.071209; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Trenkamp S, 2004, P NATL ACAD SCI USA, V101, P11903, DOI 10.1073/pnas.0404600101; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Yu L, 2006, MOL BIOL CELL, V17, P4736, DOI 10.1091/mbc.E06-04-0368; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	48	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160631	10.1371/journal.pone.0160631	http://dx.doi.org/10.1371/journal.pone.0160631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583779	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600008
J	Paul, SP				Paul, Sharad P.			Golden Spirals and Scalp Whorls: Nature's Own Design for Rapid Expansion	PLOS ONE			English	Article							TISSUE EXPANSION; ADIPOSE-TISSUE; SKIN; LOCATIONS	This paper documents what began as an exercise in curiosity-logarithmic spiral designs abound in nature-in galaxies, flowers, even pinecones, and on human scalps as whorls. Why are humans the only primates to have whorls on the scalp? Is the formation of scalp whorls mechanical or genetic? A mechanical theory has long been postulated-the mechanical theory suggests that hair whorl patterning is determined by the tension on the epidermis during rapid expansion of the cranium while the hair follicle is growing downwards-however, this has never before, to the author's knowledge, been experimentally proven conclusively. We found, that under certain conditions, we were able to experimentally recreate spirals on the scalp to demonstrate that the basis of scalp whorls is indeed mechanical-and that logarithmic spirals may be nature's own design for rapid expansion of organic tissues. Given our experiments only created whorls when certain conditions were satisfied (and not in others), they have given us great insight into the mechanical formation of skin whorls and the physiology of skin stretch. We believe that these findings will lead to many more advances in understanding skin dynamics and indeed the changes that occur in tissue when confronted by stretch.	[Paul, Sharad P.] Univ Queensland, Sch Med, 288 Herston Rd, Herston, Qld 4006, Australia; [Paul, Sharad P.] Univ Auckland, Fac Surg, 2 Pk Rd, Auckland 1023, New Zealand; [Paul, Sharad P.] Auckland Univ Technol, 55 Wellesley St E, Auckland 1010, New Zealand	University of Queensland; University of Auckland; Auckland University of Technology	Paul, SP (corresponding author), Univ Queensland, Sch Med, 288 Herston Rd, Herston, Qld 4006, Australia.; Paul, SP (corresponding author), Univ Auckland, Fac Surg, 2 Pk Rd, Auckland 1023, New Zealand.; Paul, SP (corresponding author), Auckland Univ Technol, 55 Wellesley St E, Auckland 1010, New Zealand.	sharad@sharadpaul.com	Paul, Sharad P/A-3804-2017	Paul, Sharad P/0000-0001-9601-9109				ANDERSON DB, 1972, J LIPID RES, V13, P593; [Anonymous], 2005, NATURE, V436, P757; [Anonymous], 1933, J FRANKLIN I, V215, P352; BORGES AF, 1984, PLAST RECONSTR SURG, V73, P144, DOI 10.1097/00006534-198401000-00036; Catrakis H. J., 2011, J MATH RES, V3, P3; Chandawarkar RY, 2003, DERMATOL SURG, V29, P834, DOI 10.1046/j.1524-4725.2003.29218.x; Driskell RR, 2014, EXP DERMATOL, V23, P629, DOI 10.1111/exd.12450; GIBSON T, 1978, BRIT J PLAST SURG, V31, P1, DOI 10.1016/0007-1226(78)90002-4; Hakim V, 1997, PHYS REV LETT, V79, P665, DOI 10.1103/PhysRevLett.79.665; Herron A., 2009, P ACVP ASVCP CONC AN; INGROUILLE M, 1994, NATURE, V369, P718, DOI 10.1038/369718a0; Kwak M, 2014, WOUND REPAIR REGEN, V22, P678, DOI 10.1111/wrr.12206; LANGER K, 1978, BRIT J PLAST SURG, V31, P3, DOI 10.1016/0007-1226(78)90003-6; Leung KT, 2001, NATURE, V410, P166, DOI 10.1038/35065517; Li CR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2728578; Ma J, NONLINEAR DYNAMICS, V73, P73; Naylor M., 2002, MATH MAG, V75, P163, DOI [10.1080/0025570x.2002.1517Iterations, DOI 10.1080/0025570X.2002.1517ITERATIONS]; Paine ML, 2004, J INVEST DERMATOL, V122, P1057, DOI 10.1111/j.0022-202X.2004.22420.x; Randle H., 2003, ANN REPORT LUNDY FIE, P67; SAMLASKA CP, 1989, J AM ACAD DERMATOL, V21, P553, DOI 10.1016/S0190-9622(89)70225-5; SASAKI GH, 1987, CLIN PLAST SURG, V14, P563; Schmook FP, 2001, INT J PHARM, V215, P51, DOI 10.1016/S0378-5173(00)00665-7; van Doorn WG, 2003, J EXP BOT, V54, P1801, DOI 10.1093/jxb/erg213; Wilhelmi BJ, 1998, ANN PLAS SURG, V41, P215, DOI 10.1097/00000637-199808000-00019; WUNDERLICH RC, 1975, CLIN PEDIATR, V14, P1045, DOI 10.1177/000992287501401111; Yang M, 2011, ARCH DERMATOL RES, V303, P125, DOI 10.1007/s00403-011-1123-2; Zhu YF, 2002, ARCH DERMATOL RES, V293, P560, DOI 10.1007/s00403-001-0277-8	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162026	10.1371/journal.pone.0162026	http://dx.doi.org/10.1371/journal.pone.0162026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583520	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600088
J	Souza, TXR; Macedo, CA				Souza, T. X. R.; Macedo, C. A.			Ferromagnetic Ground States in Face-Centered Cubic Hubbard Clusters	PLOS ONE			English	Article							METALLIC FERROMAGNETISM; MODEL	In this study, the ground state energies of face-centered cubic Hubbard clusters are analyzed using the Lanczos method. Examination of the ground state energy as a function of the number of particle per site n showed an energy minimum for face-centered cubic structures. This energy minimum decreased in n with increasing coulombic interaction parameter U. We found that the ground state energy had a minimum at n = 0.6, when U = 3W, where W denotes the non-interacting energy bandwidth and the face-centered cubic structure was ferromagnetic. These results, when compared with the properties of nickel, shows strong similarity with other finite temperature analyses in the literature and supports the Hirsh's conjecture that the interatomic direct exchange interaction dominates in driving the system into a ferromagnetic phase.	[Souza, T. X. R.; Macedo, C. A.] Univ Fed Sergipe, Dept Fis, BR-49100000 Sao Cristovao, SE, Brazil	Universidade Federal de Sergipe	Souza, TXR (corresponding author), Univ Fed Sergipe, Dept Fis, BR-49100000 Sao Cristovao, SE, Brazil.	t.x.r.souza@gmail.com			CAPES (Brazilian Agency)	CAPES (Brazilian Agency)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CAPES (Brazilian Agency). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank G. M. A. Almeida for the careful reading of the manuscript.	Boschi CD, 2004, EUR PHYS J B, V41, P503, DOI 10.1140/epjb/e2004-00344-1; GHOSH DK, 1971, PHYS REV LETT, V27, P1584, DOI 10.1103/PhysRevLett.27.1584; Hirsch JE, 1997, PHYS REV B, V56, P11022, DOI 10.1103/PhysRevB.56.11022; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; LANCZOS C, 1950, J RES NAT BUR STAND, V45, P255, DOI 10.6028/jres.045.026; LIEB E, 1962, PHYS REV, V125, P164, DOI 10.1103/PhysRev.125.164; LIEB EH, 1968, PHYS REV LETT, V20, P1445, DOI 10.1103/PhysRevLett.20.1445; MACEDO AMS, 1992, J MAGN MAGN MATER, V104, P679, DOI 10.1016/0304-8853(92)90981-S; Macedo CA, 2008, J MAGN MAGN MATER, V320, pE437, DOI 10.1016/j.jmmm.2008.02.081; Ribeiro AN, 2013, J KOREAN PHYS SOC, V62, P1445, DOI 10.3938/jkps.62.1445; USUKI T, 1990, J PHYS SOC JPN, V59, P1357, DOI 10.1143/JPSJ.59.1357; Walker BG, 2008, EUR PHYS J B, V66, P7, DOI 10.1140/epjb/e2008-00388-1; Wohlfarth E. P., 1980, FERROMAGNETIC MAT, V1; Zhang GP, 1998, COMPUT PHYS COMMUN, V109, P27, DOI 10.1016/S0010-4655(97)00136-7	14	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161549	10.1371/journal.pone.0161549	http://dx.doi.org/10.1371/journal.pone.0161549			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583653	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600039
J	Wikenius, E; Moe, V; Kjellevold, M; Smith, L; Lyle, R; Waagbo, R; Page, CM; Myhre, AM				Wikenius, Ellen; Moe, Vibeke; Kjellevold, Marian; Smith, Lars; Lyle, Robert; Waagbo, Rune; Page, Christian Magnus; Myhre, Anne Margrethe			The Association between Hair Cortisol and Self-Reported Symptoms of Depression in Pregnant Women	PLOS ONE			English	Article							EDINBURGH POSTNATAL DEPRESSION; MENTAL-HEALTH; MATERNAL CORTISOL; YOUNG-ADULTS; STRESS; SCALE; EXPOSURE; DISEASE; DETERMINANTS; VALIDATION	Depression has been linked to an imbalance in cortisol. Until recently, cortisol has been studied by measuring concentrations at single time points in blood or saliva samples. Cortisol concentrations vary with circadian rhythm and experiences, from time point to time point. The measurement of hair cortisol concentration (HCC) is a new method of accessing mean, long-term cortisol concentrations. Recent studies show positive associations between depression and HCC, and prenatal maternal cortisol is thought to influence the developing fetus. We therefore examined the association between HCC and self-reported symptoms of depression in second trimester pregnant women. Participants were 181 women, recruited between September 2011 and October 2013 to the Little-in-Norway (LiN)-study. These women answered the Edinburgh Postnatal Depression Rating Scale (EPDS) on self-reported symptoms of depression, and one cm maternal scalp hair was collected and analyzed for cortisol concentrations. Multiple regression analyses did not show depressive symptoms as a predictor for HCC in our selection of pregnant women, while gestational age was significantly related. In conclusion, our study indicated that symptoms of depression during pregnancy did not predict HCC, but further studies of clinically depressed, pregnant women using gestational age as an adjustment variable are warranted.	[Wikenius, Ellen; Page, Christian Magnus; Myhre, Anne Margrethe] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Moe, Vibeke; Smith, Lars] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway; [Moe, Vibeke] Ctr Child & Adolescent Mental Hlth Eastern & Sout, Oslo, Norway; [Kjellevold, Marian; Waagbo, Rune] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Lyle, Robert] Univ Oslo, Sch Pharm, Fac Math & Nat Sci, Oslo, Norway; [Lyle, Robert] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Myhre, Anne Margrethe] Oslo Univ Hosp, Child & Adolescent Mental Hlth Res Unit, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Wikenius, E (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	ellen.wikenius@medisin.uio.no	Waagbø, Rune/M-4567-2019; Kjellevold, Marian/Q-6334-2019; Kjellevold, Marian/C-2973-2012; Page, Christian/J-7129-2019	Kjellevold, Marian/0000-0001-7070-5784; Kjellevold, Marian/0000-0001-7070-5784; Page, Christian/0000-0002-1897-3666; Waagbo, Rune/0000-0001-6075-3221; Moe, Vibeke/0000-0002-8436-8341	The Research Council of Norway; Child and Adolescent Mental Health Eastern and Southern Norway (RUBP)	The Research Council of Norway(Research Council of Norway); Child and Adolescent Mental Health Eastern and Southern Norway (RUBP)	The participants of this subsample came from the Little in Norway study, which was sponsored by The Research Council of Norway. Child and Adolescent Mental Health Eastern and Southern Norway (RUBP) funded the hair cortisol analyses.	Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Boumba VA, 2006, INT J TOXICOL, V25, P143, DOI 10.1080/10915810600683028; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Dettenborn L, 2010, PSYCHONEUROENDOCRINO, V35, P1404, DOI 10.1016/j.psyneuen.2010.04.006; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Dowlati Y, 2010, NEUROPSYCH DIS TREAT, V6, P393; Gerber M, 2013, STRESS, V16, P593, DOI 10.3109/10253890.2013.823599; Gerber M, 2013, NEUROPSYCHOBIOLOGY, V68, P100, DOI 10.1159/000351735; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Hamel AF, 2011, CLIN CHIM ACTA, V412, P382, DOI 10.1016/j.cca.2010.10.019; Vives AH, 2015, J PSYCHIATR RES, V70, P38, DOI [10.1016/j.psychires.2015.08.007, 10.1016/j.jpsychires.2015.08.007]; Kalra S, 2007, CLIN INVEST MED, V30, pE103, DOI 10.25011/cim.v30i2.986; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; LeWinn KZ, 2009, INT J EPIDEMIOL, V38, P1700, DOI 10.1093/ije/dyp200; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019; Raikkonen K, 2011, STRESS, V14, P590, DOI 10.3109/10253890.2011.602147; Raul JS, 2004, CLIN BIOCHEM, V37, P1105, DOI 10.1016/j.clinbiochem.2004.02.010; SACHAR EJ, 1967, ARCH GEN PSYCHIAT, V17, P554; Skjothaug T, 2015, INFANT MENT HEALTH J, V36, P104, DOI 10.1002/imhj.21485; Skoluda N, 2012, PSYCHONEUROENDOCRINO, V37, P611, DOI 10.1016/j.psyneuen.2011.09.001; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Stalder T, 2014, PSYCHONEUROENDOCRINO, V47, P26, DOI 10.1016/j.psyneuen.2014.04.021; StatisticsNorway, 2014, BEF UTD; Staufenbiel SM, 2015, PSYCHONEUROENDOCRINO, V60, P182, DOI 10.1016/j.psyneuen.2015.06.011; Staufenbiel SM, 2015, J CLIN ENDOCR METAB, V100, P2456, DOI 10.1210/jc.2014-4328; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Wei JX, 2015, J AFFECT DISORDERS, V175, P299, DOI 10.1016/j.jad.2015.01.023; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wells S, 2014, STRESS, V17, P334, DOI 10.3109/10253890.2014.930432; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Wosu AC, 2013, ANN EPIDEMIOL, V23, P797, DOI 10.1016/j.annepidem.2013.09.006; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P267, DOI 10.1016/S0893-133X(00)00236-0	45	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161804	10.1371/journal.pone.0161804	http://dx.doi.org/10.1371/journal.pone.0161804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584584	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600061
J	Ross, J; Westaway, K; Travers, M; Morwood, MJ; Hayward, J				Ross, June; Westaway, Kira; Travers, Meg; Morwood, Michael J.; Hayward, John			Into the Past: A Step Towards a Robust Kimberley Rock Art Chronology	PLOS ONE			English	Article							MUD-WASP NESTS; ARNHEM-LAND; QUARTZ; RADIOCARBON; AUSTRALIA; AGE; STIMULATION; COMPONENT; BEESWAX; CAVE	The recent establishment of a minimum age estimate of 39.9 ka for the origin of rock art in Sulawesi has challenged claims that Western Europe was the locus for the production of the world's earliest art assemblages. Tantalising excavated evidence found across northern Australian suggests that Australia too contains a wealth of ancient art. However, the dating of rock art itself remains the greatest obstacle to be addressed if the significance of Australian assemblages are to be recognised on the world stage. A recent archaeological project in the northwest Kimberley trialled three dating techniques in order to establish chronological markers for the proposed, regional, relative stylistic sequence. Applications using optically-stimulated luminescence (OSL) provided nine minimum age estimates for fossilised mudwasp nests overlying a range of rock art styles, while Accelerator Mass Spectrometry radiocarbon (AMS C-14) results provided an additional four. Results confirm that at least one phase of the northwest Kimberley rock art assemblage is Pleistocene in origin. A complete motif located on the ceiling of a rockshelter returned a minimum age estimate of 16 +/- 1 ka. Further, our results demonstrate the inherent problems in relying solely on stylistic classifications to order rock art assemblages into temporal sequences. An earlier than expected minimum age estimate for one style and a maximum age estimate for another together illustrate that the Holocene Kimberley rock art sequence is likely to be far more complex than generally accepted with different styles produced contemporaneously well into the last few millennia. It is evident that reliance on techniques that produce minimum age estimates means that many more dating programs will need to be undertaken before the stylistic sequence can be securely dated.	[Ross, June; Travers, Meg] Univ New England, Dept Archaeol, Armidale, NSW, Australia; [Westaway, Kira] Macquarie Univ, Dept Environm Sci, Sydney, NSW, Australia; [Morwood, Michael J.] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Hayward, John] Govt Western Australia, Dept Pk & Wildlife, Kununurra, WA, Australia	University of New England; Macquarie University; University of Wollongong	Ross, J (corresponding author), Univ New England, Dept Archaeol, Armidale, NSW, Australia.	jross4@une.edu.au		Westaway, Kira/0000-0001-5315-778X	Australian Research Council [LP0991845, DP110102898]	Australian Research Council(Australian Research Council)	This work was supported by LP0991845 Australian Research Council (http://www.arc.gov.au/): JR KW MJM. Linkage partners: Kandiwal Aboriginal Corporation, Kimberley Foundation Australia, Slingair and Heliwork Pty Ltd, Department of Environment and Conservation Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by DP110102898 Australian Research Council (http://www.arc.gov.au/). U-Series dating. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken M.J., 1998, INTRO OPTICAL DATING; AKERMAN K, 1979, OCEANIA, V49, P169, DOI 10.1002/j.1834-4461.1979.tb01387.x; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Aubert M, 2012, J ARCHAEOL SCI, V39, P573, DOI 10.1016/j.jas.2011.11.009; Bahn P.G., 1993, OXBOW MONOGRAPH, V35, P99; Bednarik R.G., 1995, ROCK ART RES, V12, P86; Bednarik RG, 1995, ANTIQUITY, V69, P877, DOI 10.1017/S0003598X00082430; Bednarik RG, 2014, ROCK ART RES, V31, P225; Botter-Jensen L, 2003, RADIAT MEAS, V37, P535, DOI 10.1016/S1350-4487(03)00020-9; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; Brito RM, 2012, SWARM INTELL-US, V6, P151, DOI 10.1007/s11721-012-0068-1; Chippindale C., 1998, ARCHAEOLOGY ROCK ART; Craparo R.M., 2007, ENCY MEASUREMENT STA, V3, P889; Crawford Ian M., 1968, ART WANDJINA ABORIGI; David B, 2013, J ARCHAEOL SCI, V40, P2493, DOI 10.1016/j.jas.2012.08.015; David B, 2013, J ARCHAEOL SCI, V40, P3, DOI 10.1016/j.jas.2012.08.019; Duller GAT, 2003, RADIAT MEAS, V37, P543, DOI 10.1016/S1350-4487(03)00050-7; Fallon SJ, 2010, NUCL INSTRUM METH B, V268, P898, DOI 10.1016/j.nimb.2009.10.059; Fink D, 2004, NUCL INSTRUM METH B, V223, P109, DOI 10.1016/j.nimb.2004.04.025; GALBRAITH RF, 1990, NUCL TRACKS RAD MEAS, V17, P197; GALBRAITH RF, 1990, NUCL TRACKS RAD MEAS, V17, P207; Guerin G, 2012, GEOCHRONOMETRIA, V39, P40, DOI 10.2478/s13386-011-0056-z; Huntley J, 2015, ARCHAEOMETRY, V57, P77, DOI 10.1111/arcm.12073; Jacobs Z, 2006, RADIAT MEAS, V41, P264, DOI 10.1016/j.radmeas.2005.07.027; Jacobs Z, 2003, J HUM EVOL, V44, P613, DOI 10.1016/S0047-2484(03)00049-6; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jones R., 1985, SPECIAL PUBLICATION, V13, P165; Karadada J., 2011, UUNGUU PLANTS ANIMAL; Lewis D., 1997, AUST ARCHAEOL, V44, P1; LORBLANCHET M, 1993, OXBOW MONOGRAPH, V35; Love JRB, 1936, STONE AGE BUSHMAN TO; MILBORROW BV, 1987, AUST J BIOL SCI, V40, P15; Morwood MJ, 2010, ROCK ART RES, V27, P3; Morwood M. J., 1994, ROCK ART RES, V11, P79; Morwood M.J., 2000, BRADSHAW ART KIMBERL, P34; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Naumann I.D., 1983, Australian National Parks and Wildlife Service Special Publication, P127; Naumann ID, 1987, ROCK ART RES, V4, P27; Nelson D. E., 1995, Archaeometry, V37, P151, DOI 10.1111/j.1475-4754.1995.tb00733.x; O'Connor S, 2001, HIST OLD AGES ESSAYS, P287; O'Connor S, 2013, ANTIQUITY, V87, P539, DOI 10.1017/S0003598X00049115; Pietsch TJ, 2008, QUAT GEOCHRONOL, V3, P365, DOI 10.1016/j.quageo.2007.12.005; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Preusser F, 2006, RADIAT MEAS, V41, P871, DOI 10.1016/j.radmeas.2006.04.019; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roberts R, 1997, NATURE, V387, P696, DOI 10.1038/42690; ROBERTS RG, 1994, QUATERNARY SCI REV, V13, P575, DOI 10.1016/0277-3791(94)90080-9; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Rosenfeld A, 1997, ANTIQUITY, V71, P405, DOI 10.1017/S0003598X00085008; Ross J., 2013, GREAT CIRCLE, V35, P55; Schmidt PW, 2008, PRECAMBRIAN RES, V167, P267, DOI 10.1016/j.precamres.2008.09.002; Singarayer JS, 2000, RADIAT MEAS, V32, P873, DOI 10.1016/S1350-4487(00)00074-3; Smith MA, 2009, GEOARCHAEOLOGY, V24, P191, DOI 10.1002/gea.20262; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tacon PSC, 1995, ANTIQUITY, V69, P676, DOI 10.1017/S0003598X00082272; Tuniz C., 2000, ADV DATING AUSTR ROC, V10, P40; Ucko, 1977, FORM INDIGENOUS ART, P357; Walsh G., 1999, ARCHAEOL OCEAN, V34, P45; Walsh G. L., 1992, ROCK ART ETHNOGRAPHY, P47; Walsh G.L, 1994, BRADSHAWS ANCIENT RO; Walsh Grahame L., 2000, BRADSHAW ART KIMBERL; Walsh Grahame L., 1988, AUSTR GREATEST ROCK; Watchman A. L., 1997, ROCK ART RES, V14, P18; Watchman A.L., 1993, GEOARCHAEOLOGY, V8, P465, DOI [10.1002/(ISSN)1520-6548, DOI 10.1002/(ISSN)1520-6548, DOI 10.1002/GEA.3340080603]; Watchman AL, 2002, ARCHAEOMETRY, V44, P145, DOI 10.1111/1475-4754.00049; Watson J. A. L., 1987, Rock Art Research, V4, P17; Welch DM, 1995, ROCK ART RES, V12, P23; Welch DM, 1999, B CTR CAMUNO STUDI P, V31-32, P288; Yoshida H, 2003, QUATERNARY SCI REV, V22, P1273, DOI 10.1016/S0277-3791(03)00076-3	70	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161726	10.1371/journal.pone.0161726	http://dx.doi.org/10.1371/journal.pone.0161726			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DV4EG	27579865	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400037
J	Umair, S; Deng, Q; Roberts, JM; Shaw, RJ; Sutherland, IA; Pernthaner, A				Umair, Saleh; Deng, Qing; Roberts, Joanna M.; Shaw, Richard J.; Sutherland, Ian A.; Pernthaner, Anton			Identification of Peptide Mimics of a Glycan Epitope on the Surface of Parasitic Nematode Larvae	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRICHOSTRONGYLUS-COLUBRIFORMIS; CARBOHYDRATE ANTIGEN; TAENIA-SOLIUM; ANTIBODIES; MIMOTOPE; SHEEP; SEQUENCES; IMMUNITY; CARLA	Phage display was used to identify peptide mimics of an immunologically protective nematode glycan (CarLA) by screening a constrained C7C peptide library for ligands that bound to an anti-CarLA mAb (PAB1). Characterisation of these peptide mimotopes revealed functional similarities with an epitope that is defined by PAB1. Mimotope vaccinations of mice with three selected individual phage clones facilitated the induction of antibody responses that recognised the purified, native CarLA molecule which was obtained from Trichostrongylus colubriformis. Furthermore, these mimotopes are specifically recognised by antibodies in the saliva of animals that were immune to natural polygeneric nematode challenge. This shows that antibodies to the PAB1 epitope form part of the mucosal polyclonal anti-CarLA antibody response of nematode immune host animals. This demonstrates that the selected peptide mimotopes are of biological relevance. These peptides are the first to mimic the PAB1 epitope of CarLA, a defined larval glycan epitope which is conserved between many nematode species.	[Umair, Saleh; Deng, Qing; Roberts, Joanna M.; Shaw, Richard J.; Sutherland, Ian A.; Pernthaner, Anton] AgResearch, Hopkirk Res Inst, Palmerston North, New Zealand; [Roberts, Joanna M.] Flowjoanna Tapui Ltd, 1 Line, Palmerston North, New Zealand	AgResearch - New Zealand	Umair, S (corresponding author), AgResearch, Hopkirk Res Inst, Palmerston North, New Zealand.	saleh.umair@agresearch.co.nz		Sutherland, Ian/0000-0002-4884-6545; Shaw, Richard/0000-0001-7218-3836; Deng, Qing/0000-0003-1612-5185; Roberts, Joanna/0000-0003-0679-8976; Umair, Saleh/0000-0003-1390-7202	New Zealand Ministry for Business, Innovation and Employment	New Zealand Ministry for Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	This study was funded by the New Zealand Ministry for Business, Innovation and Employment. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Drs. Haines, Roberts, Wedlock and Zheng for reviewing the manuscript and helpful suggestions. This study was funded by the New Zealand Ministry for Business, Innovation and Employment.	Bhunia A, 2010, J AM CHEM SOC, V132, P96, DOI 10.1021/ja904334s; Capelli-Peixoto J, 2011, VACCINE, V29, P9473, DOI 10.1016/j.vaccine.2011.10.027; Gazarian K, 2012, PEPTIDES, V38, P381, DOI 10.1016/j.peptides.2012.09.021; GNANN JW, 1987, J INFECT DIS, V156, P261, DOI 10.1093/infdis/156.2.261; Harrison GBL, 2008, PARASITE IMMUNOL, V30, P577, DOI 10.1111/j.1365-3024.2008.01058.x; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P79, DOI 10.1046/j.1365-3024.2003.00606.x; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P45, DOI 10.1046/j.1365-3024.2003.00602.x; Kieber-Emmons T, 1998, IMMUNOL RES, V17, P95, DOI 10.1007/BF02786435; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386, 10.1517/14712590902870386 ]; Maass DR, 2007, INT J PARASITOL, V37, P953, DOI 10.1016/j.ijpara.2007.02.005; Maass DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000597; Matochko WL, 2014, NUCLEIC ACIDS RES, V42, P1784, DOI 10.1093/nar/gkt1104; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Mester B, 2009, BIOCHEMISTRY-US, V48, P7867, DOI 10.1021/bi900146g; Monzavi-Karbassi B, 2002, TRENDS BIOTECHNOL, V20, P207, DOI 10.1016/S0167-7799(02)01940-6; Moseri A, 2010, VIROLOGY, V401, P293, DOI 10.1016/j.virol.2010.03.007; Pernthaner A, 2012, VET IMMUNOL IMMUNOP, V148, P284, DOI 10.1016/j.vetimm.2012.06.024; Prudencio CR, 2010, VET PARASITOL, V172, P122, DOI 10.1016/j.vetpar.2010.04.012; Ramirez-Restrepo CA, 2010, ANIM FEED SCI TECH, V155, P99, DOI 10.1016/j.anifeedsci.2009.10.006; Riemer AB, 2007, IMMUNOL LETT, V113, P1, DOI 10.1016/j.imlet.2007.07.008; Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051; Shaw RJ, 1996, VET IMMUNOL IMMUNOP, V51, P235, DOI 10.1016/0165-2427(95)05530-4; Villa-Mancera A, 2011, J HELMINTHOL, V85, P51, DOI 10.1017/S0022149X1000026X; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072	24	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162016	10.1371/journal.pone.0162016	http://dx.doi.org/10.1371/journal.pone.0162016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579674	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400052
J	da Costa, TM; Morgado, PGM; Cavalcante, FS; Damasco, AP; Nouer, SA; dos Santos, KRN				da Costa, Thaina Miranda; Migueres Morgado, Priscylla Guimaraes; Cavalcante, Fernanda Sampaio; Damasco, Andreia Paredes; Nouer, Simone Aranha; Netto dos Santos, Katia Regina			Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS; METHICILLIN-RESISTANT; SUSCEPTIBILITY; STRAINS; DISSEMINATION; SURVEILLANCE; DAPTOMYCIN; PATHOGENS; LINEAGES	This study analyzed clinical and microbiological characteristics of heteroresistant (hVISA) and vancomycin-intermediate Staphylococcus aureus (VISA) from bloodstream infections (BSI) in a Brazilian teaching hospital, between 2011 and 2013. Minimum inhibitory concentrations (MIC) of antimicrobials were determined by broth microdilution method and SCCmec was detected by PCR. Isolates with a vancomycin MIC >= 2mg/L were cultured on BHI agar with 3, 4 or 6 mg/L (BHIa3, BHIa4 or BHIa6) of vancomycin and BHIa4 with casein (BHIa4ca). Macromethod Etest (R) and Etest (R) Glicopeptides Resistance Detection were also used. VISA and hVISA isolates were confirmed by the population analysis profile then typed by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing. Medical data from the patients were obtained from their medical records. Among 110 consecutive isolates, 31 (28%) were MRSA and carried the SCCmec type II (15 isolates) or IV (16 isolates). Vancomycin MIC50 and MIC90 were 1 and 2 mg/L, respectively. MRSA isolates had increased non-susceptibility to daptomycin (p = 0.0003). Six (5%) isolates were VISA, four of which were MRSA, three SCCmec type II/USA100/ST5 and one type IV/USA800/ST3192. One MRSA SCCmec II isolate grew on agar BHIa3, BHIa4 and BHIa4ca, and it was confirmed as hVISA. Among the six VISA isolates, five (83%) grew on BHIa3 and three (50%) on BHI4ca. Four of the six VISA isolates and the one hVISA isolate were from patients who had undergone dialysis. Thus, a possible dissemination of the SCCmec II/USA100/ST5 lineage may have occurred in the hospital comprising the VISA, hVISA and daptomycin non-susceptible S. aureus Brazilian isolates from health care associated bloodstream infections.	[da Costa, Thaina Miranda; Migueres Morgado, Priscylla Guimaraes; Cavalcante, Fernanda Sampaio; Damasco, Andreia Paredes; Netto dos Santos, Katia Regina] Univ Fed Rio de Janeiro, Lab Infeccao Hosp, Dept Microbiol Med, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil; [Nouer, Simone Aranha] Univ Fed Rio de Janeiro, Fac Med, Hosp Univ Clementino Fraga Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	dos Santos, KRN (corresponding author), Univ Fed Rio de Janeiro, Lab Infeccao Hosp, Dept Microbiol Med, Inst Microbiol Paulo Goes, Rio De Janeiro, Brazil.	santoskrn@micro.ufrj.br	CAVALCANTE, FERNANDA SAMPAIO/AAA-5534-2021; Miranda da Costa, Thaina/AAZ-9665-2020; da Costa, Thaina/M-6726-2017	CAVALCANTE, FERNANDA SAMPAIO/0000-0003-3542-7031; Miranda da Costa, Thaina/0000-0002-3660-1786; da Costa, Thaina/0000-0002-3660-1786	grant of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; grant of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	grant of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; grant of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants of Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro to KRNS and SAN; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to KRNS, TMC, PGMM and FSC. APD is sponsored by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman TL, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P390; Biedenbach DJ, 2016, ANTIMICROB AGENTS CH, V60, P343, DOI 10.1128/AAC.01867-15; Biedenbach DJ, 2015, ANTIMICROB AGENTS CH, V59, P4239, DOI 10.1128/AAC.00206-15; Burnham CAD, 2010, J CLIN MICROBIOL, V48, P949, DOI 10.1128/JCM.02295-09; Casapao AM, 2013, ANTIMICROB AGENTS CH, V57, P4252, DOI 10.1128/AAC.00380-13; Cavalcante Fernanda S, 2014, BMC Res Notes, V7, P759, DOI 10.1186/1756-0500-7-759; CLSI: Clinical Laboratory Standards Institute, 2013, M100S25 CLSI; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; Silveira ACDO, 2014, DIAGN MICR INFEC DIS, V79, P401, DOI 10.1016/j.diagmicrobio.2014.04.008; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; European Committee on Antimicrobial Susceptibility Testing Breakpoint, 2015, EUCAST TABL INT MICS; Caboclo RMF, 2013, AM J INFECT CONTROL, V41, pE21, DOI 10.1016/j.ajic.2012.08.008; Nunes APF, 2007, BRAZ J INFECT DIS, V11, P345, DOI 10.1590/S1413-86702007000300009; Flamm RK, 2014, BRAZ J INFECT DIS, V18, P187, DOI 10.1016/j.bjid.2013.11.005; Gomes DM, 2015, PHARMACOTHERAPY, V35, P424, DOI 10.1002/phar.1577; Grundmann H, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.49.20987; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Howden BP, 2010, CLIN MICROBIOL REV, V23, P99, DOI 10.1128/CMR.00042-09; Howe RA, 2004, EMERG INFECT DIS, V10, P855, DOI 10.3201/eid1005.030556; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073300; Kos VN, 2012, MBIO, V3, DOI 10.1128/mBio.00112-12; Marra AR, 2011, J CLIN MICROBIOL, V49, P1866, DOI 10.1128/JCM.00376-11; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Oliveira GA, 2001, INFECT CONT HOSP EP, V22, P443, DOI 10.1086/501932; Pan America Health Organization/World Health Organization. PAHO/WHO, 2013, EP AL VANC RES STAPH; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rodvold KA, 2014, CLIN INFECT DIS, V58, pS20, DOI 10.1093/cid/cit614; Satola SW, 2011, J CLIN MICROBIOL, V49, P177, DOI 10.1128/JCM.01128-10; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sousa AGP, 2014, J INFECT DEV COUNTR, V8, P558, DOI 10.3855/jidc.4395; Van Belkum A, 2009, CLIN MICROBIOL INFEC, V13, P1; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; Vandecasteele SJ, 2011, SEMIN DIALYSIS, V24, P50, DOI 10.1111/j.1525-139X.2010.00803.x; Vivoni AM, 2005, INFECT CONT HOSP EP, V26, P662, DOI 10.1086/502599; Witte W, 2004, J VET MED B, V51, P370, DOI 10.1111/j.1439-0450.2004.00774.x; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399	39	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160506	10.1371/journal.pone.0160506	http://dx.doi.org/10.1371/journal.pone.0160506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575698	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877200008
J	Bless, PJ; Ribera, JM; Schmutz, C; Zeller, A; Mausezahl, D				Bless, Philipp J.; Ribera, Joan Muela; Schmutz, Claudia; Zeller, Andreas; Mausezahl, Daniel			Acute Gastroenteritis and Campylobacteriosis in Swiss Primary Care: The Viewpoint of General Practitioners	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; RISK-FACTORS; ANTIBIOTIC-TREATMENT; INFECTIOUS DIARRHEA; SURVEILLANCE; COMMUNITY; NETHERLANDS; SALMONELLA; MANAGEMENT; PATHOGENS	Acute gastroenteritis (AG) is frequently caused by infectious intestinal diseases (IID) including food- and waterborne pathogens of public health importance. Among these pathogens, Campylobacter spp. plays a major role. Many European countries monitor selected IIDs within disease surveillance systems. In Switzerland, the information on IIDs is restricted to limited surveillance data, while no data is available for AG. We conducted a qualitative study among Swiss general practitioners (GPs) to investigate the case management of AG and campylobacteriosis patients, the associated disease burden and the determinants leading to registration in the National Notification System for Infectious Diseases (NNSID). Interviews were conducted with a semi-structured questionnaire and underwent inductive content analysis based on Grounded Theory. The questionnaire was repeatedly adapted to capture emerging themes until the point of theoretical saturation. GPs perceived AG and campylobacteriosis of little relevance to their daily work and public health in general. According to GP self-estimates each consults about two cases of AG per week and diagnoses a median of five campylobacteriosis cases per year. A large proportion of AG cases receives telephone consultations only and gets medical advice from the practice nurse. Antibiotic therapy is considered useful and stool diagnostics are performed for about a fifth of consulting AG patients. Stool diagnostics ("test") and antibiotic therapy ("treat") are interrelated and follow four strategies: "Wait & See", "Treat & See", "Treat & Test", and "Test & See". AG case management is diverse and includes different triage steps. A small proportion of AG patients have stool diagnostics performed and only positive tested patients are reported to the NNSID. As a result severe cases and cases with a history of travel abroad are overrepresented in the NNSID. The use of multiplex PCR panels in routine diagnostics likely leads to improved case management and higher case numbers in surveillance systems.	[Bless, Philipp J.; Schmutz, Claudia; Mausezahl, Daniel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bless, Philipp J.; Schmutz, Claudia; Mausezahl, Daniel] Univ Basel, Basel, Switzerland; [Ribera, Joan Muela] Partners Appl Social Sci PASS Suisse, Neuchatel, Switzerland; [Zeller, Andreas] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel	Mausezahl, D (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Mausezahl, D (corresponding author), Univ Basel, Basel, Switzerland.	daniel.maeusezahl@unibas.ch	Schmutz, Claudia/H-5444-2019; Ribera, JM/B-8181-2009	Schmutz, Claudia/0000-0002-1028-0718; Ribera, JM/0000-0003-1042-6024; muela ribera, joan/0000-0003-2111-6275	Swiss Federal Office of Public Health [12.007954]; Swiss Federal Office of Public Health, Division of Communicable Diseases	Swiss Federal Office of Public Health; Swiss Federal Office of Public Health, Division of Communicable Diseases	The Swiss Federal Office of Public Health funded the study as part of a project studying the epidemiology of campylobacteriosis among the Swiss population, Contract Number: 12.007954, URL: www.bag.admin.ch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the participants of the pilot study and the study participants. We kindly thank Sonia Ferroni Yameogo, Meike-Kathrin Zuske and Susanna Hausmann-Muela for their commitment in interviewing physicians, and Amena Briet, from the Swiss Tropical and Public Health Institute, for her critical language editing. The support of the Swiss Federal Office of Public Health, Division of Communicable Diseases for the study is gratefully acknowledged.	[Anonymous], 2016, 818101126 SR FED DEP; Baumgartner A, 2011, J FOOD PROTECT, V74, P2048, DOI 10.4315/0362-028X.JFP-11-228; Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15; Bless PJ, 2014, EUR J EPIDEMIOL, V29, P527, DOI 10.1007/s10654-014-9917-0; Crim SM, 2015, MMWR-MORBID MORTAL W, V64, P495; De Wit MAS, 2001, EPIDEMIOL INFECT, V127, P389, DOI 10.1017/S0950268801006082; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; DuPont HL, 2014, NEW ENGL J MED, V370, P1532, DOI 10.1056/NEJMra1301069; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; European Food Safety Authority and European Centre for Disease Prevention and Control, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4329, DOI 10.2903/J.EFSA.2015.43291560-7917.ES.2016.21.6.30130]; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Friesema IHM, 2012, EPIDEMIOL INFECT, V140, P1780, DOI 10.1017/S0950268811002652; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hennessy TW, 2004, CLIN INFECT DIS, V38, pS203, DOI 10.1086/381588; Huhulescu S, 2009, INFECTION, V37, P103, DOI 10.1007/s15010-008-8106-z; Janiec J, 2012, EPIDEMIOL INFECT, V140, P2045, DOI 10.1017/S0950268811002822; Karsten C, 2009, EUR J CLIN MICROBIOL, V28, P935, DOI 10.1007/s10096-009-0729-1; Ke BX, 2012, FOODBORNE PATHOG DIS, V9, P47, DOI 10.1089/fpd.2011.0964; Kubota K, 2011, J FOOD PROTECT, V74, P1592, DOI 10.4315/0362-028X.JFP-10-387; Lorenzoni L, 2014, LANCET, V384, P83, DOI 10.1016/S0140-6736(14)60571-7; McNulty CAM, 2014, BRIT J GEN PRACT, V64, pE24, DOI 10.3399/bjgp14X676429; McNulty CAM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-77; Morgan D.R., 2015, CLIN INFECT DIS, P334; Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355; Nichols GL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001179; Niederer L, 2012, APPL ENVIRON MICROB, V78, P288, DOI 10.1128/AEM.06194-11; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Scallan E, 2006, FOODBORNE PATHOG DIS, V3, P432, DOI 10.1089/fpd.2006.3.432; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scallan Elaine, 2005, Eur J Gen Pract, V11, P136; Scherer K, 2006, J FOOD PROTECT, V69, P757, DOI 10.4315/0362-028X-69.4.757; Schielke A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-30; Schmid H., 2012, FOODBORNE OUTBREAKS; Schmutz C, 2016, EUROSURVEILLANCE, V21, P9, DOI [10.2807/1560-7917.ES.2016.21.6.30130, 10.2807/1560-791730130]; SCHORR D, 1994, ZBL HYG UMWELTMED, V196, P327; Schweiger A, 2005, SCHWEIZ MED FORUM, V5, P714; Spina A, 2015, CLIN MICROBIOL INFEC, V21, P719, DOI 10.1016/j.cmi.2015.04.007; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Van Cauteren D, 2015, EPIDEMIOL INFECT, V143, P2532, DOI 10.1017/S0950268814003884; van den Brandhof Winette E, 2006, BMC Fam Pract, V7, P56, DOI 10.1186/1471-2296-7-56; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Wessels E, 2014, CLIN MICROBIOL INFEC, V20, pO182, DOI 10.1111/1469-0691.12364; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	49	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161650	10.1371/journal.pone.0161650	http://dx.doi.org/10.1371/journal.pone.0161650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603141	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000383255200020
J	An, D; Cui, YJ; Liu, X; Jia, SQ; Zheng, SY; Che, XP; Liu, Z; Zhang, XD; Zhu, DH; Li, SM				An, Dong; Cui, Yongjin; Liu, Xu; Jia, Shiqiang; Zheng, Shuyun; Che, Xiaoping; Liu, Zhe; Zhang, Xiaodong; Zhu, Dehai; Li, Shaoming			Effects of Varieties, Producing Areas, Ears, and Ear Positions of Single Maize Kernels on Near-Infrared Spectra for Identification and Traceability	PLOS ONE			English	Article							WHEAT; SPECTROSCOPY; GENOTYPES; STARCH; ORIGIN	The effects of varieties, producing areas, ears, and ear positions of maize on near-infrared (NIR) spectra were investigated to determine the factors causing the differences in NIR fingerprints of maize varieties. A total of 130 inbred lines were grown in two regions in China, and 12,350 kernel samples were analyzed through NIR spectroscopy. Spectral differences among varieties, producing areas, ears, and ear positions were determined and compared on the basis of pretreated spectra. The bands at 1300-1470, 1768-1949, 2010-2064, and 2235-2311 nm were mainly affected by the producing area. Band selection and principal component analysis were applied to improve the influence of variety on NIR spectra by processing the pretreated spectra. The degrees of the influence of varieties, producing areas, ears, and ear positions were calculated, and the percentages of the influence of varieties, producing areas, ears, and ear positions were 45.40%, 42.66%, 8.22%, and 3.72%, respectively. Therefore, genetic differences among maize inbred lines are the main factors accounted for NIR spectral differences. Producing area is a secondary factor. These results could provide a reference for researchers who authenticate varieties, perform geographical origin traceabilities, and conduct maize seed breeding.	[An, Dong; Cui, Yongjin; Liu, Xu; Jia, Shiqiang; Liu, Zhe; Zhang, Xiaodong; Zhu, Dehai; Li, Shaoming] China Agr Univ, Coll Informat & Elect Engn, Beijing 100083, Peoples R China; [An, Dong] Minist Educ, Modern Precis Agr Syst Integrat Res Key Lab, Beijing 100083, Peoples R China; [Li, Shaoming] Minist Agr, Key Lab Agr Informat Acquisit Technol Beijing, Beijing 100083, Peoples R China; [Zheng, Shuyun; Che, Xiaoping] Beijing Kings Nower Seed S&T CO LTD, Beijing 100080, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	An, D (corresponding author), China Agr Univ, Coll Informat & Elect Engn, Beijing 100083, Peoples R China.; An, D (corresponding author), Minist Educ, Modern Precis Agr Syst Integrat Res Key Lab, Beijing 100083, Peoples R China.	andongcau@163.com		Lee, Mijoon/0000-0001-7432-0427	Development and application of grating type near infrared analyzer and its common model [2014YQ470377]; China Agricultural University Education Foundation Dabeinong Education funds [1081-2413001]; National Special Fund for Agro-scientific Research in the Public Interest [201203052]; Beijing Kings Nower Seed ST CO., LTD	Development and application of grating type near infrared analyzer and its common model; China Agricultural University Education Foundation Dabeinong Education funds; National Special Fund for Agro-scientific Research in the Public Interest; Beijing Kings Nower Seed ST CO., LTD	The authors gratefully acknowledge the financial support provided by Development and application of grating type near infrared analyzer and its common model (grant no. 2014YQ470377 to Dong An), China Agricultural University Education Foundation Dabeinong Education funds (grant no. 1081-2413001 to Dong An), and National Special Fund for Agro-scientific Research in the Public Interest (grant no. 201203052 to Dong An). Coauthors Shuyun Zheng and Xiaoping Che are employed by Beijing Kings Nower Seed S&T CO., LTD. Beijing Kings Nower Seed S&T CO., LTD provided support in the form of salaries for authors SZ and XC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baxter IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087628; Cozzolino D, 2014, FOOD RES INT, V60, P262, DOI 10.1016/j.foodres.2013.08.034; Fox G, 2011, FIELD CROP RES, V120, P380, DOI 10.1016/j.fcr.2010.11.007; Garcia I, 2007, ANAL CHIM ACTA, V587, P222, DOI 10.1016/j.aca.2007.01.054; Garcia-Molina MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152292; Huang YY, 2011, SPECTROSC SPECT ANAL, V31, P2706, DOI 10.3964/j.issn.1000-0593(2011)10-2706-05; Jia SQ, 2015, J CEREAL SCI, V63, P21, DOI 10.1016/j.jcs.2014.07.003; Kindred DR, 2008, J CEREAL SCI, V48, P46, DOI 10.1016/j.jcs.2007.07.010; Redaelli R, 2013, J CEREAL SCI, V57, P193, DOI 10.1016/j.jcs.2012.09.003; Tallada JG, 2009, J CEREAL SCI, V50, P381, DOI 10.1016/j.jcs.2009.08.003; Wickramasinghe HAM, 2005, FOOD CHEM, V93, P9, DOI 10.1016/j.foodchem.2004.08.049; Zhao HY, 2014, FOOD CHEM, V152, P316, DOI 10.1016/j.foodchem.2013.11.122; Zhao HY, 2013, FOOD CHEM, V138, P1902, DOI 10.1016/j.foodchem.2012.11.037	13	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161489	10.1371/journal.pone.0161489	http://dx.doi.org/10.1371/journal.pone.0161489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598344	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800009
J	Chiou, JW; Fu, B; Chou, RH; Yu, C				Chiou, Jian Wei; Fu, Brian; Chou, Ruey-Hwang; Yu, Chin			Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CELL-SURFACE RECEPTOR; BINDING PROTEINS; THERAPEUTIC TARGET; NONINVASIVE MARKER; STRUCTURAL BASIS; SINGLE RECEPTOR; FECAL S100A12; CALGRANULIN-C; NF-KB	The receptor for advanced glycation end products (RAGE), a transmembrane receptor in the immunoglobulin superfamily, is involved in several inflammatory processes. RAGE induces cellular signaling pathways upon binding with various ligands, such as advanced glycation end products (AGEs), beta-amyloids, and S100 proteins. The solution structure of S100A12 and the V ligand-binding region of RAGE have been reported previously. Using heteronuclear NMR spectroscopy to conduct H-1-N-15 heteronuclear single quantum coherence (HSQC) titration experiments, we identified and mapped the binding interface between S100A12 and the V domain of RAGE. The NMR chemical shift data were used as the constraints for the High Ambiguity Driven biomolecular DOCKing (HADDOCK) calculation to generate a structural model of the S100A12-V domain complex. In addition, tranilast (an anti-allergic drug) showed strong interaction with S100A12 in the H-1-N-15 HSQC titration, fluorescence experiments, and WST-1 assay. The results also indicated that tranilast was located at the binding site between S100A12 and the V domain, blocking interaction between these two proteins. Our results provide the mechanistic details for a structural model and reveal a potential precursor for an inhibitor for pro-inflammatory diseases, which could be useful for the development of new drugs.	[Chiou, Jian Wei; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan; [Fu, Brian] Northwood High Sch, Irvine, CA 92620 USA; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung 40402, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.; Chou, RH (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan.; Chou, RH (corresponding author), China Med Univ, Ctr Mol Med, Taichung 40402, Taiwan.; Chou, RH (corresponding author), Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan.	rhchou@gmail.com; cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) Taiwan [MOST 103-2113-M-007-017-MY3, MOST 104-2320-B-039-031]; China Medical University, Taiwan [CMU104-S-02]	Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This research was supported by the Ministry of Science and Technology (MOST) Taiwan (Grant number MOST 103-2113-M-007-017-MY3). The partition of WST-1 assay was supported by the Ministry of Science and Technology (MOST) Taiwan (Grant number MOST 104-2320-B-039-031) and China Medical University (Grant number CMU104-S-02), Taiwan. MOST: https://www.most.gov.tw/. China Medical University: http://www.cmu.edu.tw/.	Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Darakhshan S, 2015, PHARMACOL RES, V91, P15, DOI 10.1016/j.phrs.2014.10.009; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Jong NSH, 2006, INFLAMM BOWEL DIS, V12, P566, DOI 10.1097/01.ibd.0000227626.72271.91; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; GOTTSCH JD, 1995, INVEST OPHTH VIS SCI, V36, P1541; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2003, BIOCHEM BIOPH RES CO, V307, P375, DOI 10.1016/S0006-291X(03)01190-2; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Huang YK, 2016, J BIOL CHEM, V291, P14300, DOI 10.1074/jbc.M116.722215; Huang YK, 2016, J BIOL CHEM; Hubbard S.J, 1993, NACCESS, V2; Hung KW, 2013, J BIOMOL NMR, V57, P313, DOI 10.1007/s10858-013-9781-3; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jensen JL, 2015, ACTA CRYSTALLOGR D, V71, P1176, DOI 10.1107/S1399004715004216; Kaiser T, 2007, GUT, V56, P1706, DOI 10.1136/gut.2006.113431; Kallinich T, 2010, ANN RHEUM DIS, V69, P677, DOI 10.1136/ard.2009.114363; Kang JH, 2015, IMMUNOLOGY, V144, P79, DOI 10.1111/imm.12352; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kosaki A, 2004, J CLIN ENDOCR METAB, V89, P5423, DOI 10.1210/jc.2003-032223; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li D, 2016, TUMOR BIOL, V37, P6551, DOI 10.1007/s13277-015-4460-5; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Moroz OV, 2003, MICROSC RES TECHNIQ, V60, P581, DOI 10.1002/jemt.10300; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Oesterle A, 2015, ARTERIOSCL THROM VAS, V35, P2496, DOI 10.1161/ATVBAHA.115.302072; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; Wicki R, 1996, CELL CALCIUM, V20, P459, DOI 10.1016/S0143-4160(96)90087-1; Wilsmann-Theis D, 2016, J EUR ACAD DERMATOL, V30, P1165, DOI 10.1111/jdv.13269; WL D, 2002, PYMOL MOL GRAPHICS S; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zill H, 2001, BIOCHEM BIOPH RES CO, V288, P1108, DOI 10.1006/bbrc.2001.5901; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	68	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162000	10.1371/journal.pone.0162000	http://dx.doi.org/10.1371/journal.pone.0162000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598566	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800031
J	da Silva, ES; Mulinge, M; Lemaire, M; Masquelier, C; Beraud, C; Rybicki, A; Servais, JY; Iserentant, G; Schmit, JC; Seguin-Devaux, C; Bercoff, DP				da Silva, Eveline Santos; Mulinge, Martin; Lemaire, Morgane; Masquelier, Cecile; Beraud, Cyprien; Rybicki, Arkadiusz; Servais, Jean-Yves; Iserentant, Gilles; Schmit, Jean-Claude; Seguin-Devaux, Carole; Bercoff, Danielle Perez			The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 MATRIX PROTEIN; PRIMARY HUMAN MACROPHAGES; ENV-MEDIATED FUSION; GLYCOPROTEIN INCORPORATION; VIROLOGICAL SYNAPSES; SURFACE EXPRESSION; CLATHRIN ADAPTER; PLASMA-MEMBRANE; TRANSMEMBRANE PROTEINS	The cytoplasmic tail (gp41CT) of the HIV-1 envelope (Env) mediates Env incorporation into virions and regulates Env intracellular trafficking. Little is known about the functional impact of variability in this domain. To address this issue, we compared the replication of recombinant virus pairs carrying the full Env (Env viruses) or the Env ectodomain fused to the gp41CT of NL4.3 (EnvEC viruses) (12 subtype C and 10 subtype B pairs) in primary CD4+ T-cells and monocyte-derived-macrophages (MDMs). In CD4+ T-cells, replication was as follows: B-EnvEC = B-Env>C-EnvEC>C-Env, indicating that the gp41CT of subtype C contributes to the low replicative capacity of this subtype. In MDMs, in contrast, replication capacity was comparable for all viruses regardless of subtype and of gp41CT. In CD4+ T-cells, viral entry, viral release and viral gene expression were similar. However, infectivity of free virions and cell-to-cell transmission of C-Env viruses released by CD4+ T-cells was lower, suggestive of lower Env incorporation into virions. Subtype C matrix only minimally rescued viral replication and failed to restore infectivity of free viruses and cell-to-cell transmission. Taken together, these results show that polymorphisms in the gp41CT contribute to viral replication capacity and suggest that the number of Env spikes per virion may vary across subtypes. These findings should be taken into consideration in the design of vaccines.	[da Silva, Eveline Santos; Mulinge, Martin; Lemaire, Morgane; Masquelier, Cecile; Beraud, Cyprien; Rybicki, Arkadiusz; Servais, Jean-Yves; Iserentant, Gilles; Schmit, Jean-Claude; Seguin-Devaux, Carole; Bercoff, Danielle Perez] Luxembourg Inst Hlth, Dept Infect & Immun, 29 Rue Henri Koch, L-4354 Esch Sur Alzette, Luxembourg; [Schmit, Jean-Claude] Ctr Hosp Luxembourg, Serv Natl Malad Infect, 4 Rue Ernest Barble, L-1210 Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Bercoff, DP (corresponding author), Luxembourg Inst Hlth, Dept Infect & Immun, 29 Rue Henri Koch, L-4354 Esch Sur Alzette, Luxembourg.	danielle.perezbercoff@lih.lu	Mulinge, Martin/GWU-7942-2022	Seguin-Devaux, Carole/0000-0003-0636-5222; mulinge, martin/0000-0001-9613-5425; Beraud, Cyprien/0000-0002-5503-6938; Perez Bercoff, Danielle/0000-0003-4415-0150	Luxembourg Ministry of Research and Education MESR [REC-LRTV20101106]; Fonds National de la Recherche AFR [PHD-09-115, PHD-08-074, AFR-6012272]; Luxembourg Ministry of Research and Education Grants [MESR LRTV20100604, REC-LRTV10131106]; Fonds National de la Recherche (AFR grants) [PHD-09-115, PHD-08-074, AFR-6012272]	Luxembourg Ministry of Research and Education MESR; Fonds National de la Recherche AFR(Luxembourg National Research Fund); Luxembourg Ministry of Research and Education Grants; Fonds National de la Recherche (AFR grants)(Luxembourg National Research Fund)	This work was supported by the Luxembourg Ministry of Research and Education MESR Grant# REC-LRTV20101106, and Fonds National de la Recherche AFR grant# PHD-09-115 ESS, #PHD-08-074 MM and AFR-6012272 CB (http://fnr.lu/funding-instruments/afr).; This work was supported by the Luxembourg Ministry of Research and Education Grants #MESR LRTV20100604 and REC-LRTV10131106. ESS, MM and CB were supported by PhD fellowships from the Fonds National de la Recherche (AFR grants #PHD-09-115, #PHD-08-074 and AFR-6012272 respectively).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2000, J VIROL, V74, P4891, DOI 10.1128/JVI.74.10.4891-4893.2000; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Arts EJ, 2006, INFECT SUBT C HIV 1; Baatz F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021535; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bauby H, 2010, TRAFFIC, V11, P455, DOI 10.1111/j.1600-0854.2010.01036.x; Beaumont E, 2009, J VIROL, V83, P9875, DOI 10.1128/JVI.01213-09; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Bhakta SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-37; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Blot G, 2003, J VIROL, V77, P6931, DOI 10.1128/JVI.77.12.6931-6945.2003; Blot G, 2006, J MOL BIOL, V364, P1034, DOI 10.1016/j.jmb.2006.09.080; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; BOSCH ML, 1989, SCIENCE, V244, P694, DOI 10.1126/science.2541505; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1029, P267, DOI 10.1016/0005-2736(90)90163-I; Bultmann A, 2001, J VIROL, V75, P5263, DOI 10.1128/JVI.75.11.5263-5276.2001; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Centlivre M, 2006, AIDS, V20, P657, DOI 10.1097/01.aids.0000216365.38572.2f; Centlivre M, 2005, J CLIN INVEST, V115, P348, DOI 10.1172/JCI200522873; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Checkley MA, 2013, J VIROL, V87, P3561, DOI 10.1128/JVI.03299-12; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; da Silva ES, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-54; Dale BM, 2013, IMMUNOL REV, V251, P113, DOI 10.1111/imr.12022; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; DUBAY JW, 1992, J VIROL, V66, P6616, DOI 10.1128/JVI.66.11.6616-6625.1992; Durham ND, 2015, J VIROL, V89, P9324, DOI 10.1128/JVI.00655-15; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Egan MA, 1996, J VIROL, V70, P6547, DOI 10.1128/JVI.70.10.6547-6556.1996; Emerson V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-43; Emerson V, 2010, J VIROL, V84, P1355, DOI 10.1128/JVI.01641-09; FACKE M, 1993, J VIROL, V67, P4972; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Fultz PN, 2001, J VIROL, V75, P278, DOI 10.1128/JVI.75.1.278-291.2001; Gonzalez SA, 1996, J VIROL, V70, P6384; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Groppelli E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004518; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Haller C, 2008, BIOL CHEM, V389, P1253, DOI 10.1515/BC.2008.143; Hourioux C, 2000, AIDS RES HUM RETROV, V16, P1141, DOI 10.1089/088922200414983; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; Iwatani Y, 2001, VIRUS RES, V74, P75, DOI 10.1016/S0168-1702(00)00249-5; Jacobs GB, 2012, VIRUSES-BASEL, V4, P1830, DOI 10.3390/v4091830; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Lambele M, 2007, J VIROL, V81, P125, DOI 10.1128/JVI.01659-06; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; Lee YM, 1997, J VIROL, V71, P1443, DOI 10.1128/JVI.71.2.1443-1452.1997; Liu L, 2012, J VIROL, V86, P11242, DOI 10.1128/JVI.00544-12; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MAMMANO F, 1995, J VIROL, V69, P3824, DOI 10.1128/JVI.69.6.3824-3830.1995; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Micoli KJ, 2000, THE JOURNAL OF BIOLO, P27508, DOI [10.1016/j.jviromet.2005.10.008, DOI 10.1016/J.JVIROMET.2005.10.008]; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; OWENS RJ, 1991, P NATL ACAD SCI USA, V88, P3987, DOI 10.1073/pnas.88.9.3987; Pan ZG, 1996, AM J PATHOL, V149, P903; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; Piller SC, 2000, J VIROL, V74, P11717, DOI 10.1128/JVI.74.24.11717-11723.2000; Pollakis G, 2004, J VIROL, V78, P2841, DOI 10.1128/JVI.78.6.2841-2852.2004; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Postler TS, 2012, CELL HOST MICROBE, V11, P181, DOI 10.1016/j.chom.2011.12.005; Qi ML, 2015, P NATL ACAD SCI USA, V112, P7575, DOI 10.1073/pnas.1504174112; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; ROWELL JF, 1995, J IMMUNOL, V155, P473; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Ruggiero E, 2008, J VIROL, V82, P7773, DOI 10.1128/JVI.00695-08; Ruiz A, 2013, VIROLOGY, V435, P395, DOI 10.1016/j.virol.2012.10.030; Sala M, 2006, CURR OPIN HIV AIDS, V1, P108, DOI 10.1097/01.COH.0000203835.01350.b4; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Steckbeck JD, 2014, VIRUSES-BASEL, V6, P284, DOI 10.3390/v6010284; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Van Laethem K, 2006, J VIROL METHODS, V132, P181, DOI 10.1016/j.jviromet.2005.10.008; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; Wang LP, 2000, J IMMUNOL, V164, P5369, DOI 10.4049/jimmunol.164.10.5369; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; YU XF, 1993, J VIROL, V67, P4386, DOI 10.1128/JVI.67.7.4386-4390.1993; YU XF, 1993, J VIROL, V67, P213, DOI 10.1128/JVI.67.1.213-221.1993; YUAN X, 1993, J VIROL, V67, P6387, DOI 10.1128/JVI.67.11.6387-6394.1993; Zhang H, 1999, CURR BIOL, V9, P1271, DOI 10.1016/S0960-9822(99)80511-9; Zhu Y, 2007, CHEM BIOL DRUG DES, V70, P311, DOI 10.1111/j.1747-0285.2007.00564.x	146	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161596	10.1371/journal.pone.0161596	http://dx.doi.org/10.1371/journal.pone.0161596			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598717	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800012
J	Kalle, S; Tanner, R; Arund, J; Tomson, R; Luman, M; Fridolin, I				Kalle, Sigrid; Tanner, Risto; Arund, Jurgen; Tomson, Ruth; Luman, Merike; Fridolin, Ivo			4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CORONARY-ARTERY-DISEASE; VITAMIN SUPPLEMENTATION; PYRIDOXAL-PHOSPHATE; RENAL-INSUFFICIENCY; VASCULAR-DISEASE; RISK-FACTORS; METABOLISM; PLASMA; HOMOCYSTEINE	Aim In this work we estimated the contribution of the fluorescence of 4-pyridoxic acid (4-PA) to the total fluorescence of spent dialysate with the aim of evaluating the on-line monitoring of removal of this vitamin B-6 metabolite from the blood of patients with end-stage renal disease (ESRD). Methods Spectrofluorometric analysis of spent dialysate, collected from hemodialysis and hemodiafiltration sessions of 10 patients receiving regularly pyridoxine injections after dialysis treatment, was performed in the range of Ex/Em 220-500 nm. 4-PA in dialysate samples was identified and quantified using HPLC with fluorescent and MS/MS detection. Results Averaged HPLC chromatogram of spent dialysate had many peaks in the wavelength region of Ex320/Em430 nm where 4-PA was the highest peak with contribution of 42.2 +/- 17.0% at the beginning and 47.7 +/- 18.0% in the end of the dialysis. High correlation (R = 0.88-0.95) between 4-PA concentration and fluorescence intensity of spent dialysate was found in the region of Ex310-330/Em415-500 nm, respectively. Conclusion 4-PA elimination from the blood of ESRD patients can be potentially followed using monitoring of the fluorescence of the spent dialysate during dialysis treatments.	[Kalle, Sigrid; Tanner, Risto; Arund, Jurgen; Tomson, Ruth; Luman, Merike; Fridolin, Ivo] Tallinn Univ Technol, Dept Biomed Engn, Technomedicum, Tallinn, Estonia; [Luman, Merike] North Estonian Med Ctr, Ctr Nephrol, Tallinn, Estonia	Tallinn University of Technology	Kalle, S (corresponding author), Tallinn Univ Technol, Dept Biomed Engn, Technomedicum, Tallinn, Estonia.	sigrid.kalle@ttu.ee	Fridolin, Ivo/AAE-8365-2019; Fridolin, Ivo/H-5406-2015	Fridolin, Ivo/0000-0001-7374-4287; Tanner, Risto/0000-0001-6926-2752; Luman, Merike/0000-0003-4721-149X; Kontus, Sigrid/0000-0003-1378-5452; Arund, Jurgen/0000-0002-4894-6853	European Union through the European Regional Development Fund; Estonian Ministry of Education and Research [IUT19-02]	European Union through the European Regional Development Fund(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	We would like to thank all the participating patients. The study was supported by the European Union through the European Regional Development Fund and the Estonian Ministry of Education and Research (https://www.hm.ee/en) under institutional research funding IUT19-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN MA, 1989, MED J AUSTRALIA, V150, P130, DOI 10.5694/j.1326-5377.1989.tb136390.x; ANTONELLA T, 1991, BIOCHEM SOC T, V19, pS344, DOI 10.1042/bst019344s; Bor MV, 2003, CLIN CHEM, V49, P155, DOI 10.1373/49.1.155; Busch M, 2010, NEPHRON CLIN PRACT, V114, pC38, DOI 10.1159/000245068; Cabo R, 2014, CLIN CHIM ACTA, V433, P150, DOI 10.1016/j.cca.2014.03.003; Coburn SP, 2002, AM J CLIN NUTR, V75, P57, DOI 10.1093/ajcn/75.1.57; Combs G. F., 2008, VITAMINS FUNDAMENTAL, P318; DESCOMBES E, 1993, KIDNEY INT, V43, P1319, DOI 10.1038/ki.1993.185; Descombes E, 2000, ARTIF ORGANS, V24, P773, DOI 10.1046/j.1525-1594.2000.06553.x; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Holmar J, 2012, WORLD C MED PHYS BIO, P71; Holmar J, 2011, IFMBE P, p[14, 45]; HUBER AM, 1964, J NUTR, V82, P371, DOI 10.1093/jn/82.3.371; JONES ME, 1965, ANNU REV BIOCHEM, V34, P381; Kalle S, P 5 M UR TOX CARD DI; KELSAY J, 1968, J NUTR, V94, P490, DOI 10.1093/jn/94.4.490; KLEINER MJ, 1980, AM J CLIN NUTR, V33, P1612, DOI 10.1093/ajcn/33.7.1612; LEKLEM JE, 1990, J NUTR, V120, P1503, DOI 10.1093/jn/120.suppl_11.1503; Levine S, 2002, FOOD CHEM TOXICOL, V40, P1449, DOI 10.1016/S0278-6915(02)00072-8; Lindner A, 2002, AM J KIDNEY DIS, V39, P134, DOI 10.1053/ajkd.2002.29904; Mahuren JD, 1997, METHOD ENZYMOL, V280, P22; MAKRIS A, 1974, NUTR METAB, V16, P337; Mayer EL, 1996, J AM COLL CARDIOL, V27, P517, DOI 10.1016/0735-1097(95)00508-0; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; PAGANI R, 1991, BIOCHIM BIOPHYS ACTA, V1077, P233, DOI 10.1016/0167-4838(91)90063-6; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; REDDY SK, 1958, J BIOL CHEM, V233, P691; Robinson K, 1998, CIRCULATION, V97, P437; ROBINSON K, 1995, CIRCULATION, V92, P2825, DOI 10.1161/01.CIR.92.10.2825; ROSE DP, 1975, AM J CLIN NUTR, V28, P872, DOI 10.1093/ajcn/28.8.872; Rubi B, 2012, MED HYPOTHESES, V78, P179, DOI 10.1016/j.mehy.2011.10.021; Silva V. R. da, 2012, Present knowledge in nutrition, P307; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162346	10.1371/journal.pone.0162346	http://dx.doi.org/10.1371/journal.pone.0162346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598005	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800055
J	Langkammer, C; Pirpamer, L; Seiler, S; Deistung, A; Schweser, F; Franthal, S; Homayoon, N; Katschnig-Winter, P; Koegl-Wallner, M; Pendl, T; Stoegerer, EM; Wenzel, K; Fazekas, F; Ropele, S; Reichenbach, JR; Schmidt, R; Schwingenschuh, P				Langkammer, Christian; Pirpamer, Lukas; Seiler, Stephan; Deistung, Andreas; Schweser, Ferdinand; Franthal, Sebastian; Homayoon, Nina; Katschnig-Winter, Petra; Koegl-Wallner, Mariella; Pendl, Tamara; Stoegerer, Eva Maria; Wenzel, Karoline; Fazekas, Franz; Ropele, Stefan; Reichenbach, Jurgen Rainer; Schmidt, Reinhold; Schwingenschuh, Petra			Quantitative Susceptibility Mapping in Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; BRAIN IRON; RATING-SCALE; MOVEMENT; PROGRESSION; VALIDATION; DEPOSITION; DIAGNOSIS; NUCLEUS; QSM	Background Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD). However, the findings in other subcortical deep gray matter nuclei are converse and the sensitivity of QSM and R2* for morphological changes and their relation to clinical measures of disease severity has so far been investigated only sparsely. Methods The local ethics committee approved this study and all subjects gave written informed consent. 66 patients with idiopathic Parkinson's disease and 58 control subjects underwent quantitative MRI at 3T. Susceptibility and R2* maps were reconstructed from a spoiled multi-echo 3D gradient echo sequence. Mean susceptibilities and R2* rates were measured in subcortical deep gray matter nuclei and compared between patients with PD and controls as well as related to clinical variables. Results Compared to control subjects, patients with PD had increased R2* values in the substantia nigra. QSM also showed higher susceptibilities in patients with PD in substantia nigra, in the nucleus ruber, thalamus, and globus pallidus. Magnetic susceptibility of several of these structures was correlated with the levodopa-equivalent daily dose (LEDD) and clinical markers of motor and non-motor disease severity (total MDS-UPDRS, MDS-UPDRS-I and II). Disease severity as assessed by the Hoehn & Yahr scale was correlated with magnetic susceptibility in the substantia nigra. Conclusion The established finding of higher R2* rates in the substantia nigra was extended by QSM showing superior sensitivity for PD-related tissue changes in nigrostriatal dopaminergic pathways. QSM additionally reflected the levodopa-dosage and disease severity. These results suggest a more widespread pathologic involvement and QSM as a novel means for its investigation, more sensitive than current MRI techniques.	[Langkammer, Christian; Pirpamer, Lukas; Seiler, Stephan; Franthal, Sebastian; Homayoon, Nina; Katschnig-Winter, Petra; Koegl-Wallner, Mariella; Pendl, Tamara; Stoegerer, Eva Maria; Wenzel, Karoline; Fazekas, Franz; Ropele, Stefan; Schmidt, Reinhold; Schwingenschuh, Petra] Med Univ Graz, Dept Neurol, Graz, Austria; [Deistung, Andreas; Reichenbach, Jurgen Rainer] Univ Jena, Med Phys Grp, Univ Hosp, Jena, Germany; [Schweser, Ferdinand] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY USA; [Schweser, Ferdinand] SUNY Buffalo, MRI Mol & Translat Imaging Ctr, Clin & Translat Res Ctr, Buffalo, NY USA; [Reichenbach, Jurgen Rainer] Univ Jena, Michael Stifel Ctr Data Driven & Simulat Sci Jena, Jena, Germany; [Schwingenschuh, Petra] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria	Medical University of Graz; Friedrich Schiller University of Jena; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Friedrich Schiller University of Jena; Medical University of Graz	Langkammer, C (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	christian.langkammer@medunigraz.at	Schmidt, Reinhold/E-1137-2014; Langkammer, Christian/AAC-9044-2020; Deistung, Andreas/AAN-9412-2021; Schweser, Ferdinand/Q-6932-2019; Reichenbach, Jürgen R./B-4333-2011	Schweser, Ferdinand/0000-0003-0399-9211; Reichenbach, Jürgen R./0000-0002-2640-0630; Deistung, Andreas/0000-0002-2427-1302; Langkammer, Christian/0000-0002-7097-9707; Pirpamer, Lukas/0000-0002-4390-9703	Austrian Science Fund [KLI-523, I-904]; Austrian federal state of Steiermark; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian federal state of Steiermark; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CL and LP were supported by the Austrian Science Fund (projects KLI-523 and I-904). The PROMOVE study was supported by the Austrian federal state of Steiermark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL and LP were supported by the Austrian Science Fund (projects KLI-523 and I-904). The PROMOVE study was supported by the Austrian federal state of Steiermark.	Azuma M, 2016, AM J NEURORADIOL, V37, P782, DOI 10.3174/ajnr.A4645; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Blazejewska AI, 2015, J MAGN RESON IMAGING, V41, P1065, DOI 10.1002/jmri.24644; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Du GW, 2016, MOVEMENT DISORD, V31, P317, DOI 10.1002/mds.26417; Dusek P, 2015, J TRACE ELEM MED BIO, V31, P193, DOI 10.1016/j.jtemb.2014.05.007; Dusek P, 2013, INT REV NEUROBIOL, V110, P195, DOI 10.1016/B978-0-12-410502-7.00010-7; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Esterhammer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145493; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grolez G, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0331-3; Guan XJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3489; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; He NY, 2015, HUM BRAIN MAPP, V36, P4407, DOI 10.1002/hbm.22928; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Langkammer C, 2014, NEURODEGENER DIS, V13, P189, DOI 10.1159/000353756; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Liu T, 2013, RADIOLOGY, V269, P216, DOI 10.1148/radiol.13121991; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Murakami Y, 2015, AM J NEURORADIOL, V36, P1102, DOI 10.3174/ajnr.A4260; Barbosa JHO, 2015, MAGN RESON IMAGING, V33, P559, DOI 10.1016/j.mri.2015.02.021; Parashos SA, 2014, JAMA NEUROL, V71, P710, DOI 10.1001/jamaneurol.2014.391; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Schafer A, 2012, HUM BRAIN MAPP, V33, P2831, DOI 10.1002/hbm.21404; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Sukstanskii AL, 2014, MAGN RESON MED, V71, P345, DOI 10.1002/mrm.24629; Sun HF, 2015, NEUROIMAGE, V105, P486, DOI 10.1016/j.neuroimage.2014.11.010; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tremblay L, 2015, MOVEMENT DISORD, V30, P1155, DOI 10.1002/mds.26199; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Wu B, 2012, NEUROIMAGE, V59, P297, DOI 10.1016/j.neuroimage.2011.07.019; Yoo K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125455; Zollei L, 2010, NEUROIMAGE, V51, P206, DOI 10.1016/j.neuroimage.2010.01.101	47	122	128	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162460	10.1371/journal.pone.0162460	http://dx.doi.org/10.1371/journal.pone.0162460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598250	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800066
J	Colson, PH; Gaudard, P; Fellahi, JL; Bertet, H; Faucanie, M; Amour, J; Blanloeil, Y; Lanquetot, H; Ouattara, A; Picot, MC				Colson, Pascal H.; Gaudard, Philippe; Fellahi, Jean-Luc; Bertet, Helena; Faucanie, Marie; Amour, Julien; Blanloeil, Yvonnick; Lanquetot, Herve; Ouattara, Alexandre; Picot, Marie Christine		ARCOTHOVA Grp	Active Bleeding after Cardiac Surgery: A Prospective Observational Multicenter Study	PLOS ONE			English	Article							BLOOD-CELL TRANSFUSION; THORACIC-SURGEONS; SOCIETY; CONSERVATION; PREDICTION; MANAGEMENT; MORBIDITY; MORTALITY; ANEMIA	Main Objectives To estimate the incidence of active bleeding after cardiac surgery (AB) based on a definition directly related on blood flow from chest drainage; to describe the AB characteristics and its management; to identify factors of postoperative complications. Methods AB was defined as a blood loss > 1.5 ml/kg/h for 6 consecutive hours within the first 24 hours or in case of reoperation for hemostasis during the first 12 postoperative hours. The definition was applied in a prospective longitudinal observational study involving 29 French centers; all adult patients undergoing cardiac surgery with cardiopulmonary bypass were included over a 3-month period. Perioperative data (including blood product administration) were collected. To study possible variation in clinical practice among centers, patients were classified into two groups according to the AB incidence of the center compared to the overall incidence: "Low incidence" if incidence is lower and "High incidence" if incidence is equal or greater than overall incidence. Logistic regression analysis was used to identify risk factors of postoperative complications. Results Among 4,904 patients, 129 experienced AB (2.6%), among them 52 reoperation. Postoperative bleeding loss was 1,000 [820; 1,375] ml and 1,680 [1,280; 2,300] ml at 6 and 24 hours respectively. Incidence of AB varied between centers (0 to 16%) but was independent of in-centre cardiac surgical experience. Comparisons between groups according to AB incidence showed differences in postoperative management. Body surface area, preoperative creatinine, emergency surgery, postoperative acidosis and red blood cell transfusion were risk factors of postoperative complication. Conclusions A blood loss > 1.5 ml/kg/ h for 6 consecutive hours within the first 24 hours or early re-operation for hemostasis seems a relevant definition of AB. This definition, independent of transfusion, adjusted to body weight, may assess real time bleeding occurring early after surgery.	[Colson, Pascal H.; Gaudard, Philippe] Univ Montpellier, Arnaud de Villeneuve Acad Hosp, Dept Anesthesiol & Crit Care Med, Montpellier, France; [Colson, Pascal H.] Univ Montpellier, INSERM U1191, CNRS UMR 5203, Inst Genom Fonct,Endocrinol Dept, F-34094 Montpellier, France; [Gaudard, Philippe] Univ Montpellier, CNRS UMR 9214, INSERM U1046, PhyMedExp, F-34295 Montpellier 5, France; [Fellahi, Jean-Luc] Louis Pradel Acad Hosp, Dept Anesthesiol & Crit Care Med, Bron, France; [Bertet, Helena; Faucanie, Marie] Acad Hosp, Clin Res & Epidemiol Unit, Montpellier, France; [Bertet, Helena] Acad Hosp, Clin Invest Ctr, Montpellier, France; [Amour, Julien] UPMC Univ Paris 06, Sorbonne Univ, UMR INSERM 1166, Dept Anaesthesiol & Crit Care Med, Paris, France; [Amour, Julien] IHU ICAN, Postgenom Platform, Paris, France; [Blanloeil, Yvonnick] Laennec Acad Hop, Dept Anaesthesiol & Crit Care Med, Nantes, France; [Lanquetot, Herve] Acad Hosp, Dept Anaesthesiol & Crit Care Med, Poitiers, France; [Ouattara, Alexandre] Acad Hosp, Dept Anaesthesiol & Crit Care Med 2, Bordeaux, France	Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; CHU Poitiers; CHU Bordeaux	Colson, PH (corresponding author), Univ Montpellier, Arnaud de Villeneuve Acad Hosp, Dept Anesthesiol & Crit Care Med, Montpellier, France.; Colson, PH (corresponding author), Univ Montpellier, INSERM U1191, CNRS UMR 5203, Inst Genom Fonct,Endocrinol Dept, F-34094 Montpellier, France.	p-colson@chu-montpellier.fr	PICOT, Marie-Christine/AAK-4802-2020; Colson, Philippe/P-6355-2014; Carmen, Team3/Y-7384-2019	Colson, Philippe/0000-0001-6285-0308; Carmen, Team3/0000-0002-3614-0924; Ouattara, Alexandre/0000-0002-7346-7539; Gaudard, Philippe/0000-0003-1192-8704; Lab, Carmen/0000-0002-5935-3236	French medical association of cardiothoracic and vascular anesthetists, ARCOTHOVA (Anesthesie Reanimation COeur THOrax VAisseaux)	French medical association of cardiothoracic and vascular anesthetists, ARCOTHOVA (Anesthesie Reanimation COeur THOrax VAisseaux)	The study was supported by the French medical association of cardiothoracic and vascular anesthetists, ARCOTHOVA (Anesthesie Reanimation COeur THOrax VAisseaux). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the French medical association of cardiothoracic and vascular anesthetists, ARCOTHOVA (Anesthesie Reanimation COeur THOrax VAisseaux).	Alghamdi AA, 2006, TRANSFUSION, V46, P1120, DOI 10.1111/j.1537-2995.2006.00860.x; Boening A, 2011, ANN THORAC SURG, V92, P805, DOI 10.1016/j.athoracsur.2011.02.076; Brown Helen, 2006, APPL MIXED MODELS ME; Dyke C, 2014, J THORAC CARDIOV SUR, V147, P1458, DOI 10.1016/j.jtcvs.2013.10.070; Fenger-Eriksen C, 2008, BRIT J ANAESTH, V101, P769, DOI 10.1093/bja/aen270; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Goudie R, 2015, BRIT J ANAESTH, V114, P757, DOI 10.1093/bja/aeu483; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Karkouti K, 2004, TRANSFUSION, V44, P1453, DOI 10.1111/j.1537-2995.2004.04144.x; Karkouti K, 2007, TRANSFUSION, V47, P2081, DOI 10.1111/j.1537-2995.2007.01432.x; Karkouti K, 2006, CAN J ANAESTH, V53, P781, DOI 10.1007/BF03022795; Karlsson M, 2009, THROMB HAEMOSTASIS, V102, P137, DOI 10.1160/TH08-09-0587; Karthik S, 2004, ANN THORAC SURG, V78, P837; Kirklin JW, 1986, CARDIAC SURG, P158; Koch CG, 2006, ANN THORAC SURG, V81, P1650, DOI 10.1016/j.athoracsur.2005.12.037; Kozek-Langenecker SA, 2013, EUR J ANAESTH, V30, P270, DOI 10.1097/EJA.0b013e32835f4d5b; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Nuttall GA, 2001, ANESTHESIOLOGY, V94, P773, DOI 10.1097/00000542-200105000-00014; Orlov D, 2014, ANESTH ANALG, V118, P257, DOI 10.1213/ANE.0000000000000054; Rahe-Meyer N, 2009, BRIT J ANAESTH, V102, P785, DOI 10.1093/bja/aep089; Rahe-Meyer N, 2009, J THORAC CARDIOV SUR, V138, P694, DOI 10.1016/j.jtcvs.2008.11.065; Ranucci M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002066; Ranucci M, 2013, ANN THORAC SURG, V96, P478, DOI 10.1016/j.athoracsur.2013.03.015; Ranucci M, 2011, J THORAC CARDIOV SUR, V142, DOI 10.1016/j.jtcvs.2011.04.007; Ravn HB, 2011, J CARDIOTHOR VASC AN, V25, P36, DOI 10.1053/j.jvca.2010.05.006; Stone GW, 2012, AM HEART J, V163, P522, DOI 10.1016/j.ahj.2011.11.016; UNSWORTHWHITE MJ, 1995, ANN THORAC SURG, V59, P664; Vuylsteke A, 2011, EUR J CARDIO-THORAC, V39, P924, DOI 10.1016/j.ejcts.2010.10.003	32	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162396	10.1371/journal.pone.0162396	http://dx.doi.org/10.1371/journal.pone.0162396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588817	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800054
J	Morita, R; Kihira, M; Nakatsu, Y; Nomoto, Y; Ogawa, M; Ohashi, K; Mizuno, K; Tachikawa, T; Ishimoto, Y; Morishita, Y; Tsuji, T				Morita, Ritsuko; Kihira, Miho; Nakatsu, Yousuke; Nomoto, Yohei; Ogawa, Miho; Ohashi, Kazumasa; Mizuno, Kensaku; Tachikawa, Tetsuhiko; Ishimoto, Yukitaka; Morishita, Yoshihiro; Tsuji, Takashi			Coordination of Cellular Dynamics Contributes to Tooth Epithelium Deformations	PLOS ONE			English	Article							3-DIMENSIONAL CULTURE; MORPHOGENESIS; ACTIN; CELLS; SHAPE; MOVEMENT; MOTILITY; TISSUE; ARCHITECTURE; DROSOPHILA	The morphologies of ectodermal organs are shaped by appropriate combinations of several deformation modes, such as invagination and anisotropic tissue elongation. However, how multicellular dynamics are coordinated during deformation processes remains to be elucidated. Here, we developed a four-dimensional (4D) analysis system for tracking cell movement and division at a single-cell resolution in developing tooth epithelium. The expression patterns of a Fucci probe clarified the region-and stage-specific cell cycle patterns within the tooth germ, which were in good agreement with the pattern of the volume growth rate estimated from tissue-level deformation analysis. Cellular motility was higher in the regions with higher growth rates, while the mitotic orientation was significantly biased along the direction of tissue elongation in the epithelium. Further, these spatio-temporal patterns of cellular dynamics and tissue-level deformation were highly correlated with that of the activity of cofilin, which is an actin depolymerization factor, suggesting that the coordination of cellular dynamics via actin remodeling plays an important role in tooth epithelial morphogenesis. Our system enhances the understanding of how cellular behaviors are coordinated during ectodermal organogenesis, which cannot be observed from histological analyses.	[Morita, Ritsuko; Ogawa, Miho; Tsuji, Takashi] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan; [Kihira, Miho; Nakatsu, Yousuke; Nomoto, Yohei] Tokyo Univ Sci, Grad Sch Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Tachikawa, Tetsuhiko] Showa Univ, Dept Oral Pathol, Sch Dent, Shinagawa Ku, Tokyo 1428555, Japan; [Ishimoto, Yukitaka] Akita Prefectural Univ, Dept Machine Intelligence & Syst Engn, Yurihonjo, Akita 0150055, Japan; [Morishita, Yoshihiro] RIKEN Quantitat Biol Ctr, Lab Dev Morphogeometry, Kobe, Hyogo 6500047, Japan; [Morita, Ritsuko] RIKEN Ctr Dev Biol, Lab Tissue Microenvironm, Kobe, Hyogo 6500047, Japan; [Tsuji, Takashi] Organ Technol Inc, Tokyo 1010048, Japan; [Tsuji, Takashi] RIKEN Ctr Dev Biol, Lab Organ Regenerat, Kobe, Hyogo 6500047, Japan	Tokyo University of Science; Tokyo University of Science; Tohoku University; Showa University; Akita Prefectural University; RIKEN; RIKEN; RIKEN	Tsuji, T (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan.; Tsuji, T (corresponding author), Organ Technol Inc, Tokyo 1010048, Japan.; Tsuji, T (corresponding author), RIKEN Ctr Dev Biol, Lab Organ Regenerat, Kobe, Hyogo 6500047, Japan.	t-tsuji@cdb.riken.jp	Ishimoto, Yukitaka/AAG-9588-2021; Ohashi, Kazumasa/U-7028-2019; Morita, Ritsuko/AAY-6642-2021	Ishimoto, Yukitaka/0000-0001-5570-4513; Ohashi, Kazumasa/0000-0001-7617-403X; Morita, Ritsuko/0000-0001-6550-8778	Organ Technologies Inc.;  [2311152]; Grants-in-Aid for Scientific Research [16K07335] Funding Source: KAKEN	Organ Technologies Inc.; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially funded by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 2311152) to TT and Organ Technologies Inc. This work was performed under an Invention Agreement between Tokyo University of Science, RIKEN and Organ Technologies Inc. TT is a director at Organ Technologies Inc. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Bischoff M, 2009, DEVELOPMENT, V136, P2403, DOI 10.1242/dev.035410; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Gorfinkiel N, 2011, CURR OPIN CELL BIOL, V23, P531, DOI 10.1016/j.ceb.2011.06.002; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Higuchi O, 1996, FEBS LETT, V396, P81, DOI 10.1016/0014-5793(96)01072-1; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Kuure S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001176; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee KG, 2007, CELL CYCLE, V6, P1487; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Monier B, 2015, NATURE, V518, P245, DOI 10.1038/nature14152; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Morishita Y, 2014, J THEOR BIOL, V357, P74, DOI 10.1016/j.jtbi.2014.04.027; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nowotschin S, 2009, ORGANOGENESIS, V5, P217, DOI 10.4161/org.5.4.10939; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Takigawa-Imamura H, 2015, J THEOR BIOL, V382, P284, DOI 10.1016/j.jtbi.2015.07.006; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001	44	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161336	10.1371/journal.pone.0161336	http://dx.doi.org/10.1371/journal.pone.0161336			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588418	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800007
J	Bjerge, B; Clark, N; Fisker, P; Raju, E				Bjerge, Benedikte; Clark, Nathan; Fisker, Peter; Raju, Emmanuel			Technology and Information Sharing in Disaster Relief	PLOS ONE			English	Article							COORDINATION; MANAGEMENT	This paper seeks to examine the extent to which technological advances can enhance inter-organizational information sharing in disaster relief. Our case is the Virtual OSOCC (On-Site Operations Coordination Centre) which is a part of the Global Disaster Alert and Coordination System (GDACS) under the United Nations Office for Coordination of Humanitarian Affairs (UN OCHA). The online platform, which has been developing for more than a decade, provides a unique insight into coordination behaviour among disaster management agencies and individual actors. We build our study on the analysis of a complete database of user interaction including more than 20,000 users and 11,000 comments spread across approximately 300 disaster events. Controlling for types and severities of the events, location-specific vulnerabilities, and the overall trends, we find that the introduction of new features have led to increases in user activity. We supplement the data-driven approach with evidence from semi-structured interviews with administrators and key users, as well as a survey among all users specifically designed to capture and assess the elements highlighted by both interviews and data analysis.	[Bjerge, Benedikte; Fisker, Peter] Univ Copenhagen, Fac Sci, Copenhagen, Denmark; [Clark, Nathan; Raju, Emmanuel] Univ Copenhagen, Fac Law, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Clark, N (corresponding author), Univ Copenhagen, Fac Law, Copenhagen, Denmark.	nathan.clark@jur.ku.dk		RAJU, EMMANUEL/0000-0002-2348-1850				Advanced Traning Program on Humanitarian Action, 2008, HARV SCH PUBL HLTH T; Alexander D, 2014, SCI ENG ETHICS; Chen R, 2008, COMMUN ACM, V51, P66, DOI 10.1145/1342327.1342340; Chin CPY, 2015, J ORG COMP ELECT COM, V25, P289, DOI 10.1080/10919392.2015.1058118; Comfort LK, 2004, INT J EMERGENCY MANA, V2, P295, DOI [10.1504/IJEM, DOI 10.1504/IJEM]; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; Gentner H., 2006, J CURRENT SE ASIAN A, V24, P3; Haas Eugene J., 1973, COMPLEX ORG SOCIOLOG; Hannigan J, 2012, DISASTERS BOARDERS I; Harvard Humanitarian Initiative, 2011, DIS REL 2 0 FUT INF; International Federation of Red Cross and Red Crescent Societies, DIS MAN STRAT COORD; International Federation of Red Cross and Red Crescent Societies, 2013, WORLD DIS REP 2013 F; International Federation of Red Cross and Red Crescent Societies, 2005, WORLD DIS REP 2005 F; KHAN A, 2011, IJCSET, V1, P709; Maiers C., 2005, 2005 IEEE INT PROF C; Malone TW, 1990, P C COMP SUPP COOP W; Marincioni F, 2007, INFORM TECHNOLOGIES; Martin E, 2016, DISASTERS; Nolte IM, 2012, PUBLIC MANAG REV, V14, P707, DOI 10.1080/14719037.2011.642629; Prizzia R., 2008, DISASTER MANAGEMENT; QUARANTELLI EL, 1988, J MANAGE STUD, V25, P373, DOI 10.1111/j.1467-6486.1988.tb00043.x; Raju E, 2013, THESIS; Raju E, 2013, INT J DISAST RISK RE, V4, P82, DOI 10.1016/j.ijdrr.2013.02.004; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; Raymond N, 2015, EUR INT SEC FOR; Xu Z., 2016, CONCURRENCY COMPUTAT	26	16	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161783	10.1371/journal.pone.0161783	http://dx.doi.org/10.1371/journal.pone.0161783			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584053	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600059
J	Cooper, JA; Loomis, GW; Amador, JA				Cooper, Jennifer A.; Loomis, George W.; Amador, Jose A.			Hell and High Water: Diminished Septic System Performance in Coastal Regions Due to Climate Change	PLOS ONE			English	Article							WASTE-WATER; SOIL RESPIRATION; VIRUS REMOVAL; NITROGEN; PURIFICATION; ATTENUATION; BACTERIA; GROWTH	Climate change may affect the ability of soil-based onsite wastewater treatment systems (OWTS) to treat wastewater in coastal regions of the Northeastern United States. Higher temperatures and water tables can affect treatment by reducing the volume of unsaturated soil and oxygen available for treatment, which may result in greater transport of pathogens, nutrients, and biochemical oxygen demand (BOD5) to groundwater, jeopardizing public and aquatic ecosystem health. The soil treatment area (STA) of an OWTS removes contaminants as wastewater percolates through the soil. Conventional STAs receive wastewater from the septic tank, with infiltration occurring deeper in the soil profile. In contrast, shallow narrow STAs receive pre-treated wastewater that infiltrates higher in the soil profile, which may make them more resilient to climate change. We used intact soil mesocosms to quantify the water quality functions of a conventional and two types of shallow narrow STAs under present climate (PC; 20 degrees C) and climate change (CC; 25 degrees C, 30 cm elevation in water table). Significantly greater removal of BOD5 was observed under CC for all STA types. Phosphorus removal decreased significantly from 75% (PC) to 66% (CC) in the conventional STA, and from 100% to 71-72% in shallow narrow STAs. No fecal coliform bacteria (FCB) were released under PC, whereas up to 17 and 20 CFU 100 mL(-1) were released in conventional and shallow narrow STAs, respectively, under CC. Total N removal increased from 14% (PC) to 19% (CC) in the conventional STA, but decreased in shallow narrow STAs, from 6-7% to less than 3.0%. Differences in removal of FCB and total N were not significant. Leaching of N in excess of inputs was also observed in shallow narrow STAs under CC. Our results indicate that climate change can affect contaminant removal from wastewater, with effects dependent on the contaminant and STA type.	[Cooper, Jennifer A.; Amador, Jose A.] Univ Rhode Isl, Lab Soil Ecol & Microbiol, Kingston, RI 02881 USA; [Loomis, George W.] Univ Rhode Isl, New England Onsite Wastewater Training Ctr, Kingston, RI 02881 USA; [Cooper, Jennifer A.] Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA	University of Rhode Island; University of Rhode Island; State University System of Florida; University of Florida	Cooper, JA (corresponding author), Univ Rhode Isl, Lab Soil Ecol & Microbiol, Kingston, RI 02881 USA.; Cooper, JA (corresponding author), Univ Florida, Everglades Res & Educ Ctr, Belle Glade, FL 33430 USA.	jencooper@ufl.edu			Rhode Island Sea Grant; Rhode Island Agricultural Experiment Station; University of Rhode Island Enhancement of Graduate Research Program	Rhode Island Sea Grant; Rhode Island Agricultural Experiment Station; University of Rhode Island Enhancement of Graduate Research Program	This study was funded by grants from Rhode Island Sea Grant (http://seagrant.gso.uri.edu/), the Rhode Island Agricultural Experiment Station (http://web.uri.edu/riaes/), by a grant from University of Rhode Island Enhancement of Graduate Research Program to J.A.C. (http://web.uri.edu/graduate-school/enhancement-of-graduate-research-awardsegra/), and by personal funds of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador JA, 2007, EVALUATION LEACHFIEL, P12; Anderson D. L., 1994, P 7 INT S IND SMALL, P209; [Anonymous], POTENTIAL EFFECTS SE; Beal CD, 2006, WATER RES, V40, P2327, DOI 10.1016/j.watres.2006.04.018; Bitton G., 1980, INTRO ENV VIROLOGY; Bradshaw JK, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0150; Bunnell JF, 1999, J ENVIRON MANAGE, V56, P209, DOI 10.1006/jema.1999.0273; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; CAMPBELL CA, 1976, CAN J SOIL SCI, V56, P293, DOI 10.4141/cjss76-037; COGGER CG, 1988, J ENVIRON QUAL, V17, P401, DOI 10.2134/jeq1988.00472425001700030009x; Cooper JA, 2016, ECOL ENG, V94, P22, DOI 10.1016/j.ecoleng.2016.05.059; Cooper JA, 2015, J ENVIRON QUAL, V44, P953, DOI 10.2134/jeq2014.06.0277; Crites R.W., 1998, MCGRAW HILL SERIES W; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Domenico PA, 1998, PHYS CHEM HYDROGEOLO, P296; Feachem R.G., 1980, HLTH ASPECTS EXCRETA; Fogler H.S., 2010, ESSENTIALS CHEM REAC; Gerba C.P., 1975, J IRRIGATION DRAINAG, V101, P157, DOI DOI 10.1061/JRCEA4.0001044; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Kanter RD, 1998, ON-SITE WASTEWATER TREATMENT, P509; KRISHNAMURTHY T, 1986, TOXICON, V24, P865, DOI 10.1016/0041-0101(86)90087-5; LINN DM, 1984, SOIL SCI SOC AM J, V48, P794, DOI 10.2136/sssaj1984.03615995004800040019x; Loomis GW, 2001, ON-SITE WASTEWATER TREATMENT, PROCEEDINGS, P52; Mallin MA, 2006, LIMNOL OCEANOGR, V51, P690, DOI 10.4319/lo.2006.51.1_part_2.0690; Michen B, 2010, J APPL MICROBIOL, V109, P388, DOI 10.1111/j.1365-2672.2010.04663.x; Morales I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158292; Morales I, 2015, J ENVIRON QUAL, V44, P1459, DOI 10.2134/jeq2014.12.0547; Nasser AM, 2002, WATER RES, V36, P2589, DOI 10.1016/S0043-1354(01)00461-4; NOAA. National Oceanic and Atmospheric Administration, 2011, STAT COAST US POP LI; Oakley SM, 2010, ECOL ENG, V36, P1520, DOI 10.1016/j.ecoleng.2010.04.030; Ocampo CJ, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003773; Paerl H W, 2001, ScientificWorldJournal, V1, P76; PALMSTROM N S, 1988, Lake and Reservoir Management, V4, P1; Potts DA, 2004, J ENVIRON QUAL, V33, P1828, DOI 10.2134/jeq2004.1828; POWELSON DK, 1994, WATER RES, V28, P2175, DOI 10.1016/0043-1354(94)90029-9; Quanrud DM, 2003, WATER RES, V37, P753, DOI 10.1016/S0043-1354(02)00393-7; RIDEM. Rhode Island Department of Environmental Management, 2013, GUID DES US MAINT PR; RIDEM. Rhode Island Department of Environmental Management, 2010, RUL EST MIN STAND RE; Robertson L. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P189; Robertson WD, 2012, GROUND WATER, V50, P541, DOI 10.1111/j.1745-6584.2011.00857.x; Robertson WD, 2003, GROUND WATER, V41, P48, DOI 10.1111/j.1745-6584.2003.tb02567.x; Schimel JP, 2015, MICROBIAL CONTROL CA, P155; SHUVAL HI, 1972, AM J PUBLIC HEALTH N, V62, P1045, DOI 10.2105/AJPH.62.8.1045; Siegrist RL, 2001, ON-SITE WASTEWATER TREATMENT, PROCEEDINGS, P1; Silberberg M. S., 2006, CHEM MOL NATURE MATT; Stevik TK, 2004, WATER RES, V38, P1355, DOI 10.1016/j.watres.2003.12.024; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; United States Environmental Protection Agency (USEPA), 2004, ONS WAST TREATM SYST; US Food and Drug Administration, 1992, BAD BUG BOOK FOODB P; Van Cuyk S, 2004, J ENVIRON QUAL, V33, P316, DOI 10.2134/jeq2004.0316; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7	53	44	45	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162104	10.1371/journal.pone.0162104	http://dx.doi.org/10.1371/journal.pone.0162104			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583363	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600104
J	Kagawa, RMC; Fernald, LCH; Behrman, JR				Kagawa, Rose M. C.; Fernald, Lia C. H.; Behrman, Jere R.			Weight Status and Behavioral Problems among Very Young Children in Chile	PLOS ONE			English	Article							BODY-MASS INDEX; SCHOOL-AGED CHILDREN; MENTAL-HEALTH; PRESCHOOL-CHILDREN; CHILDHOOD OBESITY; SELF-ESTEEM; OVERWEIGHT; PSYCHOPATHOLOGY; DISORDER; ASSOCIATIONS	Background/Objectives Our objective was to explore the association between weight status and behavioral problems in children before school age. We examined whether the association between weight status and behavioral problems varied by age and sex. Subjects/Methods This study used cross-sectional data from a nationally-representative sample of children and their families in Chile (N = 11,207). These children were selected using a cluster-stratified random sampling strategy. Data collection for this study took place in 2012 when the children were 1.5-6 years of age. We used multivariable analyses to examine the association between weight status and behavioral problems (assessed using the Child Behavior Checklist), while controlling for child's sex, indigenous status, birth weight, and months breastfed; primary caregiver's BMI and education level; and household wealth. Results Approximately 24% of our sample was overweight or obese. Overweight or obese girls showed more behavioral problems than normal weight girls at age 6 (beta = 0.270 SD, 95% CI = 0.047, 0.493, P = 0.018). Among boys age 1 to 5 years, overweight/obesity was associated with a small reduction in internalizing behaviors (beta = -0.09 SD, 95% CI = -0.163, -0.006, P = 0.034). Conclusions Our data suggest that the associations between weight status and behavioral problems vary across age and sex.	[Kagawa, Rose M. C.; Fernald, Lia C. H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Behrman, Jere R.] Univ Penn, Dept Econ, 3718 Locust Walk, Philadelphia, PA 19104 USA	University of California System; University of California Berkeley; University of Pennsylvania	Kagawa, RMC (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	rcalnin@berkeley.edu	Behrman, Jere R/A-9734-2009	Fernald, Lia C.H./0000-0003-1555-4607	Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD R01HD065436]; Grand Challenges Canada [0072-03]; Berkeley Population Center [R24 HD073964]; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065436, R24HD073964] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grand Challenges Canada(CGIAR); Berkeley Population Center; Berkeley Research Impact Initiative (BRII) - UC Berkeley Library; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD R01HD065436) grant on "Early Child Development Programs: Effective Interventions for Human Development" (URL: https://www.nichd.nih.gov/Pages/index.aspx), the Grand Challenges Canada (0072-03) grant on Saving Brains: "Team 1000+ Saving Brains: Economic Impacts of Poverty-Related Risk Factors During the First 1000 Days for Cognitive Development and Human Capital" (URL: http://www.grandchallenges.ca/), a pilot grant from the Berkeley Population Center (R24 HD073964) (URL: http://popcenter.berkeley.edu/grants/), and funding to support publication from the Berkeley Research Impact Initiative (BRII) sponsored by the UC Berkeley Library (URL: http://guides.lib.berkeley.edu/brii). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1978, PSYCHOL BULL, V85, P1275, DOI 10.1037/0033-2909.85.6.1275; Achenbach TM, 1983, MANUAL CHILD BEHAV C; Achenbach TM, 2001, RELIABILITY INTERNAL; Achenbach TM, 2000, RELIABILITY CROSS IN; Albala C, 2002, PUBLIC HEALTH NUTR, V5, P123, DOI 10.1079/PHN2001283; Anderson SE, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-49; Behrman J. R., 2010, ENCUESTA LONGITUDINA; Bradley RH, 2008, J PEDIATR-US, V153, P629, DOI 10.1016/j.jpeds.2008.05.026; Bravo D., ENCUESTA LONGITUDINA; Brewis A, 2003, AM J HUM BIOL, V15, P446, DOI 10.1002/ajhb.10161; Clark C, 2000, J ABNORM CHILD PSYCH, V28, P403, DOI 10.1023/A:1005176320912; Cornette R, 2008, WORLDV EVID-BASED NU, V5, P136, DOI 10.1111/j.1741-6787.2008.00127.x; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Cramer P, 1998, J APPL DEV PSYCHOL, V19, P429, DOI 10.1016/S0193-3973(99)80049-5; Datar A, 2004, ARCH PEDIAT ADOL MED, V158, P804, DOI 10.1001/archpedi.158.8.804; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Drukker M, 2009, INT J PEDIATR OBES, V4, P91, DOI 10.1080/17477160802395442; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Francis LA, 2009, ARCH PEDIAT ADOL MED, V163, P297, DOI 10.1001/archpediatrics.2008.579; Frey K. S., 1990, COMPETENCE CONSIDERE, P167; Gable S, 2009, APPL DEV SCI, V13, P88, DOI 10.1080/10888690902801970; Garthus-Niegel S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-626; Goossens L, 2009, EUR EAT DISORD REV, V17, P68, DOI 10.1002/erv.892; Griffiths LJ, 2006, ARCH DIS CHILD, V91, P121, DOI 10.1136/adc.2005.072314; Halfon N, 2013, ACAD PEDIATR, V13, P6, DOI 10.1016/j.acap.2012.10.007; Hesketh K, 2004, INT J OBESITY, V28, P1233, DOI 10.1038/sj.ijo.0802624; HILL AJ, 1994, INT J OBESITY, V18, P383; Hwang JW, 2006, J DEV BEHAV PEDIATR, V27, P18, DOI 10.1097/00004703-200602000-00003; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Janssen I, 2004, PEDIATRICS, V113, P1187, DOI 10.1542/peds.113.5.1187; Lawlor DA, 2005, ARCH DIS CHILD, V90, P692, DOI 10.1136/adc.2004.062919; Levy P, 1999, SAMPLING POPULATIONS; Lumeng JC, 2003, PEDIATRICS, V112, P1138, DOI 10.1542/peds.112.5.1138; Mackenbach JD, 2012, J DEV BEHAV PEDIATR, V33, P641, DOI 10.1097/DBP.0b013e31826419b8; McArthur LH, 2005, ADOLESCENCE, V40, P801; Moser CON, 1998, WORLD DEV, V26, P1, DOI 10.1016/S0305-750X(97)10015-8; Mulder C, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-37; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nakamura BJ, 2009, J PSYCHOPATHOL BEHAV, V31, P178, DOI 10.1007/s10862-008-9119-8; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Phillips RG, 1998, INT J OBESITY, V22, P287, DOI 10.1038/sj.ijo.0800582; Pillow BH, 1996, CHILD DEV, V67, P803, DOI 10.2307/1131862; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Pitrou I, 2010, OBESITY, V18, P809, DOI 10.1038/oby.2009.278; Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238; Puhl RM, 2007, PSYCHOL BULL, V133, P557, DOI 10.1037/0033-2909.133.4.557; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Rescorla LA, 2011, J CLIN CHILD ADOLESC, V40, P456, DOI 10.1080/15374416.2011.563472; Rofey DL, 2009, CHILD PSYCHIAT HUM D, V40, P517, DOI 10.1007/s10578-009-0141-1; Sawyer MG, 2006, AMBUL PEDIATR, V6, P306, DOI 10.1016/j.ambp.2006.08.005; Selvin S., 2004, STAT ANAL EPIDEMIOLO; Sikorski C, 2015, OBESITY, V23, P266, DOI 10.1002/oby.20952; Smolak Linda, 2004, Body Image, V1, P15, DOI 10.1016/S1740-1445(03)00008-1; STIPEK DJ, 1981, J EDUC PSYCHOL, V73, P404, DOI 10.1037/0022-0663.73.3.404; Stradmeijer M, 2000, INT J EAT DISORDER, V27, P110, DOI 10.1002/(SICI)1098-108X(200001)27:1<110::AID-EAT14>3.0.CO;2-5; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Suchert V, 2015, PREV MED, V76, P48, DOI 10.1016/j.ypmed.2015.03.026; Tate T, 2006, PEDIATR RES, V60, P637, DOI 10.1203/00006450-200611000-00036; Vila G, 2004, PSYCHOSOM MED, V66, P387, DOI 10.1097/01.psy.0000126201.12813.eb; Vio F, 2008, PUBLIC HEALTH NUTR, V11, P405, DOI 10.1017/S136898000700050X; Vollrath ME, 2011, INT J PEDIATR OBES, V6, pE408, DOI 10.3109/17477166.2010.518240; World Health Organization, 2011, BURD MORT MORB RISK; World Health Organization, 2009, WHO ANTHR VERS 3 2 2	69	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161380	10.1371/journal.pone.0161380	http://dx.doi.org/10.1371/journal.pone.0161380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583678	Green Published, gold			2022-12-27	WOS:000382855600027
J	Lord, E; Le Cam, M; Bapteste, E; Meheust, R; Makarenkov, V; Lapointe, FJ				Lord, Etienne; Le Cam, Margaux; Bapteste, Eric; Meheust, Raphael; Makarenkov, Vladimir; Lapointe, Francois-Joseph			BRIDES: A New Fast Algorithm and Software for Characterizing Evolving Similarity Networks Using Breakthroughs, Roadblocks, Impasses, Detours, Equals and Shortcuts	PLOS ONE			English	Article							DIVERSITY; PATHS; NODES	Various types of genome and gene similarity networks along with their characteristics have been increasingly used for retracing different kinds of evolutionary and ecological relationships. Here, we present a new polynomial time algorithm and the corresponding software (BRIDES) to provide characterization of different types of paths existing in evolving (or augmented) similarity networks under the constraint that such paths contain at least one node that was not present in the original network. These different paths are denoted as Breakthroughs, Roadblocks, Impasses, Detours, Equal paths, and Shortcuts. The analysis of their distribution can allow discriminating among different evolutionary hypotheses concerning genomes or genes at hand. Our approach is based on an original application of the popular shortest path Dijkstra's and Yen's algorithms. The C++ and R versions of the BRIDES program are freely available at: https://github.com/etiennelord/BRIDES.	[Lord, Etienne; Makarenkov, Vladimir] Univ Quebec, Dept Informat, Montreal, PQ, Canada; [Lord, Etienne; Le Cam, Margaux; Lapointe, Francois-Joseph] Univ Quebec, Dept Sci Biol, Montreal, PQ, Canada; [Bapteste, Eric; Meheust, Raphael] Univ Paris 06, Sorbonne Univ, Inst Biol Paris Seine, Paris, France; [Bapteste, Eric] Inst Biol Paris Seine, CNRS, UMR7138, Paris, France	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Lapointe, FJ (corresponding author), Univ Quebec, Dept Sci Biol, Montreal, PQ, Canada.	francois-joseph.lapointe@umontreal.ca		Meheust, Raphael/0000-0002-4847-426X; Bapteste, Eric/0000-0003-1966-1215	Natural Sciences and Engineering Research Council (NSERC); NSERC [OGP0155251, OGP249644]; European Research Council under the European Community's Seventh Framework Program FP7 [615274]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Research Council under the European Community's Seventh Framework Program FP7	EL is supported by a Natural Sciences and Engineering Research Council (NSERC) scholarship. VM and FJL respectively hold NSERC discovery grants OGP0155251 and OGP249644. EB is funded by the European Research Council under the European Community's Seventh Framework Program FP7 (Grant Agreement no615274).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Aylward FO, 2015, P NATL ACAD SCI USA, V112, P5443, DOI 10.1073/pnas.1502883112; Bapteste E, 2013, TRENDS GENET, V29, P439, DOI 10.1016/j.tig.2013.05.007; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Burkard RE, 1998, SIAM REV, V40, P496, DOI 10.1137/S0036144596297514; Cheng S, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00072; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Forster D, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0125-5; GOLDBERG AV, 1993, APPL MATH LETT, V6, P3, DOI 10.1016/0893-9659(93)90022-F; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Lynch MDJ, 2012, ISME J, V6, P2067, DOI 10.1038/ismej.2012.50; Martins EQV, 2003, 4OR-Q J OPER RES, V1, P121, DOI 10.1007/s10288-002-0010-2; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; OpenMP Forum, 1997, TECHNICAL REPORT; Orsini C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9627; Popa O, 2011, GENOME RES, V21, P599, DOI 10.1101/gr.115592.110; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roberts B., 2007, J GRAPH ALGORITHMS A, V11, P195, DOI DOI 10.7155/jgaa.00142; Schbath S, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/616234; VALIANT LG, 1979, SIAM J COMPUT, V8, P410, DOI 10.1137/0208032; Vardhan H, 2009, 2009 IEEE INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS & SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS (MASCOTS), P607; VERWER BJH, 1989, IEEE T PATTERN ANAL, V11, P425, DOI 10.1109/34.19041; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang B, 2014, NAT METHODS, V11, P333, DOI [10.1038/NMETH.2810, 10.1038/nmeth.2810]; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07187; YEN JY, 1970, Q APPL MATH, V27, P526, DOI 10.1090/qam/253822; Zeng W, 2009, INT J GEOGR INF SCI, V23, P531, DOI 10.1080/13658810801949850	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161474	10.1371/journal.pone.0161474	http://dx.doi.org/10.1371/journal.pone.0161474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580188	Green Published, gold			2022-12-27	WOS:000382877400025
J	Xu, Y; Yu, XL; Hu, CM; Hao, G				Xu, Yuan; Yu, Xun-Lin; Hu, Chi-Ming; Hao, Gang			Morphological and Molecular Phylogenetic Data Reveal a New Species of Primula (Primulaceae) from Hunan, China	PLOS ONE			English	Article							CAROLINELLA PRIMULACEAE; SEQUENCES; MODEL	A new species of Primulaceae, Primula undulifolia, is described from the hilly area of Hunan province in south-central China. Its morphology and distributional range suggest that it is allied to P. kwangtungensis, both adapted to subtropical climate, having contiguous distribution and similar habitat, growing on shady and moist cliffs. Petioles, scapes and pedicels of them are densely covered with rusty multicellular hairs, but the new species can be easily distinguished by its smaller flowers and narrowly oblong leaves with undulate margins. Molecular phylogenetic analysis based on four DNA markers (ITS, matK, trnL-F and rps16) confirmed the new species as an independent lineage and constitutes a main clade together with P. kwangtungensis, P. kweichouensis, P. wangii and P. hunanensis of Primula sect. Carolinella.	[Xu, Yuan; Hu, Chi-Ming] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Yu, Xun-Lin] Cent South Univ Forestry & Technol, Coll Forestry, Changsha, Hunan, Peoples R China; [Xu, Yuan; Hao, Gang] South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Central South University of Forestry & Technology; South China Agricultural University	Hao, G (corresponding author), South China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	haogang@scau.edu.cn			National Natural Science Foundation of China [31570193, 31570222]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (grant no. 31570193, 31570222, www.nsfc.gov.cn) to Gang Hao and Hai-Fei Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderberg AA, 2000, NORD J BOT, V20, P5, DOI 10.1111/j.1756-1051.2000.tb00726.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; de Vos JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0075; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gong X, 2003, NOVON, V13, P193, DOI 10.2307/3393517; Hemsley WB, 1903, HOOKERS ICONES PLANT, V28, P2775; Hemsley WB, 1902, HOOKERS ICONES PLANT, V28; Hu C.M, 1996, FLORA CHINA, V15, P39; HU CM, 1990, NORD J BOT, V10, P399, DOI 10.1111/j.1756-1051.1990.tb01779.x; Hu CM, 1994, J TROPICAL SUBTROPIC, V2, P1; Hu CM, 1990, FLORA REIPUBLICAE PO, V59, P1; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; Kallersjo M, 2000, AM J BOT, V87, P1325, DOI 10.2307/2656725; Liu YJ, 2015, PLANT SYST EVOL, V301, P2057, DOI 10.1007/s00606-015-1207-0; Martins L, 2003, PLANT SYST EVOL, V237, P75, DOI 10.1007/s00606-002-0258-1; Mast AR, 2001, INT J PLANT SCI, V162, P1381, DOI 10.1086/323444; Mast AR, 2006, NEW PHYTOL, V171, P605, DOI [10.1111/j.1469-8137.2006.01700.x, 10.1111/j.1469-8137.2006.01833.x]; Pax F., 1905, PFLANZENREICH, V237, P1; Pax F, 1889, BOT JB SYSTEMATIK PF, V10, P75; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2013, TRACER VERSION 1 6; Richards A.J., 2002, PRIMULA; Smith WW, 1941, T P BOT SOC EDINBURG, V11, P1; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trift I, 2002, SYST BOT, V27, P396; Wendelbo P, 1961, ARBOK U BERGEN MAT N, V11, P1; Yan HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122903; Yan HF, 2010, J SYST EVOL, V48, P123, DOI 10.1111/j.1759-6831.2010.00068.x; Yu XL, 2015, NORD J BOT, V33, P381, DOI 10.1111/njb.00713	32	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161172	10.1371/journal.pone.0161172	http://dx.doi.org/10.1371/journal.pone.0161172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579832	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400020
J	Chow, WZ; Bon, AH; Keating, S; Anderios, F; Halim, HA; Takebe, Y; Kamarulzaman, A; Busch, MP; Tee, KK				Chow, Wei Zhen; Bon, Abdul Hamid; Keating, Sheila; Anderios, Fread; Halim, Hazwan Abdul; Takebe, Yutaka; Kamarulzaman, Adeeba; Busch, Michael P.; Tee, Kok Keng			Extensive Genetic Diversity of HIV-1 in Incident and Prevalent Infections among Malaysian Blood Donors: Multiple Introductions of HIV-1 Genotypes from Highly Prevalent Countries	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; CIRCULATING RECOMBINANT; GENOME SEQUENCE; TYPE-1 INFECTION; IDENTIFICATION; SUBTYPES; YUNNAN; CHINA; RISK	Transfusion-transmissible infections including HIV-1 continue to pose major risks for unsafe blood transfusions due to both window phase infections and divergent viruses that may not be detected by donor screening assays. Given the recent emergence of several HIV-1 circulating recombinant forms (CRFs) in high-risk populations in the Southeast Asia region, we investigated the genetic diversity of HIV-1 among the blood donors in Kuala Lumpur, Malaysia. A total of 211 HIV-positive plasma samples detected among 730,188 donations to the National Blood Centre between 2013 and 2014 were provided (90.5% male, median age: 27.0 years old). Recent or long-term infection status at the time of donation was determined using a limiting antigen avidity enzyme immunoassay (LAg-Avidity EIA). HIV-1 gagpol genes were amplified and sequenced from residual plasma for 149 cases followed by genotype determination using phylogenetic and recombination analyses. Transmitted anti-retroviral resistance mutations were not observed among the blood donors, among which 22.7% were classified as recent or incident infections. Major circulating HIV-1 genotypes determined by neighbour-joining phylogenetic inference included CRF01_AE at 40.9% (61/149), CRF33_01B at 21.5% (32/149), and subtype B at 10.1% (15/149). Newly-described CRFs including CRF54_01B circulated at 4.0%, CRF74_01B at 2.0%, and CRF53_01B and CRF48_01B at 0.7% each. Interestingly, unique HIV-1 genotypes including African subtype G (8.7%), CRF45_cpx (1.3%), CRF02_AG (0.7%) and CRF07_BC (0.7%) from China were detected for the first time in the country. A cluster of subtype G sequences formed a distinct founder sub-lineage within the African strains. In addition, 8.7% (13/149) of HIV-infected donors had unique recombinant forms (URFs) including CRF01_AE/B' (4.7%), B'/C (2.7%) and B'/G (1.3%) recombinants. Detailed analysis identified similar recombinant structures with shared parental strains among the B'/C and B'/G URFs, some of which were sequenced from recently infected individuals, indicating the possible emergence and on-going spread of foreign clades of CRF candidates among the local population. The findings demonstrate extensive molecular complexity of HIV-1 among the infected blood donors in Malaysia, driven in part by the increased spread of recently described CRFs and multiple introductions of previously unreported genotypes from highly prevalent countries.	[Chow, Wei Zhen; Takebe, Yutaka; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia; [Bon, Abdul Hamid; Anderios, Fread; Halim, Hazwan Abdul] Natl Blood Ctr Kuala Lumpur NBCKL, Kuala Lumpur, Malaysia; [Keating, Sheila; Busch, Michael P.] BSRI, San Francisco, CA USA; [Keating, Sheila; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Toyama, Tokyo, Japan; [Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; University of California System; University of California San Francisco; National Institute of Infectious Diseases (NIID); Universiti Malaya	Tee, KK (corresponding author), Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia.; Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Tee, Kok Keng/A-8148-2008; KAMARULZAMAN, ADEEBA/B-5216-2010	Tee, Kok Keng/0000-0002-7923-5448; Keating, Sheila/0000-0002-8324-3694	Ministry of Education, Malaysia (High Impact Research) [UM.C/625/1/HIR/MOE/CHAN/02/02]; U.S. Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201000045C]	Ministry of Education, Malaysia (High Impact Research); U.S. Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	This work was supported by grant from the Ministry of Education, Malaysia (High Impact Research UM.C/625/1/HIR/MOE/CHAN/02/02). This project has also been funded in part with U.S. Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201000045C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar CS, 2013, JAIDS-J ACQ IMM DEF, V63, P387, DOI 10.1097/QAI.0b013e31828ff979; Bobkova M, 2013, AIDS REV, V15, P204; Bruzzone B, 2015, AIDS RES HUM RETROV, V31, P837, DOI [10.1089/aid.2015.0105, 10.1089/AID.2015.0105]; Busch MP, 2006, TRANSFUSION, V46, P1663, DOI 10.1111/j.1537-2995.2006.00987.x; Busch MP, 2005, TRANSFUSION, V45, P254, DOI 10.1111/j.1537-2995.2004.04215.x; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Cheong HT, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01220-15; Cheong HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133883; Chow WZ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00139-14; Chow WZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085250; Chow WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062560; Chow WZ, 2012, J VIROL, V86, P11398, DOI 10.1128/JVI.01932-12; Delatorre E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098908; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; DONEGAN E, 1990, ANN INTERN MED, V113, P733, DOI 10.7326/0003-4819-113-10-733; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Feng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19279; Han Xiaohua, 2013, Evid Based Complement Alternat Med, V2013, P156489, DOI 10.1155/2013/156489; Hara T, 2001, AIDS RES HUM RETROV, V17, P569, DOI 10.1089/08892220151126706; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Hsi J, 2014, AIDS RES HUM RETROV, V30, P389, DOI [10.1089/aid.2013.0234, 10.1089/AID.2013.0234]; Kondo M, 2013, J VIROL, V87, P5351, DOI 10.1128/JVI.02370-12; Li XX, 2013, J APPL MATH, DOI 10.1155/2013/245963; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YJ, 2012, AIDS RES HUM RETROV, V28, P1357, DOI 10.1089/aid.2011.0376; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Longosz AF, 2014, AIDS, V28, P1227, DOI 10.1097/QAD.0000000000000221; Longosz AF, 2014, AIDS RES HUM RETROV, V30, P339, DOI [10.1089/aid.2013.0169, 10.1089/AID.2013.0169]; Lu X, 2016, AIDS RES HUM RETROVI; Ly TD, 2012, J CLIN VIROL, V55, P121, DOI 10.1016/j.jcv.2012.06.012; Machado LY, 2012, AIDS RES HUM RETROV, V28, P956, DOI [10.1089/aid.2011.0295, 10.1089/AID.2011.0295]; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Ministry of Health Malaysia, 2015, GLOB AIDS RESP PROGR; Nafishah A, 2014, INDIAN J HEMATOL BLO, V30, P105, DOI 10.1007/s12288-012-0213-4; Ng KT, 2012, J VIROL, V86, P11405, DOI 10.1128/JVI.01949-12; Niama FR, 2009, AIDS RES HUM RETROV, V25, P1345, DOI 10.1089/aid.2009.0169; Ong LY, 2014, J MED VIROL, V86, P38, DOI 10.1002/jmv.23772; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qiu ZZ, 2005, AIDS RES HUM RETROV, V21, P1051, DOI 10.1089/aid.2005.21.1051; Reid G, 2007, INT J DRUG POLICY, V18, P136, DOI 10.1016/j.drugpo.2006.12.015; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2006, AIDS RES HUM RETROV, V22, P121, DOI 10.1089/aid.2006.22.121; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Wei HM, 2014, AIDS RES HUM RETROV, V30, P384, DOI [10.1089/aid.2013.0228, 10.1089/AID.2013.0228]; Wei HM, 2014, AIDS RES HUM RETROV, V30, P380, DOI [10.1089/aid.2013.0235, 10.1089/AID.2013.0235]; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Yang JY, 2001, J FORMOS MED ASSOC, V100, P89; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017; Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x	56	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161853	10.1371/journal.pone.0161853	http://dx.doi.org/10.1371/journal.pone.0161853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575746	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877200042
J	Ock, M; Ahn, J; Yoon, SJ; Jo, MW				Ock, Minsu; Ahn, Jeonghoon; Yoon, Seok-Jun; Jo, Min-Woo			Estimation of Disability Weights in the General Population of South Korea Using a Paired Comparison	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; PERSON TRADE-OFFS; GLOBAL BURDEN; DISEASE 2010; PREFERENCES; COUNTRIES; RANKING; LESSONS; VALUES	We estimated the disability weights in the South Korean population by using a paired comparison-only model wherein 'full health' and 'being dead' were included as anchor points, without resorting to a cardinal method, such as person trade-off. The study was conducted via 2 types of survey: a household survey involving computer-assisted face-to-face interviews and a web-based survey (similar to that of the GBD 2010 disability weight study). With regard to the valuation methods, paired comparison, visual analogue scale (VAS), and standard gamble (SG) were used in the household survey, whereas paired comparison and population health equivalence (PHE) were used in the web-based survey. Accordingly, we described a total of 258 health states, with 'full health' and 'being dead' designated as anchor points. In the analysis, 4 models were considered: a paired comparison-only model; hybrid model between paired comparison and PHE; VAS model; and SG model. A total of 2,728 and 3,188 individuals participated in the household and web-based survey, respectively. The Pearson correlation coefficients of the disability weights of health states between the GBD 2010 study and the current models were 0.802 for Model 2, 0.796 for Model 1, 0.681 for Model 3, and 0.574 for Model 4 (all P-values<0.001). The discrimination of values according to health state severity was most suitable in Model 1. Based on these results, the paired comparison-only model was selected as the best model for estimating disability weights in South Korea, and for maintaining simplicity in the analysis. Thus, disability weights can be more easily estimated by using paired comparison alone, with 'full health' and 'being dead' as one of the health states. As noted in our study, we believe that additional evidence regarding the universality of disability weight can be observed by using a simplified methodology of estimating disability weights.	[Ock, Minsu; Jo, Min-Woo] Univ Ulsan, Dept Prevent Med, Seoul, South Korea; [Ahn, Jeonghoon] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea; [Yoon, Seok-Jun] Korea Univ, Dept Prevent Med, Seoul, South Korea	University of Ulsan; Ewha Womans University; Korea University	Jo, MW (corresponding author), Univ Ulsan, Dept Prevent Med, Seoul, South Korea.	mdjominwoo@gmail.com	Ahn, Jeonghoon/CAA-1956-2022	Ahn, Jeonghoon/0000-0002-0177-0192; Yoon, Seok-Jun/0000-0003-3297-0071	Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea [HI13C0729]	Korean Health Technology RAMP;D Project, Ministry of Health AMP; Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (grant number: HI13C0729, http://www.khidi.or.kr/kps). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2007, INTRO CATEGORICAL AN; Ali S, 2012, BRIT MED BULL, V103, P21, DOI 10.1093/bmb/lds020; [Anonymous], 2001, NATL BURDEN DIS STUD; Arnesen T, 1999, BMJ-BRIT MED J, V319, P1423, DOI 10.1136/bmj.319.7222.1423; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Choi KS, 2013, J KOREAN MED SCI, V28, P808, DOI 10.3346/jkms.2013.28.6.808; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; EuroQol, EQ 5D; Groce NE, 1999, LANCET, V354, P756, DOI 10.1016/S0140-6736(99)06140-1; Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4; Haagsma JA, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0020-2; Kim SH, 2016, QUAL LIFE RES; Krabbe PFM, 2014, MED CARE, V52, P935, DOI 10.1097/MLR.0000000000000178; Mansley EC, 2003, HEALTH ECON, V12, P187, DOI 10.1002/hec.707; Murray, 2002, SUMMARY MEASURES POP, P205; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Murray CJL, 1996, THE GLOBAL BURDEN OF; NORD E, 1995, MED DECIS MAKING, V15, P201, DOI 10.1177/0272989X9501500302; Nord E, 2013, HEALTH POLICY, V111, P99, DOI 10.1016/j.healthpol.2013.03.019; Osterdal LP, 2009, EUR J HEALTH ECON, V10, P429, DOI 10.1007/s10198-009-0150-9; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; Rehm J, 2010, INT J METH PSYCH RES, V19, P18, DOI 10.1002/mpr.300; Salomon J.A., 2003, HLTH SYSTEMS PERFORM, P301; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schwarzinger Michael, 2003, Popul Health Metr, V1, P9, DOI 10.1186/1478-7954-1-9; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Taylor HR, 2013, LANCET, V381, P23, DOI 10.1016/S0140-6736(12)62081-9; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Torrance GW, 2001, MED DECIS MAKING, V21, P329, DOI 10.1177/02729890122062622; Ustun TB, 1999, LANCET, V354, P111, DOI 10.1016/S0140-6736(98)07507-2; Voigt K, 2014, B WORLD HEALTH ORGAN, V92, P226, DOI 10.2471/BLT.13.126227; Whitehead SJ, 2010, BRIT MED BULL, V96, P5, DOI 10.1093/bmb/ldq033; Yoon SJ, 2000, KOREAN J PREV MED, V33, P409	36	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162478	10.1371/journal.pone.0162478	http://dx.doi.org/10.1371/journal.pone.0162478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606626	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255600049
J	Cunze, S; Kochmann, J; Koch, LK; Klimpel, S				Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Klimpel, Sven			Aedes albopictus and Its Environmental Limits in Europe	PLOS ONE			English	Article							TEMPERATURE; CULICIDAE; RAINFALL; DYNAMICS; DIPTERA	The Asian tiger mosquito Aedes albopictus, native to South East Asia, is listed as one of the worst invasive vector species worldwide. In Europe the species is currently restricted to Southern Europe, but due to the ongoing climate change, Ae. albopictus is expected to expand its potential range further northwards. In addition to modelling the habitat suitability for Ae. albopictus under current and future climatic conditions in Europe by means of the maximum entropy approach, we here focused on the drivers of the habitat suitability prediction. We explored the most limiting factors for Aedes albopictus in Europe under current and future climatic conditions, a method which has been neglected in species distribution modelling so far. Ae. albopictus is one of the best-studied mosquito species, which allowed us to evaluate the applied Maxent approach for most limiting factor mapping. We identified three key limiting factors for Ae. albopictus in Europe under current climatic conditions: winter temperature in Eastern Europe, summer temperature in Southern Europe. Model findings were in good accordance with commonly known establishment thresholds in Europe based on climate chamber experiments and derived from the geographical distribution of the species. Under future climatic conditions low winter temperature were modelled to remain the most limiting factor in Eastern Europe, whereas in Central Europe annual mean temperature and summer temperatures were modelled to be replaced by summer precipitation, respectively, as most limiting factors. Changes in the climatic conditions in terms of the identified key limiting factors will be of great relevance regarding the invasive potential of the Ae. albopictus. Thus, our results may help to understand the key drivers of the suggested range expansion under climate change and may help to improve monitoring programmes. The applied approach of investigating limiting factors has proven to yield valuable results and may also provide valuable insights into the drivers of the prediction of current and future distribution of other species. This might be particularly interesting for other vector species that are of increasing public health concerns.	[Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Klimpel, Sven] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Max von Laue Str 13, D-60438 Frankfurt, Germany; [Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Klimpel, Sven] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Senckenberganlage 25, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Cunze, S (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Max von Laue Str 13, D-60438 Frankfurt, Germany.; Cunze, S (corresponding author), Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Senckenberganlage 25, D-60325 Frankfurt, Germany.	sarahcunze@gmail.com	Kochmann, Judith/AAG-3574-2021	Koch, Lisa/0000-0002-3064-8401; Kochmann, Judith/0000-0001-6312-7859	ERA-Net BiodivERsA; Deutsche Forschungsgemeinschaft [DFG KL 2087/6-1]; Austrian Science Fund [FWF I-1437]; Agence de la Recherche, BiodivERsA call for research proposals [ANR-13-EBID-0007-01]; German Federal Ministry of Food and Agriculture BMEL through the Federal Office for Agriculture and Food BLE [2819105115]	ERA-Net BiodivERsA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Agence de la Recherche, BiodivERsA call for research proposals; German Federal Ministry of Food and Agriculture BMEL through the Federal Office for Agriculture and Food BLE	The present study was funded by the ERA-Net BiodivERsA (www.biodiversa.org/), with the national funders Deutsche Forschungsgemeinschaft (www.dfg.de/) DFG KL 2087/6-1, Austrian Science Fund (www.fwf.ac.at/en/) FWF I-1437, and Agence de la Recherche (http://www.agence-nationalerecherche.fr/) ANR-13-EBID-0007-01 as part of the 2012-13 BiodivERsA call for research proposals and by the German Federal Ministry of Food and Agriculture BMEL (www.bmel.de/) through the Federal Office for Agriculture and Food BLE (www.ble.de/), grant number 2819105115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Cunze S, 2015, ENVIRON MODELL SOFTW, V72, P250, DOI 10.1016/j.envsoft.2015.05.004; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Koch LK, 2015, PARASITOLOGY RES; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Li GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131659; Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; Pachauri R. K., 2015, CLIMATE CHANGE 2014; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Phillips S., 2004, MAXIMUM ENTROPY APPR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Schroeder Boris, 2000, Zeitschrift fuer Oekologie und Naturschutz, V8, P195; Straetemans M, 2008, EURO SURVEILLANCE B, V13; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1	28	36	39	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162116	10.1371/journal.pone.0162116	http://dx.doi.org/10.1371/journal.pone.0162116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603669	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200044
J	Zonato, V; Fedele, G; Kyriacou, CP				Zonato, Valeria; Fedele, Giorgio; Kyriacou, Charalambos P.			An Intronic Polymorphism in couch potato Is Not Distributed Clinally in European Drosophila melanogaster Populations nor Does It Affect Diapause Inducibility	PLOS ONE			English	Article							CHROMOSOME INVERSION POLYMORPHISMS; CLIMATIC ADAPTATION; LATITUDINAL CLINES; NATURAL-SELECTION; LIFE-HISTORY; GENE; EXPRESSION; ASSOCIATIONS; ALLELES; TRAITS	couch potato (cpo) encodes an RNA binding protein that has been reported to be expressed in the peripheral and central nervous system of embryos, larvae and adults, including the major endocrine organ, the ring gland. A polymorphism in the D. melanogaster cpo gene coding region displays a latitudinal cline in frequency in North American populations, but as cpo lies within the inversion In(3R)Payne, which is at high frequencies and itself shows a strong cline on this continent, interpretation of the cpo cline is not straightforward. A second downstream SNP in strong linkage disequilibrium with the first has been claimed to be primarily responsible for the latitudinal cline in diapause incidence in USA populations. Here, we investigate the frequencies of these two cpo SNPs in populations of Drosophila throughout continental Europe. The advantage of studying cpo variation in Europe is the very low frequency of In(3R)Payne, which we reveal here, does not appear to be clinally distributed. We observe a very different geographical scenario for cpo variation from the one in North America, suggesting that the downstream SNP does not play a role in diapause. In an attempt to verify whether the SNPs influence diapause we subsequently generated lines with different combinations of the two cpo SNPs on known timeless (tim) genetic backgrounds, because polymorphism in the clock gene tim plays a significant role in diapause inducibility. Our results reveal that the downstream cpo SNP does not seem to play any role in diapause induction in European populations in contrast to the upstream coding cpo SNP. Consequently, all future diapause studies on strains of D. melanogaster should initially determine their tim and cpo status.	[Zonato, Valeria; Fedele, Giorgio; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England	University of Leicester	Kyriacou, CP (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cpk@leicester.ac.uk	Fedele, Giorgio/ABE-3247-2020	Fedele, Giorgio/0000-0002-9878-0070	European Commission (6th Framework, EUCLOCK) [018741]; Marie Curie ITN INsec TIME [316790]; BBSRC; Erasmus studentship	European Commission (6th Framework, EUCLOCK); Marie Curie ITN INsec TIME; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Erasmus studentship	CPK gratefully acknowledges BBSRC for studentship and the European Commission (6th Framework, EUCLOCK grant no 018741 and Marie Curie ITN INsec TIME grant no 316790), which supported VZ. GF was supported by an Erasmus studentship.	Anderson AR, 2005, MOL ECOL, V14, P851, DOI 10.1111/j.1365-294X.2005.02445.x; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1992, GENETICS, V131, P365; Cogni R, 2014, EVOLUTION, V68, P538, DOI 10.1111/evo.12291; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Glasscock E, 2005, GENETICS, V169, P2137, DOI 10.1534/genetics.104.028357; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harvie PD, 1998, GENETICS, V149, P217; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; HUDSON RR, 1987, GENETICS, V116, P153; Kankare M, 2011, J INSECT PHYSL; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; King R. C., 1970, Int. Rev. Cytol., V28, P125, DOI 10.1016/S0074-7696(08)62542-5; KNIBB WR, 1981, GENETICS, V98, P833; KNIBB WR, 1982, GENETICA, V58, P213, DOI 10.1007/BF00128015; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Lee SF, 2011, MOL ECOL, V20, P2973, DOI 10.1111/j.1365-294X.2011.05155.x; Li H, 2004, BIOINFORMATICS; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Q, 1997, GENOME RES, V7, P389, DOI 10.1101/gr.7.4.389; Machado HE, 2016, MOL ECOL; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Paaby AB, 2010, MOL ECOL, V19, P760, DOI 10.1111/j.1365-294X.2009.04508.x; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Salminen TS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11197; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Sezgin E, 2004, GENETICS, V168, P923, DOI 10.1534/genetics.104.027649; TAJIMA F, 1989, GENETICS, V123, P585; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Teets NM, 2008, AM J PHYSIOL-REG I, V294, pR1938, DOI 10.1152/ajpregu.00459.2007; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Williams KD, 1993, DIAPAUSE DROSOPHILA; Zhang Q, 2011, J INSECT PHYSL; Zhao XQ, 2016, MOL BIOL EVOL, V33, P707, DOI 10.1093/molbev/msv263	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162370	10.1371/journal.pone.0162370	http://dx.doi.org/10.1371/journal.pone.0162370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598401	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800059
J	Dashper, SG; Catmull, DV; Liu, SW; Myroforidis, H; Zalizniak, I; Palamara, JEA; Huq, NL; Reynolds, EC				Dashper, Stuart G.; Catmull, Deanne V.; Liu, Sze-Wei; Myroforidis, Helen; Zalizniak, Ilya; Palamara, Joseph E. A.; Huq, N. Laila; Reynolds, Eric C.			Casein Phosphopeptide-Amorphous Calcium Phosphate Reduces Streptococcus mutans Biofilm Development on Glass Ionomer Cement and Disrupts Established Biofilms	PLOS ONE			English	Article							ENAMEL SUBSURFACE LESIONS; FREE CHEWING GUM; CPP-ACP AGENT; IN-SITU; REMINERALIZATION; NANOCOMPLEXES; DENTISTRY; FLUORIDE; MERCURY; CARIES	Glass ionomer cements (GIC) are dental restorative materials that are suitable for modification to help prevent dental plaque (biofilm) formation. The aim of this study was to determine the effects of incorporating casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) into a GIC on the colonisation and establishment of Streptococcus mutans biofilms and the effects of aqueous CPP-ACP on established S mutans biofilms. S. mutans biofilms were either established in flow cells before a single ten min exposure to 1% w/v CPP-ACP treatment or cultured in static wells or flow cells with either GIC or GIC containing 3% w/w CPP-ACP as the substratum. The biofilms were then visualised using confocal laser scanning microscopy after BacLight LIVE/DEAD staining. A significant decrease in biovolume and average thickness of S. mutans biofilms was observed in both static and flow cell assays when 3% CPP-ACP was incorporated into the GIC substratum. A single ten min treatment with aqueous 1% CPP-ACP resulted in a 58% decrease in biofilm biomass and thickness of established S. mutans biofilms grown in a flow cell. The treatment also significantly altered the structure of these biofilms compared with controls. The incorporation of 3% CPP-ACP into GIC significantly reduced S. mutans biofilm development indicating another potential anticariogenic mechanism of this material. Additionally aqueous CPP-ACP disrupted established S. mutans biofilms. The use of CPP-ACP containing GIC combined with regular CPP-ACP treatment may lower S. mutans challenge.	[Dashper, Stuart G.; Catmull, Deanne V.; Liu, Sze-Wei; Myroforidis, Helen; Zalizniak, Ilya; Palamara, Joseph E. A.; Huq, N. Laila; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu	Huq, Laila/A-2861-2012	Huq, Laila/0000-0001-7788-4797; Dashper, Stuart/0000-0003-0106-8691; Rahma, Indah/0000-0002-6855-1146	Australian Government, Department of Industry, Innovation and Science [20080108]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Supported by the Australian Government, Department of Industry, Innovation and Science. Grant ID 20080108. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zraikat H, 2011, DENT MATER, V27, P235, DOI 10.1016/j.dental.2010.10.008; Allaker RP, 2010, J DENT RES, V89, P1175, DOI 10.1177/0022034510377794; Beyth N, 2008, DENT MATER, V24, P732, DOI 10.1016/j.dental.2007.08.003; Brownawell Amy M, 2005, Toxicol Rev, V24, P1, DOI 10.2165/00139709-200524010-00001; Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644; Cai F, 2003, AUST DENT J, V48, P240, DOI 10.1111/j.1834-7819.2003.tb00037.x; CATE JMT, 1995, J DENT RES, V74, P1266; Cochrane NJ, 2008, CARIES RES, V42, P88, DOI 10.1159/000113161; Cochrane NJ, 2012, CARIES RES, V46, P147, DOI 10.1159/000337240; Cross KJ, 2016, BIOCHEMISTRY-US, V55, P4316, DOI 10.1021/acs.biochem.6b00522; Dashper SG, 2013, J DENT, V41, P521, DOI 10.1016/j.jdent.2013.03.010; Emamieh Shila, 2015, J Conserv Dent, V18, P192, DOI 10.4103/0972-0707.157240; Forsten L, 1998, BIOMATERIALS, V19, P503, DOI 10.1016/S0142-9612(97)00130-0; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Luczaj-Cepowicz E, 2014, POSTEP HIG MED DOSW, V68, P23, DOI 10.5604/17322693.1086069; Mackert JR, 1997, CRIT REV ORAL BIOL M, V8, P410, DOI 10.1177/10454411970080040401; Magos L, 2006, ANN CLIN BIOCHEM, V43, P257, DOI 10.1258/000456306777695654; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mazzaoui SA, 2003, J DENT RES, V82, P914, DOI 10.1177/154405910308201113; McCabe JF, 2009, DENT MATER J, V28, P37; Milnar FJ, 2007, COMPEND CONTIN ED DE, V28, P238; Milnar Frank J, 2007, Compend Contin Educ Dent, V28, P234; Morgan MV, 2008, CARIES RES, V42, P171, DOI 10.1159/000128561; Nongonierma AB, 2012, CARIES RES, V46, P234, DOI 10.1159/000338381; Okada K, 2001, DENT MATER, V17, P34, DOI 10.1016/S0109-5641(00)00053-1; Oshiro Maki, 2007, J Oral Sci, V49, P115, DOI 10.2334/josnusd.49.115; Peric T, 2015, CLIN ORAL INVEST, V13, P1; Plonka KA, 2013, PEDIAT DENT, V35, p8E; Rahiotis C, 2008, J DENT, V36, P272, DOI 10.1016/j.jdent.2008.01.005; Rahiotis C, 2007, J DENT, V35, P695, DOI 10.1016/j.jdent.2007.05.008; Reynolds E C, 1998, Spec Care Dentist, V18, P8, DOI 10.1111/j.1754-4505.1998.tb01353.x; Reynolds EC, 1997, J DENT RES, V76, P1587, DOI 10.1177/00220345970760091101; Reynolds EC, 2003, J DENT RES, V82, P206, DOI 10.1177/154405910308200311; Rose RK, 2000, CARIES RES, V34, P427, DOI 10.1159/000016618; Rose RK, 2000, ARCH ORAL BIOL, V45, P569, DOI 10.1016/S0003-9969(00)00017-0; Paiva LFS, 2014, BRAZ ORAL RES, V28, P266, DOI 10.1590/1807-3107BOR-2014.vol28.0034; Schupbach P, 1996, J DENT RES, V75, P1779, DOI 10.1177/00220345960750101101; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shen P, 2001, J DENT RES, V80, P2066, DOI 10.1177/00220345010800120801; Sousa RP, 2009, J DENT, V37, P44, DOI 10.1016/j.jdent.2008.08.009; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; WILSON AD, 1972, BRIT DENT J, V132, P133, DOI 10.1038/sj.bdj.4802810; Xie D, 2011, DENT MATER, V27, P487, DOI 10.1016/j.dental.2011.02.006; Yamaguchi K, 2006, J DENT, V34, P230, DOI 10.1016/j.jdent.2005.06.005	45	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162322	10.1371/journal.pone.0162322	http://dx.doi.org/10.1371/journal.pone.0162322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589264	Green Published, gold			2022-12-27	WOS:000382877800049
J	Twardziok, M; Kleinsimon, S; Rolff, J; Jager, S; Eggert, A; Seifert, G; Delebinski, CI				Twardziok, Monika; Kleinsimon, Susann; Rolff, Jana; Jaeger, Sebastian; Eggert, Angelika; Seifert, Georg; Delebinski, Catharina I.			Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma	PLOS ONE			English	Article							ACID INDUCE APOPTOSIS; X-LINKED INHIBITOR; OLEANOLIC ACID; BETULINIC ACID; IN-VIVO; OSTEOSARCOMA CELLS; MISTLETOE EXTRACT; DRUG-COMBINATIONS; NATURAL-PRODUCTS; LUNG-CANCER	Ewing sarcoma is the second most common bone cancer in children and adolescents, with poor prognosis and outcome in similar to 70% of initial diagnoses and 10-15% of relapses. Hydrophobic triterpene acids and hydrophilic lectins and viscotoxins from European mistletoe (Viscum album L.) demonstrate anticancer properties, but have not yet been investigated for Ewing sarcoma. Commercial Viscum album L. extracts are aqueous, excluding the insoluble triterpenes. We recreated a total mistletoe effect by combining an aqueous extract (viscum) and a triterpene extract (TT) solubilized with cyclodextrins. Ewing sarcoma cells were treated with viscum, TT and viscumTT in vitro, ex vivo and in vivo. In vitro and ex vivo treatment of Ewing sarcoma cells with viscum inhibited proliferation and induced apoptosis in a dose-dependent fashion, while viscumTT combination treatment generated a synergistic effect. Apoptosis occurred via intrinsic and extrinsic apoptotic pathways, evidenced by activation of both CASP8 and CASP9. We show that viscumTT treatment shifts the balance of apoptotic regulatory proteins towards apoptosis, mainly via CLSPN, MCL1, BIRC5 and XIAP downregulation. ViscumTT also demonstrated strong antitumor activity in a cell line- and patient-derived mouse model, and may be considered an adjuvant therapy option for pediatric patients with Ewing sarcoma.	[Twardziok, Monika; Kleinsimon, Susann; Eggert, Angelika; Seifert, Georg; Delebinski, Catharina I.] Univ Med Berlin, Charite, Otto Heubner Ctr Pediat & Adolescent Med OHC, Dept Pediat Oncol Hematol, Berlin, Germany; [Twardziok, Monika] Free Univ Berlin, Inst Pharm, Dept Biol, Chem,Pharm, Berlin, Germany; [Rolff, Jana] EPO GmbH, Expt Pharmacol & Oncol, Berlin, Germany; [Jaeger, Sebastian] Birken AG, Niefern Oschelbronn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Seifert, G (corresponding author), Univ Med Berlin, Charite, Otto Heubner Ctr Pediat & Adolescent Med OHC, Dept Pediat Oncol Hematol, Berlin, Germany.	georg.seifert@charite.de	Eggert, Angelika/AAE-6907-2022	Eggert, Angelika/0000-0003-3476-8184; Delebinski, Catharina/0000-0003-2527-4385	Software AG-Stiftung (Darmstadt, Germany); Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag; EPO GmbH; Birken AG	Software AG-Stiftung (Darmstadt, Germany); Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag; EPO GmbH; Birken AG	This work was supported by the Software AG-Stiftung (Darmstadt, Germany) and the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag. EPO GmbH and Birken AG provided support in the form of salaries for authors JR and SJ respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Software AG-Stiftung (Darmstadt, Germany) and the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag. EPO GmbH and Birken AG provided support in the form of salaries for authors JR and SJ respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank K. Astrahantseff for comments on and editing of the manuscript.	Akl MR, 2014, EUR J PHARMACOL, V740, P209, DOI 10.1016/j.ejphar.2014.07.011; Amer B, 2013, PHARM BIOL, V51, P981, DOI 10.3109/13880209.2013.773520; Bache M, 2014, INT J MOL SCI, V15, P19777, DOI 10.3390/ijms151119777; Bantel H, 1999, CANCER RES, V59, P2083; Braun JM, 2002, ANTICANCER RES, V22, P4187; Bussing A, 1998, CANCER LETT, V130, P57, DOI 10.1016/S0304-3835(98)00124-4; Chakravarti B, 2012, J ETHNOPHARMACOL, V142, P72, DOI 10.1016/j.jep.2012.04.015; Choi SH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-211; Coumar MS, 2013, CANCER TREAT REV, V39, P802, DOI 10.1016/j.ctrv.2013.02.002; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Decaudin D, 1998, INT J ONCOL, V12, P141; Delebinski CI, 2012, CELL PROLIFERAT, V45, P176, DOI 10.1111/j.1365-2184.2011.00801.x; Delebinski CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133892; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P681, DOI 10.1007/s00280-008-0785-8; Ehrhardt H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.53; FOUNGBE S, 1991, J ETHNOPHARMACOL, V33, P221, DOI 10.1016/0378-8741(91)90080-W; Frantz M, 2000, ARZNEIMITTEL-FORSCH, V50, P471; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Fulda S, 1999, KLIN PADIATR, V211, P319, DOI 10.1055/s-2008-1043808; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greve B, 2012, STRAHLENTHER ONKOL, V188, P1038, DOI 10.1007/s00066-012-0223-z; He XJ, 2012, J AGR FOOD CHEM, V60, P9430, DOI 10.1021/jf3026925; Hingorani P, 2013, PEDIATR BLOOD CANCER, V60, P35, DOI 10.1002/pbc.24290; Hua YQ, 2011, INVEST NEW DRUG, V29, P258, DOI 10.1007/s10637-009-9354-1; Huber R, 2010, EUR J CLIN PHARMACOL, V66, P889, DOI 10.1007/s00228-010-0830-5; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; JUNG ML, 1990, CANCER LETT, V51, P103, DOI 10.1016/0304-3835(90)90044-X; Kaatsch P. S. C., 2014, GERMAN CHILDHOOD CAN; Kashkar H, 2010, CLIN CANCER RES, V16, P4496, DOI 10.1158/1078-0432.CCR-10-1664; Kim MS, 2000, GEN PHARMACOL-VASC S, V34, P349, DOI 10.1016/S0306-3623(01)00072-6; Klingbeil MFG, 2013, ONCOL REP, V30, P2316, DOI 10.3892/or.2013.2732; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Leal AS, 2013, ORG BIOMOL CHEM, V11, P1726, DOI 10.1039/c3ob00011g; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Lin Patrick P., 2011, Sarcoma, V2011, P276463, DOI 10.1155/2011/276463; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Lucio KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028596; Mackintosh Carlos, 2013, Recent Pat Biotechnol, V7, P98; Maletzki C, 2013, CANCER IMMUNOL IMMUN, V62, P1283, DOI 10.1007/s00262-013-1455-1; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; Nhiem NX, 2013, J NAT PROD, V76, P495, DOI 10.1021/np300490v; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Orhan DD, 2006, Z NATURFORSCH C, V61, P26; Park YK, 2012, ONCOL REP, V28, P2227, DOI 10.3892/or.2012.2026; Paronetto MP, 2013, INT J CELL BIOL, V2013, P12; Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018; Ryu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-187; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Shyu MH, 2010, J AGR FOOD CHEM, V58, P6110, DOI 10.1021/jf100574j; Society AC, 2014, AM CANC SOC CANC FAC; Soica C, 2014, MOLECULES, V19, P4924, DOI 10.3390/molecules19044924; Stahl M, 2011, PEDIATR BLOOD CANCER, V57, P549, DOI 10.1002/pbc.23040; Struh CM, 2012, PHYTOTHER RES, V26, P1507, DOI 10.1002/ptr.4604; Struh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062168; Amaral AT, 2014, ADV ANAT PATHOL, V21, P44, DOI 10.1097/PAP.0000000000000003; Timoshenko AV, 2000, BIOSCIENCE REP, V20, P199, DOI 10.1023/A:1005519603863; Ucar EO, 2012, GENET MOL RES, V11, P2801, DOI 10.4238/2012.August.24.5; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; von Schoen-Angerer T, 2014, J GASTROINTEST LIVER, V23, P449, DOI 10.15403/jgld.2014.1121.234.acpy; Wei JT, 2013, J APPL TOXICOL, V33, P756, DOI 10.1002/jat.2725; Yan SL, 2010, TOXICOL IN VITRO, V24, P842, DOI 10.1016/j.tiv.2009.12.008; Yang XL, 2012, MOLECULES, V17, P11435, DOI 10.3390/molecules171011435	67	21	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0159749	10.1371/journal.pone.0159749	http://dx.doi.org/10.1371/journal.pone.0159749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589063	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800002
J	Asencio-Hernandez, J; Kieffer, B; Delsuc, MA				Asencio-Hernandez, Julia; Kieffer, Bruno; Delsuc, Marc-Andre			NMR WaterLOGSY Reveals Weak Binding of Bisphenol A with Amyloid Fibers of a Conserved 11 Residue Peptide from Androgen Receptor	PLOS ONE			English	Article							PROSTATE-CANCER; DISEASE; DOMAIN; AGGREGATION; DISCOVERY; TERMINUS; PROTEINS; ESTROGEN; AFFINITY; HEALTH	There is growing evidence that bisphenol A (BPA), a molecule largely released in the environment, has detrimental effects on ecosystems and on human health. It acts as an endocrine disruptor targeting steroid hormone receptors, such as the estrogen receptor (ER), estrogen-related receptor (ERR) and androgen receptor (AR). BPA-derived molecules have recently been shown to interact with the AR N-terminal domain (AR-NTD), which is known to be largely intrinsically disordered. This N-terminal domain contains an 11 residue conserved domain that forms amyloid fibers upon oxidative dimerisation through its strictly conserved Cys240 residue. We investigate here the interaction of BPA, and other potential endocrine disruptors, with AR-NTD amyloid fibers using the WaterLOGSY NMR experiment. We observed a selective binding of these compounds to the amyloid fibers formed by the AR-NTD conserved region and glutamine homopolymers. This observation suggests that the high potency of endocrine disruptors may result, in part, from their ability to bind amyloid forms of nuclear receptors in addition to their cognate binding sites. This property may be exploited to design future therapeutic strategies targeting AR related diseases such as the spinal bulbar muscular atrophy or prostate cancer. The ability of NMR WaterLOGSY experiments to detect weak interactions between small ligands and amyloid fibers may prove to be of particular interest for identifying promising hit molecules.	[Asencio-Hernandez, Julia; Kieffer, Bruno; Delsuc, Marc-Andre] Univ Strasbourg, IGBMC, INSERM U596, CNRS UMR 7104, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Delsuc, MA (corresponding author), Univ Strasbourg, IGBMC, INSERM U596, CNRS UMR 7104, Illkirch Graffenstaden, France.	madelsuc@unistra.fr	Delsuc, Marc-André/ABI-5400-2020; Kieffer, Bruno/AAE-8999-2019	Delsuc, Marc-André/0000-0002-1400-5326; Asencio-Hernandez, Julia/0000-0002-8921-2805	European ITN "ReAD" Network, The ANR program blanc "ARIA"; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); European ITN "ReAD" Network	European ITN "ReAD" Network, The ANR program blanc "ARIA"(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI); European ITN "ReAD" Network	This work was supported by The European ITN "ReAD" Network, The ANR program blanc2013 "ARIA". The French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European ITN "ReAD" Network, and the ANR program blanc2013 "ARIA". Part of this work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01, and by Instruct part of the European Strategy Forum on Research Infrastructures (ESFRI) and through national member agreements. JAH thanks the European ITN "ReAD" Network for support. We thank Pascal Eberling for the peptides synthesis and Fabrice Klein for providing Q41 fibers. We thank Roland H. Stote for critical reading of the manuscript, as well as the editor Paul C. Driscoll and the anonymous reviewer for their valuable comments.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Andrushchenko VV, 2007, J PEPT SCI, V13, P37, DOI 10.1002/psc.793; Antanasijevic A, 2014, J BIOMOL NMR, V60, P37, DOI 10.1007/s10858-014-9848-9; Asencio-Hernandez J, 2014, CHEMBIOCHEM, V15, P2370, DOI 10.1002/cbic.201402420; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; BELSHAM DD, 1992, J NEUROL SCI, V112, P133, DOI 10.1016/0022-510X(92)90142-8; Bergerat JP, 2009, HUM MUTAT; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; Davranche A, 2011, HUM MOL GENET, V20, P2795, DOI 10.1093/hmg/ddr178; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fichou Y, 2015, P NATL ACAD SCI USA, V112, P6365, DOI 10.1073/pnas.1422824112; Francioso A, 2015, BIOORGAN MED CHEM, V23, P1671, DOI 10.1016/j.bmc.2015.02.041; Godbole AM, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/918707; Jochum T, 2012, BBA-MOL BASIS DIS, V1822, P1070, DOI 10.1016/j.bbadis.2012.02.006; Kohler C, 2015, METHODS MOL BIOL, V1286, P279, DOI 10.1007/978-1-4939-2447-9_22; Kumar R, 2011, LIFE SCI, V88, P565, DOI 10.1016/j.lfs.2011.01.021; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; McEwan IJ, 2012, MOL BIOSYST, V8, P82, DOI 10.1039/c1mb05249g; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Paris F, 2002, MOL CELL ENDOCRINOL, V193, P43, DOI 10.1016/S0303-7207(02)00094-1; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Sledz P, 2012, LIGAND OBSERVED NMR; Srivastava S, 2015, J ENVIRON HEALTH, V77, P20; Stockman BJ, 2002, PROG NUCL MAG RES SP, V41, P187, DOI 10.1016/S0079-6565(02)00049-3; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Tan M H Eileen, 2015, Acta Pharmacol Sin, V36, P3, DOI 10.1038/aps.2014.18; Wan W, 2014, BIOCHEMISTRY-US, V53, P2366, DOI 10.1021/bi5002807; Zhang HY, 2007, TRENDS FOOD SCI TECH, V18, P492, DOI 10.1016/j.tifs.2007.04.008	31	5	5	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161948	10.1371/journal.pone.0161948	http://dx.doi.org/10.1371/journal.pone.0161948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583469	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600077
J	Boegemann, M; Schlack, K; Fischer, AK; Gerss, J; Steinestel, J; Semjonow, A; Schrader, AJ; Krabbe, LM				Boegemann, Martin; Schlack, Katrin; Fischer, Ann-Kathrin; Gerss, Joachim; Steinestel, Julie; Semjonow, Axel; Schrader, Andres Jan; Krabbe, Laura-Maria			Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate	PLOS ONE			English	Article							BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; ANDROGEN DEPRIVATION; INCREASED EXPRESSION; CLINICAL-TRIALS; RISK; TESTOSTERONE; METAANALYSIS; SLCO2B1; PROGRESSION	Objective Even though the exact mechanism is largely unknown until now, statins are supposed to improve survival outcomes in various malignancies. For prostate cancer however, statins are known to compete with dehydroepiandrosterone (DHEAS) for the transport into the cytosol both using the cell by the Solute Carrier Transporter and thus diminish the cellular uptake of DHEAS as a precursor of androgens. Abiraterone inhibits CYP17A1 and thus effectively decreases the production of all relevant androgens including DHEAS. In this study we examined whether statins still affect survival outcome in patients with metastatic castration resistant prostate cancer (mCRPC) when treated with Abiraterone. Patients and Methods 108 men with mCRPC treated with Abiraterone from 02/2010 to 07/2015 with (n = 21) or without (n = 87) concomitant treatment with statins were investigated. Progression free survival (PFS) and overall survival (OS) were analyzed using Kaplan-Meier-estimates and univariate Cox-regression analysis. The influence on best clinical benefit under Abiraterone treatment was analyzed with bivariate and multivariate logistic regression analysis. Results PSA-decline >= 50% was not significantly different in both groups (57 vs. 53%; p = 0.73). The median PFS (9 vs. 10 months; p = 0.97) and OS (14 vs. 18 months; p = 0.77) did not differ significantly between those men treated with and without concomitant statin therapy, respectively. Accordingly, there was no improvement for best clinical benefit in patients using statins (odds ratio: 1.2 (CI: 0.4-4.2); p = 0.76). Conclusion Use of statins as concomitant medication did not improve survival outcomes or best clinical benefit in men with mCRPC treated with Abiraterone.	[Boegemann, Martin; Schlack, Katrin; Fischer, Ann-Kathrin; Steinestel, Julie; Semjonow, Axel; Schrader, Andres Jan; Krabbe, Laura-Maria] Muenster Univ, Med Ctr, Dept Urol, Munster, Germany; [Gerss, Joachim] Univ Munster, Inst Biostat & Clin Res, Schmeddingstr 56, D-48149 Munster, Germany; [Krabbe, Laura-Maria] Univ Texas Southwestern Med Ctr, Dept Urol, Dallas, TX USA	University of Munster; University of Munster; University of Texas System; University of Texas Southwestern Medical Center Dallas	Boegemann, M (corresponding author), Muenster Univ, Med Ctr, Dept Urol, Munster, Germany.	martin.boegemann@ukmuenster.de	Gerß, Joachim WO/B-5702-2013					Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Azad AA, 2015, CLIN CANCER RES, V21, P2315, DOI 10.1158/1078-0432.CCR-14-2666; Bansal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046691; Bonovas S, 2008, INT J CANCER, V123, P899, DOI 10.1002/ijc.23550; Bremmer F, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-574; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Chang SL, 2010, J CLIN ONCOL, V28, P3951, DOI 10.1200/JCO.2009.27.9406; Chen EJ, 2015, CLIN CANCER RES, V21, P1273, DOI 10.1158/1078-0432.CCR-14-1220; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fujimoto N, 2013, PROSTATE CANCER P D, V16, P336, DOI 10.1038/pcan.2013.23; Graaf MR, 2004, CANCER TREAT REV, V30, P609, DOI 10.1016/j.ctrv.2004.06.010; Hamilton RJ, 2010, CANCER-AM CANCER SOC, V116, P3389, DOI 10.1002/cncr.25308; Harshman LC, 2015, JAMA ONCOL, V1, P495, DOI 10.1001/jamaoncol.2015.0829; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Murtola TJ, 2009, PROSTATE, V69, P1017, DOI 10.1002/pros.20951; Park HS, 2013, ANN ONCOL, V24, P1427, DOI 10.1093/annonc/mdt077; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Pressler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020372; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Scosyrev E, 2013, BJU INT, V111, pE71, DOI 10.1111/j.1464-410X.2012.11527.x; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Wright JL, 2011, CANCER EPIDEM BIOMAR, V20, P619, DOI 10.1158/1055-9965.EPI-10-1023; Yang M, 2011, J CLIN ONCOL, V29, P2565, DOI 10.1200/JCO.2010.31.2405	28	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161959	10.1371/journal.pone.0161959	http://dx.doi.org/10.1371/journal.pone.0161959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583544	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600078
J	Costa, T; Boccignone, G; Cauda, F; Ferraro, M				Costa, Tommaso; Boccignone, Giuseppe; Cauda, Franco; Ferraro, Mario			The Foraging Brain: Evidence of Levy Dynamics in Brain Networks	PLOS ONE			English	Article							EXTERNAL FORCE-FIELDS; ANOMALOUS DIFFUSION; RESTING-STATE; RANDOM-WALKS; MODELS; SIGNAL; DISTRIBUTIONS; FLUCTUATIONS; VARIABILITY; PATTERNS	In this research we have analyzed functional magnetic resonance imaging (fMRI) signals of different networks in the brain under resting state condition. To such end, the dynamics of signal variation, have been conceived as a stochastic motion, namely it has been modelled through a generalized Langevin stochastic differential equation, which combines a deterministic drift component with a stochastic component where the Gaussian noise source has been replaced with a-stable noise. The parameters of the deterministic and stochastic parts of the model have been fitted from fluctuating data. Results show that the deterministic part is characterized by a simple, linear decreasing trend, and, most important, the a-stable noise, at varying characteristic index a, is the source of a spectrum of activity modes across the networks, from those originated by classic Gaussian noise (a = 2), to longer tailed behaviors generated by the more general Levy noise (1 <= a < 2). Levy motion is a specific instance of scale-free behavior, it is a source of anomalous diffusion and it has been related to many aspects of human cognition, such as information foraging through memory retrieval or visual exploration. Finally, some conclusions have been drawn on the functional significance of the dynamics corresponding to different a values.	[Costa, Tommaso; Cauda, Franco] Univ Turin, Dept Psychol, Focus Lab, Turin, Italy; [Costa, Tommaso; Cauda, Franco] Koelliker Hosp, GCS FMRI, Turin, Italy; [Boccignone, Giuseppe] Univ Milan, Dept Comp Sci, PHuSe Lab, Milan, Italy; [Ferraro, Mario] Univ Turin, Dept Phys, Turin, Italy	University of Turin; University of Milan; University of Turin	Cauda, F (corresponding author), Univ Turin, Dept Psychol, Focus Lab, Turin, Italy.; Cauda, F (corresponding author), Koelliker Hosp, GCS FMRI, Turin, Italy.	franco.cauda@unito.it	Boccignone, Giuseppe/AAH-4459-2020; Boccignone, Giuseppe/G-7542-2012; Cauda, Franco/G-5021-2010	Boccignone, Giuseppe/0000-0002-5572-0924; Boccignone, Giuseppe/0000-0002-5572-0924; Cauda, Franco/0000-0003-1526-8475				Anderson T.W., 1952, ANN MATH STAT, V23, P193, DOI [DOI 10.1214/A0MS/1177729437, 10.1214/aoms/1177729437, DOI 10.1214/AOMS/1177729437]; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bergstrom H., 1952, ARK MAT, V2, P375; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; Boccignone G, 2004, PHYSICA A, V331, P207, DOI 10.1016/j.physa.2003.09.011; Boccignone G, 2014, IEEE T CYBERNETICS, V44, P266, DOI 10.1109/TCYB.2013.2253460; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2002, CHEM PHYS, V284, P409, DOI 10.1016/S0301-0104(02)00671-7; Brockmann D, 2000, NEUROCOMPUTING, V32, P643, DOI 10.1016/S0925-2312(00)00227-7; CAPOCELLI RM, 1971, KYBERNETIK, V8, P214, DOI 10.1007/BF00288750; CHAMBERS JM, 1976, J AM STAT ASSOC, V71, P340, DOI 10.2307/2285309; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DARLING DA, 1957, ANN MATH STAT, V28, P823, DOI 10.1214/aoms/1177706788; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dubkov AA, 2008, INT J BIFURCAT CHAOS, V18, P2649, DOI 10.1142/S0218127408021877; Engmann S, 2011, JAQM, V6, P1; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2009, SCIENCE, V326, P399, DOI 10.1126/science.1174521; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GERSTEIN GL, 1964, BIOPHYS J, V4, P41, DOI 10.1016/S0006-3495(64)86768-0; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Guitart-Masip M, 2015, CEREB CORTEX; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Hills TT, 2006, COGNITIVE SCI, V30, P3, DOI 10.1207/s15516709cog0000_50; Janssen HK, 1999, EUR PHYS J B, V7, P137, DOI 10.1007/s100510050596; Jespersen S, 1999, PHYS REV E, V59, P2736, DOI 10.1103/PhysRevE.59.2736; KOUTROUVELIS IA, 1981, COMMUN STAT B-SIMUL, V10, P17, DOI 10.1080/03610918108812189; Linaro D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001102; Marlow CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139379; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mendez V., 2013, STOCHASTIC FDN MOVEM; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Nolan J., 1997, COMMUN STAT STOCHAST, V13, P759, DOI [10.1080/15326349708807450, DOI 10.1080/15326349708807450]; Olshausen BA, 1996, NETWORK-COMP NEURAL, V7, P333, DOI 10.1088/0954-898X/7/2/014; Papo D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00112; Pereira Francisco, 2009, Neuroimage, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Posadas A, 2002, J SEISMOL, V6, P61, DOI 10.1023/A:1014203530032; Rhodes T, 2007, PHYSICA A, V385, P255, DOI 10.1016/j.physa.2007.07.001; Risken H., 1989, SPRINGER SERIES SYNE, V18; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Scafetta N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.031906; Siegert S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041107; TSALLIS C, 1995, PHYS REV LETT, V75, P3589, DOI 10.1103/PhysRevLett.75.3589; van Kampen N.G., 2001, STOCHASTIC PROCESSES; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; West BJ, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00001; Wilson H.R., 1999, SPIKES DECISIONS ACT; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161702	10.1371/journal.pone.0161702	http://dx.doi.org/10.1371/journal.pone.0161702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583679	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600051
J	Fan, YR; Huang, TZ; Liu, J; Zhao, XL				Fan, Ya-Ru; Huang, Ting-Zhu; Liu, Jun; Zhao, Xi-Le			Compressive Sensing via Nonlocal Smoothed Rank Function	PLOS ONE			English	Article							ALTERNATING DIRECTION METHOD; IMAGE-RESTORATION; THRESHOLDING ALGORITHM; SIGNAL RECONSTRUCTION; MATRIX COMPLETION; SPARSITY; REGULARIZATION; MINIMIZATION; DECOMPOSITION; OPTIMIZATION	Compressive sensing (CS) theory asserts that we can reconstruct signals and images with only a small number of samples or measurements. Recent works exploiting the nonlocal similarity have led to better results in various CS studies. To better exploit the nonlocal similarity, in this paper, we propose a non-convex smoothed rank function based model for CS image reconstruction. We also propose an efficient alternating minimization method to solve the proposed model, which reduces a difficult and coupled problem to two tractable subproblems. Experimental results have shown that the proposed method performs better than several existing state-of-the-art CS methods for image reconstruction.	[Fan, Ya-Ru; Huang, Ting-Zhu; Zhao, Xi-Le] Univ Elect Sci & Technol, Sch Math Sci, Res Ctr Image & Vis Comp, Chengdu 611731, Sichuan, Peoples R China; [Liu, Jun] Northeast Normal Univ, Sch Math & Stat, Changchun 130024, Jilin, Peoples R China	University of Electronic Science & Technology of China; Northeast Normal University - China	Huang, TZ (corresponding author), Univ Elect Sci & Technol, Sch Math Sci, Res Ctr Image & Vis Comp, Chengdu 611731, Sichuan, Peoples R China.	tingzhuhuang@126.com		Huang, Ting-Zhu/0000-0001-7766-230X	973 Program [2013CB329404]; National Science Foundation of China (NSFC) [61370147, 61402082]; Fundamental Research Funds for the Central Universities [ZYGX2013Z005, ZYGX2013J106]	973 Program(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the 973 Program (2013CB329404), National Science Foundation of China (NSFC) (61370147, 61402082), the Fundamental Research Funds for the Central Universities (ZYGX2013Z005, ZYGX2013J106).	Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Buades A, 2005, INT CONF ACOUST SPEE, P25; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300; Chen C, 2015, IEEE T IMAGE PROCESS, V24, P33, DOI 10.1109/TIP.2014.2369953; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Deng LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141199; Deng W, 2013, SPIE OPTICAL ENG APP, P88580; Dong WS, 2014, IEEE T IMAGE PROCESS, V23, P3618, DOI 10.1109/TIP.2014.2329449; Dong WS, 2012, SIGNAL PROCESS-IMAGE, V27, P1109, DOI 10.1016/j.image.2012.09.003; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; DONY RD, 1995, P IEEE, V83, P288, DOI 10.1109/5.364461; Du Q, 2007, IEEE GEOSCI REMOTE S, V4, P201, DOI 10.1109/LGRS.2006.888109; Egiazarian K, 2007, IEEE IMAGE PROC, P549; Gehm ME, 2007, OPT EXPRESS, V15, P14013, DOI 10.1364/OE.15.014013; Ghasemi H, 2011, INT CONF ACOUST SPEE, P3672; Gu SH, 2014, PROC CVPR IEEE, P2862, DOI 10.1109/CVPR.2014.366; Han DR, 2015, J MATH IMAGING VIS, V51, P145, DOI 10.1007/s10851-014-0510-7; He BS, 2012, SIAM J OPTIMIZ, V22, P313, DOI 10.1137/110822347; Huang JZ, 2011, J MACH LEARN RES, V12, P3371; Ji H, 2010, PROC CVPR IEEE, P1791, DOI 10.1109/CVPR.2010.5539849; Koltchinskii V, 2009, ANN I H POINCARE-PR, V45, P7, DOI 10.1214/07-AIHP146; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122562; Liu J, 2015, INFORM SCIENCES, V295, P232, DOI 10.1016/j.ins.2014.10.041; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Mairal J, 2009, IEEE I CONF COMP VIS, P2272, DOI 10.1109/ICCV.2009.5459452; Malek-Mohammadi M, 2014, IEEE T SIGNAL PROCES, V62, P981, DOI 10.1109/TSP.2013.2295557; Mohimani H, 2009, IEEE T SIGNAL PROCES, V57, P289, DOI 10.1109/TSP.2008.2007606; Romberg J, 2008, IEEE SIGNAL PROC MAG, V25, P14, DOI 10.1109/MSP.2007.914729; Wang YL, 2010, SIAM J IMAGING SCI, V3, P462, DOI 10.1137/090772447; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Zhang XQ, 2010, SIAM J IMAGING SCI, V3, P253, DOI 10.1137/090746379; Zhao XL, 2014, SIAM J IMAGING SCI, V7, P456, DOI 10.1137/13092472X; Zhao XL, 2013, SIAM J SCI COMPUT, V35, pB1304, DOI 10.1137/130915406; Zibulevsky M, 2010, IEEE SIGNAL PROC MAG, V27, P76, DOI 10.1109/MSP.2010.936023	37	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162041	10.1371/journal.pone.0162041	http://dx.doi.org/10.1371/journal.pone.0162041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583683	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600091
J	He, W; Wang, YK; Xing, KF; Deng, W; Zhang, ZL				He, Wei; Wang, Yueke; Xing, Kefei; Deng, Wei; Zhang, Zelong			Error-Rate Estimation Based on Multi-Signal Flow Graph Model and Accelerated Radiation Tests	PLOS ONE			English	Article							DESIGN	A method of evaluating the single-event effect soft-error vulnerability of space instruments before launched has been an active research topic in recent years. In this paper, a multi-signal flow graph model is introduced to analyze the fault diagnosis and meantime to failure (MTTF) for space instruments. A model for the system functional error rate (SFER) is proposed. In addition, an experimental method and accelerated radiation testing system for a signal processing platform based on the field programmable gate array (FPGA) is presented. Based on experimental results of different ions (O, Si, Cl, Ti) under the HI-13 Tandem Accelerator, the SFER of the signal processing platform is approximately 10(-3)(error/particle/cm(2)), while the MTTF is approximately 110.7 h.	[He, Wei; Wang, Yueke; Xing, Kefei; Deng, Wei; Zhang, Zelong] Natl Univ Def Technol, Sch Mechatron Engn & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	He, W (corresponding author), Natl Univ Def Technol, Sch Mechatron Engn & Automat, Changsha, Hunan, Peoples R China.	nudthewei@163.com			National Natural Science Foundation of China [61171019, 61201031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (61171019, 61201031).	ELDER JH, 1988, IEEE T NUCL SCI, V35, P1678, DOI 10.1109/23.25521; Ghosh Johnson E., 2005, THESIS; Harboe-Sorensen R, 2013, IEEE T NUCL SCI, V60, P1816, DOI 10.1109/TNS.2013.2247630; Harward NA, 2016, IEEE 23 ANN INT S FI, P143; Jensen DC, 2013, PROCEDIA COMPUT SCI, V16, P824, DOI 10.1016/j.procs.2013.01.086; Lei HC, 2015, THESIS; Liang S, 2015, C IND ELECT APPL, P57, DOI 10.1109/ICIEA.2015.7334084; Lyu C, 2013, C IND ELECT APPL, P1874; Mansour W, 2013, IEEE T NUCL SCI, V60, P4238, DOI 10.1109/TNS.2013.2285019; Nicolaidis M, 2011, FRONT ELECTRON TEST, V41, P203, DOI 10.1007/978-1-4419-6993-4_8; Ostler PS, 2009, IEEE T NUCL SCI, V56, P3519, DOI 10.1109/TNS.2009.2033381; Rodriguez-Andina JJ, 2015, IEEE T IND INFORM, V11, P853, DOI 10.1109/TII.2015.2431223; Swift GM, 2004, XILINX SINGLE EVENT; Thibeault C, 2013, J ELECTRON TEST, V29, P457, DOI 10.1007/s10836-013-5393-9; Wang NJ, 2004, 2004 INTERNATIONAL CONFERENCE ON DEPENDABLE SYSTEMS AND NETWORKS, PROCEEDINGS, P61; Wang Z., 2011, THESIS; Wirthlin M, 2015, P IEEE, V103, P379, DOI 10.1109/JPROC.2015.2404212; Xing KF, 2011, SCI CHINA TECHNOL SC, V54, P2657, DOI 10.1007/s11431-011-4542-6; Zhu MD, 2013, IEEE T NUCL SCI, V60, P3063, DOI 10.1109/TNS.2013.2270562	19	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161378	10.1371/journal.pone.0161378	http://dx.doi.org/10.1371/journal.pone.0161378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583533	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600026
J	Howey, MCL; Sullivan, FB; Tallant, J; Kopple, RV; Palace, MW				Howey, Meghan C. L.; Sullivan, Franklin B.; Tallant, Jason; Kopple, Robert Vande; Palace, Michael W.			Detecting Precontact Anthropogenic Microtopographic Features in a Forested Landscape with Lidar: A Case Study from the Upper Great Lakes Region, AD 1000-1600	PLOS ONE			English	Article							AIRBORNE LIDAR; ARCHAEOLOGICAL FEATURES; NORTHERN MICHIGAN; FOOD STORAGE; EXAMPLE	Forested settings present challenges for understanding the full extent of past human landscape modifications. Field-based archaeological reconnaissance in forests is low-efficiency and most remote sensing techniques are of limited utility, and together, this means many past sites and features in forests are unknown. Archaeologists have increasingly used light detection and ranging (lidar), a remote sensing tool that uses pulses of light to measure reflecting surfaces at high spatial resolution, to address these limitations. Archaeology studies using lidar have made significant progress identifying permanent structures built by large-scale complex agriculturalist societies. Largely unaccounted for, however, are numerous small and more practical modifications of landscapes by smaller-scale societies. Here we show these may also be detectable with lidar by identifying remnants of food storage pits (cache pits) created by mobile hunter-gatherers in the upper Great Lakes during Late Precontact (ca. AD 1000-1600) that now only exist as subtle microtopographic features. Years of intensive field survey identified 69 cache pit groups between two inland lakes in northern Michigan, almost all of which were located within similar to 500 m of a lakeshore. Applying a novel series of image processing techniques and statistical analyses to a high spatial resolution DTM we created from commercial-grade lidar, our detection routine identified 139 high potential cache pit clusters. These included most of the previously known clusters as well as several unknown clusters located >1500 m from either lakeshore, much further from lakeshores than all previously identified cultural sites. Food storage is understood to have emerged regionally as a risk-buffering strategy after AD 1000 but our results indicate the current record of hunter-gatherer cache pit food storage is markedly incomplete and this practice and its associated impact on the landscape may be greater than anticipated. Our study also demonstrates the potential of harnessing commercial-grade lidar for other fine-grained archaeology applications.	[Howey, Meghan C. L.] Univ New Hampshire, Dept Anthropol, Durham, NH 03824 USA; [Howey, Meghan C. L.; Sullivan, Franklin B.; Palace, Michael W.] Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA; [Tallant, Jason; Kopple, Robert Vande] Univ Michigan, Biol Stn, Pellston, MI USA; [Palace, Michael W.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University of Michigan System; University of Michigan; University System Of New Hampshire; University of New Hampshire	Howey, MCL (corresponding author), Univ New Hampshire, Dept Anthropol, Durham, NH 03824 USA.; Howey, MCL (corresponding author), Univ New Hampshire, Inst Study Earth Oceans & Space, Earth Syst Res Ctr, Durham, NH 03824 USA.	meghan.howey@unh.edu		Tallant, Jason/0000-0003-4790-8772	NASA Space Archaeology [NNH11ZDA001N SAP, NNX13AO40G]; National Science Foundation [0851096]	NASA Space Archaeology; National Science Foundation(National Science Foundation (NSF))	Spatial research supported by NASA Space Archaeology NNH11ZDA001N SAP (Grant Number NNX13AO40G) (PI Palace). Field research supported by the National Science Foundation under #0851096 (PI Howey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert D.A., 1987, NATURAL ECOLOGY CULT; American Society for Photogrammetry & Remote Sensing (ASPRS), LAS SPEC VERS 1 4 R1; Artursson M, 2016, J ANTHROPOL ARCHAEOL, V41, P1, DOI 10.1016/j.jaa.2015.11.005; Brubaker K. M., 2013, APPL ENVIRON SOIL SC, V2013, DOI DOI 10.1155/2013/891534; Chase AF, 2012, P NATL ACAD SCI USA, V109, P12916, DOI 10.1073/pnas.1205198109; Chase AF, 2011, J ARCHAEOL SCI, V38, P387, DOI 10.1016/j.jas.2010.09.018; Crow P, 2007, FORESTRY, V80, P241, DOI 10.1093/forestry/cpm018; Densmore Frances, 1929, SMITHSONIAN I BUREAU, V86; Devereux BJ, 2005, ANTIQUITY, V79, P648, DOI 10.1017/S0003598X00114589; Doneus M, 2008, J ARCHAEOL SCI, V35, P882, DOI 10.1016/j.jas.2007.06.013; Dunham S.B., 2000, INTERPRETATIONS NATI, P225; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Farina, 2006, PRINCIPLES METHODS L; Grier C, 2014, CANADIAN J ARCHAEOLO, V38, P211; Heidemann HK, 2014, LIDAR BASE SPECIFICA; Holman M, 2008, ARCHAEOLOGY MOBILITY, P280; Holman M.B., 1995, MICH ARCHAEOL, V41, P47; Holman MB, 2011, WISCONSIN ARCHAEOLOG, V2, P7; Howey MCL, 2016, J ANTHROPOL ARCHAEOL, V42, P37, DOI 10.1016/j.jaa.2016.03.001; Howey MCL, 2015, J ARCHAEOL SCI, V64, P88, DOI 10.1016/j.jas.2015.10.007; INGOLD T, 1983, MAN, V18, P553, DOI 10.2307/2801597; Johnson KM, 2014, J ARCHAEOL SCI, V43, P9, DOI 10.1016/j.jas.2013.12.004; Lasaponara R, 2011, J ARCHAEOL SCI, V38, P2061, DOI 10.1016/j.jas.2010.10.003; Liebmann MJ, 2016, P NATL ACAD SCI USA, V113, pE696, DOI 10.1073/pnas.1521744113; LOVIS WA, 1976, AM ANTIQUITY, V41, P364, DOI 10.2307/279526; Lovis WA, 1978, MICH ACAD, V11, P39; Mccoy MD, 2011, J ARCHAEOL SCI, V38, P2141, DOI 10.1016/j.jas.2011.02.033; O'Shea JM., 2003, FARM ARCHAEOL OLD WO, V1, P68; Politis G., 2007, NUKAK ETHNOARCHAEOGY; Randall AR, 2014, J FIELD ARCHAEOL, V39, P162, DOI 10.1179/0093469014Z.00000000080; Schaetzl R. J., 1990, Geomorphology, V3, P113, DOI 10.1016/0169-555X(90)90040-W; Stular B, 2012, J ARCHAEOL SCI, V39, P3354, DOI 10.1016/j.jas.2012.05.029	32	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162062	10.1371/journal.pone.0162062	http://dx.doi.org/10.1371/journal.pone.0162062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DV3WN	27584031	Green Published, gold			2022-12-27	WOS:000382855600093
J	Ren, BZ; Zhang, JW; Dong, ST; Liu, P; Zhao, B				Ren, Baizhao; Zhang, Jiwang; Dong, Shuting; Liu, Peng; Zhao, Bin			Effects of Waterlogging on Leaf Mesophyll Cell Ultrastructure and Photosynthetic Characteristics of Summer Maize	PLOS ONE			English	Article							LIPID-PEROXIDATION; GROWTH; STRESS; YIELD; RESPONSES	A field experiment was performed to study the effects of waterlogging on the leaf mesophyll cell ultrastructure, chlorophyll content, gas exchange parameters, chlorophyll fluorescence, and malondialdehyde (MDA) content of summer maize (Zea mays L.) hybrids Denghai605 (DH605) and Zhengdan958 (ZD958). The waterlogging treatments were implemented for different durations (3 and 6 days) at the third leaf stage (V3), the sixth leaf stage (V6), and the 10th day after the tasseling stage (10VT). Leaf area index (LAI), chlorophyll content, photosynthetic rate (P-n), and actual photochemical efficiency (Phi(PSII)) were reduced after waterlogging, indicating that waterlogging significantly decreased photosynthetic capacity. The chloroplast shapes changed from long and oval to elliptical or circular after waterlogging. In addition, the internal structures of chloroplasts were degenerated after waterlogging. After waterlogging for 6 d at V3, the number of grana and grana lamellae of the third expanded leaf in DH605 were decreased by 26.83% and 55.95%, respectively, compared to the control (CK). Those in ZD958 were reduced by 30.08% and 31.94%, respectively. Waterlogging increased MDA content in both hybrids, suggesting an impact of waterlogging on membrane integrity and thus membrane deterioration. Waterlogging also damaged the biological membrane structure and mitochondria. Our results indicated that the physiological reactions to waterlogging were closely related to lower LAI, chlorophyll content, and Pn and to the destruction of chloroplast ultrastructure. These negative effects resulted in the decrease of grain yield in response to waterlogging. Summer maize was the most susceptible to damage when waterlogging occurred at V3, followed by V6 and 10VT, with damage increasing in the wake of waterlogging duration increasing.	[Zhang, Jiwang] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; Shandong Agr Univ, Coll Agron, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhang, JW (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	jwzhang@sdau.edu.cn			National Basic Research Program of China (973) [2015CB150404]; National Modern Agricultural Technology & Industry System [CARS-02-20]; Shandong Province Key Agricultural Project for Application Technology Innovation	National Basic Research Program of China (973)(National Basic Research Program of China); National Modern Agricultural Technology & Industry System; Shandong Province Key Agricultural Project for Application Technology Innovation	The authors are grateful for grants from National Basic Research Program of China (973, Program: 2015CB150404), National Modern Agricultural Technology & Industry System (CARS-02-20), and Shandong Province Key Agricultural Project for Application Technology Innovation.	Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Bertamini M, 2006, PHOTOSYNTHETICA, V44, P227, DOI 10.1007/s11099-006-0011-z; BURKEY KO, 1991, PLANT PHYSIOL, V97, P245, DOI 10.1104/pp.97.1.245; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; DU ZY, 1992, J AGR FOOD CHEM, V40, P1566, DOI 10.1021/jf00021a018; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILES KL, 1976, PLANT PHYSIOL, V57, P11, DOI 10.1104/pp.57.1.11; HOWELL TA, 1974, T ASAE, V17, P286, DOI 10.13031/2013.36842; Irfan M, 2010, PROTOPLASMA, V241, P3, DOI 10.1007/s00709-009-0098-8; Jackson M.B., 2004, IMPACT FLOODING STRE; Li H.S., 2000, PRINCIPLES TECHNIQUE, P119; Liu XH, 2008, BIOTECHNOLOGY B S, VS1, P38; Mielke MS, 2003, ENV EXPT BOT, V50, P123; Montgomery E., 1911, NEB AGR EXP STN ANN, V24, P108; NIKI T, 1978, PLANT CELL PHYSIOL, V19, P139; Pessarakli M, 2005, HANDBOOKOF PHOTOSYNT, P730; Pezeshki SR, 2001, ENVIRON EXP BOT, V46, P299, DOI 10.1016/S0098-8472(01)00107-1; PFISTERSIEBER M, 1994, P ROY SOC EDINB B, V102, P313, DOI 10.1017/S0269727000014305; Pociecha E, 2008, ACTA PHYSIOL PLANT, V30, P529, DOI 10.1007/s11738-008-0151-9; Ren BZ, 2014, CAN J PLANT SCI, V94, P23, DOI 10.4141/CJPS2013-175; Sauter M, 2013, CURR OPIN PLANT BIOL, V16, P282, DOI 10.1016/j.pbi.2013.03.013; Shao QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085996; Smethurst CF, 2005, PLANT SOIL, V270, P31, DOI 10.1007/s11104-004-1082-x; Vandoorne B, 2014, PLANT SOIL, V376, P291, DOI 10.1007/s11104-013-1933-4; Waldhoff D, 2002, ENVIRON EXP BOT, V48, P225, DOI 10.1016/S0098-8472(02)00037-0; Weston E, 2000, PLANTA, V211, P807, DOI 10.1007/s004250000392; Xu PL, 2008, PHYSIOL PLANTARUM, V132, P467, DOI 10.1111/j.1399-3054.2007.01036.x; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Yordanova RY, 2007, ACTA PHYSIOL PLANT, V29, P535, DOI 10.1007/s11738-007-0064-z; [郁凌华 Yu Linghua], 2013, [灾害学, Journal of Catastrophology], V28, P71; Zhou WJ, 1995, FIELD CROP RES, V44, P103, DOI 10.1016/0378-4290(95)00075-5	32	53	60	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161424	10.1371/journal.pone.0161424	http://dx.doi.org/10.1371/journal.pone.0161424			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583803	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600028
J	Tsui, SL; Wang, J; Wang, L; Dai, W; Lu, L				Tsui, Shanli; Wang, Jie; Wang, Ling; Dai, Wei; Lu, Luo			CTCF-Mediated and Pax6-Associated Gene Expression in Corneal Epithelial Cell-Specific Differentiation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CCCTC BINDING-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOLIPASE C-GAMMA-1; INDUCED PROLIFERATION; PAX6 TRANSCRIPTION; EGF; GENOME; KINASE; ACTIVATION	Background The purpose of the study is to elicit the epigenetic mechanism involving CCCTC binding factor (CTCF)-mediated chromatin remodeling that regulates PAX6 gene interaction with differentiation-associated genes to control corneal epithelial differentiation. Methods Cell cycle progression and specific keratin expressions were measured to monitor changes of differentiation- induced primary human limbal stem/progenitor (HLS/P), human corneal epithelial (HCE) and human telomerase-immortalized corneal epithelial (HTCE) cells. PAX6-interactive and differentiation- associated genes in chromatin remodeling mediated by the epigenetic factor CTCF were detected by circular chromosome conformation capture (4C) and ChIP (Chromatin immunoprecipitation)-on-chip approaches, and verified by FISH (Fluorescent in situ hybridization). Furthermore, CTCF activities were altered by CTCF-shRNA to study the effect of CTCF on mediating interaction of Pax6 and differentiation-associated genes in corneal epithelial cell fate. Results Our results demonstrated that differentiation- induced human corneal epithelial cells expressed typical corneal epithelial characteristics including morphological changes, increased keratin 12 expression and G(0)/G(1) accumulations. Expressions of CTCF and PAX6 were suppressed and elevated following the process of differentiation, respectively. During corneal epithelial cell differentiation, differentiation- induced RCN1 and ADAM17 were found interacting with PAX6 in the process of CTCF-mediated chromatin remodeling detected by 4C and verified by ChIP-on-chip and FISH. Diminished CTCF mRNA with CTCF-shRNA in HTCE cells weakened the interaction of PAX6 gene in controlling RCN1/ADAM17 and enhanced early onset of the genes in cell differentiation. Conclusion Our results explain how epigenetic factor CTCF-mediated chromatin remodeling regulates interactions between eye-specific PAX6 and those genes that are induced/associated with cell differentiation to modulate corneal epithelial cell-specific differentiation.	[Tsui, Shanli; Wang, Jie; Wang, Ling; Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA; [Dai, Wei] NYU, Dept Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Lu, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	NIH [EY15282, CA074229]; NATIONAL EYE INSTITUTE [R01EY022364, R01EY015281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY15282 to LL and CA074229 to WD.	Antes TJ, 2001, BIOCHEMISTRY-US, V40, P6731, DOI 10.1021/bi0100743; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cartier L, 2006, J NEUROBIOL, V66, P421, DOI 10.1002/neu.20225; Davis JA, 1996, J NEUROSCI, V16, P5082; Dobrovic A, 1997, CANCER RES, V57, P3347; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Islam M, 2000, EXP EYE RES, V70, P261, DOI 10.1006/exer.1999.0783; Islam M, 2001, INVEST OPHTH VIS SCI, V42, P1472; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kang SS, 2000, INVEST OPHTH VIS SCI, V41, P2164; Kang SS, 2001, CURR EYE RES, V23, P397, DOI 10.1076/ceyr.23.6.397.6965; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Koroma BM, 1997, INVEST OPHTH VIS SCI, V38, P108; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; Lu L, 2010, J BIOL CHEM, V285, P9373, DOI 10.1074/jbc.M109.094425; MARTIN P, 1992, ONCOGENE, V7, P1721; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; PLAZA S, 1995, MOL CELL BIOL, V15, P3344; Ramaesh T, 2006, INVEST OPHTH VIS SCI, V47, P1911, DOI 10.1167/iovs.05-1028; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang J, 2010, INVEST OPHTH VIS SCI, V51, P2943, DOI 10.1167/iovs.09-4639; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P946, DOI 10.1167/iovs.11-8747; Williams SC, 1998, MECH DEVELOP, V73, P225, DOI 10.1016/S0925-4773(98)00057-4; WILSON SE, 1992, INVEST OPHTH VIS SCI, V33, P1987; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Xu PX, 1999, DEVELOPMENT, V126, P383; Zhang Y, 1999, INVEST OPHTH VIS SCI, V40, P2819; Zhang Y, 1998, CURR EYE RES, V17, P294, DOI 10.1076/ceyr.17.3.294.5223; Zhang Y, 1996, EXP EYE RES, V63, P265, DOI 10.1006/exer.1996.0115; Zhang Y, 1997, INVEST OPHTH VIS SCI, V38, P1139	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162071	10.1371/journal.pone.0162071	http://dx.doi.org/10.1371/journal.pone.0162071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583466	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600097
J	Gomes, A; Guillaume, L; Grimes, DR; Fehrenbach, J; Lobjois, V; Ducommun, B				Gomes, Aurelie; Guillaume, Ludivine; Grimes, David Robert; Fehrenbach, Jerome; Lobjois, Valerie; Ducommun, Bernard			Oxygen Partial Pressure Is a Rate-Limiting Parameter for Cell Proliferation in 3D Spheroids Grown in Physioxic Culture Condition	PLOS ONE			English	Article							MULTICELLULAR SPHEROIDS; HYPOXIA; DIFFERENTIATION	The in situ oxygen partial pressure in normal and tumor tissues is in the range of a few percent. Therefore, when studying cell growth in 3D culture systems, it is essential to consider how the physiological oxygen concentration, rather than the one in the ambient air, influences the proliferation parameters. Here, we investigated the effect of reducing oxygen partial pressure from 21% to 5% on cell proliferation rate and regionalization in a 3D tumor spheroid model. We found that 5% oxygen concentration strongly inhibited spheroid growth, changed the proliferation gradient and reduced the 50% In Depth Proliferation index (IDP50), compared with culture at 21% oxygen. We then modeled the oxygen partial pressure profiles using the experimental data generated by culturing spheroids in physioxic and normoxic conditions. Although hypoxia occurred at similar depth in spheroids grown in the two conditions, oxygen partial pressure was a major rate-limiting factor with a critical effect on cell proliferation rate and regionalization only in spheroids grown in physioxic condition and not in spheroids grown at atmospheric normoxia. Our findings strengthen the need to consider conducting experiment in physioxic conditions (i.e., tissue normoxia) for proper understanding of cancer cell biology and the evaluation of anticancer drugs in 3D culture systems.	[Gomes, Aurelie; Guillaume, Ludivine; Fehrenbach, Jerome; Lobjois, Valerie; Ducommun, Bernard] UPS, Univ Toulouse, CNRS, ITAV, Toulouse, France; [Grimes, David Robert] Univ Oxford, Oxford, England; [Fehrenbach, Jerome] UPS, Univ Toulouse, CNRS, IMT, Toulouse, France; [Ducommun, Bernard] CHU Toulouse, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oxford; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Lobjois, V; Ducommun, B (corresponding author), UPS, Univ Toulouse, CNRS, ITAV, Toulouse, France.; Ducommun, B (corresponding author), CHU Toulouse, Toulouse, France.	valerie.lobjois@itav.fr; bernard.ducommun@itav.fr	Grimes, David Robert/J-7384-2013	Grimes, David Robert/0000-0003-3140-3278; DUCOMMUN, Bernard/0000-0002-7126-8368; Lobjois, Valerie/0000-0003-2428-2084	CNRS; Universite Paul Sabatier; Region Midi-Pyrenees; ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan; Agence Nationale de la Recherche ANR [12-BSV5-0008-01]; Cancer Research UK [19834] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan; Agence Nationale de la Recherche ANR(French National Research Agency (ANR)); Cancer Research UK(Cancer Research UK)	This work was supported by grants to Bernard Ducommun from the CNRS, Universite Paul Sabatier, Region Midi-Pyrenees, ITMO Cancer AVIESAN (Alliance Nationale pour les Sciences de la Vie et de la Sante, National Alliance for Life Sciences & Health) within the framework of the Cancer Plan, and Agence Nationale de la Recherche ANR (12-BSV5-0008-01).	Ansari N, 2012, METHOD CELL BIOL, V113, P295, DOI 10.1016/B978-0-12-407239-8.00013-6; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chou SC, 2004, BRIT J CANCER, V90, P728, DOI 10.1038/sj.bjc.6601585; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P59, DOI 10.1016/S1040-8428(00)00076-7; Grimes BA, 2015, BIOMEDICAL PHYS ENG, V1; Grimes DR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140080; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; GROSS MW, 1995, INT J CANCER, V61, P567, DOI 10.1002/ijc.2910610422; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; KOCH CJ, 1995, BRIT J CANCER, V72, P869, DOI 10.1038/bjc.1995.426; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pampaloni Francesco, 2009, Recent Pat Biotechnol, V3, P103; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; SUTHERLAND RM, 1986, CANCER RES, V46, P5320; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Yeom CJ, 2012, INT J MOL SCI, V13, P13949, DOI 10.3390/ijms131113949	19	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161239	10.1371/journal.pone.0161239	http://dx.doi.org/10.1371/journal.pone.0161239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575790	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877200020
J	Otis, MJD; Ayena, JC; Tremblay, LE; Fortin, PE; Menelas, BAJ				Otis, Martin J. -D.; Ayena, Johannes C.; Tremblay, Louis E.; Fortin, Pascal E.; Menelas, Bob-Antoine J.			Use of an Enactive Insole for Reducing the Risk of Falling on Different Types of Soil Using Vibrotactile Cueing for the Elderly	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENTS; RHYTHMIC AUDITORY-STIMULATION; FUNCTIONAL MOBILITY; GAIT; CUES; PEOPLE; WALKING; PREVENTION; STRATEGIES; FLOOR	Background Our daily activities imply displacements on various types of soil. For persons with gait disorder or losing functional autonomy, walking on some types of soil could be challenging because of the risk of falling it represents. Methods In this paper, we present, in a first part, the use of an enactive shoe for an automatic differentiation of several types of soil. In a second part, using a second improved prototype (an enactive insole), twelve participants with Parkinson's disease (PD) and nine age-matched controls have performed the Timed Up and Go (TUG) test on six types of soil with and without cueing. The frequency of the cueing was set at 10% above the cadence computed at the lower risk of falling (walking over the concrete). Depending on the cadence computed at the lower risk, the enactive insole activates a vibrotactile cueing aiming to improve gait and balance control. Finally, a risk index is computed using gait parameters in relation to given type of soil. Results The frequency analysis of the heel strike vibration allows the differentiation of various types of soil. The risk computed is associated to an appropriate rhythmic cueing in order to improve balance and gait impairment. The results show that a vibrotactile cueing could help to reduce the risk of falling. Conclusions Firstly, this paper demonstrates the feasibility of reducing the risk of falling while walking on different types of soil using vibrotactile cueing. We found a significant difference and a significant decrease in the computed risks of falling for most of types of soil especially for deformable soils which can lead to fall. Secondly, heel strike provides an approximation of the impulse response of the soil that can be analyzed with time and frequency-domain modeling. From these analyses, an index is computed enabling differentiation the types of soil.	[Otis, Martin J. -D.; Ayena, Johannes C.] Univ Quebec Chicoutimi UQAC, REPARTI Ctr, Dept Appl Sci, Chicoutimi, PQ, Canada; [Tremblay, Louis E.] Univ Quebec Chicoutimi, Dept Hlth Sci, Chicoutimi, PQ, Canada; [Fortin, Pascal E.] McGill Univ, Ctr Intelligent Machine, Dept Elect Engn & Comp, Montreal, PQ, Canada; [Menelas, Bob-Antoine J.] Univ Quebec Chicoutimi, Dept Math & Comp Sci, Chicoutimi, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; McGill University; University of Quebec; University of Quebec Chicoutimi	Ayena, JC (corresponding author), Univ Quebec Chicoutimi UQAC, REPARTI Ctr, Dept Appl Sci, Chicoutimi, PQ, Canada.	cossoun-johannes.ayena1@uqac.ca	Ayena, Johannes/AAJ-6842-2020	Ayena, Johannes/0000-0003-4104-8070; Fortin, Pascal E./0000-0002-0704-9590	Natural Sciences and Engineering Research Council of Canada (NSERC) [418235-2012]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the financial support of the Natural Sciences and Engineering Research Council of Canada (NSERC), under the grant number 418235-2012.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Arias P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009675; Ayub S., 2012, COMPUTER INFORMATICS, V107, P123; Azizah G, 2001, CHARACTERISTICS BAIT; Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Basta D, 2011, OTOL NEUROTOL, V32, P1492, DOI 10.1097/MAO.0b013e31823827ec; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Bhatt T, 2009, J NEUROPHYSIOL, V101, P948, DOI 10.1152/jn.91004.2008; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Brassard S, 2012, P 2 ACM WORKSH MOB S, P1; Brooks CA, 2005, IEEE T ROBOT, V21, P1185, DOI 10.1109/TRO.2005.855994; Cappellini G, 2010, J NEUROPHYSIOL, V103, P746, DOI 10.1152/jn.00499.2009; Chan A, 2005, EUR C 2005 S HAPT IN; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; COHEN HH, 1994, J SAFETY RES, V25, P19, DOI 10.1016/0022-4375(94)90004-3; Collins EG, 2008, ROB AUT IEEE INT C M; DAVIS PR, 1983, ERGONOMICS, V26, P51, DOI 10.1080/00140138308963312; Dozza M, 2004, ENG MED BIOL SOC 26; Filiatroult J, 2007, CAN J AGING, V26, P213, DOI 10.3138/cja.26.3.213; Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Galica AM, 2009, GAIT POSTURE, V30, P383, DOI 10.1016/j.gaitpost.2009.07.005; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Gottschall JS, 2011, J APPL BIOMECH, V27, P355, DOI 10.1123/jab.27.4.355; Gyllensten IC, 2011, IEEE T BIO-MED ENG, V58, P2656, DOI 10.1109/TBME.2011.2160723; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hoepflinger MA, 2010, ROB AUT ICRA IEEE IN; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Janssen M, 2010, GAIT POSTURE, V31, P213, DOI 10.1016/j.gaitpost.2009.10.008; Jenkins ME, 2009, PARKINSONISM RELAT D, V15, P697, DOI 10.1016/j.parkreldis.2009.04.004; Kang H. G., 2008, N AM C BIOM; Kim J. W., 2004, J GLOBAL POSITION SY, V3, P273, DOI DOI 10.5081/JGPS.3.1.273; Kisung K, 2010, SICE ANN C; Kobayashi Y, 2008, IEEE T NEUR SYS REH, V16, P99, DOI 10.1109/TNSRE.2007.910283; Kyriacou E, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-7; Larson AC, 2007, INT ROB SYST IEEE IN; Levesque V, 2005, BLINDNESS TECHNOLOGY, P19; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lohnes CA, 2011, GAIT POSTURE, V33, P478, DOI 10.1016/j.gaitpost.2010.12.029; Lord SR, 2010, CLIN GERIATR MED, V26, P569, DOI 10.1016/j.cger.2010.06.002; Magaa M, 2008, HAPT AUD VIS ENV GAM; Mak MKY, 2009, J NEUROL, V256, P742, DOI 10.1007/s00415-009-5007-8; Marigold DS, 2005, J NEUROPHYSIOL, V94, P1733, DOI 10.1152/jn.00019.2005; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Menant JC, 2009, GAIT POSTURE, V29, P392, DOI 10.1016/j.gaitpost.2008.10.057; Menelas Bob-Antoine J., 2012, Serious Games Development and Applications. Proceedings Third International Conference, SGDA 2012, P31, DOI 10.1007/978-3-642-33687-4_3; Milosevic M., 2013, BOD SENS NETW BSN 20; Milosevic M, 2013, BOD SENS NETW BSN IE; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Noshadi H, 2010, BIOSIGNALS 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, P264; Otis MJD, 2012, SYST MAN CYB SMC IEE; Paradiso J. A., 2004, CHI 04 HUM FACT COMP, P1341, DOI DOI 10.1145/985921.986059; Parsons J, 2015, DISABILITY REHABILIT, V38, P1; Pawlak-Osinska K, 2011, CESK SLOV NEUROL N, V74, P669; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Rocha PA, 2014, CLIN NEUROL NEUROSUR, V124, P127, DOI 10.1016/j.clineuro.2014.06.026; Suteerawattananon M, 2004, J NEUROL SCI, V219, P63, DOI 10.1016/j.jns.2003.12.007; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Thrane Gyrd, 2007, BMC Geriatr, V7, P1, DOI 10.1186/1471-2318-7-1; Tiest WMB, 2010, VISION RES, V50, P2775, DOI 10.1016/j.visres.2010.10.005; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Visell Y, 2010, HAPT S IEEE MARCH; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Weiss C, 2008, INT ROB SYST IEEE IN; Weiss C, 2006, INT ROB SYST IEEE IN; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Yang W, 2015, ASCE-ASME J RISK U B, V1, DOI 10.1115/1.4029751; Yu M, 2010, J MED SYST, V34, P787, DOI 10.1007/s10916-009-9293-6; Yuwono M, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-9; Zampieri C, 2011, PARKINSONISM RELAT D, V17, P277, DOI 10.1016/j.parkreldis.2010.08.001; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	75	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162107	10.1371/journal.pone.0162107	http://dx.doi.org/10.1371/journal.pone.0162107			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603211	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000383255200041
J	Tsui, PH; Wang, CY; Zhou, ZH; Wan, YL				Tsui, Po-Hsiang; Wang, Chiao-Yin; Zhou, Zhuhuang; Wan, Yung-Liang			Monitoring Radiofrequency Ablation Using Ultrasound Envelope Statistics and Shear Wave Elastography in the Periablation Period: An In Vitro Feasibility Study	PLOS ONE			English	Article							THERMAL ABLATION; EX-VIVO; LIVER-TUMORS; LESIONS; VOLUME	Radiofrequency ablation (RFA) is a minimally invasive method for treating tumors. Shear wave elastography (SWE) has been widely applied in evaluating tissue stiffness and final ablation size after RFA. However, the usefulness of periablation SWE imaging in assessing RFA remains unclear. Therefore, this study investigated the correlation between periablation SWE imaging and final ablation size. An in vitro porcine liver model was used for experimental validation (n = 36). During RFA with a power of 50 W, SWE images were collected using a clinical ultrasound system. To evaluate the effects of tissue temperature and gas bubbles during RFA, changes in the ablation temperature were recorded, and image echo patterns were measured using B-mode and ultrasound statistical parametric images. After RFA, the gross pathology of each tissue sample was compared with the region of change in the corresponding periablation SWE image. The experimental results showed that the tissue temperature at the ablation site varied between 70 degrees C and 100 degrees C. Hyperechoic regions and changes were observed in the echo amplitude distribution induced by gas bubbles. Under this condition, the confounding effects (including the temperature increase, tissue stiffness increase, and presence of gas bubbles) resulted in artifacts in the periablation SWE images, and the corresponding region correlated with the estimated final ablation size obtained from the gross pathology (r = 0.8). The findings confirm the feasibility of using periablation SWE imaging in assessing RFA.	[Tsui, Po-Hsiang; Wang, Chiao-Yin; Wan, Yung-Liang] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Coll Med, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Wan, Yung-Liang] Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Wan, Yung-Liang] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan; [Tsui, Po-Hsiang; Wan, Yung-Liang] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Wang, Chiao-Yin] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Zhou, Zhuhuang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Beijing University of Technology	Tsui, PH; Wan, YL (corresponding author), Chang Gung Univ, Dept Med Imaging & Radiol Sci, Coll Med, Taoyuan, Taiwan.; Tsui, PH; Wan, YL (corresponding author), Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan.; Tsui, PH; Wan, YL (corresponding author), Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan.; Tsui, PH; Wan, YL (corresponding author), Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan.	tsuiph@mail.cgu.edu.tw; ylw0518@cgmh.org.tw	Zhou, Zhuhuang/M-3301-2019; Tsui, Po-Hsiang/AHE-7426-2022	Zhou, Zhuhuang/0000-0003-0570-8473; Tsui, Po-Hsiang/0000-0002-5604-1800	Ministry of Science and Technology (Taiwan) [MOST 103-2221-E-182-001-MY3]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CMRPD1F0311, CMRPD1C0711, CIRPD1E0022]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital)	This work was supported by the Ministry of Science and Technology (Taiwan) under Grant No. MOST 103-2221-E-182-001-MY3 and the Chang Gung Memorial Hospital (Linkou, Taiwan) under Grant Nos. CMRPD1F0311, CMRPD1C0711, and CIRPD1E0022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum L, 2010, RADIOLOGY, V254, P430, DOI 10.1148/radiol.09090207; Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Erpelding TN, 2005, IEEE T ULTRASON FERR, V52, P971, DOI 10.1109/TUFFC.2005.1504019; Eyerly SA, 2015, J CARDIOVASC ELECTR, V26, P1009, DOI 10.1111/jce.12709; Fahey BJ, 2004, ULTRASOUND MED BIOL, V30, P321, DOI 10.1016/j.ultrasmedbio.2003.11.012; Fahey BJ, 2008, ULTRASOUND MED BIOL, V34, P1590, DOI 10.1016/j.ultrasmedbio.2008.03.006; Fang J, 2015, ULTRASOUND MED BIOL, V41, P498, DOI 10.1016/j.ultrasmedbio.2014.09.024; Gateau J, 2009, P 7 INT S CAV, V1, P16; Hollender P, 2013, IEEE INT ULTRA SYM, P108, DOI 10.1109/ULTSYM.2013.0028; Kiss MZ, 2009, J BIOMECH, V42, P959, DOI 10.1016/j.jbiomech.2009.03.002; Kwiecinski W, 2014, MED PHYS, V41, DOI 10.1118/1.4896820; Kwon HJ, 2011, WORLD J GASTROENTERO, V17, P1874, DOI 10.3748/wjg.v17.i14.1874; Liu W, 2004, MED PHYS, V31, P1322, DOI 10.1118/1.1738963; Machi J, 2001, J GASTROINTEST SURG, V5, P477, DOI 10.1016/S1091-255X(01)80085-8; Mariani A, 2014, J SURG RES, V188, P37, DOI 10.1016/j.jss.2013.12.024; Pareek G, 2006, J ENDOUROL, V20, P959, DOI 10.1089/end.2006.20.959; Pereira PL, 2004, RADIOLOGY, V232, P482, DOI 10.1148/radiol.2322030184; Pernot M, 2009, COMPUT CARDIOL, V36, P793; Ritz JP, 2006, J SURG RES, V133, P176, DOI 10.1016/j.jss.2005.09.028; Rivaz H, 2008, LECT NOTES COMPUT SC, V5242, P458, DOI 10.1007/978-3-540-85990-1_55; Sapin-de Brosses E, 2010, PHYS MED BIOL, V55, P1701, DOI 10.1088/0031-9155/55/6/011; Sapin-de Brosses E, 2011, PHYS MED BIOL, V56, P7755, DOI 10.1088/0031-9155/56/24/005; Shah DR, 2013, WORLD J GASTRO ONCOL, V5, P71, DOI 10.4251/wjgo.v5.i4.71; Shahmirzadi D, 2014, ULTRASOUND MED BIOL, V40, P341, DOI 10.1016/j.ultrasmedbio.2013.09.016; Sugimoto K, 2014, WORLD J GASTROENTERO, V20, P11850, DOI 10.3748/wjg.v20.i33.11850; Uehara T, 2009, HEPATOL RES, V39, P954, DOI 10.1111/j.1872-034X.2009.00537.x; Urban MW, 2009, PHYS MED BIOL, V54, P5919, DOI 10.1088/0031-9155/54/19/017; van Vledder MG, 2010, HPB, V12, P717, DOI 10.1111/j.1477-2574.2010.00247.x; Varghese T, 2004, J ULTRAS MED, V23, P535, DOI 10.7863/jum.2004.23.4.535; Varghese T, 2003, AM J ROENTGENOL, V181, P701, DOI 10.2214/ajr.181.3.1810701; Wang CY, 2013, MED PHYS, V40, DOI 10.1118/1.4808115; Winkler I, 2011, ULTRASOUND MED BIOL, V37, P755, DOI 10.1016/j.ultrasmedbio.2010.11.008; Wright AS, 2005, RADIOLOGY, V236, P132, DOI 10.1148/radiol.2361031249; Zhang M, 2008, MED PHYS, V35, P4132, DOI 10.1118/1.2968939; Zhou ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118030; Zhou ZH, 2014, P I MECH ENG H, V228, P1069, DOI 10.1177/0954411914554438	38	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162488	10.1371/journal.pone.0162488	http://dx.doi.org/10.1371/journal.pone.0162488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603012	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200069
J	Binder, WJ; Cervantes, KS; Meachen, JA				Binder, Wendy J.; Cervantes, Kassaundra S.; Meachen, Julie A.			Measures of Relative Dentary Strength in Rancho La Brea Smilodon fatalis over Time	PLOS ONE			English	Article							MANDIBULAR CORPUS; GROWTH; MALNUTRITION; PATTERNS; DENSITY	The late Pleistocene megafaunal extinction of approximately 12,000 years ago, included the demise of Smilodon fatalis, a hypercarnivore from the Rancho La Brea deposits, which has been studied across time by looking at different deposits or pits to determine morphological size and shape changes and trends during this time. To better understand functional aspects of these changes, this study focused on a measure of jaw strength over time, which can give an indication of morphological changes within the jaw that cannot be seen using surface morphometrics. By radiographing dentaries, cortical bone can be seen, which provides an estimate of resistance to bending forces while biting, and can be measured and used as an indicator of jaw strength. Measurements were taken at repeatable locations on the dentary of the depth of the cortical bone, and of a standardized measure of cortical bone, which allows for the comparison between different individuals. Specimens included those of five different pits ranging from about 37 Kybp to 13 Kybp (just before the extinction of S. fatalis). No significant difference was found in the depth of jaws at any of the measurement points from any of the pits. However, significant differences were found in both the actual thickness of cortical bone, and the standardized thickness of cortical bone at the lower P4 between pit 13 (which had the lowest amount of bone) and pit 61/67 (which had the highest). These conclusions support other studies that have shown that individuals in pit 13 were under physiological and perhaps dietary stress, which may be reflected in the deposition of cortical bone, while the opposite trend is seen in the individuals in pit 61/67. Our results further support findings suggesting Smilodon did not appear to be morphologically most vulnerable right before its extinction.	[Binder, Wendy J.; Cervantes, Kassaundra S.] Loyola Marymount Univ, Dept Biol, Los Angeles, CA 90045 USA; [Meachen, Julie A.] Des Moines Univ, Dept Anat, Des Moines, IA USA	Loyola Marymount University	Binder, WJ (corresponding author), Loyola Marymount Univ, Dept Biol, Los Angeles, CA 90045 USA.	wendy.binder@lmu.edu		Binder, Wendy/0000-0003-2580-7567	LMU Rains Research Assistant grant	LMU Rains Research Assistant grant	KC was supported by the LMU Rains Research Assistant grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank A. Farrell, G. Takeuchi, S. Cox, and J. Harris for their help with and access to the research collection at the Page Museum. We would also like to thank B. Van Valkenburgh, C. Ruff, R. O'Keefe, F. Therrien and one anonymous reviewer for discussion that improved this paper. WB and KC want to thank LMU for a Rains Research Assistant grant to KC.	Alippi RM, 2002, ARCH ORAL BIOL, V47, P47, DOI 10.1016/S0003-9969(01)00089-9; Biknevicius AR, 1997, ZOOL J LINN SOC-LOND, V120, P139; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; BIKNEVICIUS AR, 1992, ANAT RECORD, V232, P157, DOI 10.1002/ar.1092320118; Binder WJ, 2010, J VERTEBR PALEONTOL, V30, P255, DOI 10.1080/02724630903413016; Binder WJ, 2002, J VERTEBR PALEONTOL, V22, P423, DOI 10.1671/0272-4634(2002)022[0423:TVITFA]2.0.CO;2; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; Devlin MJ, 2013, J ENDOCRINOL, V217, P69, DOI 10.1530/JOE-12-0403; Friscia AR, 2008, PALAIOS, V23, P35, DOI 10.2110/palo.2005.p05-143r; Goswami A, 2015, P NATL ACAD SCI USA, V112, P4891, DOI 10.1073/pnas.1403667112; Hattori S, 2013, CALCIFIED TISSUE INT, V93, P540, DOI 10.1007/s00223-013-9787-6; Ibarra Y, 2015, PALAEOGEOGR PALAEOCL, V422, P36, DOI 10.1016/j.palaeo.2015.01.012; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Laabs BJC, 2013, EARTH PLANET SC LETT, V361, P16, DOI 10.1016/j.epsl.2012.11.018; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Lobe SL, 2006, J ANAT, V208, P795, DOI 10.1111/j.1469-7580.2006.00565.x; Meachen JA, 2014, J EVOLUTION BIOL, V27, P714, DOI 10.1111/jeb.12340; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; O'Keefe FR, 2014, PALAEONTOL ELECTRON, V17; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; Romano T, 2015, REPROD FERT DEVELOP, V27, P823, DOI 10.1071/RD13388; Romano T, 2010, BONE, V47, P1054, DOI 10.1016/j.bone.2010.08.020; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Troyer EM, 2014, J MAMMAL, V95, P421, DOI 10.1644/13-MAMM-A-164.1	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162270	10.1371/journal.pone.0162270	http://dx.doi.org/10.1371/journal.pone.0162270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598462	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800050
J	da Silva, BD; Lima, KF; Goncalves, LR; da Silveira, MB; Moraes, KCM				da Silva, Brenda de Oliveira; Lima, Kelvin Furtado; Goncalves, Leticia Rocha; da Silveira, Marina Bonfogo; Moraes, Karen C. M.			MicroRNA Profiling of the Effect of the Heptapeptide Angiotensin-(1-7) in A549 Lung Tumor Cells Reveals a Role for miRNA149-3p in Cellular Migration Processes	PLOS ONE			English	Article							CANCER; GROWTH; ACTIN; ANGIOGENESIS; XENOGRAFTS; EXPRESSION; REPRESSION; REDUCTION; MOTILITY; CHORDOMA	Lung cancer is one of the most frequent types of cancer in humans and a leading cause of death worldwide. The high mortality rates are correlated with late diagnosis, which leads to high rates of metastasis found in patients. Thus, despite all the improvement in therapeutic approaches, the development of new drugs that control cancer cell migration and metastasis are required. The heptapeptide angiotensin-(1-7) [ ang-(1-7)] has demonstrated the ability to control the growth rates of human lung cancer cells in vitro and in vivo, and the elucidation of central elements that control the fine-tuning of cancer cells migration in the presence of the ang-(1-7), will support the development of new therapeutic approaches. Ang(1-7) is a peptide hormone of the renin-angiotensin system (RAS) and this study investigates the modulatory effect of the heptapeptide on the expression pattern of microRNAs (miRNAs) in lung tumor cells, to elucidate mechanistic concerns about the effect of the peptide in the control of tumor migratory processes. Our primary aim was to compare the miRNA profiling between treated and untreated-heptapeptide cells to characterize the relevant molecule that modulates cellular migration rates. The analyses selected twenty one miRNAs, which are differentially expressed between the groups; however, statistical analyses indicated miRNA-149-3p as a relevant molecule. Once functional analyses were performed, we demonstrated that miRNA-149-3p plays a role in the cellular migration processes. This information could be useful for future investigations on drug development.	[da Silva, Brenda de Oliveira] Univ Fed Ouro Preto, Nucleo Pesquisa Biol, Ouro Preto, MG, Brazil; [Lima, Kelvin Furtado] Univ Estadual Paulista, Inst Chem, Araraquara, SP, Brazil; [Goncalves, Leticia Rocha; da Silveira, Marina Bonfogo; Moraes, Karen C. M.] Univ Estadual Paulista, Mol Biol Lab, Dept Biol, Biosci Inst, Rio Claro, SP, Brazil	Universidade Federal de Ouro Preto; Universidade Estadual Paulista; Universidade Estadual Paulista	Moraes, KCM (corresponding author), Univ Estadual Paulista, Mol Biol Lab, Dept Biol, Biosci Inst, Rio Claro, SP, Brazil.	Karenmor@rc.unesp.com	de+Moraes, Karen/AAU-1429-2021		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [475586/2012-3, 2014/07671-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475586/2012-3]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/07671-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-GRant # 475586/2012-3 - KCMM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Grante #2014/07671-2 - MBS.; We thank the professors who donate the cell lines for this study (Priolli DG, Santos RAS and Valente V) and the professor Santos AF for the machine ViiA (TM) 7 Real-Time PCR System. This study was supported by research grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (475586/2012-3) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-2014/07671-2). The authors report no conflict of interest.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BECKNER ME, 1995, CANCER RES, V55, P2140; Cao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21592; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; da Silva W, 2016, MOL CELL BIOCHEM, V411, P363, DOI 10.1007/s11010-015-2598-5; Edelstein-Keshet L, 2016, CELL SYSTEMS, V2; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Ferreira AJ, 2005, BRAZ J MED BIOL RES, V38, P499, DOI 10.1590/S0100-879X2005000400003; Ferreira AJ, 2001, HYPERTENSION, V38, P665, DOI 10.1161/01.HYP.38.3.665; Gallagher PE, 2011, CURR CANCER DRUG TAR, V11, P394; Gallagher PE, 2004, CARCINOGENESIS, V25, P2045, DOI 10.1093/carcin/bgh236; Hoffmann C, 2016, ONCOTARGET, V11, DOI 10.18632/oncotarget.7327; Khajah MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150861; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Koseoglu S, 2015, BLOOD, V126, P651, DOI 10.1182/blood-2014-12-618744; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16506; Long C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066676; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; McPherson CM, 2006, J NEUROSURG-SPINE, V5, P277, DOI 10.3171/spi.2006.5.4.277; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Menon J, 2007, CANCER RES, V67, P2809, DOI 10.1158/0008-5472.CAN-06-3614; Miyamoto Kei, 2011, Commun Integr Biol, V4, P582, DOI 10.4161/cib.4.5.16491; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Passos-Silva DG, 2015, TRENDS PHARMACOL SCI, V36, P310, DOI 10.1016/j.tips.2015.03.001; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Reid HM, 2011, CELL SIGNAL, V23, P700, DOI 10.1016/j.cellsig.2010.12.003; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Soto-Pantoja DR, 2009, MOL CANCER THER, V8, P1676, DOI 10.1158/1535-7163.MCT-09-0161; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092082; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Verano-Braga T, 2012, J PROTEOME RES, V11, P3370, DOI 10.1021/pr3001755; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Yin YK, 2013, ANTICANCER RES, V33, P1499; Zhang Wei, 2013, Transl Respir Med, V1, DOI 10.1186/2213-0802-1-12; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x; Zheng S, 2015, BIOCHEM BIOPH RES CO, V460, P333, DOI 10.1016/j.bbrc.2015.03.035	52	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162094	10.1371/journal.pone.0162094	http://dx.doi.org/10.1371/journal.pone.0162094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598578	gold, Green Published			2022-12-27	WOS:000383254800041
J	Nole, P; Duijndam, B; Stenman, A; Juhlin, CC; Kozyra, M; Larsson, C; Ingelman-Sundberg, M; Johansson, I				Nole, Paola; Duijndam, Britt; Stenman, Adam; Juhlin, C. Christofer; Kozyra, Mikael; Larsson, Catharina; Ingelman-Sundberg, Magnus; Johansson, Inger			Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas	PLOS ONE			English	Article							COLORECTAL-CANCER; CYP2W1; ENZYME; TUMORS	Human cytochome P450 2W1 (CYP2W1) enzyme is expressed in fetal colon and in colon tumors. The level of expression is higher in colon metastases than in the parent tumors and the enzyme is a possible drug target for treatment of colorectal cancer, as demonstrated in mouse xenograft studies. A previous study published in this journal reported that CYP2W1 is highly expressed in normal and transformed adrenal tissue. However, adrenal expression of CYP2W1 protein was not seen in previous studies in our research group. To clarify this inconsistency, we have used qRT-PCR and Western blotting with CYP2W1-specific antibodies to probe a panel of 27 adrenocortical carcinomas and 35 normal adrenal cortex samples. CYP2W1 mRNA expression is seen in all samples. However, significant CYP2W1 protein expression was found in only one tumor sample (a testosterone-producing adrenocortical carcinoma) and not in any normal tissue. Differences in the specificity of the CYP2W1 antibodies used in the two studies may explain the apparent discrepancy. We conclude that normal adrenal tissue lacks P450 2W1 enzyme expression; also, adrenocortical carcinomas generally do not express the enzyme. This information thus underline the colon cancer specificity of CYP2W1 enzyme expression and has implications for the development of anti-colon cancer therapies based on CYP2W1 as a drug target, since 2W1-dependent bioactivation of prodrugs for CYP2W1 will not take place in normal adrenal tissue or other non-transformed tissues.	[Nole, Paola; Duijndam, Britt; Kozyra, Mikael; Ingelman-Sundberg, Magnus; Johansson, Inger] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Stenman, Adam; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Stenman, Adam; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Univ Hosp, Canc Ctr Karolinska, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Johansson, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	inger.johansson@ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021; Stenman, Adam/AAI-3866-2021; Juhlin, Carl Christofer/C-1125-2016	Stenman, Adam/0000-0003-3248-7629; Juhlin, Carl Christofer/0000-0002-5945-9081	Vetenskapsradet (The Swedish Research Council); Cancerfonden (The Swedish Cancer Society)	Vetenskapsradet (The Swedish Research Council)(Swedish Research Council); Cancerfonden (The Swedish Cancer Society)(Swedish Cancer Society)	The funders Vetenskapsradet (The Swedish Research Council) and Cancerfonden (The Swedish Cancer Society) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; Choong E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122820; Edler D, 2009, EUR J CANCER, V45, P705, DOI 10.1016/j.ejca.2008.11.031; Gomez A, 2007, PHARMACOGENOMICS, V8, P1315, DOI 10.2217/14622416.8.10.1315; Gomez A, 2010, MOL PHARMACOL, V78, P1004, DOI 10.1124/mol.110.067652; Guo J, 2016, DRUG METAB REV, V48, P369, DOI 10.1080/03602532.2016.1188939; Juhlin CC, 2015, J CLIN ENDOCR METAB, V100, pE493, DOI 10.1210/jc.2014-3282; Karlgren M, 2006, BIOCHEM BIOPH RES CO, V341, P451, DOI 10.1016/j.bbrc.2005.12.200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronchi CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105855; Sheldrake HM, 2013, J MED CHEM, V56, P6273, DOI 10.1021/jm4000209; Stenstedt K, 2014, ACTA ONCOL, V53, P885, DOI 10.3109/0284186X.2014.887224; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238	14	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162379	10.1371/journal.pone.0162379	http://dx.doi.org/10.1371/journal.pone.0162379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598485	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800060
J	Opalach, C; Romaszko, J; Jaracz, M; Kuchta, R; Borkowska, A; Bucinski, A				Opalach, Cezary; Romaszko, Jerzy; Jaracz, Marcin; Kuchta, Robert; Borkowska, Alina; Bucinski, Adam			Coping Styles and Alcohol Dependence among Homeless People	PLOS ONE			English	Article							OF-THE-LITERATURE; MENTAL-DISORDERS; VOLUME LOSS; HEALTH; MORTALITY; CONSUMPTION; POPULATION; PREVALENCE; COUNTRIES; GERMANY	Background and Objectives The ways in which homeless individuals cope with stress may differ from those relied upon by the members of the general population and these differences may either be the result or the cause of their living conditions. The aim of the study was to determine the preferred coping style among the homeless and its relationship with alcohol dependence. Methods The study included 78 homeless individuals and involved the collection of demographic, sociological, psychological and medical data from each participant. Coping styles relied upon when dealing with stressful situations were assessed using a Polish adaptation of the Coping Inventory for Stressful Situations. Alcohol dependence was assessed using the Michigan Alcoholism Screening Test (MAST) and a quantitative analysis of alcohol consumption. Results Men accounted for 91.93% of the study population. Nearly 75% of the subjects met the alcohol dependence criterion. Significant relationships were observed between the individual's age, preferred coping style and alcohol consumption level. As an individual's age increased, the use of emotion-oriented coping styles decreased, while an increase in alcohol consumption was associated with a more frequent use of emotion-and avoidance-oriented strategies. Conclusions The findings of this study, similarly to those of many other studies of homeless individuals but investigating other areas (e.g. epidemiology of tuberculosis and traumatic injuries), are an exaggerated representation of associations observed in the general population. The results describe a group of people living on the margins of the society, often suffering from extremely advanced alcoholism, with clear evident psychodegradation. The presence of specific ways of coping with stress related to excessive alcohol consumption in this group of individuals may interfere with active participation in support programmes provided for the homeless and may further exacerbate their problems.	[Opalach, Cezary] Univ Warmia & Mazury, Fac Theol, Ul Kard Hozjusza 15, PL-11041 Olsztyn, Poland; [Romaszko, Jerzy] Univ Warmia & Mazury, Dept Family Med, Ul Warszawska 30, PL-10082 Olsztyn, Poland; [Jaracz, Marcin; Borkowska, Alina] Nicolaus Copernicus Univ Torun, Dept Clin Neuropsychol, Ludwik Rydygier Coll Med Bydgoszcz, Ul M Curie Sklodowskiej 9, PL-85094 Bydgoszcz, Poland; [Kuchta, Robert] Municipal Social Welf Ctr Olsztyn, Ul Towarowa 18, PL-10417 Olsztyn, Poland; [Bucinski, Adam] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Biopharm, Ul A Jurasza 2, PL-85089 Bydgoszcz, Poland	University of Warmia & Mazury; University of Warmia & Mazury; Nicolaus Copernicus University; Nicolaus Copernicus University	Romaszko, J (corresponding author), Univ Warmia & Mazury, Dept Family Med, Ul Warszawska 30, PL-10082 Olsztyn, Poland.	jerzy.romaszko@uwm.edu.pl	Romaszko, Jerzy/AAJ-8112-2020	Romaszko, Jerzy/0000-0002-7929-6822; Opalach, Cezary/0000-0002-3669-5524; Bucinski, Adam/0000-0002-0558-9139				Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Amore K, 2011, EUROPEAN J HOMELESSN, P5; Anderson P.Anderson, 2008, ALCOHOL EUROPE PUBLI; [Anonymous], 2013, DYNAMICS INVOLUTION; Antonovsky A, 1980, HLTH STRESS COPING, Vxiv; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Braun Eszter, 2015, Psychiatr Hung, V30, P60; Busch-Geertsema V., 2014, EXTENT PROFILE HOMEL; Coohey C, 2016, HEALTH SOC WORK, V41, P111, DOI 10.1093/hsw/hlw008; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; DELABRY LO, 1992, J STUD ALCOHOL, V53, P25, DOI 10.15288/jsa.1992.53.25; Egli M, 2012, NEUROSCI BIOBEHAV R, V36, P2179, DOI 10.1016/j.neubiorev.2012.07.010; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fekadu A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0138-x; Ferguson KM, 2010, COMMUNITY MENT HLT J, V46, P296, DOI 10.1007/s10597-009-9264-x; Fichter MM, 2001, ACTA PSYCHIAT SCAND, V103, P94, DOI 10.1034/j.1600-0447.2001.00217.x; Horvath TB, 1975, CLIN SPECTRUM EPIDEM; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Israel N, 2010, AM J COMMUN PSYCHOL, V46, P49, DOI 10.1007/s10464-010-9326-9; KARHUNEN PJ, 1994, BRIT MED J, V308, P1663, DOI 10.1136/bmj.308.6945.1663; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus R. S., 1984, STRESS APPRAISAL COP, P19; Lippert AM, 2015, SOCIOL INQ, V85, P343, DOI 10.1111/soin.12080; Ly A, 2015, CAN J PSYCHIAT, V60, P475, DOI 10.1177/070674371506001103; Medlow S, 2014, J ADOLESCENCE, V37, P531, DOI 10.1016/j.adolescence.2014.04.003; Morikawa Suimei, 2011, Nihon Koshu Eisei Zasshi, V58, P331; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Nickasch B, 2009, J AM ACAD NURSE PRAC, V21, P39, DOI 10.1111/j.1745-7599.2008.00371.x; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Noel X, 2013, CURR OPIN NEUROBIOL, V23, P632, DOI 10.1016/j.conb.2013.01.018; Nusselder WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073979; Ohtsu T, 2011, ACTA MED OKAYAMA, V65, P387; Parker James D. A, 1990, COPING INVENTORY STR; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Pfefferbaum A, 1997, ALCOHOL CLIN EXP RES, V21, P521, DOI 10.1111/j.1530-0277.1997.tb03798.x; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Poland CSOo, NAYION CENS 2011 RES; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Rhoades H, 2011, DRUG ALCOHOL DEPEN, V118, P320, DOI 10.1016/j.drugalcdep.2011.04.011; Ron M A, 1983, Psychol Med Monogr Suppl, V3, P1; Salize HJ, 2002, ADDICTION, V97, P1593, DOI 10.1046/j.1360-0443.2002.00235.x; Schanzer B, 2007, AM J PUBLIC HEALTH, V97, P464, DOI 10.2105/AJPH.2005.076190; SELYE H, 1949, RES PUBL ASSOC RES N, V29, P3; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Szczepaniak P., 2005, KWESTIONARIUSZ RADZE; Thompson S, 2010, EVAL PROGRAM PLANN, V33, P418, DOI 10.1016/j.evalprogplan.2010.02.002; Thomsen R L, 2000, Ugeskr Laeger, V162, P1205; Toro PA, 2014, AM J COMMUN PSYCHOL, V53, P134, DOI 10.1007/s10464-014-9632-8; Yoon Changgyo, 2011, J Prev Med Public Health, V44, P267, DOI 10.3961/jpmph.2011.44.6.267	53	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162381	10.1371/journal.pone.0162381	http://dx.doi.org/10.1371/journal.pone.0162381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IT	27598582	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800061
J	Sundaram, K; Rahman, MA; Mitra, S; Knoell, DL; Woodiga, SA; King, SJ; Wewers, MD				Sundaram, Kruthika; Rahman, Mohd. Akhlakur; Mitra, Srabani; Knoell, Daren L.; Woodiga, Shireen A.; King, Samantha J.; Wewers, Mark D.			I kappa B zeta Regulates Human Monocyte Pro-Inflammatory Responses Induced by Streptococcus pneumoniae	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; GELATINASE-ASSOCIATED LIPOCALIN; RESPIRATORY EPITHELIAL-CELLS; PNEUMOCOCCAL PNEUMONIA; VIRULENCE FACTORS; NUCLEAR-PROTEIN; LUNG EPITHELIUM; OCULAR SURFACE; DISEASE; MICE	Pneumococcal lung infections represent a major cause of death worldwide. Single nucleotide polymorphisms (SNPs) in the NFKBIZ gene, encoding the transcription factor I kappa B zeta, are associated with increased susceptibility to invasive pneumococcal disease. We hence analyzed how I kappa B zeta might regulate inflammatory responses to pneumococcal infection. We first demonstrate that I kappa B zeta is expressed in human blood monocytes but not in bronchial epithelial cells, in response to wild type pneumococcal strain D39. D39 transiently induced I kappa B zeta in a dose dependent manner, with subsequent induction of downstream molecules involved in host defense. Of these molecules, I kappa B zeta knockdown reduced the expression of IL-6 and GMCSF. Furthermore, I kappa B zeta overexpression increased the activity of IL-6 and GMCSF promoters, supporting the knockdown findings. Pneumococci lacking either pneumolysin or capsule still induced I kappa B zeta. While inhibition of TLR1/TLR2 blocked D39 induced I kappa B zeta expression, TLR4 inhibition did not. Blockade of p38 MAP kinase and NF kappa B suppressed D39 induced I kappa B zeta. Overall, our data demonstrates that I.B. regulates monocyte inflammatory responses to Streptococcus pneumoniae by promoting the production of IL-6 and GMCSF.	[Sundaram, Kruthika; Mitra, Srabani; Wewers, Mark D.] Ohio State Univ, Med Ctr, Pulm Allergy Crit Care & Sleep Med, Dept Internal Med,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Rahman, Mohd. Akhlakur; Knoell, Daren L.] Ohio State Univ, Coll Pharm, Dept Pharm, Columbus, OH 43210 USA; [Rahman, Mohd. Akhlakur; Knoell, Daren L.; Woodiga, Shireen A.; King, Samantha J.; Wewers, Mark D.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Woodiga, Shireen A.; King, Samantha J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [King, Samantha J.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Med Ctr, Pulm Allergy Crit Care & Sleep Med, Dept Internal Med,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Wewers, MD (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	wewers.2@osu.edu	Sundaram, Kruthika/J-4010-2019; Wewers, Mark/AAB-6202-2021; Wewers, Mark/H-8317-2015	Sundaram, Kruthika/0000-0003-0510-424X; Wewers, Mark/0000-0002-7079-5633	National Institute of Health [HL076278, HL089440]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MDW received grants HL076278 and HL089440 from National Institute of Health to support this work.	Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; ANDERSSON B, 1989, Respiration, V55, P49; Antunes G, 2002, EUR RESPIR J, V20, P990, DOI 10.1183/09031936.02.00295102; Barthelson R, 1998, INFECT IMMUN, V66, P1439, DOI 10.1128/IAI.66.4.1439-1444.1998; Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Crum NF, 2004, CLIN INFECT DIS, V39, P1148, DOI 10.1086/424522; Currie AJ, 2004, J PEDIATR-US, V144, P512, DOI 10.1016/j.jpeds.2003.10.034; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Goto Y, 2004, AM J RESP CELL MOL, V30, P620, DOI 10.1165/rcmb.2003-0312OC; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jose R, 2015, LANCET, V385, P52, DOI 10.1016/S0140-6736(15)60367-1; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Karin M., REGULATION AP 1 ACTI; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Lorenz J, 2011, EUR RESPIR J, V37, P648, DOI 10.1183/09031936.00200009; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mayer AK, DIFFERENTIAL RECOGNI; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Paterson GK, 2006, MICROBIOL-SGM, V152, P285, DOI 10.1099/mic.0.28551-0; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Raices RM, 2008, CYTOKINE, V44, P234, DOI 10.1016/j.cyto.2008.08.004; Ruiz-Gonzalez A, 1999, AM J MED, V106, P385, DOI 10.1016/S0002-9343(99)00050-9; Schmeck B, STREPTOCOCCUS PNEUMO; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Steinwede K, 2011, J IMMUNOL, V187, P5346, DOI 10.4049/jimmunol.1101413; Sundaram K, 2015, AM J RESP CELL MOL, V53, P400, DOI 10.1165/rcmb.2014-0370OC; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Ueta M, 2005, INVEST OPHTH VIS SCI, V46, P579, DOI 10.1167/iovs.04-1055; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P3387, DOI 10.1167/iovs.08-1691; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Xu F, MODULATION INFLAMMAT; Yamamoto K, 2014, AM J RESP CELL MOL, V50, P253, DOI 10.1165/rcmb.2013-0114OC; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200	54	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161931	10.1371/journal.pone.0161931	http://dx.doi.org/10.1371/journal.pone.0161931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597997	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800025
J	Yang, Y; Ma, YP; Chen, DP; Zhuo, L; Li, WG				Yang, Yue; Ma, Ye-ping; Chen, Da-peng; Zhuo, Li; Li, Wen-ge			A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy	PLOS ONE			English	Article							GLOMERULONEPHRITIS; LAMIVUDINE; EFFICACY	Hepatitis B virus-associated membranous nephropathy (HBV-MN) is the most common renal extra-hepatic manifestation in patients with chronic HBV infection. In September 2015, we searched the MEDLINE, EMBASE, and CENTRAL databases, and the reference lists of retrieved articles, to identify relevant studies. Descriptions of antiviral drugs used to treat HBV-MN were included in our review. Two authors independently screened all relevant articles, extracted data, and assessed the risk of bias. Nine hundred and fifty-four papers have been considered after electronic and manual searching, only five relevant studies were identified. Complete remission (OR = 26.87, 95% CI: 8.06 to 89.52), total remission (OR = 10.31, 95% CI: 3.59 to 29.63) of proteinuria and HBeAg clearance (OR = 20.91, 95% CI: 6.90 to 63.39) increased significantly after antiviral therapy. No significant differences were seen between interferon and nucleoside analog treatments. Our study found that antiviral therapy was an effective treatment in HBV-MN patients; interferon and nucleoside analogs were equally effective at causing proteinuria remission and HBeAg clearance.	[Yang, Yue; Ma, Ye-ping; Chen, Da-peng; Zhuo, Li; Li, Wen-ge] China Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China	China-Japan Friendship Hospital	Li, WG (corresponding author), China Japan Friendship Hosp, Dept Nephrol, Beijing, Peoples R China.	wenge_lee2002@126.com	Zhuo, Li/AAF-7903-2021		Beijing Municipal Science & Technology Commission key Project [SCW-2013-04]; China-Japan Friendship Hospital Youth Science and Technology Excellence Project [2015-QNYC-B-12]; Science Foundation of China-Japan Friendship [2013-QN-23]	Beijing Municipal Science & Technology Commission key Project; China-Japan Friendship Hospital Youth Science and Technology Excellence Project; Science Foundation of China-Japan Friendship	This work was supported by Beijing Municipal Science & Technology Commission 2013 key Project (SCW-2013-04), China-Japan Friendship Hospital Youth Science and Technology Excellence Project (2015-QNYC-B-12), and the Science Foundation of China-Japan Friendship (2013-QN-23).	Andrassy KM, 2013, KIDNEY INT, V84, P622, DOI 10.1038/ki.2013.243; [Anonymous], 2015, GUID PREV CAR TREATM; Bhimma R, 2004, AM J NEPHROL, V24, P198, DOI 10.1159/000077065; Bhimma R, 2002, PEDIATR NEPHROL, V17, P393, DOI 10.1007/s00467-001-0814-x; COMBES B, 1971, LANCET, V2, P234; Elewa U, 2011, NEPHRON CLIN PRACT, V119, pC41, DOI 10.1159/000324652; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P781, DOI 10.1111/j.1365-2036.2006.03041.x; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang Z, 2013, J VIRAL HEPATITIS, V20, P52, DOI 10.1111/jvh.12064; LAI KN, 1991, NEW ENGL J MED, V324, P1457, DOI 10.1056/NEJM199105233242103; LAI KN, 1990, NEPHRON, V54, P12; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; Liaw YF, 2009, HEPATOL INT, V3, P425, DOI 10.1007/s12072-009-9140-3; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; LIN CY, 1995, KIDNEY INT, V47, P225, DOI 10.1038/ki.1995.27; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pena A, 2001, CLIN NEPHROL, V55, P25; Sun IO, 2012, KOREAN J INTERN MED, V27, P411, DOI 10.3904/kjim.2012.27.4.411; Tang S, 2005, KIDNEY INT, V68, P1750, DOI 10.1111/j.1523-1755.2005.00591.x; Well G, 2014, NEWCASTLE OTTAWA SCA; Xu GS, 2011, EUR J INTERN MED, V22, P161, DOI 10.1016/j.ejim.2010.11.005; Yi Z, 2011, ANN HEPATOL, V10, P165, DOI 10.1016/S1665-2681(19)31565-0; Zhang Y, 2010, WORLD J GASTROENTERO, V16, P770, DOI 10.3748/wjg.v16.i6.770; Zheng XY, 2012, WORLD J GASTROENTERO, V18, P821, DOI 10.3748/wjg.v18.i8.821	26	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0160437	10.1371/journal.pone.0160437	http://dx.doi.org/10.1371/journal.pone.0160437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598699	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800002
J	Gradidge, PJL; Norris, SA; Jaff, NG; Crowther, NJ				Gradidge, Philippe Jean-Luc; Norris, Shane A.; Jaff, Nicole G.; Crowther, Nigel J.			Metabolic and Body Composition Risk Factors Associated with Metabolic Syndrome in a Cohort of Women with a High Prevalence of Cardiometabolic Disease	PLOS ONE			English	Article							CARDIOVASCULAR RISK; AFRICAN WOMEN; ENDOCRINE TRANSITION; INSULIN SENSITIVITY; ABDOMINAL ADIPOSITY; SERUM ADIPONECTIN; FAT MASS; POPULATION; ULTRASOUND; VALIDATION	Background The aetiology of the metabolic syndrome and the inter-relationship between risk factors for this syndrome are poorly understood. The purpose of this investigation was to determine the risk factors for metabolic syndrome and their interactions in a cohort of women with a high prevalence of metabolic syndrome. Materials and Methods Abdominal and whole body composition (ultrasound and dual-energy X-ray absorptiometry), blood pressure, and cardiometabolic and demographic factors were measured in a cross-sectional study of 702 black African women from Soweto, Johannesburg. Data was analysed using multivariate logistic regression. Results Metabolic syndrome was present in 49.6% of the study cohort. Logistic regression analysis demonstrated that adiponectin (odds ratio [95% CIs]: 0.84 [0.77, 0.92], p<0.0005) and abdominal subcutaneous fat (0.56 [0.39, 0.79], p = 0.001) reduced metabolic syndrome risk whilst insulin resistance (1.31 [1.16, 1.48], p<0.0005) and trunk fat-free soft-tissue mass (1.34 [1.10, 1.61], p = 0.002) increased risk. Within this group of risk factors, the relationship of adiponectin with metabolic syndrome risk, when analysed across adiponectin hexiles, was the least affected by adjustment for the other risk factors. Conclusions Adiponectin has a significant protective role against metabolic syndrome and is independent of other risk factors. The protective and possible augmentive effects of abdominal subcutaneous fat and lean trunk mass, respectively on metabolic syndrome risk demonstrate the existence of novel interactions between body composition and cardiometabolic disease.	[Gradidge, Philippe Jean-Luc] Univ Witwatersrand, Fac Hlth Sci, CESSM, Johannesburg, South Africa; [Gradidge, Philippe Jean-Luc; Norris, Shane A.; Jaff, Nicole G.] Univ Witwatersrand, Fac Hlth Sci, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Jaff, Nicole G.; Crowther, Nigel J.] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Gradidge, PJL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, CESSM, Johannesburg, South Africa.; Gradidge, PJL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	philippe.gradidge@wits.ac.za	Norris, Shane/C-4664-2014; Gradidge, Philippe/ABE-4070-2020; Gradidge, Philippe/R-5183-2017	Norris, Shane/0000-0001-7124-3788; Gradidge, Philippe/0000-0001-5225-1184; Gradidge, Philippe/0000-0001-5225-1184; Crowther, Nigel/0000-0002-5766-1745	Wellcome Trust (UK) [092097/Z/10/Z]	Wellcome Trust (UK)(Wellcome Trust)	This study was financially supported by the Wellcome Trust (UK) (grant number 092097/Z/10/Z).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Borel AL, 2015, INT J OBESITY, V39, P495, DOI 10.1038/ijo.2014.163; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Garg M K, 2012, Indian J Endocrinol Metab, V16, P116, DOI 10.4103/2230-8210.91206; Goedecke JH, 2015, DIABETOLOGIA, V58, P2647, DOI 10.1007/s00125-015-3720-7; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gradidge PJL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132914; Gradidge PJL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-934; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Guven A, 2012, INT J MED SCI, V9, P786, DOI 10.7150/ijms.4563; Jaff NG, 2015, METABOLISM, V64, P1031, DOI 10.1016/j.metabol.2015.05.009; Jaff NG, 2014, MENOPAUSE, V21, P1225, DOI [10.1097/GME.0000000000000235, 10.1097/gme.0000000000000235]; Koh SB, 2011, YONSEI MED J, V52, P234, DOI 10.3349/ymj.2011.52.2.234; Kraja AT, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-28; Yubero-Serrano EM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.53; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2003, DIABETES, V52, P2160, DOI 10.2337/diabetes.52.8.2160; Meilleur KG, 2010, J CLIN ENDOCR METAB, V95, P3517, DOI 10.1210/jc.2009-2765; Overland S, 2013, ADDICTION, V108, P2019, DOI 10.1111/add.12313; Pietrobelli A, 1999, AM J CLIN NUTR, V69, P614; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Rolfe EDL, 2011, OBESITY, V19, P1892, DOI 10.1038/oby.2011.213; Schlecht I, 2014, METABOLISM, V63, P1512, DOI 10.1016/j.metabol.2014.07.012; Senekal M, 2003, ETHNIC DIS, V13, P109; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; Twisk JWR, 1996, J EPIDEMIOL COMMUN H, V50, P505, DOI 10.1136/jech.50.5.505; Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Williams MJ, 1997, AM J CLIN NUTR, V65, P855, DOI 10.1093/ajcn/65.3.855; Zhang LJ, 2013, INT J CARDIOL, V167, P250, DOI 10.1016/j.ijcard.2011.12.079	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162247	10.1371/journal.pone.0162247	http://dx.doi.org/10.1371/journal.pone.0162247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589387	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800041
J	Li, XY; Duan, XB; Yang, K; Zhang, W; Zhang, CJ; Fu, LF; Ren, Z; Wang, CX; Wu, JH; Lu, RX; Ye, YR; He, MY; Nie, C; Yang, NB; Wang, J; Yang, HM; Liu, X; Tan, W				Li, Xinyang; Duan, Xiaobo; Yang, Kai; Zhang, Wei; Zhang, Changjiang; Fu, Longfei; Ren, Zhe; Wang, Changxi; Wu, Jinghua; Lu, Ruxue; Ye, Yanrui; He, Mengying; Nie, Chao; Yang, Naibo; Wang, Jian; Yang, Huanming; Liu, Xiao; Tan, Wen			Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; ANTIGEN-BINDING; LYMPHOBLASTIC-LEUKEMIA; ROBUST PIPELINE; FV FRAGMENT; DOMAIN; IMMUNOGLOBULINS; NANOBODIES; STABILITY; GERMLINE	Compared to classical antibodies, camel heavy chain antibodies (HCAbs) are smaller in size due to lack of the light chain and the first constant domain of the heavy chain (CH1 region). The variable regions of HCAbs (VHHs) are more soluble and stable than that of conventional antibodies (VHs). Even with such simple structure, they are still functional in antigen binding. Although HCAbs have been extensively investigated over the past two decades, most efforts have been based upon low throughput sequence analysis, and there are only limited reports trying to analyze and describe the complete immune repertoire (IR) of camel HCAbs. Here we leveraged the high-throughput data generated by Next Generation Sequencing (NGS) of the variable domains of the antibody heavy chains from three Bactrian camels to conduct in-depth comparative analyses of the immunoglobulin repertoire. These include analyses of the complementary determining region 3 (CDR3) length and distribution, mutation rate, antibody characteristic amino acids, the distribution of the cysteine (Cys) codons, and the non-classical VHHs. We found that there is higher diversity in the CDR2 than in the other sub-regions, and there is a higher mutation rate in the VHHs than in the VHs (P < 0.05). In addition to substitutions at amino acid (AA) residue positions NO. 49/50/52 between VH and VHH clones, we also observed other substitutions at the positions NO. 40/54/57/96/101 that could lead to additional structural alterations. We also found that VH-derived VHH clones, referred to as non-classical VHH clones in this study, accounted for about 8% of all clones. Further, only 5%-10% clones had the Trp > Arg AA substitution at the first position of framework 4 for all types of clones. We present, for the first time, a relatively complete picture of the Bactrian camel antibody immune repertoire, including conventional antibody (Ab) and HCAbs, using PCR and in silico analysis based on high-throughput NGS data.	[Duan, Xiaobo; Zhang, Changjiang; Ye, Yanrui; He, Mengying; Tan, Wen] South China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China; [Li, Xinyang; Yang, Kai; Zhang, Wei; Fu, Longfei; Ren, Zhe; Wang, Changxi; Wu, Jinghua; Nie, Chao; Yang, Naibo; Wang, Jian; Yang, Huanming; Liu, Xiao] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Liu, Xiao] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Duan, Xiaobo; Zhang, Changjiang; Ye, Yanrui; Tan, Wen] South China Univ Technol, Sch Biosci & Bioengn, Key Lab Ind Biotechnol, Guangdong Higher Educ Inst, Guangzhou 510006, Guangdong, Peoples R China; [Duan, Xiaobo; Zhang, Changjiang; Ye, Yanrui; Tan, Wen] South China Univ Technol, Sch Biosci & Bioengn, Preincubator Innovat Drugs & Med, Guangzhou 510006, Guangdong, Peoples R China; [Lu, Ruxue] Zhangye City Bur Anim Husb & Vet, Zhangye 734000, Gansu, Peoples R China; [Wang, Jian; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Wen] Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology; Beijing Genomics Institute (BGI); University of Copenhagen; South China University of Technology; South China University of Technology; Guangdong University of Technology	Tan, W (corresponding author), South China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China.; Liu, X (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; Liu, X (corresponding author), Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark.; Tan, W (corresponding author), South China Univ Technol, Sch Biosci & Bioengn, Key Lab Ind Biotechnol, Guangdong Higher Educ Inst, Guangzhou 510006, Guangdong, Peoples R China.; Tan, W (corresponding author), South China Univ Technol, Sch Biosci & Bioengn, Preincubator Innovat Drugs & Med, Guangzhou 510006, Guangdong, Peoples R China.; Tan, W (corresponding author), Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.	liuxiao@genomics.cn; went@gdut.edu.cn	Liu, Xiao/P-2732-2015	Liu, Xiao/0000-0002-8073-0534; Zhang, Wei/0000-0002-6968-6974; Ren, Zhe/0000-0002-9042-2383	BGI-Shenzhen-South China University of Technology, Renovation foundation [SW20130804]; Guangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering	BGI-Shenzhen-South China University of Technology, Renovation foundation; Guangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering	This work was supported by BGI-Shenzhen-South China University of Technology, Renovation foundation (SW20130804). The website of BGI-Shenzhen is http://www.genomics.cn/en/index. The website of South China University of Technology is http://www.scut.edu.cn/. Tan W and Liu X received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Brock Peters and Mr. Yi Liu for revising the manuscript. This work was supported by BGI-Shenzhen-South China University of Technology, Renovation foundation (SW20130804). We also acknowledge the supports of Guangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering.	Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Faham M, 2012, BLOOD, V120, P5173, DOI 10.1182/blood-2012-07-444042; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Griffin LM, 2014, J IMMUNOL METHODS, V405, P35, DOI 10.1016/j.jim.2014.01.003; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Klarenbeek A, 2015, MABS-AUSTIN, V7, P693, DOI 10.1080/19420862.2015.1046648; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Li ZF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10092; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Romer T, 2011, CURR OPIN BIOTECH, V22, P882, DOI 10.1016/j.copbio.2011.06.007; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Willuda J, 1999, CANCER RES, V59, P5758; Wu D, 2014, CLIN CANCER RES, V20, P4540, DOI 10.1158/1078-0432.CCR-13-3231; Zhang W, 2015, GENETICS, V201, P459, DOI 10.1534/genetics.115.176735	32	18	18	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161801	10.1371/journal.pone.0161801	http://dx.doi.org/10.1371/journal.pone.0161801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588755	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800018
J	Scherer, SD; Bauer, J; Schmaus, A; Neumaier, C; Herskind, C; Veldwijk, MR; Wenz, F; Sleeman, JP				Scherer, Sandra D.; Bauer, Jochen; Schmaus, Anja; Neumaier, Christian; Herskind, Carsten; Veldwijk, Marlon R.; Wenz, Frederik; Sleeman, Jonathan P.			TGF-beta 1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; KILOVOLTAGE X-RAYS; TGF-BETA; RADIOTHERAPY IORT; CONSERVING SURGERY; LYMPHATIC REGENERATION; LY2157299 MONOHYDRATE; SIGNALING PATHWAY; HYALURONIC-ACID; INHIBITOR	In patients with low-risk breast cancer, intraoperative radiotherapy (IORT) during breast-conserving surgery is a novel and convenient treatment option for delivering a single high dose of irradiation directly to the tumour bed. However, edema and fibrosis can develop after surgery and radiotherapy, which can subsequently impair quality of life. TGF-beta is a strong inducer of the extracellular matrix component hyaluronan (HA). TGF-beta expression and HA metabolism can be modulated by irradiation experimentally, and are involved in edema and fibrosis. We therefore hypothesized that IORT may regulate these factors. Wound fluid (WF) draining from breast lumpectomy sites was collected and levels of TGF-beta 1 and HA were determined by ELISA. Proliferation and marker expression was analyzed in primary lymphatic endothelial cells (LECs) treated with recombinant TGF-beta or WF. Our results show that IORT does not change TGF-beta 1 or HA levels in wound fluid draining from breast lumpectomy sites, and does not lead to accumulation of sHA oligosaccharides. Nevertheless, concentrations of TGF-beta 1 were high in WF from patients regardless of IORT, at concentrations well above those associated with fibrosis and the suppression of LEC identity. Consistently, we found that TGF-beta in WF is active and inhibits LEC proliferation. Furthermore, all three TGF-beta isoforms inhibited LEC proliferation and suppressed LEC marker expression at pathophysiologically relevant concentrations. Given that TGF-beta contributes to edema and plays a role in the regulation of LEC identity, we suggest that inhibition of TGF-beta directly after surgery might prevent the development of side effects such as edema and fibrosis.	[Scherer, Sandra D.; Bauer, Jochen; Schmaus, Anja; Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim, Mannheim, Germany; [Scherer, Sandra D.; Bauer, Jochen; Schmaus, Anja; Sleeman, Jonathan P.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Neumaier, Christian; Herskind, Carsten; Veldwijk, Marlon R.] Heidelberg Univ, Univ Med Mannheim, Dept Radiat Oncol, Med Fac Mannheim, Mannheim, Germany; [Bauer, Jochen] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; University of Wurzburg	Sleeman, JP (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim, Mannheim, Germany.; Sleeman, JP (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	sleeman@medma.uni-heidelberg.de	Sleeman, Jonathan P/H-2515-2013; Herskind, Carsten/J-2457-2019	Sleeman, Jonathan P/0000-0003-1718-7687; Herskind, Carsten/0000-0001-6554-5907	Carl Zeiss Meditec AG; Klinikum Mannheim GmbH (Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie); Deutsche Forschungsgemeinschaft Schwerpunkt Programm "tumor vessel interface" [SPP1190]	Carl Zeiss Meditec AG; Klinikum Mannheim GmbH (Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie); Deutsche Forschungsgemeinschaft Schwerpunkt Programm "tumor vessel interface"	This work was supported by: Carl Zeiss Meditec AG: CH FW; Klinikum Mannheim GmbH (Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie): JPS; and Deutsche Forschungsgemeinschaft Schwerpunkt Programm SPP1190 "tumor vessel interface": JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Aiba-Kojima E, 2007, WOUND REPAIR REGEN, V15, P511, DOI 10.1111/j.1524-475X.2007.00259.x; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Albeiroti S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/790203; Alvarado MD, 2014, BREAST CANCER RES TR, V143, P135, DOI 10.1007/s10549-013-2782-9; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Anscher MS, 2006, INT J RADIAT ONCOL, V65, P876, DOI 10.1016/j.ijrobp.2006.02.051; ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2010, AM J PHYSIOL-CELL PH, V299, pC589, DOI 10.1152/ajpcell.00535.2009; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Brown LC, 2015, INT J WOMENS HEALTH, V7, P449, DOI 10.2147/IJWH.S55552; Chajara A, 2000, ARTERIOSCL THROM VAS, V20, P1480, DOI 10.1161/01.ATV.20.6.1480; Chod J, 2008, EUR J GYNAECOL ONCOL, V29, P613; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Curigliano G, 2005, BREAST CANCER RES TR, V93, P35, DOI 10.1007/s10549-005-3381-1; Daar E, 2010, APPL RADIAT ISOTOPES, V68, P746, DOI 10.1016/j.apradiso.2009.10.022; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Della Sala SW, 2006, EUR J RADIOL, V59, P222, DOI 10.1016/j.ejrad.2006.03.003; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jung H, 2011, CYTOTECHNOLOGY, V63, P57, DOI 10.1007/s10616-010-9327-4; Keshtgar MRS, 2013, BREAST CANCER RES TR, V140, P519, DOI 10.1007/s10549-013-2641-8; KONG FM, 1995, ANN SURG, V222, P155, DOI 10.1097/00000658-199508000-00007; Kraus-Tiefenbacher U, 2006, ONKOLOGIE, V29, P77, DOI 10.1159/000091160; Kraus-Tiefenbacher U, 2003, ONKOLOGIE, V26, P596, DOI 10.1159/000074158; Kraus-Tiefenbacher U, 2010, INT J RADIAT ONCOL, V77, P1140, DOI 10.1016/j.ijrobp.2009.06.008; Krishnan L, 2001, CANCER, V91, P2282, DOI 10.1002/1097-0142(20010615)91:12<2282::AID-CNCR1259>3.0.CO;2-0; KUMAR S, 1989, INT J CANCER, V44, P445, DOI 10.1002/ijc.2910440311; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Liao S, 2011, CLIN CANCER RES, V17, P1415, DOI 10.1158/1078-0432.CCR-10-2429; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Moran MS, 2009, SEMIN RADIAT ONCOL, V19, P244, DOI 10.1016/j.semradonc.2009.05.007; Moritake T, 2012, INT J RADIAT ONCOL, V84, pE95, DOI 10.1016/j.ijrobp.2012.02.013; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; MORTIMER PS, 1991, BRIT J RADIOL, V64, P1140, DOI 10.1259/0007-1285-64-768-1140; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; ONO I, 1995, J DERMATOL SCI, V10, P241, DOI 10.1016/0923-1811(95)00454-Z; ONO I, 1995, BURNS, V21, P352, DOI 10.1016/0305-4179(95)00005-4; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Rodon J, 2015, CLIN CANCER RES, V21, P553, DOI 10.1158/1078-0432.CCR-14-1380; Ruano-Ravina A, 2011, CANCER LETT, V313, P15, DOI 10.1016/j.canlet.2011.08.020; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; Schmaus A, 2014, BRIT J CANCER, V111, P559, DOI 10.1038/bjc.2014.332; Schmaus A, 2014, CANCER METAST REV, V33, P1059, DOI 10.1007/s10555-014-9532-2; Sperk E, 2012, BREAST CANCER RES TR, V135, P253, DOI 10.1007/s10549-012-2168-4; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Veldwijk MR, 2015, TRANSL CANCER RES, V4, P173, DOI 10.3978/j.issn.2218.676X.2015.04.01; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Warren LEG, 2014, INT J RADIAT ONCOL, V88, P565, DOI 10.1016/j.ijrobp.2013.11.232; Wenz F, 2015, BREAST CARE, V10, P247, DOI 10.1159/000437194; Wenz F, 2010, INT J RADIAT ONCOL, V77, P1309, DOI 10.1016/j.ijrobp.2009.06.085; Wenz F, 2008, BREAST, V17, P617, DOI 10.1016/j.breast.2008.05.009; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x	73	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162221	10.1371/journal.pone.0162221	http://dx.doi.org/10.1371/journal.pone.0162221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589056	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800038
J	Ashraf, QM; Habaebi, MH; Islam, MR				Ashraf, Qazi Mamoon; Habaebi, Mohamed Hadi; Islam, Md. Rafiqul			Jammer Localization Using Wireless Devices with Mitigation by Self-Configuration	PLOS ONE			English	Article								Communication abilities of a wireless network decrease significantly in the presence of a jammer. This paper presents a reactive technique, to detect and locate the position of a jammer using a distributed collection of wireless sensor devices. We employ the theory of autonomic computing as a framework to design the same. Upon detection of a jammer, the affected nodes self-configure their power consumption which stops unnecessary waste of battery resources. The scheme then proceeds to determine the approximate location of the jammer by analysing the location of active nodes as well as the affected nodes. This is done by employing a circular curve fitting algorithm. Results indicate a high degree of accuracy in localizing a jammer has been achieved.	[Ashraf, Qazi Mamoon; Habaebi, Mohamed Hadi; Islam, Md. Rafiqul] Univ Islam Antarabangsa, Dept Elect & Comp Engn, Jalan Gombak, Selangor, Malaysia		Ashraf, QM (corresponding author), Univ Islam Antarabangsa, Dept Elect & Comp Engn, Jalan Gombak, Selangor, Malaysia.	mamoonq@gmail.com	Habaebi, Mohamed Hadi/P-2128-2017	Habaebi, Mohamed Hadi/0000-0002-2263-0850; Islam, Md Rafiqul/0000-0003-0808-2840	Ministry of Higher Education Malaysia (MOHE) under Exploratory Research Grant Scheme (ERGS) [ERGS13-023-0055]	Ministry of Higher Education Malaysia (MOHE) under Exploratory Research Grant Scheme (ERGS)	Primary Researcher: Mohamed Hadi Habaebi. This research was supported by the Ministry of Higher Education Malaysia (MOHE) under Exploratory Research Grant Scheme (ERGS) number ERGS13-023-0055. This work is protected under Malaysian Patent Pending No. PI 2014002288.	Albanese M, 2014, AD HOC NETW, V14, P84, DOI 10.1016/j.adhoc.2013.11.007; [Anonymous], 2008, 3 INT C COMM NETW CH; Ashraf Q. M., 2014, INT C CONTR ENG INF; Ashraf Q. M., 2015, RECENT ADV COMPUT SC, P215; Ashraf Q. M., 2014, IEEE INNOVATIVE SMAR; Ashraf QM, 2015, J NETW COMPUT APPL, V49, P112, DOI 10.1016/j.jnca.2014.11.011; Babaoglu O., 2005, LNCS, V3460, DOI [10.1007/b136551, DOI 10.1007/B136551]; Babar SD, 2013, 2013 3RD INTERNATIONAL CONFERENCE ON WIRELESS COMMUNICATIONS, VEHICULAR TECHNOLOGY, INFORMATION THEORY AND AEROSPACE & ELECTRONIC SYSTEMS (VITAE); Cai YF, 2013, COMPUT NETW, V57, P3799, DOI 10.1016/j.comnet.2013.09.004; Cheng T., 2012, 26 IEEE INT C ADV IN; Cheng T., 2011, 7 INT C COMP INT SEC; Habaebi M. H., 2014, Malaysia Patent Malaysian Patent, Patent No. [PI 2014002288, 2014002288]; Henrici D, 2004, LECT NOTES COMPUT SC, V3001, P219; Karim L, 2015, J NETW COMPUT APPL, V47, P137, DOI 10.1016/j.jnca.2014.07.034; Kephart JO, 2003, COMPUTER, V36, P41, DOI 10.1109/MC.2003.1160055; Kim YS, 2012, IEEE ICC; Liu H., 2009, IEEE INT C PERV COMP; Liu HB, 2011, WIREL NETW, V17, P531, DOI 10.1007/s11276-010-0295-6; Liu ZH, 2014, IEEE T PARALL DISTR, V25, P508, DOI 10.1109/TPDS.2013.33; Liu ZH, 2012, IEEE T PARALL DISTR, V23, P547, DOI 10.1109/TPDS.2011.154; Liu ZH, 2010, LECT NOTES COMPUT SC, V6131, P348; Maisonobe L., 2007, FINDING CIRCLE BEST; Mills KL, 2007, WIREL COMMUN MOB COM, V7, P823, DOI 10.1002/wcm.499; Mpitziopoulos A, 2009, IEEE COMMUN SURV TUT, V11, P42, DOI 10.1109/SURV.2009.090404; Pandarinath P., 2011, INT C EL COMP TECHN; Pelechrinis K, 2009, GLOB TELECOMM CONF, P1301; Umbach D, 2003, IEEE T INSTRUM MEAS, V52, P1881, DOI 10.1109/TIM.2003.820472; VELEZ EF, 1990, P SOC PHOTO-OPT INS, V1348, P484, DOI 10.1117/12.23502	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160311	10.1371/journal.pone.0160311	http://dx.doi.org/10.1371/journal.pone.0160311			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583378	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600004
J	Nguyen, CT; Tanaka, K; Cao, YR; Cho, SH; Xu, D; Stacey, G				Cuong The Nguyen; Tanaka, Kiwamu; Cao, Yangrong; Cho, Sung-Hwan; Xu, Dong; Stacey, Gary			Computational Analysis of the Ligand Binding Site of the Extracellular ATP Receptor, DORN1	PLOS ONE			English	Article							LEGUME LECTIN; CRYSTALLOGRAPHIC STRUCTURE; SIGNALING ROLE; TRIPHOSPHATE; RECOGNITION; PHYTOHEMAGGLUTININ; VISUALIZATION; DOCKING; GROWTH; GENES	DORN1 (also known as P2K1) is a plant receptor for extracellular ATP, which belongs to a large gene family of legume-type (L-type) lectin receptor kinases. Extracellular ATP binds to DORN1 with strong affinity through its lectin domain, and the binding triggers a variety of intracellular activities in response to biotic and abiotic stresses. However, information on the tertiary structure of the ligand binding site of DORN1 is lacking, which hampers efforts to fully elucidate the mechanism of receptor action. Available data of the crystal structures from more than 50 L-type lectins enable us to perform an in silico study of molecular interaction between DORN1 and ATP. In this study, we employed a computational approach to develop a tertiary structure model of the DORN1 lectin domain. A blind docking analysis demonstrated that ATP binds to a cavity made by four loops (defined as loops A B, C and D) of the DORN1 lectin domain with high affinity. In silico target docking of ATP to the DORN1 binding site predicted interaction with 12 residues, located on the four loops, via hydrogen bonds and hydrophobic interactions. The ATP binding pocket is structurally similar in location to the carbohydrate binding pocket of the canonical L-type lectins. However, four of the residues predicted to interact with ATP are not conserved between DORN1 and the other carbohydrate-binding lectins, suggesting that diversifying selection acting on these key residues may have led to the ATP binding activity of DORN1. The in silico model was validated by in vitro ATP binding assays using the purified extracellular lectin domain of wild-type DORN1, as well as mutated DORN1 lacking key ATP binding residues.	[Cuong The Nguyen; Cao, Yangrong; Cho, Sung-Hwan; Stacey, Gary] Univ Missouri, Div Plant Sci & Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Tanaka, Kiwamu] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Xu, Dong] Univ Missouri, Inst Informat, Dept Comp Sci, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Cao, Yangrong] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan 430070, Peoples R China	University of Missouri System; University of Missouri Columbia; Washington State University; University of Missouri System; University of Missouri Columbia; Huazhong Agricultural University	Stacey, G (corresponding author), Univ Missouri, Div Plant Sci & Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.	staceyg@missouri.edu	Tanaka, Kiwamu/E-9942-2013; Xu, Dong/Y-8605-2018; Cho, Sung-Hwan/AFO-8760-2022	Tanaka, Kiwamu/0000-0001-5045-560X; Cho, Sung-Hwan/0000-0003-2230-2037; Nguyen, Cuong/0000-0002-8700-9598	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-08ER15309]; Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea [PJ009068]; National Institute of Health [R01-GM100701]; Vietnam Education Development (VIED) scholarship; Division Of Integrative Organismal Systems [1557813] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100701] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vietnam Education Development (VIED) scholarship; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was financially supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309, the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant no. PJ009068) to GS, and the National Institute of Health grant # R01-GM100701 to DX. The Cuong T. Nguyen study program was partly funded by the Vietnam Education Development (VIED) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-08ER15309, the Next-Generation BioGreen 21 Program Systems and Synthetic Agrobiotech Center, Rural Development Administration, Republic of Korea (grant no. PJ009068) to GS, the National Institute of Health (grant no. R01-GM100701) to DX, and the Vietnam Education Development (VIED) scholarship to CTN.	Bardor M, 1999, TRENDS PLANT SCI, V4, P376, DOI 10.1016/S1360-1385(99)01461-2; Bouckaert J, 1995, PROTEINS, V23, P510, DOI 10.1002/prot.340230406; Boyum R, 1997, MICROBIOL-SGM, V143, P1901, DOI 10.1099/00221287-143-6-1901; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Choi J, 2014, SCIENCE, V343, P290, DOI 10.1126/science.343.6168.290; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2001, COMPARATIVE PROTEIN; Etzler ME, 2009, CUMMINGS RD L TYPE L; Geethanandan K, 2011, INT J BIOL MACROMOL, V49, P992, DOI 10.1016/j.ijbiomac.2011.08.021; Gouget A, 2006, PLANT PHYSIOL, V140, P81, DOI 10.1104/pp.105.066464; Hamelryck TW, 1999, J MOL BIOL, V286, P1161, DOI 10.1006/jmbi.1998.2534; Hamelryck TW, 1996, J BIOL CHEM, V271, P20479, DOI 10.1074/jbc.271.34.20479; HOLTON P, 1959, J PHYSIOL-LONDON, V145, P494, DOI 10.1113/jphysiol.1959.sp006157; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Ivanova EP, 2006, INT MICROBIOL, V9, P37; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Kim SH, 2009, BIOSCI BIOTECH BIOCH, V73, P1252, DOI 10.1271/bbb.80660; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; PARISH RW, 1980, FEBS LETT, V118, P263, DOI 10.1016/0014-5793(80)80234-1; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Sharon N, 2007, LECTINS; Shetty KN, 2013, IUBMB LIFE, V65, P633, DOI 10.1002/iub.1177; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Srobarova A, 2009, CHEM BIODIVERS, V6, P1208, DOI 10.1002/cbdv.200800158; STURM A, 1986, PLANT PHYSIOL, V81, P320, DOI 10.1104/pp.81.1.320; STURM A, 1992, EUR J BIOCHEM, V204, P313, DOI 10.1111/j.1432-1033.1992.tb16639.x; Tanaka K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00446; Thomas C, 2000, PLANT CELL, V12, P519, DOI 10.1105/tpc.12.4.519; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Damme EJ, 1998, HANDBOOK OF PLANT LE; Van Damme EJM, 1998, CRIT REV PLANT SCI, V17, P575, DOI 10.1016/S0735-2689(98)00365-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weerasinghe RR, 2009, FEBS LETT, V583, P2521, DOI 10.1016/j.febslet.2009.07.007; Wu J, 2007, PLANT PHYSIOL, V144, P961, DOI 10.1104/pp.107.097568; Wu SJ, 2008, PLANT CELL PHYSIOL, V49, P617, DOI 10.1093/pcp/pcn033; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447	55	14	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161894	10.1371/journal.pone.0161894	http://dx.doi.org/10.1371/journal.pone.0161894			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583834	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600071
J	Fontana, MF; Baccarella, A; Craft, JF; Boyle, MJ; McIntyre, TI; Wood, MD; Thorn, KS; Anidi, C; Bayat, A; Chung, MR; Hamburger, R; Kim, CY; Pearman, E; Pham, J; Tang, JJ; Boon, L; Kamya, MR; Dorsey, G; Feeney, ME; Kim, CC				Fontana, Mary F.; Baccarella, Alyssa; Craft, Joshua F.; Boyle, Michelle J.; McIntyre, Tara I.; Wood, Matthew D.; Thorn, Kurt S.; Anidi, Chioma; Bayat, Aqieda; Chung, Me Ree; Hamburger, Rebecca; Kim, Chris Y.; Pearman, Emily; Pham, Jennifer; Tang, Jia J.; Boon, Louis; Kamya, Moses R.; Dorsey, Grant; Feeney, Margaret E.; Kim, Charles C.			A Novel Model of Asymptomatic Plasmodium Parasitemia That Recapitulates Elements of the Human Immune Response to Chronic Infection	PLOS ONE			English	Article							MEMORY B-CELLS; CD4 T-CELLS; MALARIA TRANSMISSION; FALCIPARUM INFECTION; PROTECTIVE IMMUNITY; ERYTHROCYTIC STAGES; ACQUIRED-IMMUNITY; CHABAUDI-ADAMI; HEPATITIS-C; 3 SITES	In humans, immunity to Plasmodium sp. generally takes the form of protection from symptomatic malaria (i.e., 'clinical immunity') rather than infection ('sterilizing immunity'). In contrast, mice infected with Plasmodium develop sterilizing immunity, hindering progress in understanding the mechanistic basis of clinical immunity. Here we present a novel model in which mice persistently infected with P. chabaudi exhibit limited clinical symptoms despite sustaining patent parasite burdens for many months. Characterization of immune responses in persistently infected mice revealed development of CD4(+) T cell exhaustion, increased production of IL-10, and expansion of B cells with an atypical surface phenotype. Additionally, persistently infected mice displayed a dramatic increase in circulating nonclassical monocytes, a phenomenon that we also observed in humans with both chronic Plasmodium exposure and asymptomatic infection. Following pharmacological clearance of infection, previously persistently infected mice could not control a secondary challenge, indicating that persistent infection disrupts the sterilizing immunity that typically develops in mouse models of acute infection. This study establishes an animal model of asymptomatic, persistent Plasmodium infection that recapitulates several central aspects of the immune response in chronically exposed humans. As such, it provides a novel tool for dissection of immune responses that may prevent development of sterilizing immunity and limit pathology during infection.	[Fontana, Mary F.; Baccarella, Alyssa; Craft, Joshua F.; Boyle, Michelle J.; McIntyre, Tara I.; Anidi, Chioma; Bayat, Aqieda; Chung, Me Ree; Hamburger, Rebecca; Kim, Chris Y.; Pearman, Emily; Pham, Jennifer; Tang, Jia J.; Feeney, Margaret E.; Kim, Charles C.] Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA; [Boyle, Michelle J.] Bumet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Wood, Matthew D.] Univ Calif San Francisco, Div Neuropathol, Dept Pathol, San Francisco, CA 94143 USA; [Thorn, Kurt S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Boon, Louis] EPIRUS Biopharmaceut, Utrecht, Netherlands; [Kamya, Moses R.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Dorsey, Grant] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA; [Feeney, Margaret E.] Univ Calif San Francisco, Div Pediat Infect Dis & Global Hlth, Dept Pediat, San Francisco, CA 94143 USA; [Kim, Charles C.] Verily, Mountain View, CA 94043 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kim, CC (corresponding author), Univ Calif San Francisco, Div Expt Med, Dept Med, San Francisco, CA 94143 USA.	cckim47@gmail.com	Boon, Laurence/HCI-3629-2022; Boyle, Michelle/D-4223-2018; Wood, Matthew/HDN-1469-2022; Boyle, Michelle/P-7297-2019; Anidi, Chioma/AAC-2512-2019	Boyle, Michelle/0000-0002-0268-232X; Boyle, Michelle/0000-0002-0268-232X; Anidi, Chioma/0000-0002-2457-2893; Baccarella, Alyssa/0000-0001-8200-9751; Boon, Louis/0000-0002-0937-9171; Kim, Charles/0000-0001-6474-8227; Fontana, Mary/0000-0003-3630-181X; McIntyre, Tara/0000-0001-6670-9977	National Institute of Allergy and Infectious Disease (NIAID) [T32 AI060537, T32 AI007334]; National Health and Medical Research Council Australia [R00 AI085035, R21 AI114916]; UCSF Program for Breakthrough Biomedical Research; National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme; Victorian State Government Operational Infrastructure Support; National Institutes of Health, International Centers of Excellence in Malaria Research (ICEMR) program [U19 AI089674]; EPIRUS Biopharmeceuticals; University of California San Francisco; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, T32AI060537] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); UCSF Program for Breakthrough Biomedical Research; National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; National Institutes of Health, International Centers of Excellence in Malaria Research (ICEMR) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPIRUS Biopharmeceuticals; University of California San Francisco(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Disease (NIAID), T32 AI060537 and T32 AI007334 (MFF); the Dean's Office Medical Student Research Program at the University of California San Francisco (ABac); The National Health and Medical Research Council Australia (https://www.nhmrc.gov.au/) Early-Career Fellowship (MJB); and R00 AI085035, R21 AI114916, and the UCSF Program for Breakthrough Biomedical Research (CCK). The Burnet Institute is supported by the National Health and Medical Research Council Australia Infrastructure for Research Institutes Support Scheme and by the Victorian State Government Operational Infrastructure Support. Funding for human studies was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICEMR) program (U19 AI089674). EPIRUS Biopharmeceuticals provided support in the form of salary for LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "Author Contributions" section. None of the funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Batchelder JM, 2003, EXP PARASITOL, V105, P159, DOI 10.1016/j.exppara.2003.12.003; Bergmann B, 2013, SCAND J IMMUNOL, V78, P149, DOI 10.1111/sji.12073; Boutlis CS, 2006, TRENDS PARASITOL, V22, P371, DOI 10.1016/j.pt.2006.06.002; Boyle MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005041; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; CAVACINI LA, 1990, INFECT IMMUN, V58, P2946, DOI 10.1128/IAI.58.9.2946-2950.1990; Chandele A, 2011, IMMUNOLOGY, V132, P273, DOI 10.1111/j.1365-2567.2010.03363.x; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Costa PAC, 2015, J INFECT DIS, V212, P1999, DOI 10.1093/infdis/jiv306; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; de Mast Q, 2015, J INFECTION, V71, P587, DOI 10.1016/j.jinf.2015.08.005; del Portillo HA, 2012, CELL MICROBIOL, V14, P343, DOI 10.1111/j.1462-5822.2011.01741.x; DUARTE MIS, 1985, AM J TROP MED HYG, V34, P31, DOI 10.4269/ajtmh.1985.34.31; ELASED K, 1994, INFECT IMMUN, V62, P5157, DOI 10.1128/IAI.62.11.5157-5160.1994; do Rosario APF, 2008, J IMMUNOL, V181, P8344, DOI 10.4049/jimmunol.181.12.8344; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; GOOD MF, 1995, PARASITE IMMUNOL, V17, P55, DOI 10.1111/j.1365-3024.1995.tb00966.x; GRUN JL, 1981, NATURE, V290, P143, DOI 10.1038/290143a0; Hafalla JCR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002504; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Horne-Debets JM, 2013, CELL REP, V5, P1204, DOI 10.1016/j.celrep.2013.11.002; Huang BW, 2015, BIO PROTOC, V5; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Illingworth J, 2013, J IMMUNOL, V190, P1038, DOI 10.4049/jimmunol.1202438; Jagannathan P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009793; Jagannathan P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003864; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kim CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048126; LANGHORNE J, 1989, IMMUNOL REV, V112, P71, DOI 10.1111/j.1600-065X.1989.tb00553.x; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Li FJ, 2014, CURR TOP MICROBIOL, V382, P29, DOI 10.1007/978-3-319-07911-0_2; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; LONG CA, 1994, AM J TROP MED HYG, V50, P27, DOI 10.4269/ajtmh.1994.50.27; Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085; MCCOLM AA, 1983, ANN TROP MED PARASIT, V77, P355, DOI 10.1080/00034983.1983.11811724; McDermott DS, 2011, J IMMUNOL, V187, P5568, DOI 10.4049/jimmunol.1102104; Milner D, 2013, HUM PATHOL, V44, P2719, DOI 10.1016/j.humpath.2013.07.018; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; PODOBA JE, 1991, INFECT IMMUN, V59, P51, DOI 10.1128/IAI.59.1.51-58.1991; Portugal S, 2015, ELIFE, V4, DOI 10.7554/eLife.07218; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Rodriguez-Munoz Y, 2011, ALIMENT PHARM THER, V34, P960, DOI 10.1111/j.1365-2036.2011.04807.x; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Seu L, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-27; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Srivastava A, 1996, Trop Gastroenterol, V17, P172; Stephens R, 2012, TRENDS PARASITOL, V28, P73, DOI 10.1016/j.pt.2011.10.006; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Su Z, 2002, J IMMUNOL, V168, P1348, DOI 10.4049/jimmunol.168.3.1348; Sullivan RT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004894; SUSS G, 1988, INFECT IMMUN, V56, P3081; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; VANDERHEYDE HC, 1994, J IMMUNOL, V152, P4557; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wykes MN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00249; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	68	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162132	10.1371/journal.pone.0162132	http://dx.doi.org/10.1371/journal.pone.0162132			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583554	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600110
J	Premo, LS; Tostevin, GB				Premo, L. S.; Tostevin, Gilbert B.			Cultural Transmission on the Taskscape: Exploring the Effects of Taskscape Visibility on Cultural Diversity	PLOS ONE			English	Article							MODERN HUMAN-BEHAVIOR; MOBILITY; EMERGENCE; EVOLUTION; ORGANIZATION; ASSEMBLAGES; INFORMATION; POPULATION; DEMOGRAPHY; NUMBER	Culturally transmitted behavior can be structured in its performance both geographically and temporally, in terms of where and when implements are made and used on the landscape (what Ingold calls "the taskscape"). Yet cultural transmission theory has not yet explored the consequences of behaviors transmitted differently due to their enactment at different taskscape locations, what Tostevin calls "taskscape visibility." Here, we use computer simulations to explore how taskscape visibility and forager mobility affect the diversity of two selectively neutral culturally transmitted traits within a single population of social learners. The trait that can be transmitted from residential bases only (lower taskscape visibility) shows greater diversity than the trait that can be transmitted from residential bases and logistical camps (higher taskscape visibility). In addition, increased logistical mobility has a positive effect on the diversity of the trait with the lower taskscape visibility while it generally shows little to no effect on the diversity of the trait with higher taskscape visibility. Without an appreciation for the ways in which taskscape visibility and mobility can structure cultural transmission in space and through time, the difference in the observed equilibrium diversity levels of the two traits might be incorrectly interpreted as resulting from qualitatively different forms of biased cultural transmission. The results of our simulation experiment suggest that researchers may need to take the taskscape visibility into account when inferring cultural transmission from archaeological data.	[Premo, L. S.] Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA; [Premo, L. S.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Tostevin, Gilbert B.] Univ Minnesota, Dept Anthropol, Minneapolis, MN USA	Washington State University; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Premo, LS (corresponding author), Washington State Univ, Dept Anthropol, Pullman, WA 99164 USA.; Premo, LS (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	luke.premo@wsu.edu	Tostevin, Gilbert/GYR-0498-2022	Tostevin, Gilbert/0000-0003-0721-520X	Washington State University; University of Minnesota	Washington State University; University of Minnesota(University of Minnesota System)	LSP was supported by Washington State University. GBT was supported by University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel J, 2008, J ARCHAEOL METHOD TH, V15, P91, DOI 10.1007/s10816-007-9044-2; Binford L.R., 1982, J ANTHROPOL ARCHAEOL, V1, P5, DOI DOI 10.1016/0278-4165(82)90006-X; Binford L. R., 1978, NUNAMIUT ETHNOARCHAE; Binford L.R., 1973, EXPLANATION CULTURE, P227; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Blackmore S, 2000, SCI AM, V283, P64, DOI 10.1038/scientificamerican1000-64; BLEED P, 1986, AM ANTIQUITY, V51, P737, DOI 10.2307/280862; Boyd R, 2000, SCI AM, V283, P70; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081476; Butzer KW, 1982, ARCHAEOLOGY HUMAN EC; Carr Christopher, 1995, STYLE SOC PERSON ARC, P171, DOI DOI 10.1007/978-1-4899-1097-4_7; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dawkins Richard, 1976, SELFISH GENE; Gould R.A., 1980, LIVING ARCHAEOLOGY; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2008, CURR ANTHROPOL, V49, P715, DOI 10.1086/587889; INGOLD T, 1993, WORLD ARCHAEOL, V25, P152, DOI 10.1080/00438243.1993.9980235; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; KENT S, 1992, AM ANTIQUITY, V57, P635, DOI 10.2307/280827; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1963, EVOLUTION, V17, P279, DOI 10.2307/2406157; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; NEIMAN FD, 1995, AM ANTIQUITY, V60, P7, DOI 10.2307/282074; Nelson M.C., 1991, ARCHAEOLOGICAL METHO, P57, DOI DOI 10.2307/20170213; OCONNELL JF, 1987, AM ANTIQUITY, V52, P74, DOI 10.2307/281061; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Premo LS, 2015, REPLACE NEANDERTHAL, P45, DOI 10.1007/978-4-431-55363-2_5; Premo LS, 2012, HUM ECOL, V40, P647, DOI 10.1007/s10745-012-9511-6; Premo LS, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911003268; Premo LS, 2011, AM ANTIQUITY, V76, P163, DOI 10.7183/0002-7316.76.1.163; Premo LS, 2016, AM ANTIQ IN PRESS; Richerson P., 2000, DARWINIZING CULTURE, P143; Richerson P. J, 2005, NOT GENES ALONE; Richerson PJ, 2009, HUM BIOL, V81, P211, DOI 10.3378/027.081.0306; Schiffer M.B., 1987, FORMATION PROCESSES; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; SHOTT M, 1986, J ANTHROPOL RES, V42, P15, DOI 10.1086/jar.42.1.3630378; SHOTT MJ, 1989, AM ANTIQUITY, V54, P9, DOI 10.2307/281329; Tostevin G., 2007, RETHINKING HUMAN REV, P341; Tostevin GB., 2012, SEEING LITHICS MIDDL; Whallon R, 2006, J ANTHROPOL ARCHAEOL, V25, P259, DOI 10.1016/j.jaa.2005.11.004; WIESSNER P, 1983, AM ANTIQUITY, V48, P253, DOI 10.2307/280450; Wiessner P., 1982, POLITICS HIST BAND S, P61; Wilensky U., 1999, NETLOGO CTR CONNECTE; WILLEY G, 1953, BUREAU AM ETHNOLOGY, V155; Wobst H. Martin, 1977, DIRECTOR RES ESSAYS, V61, P317; Yellen J.E., 1977, STUDIES ARCHEOLOGY	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161766	10.1371/journal.pone.0161766	http://dx.doi.org/10.1371/journal.pone.0161766			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583682	Green Published, gold			2022-12-27	WOS:000382855600057
J	Hesson, JC; Lundstrom, JO; Tok, A; Ostman, O; Lundkvist, A				Hesson, Jenny Christina; Lundstrom, Jan O.; Tok, Atalay; Ostman, Orjan; Lundkvist, Ake			Temporal Variation in Sindbis Virus Antibody Prevalence in Bird Hosts in an Endemic Area in Sweden	PLOS ONE			English	Article							WESTERN EQUINE ENCEPHALOMYELITIS; LOUIS ENCEPHALITIS VIRUSES; SPARROW PASSER-DOMESTICUS; OCKELBO VIRUS; POGOSTA DISEASE; NILE-VIRUS; NEUTRALIZING ANTIBODIES; EPIDEMIOLOGIC ANALYSIS; CALIFORNIA BIRDS; CULEX-TORRENTIUM	Sindbis virus (SINV) is a mosquito-borne bird virus that occasionally causes human disease in Fennoscandia, suggested to have cyclic 7-year intervals between outbreaks. Reliable data on human infections in Sweden is however lacking. Here we investigated the SINV antibody prevalence among birds in a Swedish area endemic to SINV to scrutinize if a cyclic variation in antibody prevalence is present in the natural host of SINV. Serum from birds were sampled in the summers of 2002-2004 and 2009 in the floodplains of the River Dalalven in central Sweden, with 2002 and 2009 representing hypothesized years of SINV outbreaks. A total of 963 birds from 52 species (mainly passerines) were tested for the presence of SINV antibodies using a plaque reduction neutralization test. The highest SINV antibody prevalence was found in Turdidae species, specifically Fieldfare, Redwing and Song thrush in which more than 70% of sampled individuals had antibodies to SINV in 2009. The SINV antibody prevalence significantly varied between years with 2% in 2002, 8% in 2003, 14% in 2004 and 37% in 2009. Antibodies were found equally often in hatchlings and in adults and increased from early to late in the season. Clearly, the SINV antibody prevalence was not elevated in the bird hosts in the predicted outbreak year 2002, thus solid evidence of a cyclic occurrence of SINV in Sweden is still lacking.	[Hesson, Jenny Christina; Lundstrom, Jan O.; Tok, Atalay; Lundkvist, Ake] Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, Zoonosis Sci Ctr, Uppsala, Sweden; [Hesson, Jenny Christina] Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England; [Lundstrom, Jan O.] Nedre Dalalvens Utvecklings AB, Swedish Biol Mosquito Control Project, Gysinge, Sweden; [Ostman, Orjan] Swedish Univ Agr Sci, Inst Coastal Res, Dept Aquat Resources, Oregrund, Sweden; [Lundkvist, Ake] Univ Uppsala Hosp, Lab Clin Microbiol, Uppsala, Sweden; [Ostman, Orjan] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany	Uppsala University; University of Liverpool; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University Hospital; Ruprecht Karls University Heidelberg	Hesson, JC (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol IMBIM, Zoonosis Sci Ctr, Uppsala, Sweden.; Hesson, JC (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Dept Epidemiol & Populat Hlth, Liverpool, Merseyside, England.	jenny.hesson@imbim.uu.se	Östman, Örjan/ABF-8714-2020	Östman, Örjan/0000-0002-1930-0148	Nedre Dalalvens Utvecklings AB; BBSRC [BB/K018507/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K018507/1] Funding Source: researchfish	Nedre Dalalvens Utvecklings AB; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funder, Nedre Dalalvens Utvecklings AB, provided support in the form of salary for the author [JL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergqvist J, 2015, VECTOR-BORNE ZOONOT, V15, P133, DOI 10.1089/vbz.2014.1717; Brummer-Korvenkontio M, 2002, EPIDEMIOL INFECT, V129, P335, DOI 10.1017/S0950268802007409; Fox J., 2019, R COMPANION APPL REG, V.; FRANCY DB, 1989, AM J TROP MED HYG, V41, P355, DOI 10.4269/ajtmh.1989.41.355; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Hesson JC, 2015, EMERG INFECT DIS, V21, P875, DOI 10.3201/eid2105.141577; Jalava K, 2013, EPIDEMIOL INFECT, V141, P1857, DOI 10.1017/S095026881200249X; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kurkela S, 2005, J INFECT DIS, V191, P1820, DOI 10.1086/430007; Kurkela S, 2004, EMERG INFECT DIS, V10, P889, DOI 10.3201/eid1005.030689; Kurkela S, 2008, SCAND J INFECT DIS, V40, P167, DOI 10.1080/00365540701586996; Kurkela S, 2008, EMERG INFECT DIS, V14, P41, DOI 10.3201/eid1401.070510; Lundstrom JO, 2010, VECTOR-BORNE ZOONOT, V10, P889, DOI 10.1089/vbz.2009.0069; LUNDSTROM JO, 1991, EPIDEMIOL INFECT, V106, P567, DOI 10.1017/S0950268800067637; Lundstrom JO, 1996, J WILDLIFE DIS, V32, P87, DOI 10.7589/0090-3558-32.1.87; LUNDSTROM JO, 1992, J WILDLIFE DIS, V28, P144, DOI 10.7589/0090-3558-28.1.144; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; LUNDSTROM JO, 1993, J WILDLIFE DIS, V29, P189, DOI 10.7589/0090-3558-29.2.189; LUNDSTROM JO, 1990, J MED ENTOMOL, V27, P561, DOI 10.1093/jmedent/27.4.561; Manni T, 2008, VECTOR-BORNE ZOONOT, V8, P303, DOI 10.1089/vbz.2007.0623; MCINTOSH BM, 1976, S AFR J SCI, V72, P295; MCLEAN RG, 1983, AM J TROP MED HYG, V32, P1120, DOI 10.4269/ajtmh.1983.32.1120; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Molaei G, 2013, VECTOR-BORNE ZOONOT, V13, P312, DOI 10.1089/vbz.2012.1099; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; NIKLASSON B, 1988, J INFECT DIS, V157, P832, DOI 10.1093/infdis/157.4.832; R Core Team, 2012, R LANG ENV STAT COMP; REEVES WC, 1958, P SOC EXP BIOL MED, V97, P733, DOI 10.3181/00379727-97-23862; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2001, J MED ENTOMOL, V38, P393, DOI 10.1603/0022-2585-38.3.393; Reisen WK, 2000, J MED ENTOMOL, V37, P507, DOI 10.1603/0022-2585-37.4.507; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Rossow H, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES2015.20.33.21209; Sane J, 2010, EUROSURVEILLANCE, V15, P6; Sane J, 2012, J GEN VIROL, V93, P1984, DOI 10.1099/vir.0.042853-0; Sane J, 2012, J INFECT DIS, V206, P407, DOI 10.1093/infdis/jis358; Sane J, 2012, J VIROL METHODS, V179, P185, DOI 10.1016/j.jviromet.2011.10.021; Sane J, 2011, J INFECT DIS, V204, P459, DOI 10.1093/infdis/jir267; Svensson L., 1992, IDENTIFICATION GUIDE; TURELL MJ, 1990, J MED ENTOMOL, V27, P266, DOI 10.1093/jmedent/27.3.266; Ulfstrand S., 1976, Anser, V15, P1	44	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162005	10.1371/journal.pone.0162005	http://dx.doi.org/10.1371/journal.pone.0162005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579607	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400051
J	Thangarajah, T; Shahbazi, S; Pendegrass, CJ; Lambert, S; Alexander, S; Blunn, GW				Thangarajah, Tanujan; Shahbazi, Shirin; Pendegrass, Catherine J.; Lambert, Simon; Alexander, Susan; Blunn, Gordon W.			Tendon Reattachment to Bone in an Ovine Tendon Defect Model of Retraction Using Allogenic and Xenogenic Demineralised Bone Matrix Incorporated with Mesenchymal Stem Cells	PLOS ONE			English	Article							ROTATOR CUFF REPAIR; ARTHROSCOPIC REPAIR; IN-VIVO; AUGMENTATION; INTEGRITY; TEARS; SUPRASPINATUS; INSERTION; GROWTH	Background Tendon-bone healing following rotator cuff repairs is mainly impaired by poor tissue quality. Demineralised bone matrix promotes healing of the tendon-bone interface but its role in the treatment of tendon tears with retraction has not been investigated. We hypothesized that cortical demineralised bone matrix used with minimally manipulated mesenchymal stem cells will result in improved function and restoration of the tendon-bone interface with no difference between xenogenic and allogenic scaffolds. Materials and Methods In an ovine model, the patellar tendon was detached from the tibial tuberosity and a complete distal tendon transverse defect measuring 1 cm was created. Suture anchors were used to reattach the tendon and xenogenic demineralised bone matrix + minimally manipulated mesenchymal stem cells (n = 5), or allogenic demineralised bone matrix + minimally manipulated mesenchymal stem cells (n = 5) were used to bridge the defect. Graft incorporation into the tendon and its effect on regeneration of the enthesis was assessed using histomorphometry. Force plate analysis was used to assess functional recovery. Results Compared to the xenograft, the allograft was associated with significantly higher functional weight bearing at 6 (P = 0.047), 9 (P = 0.028), and 12 weeks (P = 0.009). In the allogenic group this was accompanied by greater remodeling of the demineralised bone matrix into tendon-like tissue in the region of the defect (p = 0.015), and a more direct type of enthesis characterized by significantly more fibrocartilage (p = 0.039). No failures of tendon-bone healing were noted in either group. Conclusion Demineralised bone matrix used with minimally manipulated mesenchymal stem cells promotes healing of the tendon-bone interface in an ovine model of acute tendon retraction, with superior mechanical and histological results associated with use of an allograft.	[Thangarajah, Tanujan; Shahbazi, Shirin; Pendegrass, Catherine J.; Blunn, Gordon W.] Royal Natl Orthopaed Hosp Trust, Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Div Surg & Intervent Sci,John Scales Ctr Biomed E, Brockley Hill, Stanmore HA7 4LP, Middx, England; [Lambert, Simon; Alexander, Susan] Royal Natl Orthopaed Hosp, Shoulder & Elbow Serv, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Thangarajah, T (corresponding author), Royal Natl Orthopaed Hosp Trust, Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Div Surg & Intervent Sci,John Scales Ctr Biomed E, Brockley Hill, Stanmore HA7 4LP, Middx, England.	tanujan1@hotmail.com	Lambert, Simon/I-1444-2019		Engineering and Physical Sciences Research Council (EPSRC) Proof of Concept; 'EPRSC Proof of Concept' grant; EPSRC [EP/I019103/1, EP/J017620/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC) Proof of Concept; 'EPRSC Proof of Concept' grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by The Engineering and Physical Sciences Research Council (EPSRC) Proof of Concept. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by: 'EPRSC Proof of Concept' grant.	Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Aurora A, 2012, J SHOULDER ELB SURG, V21, P1064, DOI 10.1016/j.jse.2011.05.014; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Bishop J, 2006, J SHOULDER ELB SURG, V15, P290, DOI 10.1016/j.jse.2005.09.017; Black LL, 2007, VET THER, V8, P272; Carr AJ, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19800; Chung SW, 2013, AM J SPORT MED, V41, P1674, DOI 10.1177/0363546513485719; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Deniz G, 2014, ARCH ORTHOP TRAUM SU, V134, P985, DOI 10.1007/s00402-014-2009-5; Dines David M, 2007, Instr Course Lect, V56, P13; Dorman Lisa J, 2012, Biomed Sci Instrum, V48, P81; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Gulati BR, 2013, CELLS TISSUES ORGANS, V198, P377, DOI 10.1159/000358231; Halder AM, 2002, J BONE JOINT SURG AM, V84A, P780, DOI 10.2106/00004623-200205000-00013; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Hernigou P, 2014, INT ORTHOP, V38, P1811, DOI 10.1007/s00264-014-2391-1; Hsu SL, 2013, J SURG RES, DOI [10.1016/j.jss.2013.09.025, DOI 10.1016/J.JSS.2013.09.025PMID]; Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369; Kalia P, 2006, TISSUE ENG, V12, P1617, DOI 10.1089/ten.2006.12.1617; Kalia P, 2009, TISSUE ENG PT A, V15, P3689, DOI [10.1089/ten.tea.2008.0676, 10.1089/ten.TEA.2008.0676]; Kilicoglu OI, 2012, ACTA ORTHOP TRAUMATO, V46, P443, DOI 10.3944/AOTT.2012.2748; Klepps S, 2004, AM J SPORT MED, V32, P1716, DOI 10.1177/0363546504265262; Liu GP, 2010, TISSUE ENG PT A, V16, P971, DOI [10.1089/ten.tea.2009.0516, 10.1089/ten.TEA.2009.0516]; Lovric V, 2012, AM J SPORT MED, V40, P2365, DOI 10.1177/0363546512457648; Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312; Merolla Giovanni, 2014, Muscles Ligaments Tendons J, V4, P425; NEER CS, 1983, J BONE JOINT SURG AM, V65, P1232, DOI 10.2106/00004623-198365090-00003; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pietrzak WS, 2012, CELL TISSUE BANK, V13, P653, DOI 10.1007/s10561-011-9286-9; Raposio E, 2014, PLAST RECONSTR SURG, V133, P1406, DOI 10.1097/PRS.0000000000000170; Schwarting T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116833; Sclamberg SG, 2004, J SHOULDER ELB SURG, V13, P538, DOI 10.1016/j.jse.2004.03.005; Sun J, 2015, MOL MED REP, V12, P4230, DOI 10.3892/mmr.2015.3954; Sundar S, 2009, J BIOMED MATER RES B, V88B, P115, DOI 10.1002/jbm.b.31157; Tashjian RZ, 2010, AM J SPORT MED, V38, P2435, DOI 10.1177/0363546510382835; Thangarajah T, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115587495; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thompson SM, 2011, J SHOULDER ELB SURG, V20, P899, DOI 10.1016/j.jse.2011.01.005; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Yokoya S, 2008, AM J SPORT MED, V36, P1298, DOI 10.1177/0363546508314416; Yokoya S, 2012, AM J SPORT MED, V40, P1259, DOI 10.1177/0363546512442343	43	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161473	10.1371/journal.pone.0161473	http://dx.doi.org/10.1371/journal.pone.0161473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606597	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600007
J	Parker, GJ; Leppert, T; Anex, DS; Hilmer, JK; Matsunami, N; Baird, L; Stevens, J; Parsawar, K; Durbin-Johnson, BP; Rocke, DM; Nelson, C; Fairbanks, DJ; Wilson, AS; Rice, RH; Woodward, SR; Bothner, B; Hart, BR; Leppert, M				Parker, Glendon J.; Leppert, Tami; Anex, Deon S.; Hilmer, Jonathan K.; Matsunami, Nori; Baird, Lisa; Stevens, Jeffery; Parsawar, Krishna; Durbin-Johnson, Blythe P.; Rocke, David M.; Nelson, Chad; Fairbanks, Daniel J.; Wilson, Andrew S.; Rice, Robert H.; Woodward, Scott R.; Bothner, Brian; Hart, Bradley R.; Leppert, Mark			Demonstration of Protein-Based Human Identification Using the Hair Shaft Proteome	PLOS ONE			English	Article							KERATIN GENE FAMILY; FORENSIC IDENTIFICATION; GENOME SEQUENCE; DNA EXTRACTION; TANDEM; PEPTIDES; REVEALS; PRESERVATION; NEANDERTHAL; PRINCIPLES	Human identification from biological material is largely dependent on the ability to characterize genetic polymorphisms in DNA. Unfortunately, DNA can degrade in the environment, sometimes below the level at which it can be amplified by PCR. Protein however is chemically more robust than DNA and can persist for longer periods. Protein also contains genetic variation in the form of single amino acid polymorphisms. These can be used to infer the status of non-synonymous single nucleotide polymorphism alleles. To demonstrate this, we used mass spectrometry-based shotgun proteomics to characterize hair shaft proteins in 66 European-American subjects. A total of 596 single nucleotide polymorphism alleles were correctly imputed in 32 loci from 22 genes of subjects' DNA and directly validated using Sanger sequencing. Estimates of the probability of resulting individual non-synonymous single nucleotide polymorphism allelic profiles in the European population, using the product rule, resulted in a maximum power of discrimination of 1 in 12,500. Imputed non-synonymous single nucleotide polymorphism profiles from European-American subjects were considerably less frequent in the African population (maximum likelihood ratio = 11,000). The converse was true for hair shafts collected from an additional 10 subjects with African ancestry, where some profiles were more frequent in the African population. Genetically variant peptides were also identified in hair shaft datasets from six archaeological skeletal remains (up to 260 years old). This study demonstrates that quantifiable measures of identity discrimination and biogeographic background can be obtained from detecting genetically variant peptides in hair shaft protein, including hair from bioarchaeological contexts.	[Parker, Glendon J.; Fairbanks, Daniel J.] Utah Valley Univ, Dept Biol, Orem, UT 84058 USA; [Parker, Glendon J.; Leppert, Tami] Prot Based Identificat Technol LLC, Orem, UT 84058 USA; [Leppert, Tami; Matsunami, Nori; Baird, Lisa; Stevens, Jeffery; Leppert, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Parker, Glendon J.; Anex, Deon S.; Hart, Bradley R.] Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA USA; [Hilmer, Jonathan K.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Parsawar, Krishna; Nelson, Chad] Univ Utah, Mass Spectrometry & Prote Core Facil, Salt Lake City, UT USA; [Durbin-Johnson, Blythe P.; Rocke, David M.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Wilson, Andrew S.] Univ Bradford, Sch Archaeol Sci, Bradford, W Yorkshire, England; [Rice, Robert H.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA	Utah System of Higher Education; Utah Valley University; Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Montana State University System; Montana State University Bozeman; Utah System of Higher Education; University of Utah; University of California System; University of California Davis; University of Bradford; University of California System; University of California Davis	Parker, GJ (corresponding author), Utah Valley Univ, Dept Biol, Orem, UT 84058 USA.; Parker, GJ (corresponding author), Prot Based Identificat Technol LLC, Orem, UT 84058 USA.; Parker, GJ (corresponding author), Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA USA.	glendon.parker@uvu.edu	Fairbanks, Daniel J./ABH-9948-2020; Rice, Robert/AAP-7813-2021	Parker, Glendon/0000-0003-2937-5853; Anex, Deon/0000-0002-3491-9379; Hilmer, Jonathan/0000-0002-1494-6353; wilson, andrew/0000-0003-1346-937X	Utah Governors Office of Commercial Development [121668, 132043]; Scholarship Activities Committee of the College of Science and Health at Utah Valley University; Murdock Charitable Trust; NIH from the COBRE Program of the National Center for Research Resources [P20RR020185, 1P20RR024237]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC5207NA27344, B601942]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; National Institutes of Justice [2011-DN-BX-K543]; National Institute of Environmental Health Sciences [2 P42 ES04699]; National Center for Advancing Translational Sciences (NIH) [UL1 TR000002]; U.S. Department of Energy by Lawrence Liver-more National Laboratory [DE-AC52-07NA27344]; College of Science & Health at Utah Valley University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER	Utah Governors Office of Commercial Development; Scholarship Activities Committee of the College of Science and Health at Utah Valley University; Murdock Charitable Trust; NIH from the COBRE Program of the National Center for Research Resources; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; National Institutes of Justice; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Advancing Translational Sciences (NIH); U.S. Department of Energy by Lawrence Liver-more National Laboratory(United States Department of Energy (DOE)); College of Science & Health at Utah Valley University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors wish to thank the Technology Commercialization Innovation Program (Contracts #121668, #132043) of the Utah Governors Office of Commercial Development, the Scholarship Activities Committee of the College of Science and Health at Utah Valley University, and Murdock Charitable Trust and NIH Grant Numbers P20RR020185 and 1P20RR024237 from the COBRE Program of the National Center for Research Resources for support of the MSU mass spectrometry facility. Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC5207NA27344 and subcontract B601942. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). Work conducted on African American and Kenyan samples was supported by National Institutes of Justice grant 2011-DN-BX-K543, National Institute of Environmental Health Sciences grant 2 P42 ES04699, and the National Center for Advancing Translational Sciences (NIH) grant #UL1 TR000002. GJP and TL were affiliated with Protein-Based Identification Technologies LLC (PBIT). The funder provided support in the form of salaries for authors GJP and TL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Authors Contributions' section.; The authors thank Jacquie Howard and Melissa Huntzinger for database construction and technical assistance, Dr. Bruce Weir (University of Washington, Seattle) for helpful statistical advice, direction and critical reading of the manuscript, Dr. Katelyn Mason (Lawrence Liver-more National Laboratory) for critical reading of the manuscript, and Drs. Haagen Klaus (George Mason University) and Jacinda Sampson (Stanford University) for their advice. We acknowledge the technical support of the University of Utah Health Sciences Center DNA sequencing, and Mass Spectrometry and Proteomics, Core Facilities. We thank the Division of Biotechnology, and the Department of Biology, in the College of Science & Health at Utah Valley University for space and resources to conduct the study. The authors thank the Technology Commercialization Innovation Program of the Utah Governor's Office of Commercial Development, the Scholarship Activities Committee of the College of Science & Health at Utah Valley University, the Murdock Charitable Trust, the COBRE Program of the National Center for Research Resources, and the National Institutes of Health. Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Liver-more National Laboratory under Contract DE-AC52-07NA27344.	Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], PLOS ONE; [Anonymous], 2009, STRENGTHENING FORENS; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Bengtsson CF, 2012, ANN ANAT, V194, P17, DOI 10.1016/j.aanat.2011.03.013; Bowden PE, 2005, J INVEST DERMATOL, V124, pXV, DOI 10.1111/j.0022-202X.2005.23647.x; Brautbar N, 1999, TOXICOL IND HEALTH, V15, P532, DOI 10.1177/074823379901500602; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Bunger MK, 2007, J PROTEOME RES, V6, P2331, DOI 10.1021/pr0700908; Butler JM, 2010, FUNDAMENTALS OF FORENSIC DNA TYPING, P1; Callaway E, 2013, NATURE, V503, P18, DOI 10.1038/503018a; Cann HM, 2002, SCIENCE, V296, P261; Cottrell JS, 2011, J PROTEOMICS, V74, P1842, DOI 10.1016/j.jprot.2011.05.014; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Curran JM, 2002, SCI JUSTICE, V42, P29, DOI 10.1016/S1355-0306(02)71794-2; Deedrick D.W., 2004, FORENSIC SCI COMMUNI, V6; Disotell TR, 2012, AM J PHYS ANTHROPOL, V149, P24, DOI 10.1002/ajpa.22159; Edson J, 2013, FORENSIC SCI INT-GEN, V7, P180, DOI 10.1016/j.fsigen.2012.10.001; Evert I.W., 1998, INTERPRETING DNA EVI, V1st; Fenyo D, 2010, METHODS MOL BIOL, V673, P189, DOI 10.1007/978-1-60761-842-3_11; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gelman A, 2003, BAYESIAN DATA ANAL, DOI [10.1038/nature11632, DOI 10.1038/NATURE11632]; Ghesquiere B, 2014, MASS SPECTROM REV, V33, P147, DOI 10.1002/mas.21386; Graffy EA, 2005, J FORENSIC SCI, V50, P1119; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hoopmann MR, 2013, CURR OPIN BIOTECH, V24, P31, DOI 10.1016/j.copbio.2012.10.013; Houck MM, 2002, J FORENSIC SCI, V47, P964; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Jia J, 2014, FORENSIC SCI INT-GEN, V8, P187, DOI 10.1016/j.fsigen.2013.09.004; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Kim JJ, 2010, INT J LEGAL MED, V124, P125, DOI 10.1007/s00414-009-0389-9; Laatsch CN, 2014, PEERJ, V2, DOI 10.7717/peerj.506; Lam H, 2011, METHODS, V54, P424, DOI 10.1016/j.ymeth.2011.01.007; Lanning KA, 2009, J FORENSIC SCI, V54, P1198, DOI 10.1111/j.1556-4029.2009.01139.x; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu F, 2014, HUM GENET, V133, P587, DOI 10.1007/s00439-013-1394-0; MARSHALL RC, 1985, J FORENSIC SCI SOC, V25, P57, DOI 10.1016/S0015-7368(85)72363-8; Mays S., 2013, SCI DEAD GUIDELINE D; McNevin D, 2005, FORENSIC SCI INT, V153, P237, DOI 10.1016/j.forsciint.2005.05.006; McNevin D, 2005, FORENSIC SCI INT, V153, P247, DOI 10.1016/j.forsciint.2005.05.005; Melton T, 2005, J FORENSIC SCI, V50, P73; Mendez FL, 2016, AM J HUM GENET, V98, P728, DOI 10.1016/j.ajhg.2016.02.023; Miyake B, 1990, Forensic Sci Rev, V2, P25; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; Oien C.T., 2009, FORENSIC SCI COMMUNI, V11; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Ottoni C, 2009, NATURWISSENSCHAFTEN, V96, P267, DOI 10.1007/s00114-008-0478-5; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Phillips C, 2013, ELECTROPHORESIS, V34, P1151, DOI 10.1002/elps.201200621; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Poinar HN, 1999, P NATL ACAD SCI USA, V96, P8426, DOI 10.1073/pnas.96.15.8426; Pruner-Bey Franz Ignace, 1864, ANTHR REV, V2, P1; Ramos-Fernandez A, 2008, MOL CELL PROTEOMICS, V7, P1748, DOI 10.1074/mcp.M800122-MCP200; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rice RH, 2011, J COSMET SCI, V62, P229; Robertsona KS, 2007, AUSTR J FORENSIC SCI, V39, P107, DOI [10.1016/j.fsigen.2019.102210, DOI 10.1016/J.FSIGEN.2019.102210]; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Rogers MA, 2005, J INVEST DERMATOL, V124, P536, DOI 10.1111/j.0022-202X.2004.23530.x; Rogers MA, 2004, DIFFERENTIATION, V72, P527, DOI 10.1111/j.1432-0436.2004.07209006.x; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; Sheynkman GM, 2014, J PROTEOME RES, V13, P228, DOI 10.1021/pr4009207; Shteynberg D, 2013, MOL CELL PROTEOMICS, V12, P2383, DOI 10.1074/mcp.R113.027797; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Solazzo C, 2014, ANAL CHEM, V86, P567, DOI 10.1021/ac4026362; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thompson A.H., 2013, TREATISE GEOCHEMISTR, DOI [10.1016/B978-0-08-095975-7.01227-4, DOI 10.1016/B978-0-08-095975-7.01227-4]; Triggs CM, 2002, FORENSIC SCI INT, V128, P108, DOI 10.1016/S0379-0738(02)00168-8; van Oorschot Roland Ah, 2010, Investig Genet, V1, P14, DOI 10.1186/2041-2223-1-14; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Weir B. S., 1996, GENETIC DATA ANAL; Wilson AS, 2007, BRIT J DERMATOL, V157, P450, DOI 10.1111/j.1365-2133.2007.07973.x; Wilson Andrew S., 2008, P123, DOI 10.1201/9781420069921.ch6; Wilson AS, 2013, MEN ARE GONE COME SH, P145; Wilson AS., 2007, FORENSIC HUMAN IDENT, P147; ZWEIG MH, 1993, CLIN CHEM, V39, P561	92	62	64	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160653	10.1371/journal.pone.0160653	http://dx.doi.org/10.1371/journal.pone.0160653			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603779	gold, Green Published			2022-12-27	WOS:000383255200006
J	Robbins, MM; Ando, C; Fawcett, KA; Grueter, CC; Hedwig, D; Iwata, Y; Lodwick, JL; Masi, S; Salmi, R; Stoinski, TS; Todd, A; Vercellio, V; Yamagiwa, J				Robbins, Martha M.; Ando, Chieko; Fawcett, Katherine A.; Grueter, Cyril C.; Hedwig, Daniela; Iwata, Yuji; Lodwick, Jessica L.; Masi, Shelly; Salmi, Roberta; Stoinski, Tara S.; Todd, Angelique; Vercellio, Veronica; Yamagiwa, Juichi			Behavioral Variation in Gorillas: Evidence of Potential Cultural Traits	PLOS ONE			English	Article							TOOL USE; WILD CHIMPANZEES; CAPUCHIN MONKEYS; FOOD AVAILABILITY; ANIMAL CULTURES; MOUNTAIN; TRADITIONS; EVOLUTION; DIET; TRANSMISSION	The question of whether any species except humans exhibits culture has generated much debate, partially due to the difficulty of providing conclusive evidence from observational studies in the wild. A starting point for demonstrating the existence of culture that has been used for many species including chimpanzees and orangutans is to show that there is geographic variation in the occurrence of particular behavioral traits inferred to be a result of social learning and not ecological or genetic influences. Gorillas live in a wide variety of habitats across Africa and they exhibit flexibility in diet, behavior, and social structure. Here we apply the 'method of exclusion' to look for the presence/absence of behaviors that could be considered potential cultural traits in well-habituated groups from five study sites of the two species of gorillas. Of the 41 behaviors considered, 23 met the criteria of potential cultural traits, of which one was foraging related, nine were environment related, seven involved social interactions, five were gestures, and one was communication related. There was a strong positive correlation between behavioral dissimilarity and geographic distance among gorilla study sites. Roughly half of all variation in potential cultural traits was intraspecific differences (i.e. variability among sites within a species) and the other 50% of potential cultural traits were differences between western and eastern gorillas. Further research is needed to investigate if the occurrence of these traits is influenced by social learning. These findings emphasize the importance of investigating cultural traits in African apes and other species to shed light on the origin of human culture.	[Robbins, Martha M.; Grueter, Cyril C.; Hedwig, Daniela] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Ando, Chieko; Iwata, Yuji] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Fawcett, Katherine A.; Stoinski, Tara S.; Vercellio, Veronica] Dian Fossey Gorilla Fund Int, Atlanta, GA USA; [Grueter, Cyril C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Lodwick, Jessica L.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA; [Masi, Shelly] Univ Paris Diderot Paris 7 Ecoanthropol & Ethnobi, CNRS, Natl Ctr Sci Res, Museum Natl Nat 1Hist,Musee Homme, Paris, France; [Salmi, Roberta] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Todd, Angelique] World Wildlife Fund CAR, Bangui, Cent Afr Republ; [Yamagiwa, Juichi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Max Planck Society; Kyoto Prefectural University; University of Western Australia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; University of Georgia; Kyoto University	Robbins, MM (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	robbins@eva.mpg.de	Hedwig, Daniela/ABH-7241-2020; Todd, Angelique/AAR-3087-2021; salmi, roberta/AAD-6267-2021	Salmi, Roberta/0000-0001-5745-2014; Grueter, Cyril C./0000-0001-8770-8148; Todd, Angelique/0000-0002-9207-4925	Max Planck Society; WWF (CAR); WCS	Max Planck Society(Max Planck SocietyFoundation CELLEX); WWF (CAR); WCS	This work was supported by the Max Planck Society.; We thank the following organizations for permission to work at the various field sites: Uganda Wildlife Authority, Uganda National Council of Science and Technology, Rwanda Development Board, Gabon National Center of Scientific Research and Technology, Gabon Agence Nationale des Parcs Nationaux, the Ministries of Education and Water and Forests of CAR and Republic of Congo for permission to work in Dzanga-Ndoki National Park. We also thank the administration of Dzanga-Sangha Protected Areas in CAR for logistic support. Special thanks go to Terence Fuh Neba for contributing to observations of the gorillas at Bai Hokou, the local Ba'Aka trackers of the Primate Habituation Program at Bai Hokou camp, Dzanga-Ndoki NP, and all for their irreplaceable help, great humour and courage. We thank WWF (CAR) and WCS for support and logistical assistance, the numerous field and research assistants, and the skilled BaAka trackers, without whom the habituation of gorillas would not have been possible at Mondika. In Gabon, we are also greatly indebted to all field assistants of Moukalaba-Doudou National Park and the people in the villages of Doussala, Konzi, and Mboungou for their kind support and hospitality. We also thank all the researchers and data technicians at Karisoke who helped with data collection as well as the field assistants of the Institute of Tropical Forest Conservation in Bwindi. Thanks to Jessica Junker and Nicole Seiler for help creating Fig 1. We appreciate useful comments from Claudio Tennie and two anonymous reviewers on a previous version of this manuscript. We thank Diane Doran-Sheehy, Kevin Langergraber, and Christophe Boesch for helpful discussions during the course of this project.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Bastian ML, 2012, BEHAVIOUR, V149, P275, DOI 10.1163/156853912X636726; Bastian ML, 2010, AM J PHYS ANTHROPOL, V143, P175, DOI 10.1002/ajpa.21304; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Boinski S, 2000, AM ANTHROPOL, V102, P741, DOI 10.1525/aa.2000.102.4.741; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Byrne RW, 2007, PHILOS T R SOC B, V362, P577, DOI 10.1098/rstb.2006.1996; Byrne RW, 2011, ANIM COGN, V14, P683, DOI 10.1007/s10071-011-0403-8; Cipolletta C, 2004, AM J PRIMATOL, V64, P193, DOI 10.1002/ajp.20072; Dean LG, 2014, BIOL REV, V89, P284, DOI 10.1111/brv.12053; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Doran DM, 1998, EVOL ANTHROPOL, V6, P120; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Doran-Sheeny DM, 2009, AM J PRIMATOL, V71, P1011, DOI 10.1002/ajp.20743; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Ganas J, 2004, INT J PRIMATOL, V25, P1043, DOI 10.1023/B:IJOP.0000043351.20129.44; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Groves CP, 2003, CAM S BIO EVOL ANTHR, V35, P15; Grueter CC, 2014, PHYSIOL BEHAV, V127, P13, DOI 10.1016/j.physbeh.2014.01.009; Grueter CC, 2013, BEHAV PROCESS, V100, P160, DOI 10.1016/j.beproc.2013.09.006; Grueter CC, 2013, AM J PRIMATOL, V75, P267, DOI 10.1002/ajp.22102; Harcourt A.H., 2007, GORILLA SOC CONFLICT; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; Hedwig D, 2015, ANIM COGN, V18, P423, DOI 10.1007/s10071-014-0812-6; Hedwig D, 2014, BEHAVIOUR, V151, P1091, DOI 10.1163/1568539X-00003175; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hirata S, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P487; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Iwata Y, 2007, PRIMATES, V48, P77, DOI 10.1007/s10329-006-0003-4; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Kinani JF, 2015, AM J PRIMATOL, V77, P353, DOI 10.1002/ajp.22351; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12456; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11356; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; Kopps AM, 2012, ANIM BEHAV, V84, P1347, DOI 10.1016/j.anbehav.2012.08.029; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Leca JB, 2010, ANIM BEHAV, V79, P117, DOI 10.1016/j.anbehav.2009.09.035; Lodwick J, 2014, LINKS FORAGING STRAT; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; Masi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129254; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; Mc Grew WC, 2001, CURR ANTHROPOL, V42, P148, DOI 10.1086/318441; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mobius Y, 2008, ANIM BEHAV, V76, P37, DOI 10.1016/j.anbehav.2008.01.008; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; Nakamura M, 2000, PRIMATES, V41, P237, DOI 10.1007/BF02557594; Nishida T, 2009, PRIMATES, V50, P23, DOI 10.1007/s10329-008-0109-y; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Perry S, 2011, PHILOS T R SOC B, V366, P988, DOI 10.1098/rstb.2010.0317; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pika S, 2003, AM J PRIMATOL, V60, P95, DOI 10.1002/ajp.10097; Ramsey G, 2007, BEHAV BRAIN SCI, V30, P1; Robbins MM, 2008, INT J PRIMATOL, V29, P999, DOI 10.1007/s10764-008-9275-4; Robbins MM, 2011, PRIMATES PERSPECTIVE, P326; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Roy J, 2014, BIOL LETTERS, V1, P10; Salmi R, 2014, AM J PHYS ANTHROPOL, V155, P379, DOI 10.1002/ajpa.22575; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024400; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Sawyer SC, 2009, FOLIA PRIMATOL, V80, P83, DOI 10.1159/000217680; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; Scott J, 2007, INT J PRIMATOL, V28, P761, DOI 10.1007/s10764-007-9161-5; Silk Joan B., 2012, P552; Taylor AB, 2003, GORILLA BIOL MULTIDI; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Thalmann OH, 2007, MOL BIOL EVOL, V24, P146, DOI 10.1093/molbev/msl160; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thornton A, 2010, P ROY SOC B-BIOL SCI, V277, P3623, DOI 10.1098/rspb.2010.0611; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; van Schaik CP, 2006, BEHAVIOUR, V143, P839, DOI 10.1163/156853906778017944; van Schaik CP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0339; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Watts DP, 2001, MOUNTAIN GORILLAS 3; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2012, EVOLUTION PRIMATE SO, P681; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; Whiten A, 2011, PHILOS T R SOC B, V366, P997, DOI 10.1098/rstb.2010.0334; Wright E, 2015, AM J PHYS ANTHROPOL, V158, P487, DOI 10.1002/ajpa.22808; Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952; Yamagiwa J, 2003, PRIMATES, V44, P359, DOI 10.1007/s10329-003-0049-5; Yamagiwa J, 2014, PRIMATES CETACEANS F; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	100	46	49	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160483	10.1371/journal.pone.0160483	http://dx.doi.org/10.1371/journal.pone.0160483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603668	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200004
J	Roy, PS; Rao, GJN; Jena, S; Samal, R; Patnaik, A; Patnaik, SSC; Jambhulkar, NN; Sharma, S; Mohapatra, T				Roy, Pritesh Sundar; Rao, Gundimeda Jwala Narasimha; Jena, Sudipta; Samal, Rashmita; Patnaik, Ashok; Patnaik, Sasank Sekhar Chyau; Jambhulkar, Nitiprasad Namdeorao; Sharma, Srigopal; Mohapatra, Trilochan			Nuclear and Chloroplast DNA Variation Provides Insights into Population Structure and Multiple Origin of Native Aromatic Rices of Odisha, India	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENETIC DIVERSITY; UPLAND RICE; SSR MARKERS; GERMPLASM; SEQUENCE; CLASSIFICATION; DOMESTICATION; VARIETIES; LANDRACE	A large number of short grain aromatic rice suited to the agro-climatic conditions and local preferences are grown in niche areas of different parts of India and their diversity is evolved over centuries as a result of selection by traditional farmers. Systematic characterization of these specialty rices has not been attempted. An effort was made to characterize 126 aromatic short grain rice landraces, collected from 19 different districts in the State of Odisha, from eastern India. High level of variation for grain quality and agronomic traits among these aromatic rices was observed and genotypes having desirable phenotypic traits like erect flag leaf, thick culm, compact and dense panicles, short plant stature, early duration, superior yield and grain quality traits were identified. A total of 24 SSR markers corresponding to the hyper variable regions of rice chromosomes were used to understand the genetic diversity and to establish the genetic relationship among the aromatic short grain rice landraces at nuclear genome level. SSR analysis of 126 genotypes from Odisha and 10 genotypes from other states revealed 110 alleles with an average of 4.583 and the Nei's genetic diversity value (He) was in the range of 0.034-0.880 revealing two sub-populations SP 1 (membership percentage-27.1%) and SP 2 (72.9%). At the organelle genomic level for the C/A repeats in PS1D sequence of chloroplasts, eight different plastid sub types and 33 haplo-types were detected. The japonica (Nipponbare) subtype (6C7A) was detected in 100 genotypes followed by O. rufipogon (KF428978) subtype (6C6A) in 13 genotypes while indica (93-11) sub type (8C8A) was seen in 14 genotypes. The tree constructed based on haplo-types suggests that short grain aromatic landraces might have independent origin of these plastid subtypes. Notably a wide range of diversity was observed among these landraces cultivated in different parts confined to the State of Odisha.	[Roy, Pritesh Sundar; Rao, Gundimeda Jwala Narasimha; Jena, Sudipta; Samal, Rashmita; Patnaik, Ashok; Patnaik, Sasank Sekhar Chyau; Jambhulkar, Nitiprasad Namdeorao; Sharma, Srigopal; Mohapatra, Trilochan] Natl Rice Res Inst, Cuttack, Odisha, India; [Mohapatra, Trilochan] DARE, ICAR, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Rao, GJN (corresponding author), Natl Rice Res Inst, Cuttack, Odisha, India.	gjnrao@gmail.com			institutional project of ICAR-National Rice Research Institute (ICAR-NRRI)	institutional project of ICAR-National Rice Research Institute (ICAR-NRRI)	This work is carried out under institutional project of ICAR-National Rice Research Institute (ICAR-NRRI).	Ahuja SC, 1995, BASMATI RICE SCENTED; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Anumalla M, 2014, J CHEM PHYS BIOL SCI, V5, P1726; Bao JS, 2006, GENET RESOUR CROP EV, V53, P323, DOI 10.1007/s10722-004-6145-6; Bhattacharjee P, 2002, INT J FOOD SCI TECH, V37, P1, DOI 10.1046/j.1365-2621.2002.00541.x; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Choudhury PR, 2001, EUPHYTICA, V118, P243, DOI 10.1023/A:1017554600145; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Das SR, 2012, IRRI TECHNICAL B, V16; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Dela Cruz N., 2000, AROMATIC RICES, P16; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Giraud G, 2013, INT FOOD AGRIBUS MAN, V16, P2; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hashimoto Z, 2004, THEOR APPL GENET, V109, P1586, DOI 10.1007/s00122-004-1794-6; Hien NL, 2007, TROPICS, V16, P343; Huang FaSong, 1998, Chinese Journal of Rice Science, V12, P172; Ishii T, 2000, THEOR APPL GENET, V100, P1257, DOI 10.1007/s001220051432; Ishikawa R, 2002, THEOR APPL GENET, V104, P976, DOI 10.1007/s00122-001-0807-y; Joshi RK, 2010, BIORES B, V4, P213; Juliano BO., 1985, RICE CHEM TECHNOLOGY; Juneja S, 2006, CURR SCI INDIA, V91, P1079; Khatam MM, 2003, PAKISTAN J BIOL SCI, V6, P511; Kibria K, 2008, BANGL J BOT, V37, P141; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Krishna Naik R., 2005, ANDHRA AGR J, V52, P52; Krishna Veni B, 2006, ORYZA, V43, P320; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin HY, 2012, BOT STUD, V53, P363; Lu FH, 2012, GENET RES, V94, P179, DOI 10.1017/S0016672312000390; Mathure S, 2011, EUPHYTICA, V179, P237, DOI 10.1007/s10681-010-0294-9; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Nachimuthu VV, 2015, RICE, V8, DOI 10.1186/s12284-015-0062-5; Nadaf AB, 2006, CURR SCI INDIA, V91, P1533; Nakamura I, 1997, BREEDING SCI, V47, P385; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oka H. I., 1988, Origin of cultivated rice.; Okoshi M, 2016, GENET RESOUR CROP EV, V63, P199, DOI 10.1007/s10722-015-0239-1; Pachauri V, 2010, J PLANT BIOCHEM BIOT, V19, P127, DOI 10.1007/BF03263333; Panda D, 2014, INT RES J ENV SCI, V3, P80; Patnaik A, 2014, INDIAN J GENET PL BR, V74, P537; Patra BC, 2003, GENET RESOUR CROP EV, V50, P825, DOI 10.1023/A:1025963411919; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Prathepha Preecha, 2008, Pak J Biol Sci, V11, P26, DOI 10.3923/pjbs.2008.26.33; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Rabbani MA, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-3; Rajamani S, 2004, ANDHRA AGR J, V51, P36; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Rana JC, 2009, GENET RESOUR CROP EV, V56, P963, DOI 10.1007/s10722-009-9415-5; Ranawake AL, 2013, J U RUHUNA, V1, P3, DOI DOI 10.4038/JUR.V1I1.6150; Rathi S, 2014, INDIAN J GENET PL BR, V74, P238, DOI 10.5958/0975-6906.2014.00161.8; Roy PS, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0086-8; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sadeghi S. M., 2011, World Applied Sciences Journal, V13, P1229; Sang T, 2013, CURR OPIN PLANT BIOL, V16, P139, DOI 10.1016/j.pbi.2013.03.003; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Singh RK, 2000, AROMATIC RICES, P292; Skuza L, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P553, DOI 10.5772/52028; Song MT, 2002, KOREAN J GENETIC, V24, P397; Subedi S., 2011, Journal of Agricultural Research (Lahore), V49, P83; Takahashi R, 2008, J HERED, V99, P593, DOI 10.1093/jhered/esn041; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Vinita Pachauri, 2013, Australian Journal of Crop Science, V7, P923; Yadav RB, 2007, J AGR TECHNOLOGY, V3, P203; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]; Zhao WG, 2013, EUPHYTICA, V191, P9, DOI 10.1007/s10681-012-0820-z	75	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162268	10.1371/journal.pone.0162268	http://dx.doi.org/10.1371/journal.pone.0162268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598392	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800049
J	Al-Shargabi, MA; Shaikh, A; Ismail, AS				Al-Shargabi, Mohammed A.; Shaikh, Asadullah; Ismail, Abdulsamad S.			Enhancing the Quality of Service for Real Time Traffic over Optical Burst Switching (OBS) Networks with Ensuring the Fairness for Other Traffics	PLOS ONE			English	Article							PHYSICAL IMPAIRMENTS	Optical burst switching (OBS) networks have been attracting much consideration as a promising approach to build the next generation optical Internet. A solution for enhancing the Quality of Service (QoS) for high priority real time traffic over OBS with the fairness among the traffic types is absent in current OBS' QoS schemes. In this paper we present a novel Real Time Quality of Service with Fairness Ratio (RT-QoSFR) scheme that can adapt the burst assembly parameters according to the traffic QoS needs in order to enhance the real time traffic QoS requirements and to ensure the fairness for other traffic. The results show that RT-QoSFR scheme is able to fulfill the real time traffic requirements (end to end delay, and loss rate) ensuring the fairness for other traffics under various conditions such as the type of real time traffic and traffic load. RT-QoSFR can guarantee that the delay of the real time traffic packets does not exceed the maximum packets transfer delay value. Furthermore, it can reduce the real time traffic packets loss, at the same time guarantee the fairness for non real time traffic packets by determining the ratio of real time traffic inside the burst to be 50-60%, 30-40%, and 10-20% for high, normal, and low traffic loads respectively.	[Al-Shargabi, Mohammed A.; Shaikh, Asadullah] Najran Univ, Coll Comp Sci & Informat Syst, Najran, Saudi Arabia; [Ismail, Abdulsamad S.] Univ Teknol Malaysia, Fac Comp, Dept Comp Sci, Johar, Malaysia	Najran University; Universiti Teknologi Malaysia	Al-Shargabi, MA (corresponding author), Najran Univ, Coll Comp Sci & Informat Syst, Najran, Saudi Arabia.	mashargabi@nu.edu.sa	Ismail, Abdul Samad/F-5015-2011; Shaikh, Asadullah/S-4815-2016	Ismail, Abdul Samad/0000-0002-0786-865X; Shaikh, Asadullah/0000-0003-4806-6159	Najran University [NU/ESCI/14/53]	Najran University	This project is funded under Najran University research grant number NU/ESCI/14/53.	Baccarelli E, 2016, IEEE NETWORK, V30, P54, DOI 10.1109/MNET.2016.7437025; Cao X, 2008, 2008 7 INT C OPT INT; Hu G, 2003, OPT FIB COMM C MAR 2, pMF100; Kantarci B, 2006, 2006 CAN C EL COMP E, P1419; Qiao C., 2000, Optical Networks Magazine, V1, P36; Qiao CM, 1999, J HIGH SPEED NETW, V8, P69; Quaglio JV, 2009, P 2 INT C SIM TOOLS, P2; Sarwar S, 2008, 2008 5TH INTERNATIONAL CONFERENCE ON BROADBAND COMMUNICATIONS, NETWORKS AND SYSTEMS (BROADNETS 2008), P140, DOI 10.1109/BROADNETS.2008.4769058; Shojafar M., 2016, ENERGY EFFICIENT ADA; Song H., 2011, P IEEE GLOB COMM C H, P1; Song HT, 2011, 2011 INTERNATIONAL CONFERENCE ON ELECTRONICS, COMMUNICATIONS AND CONTROL (ICECC), P1; Song HB, 2012, IEEE GLOB COMM CONF, P2984, DOI 10.1109/GLOCOM.2012.6503571; Song HB, 2013, J LIGHTWAVE TECHNOL, V31, P846, DOI 10.1109/JLT.2012.2235409; Song HB, 2012, J LIGHTWAVE TECHNOL, V30, P713, DOI 10.1109/JLT.2011.2180360; Venkatesh T, 2007, LECT NOTES COMPUT SC, V4534, P368; Vokkarane VM, 2003, IEEE J SEL AREA COMM, V21, P1198, DOI 10.1109/JSAC.2003.815681; Zheng HY, 2009, 2009 WRI INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND MOBILE COMPUTING: CMC 2009, VOL 2, P550, DOI 10.1109/CMC.2009.62	17	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161873	10.1371/journal.pone.0161873	http://dx.doi.org/10.1371/journal.pone.0161873			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583557	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600069
J	Cale, JA; Collignon, RM; Klutsch, JG; Kanekar, SS; Hussain, A; Erbilgin, N				Cale, Jonathan A.; Collignon, R. Maxwell; Klutsch, Jennifer G.; Kanekar, Sanat S.; Hussain, Altaf; Erbilgin, Nadir			Fungal Volatiles Can Act as Carbon Sources and Semiochemicals to Mediate Interspecific Interactions Among Bark Beetle-Associated Fungal Symbionts	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; BLUE-STAIN FUNGUS; DENDROCTONUS-PONDEROSAE; ORGANIC-COMPOUNDS; GROSMANNIA-CLAVIGERA; RANGE EXPANSION; COLEOPTERA; DYNAMICS; GROWTH; IDENTIFICATION	Mountain pine beetle (Dendroctonus ponderosae) has killed millions of hectares of pine forests in western North America. Beetle success is dependent upon a community of symbiotic fungi comprised of Grosmannia clavigera, Ophiostoma montium, and Leptographium longiclavatum. Factors regulating the dynamics of this community during pine infection are largely unknown. However, fungal volatile organic compounds (FVOCs) help shape fungal interactions in model and agricultural systems and thus may be important drivers of interactions among bark beetle-associated fungi. We investigated whether FVOCs can mediate interspecific interactions among mountain pine beetle's fungal symbionts by affecting fungal growth and reproduction. Headspace volatiles were collected and identified to determine species-specific volatile profiles. Interspecific effects of volatiles on fungal growth and conidia production were assessed by pairing physically-separated fungal cultures grown either on a carbon-poor or -rich substrate, inside a shared-headspace environment. Fungal VOC profiles differed by species and influenced the growth and/or conidia production of the other species. Further, our results showed that FVOCs can be used as carbon sources for fungi developing on carbon-poor substrates. This is the first report demonstrating that FVOCs can drive interactions among bark beetle fungal symbionts, and thus are important factors in beetle attack success.	[Cale, Jonathan A.; Klutsch, Jennifer G.; Kanekar, Sanat S.; Hussain, Altaf; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada; [Collignon, R. Maxwell] Univ Calif Riverside, Dept Entomol, Entomol Bldg, Riverside, CA 92521 USA	University of Alberta; University of California System; University of California Riverside	Cale, JA (corresponding author), Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada.	jacale@ualberta.ca	Erbilgin, Nadir/F-3675-2014; Collignon, Max/ABE-4488-2020; Hussain, Altaf/P-4178-2019	Erbilgin, Nadir/0000-0001-9912-8095; Klutsch, Jennifer/0000-0001-8839-972X; Kanekar, Sanat/0000-0003-4709-0376; Cale, Jonathan/0000-0002-8902-2032	National Sciences and Engineering Research Council of Canada; Izaak Walton Killam Memorial Student Scholarship from the University of Alberta	National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Izaak Walton Killam Memorial Student Scholarship from the University of Alberta	This work was partially supported by the National Sciences and Engineering Research Council of Canada (Discovery grant to NE; http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp) and the Izaak Walton Killam Memorial Student Scholarship from the University of Alberta (to JGK).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams AS, 2008, MICROB ECOL, V56, P460, DOI 10.1007/s00248-008-9364-0; Barriuso J, 2015, AIMS MICROBIOL, V1, P37, DOI 10.3934/microbiol.2015.1.37; Bennett JW, 2012, THE MYCOTA, P229; Bentz B.J., 2009, BARK BEETLE OUTBREAK; Bentz BJ, 2010, BIOSCIENCE, V60, P602, DOI 10.1525/bio.2010.60.8.6; Bentz BJ, 2006, ANN ENTOMOL SOC AM, V99, P189, DOI 10.1603/0013-8746(2006)099[0189:ECOFAW]2.0.CO;2; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; Bleiker KP, 2009, CAN ENTOMOL, V141, P503, DOI 10.4039/n09-034; Bleiker KP, 2009, MYCOL RES, V113, P3, DOI 10.1016/j.mycres.2008.06.004; Bracewell RR, 2015, ECOL EVOL, V5, P5109, DOI 10.1002/ece3.1772; BRAND JM, 1977, J CHEM ECOL, V3, P657, DOI 10.1007/BF00988065; British Columbia Ministry of Forests L and NRO, 2012, FACTS BCS MOUNT PIN; Chitarra GS, 2004, APPL ENVIRON MICROB, V70, P2823, DOI 10.1128/AEM.70.5.2823-2829.2004; Davis TS, 2011, MICROB ECOL, V61, P626, DOI 10.1007/s00248-010-9773-8; Davis TS, 2013, J CHEM ECOL, V39, P840, DOI 10.1007/s10886-013-0306-z; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Del Giudice L, 2008, ENVIRON MICROBIOL, V10, P2824, DOI 10.1111/j.1462-2920.2008.01703.x; DiGuistini S, 2011, P NATL ACAD SCI USA, V108, P2504, DOI 10.1073/pnas.1011289108; El Ariebi N, 2016, FUNGAL ECOL, V20, P144, DOI 10.1016/j.funeco.2015.12.013; Faheem Amin, 2010, Journal of Phytology, V2, P34; Goodsman DW, 2013, NEW PHYTOL, V197, P586, DOI 10.1111/nph.12019; Goodsman DW, 2012, ENVIRON ENTOMOL, V41, P478, DOI 10.1603/EN11205; Hanssen H, 1993, CERATOCYSTIS OPHIOST, P117; Hesse-Orce U, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-536; Hofstetter RW, 2014, ANNU REV ENTOMOL, V59, P537, DOI 10.1146/annurev-ento-011613-162039; Hulcr J, 2011, J CHEM ECOL, V37, P1374, DOI 10.1007/s10886-011-0046-x; Hung R., 2014, MYCOLOGY, V5, P1, DOI DOI 10.1080/21501203.2014.902401; Hung R, 2015, APPL MICROBIOL BIOT, V99, P3395, DOI 10.1007/s00253-015-6494-4; Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005; Karst J, 2015, NEW PHYTOL, V208, P904, DOI 10.1111/nph.13492; Kendrick B., 2000, 5 KINGDOM; Lee S, 2005, MYCOL RES, V109, P1162, DOI 10.1017/S0953756205003588; Macias-Rodriguez L, 2015, FUNGAL BIOMOLECULES: SOURCES, APPLICATIONS AND RECENT DEVELOPMENTS, P87; Man G, 2012, FS1000 USDA; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Muller A, 2013, FUNGAL GENET BIOL, V54, P25, DOI 10.1016/j.fgb.2013.02.005; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Nishino S, 2013, J PHYTOPATHOL, V161, P515, DOI 10.1111/jph.12100; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pec GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124691; Polizzi V, 2012, FUNGAL BIOL-UK, V116, P941, DOI 10.1016/j.funbio.2012.06.001; Prenafeta-Boldu FX, 2001, MYCOL RES, V105, P477, DOI 10.1017/S0953756201003719; Pureswaran DS, 2000, CHEMOECOLOGY, V10, P153, DOI 10.1007/PL00001818; Qi B, 2002, APPL MICROBIOL BIOT, V58, P684, DOI 10.1007/s00253-002-0938-3; R Core Team, 2013, R LANG ENV STAT COMP; Raffa K. F., 1980, Proceedings of the second IUFRO conference on dispersal of forest insects: evaluation, theory and management implications., P213; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; RENWICK JAA, 1976, NATURWISSENSCHAFTEN, V63, P198, DOI 10.1007/BF00624228; Roe AD, 2011, MICROB ECOL, V62, P347, DOI 10.1007/s00248-011-9841-8; Roze LV, 2007, APPL ENVIRON MICROB, V73, P7268, DOI 10.1128/AEM.00801-07; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Shepherd WP, 2013, J CHEM ECOL, V39, P481, DOI 10.1007/s10886-013-0265-4; Six DL, 2013, J CHEM ECOL, V39, P989, DOI 10.1007/s10886-013-0318-8; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Six DL, 2003, CAN J FOREST RES, V33, P1331, DOI [10.1139/x03-047, 10.1139/X03-047]; SOLHEIM H, 1995, CAN J BOT, V73, P70, DOI 10.1139/b95-009; Splivallo R, 2007, PHYTOCHEMISTRY, V68, P2584, DOI 10.1016/j.phytochem.2007.03.030; Stoppacher N, 2010, J MICROBIOL METH, V81, P187, DOI 10.1016/j.mimet.2010.03.011; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Tarkka MT, 2007, NEW PHYTOL, V175, P381, DOI 10.1111/j.1469-8137.2007.02165.x; Tewari S, 2014, INTEGRATED PEST MANAGEMENT: CURRENT CONCEPTS AND ECOLOGICAL PERSPECTIVE, P141, DOI 10.1016/B978-0-12-398529-3.00010-5; Therrien J, 2015, OECOLOGIA, V179, P467, DOI 10.1007/s00442-015-3356-9; Treu R, 2014, ECOLOGY, V95, P1096, DOI 10.1890/13-1233.1; Viiri H, 2001, TREES-STRUCT FUNCT, V15, P327, DOI 10.1007/s004680100117; WHITNEY HS, 1970, SCIENCE, V167, P54, DOI 10.1126/science.167.3914.54; Zhang QH, 2015, PLANT SOIL, V392, P101, DOI 10.1007/s11104-015-2448-y	68	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162197	10.1371/journal.pone.0162197	http://dx.doi.org/10.1371/journal.pone.0162197			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583519	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600118
J	Fujimoto, T; Inoue, T; Maki, K; Inoue-Mochita, M; Tanihara, H				Fujimoto, Tomokazu; Inoue, Toshihiro; Maki, Kei; Inoue-Mochita, Miyuki; Tanihara, Hidenobu			Vascular Endothelial Growth Factor-A Increases the Aqueous Humor Outflow Facility	PLOS ONE			English	Article							MULTIPLE PROINFLAMMATORY CYTOKINES; PROTEIN-KINASE INHIBITOR; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; MACULAR DEGENERATION; INTRAVITREAL BEVACIZUMAB; NONGLAUCOMATOUS NORMALS; SIGNAL-TRANSDUCTION; INJECTIONS; THERAPY	Purpose Anti-vascular endothelial growth factor (VEGF) antibody therapy is an effective treatment for ocular angiogenesis. Although the intraocular pressure of some patients increases after anti-VEGF therapy, the effects of VEGF-A on the aqueous humor outflow pathway remain unknown. This study investigated the effects of VEGF-A on the aqueous humor outflow pathway. Methods We used human recombinant VEGF121 and VEGF165. Trabecular meshwork (TM) and Schlemm's canal endothelial (SCE) cells were isolated from the eyes of cynomolgus monkeys. Expression of mRNA coding four VEGF receptors, VEGFR1 (FLT1), VEGFR2 (KDR), neuropilin-1, and neuropilin-2, was examined by RT-PCR. To evaluate the permeability of cell monolayers, we measured transendothelial electrical resistance (TEER). The outflow facility was measured in perfused porcine anterior segment organ cultures treated with 30 ng/mL VEGF121 for 48 h. Results Four VEGF-A-related receptor mRNAs were expressed in TM and SCE cells. The TEER of TM cells was not significantly affected by VEGF121 or VEGF165 treatment. In contrast, the TEER of SCE cells was significantly lower 48 h after treatment with 30 ng/mL VEGF121 to 69.4 +/- 12.2% of baseline (n = 10), which was a significant difference compared with the control (P = 0.0001). VEGF165 (30 ng/mL) decreased the TEER of SCE cells at 48 h after treatment to 72.3 +/- 14.1% compared with the baseline (n = 10), which was not a significant difference compared with the control (P = 0.0935). Ki8751, a selective VEGFR2 inhibitor, completely suppressed the effect of VEGF121 on SCE cell permeability, although ZM306416, a selective VEGFR1 inhibitor, did not affect the VEGF121-induced decrease in TEER. Perfusion with 30 ng/mL of VEGF121 for 48 h significantly increased the outflow facility compared with the control (47.8 +/- 28.5%, n = 5, P = 0.013). Conclusions These results suggest that VEGF-A may regulate the conventional aqueous outflow of SCE cells through VEGFR2.	[Fujimoto, Tomokazu; Inoue, Toshihiro; Maki, Kei; Inoue-Mochita, Miyuki; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan	Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Fujimoto, Tomokazu/0000-0002-4867-1925; Inoue, Toshihiro/0000-0003-3769-7609	Japan Society for the Promotion of Science KAKENHI [26293375, 15K15636, 26462664]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HT received Japan Society for the Promotion of Science KAKENHI, Grant Numbers 26293375 and 15K15636 (https://www.jsps.go.jp/english/index.html). TI received Japan Society for the Promotion of Science KAKENHI, Grant Number 26462664.	Adelman RA, 2010, J OCUL PHARMACOL TH, V26, P105, DOI 10.1089/jop.2009.0076; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; ALVARADO JA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1517; Ba J, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S86269; Falkenstein IA, 2007, RETINA-J RET VIT DIS, V27, P1044, DOI 10.1097/IAE.0b013e3180592ba6; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fujimoto T, 2012, INVEST OPHTH VIS SCI, V53, P7097, DOI 10.1167/iovs.12-9989; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Funk M, 2009, INVEST OPHTH VIS SCI, V50, P1025, DOI 10.1167/iovs.08-2510; Gismondi M, 2009, J GLAUCOMA, V18, P658, DOI 10.1097/IJG.0b013e31819c4893; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Kim JE, 2008, AM J OPHTHALMOL, V146, P930, DOI 10.1016/j.ajo.2008.07.007; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mathalone N, 2012, GRAEF ARCH CLIN EXP, V250, P1435, DOI 10.1007/s00417-012-1981-0; Ohira S, 2015, INVEST OPHTH VIS SCI, V56, P3541, DOI 10.1167/iovs.14-15918; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROHEN JW, 1983, OPHTHALMOLOGY, V90, P758; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Syriani E, 2009, INVEST OPHTH VIS SCI, V50, P3833, DOI 10.1167/iovs.08-2924; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tseng JJ, 2012, J GLAUCOMA, V21, P241, DOI 10.1097/IJG.0b013e31820d7d19; Tsuboi N, 2012, INVEST OPHTH VIS SCI, V53, P6702, DOI 10.1167/iovs.12-10376	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161332	10.1371/journal.pone.0161332	http://dx.doi.org/10.1371/journal.pone.0161332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584577	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600021
J	Janssen, KMJ; Westra, J; Chalan, P; Boots, AMH; de Smit, MJ; van Winkelhoff, AJ; Vissink, A; Brouwer, E				Janssen, Koen M. J.; Westra, Johanna; Chalan, Paulina; Boots, Annemieke M. H.; de Smit, Menke J.; van Winkelhoff, Arie Jan; Vissink, Arjan; Brouwer, Elisabeth			Regulatory CD4+T-Cell Subsets and Anti-Citrullinated Protein Antibody Repertoire: Potential Biomarkers for Arthritis Development in Seropositive Arthralgia Patients?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; T-CELLS; PERIPHERAL-BLOOD; SYNOVIAL-FLUID; TNF-ALPHA; PRECEDE; ONSET; AUTOANTIBODIES; INFLAMMATION	Objective Seropositive arthralgia patients (SAP) are at high risk of developing rheumatoid arthritis (RA). This prospective study aimed to determine whether altered peripheral regulatory T-cells (Tregs) and defined subsets, besides a broadened anti-citrullinated protein antibody (ACPA) response, may qualify as biomarkers for RA development in SAP. Methods Thirty-four consecutive SAP were prospectively assessed every 6 months for minimally 2 years. At inclusion, peripheral Treg (CD4(+)CD25(+)FoxP3(+)) numbers and subsets, defined as CD45RA(+)FoxP3(low) naive Tregs (Fr I), CD45RA(-)FoxP3(high) activated Tregs (Fr II) and CD45RA(-)FoxP3(low) non-Tregs (Fr III), were compared to age-and sex-matched healthy controls (HC, n = 16) and treatment-naive RA patients (n = 12). SAP that developed RA were compared to non-switchers and analyzed for Treg numbers and Treg subsets at inclusion. Also, Treg numbers and subsets were compared in switched SAP before and at diagnosis. To assess the ACPA repertoire, IgG and IgA reactivity was measured against citrullinated peptides from fibrinogen, alpha-enolase and vimentin. Results Treg numbers were similar between HC, SAP and RA patients. Although the bonafide Treg subsets Fr I and Fr II were comparable between groups, Fr III was increased in SAP compared to HC (p = 0.01). Fourteen (41%) SAP developed RA during follow-up. Their Treg numbers and subsets were comparable to non-switched SAP. At RA diagnosis, Treg numbers in switched SAP were similar to 6 months before. Switched SAP displayed a more diverse IgG ACPA repertoire compared to non-switched SAP (p = 0.046) and showed more IgA reactivity than non-switched SAP reaching significance for Fib1 only (p = 0.047). Conclusion Numbers of Total Treg and bonafide Treg subsets are not indicative for RA development in SAP, opposed to the ACPA repertoire.	[Janssen, Koen M. J.; Vissink, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Westra, Johanna; Chalan, Paulina; Boots, Annemieke M. H.; Brouwer, Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [de Smit, Menke J.; van Winkelhoff, Arie Jan] Univ Groningen, Univ Med Ctr Groningen, Ctr Dent & Oral Hyg, Groningen, Netherlands; [van Winkelhoff, Arie Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Brouwer, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	e.brouwer@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020	Brouwer, Elisabeth/0000-0002-5652-4423				Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Brink M, 2013, ARTHRITIS RHEUM-US, V65, P899, DOI 10.1002/art.37835; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Chalan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079370; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Han GM, 2008, CELL IMMUNOL, V253, P92, DOI 10.1016/j.cellimm.2008.05.007; Hunt L, 2016, ANN RHEUM DIS, V75, P1884, DOI 10.1136/annrheumdis-2015-207991; Jang E, 2011, J IMMUNOL, V186, P1546, DOI 10.4049/jimmunol.1002942; Janssen KMJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0690-6; Karlson EW, 2016, RHEUMATOLOGY, V55, P6, DOI 10.1093/rheumatology/keu287; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kokkonen H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3237; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Liu MF, 2005, SCAND J IMMUNOL, V62, P312, DOI 10.1111/j.1365-3083.2005.01656.x; Matsuki F, 2013, BIOCHEM BIOPH RES CO, V438, P778, DOI 10.1016/j.bbrc.2013.05.120; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Ponchel F, 2014, ANN RHEUM DIS, V73, P2047, DOI 10.1136/annrheumdis-2013-203566; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van de Stadt LA, 2011, ANN RHEUM DIS, V70, P128, DOI 10.1136/ard.2010.132662; van de Stadt LA, 2013, ANN RHEUM DIS, V72, P1920, DOI 10.1136/annrheumdis-2012-202127; van der Geest KSM, 2014, EXP GERONTOL, V60, P190, DOI 10.1016/j.exger.2014.11.005; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204	36	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162101	10.1371/journal.pone.0162101	http://dx.doi.org/10.1371/journal.pone.0162101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27585422	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600103
J	Fiskaa, T; Knutsen, E; Nikolaisen, MA; Jorgensen, TE; Johansen, SD; Perander, M; Seternes, OM				Fiskaa, Tonje; Knutsen, Erik; Nikolaisen, Marlen Aas; Jorgensen, Tor Erik; Johansen, Steinar Daae; Perander, Maria; Seternes, Ole Morten			Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines	PLOS ONE			English	Article							INTERCELLULAR TRANSFER; TRANSFERRIN RECEPTOR; MICRORNA SIGNATURES; GENE-EXPRESSION; EXOSOMES; MICROVESICLES; PROMOTE; PLASMA; STAGE; ANGIOGENESIS	Breast cancer is a heterogeneous disease, and different subtypes of breast cancer show distinct cellular morphology, gene expression, metabolism, motility, proliferation, and metastatic potential. Understanding the molecular features responsible for this heterogeneity is important for correct diagnosis and better treatment strategies. Extracellular vesicles (EVs) and their associated molecules have gained much attention as players in intercellular communication, ability to precondition specific organs for metastatic invasion, and for their potential role as circulating cancer biomarkers. EVs are released from the cells and contain proteins, DNA, and long and small RNA species. Here we show by high-throughput small RNA-sequencing that EVs from nine different breast cancer cell lines share common characteristics in terms of small RNA content that are distinct from their originating cells. Most strikingly, a highly abundant small RNA molecule derived from the nuclear 28S rRNA is vastly enriched in EVs. The miRNA profiles in EVs correlate with the cellular miRNA expression pattern, but with a few exceptions that includes miR-21. This cancer-associated miRNA is retained in breast cancer cell lines. Finally, we report that EVs from breast cancer cell lines cluster together based on their small RNA signature when compared to EVs derived from other cancer cell lines. Altogether, our data demonstrate that breast cancer cell lines manifest a specific small RNA signature in their released EVs. This opens up for further evaluation of EVs as breast cancer biomarkers.	[Fiskaa, Tonje; Knutsen, Erik; Johansen, Steinar Daae; Perander, Maria] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, MH Bldg Breivika, N-9037 Tromso, Norway; [Fiskaa, Tonje; Nikolaisen, Marlen Aas; Seternes, Ole Morten] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, MH Bldg Breivika, N-9037 Tromso, Norway; [Jorgensen, Tor Erik; Johansen, Steinar Daae] Nord Univ, Fac Biosci & Aquaculture, Marine Genom Grp, Bodo, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Nord University	Fiskaa, T (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Med Biol, MH Bldg Breivika, N-9037 Tromso, Norway.; Fiskaa, T (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, MH Bldg Breivika, N-9037 Tromso, Norway.	Tonje.Fiskaa@uit.no	Seternes, Ole Morten/M-9520-2019; Knutsen, Erik/ABH-6287-2020	Seternes, Ole Morten/0000-0001-8537-3612; Knutsen, Erik/0000-0002-4903-0150; Jorgensen, Tor Erik/0000-0002-6401-0713; Perander, Maria/0000-0002-1177-2407	University of Tromso (Strategic miRNA Initiative); Norwegian Cancer Society; Northern Norway Regional Health Authority/Helse Nord RHF	University of Tromso (Strategic miRNA Initiative); Norwegian Cancer Society(Norwegian Cancer Society); Northern Norway Regional Health Authority/Helse Nord RHF	The work was supported by University of Tromso (Strategic miRNA Initiative, SDJ, OMS), The Norwegian Cancer Society (OMS), and Northern Norway Regional Health Authority/Helse Nord RHF (TF and MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the University of Tromso (Strategic miRNA Initiative, Steinar Daae Johansen and Ole Morten Seternes), The Norwegian Cancer Society (Ole Morten Seternes) and Northern Norway Regional Health Authority/Helse Nord RHF (Tonje Fiskaa and Maria Perander).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2014, METHODS MOL BIOL, V1165, P147, DOI 10.1007/978-1-4939-0856-1_11; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Cookson VJ, 2012, CELL ONCOL, V35, P301, DOI 10.1007/s13402-012-0089-1; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Corrado C, 2013, INT J MOL SCI, V14, P5338, DOI 10.3390/ijms14035338; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Fabbri M, 2008, CANCER J, V14, P1, DOI 10.1097/PPO.0b013e318164145e; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Graves LE, 2004, CANCER RES, V64, P7045, DOI 10.1158/0008-5472.CAN-04-1800; Guduric-Fuchs J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-357; Guo L, 2013, MOL BIOL REP, V40, P2175, DOI 10.1007/s11033-012-2277-5; Guzman N, 2015, MOL CANCER RES, V13, P891, DOI 10.1158/1541-7786.MCR-14-0533; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hakulinen J, 2004, EUR J IMMUNOL, V34, P2620, DOI 10.1002/eji.200424969; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Hoffman RM, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3426; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Hussein MNA, 2007, THROMB HAEMOSTASIS, V98, P1096, DOI 10.1160/TH05-04-0231; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenjaroenpun P, 2013, PEERJ, V1, DOI 10.7717/peerj.201; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Knutsen E, 2015, NEXT GENERATION SEQU, V2; Kodahl AR, 2014, MOL ONCOL, V8, P874, DOI 10.1016/j.molonc.2014.03.002; Koga K, 2005, ANTICANCER RES, V25, P3703; Koppers-Lalic D, 2014, CELL REP, V8, P1649, DOI 10.1016/j.celrep.2014.08.027; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Lambertz U, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1260-7; Liu J, 2011, INT J ORAL SCI, V3, P165, DOI 10.4248/IJOS11063; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Miranda KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096094; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Nolte-'t Hoen ENM, 2012, NUCLEIC ACIDS RES, V40, P9272, DOI 10.1093/nar/gks658; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Tosar JP, 2015, NUCLEIC ACIDS RES, V43, P5601, DOI 10.1093/nar/gkv432; Palmero EI, 2011, GENET MOL BIOL, V34, P363, DOI 10.1590/S1415-47572011000300001; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Prasmickaite L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010731; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rye PD, 1996, INT J CANCER, V68, P682, DOI 10.1002/(SICI)1097-0215(19961127)68:5<682::AID-IJC20>3.0.CO;2-2; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Shedden K, 2003, CANCER RES, V63, P4331; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Slrnalley DM, 2008, J PROTEOME RES, V7, P2088, DOI 10.1021/pr700775x; Sopik V, 2016, BREAST CANCER RES TR, V155, P175, DOI 10.1007/s10549-015-3666-y; STEIN JM, 1991, BIOCHEM J, V274, P381, DOI 10.1042/bj2740381; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Balkom BWM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26760; van Doormaal FF, 2009, NETH J MED, V67, P266; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Zhang ZJ, 2012, ONCOL REP, V27, P903, DOI 10.3892/or.2011.1611; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	81	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161824	10.1371/journal.pone.0161824	http://dx.doi.org/10.1371/journal.pone.0161824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579604	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400043
J	Choi, JW; Lee, JM; Lee, DH; Yoon, JH; Suh, KS; Yoon, JH; Kim, YJ; Lee, JH; Yu, SJ; Han, JK				Choi, Jin Woo; Lee, Jeong Min; Lee, Dong Ho; Yoon, Jeong-Hee; Suh, Kyung-Suk; Yoon, Jung-Hwan; Kim, Yoon Jun; Lee, Jeong-Hoon; Yu, Su Jong; Han, Joon Koo			Switching Monopolar Radiofrequency Ablation Using a Separable Cluster Electrode in Patients with Hepatocellular Carcinoma: A Prospective Study	PLOS ONE			English	Article							VIVO PORCINE LIVER; PERCUTANEOUS ETHANOL INJECTION; LOW-TUBE-VOLTAGE; 1ST-LINE TREATMENT; PROGNOSTIC-FACTORS; TISSUE ABLATION; HEPATIC-TUMORS; EXPERIENCE; METASTASES; OUTCOMES	Objective This study was conducted to evaluate the outcomes of multi-channel switching RFA using a separable cluster electrode in patients with HCC. Methods From November 2011 to July 2013, 79 patients with 98 HCCs < 5 cm were enrolled and treated with RFA using a multi-channel switching radiofrequency system and a separable cluster electrode under the guidance of a real-time fusion imaging system. The primary and secondary endpoints were the 3-year local tumor progression (LTP) rate and recurrence-free survival (RFS) rate, respectively. For post hoc analyses, LTP, RFS, and major complication rates were retrospectively compared with a historical control group treated with RFA using the same radiofrequency system but with multiple internally-cooled electrodes. Results The technique success rate of the 98 tumors was 100%. Cumulative 1-year, 2-year, and 3-year LTP rates were 3.4%, 6.9%, and 12.4%, respectively. For patient-level data, cumulative 1-year, 2-year, and 3-year RFS rates were 83.9%, 68.6%, and 45.4%, respectively. On post hoc analyses, none of the baseline characteristics showed a significant difference between the separable cluster electrode and multiple internally-cooled electrodes group. Cumulative LTP and RFS rates of the two groups also showed no significant difference (p = 0.401 and p = 0.881, respectively). Finally, major complication rates of the separable cluster electrode group (5.0%, 4/79) and multiple internally-cooled electrodes group (5.9%, 4/74) were also comparable (p = 1.000). Conclusion Switching monopolar RFA using a separable cluster electrode is a feasible and efficient technique for the treatment of HCCs smaller than 5 cm, providing comparable local tumor control to multiple internally-cooled electrodes.	[Choi, Jin Woo; Lee, Jeong Min; Lee, Dong Ho; Yoon, Jeong-Hee; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Suh, Kyung-Suk] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea; [Yoon, Jung-Hwan; Kim, Yoon Jun; Lee, Jeong-Hoon; Yu, Su Jong] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Lee, JM (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	jmsh@snu.ac.kr	Lee, Jeong-Hoon/Q-1055-2018; Lee, Jeong Min/V-3429-2019; Yoon, Jeong Hee/ABA-5127-2021	Lee, Jeong-Hoon/0000-0002-0315-2080; Lee, Jeong Min/0000-0003-0561-8777; Yoon, Jeong Hee/0000-0002-9925-9973; Yoon, Jung-Hwan/0000-0002-9128-3610; Yu, Su Jong/0000-0001-8888-7977; Kim, Yoon Jun/0000-0001-9141-7773	STARmed corp [1441]	STARmed corp	This project was funded by grant #1441 to J.M. Lee from STARmed corp (http://www.starmed4u.com). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, RADIOLOGY, V273, P241, DOI 10.1148/radiol.14132958; Arata MA, 2001, J VASC INTERV RADIOL, V12, P455, DOI 10.1016/S1051-0443(07)61884-3; Brace CL, 2007, INT J HYPERTHER, V23, P387, DOI 10.1080/02656730701397858; Brace CL, 2009, J VASC INTERV RADIOL, V20, P118, DOI 10.1016/j.jvir.2008.09.021; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Brunello F, 2008, SCAND J GASTROENTERO, V43, P727, DOI 10.1080/00365520701885481; Buls N, 2015, EUR RADIOL, V25, P1023, DOI 10.1007/s00330-014-3510-5; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Choi D, 2007, EUR RADIOL, V17, P684, DOI 10.1007/s00330-006-0461-5; Cucchetti A, 2013, J HEPATOL, V59, P300, DOI 10.1016/j.jhep.2013.04.009; Elvin A, 2005, ABDOM IMAGING, V30, P427, DOI 10.1007/s00261-004-0257-5; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Gervais DA, 2006, AM J ROENTGENOL, V187, P746, DOI 10.2214/AJR.05.1106; Giorgio A, 2011, ANTICANCER RES, V31, P2291; Goldberg SN, 1998, RADIOLOGY, V209, P371, DOI 10.1148/radiology.209.2.9807561; Hong SN, 2005, J CLIN GASTROENTEROL, V39, P247, DOI 10.1097/01.mcg.0000152746.72149.31; Kang TW, 2015, RADIOLOGY, V276, P274, DOI 10.1148/radiol.15141215; Kettenbach J, 2003, AM J ROENTGENOL, V180, P1537, DOI 10.2214/ajr.180.6.1801537; Kim HR, 2010, INT J HYPERTHER, V26, P305, DOI 10.3109/02656730903555696; Kim YS, 2013, J HEPATOL, V58, P89, DOI 10.1016/j.jhep.2012.09.020; Kong WT, 2009, WORLD J GASTROENTERO, V15, P2651, DOI 10.3748/wjg.15.2651; Krucker J, 2011, J VASC INTERV RADIOL, V22, P515, DOI 10.1016/j.jvir.2010.10.033; Laeseke PF, 2006, RADIOLOGY, V241, P116, DOI 10.1148/radiol.2411051271; Lee DH, 2014, RADIOLOGY, V270, P900, DOI 10.1148/radiol.13130940; Lee ES, 2012, BRIT J RADIOL, V85, pE609, DOI 10.1259/bjr/61619687; Lee JM, 2007, INVEST RADIOL, V42, P676, DOI 10.1097/RLI.0b013e3180661aad; Lee MW, 2012, AM J ROENTGENOL, V198, P1438, DOI 10.2214/AJR.11.7568; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Lorentzen T, 1996, ACAD RADIOL, V3, P556, DOI 10.1016/S1076-6332(96)80219-4; Mahnken AH, 2013, RADIOLOGY, V266, P407, DOI 10.1148/radiol.12112544; Mazzaglia PJ, 2007, SURGERY, V142, P10, DOI 10.1016/j.surg.2007.01.036; Noda Y, 2015, EUR J RADIOL, V84, P11, DOI 10.1016/j.ejrad.2014.10.008; Park MJ, 2011, J VASC INTERV RADIOL, V22, P771, DOI 10.1016/j.jvir.2011.02.005; Robinson E, 2010, INVEST RADIOL, V45, P413, DOI 10.1097/RLI.0b013e3181dfda78; Rossi S, 1998, AM J ROENTGENOL, V170, P1015, DOI 10.2214/ajr.170.4.9530052; Seror O, 2014, J VASC INTERV RADIOL, V25, P599, DOI 10.1016/j.jvir.2013.11.025; Solbiati L, 2012, RADIOLOGY, V265, P958, DOI 10.1148/radiol.12111851; Song I, 2009, EUR RADIOL, V19, P2630, DOI 10.1007/s00330-009-1463-x; Takaki H, 2013, RADIOLOGY, V267, P285, DOI 10.1148/radiol.12121070; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Woo S, 2013, RADIOLOGY, V268, P589, DOI 10.1148/radiol.13121736; Yoon JH, 2014, KOREAN J RADIOL, V15, P235, DOI 10.3348/kjr.2014.15.2.235; Yoon JH, 2013, KOREAN J RADIOL, V14, P403, DOI 10.3348/kjr.2013.14.3.403	45	43	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161980	10.1371/journal.pone.0161980	http://dx.doi.org/10.1371/journal.pone.0161980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575787	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877200051
J	Dhalla, K; Cousens, S; Bowman, R; Wood, M; Murdoch, I				Dhalla, Kazim; Cousens, Simon; Bowman, Richard; Wood, Mark; Murdoch, Ian			Is Beta Radiation Better than 5 Flurouracil as an Adjunct for Trabeculectomy Surgery When Combined with Cataract Surgery? A Randomised Controlled Trial	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; MITOMYCIN-C; VISUAL IMPAIRMENT; 5-FLUOROURACIL; NIGERIA; PHACOTRABECULECTOMY; OUTCOMES; AFRICA	Introduction In an African setting surgery is generally accepted as the treatment of first choice for glaucoma. A problem with trabeculectomy surgery for the glaucomas is the frequent co-existence and exacerbation of cataract. We report a randomized controlled trial to compare the use of beta radiation with 5FU in combined cataract and glaucoma surgery. Participants and Methods Consenting adults aged >40 years with glaucoma, an IOP>21mmHG and cataract were enrolled and randomised to receive either 1000cG beta radiation application or sub-conjunctival 5fluorouracil (5FU) at the time of combined trabeculectomy and phaco-emulsification with lens implant surgery. Results 385 individuals were eligible for inclusion of whom 301 consented to inclusion in the study (one eye per patient). 150 were randomised to the 5FU arm and 151 received beta radiation. In the 12 months following surgery there were 40 failures (IOP>21mmHg) in the 5FU arm and 34 failures in the beta arm. The hazard ratio for the beta radiation arm compared to the 5FU arm, adjusted for IOP at baseline, was 0.83 (95% c.i. 0.54 to 1.28; P = 0.40). The improvement from mean presenting visual acuities of 0.91 and 0.86 logMAR to 0.62 and 0.54 in the 5FU and beta arms respectively was comparable between groups (P = 0.4 adjusting for baseline VA). Incidence of complications did not differ between the two groups. Discussion This study highlights several important issues in the quest for a therapeutic strategy for the glaucomas in an African context. Firstly, there is no evidence of an important difference between the use of 5FU and beta radiation as an anti-metabolite in phacotrabeculectomy. Secondly phacotrabeculectomy is a successful operation that improves visual acuity as well as controlling IOP in a majority of patients. Although the success of trabeculectomy in lowering IOP is reduced when combined with phacoemulsification compared with trabeculectomy alone, this finding has to be set against the possible need for subsequent cataract surgery following trabeculectomy alone, which represents a second trip and expense for the patient and results in 10-61% failure of the trabeculectomy at one year post-cataract surgery.	[Dhalla, Kazim; Wood, Mark] Comprehens Community Based Rehabil Hosp Tanzania, Dept Ophthalmol, Dar Es Salaam, Tanzania; [Cousens, Simon] London Sch Hyg & Trop Med LSHTM, Dept Infect Dis Epidemiol, London, England; [Bowman, Richard] London Sch Hyg & Trop Med LSHTM, Int Ctr Eye Hlth, London, England; [Murdoch, Ian] UCL, Inst Ophthalmol, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Murdoch, I (corresponding author), UCL, Inst Ophthalmol, London, England.	i.murdoch@ucl.ac.uk	Dhalla, Kazim/AAW-1985-2020; Murdoch, Ian/Z-2527-2019; Murdoch, Ian/ABB-4977-2021	Dhalla, Kazim/0000-0003-3838-1614; Murdoch, Ian/0000-0002-5453-0635	Band Aid; International Glaucoma Association; British Council for the Prevention of Blindness	Band Aid; International Glaucoma Association; British Council for the Prevention of Blindness	Band Aid (http://opencharities.org/charities/292199) is the primary charity who funded the majority of this project via a specialist charity Fight For Sight (http://www.fightforsight.org.uk/). International Glaucoma Association supported the trial, especially follow-up of the patients (http://www.glaucoma-association.com/). British Council for the Prevention of Blindness supported KD for the analysis in UK under supervision of SC and IM (http://www.bcpb.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdull MM, 2009, INVEST OPHTH VIS SCI, V50, P4114, DOI 10.1167/iovs.09-3507; Agbeja-Baiyeroju A M, 2001, Afr J Med Med Sci, V30, P39; Anand N, 2001, EYE, V15, P274, DOI 10.1038/eye.2001.93; Anand N, 2012, MIDDLE EAST AFR J OP, V19, P147, DOI 10.4103/0974-9233.92132; Ashaye AO, 2009, EYE, V23, P448, DOI 10.1038/sj.eye.6702979; Bekibele C O, 2001, West Afr J Med, V20, P223; Bowman RJC, 2010, EYE, V24, P573, DOI 10.1038/eye.2009.132; BROADWAY D, 1994, BRIT J OPHTHALMOL, V78, P466, DOI 10.1136/bjo.78.6.466; Chang L, 2006, J GLAUCOMA, V15, P475, DOI 10.1097/01.ijg.0000212271.65477.a4; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Cook C, 2009, J GLAUCOMA, V18, P4; De Fendi LI, 2013, CLIN EXP OPHTHALMOL, V41, P798, DOI 10.1111/ceo.12097; Ederer F, 2004, OPHTHALMOLOGY, V111, P651, DOI 10.1016/j.ophtha.2003.09.025; Girma Taffessework, 2006, Ethiop Med J, V44, P253; Green E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001132.pub2; Jin GJC, 2007, J CATARACT REFR SURG, V33, P1201, DOI 10.1016/j.jcrs.2007.03.050; Kabiru J, 2005, J GLAUCOMA, V14, P432, DOI 10.1097/01.ijg.0000185617.98915.36; Kim HY, 2008, J GLAUCOMA, V17, P578, DOI 10.1097/IJG.0b013e31816b304a; Kirwan JF, 2006, BMJ-BRIT MED J, V333, P942, DOI 10.1136/bmj.38971.395301.7C; Kirwan JF RC, 2012, BETA RAD GLAUCOMA SU; Komolafe O O, 2011, West Afr J Med, V30, P173; Lawan A, 2007, ANN AFR MED, V6, P180, DOI 10.4103/1596-3519.55700; Li S, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1448; Lochhead J CR, 2003, BR J OPHTHALMOL, V87; Mafwiri M, 2005, OPHTHAL EPIDEMIOL, V12, P299, DOI 10.1080/09286580500180572; Manners T, 2001, BRIT J OPHTHALMOL, V85, P159, DOI 10.1136/bjo.85.2.159; Mathenge W., 2010, THESIS; Mathew RG, 2011, BRIT J OPHTHALMOL, V95, P1350, DOI 10.1136/bjo.2010.194811; Mielke C, 2003, EYE, V17, P829, DOI 10.1038/sj.eye.6700492; Mwanza JCK, 2001, EUR J OPHTHALMOL, V11, P261, DOI 10.1177/112067210101100308; O'Donoghue H SD, 1994, INVEST OPHTHALMOL VI, V35; Ogata-Iwao M, 2013, ACTA OPHTHALMOL, V91, pe500, DOI 10.1111/aos.12133; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Quigley HA, 2000, BRIT J OPHTHALMOL, V84, P860, DOI 10.1136/bjo.84.8.860; Singh RP GI, 2001, CLIN EXPT OPHTHALMOL, V29; Siriwardena D, 2000, BRIT J OPHTHALMOL, V84, P1056, DOI 10.1136/bjo.84.9.1056; Wilkins M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002897.pub2; Yorston D, 2001, BRIT J OPHTHALMOL, V85, P1028, DOI 10.1136/bjo.85.9.1028	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161674	10.1371/journal.pone.0161674	http://dx.doi.org/10.1371/journal.pone.0161674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606611	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000383255600008
J	Hofmann, E; Faller, N; Limacher, A; Mean, M; Tritschler, T; Rodondi, N; Aujesky, D				Hofmann, Eveline; Faller, Nicolas; Limacher, Andreas; Mean, Marie; Tritschler, Tobias; Rodondi, Nicolas; Aujesky, Drahomir			Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; POPULATION-BASED-COHORT; ATRIAL-FIBRILLATION; ORAL ANTICOAGULATION; PULMONARY-EMBOLISM; RISK-FACTORS; BLEEDING RISK; MEDICATION ADHERENCE; WARFARIN THERAPY; RECURRENCE	Whether the level of education is associated with anticoagulation quality and clinical outcomes in patients with acute venous thromboembolism (VTE) is uncertain. We thus aimed to investigate the association between educational level and anticoagulation quality and clinical outcomes in elderly patients with acute VTE. We studied 817 patients aged >= 65 years with acute VTE from a Swiss prospective multicenter cohort study (09/2009-12/2013). We defined three educational levels: 1) less than high school, 2) high school, and 3) post-secondary degree. The primary outcome was the anticoagulation quality, expressed as the percentage of time spent in the therapeutic INR range (TTR). Secondary outcomes were the time to a first recurrent VTE and major bleeding. We adjusted for potential con-founders and periods of anticoagulation. Overall, 56% of patients had less than high school, 25% a high school degree, and 18% a post-secondary degree. The mean percentage of TTR was similar across educational levels (less than high school, 61%; high school, 64%; and post-secondary, 63%; P = 0.36). Within three years of follow-up, patients with less than high school, high school, and a post-secondary degree had a cumulative incidence of recurrent VTE of 14.2%, 12.9%, and 16.4%, and a cumulative incidence of major bleeding of 13.3%, 15.1%, and 15.4%, respectively. After adjustment, educational level was neither associated with anticoagulation quality nor with recurrent VTE or major bleeding. In elderly patients with VTE, we did not find an association between educational level and anticoagulation quality or clinical outcomes.	[Hofmann, Eveline; Faller, Nicolas; Mean, Marie; Tritschler, Tobias; Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Univ Hosp Bern, Dept Gen Internal Med, Bern, Switzerland; [Limacher, Andreas] Univ Bern, Dept Clin Res, Clin Trials Unit Bern, Bern, Switzerland; [Limacher, Andreas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Mean, Marie] Univ Lausanne Hosp, Dept Gen Internal Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Faller, N (corresponding author), Univ Bern, Univ Hosp Bern, Dept Gen Internal Med, Bern, Switzerland.	Nicolas.Faller@insel.ch	Tritschler, Tobias/ABH-1772-2021	Tritschler, Tobias/0000-0002-8775-0511; Rodondi, Nicolas/0000-0001-9083-6896; Mean, Marie/0000-0003-0477-7899; , Nicolas/0000-0003-1647-9311; Hofmann, Eveline/0000-0003-3357-2438	Swiss National Science Foundation [33CSCO-122659/139470]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant 33CSCO-122659/139470).	Aiyagari V, 2015, J STROKE CEREBROVASC, V24, P290, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.002; Arnsten JH, 1997, AM J MED, V103, P11, DOI 10.1016/S0002-9343(97)90048-6; Bertomeu-Gonzalez V, 2015, CLIN CARDIOL, V38, P357, DOI 10.1002/clc.22397; Cressman AM, 2015, AM HEART J, V170, P133, DOI 10.1016/j.ahj.2015.03.014; Davis NJ, 2005, ANN PHARMACOTHER, V39, P632, DOI 10.1345/aph.1E464; Costa GLD, 2012, CLIN THER, V34, P1511, DOI 10.1016/j.clinthera.2012.06.002; Costa GLD, 2011, AGE AGEING, V40, P375, DOI 10.1093/ageing/afr020; Dlott JS, 2014, CIRCULATION, V129, P1407, DOI 10.1161/CIRCULATIONAHA.113.002601; Eichinger S, 2008, ARCH INTERN MED, V168, P1678, DOI 10.1001/archinte.168.15.1678; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Fang MC, 2006, J GEN INTERN MED, V21, P841, DOI 10.1111/j.1525-1497.2006.00537.x; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Goldman DP, 2002, P NATL ACAD SCI USA, V99, P10929, DOI 10.1073/pnas.162086599; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hu A, 2006, J CARDIOVASC NURS, V21, P169, DOI 10.1097/00005082-200605000-00003; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Isma N, 2013, J THROMB THROMBOLYS, V36, P58, DOI 10.1007/s11239-012-0858-8; Jakobsson C, 2010, J THROMB HAEMOST, V8, P1242, DOI 10.1111/j.1538-7836.2010.03836.x; JohnsonGreene D, 1997, ARCH CLIN NEUROPSYCH, V12, P635, DOI 10.1016/S0887-6177(96)00046-7; Kauffman YS, 2015, PHARMACOTHERAPY, V35, P740, DOI 10.1002/phar.1616; Kneeland PP, 2010, PATIENT PREFER ADHER, V4, P51; Leiss W, 2015, J GEN INTERN MED, V30, P17, DOI 10.1007/s11606-014-2993-8; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Louzada ML, 2012, CIRCULATION, V126, P448, DOI 10.1161/CIRCULATIONAHA.111.051920; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Mean M, 2013, J THROMB THROMBOLYS, V36, P475, DOI 10.1007/s11239-013-0875-2; Melamed OC, 2011, AM J MANAG CARE, V17, P232; NIEUWENHUIS HK, 1991, BLOOD, V78, P2337, DOI 10.1182/blood.V78.9.2337.2337; Novacek G, 2010, GASTROENTEROLOGY, V139, P779, DOI 10.1053/j.gastro.2010.05.026; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Perreault S, 2005, BRIT J CLIN PHARMACO, V59, P564, DOI 10.1111/j.1365-2125.2005.02355.x; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Platt AB, 2008, PHARMACOEPIDEM DR S, V17, P853, DOI 10.1002/pds.1556; Razouki Z, 2014, J THROMB HAEMOST, V12, P628, DOI 10.1111/jth.12530; Rodriguez F, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000170; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; Rose AJ, 2013, CHEST, V143, P751, DOI 10.1378/chest.12-1119; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Shireman TI, 2006, CHEST, V130, P1390, DOI 10.1378/chest.130.5.1390; Wang Y, 2013, J THROMB THROMBOLYS, V36, P416, DOI 10.1007/s11239-013-0872-5; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Witt DM, 2009, BLOOD, V114, P952, DOI 10.1182/blood-2009-02-207928; Zoller B, 2012, THROMB RES, V129, P577, DOI 10.1016/j.thromres.2011.07.050	53	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162108	10.1371/journal.pone.0162108	http://dx.doi.org/10.1371/journal.pone.0162108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606617	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600018
J	Amador, A; Huitron-Resendiz, S; Roberts, AJ; Kamenecka, TM; Solt, LA; Burris, TP				Amador, Ariadna; Huitron-Resendiz, Salvador; Roberts, Amanda J.; Kamenecka, Theodore M.; Solt, Laura A.; Burris, Thomas P.			Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; CIRCADIAN CLOCK; CAFFEINE DEPENDENCE; METABOLIC SYNDROME; WAKE PATTERNS; MODAFINIL; DOPAMINE; ALPHA; AMPHETAMINE; DURATION	The circadian clock maintains appropriate timing for a wide range of behaviors and physiological processes. Circadian behaviors such as sleep and wakefulness are intrinsically dependent on the precise oscillation of the endogenous molecular machinery that regulates the circadian clock. The identical core clock machinery regulates myriad endocrine and metabolic functions providing a link between sleep and metabolic health. The REV-ERBs (REV-ERB alpha and REV-ERB beta) are nuclear receptors that are key regulators of the molecular clock and have been successfully targeted using small molecule ligands. Recent studies in mice suggest that REV-ERB-specific synthetic agonists modulate metabolic activity as well as alter sleep architecture, inducing wakefulness during the light period. Therefore, these small molecules represent unique tools to extensively study REV-ERB regulation of sleep and wakefulness. In these studies, our aim was to further investigate the therapeutic potential of targeting the REV-ERBs for regulation of sleep by characterizing efficacy, and optimal dosing time of the REV-ERB agonist SR9009 using electroencephalographic (EEG) recordings. Applying different experimental paradigms in mice, our studies establish that SR9009 does not lose efficacy when administered more than once a day, nor does tolerance develop when administered once a day over a three-day dosing regimen. Moreover, through use of a time response paradigm, we determined that although there is an optimal time for administration of SR9009 in terms of maximal efficacy, there is a 12-hour window in which SR9009 elicited a response. Our studies indicate that the REV-ERBs are potential therapeutic targets for treating sleep problems as those encountered as a consequence of shift work or jet lag.	[Amador, Ariadna; Kamenecka, Theodore M.; Solt, Laura A.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 34583 USA; [Huitron-Resendiz, Salvador; Roberts, Amanda J.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Burris, Thomas P.] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63104 USA	Scripps Research Institute; Scripps Research Institute; Saint Louis University	Burris, TP (corresponding author), St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63104 USA.	burristp@slu.edu	Burris, Thomas/B-3886-2016	Burris, Thomas/0000-0003-2922-4449	National Institute of Mental Health [MH093429]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a grant from the National Institute of Mental Health (MH093429) to TPB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandin C, 2015, INT J OBESITY, V39, P828, DOI 10.1038/ijo.2014.182; Banerjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6759; Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175; Bernstein GA, 2002, DRUG ALCOHOL DEPEN, V66, P1, DOI 10.1016/S0376-8716(01)00181-8; Bourgin P, 2000, J NEUROSCI, V20, P7760; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Cao JJ, 2011, ACS MED CHEM LETT, V2, P48, DOI 10.1021/ml1002025; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chang ST, 2010, CHINESE J PHYSIOL, V53, P318, DOI 10.4077/CJP.2010.AMK067; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chun SK, 2014, ACS CHEM BIOL, V9, P703, DOI 10.1021/cb400752k; Chung S, 2014, CELL, V157, P858, DOI 10.1016/j.cell.2014.03.039; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; Edgar DM, 1997, J PHARMACOL EXP THER, V283, P757; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Gilbert R M, 1984, Prog Clin Biol Res, V158, P185; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; Jones HA, 2005, EXP CLIN PSYCHOPHARM, V13, P259, DOI 10.1037/1064-1297.13.3.259; JUERGENS S, 1991, J SUBST ABUSE TREAT, V8, P43, DOI 10.1016/0740-5472(91)90026-7; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kopp C, 2002, EUR J NEUROSCI, V16, P1099, DOI 10.1046/j.1460-9568.2002.02156.x; KROBOTH PD, 1983, DRUG INTEL CLIN PHAR, V17, P495, DOI 10.1177/106002808301700701; Kronholm E, 2011, J SLEEP RES, V20, P288, DOI 10.1111/j.1365-2869.2010.00899.x; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; LEMMER B, 1987, CHRONOBIOL INT, V4, P319, DOI 10.3109/07420528709083522; Lemmer B, 2007, PHYSIOL BEHAV, V90, P285, DOI 10.1016/j.physbeh.2006.09.006; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; LUCAS EA, 1980, PSYCHOPHARMACOLOGY, V68, P179, DOI 10.1007/BF00432138; Macdermct H G, 1925, Can Med Assoc J, V15, P658; Malcolm R, 2006, AM J DRUG ALCOHOL AB, V32, P577, DOI 10.1080/00952990600920425; Mang GM, 2016, SLEEP, V39, P589, DOI 10.5665/sleep.5534; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; MROSOVSKY N, 1994, CHRONOBIOL INT, V11, P232, DOI 10.3109/07420529409067792; Nguyen TL, 2011, SYNAPSE, V65, P733, DOI 10.1002/syn.20892; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Nishino S, 1998, Sleep Res Online, V1, P49; Novak M, 1997, DRUG SAFETY, V16, P133, DOI 10.2165/00002018-199716020-00005; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; REINBERG A, 1986, INT J CLIN PHARM RES, V6, P33; RITSCHEL WA, 1994, METHOD FIND EXP CLIN, V16, P57; Roehrs T, 2002, PSYCHOPHARMACOLOGY, V161, P137, DOI 10.1007/s00213-002-1041-2; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Ruiz-Lozano T, 2016, CLIN NUTR, V35, P1308, DOI 10.1016/j.clnu.2016.02.007; Rush CR, 2002, BEHAV PHARMACOL, V13, P105, DOI 10.1097/00008877-200203000-00002; SEIDEL WF, 1985, PSYCHOPHARMACOLOGY, V87, P194, DOI 10.1007/BF00431806; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; TOURET M, 1995, NEUROSCI LETT, V189, P43, DOI 10.1016/0304-3940(95)11448-6; TREDGER JM, 1977, XENOBIOTICA, V7, P481; TUREK FW, 1986, CLIN NEUROPHARMACOL, V9, P83; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Uguen M, 2013, BRIT J PHARMACOL, V169, P632, DOI 10.1111/bph.12149; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142	68	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162452	10.1371/journal.pone.0162452	http://dx.doi.org/10.1371/journal.pone.0162452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603791	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200066
J	Boon, MY; Henry, BI; Chu, BS; Basahi, N; Suttle, CM; Luu, C; Leung, H; Hing, S				Boon, Mei Ying; Henry, Bruce Ian; Chu, Byoung Sun; Basahi, Nour; Suttle, Catherine May; Luu, Chi; Leung, Harry; Hing, Stephen			Fractal Dimension Analysis of Transient Visual Evoked Potentials: Optimisation and Applications	PLOS ONE			English	Article							STRANGE ATTRACTORS; TIME-SERIES; CHILDREN; VEP; DYNAMICS; REVERSAL	Purpose The visual evoked potential (VEP) provides a time series signal response to an external visual stimulus at the location of the visual cortex. The major VEP signal components, peak latency and amplitude, may be affected by disease processes. Additionally, the VEP contains fine detailed and non-periodic structure, of presently unclear relevance to normal function, which may be quantified using the fractal dimension. The purpose of this study is to provide a systematic investigation of the key parameters in the measurement of the fractal dimension of VEPs, to develop an optimal analysis protocol for application. Methods VEP time series were mathematically transformed using delay time, tau, and embedding dimension, m, parameters. The fractal dimension of the transformed data was obtained from a scaling analysis based on straight line fits to the numbers of pairs of points with separation less than r versus log(r) in the transformed space. Optimal tau, m, and scaling analysis were obtained by comparing the consistency of results using different sampling frequencies. The optimised method was then piloted on samples of normal and abnormal VEPs. Results Consistent fractal dimension estimates were obtained using tau = 4 ms, designating the fractal dimension = D-2 of the time series based on embedding dimension m = 7 (for 3606 Hz and 5000 Hz), m = 6 (for 1803 Hz) and m = 5 (for 1000Hz), and estimating D-2 for each embedding dimension as the steepest slope of the linear scaling region in the plot of log(C(r)) vs log(r) provided the scaling region occurred within the middle third of the plot. Piloting revealed that fractal dimensions were higher from the sampled abnormal than normal achromatic VEPs in adults (p = 0.02). Variances of fractal dimension were higher from the abnormal than normal chromatic VEPs in children (p = 0.01). Conclusions A useful analysis protocol to assess the fractal dimension of transformed VEPs has been developed.	[Boon, Mei Ying; Chu, Byoung Sun; Basahi, Nour; Suttle, Catherine May] UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Henry, Bruce Ian] UNSW Australia, Sch Math & Stat, Sydney, NSW, Australia; [Luu, Chi] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Luu, Chi] Univ Melbourne, Melbourne Med Sch, Dept Surg Ophthalmol, Parkville, Vic, Australia; [Leung, Harry; Hing, Stephen] Pk Rd Eye, Hurstville, NSW, Australia; [Chu, Byoung Sun] Catholic Univ Daegu, Sch Optometry & Vis Sci, Gyeongsangbuk Do, South Korea; [Suttle, Catherine May] City Univ London, Sch Hlth Sci Optometry & Visual Sci, London, England; [Leung, Harry] Southern Ophthalmol, Kogarah, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Catholic University of Daegu; City University London	Boon, MY (corresponding author), UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	m.boon@unsw.edu.au	Boon, Mei Ying/F-2194-2016; Henry, Bruce/AAE-6824-2020	Boon, Mei Ying/0000-0002-9759-8402; Henry, Bruce/0000-0002-4387-6155; Suttle, Catherine/0000-0001-8694-195X; Luu, Chi/0000-0002-7604-7097	UNSW Australia Goldstar Award grant	UNSW Australia Goldstar Award grant	This study was supported by a UNSW Australia Goldstar Award grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants and their families for volunteering. We thank Tiong Peng Yap for providing transient VEPs recorded at 5000 Hz sampling frequency for analysis. This study was supported by a UNSW Australia Goldstar Award grant.	Almurshedi A, 2015, RES J APPL SCI ENG T, V9, P106; ARLE JE, 1990, ELECTROEN CLIN NEURO, V75, P296, DOI 10.1016/0013-4694(90)90108-V; ARNOLD JC, 1973, EDUC PSYCHOL MEAS, V33, P301, DOI 10.1177/001316447303300209; Boon MY, 2007, VISION RES, V47, P2124, DOI 10.1016/j.visres.2007.04.019; Boon MY, 2008, J VISION, V8, DOI 10.1167/8.1.6; Boon MY, 2009, J VISION, V9, DOI 10.1167/9.6.22; Boon MY, 2011, 13 BIENN SCI M 7 ED; Casaleggio A, 1999, BIOL CYBERN, V81, P279, DOI 10.1007/s004220050562; Codina C, 2011, DEVELOPMENTAL SCI, V14, P725, DOI 10.1111/j.1467-7687.2010.01017.x; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Henry B., 2001, NONLINEAR BIOMEDICAL, V2, P1; JANOSI IM, 1994, PHYS REV E, V49, P2756, DOI 10.1103/PhysRevE.49.2756; Kanski J. J., 1989, CLIN OPHTHALMOLOGY S; KOSTELICH EJ, 1989, PHYS SCRIPTA, V40, P436, DOI 10.1088/0031-8949/40/3/030; Lai YC, 1998, PHYSICA D, V115, P1, DOI 10.1016/S0167-2789(97)00230-3; Lehmann D, 1994, Int J Neurosci, V74, P239; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; MAIER J, 1987, VISION RES, V27, P165, DOI 10.1016/0042-6989(87)90179-9; MCCULLOCH DL, 1994, ARCH OPHTHALMOL-CHIC, V112, P510, DOI 10.1001/archopht.1994.01090160086026; Mizrach B, 1996, J ECON BEHAV ORGAN, V30, P369, DOI 10.1016/S0167-2681(96)00875-X; MOSES LE, 1952, PSYCHOMETRIKA, V17, P239; Muller V, 2003, COGNITIVE BRAIN RES, V16, P104, DOI 10.1016/S0926-6410(02)00225-2; Muller V, 2001, EXP BRAIN RES, V137, P103, DOI 10.1007/s002210000638; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; Oner A, 2004, DOC OPHTHALMOL, V109, P223, DOI 10.1007/s10633-004-7098-y; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pompe MT, 2006, VISUAL NEUROSCI, V23, P447, DOI 10.1017/S0952523806233108; Pompe MT, 2012, J OPT SOC AM A, V29, pA69, DOI 10.1364/JOSAA.29.000A69; Pompe MT, 2010, OPHTHAL PHYSL OPT, V30, P693, DOI 10.1111/j.1475-1313.2010.00739.x; SCHMEISSER ET, 1993, INVEST OPHTH VIS SCI, V34, P1265; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shawkat FS, 1998, EYE, V12, P863, DOI 10.1038/eye.1998.219; Sloper J, 2016, J AAPOS, V20, P1, DOI 10.1016/j.jaapos.2015.09.013; TSONIS A, 1992, CHAOS THEORY APPL; Tsonis AA, 2009, CLIM DYNAM, V33, P1069, DOI 10.1007/s00382-008-0469-4; Zhang M, 2004, J VISION, V4, P32, DOI 10.1167/4.1.4	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161565	10.1371/journal.pone.0161565	http://dx.doi.org/10.1371/journal.pone.0161565			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598422	Green Accepted, Green Published, gold			2022-12-27	WOS:000383254800010
J	Grindel, A; Guggenberger, B; Eichberger, L; Poppelmeyer, C; Gschaider, M; Tosevska, A; Mare, G; Briskey, D; Brath, H; Wagner, KH				Grindel, Annemarie; Guggenberger, Bianca; Eichberger, Lukas; Poeppelmeyer, Christina; Gschaider, Michaela; Tosevska, Anela; Mare, George; Briskey, David; Brath, Helmut; Wagner, Karl-Heinz			Oxidative Stress, DNA Damage and DNA Repair in Female Patients with Diabetes Mellitus Type 2	PLOS ONE			English	Article							BETA-CELL FAILURE; INSULIN-RESISTANCE; GLYCEMIC CONTROL; COMET ASSAY; GLUTATHIONE; ASSOCIATION; BASE; QUANTIFICATION; COMPLICATIONS; PATHOGENESIS	Background Diabetes mellitus type 2 (T2DM) is associated with oxidative stress which in turn can lead to DNA damage. The aim of the present study was to analyze oxidative stress, DNA damage and DNA repair in regard to hyperglycemic state and diabetes duration. Methods Female T2DM patients (n = 146) were enrolled in the MIKRODIAB study and allocated in two groups regarding their glycated hemoglobin (HbA1c) level (HbA1c <= 7.5%, n = 74; HbA1c> 7.5%, n = 72). In addition, tertiles according to diabetes duration (DD) were created (DDI = 6.94 +/- 3.1 y, n = 49; DDII = 13.35 +/- 1.1 y, n = 48; DDIII = 22.90 +/- 7.3 y, n = 49). Oxidative stress parameters, including ferric reducing ability potential, malondialdehyde, oxidized and reduced glutathione, reduced thiols, oxidized LDL and F2-Isoprostane as well as the activity of antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase were measured. Damage to DNA was analyzed in peripheral blood mononuclear cells and whole blood with single cell gel electrophoresis. DNA base excision repair capacity was tested with the modified comet repair assay. Additionally, mRNA expressions of nine genes related to base excision repair were analyzed in a subset of 46 matched individuals. Results No significant differences in oxidative stress parameters, antioxidant enzyme activities, damage to DNA and base excision repair capacity, neither between a HbA1c cut off /> 7.5%, nor between diabetes duration was found. A significant up-regulation in mRNA expression was found for APEX1, LIG3 and XRCC1 in patients with > 7.5% HbA1c. Additionally, we observed higher total cholesterol, LDL-cholesterol, LDL/HDL-cholesterol, triglycerides,Framingham risk score, systolic blood pressure, BMI and lower HDL-cholesterol in the hyperglycemic group. Conclusion BMI, blood pressure and blood lipid status were worse in hyperglycemic individuals. However, no major disparities regarding oxidative stress, damage to DNA and DNA repair were present which might be due to good medical treatment with regular health checks in T2DM patients in Austria.	[Grindel, Annemarie; Guggenberger, Bianca; Eichberger, Lukas; Poeppelmeyer, Christina; Gschaider, Michaela; Tosevska, Anela; Mare, George; Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci Emerging Field Oxidat Stress & DNA, Vienna, Austria; [Grindel, Annemarie; Wagner, Karl-Heinz] Univ Vienna, Res Platform Act Ageing, Vienna, Austria; [Briskey, David] Univ Queensland, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia; [Brath, Helmut] Hlth Ctr South, Diabet Outpatient Clin, Vienna, Austria	University of Vienna; University of Vienna; University of Queensland	Grindel, A; Wagner, KH (corresponding author), Univ Vienna, Dept Nutr Sci Emerging Field Oxidat Stress & DNA, Vienna, Austria.; Grindel, A; Wagner, KH (corresponding author), Univ Vienna, Res Platform Act Ageing, Vienna, Austria.	annemarie.grindel@univie.ac.at; karl-heinz.wagner@univie.ac.at	Wagner, Karl-Heinz/B-9098-2013	Wagner, Karl-Heinz/0000-0002-1683-7265; Tosevska, Anela/0000-0002-0892-7068	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Al-Salmani K, 2011, FREE RADICAL BIO MED, V51, P719, DOI 10.1016/j.freeradbiomed.2011.05.020; Algire C, 2012, CANCER PREV RES, V5, P536, DOI 10.1158/1940-6207.CAPR-11-0536; Aouacheri O, 2015, CAN J DIABETES, V39, P44, DOI 10.1016/j.jcjd.2014.03.002; Azqueta A, 2013, DNA REPAIR, V12, P1007, DOI 10.1016/j.dnarep.2013.07.011; Azqueta A, 2013, TOXICOL IN VITRO, V27, P768, DOI 10.1016/j.tiv.2012.12.006; Azqueta A, 2009, MUTAT RES-GEN TOX EN, V674, P101, DOI 10.1016/j.mrgentox.2008.10.013; Bandeira SD, 2013, INT J MOL SCI, V14, P3265, DOI 10.3390/ijms14023265; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Beutler E, 1984, GLUTATHIONE PEROXIDA; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Bondor CI, 2015, INT UROL NEPHROL, V47, P1173, DOI 10.1007/s11255-015-1004-2; Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Brenerman BM, 2014, CARCINOGENESIS, V35, P2643, DOI 10.1093/carcin/bgu225; Briskey DR, 2014, J PHARMACEUT BIOMED, V90, P161, DOI 10.1016/j.jpba.2013.11.028; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P729, DOI 10.1016/j.bbadis.2011.12.003; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Choi SW, 2005, DIABETIC MED, V22, P1347, DOI 10.1111/j.1464-5491.2005.01647.x; D'Agostino RB, 2008, CIRCULATION, V118, pE86, DOI 10.1161/CIRCULATIONAHA.108.190154; de Beer JC, 2014, BRIT J CANCER, V110, P2361, DOI 10.1038/bjc.2014.150; Dincer Y, 2002, MUTAT RES-FUND MOL M, V505, P75, DOI 10.1016/S0027-5107(02)00143-4; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gupta S, 2013, J DIABETES COMPLICAT, V27, P548, DOI 10.1016/j.jdiacomp.2013.07.005; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HU ML, 1994, METHOD ENZYMOL, V233, P380; Ibarra-Costilla E, 2010, ACTA DIABETOL, V47, pS111, DOI 10.1007/s00592-009-0149-9; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Kumawat Manjulata, 2013, N Am J Med Sci, V5, P213, DOI 10.4103/1947-2714.109193; Lee SC, 2015, CHINESE MED J-PEKING, V128, P1543, DOI 10.4103/0366-6999.157693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manoel-Caetano FS, 2012, GENE, V511, P151, DOI 10.1016/j.gene.2012.09.090; Marin MT, 2015, J DIABETES COMPLICAT, V29, P679, DOI 10.1016/j.jdiacomp.2015.03.015; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Merecz A, 2015, ADV MED SCI-POLAND, V60, P220, DOI 10.1016/j.advms.2015.04.001; Mittendorfer B, 2005, CURR OPIN CLIN NUTR, V8, P367, DOI 10.1097/01.mco.0000172574.64019.98; Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001; Mullner E, 2014, J HUM NUTR DIET, V27, P468, DOI 10.1111/jhn.12168; Mullner E, 2013, MOL NUTR FOOD RES, V57, P328, DOI 10.1002/mnfr.201200343; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ramel A, 2004, EUR J NUTR, V43, P2, DOI 10.1007/s00394-004-0432-z; Schupp N, 2008, ATHEROSCLEROSIS, V199, P278, DOI 10.1016/j.atherosclerosis.2007.11.016; Shah NR, 2015, J MOL CELL CARDIOL, V86, P147, DOI 10.1016/j.yjmcc.2015.07.005; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tupe RS, 2014, BRIT J BIOMED SCI, V71, P93, DOI 10.1080/09674845.2014.11669971; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Xavier DJ, 2015, MUTAT RES-FUND MOL M, V776, P98, DOI 10.1016/j.mrfmmm.2015.01.016; Xavier DJ, 2014, DIABETES RES CLIN PR, V105, P356, DOI 10.1016/j.diabres.2014.06.004	58	36	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162082	10.1371/journal.pone.0162082	http://dx.doi.org/10.1371/journal.pone.0162082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598300	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800037
J	Alvaro-Meca, A; Jimenez-Garcia, R; Jimenez-Trujillo, I; Hernandez-Barrera, V; de Miguel-Diez, J; Resino, S; Lopez-de-Andres, A				Alvaro-Meca, Alejandro; Jimenez-Garcia, Rodrigo; Jimenez-Trujillo, Isabel; Hernandez-Barrera, Valentin; de Miguel-Diez, Javier; Resino, Salvador; Lopez-de-Andres, Ana			Fifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012)	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INSULIN-RESISTANCE; RISK-FACTORS; MELLITUS; MORTALITY; DISEASE; OBESITY; COHORT; AIDS	Objective To describe trends in the prevalence of diabetes among hospitalized HIV-infected patients between 1997 and 2012 in Spain and compare them with those of age- and sex-matched non-HIV-infected patients. Methods The study was based on Spanish national hospital discharge data. We performed a retrospective study for the period 1997-2012. HIV infection (HIV-infected versus non-HIV-infected [control group]) and calendar period in relation to widespread use of combination antiretroviral therapy (cART) (1997-1999; 2000-2003; 2004-2007 and 2008-2012), were the exposure variables The outcome variables were diagnosis of diabetes and in-hospital mortality (IHM). Results From 1997 to 2012, we identified 91,752 cases of diabetes: 15,398 in the HIV-infected group (403,277 hospital admissions) and 76,354 in the non-HIV-infected group (1,503,467 hospital admissions). Overall, HIV-infected patients had lower prevalence values for diabetes than non-HIV-infected patients throughout the follow-up (3.8% vs. 5.1%; p<0.001). The prevalence of diabetes increased 1.56-fold among non-HIV-infected patients and 4.2-fold among HIV-infected patients. The prevalence of diabetes in females was almost twice as high in HIV-infected patients as in non-HIV-infected patients during the last study period (4.72% vs. 2.88%; p<0.001). Diabetes showed a protective effect against IHM throughout the study period (aOR = 0.70; 95% CI, 0.65-0.75). Conclusions During the cART era, the prevalence of diabetes has increased sharply among HIV-infected hospitalized patients compared with matched non-HIV-infected subjects. The prevalence of diabetes is rising very fast among HIV-infected women. Diabetes has a protective effect on IHM among HIV-infected patients. Nevertheless, our study has several limitations. No information is available in the database used on important sociodemographic characteristics and relevant clinical variables including duration of the HIV infection, treatments used, drug resistance, treatment adherence or CD4 count, among others. Also, it is possible that increase of diabetes prevalence could reflect the improvement in recording habits.	[Alvaro-Meca, Alejandro; Jimenez-Garcia, Rodrigo; Jimenez-Trujillo, Isabel; Hernandez-Barrera, Valentin; Lopez-de-Andres, Ana] Rey Juan Carlos Univ, Fac Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Alcorcon, Comunidad De Ma, Spain; [de Miguel-Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Pneumol, Comunidad De Madrid, Spain; [Resino, Salvador] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Madrid, Comunidad De Ma, Spain	Universidad Rey Juan Carlos; Complutense University of Madrid; General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Jimenez-Garcia, R (corresponding author), Rey Juan Carlos Univ, Fac Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Alcorcon, Comunidad De Ma, Spain.	rodrigo.jimenez@urjc.es	Resino, Salvador/B-2430-2008; Lopez-de-Andres, Ana/D-4498-2019; Lopez-de-Andres, Ana/AAD-8703-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021	Resino, Salvador/0000-0001-8783-0450; Lopez-de-Andres, Ana/0000-0001-5551-5181; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Alvaro-Meca, Alejandro/0000-0003-1315-4386; Hernandez-Barrera, Valentin/0000-0001-5790-1959; de Miguel-Diez, Javier/0000-0003-4543-573X	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) [PI13/00118, PI11/00245, PI14CIII/00011, PI12/00019]; European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); Grupo de Excelencia Investigadora URJC-Banco Santander: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE) [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III); European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); Grupo de Excelencia Investigadora URJC-Banco Santander: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE)	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III grants no. PI13/00118, PI11/00245 & PI14CIII/00011 and PI12/00019) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URJC-Banco Santander No 30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Araujo S, 2014, EUR J ENDOCRINOL, V171, P545, DOI 10.1530/EJE-14-0337; Basterra-Gortari FJ, 2007, MED CLIN-BARCELONA, V129, P405; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Bindlish S, 2015, POSTGRAD MED, V127, P511, DOI 10.1080/00325481.2015.1015927; Brar I, 2007, JAIDS-J ACQ IMM DEF, V45, P66, DOI 10.1097/QAI.0b013e318031d7e3; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Bruce N., 2008, QUANTITATIVE METHODS; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Cahn P, 2010, BRAZ J INFECT DIS, V14, P158, DOI 10.1590/S1413-86702010000200008; Calza L, 2004, METAB SYNDR RELAT D, V2, P241, DOI 10.1089/met.2004.2.241; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Carnethon MR, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0446-3; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen GM, 2010, DIABETES RES CLIN PR, V89, P189, DOI 10.1016/j.diabres.2010.03.007; de Burgos-Lunar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086713; Gail MH, 2005, FREQUENCY MATCHING; Galli L, 2012, EUR J EPIDEMIOL, V27, P657, DOI 10.1007/s10654-012-9707-5; George BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104169; Grinspoon S, 2003, CLIN INFECT DIS, V37, pS85, DOI 10.1086/375885; Howard AA, 2005, CLIN INFECT DIS, V40, P1492, DOI 10.1086/429824; Jallow A, 2015, AIDS CARE, V27, P142, DOI 10.1080/09540121.2014.963012; Mejias EJ, 2014, NUTR HOSP, V29, P1335, DOI 10.3305/nh.2014.29.6.7327; Justman JE, 2003, JAIDS-J ACQ IMM DEF, V32, P298, DOI 10.1097/00126334-200303010-00009; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Nosyk B, 2013, JAIDS-J ACQ IMM DEF, V63, P653, DOI 10.1097/QAI.0b013e3182976891; Okeke NL, 2016, J INFECT DIS, V213, P1955, DOI 10.1093/infdis/jiw082; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; da Silva EFR, 2009, ARQ BRAS CARDIOL, V93, P107; Rasmussen LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044575; Ribera A, 2008, REV ESP CARDIOL, V61, P843, DOI 10.1016/S1885-5857(08)60232-7; Samaras K, 2009, JAIDS-J ACQ IMM DEF, V50, P499, DOI 10.1097/QAI.0b013e31819c291b; Santoro N, 2009, MATURITAS, V64, P160, DOI 10.1016/j.maturitas.2009.09.001; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Subdireccion General de Desarrollo Instituto Nacional de Salud, 2001, CONJ MIN BAS DAT DAT; TAYLOR JMG, 1986, STAT MED, V5, P29, DOI 10.1002/sim.4780050106; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Visnegarwala F, 2005, J INFECTION, V50, P331, DOI 10.1016/j.jinf.2004.06.001; Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086; Wyatt CM, 2006, AIDS, V20, P561, DOI 10.1097/01.aids.0000210610.52836.07; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zellweger U, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1157	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161953	10.1371/journal.pone.0161953	http://dx.doi.org/10.1371/journal.pone.0161953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589595	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800024
J	Wei, T; Chisholm, J; Sanfcaon, H				Wei, Ting; Chisholm, Joan; Sanfcaon, Helene			Characterization of a Non-Canonical Signal Peptidase Cleavage Site in a Replication Protein from Tomato Ringspot Virus	PLOS ONE			English	Article							CO-TRANSLATIONAL TRANSLOCATION; NTB-VPG PROTEIN; ENDOPLASMIC-RETICULUM; INTERNAL SIGNAL; RNA VIRUSES; SEQUENCE; NEPOVIRUS; REGION; DOMAIN; ASSOCIATION	The NTB-VPg polyprotein from tomato ringspot virus is an integral membrane replication protein associated with endoplasmic reticulum membranes. A signal peptidase (SPase) cleavage was previously detected in the C-terminal region of NTB-VPg downstream of a 14 amino acid (aa)-long hydrophobic region (termed TM2). However, the exact location of the cleavage site was not determined. Using in vitro translation assays, we show that the SPase cleavage site is conserved in the NTB-VPg protein from various ToRSV isolates, although the rate of cleavage varies from one isolate to another. Systematic site-directed mutagenesis of the NTB-VPg SPase cleavage sites of two ToRSV isolates allowed the identification of sequences that affect cleavage efficiency. We also present evidence that SPase cleavage in the ToRSV-Rasp2 isolate occurs within a GAAGG sequence likely after the AAG (GAAG/G). Mutation of a downstream MAAV sequence to AAAV resulted in SPase cleavage at both the natural GAAG/G and the mutated AAA/V sequences. Given that there is a distance of seven aa between the two cleavage sites, this indicates that there is flexibility in the positioning of the cleavage sites relative to the inner surface of the membrane and the SPase active site. SPase cleavage sites are typically located 3-7 aa downstream of the hydrophobic region. However, the NTB-VPg GAAG/G cleavage site is located 17 aa downstream of the TM2 hydrophobic region, highlighting unusual features of the NTB-VPg SPase cleavage site. A putative 11 aa-long amphipathic helix was identified immediately downstream of the TM2 region and five aa upstream of the GAAG/G cleavage site. Based on these results, we present an updated topology model in which the hydrophobic and amphipathic domains form a long tilted helix or a bent helix in the membrane lipid bilayer, with the downstream cleavage site(s) oriented parallel to the membrane inner surface.	[Wei, Ting; Sanfcaon, Helene] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Chisholm, Joan; Sanfcaon, Helene] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [Wei, Ting] Shaanxi Univ Sci & Technol, Sch Environm Sci & Engn, Xian, Shaanxi, Peoples R China	University of British Columbia; Agriculture & Agri Food Canada; Shaanxi University of Science & Technology	Sanfcaon, H (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.; Sanfcaon, H (corresponding author), Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada.	Helene.Sanfacon@agr.gc.ca		Sanfacon, Helene/0000-0003-3807-3590	Natural Sciences and Engineering Research Council of Canada [122249-2010-RGPIN]; Chinese Science Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chinese Science Council	This manuscript was funded in part by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/, Grant 122249-2010-RGPIN awarded to HS). TW was supported by a Graduate Student Fellowship from the Chinese Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; Bintintan I, 2010, J BIOL CHEM, V285, P8572, DOI 10.1074/jbc.M109.083394; Chisholm J, 2007, VIROLOGY, V368, P133, DOI 10.1016/j.virol.2007.06.032; CHOO KH, 2008, BMC BIOINFORMATI S12, V9, pS15, DOI DOI 10.1186/1471-2105-9-S12-S15; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Han SM, 2003, J VIROL, V77, P523, DOI 10.1128/JVI.77.1.523-534.2003; King RD, 1997, COMPUT APPL BIOSCI, V13, P473; KRAUSSLICH HG, 1988, BIOCHIMIE, V70, P119, DOI 10.1016/0300-9084(88)90166-6; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P4642; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P17202; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P21797; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826; Rost B, 1996, METHOD ENZYMOL, V266, P525; ROTT ME, 1995, J GEN VIROL, V76, P465, DOI 10.1099/0022-1317-76-2-465; Sanfacon H, 2005, CAN J BOT, V83, P1529, DOI 10.1139/b05-121; Sanfacon H., 2006, Floriculture, ornamental and plant biotechnology, P540; Sanfacon H, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00313; Sanfacon H, 2009, ARCH VIROL, V154, P899, DOI 10.1007/s00705-009-0367-z; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Walker M, 2015, ARCH VIROL, V160, P543, DOI 10.1007/s00705-014-2240-y; Wang AM, 2004, J GEN VIROL, V85, P535, DOI 10.1099/vir.0.19612-0; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018; Zhang G, 2006, J VIROL, V80, P10847, DOI 10.1128/JVI.00789-06; Zhang SC, 2005, J VIROL, V79, P11752, DOI 10.1128/JVI.79.18.11752-11765.2005	38	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162223	10.1371/journal.pone.0162223	http://dx.doi.org/10.1371/journal.pone.0162223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589230	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800039
J	Lindberg, MF; Miaskowski, C; Rustoen, T; Rosseland, LA; Paul, SM; Lerdal, A				Lindberg, Maren Falch; Miaskowski, Christine; Rustoen, Tone; Rosseland, Leiv Arne; Paul, Steven M.; Lerdal, Anners			Preoperative Pain, Symptoms, and Psychological Factors related to Higher Acute Pain Trajectories during Hospitalization for Total Knee Arthroplasty	PLOS ONE			English	Article							POSTOPERATIVE PAIN; POSTSURGICAL PAIN; SLEEP DISTURBANCE; PERSISTENT PAIN; OLDER-ADULTS; RISK-FACTORS; PREDICTORS; OSTEOARTHRITIS; CANCER; HIP	Objectives Unrelieved postoperative pain after total knee arthroplasty (TKA) is a significant problem. This longitudinal study investigated how preoperative pain intensity, as well as a comprehensive list of preoperative and perioperative factors, influenced the severity of acute average and worst pain after TKA. Methods Prior to surgery, 203 patients completed a demographic questionnaire, Lee Fatigue Scale, Fatigue Severity Scale, Hospital Anxiety and Depression Scale, and Brief Illness Perception Questionnaire. Brief Pain Inventory was completed prior to surgery as well as through postoperative days (POD) 0 to 4. Clinical data were extracted from medical records. Results Several factors were associated with higher levels of preoperative and postoperative pain. Lower preoperative average and worst pain intensity scores were associated with increases in average and worst postoperative pain from POD1 to POD4. A higher number of comorbidities, higher C-reactive protein values, and higher pain interference with function were associated with higher preoperative levels of average pain. Older age, higher fatigue levels, and higher scores on identity and emotional responses to osteoarthritis (OA) were associated with higher preoperative levels of worst pain. Lower perceived consequences of OA were associated with higher pain from POD1 to POD4. Males and patients with lower preoperative scores for average pain had higher worst pain following surgery. Discussion Patients at higher risk for more severe postoperative pain can be identified through an assessment of pain and other risk factors identified in this study. Future research needs to test the efficacy of interventions that modify patients' perceptions of living with OA and pain intensity before surgery on short and long term postoperative outcomes.	[Lindberg, Maren Falch] Lovisenberg Diakonale Hosp, Dept Surg, Oslo, Norway; [Lindberg, Maren Falch; Rustoen, Tone; Lerdal, Anners] Univ Oslo, Fac Med, Dept Nursing Sci, Inst Hlth & Soc, Oslo, Norway; [Miaskowski, Christine; Paul, Steven M.] Univ Calif San Francisco, Sch Nursing, San Francisco, CA 94143 USA; [Rustoen, Tone; Rosseland, Leiv Arne] Oslo Univ Hosp, Dept Res & Dev, Div Emergencies & Crit Care, Oslo, Norway; [Rosseland, Leiv Arne] Univ Oslo, Inst Clin Med, Oslo, Norway; [Lerdal, Anners] Lovisenberg Diakonale Hosp, Dept Patient Safety & Res, Oslo, Norway	University of Oslo; University of California System; University of California San Francisco; University of Oslo; University of Oslo	Lerdal, A (corresponding author), Univ Oslo, Fac Med, Dept Nursing Sci, Inst Hlth & Soc, Oslo, Norway.; Lerdal, A (corresponding author), Lovisenberg Diakonale Hosp, Dept Patient Safety & Res, Oslo, Norway.	anners.lerdal@medisin.uio.no	Paul, Steve/ABE-5400-2020; Lerdal, Anners/AAE-9429-2021	Lerdal, Anners/0000-0002-7144-5096; Lindberg, Maren Falch/0000-0003-2074-2071	Lovisenberg Diakonale Hospital; Norwegian Nursing Organization; United States-Norway Fulbright Foundation	Lovisenberg Diakonale Hospital; Norwegian Nursing Organization; United States-Norway Fulbright Foundation	The study was funded by Lovisenberg Diakonale Hospital. The PhD fellowship for M.F. Lindberg was provided by Lovisenberg Diakonale Hospital (url: www.lds.no), the Norwegian Nursing Organization (url: www.nsf.no), and the United States-Norway Fulbright Foundation (url: http://www.fulbright.no/). None of the funding sources were involved in any stage of the study.	Aasvang EK, 2016, ACTA ANAESTH SCAND, V60, P529, DOI 10.1111/aas.12667; Andersen LO, 2009, ANAESTHESIA, V64, P508, DOI 10.1111/j.1365-2044.2008.05831.x; Bertakis KD, 2004, ANN FAM MED, V2, P224, DOI 10.1370/afm.66; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Bruehl S, 2008, J BEHAV MED, V31, P71, DOI 10.1007/s10865-007-9133-4; Campesi Ilaria, 2012, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-642-30726-3_13; Caraceni A, 2012, LANCET ONCOL, V13, pE58, DOI 10.1016/S1470-2045(12)70040-2; Chapman CR, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/608359; Chapman CR, 2011, J PAIN, V12, P257, DOI 10.1016/j.jpain.2010.08.005; Cleeland CS, 1985, SEMIN ONCOL NURS, V1, P92; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dekker J, 2009, CURR OPIN RHEUMATOL, V21, P520, DOI 10.1097/BOR.0b013e32832e6eaa; Dihle A, 2006, J PAIN, V7, P272, DOI 10.1016/j.jpain.2005.11.005; Fishbain DA, 2003, PAIN MED, V4, P51, DOI 10.1046/j.1526-4637.2003.03008.x; Ghomrawi HMK, 2013, CLIN ORTHOP RELAT R, V471, P175, DOI 10.1007/s11999-012-2484-3; Halket A, 2010, J ARTHROPLASTY, V25, P254, DOI 10.1016/j.arth.2009.01.007; Havelin LI, 2013, REPORT; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P415, DOI 10.1016/j.joca.2007.12.017; Ip HYV, 2009, ANESTHESIOLOGY, V111, P657, DOI 10.1097/ALN.0b013e3181aae87a; Jenkins JB, 2015, ORTHOP NURS, V34, P36, DOI 10.1097/NOR.0000000000000112; Jin X, 2013, ANN RHEUM DIS; Joshi Girish P, 2005, Anesthesiol Clin North Am, V23, P21, DOI 10.1016/j.atc.2004.11.013; Kauppila AM, 2009, DISABIL REHABIL, V31, P370, DOI 10.1080/09638280801976159; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Klepstad P, 2002, J PAIN SYMPTOM MANAG, V24, P517, DOI 10.1016/S0885-3924(02)00526-2; Langford DJ, 2011, J PAIN, V12, P652, DOI 10.1016/j.jpain.2010.12.003; Langford DJ, 2011, J PAIN, V12, P495, DOI 10.1016/j.jpain.2010.10.015; Lavand'homme PM, 2014, CLIN ORTHOP RELAT R, V472, P1409, DOI 10.1007/s11999-013-3389-5; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee BO, 2010, J CLIN NURS, V19, P556, DOI 10.1111/j.1365-2702.2009.02972.x; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lerdal A, 2005, SCAND J PUBLIC HEALT, V33, P123, DOI 10.1080/14034940410028406; Lerdal A, 2013, QUAL LIFE RES, V22, P1467, DOI 10.1007/s11136-012-0279-3; Lindberg MF, 2017, PAIN MED, V18, P124, DOI 10.1093/pm/pnw080; Lindviksmoen G, CANCER; Liu SS, 2007, ANESTH ANALG, V104, P689, DOI 10.1213/01.ane.0000255040.71600.41; Liu SS, 2012, INT ORTHOP, V36, P2261, DOI 10.1007/s00264-012-1623-5; Lunn TH, 2013, PAIN, V154, P1878, DOI 10.1016/j.pain.2013.06.008; Merriman JD, 2010, ONCOL NURS FORUM, V37, P423, DOI 10.1188/10.ONF.423-432; Miaskowski C, 2011, SLEEP, V34, P171, DOI 10.1093/sleep/34.2.171; Morze CJ, 2013, J ARTHROPLASTY, V28, P1565, DOI 10.1016/j.arth.2013.02.029; Mosleh SM, 2014, EUR J CARDIOVASC NUR, V13, P201, DOI 10.1177/1474515113491348; Murphy L, 2012, AM J NURS, V112, pS13, DOI 10.1097/01.NAJ.0000412646.80054.21; Murphy SL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3449; Mykletun A, 2001, BRIT J PSYCHIAT, V179, P540, DOI 10.1192/bjp.179.6.540; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Pinto PR, 2013, J PAIN, V14, P502, DOI 10.1016/j.jpain.2012.12.020; Puolakka PAE, 2010, EUR J ANAESTH, V27, P455, DOI 10.1097/EJA.0b013e328335b31c; Rakel BA, 2012, PAIN, V153, P2192, DOI 10.1016/j.pain.2012.06.021; Raudenbush B, 2002, HIERARCHICAL LINEAR; Roth ML, 2007, PAIN RES MANAG, V12, P185, DOI 10.1155/2007/394960; Turk DC, 2006, PAIN, V125, P208, DOI 10.1016/j.pain.2006.09.028; Van Onselen C, 2013, J PAIN SYMPTOM MANAG, V45, P244, DOI 10.1016/j.jpainsymman.2012.02.020; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; Wylde V, 2011, ORTHOP TRAUMATOL-SUR, V97, P139, DOI 10.1016/j.otsr.2010.12.003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	58	28	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161681	10.1371/journal.pone.0161681	http://dx.doi.org/10.1371/journal.pone.0161681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583551	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600049
J	Chapman, PA; Traub, RJ; Kyaw-Tanner, MT; Owen, H; Flint, M; Cribb, TH; Mills, PC				Chapman, Phoebe A.; Traub, Rebecca J.; Kyaw-Tanner, Myat T.; Owen, Helen; Flint, Mark; Cribb, Thomas H.; Mills, Paul C.			Terminal Restriction Fragment Length Polymorphism for the Identification of Spirorchiid Ova in Tissues from the Green Sea Turtle, Chelonia mydas	PLOS ONE			English	Article							CARETTA-CARETTA; DIGENEA; PATHOLOGY; INFECTIONS; AUSTRALIA; GENUS	Blood flukes are among the most common disease causing pathogens infecting vertebrates, including humans and some of the world's most globally endangered fauna. Spirorchiid blood flukes are parasites of marine turtles, and are associated with pathology, strandings and mortalities worldwide. Their ova embolize in tissues and incite significant inflammatory responses, however attempts to draw correlations between species and lesions are frustrated by difficulties in identifying ova beyond the genus level. In this study, a newly developed terminal restriction fragment length polymorphism(T-RFLP) method was validated as a tool for differentiating between mixed spirorchiid ova in turtle tissue. Initially, a multiplex PCR was used to differentiate between the five genera of spirorchiid flukes. Following this, PCR was performed using genus/genera-specific fluorescently tagged primer pairs and PCR products digested analysis using restriction endonucleases. Using capillary electrophoresis, this T-RFLP method could differentiate between twelve species and genotypes of spirorchiid flukes in turtles. It was applied to 151 tissue samples and successfully identified the spirorchiid species present. It was found to be more sensitive than visual diagnosis, detecting infections in 28 of 32 tissues that were negative on histology. Spirorchiids were present in 96.7% of tissues tested, with Neospirorchis genotype 2 being the most prevalent, present in 93% of samples. Mixed infections were common, being present in 60.7% of samples tested. The method described here is, to our knowledge, the first use of the T-RFLP technique on host tissues or in an animal ecology context, and describes a significant advancement in the clinical capacity to diagnose a common cause of illness in our environment. It is proven as a sensitive, specific and cost-efficient means of identifying spirorchiid flukes and ova in turtles, with the potential to contribute valuable information to epidemiological and pathological studies as well as future diagnostics for this poorly understood disease.	[Chapman, Phoebe A.; Kyaw-Tanner, Myat T.; Owen, Helen; Flint, Mark; Mills, Paul C.] Univ Queensland, Vet Marine Anim Res Teaching & Investigat, Sch Vet Sci, Gatton, Qld, Australia; [Traub, Rebecca J.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Flint, Mark] Univ Florida, Sch Forest Resources & Conservat, Florida Aquariums Ctr Conservat, Apollo Beach, FL USA; [Cribb, Thomas H.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland; University of Melbourne; State University System of Florida; University of Florida; University of Queensland	Chapman, PA (corresponding author), Univ Queensland, Vet Marine Anim Res Teaching & Investigat, Sch Vet Sci, Gatton, Qld, Australia.	p.chapman3@uq.edu.au	Traub, Rebecca/A-4273-2013; Cribb, Thomas/C-4449-2008; Chapman, Phoebe/E-5044-2016	Traub, Rebecca/0000-0002-7484-7592; Cribb, Thomas/0000-0003-1092-9705; Chapman, Phoebe/0000-0002-3303-9134	Australian Research Council Linkage Project [LP110100569]	Australian Research Council Linkage Project(Australian Research Council)	This project was funded by Australian Research Council Linkage Project Grant LP110100569 (URL http://www.arc.gov.au/default.htm) awarded to PCM as first investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 1998, J WILDLIFE DIS, V34, P91, DOI 10.7589/0090-3558-34.1.91; Asher AJ, 2012, PARASITOLOGY, V139, P1005, DOI 10.1017/S0031182012000388; Chapman PA, 2015, SYST PARASITOL, V90, P67, DOI 10.1007/s11230-014-9535-y; Chen HC, 2012, J PARASITOL, V98, P437, DOI 10.1645/GE-2875.1; Fajardo V, 2008, MEAT SCI, V79, P289, DOI 10.1016/j.meatsci.2007.09.013; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; GLAZEBROOK JS, 1981, J COMP PATHOL, V91, P361, DOI 10.1016/0021-9975(81)90006-2; GLAZEBROOK JS, 1989, J COMP PATHOL, V101, P231, DOI 10.1016/0021-9975(89)90033-9; GLAZEBROOK JS, 1990, DIS AQUAT ORGAN, V9, P97, DOI 10.3354/dao009097; Glazebrook JS, 1982, P 4 INT C WILDL DIS, P159; Gordon AN, 1998, VET PATHOL, V35, P21, DOI 10.1177/030098589803500102; Greiner EC, 2013, CRC MAR BIOL SER, P427; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; Marsh TL, 1999, CURR OPIN MICROBIOL, V2, P323, DOI 10.1016/S1369-5274(99)80056-3; Platt TR, 1998, J PARASITOL, V84, P594, DOI 10.2307/3284729; Santoro M, 2007, VET REC, V161, P482, DOI 10.1136/vr.161.14.482; Smith A, 2003, CURR PROTOC NUCLEIC; Smith J. W., 1997, Helminthological Abstracts, V66, P329; Smith J. W., 1997, Helminthological Abstracts, V66, P255; Stacy BA, 2010, DIS AQUAT ORGAN, V89, P237, DOI 10.3354/dao02195; Waldron LS, 2009, APPL ENVIRON MICROB, V75, P108, DOI 10.1128/AEM.01341-08; WOLKE RE, 1982, J WILDLIFE DIS, V18, P175, DOI 10.7589/0090-3558-18.2.175; Work TM, 2005, J PARASITOL, V91, P871, DOI 10.1645/GE-454R.1	23	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162114	10.1371/journal.pone.0162114	http://dx.doi.org/10.1371/journal.pone.0162114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579605	Green Published, gold			2022-12-27	WOS:000382877400059
J	Maaroufi, NI; Nordin, A; Palmqvist, K; Gundale, MJ				Maaroufi, Nadia I.; Nordin, Annika; Palmqvist, Kristin; Gundale, Michael J.			Chronic Nitrogen Deposition Has a Minor Effect on the Quantity and Quality of Aboveground Litter in a Boreal Forest	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; LONG-TERM; HYLOCOMIUM-SPLENDENS; CARBON SEQUESTRATION; TERRESTRIAL ECOSYSTEMS; PHOSPHORUS LIMITATION; POLYTRICHUM-COMMUNE; PLANT LITTER; N ADDITIONS; DECOMPOSITION	There is evidence that anthropogenic nitrogen (N) deposition enhances carbon (C) sequestration in boreal soils. However, key underlying mechanisms explaining this increase have not been resolved. Two potentially important mechanisms are that aboveground litter production increases, or that litter quality changes in response to N enrichment. As such, our aim was to quantify whether simulated chronic N deposition caused changes in aboveground litter production or quality in a boreal forest. We conducted a long-term (17 years) stand-scale (0.1 ha) forest experiment, consisting of three N addition levels (0, 12.5, and 50 kg N ha(-1) yr(-1)) in northern Sweden, where background N deposition rates are very low. We measured the annual quantity of litter produced for 8 different litter categories, as well as their concentrations of C, N, phosphorus (P), lignin, cellulose and hemi-cellulose. Our results indicate that mosses were the only major litter component showing significant quantitative and qualitative alterations in response to the N additions, indicative of their ability to intercept a substantial portion of the N added. These effects were, however, offset by the other litter fractions where we found no changes in the total litter fluxes, or individual chemical constituents when all litter categories were summed. This study indicates that the current annual litter fluxes cannot explain the increase in soil C that has occurred in our study system in response to simulated chronic N application. These results suggest that other mechanisms are likely to explain the increased soil C accumulation rate we have observed, such as changes in soil microbial activity, or potentially transient changes in aboveground litter inputs that were no longer present at the time of our study.	[Maaroufi, Nadia I.; Gundale, Michael J.] Swedish Univ Agr Sci SLU, Dept Forest Ecol & Management, Umea, Sweden; [Nordin, Annika] Swedish Univ Agr Sci, UPSC, Dept Forest Genet & Plant Physiol, Umea, Sweden; [Palmqvist, Kristin] Umea Univ, Dept Ecol & Environm Sci EMG, Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University	Maaroufi, NI (corresponding author), Swedish Univ Agr Sci SLU, Dept Forest Ecol & Management, Umea, Sweden.	Nadia.Maaroufi@slu.se	Gundale, Michael J/O-1265-2013; Maaroufi, Nadia/AAL-3857-2021; Palmqvist, Kristin/D-5589-2016	Gundale, Michael J/0000-0003-2447-609X; Maaroufi, Nadia/0000-0002-8028-1409; Palmqvist, Kristin/0000-0002-3923-1338	Center for Environmental Research in Umea [CMF1122373]; Swedish Research Council for the project Sustainable Management of Carbon and Nitrogen in Future Forests (NiCaf) [2010-67230]; Royal Swedish Academy of Agriculture and Forestry KSLA [H14-0018-GBN]	Center for Environmental Research in Umea; Swedish Research Council for the project Sustainable Management of Carbon and Nitrogen in Future Forests (NiCaf); Royal Swedish Academy of Agriculture and Forestry KSLA	The authors received funding from the Center for Environmental Research in Umea (grant number: CMF1122373; http://www8.umu.se/cmf/index_eng.htm), the Swedish Research Council for the project Sustainable Management of Carbon and Nitrogen in Future Forests (NiCaf) (grant number: 2010-67230; http://www.formas.se/en/) and the Royal Swedish Academy of Agriculture and Forestry KSLA (grant number: H14-0018-GBN; http://www.ksla.se/en/).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Ahti T, 1968, FINNISH ZOOL BOT PUB, V5, P169; BassiriRad H, 2015, OECOLOGIA, V177, P53, DOI 10.1007/s00442-014-3119-z; Bauer GA, 2004, FOREST ECOL MANAG, V196, P173, DOI 10.1016/j.foreco.2004.03.032; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; CALLAGHAN TV, 1978, OIKOS, V31, P73, DOI 10.2307/3543386; CHAPIN FS, 1987, OECOLOGIA, V74, P310, DOI 10.1007/BF00379375; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Cotrufo MF, 2015, NAT GEOSCI, V8, P776, DOI [10.1038/ngeo2520, 10.1038/NGEO2520]; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; de Vries W, 2014, CURR OPIN ENV SUST, V9-10, P90, DOI 10.1016/j.cosust.2014.09.001; de Vries W, 2014, NAT CLIM CHANGE, V4, P425, DOI 10.1038/nclimate2255; Demoling F, 2008, SOIL BIOL BIOCHEM, V40, P370, DOI 10.1016/j.soilbio.2007.08.019; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Du EZ, 2014, ENVIRON POLLUT, V188, P166, DOI 10.1016/j.envpol.2014.02.011; Eckstein RL, 1999, OIKOS, V86, P87, DOI 10.2307/3546572; Eckstein RL, 2000, J ECOL, V88, P506, DOI 10.1046/j.1365-2745.2000.00480.x; ENTRY JA, 1995, CAN J FOREST RES, V25, P1231, DOI 10.1139/x95-135; FLANAGAN PW, 1983, CAN J FOREST RES, V13, P795, DOI 10.1139/x83-110; Franklin O, 2003, ECOSYSTEMS, V6, P644, DOI 10.1007/s10021-002-0149-x; Frey SD, 2014, BIOGEOCHEMISTRY, V121, P305, DOI 10.1007/s10533-014-0004-0; From F., 2014, LONG TERM EFFECTS NI; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gundale MJ, 2014, GLOBAL CHANGE BIOL, V20, P276, DOI 10.1111/gcb.12422; Gundale MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0797; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Haukioja E, 1998, CHEMOECOLOGY, V8, P133, DOI 10.1007/s000490050018; Hogberg P, 2006, GLOBAL CHANGE BIOL, V12, P489, DOI 10.1111/j.1365-2486.2006.01102.x; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Ishida TA, 2010, SOIL BIOL BIOCHEM, V42, P234, DOI 10.1016/j.soilbio.2009.10.021; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Johnson DW, 2000, SOIL SCI SOC AM J, V64, P1503, DOI 10.2136/sssaj2000.6441503x; Kaiser K, 2012, SOIL BIOL BIOCHEM, V52, P29, DOI 10.1016/j.soilbio.2012.04.002; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Krause K, 2012, TREE PHYSIOL, V32, P1471, DOI 10.1093/treephys/tps109; Kumordzi BB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00339.1; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lindo Z, 2013, GLOBAL CHANGE BIOL, V19, P2022, DOI 10.1111/gcb.12175; Lindo Z, 2010, ECOSYSTEMS, V13, P612, DOI 10.1007/s10021-010-9336-3; Lu M, 2011, AGR ECOSYST ENVIRON, V140, P234, DOI 10.1016/j.agee.2010.12.010; Maaroufi NI, 2015, GLOBAL CHANGE BIOL, V21, P3169, DOI 10.1111/gcb.12904; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Meunier CL, 2016, GLOBAL CHANGE BIOL, V22, P164, DOI 10.1111/gcb.12967; Misson L, 2007, AGR FOREST METEOROL, V144, P14, DOI 10.1016/j.agrformet.2007.01.006; Nakatsubo T, 1997, ECOL RES, V12, P47, DOI 10.1007/BF02523609; Nohrstedt HO, 2001, SCAND J FOREST RES, V16, P555, DOI 10.1080/02827580152699385; Nordin A, 2006, ENVIRON POLLUT, V141, P167, DOI 10.1016/j.envpol.2005.08.017; Nordin A, 2005, AMBIO, V34, P20, DOI 10.1639/0044-7447(2005)034[0020:NDATBO]2.0.CO;2; Nordin A, 2009, ECOSYSTEMS, V12, P1204, DOI 10.1007/s10021-009-9287-8; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Osborne J.W., 2010, PRACTICAL ASSESS RES, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; Palmroth S, 2014, OECOLOGIA, V175, P457, DOI 10.1007/s00442-014-2923-9; Penuelas J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3934; Phuyal M, 2008, PLANT ECOL, V196, P111, DOI 10.1007/s11258-007-9338-1; Pihl-Karlsson G, 2009, OVERVAKNING LUFTFORO; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Schaberg PG, 1997, CAN J FOREST RES, V27, P1622, DOI 10.1139/cjfr-27-10-1622; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Scott NA, 1997, OECOLOGIA, V111, P151, DOI 10.1007/s004420050219; Skre O., 1979, ECOGRAPHY, V2, P249; Strengbom J, 2002, J ECOL, V90, P61, DOI 10.1046/j.0022-0477.2001.00629.x; Sundqvist MK, 2012, FUNCT ECOL, V26, P1090, DOI 10.1111/j.1365-2435.2012.02034.x; Tamm C., 1991, NITROGEN TERRESTRIAL, DOI DOI 10.2307/2260680; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; Treseder KK, 2001, ECOLOGY, V82, P946, DOI 10.1890/0012-9658(2001)082[0946:EOSNAO]2.0.CO;2; Turetsky MR, 2012, NEW PHYTOL, V196, P49, DOI 10.1111/j.1469-8137.2012.04254.x; Van Der Heijden E, 2000, GLOBAL CHANGE BIOL, V6, P201, DOI 10.1046/j.1365-2486.2000.00303.x; van der Wal R, 2005, OECOLOGIA, V142, P159, DOI 10.1007/s00442-004-1706-0; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Vries W. de, 2009, Forest Ecology and Management, V258, P1814, DOI 10.1016/j.foreco.2009.02.034; WARING RH, 1985, OECOLOGIA, V66, P157, DOI 10.1007/BF00379849; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002	81	11	13	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162086	10.1371/journal.pone.0162086	http://dx.doi.org/10.1371/journal.pone.0162086			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580120	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400057
J	Subramanian, P; Kim, K; Krishnamoorthy, R; Mageswari, A; Selvakumar, G; Sa, T				Subramanian, Parthiban; Kim, Kiyoon; Krishnamoorthy, Ramasamy; Mageswari, Anbazhagan; Selvakumar, Gopal; Sa, Tongmin			Cold Stress Tolerance in Psychrotolerant Soil Bacteria and Their Conferred Chilling Resistance in Tomato (Solanum lycopersicum Mill.) under Low Temperatures	PLOS ONE			English	Article							SP-NOV.; GROWTH; GENE; L.; GRAPEVINE; STRAINS; ACID	The present work aimed to study the culturable diversity of psychrotolerant bacteria persistent in soil under overwintering conditions, evaluate their ability to sustain plant growth and alleviate chilling stress in tomato. Psychrotolerant bacteria were isolated from agricultural field soil samples colleced during winter and then used to study chilling stress alleviation in tomato plants (Solanum lycopersicum cv Mill). Selective isolation after enrichment at 5 degrees C yielded 40 bacterial isolates. Phylogenetic studies indicated their distribution in genera Arthrobacter, Flavimonas, Flavobacterium, Massilia, Pedobacter and Pseudomonas. Strains OS211, OB146, OB155 and OS261 consistently improved germination and plant growth when a chilling stress of 15 degrees C was imposed and therefore were selected for pot experiments. Tomato plants treated with the selected four isolates exhibited significant tolerance to chilling as observed through reduction in membrane damage and activation of antioxidant enzymes along with proline synthesis in the leaves when exposed to chilling temperature conditions (15 degrees C). Psychrotolerant physiology of the isolated bacteria combined with their ability to improve germination, plant growth and induce antioxidant capacity in tomato plants can be employed to protect plants against chilling stress.	[Subramanian, Parthiban; Kim, Kiyoon; Krishnamoorthy, Ramasamy; Selvakumar, Gopal; Sa, Tongmin] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju 361763, Chungbuk, South Korea; [Mageswari, Anbazhagan] VIT Univ, Sch Biosci & Technol, Vellore 632014, Tamil Nadu, India; [Subramanian, Parthiban] Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biotechnol, Metab Engn Div, Jeonju, South Korea; [Krishnamoorthy, Ramasamy] Tamil Nadu Agr Univ, Agr Coll & Res Inst, Dept Agr Microbiol, Madurai, Tamil Nadu, India; [Mageswari, Anbazhagan] Rural Dev Adm, Natl Inst Agr Sci, Dept Agr Biol, Jeonju, South Korea; [Selvakumar, Gopal] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Wonju, South Korea	Chungbuk National University; Vellore Institute of Technology; National Institute of Agricultural Sciences; Rural Development Administration (RDA), Republic of Korea; Tamil Nadu Agricultural University; National Institute of Agricultural Sciences; Rural Development Administration (RDA), Republic of Korea; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Sa, T (corresponding author), Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju 361763, Chungbuk, South Korea.	tomsa@chungbuk.ac.kr	Anbazhagan, Mageswari/ADJ-3389-2022; Subramanian, Parthiban/CAJ-0756-2022	Anbazhagan, Mageswari/0000-0002-9278-2614; Subramanian, Parthiban/0000-0002-4797-5791; Gopal, Selvakumar/0000-0001-7575-7022	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015R1A2A1A05001885]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2015R1A2A1A05001885).	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Antony R, 2012, MICROBIOL RES, V167, P372, DOI 10.1016/j.micres.2012.03.003; Bajerski F, 2011, INT J SYST EVOL MICR, V61, P1849, DOI 10.1099/ijs.0.027128-0; Bano N, 2003, CURR MICROBIOL, V46, P324, DOI 10.1007/s00284-002-3857-8; Barka EA, 2006, APPL ENVIRON MICROB, V72, P7246, DOI 10.1128/AEM.01047-06; Bowman JP, 2001, METHOD MICROBIOL, V30, P591, DOI 10.1016/S0580-9517(01)30064-8; Cai GH, 2014, PLANT SCI, V214, P57, DOI 10.1016/j.plantsci.2013.09.014; Chattopadhyay MK, 2006, J BIOSCIENCES, V31, P157, DOI 10.1007/BF02705244; Christner BC, 2000, ICARUS, V144, P479, DOI 10.1006/icar.1999.6288; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; De Maayer P, 2014, EMBO REP, V15, P508, DOI 10.1002/embr.201338170; Ding S, 2011, PHYSIOL PLANTARUM, V141, P141, DOI 10.1111/j.1399-3054.2010.01428.x; ElSayed AI, 2014, PLANT BIOLOGY, V16, P1, DOI 10.1111/plb.12053; Emborg J, 2006, INT J SYST EVOL MICR, V56, P2473, DOI 10.1099/ijs.0.64357-0; Fernandez O, 2012, MOL PLANT MICROBE IN, V25, P496, DOI 10.1094/MPMI-09-11-0245; Foolad MR, 2000, J AM SOC HORTIC SCI, V125, P679, DOI 10.21273/JASHS.125.6.679; Francis KP, 1998, APPL ENVIRON MICROB, V64, P3525; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gulati A, 2009, CURR MICROBIOL, V58, P371, DOI 10.1007/s00284-008-9339-x; Hantsis-Zacharov E, 2008, INT J SYST EVOL MICR, V58, P2635, DOI 10.1099/ijs.0.65819-0; Hantsis-Zacharov E, 2007, INT J SYST EVOL MICR, V57, P2344, DOI 10.1099/ijs.0.65115-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kost T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00421; Lee JW, 2012, KMAS BRIEFING CLIMAT; Margesin R, 2009, EXTREMOPHILES, V13, P257, DOI 10.1007/s00792-008-0213-3; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mercado-Blanco J, 2001, J BACTERIOL, V183, P1909, DOI 10.1128/JB.183.6.1909-1920.2001; Mishra PK, 2011, ARCH MICROBIOL, V193, P497, DOI 10.1007/s00203-011-0693-x; Mishra PK, 2010, MICROBIOL MONOGR, V18, P273, DOI 10.1007/978-3-642-13612-2_12; Miura K, 2013, INT J MOL SCI, V14, P5312, DOI 10.3390/ijms14035312; Moyer CL., 2007, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0000402.pub2, DOI 10.1002/9780470015902.A0000402.PUB2]; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Ray MK, 2006, STRESS RESPONSE MOL, P1; ROBERTSON GP, 2006, BIOL APPROACHES SUST, P27; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sahu B, 2008, J BASIC MICROB, V48, P38, DOI 10.1002/jobm.200700185; Saltveit ME, 1990, CHILLING INJURY HORT, P4; Selbmann L, 2010, POLAR BIOL, V33, P71, DOI 10.1007/s00300-009-0686-2; Selvakumar G, 2008, WORLD J MICROB BIOT, V24, P955, DOI 10.1007/s11274-007-9558-5; Shivaji S, 2005, INT J SYST EVOL MICR, V55, P1453, DOI 10.1099/ijs.0.63478-0; Shivaji S, 2011, EXTREMOPHILES, V15, P1, DOI 10.1007/s00792-010-0333-4; Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514; Solanke Amolkumar U., 2008, Physiology and Molecular Biology of Plants, V14, P69, DOI 10.1007/s12298-008-0006-2; Subramanian P, 2015, MOL PLANT MICROBE IN, V28, P1073, DOI 10.1094/MPMI-01-15-0021-R; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taulavuori E, 2001, J EXP BOT, V52, P2375, DOI 10.1093/jexbot/52.365.2375; Templer PH, 2012, PLANT SOIL, V353, P15, DOI 10.1007/s11104-011-1064-8; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P241, DOI 10.1094/MPMI-05-11-0124; Van Der Ploeg A, 2005, J HORTIC SCI BIOTECH, V80, P652; von Stetten F, 1998, J MICROBIOL METH, V34, P99, DOI 10.1016/S0167-7012(98)00077-3; Yumoto I, 2004, ARCH MICROBIOL, V181, P345, DOI 10.1007/s00203-004-0662-8; Zhang N, 2015, J EXP BOT, V66, P647, DOI 10.1093/jxb/eru336	55	57	58	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161592	10.1371/journal.pone.0161592	http://dx.doi.org/10.1371/journal.pone.0161592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580055	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400030
J	Doolette, CL; Gupta, VVSR; Lu, Y; Payne, JL; Batstone, DJ; Kirby, JK; Navarro, DA; McLaughlin, MJ				Doolette, Casey L.; Gupta, Vadakattu V. S. R.; Lu, Yang; Payne, Justin L.; Batstone, Damien J.; Kirby, Jason K.; Navarro, Divina A.; McLaughlin, Mike J.			Quantifying the Sensitivity of Soil Microbial Communities to Silver Sulfide Nanoparticles Using Metagenome Sequencing	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DOSE-RESPONSE; TOXICITY; METAL; IMPACT; BIOAVAILABILITY; TRANSFORMATION; NANOMATERIALS; INVERTEBRATES; DISTRIBUTIONS	Soils are a sink for sulfidised-silver nanoparticles (Ag2S-NPs), yet there are limited ecotoxicity data for their effects on microbial communities. Conventional toxicity tests typically target a single test species or function, which does not reflect the broader community response. Using a combination of quantitative PCR, 16S rRNA amplicon sequencing and species sensitivity distribution (SSD) methods, we have developed a new approach to calculate silver-based NP toxicity thresholds (HCx, hazardous concentrations) that are protective of specific members (operational taxonomic units, OTUs) of the soil microbial community. At the HC20 (80% of species protected), soil OTUs were significantly less sensitive to Ag2S-NPs compared to AgNPs and Ag+ (5.9, 1.4 and 1.4 mg Ag kg(-1), respectively). However at more conservative HC values, there were no significant differences. These trends in OTU responses matched with those seen in a specific microbial function (rate of nitrification) and amoA-bacteria gene abundance. This study provides a novel molecular-based framework for quantifying the effect of a toxicant on whole soil microbial communities while still determining sensitive genera/species. Methods and results described here provide a benchmark for microbial community ecotoxicological studies and we recommend that future revisions of Soil Quality Guidelines for AgNPs and other such toxicants consider this approach.	[Doolette, Casey L.; Navarro, Divina A.; McLaughlin, Mike J.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Gupta, Vadakattu V. S. R.] CSIRO Agr, Funct Microbial Ecol, Adelaide, SA, Australia; [Lu, Yang; Batstone, Damien J.] Univ Queensland, Adv Water Management Ctr AWMC, St Lucia, Qld, Australia; [Payne, Justin L.] Univ South Australia, Sch Nat & Built Environm, Adelaide, SA, Australia; [Kirby, Jason K.; Navarro, Divina A.; McLaughlin, Mike J.] CSIRO Land & Water, Environm Contaminant Mitigat & Technol Res Progra, Adelaide, SA, Australia	University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; University of South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Doolette, CL (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.	casey.doolette@adelaide.edu.au	Doolette, Casey/D-3632-2017; vvsr, Gupta/C-1722-2009; Lu, Yang/GSD-1477-2022; McLaughlin, Mike J/F-2931-2010; Kirby, Jason K/F-5942-2013; McLaughlin, Michael J/N-5888-2017; Navarro, Divina/F-5733-2013; Doolette, Casey/P-1236-2019; Payne, Justin L/B-8260-2013; Batstone, Damien/N-1896-2014	Doolette, Casey/0000-0002-8092-3520; vvsr, Gupta/0000-0001-9774-6471; Lu, Yang/0000-0003-1976-8872; McLaughlin, Mike J/0000-0001-6796-4144; McLaughlin, Michael J/0000-0001-6796-4144; Navarro, Divina/0000-0002-8271-3578; Doolette, Casey/0000-0002-8092-3520; Payne, Justin L/0000-0002-3953-7783; Kirby, Jason/0000-0001-6867-0332; Batstone, Damien/0000-0002-4294-3942	Australian Research Council [DP0879165]	Australian Research Council(Australian Research Council)	This study was supported by Australian Research Council Discovery Grant DP0879165. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-11; Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolz R. E., 1973, CRC HDB TABLES APPL; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; Calder AJ, 2012, SCI TOTAL ENVIRON, V429, P215, DOI 10.1016/j.scitotenv.2012.04.049; Campbell E, 2000, COMPUTER PROGRAM CAL, DOI [10.1021/es203732x, DOI 10.1021/ES203732X]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Checkai R, 2014, INTEGR ENVIRON ASSES, V10, P346, DOI 10.1002/ieam.1528; Colman BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057189; Cornelis G, 2013, SCI TOTAL ENVIRON, V463, P120, DOI 10.1016/j.scitotenv.2013.05.089; Cornelis G, 2012, SOIL SCI SOC AM J, V76, P891, DOI 10.2136/sssaj2011.0360; Doolette CL, 2015, J HAZARD MATER, V300, P788, DOI 10.1016/j.jhazmat.2015.08.012; Doolette CL, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-46; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fajardo C, 2014, SCI TOTAL ENVIRON, V473, P254, DOI 10.1016/j.scitotenv.2013.12.043; Farkas J, 2011, ENVIRON INT, V37, P1057, DOI 10.1016/j.envint.2011.03.006; Frampton GK, 2006, ENVIRON TOXICOL CHEM, V25, P2480, DOI 10.1897/05-438R.1; Garner KL, 2015, ENVIRON SCI TECHNOL, V49, P5753, DOI 10.1021/acs.est.5b00081; Geranio L, 2009, ENVIRON SCI TECHNOL, V43, P8113, DOI 10.1021/es9018332; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gremion F, 2004, FEMS MICROBIOL ECOL, V48, P273, DOI 10.1016/j.femsec.2004.02.004; Gupta VVSR, 2010, 19 WORLD C SOIL SCI, P1; Hansch M, 2010, J PLANT NUTR SOIL SC, V173, P554, DOI 10.1002/jpln.200900358; Holden PA, 2014, CURR OPIN BIOTECH, V27, P73, DOI 10.1016/j.copbio.2013.11.008; HSUEH YH, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0144306; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Judy JD, 2014, ADV AGRON, V123, P1, DOI 10.1016/B978-0-12-420225-2.00001-7; Kim B, 2010, ENVIRON SCI TECHNOL, V44, P7509, DOI 10.1021/es101565j; Knezevic SZ, 2007, WEED TECHNOL, V21, P840, DOI 10.1614/WT-06-161.1; Knox OGG, 2014, SOIL RES, V52, P203, DOI 10.1071/SR12361; KOBERL M, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0024452; Kumar N, 2014, PLOS ONE, DOI [10.1371/ journal. pone. 0099953, DOI 10.1371/J0URNAL.P0NE.0099953]; Kumari M, 2009, SCI TOTAL ENVIRON, V407, P5243, DOI 10.1016/j.scitotenv.2009.06.024; Langdon KA, 2014, ENVIRON TOXICOL CHEM, V33, P1170, DOI 10.1002/etc.2543; Levard C, 2013, ENVIRON SCI TECHNOL, V47, P13440, DOI 10.1021/es403527n; Li LXY, 2016, ENVIRON SCI TECHNOL, V50, P188, DOI 10.1021/acs.est.5b03982; Li RG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037127, 10.1371/journal.pone.0029392, 10.1371/journal.pone.0051897]; Lukacheva EG, 2013, BIOL BULL+, V40, P19, DOI 10.1134/S1062359012060076; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Masrahi A, 2014, ARCH ENVIRON CON TOX, V66, P504, DOI 10.1007/s00244-013-9994-1; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; R Core Team, 2021, R LANGUAGE ENV STAT; Reinsch BC, 2012, ENVIRON SCI TECHNOL, V46, P6992, DOI 10.1021/es203732x; Ritz C, 2014, ANAL DOSE RESPONSE C; Roh JY, 2009, ENVIRON SCI TECHNOL, V43, P3933, DOI 10.1021/es803477u; Salminen R., 2005, GEOCHEMICAL ATLAS EU; Schabenberger O, 1999, AGRON J, V91, P713, DOI 10.2134/agronj1999.914713x; Schlich K, 2015, ENVIRON POLLUT, V196, P321, DOI 10.1016/j.envpol.2014.10.021; Settimio L, 2014, ENVIRON POLLUT, V191, P151, DOI 10.1016/j.envpol.2014.04.030; Settimio L, 2014, ENVIRON CHEM, V11, P63, DOI 10.1071/EN13163; Shah V, 2014, J HAZARD MATER, V274, P399, DOI 10.1016/j.jhazmat.2014.04.003; Shao QX, 2000, ENVIRONMETRICS, V11, P583, DOI 10.1002/1099-095X(200009/10)11:5<583::AID-ENV456>3.0.CO;2-X; Simonin M, 2015, ENVIRON SCI POLLUT R, V22, P13710, DOI 10.1007/s11356-015-4171-x; Smolders E, 2001, ENVIRON TOXICOL CHEM, V20, P2469, DOI [10.1897/1551-5028(2001)020&lt;2469:PNRAAT&gt;2.0.CO;2, 10.1002/etc.5620201111]; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; Starnes DL, 2015, ENVIRON POLLUT, V196, P239, DOI 10.1016/j.envpol.2014.10.009; Stephen JR, 1999, APPL ENVIRON MICROB, V65, P95; STREIBIG JC, 1980, ACTA AGR SCAND, V30, P59, DOI 10.1080/00015128009435696; Sun TY, 2014, ENVIRON POLLUT, V185, P69, DOI 10.1016/j.envpol.2013.10.004; Vandevoort A., 2012, IND BIOTECHNOL, V8, P358, DOI [DOI 10.1089/IND.2012.0026, 10.1089/ind.2012.0026]; Vanwonterghem Inka, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Wang P, 2015, NANOTOXICOLOGY, V9, P1041, DOI 10.3109/17435390.2014.999139; Wang XN, 2015, SCI TOTAL ENVIRON, V508, P122, DOI 10.1016/j.scitotenv.2014.11.079; Wang XN, 2014, ENVIRON SCI POLLUT R, V21, P168, DOI 10.1007/s11356-013-2110-2; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Yang Y, 2014, WATER RES, V48, P317, DOI 10.1016/j.watres.2013.09.046; Yang Y, 2013, ENVIRON TOXICOL CHEM, V32, P1488, DOI 10.1002/etc.2230; Yin LY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047674	73	34	34	5	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161979	10.1371/journal.pone.0161979	http://dx.doi.org/10.1371/journal.pone.0161979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575719	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000382877200050
J	Weernink, MGM; van Til, JA; van Vugt, JPP; Movig, KLL; Groothuis-Oudshoorn, CGM; IJzerman, MJ				Weernink, Marieke G. M.; van Til, Janine A.; van Vugt, Jeroen P. P.; Movig, Kris L. L.; Groothuis-Oudshoorn, Catharina G. M.; IJzerman, Maarten J.			Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease	PLOS ONE			English	Article							DISCRETE-CHOICE EXPERIMENTS; QUALITY-OF-LIFE; DEEP BRAIN-STIMULATION; DECISION-MAKING; CENTERED CARE; QUESTIONNAIRE; VALIDATION; THERAPY	Introduction Little is known about how patients weigh benefits and harms of available treatments for Parkinson's Disease (oral medication, deep brain stimulation, infusion therapy). In this study we have (1) elicited patient preferences for benefits, side effects and process characteristics of treatments and (2) measured patients' preferred and perceived involvement in decision-making about treatment. Methods Preferences were elicited using a best-worst scaling case 2 experiment. Attributes were selected based on 18 patient-interviews: treatment modality, tremor, slowness of movement, posture and balance problems, drowsiness, dizziness, and dyskinesia. Subsequently, a questionnaire was distributed in which patients were asked to indicate the most and least desirable attribute in nine possible treatment scenarios. Conditional logistic analysis and latent class analysis were used to estimate preference weights and identify subgroups. Patients also indicated their preferred and perceived degree of involvement in treatment decision-making (ranging from active to collaborative to passive). Results Two preference patterns were found in the patient sample (N = 192). One class of patients focused largely on optimising the process of care, while the other class focused more on controlling motor-symptoms. Patients who had experienced advanced treatments, had a shorter disease duration, or were still employed were more likely to belong to the latter class. For both classes, the benefits of treatment were more influential than the described side effects. Furthermore, many patients (45%) preferred to take the lead in treatment decisions, however 10.8% perceived a more passive or collaborative role instead. Discussion Patients weighted the benefits and side effects of treatment differently, indicating there is no "one-size-fits-all" approach to choosing treatments. Moreover, many patients preferred an active role in decision-making about treatment. Both results stress the need for physicians to know what is important to patients and to share treatment decisions to ensure that patients receive the treatment that aligns with their preferences.	[Weernink, Marieke G. M.; van Til, Janine A.; Groothuis-Oudshoorn, Catharina G. M.; IJzerman, Maarten J.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [van Vugt, Jeroen P. P.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands; [Movig, Kris L. L.] Med Spectrum Twente, Dept Clin Pharm, Enschede, Netherlands	University of Twente; Medical Spectrum Twente; Medical Spectrum Twente	Weernink, MGM (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Hlth Technol & Serv Res, Enschede, Netherlands.	m.g.m.weernink@utwente.nl	IJzerman, Maarten J/Q-8963-2016; IJzerman, Maarten/AAB-6894-2020	IJzerman, Maarten J/0000-0001-5788-5805; IJzerman, Maarten/0000-0001-5788-5805; van Til, Janine/0000-0002-5416-5893; Groothuis-Oudshoorn, Catharina/0000-0002-4875-5379	ZonMw, the Netherlands Organization for Health Research and Development;  [80-82500-98-11234]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); 	This study was funded by ZonMw, the Netherlands Organization for Health Research and Development, http://www.zonmw.nl/nl. Janine van Til received the grant to conduct this study (grant number 80-82500-98-11234). Besides the initial review process before funding and amendments, ZonMw did not have any involvement. All researcher activities were independent of the funding source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendroth M, 2012, INT J NURS STUD, V49, P445, DOI 10.1016/j.ijnurstu.2011.10.003; Ali S, 2012, BRIT MED BULL, V103, P21, DOI 10.1093/bmb/lds020; Arbouw MEL, 2008, EUR J CLIN PHARMACOL, V64, P1021, DOI 10.1007/s00228-008-0518-2; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Clarke CE, 2009, PARKINSONISM RELAT D, V15, P728, DOI 10.1016/j.parkreldis.2009.09.005; Degner L F, 1997, Can J Nurs Res, V29, P21; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Grosset KA, 2005, MOVEMENT DISORD, V20, P616, DOI 10.1002/mds.20393; Hamberg K, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-89; Hattori N, 2012, PATIENT-RELAT OUTCOM, V3, P31, DOI 10.2147/PROM.S29443; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hung SW, 2010, J NEUROL NEUROSUR PS, V81, P1112, DOI 10.1136/jnnp.2009.173286; Jankovic J, 2000, CLIN NEUROPHARMACOL, V23, P252, DOI 10.1097/00002826-200009000-00003; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Jenkinson C, 1997, PSYCHOL HEALTH, V12, P805, DOI 10.1080/08870449708406741; Johnson FR, 2013, VALUE HEALTH, V16, P3, DOI 10.1016/j.jval.2012.08.2223; Kim MR, 2016, PARKINSONISM RELAT D, V23, P91, DOI 10.1016/j.parkreldis.2015.11.010; Kurlan R, 2005, NEUROLOGY, V64, P923, DOI 10.1212/01.WNL.0000152880.77812.5B; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Leopold NA, 2004, MOVEMENT DISORD, V19, P513, DOI 10.1002/mds.20041; Louviere J. J., 2015, BEST WORST SCALING T; Martinez-Martin P, 2012, THER ADV NEUROL DISO, V5, P105, DOI 10.1177/1756285611431974; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Martinez-Martin Pablo, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P401, DOI 10.1586/14737167.8.4.401; Muhlbacher AC, 2013, APPL HEALTH ECON HEA, V11, P163, DOI 10.1007/s40258-013-0023-3; Muller B, 2013, PARKINSONISM RELAT D, V19, P1027, DOI 10.1016/j.parkreldis.2013.07.010; Murphy R, 2013, IRISH J MED SCI, V182, P415, DOI 10.1007/s11845-013-0902-5; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Potoglou D, 2011, SOC SCI MED, V72, P1717, DOI 10.1016/j.socscimed.2011.03.027; Ryan M, 2014, SOC SCI MED, V106, P194, DOI 10.1016/j.socscimed.2014.01.013; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; van der Eijk M, 2013, PARKINSONISM RELAT D, V19, P923, DOI 10.1016/j.parkreldis.2013.04.022; Warren C, 2011, WIRES COGN SCI, V2, P193, DOI 10.1002/wcs.98; Watt Susan, 2000, Health Expect, V3, P6, DOI 10.1046/j.1369-6513.2000.00076.x; Wertheimer Albert, 2010, South Med Rev, V3, P24	36	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160771	10.1371/journal.pone.0160771	http://dx.doi.org/10.1371/journal.pone.0160771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EE	27575744	gold, Green Published			2022-12-27	WOS:000382877200009
J	Fitzpatrick, BR; Lamb, DW; Mengersen, K				Fitzpatrick, Benjamin R.; Lamb, David W.; Mengersen, Kerrie			Ultrahigh Dimensional Variable Selection for Interpolation of Point Referenced Spatial Data: A Digital Soil Mapping Case Study	PLOS ONE			English	Article							ORGANIC-CARBON; TERRAIN ATTRIBUTES; ELECTRICAL-CONDUCTIVITY; MODEL SELECTION; PREDICTION; CLIMATE; REGRESSION; LASSO; PLAIN; MAP	Modern soil mapping is characterised by the need to interpolate point referenced (geostatistical) observations and the availability of large numbers of environmental characteristics for consideration as covariates to aid this interpolation. Modelling tasks of this nature also occur in other fields such as biogeography and environmental science. This analysis employs the Least Angle Regression (LAR) algorithm for fitting Least Absolute Shrinkage and Selection Operator (LASSO) penalized Multiple Linear Regressions models. This analysis demonstrates the efficiency of the LAR algorithm at selecting covariates to aid the interpolation of geostatistical soil carbon observations. Where an exhaustive search of the models that could be constructed from 800 potential covariate terms and 60 observations would be prohibitively demanding, LASSO variable selection is accomplished with trivial computational investment.	[Fitzpatrick, Benjamin R.; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Fitzpatrick, Benjamin R.; Lamb, David W.; Mengersen, Kerrie] CRCSI, Carlton, Vic 3053, Australia; [Fitzpatrick, Benjamin R.; Mengersen, Kerrie] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia; [Lamb, David W.] Univ New England, Precis Agr Res Grp, Armidale, NSW 2351, Australia; [Mengersen, Kerrie] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of New England; Queensland University of Technology (QUT)	Fitzpatrick, BR (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.; Fitzpatrick, BR (corresponding author), CRCSI, Carlton, Vic 3053, Australia.; Fitzpatrick, BR (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia.	b1.fitzpatrick@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Fitzpatrick, Benjamin R./0000-0003-1916-0939; Lamb, David/0000-0002-2917-2231	CRC for Spatial Information (CRCSI); Australian Government Cooperative Research Centres Programme	CRC for Spatial Information (CRCSI)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government Cooperative Research Centres Programme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by the CRC for Spatial Information (CRCSI), established and supported under the Australian Government Cooperative Research Centres Programme. One of the authors (BRF) wishes to acknowledge the receipt of a Postgraduate Scholarship from the CRCSI (http://www.crcsi.com.au/).	Adhikari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105519; Ahmed SE, 2014, PENALTY SHRINKAGE PR, P5; Ahmed SE., 2014, PENALTY SHRINKAGE PR; Banerjee S., 2004, HIERARCHICAL MODELIN; Banerjee S, 2004, HIERARCHICAL MODELIN, P22; Banerjee S, 2004, HIERARCHICAL MODELIN, P175; Barnes EM, 2003, PHOTOGRAMM ENG REM S, V69, P619, DOI 10.14358/PERS.69.6.619; Betts RA, 2007, AGR FOREST METEOROL, V142, P216, DOI 10.1016/j.agrformet.2006.08.021; Bondell HD, 2010, BIOMETRICS, V66, P1069, DOI 10.1111/j.1541-0420.2010.01391.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brenning A., 2008, HAMBURGER BEITRAEGE, V19, P23; Chen F, 2008, SOIL SCI SOC AM J, V72, P186, DOI 10.2136/sssaj2007.0028; Chipman HA, 1998, J AM STAT ASSOC, V93, P935, DOI 10.2307/2669832; Chipman HA, 2002, MACH LEARN, V48, P299, DOI 10.1023/A:1013916107446; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Dlugoss V, 2010, SOIL SCI SOC AM J, V74, P922, DOI 10.2136/sssaj2009.0325; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eisfelder C, 2012, INT J REMOTE SENS, V33, P2937, DOI 10.1080/01431161.2011.620034; Engelmann JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040634; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; Franklin J, 2009, MAPPING SPECIES DIST; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gotway CA, 2002, J AM STAT ASSOC, V97, P632, DOI 10.1198/016214502760047140; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hbirkou C, 2012, GEODERMA, V175, P21, DOI 10.1016/j.geoderma.2012.01.017; Hijmans RJ, 2015, RASTER GEOGRAPHIC AN; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ibrahim JG, 2011, BIOMETRICS, V67, P495, DOI 10.1111/j.1541-0420.2010.01463.x; Johnson CK, 2001, SOIL SCI SOC AM J, V65, P1829, DOI 10.2136/sssaj2001.1829; Kheir RB, 2010, J ENVIRON MANAGE, V91, P1150, DOI 10.1016/j.jenvman.2010.01.001; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R., 2009, SOIL CARBON SEQUESTR, V2nd; Lu DS, 2016, INT J DIGIT EARTH, V9, P63, DOI 10.1080/17538947.2014.990526; Lumley T., 2009, LEAPS REGRESSION SUB; Mao DH, 2015, BIOGEOSCIENCES, V12, P1635, DOI 10.5194/bg-12-1635-2015; Meersmans J, 2012, AGRON SUSTAIN DEV, V32, P873, DOI 10.1007/s13593-012-0085-x; Miklos M, 2010, AUST J SOIL RES, V48, P248, DOI 10.1071/SR09111; Millar A, 2002, SUBSET SELECTION REG, P52; Minasny B, 2014, PROGR SOIL SCI, P45, DOI 10.1007/978-3-319-04084-4_5; Minasny B, 2013, ADV AGRON, V118, P1, DOI 10.1016/B978-0-12-405942-9.00001-3; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Muller S, 2013, STAT SCI, V28, P135, DOI 10.1214/12-STS410; Mueller TG, 2003, SOIL SCI SOC AM J, V67, P258, DOI 10.2136/sssaj2003.0258; Nychka D, 2015, FIELDS TOOLS SPATIAL; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Peng H, 2012, J MULTIVARIATE ANAL, V109, P109, DOI 10.1016/j.jmva.2012.02.005; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; R Core Team, 2021, R LANGUAGE ENV STAT; Rossel RAV, 2014, GLOBAL CHANGE BIOL, V20, P2953, DOI 10.1111/gcb.12569; SCHLESINGER WH, 1977, ANNU REV ECOL SYST, V8, P51, DOI 10.1146/annurev.es.08.110177.000411; Simbahan GC, 2006, GEODERMA, V132, P471, DOI 10.1016/j.geoderma.2005.07.001; Sudipto Banerjee, 2004, HIERARCHICAL MODELIN, P1; Terra JA, 2004, SOIL SCI, V169, P819, DOI 10.1097/00010694-200412000-00001; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Usai M Graziano, 2012, BMC Proc, V6 Suppl 2, pS9, DOI 10.1186/1753-6561-6-S2-S9; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Valdman C, 2012, EUR SIGNAL PR CONF, P2104; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiesmeier M, 2013, AGR ECOSYST ENVIRON, V176, P39, DOI 10.1016/j.agee.2013.05.012; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; Xiong X, 2014, ENVIRON MODELL SOFTW, V57, P202, DOI 10.1016/j.envsoft.2014.03.004; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735; Zuur Alain F., 2009, P1	68	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162489	10.1371/journal.pone.0162489	http://dx.doi.org/10.1371/journal.pone.0162489			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603135	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200070
J	Oh, SY; Bailenson, J; Kramer, N; Li, B				Oh, Soo Youn; Bailenson, Jeremy; Kraemer, Nicole; Li, Benjamin			Let the Avatar Brighten Your Smile: Effects of Enhancing Facial Expressions in Virtual Environments	PLOS ONE			English	Article							TRANSFORMED SOCIAL-INTERACTION; NONVERBAL CUES; NEGATIVE AFFECT; BODY POSITION; ONLINE; REPRESENTATION; COMMUNICATION; CONSEQUENCES; PERSONALITY; COPRESENCE	Previous studies demonstrated the positive effects of smiling on interpersonal outcomes. The present research examined if enhancing one's smile in a virtual environment could lead to a more positive communication experience. In the current study, participants' facial expressions were tracked and mapped on a digital avatar during a real-time dyadic conversation. The avatar's smile was rendered such that it was either a slightly enhanced version or a veridical version of the participant's actual smile. Linguistic analyses using the Linguistic Inquiry Word Count (LIWC) revealed that participants who communicated with each other via avatars that exhibited enhanced smiles used more positive words to describe their interaction experience compared to those who communicated via avatars that displayed smiling behavior reflecting the participants' actual smiles. In addition, self-report measures showed that participants in the 'enhanced smile' condition felt more positive affect after the conversation and experienced stronger social presence compared to the 'normal smile' condition. These results are particularly striking when considering the fact that most participants (> 90%) were unable to detect the smiling manipulation. This is the first study to demonstrate the positive effects of transforming unacquainted individuals' actual smiling behavior during a real-time avatar-networked conversation.	[Oh, Soo Youn; Bailenson, Jeremy; Li, Benjamin] Stanford Univ, Dept Commun, Stanford, CA 94305 USA; [Kraemer, Nicole] Univ Duisburg Essen, Dept Comp Sci & Appl Cognit Sci, Social Psychol Media & Commun, Duisburg, Germany	Stanford University; University of Duisburg Essen	Oh, SY (corresponding author), Stanford Univ, Dept Commun, Stanford, CA 94305 USA.	syoh@stanford.edu		Li, Benjamin/0000-0002-9929-9123	Google	Google(Google Incorporated)	This project was funded in part from an academic research gift from Google. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S.J., 2012, LEADERSHIP SCI TECHN, P695; Ala S.K., 2008, HICSS 08, P147, DOI DOI 10.1109/HICSS.2008.95; ARGYLE M, 1971, EUR J SOC PSYCHOL, V1, P385, DOI 10.1002/ejsp.2420010307; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; Bailenson JN, 2005, HUM COMMUN RES, V31, P511, DOI 10.1093/hcr/31.4.511; Bailenson JN, 2004, PRESENCE-VIRTUAL AUG, V13, P428, DOI 10.1162/1054746041944803; Bente G, 2008, HUM COMMUN RES, V34, P287, DOI 10.1111/j.1468-2958.2008.00322.x; Bente G, 2007, LECT NOTES COMPUT SC, V4563, P185; Biocca F, 2003, PRESENCE-VIRTUAL AUG, V12, P456, DOI 10.1162/105474603322761270; Biocca F., 2001, 4 ANN INT WORKSHOP P; Biocca F, 2002, P PRESENCE, P1; Borkenau P, 2009, J RES PERS, V43, P703, DOI 10.1016/j.jrp.2009.03.007; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Brown LM, 2006, BIOL PSYCHOL, V71, P303, DOI 10.1016/j.biopsycho.2005.06.003; Burgoon JK, 1999, COMMUN MONOGR, V66, P105, DOI 10.1080/03637759909376467; Butler EA, 2007, EMOTION, V7, P30, DOI 10.1037/1528-3542.7.1.30; Cafaro A, INTELLIGENT VIRTUAL, V7502, P67; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; DAVIS D, 1979, J PERS SOC PSYCHOL, V37, P534, DOI 10.1037/0022-3514.37.4.534; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; DeWall CN, 2009, J PERS SOC PSYCHOL, V96, P729, DOI 10.1037/a0014634; Fox J, 2015, HUM-COMPUT INTERACT, V30, P401, DOI 10.1080/07370024.2014.921494; Gibson William, 2000, NEUROMANCER; Gleason MEJ, 2008, J PERS SOC PSYCHOL, V94, P824, DOI 10.1037/0022-3514.94.5.824; Goffman E., 1959, PRESENTATION EVERYDA; Gratch J, 2006, LECT NOTES ARTIF INT, V4133, P14; Guadagno RE, 2007, MEDIA PSYCHOL, V10, P1; Guadagno RE, 2011, COMPUT HUM BEHAV, V27, P2380, DOI 10.1016/j.chb.2011.07.017; Hancock JT, 2007, CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1 AND 2, P449; Harms C., INTERNAL CONSISTENCY, P7; Hedeker D, 2009, ADDICTION, V104, P297, DOI 10.1111/j.1360-0443.2008.02435.x; Homer BD, 2008, COMPUT HUM BEHAV, V24, P786, DOI 10.1016/j.chb.2007.02.009; Hoyt CL, 2003, PRESENCE-TELEOP VIRT, V12, P183, DOI 10.1162/105474603321640932; Isbister K, 2000, INT J HUM-COMPUT ST, V53, P251, DOI 10.1006/ijhc.2000.0368; JONES SS, 1989, CHILD DEV, V60, P811, DOI 10.1111/j.1467-8624.1989.tb03512.x; Kim KJ, 2013, COMPUT HUM BEHAV, V29, P1799, DOI 10.1016/j.chb.2013.02.009; Kramer N, 2013, INT J HUM-COMPUT ST, V71, P335, DOI 10.1016/j.ijhcs.2012.09.006; KRAUT RE, 1978, J PERS SOC PSYCHOL, V36, P380, DOI 10.1037/0022-3514.36.4.380; KRAUT RE, 1979, J PERS SOC PSYCHOL, V37, P1539, DOI 10.1037/0022-3514.37.9.1539; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; LAU S, 1982, J SOC PSYCHOL, V117, P63, DOI 10.1080/00224545.1982.9713408; Makarainen M, 2015, P 19 INT AC MINDTR C, P175; Makarainen M, 2014, COGN COMPUT, V6, P708, DOI 10.1007/s12559-014-9273-0; MCGINLEY H, 1984, PERCEPT MOTOR SKILL, V58, P915, DOI 10.2466/pms.1984.58.3.915; MCGINLEY H, 1978, B PSYCHONOMIC SOC, V12, P21; McMahon JM, 2006, COMPUT STAT DATA AN, V50, P3663, DOI 10.1016/j.csda.2005.08.008; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Nakazato N, 2014, P 17 ACM C COMP SUPP; Nowak KL, 2003, PRESENCE-TELEOP VIRT, V12, P481, DOI 10.1162/105474603322761289; Pennebaker J. W., 2015, LINGUISTIC INQUIRY W; Pennebaker JW, 2001, CURR DIR PSYCHOL SCI, V10, P90, DOI 10.1111/1467-8721.00123; Platow MJ, 2005, J EXP SOC PSYCHOL, V41, P542, DOI 10.1016/j.jesp.2004.09.005; Pugh SD, 2001, ACAD MANAGE J, V44, P1018, DOI 10.2307/3069445; Rosenberg J, 2011, J COMPUT-MEDIAT COMM, V17, P1, DOI 10.1111/j.1083-6101.2011.01560.x; Siriaraya P, 2012, INTERACT COMPUT, V24, P280, DOI 10.1016/j.intcom.2012.03.003; Toma CL, 2008, PERS SOC PSYCHOL B, V34, P1023, DOI 10.1177/0146167208318067; Toma CL, 2012, J COMMUN, V62, P78, DOI 10.1111/j.1460-2466.2011.01619.x; Turkle S., 1997, LIFE SCREEN; Verhagen T, 2014, J COMPUT-MEDIAT COMM, V19, P529, DOI 10.1111/jcc4.12066; von der Putten AM, 2010, COMPUT HUM BEHAV, V26, P1641, DOI 10.1016/j.chb.2010.06.012; Walther JB, 1996, COMMUN RES, V23, P3, DOI 10.1177/009365096023001001; Walther JB, 2007, HUM COMMUN RES, V33, P1, DOI 10.1111/j.1468-2958.2007.00286.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wondra JD, 2015, PSYCHOL REV, V122, P411, DOI 10.1037/a0039252; Woo CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6380; Yee N, 2009, COMMUN RES, V36, P285, DOI 10.1177/0093650208330254; ZUCKERMAN M, 1981, J NONVERBAL BEHAV, V6, P105, DOI 10.1007/BF00987286	69	24	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161794	10.1371/journal.pone.0161794	http://dx.doi.org/10.1371/journal.pone.0161794			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603784	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200026
J	French, AS; Zadoks, RN; Skuce, PJ; Mitchell, G; Gordon-Gibbs, DK; Craine, A; Shaw, D; Gibb, SW; Taggart, MA				French, Andrew S.; Zadoks, Ruth N.; Skuce, Philip J.; Mitchell, Gillian; Gordon-Gibbs, Danielle K.; Craine, Alexandra; Shaw, David; Gibb, Stuart W.; Taggart, Mark A.			Prevalence of Liver Fluke (Fasciola hepatica) in Wild Red Deer (Cervus elaphus): Coproantigen ELISA Is a Practicable Alternative to Faecal Egg Counting for Surveillance in Remote Populations	PLOS ONE			English	Article							RUMEN FLUKE; SPATIAL-DISTRIBUTION; DAIRY HERDS; CATTLE; SHEEP; ANTIBODIES; SAMPLES; RUMINANTS; INFECTION; AGREEMENT	Red deer (Cervus elaphus) are hosts of liver fluke (Fasciola hepatica); yet, prevalence is rarely quantified in wild populations. Testing fresh samples from remote regions by faecal examination (FE) can be logistically challenging; hence, we appraise frozen storage and the use of a coproantigen ELISA (cELISA) for F. hepatica surveillance. We also present cELISA surveillance data for red deer from the Highlands of Scotland. Diagnoses in faecal samples (207 frozen, 146 fresh) were compared using a cELISA and by FE. For each storage method (frozen or fresh), agreement between the two diagnostics was estimated at individual and population levels, where population prevalence was stratified into cohorts (e.g., by sampling location). To approximate sensitivity and specificity, 65 post-slaughter whole liver examinations were used as a reference. At the individual level, FE and cELISA diagnoses agreed moderately (k(frozen) = 0.46; k(fresh) = 0.51), a likely reflection of their underlying principles. At the population level, FE and cELISA cohort prevalence correlated strongly (Pearson's R = 0.89, p < 0.0001), reflecting good agreement on relative differences between cohort prevalence. In frozen samples, prevalence by cELISA exceeded FE overall (42.8% vs. 25.8%) and in 9/12 cohorts, alluding to differences in sensitivity; though, in fresh samples, no significant difference was found. In 959 deer tested by cELISA across the Scottish Highlands, infection prevalence ranged from 9.6% to 53% by sampling location. We highlight two key advantages of cELISA over FE: i) the ability to store samples long term (frozen) without apparent loss in diagnostic power; and ii) reduced labour and the ability to process large batches. Further evaluation of cELISA sensitivity in red deer, where a range of fluke burdens can be obtained, is desirable. In the interim, the cELISA is a practicable diagnostic for F. hepatica surveillance in red deer, and its application here has revealed considerable geographic, temporal, sex and age related differences in F. hepatica prevalence in wild Scottish Highland red deer.	[French, Andrew S.; Craine, Alexandra; Gibb, Stuart W.; Taggart, Mark A.] Univ Highlands & Islands, Environm Res Inst, North Highland Coll, Castle St, Thurso KW14 7JD, Scotland; [Zadoks, Ruth N.; Skuce, Philip J.; Mitchell, Gillian; Gordon-Gibbs, Danielle K.] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Zadoks, Ruth N.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland; [Shaw, David] Univ Highlands & Islands, UHI Rural Studies Ctr, North Highland Coll, Dale Farm KW12 6UW, Halkirk, Scotland	UHI Millennium Institute; Moredun Research Institute; University of Glasgow; UHI Millennium Institute	French, AS (corresponding author), Univ Highlands & Islands, Environm Res Inst, North Highland Coll, Castle St, Thurso KW14 7JD, Scotland.	Andrew.French@uhi.ac.uk	French, Andrew/Q-8012-2016	French, Andrew/0000-0001-6662-4113; Taggart, Mark/0000-0002-0649-8490; Gibb, Stuart/0000-0003-3882-338X; Zadoks, Ruth/0000-0002-1164-8000	Highlands and Islands Scotland European Social Fund programme; Scottish Government's Rural and Environment Science and Analytical Services Division; BBSRC [BB/K015346/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K015346/1] Funding Source: researchfish	Highlands and Islands Scotland European Social Fund programme; Scottish Government's Rural and Environment Science and Analytical Services Division; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ASF's studentship was funded by the Highlands and Islands Scotland European Social Fund 2007-2013 programme. Funding for contributions by GM, PJS and RNZ was obtained from the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014; Alasaad S, 2007, PARASITOL RES, V101, P1245, DOI 10.1007/s00436-007-0628-2; Arias MS, 2013, RES VET SCI, V95, P1031, DOI 10.1016/j.rvsc.2013.07.027; BARTH D, 1973, Zeitschrift fuer Jagdwissenschaft, V19, P183, DOI 10.1007/BF01904174; Bennema SC, 2011, INT J PARASITOL, V41, P225, DOI 10.1016/j.ijpara.2010.09.003; Bohm M, 2006, VET J, V171, P287, DOI 10.1016/j.tvjl.2004.10.020; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Brockwell YM, 2013, VET PARASITOL, V196, P417, DOI 10.1016/j.vetpar.2013.04.012; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DURBIN C. G., 1952, PROC HELMINTHOL SOC WASHINGTON, V19, P120; Flanagan AM, 2011, VET PARASITOL, V176, P34, DOI 10.1016/j.vetpar.2010.10.037; FOREYT WJ, 1986, J AM VET MED ASSOC, V189, P1065; Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126; Gordon DK, 2013, VET PARASITOL, V195, P65, DOI 10.1016/j.vetpar.2013.01.014; Gordon DK, 2012, VET PARASITOL, V187, P436, DOI 10.1016/j.vetpar.2012.02.009; Gordon-Gibbs D, 2014, THESIS; Hoby S, 2006, VET PARASITOL, V138, P337, DOI 10.1016/j.vetpar.2006.01.028; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Issia L, 2009, VET PARASITOL, V165, P341, DOI 10.1016/j.vetpar.2009.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEIPER J. W. G., 1938, JOUR HELMINTHOL, V16, P173, DOI 10.1017/S0022149X00018551; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009; Menard A, 2001, VET RES, V32, P499, DOI 10.1051/vetres:2001141; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2010, PARASITOL INT, V59, P610, DOI 10.1016/j.parint.2010.09.001; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Mezo M, 2013, VET PARASITOL, V198, P274, DOI 10.1016/j.vetpar.2013.09.009; MITCHELL B, 1986, BIOL CONSERV, V37, P237, DOI 10.1016/0006-3207(86)90084-4; O'Toole A, 2014, PARASITOL RES, V113, P4097, DOI 10.1007/s00436-014-4078-3; Palmer DG, 2014, AUST VET J, V92, P357, DOI 10.1111/avj.12224; R Core Team, 2013, R LANG ENV STAT COMP; R Studio Team, 2016, RSTUDIO INT DEV ENV; Rinaldi L, 2011, VET PARASITOL, V177, P345, DOI 10.1016/j.vetpar.2010.12.010; Rondelaud D, 2001, PARASITOL RES, V87, P475, DOI 10.1007/s004360100385; ROSS JG, 1968, VET REC, V82, P587; Shimalov VV, 2000, PARASITOL RES, V86, P342, DOI 10.1007/s004360050056; Arias MS, 2012, J PARASITOL, V98, P754, DOI 10.1645/GE-2804.1; Toolan DP, 2015, VET PARASITOL, V212, P168, DOI 10.1016/j.vetpar.2015.07.040; Ubeira FM, 2009, AM J TROP MED HYG, V81, P156, DOI 10.4269/ajtmh.2009.81.156; van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991; van Wyk JA, 2002, ONDERSTEPOORT J VET, V69, P299; Walker SM, 2011, VET PARASITOL, V177, P179, DOI 10.1016/j.vetpar.2010.11.043	46	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162420	10.1371/journal.pone.0162420	http://dx.doi.org/10.1371/journal.pone.0162420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598003	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000383254800065
J	Abfalter, CM; Schonauer, E; Ponnuraj, K; Huemer, M; Gadermaier, G; Regl, C; Briza, P; Ferreira, F; Huber, CG; Brandstetter, H; Posselt, G; Wessler, S				Abfalter, Carmen M.; Schoenauer, Esther; Ponnuraj, Karthe; Huemer, Markus; Gadermaier, Gabriele; Regl, Christof; Briza, Peter; Ferreira, Fatima; Huber, Christian G.; Brandstetter, Hans; Posselt, Gernot; Wessler, Silja			Cloning, Purification and Characterization of the Collagenase ColA Expressed by Bacillus cereus ATCC 14579	PLOS ONE			English	Article							CLOSTRIDIUM-HISTOLYTICUM; COLLAGENOLYTIC ACTIVITY; NUCLEOTIDE-SEQUENCE; VIBRIO-VULNIFICUS; PHOSPHOLIPASE-C; IDENTIFICATION; REVEALS; GENE; ACTIVATION; SECRETION	Bacterial collagenases differ considerably in their structure and functions. The collagenases ColH and ColG from Clostridium histolyticum and ColA expressed by Clostridium perfringens are well-characterized collagenases that cleave triple-helical collagen, which were therefore termed as 'true' collagenases. ColA from Bacillus cereus (B. cereus) has been added to the collection of true collagenases. However, the molecular characteristics of B. cereus ColA are less understood. In this study, we identified ColA as a secreted true collagenase from B. cereus ATCC 14579, which is transcriptionally controlled by the regulon phospholipase C regulator (PlcR). B. cereus ATCC 14579 ColA was cloned to express recombinant wildtype ColA (ColA(wt)) and mutated to a proteolytically inactive (ColA(E501A)) version. Recombinant ColAwt was tested for gelatinolytic and collagenolytic activities and ColA(E501A) was used for the production of a polyclonal anti-ColA antibody. Comparison of ColAwt activity with homologous proteases in additional strains of B. cereus sensu lato (B. cereus s.l.) and related clostridial collagenases revealed that B. cereus ATCC 14579 ColA is a highly active peptidolytic and collagenolytic protease. These findings could lead to a deeper insight into the function and mechanism of bacterial collagenases which are used in medical and biotechnological applications.	[Abfalter, Carmen M.; Huemer, Markus; Posselt, Gernot; Wessler, Silja] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Microbiol, Salzburg, Austria; [Schoenauer, Esther; Brandstetter, Hans] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Struct Biol, Salzburg, Austria; [Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Guindy Campus, Chennai, Tamil Nadu, India; [Gadermaier, Gabriele; Briza, Peter; Ferreira, Fatima] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Allergy & Immunol, Salzburg, Austria; [Regl, Christof; Huber, Christian G.] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Chem & Bioanalyt, Salzburg, Austria	Salzburg University; Salzburg University; University of Madras; Salzburg University; Salzburg University	Wessler, S (corresponding author), Paris Lodron Univ Salzburg, Dept Mol Biol, Div Microbiol, Salzburg, Austria.	silja.wessler@sbg.ac.at	Brandstetter, Hans/E-6754-2011; Huber, Christian G./E-5445-2011; Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011; Posselt, Gernot/K-1747-2015; Wessler, Silja/C-6309-2015; Briza, Peter/D-7309-2012; Gadermaier, Gabriele/L-5997-2015	Brandstetter, Hans/0000-0002-6089-3045; Huber, Christian G./0000-0001-8358-1880; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Posselt, Gernot/0000-0002-0593-6620; Wessler, Silja/0000-0001-7011-6162; Briza, Peter/0000-0002-4941-6782; Gadermaier, Gabriele/0000-0002-4886-417X; Schonauer, Esther/0000-0002-2625-9446; Huemer, Markus/0000-0002-4308-1619	University of Salzburg	University of Salzburg	We thank Michel Gohar, Didier Lereclus and Nalini Ramarao for providing bacterial strains and are grateful to Isabel J. Hoppe for providing ColG protein. This work was supported by the publication funds of the University of Salzburg.	Abfalter Carmen M, 2015, Br Microbiol Res J, V7, P62, DOI 10.9734/BMRJ/2015/16402; Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BARRIE D, 1992, J INFECTION, V25, P291, DOI 10.1016/0163-4453(92)91579-Z; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Chang SC, 1997, BIOCHEM J, V321, P29, DOI 10.1042/bj3210029; CHANG SC, 1994, J BIOL CHEM, V269, P3548; Darbar A, 2005, J ORTHOP TRAUMA, V19, P353; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Eckhard U, 2008, ACTA CRYSTALLOGR F, V64, P419, DOI 10.1107/S1744309108010476; Eckhard U, 2014, J PROTEOMICS, V100, P102, DOI 10.1016/j.jprot.2013.10.004; Eckhard U, 2013, J BIOL CHEM, V288, P20184, DOI 10.1074/jbc.M112.448548; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; Eckhard U, 2009, BIOL CHEM, V390, P11, DOI 10.1515/BC.2009.004; Frankard J, 2004, EUR J CLIN MICROBIOL, V23, P725, DOI 10.1007/s10096-004-1180-y; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GRANT GA, 1987, J BIOL CHEM, V262, P5886; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Katsuya H, 2009, J INFECT CHEMOTHER, V15, P39, DOI 10.1007/s10156-008-0654-8; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kopel AC, 2008, OPHTHAL SURG LAS IM, V39, P153, DOI 10.3928/15428877-20080301-10; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Krause A, 1996, J TRAUMA, V41, P546, DOI 10.1097/00005373-199609000-00030; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Letunic I, 2015, NUCLEIC ACIDS RES, V43, P9; LOESCHE WJ, 1974, INFECT IMMUN, V9, P329, DOI 10.1128/IAI.9.2.329-336.1974; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lund T, 1999, FEMS MICROBIOL LETT, V178, P355, DOI 10.1016/S0378-1097(99)00382-1; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; MAKINEN KK, 1987, J BIOL CHEM, V262, P12488; Marshman LAG, 2000, BRIT J NEUROSURG, V14, P580; MATSUSHITA O, 1994, J BACTERIOL, V176, P149, DOI 10.1128/JB.176.1.149-156.1994; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, TOXICON, V39, P1769, DOI 10.1016/S0041-0101(01)00163-5; Miller JJ, 2008, AM J OPHTHALMOL, V145, P883, DOI 10.1016/j.ajo.2007.12.026; MIYOSHI N, 1987, MICROBIOL IMMUNOL, V31, P13, DOI 10.1111/j.1348-0421.1987.tb03064.x; Peak TC, 2015, BIOL-TARGETS THER, V9, P107, DOI 10.2147/BTT.S65619; PEIMER CA, 2015, THE JOURNAL OF HAND, V40, P141, DOI DOI 10.1177/1753193414528843; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; SMITH GC, 1982, INFECT IMMUN, V35, P1155, DOI 10.1128/IAI.35.3.1155-1156.1982; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; WANDERSMAN C, 1989, MOL MICROBIOL, V3, P1825, DOI 10.1111/j.1365-2958.1989.tb00169.x; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; YOSHIHARA K, 1994, J BACTERIOL, V176, P6489, DOI 10.1128/JB.176.21.6489-6496.1994; Zigha A, 2006, ARCH MICROBIOL, V185, P222, DOI 10.1007/s00203-006-0090-z	60	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162433	10.1371/journal.pone.0162433	http://dx.doi.org/10.1371/journal.pone.0162433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588686	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877800062
J	Hasegawa, K; Saiura, A; Takayama, T; Miyagawa, S; Yamamoto, J; Ijichi, M; Teruya, M; Yoshimi, F; Kawasaki, S; Koyama, H; Oba, M; Takahashi, M; Mizunuma, N; Matsuyama, Y; Watanabe, T; Makuuchi, M; Kokudo, N				Hasegawa, Kiyoshi; Saiura, Akio; Takayama, Tadatoshi; Miyagawa, Shinichi; Yamamoto, Junji; Ijichi, Masayoshi; Teruya, Masanori; Yoshimi, Fuyo; Kawasaki, Seiji; Koyama, Hiroto; Oba, Masaru; Takahashi, Michiro; Mizunuma, Nobuyuki; Matsuyama, Yutaka; Watanabe, Toshiaki; Makuuchi, Masatoshi; Kokudo, Norihiro			Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial	PLOS ONE			English	Article							III COLON-CANCER; INTRAVENOUS FLUOROURACIL; PHASE-III; STAGE-II; HEPATIC RESECTION; PLUS LEUCOVORIN; FOLINIC ACID; NSABP C-07; CHEMOTHERAPY; SURGERY	Background The high recurrence rate after surgery for colorectal cancer liver metastasis (CLM) remains a crucial problem. The aim of this trial was to evaluate the efficacy of adjuvant therapy with uracil-tegafur and leucovorin (UFT/LV). Methods In the multicenter, open-label, phase III trial, patients undergoing curative resection of CLM were randomly assigned in a 1:1 ratio to either the UFT/LV group or surgery alone group. The UFT/LV group orally received 5 cycles of adjuvant UFT/LV (UFT 300mg/m(2) and LV 75mg/day for 28 days followed by a 7-day rest per cycle). The primary endpoint was recurrence-free survival (RFS). Secondary endpoints included overall survival (OS). Results Between February 2004 and December 2010, 180 patients (90 in each group) were enrolled into the study. Of these, 3 patients (2 in the UFT/LV group and 1 in the surgery alone group) were excluded from the efficacy analysis. Median follow-up was 4.76 (range, 0.15-9.84) years. The RFS rate at 3 years was higher in the UFT/LV group (38.6%, n = 88) than in the surgery alone group (32.3%, n = 89). The median RFS in the UFT/LV and surgery alone groups were 1.45 years and 0.70 years, respectively. UFT/LV significantly prolonged the RFS compared with surgery alone with the hazard ratio of 0.56 (95% confidence interval, 0.38-0.83; P = 0.003). The hazard ratio for death of the UFT/LV group against the surgery alone group was not significant (0.80; 95% confidence interval, 0.48-1.35; P = 0.409). Conclusion Adjuvant therapy with UFT/LV effectively prolongs RFS after hepatic resection for CLM and can be recommended as an alternative choice.	[Hasegawa, Kiyoshi; Oba, Masaru; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan; [Saiura, Akio; Takahashi, Michiro] Canc Inst Hosp, Japanese Fdn Canc Res, Dept Gastrointestinal Surg, Tokyo, Japan; [Takayama, Tadatoshi] Nihon Univ, Sch Med, Dept Digest Surg, Tokyo, Japan; [Miyagawa, Shinichi] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano, Japan; [Yamamoto, Junji] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama, Japan; [Ijichi, Masayoshi] JCHO Tokyo Yamate Med Ctr, Dept Surg, Tokyo, Japan; [Teruya, Masanori] Showa Gen Hosp, Dept Surg, Tokyo, Japan; [Yoshimi, Fuyo] Ibaraki Prefectural Cent Hosp & Canc Ctr, Dept Surg, Ibaraki, Japan; [Kawasaki, Seiji] Juntendo Univ, Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Koyama, Hiroto] JCHO Tokyo Takanawa Hosp, Dept Surg, Tokyo, Japan; [Mizunuma, Nobuyuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol, Tokyo, Japan; [Matsuyama, Yutaka] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Watanabe, Toshiaki] Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan; [Makuuchi, Masatoshi] Japanese Red Cross Med Ctr, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan	University of Tokyo; Japanese Foundation for Cancer Research; Nihon University; Shinshu University; National Defense Medical College - Japan; Juntendo University; Japanese Foundation for Cancer Research; University of Tokyo; University of Tokyo; Japanese Red Cross Medical Center; University of Tokyo	Kokudo, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp	Saiura, Akio/AAH-5008-2020	Saiura, Akio/0000-0001-5600-2847	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Foundation for Multidisciplinary Treatment of Cancer; Public Trust Haraguchi Memorial Cancer Research Fund; Japanese Clinical Oncology Fund	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Foundation for Multidisciplinary Treatment of Cancer(Japanese Foundation for Multidisciplinary Treatment of Cancer); Public Trust Haraguchi Memorial Cancer Research Fund; Japanese Clinical Oncology Fund	This trial was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NK); Japanese Foundation for Multidisciplinary Treatment of Cancer (to KH); Public Trust Haraguchi Memorial Cancer Research Fund (to KH); and Japanese Clinical Oncology Fund (to KH). These sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Araujo R, 2013, ANN SURG ONCOL, V20, P4312, DOI 10.1245/s10434-013-3162-8; Arnold D, 2011, CURR COLORECT CANC R, V7, P180, DOI 10.1007/s11888-011-0096-z; Beppu T, 2012, J HEPATO-BIL-PAN SCI, V19, P72, DOI 10.1007/s00534-011-0460-z; Borner MM, 2002, EUR J CANCER, V38, P349, DOI 10.1016/S0959-8049(01)00371-9; Choti MA, 2008, CURR COLORECT CANC R, V4, P160, DOI 10.1007/s11888-008-0026-x; Douillard JY, 2002, J CLIN ONCOL, V20, P3605, DOI 10.1200/JCO.2002.04.123; Fong YM, 2013, LANCET ONCOL, V14, P1148, DOI 10.1016/S1470-2045(13)70478-9; Kokudo N, 2007, J CLIN ONCOL, V25, P1299, DOI 10.1200/JCO.2006.09.9069; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Lembersky BC, 2006, J CLIN ONCOL, V24, P2059, DOI 10.1200/JCO.2005.04.7498; Lorenz M, 1998, ANN SURG, V228, P756, DOI 10.1097/00000658-199812000-00006; Mitry E, 2008, J CLIN ONCOL, V26, P4906, DOI 10.1200/JCO.2008.17.3781; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Oba M, 2014, ANN SURG ONCOL, V21, P1817, DOI 10.1245/s10434-014-3504-1; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Primrose J, 2014, LANCET ONCOL, V15, P601, DOI 10.1016/S1470-2045(14)70105-6; Rudroff C, 1999, LANGENBECK ARCH SURG, V384, P243, DOI 10.1007/s004230050199; Saiura A, 2014, DRUG DISCOV THER, V8, P48, DOI 10.5582/ddt.8.48; Schulze T, 2009, CANCER IMMUNOL IMMUN, V58, P61, DOI 10.1007/s00262-008-0526-1; Shimada Y, 2014, EUR J CANCER, V50, P2231, DOI 10.1016/j.ejca.2014.05.025; Ychou M, 2009, ANN ONCOL, V20, P1964, DOI 10.1093/annonc/mdp236; Yothers G, 2011, J CLIN ONCOL, V29, P3768, DOI 10.1200/JCO.2011.36.4539	26	62	63	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162400	10.1371/journal.pone.0162400	http://dx.doi.org/10.1371/journal.pone.0162400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588959	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800055
J	Klein, S; Hinuber, C; Hittatiya, K; Schierwagen, R; Uschner, FE; Strassburg, CP; Fischer, HP; Spengler, U; Trebicka, J				Klein, Sabine; Hinueber, Christian; Hittatiya, Kanishka; Schierwagen, Robert; Uschner, Frank Erhard; Strassburg, Christian P.; Fischer, Hans-Peter; Spengler, Ulrich; Trebicka, Jonel			Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SECONDARY BILIARY-CIRRHOSIS; DUCT-LIGATED RATS; RHO-KINASE; ACTIVATION; FIBROSIS; RECEPTOR; DEFICIENCY; MANAGEMENT; PRESSURE	Background Non-cirrhotic idiopathic portal hypertension (NCIPH) is characterized by splenomegaly, anemia and portal hypertension, while liver function is preserved. However, no animal models have been established yet. This study assessed a rat model of NCIPH and characterized the hemodynamics, and compared it to human NCIPH. Methods Portal pressure (PP) was measured invasively and coloured microspheres were injected in the ileocecal vein in rats. This procedure was performed weekly for 3 weeks (weekly embolization). Rats without and with single embolization served as controls. After four weeks (one week after last embolization), hemodynamics were investigated, hepatic fibrosis and accumulation of myofibroblasts were analysed. General characteristics, laboratory analyses and liver histology were collected in patients with NCIPH. Results Weekly embolization induced a hyperdynamic circulation, with increased PP. The mesenteric flow and hepatic hydroxyproline content was significantly higher in weekly embolized compared to single embolized rats (mesenteric flow +54.1%, hydroxyproline +41.7%). Mesenteric blood flow and shunt volumes increased, whereas splanchnic vascular resistance was decreased in the weekly embolization group. Fibrotic markers alpha SMA and Desmin were upregulated in weekly embolized rats. Discussion This study establishes a model using repetitive embolization via portal veins, comparable with human NCIPH and may serve to test new therapies.	[Klein, Sabine; Hinueber, Christian; Schierwagen, Robert; Uschner, Frank Erhard; Strassburg, Christian P.; Spengler, Ulrich; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Hittatiya, Kanishka; Fischer, Hans-Peter] Univ Bonn, Inst Pathol, Bonn, Germany; [Trebicka, Jonel] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark	University of Bonn; University of Bonn; University of Southern Denmark	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Trebicka, J (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.	jonel.trebicka@ukb.uni-bonn.de	Klein, Sabine/U-1098-2018; Schierwagen, Robert/AAE-6305-2019	Klein, Sabine/0000-0001-6691-2895; Schierwagen, Robert/0000-0002-2195-3666; Uschner, Frank Erhard/0000-0002-3760-2887	Deutsche Forschungsgemeinschaft [SFB TRR57 18]; H. J. & W. Hector Foundation [M60.2]; Ernst-Bertha-Grimke [6/15]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. J. & W. Hector Foundation; Ernst-Bertha-Grimke	The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57 project 18), H. J. & W. Hector Foundation (M60.2), Ernst-Bertha-Grimke (6/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayan K, 2009, J THROMB THROMBOLYS, V28, P57, DOI 10.1007/s11239-008-0244-8; Biecker E, 2008, LIVER INT, V28, P331, DOI 10.1111/j.1478-3231.2008.01664.x; Flecknell PA, 1999, VET REC, V144, P65, DOI 10.1136/vr.144.3.65; GERAGHTY JG, 1989, AM J PHYSIOL, V257, pG52, DOI 10.1152/ajpgi.1989.257.1.G52; Grace JA, 2013, GASTROENTEROLOGY, V145, P874, DOI 10.1053/j.gastro.2013.06.036; Granzow M, 2014, HEPATOLOGY, V60, P334, DOI 10.1002/hep.27117; HAKKINEN JP, 1995, CARDIOVASC RES, V29, P74, DOI 10.1016/S0008-6363(96)88549-X; Heller J, 2005, LIVER INT, V25, P657, DOI 10.1111/j.1478-3231.2005.01053.x; Hennenberg M, 2008, GUT, V57, P1300, DOI 10.1136/gut.2007.144584; Hennenberg M, 2009, BRIT J PHARMACOL, V157, P258, DOI 10.1111/j.1476-5381.2009.00158.x; Hennenberg M, 2009, LIVER INT, V29, P933, DOI 10.1111/j.1478-3231.2009.02010.x; Hillaire S, 2002, GUT, V51, P275, DOI 10.1136/gut.51.2.275; Horai Y, 2010, INTERNAL MED, V49, P2013, DOI 10.2169/internalmedicine.49.3834; Khanna R, 2014, J HEPATOL, V60, P421, DOI 10.1016/j.jhep.2013.08.013; Moleda L, 2011, GUT, V60, P1122, DOI 10.1136/gut.2010.226407; Sarin SK, 2002, J GASTROEN HEPATOL, V17, P526, DOI 10.1046/j.1440-1746.2002.02764.x; Sawada S, 2007, J GASTROEN HEPATOL, V22, P204, DOI 10.1111/j.1440-1746.2006.04492.x; Schouten JNL, 2012, ALIMENT PHARM THER, V35, P1424, DOI 10.1111/j.1365-2036.2012.05112.x; Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422; Siramolpiwat S, 2014, HEPATOLOGY, V59, P2276, DOI 10.1002/hep.26904; Tanaka T, 2013, INTRACTABLE RARE DIS, V2, P94, DOI 10.5582/irdr.2013.v2.3.94; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025; Trebicka J, 2009, HEPATOLOGY, V50, P1924, DOI 10.1002/hep.23222	25	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162144	10.1371/journal.pone.0162144	http://dx.doi.org/10.1371/journal.pone.0162144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589391	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877800032
J	Kwon, JE; Lee, JW; Im, JP; Kim, JW; Kim, SH; Koh, SJ; Kim, BG; Lee, KL; Kim, SG; Kim, JS; Jung, HC				Kwon, Ji Eun; Lee, Jung Won; Im, Jong Pil; Kim, Ji Won; Kim, Su Hwan; Koh, Seong-Joon; Kim, Byeong Gwan; Lee, Kook Lae; Kim, Sang Gyun; Kim, Joo Sung; Jung, Hyun Chae			Comparable Efficacy of a 1-L PEG and Ascorbic Acid Solution Administered with Bisacodyl versus a 2-L PEG and Ascorbic Acid Solution for Colonoscopy Preparation: A Prospective, Randomized and Investigator-Blinded Trial	PLOS ONE			English	Article							VOLUME BOWEL PREPARATION; POLYETHYLENE-GLYCOL; PREPARATION QUALITY; MAGNESIUM CITRATE; LAVAGE; IMPACT; FORMULATIONS; CONSTIPATION; ADEQUATE; INTERVAL	Background Two liters of polyethylene glycol ( PEG) solution administered with ascorbic acid (Asc) can provide efficacy similar to that of a 4-L PEG solution for colonoscopy preparation. In addition, oral bisacodyl (Bis) has been shown to reduce the volume of PEG needed for a bowel preparation with comparable efficacy. This study aimed to compare the efficacy, tolerability and safety of a 2-L PEG solution mixed with Asc versus the combination of Bis, Asc and a 1-L PEG solution. Methods This was a prospective, randomized, multi-centre, single-blind, non-inferiority trial. Participants who were scheduled for colonoscopy were included and randomized to receive either 2-L PEG and Asc (2L PEG/Asc group) or 1-L PEG, Asc and 20 mg Bis (1L PEG/Asc + Bis group). The quality of bowel preparation was assessed using the Boston Bowel Preparation Scale. Data regarding tolerance, compliance and adverse events were also gathered. Results A total of 187 participants were analyzed; 96 were allocated to the 2L PEG/Asc group and 91 to the 1L PEG/Asc + Bis group. Bowel preparation was adequate in 87.5% (84/96) of patients in the 2L PEG/Asc group and 94.5% of the 1L PEG/Asc + Bis group (86/91, p = 0.10). There was no significant difference between the two groups with respect to compliance, tolerability or safety. The patients allocated to the 1L PEG/Asc + Bis group expressed more willingness to repeat the procedure than patients in the 2L PEG/Asc group (p = 0.01). Conclusions Bowel preparation with Bis and a 1-L PEG/Asc solution is as effective, well-tolerated, and safe as a 2-L PEG/Asc solution.	[Kwon, Ji Eun] Armed Forces Capital Hosp, Dept Internal Med, Bundang, South Korea; [Lee, Jung Won; Im, Jong Pil; Kim, Sang Gyun; Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Jung Won; Im, Jong Pil; Kim, Sang Gyun; Kim, Joo Sung; Jung, Hyun Chae] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Kim, Ji Won; Kim, Su Hwan; Koh, Seong-Joon; Kim, Byeong Gwan; Lee, Kook Lae] Seoul Natl Univ, Coll Med, Dept Internal Med, Boramae Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Boramae Hosp, Seoul, South Korea.	kjwjor@snu.ac.kr	KIM, SUHWAN/GSE-0120-2022	Kwon, Ji Eun/0000-0001-6615-8319	TaeJoon Pharmaceuticals	TaeJoon Pharmaceuticals	The work was funded by TaeJoon Pharmaceuticals and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All aspects of the analysis and its writing were carried out by the authors.; The work was funded by TaeJoon Pharmaceuticals and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All aspects of the analysis and its writing were carried out by the authors. The authors have declared that no competing interests exist and the funding does not alter our adherence to PLOS ONE policies on sharing data and materials.	ADAMS WJ, 1994, DIS COLON RECTUM, V37, P229, DOI 10.1007/BF02048160; Ajani S, 2012, BMJ CASE REP; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Bae SE, 2013, GUT LIVER, V7, P423, DOI 10.5009/gnl.2013.7.4.423; Baudet JS, 2010, AM J GASTROENTEROL, V105, P700, DOI 10.1038/ajg.2009.637; Bharucha AE, 2012, NEUROGASTROENT MOTIL, V24, P977, DOI 10.1111/nmo.12019; BRADY CE, 1987, ANN CLIN RES, V19, P34; Brahmania M, 2014, GASTROINTEST ENDOSC, V79, P408, DOI 10.1016/j.gie.2013.08.035; Burke CA, 2007, GASTROINTEST ENDOSC, V66, P565, DOI 10.1016/j.gie.2007.03.1084; Calderwood AH, 2014, GASTROINTEST ENDOSC, V80, P269, DOI 10.1016/j.gie.2014.01.031; Cha JM, 2014, INTEST RES, V12, P110, DOI 10.5217/ir.2014.12.2.110; Clark BT, 2016, GASTROENTEROLOGY, V150, P396, DOI 10.1053/j.gastro.2015.09.041; Cohen LB, 2010, ALIMENT PHARM THER, V32, P637, DOI 10.1111/j.1365-2036.2010.04390.x; Collazo TH, 2015, GUT LIVER, V9, P502, DOI 10.5009/gnl14039; Ell C, 2003, ENDOSCOPY, V35, P300, DOI 10.1055/s-2003-38150; Ell C, 2008, AM J GASTROENTEROL, V103, P883, DOI 10.1111/j.1572-0241.2007.01708.x; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Jeon SR, 2015, INT J COLORECTAL DIS, V30, P251, DOI 10.1007/s00384-014-2066-9; Johnson DA, 2014, GASTROENTEROLOGY, V147, P903, DOI 10.1053/j.gastro.2014.07.002; Kamm MA, 2011, CLIN GASTROENTEROL H, V9, P577, DOI 10.1016/j.cgh.2011.03.026; Kao D, 2011, CAN J GASTROENTEROL, V25, P657, DOI 10.1155/2011/486084; Kim TK, 2014, GUT LIVER, V8, P625, DOI 10.5009/gnl13228; Klaschik E, 2003, SUPPORT CARE CANCER, V11, P679, DOI 10.1007/s00520-003-0525-x; Lai EJ, 2009, GASTROINTEST ENDOSC, V69, P620, DOI 10.1016/j.gie.2008.05.057; Lee HS, 2014, INTEST RES, V12, P1, DOI 10.5217/ir.2014.12.1.1; Mittal S, 2010, GASTROINTEST ENDOSC, V71, P221, DOI 10.1016/j.gie.2009.04.031; Radaelli F, 2005, AM J GASTROENTEROL, V100, P2674, DOI 10.1111/j.1572-0241.2005.00335.x; Repici A, 2012, ALIMENT PHARM THER, V36, P717, DOI 10.1111/apt.12026; Rosenfeld G, 2010, CAN J GASTROENTEROL, V24, P543, DOI 10.1155/2010/718628; Sharma VK, 1998, GASTROINTEST ENDOSC, V47, P167, DOI 10.1016/S0016-5107(98)70351-7; Siddiqui AA, 2009, GASTROINTEST ENDOSC, V69, P700, DOI 10.1016/j.gie.2008.09.047; Wang Huann-Sheng, 2003, J Chin Med Assoc, V66, P364	33	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162051	10.1371/journal.pone.0162051	http://dx.doi.org/10.1371/journal.pone.0162051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588943	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877800028
J	Steca, P; D'Addario, M; Magrin, ME; Miglioretti, M; Monzani, D; Pancani, L; Sarini, M; Scrignaro, M; Vecchio, L; Fattirolli, F; Giannattasio, C; Cesana, F; Riccobono, SP; Greco, A				Steca, Patrizia; D'Addario, Marco; Magrin, Maria Elena; Miglioretti, Massimo; Monzani, Dario; Pancani, Luca; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; Fattirolli, Francesco; Giannattasio, Cristina; Cesana, Francesca; Riccobono, Salvatore Pio; Greco, Andrea			A Type A and Type D Combined Personality Typology in Essential Hypertension and Acute Coronary Syndrome Patients: Associations with Demographic, Psychological, Clinical, and Lifestyle Indicators	PLOS ONE			English	Article							QUALITY-OF-LIFE; ISCHEMIC-HEART-DISEASE; IMPAIRED HEALTH-STATUS; BEHAVIOR PATTERN; ILLNESS PERCEPTION; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL FACTORS; SELF-EFFICACY; MYOCARDIAL-INFARCTION; CLUSTER-ANALYSIS	Many studies have focused on Type A and Type D personality types in the context of cardiovascular diseases (CVDs), but nothing is known about how these personality types combine to create new profiles. The present study aimed to develop a typology of Type A and Type D personality in two groups of patients affected by and at risk for coronary disease. The study involved 711 patients: 51.6% with acute coronary syndrome, 48.4% with essential hypertension (mean age = 56.4 years; SD = 9.7 years; 70.7% men). Cluster analysis was applied. External variables, such as socio-demographic, psychological, lifestyle, and clinical parameters, were assessed. Six groups, each with its own unique combined personality profile scores, were identified: Type D, Type A-Negatively Affected, Not Type A-Negatively Affected, Socially Inhibited-Positively Affected, Not Socially Inhibited, and Not Type A-Not Type D. The Type A-Negatively Affected cluster and, to a lesser extent, the Type D cluster, displayed the worst profile: namely higher total cardiovascular risk index, physical inactivity, higher anxiety and depression, and lower self-esteem, optimism, and health status. Identifying combined personality profiles is important in clinical research and practice in cardiovascular diseases. Practical implications are discussed.	[Steca, Patrizia; D'Addario, Marco; Magrin, Maria Elena; Miglioretti, Massimo; Monzani, Dario; Pancani, Luca; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; Greco, Andrea] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Fattirolli, Francesco] Univ Florence, Cardiac Rehabil Unit, Dept Med & Surg Crit Care, Florence, Italy; [Fattirolli, Francesco] Azienda Osped Univ Careggi, Florence, Italy; [Giannattasio, Cristina; Cesana, Francesca] Univ Milano Bicocca, Dept Hlth Sci, Milan, Italy; [Giannattasio, Cristina; Cesana, Francesca; Riccobono, Salvatore Pio] Osped Niguarda Ca Granda, Cardiovasc A De Gasperis Dept, Cardiol 4, Milan, Italy	University of Milano-Bicocca; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Greco, A (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	andrea.greco@unimib.it	Pancani, Luca/L-9475-2019; Monzani, Dario/AAR-2609-2021; D'Addario, Marco/AAY-6426-2021; Vecchio, Luca/C-1670-2013; Greco, Andrea/I-7266-2016; Monzani, Dario/AAP-4501-2020	Pancani, Luca/0000-0002-7834-3826; Vecchio, Luca/0000-0001-6784-2817; Greco, Andrea/0000-0002-8086-2801; D'ADDARIO, MARCO/0000-0002-7659-885X	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [RBFR08YVUL]	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca"	This work was supported by the Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [grant number RBFR08YVUL]; Principal Investigator: PS, http://futuroinricerca.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Asadi J. N., 2010, Eastern Mediterranean Health Journal, V16, P740; Al-Lami FH, 1997, RISK FACTORS ANAL MY; Al-Ruzzeh S, 2005, HEART, V91, P1557, DOI 10.1136/hrt.2004.047068; Aldenderfer MS., 1984, CLUSTER ANAL; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Aquarius AE, 2005, AM J CARDIOL, V96, P996, DOI 10.1016/j.amjcard.2005.05.059; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408; BAKER FB, 1975, J AM STAT ASSOC, V70, P31, DOI 10.2307/2285371; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; Barefoot JC, 2011, ARCH INTERN MED, V171, P929, DOI 10.1001/archinternmed.2011.41; Barth J, 2015, HEALTH QUAL LIFE OUT, V3, P15; Barth J, 2010, PSYCHOSOM MED, V72, P229, DOI 10.1097/PSY.0b013e3181d01611; Bean D, 2007, PSYCHOL HEALTH, V22, P787, DOI 10.1080/14768320600976240; Bergman LR, 2001, EUR PSYCHOL, V6, P177, DOI 10.1027//1016-9040.6.3.177; Bergman LR, 2003, SERIES PATHS LIFE, V4; Bergman LR, 2002, SPLEINER STAT PACKAG; Bergman LR, 1998, INDIVIDUAL FOCUS DEV; Bertolotti G, 2012, ACT NERV SUPER REDIV, V54, P21; BLUMENTHAL JA, 1978, CIRCULATION, V58, P634, DOI 10.1161/01.CIR.58.4.634; BRACKETT CD, 1988, AM J CARDIOL, V61, P979, DOI 10.1016/0002-9149(88)90110-5; Breckenridge JN, 2000, MULTIVAR BEHAV RES, V35, P261, DOI 10.1207/S15327906MBR3502_5; Breckernridge JN, 1989, APPL PSYCH MEAS, V16, P119; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; BUCHMAN BP, 1991, J PSYCHOSOM RES, V35, P197, DOI 10.1016/0022-3999(91)90074-X; Carlson ED, 2005, RES NURS HEALTH, V28, P306, DOI 10.1002/nur.20084; CASE RB, 1985, NEW ENGL J MED, V312, P737, DOI 10.1056/NEJM198503213121201; Chauvet-Gelinier JC, DIABETES METABOLISM; CHESNEY M A, 1981, Journal of Behavioral Medicine, V4, P217, DOI 10.1007/BF00844272; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen L, 1997, PSYCHOL HEALTH, V12, P619, DOI 10.1080/08870449708407410; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Conraads VM, 2006, INT J CARDIOL, V113, P34, DOI 10.1016/j.ijcard.2005.10.013; Cosci F, 2012, ADV PSYCHOSOM MED, V32, P133, DOI 10.1159/000330014; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Coyne JC, 2012, J PSYCHOSOM RES, V73, P401, DOI 10.1016/j.jpsychores.2012.09.016; Coyne JC, 2011, PSYCHOSOM MED, V73, P557, DOI 10.1097/PSY.0b013e318227ac75; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dembroski T M, 1978, J Behav Med, V1, P159, DOI 10.1007/BF00846637; DEMBROSKI TM, 1985, PSYCHOSOM MED, V47, P219, DOI 10.1097/00006842-198505000-00001; DEMBROSKI TM, 1989, PSYCHOSOM MED, V51, P514, DOI 10.1097/00006842-198909000-00003; DENOLLET J, 1995, PSYCHOSOM MED, V57, P582, DOI 10.1097/00006842-199511000-00011; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2006, EUR HEART J, V27, P171, DOI 10.1093/eurheartj/ehi616; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Denollet J, 1998, CIRCULATION, V97, P167, DOI 10.1161/01.CIR.97.2.167; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; DIAMOND EL, 1982, PSYCHOL BULL, V92, P410, DOI 10.1037/0033-2909.92.2.410; DIMSDALE JE, 1978, AM J CARDIOL, V42, P583, DOI 10.1016/0002-9149(78)90627-6; DIMSDALE JE, 1981, AM J CARDIOL, V47, P73, DOI 10.1016/0002-9149(81)90292-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; FRIEDMAN M, 1977, B NEW YORK ACAD MED, V53, P593; Gallacher JEJ, 2003, PSYCHOSOM MED, V65, P339, DOI 10.1097/01.PSY.0000041608.55974.A8; Gallagher J, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0667-8; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldston K, 2008, CLIN PSYCHOL REV, V28, P288, DOI 10.1016/j.cpr.2007.05.005; Gore SW., 2000, ENHANCING STUDENTS E; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grande G, 2012, ANN BEHAV MED, V43, P299, DOI 10.1007/s12160-011-9339-0; Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc; Greco A, 2014, INT J BEHAV MED, V21, P221, DOI 10.1007/s12529-013-9290-5; Greco A, 2015, BEHAV MED, V41, P9, DOI 10.1080/08964289.2013.855159; Gremigni P., 2005, PSICOTER COGN COMPOR, V11, P7, DOI DOI 10.13140/2.1.2918.9765; Gulliksson M, 2011, ARCH INTERN MED, V171, P134, DOI 10.1001/archinternmed.2010.510; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P362, DOI 10.1093/oxfordjournals.aje.a112556; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; HIGUCHI S, 1994, ALCOHOL CLIN EXP RES, V18, P305, DOI 10.1111/j.1530-0277.1994.tb00018.x; HOWARD JH, 1976, J HUM STRESS, V2, P24, DOI 10.1080/0097840X.1976.9937486; Hu J, 2008, MENTAL HLTH NURSING, V29, P895, DOI DOI 10.1080/01612840802182938; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUBERT LJ, 1976, PSYCHOL BULL, V83, P1072, DOI 10.1037/0033-2909.83.6.1072; IRVINE J, 1991, HYPERTENSION, V18, P72, DOI 10.1161/01.HYP.18.1.72; Jamil G, 2013, AM J CARDIOVASC DIS, V3, P163; JOHNSTON DW, 1993, J ROY SOC MED, V86, P406; JULKUNEN J, 1993, J PSYCHOSOM RES, V37, P11, DOI 10.1016/0022-3999(93)90119-Z; Keltikangas-Jarvinen L, 1999, ARTERIOSCL THROM VAS, V19, P1998, DOI 10.1161/01.ATV.19.8.1998; KIRKCALDY BD, 1993, PERS INDIV DIFFER, V15, P69, DOI 10.1016/0191-8869(93)90042-2; KORNITZER M, 1981, PSYCHOSOM MED, V43, P133, DOI 10.1097/00006842-198104000-00005; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Kupper N, 2013, INT J CARDIOL, V166, P327, DOI 10.1016/j.ijcard.2011.10.084; Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z; Lenzen MJ, 2007, HEART, V93, P339, DOI 10.1136/hrt.2005.086868; Leventhal H., 1984, HDB PSYCHOL HLTH, P219, DOI DOI 10.1201/9781003044307-9; Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x; Madden T. E, 2000, GENDER EMOTION SOCIA, P277, DOI DOI 10.1017/CBO9780511628191; Maes S, 2005, APPL PSYCHOL-INT REV, V54, P267, DOI 10.1111/j.1464-0597.2005.00210.x; Magnusson D, 1998, METHODS AND MODELS FOR STUDYING THE INDIVIDUAL, P33; MAGNUSSON D, 1992, EUR J PERSONALITY, V6, P119, DOI 10.1002/per.2410060205; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Martens EJ, 2010, J CLIN PSYCHIAT, V71, P778, DOI 10.4088/JCP.08m04765blu; Maruta T., 2000, MAYO CLIN P, V75, P318, DOI DOI 10.4065/75.2.140; Matthews G, 2003, EUR J PERSONALITY, V17, P157, DOI 10.1002/per.476; MATTHEWS KA, 1988, PSYCHOL BULL, V104, P373, DOI 10.1037/0033-2909.104.3.373; MATTHEWS KA, 1977, J CHRON DIS, V30, P489, DOI 10.1016/0021-9681(77)90071-6; MILLIGAN GW, 1981, PSYCHOMETRIKA, V46, P187, DOI 10.1007/BF02293899; Mols F, 2012, J PSYCHOSOM RES, V73, P232, DOI 10.1016/j.jpsychores.2012.07.004; Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714; Monzani D, 2014, J ADOLESCENCE, V37, P97, DOI 10.1016/j.adolescence.2013.11.006; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Myrtek M, 2001, INT J CARDIOL, V79, P245, DOI 10.1016/S0167-5273(01)00441-7; MYRTEK M, 1995, PERS INDIV DIFFER, V18, P491, DOI 10.1016/0191-8869(94)00197-Z; Nadkarni S, 2011, ARTERIOSCL THROM VAS, V31, P2749, DOI 10.1161/ATVBAHA.111.235176; Oginska-Bulik N., 2014, POLISH J APPL PSYCHO, V12, P29; Orth-Gomer K, 2009, CIRC-CARDIOVASC QUAL, V2, P25, DOI 10.1161/CIRCOUTCOMES.108.812859; Pain D, 2006, PSICOLOGIA SALUTE, V1, P81, DOI DOI 10.1400/91143; Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7; Pedersen SS, 2007, INT J CARDIOL, V114, P358, DOI 10.1016/j.ijcard.2005.12.018; Pedersen SS, 2006, J PSYCHOSOM RES, V61, P783, DOI 10.1016/j.jpsychores.2006.06.009; Perbandt K, 2006, PSYCHOTHER PSYCH MED, V56, P310, DOI 10.1055/s-2006-932663; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Raibhoge CM, 2015, INT J ADV HLTH SCI, V5, P86; Ritzel RM, 2013, HORM BEHAV, V63, P238, DOI 10.1016/j.yhbeh.2012.04.007; ROHLFS J, 1974, BELL J ECON, V5, P16, DOI 10.2307/3003090; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; ROSENMAN RH, 1964, JAMA-J AM MED ASSOC, V189, P15; ROSENMAN RH, 1975, JAMA-J AM MED ASSOC, V233, P872, DOI 10.1001/jama.233.8.872; ROSENMAN RH, 1961, CIRCULATION, V24, P1173, DOI 10.1161/01.CIR.24.5.1173; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schiffer AA, 2008, EUR J HEART FAIL, V10, P802, DOI 10.1016/j.ejheart.2008.06.012; Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822; Scholte RHJ, 2005, MERRILL PALMER QUART, V51, P258, DOI 10.1353/mpq.2005.0019; Schroeder KE, 2000, HYPERTENSION, V36, P830, DOI 10.1161/01.HYP.36.5.830; SCHWARZER R, 1994, PSYCHOL HEALTH, V9, P161, DOI 10.1080/08870449408407475; SEEMAN TE, 1987, PSYCHOSOM MED, V49, P341, DOI 10.1097/00006842-198707000-00003; Sharma A., 2012, ADV ASIAN SOCIAL SCI, V3, P751; Sharma Jogendra, 2012, Nurs J India, V103, P245; Shek DTL, 1997, SOC BEHAV PERSONAL, V25, P277, DOI 10.2224/sbp.1997.25.3.277; SHEKELLE RB, 1976, J CHRON DIS, V29, P381, DOI 10.1016/0021-9681(76)90059-X; SHEKELLE RB, 1983, PSYCHOSOM MED, V45, P109, DOI 10.1097/00006842-198305000-00003; Shin Jinho, 2014, Hanyang Medical Reviews, V34, P72, DOI 10.7599/hmr.2014.34.2.72; Sirri L, 2007, J PERS ASSESS, V89, P216, DOI 10.1080/00223890701629649; Smith DF, 1996, SCAND J PSYCHOL, V37, P249, DOI 10.1111/j.1467-9450.1996.tb00657.x; Smith GCS, 2006, PEDIATRICS, V117, P60, DOI 10.1542/peds.2004-2828; Soto GE, 2004, CIRCULATION, V110, P546, DOI 10.1161/01.CIR.0000136991.85540.A9; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Staniute M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-014-0204-2; Steca P, 2013, PSYCHOL HEALTH, V28, P765, DOI 10.1080/08870446.2012.759223; Steca P, 2014, ASSESSMENT, V22, P1; Steca P, 2015, APPL PSYCHOL HLTH WE; Svansdottir E, 2012, J BEHAV MED, V35, P155, DOI 10.1007/s10865-011-9337-5; Tan PN, 2006, INTRO DATA MINING, p[227, 276, 633]; Thomas F, 2001, HYPERTENSION, V37, P1256, DOI 10.1161/01.HYP.37.5.1256; Tinsley HEA, 2000, HDB APPL MULTIVARIAT, DOI [10.1016/B978-012691360-6/50002-1, DOI 10.1016/B978-012691360-6/50002-1, 10.1016/b978-012691360-6/50002-1]; Topolski Tari D, 2006, Prev Chronic Dis, V3, pA118; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trovato GM, 2012, CLIN TER, V163, P281; VOGT TM, 1992, J CLIN EPIDEMIOL, V45, P659, DOI 10.1016/0895-4356(92)90138-D; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Weatherall M, 2010, EUR RESPIR J, V36, P472, DOI 10.1183/09031936.00035210; Welin C, 2000, J INTERN MED, V247, P629, DOI 10.1046/j.1365-2796.2000.00694.x; Whalley B, 2014, INT J BEHAV MED, V21, P109, DOI 10.1007/s12529-012-9282-x; Williams L, 2012, J PSYCHOSOM RES, V72, P422, DOI 10.1016/j.jpsychores.2012.02.007; Williams L, 2011, J PSYCHOSOM RES, V70, P141, DOI 10.1016/j.jpsychores.2010.07.015; Williams PG, 2002, PERS SOC PSYCHOL B, V28, P1015, DOI 10.1177/01461672022811001; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zotti AM., 2000, LINEE GUIDA SCREENIN	170	14	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161840	10.1371/journal.pone.0161840	http://dx.doi.org/10.1371/journal.pone.0161840			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589065	Green Published, gold			2022-12-27	WOS:000382877800020
J	Guo, M; Wang, XM; Lu, XW; Wang, HZ; Brodelius, PE				Guo, Ming; Wang, Xiaomeng; Lu, Xiaowang; Wang, Hongzheng; Brodelius, Peter E.			alpha-Mangostin Extraction from the Native Mangosteen (Garcinia mangostana L.) and the Binding Mechanisms of alpha-Mangostin to HSA or TRF	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; DRUG; PROTEOMICS; DYNAMICS; THERMODYNAMICS; SPECTROSCOPIES; IDENTIFICATION; TRANSFERRIN; XANTHONES; NETWORKS	In order to obtain the biological active compound, alpha-mangostin, from the traditional native mangosteen (Garcinia mangostana L.), an extraction method for industrial application was explored. A high yield of a-mangostin (5.2%) was obtained by extraction from dried mangosteen pericarps with subsequent purification on macroporous resin HPD-400. The chemical structure of alpha-mangostin was verified mass spectrometry (MS), nuclear magnetic resonance (H-1 NMR and C-13 NMR), infrared spectroscopy (IR) and UV-Vis spectroscopy. The purity of the obtained alpha-mangostin was 95.6% as determined by HPLC analysis. The binding of native alpha-mangostin to human serum albumin (HSA) or transferrin (TRF) was explored by combining spectral experiments with molecular modeling. The results showed that amangostin binds to HSA or TRF as static complexes but the binding affinities were different in different systems. The binding constants and thermodynamic parameters were measured by fluorescence spectroscopy and absorbance spectra. The association constant of HSA or TRF binding to alpha-mangostin is 6.4832x10(5) L/mol and 1.4652x10(5) L/mol at 298 K and 7.8619x10(5) L/mol and 1.1582x10(5) L/mol at 310 K, respectively. The binding distance, the energy transfer efficiency between alpha-mangostin and HSA or TRF were also obtained by virtue of the Forster theory of non-radiation energy transfer. The effect of alpha-mangostin on the HSA or TRF conformation was analyzed by synchronous spectrometry and fluorescence polarization studies. Molecular docking results reveal that the main interaction between amangostin and HSA is hydrophobic interactions, while the main interaction between alpha-mangostin and TRF is hydrogen bonding and Van der Waals forces. These results are consistent with spectral results.	[Guo, Ming; Wang, Xiaomeng; Lu, Xiaowang] Zhejiang Agr & Forestry Univ, Sch Sci, Linan 311300, Peoples R China; [Wang, Hongzheng] Zhejiang Agr & Forestry Univ, Sch Forestry & Biotechnol, Linan 311300, Peoples R China; [Brodelius, Peter E.] Linnaeus Univ, Dept Chem & Biomed Sci, S-39182 Kalmar, Sweden	Zhejiang A&F University; Zhejiang A&F University; Linnaeus University	Guo, M (corresponding author), Zhejiang Agr & Forestry Univ, Sch Sci, Linan 311300, Peoples R China.; Brodelius, PE (corresponding author), Linnaeus Univ, Dept Chem & Biomed Sci, S-39182 Kalmar, Sweden.	tdky@hotmail.com; peter.brodelius@lnu.se			Zhejiang Provincial Natural Science Foundation of China [LY14E030016]; Pre-research Project of Research Center of Biomass Resource Utilization of Zhejiang A F University [2013SWZ02-1]; Open Fund of Zhejiang Provincial Top Key Discipline of Forestry Engineering [2014LYGCZ017]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Pre-research Project of Research Center of Biomass Resource Utilization of Zhejiang A F University; Open Fund of Zhejiang Provincial Top Key Discipline of Forestry Engineering	This work was financially supported by grants to MG from the Zhejiang Provincial Natural Science Foundation of China (No. LY14E030016), the Pre-research Project of Research Center of Biomass Resource Utilization of Zhejiang A & F University (2013SWZ02-1), the Open Fund of Zhejiang Provincial Top Key Discipline of Forestry Engineering (2014LYGCZ017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; [Anonymous], 2008, THESIS; Ba Q, 2015, TOXICOL APPL PHARM, V283, P83, DOI 10.1016/j.taap.2015.01.006; BarnumHuckins KM, 1997, TOXICOLOGY, V118, P11, DOI 10.1016/S0300-483X(96)03586-X; Cordova-Sintjago TC, 2015, MOL PHYS, V113, P348, DOI 10.1080/00268976.2014.952695; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Cui FL, 2009, J PHOTOCH PHOTOBIO B, V95, P162, DOI 10.1016/j.jphotobiol.2009.03.001; Dangkoob F, 2015, SPECTROCHIM ACTA A, V137, P1106, DOI 10.1016/j.saa.2014.08.149; Ding KK, 2015, J HAZARD MATER, V299, P486, DOI 10.1016/j.jhazmat.2015.07.050; Dogan A, 2014, EXPERT REV PROTEOMIC, V11, P531, DOI 10.1586/14789450.2014.953062; Ee GCL, 2006, NAT PROD RES, V20, P1067, DOI 10.1080/14786410500463114; Ge F, 2011, ANAL SCI, V27, P79, DOI 10.2116/analsci.27.79; Guo M, 2004, ANAL SCI, V20, P465, DOI 10.2116/analsci.20.465; Guo M, 2008, EUR J MED CHEM, V43, P2140, DOI 10.1016/j.ejmech.2007.11.006; He WY, 2006, J PHOTOCH PHOTOBIO A, V182, P158, DOI 10.1016/j.jphotochem.2006.02.004; Hu YJ, 2006, J PHOTOCH PHOTOBIO A, V179, P324, DOI 10.1016/j.jphotochem.2005.08.037; Ketsa S, 2011, WOODHEAD PUBL FOOD S, P1; Khan SN, 2008, EUR J PHARM SCI, V35, P371, DOI 10.1016/j.ejps.2008.07.010; Kosem N, 2013, J NAT MED-TOKYO, V67, P255, DOI 10.1007/s11418-012-0673-8; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li Y, 2012, ACTA CHIM SINICA, V70, P143, DOI 10.6023/A1109211; Lin XG, 2015, INT J THERMOPHYS, V36, P919, DOI 10.1007/s10765-014-1657-6; Liu LS, 2011, ACTA CHIM SINICA, V69, P2589; Liu XC, 2007, PROG MOD BIOMED, V7, P325; Liu Y, 2009, ACTA CHIM SINICA, V67, P629; McMorran LM, 2014, ARCH BIOCHEM BIOPHYS, V564, P265, DOI 10.1016/j.abb.2014.02.011; Mendoza-Martinez C, 2015, EUR J MED CHEM, V92, P314, DOI 10.1016/j.ejmech.2014.12.051; Moongkarndi P, 2014, J PHARM PHARMACOL, V66, P1171, DOI 10.1111/jphp.12239; Mottarella SE, 2014, J CHEM INF MODEL, V54, P2068, DOI 10.1021/ci500115j; Pedraza-Chaverri J, 2008, FOOD CHEM TOXICOL, V46, P3227, DOI 10.1016/j.fct.2008.07.024; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Ray S, 2012, J PROTEOMICS, V75, P2515, DOI 10.1016/j.jprot.2012.03.014; Ross PD, 1996, BIOPHYS J, V71, P2144, DOI 10.1016/S0006-3495(96)79415-8; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; SEN AK, 1982, PHYTOCHEMISTRY, V21, P1747, DOI 10.1016/0031-9422(82)85052-8; Shahraki S, 2016, J IRAN CHEM SOC, V13, P723, DOI 10.1007/s13738-015-0784-8; Shao X, 2016, SPECTROCHIM ACTA A, V161, P1, DOI 10.1016/j.saa.2016.02.015; Tabassum S, 2012, MOL BIOSYST, V8, P2424, DOI 10.1039/c2mb25119a; Tabassum S, 2012, J PHOTOCH PHOTOBIO B, V114, P132, DOI 10.1016/j.jphotobiol.2012.05.021; Tian ZY, 2015, J PHOTOCH PHOTOBIO B, V142, P103, DOI 10.1016/j.jphotobiol.2014.10.013; Vizcaino JA, 2010, J PROTEOMICS, V73, P2136, DOI 10.1016/j.jprot.2010.06.008; Vlasova IM, 2013, J MOL STRUCT, V1034, P89, DOI 10.1016/j.molstruc.2012.08.053; Weecharangsan W, 2006, MED PRIN PRACT, V15, P281, DOI 10.1159/000092991; Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1; Xiong L. M., 2011, CHEM RES, V22, P9; Yu LM, 2014, MOD FOOD SCI TECHNOL, V30, P296; Yu LM, 2014, MOD FOOD SCI TECHNOL, V30, P287; Yuan JL, 2007, J PHOTOCH PHOTOBIO A, V191, P104, DOI 10.1016/j.jphotochem.2007.04.010; Zarena AS, 2012, FOOD CHEM, V130, P665, DOI 10.1016/j.foodchem.2011.07.106; Zhang C, 2011, THESIS; Zhang MX, 2004, J AM SOC MASS SPECTR, V15, P1658, DOI 10.1016/j.jasms.2004.08.009; Zhao Xin, 2009, Chinese Pharmacological Bulletin, V25, P988; Zhuang SL, 2016, CHEMOSPHERE, V144, P1050, DOI 10.1016/j.chemosphere.2015.09.085	54	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161566	10.1371/journal.pone.0161566	http://dx.doi.org/10.1371/journal.pone.0161566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584012	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600041
J	Imtiaz, M; Hayat, T; Alsaedi, A				Imtiaz, Maria; Hayat, Tasawar; Alsaedi, Ahmed			MHD Convective Flow of Jeffrey Fluid Due to a Curved Stretching Surface with Homogeneous-Heterogeneous Reactions	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER; NANOFLUID FLOW; THERMAL-RADIATION; MIXED CONVECTION; COMPLEX NETWORK; PARTIAL SLIP; MODEL; MAGNETOHYDRODYNAMICS; SERIES	This paper looks at the flow of Jeffrey fluid due to a curved stretching sheet. Effect of homogeneous-heterogeneous reactions is considered. An electrically conducting fluid in the presence of applied magnetic field is considered. Convective boundary conditions model the heat transfer analysis. Transformation method reduces the governing nonlinear partial differential equations into the ordinary differential equations. Convergence of the obtained series solutions is explicitly discussed. Characteristics of sundry parameters on the velocity, temperature and concentration profiles are analyzed by plotting graphs. Computations for pressure, skin friction coefficient and surface heat transfer rate are presented and examined. It is noted that fluid velocity and temperature through curvature parameter are enhanced. Increasing values of Biot number correspond to the enhancement in temperature and Nusselt number.	[Imtiaz, Maria; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Imtiaz, M (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	mi_qau@gmail.com	Hayat, Tasawar/Y-2524-2019; Imtiaz, Maria/AAE-2547-2021; Alsaedi, Ahmed/A-2094-2013	Alsaedi, Ahmed/0000-0003-3452-8922				Abbas Z, 2016, J MOL LIQ, V215, P756, DOI 10.1016/j.molliq.2016.01.012; Abbasbandy Saeid, 2014, Mathematical and Computational Applications, V19, P124; [Anonymous], 2014, J KING SAUD UNIV SCI, DOI DOI 10.1016/j.jksus.2013.08.004; Bachok N, 2011, COMMUN NONLINEAR SCI, V16, P4296, DOI 10.1016/j.cnsns.2011.01.008; CHAUDHARY MA, 1995, FLUID DYN RES, V16, P311, DOI 10.1016/0169-5983(95)00015-6; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Das K., 2012, INDIAN J MATH, V54, P19; Ellahi R, 2015, J MAGN MAGN MATER, V393, P284, DOI 10.1016/j.jmmm.2015.05.071; Ellahi R, 2015, INT J HEAT MASS TRAN, V81, P449, DOI 10.1016/j.ijheatmasstransfer.2014.10.041; Farooq M, 2015, J MECH, V33, P1; Farooq U, 2015, NUMER ALGORITHMS, V70, P43, DOI 10.1007/s11075-014-9934-9; Ganji DD, 2014, FRONT MECH ENG-PRC, V9, P270, DOI 10.1007/s11465-014-0303-0; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2016, IEEE T INSTRUM MEAS, V65, P1690, DOI 10.1109/TIM.2016.2540862; Hamad M. A. A., 2013, J FLUIDS, V2013, P8; Hatami M, 2013, J MOL LIQ, V187, P294, DOI 10.1016/j.molliq.2013.08.008; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P966, DOI 10.1016/j.nonrwa.2007.11.020; Hayat T, 2015, J AEROSPACE ENG, DOI [10.1061/(ASCE)AS.1943-5525.0000568,04015063, DOI 10.1061/(ASCE)AS.1943-5525.0000568,04015063]; Hayat T, 2016, J MAGN MAGN MATER, V413, P39, DOI 10.1016/j.jmmm.2016.04.025; Hayat T, 2016, J MAGN MAGN MATER, V401, P296, DOI 10.1016/j.jmmm.2015.10.039; Hayat T, 2015, J MAGN MAGN MATER, V395, P294, DOI 10.1016/j.jmmm.2015.07.092; Hsiao KL, 2016, APPL THERM ENG, V98, P850, DOI 10.1016/j.applthermaleng.2015.12.138; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; Hsiao KL, 2010, COMMUN NONLINEAR SCI, V15, P1803, DOI 10.1016/j.cnsns.2009.07.006; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Khan WA, 2012, J HEAT TRANS-T ASME, V134, DOI 10.1115/1.4007138; Lin YH, 2015, POWDER TECHNOL, V274, P324, DOI 10.1016/j.powtec.2015.01.039; Mabood F, 2016, EUR PHYS J PLUS, V131, DOI 10.1140/epjp/i2016-16003-1; Malvandi A, 2014, POWDER TECHNOL, V253, P377, DOI 10.1016/j.powtec.2013.11.049; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Naveed M, 2016, ENG SCI TECHNOL, V19, P841, DOI 10.1016/j.jestch.2015.11.009; Reddy GB, 2015, AIN SHAMS ENG J, V6, P355, DOI 10.1016/j.asej.2014.09.004; Rosca NC, 2015, EUR J MECH B-FLUID, V51, P61, DOI 10.1016/j.euromechflu.2015.01.001; Sajid M, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/2/024703; Shaw S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-77; Shehzad SA, 2014, APPL MATH COMPUT, V248, P273, DOI 10.1016/j.amc.2014.09.091; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; [特里帕蒂D Tripathi D], 2011, [应用数学和力学, Applied Mathematics and Mechanics], V32, P1148	42	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161641	10.1371/journal.pone.0161641	http://dx.doi.org/10.1371/journal.pone.0161641			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583457	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600047
J	Koch, J; Flemming, J; Zeffiro, T; Rufer, M; Orr, SP; Mueller-Pfeiffer, C				Koch, Jennifer; Flemming, Jan; Zeffiro, Thomas; Rufer, Michael; Orr, Scott P.; Mueller-Pfeiffer, Christoph			Effects of Posture and Stimulus Spectral Composition on Peripheral Physiological Responses to Loud Sounds	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; STARTLING TONES; VIETNAM VETERANS; TRAUMA SURVIVORS; HEART-RATE; INTENSITY; REACTIVITY; AMPLITUDE; DURATION; WOMEN	In the "loud-tone" procedure, a series of brief, loud, pure-tone stimuli are presented in a task-free situation. It is an established paradigm for measuring autonomic sensitization in posttraumatic stress disorder (PTSD). Successful use of this procedure during fMRI requires elicitation of brain responses that have sufficient signal-noise ratios when recorded in a supine, rather than sitting, position. We investigated the modulating effects of posture and stimulus spectral composition on peripheral psychophysiological responses to loud sounds. Healthy subjects (N = 24) weekly engaged in a loud-tone-like procedure that presented 500 msec, 95 dB sound pressure level, pure-tone or white-noise stimuli, either while sitting or supine and while peripheral physiological responses were recorded. Heart rate, skin conductance, and eye blink electromyographic responses were larger to white-noise than pure-tone stimuli (p's < 0.001, generalized eta squared 0.073-0.076). Psychophysiological responses to the stimuli were similar in the sitting and supine position (p's >= 0.082). Presenting white noise, rather than pure-tone, stimuli may improve the detection sensitivity of the neural concomitants of heightened autonomic responses by generating larger responses. Recording in the supine position appears to have little or no impact on psychophysiological response magnitudes to the auditory stimuli.	[Koch, Jennifer; Flemming, Jan; Rufer, Michael; Mueller-Pfeiffer, Christoph] Univ Zurich Hosp, Dept Psychiat & Psychotherapy, Zurich, Switzerland; [Zeffiro, Thomas] Massachusetts Gen Hosp, Neural Syst Grp, Boston, MA 02114 USA; [Orr, Scott P.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Orr, Scott P.] Harvard Med Sch, Boston, MA USA	University of Zurich; University Zurich Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Mueller-Pfeiffer, C (corresponding author), Univ Zurich Hosp, Dept Psychiat & Psychotherapy, Zurich, Switzerland.	christoph.mueller-pfeiffer@access.uzh.ch	Zeffiro, Thomas/AAE-3441-2019	Zeffiro, Thomas/0000-0002-0846-4577; Rufer, Michael/0000-0003-4964-4213				BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BLUMENTHAL TD, 1988, PSYCHOPHYSIOLOGY, V25, P607, DOI 10.1111/j.1469-8986.1988.tb01897.x; BLUMENTHAL TD, 1986, PSYCHOPHYSIOLOGY, V23, P635, DOI 10.1111/j.1469-8986.1986.tb00682.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Carson MA, 2007, J TRAUMA STRESS, V20, P657, DOI 10.1002/jts.20218; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; Edelberg R., 1972, Handbook Psychophysiol, V1972, P367; Franke GH., 2000, BRIEF SYMPTOM INVENT; GRAHAM FK, 1973, PSYCHOPHYSIOLOGY, V10, P347, DOI 10.1111/j.1469-8986.1973.tb00792.x; Hautzinger M, 1994, BECK DEPRESSIONS INV; Jones AYM, 2004, HEART LUNG, V33, P281, DOI 10.1016/j.hrtlng.2004.04.004; Jones AYM, 2003, CHINESE J PHYSIOL, V46, P63; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; Laux L., 1981, STATE TRAIT ANGSTINV; Metzger LJ, 1999, J ABNORM PSYCHOL, V108, P347, DOI 10.1037/0021-843X.108.2.347; Miles-Chan JL, 2014, CLIN NUTR, V33, P175, DOI 10.1016/j.clnu.2013.11.009; Mueller-Pfeiffer C, 2014, PSYCHOPHYSIOLOGY, V51, P60, DOI 10.1111/psyp.12142; Orr S. P., 2004, ASSESSING PSYCHOL TR, P289; Orr SP, 1998, J CONSULT CLIN PSYCH, V66, P906, DOI 10.1037/0022-006X.66.6.906; Orr SP, 1997, PSYCHIAT RES, V73, P103, DOI 10.1016/S0165-1781(97)00110-8; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; Orr SP, 1997, BIOL PSYCHIAT, V41, P319, DOI 10.1016/S0006-3223(95)00671-0; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pole N, 2007, PSYCHOL BULL, V133, P725, DOI 10.1037/0033-2909.133.5.725; SHALEV AY, 1992, ARCH GEN PSYCHIAT, V49, P870; Shalev AY, 1997, PSYCHIAT RES, V69, P1, DOI 10.1016/S0165-1781(96)03001-6; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P530, DOI 10.1016/j.neubiorev.2006.11.010; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Team RDC, 2014, R LANG ENV STAT COMP; TURPIN G, 1986, PSYCHOPHYSIOLOGY, V23, P1, DOI 10.1111/j.1469-8986.1986.tb00583.x; TURPIN G, 1983, PSYCHOPHYSIOLOGY, V20, P611, DOI 10.1111/j.1469-8986.1983.tb00927.x; Turpin G, 1999, PSYCHOPHYSIOLOGY, V36, P453, DOI 10.1017/S0048577299971974; TURPIN G, 1979, PSYCHOPHYSIOLOGY, V16, P582, DOI 10.1111/j.1469-8986.1979.tb01525.x; ZAHEJSKY J, 1968, ARCH KLIN EXP DERM, V233, P227, DOI 10.1007/BF00496441	37	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161237	10.1371/journal.pone.0161237	http://dx.doi.org/10.1371/journal.pone.0161237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583659	Green Published, Green Accepted, gold			2022-12-27	WOS:000382855600017
J	Kramer, B; Finnemann, C; Sastre, B; Lutz, P; Glassner, A; Wolter, F; Goeser, F; Kokordelis, P; Kaczmarek, D; Nischalke, HD; Strassburg, CP; Spengler, U; Nattermann, J				Kraemer, Benjamin; Finnemann, Claudia; Sastre, Beatriz; Lutz, Philipp; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Kokordelis, Pavlos; Kaczmarek, Dominik; Nischalke, Hans-Dieter; Strassburg, Christian P.; Spengler, Ulrich; Nattermann, Jacob			IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C	PLOS ONE			English	Article							INTERFERON-STIMULATED GENES; GENOME-WIDE ASSOCIATION; NATURAL-KILLER-CELLS; VIRUS-INFECTION; TREATMENT FAILURE; IL28B GENOTYPE; UP-REGULATION; IFN-GAMMA; IN-VIVO; EXPRESSION	Background Immuno-genetic studies suggest a functional link between NK cells and lambda-IFNs. We recently showed that NK cells are negative for the IFN-lambda receptor IFN-lambda R1 and do not respond to IFN-lambda, suggesting a rather indirect association between IL-28B genotype and NK cell activity. Methods A total of 75 HCV(+) patients and 67 healthy controls were enrolled into this study. IL-28B (rs12979860) and IFNL-4 (rs368234815) genotypes were determined by rtPCR. Total PBMC, monocytes, and NK cells were stimulated with IL-29, the TLR-7/8 agonist R848, or a combination of both. NK cell IFN-. response was analysed by FACS. IL-12 and IL-18 secretion of monocytes was studied by ELISA. In blocking experiments anti-IL-12/anti-IL-18 were used. Results Following stimulation of total PBMCs with R848 we found NK cell IFN-. responses to vary with the IL-28B genotype, with carriers of a T/T genotype displaying the lowest frequency of IFN-lambda(+) NK cells. When isolated NK cells were studied no such associations were observed, indicating an indirect association between IL-28B genotype and NK cell activity. Accordingly, we found R848-stimulated monocytes of patients with a T/T genotype to be significantly less effective in triggering NK cell IFN-. production than monocytes from carriers of a non-T/T genotype. In line with these findings we observed monocytes from T/T patients to secrete significantly lower concentrations of IL-12 than monocytes from non-T/T individuals. Conclusions Our data indicate that monocytes from carriers of an IL-28B T/T genotype display a reduced ability to stimulate NK cell activity and, thus, provide a link between IL-28B genotype and NK functions.	[Kraemer, Benjamin; Finnemann, Claudia; Lutz, Philipp; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Kokordelis, Pavlos; Kaczmarek, Dominik; Nischalke, Hans-Dieter; Strassburg, Christian P.; Spengler, Ulrich; Nattermann, Jacob] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Kraemer, Benjamin; Finnemann, Claudia; Lutz, Philipp; Glaessner, Andreas; Wolter, Franziska; Goeser, Felix; Kokordelis, Pavlos; Kaczmarek, Dominik; Nischalke, Hans-Dieter; Strassburg, Christian P.; Spengler, Ulrich; Nattermann, Jacob] German Ctr Infect Res DZIF, Bonn, Germany; [Sastre, Beatriz] Univ Hosp Ramon y Cajal, Inst Hlth Res IRYCIS, Dept Infect Dis, Madrid, Spain; [Sastre, Beatriz] AIDS Res Network RIS RETICS, Madrid, Spain	University of Bonn; German Center for Infection Research; Hospital Universitario Ramon y Cajal	Kramer, B (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Kramer, B (corresponding author), German Ctr Infect Res DZIF, Bonn, Germany.	Benjamin.Kraemer@ukb.uni-bonn.de	Goeser, Felix/AAT-4315-2021; Sastre, Beatriz/AAL-3652-2021; Sastre, Beatriz/F-1715-2015; Krämer, Benjamin/AAC-9618-2019	Goeser, Felix/0000-0003-3190-9981; Sastre, Beatriz/0000-0002-2394-6849; Krämer, Benjamin/0000-0002-1385-9709; Nischalke, Hans Dieter/0000-0002-3457-0023; Kaczmarek, Dominik/0000-0003-0093-7832; Lutz, Philipp/0000-0002-4921-200X	German Research Foundation [DFG KR 4521/1-1, DFG SFB/TR 57]; H. W. and J. Hector Foundation [M69]; DFG [KR 4521/1-1, SFB/TR 57]; H. W. and J. Hector Foundation	German Research Foundation(German Research Foundation (DFG)); H. W. and J. Hector Foundation; DFG(German Research Foundation (DFG)); H. W. and J. Hector Foundation	This work was supported by the German Research Foundation (DFG KR 4521/1-1 to BK, and DFG SFB/TR 57 to US and JN) and the H. W. and J. Hector Foundation (M69 to JN). PhD position for BK was funded by DFG KR 4521/1-1. Technician position for CF was funded by DFG SFB/TR 57. Laboratory material was funded by DFG KR 4521/1-1, DFG SFB/TR 57 and the H. W. and J. Hector Foundation. DFG and H. W. and J. Hector Foundation are external funding organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Arima K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000567; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen Yi, 2016, J INFECT DIS, DOI [10.1093/infdis/jiw235, DOI 10.1093/INFDIS/JIW23534]; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Dultz G, 2016, J VIRAL HEPATITIS, V23, P267, DOI 10.1111/jvh.12488; Fehniger TA, 1999, J IMMUNOL, V162, P4511; de Sa KSG, 2016, CYTOKINE, V77, P79, DOI 10.1016/j.cyto.2015.11.004; Hart OM, 2005, J IMMUNOL BALTIM MD, V1950, P175; Honda M, 2014, HEPATOLOGY, V59, P828, DOI 10.1002/hep.26788; Jouvin-Marche E, 2014, J INFECT DIS, V209, P1907, DOI 10.1093/infdis/jiu016; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Kramer B, 2011, P NATL ACAD SCI USA, V108, pE519, DOI 10.1073/pnas.1108850108; Larange A, 2009, J LEUKOCYTE BIOL, V85, P673, DOI 10.1189/jlb.0808504; Matsuura K, 2016, J MED VIROL, V88, P185, DOI 10.1002/jmv.24334; McGilvray I, 2012, GASTROENTEROLOGY, V142, P1122, DOI 10.1053/j.gastro.2012.01.028; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Mizukoshi E, 1999, J INTERF CYTOK RES, V19, P1019, DOI 10.1089/107999099313235; Morrison MH, 2014, HUM IMMUNOL, V75, P996, DOI 10.1016/j.humimm.2014.06.016; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Par G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067770; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Puig M, 2012, J LEUKOCYTE BIOL, V91, P147, DOI 10.1189/jlb.0711371; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Serti E, 2014, GASTROENTEROLOGY, V147, P209, DOI 10.1053/j.gastro.2014.03.046; Shirey KA, 2006, J INTERF CYTOK RES, V26, P53, DOI 10.1089/jir.2006.26.53; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Sung PS, 2015, P NATL ACAD SCI USA, V112, P10443, DOI 10.1073/pnas.1513341112; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Zhang YL, 2009, J HEPATOL, V51, P29, DOI 10.1016/j.jhep.2009.03.012	43	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162068	10.1371/journal.pone.0162068	http://dx.doi.org/10.1371/journal.pone.0162068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583440	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600096
J	Medeiros, CR; Hepp, LU; Patricio, J; Molozzi, J				Medeiros, Carlinda Railly; Hepp, Luiz Ubiratan; Patricio, Joana; Molozzi, Joseline			Tropical Estuarine Macrobenthic Communities Are Structured by Turnover Rather than Nestedness	PLOS ONE			English	Article							STREAM MACROINVERTEBRATE COMMUNITIES; BETA-DIVERSITY; SPECIES-DIVERSITY; SALINITY; ORGANIZATION; LANDSCAPES; SIMILARITY; FRAMEWORK; SEDIMENTS; RICHNESS	Turnover (i.e., species substitution) and nestedness (i.e., subsets of species from more diverse locations), the two main mechanisms used to explain the beta diversity of biological communities, have different implications for biodiversity conservation. To better understand how these mechanisms contribute to beta diversity, we tested the following hypotheses: (i) greater dissimilarity in community composition occurs between estuarine zones than other hierarchical level studied; (ii) beta diversity in these communities develops by turnover in estuaries with a lower degree of anthropogenic impact, but by nestedness in estuaries with a greater degree of anthropogenic impact; and (iii) the structuring mechanism is independent of season. We studied two tropical estuaries (dry and wet seasons) that vary in terms of land-use of the drainage basins. Subtidal benthic macroinvertebrates were sampled along the estuarine gradient in each of the two estuaries. The additive partitioning approach to species diversity was used to determine the hierarchical scale with the greatest dissimilarity in community composition. General beta diversity was measured using the Sorensen dissimilarity index, partitioning the turnover and nestedness components. The greatest dissimilarity in the composition of the communities occurred between the zones along the estuarine gradient in both seasons (dry = 58.6%; wet = 46.3%). In the estuary with a lower degree of anthropogenic influence, benthic macroinvertebrate diversity was generated by turnover regardless of the season. In the estuary with a greater degree of anthropogenic impact, beta diversity was structured by turnover during the dry season and a combination of both mechanisms during the wet season. We conclude that turnover is the principal mechanism responsible for beta diversity in benthic macroinvertebrate communities in tropical estuaries.	[Medeiros, Carlinda Railly] State Univ Paraiba, Postgrad Program Ecol & Conservat, Campina Grande, Paraiba, Brazil; [Hepp, Luiz Ubiratan] Integrated Reg Univ Alto Uruguai & Missoes, Dept Biol Sci, Erechim, RS, Brazil; [Patricio, Joana] Univ Coimbra, Sch Sci & Technol, MARE Ctr Marine & Environm Sci, Coimbra, Portugal; [Molozzi, Joseline] State Univ Paraiba, Dept Biol Sci, Campina Grande, Paraiba, Brazil	Universidade Estadual da Paraiba; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade de Coimbra; Universidade Estadual da Paraiba	Medeiros, CR (corresponding author), State Univ Paraiba, Postgrad Program Ecol & Conservat, Campina Grande, Paraiba, Brazil.	carlindarailly@gmail.com	Medeiros, Carlinda Raílly/AAW-2991-2021; Molozzi, Joseline/M-3951-2014; Hepp, Luiz Ubiratan/H-9133-2012	Medeiros, Carlinda Raílly/0000-0002-7332-2399; Molozzi, Joseline/0000-0002-8256-5739; Hepp, Luiz Ubiratan/0000-0002-8499-9549	"What lessons can we draw from the ecological functioning of estuarine systems in Paraiba? Analyses of the effects of natural and anthropogenic disturbances", under the Brazilian program Science Without Borders (Special Visiting Researcher) [173/2012]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [471272/2012-8]	"What lessons can we draw from the ecological functioning of estuarine systems in Paraiba? Analyses of the effects of natural and anthropogenic disturbances", under the Brazilian program Science Without Borders (Special Visiting Researcher); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Project No. 173/2012 "What lessons can we draw from the ecological functioning of estuarine systems in Paraiba? Analyses of the effects of natural and anthropogenic disturbances", under the Brazilian program Science Without Borders (Special Visiting Researcher). LUH received financial support from Conselho Nacional de Pesquisa e Desenvolvimento (CNPq proc. # 471272/2012-8). We are grateful to the Universidade Estadual da Paraiba, Laboratorio de Ecologia de Bentos and Laboratorio de Ecologia Aquatica for technical support, and to Dr. Paulo Lana for his help in identifying the polychaetes. Dr. A. Leyva helped with English editing of the manuscript.	AESA-Agencia executiva de gestao das aguas do estado da paraiba, 2014, CHUV AC AN MUN RIO T; Alves AS, 2013, ECOL INDIC, V24, P462, DOI 10.1016/j.ecolind.2012.07.013; Alves RRD, 2003, INTERCIENCIA, V28, P36; Amaral A.C., 1996, ANNELIDA POLYCHAETA; Amaral A. Cecilia Z., 1998, Revista Brasileira de Biologia, V58, P307; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Angeler DG, 2013, DIVERS DISTRIB, V19, P772, DOI 10.1111/ddi.12029; Attrill MJ, 2002, J ANIM ECOL, V71, P262, DOI 10.1046/j.1365-2656.2002.00593.x; Barros F, 2014, ESTUAR COAST SHELF S, V149, P223, DOI 10.1016/j.ecss.2014.08.025; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blanchet H, 2014, J SEA RES, V90, P95, DOI 10.1016/j.seares.2014.02.014; Bleich S, 2011, MAR ECOL PROG SER, V436, P101, DOI 10.3354/meps09219; Boyero L, 2001, HYDROBIOLOGIA, V464, P219, DOI 10.1023/A:1013922307096; Cartier V., 2011, Journal of Experimental Marine Biology and Ecology, V405, P93, DOI 10.1016/j.jembe.2011.05.019; Costa RS, 2015, MARINE FRESHWATER RE, V1, P1; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Diaz-Jaramillo M, 2013, SCI TOTAL ENVIRON, V442, P198, DOI 10.1016/j.scitotenv.2012.10.039; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Guedes L., 2011, AN 15 S BRAS SENS RE, P3538; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Heino J, 2007, ECOGRAPHY, V30, P217, DOI 10.1111/j.2007.0906-7590.04894.x; Heino J, 2015, ECOL EVOL, V5, P1235, DOI 10.1002/ece3.1439; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2014, CURR OPIN INSECT SCI, V2, P7, DOI 10.1016/j.cois.2014.06.002; Hepp LU, 2013, HYDROBIOLOGIA, V703, P239, DOI 10.1007/s10750-012-1367-7; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Koppen W., 1930, HDB KLIMATOLOGIE; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lamouroux N, 2004, J N AM BENTHOL SOC, V23, P449, DOI 10.1899/0887-3593(2004)023<0449:BTOSMC>2.0.CO;2; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Marcelino RL, 2005, TROPICAL OCEANOGRAPH, V33, P183; Mikkelsen PM, 2008, SEASHELLS SO FLORIDA; Mil-Homens M, 2014, MAR POLLUT BULL, V84, P135, DOI 10.1016/j.marpolbul.2014.05.026; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Puente A, 2008, ECOL INDIC, V8, P373, DOI 10.1016/j.ecolind.2007.04.002; R Core Team, 2013, R LANG ENV STAT COMP; Remane A., 1934, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V37, P34; RIOS E.C., 1985, SEASHELLS BRAZIL; Rundle S. D., 1998, Aquatic Ecology, V32, P211, DOI 10.1023/A:1009934828611; Si X, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0132708; Sousa R, 2008, AQUAT CONSERV, V18, P1063, DOI 10.1002/aqc.871; Trivinho-Strixino S., 2011, LARVAS CHIRONOMIDAE, P1; TUNNELL JR J.W., 2010, ENCY TEXAS SEASHELLS; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Veech JA, 2009, PARTITION SOFTWARE H; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469; Zonta R, 2007, MAR POLLUT BULL, V55, P403, DOI 10.1016/j.marpolbul.2007.09.003	60	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161082	10.1371/journal.pone.0161082	http://dx.doi.org/10.1371/journal.pone.0161082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584726	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600013
J	Zhou, FC; Resendiz, M; Lo, CL; Chen, YY				Zhou, Feng C.; Resendiz, Marisol; Lo, Chiao-Ling; Chen, Yuanyuan			Cell-Wide DNA De-Methylation and Re-Methylation of Purkinje Neurons in the Developing Cerebellum	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; EMBRYONIC STEM-CELLS; POSTMITOTIC NEURONS; GENE-REGULATION; MAMMALIAN DNA; TET PROTEINS; MOUSE; 5-HYDROXYMETHYLCYTOSINE; GENOME; DEMETHYLATION	Global DNA de-methylation is thought to occur only during pre-implantation and gametogenesis in mammals. Scalable, cell-wide de-methylation has not been demonstrated beyond totipotent stages. Here, we observed a large scale de-methylation and subsequent re-methylation (CDR) (including 5-methylcytosine (5mC) and 5-hydroxylmethylcytosine (5hmC)) in post-mitotic cerebellar Purkinje cells (PC) through the course of normal development. Through single cell immuno-identification and cell-specific quantitative methylation assays, we demonstrate that the CDR event is an intrinsically scheduled program, occurring in nearly every PC. Meanwhile, cerebellar granule cells and basket interneurons adopt their own DNA methylation program, independent of PCs. DNA de-methylation was further demonstrated at the gene level, on genes pertinent to PC development. The PC, being one of the largest neurons in the brain, may showcase an amplified epigenetic cycle which may mediate stage transformation including cell cycle arrest, vast axonal-dendritic growth, and synaptogenesis at the onset of neuronal specificity. This discovery is a key step toward better understanding the breadth and role of DNA methylation and de-methylation during neural ontology.	[Zhou, Feng C.; Lo, Chiao-Ling; Chen, Yuanyuan] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Zhou, Feng C.; Resendiz, Marisol] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhou, FC (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.; Zhou, FC (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	imce100@iu.edu			NIH [AA016698, AA024216, P50 AA07611]; W. M. Keck Foundation; Indiana CTSI Cohort 11 core pilot grant [UL1 TR001108]; IUCR grant from Indiana University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016698, P50AA007611, R21AA024216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Indiana CTSI Cohort 11 core pilot grant; IUCR grant from Indiana University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by NIH awards AA016698, AA024216, and P50 AA07611. Additional funding was made possible by the W. M. Keck Foundation, Indiana CTSI Cohort 11 core pilot grant UL1 TR001108 and an IUCR grant from Indiana University to FCZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by NIH awards AA016698, AA024216, and P50 AA07611. Additional funding was made possible by the W. M. Keck Foundation, Indiana CTSI Cohort 11 core pilot grant UL1 TR001108 and an IUCR grant from Indiana University to FCZ. No conflicts of interest played a role in the design, interpretation, or submission of this study.	ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Arancillo M, 2015, J NEUROPHYSIOL, V113, P578, DOI 10.1152/jn.00586.2014; Chen YY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00046; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060503; Fox C A, 1967, Prog Brain Res, V25, P174; Gavin DP, 2013, NEUROPHARMACOLOGY, V75, P233, DOI 10.1016/j.neuropharm.2013.07.036; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; GOODLETT CR, 1990, DEV BRAIN RES, V53, P131, DOI 10.1016/0165-3806(90)90133-J; Guo Junjie U, 2014, Front Biol (Beijing), V9, P66; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hales BF, 2011, BIRTH DEFECTS RES A, V91, P652, DOI 10.1002/bdra.20781; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kagami Yoshihiro, 2001, Gene Expression Patterns, V1, P39, DOI 10.1016/S1567-133X(01)00007-2; Kim M, 2014, HUM MOL GENET, V23, P657, DOI 10.1093/hmg/ddt453; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Meng H, 2014, INT J MOL SCI, V15, P22604, DOI 10.3390/ijms151222604; Miller G, 2010, SCIENCE, V329, P27, DOI 10.1126/science.329.5987.27; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nakamura T, 2012, NATURE, V486, P415, DOI 10.1038/nature11093; Nishioka M, 2013, INT J DEV NEUROSCI, V31, P89, DOI 10.1016/j.ijdevneu.2012.11.007; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt091; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wright EM, 2008, ANNOTATION REPORT CE; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu GL, 2014, BMB REP, V47, P609, DOI 10.5483/BMBRep.2014.47.11.223; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zhou Feng C, 2012, Front Biol (Beijing), V7, P485; Zhou FC, 2011, BIRTH DEFECTS RES A, V91, P703, DOI 10.1002/bdra.20820	49	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162063	10.1371/journal.pone.0162063	http://dx.doi.org/10.1371/journal.pone.0162063			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583369	Green Published, gold			2022-12-27	WOS:000382855600094
J	Chapman, CA; Friant, S; Godfrey, K; Liu, C; Sakar, D; Schoof, VAM; Sengupta, R; Twinomugisha, D; Valenta, K; Goldberg, TL				Chapman, Colin A.; Friant, Sagan; Godfrey, Kathleen; Liu, Cynthia; Sakar, Dipto; Schoof, Valerie A. M.; Sengupta, Raja; Twinomugisha, Dennis; Valenta, Kim; Goldberg, Tony L.			Social Behaviours and Networks of Vervet Monkeys Are Influenced by Gastrointestinal Parasites	PLOS ONE			English	Article							INFECTIOUS-DISEASES; NONHUMAN-PRIMATES; COLOBUS MONKEYS; ENERGY; ECOLOGY; TRANSMISSION; CHIMPANZEES; IVERMECTIN; NUTRITION; NEMATODES	Substantial research has shown that while some parasite infections can be fatal to hosts, most infections are sub-clinical and non-lethal. Such sub-clinical infections can nonetheless have negative consequences for the long-term fitness of the host such as reducing juvenile growth and the host's ability to compete for food and mates. With such effects, infected individuals are expected to exhibit behavioural changes. Here we use a parasite removal experiment to quantify how gastrointestinal parasite infections affect the behaviour of vervet monkeys (Chlorocebus aethiops) at Lake Nabugabo, Uganda. Behavioural profiles and the structure of nearest neighbour relationships varied significantly. As predicted, after deworming the duration of the resting events decreased, which is consistent with the idea that parasite infections are energetically costly. In contrast to what was predicted, we could not reject the null hypothesis and we observed no change in either the frequency or duration of grooming, but we found that the duration of travel events increased. A network analysis revealed that after deworming, individuals tended to have more nearest neighbours and hence probably more frequent interactions, with this effect being particularly marked for juveniles. The heightened response by juveniles may indicate that they are avoiding infected individuals more than other age classes because it is too costly to move energy away from growth. We consider that populations with high parasite burden may have difficulties developing social networks and behaviours that could have cascading effects that impact the population in general.	[Chapman, Colin A.; Valenta, Kim] McGill Univ, McGill Sch Environm, Montreal, PQ H3A 2T7, Canada; [Chapman, Colin A.; Valenta, Kim] McGill Univ, Dept Anthropol, Montreal, PQ H3A 2T7, Canada; [Chapman, Colin A.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Chapman, Colin A.; Twinomugisha, Dennis; Goldberg, Tony L.] Makerere Univ, Biol Field Stn, POB 967, Ft Portal, Uganda; [Friant, Sagan; Goldberg, Tony L.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53715 USA; [Godfrey, Kathleen] McGill Univ, Dept Anthropol, Montreal, PQ H3A 1B1, Canada; [Liu, Cynthia] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Sakar, Dipto; Sengupta, Raja] McGill Univ, Dept Geog, Montreal, PQ H3A 2T7, Canada; [Schoof, Valerie A. M.] York Univ, Bilingual Biol Program, Dept Multidisciplinary Studies, Glendon Campus, Toronto, ON M3J 1P3, Canada; [Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	McGill University; McGill University; Wildlife Conservation Society; Makerere University; University of Wisconsin System; University of Wisconsin Madison; McGill University; McGill University; McGill University; York University - Canada; University of Wisconsin System; University of Wisconsin Madison	Chapman, CA (corresponding author), McGill Univ, McGill Sch Environm, Montreal, PQ H3A 2T7, Canada.; Chapman, CA (corresponding author), McGill Univ, Dept Anthropol, Montreal, PQ H3A 2T7, Canada.; Chapman, CA (corresponding author), Wildlife Conservat Soc, Bronx, NY 10460 USA.; Chapman, CA (corresponding author), Makerere Univ, Biol Field Stn, POB 967, Ft Portal, Uganda.	Colin.Chapman@McGill.ca	Chapman, Colin/S-1911-2019	Chapman, Colin/0000-0002-8827-8140; Sengupta, Raja/0000-0003-4914-5844; Sarkar, Dipto/0000-0003-2254-049X	Canada Research Chair Program; Natural Science and Engineering Research Council of Canada; Fonds Quebecois de la Recherche sur la Nature et les Technologies; National Geographic Society; National Institute of Health [TW009237]; UK Economic and Social Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007414] Funding Source: NIH RePORTER	Canada Research Chair Program(Canada Research Chairs); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies(FQRNT); National Geographic Society(National Geographic Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the research was provided by the Canada Research Chair Program (CAC), Natural Science and Engineering Research Council of Canada (CAC), Fonds Quebecois de la Recherche sur la Nature et les Technologies (CAC), National Geographic Society (CAC), National Institute of Health Grant TW009237 (TLG, CAC), and the UK Economic and Social Research Council (TLG, CAC).	Altizer S, 2007, J ANIM ECOL, V76, P304, DOI 10.1111/j.1365-2656.2007.01214.x; Beros S, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1473; Chapman CA, 2005, EVOL ANTHROPOL, V14, P134, DOI 10.1002/evan.20068; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Cheng TC, 1973, GEN PARISITOLOGY; COLLIAS NICHOLAS, 1952, PROC AMER PHIL SOC, V96, P143; Deputte BL, 2000, ADV STUD BEHAV, V29, P99, DOI 10.1016/S0065-3454(08)60104-7; Despommier DD., 1995, PARASITIC DIS; Dufour JP, 2006, J MED PRIMATOL, V35, P172, DOI 10.1111/j.1600-0684.2006.00154.x; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Gaetano TJ, 2014, S AFR J WILDL RES, V44, P56, DOI 10.3957/056.044.0105; Garcia LS., 1999, PRACTICAL GUIDE DIAG; Gasser RB, 2006, PARASITOLOGY, V132, P453, DOI 10.1017/S0031182005009406; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003256; Ghai RR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002641; Ghai RR, P ROYAL SOC IN PRESS; Gillespie TR, 2005, J PARASITOL, V91, P569, DOI 10.1645/GE-434R; GLANDER K E, 1982, Yearbook of Physical Anthropology, V25, P1; Goldberg TL, 2008, EMERG INFECT DIS, V14, P801, DOI 10.3201/eid1405.071686; Greiner EC, 2009, CAM S BIO EVOL ANTHR, V57, P3; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hasegawa H, 2009, CAM S BIO EVOL ANTHR, V57, P29; Hechinger RF, 2013, AM NAT, V182, P234, DOI 10.1086/670820; HOLMES PH, 1993, P NUTR SOC, V52, P113, DOI 10.1079/PNS19930043; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Hudson PJ, 2001, ECOLOGY WILDLIFE DIS; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; JAMES C, 1983, T ROY SOC TROP MED H, V77, P51, DOI 10.1016/0035-9203(83)90012-3; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Johnson-Delaney Cathy A, 2009, Vet Clin North Am Exot Anim Pract, V12, P563, DOI 10.1016/j.cvex.2009.07.002; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Krief S, 2005, J ETHNOPHARMACOL, V101, P1, DOI 10.1016/j.jep.2005.03.024; Kynkaanniemi SM, 2014, PARASITOL RES, V113, P1489, DOI 10.1007/s00436-014-3790-3; Lynn RC., 1999, GEORGIS PARASITOLOGY; Mukaratirwa S, 2008, ONDERSTEPOORT J VET, V75, P173; MUNGER JC, 1994, CAN J ZOOL, V72, P166, DOI 10.1139/z94-021; MUNGER JC, 1989, ECOLOGY, V70, P904, DOI 10.2307/1941358; Murray DL, 1997, J ANIM ECOL, V66, P250, DOI 10.2307/6026; Navarro V.P, 2002, ARAGON AGER, V2, P101; Nilsson JA, 2003, BEHAV ECOL, V14, P175, DOI 10.1093/beheco/14.2.175; Nunn CL, 2008, EVOL ECOL, V22, P519, DOI 10.1007/s10682-007-9180-x; Nunn CL, 2006, INFECT DIS PRIMATES; Parkins J J, 1989, Nutr Res Rev, V2, P227, DOI 10.1079/NRR19890016; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; POLDERMAN AM, 1995, PARASITOL TODAY, V11, P451, DOI 10.1016/0169-4758(95)80058-1; POPPI DP, 1990, PROC NEW ZEAL SOC AN, V50, P237; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Robar N, 2011, CAN J ZOOL, V89, P1146, DOI 10.1139/Z11-084; Sa RM, 2013, AM J PRIMATOL, V75, P1032, DOI 10.1002/ajp.22170; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sloss M., 1994, VET CLIN PARASITOLOG; Stampone M. D., 2011, Research Journal of Environmental and Earth Sciences, V3, P14; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; SYKES AR, 1994, ANIM PROD, V59, P155, DOI 10.1017/S0003356100007649; Teichroeb JA, 2014, ANIM COGN, V17, P517, DOI 10.1007/s10071-013-0683-2; Mati VLT, 2013, J PARASITOL, V99, P1009, DOI 10.1645/13-288.1; Tutin CEG, 2000, B SOC PATHOL EXOT, V93, P157; Valenta K, INTEGRATIVE ZO UNPUB; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wang T, 2008, VET PARASITOL, V153, P121, DOI 10.1016/j.vetpar.2008.01.012; Wren BT, 2015, COMP PARASITOL, V82, P101, DOI 10.1654/4712RR.1; Wren BT, 2006, 122 ANN M IND AC SCI, V1, P42; YOUNG TP, 1994, CONSERV BIOL, V8, P410, DOI 10.1046/j.1523-1739.1994.08020410.x	66	24	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161113	10.1371/journal.pone.0161113	http://dx.doi.org/10.1371/journal.pone.0161113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580121	Green Published, gold			2022-12-27	WOS:000382877400016
J	Fang, C; Chen, XJ; Zhou, MM				Fang, Chao; Chen, Xuejun; Zhou, Mingming			Epidemiology and Cytokine Levels among Children with Nosocomial Multidrug-Resistant Acinetobacter baumannii Complex in a Tertiary Hospital of Eastern China	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; INFECTIONS; IL-6; CANCER; SURVEILLANCE; INFLAMMATION; STRATEGIES; MORTALITY	Background and aim The present study was aimed at assessing the characteristics of children with nosocomial multidrug-resistant Acinetobacter baumannii complex (MDR ABC) in a tertiary hospital of eastern China. MDR ABC poses a serious threat to public health. However, information on nosocomial MDR ABC in children is lacking. Method This study retrospectively reviewed the cases in a tertiary hospital of eastern China between January 1, 2011, and December 31, 2014 (excluding outpatients). Results A total of 377 non-duplicated nosocomial ABC isolates were collected from various samples including 200 (53.1%) MDR ABC isolates. Moreover, 158 of the 200 MDR ABC isolates were collected from intensive care units (ICUs; MDR constituent ratios, 62.5%), while 98 of the 200 MDR ABC isolates were collected from children older than 1 year (MDR constituent ratios, 62.8%). Multivariate logistic analysis revealed that being in the surgical intensive care unit (SICU), prolonged hospital stay, surgical intervention, and mechanical ventilation were independent risk factors for MDR acquisition among children with nosocomial ABC. The interleukin (IL)-6 level of children with nosocomial MDR ABC was significantly lower than that of the children with nosocomial non-MDR ABC. Conclusion Nosocomial MDR ABC infection is a serious concern in pediatric patients. Being in the SICU, prolonged hospital stay, surgical intervention, and mechanical ventilation increased the risk of nosocomial MDR ABC. IL-6 might be involved in developing nosocomial MDR ABC among children.	[Fang, Chao; Chen, Xuejun; Zhou, Mingming] Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab Dept, Binsheng Rd 3333, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Fang, C (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab Dept, Binsheng Rd 3333, Hangzhou, Zhejiang, Peoples R China.	fangchao23467@126.com		Fang, Chao/0000-0002-3903-9303				Chen CH, 2015, INT J ENV RES PUB HE, V12, P8871, DOI 10.3390/ijerph120808871; Clinical and Laboratory Standards Institute, 2014, PERF STAND ANT DISK, P56; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; He SZ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00507; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ireland SJ, 2015, CYTOKINE, V73, P236, DOI 10.1016/j.cyto.2015.01.009; Jones RN, 2007, J CLIN MICROBIOL, V45, P227, DOI 10.1128/JCM.01588-06; Kapoor K, 2014, IRAN J PEDIATR, V24, P569; Kim SY, 2012, J KOREAN MED SCI, V27, P939, DOI 10.3346/jkms.2012.27.8.939; Kumar A, 2014, J INFECT DEV COUNTR, V8, P1049, DOI 10.3855/jidc.4248; Kuo SC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-200; Le Hello S, 2010, SCAND J INFECT DIS, V42, P821, DOI 10.3109/00365548.2010.496087; Liu QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130701; Lopes BS, 2013, J INFECT DEV COUNTR, V7, P323, DOI 10.3855/jidc.2711; Mikucki ME, 2013, INT J HYPERTHER, V29, P464, DOI 10.3109/02656736.2013.807440; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Prata-Rocha ML, 2012, BRAZ J INFECT DIS, V16, P237, DOI 10.1590/S1413-86702012000300004; Reddy D, 2015, J TROP PEDIATRICS, V61, P182, DOI 10.1093/tropej/fmv017; Rim JH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/535027; Saballs M, 2006, J ANTIMICROB CHEMOTH, V58, P697, DOI 10.1093/jac/dkl274; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Stelling JM, 1997, CLIN INFECT DIS, V24, pS157, DOI 10.1093/clinids/24.Supplement_1.S157; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Tawney A, 2015, INFECT CONT HOSP EP, V36, P1108, DOI 10.1017/ice.2015.140; Vali L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00743; Van Looveren M, 2004, CLIN MICROBIOL INFEC, V10, P684, DOI 10.1111/j.1469-0691.2004.00942.x; Waldner MJ, 2014, SEMIN IMMUNOL, V26, P75, DOI 10.1016/j.smim.2013.12.003; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Ye Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098745; Zhang Y, 2014, ADV EXP MED BIOL, V841, P45, DOI 10.1007/978-94-017-9487-9_3; Zhou Y, 2015, GENET MOL RES, V14, P7092, DOI 10.4238/2015.June.29.2	32	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161690	10.1371/journal.pone.0161690	http://dx.doi.org/10.1371/journal.pone.0161690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579592	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400035
J	Zhang, M; Mo, H; Sun, W; Guo, Y; Li, J				Zhang, Mei; Mo, Hui; Sun, Wen; Guo, Yan; Li, Jing			Systematic Isolation and Characterization of Cadmium Tolerant Genes in Tobacco: A cDNA Library Construction and Screening Approach	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; DEFENSE HYPOTHESIS; RESISTANCE PROTEIN; NICOTIANA-TABACUM; HYDROGEN-PEROXIDE; STRESS; TRANSCRIPTION; METALLOTHIONEINS; ACCUMULATION; GLUTATHIONE	Heavy metal pollution is a major limiting factor that severely affects plant growth worldwide, and the accumulation of heavy metal in the plant may be hazardous to human health. To identify the processes involved in cadmium detoxification, we constructed a cDNA library of tobacco roots acclimated to cadmium (Cd) stress. According to the results of functional screening cDNA library with a yeast Cd-sensitive mutant, ycf1 Delta, we obtained a series of candidate genes that were involved in Cd response. Sequence analysis and yeast functional complementation of 24 positive cDNA clones revealed that, in addition to antioxidant genes, genes implicated in abiotic and biotic stress defenses, cellular metabolism, and signal transduction showed Cd detoxification effects in yeast. The real time RT-PCR analyses revealed that some Cd tolerance/detoxification genes may be able to anticipate in other stresses such as biotic defense and water balance in tobacco. Taken together, our data suggest that plants' acclimation to Cd stress is a highly complex process associated with broad gene functions. Moreover, our results provide insights into the Cd detoxification mechanisms along with the antioxidant system, defense gene induction, and calcium signal pathway.	[Zhang, Mei; Mo, Hui; Sun, Wen; Guo, Yan; Li, Jing] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Sun, Wen; Guo, Yan; Li, Jing] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, M (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	zhangmei@scbg.ac.cn		Zhang, Mei/0000-0003-0976-3867	National Natural Sciences Foundation of China [31271702, 31570257]; Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project for Young Scientists of the South China Botanical Garden	This research was supported by the National Natural Sciences Foundation of China (Grant no. 31271702 and 31570257) and Knowledge Innovation Project for Young Scientists of the South China Botanical Garden, awarded to M. Zhang. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2005, PLANT BIOTECHNOL, V22, P157, DOI [10.5511/plantbiotechnology.22.157, DOI 10.5511/PLANTBIOTECHNOLOGY.22.157]; Bekesiova B, 2008, MOL BIOL REP, V35, P579, DOI 10.1007/s11033-007-9127-x; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Boulila-Zoghlami L, 2011, PLANTA, V234, P857, DOI 10.1007/s00425-011-1468-y; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; Cao Chen-liang, 2015, Yingyong Shengtai Xuebao, V26, P1279; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; CLARKE BB, 1989, JAPCA J AIR WASTE MA, V39, P1319, DOI 10.1080/08940630.1989.10466625; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Fones H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001093; Ghanta S, 2011, PLANT SIGNAL BEHAV, V6, P607, DOI [10.4161/psb.6.4.15402, 10.4161/psb.6.6.15147]; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Hassinen VH, 2011, PLANT BIOLOGY, V13, P225, DOI 10.1111/j.1438-8677.2010.00398.x; Horger AC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00395; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Janiak A, 2016, J EXP BOT, V67, P1003, DOI 10.1093/jxb/erv512; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Li GW, 2014, BBA-GEN SUBJECTS, V1840, P1574, DOI 10.1016/j.bbagen.2013.11.004; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Liu YL, 2004, J BIOL CHEM, V279, P2101, DOI 10.1074/jbc.M310029200; Meharg AA, 2013, ENVIRON SCI TECHNOL, V47, P5613, DOI 10.1021/es400521h; Ministry of Environmental Protection & Ministry of Land and Resources of People's Republic of China, 2014, COMM SOIL POLL STAT; Nahirnak V, 2012, PLANT SIGNAL BEHAV, V7, P1004, DOI 10.4161/psb.20813; O'Connor RJ, 2010, TOB CONTROL, V19, DOI 10.1136/tc.2009.030163; Oono Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096946; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; PONSTEIN AS, 1994, PLANT PHYSIOL, V104, P109, DOI 10.1104/pp.104.1.109; Poschenrieder C, 2006, TRENDS PLANT SCI, V11, P288, DOI 10.1016/j.tplants.2006.04.007; Rubinovich L, 2014, MOL PLANT, V7, P244, DOI 10.1093/mp/sst141; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schutzendubel A, 2001, PLANT PHYSIOL, V127, P887, DOI 10.1104/pp.010318; Sewelam N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00187; Shang YL, 2006, P NATL ACAD SCI USA, V103, P19200, DOI 10.1073/pnas.0607279103; Sharma SS, 2016, PLANT CELL ENVIRON, V39, P1112, DOI 10.1111/pce.12706; Song WY, 2010, PLANT CELL, V22, P2237, DOI 10.1105/tpc.109.070185; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Ueki S, 2002, NAT CELL BIOL, V4, P478, DOI 10.1038/ncb806; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Yamamoto S, 2004, BBA-GENE STRUCT EXPR, V1679, P279, DOI 10.1016/j.bbaexp.2004.07.005; Zhang HJ, 2012, MOL PLANT MICROBE IN, V25, P1639, DOI 10.1094/MPMI-11-11-0293; Zhang J, 2015, J PLANT PHYSIOL, V178, P17, DOI 10.1016/j.jplph.2015.01.017; Zhang XT, 2013, MOL BIOL REP, V40, P1407, DOI 10.1007/s11033-012-2184-9	51	12	12	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161147	10.1371/journal.pone.0161147	http://dx.doi.org/10.1371/journal.pone.0161147			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579677	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400019
J	Hackett, JL; Wang, XF; Smith, BR; Macdonald, SJ				Hackett, Jennifer L.; Wang, Xiaofei; Smith, Brittny R.; Macdonald, Stuart J.			Mapping QTL Contributing to Variation in Posterior Lobe Morphology between Strains of Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADVANCED INTERCROSS LINES; SYNTHETIC POPULATION RESOURCE; GENETIC REFERENCE PANEL; CRYPTIC FEMALE CHOICE; GENITAL MORPHOLOGY; COMPLEX TRAITS; RECOMBINANT POPULATIONS; MISSING HERITABILITY; NATURAL-POPULATIONS	Closely-related, and otherwise morphologically similar insect species frequently show striking divergence in the shape and/or size of male genital structures, a phenomenon thought to be driven by sexual selection. Comparative interspecific studies can help elucidate the evolutionary forces acting on genital structures to drive this rapid differentiation. However, genetic dissection of sexual trait divergence between species is frequently hampered by the difficulty generating interspecific recombinants. Intraspecific variation can be leveraged to investigate the genetics of rapidly-evolving sexual traits, and here we carry out a genetic analysis of variation in the posterior lobe within D. melanogaster. The lobe is a male-specific process emerging from the genital arch of D. melanogaster and three closely-related species, is essential for copulation, and shows radical divergence in form across species. There is also abundant variation within species in the shape and size of the lobe, and while this variation is considerably more subtle than that seen among species, it nonetheless provides the raw material for QTL mapping. We created an advanced intercross population from a pair of phenotypically-different inbred strains, and after phenotyping and genotyping-by-sequencing the recombinants, mapped several QTL contributing to various measures of lobe morphology. The additional generations of crossing over in our mapping population led to QTL intervals that are smaller than is typical for an F-2 mapping design. The intervals we map overlap with a pair of lobe QTL we previously identified in an independent mapping cross, potentially suggesting a level of shared genetic control of trait variation. Our QTL additionally implicate a suite of genes that have been shown to contribute to the development of the posterior lobe. These loci are strong candidates to harbor naturally-segregating sites contributing to phenotypic variation within D. melanogaster, and may also be those contributing to divergence in lobe morphology between species.	[Hackett, Jennifer L.; Wang, Xiaofei; Smith, Brittny R.; Macdonald, Stuart J.] Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA; [Macdonald, Stuart J.] Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Macdonald, SJ (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.; Macdonald, SJ (corresponding author), Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66047 USA.	sjmac@ku.edu		Macdonald, Stuart/0000-0002-9421-002X	NIH [R01 GM085260, P20 GM103638, P20 GM103418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, R01GM085260, P20GM103638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH R01 GM085260 to SJM. The KU Genome Sequencing Core is supported by NIH P20 GM103638, and the KINBRE Bioinformatics Core is supported by NIH P20 GM103418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Broman KW, 2006, GENETICS, V174, P2151, DOI 10.1534/genetics.106.061176; Broman KW, 2012, G3-GENES GENOM GENET, V2, P199, DOI 10.1534/g3.111.001818; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; CHURCHILL GA, 1994, GENETICS, V138, P963; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; COYNE JA, 1986, EVOLUTION, V40, P673, DOI 10.1111/j.1558-5646.1986.tb00530.x; DARVASI A, 1995, GENETICS, V141, P1199; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frazee SR, 2015, ECOL EVOL, V5, P4437, DOI 10.1002/ece3.1721; Glassford WJ, 2015, DEV CELL, V34, P520, DOI 10.1016/j.devcel.2015.08.005; Holeski LM, 2014, G3-GENES GENOM GENET, V4, P813, DOI 10.1534/g3.113.010124; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LACHAISE D, 1988, EVOL BIOL, V22, P159; Laurie CC, 1997, GENETICS, V145, P339; LeVasseur-Viens H, 2015, EVOLUTION, V69, P1797, DOI 10.1111/evo.12685; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 1996, GENETICS, V142, P1129; Liu SC, 1996, GENETICS, V142, P247; Long AD, 1996, GENETICS, V144, P1497; Long AD, 1998, GENETICS, V149, P999; Long AD, 2014, TRENDS GENET, V30, P488, DOI 10.1016/j.tig.2014.07.009; Macdonald SJ, 1999, GENETICS, V153, P1683; Macdonald SJ, 2007, GENETICS, V176, P1261, DOI 10.1534/genetics.106.069641; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Masly JP, 2014, EVOLUTION, V68, P2401, DOI 10.1111/evo.12436; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNeil CL, 2011, G3-GENES GENOM GENET, V1, P343, DOI 10.1534/g3.111.000661; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Parker CC, 2014, GENETICS, V198, P103, DOI 10.1534/genetics.114.167056; Rockman MV, 2008, GENETICS, V179, P1069, DOI 10.1534/genetics.107.083873; Schielzeth H, 2014, ANN NY ACAD SCI, V1320, P35, DOI 10.1111/nyas.12397; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sen S, 2001, GENETICS, V159, P371; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Stern DL, 2014, TRENDS GENET, V30, P547, DOI 10.1016/j.tig.2014.09.006; Takahara B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132846; Tanaka KM, 2015, GENETICS, V200, P357, DOI 10.1534/genetics.114.174045; Turner TL, 2014, MOL ECOL, V23, P2377, DOI 10.1111/mec.12719; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Zeng ZB, 2000, GENETICS, V154, P299	60	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162573	10.1371/journal.pone.0162573	http://dx.doi.org/10.1371/journal.pone.0162573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606594	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255600067
J	Yang, L; Guo, S; Chen, QW; Chen, FJ; Yuan, LX; Mi, GH				Yang, Lan; Guo, Song; Chen, Qinwu; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Use of the Stable Nitrogen Isotope to Reveal the Source-Sink Regulation of Nitrogen Uptake and Remobilization during Grain Filling Phase in Maize	PLOS ONE			English	Article							USE EFFICIENCY; LEAF SENESCENCE; EAR REMOVAL; ROOT-GROWTH; DRY-MATTER; STAY-GREEN; HYBRIDS; YIELD; N-15; CARBON	Although the remobilization of vegetative nitrogen (N) and post-silking N both contribute to grain N in maize (Zea mays L.), their regulation by grain sink strength is poorly understood. Here we use N-15 labeling to analyze the dynamic behaviors of both pre- and post-silking N in relation to source and sink manipulation in maize plants. The results showed that the remobilization of pre-silking N started immediately after silking and the remobilized pre-silking N had a greater contribution to grain N during early grain filling, with post-silking N importance increasing during the later filling stage. The amount of post-silking N uptake was largely driven by post-silking dry matter accumulation in both grain as well as vegetative organs. Prevention of pollination during silking had less effect on post-silking N uptake, as a consequence of compensatory growth of stems, husk + cob and roots. Also, leaves continuously export N even though grain sink was removed. The remobilization efficiency of N in the leaf and stem increased with increasing grain yield (hence N requirement). It is suggested that the remobilization of N in the leaf is controlled by sink strength but not the leaf per se. Enhancing post-silking N uptake rather than N remobilization is more likely to increase grain N accumulation.	[Yang, Lan; Guo, Song; Chen, Qinwu; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Ctr Resources Environm & Food Secur, Beijing, Peoples R China; [Guo, Song] Sichuan Acad Agr Sci, Soil & Fertilizer Res Inst, Chengdu, Peoples R China	China Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS)	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Ctr Resources Environm & Food Secur, Beijing, Peoples R China.	miguohua@cau.edu.cn	Yuan, Lixing/I-2727-2012	Yuan, Lixing/0000-0003-0233-6184; Chen, Qinwu/0000-0002-4134-6185; Chen, Fanjun/0000-0001-8105-1683	National Science Foundation of China [31272233, 31421092]; National Basic Research Program of China [2015CB150402]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support was provided by the National Science Foundation of China (grant nos. 31272233 and 31421092) and the National Basic Research Program of China (2015CB150402). GHM received the funding.	Antonietta M, 2014, FIELD CROP RES, V155, P111, DOI 10.1016/j.fcr.2013.09.016; Chen XC, 2013, GLOBAL CHANGE BIOL, V19, P923, DOI 10.1111/gcb.12093; Chen YL, 2015, EUR J AGRON, V62, P79, DOI 10.1016/j.eja.2014.09.008; Chen YL, 2014, FIELD CROP RES, V159, P1, DOI 10.1016/j.fcr.2014.01.002; CHRISTENSEN LE, 1981, PLANT PHYSIOL, V68, P1180, DOI 10.1104/pp.68.5.1180; Ciampitti IA, 2013, CROP SCI, V53, P366, DOI 10.2135/cropsci2012.07.0439; CLIQUET JB, 1990, PLANT PHYSIOL, V92, P79, DOI 10.1104/pp.92.1.79; CLIQUET JB, 1990, PLANT PHYSIOL, V94, P1547, DOI 10.1104/pp.94.4.1547; CRAFTSBRANDNER SJ, 1984, PLANT PHYSIOL, V74, P360, DOI 10.1104/pp.74.2.360; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Gallais A, 2007, CROP SCI, V47, P685, DOI 10.2135/cropsci2006.08.0523; Gallais A, 2006, NEW PHYTOL, V172, P696, DOI 10.1111/j.1469-8137.2006.01890.x; Hirel B, 2006, NEW PHYTOL, V169, P445, DOI 10.1111/j.1469-8137.2006.01641.x; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Ma BL, 1998, PLANT SOIL, V199, P283, DOI 10.1023/A:1004397219723; Ma BL, 1998, COMMUN SOIL SCI PLAN, V29, P2459, DOI 10.1080/00103629809370124; Masclaux-Daubresse C, 2008, PLANT BIOLOGY, V10, P23, DOI 10.1111/j.1438-8677.2008.00097.x; Mi GH, 2003, J PLANT NUTR, V26, P237, DOI 10.1081/PLN-120016507; Mu XH, 2015, EUR J AGRON, V63, P55, DOI 10.1016/j.eja.2014.11.009; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Niu JF, 2010, J PLANT NUTR SOIL SC, V173, P306, DOI 10.1002/jpln.200800316; PAN WL, 1986, PLANT PHYSIOL, V82, P247, DOI 10.1104/pp.82.1.247; PAN WL, 1995, CROP SCI, V35, P836, DOI 10.2135/cropsci1995.0011183X003500030034x; Pommel B, 2006, EUR J AGRON, V24, P203, DOI 10.1016/j.eja.2005.10.001; Rajcan I, 1999, FIELD CROP RES, V60, P255, DOI 10.1016/S0378-4290(98)00143-9; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; REED AJ, 1988, CROP SCI, V28, P819, DOI 10.2135/cropsci1988.0011183X002800050020x; Seebauer JR, 2010, J EXP BOT, V61, P511, DOI 10.1093/jxb/erp324; Subedi KD, 2005, CROP SCI, V45, P740, DOI 10.2135/cropsci2005.0740; TA CT, 1991, PLANT PHYSIOL, V97, P1375, DOI 10.1104/pp.97.4.1375; TA CT, 1992, CROP SCI, V32, P443, DOI 10.2135/cropsci1992.0011183X003200020032x; Tran Thi Sen, 1998, Canadian Journal of Soil Science, V78, P597; UHART SA, 1995, CROP SCI, V35, P1376, DOI [10.2135/cropsci1995.0011183X003500050020x, 10.2135/cropsci1995.0011183X003500010034x, 10.2135/cropsci1995.0011183X003500050021x]; Valentinuz OR, 2004, CROP SCI, V44, P827, DOI 10.2135/cropsci2004.0827; WEILAND RT, 1992, AUST J PLANT PHYSIOL, V19, P77, DOI 10.1071/PP9920077; Yan HF, 2011, CROP SCI, V51, P265, DOI 10.2135/cropsci2010.03.0180	39	18	25	6	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162201	10.1371/journal.pone.0162201	http://dx.doi.org/10.1371/journal.pone.0162201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606628	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600028
J	Figueroa, A; McKelvy, AD; Grismer, LL; Bell, CD; Lailvaux, SP				Figueroa, Alex; McKelvy, Alexander D.; Grismer, L. Lee; Bell, Charles D.; Lailvaux, Simon P.			A Species-Level Phylogeny of Extant Snakes with Description of a New Colubrid Subfamily and Genus	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; MISSING DATA; EVOLUTIONARY HISTORY; LARGE-SCALE; REVISED CLASSIFICATION; SERPENTES COLUBRIDAE; MAXIMUM-LIKELIHOOD; TAXONOMIC REVISION; RAPID RADIATION; 4 NUCLEAR	Background With over 3,500 species encompassing a diverse range of morphologies and ecologies, snakes make up 36% of squamate diversity. Despite several attempts at estimating higher-level snake relationships and numerous assessments of generic- or species-level phylogenies, a large-scale species-level phylogeny solely focusing on snakes has not been completed. Here, we provide the largest-yet estimate of the snake tree of life using maximum likelihood on a supermatrix of 1745 taxa (1652 snake species + 7 outgroup taxa) and 9,523 base pairs from 10 loci (5 nuclear, 5 mitochondrial), including previously unsequenced genera (2) and species Results Increased taxon sampling resulted in a phylogeny with a new higher-level topology and corroborate many lower-level relationships, strengthened by high nodal support values (> 85%) down to the species level (73.69% of nodes). Although the majority of families and subfamilies were strongly supported as monophyletic with > 88% support values, some families and numerous genera were paraphyletic, primarily due to limited taxon and loci sampling leading to a sparse supermatrix and minimal sequence overlap between some closely-related taxa. With all rogue taxa and incertae sedis species eliminated, higher-level relationships and support values remained relatively unchanged, except in five problematic clades. Conclusion Our analyses resulted in new topologies at higher- and lower-levels; resolved several previous topological issues; established novel paraphyletic affiliations; designated a new subfamily, Ahaetuliinae, for the genera Ahaetulla, Chrysopelea, Dendrelaphis, and Dryophiops; and appointed Hemerophis (Coluber) zebrinus to a new genus, Mopanveldophis. Although we provide insight into some distinguished problematic nodes, at the deeper phylogenetic scale, resolution of these nodes may require sampling of more slowly-evolving nuclear genes.	[Figueroa, Alex; Bell, Charles D.; Lailvaux, Simon P.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [McKelvy, Alexander D.] CUNY, Grad Sch & Ctr, Dept Biol, New York, NY 10021 USA; [McKelvy, Alexander D.] CUNY Coll Staten Isl, Dept Biol, 6S-143,2800 Victory Blvd, Staten Isl, NY USA; [Grismer, L. Lee] La Sierra Univ, Dept Biol, 4500 Riverwalk Pkwy, Riverside, CA USA	University of Louisiana System; University of New Orleans; City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY)	Figueroa, A (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	afigueroa21@gmail.com	Figueroa, Alex/AAN-3626-2020; Lailvaux, Simon/C-3121-2008	Figueroa, Alex/0000-0002-5083-9993; 	National Science Foundation East Asia & Pacific Summer Institute [OISE-1107819]; University of New Orleans College of Sciences Graduate Student Research Grant; University of New Orleans Department of Biological Science Dissertation Enhancement Award; University of New Orleans Dissertation Improvement Grant; University of New Orleans Latin American Studies Abroad Program Award; NSF [DEB-9200779, DEB-9505518]; Museum of Vertebrate Zoology (MVZ); Peabody Museum of Natural History Yale University (YPM)	National Science Foundation East Asia & Pacific Summer Institute; University of New Orleans College of Sciences Graduate Student Research Grant; University of New Orleans Department of Biological Science Dissertation Enhancement Award; University of New Orleans Dissertation Improvement Grant; University of New Orleans Latin American Studies Abroad Program Award; NSF(National Science Foundation (NSF)); Museum of Vertebrate Zoology (MVZ); Peabody Museum of Natural History Yale University (YPM)	This work was supported by National Science Foundation East Asia & Pacific Summer Institute (OISE-1107819); University of New Orleans College of Sciences Graduate Student Research Grant; University of New Orleans Department of Biological Science Dissertation Enhancement Award; University of New Orleans Dissertation Improvement Grant; and University of New Orleans Latin American Studies Abroad Program Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the many researchers who donated tissue samples to museum collections and uploaded their sequences on GenBank. For supporting this research in the way of loaning tissue samples, we would like to acknowledge curators and staff at the Ambrose Monell Cryo Collection (AMCC) at the American Museum of Natural History, New York (AMNH), the California Academy of Sciences (CAS), the Field Museum of Natural History (FMNH), the Natural History Museum & Biodiversity Research Center at the University of Kansas (KU), and the LSU Museum of Natural Science Collection of Genetic Resources (LSUMNS) and L.J. Vitt and his NSF grants DEB-9200779 and DEB-9505518, the Museum of Vertebrate Zoology (MVZ), and the Peabody Museum of Natural History Yale University (YPM).	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Alfaro ME, 2001, MOL PHYLOGENET EVOL, V21, P408, DOI 10.1006/mpev.2001.1024; Alfaro ME, 2008, MOL PHYLOGENET EVOL, V46, P576, DOI 10.1016/j.ympev.2007.10.024; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bauer Aaron M., 2001, Herpetozoa, V14, P75; Bohme W, 2011, SALAMANDRA, V47, P120; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Boulenger G.A., 1896, CATALOGUE SNAKES BRI, V3; Broadley Donald G., 1997, Madoqua, V19, P171; Brongersma L. D., 1938, Zoologische Mededeelingen Leiden, VXX, P240; Burbrink FT, 2007, MOL PHYLOGENET EVOL, V43, P173, DOI 10.1016/j.ympev.2006.09.009; Burbrink FT, 2011, REPROD BIOL PHYLOGEN, V9, P19; Burleigh JG, 2015, MOL PHYLOGENET EVOL, V84, P53, DOI 10.1016/j.ympev.2014.12.003; Cadle J. E., 1988, U CALIFORNIA PUBL ZO, V119, P1; Carranza S, 2006, MOL PHYLOGENET EVOL, V40, P532, DOI 10.1016/j.ympev.2006.03.028; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Chen X, 2014, ZOOTAXA, V3881, P532, DOI 10.11646/zootaxa.3881.6.3; Chen X, 2013, MOL PHYLOGENET EVOL, V66, P254, DOI 10.1016/j.ympev.2012.09.032; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Dowling HG, 1996, J ZOOL, V240, P1, DOI 10.1111/j.1469-7998.1996.tb05482.x; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; Gower DJ, 2005, J ZOOL SYST EVOL RES, V43, P315, DOI 10.1111/j.1439-0469.2005.00315.x; Grazziotin FG, 2012, CLADISTICS, V28, P437, DOI 10.1111/j.1096-0031.2012.00393.x; Grismer LL, 2014, ZOOTAXA, V3815, P51, DOI 10.11646/zootaxa.3815.1.3; Guo P, 2014, ZOOTAXA, V3873, P425, DOI 10.11646/zootaxa.3873.4.5; Harvey P. H., 1991, COMP METHOD EVOLUTIO, V239; Hedges S. Blair, 2014, Caribbean Herpetology, V49; Hedges SB, 2009, ZOOTAXA, P1; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HEISE PJ, 1995, MOL BIOL EVOL, V12, P259; Herrmann HW, 2013, J ARID ENVIRON, V93, P94, DOI 10.1016/j.jaridenv.2012.05.003; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelly CMR, 2008, MOL PHYLOGENET EVOL, V47, P1045, DOI 10.1016/j.ympev.2008.03.025; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Kelly CMR, 2003, SYST BIOL, V52, P439, DOI 10.1080/10635150390218132; Kluge AG, 1993, REC AUS MUS S19, V77; Kornilios P, 2013, MOL PHYLOGENET EVOL, V68, P35, DOI 10.1016/j.ympev.2013.03.009; Lambert SM, 2015, MOL PHYLOGENET EVOL, V82, P146, DOI 10.1016/j.ympev.2014.10.004; Lawson R, 2005, MOL PHYLOGENET EVOL, V37, P581, DOI 10.1016/j.ympev.2005.07.016; Lawson R, 2004, J ZOOL, V263, P285, DOI 10.1017/S0952836904005278; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Lenk P, 2001, AMPHIBIA-REPTILIA, V22, P329, DOI 10.1163/156853801317050124; Lenk P, 2001, MOL PHYLOGENET EVOL, V19, P94, DOI 10.1006/mpev.2001.0912; Link HF, 1807, BESCHREIBUNG NATURAL, V2; Malhotra A, 2004, MOL PHYLOGENET EVOL, V32, P83, DOI 10.1016/j.ympev.2004.02.008; Malhotra A, 2010, MOL PHYLOGENET EVOL, V54, P172, DOI 10.1016/j.ympev.2009.09.007; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; McVay JD, 2015, BIOL J LINN SOC, V116, P1, DOI 10.1111/bij.12558; Miller M.A., 2010, P GAT COMP ENV WORKS; Mullin S.J., 2009, SNAKES ECOLOGY CONSE, V1st; Murphy JC, 2011, MOL PHYLOGENET EVOL, V61, P953, DOI 10.1016/j.ympev.2011.08.013; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Nagy ZT, 2004, J ZOOL SYST EVOL RES, V42, P223, DOI 10.1111/j.1439-0469.2004.00249.x; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Noonan BP, 2006, MOL PHYLOGENET EVOL, V40, P347, DOI 10.1016/j.ympev.2006.03.010; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Peng LF, 2014, ASIAN HERPETOL RES, V5, P228, DOI 10.3724/SP.J.1245.2014.00228; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Piwczynski M, 2014, SYST ENTOMOL, V39, P783, DOI 10.1111/syen.12086; Pyron RA, 2014, MOL PHYLOGENET EVOL, V81, P221, DOI 10.1016/j.ympev.2014.08.023; Pyron RA, 2014, ZOOTAXA, V3846, P249, DOI 10.11646/zootaxa.3846.2.5; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2013, MOL PHYLOGENET EVOL, V66, P969, DOI 10.1016/j.ympev.2012.12.004; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2014, ZOOTAXA, V3829, P1, DOI 10.11646/zootaxa.3829.1.1; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Rawlings LH, 2008, BIOL J LINN SOC, V93, P603, DOI 10.1111/j.1095-8312.2007.00904.x; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Reynolds RG, 2014, MOL PHYLOGENET EVOL, V71, P201, DOI 10.1016/j.ympev.2013.11.011; RIEPPEL O, 1988, EVOL BIOL, V22, P37; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2013, MOL PHYLOGENET EVOL, V66, P575, DOI 10.1016/j.ympev.2012.09.021; Sanders KL, 2010, MOL PHYLOGENET EVOL, V56, P857, DOI 10.1016/j.ympev.2010.04.031; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Savage J. M., 1956, Bulletin of Zoological Nomenclature, V12, P147; Scanlon JD, 2011, REPROD BIOL PHYLOGEN, V9, P55; Schatti B, 2008, REV SUISSE ZOOL, V115, P595, DOI 10.5962/bhl.part.80448; Schulz KD, 1995, MONOGRAPH COLUBRID S; Seigel R.A., 1993, SNAKES ECOLOGY BEHAV; Seigel RA., 1987, SNAKES ECOLOGY EVOLU; Slowinski JB, 2002, MOL PHYLOGENET EVOL, V24, P194, DOI 10.1016/S1055-7903(02)00239-7; Smid J, 2015, ZOOTAXA, V4033, P380, DOI 10.11646/zootaxa.4033.3.4; Socha JJ, 2011, INTEGR COMP BIOL, V51, P969, DOI 10.1093/icb/icr092; Soltis DE, 2013, AM J BOT, V100, P916, DOI 10.3732/ajb.1300044; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Teynie A, 2015, ZOOTAXA, V3926, P523, DOI 10.11646/zootaxa.3926.4.4; Thomson RC, 2009, SYST BIOL, V59, P42, DOI DOI 10.1093/SYSBI0/; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P., REPTILE DATABASE; Underwood G., 1967, CONTRIBUTION CLASSIF; Utiger Urs, 2002, Russian Journal of Herpetology, V9, P105; Vidal N, 2002, CR BIOL, V325, P987, DOI 10.1016/S1631-0691(02)01509-3; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Vidal N, 2010, BIOL LETTERS, V6, P558, DOI 10.1098/rsbl.2010.0220; Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003; Vidal N, 2008, ZOOTAXA, P51, DOI 10.11646/zootaxa.1945.1.3; Vidal Nicolas, 2009, P390; Wallach V., 2014, SNAKES WORLD CATALOG; Walls G. L., 1942, P1; Wang XH, 2014, ASIAN HERPETOL RES, V5, P137, DOI 10.3724/SP.J.1245.2014.00137; Weinstein SA, 2011, ELSEV INSIGHT, P1; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; You CW, 2015, ZOOL SCR, V44, P349, DOI 10.1111/zsc.12111; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115; Zhang BL, 2013, ASIAN HERPETOL RES, V4, P155, DOI 10.3724/SP.J.1245.2013.00155; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	126	217	242	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161070	10.1371/journal.pone.0161070	http://dx.doi.org/10.1371/journal.pone.0161070			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603205	gold, Green Published			2022-12-27	WOS:000383255200011
J	Milidonis, X; Lennen, RJ; Jansen, MA; Mueller, S; Boehm-Sturm, P; Holmes, WM; Sena, ES; Macleod, MR; Marshall, I				Milidonis, Xenios; Lennen, Ross J.; Jansen, Maurits A.; Mueller, Susanne; Boehm-Sturm, Philipp; Holmes, William M.; Sena, Emily S.; Macleod, Malcolm R.; Marshall, Ian			Multicenter Evaluation of Geometric Accuracy of MRI Protocols Used in Experimental Stroke	PLOS ONE			English	Article							BRAIN; RELIABILITY; VOLUMETRY; PHANTOM; MODELS; CANCER; ADNI; RAT	It has recently been suggested that multicenter preclinical stroke studies should be carried out to improve translation from bench to bedside, but the accuracy of magnetic resonance imaging (MRI) scanners routinely used in experimental stroke has not yet been evaluated. We aimed to assess and compare geometric accuracy of preclinical scanners and examine the longitudinal stability of one scanner using a simple quality assurance (QA) protocol. Six 7 Tesla animal scanners across six different preclinical imaging centers throughout Europe were used to scan a small structural phantom and estimate linear scaling errors in all orthogonal directions and volumetric errors. Between-scanner imaging consisted of a standard sequence and each center's preferred sequence for the assessment of infarct size in rat models of stroke. The standard sequence was also used to evaluate the drift in accuracy of the worst performing scanner over a period of six months following basic gradient calibration. Scaling and volumetric errors using the standard sequence were less variable than corresponding errors using different stroke sequences. The errors for one scanner, estimated using the standard sequence, were very high (above 4% scaling errors for each orthogonal direction, 18.73% volumetric error). Calibration of the gradient coils in this system reduced scaling errors to within +/- 1.0%; these remained stable during the subsequent 6-month assessment. In conclusion, despite decades of use in experimental studies, preclinical MRI still suffers from poor and variable geometric accuracy, influenced by the use of miscalibrated systems and various types of sequences for the same purpose. For effective pooling of data in multicenter studies, centers should adopt standardized procedures for system QA and in vivo imaging.	[Milidonis, Xenios; Sena, Emily S.; Macleod, Malcolm R.; Marshall, Ian] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Lennen, Ross J.; Jansen, Maurits A.] Univ Edinburgh, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Lennen, Ross J.; Jansen, Maurits A.; Marshall, Ian] Univ Edinburgh, Edinburgh Preclin Imaging, Edinburgh, Midlothian, Scotland; [Mueller, Susanne; Boehm-Sturm, Philipp] Charite, Ctr Stroke Res Berlin, Dept Expt Neurol, Berlin, Germany; [Mueller, Susanne; Boehm-Sturm, Philipp] Charite, Ctr Stroke Res Berlin, Core Facil Expt MRIs 7 T, Berlin, Germany; [Mueller, Susanne; Boehm-Sturm, Philipp] Charite, Cluster Excellence NeuroCure, Berlin, Germany; [Holmes, William M.] Univ Glasgow, Glasgow Expt MRI Ctr, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Glasgow	Milidonis, X (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	x.milidonis@sms.ed.ac.uk	holmes, william/AAP-3417-2021; Jansen, Maurits/B-3913-2012; Macleod, Malcolm Robert/B-2052-2010	Jansen, Maurits/0000-0002-7077-0188; Macleod, Malcolm Robert/0000-0001-9187-9839; Milidonis, Xenios/0000-0002-5446-9459; Mueller, Susanne/0000-0002-5053-2211; Boehm-Sturm, Philipp/0000-0001-8777-4823	Multicentre Preclinical Animal Research Team (Multi-PART); European Commission's Seventh Framework Programme [603043]; German Federal Ministry of Education and Research (BMBF) (Center for Stroke Research Berlin) [01EO0801]; Edinburgh Imaging, University of Edinburgh studentship; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	Multicentre Preclinical Animal Research Team (Multi-PART); European Commission's Seventh Framework Programme; German Federal Ministry of Education and Research (BMBF) (Center for Stroke Research Berlin)(Federal Ministry of Education & Research (BMBF)); Edinburgh Imaging, University of Edinburgh studentship; National Centre for the Replacement	This study was partially supported by the Multicentre Preclinical Animal Research Team (Multi-PART, http://www.multi-part.org), an international collaboration funded by the European Commission's Seventh Framework Programme (FP7/2007-2013, http://cordis.europa.eu/fp7/) under grant agreement no. 603043, and by the German Federal Ministry of Education and Research (BMBF, https://www.bmbf.de/en/index.html) under grant agreement no. 01EO0801 (Center for Stroke Research Berlin). XM is funded by an Edinburgh Imaging, The University of Edinburgh studentship (http://www.ed.ac.uk/edinburgh-imaging). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bath PMW, 2009, INT J STROKE, V4, P471, DOI 10.1111/j.1747-4949.2009.00386.x; Caramanos Z, 2010, NEUROIMAGE, V49, P1601, DOI 10.1016/j.neuroimage.2009.08.008; Dirnagl U, 2013, STROKE, V44, P1754, DOI 10.1161/STROKEAHA.113.000734; Fagan AJ, 2008, J MAGN RESON IMAGING, V27, P469, DOI 10.1002/jmri.21246; Farr TD, 2010, J CEREBR BLOOD F MET, V30, P703, DOI 10.1038/jcbfm.2010.5; Gunter JL, 2009, MED PHYS, V36, P2193, DOI 10.1118/1.3116776; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Karki K, 2010, BRAIN RES, V1360, P168, DOI 10.1016/j.brainres.2010.08.098; Khan AF, 2012, J MAGN RESON IMAGING, V36, P476, DOI 10.1002/jmri.23612; Lee Yongsook C, 2011, BMC Med Phys, V11, P1, DOI 10.1186/1756-6649-11-1; Luft AR, 1996, J MAGN RESON IMAGING, V6, P700, DOI 10.1002/jmri.1880060421; Maysami S, 2016, J CEREBR BLOOD F MET, V36, P596, DOI 10.1177/0271678X15606714; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; Nathoo N, 2014, MULT SCLER J, V20, P3, DOI 10.1177/1352458513512709; Noebauer-Huhmann IM, 2008, P 16 SCI M INT SOC M; O'Callaghan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096568; Price R, 2015, MAGNETIC RESONANCE I; Quercioli F, 1998, APPL OPTICS, V37, P3408, DOI 10.1364/AO.37.003408; Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167; ROSEN GD, 1990, J NEUROSCI METH, V35, P115, DOI 10.1016/0165-0270(90)90101-K; Sahin B, 2003, EUR J RADIOL, V47, P164, DOI 10.1016/S0720-048X(02)00152-3; Shackelford JF, 2015, CRC MATERIALS SCIENCE AND ENGINEERING HANDBOOK, 4TH EDITION, P461; Teh I, 2017, MAGN RESON MED, V77, P170, DOI 10.1002/mrm.26105; Tustison N., 2010, INSIGHT J, V9, DOI [10.54294/jculxw, DOI 10.54294/JCULXW]; Wang D, 2004, MAGN RESON IMAGING, V22, P1211, DOI 10.1016/j.mri.2004.08.012; Wapler MC, 2014, J MAGN RESON, V242, P233, DOI 10.1016/j.jmr.2014.02.005; Wegener S, 2006, J CEREBR BLOOD F MET, V26, P38, DOI 10.1038/sj.jcbfm.9600166; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Yoshimaru E, 2014, MAGN RESON MED, V71, P880, DOI 10.1002/mrm.24678; Young MR, 2009, NEOPLASIA, V11, P237, DOI 10.1593/neo.81326	32	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162545	10.1371/journal.pone.0162545	http://dx.doi.org/10.1371/journal.pone.0162545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603704	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000383255200075
J	Weaver, SR; Bohrer, JC; Prichard, AS; Perez, PK; Streckenbach, LJ; Olson, JM; Cook, ME; Hernandez, LL				Weaver, Samantha R.; Bohrer, Justin C.; Prichard, Allan S.; Perez, Paola K.; Streckenbach, Liana J.; Olson, Jake M.; Cook, Mark E.; Hernandez, Laura L.			Serotonin Deficiency Rescues Lactation on Day 1 in Mice Fed a High Fat Diet	PLOS ONE			English	Article							MAMMARY-GLAND INVOLUTION; MATERNAL OBESITY; TRYPTOPHAN-HYDROXYLASE; PERIPHERAL SEROTONIN; ADIPOSE-TISSUE; DELAYED-ONSET; NITRIC-OXIDE; PREGNANCY; INFLAMMATION; WEIGHT	Obesity is an inflammatory state associated with delayed lactogenesis stage II and altered mammary gland morphology. Serotonin mediates inflammation and mammary gland involution. The objective of this study was to determine if a genetic deficiency of tryptophan hydroxylase 1, the rate-limiting enzyme in peripheral serotonin synthesis, would result in an improved ability to lactate in dams fed a high fat diet. Twenty-six female mice were fed a high (HFD) or low fat (LFD) diet throughout pregnancy and lactation. Fourteen mice were genetically deficient for Tph1 (Tph1(-/-)), and twelve were wild type. Milk yield, pup mortality, and dam weights were recorded and milk samples were collected. On day 10 of lactation, dams were sacrificed and mammary glands were harvested for RT-PCR and histological evaluation. HFD dams weighed more than LFD dams at the onset of lactation. WT HFD dams were unable to lactate on day 1 of lactation and exhibited increased pup mortality relative to all other treatments, including Tph1(-/-) HFD dams. mRNA expression of immune markers C-X-C motif chemokine 5 and tumor necrosis factor alpha were elevated in WT HFD mammary glands. Mammary gland histology showed a reduced number of alveoli in WT compared to Tph1(-/-) dams, regardless of diet, and the alveoli of HFD dams were smaller than those of LFD dams. Finally, fatty acid profile in milk was dynamic in both early and peak lactation, with reduced de novo synthesis of fatty acids on day 10 of lactation in the HFD groups. Administration of a HFD to C57BL/6 dams produced an obese phenotype in the mammary gland, which was alleviated by a genetic deficiency of Tph1. Serotonin may modulate the effects of obesity on the mammary gland, potentially contributing to the delayed onset of lactogenesis seen in obese women.	[Weaver, Samantha R.; Prichard, Allan S.; Perez, Paola K.; Streckenbach, Liana J.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Bohrer, Justin C.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Olson, Jake M.; Cook, Mark E.; Hernandez, Laura L.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu		Hernandez, Laura/0000-0001-7591-5203				Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bautista CJ, 2016, BRIT J NUTR, V115, P538, DOI 10.1017/S0007114515004547; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Burke LK, 2015, J NEUROENDOCRINOL, V27, P389, DOI 10.1111/jne.12287; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Flint DJ, 2005, DOMEST ANIM ENDOCRIN, V29, P274, DOI 10.1016/j.domaniend.2005.02.021; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; Horseman ND, 2014, ANNU REV ANIM BIOSCI, V2, P353, DOI 10.1146/annurev-animal-022513-114227; Huebner SM, 2010, J NUTR, V140, P1454, DOI 10.3945/jn.109.120527; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Kierson JA, 2006, ACTA PAEDIATR, V95, P991, DOI 10.1080/08035250600669769; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Miranda RA, CROSS FOSTERING REDU; Mishra AC, 2010, J PSYCHOPHARMACOL, V24, P1089, DOI 10.1177/0269881108100775; Mozes S, 2014, EUR J NUTR, V53, P1273, DOI 10.1007/s00394-013-0630-7; Murney R, 2015, J DAIRY SCI, V98, P5422, DOI 10.3168/jds.2015-9425; Neuenschwander S, 1996, J CLIN INVEST, V97, P2225, DOI 10.1172/JCI118663; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; Nowak R, 2000, REV REPROD, V5, P153, DOI 10.1530/ror.0.0050153; Nunemaker CS, 2014, J ENDOCRINOL, V222, P267, DOI 10.1530/JOE-14-0126; Oddy WH, 2006, J PEDIATR-US, V149, P185, DOI 10.1016/j.jpeds.2006.04.005; Pai VP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/364746; Park JH, 2016, LAB ANIM-UK, V50, P94, DOI 10.1177/0023677215590526; Payolla TB, 2016, MOL CELL ENDOCRINOL, V422, P192, DOI 10.1016/j.mce.2015.12.004; Politz Mark, 2013, Bio Protoc, V3; Rasmussen KM, 2001, J NUTR, V131, p3009S, DOI 10.1093/jn/131.11.3009S; Rasmussen KM, 2004, PEDIATRICS, V113, pE465, DOI 10.1542/peds.113.5.e465; Ritze Y, 2016, NEUROGASTROENT MOTIL, V28, P806, DOI 10.1111/nmo.12773; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; Saben JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098066; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Vanhouten JN, 2003, ENDOCRINOLOGY, V144, P5521, DOI 10.1210/en.2003-0892; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Walker M, 2008, J PERINAT NEONAT NUR, V22, P267, DOI 10.1097/01.JPN.0000341356.45446.23; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Watanabe H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147143; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; Zaragoza R, 2010, BIOCHEM J, V428, P451, DOI 10.1042/BJ20091091	58	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162432	10.1371/journal.pone.0162432	http://dx.doi.org/10.1371/journal.pone.0162432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603698	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200065
J	Chang, KH; Chang, YC; Chain, K; Chung, HY				Chang, Kuei-Hu; Chang, Yung-Chia; Chain, Kai; Chung, Hsiang-Yu			Integrating Soft Set Theory and Fuzzy Linguistic Model to Evaluate the Performance of Training Simulation Systems	PLOS ONE			English	Article							DECISION-MAKING; AGGREGATION OPERATORS; REPRESENTATION MODEL; 2-TUPLE; INFORMATION; SELECTION; IPA; SATISFACTION; PARAMETERS; REGRESSION	The advancement of high technologies and the arrival of the information age have caused changes to the modern warfare. The military forces of many countries have replaced partially real training drills with training simulation systems to achieve combat readiness. However, considerable types of training simulation systems are used in military settings. In addition, differences in system set up time, functions, the environment, and the competency of system operators, as well as incomplete information have made it difficult to evaluate the performance of training simulation systems. To address the aforementioned problems, this study integrated analytic hierarchy process, soft set theory, and the fuzzy linguistic representation model to evaluate the performance of various training simulation systems. Furthermore, importance-performance analysis was adopted to examine the influence of saving costs and training safety of training simulation systems. The findings of this study are expected to facilitate applying military training simulation systems, avoiding wasting of resources (e.g., low utility and idle time), and providing data for subsequent applications and analysis. To verify the method proposed in this study, the numerical examples of the performance evaluation of training simulation systems were adopted and compared with the numerical results of an AHP and a novel AHP-based ranking technique. The results verified that not only could expert-provided questionnaire information be fully considered to lower the repetition rate of performance ranking, but a two-dimensional graph could also be used to help administrators allocate limited resources, thereby enhancing the investment benefits and training effectiveness of a training simulation system.	[Chang, Kuei-Hu] ROC Mil Acad, Dept Management Sci, Kaohsiung 830, Taiwan; [Chang, Yung-Chia; Chung, Hsiang-Yu] Natl Chiao Tung Univ, Dept Ind Engn & Management, Hsinchu 300, Taiwan; [Chain, Kai] ROC Mil Acad, Dept Comp & Informat Sci, Kaohsiung 830, Taiwan; [Chang, Kuei-Hu] 1 Wei Wu Rd, Kaohsiung 830, Taiwan	National Yang Ming Chiao Tung University	Chang, KH (corresponding author), ROC Mil Acad, Dept Management Sci, Kaohsiung 830, Taiwan.; Chang, KH (corresponding author), 1 Wei Wu Rd, Kaohsiung 830, Taiwan.	evenken2002@yahoo.com.tw	鍾, 翔宇/GXG-6867-2022; Chang, Kuei-Hu/ADO-7574-2022	Chang, Kuei-Hu/0000-0002-9630-7386; Chang, Yung-Chia/0000-0001-6272-3560	Ministry of Science and Technology of the Republic of China [MOST 103-2410-H-145-002, MOST 104-2623-E-145-001-D, MOST 105-2410-H-145-002, MOST 104-2410-H-145-001]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors would like to thank the Ministry of Science and Technology of the Republic of China, for financially supporting this research under Contract No. MOST 103-2410-H-145-002, MOST 104-2623-E-145-001-D, MOST 105-2410-H-145-002, and MOST 104-2410-H-145-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2013, APPL SOFT COMPUT, V13, P3552, DOI 10.1016/j.asoc.2013.03.015; Ali MI, 2012, APPL SOFT COMPUT, V12, P1814, DOI 10.1016/j.asoc.2012.01.002; Basu TM, 2012, APPL SOFT COMPUT, V12, P3260, DOI 10.1016/j.asoc.2012.05.006; Benitez J, 2015, J COMPUT APPL MATH, V290, P412, DOI 10.1016/j.cam.2015.05.023; Caber M., 2012, Journal of Vacation Marketing, V18, P43, DOI 10.1177/1356766711428802; Chang KH, 2015, P I MECH ENG B-J ENG, V229, P1635, DOI 10.1177/0954405414539498; Chang KH, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/956757; Chang KH, 2014, SOFT COMPUT, V18, P169, DOI 10.1007/s00500-013-1045-3; Chang KC, 2012, INT J TOUR RES, V14, P205, DOI 10.1002/jtr.839; Chao KH, 2016, INT J ELECTRON, V103, P424, DOI 10.1080/00207217.2015.1036376; Chen JK, 2012, SCIENTOMETRICS, V93, P1119, DOI 10.1007/s11192-012-0759-9; Chen LF, 2014, TOURISM MANAGE, V41, P119, DOI 10.1016/j.tourman.2013.09.003; Chiappone S, 2016, EXPERT SYST APPL, V44, P147, DOI 10.1016/j.eswa.2015.09.024; Chou CC, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/656757; Chou JS, 2012, TRANSPORT POLICY, V22, P36, DOI 10.1016/j.tranpol.2012.05.009; Chu CH, 2015, TOURISM MANAGE, V47, P47, DOI 10.1016/j.tourman.2014.09.008; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Dong YC, 2011, IEEE T FUZZY SYST, V19, P13, DOI 10.1109/TFUZZ.2010.2073713; Dutta B, 2015, APPL SOFT COMPUT, V37, P166, DOI 10.1016/j.asoc.2015.08.017; Gaetan S, 2015, AEROSP MED HUM PERF, V86, P1052, DOI 10.3357/AMHP.4228.2015; Hassanpoor A, 2016, IEEE T POWER ELECTR, V31, P2780, DOI 10.1109/TPEL.2015.2448573; Herrera F, 2000, INT J UNCERTAIN FUZZ, V8, P539, DOI 10.1142/S0218488500000381; Herrera F, 2000, IEEE T FUZZY SYST, V8, P746, DOI 10.1109/91.890332; Herrera-Viedma E, 2010, INT J COMPUT INT SYS, V3, P420; Ho LH, 2012, EXPERT SYST APPL, V39, P7102, DOI 10.1016/j.eswa.2012.01.034; Honn KA, 2016, ACCIDENT ANAL PREV, V86, P199, DOI 10.1016/j.aap.2015.10.005; Hontvedt M, 2015, LEARN CULT SOC INTER, V7, P71, DOI 10.1016/j.lcsi.2015.07.003; Huttunen K, 2011, APPL ERGON, V42, P348, DOI 10.1016/j.apergo.2010.08.005; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Ko WC, 2015, COMPUT IND, V73, P117, DOI 10.1016/j.compind.2015.07.008; Kong Z, 2015, APPL MATH MODEL, V39, P4808, DOI 10.1016/j.apm.2015.03.055; Lahtinen TMM, 2007, AVIAT SPACE ENVIR MD, V78, P387; Li N, 2016, J MATER PROCESS TECH, V228, P2, DOI 10.1016/j.jmatprotec.2015.09.043; Li Y, 2015, TECHNOL ECON DEV ECO, V21, P797, DOI 10.3846/20294913.2015.1055614; Liu HC, 2015, QUAL RELIAB ENG INT, V31, P761, DOI 10.1002/qre.1633; Lolli F, 2014, INT J PROD ECON, V156, P62, DOI 10.1016/j.ijpe.2014.05.015; Lu H, 2008, CHIN J MECH ENG-EN, V21, P47, DOI 10.3901/CJME.2008.01.047; Maji PK, 2003, COMPUT MATH APPL, V45, P555, DOI 10.1016/S0898-1221(03)00016-6; MARTILLA JA, 1977, J MARKETING, V41, P77, DOI 10.2307/1250495; Mendel J.M., 2010, PERCEPTUAL COMPUTING; Molodtsov D, 1999, COMPUT MATH APPL, V37, P19, DOI 10.1016/S0898-1221(99)00056-5; Montes R, 2015, APPL SOFT COMPUT, V35, P949, DOI 10.1016/j.asoc.2015.01.030; Parreiras RO, 2010, INFORM SCIENCES, V180, P1075, DOI 10.1016/j.ins.2009.11.046; Rao CJ, 2015, TRANSPORT RES D-TR E, V36, P29, DOI 10.1016/j.trd.2015.02.008; Rezaei J, 2014, EXPERT SYST APPL, V41, P8165, DOI 10.1016/j.eswa.2014.07.005; Rodriguez A, 2016, EXPERT SYST APPL, V45, P273, DOI 10.1016/j.eswa.2015.09.056; Saaty TL, 2006, EUR J OPER RES, V168, P557, DOI 10.1016/j.ejor.2004.04.032; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Saaty TL., 1980, ANAL HIERARCHY PROCE; Sato Y, 2015, INT J PROD ECON, V170, P422, DOI 10.1016/j.ijpe.2015.08.001; Shen LX, 2015, RESOUR POLICY, V46, P15, DOI 10.1016/j.resourpol.2013.10.006; Solymos O, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0109-6; Tanase C, 2009, STUD COMPUT INTELL, V237, P313; Tao ZF, 2015, APPL SOFT COMPUT, V34, P587, DOI 10.1016/j.asoc.2015.04.051; Tao ZF, 2015, SOFT COMPUT, V19, P1201, DOI 10.1007/s00500-014-1335-4; Tavana M, 2011, EXPERT SYST APPL, V38, P13588, DOI 10.1016/j.eswa.2011.04.108; Temme LA, 2010, AVIAT SPACE ENVIR MD, V81, P654, DOI 10.3357/ASEM.2690.2010; Tian ZH, 2014, WIT TRANS INFO COMM, V46, P2953, DOI 10.2495/ISME20134013; Tripathi K, 2016, SECUR J, V29, P87, DOI 10.1057/sj.2015.46; Tseng ML, 2011, ENVIRON MONIT ASSESS, V175, P367, DOI 10.1007/s10661-010-1537-x; Wan SP, 2013, KNOWL-BASED SYST, V45, P31, DOI 10.1016/j.knosys.2013.02.002; Wang LX, 2015, IEEE T FUZZY SYST, V23, P787, DOI 10.1109/TFUZZ.2014.2327994; Wei GW, 2012, EXPERT SYST APPL, V39, P5881, DOI 10.1016/j.eswa.2011.11.120; Wu DR, 2013, IEEE T FUZZY SYST, V21, P80, DOI 10.1109/TFUZZ.2012.2201728; Zaal PMT, 2015, J AIRCRAFT, V52, P1971, DOI 10.2514/1.C033115; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang SL, 2011, COMPUT MATH APPL, V62, P1916, DOI 10.1016/j.camwa.2011.06.035; Zulueta Y, 2016, APPL MATH MODEL, V40, P1402, DOI 10.1016/j.apm.2015.07.016	68	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162092	10.1371/journal.pone.0162092	http://dx.doi.org/10.1371/journal.pone.0162092			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598390	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800039
J	Choi, SH; Park, SJ; Kim, NR				Choi, Seong Hye; Park, Sang Jun; Kim, Na Rae			Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RETINAL PATHOLOGY; MOUSE MODEL; RECOMMENDATIONS; DEMENTIA; DEGENERATION; WORKGROUPS	Purpose We investigated the association of the macular ganglion cell-inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (RNFL) thicknesses with disease progression in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Methods We recruited 42 patients with AD, 26 with MCI, and 66 normal elderly controls. The thicknesses of the RNFL and GCIPL were measured via spectral-domain optic coherent tomography in all participants at baseline. The patients with MCI or AD underwent clinical and neuropsychological tests at baseline and once every year thereafter for 2 years. Results The Clinical Dementia Rating scale-Sum of Boxes (CDR-SB) score exhibited significant negative relationships with the average GCIPL thickness (beta = -0.15, p < 0.05) and the GCIPL thickness in the superotemporal, superonasal, and inferonasal sectors. The composite memory score exhibited significant positive associations with the average GCIPL thickness and the GCIPL thickness in the superotemporal, inferonasal, and inferotemporal sectors. The temporal RNFL thickness, the average and minimum GCIPL thicknesses, and the GCIPL thickness in the inferonasal, inferior, and inferotemporal sectors at baseline were significantly reduced in MCI patients who were converted to AD compared to stable MCI patients. The change of CDR-SB from baseline to 2 years exhibited significant negative associations with the average (beta = -0.150, p = 0.006) and minimum GCIPL thicknesses as well as GCIPL thickness in the superotemporal, superior, superonasal, and inferonasal sectors at baseline. Conclusions Our data suggest that macular GCIPL thickness represents a promising biomarker for monitoring the progression of MCI and AD.	[Choi, Seong Hye] Inha Univ, Dept Neurol, Sch Med, Inchon, South Korea; [Park, Sang Jun; Kim, Na Rae] Inha Univ, Sch Med, Dept Ophthalmol, Inchon, South Korea; [Park, Sang Jun; Kim, Na Rae] Inha Univ, Sch Med, Inha Vis Sci Lab, Inchon, South Korea	Inha University; Inha University; Inha University	Kim, NR (corresponding author), Inha Univ, Sch Med, Dept Ophthalmol, Inchon, South Korea.; Kim, NR (corresponding author), Inha Univ, Sch Med, Inha Vis Sci Lab, Inchon, South Korea.	nrkim@inha.ac.kr		Kim, Na Rae/0000-0003-4224-5447	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2016R1A1A1A05005484]; Original Technology Research Program for Brain Science through NRF - Korean government (MSIP) [2014M3C7A1064752]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Original Technology Research Program for Brain Science through NRF - Korean government (MSIP)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (No. 2016R1A1A1A05005484) and by the Original Technology Research Program for Brain Science through the NRF funded by the Korean government (MSIP) (No. 2014M3C7A1064752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bayhan HA, 2015, CLIN EXP OPHTHALMOL, V43, P145, DOI 10.1111/ceo.12386; Belleville S, 2014, J ALZHEIMERS DIS, V42, pS375, DOI 10.3233/JAD-141470; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Choi SH, 2012, NEUROL SCI, V33, P839, DOI 10.1007/s10072-011-0845-4; Choi SH, 2003, ALZ DIS ASSOC DIS, V17, P98, DOI 10.1097/00002093-200304000-00008; Christensen K. J., 1991, PSYCHOL ASSESSMENT J, V3, P168, DOI [10.1037/1040-3590.3.2.168, DOI 10.1037/1040-3590.3.2.168]; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; Garcia-Martin ES, 2014, OPHTHALMOLOGY, V121, P1149, DOI 10.1016/j.ophtha.2013.12.023; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Kim HJ, 2015, J ALZHEIMERS DIS, V48, P1043, DOI 10.3233/JAD-143018; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; La Morgia C, 2016, ANN NEUROL, V79, P90, DOI 10.1002/ana.24548; Liu M, 2011, EXP EYE RES, V92, P244, DOI 10.1016/j.exer.2011.01.014; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parnell Miles, 2012, Int J Alzheimers Dis, V2012, P786494, DOI 10.1155/2012/786494; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Williams PA, 2013, NEUROBIOL AGING, V34, P1799, DOI 10.1016/j.neurobiolaging.2013.01.006	38	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162202	10.1371/journal.pone.0162202	http://dx.doi.org/10.1371/journal.pone.0162202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598262	gold, Green Published, Green Submitted			2022-12-27	WOS:000383254800046
J	Dai, M; Liou, B; Swope, B; Wang, XH; Zhang, WJ; Inskeep, V; Grabowski, GA; Sun, Y; Pan, D				Dai, Mei; Liou, Benjamin; Swope, Brittany; Wang, Xiaohong; Zhang, Wujuan; Inskeep, Venette; Grabowski, Gregory A.; Sun, Ying; Pan, Dao			Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE IIIA; LYSOSOMAL STORAGE DISEASES; CHRONIC RESTRAINT STRESS; BLOOD-BRAIN-BARRIER; OF-THE-LITERATURE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; HURLER-SYNDROME; SEX-DIFFERENCES	To study the neuronal deficits in neuronopathic Gaucher Disease (nGD), the chronological behavioral profiles and the age of onset of brain abnormalities were characterized in a chronic nGD mouse model (9V/null). Progressive accumulation of glucosylceramide (GC) and glucosylsphingosine (GS) in the brain of 9V/null mice were observed at as early as 6 and 3 months of age for GC and GS, respectively. Abnormal accumulation of a-synuclein was present in the 9V/null brain as detected by immunofluorescence and Western blot analysis. In a repeated open-field test, the 9V/null mice (9 months and older) displayed significantly less environmental habituation and spent more time exploring the open-field than age-matched WT group, indicating the onset of short-term spatial memory deficits. In the marble burying test, the 9V/null group had a shorter latency to initiate burying activity at 3 months of age, whereas the latency increased significantly at >= 12 months of age; 9V/null females buried significantly more marbles to completion than the WT group, suggesting an abnormal response to the instinctive behavior and an abnormal activity in non-associative anxiety-like behavior. In the conditional fear test, only the 9V/null males exhibited a significant decrease in response to contextual fear, but both genders showed less response to auditory-cued fear compared to age-and gender-matched WT at 12 months of age. These results indicate hippocampus-related emotional memory defects. Abnormal gait emerged in 9V/null mice with wider front-paw and hind-paw widths, as well as longer stride in a gender-dependent manner with different ages of onset. Significantly higher liver-and spleen-to-body weight ratios were detected in 9V/null mice with different ages of onsets. These data provide temporal evaluation of neurobehavioral dysfunctions and brain pathology in 9V/null mice that can be used for experimental designs to evaluate novel therapies for nGD.	[Dai, Mei; Swope, Brittany; Wang, Xiaohong; Pan, Dao] Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Liou, Benjamin; Inskeep, Venette; Grabowski, Gregory A.; Sun, Ying] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Swope, Brittany; Sun, Ying; Pan, Dao] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH USA; [Zhang, Wujuan] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Pan, D (corresponding author), Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Sun, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.; Sun, Y; Pan, D (corresponding author), Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH USA.	ying.sun@cchmc.org; Dao.pan@cchmc.org			NIH [R01 NS086134, R01 DK36729, R01 NS064330]; Cincinnati Children's Hospital Medical Center RIP awards; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064330, R01NS086134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital Medical Center RIP awards; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants (R01 NS086134, R01 DK36729, and R01 NS064330) and Cincinnati Children's Hospital Medical Center RIP awards (to D.P. and to Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2016, NEUROSCIENCE, V321, P121, DOI 10.1016/j.neuroscience.2015.11.009; Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Anheim M, 2012, NEUROLOGY, V78, P417, DOI 10.1212/WNL.0b013e318245f476; [Anonymous], 2013, ADV DIFFER EQU, DOI DOI 10.1371/J0URNAL.P0NE.0057560; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Barnes S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116023; Beavan M, 2015, JAMA NEUROL, V72, P201, DOI 10.1001/jamaneurol.2014.2950; Biegstraaten M, 2008, J INHERIT METAB DIS, V31, P337, DOI 10.1007/s10545-008-0832-y; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Burrow TA, 2015, MOL GENET METAB, V114, P233, DOI 10.1016/j.ymgme.2014.08.011; Cabrera-Salazar MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043310; Carter R.J., 2001, CURRENT PROTOCOLS NE; Case LK, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0591-7; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cherin P, 2010, J INHERIT METAB DIS, V33, P331, DOI 10.1007/s10545-010-9095-5; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cox TM, 2015, AM J HEMATOL, V90, pS25, DOI 10.1002/ajh.24057; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dasgupta N, 2015, HUM MOL GENET, V24, P7031, DOI 10.1093/hmg/ddv404; DePaolo J, 2009, MOVEMENT DISORD, V24, P1571, DOI 10.1002/mds.22538; El-Amouri SS, 2014, MOL THER, V22, P2028, DOI 10.1038/mt.2014.152; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fishbein I, 2014, BRAIN, V137, P3235, DOI 10.1093/brain/awu291; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Geldenhuys WJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1175; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Ginns EI, 2014, MOL GENET METAB, V111, P152, DOI 10.1016/j.ymgme.2013.12.003; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; Grabowski GA, 2010, THE ONLINE METABOLIC; Grabowski Gregory A, 2006, Expert Opin Drug Deliv, V3, P771, DOI 10.1517/17425247.3.6.771; Grabowski GA, 2015, AM J HEMATOL, V90, pS12, DOI 10.1002/ajh.24063; Hayashi E, 2010, PHARMACOLOGY, V86, P293, DOI 10.1159/000321190; Hemsley KM, 2005, BEHAV BRAIN RES, V158, P191, DOI 10.1016/j.bbr.2004.08.019; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McNeill A, 2012, J NEUROL NEUROSUR PS, V83, P853, DOI 10.1136/jnnp-2012-302402; Mehta A, 2006, EUR J INTERN MED, V17, pS2, DOI 10.1016/j.ejim.2006.07.005; Michelakakis H, 2002, BLOOD CELL MOL DIS, V28, P1, DOI 10.1006/bcmd.2001.0477; Mignot C, 2006, BRAIN DEV-JPN, V28, P39, DOI 10.1016/j.braindev.2005.04.005; Mitra R, 2005, NEUROSCI LETT, V383, P278, DOI 10.1016/j.neulet.2005.04.037; Moussaud S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-43; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; NILSSON O, 1982, CLIN GENET, V22, P274; Noelker C, 2015, J NEUROL SCI, V356, P129, DOI 10.1016/j.jns.2015.06.030; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pan D, 2008, BRAIN RES, V1188, P241, DOI 10.1016/j.brainres.2007.10.036; Park JK, 2003, PEDIATR RES, V53, P387, DOI 10.1203/01.PDR.0000049515.79882.94; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Quirk GJ, 2010, NATURE, V463, P36, DOI 10.1038/463036a; Sanders A, 2013, BLOOD CELL MOL DIS, V51, P109, DOI 10.1016/j.bcmd.2013.03.006; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Shayman JA, 2014, J LIPID RES, V55, P993, DOI 10.1194/jlr.E049817; Shulman Lisa M, 2006, Expert Rev Neurother, V6, P407; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Sidransky E, 2009, NEUROLOGY, V73, P1424, DOI 10.1212/WNL.0b013e3181b28601; Skelton MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016187; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Sugimoto H, 2014, BEHAV BRAIN RES, V272, P100, DOI 10.1016/j.bbr.2014.06.048; Sun Y, 2013, HUM MOL GENET, V22, P2435, DOI 10.1093/hmg/ddt096; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Tayebi N, 1998, PEDIATR RES, V43, P571, DOI 10.1203/00006450-199805000-00003; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Wang DR, 2009, P NATL ACAD SCI USA, V106, P19958, DOI 10.1073/pnas.0908528106; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 2008, MOL GENET METAB, V94, P190, DOI 10.1016/j.ymgme.2008.01.013; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010	99	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162367	10.1371/journal.pone.0162367	http://dx.doi.org/10.1371/journal.pone.0162367			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598339	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800058
J	Hadrup, N; Svingen, T; Mandrup, K; Skov, K; Pedersen, M; Frederiksen, H; Frandsen, HL; Vinggaard, AM				Hadrup, Niels; Svingen, Terje; Mandrup, Karen; Skov, Kasper; Pedersen, Mikael; Frederiksen, Hanne; Frandsen, Henrik Lauritz; Vinggaard, Anne Marie			Juvenile Male Rats Exposed to a Low-Dose Mixture of Twenty-Seven Environmental Chemicals Display Adverse Health Effects	PLOS ONE			English	Article							BISPHENOL-A; PHTHALATE METABOLITES; DISRUPTING CHEMICALS; DIETARY EXPOSURE; DANISH CHILDREN; UNITED-STATES; PLASMA; TCDD; ORGANOCHLORINE; CONTAMINANTS	Humans are exposed to a large number of environmental chemicals in their daily life, many of which are readily detectable in blood or urine. It remains uncertain if these chemicals can cause adverse health effects when present together at low doses. In this study we have tested whether a mixture of 27 chemicals administered orally to juvenile male rats for three months could leave a pathophysiological footprint. The mixture contained metals, perfluorinated compounds, PCB, dioxins, pesticides, heterocyclic amines, phthalate, PAHs and others, with a combined dose of 0.16 (Low dose), 0.47 (Mid dose) or 1.6 (High dose) mg/kg bw/day. The lowest dose was designed with the aim of obtaining plasma or urine concentrations in rats at levels approaching those observed in humans. Some single congeners were administered at doses representative of combined doses for chemical groups. With this baseline, we found effects on weight, histology and gene expression in the liver, as well as changes to the blood plasma metabolome in all exposure groups, including low-dose. Additional adverse effects were observed in the higher dosed groups, including enlarged kidneys and alterations to the metabolome. No significant effects on reproductive parameters were observed.	[Hadrup, Niels; Svingen, Terje; Mandrup, Karen; Vinggaard, Anne Marie] Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, DK-2400 Soborg, Denmark; [Skov, Kasper; Pedersen, Mikael; Frandsen, Henrik Lauritz] Tech Univ Denmark, Natl Food Inst, Div Food Chem, DK-2400 Soborg, Denmark; [Frederiksen, Hanne] Copenhagen Univ Hosp, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Rigshospitalet; University of Copenhagen	Hadrup, N (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, DK-2400 Soborg, Denmark.	niels.hadrup@gmail.com	Svingen, Terje/A-5283-2010; Frederiksen, Hanne/N-8632-2013	Svingen, Terje/0000-0003-4650-7651; Frederiksen, Hanne/0000-0002-3180-9879; Hadrup, Niels/0000-0002-1188-445X; Vinggaard, Anne Marie/0000-0002-6822-3572; Pedersen, Mikael/0000-0001-6540-4805	Ministry of Food, Agriculture and Fisheries of Denmark; Danish Veterinary and Food Administration; EDMaRC - International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health	Ministry of Food, Agriculture and Fisheries of Denmark; Danish Veterinary and Food Administration; EDMaRC - International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health	This work was supported by The Ministry of Food, Agriculture and Fisheries of Denmark and the Danish Veterinary and Food Administration and EDMaRC - International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2013, TOXICOLOGY, V307, P89, DOI 10.1016/j.tox.2012.09.011; [Anonymous], [No title captured]; Bakker M, 2003, INDICATOR PCBS FOODS; Bashir S, 2006, TOXICOLOGY, V217, P63, DOI 10.1016/j.tox.2005.08.023; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chen HL, 2010, BIRTH DEFECTS RES C, V90, P272, DOI 10.1002/bdrc.20192; Christiansen S, 2014, REPRODUCTION, V147, P477, DOI 10.1530/REP-13-0377; Chu I, 1996, J APPL TOXICOL, V16, P121, DOI 10.1002/(SICI)1099-1263(199603)16:2<121::AID-JAT320>3.0.CO;2-G; Crofton KM, 2005, ENVIRON HEALTH PERSP, V113, P1549, DOI 10.1289/ehp.8195; Demur C, 2013, TOXICOLOGY, V308, P74, DOI 10.1016/j.tox.2013.03.004; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Frederiksen H, 2013, INT J HYG ENVIR HEAL, V216, P710, DOI 10.1016/j.ijheh.2013.01.007; Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; GUSTAFSSON J, 1985, J CLIN INVEST, V75, P604, DOI 10.1172/JCI111737; Hadrup N, 2015, ARCH TOXICOL; HERA, 2004, HERA RISK ASS AHTN 6; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; KOCIBA RJ, 1976, TOXICOL APPL PHARM, V35, P553, DOI 10.1016/0041-008X(76)90078-8; Kortenkamp A, 2014, REPRODUCTION, V147, P515, DOI 10.1530/REP-13-0440; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013; Maranghi F, 2013, FOOD CHEM TOXICOL, V56, P443, DOI 10.1016/j.fct.2013.02.056; Merhi M, 2010, TOXICOLOGY, V267, P80, DOI 10.1016/j.tox.2009.10.024; Nukaya M, 2009, P NATL ACAD SCI USA, V106, P4923, DOI 10.1073/pnas.0809613106; R Core Team, 2012, R LANG ENV STAT COMP; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rey RA, 2014, ANN ENDOCRINOL-PARIS, V75, P58, DOI 10.1016/j.ando.2014.03.001; Ronn M, 2013, TOXICOLOGY, V303, P125, DOI 10.1016/j.tox.2012.09.013; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shintyapina AB, 2014, B EXP BIOL MED+, V157, P473, DOI 10.1007/s10517-014-2594-x; Skov K, 2015, J CHROMATOGR B, V978, P83, DOI 10.1016/j.jchromb.2014.11.033; Stanko JP, 2010, REPROD TOXICOL, V30, P540, DOI 10.1016/j.reprotox.2010.07.006; Sun H, 2013, ONCOGENE, V32, P234, DOI 10.1038/onc.2012.34; Svingen T, 2016, J EPIDEMIOL COMMUN H, V70, P322, DOI 10.1136/jech-2015-206268; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Veeravalli S, 2014, BIOCHEM PHARMACOL, V90, P88, DOI 10.1016/j.bcp.2014.04.007; Wade MG, 2002, TOXICOL SCI, V67, P131, DOI 10.1093/toxsci/67.1.131; WAKABAYASHI K, 1993, ENVIRON HEALTH PERSP, V99, P129, DOI 10.2307/3431468; Wan HT, 2013, J HAZARD MATER, V261, P763, DOI 10.1016/j.jhazmat.2013.01.034; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xia W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090443; Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022	47	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162027	10.1371/journal.pone.0162027	http://dx.doi.org/10.1371/journal.pone.0162027			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598887	Green Submitted, gold, Green Published			2022-12-27	WOS:000383254800033
J	Loiseau, C; Augenstreich, J; Marchand, A; Harte, E; Garcia, M; Verdon, J; Mesnil, M; Lecomte, S; Berjeaud, JM				Loiseau, Clemence; Augenstreich, Jacques; Marchand, Adrienne; Harte, Etienne; Garcia, Martine; Verdon, Julien; Mesnil, Marc; Lecomte, Sophie; Berjeaud, Jean-Marc			Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging	PLOS ONE			English	Article							ANTI-LEGIONELLA PEPTIDE; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIMICROBIAL PEPTIDES; LASSO PEPTIDE; SINGLE; SPECTROSCOPY; DEFENSINS; STRAIN; LINES; PLANTARICIN	Antimicrobial peptides can be used as therapeutic agents against cancer cells. Warnericin RK and derivatives (WarnG20D and WarnF14V) were tested on various, solid tumor or leukemia, cancer cells. These peptides appeared to be cytotoxic on all the cell types tested, cancerous as well healthy, but very interestingly displayed no deleterious effect on healthy mononuclear cells. The mode of action of the peptide was proposed to be membranolytic, using chemical Raman imaging. Addition of peptide induced a large disorganization of the membrane leading to the loss of the content of inner compartments of Jurkat cell, whereas no effect was observed on the healthy mononuclear cells. The less hemolytic peptides WarnG20D and WarnF14V could be good candidates for the leukemia treatment.	[Loiseau, Clemence; Augenstreich, Jacques; Marchand, Adrienne; Verdon, Julien; Berjeaud, Jean-Marc] Univ Poitiers, Equipe Microbiol Eau, Lab Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France; [Augenstreich, Jacques; Harte, Etienne; Lecomte, Sophie] Univ Bordeaux, Inst Chim Biol Membranes & Nanoobjets, CNRS, UMR 5248, Pessac, France; [Garcia, Martine] Lab Inflammat Tissus Epitheliaux & Cytokines EA 4, Poitiers, France; [Mesnil, Marc] CNRS ERL 7368, Signalisat & Transports Ioniques Membranaires, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Berjeaud, JM (corresponding author), Univ Poitiers, Equipe Microbiol Eau, Lab Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France.	jean-marc.berjeaud@univ-poitiers.fr	Berjeaud, Jean-Marc/ABF-9966-2021; Berjeaud, Jean-Marc/GOP-0237-2022; harté, étienne/D-2721-2013	Berjeaud, Jean-Marc/0000-0001-9013-8430; harté, étienne/0000-0002-5642-887X; Mesnil, Marc/0000-0003-4922-0365; Verdon, Julien/0000-0002-9722-8719; Augenstreich, Jacques/0000-0003-2147-2675				Al-Benna S, 2012, ARCH GYNECOL OBSTET, V285, P1153, DOI 10.1007/s00404-011-2018-3; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; BAKER MA, 1993, CANCER RES, V53, P3052; Benevides JM, 2005, J RAMAN SPECTROSC, V36, P279, DOI 10.1002/jrs.1324; Brun M, 2015, FOOD RES INT, V67, P366, DOI 10.1016/j.foodres.2014.11.044; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Clede S, 2013, ANALYST, V138, P5627, DOI 10.1039/c3an00807j; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dieing T., 2011, CONFOCAL RAMAN MICRO; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Droin N, 2009, J PROTEOMICS, V72, P918, DOI 10.1016/j.jprot.2009.01.002; Elsard SS, 2015, J ORG CHEM, V80, P10252, DOI 10.1021/acs.joc.5b01878; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gajski G, 2013, ENVIRON TOXICOL PHAR, V36, P697, DOI 10.1016/j.etap.2013.06.009; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Harris V, 2011, CLIN ONCOL-UK, V23, P706, DOI 10.1016/j.clon.2011.04.014; Hechard Y, 2005, FEMS MICROBIOL LETT, V252, P19, DOI 10.1016/j.femsle.2005.03.046; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kamarajan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131008; Kann B, 2015, ADV DRUG DELIVER REV, V89, P71, DOI 10.1016/j.addr.2015.02.006; Lee DG, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-21; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Marchand A, 2011, PEPTIDES, V32, P845, DOI 10.1016/j.peptides.2011.01.025; Marchand A, 2015, MOL CELL BIOCHEM, V405, P159, DOI 10.1007/s11010-015-2407-1; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NAUS CCG, 1992, CANCER RES, V52, P4208; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Niggemann J, 2014, CHEMBIOCHEM, V15, P1021, DOI 10.1002/cbic.201300778; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; PETICOLAS WL, 1987, BIOL APPLICATIONS RA, V1, P81; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Qiao J, 2011, ANALYST, V136, P2077, DOI 10.1039/c1an15067g; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Sand SL, 2007, J MEMBRANE BIOL, V216, P61, DOI 10.1007/s00232-007-9030-3; Schie IW, 2014, ANALYST, V139, P2726, DOI 10.1039/c4an00250d; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Tareq FS, 2014, MAR DRUGS, V12, P871, DOI 10.3390/md12020871; Um S, 2013, J NAT PROD, V76, P873, DOI 10.1021/np300902g; Verdon J, 2008, PEPTIDES, V29, P978, DOI 10.1016/j.peptides.2008.01.017; Verdon J, 2011, BBA-BIOMEMBRANES, V1808, P1146, DOI 10.1016/j.bbamem.2010.12.011; Verdon J, 2009, BIOPHYS J, V97, P1933, DOI 10.1016/j.bpj.2009.06.053; Verdon J, 2009, PEPTIDES, V30, P817, DOI 10.1016/j.peptides.2008.12.017; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945	52	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162007	10.1371/journal.pone.0162007	http://dx.doi.org/10.1371/journal.pone.0162007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598770	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800032
J	Tan, L; Moriel, DG; Totsika, M; Beatson, SA; Schembri, MA				Tan, Lendl; Moriel, Danilo G.; Totsika, Makrina; Beatson, Scott A.; Schembri, Mark A.			Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; DEPENDENT TRANSCRIPTION TERMINATION; PROTEIN H-NS; BIOFILM FORMATION; RNA-POLYMERASE; NUSA PROTEIN; MOLECULAR CHARACTERIZATION; AUTOTRANSPORTER PROTEINS; ANTIBIOTIC-RESISTANCE; GLOBAL DISSEMINATION	Extra-intestinal pathogenic Escherichia coli (ExPEC) are responsible for diverse infections including meningitis, sepsis and urinary tract infections. The alarming rise in anti-microbial resistance amongst ExPEC complicates treatment and has highlighted the need for alternative preventive measures. SslE is a lipoprotein secreted by a dedicated type II secretion system in E. coli that was first identified as a potential vaccine candidate using reverse genetics. Although the function and protective efficacy of SslE has been studied, the molecular mechanisms that regulate SslE expression remain to be fully elucidated. Here, we show that while the expression of SslE can be detected in E. coli culture supernatants, different strains express and secrete different amounts of SslE when grown under the same conditions. While the histone-like transcriptional regulator H-NS strongly represses sslE at ambient temperatures, the variation in SslE expression at human physiological temperature suggested a more complex mode of regulation. Using a genetic screen to identify novel regulators of sslE in the high SslE-expressing strain UTI89, we defined a new role for the nucleoid-associated regulator Fis and the ribosome-binding GTPase TypA as positive regulators of sslE transcription. We also showed that Fis-mediated enhancement of sslE transcription is dependent on a putative Fis-binding sequence located upstream of the -35 sequence in the core promoter element, and provide evidence to suggest that Fis may work in complex with H-NS to control SslE expression. Overall, this study has defined a new mechanism for sslE regulation and increases our understanding of this broadly conserved E. coli vaccine antigen.	[Tan, Lendl; Moriel, Danilo G.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Totsika, Makrina] Queensland Univ Technol, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia	University of Queensland; Queensland University of Technology (QUT)	Schembri, MA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Tan, Lendl/Y-2149-2018; Totsika, Makrina/A-8993-2011	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Tan, Lendl/0000-0002-9955-2440; Totsika, Makrina/0000-0003-2468-0293	Australian National Health and Medical Research Council (NHMRC) [GNT1042651, GNT1067455]; NHMRC Senior Research Fellowship [GNT1106930]; ARC Discovery Early Career Researcher Award [DE130101169]; NHMRC Career Development Fellowship [GNT1090456]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Discovery Early Career Researcher Award(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC; GNT1042651 and GNT1067455). MAS is supported by an NHMRC Senior Research Fellowship (GNT1106930), MT is supported by an ARC Discovery Early Career Researcher Award (DE130101169) and SAB is supported by an NHMRC Career Development Fellowship (GNT1090456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Afflerbach H, 1999, J MOL BIOL, V286, P339, DOI 10.1006/jmbi.1998.2494; Allsopp LP, 2012, J BACTERIOL, V194, P5769, DOI 10.1128/JB.01264-12; Allsopp LP, 2012, INFECT IMMUN, V80, P321, DOI 10.1128/IAI.05322-11; Allsopp LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09; [Anonymous], 2005, Nat Methods, V2, P629; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baldi DL, 2012, INFECT IMMUN, V80, P2042, DOI 10.1128/IAI.06160-11; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Bauer HW, 2005, EUR UROL, V47, P542, DOI 10.1016/j.eururo.2004.12.009; Bauer HW, 2002, INT J ANTIMICROB AG, V19, P451, DOI 10.1016/S0924-8579(02)00106-1; Beach MB, 1998, J BACTERIOL, V180, P5932, DOI 10.1128/JB.180.22.5932-5946.1998; Bishop AC, 2002, J BIOL CHEM, V277, P25090, DOI 10.1074/jbc.M203208200; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOSCH L, 1990, BIOCHIM BIOPHYS ACTA, V1050, P293, DOI 10.1016/0167-4781(90)90184-4; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Browning DF, 2000, MOL MICROBIOL, V37, P1258, DOI 10.1046/j.1365-2958.2000.02087.x; Brumbaugh AR, 2013, INFECT IMMUN, V81, P3309, DOI 10.1128/IAI.00470-13; Brumbaugh AR, 2012, EXPERT REV VACCINES, V11, P663, DOI [10.1586/erv.12.36, 10.1586/ERV.12.36]; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choudhury P, 2015, J BACTERIOL, V197, P1819, DOI 10.1128/JB.00023-15; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeCanio MS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-130; deLivron MA, 2009, BIOCHEMISTRY-US, V48, P10533, DOI 10.1021/bi901026z; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Dunstan RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003117; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Fan H, 2015, J BIOL CHEM, DOI [10.1074/, DOI 10.1074/101]; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; FILLOUX A, 1990, EMBO J, V9, P4323, DOI 10.1002/j.1460-2075.1990.tb07881.x; FILUTOWICZ M, 1992, J BACTERIOL, V174, P398, DOI 10.1128/jb.174.2.398-407.1992; Forde BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104400; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; FRIEDMAN DI, 1974, VIROLOGY, V58, P141, DOI 10.1016/0042-6822(74)90149-4; Gerganova V, 2015, J BIOL CHEM, V290, P8095, DOI 10.1074/jbc.M114.628131; Goldberg MD, 2001, MOL MICROBIOL, V41, P549, DOI 10.1046/j.1365-2958.2001.02526.x; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; GREENBLATT J, 1980, P NATL ACAD SCI-BIOL, V77, P1991, DOI 10.1073/pnas.77.4.1991; Gupta K, 2002, AM J MED, V113, p29S; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Hernandes RT, 2013, INFECT IMMUN, V81, P3793, DOI 10.1128/IAI.00620-13; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Iwobi A, 2003, INFECT IMMUN, V71, P1872, DOI 10.1128/IAI.71.4.1872-1879.2003; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Kainz M, 1998, J MOL BIOL, V284, P1379, DOI 10.1006/jmbi.1998.2272; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Kotlajich MV, 2015, ELIFE, V4, DOI 10.7554/eLife.04970; KUNG HF, 1975, J BIOL CHEM, V250, P1556; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo QW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003446; Luo QW, 2014, INFECT IMMUN, V82, P509, DOI 10.1128/IAI.01106-13; Madrid C, 2002, J BACTERIOL, V184, P5058, DOI 10.1128/JB.184.18.5058-5066.2002; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Miller JH, 1992, SHORT COURSE BACTERI, DOI DOI 10.1006/JMBI.1998.2272; Moriel DG, 2013, CURR PHARM BIOTECHNO, V14, P967; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Muller CM, 2006, J BACTERIOL, V188, P5428, DOI 10.1128/JB.01956-05; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nafissi M, 2012, J BACTERIOL, V194, P2458, DOI 10.1128/JB.00053-12; NAKAMURA Y, 1983, MOL GEN GENET, V190, P196, DOI 10.1007/BF00330640; NAKAMURA Y, 1986, J MOL BIOL, V189, P103, DOI 10.1016/0022-2836(86)90384-0; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; Nesta B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004124; Nichols KB, 2016, J BACTERIOL, V198, P1487, DOI 10.1128/JB.00791-15; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Nowak-Lovato K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002881; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Peirano G, 2011, ANTIMICROB AGENTS CH, V55, P2986, DOI 10.1128/AAC.01763-10; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Ronald A, 2002, AM J MED, V113, p14S; Rossiter AE, 2011, MOL MICROBIOL, V81, P179, DOI 10.1111/j.1365-2958.2011.07685.x; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Roy K, 2010, INFECT IMMUN, V78, P3027, DOI 10.1128/IAI.00264-10; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, INFECT IMMUN, V71, P7164, DOI 10.1128/IAI.71.12.7164-7169.2003; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Saxena S, 2011, J BACTERIOL, V193, P3832, DOI 10.1128/JB.00220-11; SCHAUER AT, 1987, J MOL BIOL, V194, P679, DOI 10.1016/0022-2836(87)90245-2; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Scott K, 2003, BRIT J BIOMED SCI, V60, P168, DOI 10.1080/09674845.2003.11978047; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; TIPPNER D, 1994, MOL MICROBIOL, V11, P589, DOI 10.1111/j.1365-2958.1994.tb00339.x; Totsika M, 2012, APPL ENVIRON MICROB, V78, P2179, DOI 10.1128/AEM.06680-11; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; Valeri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117486; Vogel U, 1997, J BIOL CHEM, V272, P12265, DOI 10.1074/jbc.272.19.12265; Wurpel DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093177; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825; Yakhnin AV, 2002, P NATL ACAD SCI USA, V99, P11067, DOI 10.1073/pnas.162373299; YAMADA H, 1991, MOL GEN GENET, V230, P332, DOI 10.1007/BF00290685; Yang J, 2007, J BACTERIOL, V189, P142, DOI 10.1128/JB.01115-06; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08; ZHENG CH, 1994, P NATL ACAD SCI USA, V91, P7543, DOI 10.1073/pnas.91.16.7543; Zhou J, 2011, MOL CELL, V44, P635, DOI 10.1016/j.molcel.2011.09.018	118	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162391	10.1371/journal.pone.0162391	http://dx.doi.org/10.1371/journal.pone.0162391			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598999	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800064
J	Zielinski, BL; Allen, AE; Carpenter, EJ; Coles, VJ; Crump, BC; Doherty, M; Foster, RA; Goes, JI; Gomes, HR; Hood, RR; McCrow, JP; Montoya, JP; Moustafa, A; Satinsky, BM; Sharma, S; Smith, CB; Yager, PL; Paul, JH				Zielinski, Brian L.; Allen, Andrew E.; Carpenter, Edward J.; Coles, Victoria J.; Crump, Byron C.; Doherty, Mary; Foster, Rachel A.; Goes, Joaquim I.; Gomes, Helga R.; Hood, Raleigh R.; McCrow, John P.; Montoya, Joseph P.; Moustafa, Ahmed; Satinsky, Brandon M.; Sharma, Shalabh; Smith, Christa B.; Yager, Patricia L.; Paul, John H.			Patterns of Transcript Abundance of Eukaryotic Biogeochemically-Relevant Genes in the Amazon River Plume	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CYLINDROTHECA-FUSIFORMIS; EXPRESSION ANALYSIS; NITROGEN-FIXATION; PHYTOPLANKTON; RNA; SEQUENCES; EVOLUTION; TRANSPORTERS; PRODUCTIVITY	The Amazon River has the largest discharge of all rivers on Earth, and its complex plume system fuels a wide array of biogeochemical processes, across a large area of the western tropical North Atlantic. The plume thus stimulates microbial processes affecting carbon sequestration and nutrient cycles at a global scale. Chromosomal gene expression patterns of the 2.0 to 156 mu m size-fraction eukaryotic microbial community were investigated in the Amazon River Plume, generating a robust dataset (more than 100 million mRNA sequences) that depicts the metabolic capabilities and interactions among the eukaryotic microbes. Combining classical oceanographic field measurements with metatranscriptomics yielded characterization of the hydrographic conditions simultaneous with a quantification of transcriptional activity and identity of the community. We highlight the patterns of eukaryotic gene expression for 31 biogeochemically significant gene targets hypothesized to be valuable within forecasting models. An advantage to this targeted approach is that the database of reference sequences used to identify the target genes was selectively constructed and highly curated optimizing taxonomic coverage, throughput, and the accuracy of annotations. A coastal diatom bloom highly expressed nitrate transporters and carbonic anhydrase presumably to support high growth rates and enhance uptake of low levels of dissolved nitrate and CO2. Diatom-diazotroph association (DDA: diatoms with nitrogen fixing symbionts) blooms were common when surface salinity was mesohaline and dissolved nitrate concentrations were below detection, and hence did not show evidence of nitrate utilization, suggesting they relied on ammonium transporters to aquire recently fixed nitrogen. These DDA blooms in the outer plume had rapid turnover of the photosystem D1 protein presumably caused by photodegradation under increased light penetration in clearer waters, and increased expression of silicon transporters as silicon became limiting. Expression of these genes, including carbonic anhydrase and transporters for nitrate and phosphate, were found to reflect the physiological status and biogeochemistry of river plume environments. These relatively stable patterns of eukaryotic transcript abundance occurred over modest spatiotemporal scales, with similarity observed in sample duplicates collected up to 2.45 km in space and 120 minutes in time. These results confirm the use of metatranscriptomics as a valuable tool to understand and predict microbial community function.	[Zielinski, Brian L.; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Allen, Andrew E.; McCrow, John P.] J Craig Venter Inst, Dept Microbial & Environm Genom, San Diego, CA USA; [Carpenter, Edward J.] San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA; [Coles, Victoria J.; Hood, Raleigh R.] Univ Maryland, Horn Point Lab, Ctr Environm Sci, Cambridge, MD USA; [Crump, Byron C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Doherty, Mary] Rhodes Coll, Memphis, TN 38112 USA; [Foster, Rachel A.] Univ Calif Santa Cruz, Ocean Sci, Santa Cruz, CA 95064 USA; [Goes, Joaquim I.; Gomes, Helga R.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Montoya, Joseph P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Moustafa, Ahmed] Amer Univ Cairo, Dept Biol, New Cairo, Egypt; [Moustafa, Ahmed] Amer Univ Cairo, Biotechnol Grad Program, New Cairo, Egypt; [Satinsky, Brandon M.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sharma, Shalabh; Smith, Christa B.; Yager, Patricia L.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Foster, Rachel A.] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden	State University System of Florida; University of South Florida; J. Craig Venter Institute; California State University System; San Francisco State University; University System of Maryland; University of Maryland Center for Environmental Science; Oregon State University; University of California System; University of California Santa Cruz; Columbia University; University System of Georgia; Georgia Institute of Technology; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; Stockholm University	Paul, JH (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	jpaul@usf.edu	Coles, Victoria/AAB-3331-2022; Montoya, Joseph/C-3115-2013; Moustafa, Ahmed/AAZ-3991-2020; Hood, Raleigh/AGW-0453-2022; Allen, Andrew E/C-4896-2012; Crump, Byron/ABF-3711-2020; Yager, Patricia L/K-8020-2014; Moustafa, Ahmed/C-5234-2009	Montoya, Joseph/0000-0001-7197-4660; Moustafa, Ahmed/0000-0002-0111-3555; Allen, Andrew E/0000-0001-5911-6081; Yager, Patricia L/0000-0002-8462-6427; Moustafa, Ahmed/0000-0002-0111-3555; McCrow, John/0000-0002-7014-5040; Coles, Victoria/0000-0002-7247-0007; Crump, Byron/0000-0001-7062-1273; Hood, Raleigh/0000-0002-7248-3481; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation [2293, 2928, 3828]; National Science Foundation (NSF) [NSF-OCE 0934095, NSF-OCE 0929015, OCE-1136477]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF))	Funding was provided by the Gordon and Betty Moore Foundation as part of the River Ocean Continuum of the Amazon (ROCA) project (Grants GBMF #2293 and #2928). This funded BLZ EJC VJC BCC MD RAF JIG RG RRH J.P. Montoya BMS SS CBS PLY and JHP. This agency contributed to the study design and the data analysis only. They encourage publication of the data. Gordon and Betty Moore Foundation funded AEA, J.P. McCrow and AM (Grant #3828). This agency contributed to the study design and the data analysis only. They encourage publication of the data. The National Science Foundation (NSF) funded the cruise and all the supporting data (Grant NSF-OCE 0934095). This funded BLZ EJC VJC BCC MD RAF JIG HRG RRH J.P. Montoya BMS SS CBS PLY and JHP. This agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Science Foundation (NSF) funded RAF (Grant NSF-OCE 0929015). This agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Science Foundation (NSF) funded AEA J.P. McCrow and AM (OCE-1136477). This agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Gordon and Betty Moore Foundation as part of the River Ocean Continuum of the Amazon (ROCA) project (Grants GBMF #2293 and #2928). The National Science Foundation (NSF) funded the cruise and all the supporting data (Grant NSF-OCE 0934095; RAF is funded by NSF-OCE 0929015); JPMcCrow, AEA and AM were funded by the Gordon and Betty Moore Foundation (Grant GBMF #3828) and the NSF (Grant OCE-1136477). We thank the captain and crew of the RV Knorr for excellent at-sea support. The authors declare no competing interests.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bombar D, 2011, MAR ECOL PROG SER, V424, P39, DOI 10.3354/meps08976; Bouchard JN, 2006, PHOTOCHEM PHOTOBIOL, V82, P936, DOI 10.1562/2005-08-31-IR-666; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Chakraborty S, 2015, MAR ECOL PROG SER, V521, P31, DOI 10.3354/meps11107; Chew LL, 2011, HYDROBIOLOGIA, V666, P127, DOI 10.1007/s10750-010-0092-3; Coles VJ, 2013, J GEOPHYS RES-OCEANS, V118, P6894, DOI 10.1002/2013JC008981; DAGG MJ, 1991, CONT SHELF RES, V11, P1409, DOI 10.1016/0278-4343(91)90043-6; Del Vecchio R, 2004, J GEOPHYS RES-OCEANS, V109, DOI [10.1029/2004JC002503, 10.1029/2004jc002503]; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; Foster RA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1197, DOI 10.1016/B978-0-12-372522-6.00027-X; Foster RA, 2009, ENVIRON MICROBIOL, V11, P741, DOI 10.1111/j.1462-2920.2008.01796.x; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Goes JI, 2014, PROG OCEANOGR, V120, P29, DOI 10.1016/j.pocean.2013.07.010; Hayes R, 1999, TRENDS BIOCHEM SCI, V24, P199, DOI 10.1016/S0968-0004(99)01388-2; Hickey BM, 2010, J GEOPHYS RES OCEANS, V115; Hildebrand M, 2005, J PHYCOL, V41, P105, DOI 10.1111/j.1529-8817.2005.04108.x; Hildebrand M, 1998, MOL GEN GENET, V260, P480, DOI 10.1007/s004380050920; Hilton JA, 2015, ISME J, V9, P1557, DOI 10.1038/ismej.2014.240; Hilton JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2748; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Huang LM, 2004, MAR POLLUT BULL, V49, P588, DOI 10.1016/j.marpolbul.2004.03.015; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; MAGUE TH, 1974, MAR BIOL, V24, P109, DOI 10.1007/BF00389344; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MCLACHLA.J, 1965, CAN J BOTANY, V43, P707, DOI 10.1139/b65-079; McLACHLAN J., 1966, P511; Medeiros PM, 2015, GLOBAL BIOGEOCHEM CY; Molleri GSF, 2010, CONT SHELF RES, V30, P342, DOI 10.1016/j.csr.2009.11.015; Moroney JV, 2001, PLANT CELL ENVIRON, V24, P141, DOI 10.1111/j.1365-3040.2001.00669.x; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rivers AR, 2013, ISME J, V7, P2315, DOI 10.1038/ismej.2013.129; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Round F. E., 1990, DIATOMS BIOL MORPHOL; Salisbury J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006989; Satinsky BM, 2014, P NATL ACAD SCI USA; Satinsky BM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-17; Schaeffer BA, 2012, MAR POLLUT BULL, V64, P1705, DOI 10.1016/j.marpolbul.2012.03.017; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith WO, 1996, CONT SHELF RES, V16, P291, DOI 10.1016/0278-4343(95)00007-N; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stukel M, 2013, BIOGEOSCIENCES DISCU, V10; Stukel MR, 2014, BIOGEOSCIENCES, V11, P3259, DOI 10.5194/bg-11-3259-2014; Subramaniam A, 2008, P NATL ACAD SCI USA, V105, P10460, DOI 10.1073/pnas.0710279105; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Villareal TA, 2003, MICROB ECOL, V45, P1, DOI 10.1007/s00248-002-1012-5; Ward B, 2013, MARINE NIGROGEN CYCL, V368; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yeung LY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053356; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	68	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0160929	10.1371/journal.pone.0160929	http://dx.doi.org/10.1371/journal.pone.0160929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598790	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800003
J	Maiwald, T; Hass, H; Steiert, B; Vanlier, J; Engesser, R; Raue, A; Kipkeew, F; Bock, HH; Kaschek, D; Kreutz, C; Timmer, J				Maiwald, Tim; Hass, Helge; Steiert, Bernhard; Vanlier, Joep; Engesser, Raphael; Raue, Andreas; Kipkeew, Friederike; Bock, Hans H.; Kaschek, Daniel; Kreutz, Clemens; Timmer, Jens			Driving the Model to Its Limit: Profile Likelihood Based Model Reduction	PLOS ONE			English	Article							COMPLEXITY REDUCTION; BIOCHEMICAL NETWORKS; INVARIANT MANIFOLD; CHEMICAL-KINETICS; BRAIN-DEVELOPMENT; REELIN; RECEPTORS; DYNAMICS	In systems biology, one of the major tasks is to tailor model complexity to information content of the data. A useful model should describe the data and produce well-determined parameter estimates and predictions. Too small of a model will not be able to describe the data whereas a model which is too large tends to overfit measurement errors and does not provide precise predictions. Typically, the model is modified and tuned to fit the data, which often results in an oversized model. To restore the balance between model complexity and available measurements, either new data has to be gathered or the model has to be reduced. In this manuscript, we present a data-based method for reducing non-linear models. The profile likelihood is utilised to assess parameter identifiability and designate likely candidates for reduction. Parameter dependencies are analysed along profiles, providing context-dependent suggestions for the type of reduction. We discriminate four distinct scenarios, each associated with a specific model reduction strategy. Iterating the presented procedure eventually results in an identifiable model, which is capable of generating precise and testable predictions. Source code for all toy examples is provided within the freely available, open-source modelling environment Data2Dynamics based on MATLAB available at http://www.data2dynamics.org/, as well as the R packages dMod/cOde available at https://github.com/dkaschek/. Moreover, the concept is generally applicable and can readily be used with any software capable of calculating the profile likelihood.	[Maiwald, Tim; Hass, Helge; Steiert, Bernhard; Vanlier, Joep; Engesser, Raphael; Kaschek, Daniel; Kreutz, Clemens; Timmer, Jens] Univ Freiburg, Inst Phys, Freiburg, Germany; [Raue, Andreas] Merrimack Pharmaceut, Boston, MA USA; [Kipkeew, Friederike; Bock, Hans H.] Univ Hosp Duesseldorf, Dept Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Kreutz, Clemens; Timmer, Jens] Univ Freiburg, Ctr Biosyst Anal ZBSA, Freiburg, Germany; [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Timmer, J (corresponding author), Univ Freiburg, Inst Phys, Freiburg, Germany.; Timmer, J (corresponding author), Univ Freiburg, Ctr Biosyst Anal ZBSA, Freiburg, Germany.; Timmer, J (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.	jeti@fdm.uni-freiburg.de	Kreutz, Clemens/ABC-9732-2020; Bock, Hans/AAF-2635-2021	Kreutz, Clemens/0000-0002-8796-5766; Maiwald, Tim/0000-0002-4525-9556	German Ministry of Education and Research [031L0048, 0316042G, 0316174C, 0316182B, 031A604B]; EU-IMI grant MIP-DILI [115336]; DFG grant [FOR1202, TI315/10-1]; Merrimack Pharmaceuticals	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); EU-IMI grant MIP-DILI; DFG grant(German Research Foundation (DFG)); Merrimack Pharmaceuticals	This work was supported by the German Ministry of Education and Research through the grants LiSyM (Grant No. 031L0048), LungSys II (Grant No. 0316042G), ReelinSys (Grant No. 0316174C), SBEpo (Grant No. 0316182B), IMOMESIC (Grant No. 031A604B). This work was also supported by the EU-IMI grant MIP-DILI (Grant No. 115336) and the DFG grant FOR1202 (TP7, Grant No. TI315/10-1). Merrimack Pharmaceuticals provided support in the form of salaries for author AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of author AR are articulated in the 'author contributions' section.	Apri M, 2012, J THEOR BIOL, V304, P16, DOI 10.1016/j.jtbi.2012.03.019; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Boulier F, 2011, MATH COMPUT SCI, V5, P289, DOI 10.1007/s11786-011-0093-2; Caffrey JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110415; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; D'Arcangelo G, 2005, INT REV NEUROBIOL, V71, P383, DOI 10.1016/S0074-7742(05)71016-3; Drakew A, 1998, NEUROSCIENCE, V82, P1079; Fatemi SH, 2001, MOL PSYCHIATR, V6, P129, DOI 10.1038/sj.mp.4000129; FEDER PI, 1968, ANN MATH STAT, V39, P2044, DOI 10.1214/aoms/1177698032; Feng LB, 2009, MOL CELL BIOL, V29, P324, DOI 10.1128/MCB.00663-08; Fisher Ronald A., 1912, MESSENGER MATH, V41, P155; Gorban AN, 2003, CHEM ENG SCI, V58, P4751, DOI 10.1016/j.ces.2002.12.001; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kreutz C, 2007, BIOINFORMATICS, V23, P2747, DOI 10.1093/bioinformatics/btm397; LEIS JR, 1988, ACM T MATH SOFTWARE, V14, P45, DOI 10.1145/42288.46156; Maurya MR, 2005, IEE P SYST BIOL, V152, P229, DOI 10.1049/ip-syb:20050014; Merkt B, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012920; Petzold L, 1999, AICHE J, V45, P869, DOI 10.1002/aic.690450418; Quaiser T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-30; Quinn GP, 2003, EXPT DESIGN DATA ANA; Radulescu O., 2012, Frontiers in Genetics, V3, P131, DOI 10.3389/fgene.2012.00131; Raue A, 2015, BIOINFORMATICS, V31, P3558, DOI 10.1093/bioinformatics/btv405; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074335; Roussel MR, 2001, CHAOS, V11, P196, DOI 10.1063/1.1349891; Schmidt H, 2008, BIOINFORMATICS, V24, P848, DOI 10.1093/bioinformatics/btn035; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Segel IH, 1968, BIOCH CALCULATIONS T; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Steiert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040052; Sunnaker M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-140; Swameye I, 2003, P NATL ACAD SCI USA, V100, P1028, DOI 10.1073/pnas.0237333100; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Transtrum MK, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.098701; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496	39	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162366	10.1371/journal.pone.0162366	http://dx.doi.org/10.1371/journal.pone.0162366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588423	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800052
J	Han, KH; Kim, AR; Kim, MY; Ahn, S; Oh, SH; Song, JH; Choi, BY				Han, Kyu-Hee; Kim, Ah Reum; Kim, Min Young; Ahn, Soyeon; Oh, Seung-Ha; Song, Ju Hun; Choi, Byung Yoon			Establishment of a Flexible Real-Time Polymerase Chain Reaction-Based Platform for Detecting Prevalent Deafness Mutations Associated with Variable Degree of Sensorineural Hearing Loss in Koreans	PLOS ONE			English	Article							EMBEDDED TISSUE SPECIMENS; CELL LUNG-CANCER; MITOCHONDRIAL GENE-MUTATIONS; ANALYTIC PERFORMANCE; VESTIBULAR AQUEDUCT; CDH23 MUTATIONS; PCR ASSAY; IDENTIFICATION; FREQUENCIES; CHINA	Many cutting-edge technologies based on next-generation sequencing (NGS) have been employed to identify candidate variants responsible for sensorineural hearing loss (SNHL). However, these methods have limitations preventing their wide clinical use for primary screening, in that they remain costly and it is not always suitable to analyze massive amounts of data. Several different DNA chips have been developed for screening prevalent mutations at a lower cost. However, most of these platforms do not offer the flexibility to add or remove target mutations, thereby limiting their wider use in a field that requires frequent updates. Therefore, we aimed to establish a simpler and more flexible molecular diagnostic platform based on ethnicity-specific mutation spectrums of SNHL, which would enable bypassing unnecessary filtering steps in a substantial portion of cases. In addition, we expanded the screening platform to cover varying degrees of SNHL. With this aim, we selected 11 variants of 5 genes (GJB2, SLC26A4, MTRNR1, TMPRSS3, and CDH23) showing high prevalence with varying degrees in Koreans and developed the U-TOP (TM) HL Genotyping Kit, a real-time PCR-based method using the MeltingArray technique and peptide nucleic acid probes. The results of 271 DNA samples with wild type sequences or mutations in homo-or heterozygote form were compared between the U-TOP (TM) HL Genotyping Kit and Sanger sequencing. The positive and negative predictive values were 100%, and this method showed perfect agreement with Sanger sequencing, with a Kappa value of 1.00. The U-TOP (TM) HL Genotyping Kit showed excellent performance in detecting varying degrees and phenotypes of SNHL mutations in both homozygote and heterozygote forms, which are highly prevalent in the Korean population. This platform will serve as a useful and cost-effective first-line screening tool for varying degrees of genetic SNHL and facilitate genome-based personalized hearing rehabilitation for the Korean population.	[Han, Kyu-Hee; Song, Ju Hun] Natl Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Ah Reum; Kim, Min Young; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea; [Kim, Ah Reum] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Oh, Seung-Ha] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Choi, Byung Yoon] Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon, South Korea	National Medical Center - Korea; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Choi, BY (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea.; Choi, BY (corresponding author), Seoul Natl Univ, Coll Med, Wide River Inst Immunol, Hongcheon, South Korea.	choiby@snubh.org			Daejeon IRPE (Institute for Regional Program Evaluation Promotion) Project through Research and Development for Regional Industry of the MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea [R0004264]; Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [HI14C1867, H12C0014]	Daejeon IRPE (Institute for Regional Program Evaluation Promotion) Project through Research and Development for Regional Industry of the MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea; Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea	This research was supported by the Daejeon IRPE (Institute for Regional Program Evaluation Promotion) Project (R0004264) through the Research and Development for Regional Industry of the MOTIE (Ministry of Trade, Industry and Energy) Republic of Korea. This study was also supported by funding from the Korean Healthcare Technology R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (HI14C1867 and H12C0014 to BYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson S, 2012, ARCH PATHOL LAB MED, V136, P1385, DOI 10.5858/arpa.2011-0505-OA; Bae JW, 2008, INT J MOL MED, V22, P175, DOI 10.3892/ijmm_00000005; Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463; Catteau A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-58; Chang MY, 2015, MOL CELLS, V38, P781, DOI 10.14348/molcells.2015.0078; Chang YS, 2014, CLIN CHIM ACTA, V436, P169, DOI 10.1016/j.cca.2014.05.008; Choi BY, 2009, GENET TEST MOL BIOMA, V13, P679, DOI 10.1089/gtmb.2009.0054; Choi SY, 2009, CLIN EXP OTORHINOLAR, V2, P44, DOI 10.3342/ceo.2009.2.1.44; Chun JY, 2014, J MOL DIAGN, V16, P573, DOI 10.1016/j.jmoldx.2014.04.006; Chung J, 2014, J MOL MED, V92, P651, DOI 10.1007/s00109-014-1128-3; Svidnicki MCCM, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0232-8; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Eriksson M, 1996, NAT STRUCT BIOL, V3, P410, DOI 10.1038/nsb0596-410; Hur D, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0027-5; Kenneth J., 2011, ASCO ANN M, P10523; Kim SY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0624-8; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125416; Kim SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061592; Kimura H, 2014, LUNG CANCER, V83, P329, DOI 10.1016/j.lungcan.2013.12.012; Kudo T, 2000, AM J MED GENET, V90, P141, DOI 10.1002/(SICI)1096-8628(20000117)90:2<141::AID-AJMG10>3.0.CO;2-G; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036621; Li ZY, 2005, HUM GENET, V117, P9, DOI 10.1007/s00439-005-1276-1; Liu XZ, 2001, ANN OTO RHINOL LARYN, V110, P356, DOI 10.1177/000348940111000412; Lopez-Rios F, 2013, J CLIN PATHOL, V66, P381, DOI 10.1136/jclinpath-2012-201240; Lopez-Rios F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053733; Miyagawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040366; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; O'Donnell P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-210; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Park JH, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0167-8; Qiu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09211; Rah YC, 2015, LARYNGOSCOPE, V125, pE216, DOI 10.1002/lary.25079; Rebscher SJ, 2008, J REHABIL RES DEV, V45, P731, DOI 10.1682/JRRD.2007.08.0119; Sagong B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057237; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; Wagatsuma M, 2007, CLIN GENET, V72, P339, DOI 10.1111/j.1399-0004.2007.00833.x; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; Woo HM, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-46; 정한신, 2004, [Korean Journal of Otorhinolaryngology Head and Neck Surgery, 대한이비인후과학회지 두경부외과학], V47, P206	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161756	10.1371/journal.pone.0161756	http://dx.doi.org/10.1371/journal.pone.0161756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583405	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600055
J	Rahman, M; Yunus, FM; Shah, R; Jhohura, FT; Mistry, SK; Quayyum, T; Aktar, B; Afsana, K				Rahman, Mahfuzar; Yunus, Fakir Md.; Shah, Rasheduzzaman; Jhohura, Fatema Tuz; Mistry, Sabuj Kanti; Quayyum, Tasmeen; Aktar, Bachera; Afsana, Kaosar			A Controlled Before-and-After Perspective on the Improving Maternal, Neonatal, and Child Survival Program in Rural Bangladesh: An Impact Analysis	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; ANTENATAL CARE; WOMENS GROUPS; NEWBORN; MORTALITY; MORBIDITY; KNOWLEDGE; COUNTDOWN; COVERAGE; DURATION	Objectives We evaluated the impact of the Improving Maternal, Neonatal, and Child Survival (IMNCS) project, which is being implemented by BRAC in rural communities in Bangladesh. Methods Four districts received program intervention i.e. trained community health workers to deliver essential maternal, neonatal, and child healthcare and nutrition services while two districts were treated as comparison group. A quasi-experimental study design (compared before-and- after) was undertaken. Baseline survey was conducted in 2008 among 7200 women followed by end line in 2012 among 4800 women with similar characteristics in the same villages. We evaluated maternal antenatal and post natal checkup, birth plans and delivery, complication and referred cases during antenatal checkup and post natal period, and child health indicators such as birth asphyxia, neonatal sepsis, and its management by the medically trained provider. Findings Increased number (four or more) antenatal visits, skill-birth attended delivery and postnatal visits (three or more) in the intervention group preceding four-year intervention period were observed compare to their counterpart. We noted negative difference-in-difference estimator (-5.0%, P = 0.159) regarding to the all major birth plans i.e. delivery place, birth attendant, and saved money in the comparison areas. Significant reduction of ante-partum and intra-partum complications occurred in the intervention group, contrary complications of such event increased in the comparison areas (-6.3%, P<0.05 and -20.5%, P<0.001 respectively). Referral case to the health centers due to these complications boosted significantly in intervention group than comparison group (2.3%, P<0.01 and 6.6%, P<0.001 respectively). Mother's knowledge of breastfeeding initiation and the practice of initiating breastfeeding within an hour of birth amplified significantly (14.6%, P<0.001 and 8.3%, P<0.001 respectively). We did not find any significant difference regards to the management of low birth weight by the medically trained health care provider and complete vaccination between the intervention and comparison arm. Conclusion Medically trained health care provider assisted community based public health intervention could increase number of antenatal and postnatal visit, thereby could decrease pregnancy associated complications. These interventions may be considered for further up scaling when resources are limited.	[Rahman, Mahfuzar; Yunus, Fakir Md.; Jhohura, Fatema Tuz; Mistry, Sabuj Kanti; Quayyum, Tasmeen] BRAC Ctr, BRAC, Res & Evaluat Div, 75 Mohakhali, Dhaka, Bangladesh; [Shah, Rasheduzzaman] Save Children USA, Dept Global Hlth, Washington, DC USA; [Aktar, Bachera; Afsana, Kaosar] BRAC Ctr, BRAC, Hlth Nutr & Populat Programme, 75 Mohakhali, Dhaka, Bangladesh; [Afsana, Kaosar] BRAC Univ, James P Grant Sch Publ Hlth, 68 Shahid Tajuddin Ahmed Sharani, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC Research & Evaluation Division (RED); Save the Children; Bangladesh Rural Advancement Committee BRAC; Bangladesh Rural Advancement Committee BRAC; BRAC University	Rahman, M (corresponding author), BRAC Ctr, BRAC, Res & Evaluat Div, 75 Mohakhali, Dhaka, Bangladesh.	mahfuzar.rahman@brac.net	Shah, Rashed Z/D-4688-2015; Yunus, Fakir Md/H-3170-2019; Shah, Rashed/Q-4965-2019	Shah, Rashed Z/0000-0001-9488-5134; Yunus, Fakir Md/0000-0002-0614-000X; Shah, Rashed/0000-0001-9488-5134; Afsana, Kaosar/0000-0002-5197-8151; Aktar, Bachera/0000-0003-0242-1792	AusAID; UKAID; Strategic Partnership Agreement (SPA)	AusAID(Australian Aid (AusAID)); UKAID(CGIAR); Strategic Partnership Agreement (SPA)	This research activity was funded by the Strategic Partnership Agreement (SPA) with AusAID and UKAID. BRAC acknowledges with gratitude the commitment of the AusAID and UKAID to its research efforts.	Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Ahmed SM, 2008, TAKING HEALTHCARE CO; Ni Bhuinneain GMN, 2015, BJOG-INT J OBSTET GY, V122, P174, DOI 10.1111/1471-0528.13218; Bhutta ZA., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2013, NEW ENGL J MED, V369, P2226, DOI 10.1056/NEJMra1111853; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Chezem J, 2003, JOGNN-J OBST GYN NEO, V32, P40, DOI 10.1177/0884217502239799; Dennis CL, 2002, JOGNN-J OBST GYN NEO, V31, P12, DOI 10.1111/j.1552-6909.2002.tb00019.x; Fottrell E, 2013, JAMA PEDIATR, V167, P816, DOI 10.1001/jamapediatrics.2013.2534; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hajizadeh M, 2014, INT J EQUITY HEALTH, V13, DOI [10.1186/s12939-014-0120-4, 10.1186/1475-9276-13-18]; Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62425-9; Koski-Rahikkala H, 2006, J EPIDEMIOL COMMUN H, V60, P968, DOI 10.1136/jech.2005.044735; Kumar GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-357; Langer A, 2013, LANCET, V381, P601, DOI 10.1016/S0140-6736(13)60259-7; Lassi ZS, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S2-S2; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lechner Michael, 2011, Foundations and Trends in Econometrics, V4, P165, DOI 10.1561/0800000014; Lewycka S, 2013, LANCET, V381, P1721, DOI 10.1016/S0140-6736(12)61959-X; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mason E, 2014, LANCET, V384, P455, DOI 10.1016/S0140-6736(14)60750-9; Mattar CN, 2007, OBSTET GYNECOL, V109, P73, DOI 10.1097/01.AOG.0000249613.15466.26; McDonagh M, 1996, HEALTH POLICY PLANN, V11, P1, DOI 10.1093/heapol/11.1.1; More NS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001257; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Nemcek MA, 2003, PUBLIC HEALTH NURS, V20, P260, DOI 10.1046/j.1525-1446.2003.20403.x; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Rahman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136898; Rashidian A, 2014, PUBLIC HEALTH, V128, P872, DOI 10.1016/j.puhe.2014.08.005; Requejo J, 2013, ACCOUNTABILITY FOR M; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Salam RA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-S1-S3; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schafer E, 1998, BIRTH-ISS PERINAT C, V25, P101, DOI 10.1046/j.1523-536x.1998.00101.x; Suresh Sithara, 2014, Indian J Public Health, V58, P270, DOI 10.4103/0019-557X.146292; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Undie CC, 2014, INT J GYNECOL OBSTET, V126, P8, DOI 10.1016/j.ijgo.2013.12.016; Upadhyay P, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-92; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Vogel JP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-19; Yanagisawa S, 2015, HEALTH POLICY PLANN, V30, P1184, DOI 10.1093/heapol/czu133	50	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161647	10.1371/journal.pone.0161647	http://dx.doi.org/10.1371/journal.pone.0161647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583478	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600048
J	Schaker, PDC; Palhares, AC; Taniguti, LM; Peters, LP; Creste, S; Aitken, KS; Van Sluys, MA; Kitajima, JP; Vieira, MLC; Monteiro-Vitorello, CB				Schaker, Patricia D. C.; Palhares, Alessandra C.; Taniguti, Lucas M.; Peters, Leila P.; Creste, Silvana; Aitken, Karen S.; Van Sluys, Marie-Anne; Kitajima, Joao P.; Vieira, Maria L. C.; Monteiro-Vitorello, Claudia B.			RNAseq Transcriptional Profiling following Whip Development in Sugarcane Smut Disease	PLOS ONE			English	Article							RESISTANCE; PROTEINS; PATHOGEN; SUCROSE; SEQ	Sugarcane smut disease is caused by the biotrophic fungus Sporisorium scitamineum. The disease is characterized by the development of a whip-like structure from the primary meristems, where billions of teliospores are produced. Sugarcane smut also causes tillering and low sucrose and high fiber contents, reducing cane productivity. We investigated the biological events contributing to disease symptoms in a smut intermediate-resistant sugarcane genotype by examining the transcriptional profiles (RNAseq) shortly after inoculating the plants and immediately after whip emission. The overall picture of disease progression suggests that premature transcriptional reprogramming of the shoot meristem functions continues until the emergence of the whip. The guidance of this altered pattern is potentially primarily related to auxin mobilization in addition to the involvement of other hormonal imbalances. The consequences associated with whip emission are the modulation of typical meristematic functions toward reproductive organ differentiation, requiring strong changes in carbon partitioning and energy production. These changes include the overexpression of genes coding for invertases and trehalose-6P synthase, as well as other enzymes from key metabolic pathways, such as from lignin biosynthesis. This is the first report describing changes in the transcriptional profiles following whip development, providing a hypothetical model and candidate genes to further study sugarcane smut disease progression.	[Schaker, Patricia D. C.; Palhares, Alessandra C.; Taniguti, Lucas M.; Peters, Leila P.; Vieira, Maria L. C.; Monteiro-Vitorello, Claudia B.] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Creste, Silvana] Ctr Cana, Inst Agron Campinas, Ribeirao Preto, SP, Brazil; [Aitken, Karen S.] CSIRO Agr, Queensland Biosci Precinct, St Lucia, Qld, Australia; [Van Sluys, Marie-Anne] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, Qld, Brazil; [Kitajima, Joao P.] Mendel Anal Genom, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto Agronomico de Campinas (IAC); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Universidade de Sao Paulo	Monteiro-Vitorello, CB (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil.	cbmontei@usp.br	Dayane Carvalho Schaker, Patricia/G-4268-2012; aitken, karen/I-5817-2012; Vieira, Maria Lucia Carneiro/D-1628-2012; Monteiro-Vitorello, Claudia B/F-2436-2012; Van Sluys, Marie-Anne/A-8483-2012	Dayane Carvalho Schaker, Patricia/0000-0002-1215-9735; aitken, karen/0000-0003-4372-0721; Vieira, Maria Lucia Carneiro/0000-0003-0341-5714; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Van Sluys, Marie-Anne/0000-0002-6506-2734; Creste, Silvana/0000-0002-3315-3332; Peters, Leila Priscila/0000-0002-9469-5290; Taniguti, Lucas Mitsuo/0000-0002-2682-7343	Brazilian institution FAPESP [2010/05591-9, 2015/07112-4, 2012/09524-0, 2013/25599-2, 2014/17034-8, 2013/150147]; Mendelics Analise Genomica	Brazilian institution FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Mendelics Analise Genomica	The authors acknowledge the support of the Brazilian institution FAPESP (grant numbers 2010/05591-9; 2015/07112-4 [C.B.M.-V.] and fellowships to A.C.P. (2012/09524-0); P.D.C.S (2013/25599-2); L.M.T (2014/17034-8); L.P.P (2013/150147). We thank the sequencing facility Center of Functional Genomics (USP, Campus "Luiz de Queiroz"); NAP/MEPA (Nucleo de Apoio a Pesquisa em Microscopia Eletronica Aplicada a Agricultura) and Laboratorios de Genetica Molecular, Departamento de Fitopatologia e Nematologia, and Plantas Horticulas, Departamento de Producao Vegetal, ESALQ. Mendelics Analise Genomica provided support in the form of a salary for author JPK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of JPK are articulated in the 'author contributions' section.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; [Anonymous], 2015, NUCLEIC ACIDS RES, V28, P43; Bakkeren G, 2008, FUNGAL GENET BIOL, P45; Barnabas L, 2016, PROTEOMICS, V16, P1111, DOI 10.1002/pmic.201500245; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Borras-Hidalgo O, 2005, PLANT PHYSIOL BIOCH, V43, P12; Brefort T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003866; Bruce SA, 2011, J PLANT GROWTH REGUL, V30, P51, DOI 10.1007/s00344-010-9166-8; Bueno C. R. N. C, 2011, THESIS; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; CHAO CP, 1990, PHYTOPATHOLOGY, V80, P622, DOI 10.1094/Phyto-80-622; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; de Castro E, 2006, NUCLEIC ACIDS RES, V1, P34; de Setta N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-540; Dean JFD, 1998, LIGNIN LIGNAN BIOSYN, P8; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Eckardt NA., 2010, PLANT CELL, V22, P5; ECKER JR, 1987, P NATL ACAD SCI USA, V84, P5202, DOI 10.1073/pnas.84.15.5202; FAOSTAT (Food and Agriculture Organization Statistics), 2013, FOOD AGR ORG STAT DA; Forsthoefel NR, 2005, PLANT CELL PHYSL, V46, P6; Gao L, 2013, PLANT J, V75, P903, DOI 10.1111/tpj.12270; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; Ghareeb H, 2011, PLANT PHYSIOL, V156, P4; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; He J-X, 2005, SCI, V307, P5715; Hector E, 1992, 21 C INT SOC SUG TEC, P565; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Iskandar H, 2004, PLANT MOL BIOL REP, V22, P4; Jain M, 2007, PLANT PHYSIOL, V143, P4; James GL, 1973, P S AFRICAN SUGAR TE, P179; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kaufmann K, 2010, SCI, V328, P5974; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kim Dong-Hwan, 2014, Arabidopsis Book, V12, pe0171, DOI 10.1199/tab.0171; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lagercrantz U, 2000, MOL BIOL EVOL, V17, P1499, DOI 10.1093/oxfordjournals.molbev.a026249; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lao M, 2008, PLANT CELL REP, V27, P1103, DOI 10.1007/s00299-008-0524-y; Lee YK, 2006, FOR SCI TECHNOL, V2, P1, DOI 10.1080/21580103.2006.9656293; Legaz ME, 1998, J EXP BOT, V49, P1723, DOI 10.1093/jexbot/49.327.1723; Legaz ME, 2011, SCI MICROBIAL PATHOG; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu Y, 2011, CROP SCI, V51, P2749, DOI 10.2135/cropsci2011.02.0083; Lloyd H. L., 1980, South African Sugar Journal, V64, P347; LLOYD HL, 1983, PLANT DIS, V67, P1103, DOI 10.1094/PD-67-1103; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe RGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103098; Mason MG, 2014, P NATL ACAD SCI USA, V111, P16; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Murai K, 2013, PLANTS, V2, P3; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Palhares AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-51; Papini-Terzi FS, 2005, DNA RES, V12, P27, DOI 10.1093/dnares/12.1.27; Pastuglia M, 1997, PLANT CELL, V9, P11; PEROS JP, 1983, AGRONOMIE, V3, P629, DOI 10.1051/agro:19830703; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinon D, 1999, PLANT PHYSIOL BIOCH, V37, P57, DOI 10.1016/S0981-9428(99)80067-9; Que YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080140; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P4; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rossi M, 2003, MOL GENET GENOMICS, V269, P406, DOI 10.1007/s00438-003-0849-8; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Santiago R, 2012, PHYSIOL PLANTARUM, V145, P245, DOI 10.1111/j.1399-3054.2012.01577.x; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Song W-Y, 1995, SCI, V270, P5243; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Suga S, 2005, PLANT CELL PHYSIOL, V46, pS17; Sundar A.R., 2012, BOTANY, P107; Taniguti LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129318; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Thokoane L. N., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P104; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P8; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; Tremblay A, 2011, SEQUENCING, V2011, P1, DOI DOI 10.1155/2011/827250; van Ooijen G, 2008, MOL PLANT, V1, P401, DOI 10.1093/mp/ssn009; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wahl V, 2013, SCI, V339, P6120; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wu QB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/298920; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; You-Xiong Q, 2011, J BIOMED BIOTECHNOL, V14, P2011; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	93	35	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162237	10.1371/journal.pone.0162237	http://dx.doi.org/10.1371/journal.pone.0162237			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583836	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600121
J	Wang, L; Cui, Y; Zhang, L; Sheng, JD; Yang, Y; Kuang, GY; Fan, Y; Zhang, Q; Jin, J				Wang, Lu; Cui, Yun; Zhang, Lian; Sheng, Jindong; Yang, Yang; Kuang, Guanyu; Fan, Yu; Zhang, Qian; Jin, Jie			The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features	PLOS ONE			English	Article							CYCLIN D2 EXPRESSION; TUMOR-SUPPRESSOR; DNA METHYLATION; CARCINOMA; GENE; HYPERMETHYLATION; OVEREXPRESSION; PROLIFERATION; INACTIVATION; PROTEIN	Cyclin D2 (CCND2) is a member of the D-type cyclins, which plays a pivotal role in cell cycle regulation, differentiation and malignant transformation. However, its expression status and relative regulation mechanism remains unclear in renal cell cancer (RCC). In our study, the mRNA expression level of CCND2 is down-regulated in 22/23 paired RCC tissues (p<0.05). In addition, its protein expression level is also decreased in 43/43 RCC tumor tissues compared with its corresponding non-malignant tissues (p<0.001). We further detected that CCND2 was down-regulated or silenced in 6/7 RCC cell lines, but expressed in "normal" human proximal tubular (HK-2) cell line. Subsequently, MSP and BGS results showed that the methylation status in CCND2 promoter region is closely associated with its expression level in RCC cell lines. Treatment with 5-Aza with or without TSA restored CCND2 expression in several methylated RCC cell lines. Among the 102 RCC tumors, methylation of CCND2 was detected in 29/102 (28%) cases. Only 2/23 (8.7%) adjacent non-malignant tissues showed methylation. We then analyzed the correlation of clinical features and its promoter methylation. Collectively, our data suggested that loss of CCND2 expression is closely associated with the promoter aberrant methylation.	[Wang, Lu; Cui, Yun; Sheng, Jindong; Kuang, Guanyu; Fan, Yu; Zhang, Qian; Jin, Jie] Peking Univ, Hosp 1, Dept Urol, Beijing 100034, Peoples R China; [Wang, Lu; Cui, Yun; Sheng, Jindong; Kuang, Guanyu; Fan, Yu; Zhang, Qian; Jin, Jie] Peking Univ, Inst Urol, Beijing 100034, Peoples R China; [Zhang, Lian] Natl Res Ctr Genitourinary Oncol, Beijing 100034, Peoples R China; [Cui, Yun] Urogenital Dis Male Mol Diag & Treatment Ctr, Beijing 100034, Peoples R China; [Yang, Yang] Natl Urol Canc Ctr, Beijing 100034, Peoples R China	Peking University; Peking University	Zhang, Q; Jin, J (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100034, Peoples R China.; Zhang, Q; Jin, J (corresponding author), Peking Univ, Inst Urol, Beijing 100034, Peoples R China.	zhangqian@bjmu.edu.cn; jinjie@vip.163.com			National Natural Science Foundation [81272290, 81572510, 81370858, 81570683]; Beijing Municipal Science and Technology Commission [Z131107002213130]; Beijing Natural Science Foundation [7142161]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by grants from the National Natural Science Foundation (No. 81272290, No. 81572510, No. 81370858 and No. 81570683), Beijing Municipal Science and Technology Commission (No. Z131107002213130) and Beijing Natural Science Foundation (No. 7142161).	[Anonymous], J MOL MED, V93, P691; Baylin SB, 1998, ADV CANCER RES, V72, P141; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Du ZF, 2016, ONCOTARGET, V7, P21618, DOI 10.18632/oncotarget.7822; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Evron E, 2001, CANCER RES, V61, P2782; Fackler MJ, 2003, INT J CANCER, V107, P970, DOI 10.1002/ijc.11508; Hedberg Y, 2002, ACTA ONCOL, V41, P175, DOI 10.1080/028418602753669562; Henrique R, 2006, J MOL MED, V84, P911, DOI 10.1007/s00109-006-0099-4; Hsu A, 2011, CLIN EPIGENETICS, V3, DOI 10.1186/1868-7083-3-3; Lima MS, 2014, INT UROL NEPHROL, V46, P905, DOI 10.1007/s11255-013-0602-0; Matsubayashi H, 2003, CLIN CANCER RES, V9, P1446; Mermelshtein A, 2005, BRIT J CANCER, V93, P338, DOI 10.1038/sj.bjc.6602709; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; Meyyappan M, 1996, BIOL SIGNAL, V5, P130; Padar A, 2003, CLIN CANCER RES, V9, P4730; SHAPIRO GI, 1995, CANCER RES, V55, P6200; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; SINCLAIR AJ, 1995, J VIROL, V69, P1292, DOI 10.1128/JVI.69.2.1292-1295.1995; Takano Y, 1999, J PATHOL, V189, P194; Takano Y, 2000, AM J PATHOL, V156, P585, DOI 10.1016/S0002-9440(10)64763-3; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tsihlias J, 1999, ANNU REV MED, V50, P401; Uchida K, 2002, INT J UROL, V9, P19, DOI 10.1046/j.1442-2042.2002.00418.x; Virmani A, 2003, INT J CANCER, V107, P341, DOI 10.1002/ijc.11393; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Xu B, 2015, INT J MOL SCI, V16, P1051, DOI 10.3390/ijms16011051; Yu J, 2003, BRIT J CANCER, V88, P1560, DOI 10.1038/sj.bjc.6600940; Zhang L, 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1371/J0URNAL.PGEN.1005164; Zhang PM, 1999, CURR OPIN CELL BIOL, V11, P655, DOI 10.1016/S0955-0674(99)00032-0; Zhang Q, 2014, CANCER LETT, V354, P227, DOI 10.1016/j.canlet.2014.07.040; Zhang Q, 2014, MOL CELL ENDOCRINOL, V382, P583, DOI 10.1016/j.mce.2013.03.016; Zhang QA, 2010, J UROLOGY, V184, P731, DOI 10.1016/j.juro.2010.03.108; Zhang Q, 2007, CANCER LETT, V249, P220, DOI 10.1016/j.canlet.2006.08.019	37	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161859	10.1371/journal.pone.0161859	http://dx.doi.org/10.1371/journal.pone.0161859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583477	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600067
J	Wei, Z; Du, YG; Zhang, J; Tai, BJ; Du, MQ; Jiang, H				Wei, Zhao; Du, Yangge; Zhang, Jing; Tai, Baojun; Du, Minquan; Jiang, Han			Prevalence and Indicators of Tooth Wear among Chinese Adults	PLOS ONE			English	Article							DENTAL EROSIVE WEAR; EXAMINATION BEWE; SCORING SYSTEM; ADOLESCENTS; TEETH; RISK; AGE; BEVERAGES; SURFACES; OPTIONS	Numerous epidemiological studies have focused on the prevalence and related indicators of tooth wear. However, no sufficient studies have been conducted with Chinese adults. The purpose of this study was to assess the prevalence of tooth wear and identify related indicators among adults aged 36 to 74 years in Wuhan City, P.R. China. A cross-sectional and analytic study was conducted with 720 participants, aged 35-49 yrs and 50-74 yrs, in 2014. Each age group included 360 participants, of which 50% were males and 50% were females. All participants completed a questionnaire before examination. Tooth wear was assessed using the modified Basic Erosive Wear Examination (BEWE) index. The data were analyzed using the chi-square test and binary logistic regression analysis. The prevalence of tooth wear was 67.5% and 100% in the 35-49 and 50-74 age groups, respectively. The prevalence of dentin exposure was 64.7% and 98.3%, respectively. A significantly higher prevalence of tooth wear and dentin exposure was found in the 50-74 yr group than in the 35-49 yr group (p < 0.05). Critical indicators of tooth wear and dentin exposure included high frequency of acidic drinks and foods consumption, low socio-economic status, and unilateral chewing. The frequency of changing toothbrushes and the habit of drinking water during meals were associated with tooth wear. In addition, the usage of hard-bristle toothbrushes and consuming vitamin C and aspirin were found to be linked with dentin exposure. In conclusion, the prevalence of tooth wear and dentin exposure observed in Chinese adults was high, and the results revealed an association between tooth wear and socio-behavioral risk indicators.	[Du, Minquan; Jiang, Han] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan, Peoples R China	Wuhan University; Wuhan University	Du, MQ; Jiang, H (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.	duminquan@whu.edu.cn; jhqwe55@hotmail.com	Du, Min Quan/V-7359-2018	Du, Min Quan/0000-0002-5043-9981				Al-Dlaigan YH, 2001, BRIT DENT J, V190, P145; Bahal P, 2014, CASE REP DENT, V2014, DOI 10.1155/2014/485387; Barbour Michele E, 2006, J Clin Dent, V17, P88; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS65, DOI 10.1007/s00784-007-0181-5; Bartlett DW, 2013, J DENT, V41, P1007, DOI 10.1016/j.jdent.2013.08.018; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS27, DOI 10.1007/s00784-007-0177-1; Burke FM, 2010, COMMUNITY DENT ORAL, V38, P415, DOI 10.1111/j.1600-0528.2010.00550.x; Dixon B, 2012, BRIT DENT J, V213, DOI 10.1038/sj.bdj.2012.670; Eccles J D, 1982, Dent Update, V9, P373; Ehlen LA, 2008, NUTR RES, V28, P299, DOI 10.1016/j.nutres.2008.03.001; Gomes SGF, 2011, BRAZ ORAL RES, V25, P446, DOI 10.1590/S1806-83242011000500012; Ganss C, 2006, CARIES RES, V40, P208, DOI 10.1159/000092227; Pineda AEGA, 2016, J AM DENT ASSOC, V147, P92, DOI 10.1016/j.adaj.2015.07.016; Grace EG, 2004, J AM DENT ASSOC, V135, P911, DOI 10.14219/jada.archive.2004.0337; Gupta Vivek V, 2015, J Clin Exp Dent, V7, pe649, DOI 10.4317/jced.52332; Hays G L, 1992, Am J Dent, V5, P269; Iwashita H, 2014, J PROSTHODONT RES, V58, P223, DOI 10.1016/j.jpor.2014.04.002; Kakudo Y, 1969, J Osaka Dent Univ, V3, P187; Kitasako Y, 2015, J DENT, V43, P418, DOI 10.1016/j.jdent.2015.02.004; Li HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034566; Liu B, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-65; MANLY RS, 1965, J DENT RES, V44, P533, DOI 10.1177/00220345650440031601; McCracken M, 2000, J Prosthodont, V9, P95, DOI 10.1111/j.1532-849X.2000.00095.x; Milosevic A, 2004, BRIT DENT J, V197, P475, DOI 10.1038/sj.bdj.4811747; Mulic A, 2010, CARIES RES, V44, P294, DOI 10.1159/000314811; Muller-Bolla M, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0133-4; Muts EJ, 2014, J PROSTHET DENT, V112, P752, DOI 10.1016/j.prosdent.2014.01.018; Ramalho A, 2006, WEAR, V260, P361, DOI 10.1016/j.wear.2005.02.121; Schierz O, 2014, J PROSTHET DENT, V112, P465, DOI 10.1016/j.prosdent.2013.12.005; SMITH BGN, 1984, BRIT DENT J, V156, P435, DOI 10.1038/sj.bdj.4805394; Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278; Vered Y, 2014, CLIN ORAL INVEST, V18, P1985, DOI 10.1007/s00784-013-1175-0; Zhang J, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0104-9	33	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162181	10.1371/journal.pone.0162181	http://dx.doi.org/10.1371/journal.pone.0162181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583435	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600116
J	Zhu, LL; Niu, ZD; Nie, YX; Yang, Y; Li, K; Jin, Z; Wei, JY				Zhu, Linlin; Niu, Zhendong; Nie, Yaoxin; Yang, Yang; Li, Ke; Jin, Zhen; Wei, Jieyao			The Brain Effective Connectivity of Chinese during Rhyming Task	PLOS ONE			English	Article							EVENT-RELATED FMRI; INFERIOR PREFRONTAL CORTEX; CORTICAL ORGANIZATION; SPEECH-PERCEPTION; ALPHABETIC WORDS; SPOKEN LANGUAGE; JAPANESE KANJI; APHASIA; METAANALYSIS; CHARACTERS	With regard to brain language processing, the activation patterns have been well studied, and recently there are great interest in the connectivity models. The crucial brain areas for phonological processing involves left inferior frontal gyrus (LIFG), left inferior parietal lobule (LIPL) and left posterior middle temporal gyrus (LpMTG). Specially in Chinese processing, the left middle frontal gyrus (LMFG) is considered as an essential region. However, the connectivity pattern among these brain areas is not well understood. In this study, a rhyming experiment of Chinese was conducted, and the Dynamic causal modeling (DCM) and the Bayesian model selection (BMS) were used to examine the interaction between brain regions and choose the best model for rhyming task of Chinese. By examining the interactions, it was found that LMFG exerted inhibitory modulation on LIPL and LIFG; the phonological processing enhanced the connection from LIPL to LIFG and LMFG, which suggested the important roles of these connections for the increased phonological load; And LpMTG modulated LIFG and LMFG negatively, and LIPL positively under rhyming judgment task.	[Zhu, Linlin; Niu, Zhendong; Nie, Yaoxin; Wei, Jieyao] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China; [Yang, Yang] Univ Hong Kong, Dept Linguist, Hong Kong, Hong Kong, Peoples R China; [Li, Ke; Jin, Zhen] 306th Hosp PLA, Beijing, Peoples R China	Beijing Institute of Technology; University of Hong Kong	Niu, ZD (corresponding author), Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China.	zniu@bit.edu.cn			National Strategic Basic Research Program ("973" Program) of the Ministry of Science and Technology of China [2012CB720702]	National Strategic Basic Research Program ("973" Program) of the Ministry of Science and Technology of China	This study was supported by the National Strategic Basic Research Program ("973" Program) of the Ministry of Science and Technology of China (Grant No.: 2012CB720702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baoguo C, 2003, ACTA PSYCHOL SINICA, V35, P576; BATES E, 1991, BRAIN LANG, V41, P203, DOI 10.1016/0093-934X(91)90153-R; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Bitan T, 2007, NEUROIMAGE, V38, P564, DOI 10.1016/j.neuroimage.2007.07.048; Bitan T, 2009, J COGNITIVE NEUROSCI, V21, P1135, DOI 10.1162/jocn.2009.21065; Booth JR, 2008, BRAIN RES, V1189, P78, DOI 10.1016/j.brainres.2007.10.080; Booth JR, 2006, BRAIN RES, V1071, P197, DOI 10.1016/j.brainres.2005.11.097; Brambati SM, 2009, NEUROPSYCHOLOGIA, V47, P1893, DOI 10.1016/j.neuropsychologia.2009.02.033; Cao F, 2011, NEUROIMAGE, V57, P750, DOI 10.1016/j.neuroimage.2010.09.047; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Chen S, 1998, APHASIOLOGY, V12, P5, DOI 10.1080/02687039808249441; Crepaldi D, 2011, BRAIN LANG, V116, P33, DOI 10.1016/j.bandl.2010.09.005; de Zubicaray GI, 2001, HUM BRAIN MAPP, V14, P218, DOI 10.1002/hbm.1054; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Dong Y, 2005, NEUROSCI RES, V52, P139, DOI 10.1016/j.neures.2005.02.005; Duncan KJK, 2014, CEREB CORTEX, V24, P1601, DOI 10.1093/cercor/bht015; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Heim S, 2009, HUM BRAIN MAPP, V30, P392, DOI 10.1002/hbm.20512; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2011, BRAIN LANG, V119, P214, DOI 10.1016/j.bandl.2011.08.001; Hoffman P, 2012, APHASIOLOGY, V26, P1119, DOI 10.1080/02687038.2011.608838; Hu ZH, 2012, BRAIN TOPOGR, V25, P362, DOI 10.1007/s10548-012-0230-5; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kellmeyer P, 2013, BRAIN LANG, V127, P241, DOI 10.1016/j.bandl.2013.09.011; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; Kuo WJ, 2003, NEUROIMAGE, V18, P720, DOI 10.1016/S1053-8119(03)00015-6; Kuo WJ, 2001, NEUROREPORT, V12, P3997, DOI 10.1097/00001756-200112210-00029; Lee CY, 2004, NEUROIMAGE, V23, P1235, DOI 10.1016/j.neuroimage.2004.07.064; Liu L, 2006, NEUROIMAGE, V29, P515, DOI 10.1016/j.neuroimage.2005.07.046; Liu L, 2009, J COGNITIVE NEUROSCI, V21, P1473, DOI 10.1162/jocn.2009.21141; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2009, YEAR COGNITIVE NEURO, P62; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; Richlan F, 2009, HUM BRAIN MAPP, V30, P3299, DOI 10.1002/hbm.20752; Rimol LM, 2005, NEUROIMAGE, V26, P1059, DOI 10.1016/j.neuroimage.2005.03.028; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Sass K, 2009, NEUROIMAGE, V45, P224, DOI 10.1016/j.neuroimage.2008.10.014; Seghier ML, 2010, CEREB CORTEX, V20, P570, DOI 10.1093/cercor/bhp123; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Stephan KE, 2010, WIRES COGN SCI, V1, P446, DOI 10.1002/wcs.58; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Tan LH, 2001, NEUROREPORT, V12, P83, DOI 10.1097/00001756-200101220-00024; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Vigliocco G, 2011, NEUROSCI BIOBEHAV R, V35, P407, DOI 10.1016/j.neubiorev.2010.04.007; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wu CY, 2014, BRAIN LANG, V135, P32, DOI 10.1016/j.bandl.2014.04.005; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105; Xing, 1997, 5 WORLD CHIN TEACH S; Xu M, 2015, HUM BRAIN MAPP, V36, P2580, DOI 10.1002/hbm.22792; Zhu LL, 2014, HUM BRAIN MAPP, V35, P2607, DOI 10.1002/hbm.22354; 陈宝国, 2001, [心理学报, Acta Psychologica Sinica], V33, P1	64	4	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162158	10.1371/journal.pone.0162158	http://dx.doi.org/10.1371/journal.pone.0162158			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583349	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600114
J	Goldman, SE; Moshkovits, I; Shemesh, A; Filiba, A; Tsirulsky, Y; Vronov, E; Shagan, M; Apte, RN; Benharroch, D; Karo-Atar, D; Dagan, R; Munitz, A; Nebenzahl, YM; Porgador, A				Goldman, Shirin Elhaik; Moshkovits, Itay; Shemesh, Avishai; Filiba, Ayelet; Tsirulsky, Yevgeny; Vronov, Elena; Shagan, Marilou; Apte, Ron N.; Benharroch, Daniel; Karo-Atar, Danielle; Dagan, Ron; Munitz, Ariel; Nebenzahl, Yaffa Mizrachi; Porgador, Angel			Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway Inflammation	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; VIRUS-INFECTED CELLS; HUMAN NK CELLS; CC-CHEMOKINE; CYTOTOXICITY RECEPTORS; EPITHELIAL-CELLS; ACTIVATING RECEPTORS; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; INTERFERON-GAMMA	The function of NCR1 was studied in a model of experimental asthma, classified as a type 1 hypersensitivity reaction, in mice. IgE levels were significantly increased in the serum of OVA immunized NCR1 deficient (NCR1(gfp/gfp)) mice in comparison to OVA immunized wild type (NCR1(+/+)) and adjuvant immunized mice. Histological analysis of OVA immunized NCR1(gfp/gfp) mice revealed no preservation of the lung structure and overwhelming peribronchial and perivascular granulocytes together with mononuclear cells infiltration. OVA immunized NCR+/+ mice demonstrated preserved lung structure and peribronchial and perivascular immune cell infiltration to a lower extent than that in NCR1(gfp/gfp) mice. Adjuvant immunized mice demonstrated lung structure preservation and no immune cell infiltration. OVA immunization caused an increase in PAS production independently of NCR1 presence. Bronchoalveolar lavage (BAL) revealed NCR1 dependent decreased percentages of eosinophils and increased percentages of lymphocytes and macrophages following OVA immunization. In the OVA immunized NCR1(gfp/gfp) mice the protein levels of eosinophils' (CCL24) and Th2 CD4(+) T-cells' chemoattractants (CCL17, and CCL24) in the BAL are increased in comparison with OVA immunized NCR+/+ mice. In the presence of NCR1, OVA immunization caused an increase in NK cells numbers and decreased NCR1 ligand expression on CD11c(+) GR1(+) cells and decreased NCR1 mRNA expression in the BAL. OVA immunization resulted in significantly increased IL-13, IL-4 and CCL17 mRNA expression in NCR1(+/+) and NCR1(gfp/gfp) mice. IL-17 and TNF alpha expression increased only in OVA-immunized NCR1(+/+) mice. IL-6 mRNA increased only in OVA immunized NCR1(gfp/gfp) mice. Collectively, it is demonstrated that NCR1 dampens allergic eosinophilic airway inflammation.	[Goldman, Shirin Elhaik; Shemesh, Avishai; Filiba, Ayelet; Tsirulsky, Yevgeny; Vronov, Elena; Shagan, Marilou; Apte, Ron N.; Nebenzahl, Yaffa Mizrachi; Porgador, Angel] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel; [Moshkovits, Itay; Karo-Atar, Danielle; Munitz, Ariel; Nebenzahl, Yaffa Mizrachi] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Benharroch, Daniel] Soroka Univ, Med Ctr, Dept Pathol, Bear Sheva, Israel; [Dagan, Ron] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel	Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University	Nebenzahl, YM; Porgador, A (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol Immunol & Genet, IL-84105 Beer Sheva, Israel.; Nebenzahl, YM (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.; Porgador, A (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel.	ymizr@bgu.ac.il; angel@bgu.ac.il	Goldman, Shirin/AAU-9596-2020	Karo-Atar, Danielle/0000-0002-0225-8836; Porgador, Angel/0000-0003-1540-4449	Israel Cancer Research Foundation Research Career Development Award [4476, 5540, 3000003867]; Center for Emerging Diseases [2506]; Israel Science Foundation [613/04, 304/12, 955/11]; US/Israel Binational Science Foundation [2011123]; Israeli Ministry of Science and Technology/German Cancer Research Center program [CA142]; US / Israel Bi-national Science Foundation [2009222, 2011244]; Israel Cancer Association [20150002]; Israel Ministry of Health [3-10117]; Boaz and Varda Dotan Center Grant for Hemato-oncology Research; ISEF Foundation	Israel Cancer Research Foundation Research Career Development Award; Center for Emerging Diseases; Israel Science Foundation(Israel Science Foundation); US/Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israeli Ministry of Science and Technology/German Cancer Research Center program; US / Israel Bi-national Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Association; Israel Ministry of Health; Boaz and Varda Dotan Center Grant for Hemato-oncology Research; ISEF Foundation	This work was supported by the Israel Cancer Research Foundation Research Career Development Award, 4476; 5540; 3000003867; The Center for Emerging Diseases, 2506; The Israel Science Foundation, 613/04; to Yaffa Mizrachi Nebenzahl. US/Israel Binational Science Foundation, 2011123; Israel Science Foundation, 304/12; Israeli Ministry of Science and Technology/German Cancer Research Center program, CA142 to Angel Porgador. The US / Israel Bi-national Science Foundation, 2009222; 2011244; The Israel Science Foundation, 955/11; The Israel Cancer Association, 20150002; the Israel Ministry of Health, 3-10117; the Boaz and Varda Dotan Center Grant for Hemato-oncology Research to Ariel Munitz; ISEF Foundation to Shirin Elhaik Goldman. The funders/sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; Akahira-Azuma M, 2004, IMMUNOLOGY, V111, P306, DOI 10.1111/j.0019-2805.2004.01818.x; Andrew DP, 1998, J IMMUNOL, V161, P5027; Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Awad A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094492; Barnig C, 2015, EUR RESPIR REV, V24, P141, DOI 10.1183/09059180.00012514; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Blery M, 2000, HUM IMMUNOL, V61, P51, DOI 10.1016/S0198-8859(99)00157-3; Brewer JM, 1999, J IMMUNOL, V163, P6448; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Chang MS, 1997, J BIOL CHEM, V272, P25229, DOI 10.1074/jbc.272.40.25229; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; Crapster-Pregont M, 2012, J ALLERGY CLIN IMMUN, V129, P1621, DOI 10.1016/j.jaci.2012.01.052; Das R, 2014, MED MICROBIOL IMMUN, V203, P303, DOI 10.1007/s00430-014-0338-1; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Deniz G, 2013, J ALLERGY CLIN IMMUN, V132, P527, DOI 10.1016/j.jaci.2013.07.030; Moreira-Silva EAD, 2014, VIRUS RES, V184, P20, DOI 10.1016/j.virusres.2014.02.001; Elhaik-Goldman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023472; Farhadi N, 2014, J ALLERGY CLIN IMMUN, V133, P827, DOI 10.1016/j.jaci.2013.09.048; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Funamizu A, 2014, AM J REPROD IMMUNOL, V71, P359, DOI 10.1111/aji.12206; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Ghadially H, 2005, J IMMUNOL, V174, P5620, DOI 10.4049/jimmunol.174.9.5620; Ghadially H, 2013, EUR J IMMUNOL, V43, P3006, DOI 10.1002/eji.201343388; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; Haworth O, 2011, J IMMUNOL, V186, P6129, DOI 10.4049/jimmunol.1004007; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; JIRA M, 1988, ALLERGY, V43, P294, DOI 10.1111/j.1398-9995.1988.tb00903.x; Jovanovic K, 2014, CLIN EXP IMMUNOL, V178, P201, DOI 10.1111/cei.12409; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; Kirwan SE, 2007, CURR OPIN IMMUNOL, V19, P46, DOI 10.1016/j.coi.2006.11.012; Korsgren M, 1999, J EXP MED, V189, P553, DOI 10.1084/jem.189.3.553; Kubo T, 2008, J INTERF CYTOK RES, V28, P725, DOI 10.1089/jir.2008.0035; Lin SJ, 2003, ALLERGY, V58, P67, DOI 10.1034/j.1398-9995.2003.t01-1-23697.x; Makita N, 2015, INT IMMUNOL, V27, P131, DOI 10.1093/intimm/dxu090; Mandelboim O, 2001, INT J BIOCHEM CELL B, V33, P1147, DOI 10.1016/S1357-2725(01)00078-4; Marashian SM, 2015, IRAN J ALLERGY ASTHM, V14, P346; Mathias CB, 2015, CURR ALLERGY ASTHM R, V15, DOI 10.1007/s11882-014-0500-2; Mavoungou E, 2005, CLIN EXP IMMUNOL, V139, P287, DOI 10.1111/j.1365-2249.2004.02686.x; Mesdaghi M, 2010, INT ARCH ALLERGY IMM, V153, P234, DOI 10.1159/000314363; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Ple C, 2010, SCAND J IMMUNOL, V72, P118, DOI 10.1111/j.1365-3083.2010.02419.x; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P325, DOI 10.1080/17402520600578194; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rosental B, 2011, J IMMUNOL, V187, P5693, DOI 10.4049/jimmunol.1102267; Ross R, 1999, J INVEST DERMATOL, V113, P991, DOI 10.1046/j.1523-1747.1999.00803.x; Salazar F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00356; Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Shao ZF, 2009, J ALLERGY CLIN IMMUN, V123, P917, DOI 10.1016/j.jaci.2009.01.052; Shum Bennett O. V., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000707; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; Thoren FB, 2012, J IMMUNOL, V188, P1668, DOI 10.4049/jimmunol.1102002; TIMONEN T, 1985, CLIN EXP IMMUNOL, V59, P85; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; von Bubnoff D, 2010, J ALLERGY CLIN IMMUN, V125, P60, DOI 10.1016/j.jaci.2009.11.020; Walsh GM, 2015, EXPERT OPIN EMERG DR, V20, P349, DOI 10.1517/14728214.2015.1050377; Woo Yeonduk, 2014, Immune Netw, V14, P171, DOI 10.4110/in.2014.14.4.171; Yokota M, 2013, AM J REPROD IMMUNOL, V69, P202, DOI 10.1111/aji.12062; Yossef R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118936; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	70	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160779	10.1371/journal.pone.0160779	http://dx.doi.org/10.1371/journal.pone.0160779			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580126	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400009
J	Koch, A; Gulani, J; King, G; Hieber, K; Chappell, M; Ossetrova, N				Koch, Amory; Gulani, Jatinder; King, Gregory; Hieber, Kevin; Chappell, Mark; Ossetrova, Natalia			Establishment of Early Endpoints in Mouse Total-Body Irradiation Model	PLOS ONE			English	Article							ACUTE-RADIATION-SYNDROME; BIODOSIMETRY APPLICATIONS; MEDICAL COUNTERMEASURES; INJURY ASSESSMENT; EXPOSURE; BIOMARKERS; PROTEIN; MICE	Acute radiation sickness (ARS) following exposure to ionizing irradiation is characterized by radiation-induced multiorgan dysfunction/failure that refers to progressive dysfunction of two or more organ systems, the etiological agent being radiation damage to cells and tissues over time. Radiation sensitivity data on humans and animals has made it possible to describe the signs associated with ARS. A mouse model of total-body irradiation (TBI) has previously been developed that represents the likely scenario of exposure in the human population. Herein, we present the Mouse Intervention Scoring System (MISS) developed at the Veterinary Sciences Department (VSD) of the Armed Forces Radiobiology Research Institute (AFRRI) to identify moribund mice and decrease the numbers of mice found dead, which is therefore a more humane refinement to death as the endpoint. Survival rates were compared to changes in body weights and temperatures in the mouse (CD2F1 male) TBI model (6-14 Gy, Co-60 gamma-rays at 0.6 Gy min(-1)), which informed improvements to the Scoring System. Individual tracking of animals via implanted microchips allowed for assessment of criteria based on individuals rather than by group averages. From a total of 132 mice (92 irradiated), 51 mice were euthanized versus only four mice that were found dead (7% of non-survivors). In this case, all four mice were found dead after overnight periods between observations. Weight loss alone was indicative of imminent succumbing to radiation injury, however mice did not always become moribund within 24 hours while having weight loss >30%. Only one survivor had a weight loss of greater than 30%. Temperature significantly dropped only 2-4 days before death/euthanasia in 10 and 14 Gy animals. The score system demonstrates a significant refinement as compared to using subjective assessment of morbidity or death as the endpoint for these survival studies.	[Koch, Amory; Gulani, Jatinder; Chappell, Mark] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Bethesda, MD 20814 USA; [Gulani, Jatinder; Hieber, Kevin] Henry M Jackson Fdn, Bethesda, MD USA; [King, Gregory; Hieber, Kevin; Ossetrova, Natalia] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Sci Res Dept, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Koch, A (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Bethesda, MD 20814 USA.	amory.l.koch.mil@mail.mil			Defense Threat Reduction Agency (DTRA) grant CBM [RAD.03.10.AR.002]; AFRRI Veterinary and Radiation Sciences Departments	Defense Threat Reduction Agency (DTRA) grant CBM; AFRRI Veterinary and Radiation Sciences Departments	This work was supported by Defense Threat Reduction Agency (DTRA) grant CBM. RAD.03.10.AR.002 (awarded to NO FY10-12). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research was supported by the Defense Threat Reduction Agency (DTRA) grant CBM. RAD.03.10.AR.002 (awarded to Dr. Natalia Ossetrova). We would like to thank the AFRRI Veterinary and Radiation Sciences Departments for their support, Dr. William F. Blakely for helpful discussions, David Sandgren, Donald Condliffe, Patrick Ney, Katya Krasnopolsky, and Arifur Rahman for technical contributions, and Mark Whitnall and Francis Duffy for editing assistance. The opinions, conclusions, and recommendations expressed or implied do not necessarily reflect the view of the Department of Defense or any other department or agency of the U.S. federal government.	Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Blakely WF, 2007, RADIAT MEAS, V42, P1164, DOI 10.1016/j.radmeas.2007.05.013; Blakely WF, 2014, RADIAT PROT DOSIM, V159, P46, DOI 10.1093/rpd/ncu127; Blakely WF, 2011, RADIAT MEAS, V46, P898, DOI 10.1016/j.radmeas.2011.05.006; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; DiCarlo AL, DISASTER MED PUBLIC, V5, pS32; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Farese AM, 2012, HEALTH PHYS, V103, P367, DOI 10.1097/HP.0b013e31825f75a7; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; Goans RE, 2013, TXB MILITARY MED, P17; Kumar K. S., 2009, TOCOTRIENOLS VITAMIN, P379; Landauer MR, 2005, TRG099 NATO, V17, P1; Layton RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020641; LUSHBAUGH C C, 1969, Advances in Radiation Biology, P277; MacVittie TJ, 2005, HEALTH PHYS, V89, P546, DOI 10.1097/01.HP.0000173143.69659.5b; Nunamaker EA, 2013, COMPARATIVE MED, V63, P22; Ossetrova NI, 2007, RADIAT MEAS, V42, P1158, DOI 10.1016/j.radmeas.2007.05.031; Ossetrova NI, 2011, RADIAT MEAS, V46, P1019, DOI 10.1016/j.radmeas.2011.05.021; Ossetrova NI, 2014, RADIAT PROT DOSIM, V159, P61, DOI 10.1093/rpd/ncu165; Ossetrova NI, 2014, HEALTH PHYS, V106, P772, DOI 10.1097/HP.0000000000000094; Ossetrova NI, 2010, HEALTH PHYS, V98, P204, DOI 10.1097/HP.0b013e3181abaabf; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Ossetrova NI, 2011, 3 INT S RAD EM MED H, P105; Plett PA, 2012, HEALTH PHYS, V103, P343, DOI 10.1097/HP.0b013e3182667309; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Satyamitra M, 2011, RADIAT RES, V175, P746, DOI 10.1667/RR2462.1; Shang SB, 2012, VACCINE, V30, P1572, DOI 10.1016/j.vaccine.2011.12.114; Srinivasan V, 2008, IMMUNOPHARM IMMUNOT, V30, P271, DOI [10.1080/08923970801925331, 10.1080/08923970801925331 ]; Vriesendorp H M, 1980, Haematol Blood Transfus, V25, P349; Waselenko SK, 2004, ANN INTERN MED, V140, P1087; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1	32	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161079	10.1371/journal.pone.0161079	http://dx.doi.org/10.1371/journal.pone.0161079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579862	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400014
J	Lietz, J; Westermann, C; Nienhaus, A; Schablon, A				Lietz, Janna; Westermann, Claudia; Nienhaus, Albert; Schablon, Anja			The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies	PLOS ONE			English	Review							1ST WAVE; VIRUS-INFECTION; WORKERS; SEROPREVALENCE; ANTIBODIES; OUTBREAK; EXPOSURE; QUALITY	Introduction The aim of this review was to record systematically and assess the published literature relating to the occupational risk of influenza A (H1N1) infection among healthcare personnel during the 2009 pandemic. Methods The literature search was performed in June 2015. An update was carried out in May 2016. It was applied to the electronic databases EMBASE, MEDLINE, PsycINFO, PubMed, CINAHL and Google Scholar. The quality assessment was conducted with a tool using eight criteria. A meta-analysis was carried out to compute pooled effect estimates for influenza A (H1N1) infection. Results A total of 26 studies were included in the review, 15 studies met the criteria for the meta-analysis. After a sensitivity analysis the pooled analysis showed a significantly increased odds for influenza A (H1N1) infection for healthcare personnel compared to controls/comparisons (OR = 2.08, 95% CI = 1.73 to 2.51). The pooled prevalence rate for healthcare personnel alone was 6.3%. Conclusions This review corroborates the assumption that healthcare personnel were particularly at risk of influenza A (H1N1) infection during the 2009 pandemic. Healthcare facilities should intensify their focus on strategies to prevent infections among healthcare personnel, especially during the first period of pandemics.	[Lietz, Janna] Inst Biostat & Social Welf Matters, Hamburg, Germany; [Westermann, Claudia; Nienhaus, Albert; Schablon, Anja] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Competence Ctr Epidemiol & Hlth Serv Res Nursing, Hamburg, Germany; [Nienhaus, Albert] German Social Accid Insurance Inst Hlth & Welf Se, Dept Occupat Hlth Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Westermann, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Competence Ctr Epidemiol & Hlth Serv Res Nursing, Hamburg, Germany.	c.westermann@uke.de		Lietz, Janna/0000-0003-2307-7214	German Social Accident Insurance Institution	German Social Accident Insurance Institution	No special funding was received for this study. However, the Institute for Health Service Research in Dermatology and Nursing (IVDP) of the University Medical Centre Hamburg-Eppendorf (UKE) receives an unrestricted fund from the German Social Accident Insurance Institution for the Health and Welfare Services (BGW) on an annual basis to maintain the working group at the UKE. The funder played no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript. The BGW is not responsible for the contents of the present review.	Aguilar-Madrid G, 2015, ARCH MED RES, V46, P154, DOI 10.1016/j.arcmed.2015.03.001; Alagappan K, 2013, EMERG INFECT DIS, V19, P140, DOI 10.3201/eid1901.111640; Apisarnthanarak A, 2010, CLIN INFECT DIS, V51, P368, DOI 10.1086/654807; Balkhy HH, 2010, INFECT CONT HOSP EP, V31, P1004, DOI 10.1086/656241; Banach DB, 2011, INFECT CONT HOSP EP, V32, P293, DOI 10.1086/658911; Bandaranayake D, 2010, SEROPREVALENCE 2009; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Bhadelia N, 2013, INFECT CONT HOSP EP, V34, P825, DOI 10.1086/671271; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centre for Reviews and Dissemination, 2009, SYSTEMATIC REV CRDS; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen MIC, 2010, EMERG INFECT DIS, V16, P1554, DOI 10.3201/eid1610.100516; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Cheng VCC, 2010, J HOSP INFECT, V74, P271, DOI 10.1016/j.jhin.2009.09.009; Choi SH, 2011, J INFECTION, V63, P267, DOI 10.1016/j.jinf.2011.04.009; Costa JT, 2012, INT ARCH OCC ENV HEA, V85, P747, DOI 10.1007/s00420-011-0714-8; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Haagsma JA, 2012, OCCUP ENVIRON MED, V69, P140, DOI 10.1136/oemed-2011-100068; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ho PL, 2007, INT J TUBERC LUNG D, V11, P710; Hudson B, 2013, BRIT J GEN PRACT, V63, pE416, DOI 10.3399/bjgp13X668212; Jaeger JL, 2009, INFECT CONT HOSP EP, V2011, P1149, DOI DOI 10.1086/662709; Kiertiburanakul S, 2010, J HOSP INFECT, V74, P300, DOI 10.1016/j.jhin.2009.11.001; Kumar S, 2011, PEDIATR EMERG CARE, V27, P804, DOI 10.1097/PEC.0b013e31822c125e; Kuster SP, 2013, EMERG INFECT DIS, V19, P606, DOI 10.3201/eid1904.111812; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Lobo RD, 2013, AM J INFECT CONTROL, V41, P645, DOI 10.1016/j.ajic.2012.08.012; Loney P L, 1998, Chronic Dis Can, V19, P170; Loney PL, 1999, PHYS THER, V79, P384, DOI 10.1093/ptj/79.4.384; Magill SS, 2011, INFECT CONT HOSP EP, V32, P611, DOI 10.1086/660097; Makkoch J, 2010, ASIAN PAC J ALLERGY, V28, P67; Marshall C, 2011, EMERG INFECT DIS, V17, P1000, DOI [10.3201/eid1706.101030, 10.3201/eid/1706.101030]; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; Nukui Y, 2012, INFECT CONT HOSP EP, V33, P58, DOI 10.1086/663208; Olalla J, 2012, ENFERM INFEC MICR CL, V30, P371, DOI 10.1016/j.eimc.2011.11.019; Robert Koch-Institut (RKI), 2013, INFL SAIS INFL INFL; Santos CD, 2010, DISASTER MED PUBLIC, V4, P47, DOI 10.1017/S193578930000241X; Sepkowitz KA, 2005, EMERG INFECT DIS, V11, P1003, DOI 10.3201/eid1107.401038; Seto WH, 2009, CLIN INFECT DIS, V2011, P280, DOI DOI 10.1093/CID/CIR375; Smit PM, 2012, INT ARCH OCC ENV HEA, V85, P163, DOI 10.1007/s00420-011-0652-5; Smith K, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/407505; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; Toyokawa T, 2011, J INFECTION, V63, P281, DOI 10.1016/j.jinf.2011.05.001; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919; Yang P, 2012, INFLUENZA OTHER RESP, V6, P381, DOI 10.1111/j.1750-2659.2011.00326.x; Yen TY, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-89; Yeom JS, 2011, EUR J CLIN MICROBIOL, V30, P1201, DOI 10.1007/s10096-011-1213-2; Zhou Y, 2011, J HOSP INFECT, V78, P308, DOI 10.1016/j.jhin.2011.02.017	54	52	61	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0162061	10.1371/journal.pone.0162061	http://dx.doi.org/10.1371/journal.pone.0162061			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579923	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400055
J	Masaki, Y; Shimizu, Y; Yoshioka, T; Feng, F; Zhao, SJ; Higashino, K; Numata, Y; Kuge, Y				Masaki, Yukiko; Shimizu, Yoichi; Yoshioka, Takeshi; Feng, Fei; Zhao, Songji; Higashino, Kenichi; Numata, Yoshito; Kuge, Yuji			Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia	PLOS ONE			English	Article							DRUG DEVELOPMENT; GLUTATHIONE; 1-METHYL-2-NITROSOIMIDAZOLE; MALDI; CYTOTOXICITY; IONIZATION; DEPLETION; THIOLS; CELLS	Hypoxia, or low oxygen concentration, is a key factor promoting tumor progression and angiogenesis and resistance of cancer to radiotherapy and chemotherapy. 2-Nitroimidazole- based agents have been widely used in pathological and nuclear medicine examinations to detect hypoxic regions in tumors; in particular, pimonidazole is used for histochemical staining of hypoxic regions. It is considered to accumulate in hypoxic cells via covalent binding with macromolecules or by forming reductive metabolites after reduction of its nitro group. However, the detailed mechanism of its accumulation remains unknown. In this study, we investigated the accumulation mechanism of pimonidazole in hypoxic tumor tissues in a mouse model by mass spectrometric analyses including imaging mass spectrometry (IMS). Pimonidazole and its reductive metabolites were observed in the tumor tissues. However, their locations in the tumor sections were not similar to the positively stained areas in pimonidazole-immunohistochemistry, an area considered hypoxic. The glutathione conjugate of reduced pimonidazole, a low-molecular-weight metabolite of pimonidazole, was found in tumor tissues by LC-MS analysis, and our IMS study determined that the intratumor localization of the glutathione conjugate was consistent with the area positively immunostained for pimonidazole. We also found complementary localization of the glutathione conjugate and reduced glutathione (GSH), implying that formation of the glutathione conjugate occurred in the tumor tissue. These results suggest that in hypoxic tumor cells, pimonidazole is reduced at its nitro group, followed by conjugation with GSH.	[Masaki, Yukiko; Yoshioka, Takeshi; Higashino, Kenichi; Numata, Yoshito; Kuge, Yuji] Shionogi & Co Ltd, Discovery Res Lab Innovat Frontier Med, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido, Japan; [Shimizu, Yoichi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Shimizu, Yoichi; Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan; [Feng, Fei; Zhao, Songji; Kuge, Yuji] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Shionogi & Company Limited; Hokkaido University; Hokkaido University; Hokkaido University	Shimizu, Y (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.; Shimizu, Y (corresponding author), Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan.	yshimizu@pharm.hokudai.ac.jp		Yoshioka, Takeshi/0000-0002-8658-8081	Shionogi Co., Ltd.; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan	Shionogi Co., Ltd.; Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.jst.go.jp/shincho/sentanyugo/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded by Shionogi & Co., Ltd. (http://www.shionogi.co.jp/index.html). The funder provided support in the form of salaries for authors [YM TY KH YN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom M, 2003, EUR J CLIN PHARMACOL, V59, P357, DOI 10.1007/s00228-003-0643-x; BERUBE LR, 1992, INT J RADIAT ONCOL, V22, P817, DOI 10.1016/0360-3016(92)90531-L; BERUBE LR, 1991, BIOCHEM PHARMACOL, V42, P2153, DOI 10.1016/0006-2952(91)90351-5; BREZDEN CB, 1994, BIOCHEM PHARMACOL, V48, P361, DOI 10.1016/0006-2952(94)90108-2; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Fatema CN, 2013, ANN NUCL MED, V27, P355, DOI 10.1007/s12149-013-0693-9; Gobey J, 2005, ANAL CHEM, V77, P5643, DOI 10.1021/ac0506130; Horsman MR, 2012, NAT REV CLIN ONCOL, V9, P674, DOI 10.1038/nrclinonc.2012.171; Inazawa K, 2004, EXP MOL PATHOL, V76, P153, DOI 10.1016/j.yexmp.2003.11.002; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Ma SG, 2009, CHEM-BIOL INTERACT, V179, P25, DOI 10.1016/j.cbi.2008.09.014; MARTO JA, 1995, ANAL CHEM, V67, P3979, DOI 10.1021/ac00117a025; Masaki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16802; MULCAHY RT, 1989, BIOCHEM PHARMACOL, V38, P1667, DOI 10.1016/0006-2952(89)90315-8; NUNN A, 1995, EUR J NUCL MED, V22, P265, DOI 10.1007/BF01081524; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Vaidyanathan S, 2006, RAPID COMMUN MASS SP, V20, P1192, DOI 10.1002/rcm.2434; VARGHESE AJ, 1981, CHEM-BIOL INTERACT, V36, P141, DOI 10.1016/0009-2797(81)90016-8; VARGHESE AJ, 1983, BIOCHEM BIOPH RES CO, V112, P1013, DOI 10.1016/0006-291X(83)91719-9; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xie C, 2013, ANAL CHIM ACTA, V788, P89, DOI 10.1016/j.aca.2013.06.022; Xue YJ, 2012, BIOANALYSIS, V4, P2637, DOI [10.4155/BIO.12.252, 10.4155/bio.12.252]	23	18	18	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161639	10.1371/journal.pone.0161639	http://dx.doi.org/10.1371/journal.pone.0161639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580239	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400033
J	Ebenezer, PJ; Wilson, CB; Wilson, LD; Nair, AR; Francis, J				Ebenezer, Philip J.; Wilson, C. Brad; Wilson, Leslie D.; Nair, Anand R.; Francis, J.			The Anti-Inflammatory Effects of Blueberries in an Animal Model of Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTECTIVE ROLE; BRAIN-INJURY; INFLAMMATION; MICE; ACTIVATION; ANXIETY; ACID; HIPPOCAMPUS; VACCINATION	Post-traumatic stress disorder (PTSD) is a trauma and stressor-related disorder that results in a prolonged stress response. It is associated with increased oxidative stress and inflammation in the prefrontal cortex (PFC) and hippocampus (HC). The only approved therapy for PTSD is selective serotonin re-uptake inhibitors (SSRIs), but their efficacy ismarginal. Recently, we demonstrated that over-production of norepinephrine (NE) as the possible reason for the lack of efficacy of SSRIs. Hence, there is a need for novel therapeutic approaches for the treatment of PTSD. In this study, we investigated the anti-inflammatory role of blueberries in modulating inflammatory markers and neurotransmitter levels in PTSD. Rats were fed either a blueberry enriched (2%) or a control diet. Rats were exposed to cats for one hour on days 1 and 11 of a 31-day schedule to simulate traumatic conditions. The rats were also subjected to psychosocial stress via daily cage cohort changes. At the end of the study, the rats were euthanized and the PFC and HC were isolated. Monoamines were measured by high-performance liquid chromatography. Reactive oxygen species (ROS), gene and protein expression levels of inflammatory cytokines were alsomeasured. In our PTSD-model, NE levels were increased and 5-HT levels were decreased when compared to control. In contrast, a blueberry enriched diet increased 5-HT without affecting NE levels. The rate limiting enzymes tyrosine hydroxylase and tryptophan hydroxylase were also studied and they confirmed our findings. The enhanced levels free radicals, gene and protein expression of inflammatory cytokines seen in the PTSD group were normalized with a blueberry enriched diet. Decreased anxiety in this group was shown by improved performance on the elevated plus-maze. These findings indicate blueberries can attenuate oxidative stress and inflammation and restore neurotransmitter imbalances in a ratmodel of PTSD.	[Ebenezer, Philip J.; Wilson, C. Brad; Nair, Anand R.; Francis, J.] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Wilson, Leslie D.] Louisiana State Univ, Sch Vet Med, Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu			Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-15-1-0061]; United States Highbush Blueberry Council	Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program; United States Highbush Blueberry Council	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program 2014 under Award No. W81XWH-15-1-0061 and United States Highbush Blueberry Council for JF. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense or United States Highbush Blueberry Council. There was no additional external funding received for this study.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Alam Q., 2015, CURR PHARM DES; Baker DG, 2001, NEUROIMMUNOMODULAT, V9, P209, DOI 10.1159/000049028; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Brewin CR, 2000, J TRAUMA STRESS, V13, P499, DOI 10.1023/A:1007741526169; Chaki S, 2003, EUR J PHARMACOL, V464, P49, DOI 10.1016/S0014-2999(03)01368-2; Chaki S, 2003, J PHARMACOL EXP THER, V304, P818, DOI 10.1124/jpet.102.044826; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; Chuang CY, 2014, FREE RADICAL RES, V48, P970, DOI 10.3109/10715762.2014.920087; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Denev P, 2014, FOOD CHEM, V157, P37, DOI 10.1016/j.foodchem.2014.02.022; Diamond DM, 2016, J NEUROSCI RES, V94, P437, DOI 10.1002/jnr.23684; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Eyre H, 2012, BRAIN BEHAV IMMUN, V26, P251, DOI 10.1016/j.bbi.2011.09.015; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Garate I, 2013, BIOL PSYCHIAT, V73, P32, DOI 10.1016/j.biopsych.2012.07.005; Hohne C, 2013, BRAIN, V136, P1746, DOI 10.1093/brain/awt064; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Huang M, 2012, J ETHNOPHARMACOL, V143, P228, DOI 10.1016/j.jep.2012.06.028; Jesudason EP, 2007, MOL CELL BIOCHEM, V298, P69, DOI 10.1007/s11010-006-9353-x; Jesudason EP, 2005, BRAIN RES BULL, V65, P361, DOI 10.1016/j.brainresbull.2005.01.010; Jiang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152371; Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001; Joseph SV, 2014, J AGR FOOD CHEM, V62, P3886, DOI 10.1021/jf4044056; Lemieux A, 2008, BRAIN BEHAV IMMUN, V22, P994, DOI 10.1016/j.bbi.2008.02.005; Liu YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127813; Loganovsky KN, 2013, CNS SPECTRUMS, V18, P95, DOI 10.1017/S109285291200096X; Maddox SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054463; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Nawaz MI, 2015, J RECEPT SIG TRANSD, V35, P340, DOI 10.3109/10799893.2014.984309; Nie H, 2014, PROG NEURO-PSYCHOPH, V51, P16, DOI 10.1016/j.pnpbp.2014.01.002; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Potter KA, 2014, ACTA BIOMATER, V10, P2209, DOI 10.1016/j.actbio.2014.01.018; Poulose SM, 2014, BRAIN RES, V1593, P9, DOI 10.1016/j.brainres.2014.10.028; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Shukitt-Hale B, 2012, GERONTOLOGY, V58, P518, DOI 10.1159/000341101; Tataranno ML, 2015, CLIN PERINATOL, V42, P529, DOI 10.1016/j.clp.2015.04.011; Taverniti V, 2014, J AGR FOOD CHEM, V62, P8346, DOI 10.1021/jf502180j; Varman DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127945; Vida C, 2014, CURR PHARM DESIGN, V20, P4656; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Weston CSE, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00037; Wilson CB, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00256; Wilson CB, 2014, BEHAV BRAIN RES, V268, P72, DOI 10.1016/j.bbr.2014.03.029; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Wolf EG, 2015, UNDERSEA HYPERBAR M, V42, P313; Zhao MY, 2015, J FOOD SCI, V80, pH869, DOI 10.1111/1750-3841.12815; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	58	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160923	10.1371/journal.pone.0160923	http://dx.doi.org/10.1371/journal.pone.0160923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603014	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200009
J	Berden, FAC; de Knegt, RJ; Blokzijl, H; Kuiken, SD; van Erpecum, KJL; Willemse, SB; den Hollander, J; van Vonderen, MGA; Friederich, P; van Hoek, B; van Nieuwkerk, CMJ; Drenth, JPH; Kievit, W				Berden, Floor A. C.; de Knegt, Robert J.; Blokzijl, Hans; Kuiken, Sjoerd D.; van Erpecum, Karel J. L.; Willemse, Sophie B.; den Hollander, Jan; van Vonderen, Marit G. A.; Friederich, Pieter; van Hoek, Bart; van Nieuwkerk, Carin M. J.; Drenth, Joost P. H.; Kievit, Wietske			Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study	PLOS ONE			English	Article							GENOTYPE 1 INFECTION; ADVANCED HEPATOCELLULAR-CARCINOMA; SUSTAINED VIROLOGICAL RESPONSE; TREATMENT-EXPERIENCED PATIENTS; RANDOMIZED CONTROLLED-TRIALS; VIRUS-INFECTION; HCV INFECTION; REAL-WORLD; BOCEPREVIR; TELAPREVIR	Background Approval of drugs in chronic hepatitis C is supported by registration trials. These trials might have limited generalizability through use of strict eligibility criteria. We compared effectiveness and safety of real world hepatitis C patients eligible and ineligible for registration trials. Methods We performed a nationwide, multicenter, retrospective cohort study of chronic hepatitis C patients treated in the real world. We applied a combined set of inclusion and exclusion criteria of registration trials to our cohort to determine eligibility. We compared effectiveness and safety in eligible vs. ineligible patients, and performed sensitivity analyses with strict criteria. Further, we used log binomial regression to assess relative risks of criteria on outcomes. Results In this cohort (n = 467) 47% of patients would have been ineligible for registration trials. Main exclusion criteria were related to hepatic decompensation and co-morbidity (cardiac disease, anemia, malignancy and neutropenia), and were associated with an increased risk for serious adverse events (RR 1.45-2.31). Ineligible patients developed significantly more serious adverse events than eligible patients (27% vs. 11%, p<0.001). Effectiveness was decreased if strict criteria were used. Conclusions Nearly half of real world hepatitis C patients would have been excluded from registration trials, and these patients are at increased risk to develop serious adverse events. Hepatic decompensation and co-morbidity were important exclusion criteria, and were related to toxicity. Therefore, new drugs should also be studied in these patients, to genuinely assess benefits and risk of therapy in the real world population.	[Berden, Floor A. C.; Drenth, Joost P. H.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands; [de Knegt, Robert J.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Blokzijl, Hans] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Kuiken, Sjoerd D.] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [van Erpecum, Karel J. L.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Willemse, Sophie B.] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [den Hollander, Jan] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands; [van Vonderen, Marit G. A.] Med Ctr Leeuwarden, Dept Internal Med, Leeuwarden, Netherlands; [Friederich, Pieter] Catharina Hosp, Dept Gastroenterol & Hepatol, Eindhoven, Netherlands; [van Hoek, Bart] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands; [van Nieuwkerk, Carin M. J.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Kievit, Wietske] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands	Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Onze Lieve Vrouwe Gasthuis Hospital; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Maasstad Hospital; Medical Center Leeuwarden; Catharina Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	Drenth, JPH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands.	joostphdrenth@cs.com	Kievit, Wietske/A-5666-2015; Drenth, J.P.H./H-8025-2014; van Hoek, Bart/AAU-8953-2020; Drenth, Joost/V-7436-2019; De Knegt, Robert/X-4629-2019	De Knegt, Robert/0000-0003-0934-6975; van Hoek, Bart/0000-0001-6527-764X	AbbVie B.V. [ACA-NETH-14-04]	AbbVie B.V.	This research was funded by AbbVie B.V. (grant number #ACA-NETH-14-04). The data used for this analysis originate from a registry of Hepatitis C patients treated with telaprevir and boceprevir. This registry was financially supported by AbbVie B.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ahn J, 2016, ALIMENT PHARM THER, V43, P134, DOI 10.1111/apt.13440; Alqahtani SA, 2015, HEPATOLOGY, V62, P25, DOI 10.1002/hep.27890; American Association for the Study of Liver Diseases (AASLD) Infectious Diseases Society of America (IDSA), 2016, HCV GUID REC TEST MA; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Buti M, 2014, GASTROENTEROLOGY, V146, P744, DOI 10.1053/j.gastro.2013.11.047; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; FDA, 2013, FULL PRESCR INF NEX; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, GUT, V63, P1033, DOI 10.1136/gutjnl-2013-306480; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Flamm SL, 2013, CLIN GASTROENTEROL H, V11, P81, DOI 10.1016/j.cgh.2012.10.006; Gordon SC, 2015, J HEPATOL, V62, P286, DOI 10.1016/j.jhep.2014.08.052; Ha C, 2012, CLIN GASTROENTEROL H, V10, P1002, DOI 10.1016/j.cgh.2012.02.004; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; HHS. U FDA. CDER. CBER, 2012, GUID IND INV; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kieran J, 2013, CLIN INFECT DIS, V56, P228, DOI 10.1093/cid/cis880; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Kim HY, 2013, J GASTROEN HEPATOL, V28, P1756, DOI 10.1111/jgh.12310; Lamers H, 2013, NETH J MED, V71, P377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Majid A, 2014, J VIRAL HEPATITIS, V21, P585, DOI 10.1111/jvh.12201; Muir AJ, 2014, AM J GASTROENTEROL, V109, P628, DOI 10.1038/ajg.2014.66; National Cancer Institute N NIH DHHS, 2009, COMM TERM CRIT ADV E; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Peppercorn JM, 2004, LANCET, V363, P263, DOI 10.1016/S0140-6736(03)15383-4; Perumalswami PV, 2016, J VIRAL HEPATITIS, V23, P667, DOI 10.1111/jvh.12530; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Saeed S, 2016, CLIN INFECT DIS, V62, P919, DOI 10.1093/cid/civ1222; Saxena V, 2015, HEPATOLOGY, V62, P715, DOI 10.1002/hep.27922; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013; US Food and Drug Administration, 2018, FDA DRUG SAF COMM FD; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Vierling JM, 2014, J HEPATOL, V60, P748, DOI 10.1016/j.jhep.2013.12.013; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	42	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161821	10.1371/journal.pone.0161821	http://dx.doi.org/10.1371/journal.pone.0161821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598789	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800022
J	Xin, S; Tao, CC; Li, HB				Xin, Shan; Tao, Chengcheng; Li, Hongbin			Cloning and Functional Analysis of the Promoter of an Ascorbate Oxidase Gene from Gossypium hirsutum	PLOS ONE			English	Article							FRUIT-DEVELOPMENT; TOBACCO PLANTS; REDOX STATE; EXPRESSION; PUMPKIN; AUXIN; CDNA; BIOSYNTHESIS; PEROXIDASE; ELONGATION	Apoplastic ascorbate oxidase (AO) plays significant roles in plant cell growth. However, the mechanism of underlying the transcriptional regulation of AO in Gossypium hirsutum remains unclear. Here, we obtained a 1,920-bp promoter sequence from the Gossypium hirsutum ascorbate oxidase (GhAO1) gene, and this GhAO1 promoter included a number of known cis-elements. Promoter activity analysis in overexpressing pGhAO1::GFP-GUS tobacco (Nicotiana benthamiana) showed that the GhAO1 promoter exhibited high activity, driving strong reporter gene expression in tobacco trichomes, leaves and roots. Promoter 5'-deletion analysis demonstrated that truncated GhAO1 promoters with serial 5'-end deletions had different GUS activities. A 360-bp fragment was sufficient to activate GUS expression. The P-1040 region had less GUS activity than the P-720 region, suggesting that the 320-bp region from nucleotide -720 to -1040 might include a cis-element acting as a silencer. Interestingly, an auxin-responsive cis-acting element (TGA-element) was uncovered in the promoter. To analyze the function of the TGA-element, tobacco leaves transformed with promoters with different 5' truncations were treated with indole-3-acetic acid (IAA). Tobacco leaves transformed with the promoter regions containing the TGA-element showed significantly increased GUS activity after IAA treatment, implying that the fragment spanning nucleotides -1760 to -1600 (which includes the TGA-element) might be a key component for IAA responsiveness. Analyses of the AO promoter region and AO expression pattern in Gossypium arboreum (Ga, diploid cotton with an AA genome), Gossypium raimondii (Gr, diploid cotton with a DD genome) and Gossypium hirsutum (Gh, tetraploid cotton with an AADD genome) indicated that AO promoter activation and AO transcription were detected together only in D genome/sub-genome (Gr and Gh) cotton. Taken together, these results suggest that the 1,920-bp GhAO1 promoter is a functional sequence with a potential effect on fiber cell development, mediated by TGA-element containing sequences, via the auxin-signaling pathway.	[Xin, Shan; Tao, Chengcheng; Li, Hongbin] Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China	Shihezi University	Li, HB (corresponding author), Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China.	lihb@shzu.edu.cn		Li, Hongbin/0000-0001-5350-7540	National Natural Science Foundation of China [31260339]; Germplasm resource innovation project of Bingtuan [2012BB050]; Distinguished Youth innovation foundation of Bingtuan [2014CD003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Germplasm resource innovation project of Bingtuan; Distinguished Youth innovation foundation of Bingtuan	This work was supported by National Natural Science Foundation of China (Grant number 31260339), Germplasm resource innovation project of Bingtuan (Grant number 2012BB050), and Distinguished Youth innovation foundation of Bingtuan (Grant number 2014CD003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRIERBRYGOO H, 1989, P NATL ACAD SCI USA, V86, P891, DOI 10.1073/pnas.86.3.891; Cervera M, 2005, METH MOL B, V286, P203; CHEN JY, 2015, PLOS GENET, V11, DOI DOI 10.1371/JOURNAL.PONE.0129870; De Tullio MC, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23213; Diallinas G, 1997, PLANT MOL BIOL, V34, P759, DOI 10.1023/A:1005851527227; Ding MQ, 2014, GENE, V535, P273, DOI 10.1016/j.gene.2013.11.017; ESAKA M, 1990, EUR J BIOCHEM, V191, P537, DOI 10.1111/j.1432-1033.1990.tb19154.x; ESAKA M, 1992, PLANT PHYSIOL, V100, P231, DOI 10.1104/pp.100.1.231; ESAKA M, 1988, PLANT PHYSIOL, V88, P656, DOI 10.1104/pp.88.3.656; Fotopoulos V, 2006, J EXP BOT, V57, P3933, DOI 10.1093/jxb/erl147; Fotopoulos V, 2013, PLANT PHYSIOL BIOCH, V73, P154, DOI 10.1016/j.plaphy.2013.09.002; Gong WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112966; Green MA, 2005, NATURE, V433, P83, DOI 10.1038/nature03172; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; John ME, 1996, P NATL ACAD SCI USA, V93, P12768, DOI 10.1073/pnas.93.23.12768; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kato N, 1996, PLANT MOL BIOL, V30, P833, DOI 10.1007/BF00019015; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125046; Kisu Y, 1997, PLANT CELL PHYSIOL, V38, P631, DOI 10.1093/oxfordjournals.pcp.a029214; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; OHKAWA J, 1989, P NATL ACAD SCI USA, V86, P1239, DOI 10.1073/pnas.86.4.1239; OHKAWA J, 1994, PLANT CELL REP, V13, P481, DOI 10.1007/BF00232941; Pignocchi C, 2003, PLANT PHYSIOL, V132, P1631, DOI 10.1104/pp.103.022798; Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4; Pignocchi C, 2006, PLANT PHYSIOL, V141, P423, DOI 10.1104/pp.106.078469; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Qin YM, 2008, PLANT SIGNAL BEHAV, V3, P194, DOI 10.4161/psb.3.3.5208; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stomp AM, 1992, METHOD MOL BIOL, P103, DOI [10.1385/0-89603-191-8:103, DOI 10.1385/0-89603-191-8:103]; Tang WX, 2014, PLANT MOL BIOL, V85, P613, DOI 10.1007/s11103-014-0208-7; Wang J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-961; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	37	18	21	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161695	10.1371/journal.pone.0161695	http://dx.doi.org/10.1371/journal.pone.0161695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597995	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800015
J	Yuki, T; Tobiishi, M; Kusaka-Kikushima, A; Ota, Y; Tokura, Y				Yuki, Takuo; Tobiishi, Megumi; Kusaka-Kikushima, Ayumi; Ota, Yukiko; Tokura, Yoshiki			Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17	PLOS ONE			English	Article							STRATUM-CORNEUM BARRIER; CLAUDIN-1-DEFICIENT MICE; EPIDERMAL BARRIER; FILAGGRIN; KERATINOCYTES; EXPRESSION; PROTEINS; OCCLUDIN; PSORIASIS; DISEASE	Tight junction (TJ) dysfunction in the stratum granulosum leads to aberrant barrier function of the stratum corneum (SC) in the epidermis. However, it is unclear whether TJs are perturbed in atopic dermatitis (AD), a representative aberrant SC-related skin disease, and whether some factors related to AD pathogenesis induce TJ dysfunction. To address these issues, we investigated the alterations of TJs in AD skin and the effects of Th2 and Th17 cytokines on TJs in a skin-equivalent model. The levels of TJ proteins were determined in the epidermis of nonlesional and lesional skin sites of AD. Western blot and immunohisto-chemical analyses revealed that the levels of zonula occludens 1 were decreased in the nonlesional sites of AD, and the levels of zonula occludens 1 and claudin-1 were decreased in the lesional sites relative to the levels in skin from healthy subjects. Next, we examined the effects of interleukin (IL)-4, tumor necrosis factor-a, IL-17, and IL-22 on the TJ barrier in a skin-equivalent model. Only IL-17 impaired the TJ barrier. Furthermore, we observed a defect in filaggrin monomer degradation in the IL-17-treated skin model. Thus, TJs are dysfunctional in AD, at least partly, due to the effect of IL-17, which may result in an aberrant SC barrier.	[Yuki, Takuo; Tobiishi, Megumi; Kusaka-Kikushima, Ayumi; Ota, Yukiko] Kao Corp, Biol Sci Res, Odawara, Kanagawa, Japan; [Tokura, Yoshiki] Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan	KAO Corporation; Hamamatsu University School of Medicine	Yuki, T (corresponding author), Kao Corp, Biol Sci Res, Odawara, Kanagawa, Japan.	yuki.takuo@kao.co.jp			Kao Corporation	Kao Corporation	Kao Corporation provided support in the form of salaries for authors Takuo Yuki, Megumi Tobiishi, Ayumi Kusaka, and Yukiko Ota, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; del Giudice MM, 2006, ALLERGY ASTHMA PROC, V27, P451, DOI 10.2500/aap.2006.27.2887; Donetti E, 2014, CYTOKINE, V68, P1, DOI 10.1016/j.cyto.2014.03.003; Eichenfield LF, 2004, ALLERGY, V59, P86, DOI 10.1111/j.1398-9995.2004.00569.x; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gutowska-Owsiak D, 2012, EXP DERMATOL, V21, P104, DOI 10.1111/j.1600-0625.2011.01412.x; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Kabashima-Kubo R, 2012, J DERMATOL SCI, V67, P37, DOI 10.1016/j.jdermsci.2012.04.004; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuo IH, 2013, J INVEST DERMATOL, V133, P988, DOI 10.1038/jid.2012.437; Morita K, 2004, BRIT J DERMATOL, V151, P328, DOI 10.1111/j.1365-2133.2004.06029.x; Morita K, 2002, J INVEST DERMATOL, V118, P1073, DOI 10.1046/j.1523-1747.2002.01774.x; Nakagawa N, 2004, J INVEST DERMATOL, V122, P755, DOI 10.1111/j.0022-202X.2004.22317.x; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x; Raiko L, 2009, DERMATOL REP, V1, P1, DOI 10.4081/dr.2009.e1; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Sugawara T, 2013, J DERMATOL SCI, V70, P12, DOI 10.1016/j.jdermsci.2013.01.002; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Yoshida Y, 2001, ARCH DERMATOL RES, V293, P239, DOI 10.1007/s004030100221; Yuki T, 2007, EXP DERMATOL, V16, P324, DOI 10.1111/j.1600-0625.2006.00539.x; Yuki T, 2013, J DERMATOL SCI, V69, P148, DOI 10.1016/j.jdermsci.2012.11.595; Yuki T, 2011, J IMMUNOL, V187, P3230, DOI 10.4049/jimmunol.1100058; Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385	38	76	85	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161759	10.1371/journal.pone.0161759	http://dx.doi.org/10.1371/journal.pone.0161759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588419	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800016
J	Hu, MT; Hsu, AT; Su, FC				Hu, Meng-Tzu; Hsu, Ar-Tyan; Su, Fong-Chin			Kinematic Analyses of the Thumb during Simulated Posteroanterior Glide Mobilization	PLOS ONE			English	Article							BASAL JOINT; PHYSIOTHERAPISTS; HYPERMOBILITY; MANIPULATION; VARIABILITY; PERFORMANCE; PREVALENCE; WORKSPACE; POSITION	Objective Thumb problems are common in some health professionals such as physical therapists. The purpose of this case-control study is to investigate the influence of clinical experience and different mobilization techniques on the kinematics of the thumb. Methods Twenty-three participants without exposure to manual techniques (the Novice Group) and fifteen physical therapists with at least 3 years of orthopedic experience (the Experienced Group) participated. The kinematics of the thumb while performing 3 different simulated posteroanterior (PA) glide mobilization techniques on a load cell was monitored. These 3 techniques were: 1) unsupported, 2) with digital support and 3) with thumb interphalangeal joint supported by the index finger. The amount of forces exerted were 25% to 100% of maximum effort at 25% increments. The main effects of experience and technique on thumb kinematics were assessed. Results Both experience and technique had main effects on the flexion/extension angles of the thumb joints. Experienced participants assumed a more flexed position at the carpometacarpal (CMC) joint, and the novice participants performed with angles closer to the neutral position (F = 7.593, p = 0.010). Participants' metacarpophalangeal (MCP) joints were in a more flexed position while performing PA glide with thumb interphalangeal (IP) joint supported by the index as compared to the other two techniques (p < .001). Conclusions Negative correlations were generally obtained between the sagittal plane angles of adjacent thumb joints during mobilization/manipulation. Therapists are recommended to treat patient with more stable PA glide mobilization techniques, such as PA glide with thumb interphalangeal joint supported by the index finger, to prevent potential mobilization-related thumb disorders.	[Hu, Meng-Tzu; Su, Fong-Chin] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan, Taiwan; [Hsu, Ar-Tyan] Natl Cheng Kung Univ, Coll Med, Dept Phys Therapy, Tainan, Taiwan; [Hsu, Ar-Tyan] Natl Cheng Kung Univ, Coll Med, Inst Allied Hlth Sci, Tainan, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Hu, Meng-Tzu] Tzu Hui Inst Technol, Dept Phys Therapy, Pingtung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan, Taiwan.; Su, FC (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011	SU, FONG-CHIN/0000-0002-3870-4842	National Science Council, Taiwan [NSC93-2320-B-006-063]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grant (NSC93-2320-B-006-063) from the National Science Council, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudette B, 2014, J MED BIOL ENG, V34, P448, DOI 10.5405/jmbe.1697; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Brand PW, 1993, CLIN MECH HAND, P192; Buckingham G, 2007, AUST J PHYSIOTHER, V53, P55, DOI 10.1016/S0004-9514(07)70062-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cromie JE, 2000, PHYS THER, V80, P336, DOI 10.1093/ptj/80.4.336; DARLING WG, 1987, J MOTOR BEHAV, V19, P291; Descarreaux M, 2010, J MANIP PHYSIOL THER, V33, P226, DOI 10.1016/j.jmpt.2010.01.011; EATON RG, 1969, J BONE JOINT SURG AM, VA 51, P661, DOI 10.2106/00004623-196951040-00004; EATON RG, 1973, J BONE JOINT SURG AM, VA 55, P1655, DOI 10.2106/00004623-197355080-00010; Fattapposta F, 1996, ELECTROEN CLIN NEURO, V99, P495, DOI 10.1016/S0013-4694(96)96560-8; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gabriel DA, 2002, J ELECTROMYOGR KINES, V12, P407, DOI 10.1016/S1050-6411(02)00026-3; Halilaj E, 2014, CLIN ORTHOP RELAT R, V472, P1114, DOI 10.1007/s11999-013-3063-y; Hu MT, 2014, MANUAL THER, V19, P484, DOI 10.1016/j.math.2014.05.003; Hu MT, 2009, MANUAL THER, V14, P490, DOI 10.1016/j.math.2008.10.003; Kuo LC, 2009, J ELECTROMYOGR KINES, V19, P829, DOI 10.1016/j.jelekin.2008.07.008; Li ZM, 2008, J ORTHOP RES, V26, P1289, DOI 10.1002/jor.20641; Li ZM, 2007, J BIOMECH, V40, P502, DOI 10.1016/j.jbiomech.2006.02.019; Lin HT, 2011, CLIN BIOMECH, V26, P371, DOI 10.1016/j.clinbiomech.2010.11.009; Maitland G., 2001, MAITLANDS VERTEBRAL, V6th; MALLIK AK, 1994, BRIT J RHEUMATOL, V33, P631; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; McMahon M, 2006, AUST J PHYSIOTHER, V52, P287, DOI 10.1016/S0004-9514(06)70009-5; Moulton MJR, 2001, J BONE JOINT SURG AM, V83A, P709, DOI 10.2106/00004623-200105000-00009; Nordin M, 1989, BASIC BIOMECHANICS M; Tang J, 2008, ERGONOMICS, V51, P1109, DOI 10.1080/00140130801958667; Wajon A, 2007, MANUAL THER, V12, P12, DOI 10.1016/j.math.2005.09.003; Wajon Anne, 2003, J Hand Ther, V16, P237, DOI 10.1016/S0894-1130(03)00039-5; West DJ, 2001, AUST J PHYSIOTHER, V47, P179, DOI 10.1016/S0004-9514(14)60265-8; Wolf JM, 2011, J AM ACAD ORTHOP SUR, V19, P463, DOI 10.5435/00124635-201108000-00002; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Zancolli EA, 2001, HAND CLIN, V17, P13	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161624	10.1371/journal.pone.0161624	http://dx.doi.org/10.1371/journal.pone.0161624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583407	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600045
J	Li, XH; Zhuang, L; Zhang, XM; Wang, J; Chen, TW; Li, LJ; Aduah, EA; Hu, JN				Li, Xinghui; Zhuang, Ling; Zhang, Xiaoming; Wang, Jian; Chen, Tianwu; Li, Liangjun; Aduah, Emmanuel Ajedichiga; Hu, Jiani			Preliminary Study of MR Diffusion Tensor Imaging of Pancreas for the Diagnosis of Acute Pancreatitis	PLOS ONE			English	Article							LIVER FIBROSIS; WHITE-MATTER; TRACTOGRAPHY; INFLAMMATION; SEVERITY; EFFICACY; MOTOR; DTI; CT	Objectives To evaluate the feasibility of differentiating between acute pancreatitis (AP) and healthy pancreas using diffusion tensor imaging (DTI) and correlate apparent diffusion coefficient (ADC)/fractional anisotropy (FA) values with the severity of AP. Material and Methods 66 patients diagnosed with AP and 20 normal controls (NC) underwent DTI sequences and routine pancreatic MR sequences on a 3.0T MRI scanner. Average ADC and FA values of the pancreatic were measured. Differences of FA and ADC values between the AP group and the NC group with AP and healthy pancreas were compared by two-sample independent t-test. The severity of AP on MRI was classified into subgroups using MR severity index (MRSI), where the mean FA and ADC values were calculated. Relationship among the FA values, ADC values and MRSI were analyzed using Spearman's rank correlation coefficients. Results The pancreatic mean ADC value in the AP group (1.68 +/- 0.45x10(-3)mm(2)/s) was significantly lower than in the NC group (2.09 +/- 0.55x10(-3)mm(2)/s) (P = 0.02); the same as mean FA value (0.39 +/- 0.23 vs 0.54 +/- 0.12, P = 0.00). In the subgroup analysis, the pancreatic ADC and FA value of edema AP patients was significantly higher than necrosis AP patients with P = 0.000 and P = 0.001 respectively. In addition, as severity of pancreatitis increased according to MRSI, lower pancreatic ADC (r = -0.635) and FA value (r = -0.654) were noted. Conclusion Both FA and ADC value from DTI can be used to differentiate AP patients from NC. Both ADC and FA value of pancreas have a negative correlation with the severity of AP.	[Li, Xinghui; Zhang, Xiaoming; Wang, Jian; Chen, Tianwu; Li, Liangjun] First Mil Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Li, Xinghui; Zhang, Xiaoming; Wang, Jian; Chen, Tianwu; Li, Liangjun] North Sichuan Med Coll, Dept Radiol, Affiliated Hosp, Nanchong, Peoples R China; [Zhuang, Ling] Wayne State Univ, Dept Radiat Oncol, Detroit, MI 48202 USA; [Aduah, Emmanuel Ajedichiga] North Sichuan Med Coll, Dept Surg, Affiliated Hosp, Nanchong, Peoples R China; [Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Southern Medical University - China; North Sichuan Medical University; Wayne State University; North Sichuan Medical University; Wayne State University	Zhang, XM; Wang, J (corresponding author), First Mil Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China.; Zhang, XM; Wang, J (corresponding author), North Sichuan Med Coll, Dept Radiol, Affiliated Hosp, Nanchong, Peoples R China.	cjr.zhxm@vip.163.com; wangjian811@tom.com	Zhang, Xiao Ming/H-7104-2019	Zhang, Xiao Ming/0000-0001-5327-8506				Akisik MF, 2009, RADIOLOGY, V250, P103, DOI 10.1148/radiol.2493080160; al-Eryani S, 1998, Bratisl Lek Listy, V99, P303; Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; Bagadia A, 2011, J CLIN NEUROSCI, V18, P633, DOI 10.1016/j.jocn.2010.08.026; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Baron T, 2013, CLEV CLIN J MED, V80, P350, DOI 10.3949/ccjm.80gr.13001; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Busireddy Kiran K, 2014, World J Gastrointest Pathophysiol, V5, P252, DOI 10.4291/wjgp.v5.i3.252; Cheung JS, 2010, NMR BIOMED, V23, P496, DOI 10.1002/nbm.1486; Dembinski A, 2003, EUR J PHARMACOL, V473, P207, DOI 10.1016/S0014-2999(03)01994-0; Erturk SM, 2014, ACTA RADIOL, V55, P654, DOI 10.1177/0284185113504916; In't Veld P, 2010, ADV EXP MED BIOL, V654, P1, DOI 10.1007/978-90-481-3271-3_1; KLAR E, 1992, HELV CHIR ACTA, V59, P7; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Kovanlikaya I, 2011, EUR J RADIOL, V77, P383, DOI 10.1016/j.ejrad.2009.08.012; Lecesne R, 1999, RADIOLOGY, V211, P727, DOI 10.1148/radiology.211.3.r99jn08727; Li XH, 2012, EUR J RADIOL, V81, pE880, DOI 10.1016/j.ejrad.2012.04.032; Li XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135568; Lund H, 2006, SCAND J GASTROENTERO, V41, P234, DOI 10.1080/00365520510024133; Meng X, 2013, CLIN RADIOL, V68, P815, DOI 10.1016/j.crad.2013.03.009; Miller FH, 2004, AM J ROENTGENOL, V183, P1637, DOI 10.2214/ajr.183.6.01831637; Nissan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115783; Shinya S, 2009, HEPATO-GASTROENTEROL, V56, P1407; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Tang W, 2011, EUR J RADIOL, V80, P637, DOI 10.1016/j.ejrad.2010.08.020; Taniguchi T, 2009, JPN J RADIOL, V27, P138, DOI 10.1007/s11604-008-0311-2; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Taylor SL, 2005, AM J SURG, V189, P219, DOI 10.1016/j.amjsurg.2004.11.010; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; Thomas S, 2012, EMERG RADIOL, V19, P5, DOI 10.1007/s10140-011-0983-2; Tosun M, 2013, EUR J RADIOL, V82, P203, DOI 10.1016/j.ejrad.2012.09.009; Viremouneix L, 2007, J MAGN RESON IMAGING, V26, P331, DOI 10.1002/jmri.21037; Watanabe T, 1999, PANCREAS, V18, P349, DOI 10.1097/00006676-199905000-00004; Yencilek E, 2014, TURK J GASTROENTEROL, V25, P553, DOI 10.5152/tjg.2014.6416; Zheng ZF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113469; Zhu FP, 2012, NEUROSURGERY, V71, P1170, DOI 10.1227/NEU.0b013e318271bc61	37	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160115	10.1371/journal.pone.0160115	http://dx.doi.org/10.1371/journal.pone.0160115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584016	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600003
J	Narath, SH; Mautner, SI; Svehlikova, E; Schultes, B; Pieber, TR; Sinner, FM; Gander, E; Libiseller, G; Schimek, MG; Sourij, H; Magnes, C				Narath, Sophie H.; Mautner, Selma I.; Svehlikova, Eva; Schultes, Bernd; Pieber, Thomas R.; Sinner, Frank M.; Gander, Edgar; Libiseller, Gunnar; Schimek, Michael G.; Sourij, Harald; Magnes, Christoph			An Untargeted Metabolomics Approach to Characterize Short-Term and Long-Term Metabolic Changes after Bariatric Surgery	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; Y GASTRIC BYPASS; CHAIN AMINO-ACIDS; BRANCHED-CHAIN; INSULIN-RESISTANCE; LIFE-STYLE; OBESE; BIOMARKERS; HMDB; PHOSPHATIDYLCHOLINE	Bariatric surgery is currently one of the most effective treatments for obesity and leads to significant weight reduction, improved cardiovascular risk factors and overall survival in treated patients. To date, most studies focused on short-term effects of bariatric surgery on the metabolic profile and found high variation in the individual responses to surgery. The aim of this study was to identify relevant metabolic changes not only shortly after bariatric surgery (Roux-en-Y gastric bypass) but also up to one year after the intervention by using untargeted metabolomics. 132 serum samples taken from 44 patients before surgery, after hospital discharge (1-3 weeks after surgery) and at a 1-year follow-up during a prospective study (NCT01271062) performed at two study centers (Austria and Switzerland). The samples included 24 patients with type 2 diabetes at baseline, thereof 9 with diabetes remission after one year. The samples were analyzed by using liquid chromatography coupled to high resolution mass spectrometry (LC-HRMS, HILIC-QExactive). Raw data was processed with XCMS and drift-corrected through quantile regression based on quality controls. 177 relevant metabolic features were selected through Random Forests and univariate testing and 36 metabolites were identified. Identified metabolites included trimethylamine-N-oxide, alanine, phenylalanine and indoxyl-sulfate which are known markers for cardiovascular risk. In addition we found a significant decrease in alanine after one year in the group of patients with diabetes remission relative to non-remission. Our analysis highlights the importance of assessing multiple points in time in subjects undergoing bariatric surgery to enable the identification of biomarkers for treatment response, cardiovascular benefit and diabetes remission. Key-findings include different trend pattern over time for various metabolites and demonstrated that short term changes should not necessarily be used to identify important long term effects of bariatric surgery.	[Narath, Sophie H.; Mautner, Selma I.; Pieber, Thomas R.; Sinner, Frank M.; Gander, Edgar; Libiseller, Gunnar; Magnes, Christoph] JOANNEUM RES Forsch Gesell mbH, Hlth Inst Biomed & Hlth Sci, Graz, Austria; [Mautner, Selma I.; Svehlikova, Eva; Pieber, Thomas R.; Sinner, Frank M.; Sourij, Harald] Med Univ Graz, Dept Internal Med, Div Endocrinol & Diabetol, Graz, Austria; [Schimek, Michael G.] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Schultes, Bernd] eSwiss Med & Surg Ctr, St Gallen, Switzerland; [Mautner, Selma I.; Pieber, Thomas R.; Sourij, Harald] CBmed Ctr Biomarker Res Med, Stiftingtalstr 5, A-8010 Graz, Austria	Medical University of Graz; Medical University of Graz	Sourij, H (corresponding author), Med Univ Graz, Dept Internal Med, Div Endocrinol & Diabetol, Graz, Austria.; Sourij, H (corresponding author), CBmed Ctr Biomarker Res Med, Stiftingtalstr 5, A-8010 Graz, Austria.	ha.sourij@medunigraz.at	Sourij, Harald/V-3370-2019	Mautner, Selma/0000-0003-0786-7128; Sourij, Harald/0000-0003-3510-9594; Magnes, Christoph/0000-0002-5153-7444; Pieber, Thomas/0000-0003-3554-0405	Austrian Federal Ministry for Transport, Innovation and Technology (bmvit), Project Met2Net, EFSD/MSD Clinical Research Programme	Austrian Federal Ministry for Transport, Innovation and Technology (bmvit), Project Met2Net, EFSD/MSD Clinical Research Programme	This work was supported financially by the Austrian Federal Ministry for Transport, Innovation and Technology (bmvit), Project Met2Net, EFSD/MSD Clinical Research Programme 2009.	Ai FF, 2014, FOOD CHEM, V143, P472, DOI 10.1016/j.foodchem.2013.08.013; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Arora T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126401; Ashrafian H, 2014, J PROTEOME RES, V13, P570, DOI 10.1021/pr400748f; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benotti P, 2014, ANN SURG, V259, P123, DOI 10.1097/SLA.0b013e31828a0ee4; Bergman RN, 2014, CURR OPIN BIOTECH, V28, P165, DOI 10.1016/j.copbio.2014.05.007; Bojsen-Moller KN, 2014, DIABETES, V63; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Chen Tianlu, 2013, Evid Based Complement Alternat Med, V2013, P298183, DOI 10.1155/2013/298183; Courcoulas AP, 2014, JAMA SURG, V149, P1323, DOI 10.1001/jamasurg.2014.2440; Dixon JB, 2014, LANCET DIABETES ENDO, V2, P100, DOI 10.1016/S2213-8587(14)70021-X; Dixon JB, 2012, LANCET, V379, P2300, DOI 10.1016/S0140-6736(12)60401-2; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunn WB, 2013, CURR CARDIOVASC RISK, V7, P25, DOI 10.1007/s12170-012-0282-9; Dunn WB, 2012, BIOANALYSIS, V4, P2249, DOI [10.4155/BIO.12.204, 10.4155/bio.12.204]; Dutia R, 2014, DIABETES, V63, P1214, DOI 10.2337/db13-1176; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Friedrich N, 2012, OMICS, V16, P612, DOI 10.1089/omi.2012.0066; Goldfine AB, 2014, DIABETES, V63, P1454, DOI 10.2337/db13-1918; Hanzu FA, 2014, OBESITY, V22, P698, DOI 10.1002/oby.20541; Heber D, 2010, J CLIN ENDOCR METAB, V95, P4823, DOI 10.1210/jc.2009-2128; Ho JE, 2013, DIABETES, V62, P2689, DOI 10.2337/db12-0754; Hofso D, 2010, EUR J ENDOCRINOL, V163, P735, DOI 10.1530/EJE-10-0514; Jimenez A, 2013, OBES SURG, V23, P494, DOI 10.1007/s11695-012-0817-7; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kashyap SR, 2010, CLEV CLIN J MED, V77, P468, DOI 10.3949/ccjm.77a.09135; Klein MS, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3898502; Koenker R, 2013, PACKAGE QUANTREG; Koenker R, 2005, QUANTILE REGRESSION, DOI [10.1017/CBO9780511754098, DOI 10.1017/CBO9780511754098]; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; Laferrere B, 2011, SCI TRANSL MED, V3, DOI DOI 10.1089/OMI.2012.0066; Lee J, 2012, ANAL SCI, V28, P801, DOI 10.2116/analsci.28.801; Libiseller G, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0562-8; Lin XH, 2011, METABOLOMICS, V7, P549, DOI 10.1007/s11306-011-0274-7; Liu XB, 2014, ANAL BIOANAL CHEM, V406, P1985, DOI 10.1007/s00216-013-7610-x; Magkos F, 2013, DIABETES, V62, P2757, DOI 10.2337/db13-0185; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Milburn MV, 2013, ANNU REV MED, V64, P291, DOI 10.1146/annurev-med-061511-134747; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicoletti CF, 2013, SURG OBES RELAT DIS, V9, P1008, DOI 10.1016/j.soard.2013.07.004; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Panunzi S, 2016, DIABETES CARE, V39, P166, DOI 10.2337/dc15-0575; Pilbrow A, 2014, CIRC-CARDIOVASC GENE, V7, P89, DOI [10.1161/CIRCGENETICS.114.000521, 10.1161/CIRCGENETICS.114.000528]; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Rhee EP, 2012, CLIN CHEM, V58, P139, DOI 10.1373/clinchem.2011.169573; Roberts LD, 2014, LANCET DIABETES ENDO, V2, P65, DOI 10.1016/S2213-8587(13)70143-8; Saccenti E, 2013, METABOLOMICS; Saccenti E, 2015, J PROTEOME RES, V14, P1101, DOI 10.1021/pr501075r; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Sigruener A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085724; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smith ACA, 2014, PACKAGE XCMS; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Stewart B. W., 2003, World Cancer Report; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sugimoto M, 2012, CURR BIOINFORM, V7, P96, DOI 10.2174/157489312799304431; Suhre K, 2014, J ENDOCRINOL, V221, pR75, DOI 10.1530/JOE-14-0024; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Svehlikova E, 2014, DIABETOLOGIA, V57, pS59; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Touw WG, 2013, BRIEF BIOINFORM, V14, P315, DOI 10.1093/bib/bbs034; Vest AR, 2013, CIRCULATION, V127, P945, DOI 10.1161/CIRCULATIONAHA.112.103275; Walford GA, 2014, DIABETES CARE, V37, P2508, DOI 10.2337/dc14-0560; Walford GA, 2013, METABOLISM, V62, P1772, DOI 10.1016/j.metabol.2013.07.003; Wang SY, 2013, ANAL CHEM, V85, P1037, DOI 10.1021/ac302877x; Wang ZN, 2014, EUR HEART J, V35, P904, DOI 10.1093/eurheartj/ehu002; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; WHO, 2015, OB OV, DOI DOI 10.1161/CIRCULATIONAHA.112.103275; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang SQ, 2011, BMC BIOINFORMATICS, V12, DOI [10.1186/1471-2105-12-238, 10.1186/1471-2105-12-450]	87	37	37	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161425	10.1371/journal.pone.0161425	http://dx.doi.org/10.1371/journal.pone.0161425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584017	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600029
J	Quoilin, C; Lambert, J; Jacob, B; Klein, PA; Duque, J				Quoilin, Caroline; Lambert, Julien; Jacob, Benvenuto; Klein, Pierre-Alexandre; Duque, Julie			Comparison of Motor Inhibition in Variants of the Instructed-Delay Choice Reaction Time Task	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RESPONSE PREPARATION; CORTICOSPINAL EXCITABILITY; MOVEMENT PREPARATION; MECHANISMS; SUPPRESSION; REPRESENTATION; ATTENTION	Using instructed-delay choice reaction time (RT) paradigms, many previous studies have shown that the motor system is transiently inhibited during response preparation: motor-evoked potentials (MEPs) elicited by transcranial magnetic stimulation (TMS) over the primary motor cortex are typically suppressed during the delay period. This effect has been observed in both selected and non-selected effectors, although MEP changes in selected effectors have been more inconsistent across task versions. Here, we compared changes in MEP amplitudes in three different variants of an instructed-delay choice RT task. All variants required participants to choose between left and right index finger movements but the responses were either provided "in the air" (Variant 1), on a regular keyboard (Variant 2), or on a response device designed to control from premature responses (Variant 3). The task variants also differed according to the visual layout (more concrete in Variant 3) and depending on whether participants received a feedback of their performance (absent in Variant 1). Behavior was globally comparable between the three variants of the task although the propensity to respond prematurely was highest in Variant 2 and lowest in Variant 3. MEPs elicited in a non-selected hand were similarly suppressed in the three variants of the task. However, significant differences emerged when considering MEPs elicited in the selected hand: these MEPs were suppressed in Variants 1 and 3 whereas they were often facilitated in Variant 2, especially in the right dominant hand. In conclusion, MEPs elicited in selected muscles seem to be more sensitive to small variations to the task design than those recorded in non-selected effectors, probably because they reflect a complex combination of inhibitory and facilitatory influences on the motor output system. Finally, the use of a standard keyboard seems to be particularly inappropriate because it encourages participants to respond promptly with no means to control for premature responses, probably increasing the relative amount of facilitatory influences at the time motor inhibition is probed.	[Quoilin, Caroline; Lambert, Julien; Jacob, Benvenuto; Klein, Pierre-Alexandre; Duque, Julie] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium	Universite Catholique Louvain	Quoilin, C (corresponding author), Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium.	caroline.quoilin@uclouvain.be		Lambert, Julien/0000-0002-7571-4740; Duque, Julie/0000-0001-9575-7097	Belgian National Funds for Scientific Research (FRS-FNRS) [MIS F.4512.14]	Belgian National Funds for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by grants from the Belgian National Funds for Scientific Research (FRS-FNRS): CQ was funded as a post-doctoral researcher by a grant obtained by JD (MIS F.4512.14) and PAK as a doctoral research fellow (Aspirant FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bestmann S, 2016, NEUROSCIENTIST, V22, P392, DOI 10.1177/1073858415592594; Bestmann S, 2015, EXP BRAIN RES, V233, P679, DOI 10.1007/s00221-014-4183-7; Davranche K, 2007, EUR J NEUROSCI, V25, P3766, DOI 10.1111/j.1460-9568.2007.05588.x; Derosiere G, 2015, CEREB CORTEX, V25, P66, DOI 10.1093/cercor/bht206; Duque J, 2014, NEUROPSYCHOLOGIA, V65, P287, DOI 10.1016/j.neuropsychologia.2014.08.006; Duque J, 2012, J NEUROSCI, V32, P806, DOI 10.1523/JNEUROSCI.4299-12.2012; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Greenhouse I, 2015, J NEUROSCI, V35, P10675, DOI 10.1523/JNEUROSCI.1436-15.2015; Greenhouse I, 2015, J NEUROPHYSIOL, V113, P2792, DOI 10.1152/jn.00999.2014; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Hasbroucq T, 1999, EXP BRAIN RES, V124, P33, DOI 10.1007/s002210050597; Hasbroucq T, 1997, BRAIN RES COGN BRAIN, V3, P185; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Klein PA, 2016, NEUROIMAGE, V125, P220, DOI 10.1016/j.neuroimage.2015.10.007; Klein PA, 2012, J NEUROSCI, V32, P18124, DOI 10.1523/JNEUROSCI.1701-12.2012; Labruna L, 2014, J COGNITIVE NEUROSCI, V26, P269, DOI 10.1162/jocn_a_00492; Lebon F, 2016, CEREB CORTEX, V115, P1279; MACDONELL RAL, 1991, NEUROLOGY, V41, P1441, DOI 10.1212/WNL.41.9.1441; Mars RB, 2007, EXP BRAIN RES, V182, P125, DOI 10.1007/s00221-007-1055-4; Murakami M, 2015, CURR OPIN NEUROBIOL, V33, P40, DOI 10.1016/j.conb.2015.01.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Quoilin C, 2015, J NEUROSCI, V35, P16297, DOI 10.1523/JNEUROSCI.3664-15.2015; Sinclair C, 2008, EXP BRAIN RES, V186, P385, DOI 10.1007/s00221-007-1241-4; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; van den Hurk P, 2007, J NEUROPHYSIOL, V97, P1642, DOI 10.1152/jn.01005.2006; Vandermeeren Y, 2009, EUR J NEUROSCI, V29, P845, DOI 10.1111/j.1460-9568.2009.06619.x; Wilhelm E, 2016, FRONT HUM N IN PRESS	28	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161964	10.1371/journal.pone.0161964	http://dx.doi.org/10.1371/journal.pone.0161964			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579905	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877400048
J	Chen, TL; Zheng, XJ; Ma, XJ; Bao, YQ; Ni, Y; Hu, C; Rajani, C; Huang, FJ; Zhao, AH; Jia, WP; Jia, W				Chen, Tianlu; Zheng, Xiaojiao; Ma, Xiaojing; Bao, Yuqian; Ni, Yan; Hu, Cheng; Rajani, Cynthia; Huang, Fengjie; Zhao, Aihua; Jia, Weiping; Jia, Wei			Tryptophan Predicts the Risk for Future Type 2 Diabetes	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; INSULIN SENSITIVITY; GUT MICROBIOTA; METABOLITE PROFILES; GLUCOSE; SECRETION; RESISTANCE; MELLITUS; POPULATION; MECHANISMS	Recently, 5 amino acids were identified and verified as important metabolites highly associated with type 2 diabetes (T2D) development. This report aims to assess the association of tryptophan with the development of T2D and to evaluate its performance with existing amino acid markers. A total of 213 participants selected from a ten-year longitudinal Shanghai Diabetes Study (SHDS) were examined in two ways: 1) 51 subjects who developed diabetes and 162 individuals who remained metabolically healthy in 10 years; 2) the same 51 future diabetes and 23 strictly matched ones selected from the 162 healthy individuals. Baseline fasting serum tryptophan concentrations were quantitatively measured using ultra-performance liquid chromatography triple quadruple mass spectrometry. First, serum tryptophan level was found significantly higher in future T2D and was positively and independently associated with diabetes onset risk. Patients with higher tryptophan level tended to present higher degree of insulin resistance and secretion, triglyceride and blood pressure. Second, the prediction potential of tryptophan is non-inferior to the 5 existing amino acids. The predictive performance of the combined score improved after taking tryptophan into account. Our findings unveiled the potential of tryptophan as a new marker associated with diabetes risk in Chinese populations. The addition of tryptophan provided complementary value to the existing amino acid predictors.	[Chen, Tianlu; Zheng, Xiaojiao; Huang, Fengjie; Zhao, Aihua; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Chen, Tianlu; Zheng, Xiaojiao; Huang, Fengjie; Zhao, Aihua; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China; [Ma, Xiaojing; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Diabet Inst, Shanghai, Peoples R China; [Ni, Yan; Rajani, Cynthia; Jia, Wei] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Jia, WP; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.; Jia, WP; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China.; Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Diabet Inst, Shanghai, Peoples R China.; Jia, W (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.	wpjia@sjtu.edu.cn; wjia@cc.hawaii.edu	Hu, Cheng/C-3346-2008; Jia, Wei/AAN-5102-2020	Hu, Cheng/0000-0003-4314-2386; Jia, Wei/0000-0002-3739-8994	International Science & Technology Cooperation Program of China [2014DFA31870]; Major State Basic Research Development Program [2011CB504001]	International Science & Technology Cooperation Program of China; Major State Basic Research Development Program(National Basic Research Program of China)	This work was supported by International Science & Technology Cooperation Program of China (2014DFA31870, http://www.most.gov.cn/kjjh/xmsb/) and Major State Basic Research Development Program (2011CB504001, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm).	Allin KH, 2015, EUR J ENDOCRINOL, V172, pR167, DOI 10.1530/EJE-14-0874; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Bennet H, 2015, PEPTIDES, V71, P113, DOI 10.1016/j.peptides.2015.07.008; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Chen T, 2016, SCI REP; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Gu YJ, 2013, J PROTEOME RES, V12, P5801, DOI 10.1021/pr4008199; Han JL, 2014, WORLD J GASTROENTERO, V20, P17737, DOI 10.3748/wjg.v20.i47.17737; Herrera R, 2003, PEDIATR NEUROL, V28, P20, DOI 10.1016/S0887-8994(02)00462-9; Holman RR, 1998, DIABETES RES CLIN PR, V40, pS21; Iida H, 2015, J MOL ENDOCRINOL, V55, P41, DOI 10.1530/JME-14-0299; Inubushi T, 2012, J NUTR SCI VITAMINOL, V58, P415, DOI 10.3177/jnsv.58.415; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim K, 2015, ENDOCRINOLOGY, V156, P444, DOI 10.1210/en.2014-1687; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Lin ZW, 2015, ENDOCRINE, V48, P179, DOI 10.1007/s12020-014-0244-8; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mahendran Y, 2013, DIABETES CARE, V36, P3732, DOI 10.2337/dc13-0800; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Oxenkrug Gregory, 2015, Integr Mol Med, V2, P365; Oxenkrug G, 2013, MOL NEUROBIOL, V48, P294, DOI 10.1007/s12035-013-8497-4; Oxenkrug GF, 2015, MOL NEUROBIOL, V52, P805, DOI 10.1007/s12035-015-9232-0; Pedersen ER, 2015, ARTERIOSCL THROM VAS, V35, P455, DOI 10.1161/ATVBAHA.114.304674; Piccolo BD, 2016, AM J PHYSIOL-ENDOC M, V310, pE958, DOI 10.1152/ajpendo.00052.2016; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reginaldo C, 2015, FASEB J S, V29; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Tillin T, 2015, DIABETOLOGIA, V58, P968, DOI 10.1007/s00125-015-3517-8; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; World Health Organization DoNDSG, 1999, DONDSG DEF DIAGN CLA; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wurtz P, 2012, DIABETES CARE, V35, P1749, DOI 10.2337/dc11-1838; Xie GX, 2014, J PROTEOME RES, V13, P4062, DOI 10.1021/pr500434s; Yu H, 2015, J CLIN ENDOCR METAB; Yu HY, 2015, SURG OBES RELAT DIS, V11, P6, DOI 10.1016/j.soard.2014.06.019; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126082	49	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162192	10.1371/journal.pone.0162192	http://dx.doi.org/10.1371/journal.pone.0162192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598004	Green Submitted, Green Published, gold			2022-12-27	WOS:000383254800045
J	Katsuyama, N; Usui, N; Taira, M				Katsuyama, Narumi; Usui, Nobuo; Taira, Masato			Activation of the Human MT Complex by Motion in Depth Induced by a Moving Cast Shadow	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; VISUAL CORTICAL AREAS; HUMAN BRAIN; 3-DIMENSIONAL MOTION; STEREOSCOPIC DEPTH; MOVEMENT VISION; MACAQUE MONKEY; PLUS COMPLEX; PERCEPTION; CORTEX	A moving cast shadow is a powerful monocular depth cue for motion perception in depth. For example, when a cast shadow moves away from or toward an object in a two-dimensional plane, the object appears to move toward or away from the observer in depth, respectively, whereas the size and position of the object are constant. Although the cortical mechanisms underlying motion perception in depth by cast shadow are unknown, the human MT complex (hMT+) is likely involved in the process, as it is sensitive to motion in depth represented by binocular depth cues. In the present study, we examined this possibility by using a functional magnetic resonance imaging (fMRI) technique. First, we identified the cortical regions sensitive to the motion of a square in depth represented via binocular disparity. Consistent with previous studies, we observed significant activation in the bilateral hMT+, and defined functional regions of interest (ROIs) there. We then investigated the activity of the ROIs during observation of the following stimuli: 1) a central square that appeared to move back and forth via a moving cast shadow (mCS); 2) a segmented and scrambled cast shadow presented beside the square (sCS); and 3) no cast shadow (nCS). Participants perceived motion of the square in depth in the mCS condition only. The activity of the hMT+ was significantly higher in the mCS compared with the sCS and nCS conditions. Moreover, the hMT+ was activated equally in both hemispheres in the mCS condition, despite presentation of the cast shadow in the bottom-right quadrant of the stimulus. Perception of the square moving in depth across visual hemifields may be reflected in the bilateral activation of the hMT+. We concluded that the hMT+ is involved in motion perception in depth induced by moving cast shadow and by binocular disparity.	[Katsuyama, Narumi; Usui, Nobuo; Taira, Masato] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cognit Neurobiol, Bunkyo Ku, Tokyo, Japan; [Katsuyama, Narumi; Usui, Nobuo; Taira, Masato] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Katsuyama, N (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cognit Neurobiol, Bunkyo Ku, Tokyo, Japan.; Katsuyama, N (corresponding author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan.	katz.cnb@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17022038]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#17022038 to MT), http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm (in Japanese), http://www.mext.go.jp/english/ (the home of website for the Ministry of Education, Culture, Sports, Science and Technology of Japan in English). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Solidray Co., Ltd. for their technical support with 3D graphics. This research was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#17022038 to MT).	Ajina S, 2015, ELIFE, V4, DOI 10.7554/eLife.08935; Akin B, 2014, J VISION, V14, DOI 10.1167/14.12.30; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Czuba TB, 2014, J NEUROSCI, V34, P15522, DOI 10.1523/JNEUROSCI.1081-14.2014; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Ffytche DH, 2000, EUR J NEUROSCI, V12, P3015, DOI 10.1046/j.1460-9568.2000.00177.x; Fortin A, 2002, NEUROREPORT, V13, P895, DOI 10.1097/00001756-200205070-00032; Hervais-Adelman A, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00051; Howard IP, 2012, PERCEIVING IN DEPTH, V3; Huk AC, 2002, J NEUROSCI, V22, P7195; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Kersten D, 1997, PERCEPTION, V26, P171, DOI 10.1068/p260171; Khuu SK, 2014, J VISION, V14, DOI 10.1167/14.3.25; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Likova LT, 2007, NEUROIMAGE, V38, P293, DOI 10.1016/j.neuroimage.2007.06.039; Liu ZM, 2009, NEUROIMAGE, V46, P989, DOI 10.1016/j.neuroimage.2009.03.028; Mamassian P, 1998, TRENDS COGN SCI, V2, P288, DOI 10.1016/S1364-6613(98)01204-2; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mizutani S, 2015, BEHAV BRAIN RES, V288, P63, DOI 10.1016/j.bbr.2015.04.005; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Peuskens H, 2001, J NEUROSCI, V21, P2451, DOI 10.1523/JNEUROSCI.21-07-02451.2001; Ptito M, 2003, NEUROIMAGE, V19, P246, DOI 10.1016/S1053-8119(03)00082-X; Ptito M, 2001, NEUROIMAGE, V14, P1409, DOI 10.1006/nimg.2001.0947; Rokers B, 2009, NAT NEUROSCI, V12, P1050, DOI 10.1038/nn.2343; Sanada TM, 2014, J NEUROSCI, V34, P15508, DOI 10.1523/JNEUROSCI.1072-14.2014; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamietto M, 2016, CURR BIOL, V26, pR70, DOI 10.1016/j.cub.2015.11.026; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Wilms M, 2005, ANAT EMBRYOL, V210, P485, DOI 10.1007/s00429-005-0064-y; Wunderlich G, 2002, NEUROSCIENCE, V112, P535, DOI 10.1016/S0306-4522(02)00110-0; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; ZIHL J, 1991, BRAIN, V114, P2235, DOI 10.1093/brain/114.5.2235; Zihr J, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00006	48	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162555	10.1371/journal.pone.0162555	http://dx.doi.org/10.1371/journal.pone.0162555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597999	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800075
J	Perez-Ricart, A; Galicia-Basart, M; Alcalde-Rodrigo, M; Segarra-Medrano, A; Sune-Negre, JM; Montoro-Ronsano, JB				Perez-Ricart, Ariadna; Galicia-Basart, Maria; Alcalde-Rodrigo, Maria; Segarra-Medrano, Alfons; Sune-Negre, Josep-Maria; Montoro-Ronsano, Jose-Bruno			Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis	PLOS ONE			English	Article							DOSE VITAMIN-D; MINERAL METABOLISM; BONE; HEMODIALYSIS; PHOSPHORUS; EFFICACY; CALCIUM; HCL	Background Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (CKD) patients. Cinacalcet could be a therapeutic option although its use is controversial in patients not receiving dialysis. Thus, the aim of this study is to assess the effectiveness and safety of cinacalcet in patients with CKD and SHPT without renal replacement treatment (RRT) and without renal transplantation (RT). Methods A retrospective observational study was conducted. Patients were included if they had collected cinacalcet, under off-label use, during 2010 and 2011. Patients selected were followed from the beginning of cinacalcet therapy for one year of treatment. Results A total of 37 patients were included with CKD stage 3 (38%), 4 (51%) and 5 (11%). Baseline mean PTH value was 400.86 +/- 168.60 mg/dl. At 12 months, a 67% of patients achieved at least a 30% reduction in their PTH value (p<0.001; CI 49.7-83.6), and the overall mean reduction of PTH values was 38% (p<0.001; IC -49.1, -27.5). A 28% of the patients achieved KDOQI PTH goals (p = 0.003, CI 12%-50%). At 12 months, mean serum calcium values decreased by 6% and mean serum phosphorus values increased by 13%. A 19% of patients experienced hypocalcemia episodes while an increase of 24% in hyperphosphatemia episodes was observed. A 25% of patients finished cinacalcet before a year of treatment. Main withdrawal reasons were: gastrointestinal and other discomfort (8%), hypocalcaemia (8%), non-compliance (3%), interactions (3%) and excess of efficacy (3%). Conclusions Cinacalcet was effective in patients with CKD and SHPT not receiving dialysis. Electrolytic imbalances could be managed with administration of vitamin D and analogues or phosphate binders.	[Perez-Ricart, Ariadna; Alcalde-Rodrigo, Maria; Montoro-Ronsano, Jose-Bruno] Hosp Univ Vall dHebron, Dept Pharm, Barcelona, Spain; [Galicia-Basart, Maria; Segarra-Medrano, Alfons] Hosp Univ Vall dHebron, Dept Nephrol, Barcelona, Spain; [Sune-Negre, Josep-Maria] Univ Barcelona, Fac Pharm, Barcelona, Spain; [Perez-Ricart, Ariadna] Hosp Nostra Senyora de Meritxell, Dept Pharm, Escaldes Engordany, Andorra	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; University of Barcelona	Montoro-Ronsano, JB (corresponding author), Hosp Univ Vall dHebron, Dept Pharm, Barcelona, Spain.	bmontoro@vhebron.net	Segarra, Alfons/R-9077-2019; Montoro-Ronsano, J.Bruno/T-2232-2018	Segarra, Alfons/0000-0002-4349-2856; Montoro-Ronsano, J.Bruno/0000-0003-4390-2189; Perez-Ricart, Ariadna/0000-0002-2983-5496; Galicia Basart, Maria/0000-0002-8125-5974	Col-legi Oficial de Farmaceutics de Barcelona [COFB-JG-15052014]	Col-legi Oficial de Farmaceutics de Barcelona	This work was supported by the Col-legi Oficial de Farmaceutics de Barcelona (www.cofb.net), Grant COFB-JG-15052014 to APR, MAR, ASM, JBMR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Block GA, 2008, NEPHROL DIAL TRANSPL, V23, P2311, DOI 10.1093/ndt/gfn026; Bover J, 2011, NEPHRON CLIN PRACT, V118, pC109, DOI 10.1159/000319882; Charytan C, 2005, AM J KIDNEY DIS, V46, P58, DOI 10.1053/j.ajkd.2005.04.013; Chonchol M, 2008, CLIN KIDNEY J, V1, pI36, DOI 10.1093/ndtplus/sfm043; Chonchol M, 2009, AM J KIDNEY DIS, V53, P197, DOI 10.1053/j.ajkd.2008.09.021; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coyne DW, 2008, NAT CLIN PRACT NEPHR, V4, P364, DOI 10.1038/ncpneph0821; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Fishbane S, 2008, CLIN J AM SOC NEPHRO, V3, P1718, DOI 10.2215/CJN.01040308; Food and Dru Administration, 2004, SENS; Forslund T, 2009, CLIN MED INSIGHTS-TH, V1, P801; Gorriz JL, 2013, NEFROLOGIA, V33, P46, DOI 10.3265/Nefrologia.pre2012.Nov.11703; Sanchez JGH, 2011, NEFROLOGIA, V31, P697, DOI 10.3265/Nefrologia.pre2011.Aug.11030; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lindberg JS, 2005, J AM SOC NEPHROL, V16, P800, DOI 10.1681/ASN.2004060512; Mercadal Orfila G, 2012, Farm Hosp, V36, P11, DOI 10.1016/j.farma.2010.10.008; Messa P, 2008, CLIN J AM SOC NEPHRO, V3, P36, DOI 10.2215/CJN.03591006; Miguel JL, 2009, 5 INT S ADV BON MIN; Moe SM, 2005, KIDNEY INT, V67, P760, DOI 10.1111/j.1523-1755.2005.67139.x; Montenegro J, 2012, NEPHROLOGY, V17, P26, DOI 10.1111/j.1440-1797.2011.01530.x; National Institute for Health and Clinical Excellence, 2007, CIN TREATM SEC HYP P; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Ramos A, 2009, 39 C SOC ESP NEFR PA; Torres PS, 2010, NEFROLOGIA, V30, P443, DOI 10.3265/Nefrologia.pre2010.May.10451; Stompor T, 2014, WORLD J CARDIOL, V6, P115, DOI 10.4330/wjc.v6.i4.115; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Urena P, 2009, NEPHROL DIAL TRANSPL, V24, P2852, DOI 10.1093/ndt/gfp144; Urena-Torres P, 2013, NEPHROL DIAL TRANSPL, V28, P1241, DOI 10.1093/ndt/gfs568; Verheyen N, 2013, EXPERT OPIN PHARMACO, V14, P793, DOI 10.1517/14656566.2013.777041	32	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161527	10.1371/journal.pone.0161527	http://dx.doi.org/10.1371/journal.pone.0161527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588942	gold, Green Published			2022-12-27	WOS:000382877800010
J	Cardoso, J; Mesquita, M; Pereira, AD; Bettencourt-Dias, M; Chaves, P; Pereira-Leal, JB				Cardoso, Joana; Mesquita, Marta; Pereira, Antonio Dias; Bettencourt-Dias, Monica; Chaves, Paula; Pereira-Leal, Jose B.			CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett's Esophagus Malignant Progression	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; POOR-PROGNOSIS; ADENOCARCINOMA; BIOMARKERS; SURVEILLANCE; GROWTH; PROLIFERATION	Barrett's esophagus is the major risk factor for esophageal adenocarcinoma. It has a low but non-neglectable risk, high surveillance costs and no reliable risk stratification markers. We sought to identify early biomarkers, predictive of Barrett's malignant progression, using a meta-analysis approach on gene expression data. This in silico strategy was followed by experimental validation in a cohort of patients with extended follow up from the Instituto Portugues de Oncologia de Lisboa de Francisco Gentil EPE (Portugal). Bioinformatics and systems biology approaches singled out two candidate predictive markers for Barrett's progression, CYR61 and TAZ. Although previously implicated in other malignancies and in epithelial-to-mesenchymal transition phenotypes, our experimental validation shows for the first time that CYR61 and TAZ have the potential to be predictive biomarkers for cancer progression. Experimental validation by reverse transcriptase quantitative PCR and immunohistochemistry confirmed the up-regulation of both genes in Barrett's samples associated with high-grade dysplasia/adenocarcinoma. In our cohort CYR61 and TAZ up-regulation ranged from one to ten years prior to progression to adenocarcinoma in Barrett's esophagus index samples. Finally, we found that CYR61 and TAZ over-expression is correlated with early focal signs of epithelial to mesenchymal transition. Our results highlight both CYR61 and TAZ genes as potential predictive biomarkers for stratification of the risk for development of adenocarcinoma and suggest a potential mechanistic route for Barrett's esophagus neoplastic progression.	[Cardoso, Joana; Bettencourt-Dias, Monica; Pereira-Leal, Jose B.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Cardoso, Joana; Pereira-Leal, Jose B.] Ophi Precis Med, Lisbon, Portugal; [Mesquita, Marta; Chaves, Paula] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Serv Anat Patol, Lisbon, Portugal; [Mesquita, Marta; Pereira, Antonio Dias; Chaves, Paula] Univ Beira Interior, Fac Ciencias Saude, Covilha, Portugal; [Pereira, Antonio Dias] EPE, Inst Portugues Oncol Lisboa Francisco Gentil, Serv Gastrenterol, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Universidade da Beira Interior	Cardoso, J (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.; Cardoso, J (corresponding author), Ophi Precis Med, Lisbon, Portugal.	jvaz@ophiomics.com	Bettencourt-Dias, Monica/B-5176-2015	Bettencourt-Dias, Monica/0000-0003-1987-5598; Dias Pereira, Antonio/0000-0002-7695-974X; Chaves, Paula/0000-0002-0732-2059; Cardoso, Joana/0000-0002-8720-8845; Pereira Leal, Jose/0000-0002-3111-7119; Mesquita, Marta/0000-0003-4738-8949	FCT [HMSP-CTSAU-ICT-0075-2009, SFRH-BPD-26487-2006]; Ophiomics Precision Medicine; Fundação para a Ciência e a Tecnologia [HMSP-CT/SAU-ICT/0075/2009] Funding Source: FCT	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Ophiomics Precision Medicine; Fundação para a Ciência e a Tecnologia	This work was supported by funding from FCT grants HMSP-CTSAU-ICT-0075-2009 and SFRH-BPD-26487-2006. Ophiomics Precision Medicine provided support in the form of salaries for authors JC and JPL but these funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aldulaimi DM, 2005, EUR J GASTROEN HEPAT, V17, P943, DOI 10.1097/00042737-200509000-00010; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chandrasoma PT, 2001, AM J SURG PATHOL, V25, P1188, DOI 10.1097/00000478-200109000-00010; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen G, 2011, AFR J PHARM PHARMACO, V5, P2517, DOI 10.5897/AJPP11.708; Chintalapudi MR, 2008, CARCINOGENESIS, V29, P696, DOI 10.1093/carcin/bgn019; Cook MB, 2007, CANCER EPIDEM BIOMAR, V16, P2090, DOI 10.1158/1055-9965.EPI-07-0432; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; D'Antonio KB, 2010, J UROLOGY, V183, P1604, DOI 10.1016/j.juro.2009.12.006; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Di Martino E, 2006, BIOMARKERS, V11, P547, DOI 10.1080/13547500600896791; Duggan SP, 2006, CARCINOGENESIS, V27, P319, DOI 10.1093/carcin/bgi211; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fitzgerald R, 2011, PRE-INVASIVE DISEASE: PATHOGENESIS AND CLINICAL MANAGEMENT, P315, DOI 10.1007/978-1-4419-6694-0_16; Fitzgerald RC, 2014, GUT, V63, P7, DOI 10.1136/gutjnl-2013-305372; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haque I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-8; Hirst NG, 2011, J GASTROEN HEPATOL, V26, P247, DOI 10.1111/j.1440-1746.2010.06506.x; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Hsu YL, 2015, ONCOGENE, V34, P4056, DOI 10.1038/onc.2014.333; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kok SH, 2010, HEAD NECK-J SCI SPEC, V32, P1665, DOI 10.1002/hed.21381; Ladwa R, 2011, J CLIN PATHOL, V64, P58, DOI 10.1136/jcp.2010.082768; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Leopold PL, 2012, SEMIN CANCER BIOL, V22, P471, DOI 10.1016/j.semcancer.2012.07.003; Li ZY, 2012, COMPUT ENG APPL, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0040132; Lin MT, 2007, J BIOL CHEM, V282, P34594, DOI 10.1074/jbc.M706600200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maity G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04995; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Modak C, 2010, BIOCHEM BIOPH RES CO, V392, P533, DOI 10.1016/j.bbrc.2010.01.057; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Moyes LH, 2011, J CLIN PATHOL, V64, P742, DOI 10.1136/jclinpath-2011-200084; Nancarrow DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022513; Ong CAJ, 2010, WORLD J GASTROENTERO, V16, P5669, DOI 10.3748/wjg.v16.i45.5669; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Pan J, 2012, ONCOL REP, V28, P179, DOI 10.3892/or.2012.1751; Park WG, 2015, AM J GASTROENTEROL, V110, P60, DOI 10.1038/ajg.2014.384; R Development Core Team, 2009, R A LANGUAGE AND ENV; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Sabile AA, 2012, J BONE MINER RES, V27, P58, DOI 10.1002/jbmr.535; Selaru FM, 2007, BIOINFORM BIOL INSIG, V1, P127; Shen HM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0117-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somerville M, 2008, EUR J CANCER, V44, P588, DOI 10.1016/j.ejca.2008.01.015; Spechler SJ, 2010, GASTROENTEROLOGY, V138, P854, DOI 10.1053/j.gastro.2010.01.002; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Tang QL, 2011, ORAL ONCOL, V47, P365, DOI 10.1016/j.oraloncology.2011.02.022; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Terada N, 2012, PROSTATE, V72, P966, DOI 10.1002/pros.21501; Terada N, 2012, ASIAN J ANDROL, V14, P405, DOI 10.1038/aja.2011.149; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tomizawa Y, 2012, ONCOL LETT, V3, P1059, DOI 10.3892/ol.2012.632; Tsai MS, 2002, ONCOGENE, V21, P8178, DOI 10.1038/sj.onc.1205682; Varghese S, 2012, GASTROENTEROLOGY, V142, P435, DOI 10.1053/j.gastro.2012.01.013; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Watts GS, 2007, INT J CANCER, V121, P2132, DOI 10.1002/ijc.22898; Whiteman DC, 2015, J GASTROEN HEPATOL, V30, P804, DOI 10.1111/jgh.12913; Xie D, 2004, CLIN CANCER RES, V10, P2072, DOI 10.1158/1078-0432.CCR-0659-03; Xie JJ, 2011, INT J MOL MED, V27, P429, DOI 10.3892/ijmm.2011.603; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao ZS, 2011, J SURG ONCOL, V104, P525, DOI 10.1002/jso.21984; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606; Zhou ZQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-291; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	82	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161967	10.1371/journal.pone.0161967	http://dx.doi.org/10.1371/journal.pone.0161967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583562	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600079
J	Churchyard, G; Mlisana, K; Karuna, S; Williamson, AL; Williamson, C; Morris, L; Tomaras, GD; De Rosa, SC; Gilbert, PB; Gu, N; Yu, CC; Mkhize, NN; Hermanus, T; Allen, M; Pensiero, M; Barnett, SW; Gray, G; Bekker, LG; Montefiori, DC; Kublin, J; Corey, L				Churchyard, Gavin; Mlisana, Koleka; Karuna, Shelly; Williamson, Anna-Lise; Williamson, Carolyn; Morris, Lynn; Tomaras, Georgia D.; De Rosa, Stephen C.; Gilbert, Peter B.; Gu, Niya; Yu, Chenchen; Mkhize, Nonhlanhla N.; Hermanus, Tandile; Allen, Mary; Pensiero, Michael; Barnett, Susan W.; Gray, Glenda; Bekker, Linda-Gail; Montefiori, David C.; Kublin, James; Corey, Lawrence			Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 SUBTYPE-C; T-CELL RESPONSES; SMALLPOX VACCINATION; CLINICAL-TRIAL; EFFICACY TRIAL; DOUBLE-BLIND; MVA-B; IMMUNOGENICITY; ANTIBODIES	Background The safety and immunogenicity of SAAVI DNA-C2 (4 mg IM), SAAVI MVA-C (2.9 x 10(9) pfu IM) and Novartis V2-deleted subtype C gp140 (100 mcg) with MF59 adjuvant in various vaccination regimens was evaluated in HIV-uninfected adults in South Africa. Methods Participants at three South African sites were randomized (1:1:1:1) to one of four vaccine regimens: MVA prime, sequential gp140 protein boost (M/M/P/P); concurrent MVA/gp140 (MP/MP); DNA prime, sequential MVA boost (D/D/M/M); DNA prime, concurrentMVA/gp140 boost (D/D/MP/MP) or placebo. Peak HIV specific humoral and cellular responses were measured. Results 184 participants were enrolled: 52% were female, all were Black/African, median age was 23 years (range, 18-42 years) and 79% completed all vaccinations. 159 participants reported at least one adverse event, 92.5% were mild or moderate. Five, unrelated, serious adverse events were reported. The M/M/P/P and D/D/MP/MP regimens induced the strongest peak neutralizing and binding antibody responses and the greatest CD4+ T-cell responses to Env. All peak neutralizing and binding antibody responses decayed with time. The MVA, but not DNA, prime contributed to the humoral and cellular immune responses. The D/D/M/M regimen was poorly immunogenic overall but did induce modest CD4+ T-cell responses to Gag and Pol. CD8+ T-cell responses to any antigen were low for all regimens. Conclusions The SAAVI DNA-C2, SAAVI MVA-C and Novartis gp140 with MF59 adjuvant in various combinations were safe and induced neutralizing and binding antibodies and cellular immune responses. Sequential immunization with gp140 boosted immune responses primed by MVA or DNA. The best overall immune responses were seen with the M/M/P/P regimen.	[Churchyard, Gavin] Aurum Inst Hlth Res, Klerksdorp, South Africa; [Churchyard, Gavin] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Churchyard, Gavin] Med Res Council Collaborating Ctr, Adv Care & Treatment TB & HIV, Klerksdorp, South Africa; [Mlisana, Koleka] Univ KwaZulu Natal, Durban, South Africa; [Karuna, Shelly; De Rosa, Stephen C.; Gilbert, Peter B.; Gu, Niya; Yu, Chenchen; Kublin, James; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Williamson, Anna-Lise; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, Cape Town, South Africa; [Williamson, Anna-Lise; Williamson, Carolyn] Natl Hlth Lab Serv Observ, Cape Town, South Africa; [Morris, Lynn; Mkhize, Nonhlanhla N.; Hermanus, Tandile] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [De Rosa, Stephen C.; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Allen, Mary; Pensiero, Michael] NIAID, Vaccine Res Program, Div Aids, NIH, Bethesda, MD USA; [Barnett, Susan W.] Novartis Vaccines & Diagnost, Cambridge, MA USA; [Gray, Glenda] South African Med Res Council, Cape Town, South Africa; [Gray, Glenda] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Montefiori, David C.] Duke Univ, Med Ctr, Lab AIDS Vaccine Res & Dev, Durham, NC USA	University of Witwatersrand; University of Kwazulu Natal; Fred Hutchinson Cancer Center; University of Cape Town; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Duke University; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis; South African Medical Research Council; University of Witwatersrand; University of Cape Town; Duke University	Churchyard, G (corresponding author), Aurum Inst Hlth Res, Klerksdorp, South Africa.; Churchyard, G (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.; Churchyard, G (corresponding author), Med Res Council Collaborating Ctr, Adv Care & Treatment TB & HIV, Klerksdorp, South Africa.	GChurchyard@auruminstitute.org	Corey, Lawrence/AAE-1796-2020; Morris, Lynn/V-3941-2018; Bekker, Linda-Gail/AAZ-8929-2020; Mlisana, Koleka/N-6204-2013	Corey, Lawrence/0000-0002-2179-2436; Morris, Lynn/0000-0003-3961-7828; BEKKER, LINDA-GAIL/0000-0002-0755-4386; , Carolyn/0000-0003-0125-1226; Williamson, Anna-Lise/0000-0002-5467-1200; Churchyard, Gavin/0000-0002-4269-3699; Mlisana, Koleka/0000-0002-8436-3268	National Institute of Allergy and Infectious Diseases (NIAID) (U.S. Public Health Service) [UM1 AI068614, UM1 AI068635, UM1 AI068618, UM1 AI069469, UM1 AI069453, UM1 AI069519]; NIAID-NIH [N01-AI-25473]; South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF), South Africa; Division of Acquired Immunodeficiency Syndrome of the U. S. National Institute of Allergy and Infectious Diseases (NIAID); Novartis Vaccines and Diagnostics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068614, UM1AI069453, UM1AI068635, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) (U.S. Public Health Service); NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF), South Africa; Division of Acquired Immunodeficiency Syndrome of the U. S. National Institute of Allergy and Infectious Diseases (NIAID); Novartis Vaccines and Diagnostics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID) (https://www.niaid.nih.gov/) (U.S. Public Health Service Grants UM1 AI068614 [LOC: HIV Vaccine Trials Network], UM1 AI068635 [HVTN SDMC FHCRC], UM1 AI068618 [HVTN Laboratory Center FHCRC, Duke], UM1 AI069469 [Klerksdorp Clinical Research Site], UM1 AI069453 [Soweto-Bara Clinical Research Site] and UM1 AI069519 [Cape Town Clinical Research Site]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or National Institutes of Health (NIH). Funding for the production of the TV1 gp140 protein was provided to Novartis Vaccines and Diagnostics from NIAID-NIH contract N01-AI-25473, TO#1. The SAAVI/MRC are acknowledged for supporting the product development and funding the potency assays for SAAVI DNA-C2. Part of this work (ALW) is based on the research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF), South Africa (http://www.nrf.ac.za/division/rcce/instruments/research-chairs). Any opinion, finding and conclusion or recommendation expressed in this material is that of the ALW and the NRF does not accept any liability in this regard. Susan W. Barnett was an employee and stakeholder of Novartis Vaccines and Diagnostics and contributed to the study design, data analysis and writeup of the manuscript. Mary Allen and Michael Pensiero are employed by the National Institute of Allergy and Infectious Diseases (NIAID), the study sponsor. The funder provided partial salary support for the following authors: GC, KM, SK, CW, A-LW, LM, GDT, SCD, PG, NG, CY, GG, LGB, DCM, JK, LC. The funder (U. S. National Institute of Allergy and Infectious Diseases (NIAID)) represented by MA and MP contributed to the study design, review of data analysis, the decision to publish, and review of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Role of the Funding Source: The study and report were reviewed by the Division of Acquired Immunodeficiency Syndrome of the U. S. National Institute of Allergy and Infectious Diseases (NIAID), as well as Novartis Vaccines and Diagnostics. The corresponding author had full access to all of the data in the study and had final responsibility for the decision to submit for publication. Novartis Vaccines provided support in the form of salary for author Susan W. Barnett (SWB) and provision of study products. NIAID and SWB contributed to the study design, review of data analysis, the decision to publish and review of the manuscript. The specific roles of the NIAID and SWB are articulated in the 'author contributions' section.	Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Burgers WA, 2009, J GEN VIROL, V90, P468, DOI 10.1099/vir.0.004614-0; Cassimatis DC, 2004, J AM COLL CARDIOL, V43, P1503, DOI 10.1016/j.jacc.2003.11.053; De Rosa SC, 2012, CYTOM PART A, V81A, P1019, DOI 10.1002/cyto.a.22218; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Gomez CE, 2012, HUM VACC IMMUNOTHER, V8, P1192, DOI 10.4161/hv.20778; Gomez CE, 2011, J VIROL, V85, P11468, DOI 10.1128/JVI.05165-11; Elizaga ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054407; Frahm N, 2011, PRIME PROTEIN BOOST; Garcia F, 2011, VACCINE, V29, P8309, DOI 10.1016/j.vaccine.2011.08.098; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Gorse GJ, 2012, CLIN VACCINE IMMUNOL, V19, P649, DOI 10.1128/CVI.00038-12; Gray G, 2011, C RETR OPP INF CROI; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang YD, 2009, STAT BIOPHARM RES, V1, P81, DOI 10.1198/sbr.2009.0008; Karasavvas N, 2013, INVESTIGATION ANTIBO; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; Lian Y, 2005, J VIROL, V79, P13338, DOI 10.1128/JVI.79.21.13338-13349.2005; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Liu W, 1997, J STAT PLAN INFER, V62, P255, DOI 10.1016/S0378-3758(96)00193-0; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Morris L, 2013, BOOSTING ANTIBODY RE; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/erv.12.140, 10.1586/ERV.12.140]; Pal R, 2006, VIROLOGY, V348, P341, DOI 10.1016/j.virol.2005.12.029; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richmond JFL, 1998, J VIROL, V72, P9092, DOI 10.1128/JVI.72.11.9092-9100.1998; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shephard E, 2008, AIDS RES HUM RETROV, V24, P207, DOI 10.1089/aid.2007.0206; Shisana O, 2012, S AFRICAN NATL HIV P; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; UNAIDS, 2013, UNAIDSJC25021E; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Wang S, 2008, VACCINE, V26, P3946, DOI 10.1016/j.vaccine.2008.04.025; Williamson AL, 2012, SAMJ S AFR MED J, V102, P452, DOI 10.7196/SAMJ.5668; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	55	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161753	10.1371/journal.pone.0161753	http://dx.doi.org/10.1371/journal.pone.0161753			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583368	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600054
J	Constant, D; Harries, J; Malaba, T; Myer, L; Patel, M; Petro, G; Grossman, D				Constant, Deborah; Harries, Jane; Malaba, Thokozile; Myer, Landon; Patel, Malika; Petro, Gregory; Grossman, Daniel			Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa	PLOS ONE			English	Article							2ND TRIMESTER ABORTION; RANDOMIZED CONTROLLED-TRIAL; PREGNANCY; TERMINATION; MISOPROSTOL; ACCEPTABILITY; INTERVALS; SAFETY; INDIA; CARE	Objective To document clinical outcomes and women's experiences following the introduction of mifepristone into South African public sector second-trimester medical abortion services, and compare with historic cohorts receiving misoprostol-only. Methods Repeated cross-sectional observational studies documented service delivery and experiences of women undergoing second-trimester medical abortion in public sector hospitals in the Western Cape, South Africa. Women recruited to the study in 2008 (n = 84) and 2010 (n = 58) received misoprostol only. Those recruited in 2014 (n = 208) received mifepristone and misoprostol. Consenting women were interviewed during hospitalization by study field-workers with respect to socio-demographic information, reproductive history, and their experiences with the abortion. Clinical details were extracted from medical charts following discharge. Telephone follow-up interviews to record delayed complications were conducted 2-4 weeks after discharge for the 2014 cohort. Results The 2014 cohort received 200 mg mifepristone, which was self-administered 24-48 hours prior to admission. For all cohorts, following hospital admission, initial misoprostol doses were generally administered vaginally: 800 mcg in the 2014 cohort and 600 mcg in the earlier cohorts. Women received subsequent doses of misoprostol 400 mcg orally every 3-4 hours until fetal expulsion. Thereafter, uterine evacuation of placental tissue was performed as needed. With one exception, all women in all cohorts expelled the fetus. Median time-to-fetal expulsion was reduced to 8.0 hours from 14.5 hours (p<0.001) in the mifepristone compared to the 2010 misoprostol-only cohort (time of fetal expulsion was not recorded in 2008). Uterine evacuation of placental tissue using curettage or vacuum aspiration was more often performed (76% vs. 58%, p<0.001) for those receiving mifepristone; major complication rates were unchanged. Hospitalization duration and extreme pain levels were reduced (p<0.001), but side effects of medication were similar or more common for the mifepristone cohort. Overall satisfaction remained unchanged (95% vs. 91%), while other acceptability measures were higher (p<0.001) for the mifepristone compared to the misoprostol-only cohorts. Conclusion The introduction of a combined mifepristone-misoprostol regimen into public sector second-trimester medical abortion services in South Africa has been successful with shorter time-to-abortion events, less extreme pain and greater acceptability for women. High rates of uterine evacuation for placental tissue need to be addressed.	[Constant, Deborah; Harries, Jane; Malaba, Thokozile] Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Constant, Deborah; Malaba, Thokozile; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa; [Patel, Malika; Petro, Gregory] Univ Cape Town, Dept Obstet & Gynaecol, Cape Town, South Africa; [Patel, Malika] Groote Schuur Hosp, Cape Town, South Africa; [Petro, Gregory] New Somerset Hosp, Cape Town, South Africa; [Grossman, Daniel] Ibis Reprod Hlth, Oakland, CA USA; [Grossman, Daniel] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod, Bixby Ctr Global Reprod Hlth, ANSIRH, Oakland, CA USA	University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of California System; University of California San Francisco	Constant, D (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa.; Constant, D (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, South Africa.	Deborah.constant@uct.ac.za	Harries, Jane/R-6504-2019; Petro, Gregory A/I-6563-2016	Harries, Jane/0000-0001-7359-8419; Petro, Gregory A/0000-0003-4529-2820; Malaba, Thokozile/0000-0003-0938-5587; Constant, Deborah/0000-0002-7176-9963	Safe Abortion Action Fund; William and Flora Hewlett Foundation; University of Cape Town Research office; South African Medical Research Council; Harry Crossley Clinical Research Fellowship	Safe Abortion Action Fund; William and Flora Hewlett Foundation; University of Cape Town Research office; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Harry Crossley Clinical Research Fellowship	The study was funded by the Safe Abortion Action Fund with contributions from the William and Flora Hewlett Foundation, the University of Cape Town Research office, the South African Medical Research Council and the Harry Crossley Clinical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson IM, 2014, CONTRACEPTION, V89, P460, DOI 10.1016/j.contraception.2014.01.012; [Anonymous], 2013, Obstet Gynecol, V121, P1394, DOI 10.1097/01.AOG.0000431056.79334.cc; [Anonymous], 2014, SINJ TOPS 2014 2015; Ashok PW, 2004, CONTRACEPTION, V69, P51, DOI 10.1016/j.contraception.2003.09.006; Baldwin M, 2014, CONTRACEPTION, V90, P562, DOI 10.1016/j.contraception.2014.08.010; Basu J. K., 2012, Southern African Journal of Epidemiology & Infection, V27, P34; Berer M, 2008, REPROD HEALTH MATTER, V16, P3, DOI 10.1016/S0968-8080(08)31395-0; Cleeve A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149172; Dabash R, 2015, INT J GYNECOL OBSTET, V130, P40, DOI 10.1016/j.ijgo.2015.02.023; Dalvie SS, 2008, REPROD HEALTH MATTER, V16, P37, DOI 10.1016/S0968-8080(08)31384-6; Dickinson JE, 2010, AUST NZ J OBSTET GYN, V50, P60, DOI 10.1111/j.1479-828X.2009.01117.x; Edelman A, 2015, INT J GYNECOL OBSTET, V128, P177, DOI 10.1016/j.ijgo.2014.07.035; Gewell-Danielsson K, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)31371-8; Goh SE, 2006, CONTRACEPTION, V73, P516, DOI 10.1016/j.contraception.2005.12.004; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Grossman D, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-224; Harries J, 2012, J BIOSOC SCI, V44, P197, DOI 10.1017/S0021932011000678; Harries J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-16; Harris LH, 2008, REPROD HEALTH MATTER, V16, P74, DOI 10.1016/S0968-8080(08)31396-2; Harris LH, 2011, INT J GYNECOL OBSTET, V115, P77, DOI 10.1016/j.ijgo.2011.05.018; Hoang TTD, 2008, REPROD HEALTH MATTER, V16, P145, DOI 10.1016/S0968-8080(08)31393-7; Hou SP, 2010, INT J GYNECOL OBSTET, V111, P126, DOI 10.1016/j.ijgo.2010.06.008; Kallner HK, 2015, BJOG-INT J OBSTET GY, V122, P510, DOI 10.1111/1471-0528.12982; Kallner HK, 2012, CONTRACEPTION, V85, P394, DOI 10.1016/j.contraception.2011.08.009; Kapp N, 2007, OBSTET GYNECOL, V110, P1304, DOI 10.1097/01.AOG.0000289577.32274.a5; Kranti KK, 2014, J OBSTET GYN INDIA, V64, P102, DOI 10.1007/s13224-013-0472-5; Lalitkumar S, 2007, HUM REPROD UPDATE, V13, P37, DOI 10.1093/humupd/dml049; Mentula M, 2011, HUM REPROD, V26, P2690, DOI 10.1093/humrep/der218; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Ngoc Nguyen Thi Nhu, 2011, Obstet Gynecol, V118, P601, DOI 10.1097/AOG.0b013e318227214e; Paul M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133354; Rose SB, 2006, AUST NZ J OBSTET GYN, V46, P479, DOI 10.1111/j.1479-828X.2006.00646.x; Samandari G, 2012, REPROD HLTH, V9, P1742; Tripti N, 2011, J OBSTET GYN INDIA, V61, P659, DOI 10.1007/s13224-011-0118-4; World Health Organization, 2014, CLIN PRACT HDB SAF A; Zavier AJF, 2012, GLOB PUBLIC HEALTH, V7, P897, DOI 10.1080/17441692.2011.651734; Zhirova IA, 2004, STUD FAMILY PLANN, V35, P178, DOI 10.1111/j.1728-4465.2004.00021.x	37	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161843	10.1371/journal.pone.0161843	http://dx.doi.org/10.1371/journal.pone.0161843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583448	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600066
J	Huang, CH; Li, HJ; Wu, NL; Hsiao, CY; Lin, CN; Chang, HH; Hung, CF				Huang, Cheng-Hua; Li, Hsin-Ju; Wu, Nan-Lin; Hsiao, Chien-Yu; Lin, Chun-Nan; Chang, Hsun-Hsien; Hung, Chi-Feng			Photoprotective Effects of Cycloheterophyllin against UVA-Induced Damage and Oxidative Stress in Human Dermal Fibroblasts	PLOS ONE			English	Article							ULTRAVIOLET-B IRRADIATION; EPIDERMAL-GROWTH-FACTOR; HAIR FOLLICLE; SIGNAL-TRANSDUCTION; HUMAN KERATINOCYTES; MELANIN; ACTIVATION; RECEPTOR; STIMULATION; ANTIOXIDANT	Ultraviolet (UV) radiation, particularly ultraviolet A (UVA), is known to play a major role in photoaging of the human skin. Many studies have demonstrated that UV exposure causes the skin cells to generate reactive oxygen species and activates the mitogen-activated protein kinase (MAPK) pathway. Previous studies have also demonstrated that cycloheterophyllin has an antioxidant effect and can effectively scavenge free radicals. Extending the aforementioned investigations, in this study, human dermal fibroblasts were used to investigate the protective effect of cycloheterophyllin against UV-induced damage. We found that cycloheterophyllin not only significantly increased cell viability, but also attenuated the phosphorylation of MAPK after UVA exposure. Furthermore, cycloheterophyllin could reduce hydrogen peroxide (H2O2) generation and down-regulate H2O2-induced MAPK phosphorylation. In the in vivo studies, the topical application of cycloheterophyllin before UVA irradiation significantly decreased trans-epidermal water loss (TEWL), erythema, and blood flow rate. These results indicate that cycloheterophyllin is a photoprotective agent that inhibits UVA-induced oxidative stress and damage, and could be used in the research on and prevention of skin photoaging.	[Huang, Cheng-Hua; Hung, Chi-Feng] Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan; [Huang, Cheng-Hua] Cathay Gen Hosp, Dept Internal Med, Taipei, Taiwan; [Li, Hsin-Ju] Fu Jen Catholic Univ, Dept Chem, New Taipei, Taiwan; [Wu, Nan-Lin] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Wu, Nan-Lin] Mackay Mem Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Nan-Lin] Mackay Jr Coll Med Nursing & Management, New Taipei, Taiwan; [Hsiao, Chien-Yu] Chang Gung Univ Sci & Technol, Dept Nutr & Hlth Sci, Taoyuan, Taiwan; [Hsiao, Chien-Yu] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Lin, Chun-Nan] Kaohsiung Med Univ, Coll Pharm, Kaohsiung, Taiwan; [Chang, Hsun-Hsien] Harvard Med Sch, Biomed Cybernet Lab, Boston, MA USA	Fu Jen Catholic University; Cathay General Hospital; Fu Jen Catholic University; Mackay Medical College; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Kaohsiung Medical University; Harvard University; Harvard Medical School	Hung, CF (corresponding author), Fu Jen Catholic Univ, Sch Med, New Taipei, Taiwan.	skin@mail.fju.edu.tw	Hung, Chi-Feng/AAL-4977-2021	Hung, Chi-Feng/0000-0003-3478-5451	Fu-Jen Catholic University; Ministry of Science and Technology and Cathay General Hospital in Taiwan	Fu-Jen Catholic University; Ministry of Science and Technology and Cathay General Hospital in Taiwan	This work is supported by research grants from Fu-Jen Catholic University, Ministry of Science and Technology and Cathay General Hospital in Taiwan.r This work was supported by research grants from the Fu-Jen Catholic University, the Ministry of Science and Technology, and the Cathay General Hospital in Taiwan.	Afaq F, 2011, ARCH BIOCHEM BIOPHYS, V508, P144, DOI 10.1016/j.abb.2010.12.007; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Ashida M, 2003, EXP DERMATOL, V12, P445, DOI 10.1034/j.1600-0625.2003.00101.x; Assefa Z, 1997, J INVEST DERMATOL, V108, P886, DOI 10.1111/1523-1747.ep12292595; Bikle DD, 2011, DISCOV MED, V11, P7; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; BUSTAMANTE J, 1993, PIGM CELL RES, V6, P348, DOI 10.1111/j.1600-0749.1993.tb00612.x; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; CHASE HB, 1954, PHYSIOL REV, V34, P113, DOI 10.1152/physrev.1954.34.1.113; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Fisher G J, 1998, J Investig Dermatol Symp Proc, V3, P61; Geyfman M, 2015, BIOL REV, V90, P1179, DOI 10.1111/brv.12151; Guo W, 2010, PHYTOTHER RES, V24, P352, DOI 10.1002/ptr.2943; Hema M. R., 2011, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V2, P886; Hou LC, 2013, EXP TOXICOL PATHOL, V65, P1145, DOI 10.1016/j.etp.2013.05.006; Huang CC, 2005, ARCH DERMATOL RES, V296, P473, DOI 10.1007/s00403-005-0540-5; Hung CF, 2013, FASEB J, P27; Ito T, 2010, J DERMATOL SCI, V60, P67, DOI 10.1016/j.jdermsci.2010.09.006; Jantan I, 2010, J NAT MED-TOKYO, V64, P365, DOI 10.1007/s11418-010-0410-0; KAIDBEY KH, 1979, J AM ACAD DERMATOL, V1, P249, DOI 10.1016/S0190-9622(79)70018-1; Ko FN, 1998, FREE RADICAL BIO MED, V25, P160, DOI 10.1016/S0891-5849(98)00031-8; Lin CN, 1996, J NAT PROD, V59, P834, DOI 10.1021/np960376j; Liu HS, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-18; Matsumura Yasuhiro, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S146239940200532X; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Nichols JA, 2010, ARCH DERMATOL RES, V302, P71, DOI 10.1007/s00403-009-1001-3; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Ortonne JP, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.146.s61.3.x; Pattison DI, 2006, EXP SUPPL, V96, P131; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7; Rzepka Z, 2016, POSTEP HIG MED DOSW, V70, P695, DOI 10.5604/17322693.1208033; Schieke SM, 2005, J INVEST DERMATOL, V124, P857, DOI 10.1111/j.0022-202X.2005.23671.x; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sim GS, 2007, ARCH PHARM RES, V30, P290, DOI 10.1007/BF02977608; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2014, INT J MOL SCI, V15, P17705, DOI 10.3390/ijms151017705; SLOMINSKI AT, 2014, ANTI-CANCER AGENT ME, V14, P77, DOI DOI 10.2174/18715206113139990308; Sodhi A, 2003, IMMUNOL LETT, V90, P123, DOI 10.1016/j.imlet.2003.08.008; Solano F., 2014, NEW J SCI, V2014, P498276, DOI [10.1155/2014/498276, DOI 10.1155/2014/498276]; Song XZ, 2008, INT J MOL MED, V22, P9; Svobodova A, 2007, J DERMATOL SCI, V46, P21, DOI 10.1016/j.jdermsci.2006.12.009; TYRRELL RM, 1986, PHOTOCHEM PHOTOBIOL, V44, P561, DOI 10.1111/j.1751-1097.1986.tb04709.x; van Beek N, 2008, J CLIN ENDOCR METAB, V93, P4381, DOI 10.1210/jc.2008-0283; Vanhooke JL, 2006, P NATL ACAD SCI USA, V103, P75, DOI 10.1073/pnas.0509734103; Wang JP, 1997, N-S ARCH PHARMACOL, V355, P551, DOI 10.1007/PL00004982; Wei BL, 2005, J AGR FOOD CHEM, V53, P3867, DOI 10.1021/jf047873n; Wu NL, 2011, J AGR FOOD CHEM, V59, P8391, DOI 10.1021/jf200931t; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yusuf N, 2007, PHOTODERMATOL PHOTO, V23, P48, DOI 10.1111/j.1600-0781.2007.00262.x	52	18	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161767	10.1371/journal.pone.0161767	http://dx.doi.org/10.1371/journal.pone.0161767			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583973	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600058
J	Matson, PG; Ladd, TM; Halewood, ER; Sangodkar, RP; Chmelka, BF; Iglesias-Rodriguez, D				Matson, Paul G.; Ladd, Tanika M.; Halewood, Elisa R.; Sangodkar, Rahul P.; Chmelka, Bradley F.; Iglesias-Rodriguez, Debora			Intraspecific Differences in Biogeochemical Responses to Thermal Change in the Coccolithophore Emiliania huxleyi	PLOS ONE			English	Article							SOLID-STATE NMR; AMORPHOUS CALCIUM-CARBONATE; INTRACELLULAR CALCIFICATION; GENETIC DIFFERENTIATION; ELEVATED PCO(2); CA-43 NMR; GROWTH; OCEAN; TEMPERATURE; MORPHOLOGY	The species concept in marine phytoplankton is defined based on genomic, morphological, and functional properties. Reports of intraspecific diversity are widespread across major phytoplankton groups but the impacts of this variation on ecological and biogeochemical processes are often overlooked. Intraspecific diversity is well known within coccolitho-phores, which play an important role in the marine carbon cycle via production of particulate inorganic carbon. In this study, we investigated strain-specific responses to temperature in terms of morphology, carbon production, and carbonate mineralogy using a combination of microscopy, elemental analysis, flow cytometry, and nuclear magnetic resonance. Two strains of the cosmopolitan coccolithophore E. huxleyi isolated from different regions (subtropical, CCMP371; temperate, CCMP3266) were cultured under a range of temperature conditions (10 degrees C, 15 degrees C, and 20 degrees C) using batch cultures and sampled during both exponential and stationary growth. Results for both strains showed that growth rates decreased at lower temperatures while coccosphere size increased. Between 15 degrees C and 20 degrees C, both strains produced similar amounts of total carbon, but differed in allocation of that carbon between particulate inorganic carbon (PIC) and particulate organic carbon (POC), though temperature effects were not detected. Between 10 degrees C and 20 degrees C, temperature effects on daily production of PIC and POC, as well as the cellular quota of POC were detected in CCMP3266. Strain-specific differences in coccolith shedding rates were found during exponential growth. In addition, daily shedding rates were negatively related to temperature in CCMP371 but not in CCMP3266. Despite differences in rates of particulate inorganic carbon production, both strains were found to produce coccoliths composed entirely of pure calcite, as established by solid-state C-13 and Ca-43 NMR and X-ray diffraction measurements. These results highlight the limitations of the species concept and the need for a trait-based system to better quantify diversity within marine phytoplankton communities.	[Matson, Paul G.; Ladd, Tanika M.; Iglesias-Rodriguez, Debora] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Matson, Paul G.; Halewood, Elisa R.; Iglesias-Rodriguez, Debora] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Sangodkar, Rahul P.; Chmelka, Bradley F.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Matson, PG (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.; Matson, PG (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	pmatson@gmail.com	Matson, Paul/AAB-9767-2019; Sangodkar, Rahul/ABD-3007-2020	Matson, Paul/0000-0003-2105-7308; Ladd, Tanika/0000-0001-5834-8358	U.S. National Science Foundation [MRI-1337400, CBET-1335694]; Materials Research Science and Engineering Center program of the U.S. National Science Foundation [DMR-1121053]	U.S. National Science Foundation(National Science Foundation (NSF)); Materials Research Science and Engineering Center program of the U.S. National Science Foundation	This work was supported in part by a grant to MDIR from the U.S. National Science Foundation award number MRI-1337400. Additional support was provided in part by a grant to BFC from the U.S. National Science Foundation award number CBET-1335694. Solid-state 13C MAS NMR measurements were conducted using the Central Facilities of the UCSB Materials Research Laboratory supported by the Materials Research Science and Engineering Center program of the U.S. National Science Foundation under award number DMR-1121053. Solid-state 43Ca MAS NMR measurements that were conducted at the U.S. National High Magnetic Field Laboratory in Tallahassee, Florida, which is supported by the U.S National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes F, 1999, OCEANOL ACTA, V22, P67, DOI 10.1016/S0399-1784(99)80034-6; Akiva-Tal A, 2011, P NATL ACAD SCI USA, V108, P14763, DOI 10.1073/pnas.1102608108; ALLDREDGE AL, 1991, DEEP-SEA RES, V38, P431, DOI 10.1016/0198-0149(91)90045-H; Andersen R. A., 2005, ALGAL CULTURING TECH; Atkinson D, 2003, P ROY SOC B-BIOL SCI, V270, P2605, DOI 10.1098/rspb.2003.2538; BALCH WM, 1993, J PHYCOL, V29, P566, DOI 10.1111/j.0022-3646.1993.00566.x; BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S; Balch WM, 1996, LIMNOL OCEANOGR, V41, P1684, DOI 10.4319/lo.1996.41.8.1684; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Ben Shir I, 2014, ISR J CHEM, V54, P74, DOI 10.1002/ijch.201300121; Ben Shir I, 2013, CHEM MATER, V25, P4595, DOI 10.1021/cm4028226; Blanco-Ameijeiras S., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0157697; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bonachela JA, 2016, J PLANKTON RES, V38, P1021, DOI 10.1093/plankt/fbv087; BRAND LE, 1982, LIMNOL OCEANOGR, V27, P236, DOI 10.4319/lo.1982.27.2.0236; Bryce DL, 2008, J AM CHEM SOC, V130, P9282, DOI 10.1021/ja8017253; Bryce DL, 2010, DALTON T, V39, P8593, DOI 10.1039/c0dt00416b; Burkholder JM, 2009, HARMFUL ALGAE, V8, P744, DOI 10.1016/j.hal.2009.03.006; Cook SS, 2013, PHYCOLOGIA, V52, P368, DOI 10.2216/12-111.1; Crawford DW, 1997, LIMNOL OCEANOGR, V42, P365, DOI 10.4319/lo.1997.42.2.0365; De Bodt C, 2010, BIOGEOSCIENCES, V7, P1401, DOI 10.5194/bg-7-1401-2010; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; DEJONG E, 1979, EUR J BIOCHEM, V99, P559; DEJONG EW, 1976, EUR J BIOCHEM, V70, P611; Engel A, 2009, DEEP-SEA RES PT II, V56, P1396, DOI 10.1016/j.dsr2.2008.11.027; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Fritz JJ, 1996, J EXP MAR BIOL ECOL, V207, P127, DOI 10.1016/S0022-0981(96)02633-0; Fritz JJ, 1999, MAR BIOL, V133, P509, DOI 10.1007/s002270050491; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gamfeldt L, 2015, OIKOS, V124, P252, DOI 10.1111/oik.01549; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Gertman R, 2008, J AM CHEM SOC, V130, P13425, DOI 10.1021/ja803985d; Gervais C, 2008, CHEM PHYS LETT, V464, P42, DOI 10.1016/j.cplett.2008.09.004; GIRAUDEAU J, 1995, CONT SHELF RES, V15, P1825, DOI 10.1016/0278-4343(94)00095-5; Godoi RHM, 2009, MICROCHEM J, V91, P266, DOI 10.1016/j.microc.2008.12.009; Harvey EL, 2015, J PLANKTON RES, V37, P1137, DOI 10.1093/plankt/fbv081; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; Henderiks J, 2012, MAR ECOL PROG SER, V448, P51, DOI 10.3354/meps09535; Hoffmann R, 2015, BIOGEOSCIENCES, V12, P825, DOI 10.5194/bg-12-825-2015; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; HONJO S, 1982, DEEP-SEA RES, V29, P609, DOI 10.1016/0198-0149(82)90079-6; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Hutchins DA, 2011, NATURE, V476, P41, DOI 10.1038/476041a; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Iglesias-Rodriguez MD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001454; Iglesias-Rodriguez MD., 2002, EOS T AM GEOPHYS UN, V83, P365, DOI [10.1029/2002EO000267, DOI 10.1029/2002EO000267]; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; Kolb A, 2013, LIMNOL OCEANOGR, V58, P932, DOI 10.4319/lo.2013.58.3.0932; Kottmeier DM, 2014, PHOTOSYNTH RES, V121, P265, DOI 10.1007/s11120-014-9984-9; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lefebvre SC, 2012, GLOBAL CHANGE BIOL, V18, P493, DOI 10.1111/j.1365-2486.2011.02575.x; MANN S, 1988, PROC R SOC SER B-BIO, V234, P441, DOI 10.1098/rspb.1988.0057; Marie D, 2014, CYTOM PART A, V85A, P962, DOI 10.1002/cyto.a.22517; Michel FM, 2008, CHEM MATER, V20, P4720, DOI 10.1021/cm800324v; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Moudrakovski IL, 2013, ANNU REP NMR SPECTRO, V79, P129, DOI 10.1016/B978-0-12-408098-0.00004-5; Nebel H, 2008, INORG CHEM, V47, P7874, DOI 10.1021/ic8007409; Oviedo AM, 2014, J EXP MAR BIOL ECOL, V459, P105, DOI 10.1016/j.jembe.2014.04.021; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rouco M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00155; Rynearson TA, 2005, MOL ECOL, V14, P1631, DOI 10.1111/j.1365-294X.2005.02526.x; Saruwatari K, 2015, BIOGEOSCIENCES DISCU, V2015, P17751, DOI [10.5194/bgd-12-17751-2015, DOI 10.5194/BGD-12-17751-2015]; Satoh M, 2009, MAR BIOTECHNOL, V11, P327, DOI 10.1007/s10126-008-9147-0; Schmidt K, 2014, BIOGEOSCIENCES, V11, P135, DOI 10.5194/bg-11-135-2014; Sett S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088308; Singer JW, 2012, CHEM MATER, V24, P1828, DOI 10.1021/cm300389q; Smith C.E., 2014, J DATA SCI, V12, P385, DOI 10.6339/jds.201407_12(3).0001; Sorrosa JM, 2005, MAR BIOTECHNOL, V7, P128, DOI 10.1007/s10126-004-0478-1; Stanley SM, 2005, GEOLOGY, V33, P593, DOI 10.1130/G21405.1; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; WESTBROEK P, 1989, J PROTOZOOL, V36, P368, DOI 10.1111/j.1550-7408.1989.tb05528.x; WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x; Winter A, 2014, J PLANKTON RES, V36, P316, DOI 10.1093/plankt/fbt110; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Zuur Alain F., 2009, P1	80	12	13	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162313	10.1371/journal.pone.0162313	http://dx.doi.org/10.1371/journal.pone.0162313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584038	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600129
J	Ochoa, M; Malbert, CH; Meurice, P; Val-Laillet, D				Ochoa, Melissa; Malbert, Charles-Henri; Meurice, Paul; Val-Laillet, David			Effects of Chronic Consumption of Sugar-Enriched Diets on Brain Metabolism and Insulin Sensitivity in Adult Yucatan Minipigs	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EATING BEHAVIOR; PALATABLE FOOD; D2 RECEPTORS; FRUCTOSE; GLUCOSE; DOPAMINE; REWARD; RESISTANCE; OBESITY	Excessive sugar intake might increase the risk to develop eating disorders via an altered reward circuitry, but it remains unknown whether different sugar sources induce different neural effects and whether these effects are dependent from body weight. Therefore, we compared the effects of three high-fat and isocaloric diets varying only in their carbohydrate sources on brain activity of reward-related regions, and assessed whether brain activity is dependent on insulin sensitivity. Twenty-four minipigs underwent (18)FDG PET brain imaging following 7-month intake of high-fat diets of which 20% in dry matter weight (36.3% of metabolisable energy) was provided by starch, glucose or fructose (n = 8 per diet). Animals were then subjected to a euglycemic hyperinsulinemic clamp to determine peripheral insulin sensitivity. After a 7-month diet treatment, all groups had substantial increases in body weight (from 36.02 +/- 0.85 to 63.33 +/- 0.81 kg; P<0.0001), regardless of the diet. All groups presented similar insulin sensitivity index (ISI = 1.39 +/- 0.10 mL.min(-1).mu UI.kg). Compared to starch, chronic exposure to fructose and glucose induced bilateral brain activations, i.e. increased basal cerebral glucose metabolism, in several reward-related brain regions including the anterior and dorsolateral prefrontal cortex, the orbitofrontal cortex, the anterior cingulate cortex, the caudate and putamen. The lack of differences in insulin sensitivity index and body weight suggests that the observed differences in basal brain glucose metabolism are not related to differences in peripheral insulin sensitivity and weight gain. The differences in basal brain metabolism in reward-related brain areas suggest the onset of cerebral functional alterations induced by chronic consumption of dietary sugars. Further studies should explore the underlying mechanisms, such as the availability of intestinal and brain sugar transporter, or the appearance of addictive-like behavioral correlates of these brain functional characteristics.	[Ochoa, Melissa; Meurice, Paul; Val-Laillet, David] INRA, ADNC UR1341, St Gilles, France; [Malbert, Charles-Henri] INRA, Ani Scans US1395, St Gilles, France	INRAE; INRAE	Val-Laillet, D (corresponding author), INRA, ADNC UR1341, St Gilles, France.	david.val-laillet@rennes.inra.fr	VAL-LAILLET, David/AAH-6454-2021; Val-Laillet, David/B-4328-2008	Val-Laillet, David/0000-0002-6256-7737; Malbert, Charles-Henri/0000-0002-0665-4545	INRA, Human Nutrition division	INRA, Human Nutrition division	The PhD grant of Melissa Ochoa was provided by INRA, Human Nutrition division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received no specific funding for this work and have declared that no specific interests exist. The PhD grant of Melissa Ochoa was provided by INRA, Human Nutrition division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the efforts and cooperation of the scientific and technical staff who contributed to this study and/or took care of the animals: Isabelle Nogret, Sylvie Guerin, Eric Bobilier, Alain Chauvin, Mickael Genissel, Julien Georges, Regis Janvier, Vincent Piedvache and Francis Legouevec.	Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Bello NT, 2002, NEUROREPORT, V13, P1575, DOI 10.1097/00001756-200208270-00017; Bingham EM, 2002, DIABETES, V51, P3384, DOI 10.2337/diabetes.51.12.3384; Burger KS, 2011, NEUROIMAGE, V55, P233, DOI 10.1016/j.neuroimage.2010.12.009; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Daly ME, 1997, AM J CLIN NUTR, V66, P1072, DOI 10.1093/ajcn/66.5.1072; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Escott-Stump, 2008, KRAUSES FOOD NUTR TH; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Havel PJ, 1997, EXP CLIN ENDOCRINOL, V105, P37, DOI DOI 10.1055/S-0029-1211853; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kelley AE, 2003, EUR J NEUROSCI, V18, P2592, DOI 10.1046/j.1460-9568.2003.02991.x; Le DSNT, 2007, AM J CLIN NUTR, V86, P573, DOI 10.1093/ajcn/86.3.573; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Luo S, 2015, P NATL ACAD SCI USA, V112, P6509, DOI 10.1073/pnas.1503358112; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; MARTINEZ FJ, 1994, HYPERTENSION, V23, P456, DOI 10.1161/01.HYP.23.4.456; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Ng J, 2011, APPETITE, V57, P65, DOI 10.1016/j.appet.2011.03.017; Ochoa M, 2015, EUR J NUTR, V54, P1, DOI 10.1007/s00394-014-0776-y; Ochoa M, 2014, APPL ANIM BEHAV SCI, V157, P61, DOI 10.1016/j.applanim.2014.05.010; ONO T, 1984, BRAIN RES, V311, P323, DOI 10.1016/0006-8993(84)90095-7; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Pritchett CE, 2011, PHYSIOL BEHAV, V104, P111, DOI 10.1016/j.physbeh.2011.04.048; Rorabaugh JM, 2015, NEUROSCIENCE, V301, P213, DOI 10.1016/j.neuroscience.2015.06.015; Roura E, 2016, NUTRITION RESEARCH R; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Sauvant D., 2004, Tables of composition and nutritional value of feed materials: pigs, poultry, cattle, sheep, goats, rabbits, horses and fish; Schmidt KC, 2002, Q J NUCL MED, V46, P70; Sebert SP, 2005, INT J OBESITY, V29, P324, DOI 10.1038/sj.ijo.0802823; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stice E, 2013, NEUROSCI BIOBEHAV R, V37, P2047, DOI 10.1016/j.neubiorev.2012.12.001; Stice E, 2013, AM J CLIN NUTR, V98, P1377, DOI 10.3945/ajcn.113.069443; Stice E, 2010, J NEUROSCI, V30, P13105, DOI 10.1523/JNEUROSCI.2105-10.2010; Tappy L, 2010, NUTRITION, V26, P1044, DOI 10.1016/j.nut.2010.02.014; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016; Val-Laillet D, 2010, BRIT J NUTR, V104, P1719, DOI 10.1017/S0007114510002667; Val-Laillet D, 2010, PHYSIOL BEHAV, V101, P462, DOI 10.1016/j.physbeh.2010.07.014; Val-Laillet D, 2010, APPETITE, V55, P245, DOI 10.1016/j.appet.2010.06.008; Val-Laillet D, 2011, OBESITY, V19, P749, DOI 10.1038/oby.2010.292; Ventura EE, 2011, OBESITY, V19, P868, DOI 10.1038/oby.2010.255; Verhagen JV, 2003, J NEUROPHYSIOL, V90, P1514, DOI 10.1152/jn.00320.2003; Volkow N D, 2012, Curr Top Behav Neurosci, V11, P1, DOI 10.1007/7854_2011_169; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469	58	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161228	10.1371/journal.pone.0161228	http://dx.doi.org/10.1371/journal.pone.0161228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583555	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600016
J	Santos, JD; Coelho, FC; Bliman, PA				Santos, Joyce de Figueiro; Coelho, Flavio Codeco; Bliman, Pierre-Alexandre			Behavioral Modulation of Infestation by Varroa destructor in Bee Colonies. Implications for Colony Stability	PLOS ONE			English	Article							AFRICANIZED HONEY-BEES; APIS-MELLIFERA; HYGIENIC BEHAVIOR; JACOBSONI; BRAZIL; REPRODUCTION; RESISTANCE; ANDERSON; SYSTEMS; TRUEMAN	Colony Collapse Disorder (CCD) has become a global problem for beekeepers and for the crops that depend on bee pollination. While many factors are known to increase the risk of colony collapse, the ectoparasitic mite Varroa destructor is considered to be the most serious one. Although this mite is unlikely to cause the collapse of hives itself, it is the vector for many viral diseases which are among the likely causes for Colony Collapse Disorder. The effects of V. destructor infestation differ from one part of the world to another, with greater morbidity and higher colony losses in European honey bees (EHB) in Europe, Asia and North America. Although this mite has been present in Brazil for many years, there have been no reports of colony losses amongst Africanized Honey Bees (AHB). Studies carried out in Mexico have highlighted different behavioral responses by the AHB to the presence of the mite, notably as far as grooming and hygienic behavior are concerned. Could these explain why the AHB are less susceptible to Colony Collapse Disorder? In order to answer this question, we have developed a mathematical model of the infestation dynamics to analyze the role of resistance behavior by bees in the overall health of the colony, and as a consequence, its ability to face epidemiological challenges.	[Santos, Joyce de Figueiro; Coelho, Flavio Codeco; Bliman, Pierre-Alexandre] Getulio Vargas Fdn, Appl Math Sch, Rio De Janeiro, RJ, Brazil; [Bliman, Pierre-Alexandre] Univ Paris 06, Sorbonne Univ, Inria, Lab JL Lions UMR CNRS 7598, Paris, France	Getulio Vargas Foundation; Inria; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Coelho, FC (corresponding author), Getulio Vargas Fdn, Appl Math Sch, Rio De Janeiro, RJ, Brazil.	fccoelho@fgv.br	Coelho, Flavio Codeço/L-1089-2018; Coelho, Flavio/L-1089-2018	Coelho, Flavio Codeço/0000-0003-0635-8989; Coelho, Flavio/0000-0003-3868-4391				Angeli D, 2004, LECT NOTES CONTR INF, V301, P135; Angeli D, 2003, IEEE T AUTOMAT CONTR, V48, P1684, DOI 10.1109/TAC.2003.817920; Arechavaleta-Velasco ME, 2001, APIDOLOGIE, V32, P157, DOI 10.1051/apido:2001121; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Calderon RA, 2010, EXP APPL ACAROL, V50, P281, DOI 10.1007/s10493-009-9325-4; Carneiro FE, 2007, NEOTROP ENTOMOL, V36, P949, DOI 10.1590/S1519-566X2007000600018; Coppel WA, 1965, STABILITY ASYMPTOTIC, V11; Correa-Marques MH, 1998, APIDOLOGIE, V29, P283, DOI 10.1051/apido:19980307; FdM Pereira, 2002, ORG SOCIAL DESENVOLV; Gouze JL, 1988, RR0894; HIRSCH MW, 1988, J REINE ANGEW MATH, V383, P1, DOI 10.1515/crll.1988.383.1; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Medina LM, 1999, EXP APPL ACAROL, V23, P659, DOI 10.1023/A:1006275525463; Mondragon L, 2005, APIDOLOGIE, V36, P345, DOI 10.1051/apido:2005022; MORETTO G, 1993, REV BRAS GENET, V16, P71; MORETTO G, 1991, APIDOLOGIE, V22, P197, DOI 10.1051/apido:19910303; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pinto FA, 2012, ARQ BRAS MED VET ZOO, V64, P1194, DOI 10.1590/S0102-09352012000500017; Ratti V, 2012, CANADIAN APPL MATH Q; Smith H. L, 2008, MONOTONE DYNAMICAL S, V41; Spivak M, 1996, APIDOLOGIE, V27, P245, DOI 10.1051/apido:19960407; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vandame R, 2000, CAN J ZOOL, V78, P2037, DOI 10.1139/cjz-78-11-2037; Vandame R, 2002, APIDOLOGIE, V33, P433, DOI 10.1051/apido:2002025	24	6	6	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160465	10.1371/journal.pone.0160465	http://dx.doi.org/10.1371/journal.pone.0160465			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583438	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600006
J	Zelaya, CE; Minh, NL; Lau, B; Latkin, CA; Ha, TV; Quan, VM; Mo, TT; Sripaipan, T; Davis, WW; Celentano, DD; Frangakis, C; Go, VF				Zelaya, Carla E.; Nguyen Le Minh; Lau, Bryan; Latkin, Carl A.; Tran Viet Ha; Vu Minh Quan; Thi Tran Mo; Sripaipan, Teerada; Davis, Wendy W.; Celentano, David D.; Frangakis, Constantine; Go, Vivian F.			The Effect of a Multi-Level Intervention on the Initiation of Antiretroviral Therapy (ART) among HIV-Infected Men Who Inject Drugs and Were Diagnosed Late in Thai Nguyen, Vietnam	PLOS ONE			English	Article							COMPETING RISKS; STRUCTURAL BARRIERS; TREATMENT OUTCOMES; USERS; PREVENTION; PEOPLE; SERVICES; STIGMA; CARE; STRATEGIES	Background In Vietnam, an estimated 256,000 people are living with HIV, and 58% of HIV-infections reported are among people who inject drugs (PWID). While antiretroviral therapy (ART) is widely available in Vietnam, marginalized hard-to-reach male PWID, demonstrate significantly reduced and delayed access to ART. Methods We investigated the effect of a randomized four-arm multi-level intervention trial on ART initiation among male PWID. Our analysis was conducted among a subset of trial participants (n = 136), who were newly diagnosed as HIV-infected, treatment naive, and eligible for ART (baseline late diagnosis). The trial arms included: 1, standard of care (HIV testing and counseling); 2, structural-level intervention (door-to-door communications and community video screenings); 3, individual-level intervention (counseling plus group support); and 4, individual-level plus structural-level intervention. In a time-to-event analysis, we used a nonparametric approach for competing risks to estimate cumulative incidence function (CIF) for ART initiation (event of interest) by arm and the difference in CIF for each trial arm as compared to Arm 1. Follow-up was conducted at 6, 12, 18 and 24 months. Data collection occurred from 2009 to 2013. Findings By 24-months, 61.0% initiated ART, and 30.9% had died prior to ART initiation. In the first 6 months, participants in arm 4 (individual plus community intervention) had a 28% (95% confidence interval (CI): 6-50%) increased probability of initiating ART. Despite increasing coverage of ART in all arms throughout follow-up, participants in arm 4 retained a 31% (95% CI: 5-56%) increased probability of initiating ART. The individual and community components of the intervention were only effective when delivered together. Conclusions Marginalized, hard-to-reach men, who do not routinely engage in HIV services, and therefore come into care late, may benefit significantly from both individual counseling and group support, in combination with community-focused stigma reduction, when being referred and attempting to initiate urgently needed ART.	[Zelaya, Carla E.; Lau, Bryan; Vu Minh Quan; Davis, Wendy W.; Celentano, David D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA; [Nguyen Le Minh] Ctr Prevent Med Thai Nguyen, 971 Duong Tu Minh Rd, Thai Nguyen City, Vietnam; [Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, 624 N Broadway,Hampton House 737, Baltimore, MD 21205 USA; [Tran Viet Ha; Thi Tran Mo] Univ N Carolina, 6,Lane 76,Linh Lang St, Hanoi, Vietnam; [Sripaipan, Teerada; Go, Vivian F.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, 361 Rosenau Hall,Campus Box 7440, Chapel Hill, NC 27599 USA; [Frangakis, Constantine] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, 615 N Wolfe St,Room E3642, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zelaya, CE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.	czelaya1@jhu.edu		Vu, Quan/0000-0003-4462-0546	U.S. National Institute on Drug Abuse (NIDA) [1R01DA22962-01A1]; Johns Hopkins University Center for AIDS Research, NIH funded program [P30AI094189]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189, P30AI050410] Funding Source: NIH RePORTER	U.S. National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Johns Hopkins University Center for AIDS Research, NIH funded program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by both the U.S. National Institute on Drug Abuse (NIDA) through fund 1R01DA22962-01A1 (Johns Hopkins University (JHU) - Vivian Go, PI) and by a 2013 developmental grant from the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allignol A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-86; [Anonymous], 2012, NATL COMMITTEE AIDS; [Anonymous], 2013, REP DIV SOC EV PREV; Celentano DD, 2007, CLIN INFECT DIS, V45, pS318, DOI 10.1086/522557; Celentano DD, 1998, JAMA-J AM MED ASSOC, V280, P544, DOI 10.1001/jama.280.6.544; Chakrapani V, 2014, AIDS CARE, V26, P835, DOI 10.1080/09540121.2013.861573; Coates TJ, 2013, JAIDS-J ACQ IMM DEF, V63, pS179, DOI 10.1097/QAI.0b013e318299eff0; Tran DA, 2013, HIV CLIN TRIALS, V14, P21, DOI [10.1410/hct1401-21, 10.1310/hct1401-21]; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Des Jarlais DC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-53; Thanh DC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-428; GAYNOR JJ, 1993, J AM STAT ASSOC, V88, P400, DOI 10.2307/2290318; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Go VF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125909; Hammett TM, 2008, ADDICTION, V103, P137, DOI 10.1111/j.1360-0443.2007.02053.x; Kalbfleisch JD, 1980, THE STATISTICAL ANAL; Kincaid DL, 2000, SOC SCI MED, V50, P215, DOI 10.1016/S0277-9536(99)00276-2; KORN EL, 1992, STAT MED, V11, P813, DOI 10.1002/sim.4780110611; Latkin C, 2013, ADDICTION, V108, P934, DOI 10.1111/add.12095; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lim T, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18637; Lin DY, 1997, STAT MED, V16, P901, DOI 10.1002/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M; Malta M, 2014, CURR HIV-AIDS REP, V11, P52, DOI 10.1007/s11904-013-0196-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; National Committee for AIDS DaPPaC, 2014, FOLL 2011 POL DECL H; Nguyen Tam T M, 2012, Adv Prev Med, V2012, P732484, DOI 10.1155/2012/732484; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; Petersen Z, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-13; Rangarajan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108939; Rodriguez-Arenas MA, 2006, AIDS RES HUM RETROV, V22, P715, DOI 10.1089/aid.2006.22.715; Rudolph AE, 2012, AIDS CARE, V24, P239, DOI 10.1080/09540121.2011.596517; Salter ML, 2010, AIDS EDUC PREV, V22, P558, DOI 10.1521/aeap.2010.22.6.558; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Tedrow VA, 2012, AIDS BEHAV, V16, P1217, DOI 10.1007/s10461-011-0009-9; The World Bank, 2013, ANT THER COV PEOPL L; Ti LP, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-20; UNAIDS, 2014, GAP REP 2014 PEOPL W; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2; Vietnam MoHo, 2008, SOC REP VIETN 3 COUN; Wang CL, 2004, J INFECT DIS, V190, P1046, DOI 10.1086/422848; Wolfe D, 2007, INT J DRUG POLICY, V18, P246, DOI 10.1016/j.drugpo.2007.01.012; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161718	10.1371/journal.pone.0161718	http://dx.doi.org/10.1371/journal.pone.0161718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579772	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877400036
J	Pohlen, M; Thoennissen, NH; Braess, J; Thudium, J; Schmid, C; Kochanek, M; Kreuzer, KA; Lebiedz, P; Gorlich, D; Gerth, HU; Rohde, C; Kessler, T; Muller-Tidow, C; Stelljes, M; Buchner, T; Schlimok, G; Hallek, M; Waltenberger, J; Hiddemann, W; Berdel, WE; Heilmeier, B; Krug, U				Pohlen, Michele; Thoennissen, Nils H.; Braess, Jan; Thudium, Johannes; Schmid, Christoph; Kochanek, Matthias; Kreuzer, Karl-Anton; Lebiedz, Pia; Goerlich, Dennis; Gerth, Hans U.; Rohde, Christian; Kessler, Torsten; Mueller-Tidow, Carsten; Stelljes, Matthias; Buechner, Thomas; Schlimok, Guenter; Hallek, Michael; Waltenberger, Johannes; Hiddemann, Wolfgang; Berdel, Wolfgang E.; Heilmeier, Bernhard; Krug, Utz			Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk Prediction	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PROGNOSTIC-FACTORS; COMPLETE REMISSION; APACHE-II; MULTICENTER; SURVIVAL; CANCER; SCORE; TRANSPLANTATION; CHEMOTHERAPY	Background This retrospective, multicenter study aimed to reveal risk predictors for mortality in the intensive care unit (ICU) as well as survival after ICU discharge in patients with acute myeloid leukemia (AML) requiring treatment in the ICU. Methods and Results Multivariate analysis of data for 187 adults with AML treated in the ICU in one institution revealed the following as independent prognostic factors for death in the ICU: arterial oxygen partial pressure below 72 mmHg, active AML and systemic inflammatory response syndrome upon ICU admission, and need for hemodialysis and mechanical ventilation in the ICU. Based on these variables, we developed an ICU mortality score and validated the score in an independent cohort of 264 patients treated in the ICU in three additional tertiary hospitals. Compared with the Simplified Acute Physiology Score (SAPS) II, the Logistic Organ Dysfunction (LOD) score, and the Sequential Organ Failure Assessment (SOFA) score, our score yielded a better prediction of ICU mortality in the receiver operatorcharacteristics (ROC) analysis (AUC = 0.913 vs. AUC = 0.710 [SAPS II], AUC = 0.708 [LOD], and 0.770 [SOFA] in the training cohort; AUC = 0.841 for the developed score vs. AUC = 0.730 [SAPSII], AUC = 0.773 [LOD], and 0.783 [SOFA] in the validation cohort). Factors predicting decreased survival after ICU discharge were as follows: relapse or refractory disease, previous allogeneic stem cell transplantation, time between hospital admission and ICU admission, time spent in ICU, impaired diuresis, Glasgow Coma Scale <8 and hematocrit of >= 25% at ICU admission. Based on these factors, an ICU survival score was created and used for risk stratification into three risk groups. This stratification discriminated distinct survival rates after ICU discharge. Conclusions Our data emphasize that although individual risks differ widely depending on the patient and disease status, a substantial portion of critically ill patients with AML benefit from intensive care.	[Pohlen, Michele; Thoennissen, Nils H.; Rohde, Christian; Kessler, Torsten; Mueller-Tidow, Carsten; Stelljes, Matthias; Buechner, Thomas; Berdel, Wolfgang E.; Krug, Utz] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany; [Braess, Jan; Thudium, Johannes; Hiddemann, Wolfgang] Univ Hosp Grosshadern, Dept Med Hematol & Oncol 3, Munich, Germany; [Schmid, Christoph; Schlimok, Guenter; Heilmeier, Bernhard] Klinikum Augsburg, Dept Med 2, Augsburg, Germany; [Kochanek, Matthias; Kreuzer, Karl-Anton; Hallek, Michael] Univ Hosp Cologne, Dept Med 1, Cologne, Germany; [Lebiedz, Pia; Waltenberger, Johannes] Univ Hosp Muenster, Dept Cardiovasc Med, Munster, Germany; [Goerlich, Dennis] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Gerth, Hans U.] Univ Hosp Muenster, Dept Med Hematol & Oncol D, Munster, Germany; [Thoennissen, Nils H.] Hosp Kloster Paradiese, Soest Paradiese, Germany; [Braess, Jan; Heilmeier, Bernhard] Hosp Barmherzigen Brueder, Dept Hematol & Oncol, Regensburg, Germany; [Rohde, Christian; Mueller-Tidow, Carsten] Univ Hosp Halle Wittenberg, Dept Med 4, Halle, Saale, Germany; [Krug, Utz] Klinikum Leverkusen, Dept Med 3, Leverkusen, Germany	University of Munster; University of Munich; Klinikum Augsburg; University of Cologne; University of Munster; University of Munster; University of Munster; Martin Luther University Halle Wittenberg	Pohlen, M (corresponding author), Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany.	michele.pohlen@ukmuenster.de	Kessler, Torsten/S-3319-2016; Schmid, Christoph/AAS-6419-2021; Hallek, Michael/Y-3191-2019; Müller-Tidow, Carsten/O-7207-2018; Görlich, Dennis/C-8950-2012	Kessler, Torsten/0000-0001-7679-5362; Schmid, Christoph/0000-0001-7070-487X; Hallek, Michael/0000-0002-7425-4455; Müller-Tidow, Carsten/0000-0002-7166-5232; Görlich, Dennis/0000-0002-2574-9419	Open Access Publication Fund of University of Muenster	Open Access Publication Fund of University of Muenster	We acknowledge support by Open Access Publication Fund of University of Muenster.	Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Bird GT, 2012, BRIT J ANAESTH, V108, P452, DOI 10.1093/bja/aer449; Bornhauser M, 2012, LANCET ONCOL, V13, P1035, DOI 10.1016/S1470-2045(12)70349-2; Braess J, 2009, BLOOD, V113, P3903, DOI 10.1182/blood-2008-07-162842; Brunnberg U, 2012, ANN ONCOL, V23, P990, DOI 10.1093/annonc/mdr346; Buchner T, 2012, J CLIN ONCOL, V30, P3604, DOI 10.1200/JCO.2012.42.2907; des Ordons ALR, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-516; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FOX MJ, 1979, AM J MED, V67, P742, DOI 10.1016/0002-9343(79)90728-9; Geerse DA, 2011, EUR J INTERN MED, V22, P57, DOI 10.1016/j.ejim.2010.11.003; Hampshire PA, 2009, CRIT CARE, V13, DOI 10.1186/cc8016; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Jackson K, 2014, LEUKEMIA LYMPHOMA, V55, P97, DOI 10.3109/10428194.2013.796045; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; Leal-Noval SR, 2013, INTENS CARE MED, V39, P445, DOI 10.1007/s00134-012-2757-z; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1986, CRIT CARE MED, V14, P754; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Legrand M, 2012, CRIT CARE MED, V40, P43, DOI 10.1097/CCM.0b013e31822b50c2; Lengline E, 2012, LEUKEMIA LYMPHOMA, V53, P1352, DOI 10.3109/10428194.2011.649752; Namendys-Silva SA, 2013, ANN HEMATOL, V92, P699, DOI 10.1007/s00277-013-1675-7; Owczuk R, 2005, SUPPORT CARE CANCER, V13, P332, DOI 10.1007/s00520-004-0750-y; Schellongowski P, 2011, HAEMATOL-HEMATOL J, V96, P231, DOI 10.3324/haematol.2010.031583; Schmid C, 2006, BLOOD, V108, P1092, DOI 10.1182/blood-2005-10-4165; Sculier JP, 2000, CRIT CARE MED, V28, P2786, DOI 10.1097/00003246-200008000-00018; Soares M, 2006, J CLIN ONCOL, V24, P4003, DOI 10.1200/JCO.2006.05.7869; Sorror ML, 2014, J CLIN ONCOL, V32, P3249, DOI 10.1200/JCO.2013.53.8157; Stelljes M, 2011, HAEMATOL-HEMATOL J, V96, P972, DOI 10.3324/haematol.2011.041004; TEASDALE G, 1983, LANCET, V2, P678; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vogelzang NJ, 2012, J CLIN ONCOL, V30, P88, DOI 10.1200/JCO.2011.40.1919; Walter RB, 2010, J CLIN ONCOL, V28, P1766, DOI 10.1200/JCO.2009.25.1066; Yeo CD, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.014; Young JAH, 2008, BEST PRACT RES CL HA, V21, P343, DOI 10.1016/j.beha.2008.02.017	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0160871	10.1371/journal.pone.0160871	http://dx.doi.org/10.1371/journal.pone.0160871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575819	Green Published, gold			2022-12-27	WOS:000382877200010
J	Nickson, D; Timming, AR; Re, D; Perrett, DI				Nickson, Dennis; Timming, Andrew R.; Re, Daniel; Perrett, David I.			Subtle Increases in BMI within a Healthy Weight Range Still Reduce Womens Employment Chances in the Service Sector	PLOS ONE			English	Article							AESTHETIC LABOR; RETAIL; DISCRIMINATION; APPLICANTS; OBESITY; BIAS	Using mixed design analysis of variance (ANOVA), this paper investigates the effects of a subtle simulated increase in adiposity on women's employment chances in the service sector. Employing a unique simulation of altering individuals' BMIs and the literature on "aesthetic labour", the study suggests that, especially for women, being heavier, but still within a healthy BMI, deleteriously impacts on hireability ratings. The paper explores the gendered dimension of this prejudice by asking whether female employees at the upper end of a healthy BMI range are likely to be viewed more negatively than their overtly overweight male counterparts. The paper concludes by considering the implications of these findings.	[Nickson, Dennis] Univ Strathclyde, Strathclyde Business Sch, Dept Human Resource Management, Glasgow, Lanark, Scotland; [Timming, Andrew R.] Univ St Andrews, Sch Management, St Andrews, Fife, Scotland; [Re, Daniel] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Strathclyde; University of St Andrews; University of Toronto; University of St Andrews	Nickson, D (corresponding author), Univ Strathclyde, Strathclyde Business Sch, Dept Human Resource Management, Glasgow, Lanark, Scotland.	d.p.nickson@strath.ac.uk	Nickson, Dennis/I-2886-2019	Nickson, Dennis/0000-0002-3328-0729; Timming, Andrew R/0000-0001-8773-8873; Perrett, David/0000-0002-6025-0939				Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; BERNSTEN V, 1975, J APPL PSYCHOL, V60, P266, DOI 10.1037/h0076544; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Cummins ER, 2015, GENDER SOC, V29, P623, DOI 10.1177/0891243215591949; Czerniawski AM, 2012, J CONTEMP ETHNOGR, V41, P127, DOI 10.1177/0891241611413579; Dipboye R., 1990, INT REV IND ORG PSYC, V5, P1; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Finkelstein LM, 2007, HUM RESOUR MANAGE-US, V46, P203, DOI 10.1002/hrm.20157; Flint SW, 2014, INT J DISCRIM LAW, V14, P183, DOI 10.1177/1358229114534550; Frey H., 2015, WIDENER LAW REV, V21, P95; Gatta Mary, 2011, RETAIL WORK, P49, DOI [DOI 10.1007/978-0-230-34488-4, 10.1007/978-0-230-34488-4]; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gruys K, 2012, SOC PROBL, V59, P481, DOI 10.1525/sp.2012.59.4.481; Harris C, 2014, HOSPITALITY SOC, V3, P111; Hay O, 2003, INT J DISCRIMINATION, V6, P69; Haynes K, 2012, GENDER WORK ORGAN, V19, P489, DOI 10.1111/j.1468-0432.2011.00583.x; Hilpern K, 2005, OVERWEIGHT UNDERPAID, P4; Human Resource Management International Digest, 2006, SURVIVAL FITTEST, V14, P26; Huzell H, 2012, ECON IND DEMOCRACY, V33, P103, DOI 10.1177/0143831X11427590; Jeffery R., 2014, PEOPLE MANAGEMENT, P16; KLESGES RC, 1990, INT J OBESITY, V14, P527; LARKIN JC, 1979, SOCIOL WORK OCCUP, V6, P312, DOI 10.1177/073088847900600303; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; MacDonald CL, 2009, SERVICE WORK CRITICA, P113; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McDowell Linda., 2009, WORKING BODIES INTER; Nickson Dennis., 2001, CUSTOMER SERVICE EMP, P170, DOI DOI 10.1108/03090560610681069; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Paus? Cat., 2014, FAT STUDIES, V3, DOI [10.1080/21604851.2014.889487, DOI 10.1080/21604851.2014.889487]; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pettinger Lynne., 2004, CONSUMP MARK CULT, V7, P165, DOI [DOI 10.1080/1025386042000246214, 10.1080/1025386042000246214]; PINGITORE R, 1994, J APPL PSYCHOL, V79, P909, DOI 10.1037/0021-9010.79.6.909; Re D. E., 2014, Q J EXPT PSYCHOL, V67, P1; Rooth DO, 2009, J HUM RESOUR, V44, P710, DOI 10.1353/jhr.2009.0027; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Rudolph CW, 2009, J VOCAT BEHAV, V74, P1, DOI 10.1016/j.jvb.2008.09.008; Ruggs EN, 2015, J APPL PSYCHOL, V100, P1483, DOI 10.1037/apl0000017; Silvester J, 1996, INT J SELECT ASSESS, V4, P63, DOI 10.1111/j.1468-2389.1996.tb00060.x; Smith NA, 2016, CORNELL HOSP Q, V57, P314, DOI 10.1177/1938965515622564; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Timming AR, 2017, HUM RESOUR MANAGE-US, V56, P133, DOI 10.1002/hrm.21770; Timming AR, 2015, WORK EMPLOY SOC, V29, P60, DOI 10.1177/0950017014528402; Trethewey A, 1999, ORGAN STUD, V20, P423, DOI 10.1177/0170840699203003; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; WARHURST C., 2012, INT J WORK ORG EMOTI, V5, P72; Warhurst C, 2007, WORK EMPLOY SOC, V21, P103, DOI 10.1177/0950017007073622; Williams CL, 2010, WORK OCCUPATION, V37, P349, DOI 10.1177/0730888410373744; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306	49	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0159659	10.1371/journal.pone.0159659	http://dx.doi.org/10.1371/journal.pone.0159659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603519	Green Published, Green Accepted, gold			2022-12-27	WOS:000383255200003
J	Moroni, S; Moscatelli, G; Bournissen, FG; Gonzalez, N; Ballering, G; Freilij, H; Salgueiro, F; Altcheh, J				Moroni, Samanta; Moscatelli, Guillermo; Garcia Bournissen, Facundo; Gonzalez, Nicolas; Ballering, Griselda; Freilij, Hector; Salgueiro, Fabian; Altcheh, Jaime			Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; HYDATID-DISEASE	Introduction Cystic echinococcosis is endemic in Argentina. The standard pharmacological treatment for the disease is albendazole, but surgery is a common alternative. Even though primary infection occurs mainly in the pediatric population, the optimal therapeutic option in pediatrics is not clearly defined and few pediatric cohorts with cystic echinococcosis treated with albendazole have been described to date. Objective To describe therapeutic response to albendazole in a cohort of pediatric patients with abdominal cystic echinococcosis. Population and Methods Patients (0-18 years old) with abdominal cystic echinococcosis who were treated with albendazole between January 1998 and August 2013. Diagnosis of abdominal cystic echinococcosis was made by ultrasound. All patients received albendazole, 10-15 mg/kg/day. Epidemiological data, symptoms, number, location and outcome of the cysts, serology and treatment received were analyzed. The parameter used to assess treatment response was cyst changes evaluated by ultrasound follow up using the WHO-IWGE classification. Results A total of 28 patients (with 46 abdominal cysts) were included in the cohort. Mean age at enrolment was 9.4 years and mean duration of follow-up, 23.8 months. All patients resided in rural areas and had had contact with dogs. The asymptomatic form of the disease was the most common presentation. All patients received albendazole (mean duration: 142.5 days), with low incidence of adverse events. Albendazole had a positive effect on most of the cysts. Surgery was performed in 13 patients. Conclusion Treatment with albendazole for uncomplicated cystic echinococcosis cysts is safe and effective, and can potentially reduce the need for surgical intervention.	[Moroni, Samanta; Moscatelli, Guillermo; Garcia Bournissen, Facundo; Gonzalez, Nicolas; Ballering, Griselda; Freilij, Hector; Altcheh, Jaime] Buenos Aires Children Hosp Ricardo Gutierrez, Parasitol & Chagas Serv, Buenos Aires, DF, Argentina; [Salgueiro, Fabian] Buenos Aires Children Hosp Ricardo Gutierrez, Dept Surg, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Hospital de Ninos Doctor Ricardo Gutierrez	Moroni, S (corresponding author), Buenos Aires Children Hosp Ricardo Gutierrez, Parasitol & Chagas Serv, Buenos Aires, DF, Argentina.	samantamoroni@yahoo.com.ar	GARCIA-BOURNISSEN, FACUNDO/E-8286-2015	GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X; Altcheh, jaime/0000-0002-5865-7991				Altcheh J, 2009, 23 C MUND HID COL SA; Altcheh J, 2008, 6 C ARG INF PED BUEN; [Anonymous], 2012, HID DIAGN HID GUIA E; Brunetti E, 2010, EXPERT CONSENSUS DIA; Brunetti E, 2009, CURR OPIN INFECT DIS, V22, P497, DOI 10.1097/QCO.0b013e328330331c; DEROSA F, 1990, ANN TROP MED PARASIT, V84, P467, DOI 10.1080/00034983.1990.11812496; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Freilij H, 2005, PARASITOL LATINOAM, V60, P236; GHARBI HA, 1981, RADIOLOGY, V139, P459, DOI 10.1148/radiology.139.2.7220891; GILGRANDE LA, 1993, LANCET, V342, P1269, DOI 10.1016/0140-6736(93)92361-V; Guillermo Moscatelli, 2011, HIDATIDOSIS ECHINOCO, P770; Hosch W, 2008, NMR BIOMED, V21, P734, DOI 10.1002/nbm.1252; Larrieu E, 2011, ACTA TROP, V117, P1, DOI 10.1016/j.actatropica.2010.08.006; Liu YH, 2003, FUND CLIN PHARM, V17, P205; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; STEIGER U, 1990, CLIN PHARMACOL THER, V47, P347, DOI 10.1038/clpt.1990.38; Stojkovic M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000524; Todorov T, 2000, ANN TROP MED PARASIT, V94, P135, DOI 10.1080/00034980057473; WILSON JF, 1987, AM J TROP MED HYG, V37, P162, DOI 10.4269/ajtmh.1987.37.162	20	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0160472	10.1371/journal.pone.0160472	http://dx.doi.org/10.1371/journal.pone.0160472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589236	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800003
J	Harada, N; Ishihara, M; Horiuchi, H; Ito, Y; Tabata, H; Suzuki, YA; Nakano, Y; Yamaji, R; Inui, H				Harada, Naoki; Ishihara, Mikako; Horiuchi, Hiroko; Ito, Yuta; Tabata, Hiromitsu; Suzuki, Yasushi A.; Nakano, Yoshihisa; Yamaji, Ryoichi; Inui, Hiroshi			Mogrol Derived from Siraitia grosvenorii Mogrosides Suppresses 3T3-L1 Adipocyte Differentiation by Reducing cAMP-Response Element-Binding Protein Phosphorylation and Increasing AMP-Activated Protein Kinase Phosphorylation	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; ADIPOSE CONVERSION; CUCURBITANE-GLYCOSIDES; NUCLEAR RECEPTORS; C/EBP-BETA; CELLS; ADIPOGENESIS; EXPRESSION; OBESITY; AICAR	This study investigated the effects of mogrol, an aglycone of mogrosides from Siraitia grosvenorii, on adipogenesis in 3T3-L1 preadipocytes. Mogrol, but not mogrosides, suppressed triglyceride accumulation by affecting early (days 0-2) and late (days 4-8), but not middle (days 2-4), differentiation stages. At the late stage, mogrol increased AMP-activated protein kinase (AMPK) phosphorylation and reduced glycerol-3-phosphate dehydrogenase activity. At the early stage, mogrol promoted AMPK phosphorylation, inhibited the induction of CCAAT/enhancer-binding protein beta (C/EBP beta; a master regulator of adipogenesis), and reduced 3T3-L1 cell contents (e.g., clonal expansion). In addition, mogrol, but not the AMPK activator AICAR, suppressed the phosphorylation and activity of the cAMP response element-binding protein (CREB), which regulates C/EBP beta expression. These results indicated that mogrol suppressed adipogenesis by reducing CREB activation in the initial stage of cell differentiation and by activating AMPK signaling in both the early and late stages of this process.	[Harada, Naoki; Ishihara, Mikako; Horiuchi, Hiroko; Ito, Yuta; Yamaji, Ryoichi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka, Japan; [Ito, Yuta; Tabata, Hiromitsu; Suzuki, Yasushi A.] Saraya Co Ltd, Biochem Lab, Kashiwara, Osaka, Japan; [Nakano, Yoshihisa; Inui, Hiroshi] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka, Japan; [Inui, Hiroshi] Osaka Prefecture Univ, Dept Nutr, Habikino, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Harada, N (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka, Japan.; Inui, H (corresponding author), Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Sakai, Osaka, Japan.; Inui, H (corresponding author), Osaka Prefecture Univ, Dept Nutr, Habikino, Osaka, Japan.	harada@biochem.osakafu-u.ac.jp; inui@biochem.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020	Harada, Naoki/0000-0003-3846-388X	Japan Society for the Promotion of Science [20580140, 15H02900]; Saraya Company Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Saraya Company Ltd.	This work was funded by the Japan Society for the Promotion of Science, grant numbers: 20580140 and 15H02900, https://kaken.nii.ac.jp/ja/index (HI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder Saraya Company Ltd. provided support in the form of salaries for authors YI, HT, and YAS, but did not have any role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Chen XB, 2011, BIOORGAN MED CHEM, V19, P5776, DOI 10.1016/j.bmc.2011.08.030; Choi Y, 2011, J AGR FOOD CHEM, V59, P12843, DOI 10.1021/jf2033208; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Daval M, 2005, J BIOL CHEM, V280, P25250, DOI 10.1074/jbc.M414222200; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuyashiki T, 2004, BIOSCI BIOTECH BIOCH, V68, P2353, DOI 10.1271/bbb.68.2353; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Habinowski SA, 2001, BIOCHEM BIOPH RES CO, V286, P852, DOI 10.1006/bbrc.2001.5484; Harada N, 2007, J BIOL CHEM, V282, P22651, DOI 10.1074/jbc.M610724200; Harmon AW, 2002, BIOCHEM J, V367, P203, DOI 10.1042/BJ20020300; Horiuchi H, 2014, J NUTR SCI VITAMINOL, V60, P291, DOI 10.3177/jnsv.60.291; Hsu CL, 2006, MOL NUTR FOOD RES, V50, P1072, DOI 10.1002/mnfr.200600040; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; KASAI R, 1989, AGR BIOL CHEM TOKYO, V53, P3347, DOI 10.1080/00021369.1989.10869815; Kawada T, 2000, BIOFACTORS, V13, P103, DOI 10.1002/biof.5520130117; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KURIHARCUCH W, 1978, CELL, V14, P53, DOI 10.1016/0092-8674(78)90300-8; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Leff T, 2003, BIOCHEM SOC T, V31, P224; Li SF, 2013, AM J PHYSIOL-ENDOC M, V304, pE990, DOI 10.1152/ajpendo.00608.2012; MATSUMOTO K, 1990, CHEM PHARM BULL, V38, P2030, DOI 10.1248/cpb.38.2030; Murata Y, 2010, BIOSCI BIOTECH BIOCH, V74, P673, DOI 10.1271/bbb.90832; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Suzuki YA, 2005, J AGR FOOD CHEM, V53, P2941, DOI 10.1021/jf0478105; Suzuki YA, 2007, BRIT J NUTR, V97, P770, DOI 10.1017/S0007114507381300; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WISE LS, 1979, J BIOL CHEM, V254, P273; Xu F, 2015, J PHARMACEUT BIOMED, V115, P418, DOI 10.1016/j.jpba.2015.07.024; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yin W, 2003, J BIOL CHEM, V278, P43074, DOI 10.1074/jbc.M308484200; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125667; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	44	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162252	10.1371/journal.pone.0162252	http://dx.doi.org/10.1371/journal.pone.0162252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583359	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600124
J	Wu, XF; Zhang, ZZ; Li, X; Lin, QZ; Chen, G; Lu, JP; Zeng, Y; Hu, D; Huang, K; Lin, ZW; Yan, J				Wu, Xiufeng; Zhang, Zhenzhen; Li, Xin; Lin, Qingzhong; Chen, Gang; Lu, Jianping; Zeng, Yi; Hu, Dan; Huang, Kai; Lin, Zhiwu; Yan, Jun			Poorer Prognosis of Primary Signet-Ring Cell Carcinoma of the Breast Compared with Mucinous Carcinoma	PLOS ONE			English	Article							LOBULAR CARCINOMA; PREDICTIVE-VALUE; LABELING INDEX; CANCER; FEATURES; RECEPTOR; VARIANT; KI-67	Primary signet-ring cell carcinoma (PSRCC) of the breast is a rare entity and classified under mucin producing tumors in the WHO classification. However, little is known about the clinicopathological characteristics and clinical outcomes of PSRCC as opposed to mucinous carcinoma. Eleven patients with PSRCC in our center from 1995 to 2010 were evaluated in this study, as compared to 50 cases of mucinous breast cancer (MBC) during the same period. The clinicopathologic features of PSRCC compared to MBC were assessed. Furthermore, overall survival (OS) and disease-free survival (DFS) were calculated at 5 years of follow up. Patients with PSRCC showed more frequent lymphatic metastasis, higher Ki67 labeling index and more advanced stage disease than that of MBC (P = 0.018, p = 0.023, P = 0.000, respectively), although there was no difference in age, tumor size, and ER, PR expression between PSRCC and MBC. In addition, PSRCC was associated with simultaneous vimentin upregulation and E-cadherin downregulation. The 5-year OS of PSRCC (54.5%) was significantly lower than that of MBC (88%) (P = 0.004). Similarly, the DFS of PSRCC was poorer than that of MBC significantly (5-year DFS: 27.3% vs. 80%, P = 0.000). Conclusions Our results confirmed the more aggressive behavior of PSRCC compared to MBC. This tumor is frequently associated with more frequent lymphatic metastasis, higher Ki67 labeling index, more advanced stage disease as well as simultaneous vimentin upregulation and E-cadherin downregulation. Different management guidelines should be considered for the two types.	[Wu, Xiufeng; Lin, Qingzhong; Zeng, Yi; Huang, Kai; Yan, Jun] Fujian Med Univ, Teaching Hosp, Dept Surg, Fujian Prov Tumor Hosp, Fuzhou 350014, Fujian, Peoples R China; [Zhang, Zhenzhen] Fujian Med Univ, Dept Pathol, Affiliated Hosp 1, Fuzhou 350014, Fujian, Peoples R China; [Li, Xin] Fujian Med Univ, Fujian Inst Hematol, Union Hosp, Fuzhou 350014, Fujian, Peoples R China; [Chen, Gang; Lu, Jianping; Hu, Dan] Fujian Med Univ, Fujian Prov Tumor Hosp, Dept Pathol, Teaching Hosp, Fuzhou 350014, Fujian, Peoples R China; [Lin, Zhiwu] Fujian Med Univ, Fujian Prov Hosp, Dept Surg, Teaching Hosp, Fuzhou 350014, Fujian, Peoples R China; [Yan, Jun] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou 510515, Guangdong, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Provincial Hospital; Southern Medical University - China	Wu, XF; Yan, J (corresponding author), Fujian Med Univ, Teaching Hosp, Dept Surg, Fujian Prov Tumor Hosp, Fuzhou 350014, Fujian, Peoples R China.; Yan, J (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou 510515, Guangdong, Peoples R China.	wxf200104@hotmail.com; yanjunfudan@163.com			Natural Science Foundation of Fujian Province [2014J01300, 2016J01508]; Program from Education Bureau of Fujian Province [JB13127]; Special Fund for Guangdong Province Public Research and Capacity Building [2014B020215002]; Natural Science Foundation of Guangdong Province [2015A030308006]; National clinical key specialty construction program; Innovation Research of Fujian Health Bureau [2012-CXB-7]; High Level Research Matching Foundation of Nanfang Hospital; Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University	Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Program from Education Bureau of Fujian Province; Special Fund for Guangdong Province Public Research and Capacity Building; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National clinical key specialty construction program; Innovation Research of Fujian Health Bureau; High Level Research Matching Foundation of Nanfang Hospital; Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University	This work was supported by the Natural Science Foundation of Fujian Province (2014J01300, 2016J01508), the Program from Education Bureau of Fujian Province (JB13127), the Special Fund for Guangdong Province Public Research and Capacity Building (2014B020215002), the Natural Science Foundation of Guangdong Province (2015A030308006), the National clinical key specialty construction program, the Innovation Research of Fujian Health Bureau (2012-CXB-7), the High Level Research Matching Foundation of Nanfang Hospital, and the Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Natural Science Foundation of Fujian Province (2014J01300, 2016J01508), the Program from Education Bureau of Fujian Province (JB13127), the Special Fund for Guangdong Province Public Research and Capacity Building (2014B020215002), the Natural Science Foundation of Guangdong Province (2015A030308006), the National clinical key specialty construction program, the Innovation Research of Fujian Health Bureau (2012-CXB-7), the High Level Research Matching Foundation of Nanfang Hospital, and the Scientific Research Foundation for High Level Talents in Nanfang Hospital of Southern Medical University.	Aleskandarany MA, 2011, BREAST CANCER RES TR, V127, P591, DOI 10.1007/s10549-010-1028-3; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Denkert C, 2013, ANN ONCOL, V24, P2786, DOI 10.1093/annonc/mdt350; Di Saverio S1, 2008, BREAST CANC RES TREA, V111, P541; Edge SB, 2009, AM JOINT COMMITTEE C; Ellis IO, 2003, TUMORS BREAST FEMALE, P30; ELTORKY M, 1994, ARCH PATHOL LAB MED, V118, P245; Fadare O, 2006, PATHOL INT, V56, P683, DOI 10.1111/j.1440-1827.2006.02030.x; FROST AR, 1995, ARCH PATHOL LAB MED, V119, P64; Harbeck N, 2013, BREAST CARE, V8, P110, DOI 10.1159/000350777; HARRIS M, 1978, HISTOPATHOLOGY, V2, P171, DOI 10.1111/j.1365-2559.1978.tb01707.x; He CL, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0538-1; HULL MT, 1980, AM J CLIN PATHOL, V73, P31; Jensen E V, 1966, Proc Can Cancer Conf, V6, P143; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karabagli P, 2013, BREAST CANCER-TOKYO, V20, P363, DOI 10.1007/s12282-010-0210-0; Kim SJ, 2013, CLIN IMAG, V37, P569, DOI 10.1016/j.clinimag.2012.09.005; Lakhani S, 2012, WHO CLASSIFICATION T, P48; Liu SM, 2000, PATHOL INT, V50, P67, DOI 10.1046/j.1440-1827.2000.01007.x; MERINO MJ, 1981, CANCER-AM CANCER SOC, V48, P1830, DOI 10.1002/1097-0142(19811015)48:8<1830::AID-CNCR2820480821>3.0.CO;2-H; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; Nitz U, 2014, ANN ONCOL, V25, P1551, DOI 10.1093/annonc/mdu186; Paramo JC, 2002, ANN SURG ONCOL, V9, P161, DOI 10.1245/aso.2002.9.2.161; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qureshi S S, 2005, J Postgrad Med, V51, P125; Sandhu J, 2013, J CYTOL, V30, P204, DOI 10.4103/0970-9371.117646; Saphir O., 1941, SURG GYNECOL OBSTET, V72, P08; Sato T, 2007, ASIAN J SURG, V30, P220, DOI 10.1016/S1015-9584(08)60026-3; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; STEINBRECHER JS, 1976, CANCER, V37, P828, DOI 10.1002/1097-0142(197602)37:2<828::AID-CNCR2820370231>3.0.CO;2-N; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; von Minckwitz G, 2013, CLIN CANCER RES, V19, P4521, DOI 10.1158/1078-0432.CCR-12-3628; Wang GS, 2012, MOL MED REP, V6, P779, DOI 10.3892/mmr.2012.981; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Zhang M, 2014, J CANCER RES CLIN, V140, P265, DOI 10.1007/s00432-013-1559-1	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162088	10.1371/journal.pone.0162088	http://dx.doi.org/10.1371/journal.pone.0162088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583684	gold, Green Submitted, Green Published			2022-12-27	WOS:000382855600100
J	Ilic, I; Jankovic, S; Ilic, M				Ilic, Irena; Jankovic, Slobodan; Ilic, Milena			Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis	PLOS ONE			English	Article							III COLON-CANCER; 1ST-LINE TREATMENT; PHASE-II; FLUOROURACIL; LEUCOVORIN; METAANALYSIS; CAPECITABINE; COMBINATION; EFFICACY; THERAPY	Background Colorectal cancer is one of the leading causes of cancer deaths in both sexes in the world. Improvement of existing therapy modalities and implementing new ones in order to improve survival of patients with colorectal cancer represents a great challenge for medicine. The aim of this paper was to assess the impact that adding bevacizumab to chemotherapy has on survival in patients with metastatic colorectal cancer, compared to the use of chemotherapy alone. Methods Hazard ratios (HRs) with their 95% confidence intervals (CI) were determined from the studies and pooled. Two-sided p values were reported and considered to indicate statistical significance if less than 0.05. Results A total of 12 studies that meet the inclusion criteria were identified in the literature search, 3 phase II studies and 9 phase III studies. Based on the random effects meta-analysis, a statistically significant improvement was identified for both overall survival (HR = 0.84; 95% CI: 0.74-0.94; p = 0.003) and progression free survival (HR = 0.64; 95% CI: 0.55-0.73; p < 0.00001) in patients with metastatic colorectal cancer when bevacizumab was added to chemotherapy, compared to chemotherapy treatment alone. Conclusion The findings of this meta analysis confirm the benefit of adding bevacizumab to chemotherapy in terms of survival and progression free survival, but the magnitude of this effect is not consistent throughout the included studies. This suggests the need for further research of interaction of bevacizumab with chemotherapeutic agents as well as recognition of patients' characteristics important for the treatment selection criteria.	[Ilic, Irena] Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia; [Jankovic, Slobodan] Univ Kragujevac, Fac Med Sci, Dept Pharmacol, Kragujevac, Serbia; [Ilic, Milena] Univ Kragujevac, Fac Med Sci, Dept Epidemiol, Kragujevac, Serbia	University of Kragujevac; University of Kragujevac; University of Kragujevac	Ilic, I (corresponding author), Univ Kragujevac, Fac Med Sci, Kragujevac, Serbia.	ajrini10@gmail.com	Ilic, Milena/W-1498-2019; Jankovic, Slobodan/Q-4607-2016; Ilic, Irena/T-8121-2019	Jankovic, Slobodan/0000-0002-1519-8828; Ilic, Irena/0000-0001-5347-3264; Ilic, Milena/0000-0003-3229-4990				Allegra CJ, 2013, J CLIN ONCOL, V31, P359, DOI 10.1200/JCO.2012.44.4711; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Amit L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051780; [Anonymous], 2014, REV MAN REVMAN COMP; Chen YX, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/594930; Cunningham D, 2013, LANCET ONCOL, V14, P1077, DOI 10.1016/S1470-2045(13)70154-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Guan Zhong-Zhen, 2011, Chin J Cancer, V30, P682, DOI 10.5732/cjc.011.10188; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hung A, 2013, ONCOLOGIST, V18, P54, DOI 10.1634/theoncologist.2012-0050; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz HI, 2013, ONCOLOGIST, V18, P1004, DOI 10.1634/theoncologist.2013-0107; Hurwitz HI, 2005, J CLIN ONCOL, V23, P3502, DOI 10.1200/JCO.2005.10.017; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Labianca R, 2010, ANN ONCOL, V21, pv70, DOI 10.1093/annonc/mdq168; Lan YT, 2012, INT J COLORECTAL DIS, V27, P657, DOI 10.1007/s00384-011-1366-6; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Lv C, 2013, CANCER BIOTHER RADIO, V28, P501, DOI 10.1089/cbr.2012.1458; Macedo LT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-89; Moehler M, 2009, WORLD J GASTROENTERO, V15, P449, DOI 10.3748/wjg.15.449; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Institutes of Health, 2015, QUAL ASS CONTR INT S; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Passardi A, 2015, ANN ONCOL, V26, P1201, DOI 10.1093/annonc/mdv130; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Spitalnic Stuart, 2005, HOSP PHYS, V44, P43; Stathopoulos GP, 2010, ONCOLOGY-BASEL, V78, P376, DOI 10.1159/000320520; Su Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035629; Tebbutt NC, 2010, J CLIN ONCOL, V28, P3191, DOI 10.1200/JCO.2009.27.7723; Thornton AD, 2006, BRIT J SURG, V93, P1456, DOI 10.1002/bjs.5624; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2004, DOI 10.1200/JCO.2010.29.5436; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Welch S, 2010, ANN ONCOL, V21, P1152, DOI 10.1093/annonc/mdp533; Zhang GL, 2015, INT J CLIN EXP MED, V8, P1434	42	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161912	10.1371/journal.pone.0161912	http://dx.doi.org/10.1371/journal.pone.0161912			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579775	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400046
J	Saigusa, D; Okamura, Y; Motoike, IN; Katoh, Y; Kurosawa, Y; Saijyo, R; Koshiba, S; Yasuda, J; Motohashi, H; Sugawara, J; Tanabe, O; Kinoshita, K; Yamamoto, M				Saigusa, Daisuke; Okamura, Yasunobu; Motoike, Ikuko N.; Katoh, Yasutake; Kurosawa, Yasuhiro; Saijyo, Reina; Koshiba, Seizo; Yasuda, Jun; Motohashi, Hozumi; Sugawara, Junichi; Tanabe, Osamu; Kinoshita, Kengo; Yamamoto, Masayuki			Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; LIQUID-CHROMATOGRAPHY; LARGE-SCALE; UPLC-MS; GAS-CHROMATOGRAPHY; BLOOD-SAMPLES; PLASMA; URINE; SERUM; ASSOCIATION	Metabolomics is a promising avenue for biomarker discovery. Although the quality of metabolomic analyses, especially global metabolomics (G-Met) using mass spectrometry (MS), largely depends on the instrumentation, potential bottlenecks still exist at several basic levels in the metabolomics workflow. Therefore, we established a precise protocol initially for the G-Met analyses of human blood plasma to overcome some these difficulties. In our protocol, samples are deproteinized in a 96-well plate using an automated liquid-handling system, and conducted either using a UHPLC-QTOF/MS system equipped with a reverse phase column or a LC-FTMS system equipped with a normal phase column. A normalization protocol of G-Met data was also developed to compensate for intra-and inter-batch differences, and the variations were significantly reduced along with our normalization, especially for the UHPLC-QTOF/MS data with a C18 reverse-phase column for positive ions. Secondly, we examined the changes in metabolomic profiles caused by the storage of EDTA-blood specimens to identify quality markers for the evaluation of the specimens' preanalytical conditions. Forty quality markers, including lysophospholipids, dipeptides, fatty acids, succinic acid, amino acids, glucose, and uric acid were identified by G-Met for the evaluation of plasma sample quality and established the equation of calculating the quality score. We applied our quality markers to a small-scale study to evaluate the quality of clinical samples. The G-Met protocols and quality markers established here should prove useful for the discovery and development of biomarkers for a wider range of diseases.	[Saigusa, Daisuke; Motoike, Ikuko N.; Katoh, Yasutake; Saijyo, Reina; Koshiba, Seizo; Yasuda, Jun; Motohashi, Hozumi; Sugawara, Junichi; Tanabe, Osamu; Kinoshita, Kengo; Yamamoto, Masayuki] Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan; [Saigusa, Daisuke; Koshiba, Seizo; Yamamoto, Masayuki] Tohoku Univ, Sch Med, Med Biochem, Sendai, Miyagi, Japan; [Saigusa, Daisuke] Japan Agcy Med Res & Dev AMED, CREST, Chiyoda Ku, Tokyo, Japan; [Okamura, Yasunobu; Motoike, Ikuko N.; Kinoshita, Kengo] Tohoku Univ, Grad Sch Informat Sci, Dept Syst Bioinformat, Sendai, Miyagi, Japan; [Katoh, Yasutake] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi, Japan; [Kurosawa, Yasuhiro; Sugawara, Junichi] Tohoku Univ, Grad Sch Med, Dept Gynecol & Obstet, Sendai, Miyagi, Japan; [Motohashi, Hozumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Gene Express Regulat, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; Tohoku University; Tohoku University; Tohoku University	Saigusa, D; Yamamoto, M (corresponding author), Tohoku Univ, Tohoku Med Megabank Org, Dept Integrat Genom, Sendai, Miyagi, Japan.; Saigusa, D; Yamamoto, M (corresponding author), Tohoku Univ, Sch Med, Med Biochem, Sendai, Miyagi, Japan.; Saigusa, D (corresponding author), Japan Agcy Med Res & Dev AMED, CREST, Chiyoda Ku, Tokyo, Japan.	saigusa@m.tohoku.ac.jp; masiyamamoto@med.tohoku.ac.jp	Yamamoto, Masayuki/A-4873-2010; Sugawara, Junichi/O-2190-2013; Kinoshita, Kengo/E-9688-2011; Motohashi, Hozumi/AAZ-2628-2020	Yamamoto, Masayuki/0000-0002-9073-9436; Kinoshita, Kengo/0000-0003-3453-2171; Okamura, Yasunobu/0000-0001-9847-9037; Yasuda, Jun/0000-0002-3887-6871; xing zhi, shi zhi/0000-0003-3289-5681; Saigusa, Daisuke/0000-0001-9484-9870	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanzawa Medical Research Foundation; CREST, AMED [J160000701]; Tohoku Medical Megabank Project (Special Account for Reconstruction from the Great East Japan Earthquake); Grants-in-Aid for Scientific Research [26440018] Funding Source: KAKEN	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); CREST, AMED; Tohoku Medical Megabank Project (Special Account for Reconstruction from the Great East Japan Earthquake); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This investigation was also supported in parts by 2015 The Mochida Memorial Foundation for Medical and Pharmaceutical Research (http://www.mochida.co.jp/zaidan/index.html), 2015 Kanzawa Medical Research Foundation (http://www.kissei.co.jp/fund/fund.htm), and CREST, AMED (J160000701). This work was partially supported by the Tohoku Medical Megabank Project (Special Account for Reconstruction from the Great East Japan Earthquake). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Bamba T, 2012, J CHROMATOGR A, V1250, P212, DOI 10.1016/j.chroma.2012.05.068; Bernini P, 2011, J BIOMOL NMR, V49, P231, DOI 10.1007/s10858-011-9489-1; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Dumas ME, 2014, GASTROENTEROLOGY, V146, P46, DOI 10.1053/j.gastro.2013.11.001; Dunn WB, 2012, BIOANALYSIS, V4, P2249, DOI [10.4155/BIO.12.204, 10.4155/bio.12.204]; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Elliott P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5680; Emwas AH, 2015, METABOLOMICS, V11, P872, DOI 10.1007/s11306-014-0746-7; Gray N, 2015, J PROTEOME RES, V14, P2714, DOI 10.1021/acs.jproteome.5b00203; Hirayama A., 2015, ELECTROPHORESIS; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kamlage B, 2014, CLIN CHEM, V60, P399, DOI 10.1373/clinchem.2013.211979; Kamleh MA, 2012, ANAL CHEM, V84, P2670, DOI 10.1021/ac202733q; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Martin JC, 2015, METABOLOMICS, V11, P807, DOI 10.1007/s11306-014-0740-0; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Miyamoto S, 2015, METABOLITES, V5, P192, DOI 10.3390/metabo5020192; Monton MRN, 2007, J CHROMATOGR A, V1168, P237, DOI 10.1016/j.chroma.2007.02.065; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Nicholson JK, 2012, NATURE, V491, P384, DOI 10.1038/nature11708; Sarafian MH, 2014, ANAL CHEM, V86, P5766, DOI 10.1021/ac500317c; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Skov K, 2015, J CHROMATOGR B, V978, P83, DOI 10.1016/j.jchromb.2014.11.033; Stanberry L, 2013, METABOLITES, V3, P741, DOI 10.3390/metabo3030741; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Swann JR, 2013, J PROTEOME RES, V12, P3166, DOI 10.1021/pr4000152; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Thevenot EA, 2015, J PROTEOME RES, V14, P3322, DOI 10.1021/acs.jproteome.5b00354; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Yin PY, 2015, ANAL BIOANAL CHEM, V407, P4879, DOI 10.1007/s00216-015-8565-x; Yin PY, 2013, CLIN CHEM, V59, P833, DOI 10.1373/clinchem.2012.199257; Yoshida M, 2012, J GASTROENTEROL, V47, P9, DOI 10.1007/s00535-011-0493-8; Yugi K, 2014, CELL REP, V8, P1171, DOI 10.1016/j.celrep.2014.07.021; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738	38	42	42	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160555	10.1371/journal.pone.0160555	http://dx.doi.org/10.1371/journal.pone.0160555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579980	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400007
J	Stein, AC; Gaetano, JN; Jacobs, J; Kunnavakkam, R; Bissonnette, M; Pekow, J				Stein, Adam C.; Gaetano, John Nick; Jacobs, Jeffrey; Kunnavakkam, Rangesh; Bissonnette, Marc; Pekow, Joel			Northern Latitude but Not Season Is Associated with Increased Rates of Hospitalizations Related to Inflammatory Bowel Disease: Results of a Multi-Year Analysis of a National Cohort	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; UNITED-STATES; RISK; EXACERBATIONS; EXPOSURE; ADMISSIONS; SYMPTOMS; FLARES	Background and Aims There is growing evidence that the incidence and severity of inflammatory bowel disease (IBD) may be geographically and seasonally related. Why these associations are observed remains unclear. We assessed the impact of geographic location, season, and exposure to ultraviolet light on disease severity by measuring national hospital IBD-related discharge rates. Methods Utilizing the Nationwide Inpatient Sample (NIS), we identified all patients with IBD-related discharges from 2001-2007. Patients were included if they were discharged from states above the 40th parallel (north) or at or below the 35th parallel (south); and their discharge fell within the winter (January, February, and March) or summer (July, August, and September). Groups of patients were assessed comparing north to south within each season, and summer to winter within each region. UV index was recorded from the National Weather Service data and compared to monthly discharge rates. Results There was a consistent pattern of increased IBD-related hospitalization rates in northern states compared to southern states for both ulcerative colitis and Crohn's disease. Differences in IBD-related hospitalization rates by season, however, were not uniform across the years studied. UV index was significantly inversely associated although not proportional to discharge rates for both Crohn's disease and ulcerative colitis. Conclusions In the US, there is a significant increased rate of IBD-related hospitalizations in the northern compared to southern states, which not fully explained by differences in UV exposure.	[Stein, Adam C.; Gaetano, John Nick; Jacobs, Jeffrey; Bissonnette, Marc; Pekow, Joel] Univ Chicago, Dept Med, Sect Gastroenterol Hepatol & Nutr, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Kunnavakkam, Rangesh] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Pekow, J (corresponding author), Univ Chicago, Dept Med, Sect Gastroenterol Hepatol & Nutr, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jpekow@medicine.bsd.uchicago.edu		Jacobs, Jeffrey/0000-0001-9066-5900; Pekow, Joel/0000-0002-4790-8994	National Institutes of Health [K08 DK09015, P30DK42086]; NATIONAL CANCER INSTITUTE [R01CA164124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (K08 DK09015 (JP), P30DK42086). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2008, AM J GASTROENTEROL, V103, P2789, DOI 10.1111/j.1572-0241.2008.02054.x; Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; Aratari A, 2006, DIGEST LIVER DIS, V38, P319, DOI 10.1016/j.dld.2005.10.002; Ardizzone S, 2009, INT J IMMUNOPATH PH, V22, P63, DOI 10.1177/039463200902200108; Auslander JN, 2005, AM J GASTROENTEROL, V100, P2233, DOI 10.1111/j.1572-0241.2005.50127.x; Cantorna MT, 2000, J NUTR, V130, P2648, DOI 10.1093/jn/130.11.2648; DON BAC, 1984, LANCET, V2, P1156; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Duarte-Garcia A, 2012, J RHEUMATOL, V39, P1392, DOI 10.3899/jrheum.111196; Economou M, 2008, INFLAMM BOWEL DIS, V14, P709, DOI 10.1002/ibd.20352; Govani SM, 2015, J CROHNS COLITIS, V9, P77, DOI 10.1093/ecco-jcc/jju002; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hazratjee N, 2013, AM J GASTROENTEROL, V108, P1024, DOI 10.1038/ajg.2012.343; Jantchou P, 2014, INFLAMM BOWEL DIS, V20, P75, DOI 10.1097/01.MIB.0000436275.12131.4f; Karamanolis DG, 1997, HEPATO-GASTROENTEROL, V44, P1334; Kasahara AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065785; Khalili H, 2012, GUT, V61, P1686, DOI 10.1136/gutjnl-2011-301574; Lee JH, 2015, DIGEST DIS SCI, V60, P3373, DOI 10.1007/s10620-015-3863-x; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; Limketkai BN, 2014, ALIMENT PHARM THER, V40, P508, DOI 10.1111/apt.12845; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Nerich V, 2011, ALIMENT PHARM THER, V33, P940, DOI 10.1111/j.1365-2036.2011.04601.x; Nerich V, 2010, INFLAMM BOWEL DIS, V16, P813, DOI 10.1002/ibd.21122; Ng SC, 2013, GUT, V62, P630, DOI 10.1136/gutjnl-2012-303661; Sample HNI, 2013, HEALTHC COST UT PROJ; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; SONNENBERG A, 1994, AM J GASTROENTEROL, V89, P847; SONNENBERG A, 1991, GASTROENTEROLOGY, V101, P122, DOI 10.1016/0016-5085(91)90468-Z; TYSK C, 1993, SCAND J GASTROENTERO, V28, P95, DOI 10.3109/00365529309096052; Ulitsky A, 2011, JPEN-PARENTER ENTER, V35, P308, DOI 10.1177/0148607110381267; Zeng L, 1996, SCAND J GASTROENTERO, V31, P79, DOI 10.3109/00365529609031631	32	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161523	10.1371/journal.pone.0161523	http://dx.doi.org/10.1371/journal.pone.0161523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579718	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877400027
J	Inostroza, L; Palme, M; de la Barrera, F				Inostroza, Luis; Palme, Massimo; de la Barrera, Francisco			A Heat Vulnerability Index: Spatial Patterns of Exposure, Sensitivity and Adaptive Capacity for Santiago de Chile	PLOS ONE			English	Article							SOCIAL VULNERABILITY; METROPOLITAN REGION; AIR-POLLUTION; URBAN; ISLAND; TEMPERATURE; CLIMATE; SURFACE; INDICATORS; SUSTAINABILITY	Climate change will worsen the high levels of urban vulnerability in Latin American cities due to specific environmental stressors. Some impacts of climate change, such as high temperatures in urban environments, have not yet been addressed through adaptation strategies, which are based on poorly supported data. These impacts remain outside the scope of urban planning. New spatially explicit approaches that identify highly vulnerable urban areas and include specific adaptation requirements are needed in current urban planning practices to cope with heat hazards. In this paper, a heat vulnerability index is proposed for Santiago, Chile. The index was created using a GIS-based spatial information system and was constructed from spatially explicit indexes for exposure, sensitivity and adaptive capacity levels derived from remote sensing data and socio-economic information assessed via principal component analysis (PCA). The objective of this study is to determine the levels of heat vulnerability at local scales by providing insights into these indexes at the intra city scale. The results reveal a spatial pattern of heat vulnerability with strong variations among individual spatial indexes. While exposure and adaptive capacities depict a clear spatial pattern, sensitivity follows a complex spatial distribution. These conditions change when examining PCA results, showing that sensitivity is more robust than exposure and adaptive capacity. These indexes can be used both for urban planning purposes and for proposing specific policies and measures that can help minimize heat hazards in highly dynamic urban areas. The proposed methodology can be applied to other Latin American cities to support policy making.	[Inostroza, Luis] Tech Univ Dresden, Inst Photogrammetry & Remote Sensing, D-01062 Dresden, Germany; [Inostroza, Luis] Univ Autonoma Chile, Temuco, Chile; [Palme, Massimo] Univ Catolica Norte, Escuela Arquitectura, Angamos 610, Antofagasta, Chile; [Palme, Massimo] Inst Nacl Eficiencia Energet & Energia Renovable, Inaquito & Serrano, Quito, Ecuador; [de la Barrera, Francisco] Pontificia Univ Catolica Chile, Inst Geog, Vicuna Mackenna 4860, Macul, Santiago De Chi, Chile; [de la Barrera, Francisco] Pontificia Univ Catolica Chile, Ctr Desarrollo Urbano Sustentable, Vicuna Mackenna 4860, Macul, Santiago De Chi, Chile	Technische Universitat Dresden; Universidad Autonoma de Chile; Universidad Catolica del Norte; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Inostroza, L (corresponding author), Tech Univ Dresden, Inst Photogrammetry & Remote Sensing, D-01062 Dresden, Germany.; Inostroza, L (corresponding author), Univ Autonoma Chile, Temuco, Chile.	inostroza@technotope.org	Palme, Massimo/H-5322-2011; Inostroza, Luis/N-1524-2014	Palme, Massimo/0000-0003-1166-2926; Inostroza, Luis/0000-0002-6303-4529; de la Barrera, Francisco/0000-0002-6854-3197	Lincoln Institute [ULI091112]; Fondecyt [111458, 3150403]; CONICYT-FONDECYT [3150403]	Lincoln Institute; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	LI was recipient of the Lincoln Institute research project: ULI091112 to develop the methodology of this research. MS counted with the financial support of the Fondecyt Projects 111458 and 3150403. FB counted with the financial support of the CONICYT-FONDECYT 3150403 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya, 2011, VULNERABILITY ADAPTA; Adger WN, 2003, ECON GEOGR, V79, P387; Angel S., 2005, DYNAMICS GLOBAL URBA; ANIELLO C, 1995, COMPUT GEOSCI-UK, V21, P965, DOI 10.1016/0098-3004(95)00033-5; [Anonymous], 1992, FUNDAMENTALS REMOTE; [Anonymous], 2009, RES MONOGR; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Baklanov A, 2016, ATMOS ENVIRON, V126, P235, DOI 10.1016/j.atmosenv.2015.11.059; Banzhaf E, 2014, ECOL INDIC, V45, P664, DOI 10.1016/j.ecolind.2014.06.002; Bao JZ, 2015, INT J ENV RES PUB HE, V12, P7220, DOI 10.3390/ijerph120707220; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Blakely EJ, 2007, LINCOLN I LAND POLIC, P1; Brain L, 1987, LANDSAT MSS TM POSTC; Bulkeley H, 2013, LOCAL ENVIRON, V18, P646, DOI 10.1080/13549839.2013.788479; Chow WTL, 2012, B AM METEOROL SOC, V93, P517, DOI 10.1175/BAMS-D-11-00011.1; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; de la Barrera F, 2016, ECOL INDIC, V62, P212, DOI 10.1016/j.ecolind.2015.10.027; Dong WH, 2014, SUSTAINABILITY-BASEL, V6, P7334, DOI 10.3390/su6107334; Folberth GA, 2015, ENVIRON POLLUT, V203, P235, DOI 10.1016/j.envpol.2014.09.004; Gorsuch R., 1983, FACTOR ANAL; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Icaza LE, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040320; Inostroza L, REGIONAL ENV CHANGE, P1; Inostroza L., 2014, MEASURING CLIMATE CH; Inostroza L, 2014, J LAND USE MOBI 0518; Inostroza L., 2016, LANDSCAPE U IN PRESS, DOI 10.1016/j.landurbplan.2016.03.021; Inostroza L, 2016, CAMBIO CLIMATICO LEC, P391; Inostroza L, 2013, J ENVIRON MANAGE, V115, P87, DOI 10.1016/j.jenvman.2012.11.007; Instituto Nacional de Estadistica (INE Chile), 2012, CENS POBL VIV 2012; IPCC, 2012, MANAGING RISKS EXTRE; Johnson DP, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-57; Kosatsky Tom, 2005, Euro Surveill, V10, P148; Krellenberg K, 2013, APPL GEOGR, V38, P86, DOI 10.1016/j.apgeog.2012.11.017; Lindley S., 2011, CLIMATE CHANGE JUSTI; Matthews T., 2011, CLIMATE CHANGE ADAPT; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; Palme M, 2014, SUSTAINABILITY-BASEL, V6, P3321, DOI 10.3390/su6063321; Palme M, 2013, SUSTAINABILITY-BASEL, V5, P2840, DOI 10.3390/su5072840; Pena MA, 2008, INT J REMOTE SENS, V29, P4385, DOI 10.1080/01431160801908137; Prihodko L, 1997, REMOTE SENS ENVIRON, V60, P335, DOI 10.1016/S0034-4257(96)00216-7; Revich B. A., 2011, KOLOGIYA CHELOVEKA, P3; Rizwan AM, 2008, J ENVIRON SCI, V20, P120, DOI 10.1016/S1001-0742(08)60019-4; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Romero H, 1999, ATMOS ENVIRON, V33, P4039, DOI 10.1016/S1352-2310(99)00145-4; Romero Hugo, 2010, Revista INVI, V25, P151; Romero-Lankao P, 2013, SOC SCI MED, V83, P110, DOI 10.1016/j.socscimed.2013.01.009; Sabatini F, 2009, URBAN SEGREGATION AND GOVERNANCE IN THE AMERICAS, P121; Espinoza PS, 2014, REV GEOGR NORTE GD, P123; Schmidtlein MC, 2008, RISK ANAL, V28, P1099, DOI 10.1111/j.1539-6924.2008.01072.x; Schwarz N, 2012, ECOL INDIC, V18, P693, DOI 10.1016/j.ecolind.2012.01.001; Stafoggia M, 2006, EPIDEMIOLOGY, P17; Sun QQ, 2010, ENVIRON EARTH SCI, V59, P1047, DOI 10.1007/s12665-009-0096-3; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Tibbetts J, 2002, ENVIRON HEALTH PERSP, V110, pA674, DOI 10.1289/ehp.110-a674; Tomlinson CJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-42; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Welz J, 2016, EURE, V42, P251, DOI 10.4067/S0250-71612016000100011; Wilhelmi O.V., 2004, NAT HAZARDS REV, V5, P147, DOI [10.1061/(ASCE)1527-6988(2004)5:3(147)., DOI 10.1061/(ASCE)1527-6988(2004)5:3(147)]; Wilhelmi OV, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014021; Wolf J, 2010, GLOBAL ENVIRON CHANG, V20, P44, DOI 10.1016/j.gloenvcha.2009.09.004; Wolf T, 2013, WEATHER CLIM EXTREME, V1, P59, DOI 10.1016/j.wace.2013.07.004; Wong NH, 2005, HABITAT INT, V29, P547, DOI 10.1016/j.habitatint.2004.04.008; Xiao R, 2008, PHOTOGRAMMETRIC ENG, P74; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	65	83	90	8	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162464	10.1371/journal.pone.0162464	http://dx.doi.org/10.1371/journal.pone.0162464			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606592	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255600047
J	Alimardani, M; Nishio, S; Ishiguro, H				Alimardani, Maryam; Nishio, Shuichi; Ishiguro, Hiroshi			The Importance of Visual Feedback Design in BCIs; from Embodiment to Motor Imagery Learning	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MIRROR-NEURON SYSTEM; MU-RHYTHM; HUMANOID ROBOT; SSVEP BCI; EEG; CLASSIFICATION; PROSTHESIS; OWNERSHIP; MOVEMENT	Brain computer interfaces (BCIs) have been developed and implemented in many areas as a new communication channel between the human brain and external devices. Despite their rapid growth and broad popularity, the inaccurate performance and cost of user-training are yet the main issues that prevent their application out of the research and clinical environment. We previously introduced a BCI system for the control of a very humanlike android that could raise a sense of embodiment and agency in the operators only by imagining a movement (motor imagery) and watching the robot perform it. Also using the same setup, we further discovered that the positive bias of subjects' performance both increased their sensation of embodiment and improved their motor imagery skills in a short period. In this work, we studied the shared mechanism between the experience of embodiment and motor imagery. We compared the trend of motor imagery learning when two groups of subjects BCI-operated different looking robots, a very humanlike android's hands and a pair of metallic gripper. Although our experiments did not show a significant change of learning between the two groups immediately during one session, the android group revealed better motor imagery skills in the follow up session when both groups repeated the task using the non-humanlike gripper. This result shows that motor imagery skills learnt during the BCI-operation of humanlike hands are more robust to time and visual feedback changes. We discuss the role of embodiment and mirror neuron system in such outcome and propose the application of androids for efficient BCI training.	[Alimardani, Maryam] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan; [Nishio, Shuichi; Ishiguro, Hiroshi] Adv Telecommun Res Inst Int ATR, Kyoto, Japan; [Ishiguro, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Osaka, Japan	University of Tokyo; Advanced Telecommunications Research Institute International; Osaka University	Alimardani, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	maryam@ardbeg.c.u-tokyo.ac.jp			KAKENHI [25220004, 26540109, 15F15046]; ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This research was supported by KAKENHI (https://www.jsps.go.jp/english/e-grants/) (Grant-in-Aid for Scientific Research) grant number 25220004 to HI, 26540109 to SN and 15F15046 to MA. This research was also supported by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan) to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Grants-in-Aid for Scientific Research 25220004, 26540109 and 15F15046 and also by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Abbott A, 2006, NATURE, V442, P125, DOI 10.1038/442125a; Adams JA, 1975, P HUM FACT ERG SOC A, V19, P162; Alimardani M, 2013, FRONTIERS SYSTEMS NE, V8, P52; Alimardani M, 2014, BIOM ROB BIOM 2014 5, P403; Alimardani M, 2013, SCI REPORTS, P3; Anatole L, 2008, COMPUTER, V1, P66; ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; Barbero A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-34; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cecotti H, 2011, J PHYSIOL-PARIS, V105, P106, DOI 10.1016/j.jphysparis.2011.08.003; Cohen O, 2014, PRESENCE-TELEOP VIRT, V23, P229, DOI 10.1162/PRES_a_00191; Cohen O, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035006; Curran EA, 2003, BRAIN COGNITION, P51; Dal Seno Bernardo, 2010, Comput Intell Neurosci, P307254, DOI 10.1155/2010/307254; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Ehrsson HH, 2003, J NEUROPHYSIOL, P90; Evans N, 2013, NEUROIMAGE, V64, P216, DOI 10.1016/j.neuroimage.2012.09.027; Fabiani GE, 2004, IEEE T NEUR SYS REH, V12, P331, DOI 10.1109/TNSRE.2004.834627; FLEISHMAN EA, 1963, J EXP PSYCHOL, V66, P6, DOI 10.1037/h0046677; Fukumura K, 2007, INT J NEUROSCI, V117, P1039, DOI 10.1080/00207450600936841; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Gonzalez-Franco M, 2011, IEEE ENG MED BIO, P6323, DOI 10.1109/IEMBS.2011.6091560; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Guger C., 1999, P AAATE 5 EUR C ADV, P3; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Horki P, 2011, MED BIOL ENG COMPUT, V49, P567, DOI 10.1007/s11517-011-0750-2; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jin J, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500112; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00086, 10.3389/fninf.2011.00030]; Kauhanen L., 2006, P 3 INT BRAIN COMP I; Kishore S, 2014, PRESENCE-TELEOP VIRT, V23, P242, DOI 10.1162/PRES_a_00192; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Leeb R., 2007, COMPUTATIONAL INTELL; Leonardis D, 2014, PRESENCE-TELEOP VIRT, V23, P253, DOI 10.1162/PRES_a_00190; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Lotte F, FLAWS CURRENT HUMAN; Lotte F., 2012, PRACTICAL BRAIN COMP, P197, DOI [10.1007/978-3-642-29746-5, DOI 10.1007/978-3-642-29746-5]; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Muller-Putz GR, 2008, IEEE T BIO-MED ENG, V55, P361, DOI 10.1109/TBME.2007.897815; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Neumann N, 2003, IEEE T NEUR SYS REH, V11, P169, DOI 10.1109/TNSRE.2003.814431; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2006, PROG BRAIN RES, V159, P393, DOI 10.1016/S0079-6123(06)59025-9; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petit D, 2015, IEEE INT CONF ROBOT, P2882, DOI 10.1109/ICRA.2015.7139592; Pfurtscheller G, 2006, BRAIN RES, V1071, P145, DOI 10.1016/j.brainres.2005.11.083; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Spence C, 2015, CLIN SYSTEMS NEUROSC, P151, DOI 10.1007/978-4-431-55037-2_9; Thobbi A, 2010, INT J ARITF INTELL M, V10, P41; Townsend G, 2004, IEEE T NEUR SYS REH, V12, P258, DOI 10.1109/TNSRE.2004.827220; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Yin EW, 2015, IEEE T BIO-MED ENG, V62, P1447, DOI 10.1109/TBME.2014.2320948; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012	69	28	31	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161945	10.1371/journal.pone.0161945	http://dx.doi.org/10.1371/journal.pone.0161945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598310	Green Submitted, gold, Green Published			2022-12-27	WOS:000383254800027
J	Hayat, T; Awais, M; Imtiaz, A				Hayat, Tasawar; Awais, Muhammad; Imtiaz, Amna			Heat Source/Sink in a Magneto-Hydrodynamic Non-Newtonian Fluid Flow in a Porous Medium: Dual Solutions	PLOS ONE			English	Article							3RD GRADE FLUID; MHD; CHANNEL; NANOFLUID	This communication deals with the properties of heat source/sink in a magneto-hydrodynamic flow of a non-Newtonian fluid immersed in a porous medium. Shrinking phenomenon along with the permeability of the wall is considered. Mathematical modelling is performed to convert the considered physical process into set of coupled nonlinear mathematical equations. Suitable transformations are invoked to convert the set of partial differential equations into nonlinear ordinary differential equations which are tackled numerically for the solution computations. It is noted that dual solutions for various physical parameters exist which are analyzed in detail.	[Hayat, Tasawar; Imtiaz, Amna] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Awais, Muhammad] COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan	Quaid I Azam University; COMSATS University Islamabad (CUI)	Awais, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan.	awais_mm@yahoo.com	Awais, Muhammad/AAZ-3455-2020; Hayat, Tasawar/Y-2524-2019; Awais, Muhammad/HCI-3725-2022					Adesanya SO, 2015, ALEX ENG J, V54, P615, DOI 10.1016/j.aej.2015.05.014; Awais M, 2015, BRAZ J CHEM ENG, V32, P555, DOI 10.1590/0104-6632.20150322s00001918; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2010, INT J NUMER METH FL, V63, P847, DOI 10.1002/fld.2105; Fetecau C, 2013, Z NATURFORSCH A, V68, P659, DOI 10.5560/ZNA.2013-0041; Freidoonimehr N, 2015, INT J THERM SCI, V87, P136, DOI 10.1016/j.ijthermalsci.2014.08.009; Iqbal Z, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000546; Mehmood OU, 2015, APPL BIONICS BIOMECH, V2015, P1, DOI 10.1155/2015/283892; Rashidi MM, 2014, ADV MECH ENG, DOI 10.1155/2014/735939; Rashidi MM, 2012, J APPL MATH, DOI 10.1155/2012/780415; Rashidi MM, 2014, AIN SHAMS ENG J, V5, P901, DOI 10.1016/j.asej.2014.02.007; Raza J, 2016, J MOL LIQ, V219, P703, DOI 10.1016/j.molliq.2016.04.003; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2014, COMM NUMER ANAL, V2014; Turkyilmazoglu M, 2012, COMPUT FLUIDS, V70, P53, DOI 10.1016/j.compfluid.2012.01.009	15	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162205	10.1371/journal.pone.0162205	http://dx.doi.org/10.1371/journal.pone.0162205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598314	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800047
J	Berman, J; Sheng, YM; Gomez, LG; Veiga, T; Ni, XZ; Farre, G; Capell, T; Guitian, J; Guitian, P; Sandmann, G; Christou, P; Zhu, CF				Berman, Judit; Sheng, Yanmin; Gomez Gomez, Lourdes; Veiga, Tania; Ni, Xiuzhen; Farre, Gemma; Capell, Teresa; Guitian, Javier; Guitian, Pablo; Sandmann, Gerhard; Christou, Paul; Zhu, Changfu			Red Anthocyanins and Yellow Carotenoids Form the Color of Orange-Flower Gentian (Gentiana lutea L. var. aurantiaca)	PLOS ONE			English	Article							DIHYDROFLAVONOL 4-REDUCTASE; GENE-EXPRESSION; FLAVONOID BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; PETUNIA-HYBRIDA; CDNA CLONING; TRIFLORA; IDENTIFICATION; BIOCHEMISTRY; EVOLUTION	Flower color is an important characteristic that determines the commercial value of ornamental plants. Gentian flowers occur in a limited range of colors because this species is not widely cultivated as a cut flower. Gentiana lutea L. var. aurantiaca (abbr, aurantiaca) is characterized by its orange flowers, but the specific pigments responsible for this coloration are unknown. We therefore investigated the carotenoid and flavonoid composition of petals during flower development in the orange-flowered gentian variety of aurantiaca and the yellow-flowered variety of G. lutea L. var. lutea (abbr, lutea). We observed minor varietal differences in the concentration of carotenoids at the early and final stages, but only aurantiaca petals accumulated pelargonidin glycosides, whereas these compounds were not found in lutea petals. We cloned and sequenced the anthocyanin biosynthetic gene fragments from petals, and analyzed the expression of these genes in the petals of both varieties to determine the molecular mechanisms responsible for the differences in petal color. Comparisons of deduced amino acid sequences encoded by the isolated anthocyanin cDNA fragments indicated that chalcone synthase (CHS), chalcone isomerase (CHI), anthocyanidin synthase 1 (ANS1) and ANS2 are identical in both aurantiaca and lutea varieties whereas minor amino acid differences of the deduced flavonone 3-hydroxylase (F3H) and dihydroflavonol 4-reductase (DFR) between both varieties were observed. The aurantiaca petals expressed substantially higher levels of transcripts representing CHS, F3H, DFR, ANS and UDP-glucose: flavonoid-3-O-glucosyltransferase genes, compared to lutea petals. Pelargonidin glycoside synthesis in aurantiaca petals therefore appears to reflect the higher steady-state levels of pelargonidin synthesis transcripts. Moreover, possible changes in the substrate specificity of DFR enzymes may represent additional mechanisms for producing red pelargonidin glycosides in petals of aurantiaca. Our report describing the exclusive accumulation of pelargonidin glycosides in aurantiaca petals may facilitate the modification of gentian flower color by the production of red anthocyanins.	[Berman, Judit; Farre, Gemma; Capell, Teresa; Christou, Paul; Zhu, Changfu] Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain; [Sheng, Yanmin; Ni, Xiuzhen; Zhu, Changfu] Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Gomez Gomez, Lourdes] Univ Castilla La Mancha, Fac Farm, Inst Bot, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Veiga, Tania; Guitian, Javier; Guitian, Pablo] Univ Santiago de Compostela, Dept Bot, Galicia, Spain; [Sandmann, Gerhard] Goethe Univ Frankfurt, Biosynth Grp, Mol Biosci, Frankfurt, Germany; [Christou, Paul] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain	Universitat de Lleida; Changchun Normal University; Universidad de Castilla-La Mancha; Universidade de Santiago de Compostela; Goethe University Frankfurt; ICREA	Zhu, CF (corresponding author), Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain.; Zhu, CF (corresponding author), Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China.	zhu@pvcf.udl.cat	Guitian, Javier/O-5744-2019; Capell, Teresa/AAD-8609-2022; Gomez-Gomez, Lourdes/AAF-2371-2020; Capell, Teresa/B-2757-2011; Zhu, Changfu/C-8446-2011	Guitian, Javier/0000-0003-0799-0476; Gomez-Gomez, Lourdes/0000-0003-2586-4457; Capell, Teresa/0000-0002-6436-4538; Berman, Judit/0000-0002-0972-8941; Zhu, Changfu/0000-0003-2834-2742	MICINN, Spain [BIO2014-54441-P, BIO2014-54426-P, BIO2013-44239-R, BIO2011-23324, BIO2011-22525, PIM2010PKB-00746]; National Natural Science Foundation of China [31270344]; Plan Nacional de I + D + I; IBERCAROT network [112RT0445]; PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain [BIO2015-71703-REDT]; COSTaction (EUROCAROTEN) [OC-2015-1-19780]; European Union Framework 7 European Research Council IDEAS Advanced Grant; Program-BIOFORCE; ERC Proof of Concept Grant; Catalan Government Agricultural Biotechnology Research Group [2014 SGR 1296]; Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria; ICREA Funding Source: Custom	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan Nacional de I + D + I; IBERCAROT network; PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain; COSTaction (EUROCAROTEN); European Union Framework 7 European Research Council IDEAS Advanced Grant; Program-BIOFORCE; ERC Proof of Concept Grant; Catalan Government Agricultural Biotechnology Research Group; Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria; ICREA(ICREA)	This work was supported by MICINN, Spain (BIO2014-54441-P, BIO2014-54426-P, BIO2013-44239-R, BIO2011-23324, BIO2011-22525, PIM2010PKB-00746); the National Natural Science Foundation of China (31270344); the Plan Nacional de I + D + I (2008-2011); the IBERCAROT network (112RT0445); PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain (BIO2015-71703-REDT); COSTaction (EUROCAROTEN, OC-2015-1-19780); European Union Framework 7 European Research Council IDEAS Advanced Grant (to P.C.) Program-BIOFORCE; and ERC Proof of Concept Grant (to P.C), Catalan Government 2014 SGR 1296 Agricultural Biotechnology Research Group. T.V. was supported by a Ph.D. grant from the Plan Galego de Investigacion e Crecemento 2011/2015 (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; T.V. was supported by a PhD grant from the Plan Galego de Investigacion e Crecemento 2011/2015 (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria.	Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; FORKMANN G, 1987, Z NATURFORSCH C, V42, P1146; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; Fukuchi-Mizutani M, 2003, PLANT PHYSIOL, V132, P1652, DOI 10.1104/pp.102.018242; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Gonzalez-Lopez O, 2014, INT J MOL SCI, V15, P10052, DOI 10.3390/ijms150610052; Goodwin TW, 1998, PLANT PIGMENTS, P62; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOSOKAWA K, 1995, PHYTOCHEMISTRY, V40, P941, DOI 10.1016/0031-9422(95)00242-Y; Jensen SR, 2002, GENTIANACEAE SYSTEMA, P573, DOI DOI 10.1017/CBO9780511541865.007; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Kishimoto S, 2007, J JPN SOC HORTIC SCI, V76, P250, DOI 10.2503/jjshs.76.250; Kobayashi H, 1998, PLANT SCI, V131, P173, DOI 10.1016/S0168-9452(97)00236-7; Kohlein F, 1991, GENTIANS, P9; Miosic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112707; Moehs CP, 2001, PLANT MOL BIOL, V45, P281, DOI 10.1023/A:1006417009203; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Nakatsuka T, 2005, PLANT SCI, V169, P949, DOI 10.1016/j.plantsci.2005.06.013; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Nishihara M, 2008, FLORICULTURAL ORNAME, P57; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Renobales SG, 2012, FLORA; Renobales SG, 2002, ANALES JARDIN BOT MA, V60, P461; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; Sobral M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132522; Strain HH, 1938, J BIOL CHEM, V123, P425; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; Tanaka T, 2013, PHIL T R SOC LOND BI, V368; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Tanaka Yoshikazu, 2006, Phytochemistry Reviews, V5, P283, DOI 10.1007/s11101-006-9003-7; Zhu CF, 2002, PLANT MOL BIOL, V48, P277, DOI 10.1023/A:1013383120392; Zhua CF, 2003, BBA-GENE STRUCT EXPR, V1625, P305, DOI 10.1016/S0167-4781(03)00017-4	39	14	16	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162410	10.1371/journal.pone.0162410	http://dx.doi.org/10.1371/journal.pone.0162410			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589396	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800059
J	Goto, S; Yoshioka, T; Ohta, S; Kita, M; Hamada, H; Shimizu, T				Goto, Shingo; Yoshioka, Terutaka; Ohta, Satoshi; Kita, Masayuki; Hamada, Hiroko; Shimizu, Tokurou			Segregation and Heritability of Male Sterility in Populations Derived from Progeny of Satsuma Mandarin	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ENVIRONMENTAL VARIATIONS; GENETIC-DIFFERENCES; ABORTED ANTHERS; CYBRID PLANTS; CITRUS; IDENTIFICATION; SEEDLESSNESS; CULTIVARS; SELECTION	Male sterility derived from Satsuma mandarin (Citrus unshiu) has been used in Japanese citrus breeding programs to obtain seedless cultivars, which is a desirable trait for consumers. Male sterility has often been evaluated by anther development or pollen fertility; however, the inheritance and heritability of male sterility derived from Satsuma is poorly understood. In this study, we investigated the mode of inheritance and broad-sense heritability of male sterility derived from Satsuma. Initially, we evaluated the total number of pollen grains per anther and apparent pollen fertility, as indicated by lactophenol blue staining, in 15 citrus cultivars and selections to understand the male sterility of Satsuma. The results indicated that male sterility was primarily caused by decreased number of pollen grains per anther in progeny of Satsuma. We also evaluated these traits in three F-1 populations (hyuganatsu x 'Okitsu No. 56', 'Okitsu No. 46' x 'Okitsu No. 56' and 'Okitsu No. 46' x 'Kara'), of which the parents are derived from Satsuma. Individuals in these populations showed strong segregation for number of pollen grains per anther. The apparent fertility of pollen also showed segregation but was almost constant at 70%-90%. The estimated broad-sense heritability for the number of pollen grains per anther was as high as 0.898 in the 'Okitsu No. 46' x 'Okitsu No. 56' and 'Okitsu No. 46' x 'Kara' populations. These results indicated that the number of pollen grains per anther primarily determined male sterility among progeny of Satsuma, and this trait was inherited by the progeny. Development of DNA markers closely linked to male sterility using the F1 populations of 'Okitsu No. 46' x 'Okitsu No. 56' and 'Okitsu No. 46' x 'Kara' is expected to contribute to the breeding of novel seedless citrus cultivars.	[Goto, Shingo; Yoshioka, Terutaka; Ohta, Satoshi; Kita, Masayuki; Hamada, Hiroko; Shimizu, Tokurou] NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shizuoka, Japan; [Kita, Masayuki] NARO, Western Reg Agr Res Ctr, Div Hillside Hort Res, Zentsuji, Kagawa, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Shimizu, T (corresponding author), NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shizuoka, Japan.	tshimizu@affrc.go.jp	Goto, Shingo/AAU-4777-2021	Goto, Shingo/0000-0002-2298-7016	Institute of Fruit Tree and Tea Science, NARO, Japan; Grants-in-Aid for Scientific Research [15K18643] Funding Source: KAKEN	Institute of Fruit Tree and Tea Science, NARO, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the basic research fund of the Institute of Fruit Tree and Tea Science, NARO, Japan.	Cai XD, 2007, PLANT CELL TISS ORG, V90, P275, DOI 10.1007/s11240-007-9266-8; Campbell R. C., 1974, STAT BIOL, V2nd; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; 채치원, 2011, [Journal of Life Science, 생명과학회지], V21, P1659; Goto S, 2016, ACTA HORTIC, V1135, P103, DOI 10.17660/ActaHortic.2016.1135.12; Guo WW, 2013, SCI HORTIC-AMSTERDAM, V163, P20, DOI 10.1016/j.scienta.2013.07.018; Guo WW, 2004, PLANT CELL REP, V22, P752, DOI 10.1007/s00299-003-0747-x; Hasegawa Y, 2013, J JPN SOC FOOD SCI, V60, P609; IWAMASA M., 1966, Bulletin of the Horticultural Research Station, P1; IWASAKI T., 1966, Bulletin of the Horticultural Research Station, P83; Kaminuma E, 2013, NUCLEIC ACIDS RES, V41, pD880, DOI 10.1093/nar/gks1216; Kaul, 1988, MALE STERILITY HIGHE; Kunihisa M, 2014, BREEDING SCI, V64, P240, DOI 10.1270/jsbbs.64.240; Nakano M, 2001, J JPN SOC HORTIC SCI, V70, P539, DOI 10.2503/jjshs.70.539; Nishio S, 2014, HORTSCIENCE, V49, P696, DOI 10.21273/HORTSCI.49.6.696; Nishio S, 2011, HORTSCIENCE, V46, P1540, DOI 10.21273/HORTSCI.46.11.1540; Nishiura M., 1983, B FRUIT TREE RES STN, V10, P1; Nonaka K, 2012, J AM SOC HORTIC SCI, V137, P243, DOI 10.21273/JASHS.137.4.243; Siviero A, 2006, J APPL GENET, V47, P23, DOI 10.1007/BF03194595; Vardi A, 2008, J AM SOC HORTIC SCI, V133, P117, DOI 10.21273/JASHS.133.1.117; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Xiao SX, 2014, PLANT CELL TISS ORG, V116, P81, DOI 10.1007/s11240-013-0384-1; Yamada M, 2002, HORTSCIENCE, V37, P164, DOI 10.21273/HORTSCI.37.1.164; YAMADA M, 1993, HORTSCIENCE, V28, P838, DOI 10.21273/HORTSCI.28.8.838; Yamamoto M, 1997, SCI HORTIC-AMSTERDAM, V70, P9, DOI 10.1016/S0304-4238(97)00017-4; YAMAMOTO M, 1992, J JPN SOC HORTIC SCI, V60, P791, DOI 10.2503/jjshs.60.791; YAMAMOTO M, 1995, J JPN SOC HORTIC SCI, V64, P23, DOI 10.2503/jjshs.64.23; Yamamoto M, 1996, J JPN SOC HORTIC SCI, V65, P291, DOI 10.2503/jjshs.65.291; Yoshida Toshio, 2005, Bulletin of the National Institute of Fruit Tree Science, P37; Zheng BB, 2014, J PROTEOME RES, V13, P2998, DOI 10.1021/pr500126g; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	31	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162408	10.1371/journal.pone.0162408	http://dx.doi.org/10.1371/journal.pone.0162408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589237	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800057
J	Luo, XT; Zhang, JF; Castelberg, R; Wu, T; Yu, PM; He, CQ; Wang, P				Luo, Xiaotian; Zhang, Jifeng; Castelberg, Rachel; Wu, Tao; Yu, Pengming; He, Chengqi; Wang, Pu			The Effects of Traditional Chinese Exercise in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis	PLOS ONE			English	Article							KNEE EXTENSOR STRENGTH; TAI-CHI EXERCISE; REHABILITATION PROGRAM; HEART-FAILURE; COPD; QIGONG; QUALITY; HEALTH; COMPLEMENTARY; INDIVIDUALS	Background Chronic obstructive pulmonary disease (COPD) is a major public health problem worldwide. However, several studies that have assessed the role of traditional Chinese exercise in the management of this disease include broad variations in sample sizes and results. Therefore, this meta-analysis was conducted to assess the effects of traditional Chinese exercise on patients with COPD. Methods Two investigators independently identified and extracted data from selected articles. A computerized search of electronic databases through August 2015 was conducted. Mean differences (MDs) and 95% confidence intervals (CIs) were calculated to analyze the combined data. The methodological quality was evaluated using the Cochrane risk-of-bias tool. Heterogeneity was assessed with the I-2 test. Results Ten randomized, controlled trials (RCTs) involving 622 patients met the inclusion criteria. There were significant improvements in the 6-minute walking distance test (6 MWD;MWD = 12.10 m; 95% CI, 7.56-16.65 m; p<0.001); forced expiratory volume in one second (FEV1% predicted; WMD = 9.02; 95% CI, 6.80-11.23; p<0.00001); forced expiratory volume in 1 second/forced vital capacity (FEV(1)/FVC) ratio (Tiffenau Index; WMD = 6.67; 95% CI, 5.09-8.24; p<0.00001); and quality of life, as evaluated by the Chronic Respiratory Disease Questionnaire (CRDQ; WMD = 0.85 score; 95% CI, 0.52-1.18; p<0.00001). Conclusions Traditional Chinese exercise could provide an effective alternative method for managing COPD. Larger and higher-quality trials are required.	[Luo, Xiaotian; Wu, Tao; Yu, Pengming; He, Chengqi; Wang, Pu] Sichuan Univ, West China Hosp, Dept Rehabil Med Ctr, Chengdu, Sichuan, Peoples R China; [Luo, Xiaotian; He, Chengqi; Wang, Pu] Dept Key Lab Rehabil Med Sichuan, Chengdu, Sichuan, Peoples R China; [Zhang, Jifeng] Datong Second Peoples Hosp, Dept Gen Surg Med, Datong, Shanxi, Peoples R China; [Castelberg, Rachel] Univ North Texas Hlth Sci Ctr, Dept Phys Therapy, 3500 Camp Bowie Blvd, Ft Worth, TX USA	Sichuan University; University of North Texas System; University of North Texas Health Science Center	He, CQ; Wang, P (corresponding author), Sichuan Univ, West China Hosp, Dept Rehabil Med Ctr, Chengdu, Sichuan, Peoples R China.; He, CQ; Wang, P (corresponding author), Dept Key Lab Rehabil Med Sichuan, Chengdu, Sichuan, Peoples R China.	hxkfhcq@163.com; wangpu0816@qq.com			National Natural Science Foundation of China [81401858, 0040205401634]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (grant no. 81401858); author Pu Wang designed the study. This study is also supported by the National Natural Science Foundation of China (grant no. 0040205401634); author Chengqi He made the decision to publish.	Cambach W, 1997, EUR RESPIR J, V10, P104, DOI 10.1183/09031936.97.10010104; Chan AWK, 2013, COMPLEMENT THER MED, V21, P585, DOI 10.1016/j.ctim.2013.09.008; Chan AWK, 2013, SCI WORLD J, DOI 10.1155/2013/425082; Chan AWK, 2011, COMPLEMENT THER MED, V19, P3, DOI 10.1016/j.ctim.2010.12.007; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Chen YW, 2016, BRIT J SPORT MED, V50, P397, DOI 10.1136/bjsports-2014-094388; Christou EA, 2003, J GERONTOL A-BIOL, V58, P763; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ding M, 2014, J ALTERN COMPLEM MED, V20, P79, DOI 10.1089/acm.2013.0087; Ding M, 2012, AM J PHYS MED REHAB, V91, P1091, DOI 10.1097/PHM.0b013e31826edd21; Green RH, 2001, THORAX, V56, P143, DOI 10.1136/thorax.56.2.143; Guell R, 2000, CHEST, V117, P976, DOI 10.1378/chest.117.4.976; Guo JB, 2016, CLIN REHABIL, V30, P750, DOI 10.1177/0269215515604903; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lacasse Y, 2007, Eura Medicophys, V43, P475; Lan C, 1998, MED SCI SPORT EXER, V30, P345, DOI 10.1097/00005768-199803000-00003; Lan C, 2000, ARCH PHYS MED REHAB, V81, P604, DOI 10.1053/mr.2000.3849; Langhorst J, 2012, SCHMERZ, V26, P311, DOI 10.1007/s00482-012-1178-9; Leung RWM, 2013, EUR RESPIR J, V41, P1051, DOI 10.1183/09031936.00036912; Li JX, 2009, J BIOMECH, V42, P967, DOI 10.1016/j.jbiomech.2009.03.001; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu XD, 2012, HONG KONG J OCCUP TH, V22, P38, DOI 10.1016/j.hkjot.2012.06.002; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008465.pub2; Ng BHP, 2014, J CARDIOPULM REHABIL, V34, P367, DOI 10.1097/HCR.0000000000000062; Ng BHP, 2011, J ALTERN COMPLEM MED, V17, P243, DOI 10.1089/acm.2010.0215; Ng L, 2014, EUR J INTEGR MED, V6, P248, DOI 10.1016/j.eujim.2014.01.007; Niu RC, 2014, HEART LUNG CIRC, V23, P347, DOI 10.1016/j.hlc.2013.10.057; Puhan MA, 2011, EUR RESPIR J, V37, P784, DOI 10.1183/09031936.00063810; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sharma M, 2013, J EVID-BASED INTEGR, V18, P209, DOI 10.1177/2156587213478174; Spruit MA, 2013, EUR RESPIR J, V41, P1005, DOI 10.1183/09031936.00128512; Spruit MA, 2012, J AM MED DIR ASSOC, V13, P291, DOI 10.1016/j.jamda.2011.06.009; The Chinese Medical Association Respiratory Neurology Chronic Obstructive Pulmonary Disease Committee, 2013, CHIN J TUBERE RESPIR, V36, P255; Tsang WWN, 2005, MED SCI SPORT EXER, V37, P280, DOI 10.1249/01.MSS.0000152735.06282.58; Wu G, 2004, J ELECTROMYOGR KINES, V14, P343, DOI 10.1016/j.jelekin.2003.09.002; Wu G, 2002, ARCH PHYS MED REHAB, V83, P1364, DOI 10.1053/apmr.2002.34596; Wu WB, 2014, INT J CHRONIC OBSTR, V9, P1253, DOI 10.2147/COPD.S70862; Xu D, 2004, BRIT J SPORT MED, V38, P50, DOI 10.1136/bjsm.2002.003335; Xu DQ, 2005, AGE AGEING, V34, P439, DOI 10.1093/ageing/afi114; Yan Jun-Hong, 2013, PLoS One, V8, pe61806, DOI 10.1371/journal.pone.0061806; Yeh GY, 2010, RESP CARE, V55, P1475; Yeh GY, 2004, AM J MED, V117, P541, DOI 10.1016/j.amjmed.2004.04.016; 杜舒婷, 2013, [中国康复医学杂志, Chinese Journal of Rehabilitation Medicine], V28, P374	45	23	25	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161564	10.1371/journal.pone.0161564	http://dx.doi.org/10.1371/journal.pone.0161564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589054	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877800011
J	Matsushika, A; Negi, K; Suzuki, T; Goshima, T; Hoshino, T				Matsushika, Akinori; Negi, Kanako; Suzuki, Toshihiro; Goshima, Tetsuya; Hoshino, Tamotsu			Identification and Characterization of a Novel Issatchenkia orientalis GPI-Anchored Protein, IoGas1, Required for Resistance to Low pH and Salt Stress	PLOS ONE			English	Article							ENGINEERED SACCHAROMYCES-CEREVISIAE; MULTIPLE SEQUENCE ALIGNMENT; GLUCAN-REMODELING ENZYMES; ETHANOL-PRODUCTION; CANDIDA-ALBICANS; GLUCANOSYLTRANSFERASE GAS1; BIOETHANOL PRODUCTION; REGULATED GENE; CROSS-LINKING; LACTIC-ACID	The use of yeasts tolerant to acid (low pH) and salt stress is of industrial importance for several bioproduction processes. To identify new candidate genes having potential roles in low-pH tolerance, we screened an expression genomic DNA library of a multiple-stress-tolerant yeast, Issatchenkia orientalis (Pichia kudriavzevii), for clones that allowed Saccharomyces cerevisiae cells to grow under highly acidic conditions (pH 2.0). A genomic DNA clone containing two putative open reading frames was obtained, of which the putative protein-coding gene comprising 1629 bp was retransformed into the host. This transformant grew significantly at pH 2.0, and at pH 2.5 in the presence of 7.5% Na2SO4. The predicted amino acid sequence of this new gene, named I. orientalis GAS1 (IoGAS1), was 60% identical to the S. cerevisiae Gas1 protein, a glycosylphosphatidylinositol-anchored protein essential for maintaining cell wall integrity, and 58-59% identical to Candida albicans Phr1 and Phr2, pH-responsive proteins implicated in cell wall assembly and virulence. Northern hybridization analyses indicated that, as for the C. albicans homologs, IoGAS1 expression was pH-dependent, with expression increasing with decreasing pH (from 4.0 to 2.0) of the medium. These results suggest that IoGAS1 represents a novel pH-regulated system required for the adaptation of I. orientalis to environments of diverse pH. Heterologous expression of IoGAS1 complemented the growth and morphological defects of a S. cerevisiae gas1 Delta mutant, demonstrating that IoGAS1 and the corresponding S. cerevisiae gene play similar roles in cell wall biosynthesis. Site-directed mutagenesis experiments revealed that two conserved glutamate residues (E161 and E262) in the IoGas1 protein play a crucial role in yeast morphogenesis and tolerance to low pH and salt stress. Furthermore, overexpression of IoGAS1 in S. cerevisiae remarkably improved the ethanol fermentation ability at pH 2.5, and at pH 2.0 in the presence of salt (5% Na2SO4), compared to that of a reference strain. Our results strongly suggest that constitutive expression of the IoGAS1 gene in S. cerevisiae could be advantageous for several fermentation processes under these stress conditions.	[Matsushika, Akinori; Negi, Kanako; Suzuki, Toshihiro; Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem ISC, Hiroshima, Japan; [Matsushika, Akinori; Hoshino, Tamotsu] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima, Japan; [Goshima, Tetsuya] Natl Res Inst Brewing, Hiroshima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University	Matsushika, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem ISC, Hiroshima, Japan.; Matsushika, A (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima, Japan.	a-matsushika@aist.go.jp	Matsushika, Akinori/B-8721-2018; HOSHINO, Tamotsu/R-2959-2019; Hoshino, Tamotsu/F-3357-2017	Matsushika, Akinori/0000-0002-5283-2875; Hoshino, Tamotsu/0000-0001-5211-6425	New Energy and Industrial Technology Development Organization (NEDO), Japan	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was funded by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Balat M, 2008, PROG ENERG COMBUST, V34, P551, DOI 10.1016/j.pecs.2007.11.001; Benjaphokee S, 2012, NEW BIOTECHNOL, V29, P379, DOI 10.1016/j.nbt.2011.07.002; Carotti C, 2004, EUR J BIOCHEM, V271, P3635, DOI 10.1111/j.1432-1033.2004.04297.x; Casey E, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-83; Dandi ND, 2013, ANTON LEEUW INT J G, V103, P723, DOI 10.1007/s10482-012-9854-4; Dogan A, 2014, APPL BIOCHEM BIOTECH, V174, P28, DOI [10.100, 10.1007/s12010-014-1006-z]; Edgardo A, 2008, ENZYME MICROB TECH, V43, P120, DOI 10.1016/j.enzmictec.2007.08.006; Eustice M, 2014, GENETICS, V196, P1029, DOI 10.1534/genetics.113.158824; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Garcia MJ, 1997, MICROBIOL-UK, V143, P1125, DOI 10.1099/00221287-143-4-1125; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; GATTI E, 1994, J BIOL CHEM, V269, P19695; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Ha CW, 2014, NUCLEIC ACIDS RES, V42, P8486, DOI 10.1093/nar/gku570; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hisamatsu M., 2006, J APPL GLYCOSCI, V53, P111, DOI DOI 10.5458/JAG.53.111; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; Ishida N, 2005, APPL ENVIRON MICROB, V71, P1964, DOI 10.1128/AEM.71.4.1964-1970.2005; Isono N, 2012, J BIOSCI BIOENG, V113, P76, DOI 10.1016/j.jbiosc.2011.09.004; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KANG YS, 1990, MOL CELL BIOL, V10, P2582, DOI 10.1128/MCB.10.6.2582; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitagawa T, 2010, APPL MICROBIOL BIOT, V87, P1841, DOI 10.1007/s00253-010-2629-9; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Koch MR, 2009, P NATL ACAD SCI USA, V106, P11224, DOI 10.1073/pnas.0900809106; Kovacova K, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fou011; Kwon YJ, 2011, BIORESOURCE TECHNOL, V102, P8099, DOI 10.1016/j.biortech.2011.06.035; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Ma MG, 2010, APPL MICROBIOL BIOT, V87, P829, DOI 10.1007/s00253-010-2594-3; MAIORELLA BL, 1984, BIOTECHNOL BIOENG, V26, P1155, DOI 10.1002/bit.260261004; Marx H, 2006, FEMS MICROBIOL LETT, V264, P40, DOI 10.1111/j.1574-6968.2006.00427.x; Matsushika A, 2008, APPL MICROBIOL BIOT, V81, P243, DOI 10.1007/s00253-008-1649-1; Matsushika A, 2012, APPL BIOCHEM BIOTECH, V168, P2094, DOI 10.1007/s12010-012-9920-4; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Matsushika A, 2010, J BIOSCI BIOENG, V110, P102, DOI 10.1016/j.jbiosc.2010.01.002; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Mazan M, 2011, BIOCHEM J, V438, P275, DOI 10.1042/BJ20110405; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P7453, DOI 10.1128/AEM.69.12.7453-7461.2003; Mira NP, 2010, OMICS, V14, P525, DOI 10.1089/omi.2010.0072; Modig T, 2007, APPL MICROBIOL BIOT, V75, P289, DOI 10.1007/s00253-006-0821-8; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Nilvebrant NO, 2003, APPL BIOCHEM BIOTECH, V105, P615; Oberoi HS, 2012, J IND MICROBIOL BIOT, V39, P557, DOI 10.1007/s10295-011-1060-2; Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Papaleo E, 2006, J MOL MODEL, V12, P237, DOI 10.1007/s00894-005-0025-7; Passolunghi S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-7; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Prista C, 1997, APPL ENVIRON MICROB, V63, P4005, DOI 10.1128/AEM.63.10.4005-4009.1997; Radecka D, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov053; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Rolli E, 2011, MOL BIOL CELL, V22, P1585, DOI 10.1091/mbc.E10-03-0268; Ruyters S, 2015, J IND MICROBIOL BIOT, V42, P39, DOI 10.1007/s10295-014-1544-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Sillo F, 2013, FUNGAL GENET BIOL, V53, P10, DOI 10.1016/j.fgb.2013.01.010; Skrzypek M, 1997, J BACTERIOL, V179, P1513, DOI 10.1128/jb.179.5.1513-1520.1997; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Suzuki T, 2013, J BIOSCI BIOENG, V115, P467, DOI 10.1016/j.jbiosc.2012.11.014; Tao F, 2005, PROCESS BIOCHEM, V40, P183, DOI 10.1016/j.procbio.2003.11.054; Thalagala T. A. T. P., 2009, Journal of Applied Glycoscience, V56, P7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turchini A, 2000, J BACTERIOL, V182, P1167, DOI 10.1128/JB.182.4.1167-1171.2000; Vai M, 1996, YEAST, V12, P361, DOI 10.1002/(SICI)1097-0061(19960330)12:4<361::AID-YEA920>3.0.CO;2-T; VAI M, 1991, J BIOL CHEM, V266, P12242; Watanabe I, 2008, J IND MICROBIOL BIOT, V35, P1117, DOI 10.1007/s10295-008-0390-1; WEI CJ, 1982, APPL ENVIRON MICROB, V43, P757, DOI 10.1128/AEM.43.4.757-763.1982; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	90	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161888	10.1371/journal.pone.0161888	http://dx.doi.org/10.1371/journal.pone.0161888			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589271	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877800022
J	Paras-Bravo, P; Paz-Zulueta, M; Sarabia-Lavin, R; Amo-Setien, FJ; Herrero-Montes, M; Olavarria-Beivide, E; Rodriguez-Rodriguez, M; Torres-Manrique, B; Rodriguez-de la Vega, C; Caso-Alvarez, V; Gonzalez-Parralo, L; Antolin-Juarez, FM				Paras-Bravo, Paula; Paz-Zulueta, Maria; Sarabia-Lavin, Raquel; Jose Amo-Setien, Francisco; Herrero-Montes, Manuel; Olavarria-Beivide, Encarnacion; Rodriguez-Rodriguez, Mercedes; Torres-Manrique, Blanca; Rodriguez-de la Vega, Carlos; Caso-Alvarez, Vanesa; Gonzalez-Parralo, Laura; Manuel Antolin-Juarez, Francisco			Complications of Peripherally Inserted Central Venous Catheters: A Retrospective Cohort Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; CHEMOTHERAPY PATIENTS; VEIN-THROMBOSIS; CARE; MANAGEMENT; PLACEMENT; ADULTS; LINES; RISK	Background and Aim The use of venous catheters is a widespread practice, especially in oncological and oncohematological units. The objective of this study was to evaluate the complications associated with peripherally inserted central catheters (PICCs) in a cohort of patients. Materials and Methods In this retrospective cohort study, we included all patient carrying PICCs (n = 603) inserted at our institute between October 2010 and December 2013. The main variables collected were medical diagnosis, catheter care, location, duration of catheterization, reasons for catheter removal, complications, and nursing care. Complications were classified as infection, thrombosis, phlebitis, migration, edema, and/or ecchymosis. Results All patients were treated according to the same "nursing care" protocol. The incidence rate of complications was two cases per 1000 days of catheter duration. The most relevant complications were infection and thrombosis, both with an incidence of 0.17 cases per 1000 days of the total catheterization period. The total average duration of catheterization was 170 days [SD 6.06]. Additionally to "end of treatment" (48.42%) and "exitus", (22.53%) the most frequent cause of removal was migration (displacement towards the exterior) of the catheter (5.80%). Conclusions PICCs are safe devices that allow the administration of long-term treatment and preserve the integrity of the venous system of the patient. Proper care of the catheter is very important to improve the quality life of patients with oncologic and hematologic conditions. Therefore, correct training of professionals and patients as well as following the latest scientific recommendations are particularly relevant.	[Paras-Bravo, Paula; Paz-Zulueta, Maria; Sarabia-Lavin, Raquel; Jose Amo-Setien, Francisco] Univ Cantabria, Dept Enfermeria, Santander, Cantabria, Spain; [Herrero-Montes, Manuel; Olavarria-Beivide, Encarnacion; Rodriguez-Rodriguez, Mercedes; Torres-Manrique, Blanca; Rodriguez-de la Vega, Carlos; Caso-Alvarez, Vanesa; Gonzalez-Parralo, Laura; Manuel Antolin-Juarez, Francisco] Serv Cantabro Salud, Santander, Cantabria, Spain	Universidad de Cantabria	Paras-Bravo, P (corresponding author), Univ Cantabria, Dept Enfermeria, Santander, Cantabria, Spain.	paula.paras@unican.es	Parás-Bravo, Paula/AAC-7250-2020; Herrero-Montes, Manuel/AAV-1583-2020	Parás-Bravo, Paula/0000-0001-7745-3006; Herrero-Montes, Manuel/0000-0002-5732-8344; Sarabia-Lavin, Raquel/0000-0003-3679-4327				Adams S, 2007, CENTRAL VENOUS ACCES; Aw A, 2012, THROMB RES, V130, P323, DOI 10.1016/j.thromres.2012.02.048; Baxi SM, 2013, INFECT CONT HOSP EP, V34, P785, DOI 10.1086/671266; Camp-Sorrell Dawn, 2010, Semin Oncol Nurs, V26, P80, DOI 10.1016/j.soncn.2010.02.001; Chan RJ, 2012, CANCER NURS, V35, pE35, DOI 10.1097/NCC.0b013e3182352916; Chernecky Cynthia, 2010, Semin Oncol Nurs, V26, P79, DOI 10.1016/j.soncn.2010.02.005; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; de Naurois J1, MANAGEMENT FEBRILE N; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002; Fernandez-de-Maya J, 2013, EUR J ONCOL NURS, V17, P835, DOI 10.1016/j.ejon.2013.06.008; Gallieni M, 2008, CA-CANCER J CLIN, V58, P323, DOI 10.3322/CA.2008.0015; Galvez R., 2010, MANUAL MED INTENSIVA, P27; Grant JD, 2012, THROMB HAEMOSTASIS, V108, P1097, DOI 10.1160/TH12-05-0352; Moraza-Dulanto MI, 2012, ENFERM CLIN, V22, P135, DOI 10.1016/j.enfcli.2012.04.002; Leroyer C, 2013, MED MALADIES INFECT, V43, P350, DOI 10.1016/j.medmal.2013.06.013; Leung TK, 2011, CANCER NURS, V34, pE25, DOI 10.1097/NCC.0b013e3181f1ad6f; Li J, 2014, EUR J ONCOL NURS, V18, P94, DOI 10.1016/j.ejon.2013.08.003; Manasek V, 2012, Klin Onkol, V25, P9; Marsh N, 2015, J EVAL CLIN PRACT, V21, P893, DOI 10.1111/jep.12396; Mollee P, 2011, J HOSP INFECT, V78, P26, DOI 10.1016/j.jhin.2011.01.018; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Registered Nurses Association of Ontario, 2005, CAR MAINT RED VASC A; Registered Nurses Association of Ontario, 2004, ASS DEV SEL VASC ACC; Santolim Thais Queiroz, 2012, Br J Nurs, V21, pS30; Santolim TQ, 2012, BR J NURS, V21, pS30; Schiffer CA, 2013, J CLIN ONCOL, V31, P1357, DOI 10.1200/JCO.2012.45.5733; Seckold T, 2015, J VASC ACCESS, V16, P167, DOI 10.5301/jva.5000330; The Joanna Briggs Institute, BEST PRACT MAN PER I; The RCN IV Therapy Forum, 2010, STAND INF THER; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Wolf J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135904	31	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162479	10.1371/journal.pone.0162479	http://dx.doi.org/10.1371/journal.pone.0162479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588946	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800064
J	Renfroe, JB; Bradley, MM; Sege, CT; Bowers, D				Renfroe, Jenna B.; Bradley, Margaret M.; Sege, Christopher T.; Bowers, Dawn			Emotional Modulation of the Late Positive Potential during Picture Free Viewing in Older and Young Adults	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; NEGATIVITY BIAS; EVALUATIVE CATEGORIZATION; MOTIVATED ATTENTION; AROUSAL; MEMORY; AGE; PERCEPTION; RESPONSES	Hedonic bias during free viewing of novel emotional and neutral scenes was investigated in older adults and college students. A neurophysiological index of emotional picture processing-the amplitude of the centroparietal late positive potential (LPP)-was recorded from the scalp using a dense sensor array while participants (29 older adults; 21 college students) viewed emotionally engaging or mundane natural scenes that varied in specific content. Both students and older adults showed LPP enhancement when viewing affective, compared to neutral, scenes, and there was no difference in LPP amplitude between older individuals and college students when viewing neutral everyday scenes. However, compared to the college students, older individuals showed attenuated LPP amplitude when viewing emotional scenes, regardless of hedonic valence or specific content. Age related differences could be mediated by a reduction in reactive emotional arousal with age, possible mediated by repeated life exposure to emotional stimuli.	[Renfroe, Jenna B.; Bradley, Margaret M.; Sege, Christopher T.; Bowers, Dawn] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Renfroe, JB (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	jenna.renfroe.phd@gmail.com			NRSA by the NIH National Institute of Neurological Disorders and Stroke (NINDS) [F31 NS 073331-01]	NRSA by the NIH National Institute of Neurological Disorders and Stroke (NINDS)	This work was supported by an NRSA awarded to the first author (JR) by the NIH National Institute of Neurological Disorders and Stroke (NINDS) (F31 NS 073331-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CARSTENSEN LL, 1992, PSYCHOL AGING, V7, P331, DOI 10.1037/0882-7974.7.3.331; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; Comblain C, 2005, EXP AGING RES, V31, P173, DOI 10.1080/03610730590915010; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Diedrich O, 1997, J PSYCHOPHYSIOL, V11, P71; Dufey M, 2011, SOC NEUROSCI-UK, V6, P48, DOI 10.1080/17470911003691402; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Foster SM, 2013, PSYCHOL AGING, V28, P179, DOI 10.1037/a0030928; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Gavazzeni J, 2008, PSYCHOPHYSIOLOGY, V45, P148, DOI 10.1111/j.1469-8986.2007.00596.x; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Keil A, 2009, PSYCHOL AGING, V24, P668, DOI 10.1037/a0016969; Kisley MA, 2007, PSYCHOL SCI, V18, P838, DOI 10.1111/j.1467-9280.2007.01988.x; Lang P.J., 2008, A8 U FLOR; Lang P.J., 1968, RES PSYCHOTHER, P90, DOI [10.1037/10546-004, DOI 10.1037/10546-004]; Langeslag SJE, 2009, EMOTION, V9, P369, DOI 10.1037/a0015356; Leite J, 2012, INT J PSYCHOPHYSIOL, V83, P375, DOI 10.1016/j.ijpsycho.2011.12.005; LEVENSON RW, 1991, PSYCHOL AGING, V6, P28, DOI 10.1037/0882-7974.6.1.28; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mathieu NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099523; McTeague LM, 2012, PSYCHOPHYSIOLOGY, P336; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Rehmert AE, 2013, EMOTION, V13, P949, DOI 10.1037/a0032771; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Simola J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00041; Spielberger C. D., 1999, USE PSYCHOL TESTING, P993; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Weinberg A, 2012, INT J PSYCHOPHYSIOL, V84, P149, DOI 10.1016/j.ijpsycho.2012.01.023; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wiens S, 2011, BIOL PSYCHOL, V86, P83, DOI 10.1016/j.biopsycho.2010.11.001; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162323	10.1371/journal.pone.0162323	http://dx.doi.org/10.1371/journal.pone.0162323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589393	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800050
J	Bajenova, O; Gorbunova, A; Evsyukov, I; Rayko, M; Gapon, S; Bozhokina, E; Shishkin, A; O'Brien, SJ				Bajenova, Olga; Gorbunova, Anna; Evsyukov, Igor; Rayko, Michael; Gapon, Svetlana; Bozhokina, Ekaterina; Shishkin, Alexander; O'Brien, Stephen J.			The Genome-Wide Analysis of Carcinoembryonic Antigen Signaling by Colorectal Cancer Cells Using RNA Sequencing	PLOS ONE			English	Article							EXPRESSION ANALYSIS; TUMOR-MARKERS; HNRNP M; METASTASIS; COMPLEXES; UPDATE; GENE	Carcinoembryonic antigen (CEA, CEACAM5, CD66) is a promoter of metastasis in epithelial cancers that is widely used as a prognostic clinical marker of metastasis. The aim of this study is to identify the network of genes that are associated with CEA-induced colorectal cancer liver metastasis. We compared the genome-wide transcriptomic profiles of CEA positive (MIP101 clone 8) and CEA negative (MIP 101) colorectal cancer cell lines with different metastatic potential in vivo. The CEA-producing cells displayed quantitative changes in the level of expression for 100 genes (over-expressed or down-regulated). They were confirmed by quantitative RT-PCR. The KEGG pathway analysis identified 4 significantly enriched pathways: cytokine-cytokine receptor interaction, MAPK signaling pathway, TGFbeta signaling pathway and pyrimidine metabolism. Our results suggest that CEA production by colorectal cancer cells triggers colorectal cancer progression by inducing the epithelial-mesenchymal transition, increasing tumor cell invasiveness into the surrounding tissues and suppressing stress and apoptotic signaling. The novel gene expression distinctions establish the relationships between the existing cancer markers and implicate new potential biomarkers for colorectal cancer hepatic metastasis.	[Bajenova, Olga; Gorbunova, Anna; Evsyukov, Igor; Rayko, Michael; O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg, Russia; [Bajenova, Olga] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia; [Bozhokina, Ekaterina] RAS, Inst Cytol, St Petersburg, Russia; [Gapon, Svetlana] Boston Childrens Hosp, Boston, MA USA; [Shishkin, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [O'Brien, Stephen J.] Nova Southeastern Univ, Oceanog Ctr, 8000 N Ocean Dr, Ft Lauderdale, FL 33004 USA	Saint Petersburg State University; Saint Petersburg State University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Harvard University; Boston Children's Hospital; California Institute of Technology; Nova Southeastern University	Bajenova, O (corresponding author), St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg, Russia.; Bajenova, O (corresponding author), St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg, Russia.	obajen@gmail.com	OBRIEN, STEPHEN/ABD-1346-2020; Evsyukov, Igor/N-2037-2015; Bozhokina, Ekaterina/AAC-9573-2021; Rayko, Mikhail/N-4760-2019; Evsyukov, Igor/AAR-2511-2021	Rayko, Mikhail/0000-0002-3737-1521; Evsyukov, Igor/0000-0003-1810-429X; Bajenova, Olga/0000-0001-7506-4736; OBRIEN, STEPHEN/0000-0001-7857-0757	Russian Foundation for Fundamental Research, grant RFFI [11-04-01711]; Government of the Russian Federation mega grant [11G34.31.0068]	Russian Foundation for Fundamental Research, grant RFFI; Government of the Russian Federation mega grant	This work was financially supported by the Russian Foundation for Fundamental Research, grant RFFI # 11-04-01711 to OB, by the Government of the Russian Federation mega grant 11G34.31.0068 to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenova O, 2003, EXP CELL RES, V291, P228, DOI 10.1016/S0014-4827(03)00373-2; Bajenova O, 2014, EXP CELL RES, V324, P115, DOI 10.1016/j.yexcr.2014.04.007; Bajenova OV, 2001, J BIOL CHEM, V276, P31067, DOI 10.1074/jbc.M104093200; Bramswig KH, 2013, CANCER RES, V73, P6584, DOI 10.1158/0008-5472.CAN-13-0123; Chen SJ, 2014, AM J PHYSIOL-GASTR L, V306, pG394, DOI 10.1152/ajpgi.00328.2013; Duffy MJ, 2014, INT J CANCER, V134, P2513, DOI 10.1002/ijc.28384; Hessle V, 2009, MOL BIOL CELL, V20, P3459, DOI 10.1091/mbc.E09-01-0079; HOSTETTER RB, 1990, J NATL CANCER I, V82, P380, DOI 10.1093/jnci/82.5.380; Jensen-Jarolim E, 2015, CANCER IMMUNOL IMMUN, V64, P531, DOI 10.1007/s00262-015-1684-6; Jessup JM, 1998, CELL ADHES COMMUN S, V5, P195; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Malati T, 2007, INDIAN J CLIN BIOCHE, V22, P17, DOI 10.1007/BF02913308; Marko M, 2014, MOL BIOL REP, V41, P2687, DOI 10.1007/s11033-014-3128-3; Ordonez C, 2000, CANCER RES, V60, P3419; Paschos KA, 2014, WORLD J GASTROENTERO, V20, P3719, DOI 10.3748/wjg.v20.i14.3719; Pavlopoulou A, 2014, BIOL EVOL, V6, P1314, DOI [10.1093/gbe/, DOI 10.1093/GBE/]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Thomas P, 2011, CLIN EXP METASTAS, V28, P923, DOI 10.1007/s10585-011-9419-3; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Warzecha CC, 2012, SEMIN CANCER BIOL, V22, P417, DOI 10.1016/j.semcancer.2012.04.003; Williams Alexander G, 2014, Curr Protoc Hum Genet, V83, DOI 10.1002/0471142905.hg1113s83; Xu YL, 2014, GENE DEV, V28, P1191, DOI 10.1101/gad.241968.114; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200	26	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161256	10.1371/journal.pone.0161256	http://dx.doi.org/10.1371/journal.pone.0161256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583792	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000382855600018
J	Ishangulyyeva, G; Najar, A; Curtis, JM; Erbilgin, N				Ishangulyyeva, Guncha; Najar, Ahmed; Curtis, Jonathan M.; Erbilgin, Nadir			Fatty Acid Composition of Novel Host Jack Pine Do Not Prevent Host Acceptance and Colonization by the Invasive Mountain Pine Beetle and Its Symbiotic Fungus	PLOS ONE			English	Article							INSECT HERBIVORE; DENDROCTONUS-PONDEROSAE; POPULATION-DYNAMICS; ERUPTIVE HERBIVORE; RANGE EXPANSION; LINOLENIC ACID; BOREAL FOREST; SCOTS PINE; BIOSYNTHESIS; PLANTS	Fatty acids are major components of plant lipids and can affect growth and development of insect herbivores. Despite a large literature examining the roles of fatty acids in conifers, relatively few studies have tested the effects of fatty acids on insect herbivores and their microbial symbionts. Particularly, whether fatty acids can affect the suitability of conifers for insect herbivores has never been studied before. Thus, we evaluated if composition of fatty acids impede or facilitate colonization of jack pine (Pinus banksiana) by the invasive mountain pine beetle (Dendroctonus ponderosae) and its symbiotic fungus (Grosmannia clavigera). This is the first study to examine the effects of tree fatty acids on any bark beetle species and its symbiotic fungus. In a novel bioassay, we found that plant tissues (hosts and non-host) amended with synthetic fatty acids at concentrations representative of jack pine were compatible with beetle larvae. Likewise, G. clavigera grew in media amended with lipid fractions or synthetic fatty acids at concentrations present in jack pine. In contrast, fatty acids and lipid composition of a non-host were not suitable for the beetle larvae or the fungus. Apparently, concentrations of individual, rather than total, fatty acids determined the suitability of jack pine. Furthermore, sampling of host and non-host tree species across Canada demonstrated that the composition of jack pine fatty acids was similar to the different populations of beetle's historical hosts. These results demonstrate that fatty acids composition compatible with insect herbivores and their microbial symbionts can be important factor defining host suitability to invasive insects.	[Ishangulyyeva, Guncha; Najar, Ahmed; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada; [Curtis, Jonathan M.] Univ Alberta, Dept Agr Food & Nutr Sci, 3-60D South Acad Bldg, Edmonton, AB T6G 2P5, Canada	University of Alberta; University of Alberta	Erbilgin, N (corresponding author), Univ Alberta, Dept Renewable Resources, 4-42 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada.	erbilgin@ualberta.ca	Erbilgin, Nadir/F-3675-2014	Erbilgin, Nadir/0000-0001-9912-8095	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC-Discovery to NE.	Ammunet T, 2011, ECOGRAPHY, V34, P848, DOI 10.1111/j.1600-0587.2011.06685.x; ANDREWS TL, 1972, PESTIC BIOCHEM PHYS, V2, P257, DOI 10.1016/0048-3575(72)90028-4; Angelcheva L, 2014, NEW PHYTOL, V204, P545, DOI 10.1111/nph.12950; Avis TJ, 2001, APPL ENVIRON MICROB, V67, P956, DOI 10.1128/AEM.67.2.956-960.2001; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; Bleiker KP, 2007, ENVIRON ENTOMOL, V36, P1384, DOI 10.1603/0046-225X(2007)36[1384:DBOFAT]2.0.CO;2; BRACKEN GK, 1982, CAN ENTOMOL, V114, P567, DOI 10.4039/Ent114567-7; Cale JA, 2015, CAN J FOREST RES, V45, P1873, DOI 10.1139/cjfr-2015-0277; Cullingham CI, 2011, MOL ECOL, V20, P2157, DOI 10.1111/j.1365-294X.2011.05086.x; Curtis JM, 2008, J AM OIL CHEM SOC, V85, P297, DOI 10.1007/s11746-008-1194-1; De Moraes CM, 2004, P NATL ACAD SCI USA, V101, P8993, DOI 10.1073/pnas.0403248101; Dworkin I, 2009, GENETICS, V181, P721, DOI 10.1534/genetics.108.093419; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Feeny P., 1991, P315; FISCHER C, 1991, TREES-STRUCT FUNCT, V5, P187, DOI 10.1007/BF00227524; Futuyma DJ, 2001, ENCY BIODIVERSITY, V1, P753; GAO Y, 1994, MATER ORGANISMEN, V28, P105; Goodsman DW, 2012, ENVIRON ENTOMOL, V41, P478, DOI 10.1603/EN11205; Grant GG, 2000, ENVIRON ENTOMOL, V29, P164, DOI 10.1603/0046-225X(2000)029[0164:OROSBL]2.0.CO;2; Hansen AK, 2014, MOL ECOL, V23, P1473, DOI 10.1111/mec.12421; Harwood JL, 2005, BIOL SCI SER, P27; Joern A, 2012, ECOLOGY, V93, P1002, DOI 10.1890/11-1142.1; KYBURZ S, 1991, EUR J FOREST PATHOL, V21, P49; Mansson PE, 2006, ENTOMOL EXP APPL, V121, P191, DOI [10.1111/j.1570-8703.2006.00481.x, 10.1111/j.1570-7458.2006.00481.x]; Murphy SM, 2006, ECOL MONOGR, V76, P399, DOI 10.1890/0012-9615(2006)076[0399:CFOANO]2.0.CO;2; Myrholm CL, 2016, CAN ENTOMOL, V148, P68, DOI 10.4039/tce.2015.28; Novak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120119; Otte T, 2015, J CHEM ECOL, V41, P32, DOI 10.1007/s10886-014-0535-9; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; REID RW, 1970, CAN ENTOMOL, V102, P617, DOI 10.4039/Ent102617-5; Roeder KA, 2014, FUNCT ECOL, V28, P1135, DOI 10.1111/1365-2435.12262; RULE GS, 1989, ARCH INSECT BIOCHEM, V12, P89, DOI 10.1002/arch.940120203; SAFRANYIK L, 1983, Journal of the Entomological Society of British Columbia, V80, P10; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Santana O, 2012, CHEM BIODIVERS, V9, P567, DOI 10.1002/cbdv.201100083; Schoonhoven L. M., 2005, Insect-plant biology; Scriber JM, 2010, INSECT SCI, V17, P471, DOI 10.1111/j.1744-7917.2010.01357.x; Shepherd T, 1999, PHYTOCHEMISTRY, V52, P1239, DOI 10.1016/S0031-9422(99)00413-6; Six Diana L., 2012, Insects, V3, P339, DOI 10.3390/insects3010339; Slansky F. Jr, 1985, P87; Song MM, 2014, J CHEM ECOL, V40, P181, DOI 10.1007/s10886-014-0381-9; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; VANDERWEL D, 1992, J CHEM ECOL, V18, P1389, DOI 10.1007/BF00994364; Wallin KF, 2004, ECOL MONOGR, V74, P101, DOI 10.1890/02-4004; Walters D, 2004, MYCOPATHOLOGIA, V157, P87, DOI 10.1023/B:MYCO.0000012222.68156.2c; Wang YM, 2006, J LIPID RES, V47, P530, DOI 10.1194/jlr.M500346-JLR200; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Wolff RL, 1997, TREES-STRUCT FUNCT, V12, P113; Wolff RL, 2001, LIPIDS, V36, P439, DOI 10.1007/s11745-001-0741-5; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.	52	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162046	10.1371/journal.pone.0162046	http://dx.doi.org/10.1371/journal.pone.0162046			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583820	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600092
J	Kalilani, L; Asgharnejad, M; Palokangas, T; Durgin, T				Kalilani, Linda; Asgharnejad, Mahnaz; Palokangas, Tuire; Durgin, Tracy			Comparing the Incidence of Falls/Fractures in Parkinson's Disease Patients in the US Population	PLOS ONE			English	Article							BONE-MINERAL DENSITY; FRACTURE RISK; WOMEN; FALLS; HIP; OSTEOPOROSIS; EPIDEMIOLOGY; COHORT	Patients with Parkinson's disease (PD) may experience falls and/or fractures as a result of disease symptoms. There are limited data available from long-term studies estimating the incidence of falls/fractures in patients with PD. The objective was to compare the incidence rate of falls/fractures in PD patients with non-PD patients in a US population. This was a retrospective study using a US-based claims database (Truven Health MarketScan (R)) that compared the incidence rate of falls/fractures in PD subjects with non-PD subjects. The study period included the 12 months prior to index date (defined as earliest PD diagnosis [International Classification of Diseases, Ninth Revision, Clinical Modification code 332.0]) and a postindex period to the end of data availability. Fractures were defined by inpatient/outpatient claims as a principal or secondary diagnosis and accompanying procedure codes during the postindex period. Incidence rates and 95% CIs for falls/fractures were calculated as the number of events per 10,000 person-years of follow-up using negative binomial or Poisson regression models. Twenty-eight thousand two hundred and eighty PD subjects were matched to non-PD subjects for the analysis (mean [SD] age, 71.4 [11.8] years; 53% male). A higher incidence rate (adjusted for comorbidities and medications) of all fall/fracture cases and by fall and fracture types was observed for PD subjects versus non-PD subjects; the overall adjusted incidence rate ratio comparing PD to non-PD subjects was 2.05; 95% CI, 1.88-2.24. The incidence rate of falls/fractures was significantly higher in subjects with PD compared with non-PD subjects in a US population.	[Kalilani, Linda; Asgharnejad, Mahnaz] UCB Pharma, Raleigh, NC 27617 USA; [Palokangas, Tuire] UCB Pharma, Monheim, Germany; [Durgin, Tracy] UCB Pharma, Atlanta, GA USA	UCB Pharma SA; UCB Pharma SA; UCB Pharma SA	Kalilani, L (corresponding author), UCB Pharma, Raleigh, NC 27617 USA.	linda.kalilani@ucb.com			UCB Pharma, Brussels, Belgium	UCB Pharma, Brussels, Belgium(UCB Pharma SA)	This study was supported by UCB Pharma, Brussels, Belgium. Linda Kalilani, Mahnaz Asgharnejad, Tuire Palokangas, and Tracy Durgin are employees of UCB Pharma. The funder provided support in the form of salaries for authors [LK, MA, TP, TD], who designed the retrospective analysis ('study'), performed the statistical analysis, and decided to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Balash Y, 2005, J NEUROL, V252, P1310, DOI 10.1007/s00415-005-0855-3; Benzinger P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097073; Bezza A, 2008, RHEUMATOL INT, V28, P1205, DOI 10.1007/s00296-008-0632-6; Bhandari M, 2002, J ORTHOP TRAUMA, V16, P562, DOI 10.1097/00005131-200209000-00004; Cassell E, 2000, HAZARD, V45, P1; Cummings SR, 1998, NEW ENGL J MED, V339, P733, DOI 10.1056/NEJM199809103391104; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Genever RW, 2005, AGE AGEING, V34, P21, DOI 10.1093/ageing/afh203; Gnadinger M, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13154; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Hla MM, 1996, AM J CLIN NUTR, V64, P354, DOI 10.1093/ajcn/64.3.345; Huang YF, 2015, OSTEOPOROSIS INT, V26, P1723, DOI 10.1007/s00198-015-3052-y; Lyell V, 2015, AGE AGEING, V44, P34, DOI 10.1093/ageing/afu122; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; Melton LJ, 2006, MOVEMENT DISORD, V21, P1361, DOI 10.1002/mds.20946; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Schousboe JT, 2013, OSTEOPOROSIS INT, V24, P801, DOI 10.1007/s00198-012-2210-8; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Tan L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094379; Torsney KM, 2014, J NEUROL NEUROSUR PS, V85, P1159, DOI 10.1136/jnnp-2013-307307; Vestergaard P, 2007, CALCIFIED TISSUE INT, V81, P153, DOI 10.1007/s00223-007-9065-6; Wielinski CL, 2005, MOVEMENT DISORD, V20, P410, DOI 10.1002/mds.20347; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	27	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161689	10.1371/journal.pone.0161689	http://dx.doi.org/10.1371/journal.pone.0161689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583564	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600050
J	Li, XH; Zhang, YZ; Wei, ZW; Guan, ZB; Cai, YJ; Liao, XR				Li, Xunhang; Zhang, Yanzhou; Wei, Zhiwen; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru			Antifungal Activity of Isolated Bacillus amyloliquefaciens SYBC H47 for the Biocontrol of Peach Gummosis	PLOS ONE			English	Article							SUBTILIS SUBSP SUBTILIS; TOF MS ANALYSIS; BOTRYOSPHAERIA-DOTHIDEA; ANTIMICROBIAL ACTIVITY; CYCLIC LIPOPEPTIDES; BIOLOGICAL-CONTROL; FENGYCIN; STRAINS; IDENTIFICATION; ITURIN	The gummosis disease is caused by Botryosphaeria dothidea (Moug. ex. Fr) Ces. et de Not., and it is one of the most important diseases of stone fruits worldwide. The use of biocontrol as an alternative approach to synthetic chemical fungicides has aroused general concern about how to control plant diseases that are caused by phytopathogens. The aim of this study is to isolate Bacillus strains from raw honeys with the capacity to inhibit B. dothidea and to explore the mechanisms by which they could be used in the biocontrol of peach gummosis. Bacillus amyloliquefaciens SYBC H47 was isolated and identified on the basis of its physiological and biochemical characteristics and its 16S rRNA and gyrB gene sequences. The cell suspension and the cell-free supernatant of its culture showed significant antifungal activity against Aspergillus niger, Mucor racemosus, Fusarium oxysporum, Penicillium citrinum, and Candida albicans by agar-diffusion assays. The primary antifungal substances were bacillomycin L, fengycin, and surfactin, which were analyzed by HPLC LC/ESI-MS/MS. Bacillomycin L showed the best inhibitory effect against conidial germination of B. dothidea, followed by fengycin and surfactin. Surfactin had limited effects on mycelial growth, contrary to those of bacillomycin L and fengycin. However, a mixture of the three lipopeptides had a synergistic effect that disrupted the structure of the conidia and mycelia. In order to reduce the production cost, the use of waste frying peanut oil and soy oil as the sole carbon source increased the lipopeptide yield levels by approximately 17% (2.42 g/L) and 110% (4.35 g/L), respectively. In a field trial, the decreases in the infected gummosis rate (IGR) and the disease severity index (DSI) through cell suspension treatments were 20% and 57.5% (in 2014), respectively, and 40% and 57.5% (in 2015), respectively, in comparison with the control. In conclusion, B. amyloliquefaciens SYBC H47 could inhibit the germination of conidia and the growth of mycelia from B. dothidea; therefore, this strain behaves as a potential biocontrol agent against the gummosis disease.	[Li, Xunhang; Zhang, Yanzhou; Wei, Zhiwen; Guan, Zhengbing; Cai, Yujie; Liao, Xiangru] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Li, Xunhang] Jiangxi Agr Univ, Biosci & Engn Coll, Nanchang 330045, Peoples R China	Jiangnan University; Jiangxi Agricultural University	Liao, XR (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	liaoxiangru@163.com		li, xunhang/0000-0003-4603-8322	Development of Science-technology of agriculture supporting project of Wuxi [CLE01N1310]; Collaborative Innovation Involving Production, Teaching and Research funds of Jiangsu Province [BY2014023-28]; Young Science Fund of Jiangxi Province [20122BAB214027]	Development of Science-technology of agriculture supporting project of Wuxi; Collaborative Innovation Involving Production, Teaching and Research funds of Jiangsu Province; Young Science Fund of Jiangxi Province	This work was funded by the Development of Science-technology of agriculture supporting project of Wuxi (CLE01N1310); Collaborative Innovation Involving Production, Teaching and Research funds of Jiangsu Province (BY2014023-28); and Young Science Fund of Jiangxi Province (20122BAB214027).	Akpa E, 2001, APPL BIOCHEM BIOTECH, V91-3, P551, DOI 10.1385/ABAB:91-93:1-9:551; Aktuganov G, 2014, J CHROMATOGR B, V973, P9, DOI 10.1016/j.jchromb.2014.09.042; Ali Khanzada M, 2005, PAK J BOT, V37, P1023; Alvarez F, 2012, J APPL MICROBIOL, V112, P159, DOI 10.1111/j.1365-2672.2011.05182.x; Aranda FJ, 2005, BBA-BIOMEMBRANES, V1713, P51, DOI 10.1016/j.bbamem.2005.05.003; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Banat IM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00697; Beckman TG, 2003, HORTSCIENCE, V38, P1141, DOI 10.21273/HORTSCI.38.6.1141; Bednarski W, 2004, BIORESOURCE TECHNOL, V95, P15, DOI 10.1016/j.biortech.2004.01.009; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Brown JH, 1939, AM J PUBLIC HEALTH N, V29, P404, DOI 10.2105/AJPH.29.4.404; Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4; Choi SM, 2011, ARCH PHARM RES, V34, P289, DOI 10.1007/s12272-011-0215-z; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Damm U, 2007, MYCOLOGIA, V99, P664, DOI 10.3852/mycologia.99.5.664; Deleu M, 2005, J COLLOID INTERF SCI, V283, P358, DOI 10.1016/j.jcis.2004.09.036; Duan YB, 2014, J PEST SCI, V87, P221, DOI 10.1007/s10340-013-0526-6; Dunne C, 1997, MICROBIOL-UK, V143, P3921, DOI 10.1099/00221287-143-12-3921; Fox SL, 2000, BIORESOURCE TECHNOL, V75, P235, DOI 10.1016/S0960-8524(00)00059-6; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; FRIDLENDER M, 1993, SOIL BIOL BIOCHEM, V25, P1211, DOI 10.1016/0038-0717(93)90217-Y; Ghribi D, 2011, AFR J MICROBIOL RES, V5, P4927, DOI 10.5897/AJMR11.1125; Gong AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116871; Guo QG, 2014, MICROBIOL RES, V169, P533, DOI 10.1016/j.micres.2013.12.001; Haba E, 2000, J APPL MICROBIOL, V88, P379, DOI 10.1046/j.1365-2672.2000.00961.x; HOURDOU ML, 1989, LIPIDS, V24, P940, DOI 10.1007/BF02544538; Hutsebaut D, 2006, SYST APPL MICROBIOL, V29, P650, DOI 10.1016/j.syapm.2006.02.001; Idris EE, 2004, Z PFLANZENK PFLANZEN, V111, P583; Islam Md. Rezuanul, 2012, Mycobiology, V40, P59, DOI 10.5941/MYCO.2012.40.1.059; Kumar P, 2012, MICROBIOL RES, V167, P493, DOI 10.1016/j.micres.2012.05.002; Lee HJ, 2008, INT J FOOD MICROBIOL, V126, P240, DOI 10.1016/j.ijfoodmicro.2008.04.030; Ma ZH, 2001, PLANT DIS, V85, P183, DOI 10.1094/PDIS.2001.85.2.183; Madhaiyan M, 2010, INT J SYST EVOL MICR, V60, P2490, DOI 10.1099/ijs.0.015487-0; MAGETDANA R, 1994, TOXICOLOGY, V87, P151, DOI 10.1016/0300-483X(94)90159-7; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Meena KR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/473050; MICHAILIDES TJ, 1991, PHYTOPATHOLOGY, V81, P566, DOI 10.1094/Phyto-81-566; Minaxi, 2012, APPL SOIL ECOL, V59, P124, DOI 10.1016/j.apsoil.2011.08.001; Monaci L, 2016, RAPID COMMUN MASS SP, V30, P45, DOI 10.1002/rcm.7408; Ongena M, 2005, APPL MICROBIOL BIOT, V69, P29, DOI 10.1007/s00253-005-1940-3; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Perneel M, 2007, J APPL MICROBIOL, V103, P1007, DOI 10.1111/j.1365-2672.2007.03345.x; Pluhacek T, 2016, MASS SPECTROM REV, V35, P35, DOI 10.1002/mas.21461; Pradhan AK, 2013, APPL BIOCHEM BIOTECH, V171, P1362, DOI 10.1007/s12010-013-0428-3; Price NPJ, 2007, FEMS MICROBIOL LETT, V271, P83, DOI 10.1111/j.1574-6968.2007.00702.x; PUSEY PL, 1993, PLANT DIS, V77, P170, DOI 10.1094/PD-77-0170; Rajkumar M, 2010, TRENDS BIOTECHNOL, V28, P142, DOI 10.1016/j.tibtech.2009.12.002; Ramesh A, 2013, J VIROL MICROBIOL, V2013, DOI 10.5171/2013.446006; Romero D, 2007, J APPL MICROBIOL, V103, P969, DOI 10.1111/j.1365-2672.2007.03323.x; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Shoda M, 2000, J BIOSCI BIOENG, V89, P515, DOI 10.1016/S1389-1723(00)80049-3; Torres MJ, 2016, MICROBIOL RES, V182, P31, DOI 10.1016/j.micres.2015.09.005; Torres MJ, 2015, WORLD J MICROB BIOT, V31, P929, DOI 10.1007/s11274-015-1847-9; Trummler K, 2003, EUR J LIPID SCI TECH, V105, P563, DOI 10.1002/ejlt.200300816; Vance-Harrop MH, 2003, BRAZ J MICROBIOL, V34, P120, DOI 10.1590/S1517-83822003000200006; VanGinkel M, 1996, PLANT DIS, V80, P863, DOI 10.1094/PD-80-0863; Volpon L, 1999, EUR J BIOCHEM, V264, P200, DOI 10.1046/j.1432-1327.1999.00605.x; Waewthongrak W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109386; Wang LT, 2008, INT J SYST EVOL MICR, V58, P671, DOI 10.1099/ijs.0.65191-0; Williams BH, 2002, J MASS SPECTROM, V37, P259, DOI 10.1002/jms.279; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Yang H, 2015, ANAL BIOANAL CHEM, V407, P2529, DOI 10.1007/s00216-015-8486-8; Zhang B, 2013, BBA-BIOMEMBRANES, V1828, P2230, DOI 10.1016/j.bbamem.2013.05.033; Zhao PC, 2014, J BASIC MICROB, V54, P448, DOI 10.1002/jobm.201200414; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092486; Zhu Z, 2013, J ENVIRON MANAGE, V127, P96, DOI 10.1016/j.jenvman.2013.04.017	67	26	33	11	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162125	10.1371/journal.pone.0162125	http://dx.doi.org/10.1371/journal.pone.0162125			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583463	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600108
J	Shishavan, MH; Bidadkosh, A; Yazdani, S; Lambooy, S; van den Born, J; Buikema, H; Henning, RH; Deelman, LE				Shishavan, Mahdi Hamidi; Bidadkosh, Arash; Yazdani, Saleh; Lambooy, Sebastiaan; van den Born, Jacob; Buikema, Hendrik; Henning, Robert H.; Deelman, Leo E.			Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; SPHINGOSINE-1-PHOSPHATE RECEPTOR-2; COX-2 EXPRESSION; INHIBITION; HEART; VASOCONSTRICTION; CONSTRICTION; VASCULATURE; RESISTANCE; MODULATOR	The sphingosine-1-phosphate (S1P) analog FTY720 exerts pleiotropic effects on the cardiovascular system and causes down-regulation of S1P receptors. Myogenic constriction is an important mechanism regulating resistance vessel function and is known to be modulated by S1P. Here we investigated myogenic constriction and vascular function of mesenteric arteries of rats chronically treated with FTY720. Wistar rats received FTY720 1mg/kg/daily for six weeks. At termination, blood pressure was recorded and small mesenteric arteries collected for vascular studies in a perfusion set up. Myogenic constriction to increased intraluminal pressure was low, but a sub-threshold dose of S1P profoundly augmented myogenic constriction in arteries of both controls and animals chronically treated with FTY720. Interestingly, endothelial denudation blocked the response to S1P in arteries of FTY720-treated animals, but not in control rats. In acute experiments, presence of FTY720 significantly augmented the contractile response to S1P, an effect that was partially abolished after the inhibition of cyclooxygenase (COX-)-derived prostaglandins. FTY720 down regulated S1P1 but not S1P2 in renal resistance arteries and in cultured human endothelial cells. This study therefore demonstrates the endothelium is able to compensate for the complete loss of responsiveness of the smooth muscle layer to S1P after long term FTY720 treatment through a mechanism that most likely involves enhanced production of contractile prostaglandins by the endothelium.	[Shishavan, Mahdi Hamidi; Bidadkosh, Arash; Lambooy, Sebastiaan; Buikema, Hendrik; Henning, Robert H.; Deelman, Leo E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Dept Med, Groningen, Netherlands; [Yazdani, Saleh; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Med, Groningen, Netherlands	University of Groningen; University of Groningen	Shishavan, MH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Dept Med, Groningen, Netherlands.	m.hamidi.shishavan@umcg.nl	Henning, Robert H/AAY-5222-2020; Deelman, Leo/A-9140-2018	Deelman, Leo/0000-0003-1798-8353; Henning, Robert/0000-0002-5135-4621	University Medical Center Groningen	University Medical Center Groningen	The author(s) received funding from University Medical Center Groningen for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, J MOL HISTOL, V39, P527, DOI 10.1007/s10735-008-9193-y; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2002, CURR OPIN IMMUNOL, V14, P569, DOI 10.1016/S0952-7915(02)00374-6; Danieli-Betto D, 2010, AM J PHYSIOL-CELL PH, V298, pC550, DOI 10.1152/ajpcell.00072.2009; Delaey C, 2002, EXP EYE RES, V75, P243, DOI 10.1006/exer.2002.2028; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Gonzalez-Cabrera Pedro J, 2014, F1000Prime Rep, V6, P109, DOI 10.12703/P6-109; Guan ZR, 2014, J AM SOC NEPHROL, V25, P1774, DOI 10.1681/ASN.2013060656; Ham A, 2014, KIDNEY INT, V85, P807, DOI 10.1038/ki.2013.345; Hoefer J, 2010, CIRC RES, V107, P923, DOI 10.1161/CIRCRESAHA.110.226464; Hsieh HL, 2006, J CELL PHYSIOL, V207, P757, DOI 10.1002/jcp.20621; Huang KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043874; Hui S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138142; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kataoka H, 2005, CELL MOL IMMUNOL, V2, P439; Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Ohmori T, 2003, CARDIOVASC RES, V58, P170, DOI 10.1016/S0008-6363(03)00260-8; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Salomone S, 2008, BRIT J PHARMACOL, V153, P140, DOI 10.1038/sj.bjp.0707581; Samarska IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097196; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Spijkers LJA, 2012, BRIT J PHARMACOL, V166, P1411, DOI 10.1111/j.1476-5381.2012.01865.x; Spijkers LJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021817; Vavrinec P, 2011, J RENIN-ANGIO-ALDO S, V12, P184, DOI 10.1177/1470320310391328; Volzke A, 2014, BBA-MOL CELL BIOL L, V1841, P11, DOI 10.1016/j.bbalip.2013.09.009; Wang F, 2010, J CLIN INVEST, V120, P3979, DOI 10.1172/JCI42315; Zimmer J, 2016, PEDIATR SURG INT, V32, P147, DOI 10.1007/s00383-015-3825-6	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162029	10.1371/journal.pone.0162029	http://dx.doi.org/10.1371/journal.pone.0162029			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583547	gold, Green Published, Green Submitted			2022-12-27	WOS:000382855600089
J	Ushiki, T; Huntington, ND; Glaser, SP; Kiu, H; Georgiou, A; Zhang, JG; Metcalf, D; Nicola, NA; Roberts, AW; Alexander, WS				Ushiki, Takashi; Huntington, Nicholas D.; Glaser, Stefan P.; Kiu, Hiu; Georgiou, Angela; Zhang, Jian-Guo; Metcalf, Donald; Nicola, Nicos A.; Roberts, Andrew W.; Alexander, Warren S.			Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells	PLOS ONE			English	Article							CYTOKINE SIGNALING SOCS; IN-VITRO; T-CELLS; SUPPRESSOR; INHIBITION; LETHALITY; PATHWAYS; PROTEINS; ABSENCE; VIVO	The Suppressors of Cytokine Signalling (SOCS) proteins are negative regulators of cytokine signalling required to prevent excess cellular responses. SOCS1 and SOCS3 are essential to prevent inflammatory disease, SOCS1 by attenuating responses to IFN gamma and gamma-common (gamma c) cytokines, and SOCS3 via regulation of G-CSF and IL-6 signalling. SOCS1 and SOCS3 show significant sequence homology and are the only SOCS proteins to possess a KIR domain. The possibility of overlapping or redundant functions was investigated in inflammatory disease via generation of mice lacking both SOCS1 and SOCS3 in hematopoietic cells. Loss of SOCS3 significantly accelerated the pathology and inflammatory disease characteristic of SOCS1 deficiency. We propose a model in which SOCS1 and SOCS3 operate independently to control specific cytokine responses and together modulate the proliferation and activation of lymphoid and myeloid cells to prevent rapid inflammatory disease.	[Ushiki, Takashi; Glaser, Stefan P.; Kiu, Hiu; Georgiou, Angela; Zhang, Jian-Guo; Metcalf, Donald; Nicola, Nicos A.; Roberts, Andrew W.; Alexander, Warren S.] Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic, Australia; [Huntington, Nicholas D.] Walter & Eliza Hall Inst Med Res, Mol Immunol Div, Parkville, Vic, Australia; [Ushiki, Takashi] Niigata Univ, Div Transfus & Regenerat Med, Med & Dent Hosp, Niigata, Japan; [Huntington, Nicholas D.; Glaser, Stefan P.; Zhang, Jian-Guo; Metcalf, Donald; Nicola, Nicos A.; Roberts, Andrew W.; Alexander, Warren S.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Niigata University; University of Melbourne	Alexander, WS (corresponding author), Walter & Eliza Hall Inst Med Res, Canc & Haematol Div, Parkville, Vic, Australia.; Alexander, WS (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	alexandw@wehi.edu.au	Roberts, Andrew W./C-6736-2012; Huntington, NICHOLAS/AAV-4704-2020	Roberts, Andrew W./0000-0002-7341-5720; Huntington, NICHOLAS/0000-0002-5267-7211	Australian National Health and Medical Research Council (NHMRC) [361646, 1016647, 1058344, 0461276, 1078737, 637309, 1079560]; Victorian State Government Operational Infrastructure Support Grant; Australia Cancer Research Fund	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support Grant; Australia Cancer Research Fund	This work was supported by a Program Grant (1016647), Fellowships (WSA:1058344, NDH:0461276, NAN:1078737, AWR:637309, 1079560) and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council (NHMRC, https://www.nhmrc.gov.au), a Victorian State Government Operational Infrastructure Support Grant and the Australia Cancer Research Fund (https://acrf.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed CMI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00183; Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; CHERVENICK PA, 1968, AM J PHYSIOL, V215, P353, DOI 10.1152/ajplegacy.1968.215.2.353; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Cornish AL, 2003, J IMMUNOL, V170, P878, DOI 10.4049/jimmunol.170.2.878; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2012, IMMUNOL CELL BIOL, V90, P124, DOI 10.1038/icb.2011.29; Croom HA, 2008, MOL IMMUNOL, V45, P2888, DOI 10.1016/j.molimm.2008.01.024; Davey GM, 2005, J EXP MED, V202, P1099, DOI 10.1084/jem.20050003; Kershaw NJ, 2013, BIOCHEM SOC T, V41, P1042, DOI 10.1042/BST20130077; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Kiu H, 2007, GROWTH FACTORS, V25, P319, DOI 10.1080/08977190701830151; Kiu H, 2009, GROWTH FACTORS, V27, P384, DOI 10.3109/08977190903210954; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Metcalf D, 2002, P NATL ACAD SCI USA, V99, P943, DOI 10.1073/pnas.022628499; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Takahashi R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/943149; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Ushiki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011114; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200	27	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162111	10.1371/journal.pone.0162111	http://dx.doi.org/10.1371/journal.pone.0162111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583437	Green Published, gold			2022-12-27	WOS:000382855600106
J	Wermuth, PJ; Li, ZD; Mendoza, FA; Jimenez, SA				Wermuth, Peter J.; Li, Zhaodong; Mendoza, Fabian A.; Jimenez, Sergio A.			Stimulation of Transforming Growth Factor-beta 1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; FACTOR-BETA; SYSTEMIC-SCLEROSIS; TGF-BETA; CARDIAC FIBROSIS; FIBROTIC DISEASES; FACTOR EXPRESSION; LUNG FIBROBLASTS; KIDNEY FIBROSIS; IN-VITRO	TGF-beta-induced endothelial-to-mesenchymal transition (EndoMT) is a newly recognized source of profibrotic activated myofibroblasts and has been suggested to play a role in the pathogenesis of various fibrotic processes. Endothelin-1 (ET-1) has been implicated in the development of tissue fibrosis but its participation in TGF-beta-induced EndoMT has not been studied. Here we evaluated the role of ET-1 on TGF-beta 1-induced EndoMT in immunopurified CD31(+)/CD102(+) murine lung microvascular endothelial cells. The expression levels of alpha-smooth muscle actin (alpha-SMA), of relevant profibrotic genes, and of various transcription factors involved in the EndoMT process were assessed employing quantitative RT-PCR, immunofluorescence histology and Western blot analysis. TGF-beta 1 caused potent induction of EndoMT whereas ET-1 alone had a minimal effect. However, ET-1 potentiated TGF-beta 1-induced EndoMT and TGF-beta 1-stimulated expression of mesenchymal cell specific and profibrotic genes and proteins. ET-1 also induced expression of the TGF-beta receptor 1 and 2 genes, suggesting a plausible autocrine mechanism to potentiate TGF-beta-mediated EndoMT and fibrosis. Stimulation of TGF-beta 1-induced skin and lung fibrosis by ET-1 was confirmed in vivo in an animal model of TGF-beta 1-induced tissue fibrosis. These results suggest a novel role for ET-1 in the establishment and progression of tissue fibrosis.	[Wermuth, Peter J.; Li, Zhaodong; Jimenez, Sergio A.] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; [Mendoza, Fabian A.] Thomas Jefferson Univ, Div Rheumatol, Dept Med, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Jimenez, SA (corresponding author), Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA.	Sergio.jimenez@jefferson.edu		Wermuth, Peter/0000-0002-0242-7265; Jimenez, Sergio/0000-0001-5213-1203	National Institutes of Health [AR19616]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by AR19616 National Institutes of Health www.nih.gov SAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham David, 2005, Current Vascular Pharmacology, V3, P369; Arciniegas E, 2005, ENDOTHELIUM-J ENDOTH, V12, P193, DOI 10.1080/10623320500227283; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chester Adrian H, 2014, Glob Cardiol Sci Pract, V2014, P62, DOI 10.5339/gcsp.2014.29; Cipriani P, 2015, J RHEUMATOL, V42, P1808, DOI 10.3899/jrheum.150088; Cutolo M, 2015, J RHEUMATOL, V42, P456, DOI 10.3899/jrheum.141070; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; Good RB, 2015, AM J PATHOL, V185, P1850, DOI 10.1016/j.ajpath.2015.03.019; Goumans MJ, 2008, TRENDS CARDIOVAS MED, V18, P293, DOI 10.1016/j.tcm.2009.01.001; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; Jimenez SA, 2016, MATRIX BIOL, V51, P26, DOI 10.1016/j.matbio.2016.01.012; Jing J, 2015, EUR CYTOKINE NETW, V26, P10, DOI 10.1684/ecn.2015.0360; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lagares D, 2010, ARTHRITIS RHEUM-US, V62, P878, DOI 10.1002/art.27307; Lambers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073399; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Li JH, 2010, NEPHROLOGY, V15, P507, DOI 10.1111/j.1440-1797.2010.01319.x; Li MR, 2016, EXP BIOL MED, V241, P1, DOI 10.1177/1535370215597194; Li ZD, 2013, AM J PATHOL, V182, P325, DOI 10.1016/j.ajpath.2012.10.022; Li ZD, 2011, ARTHRITIS RHEUM-US, V63, P2473, DOI 10.1002/art.30317; Makino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097972; Manne J, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/436053; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; MASAKI T, 1989, J CARDIOVASC PHARM, V13, pS1, DOI 10.1097/00005344-198900135-00002; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Medici D, 2001, BIOCHEM J, V437, P515; Mendoza FA, 2016, ARTHRITIS RHEUMATOL, V68, P210, DOI 10.1002/art.39421; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Piera-Velazquez S, 2016, J CLIN MED, V5, DOI 10.3390/jcm5040045; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Postlethwaite AE, 2004, CURR OPIN RHEUMATOL, V16, P733, DOI 10.1097/01.bor.0000139310.77347.9c; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; Rieder F, 2011, AM J PATHOL, V179, P2660, DOI 10.1016/j.ajpath.2011.07.042; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Rodriguez-Pascual F, 2014, LIFE SCI, V118, P156, DOI 10.1016/j.lfs.2013.12.024; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shephard P, 2004, THROMB HAEMOSTASIS, V92, P262, DOI 10.1160/TH03-11-0669; Simonson MS, 2011, J BIOL CHEM, V286, P11003, DOI 10.1074/jbc.M110.190793; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Swigris JJ, 2010, BIODRUGS, V24, P49, DOI 10.2165/11319550-000000000-00000; ten Dijke P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002722; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Meeteren LA, 2012, CELL TISSUE RES, V347, P177, DOI 10.1007/s00441-011-1222-6; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Weng CM, 2014, BIOCHEM PHARMACOL, V88, P402, DOI 10.1016/j.bcp.2014.01.030; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	63	57	58	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161988	10.1371/journal.pone.0161988	http://dx.doi.org/10.1371/journal.pone.0161988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583804	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600081
J	Zhu, H; Wang, NJ; Han, B; Li, Q; Chen, Y; Zhu, CF; Chen, YC; Xia, FZ; Cang, Z; Lu, M; Chen, C; Lin, DP; Lu, YL				Zhu, Hui; Wang, Ningjian; Han, Bing; Li, Qin; Chen, Yi; Zhu, Chunfang; Chen, Yingchao; Xia, Fangzhen; Cang, Zhen; Lu, Meng; Chen, Chi; Lin, Dongping; Lu, Yingli			Low Sex Hormone-Binding Globulin Levels Associate with Prediabetes in Chinese Men Independent of Total Testosterone	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; RISK-FACTORS; METABOLIC SYNDROME; OBESE MEN; WOMEN; PREVALENCE; INSULIN; GLUCOSE; HYPOGONADISM; PREDICTOR	Objective The association ns between prediabetes and androgens have been rarely reported, especially in Chinese men. We aimed to investigate whether androgens were associated with the prevalence of prediabetes diagnosed with new American Diabetes Association criteria in Chinese men and then to assess which androgen value was the most relevant factor. Methods A total of 2654 men (52.6 +/- 13.4 years old) were selected. Serum total testosterone (TT), sex hormone-binding globulin (SHBG) and free testosterone (FT) were measured. Covariance analysis of different androgen values were performed in age subgroups. Multinomial logistic regression was used for the association of TT, SHBG and FT with prediabetes and diabetes, as well as prediabetes in age subgroups. Results According to ADA new criteria, normoglycemia, prediabetes, and diabetes were diagnosed in 1405, 907 and 342 men, respectively. In covariance analysis, SHBG of prediabetes were found lower than that of normoglycemia but higher than that of diabetes (P <0.05). In multi-nomial logistic regression, serum TT and SHBG were inversely associated with prediabetes and diabetes. While, after full adjustment for age, residence area, economic status, waist circumference, metabolic factors, other two androgen values and HOMA-IR, only the associations of SHBG with prevalence of prediabetes and diabetes persisted statistically significant, especially in the elderly with prediabetes (all P for trend <0.05). Conclusions Serum androgen was inversely associated with prediabetes and diabetes in Chinese men. Low serum SHBG was the most relevant factor for prediabetes and diabetes. Whether it is an independent predictor for incident prediabetes in Chinese men needs further explorations.	[Zhu, Hui; Wang, Ningjian; Han, Bing; Li, Qin; Chen, Yi; Zhu, Chunfang; Chen, Yingchao; Xia, Fangzhen; Cang, Zhen; Lu, Meng; Chen, Chi; Lin, Dongping; Lu, Yingli] Shanghai Jiao Tong Univ, Sch Med, Inst & Dept Endocrinol & Metab, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University	Lu, YL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst & Dept Endocrinol & Metab, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China.	luyingli2008@126.com						Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Botella-Carretero JI, 2013, J ENDOCRINOL INVEST, V36, P227, DOI 10.3275/8469; Brambilla DJ, 2007, CLIN ENDOCRINOL, V67, P853, DOI 10.1111/j.1365-2265.2007.02976.x; Brand JS, 2011, CLIN ENDOCRINOL, V74, P572, DOI 10.1111/j.1365-2265.2010.03951.x; Cavalot F, 2006, J CLIN ENDOCR METAB, V91, P813, DOI 10.1210/jc.2005-1005; Corona G, 2011, INT J ANDROL, V34, P528, DOI 10.1111/j.1365-2605.2010.01117.x; Ding EL, 2007, DIABETOLOGIA, V50, P2076, DOI 10.1007/s00125-007-0785-y; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Farias JM, 2014, J CLIN ENDOCR METAB, V99, P4698, DOI 10.1210/jc.2014-2585; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Haider A, 2014, OBES RES CLIN PRACT, V8, pE339, DOI 10.1016/j.orcp.2013.10.005; Ho CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074173; Kalyani RR, 2009, J CLIN ENDOCR METAB, V94, P4127, DOI 10.1210/jc.2009-0910; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lakshman KM, 2010, J GERONTOL A-BIOL, V65, P503, DOI 10.1093/gerona/glq002; Le TN, 2012, TRENDS ENDOCRIN MET, V23, P32, DOI 10.1016/j.tem.2011.09.005; NIELSEN J, 1969, J CLIN ENDOCR METAB, V29, P1062, DOI 10.1210/jcem-29-8-1062; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; Rabijewski M, 2014, AGING MALE, V17, P141, DOI 10.3109/13685538.2014.936000; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Salminen M, 2015, GERIATR GERONTOL INT, V15, P559, DOI 10.1111/ggi.12312; Saukkonen T, 2011, DIABETES CARE, V34, P2314, DOI 10.2337/dc11-0183; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Simo R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Stefan N, 2009, NEW ENGL J MED, V361, P2675, DOI 10.1056/NEJMc0910143; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tanabe M, 2014, ENDOCR J; Vikan T, 2010, EUR J ENDOCRINOL, V162, P747, DOI 10.1530/EJE-09-0943; Wang C, 2011, DIABETES CARE, V34, P1669, DOI 10.2337/dc10-2339; Wang N, 2015, ACTA DIABETOL, V12, P12; Xu L, 2014, AM J HUM BIOL, V26, P99, DOI 10.1002/ajhb.22482; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zarotsky V, 2014, ANDROLOGY-US, V2, P819, DOI 10.1111/andr.274	40	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162004	10.1371/journal.pone.0162004	http://dx.doi.org/10.1371/journal.pone.0162004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583401	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600085
J	Hajian, B; Scocchera, E; Keshipeddy, S; G-Dayanandan, N; Shoen, C; Krucinska, J; Reeve, S; Cynamon, M; Anderson, AC; Wright, DL				Hajian, Behnoush; Scocchera, Eric; Keshipeddy, Santosh; G-Dayanandan, Narendran; Shoen, Carolyn; Krucinska, Jolanta; Reeve, Stephanie; Cynamon, Michael; Anderson, Amy C.; Wright, Dennis L.			Propargyl-Linked Antifolates Are Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							DIHYDROFOLATE-REDUCTASE; CRYSTAL-STRUCTURES; CANDIDA-ALBICANS; REVEAL; LOPINAVIR/RITONAVIR; PERMEABILITY; MECHANISMS; FEATURES; DESIGN; TOOL	Mycobacterium tuberculosis continues to cause widespread, life-threatening disease. In the last decade, this threat has grown dramatically as multi-and extensively-drug resistant (MDR and XDR) bacteria have spread globally and the number of agents that effectively treat these infections is significantly reduced. We have been developing the propargyl-linked antifolates (PLAs) as potent inhibitors of the essential enzyme dihydrofolate reductase (DHFR) from bacteria and recently found that charged PLAs with partial zwitterionic character showed improved mycobacterial cell permeability. Building on a hypothesis that these PLAs may penetrate the outer membrane of M. tuberculosis and inhibit the essential cytoplasmic DHFR, we screened a group of PLAs for antitubercular activity. In this work, we identified several PLAs as potent inhibitors of the growth of M. tuberculosis with several of the compounds exhibiting minimum inhibition concentrations equal to or less than 1 mu g/mL. Furthermore, two of the compounds were very potent inhibitors of MDR and XDR strains. A high resolution crystal structure of one PLA bound to DHFR from M. tuberculosis reveals the interactions of the ligands with the target enzyme.	[Hajian, Behnoush; Scocchera, Eric; Keshipeddy, Santosh; G-Dayanandan, Narendran; Krucinska, Jolanta; Reeve, Stephanie; Anderson, Amy C.; Wright, Dennis L.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Shoen, Carolyn; Cynamon, Michael] Vet Affairs Med Ctr, Syracuse, NY USA	University of Connecticut; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Anderson, AC; Wright, DL (corresponding author), Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	amy.anderson@uconn.edu; dennis.wright@uconn.edu	Reeve, Stephanie/P-9563-2018; Reeve, Stephanie/AAX-8449-2020	Reeve, Stephanie/0000-0003-2064-405X; Reeve, Stephanie/0000-0003-2064-405X; Wright, Dennis/0000-0003-4634-3351	National Institutes of Health [AI104841, AI111957]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111957, R01AI104841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI104841 and AI111957 to ACA and DLW, https://projectreporter.nih.gov/project_info_description.cfm?aid=8960331&icde=29395386&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC, https://projectreporter.nih.gov/project_info_description.cfm?aid=8997401&icde=29395386&ddparam=& ddvalue=&ddsub=& cr=csb=default&cs=ASC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balasubramanian V, 2014, ANTIMICROB AGENTS CH, V58, P495, DOI 10.1128/AAC.01903-13; Cipriani P, 2014, EXPERT REV CLIN IMMU, V10, P1519, DOI 10.1586/1744666X.2014.962996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey KM, 2012, ANTIMICROB AGENTS CH, V56, P3556, DOI 10.1128/AAC.06263-11; Frey KM, 2010, J STRUCT BIOL, V170, P93, DOI 10.1016/j.jsb.2009.12.011; Frey KM, 2009, J MOL BIOL, V387, P1298, DOI 10.1016/j.jmb.2009.02.045; G-Dayanandan N, 2014, J MED CHEM, V57, P2643, DOI 10.1021/jm401916j; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gillespie SH, 2002, ANTIMICROB AGENTS CH, V46, P267, DOI 10.1128/AAC.46.2.267-274.2002; Hagner Nicole, 2010, Cancer Manag Res, V2, P293, DOI 10.2147/CMR.S10043; Hong W, 2015, SCI REPORTS, V5, P1; Keshipeddy S, 2015, J AM CHEM SOC, V137, P8983, DOI 10.1021/jacs.5b01442; Khachi H, 2009, J ANTIMICROB CHEMOTH, V64, P871, DOI 10.1093/jac/dkp263; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kumar A, 2015, ACS INFECT DIS, V1, P604, DOI 10.1021/acsinfecdis.5b00063; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039961; L'homme RFA, 2009, AIDS, V23, P863, DOI 10.1097/QAD.0b013e328329148e; Lamb KM, 2014, ANTIMICROB AGENTS CH, V58, P7484, DOI 10.1128/AAC.03555-14; Lamb KM, 2013, BIOCHEMISTRY-US, V52, P7318, DOI 10.1021/bi400852h; Lee SH, 2013, MOLECULES, V18, P13870, DOI 10.3390/molecules181113870; Lele AC, 2015, ACS MED CHEM LETT, V6, P1140, DOI 10.1021/acsmedchemlett.5b00367; Li RB, 2000, J MOL BIOL, V295, P307, DOI 10.1006/jmbi.1999.3328; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lombardo M, 2015, ACS INF DIS; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Merget B, 2013, BIOINFORMATICS, V29, P62, DOI 10.1093/bioinformatics/bts641; Nixon MR, 2014, CHEM BIOL, V21, P819, DOI 10.1016/j.chembiol.2014.04.009; Paulsen JL, 2013, BIOORG MED CHEM LETT, V23, P1279, DOI 10.1016/j.bmcl.2013.01.008; Paulsen JL, 2011, CHEM BIOL DRUG DES, V78, P505, DOI 10.1111/j.1747-0285.2011.01169.x; Ruslami R, 2010, ANTIMICROB AGENTS CH, V54, P1068, DOI 10.1128/AAC.00447-09; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scocchera E, 2016, ACS MED CHEM LETT, V7, P692, DOI 10.1021/acsmedchemlett.6b00120; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029434; Zhou WD, 2013, MEDCHEMCOMM, V4, P908, DOI 10.1039/c3md00104k	41	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161740	10.1371/journal.pone.0161740	http://dx.doi.org/10.1371/journal.pone.0161740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580226	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400039
J	Kam, CCS; Zhou, MM				Kam, Chester Chun Seng; Zhou, Mingming			Is the Dark Triad Better Studied Using a Variable- or a Person-Centered Approach? An Exploratory Investigation	PLOS ONE			English	Article							TAXOMETRIC ANALYSIS; MIXTURE-MODELS; PSYCHOPATHY; TRAITS; SUBTYPES; MACHIAVELLIANISM; PERSONALITIES; NARCISSISM; DIMENSIONALITY; SENSITIVITY	Despite Allport's early call to study personality as a coordinated system of traits within individual rather than separate traits, researchers often assume personality variables are largely distinct, independent characteristics. In the current research, we examined the usual assumption that Dark Triad traits (narcissism, psychopathy, and Machiavellianism) are best studied using a variable-centered (dimensional), rather than a person-centered (taxonic), approach. Results showed that a variable-centered approach is appropriate in understanding the Dark Triad, and yet individuals scoring high on one Dark Triad dimension also tend to score high on other dimensions. Based on these results, we concluded that it is appropriate to study individual differences in the Dark Triad (inferences based on persons) by capturing the common variance among the three traits using a variable-centered approach, rather than treating these traits as independent or uncoordinated characteristics.	[Kam, Chester Chun Seng; Zhou, Mingming] Univ Macau, Taipa, Macau, Peoples R China; [Kam, Chester Chun Seng] Univ Western Ontario, London, ON, Canada	University of Macau; Western University (University of Western Ontario)	Kam, CCS (corresponding author), Univ Macau, Taipa, Macau, Peoples R China.; Kam, CCS (corresponding author), Univ Western Ontario, London, ON, Canada.	ChesterKam@umac.mo			University of Macau under Multi-Year Research Grant [MYRG2015-00076-FED]	University of Macau under Multi-Year Research Grant	This study was supported by the University of Macau funding to Chester Chun Seng Kam under Multi-Year Research Grant (MYRG2015-00076-FED). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AO, 2015, SCHIZOPHRENIA BULL, V41, P879, DOI 10.1093/schbul/sbu163; Allport G. W., 1961, PATTERN GROWTH PERSO; Allport G. W., 1937, PERSONALITY PSYCHOL; Asendorpf JB, 2005, HDB PERSONALITY PROC; Bakk Z, 2016, STRUCT EQU MODELING, V23, P20, DOI 10.1080/10705511.2014.955104; Bauer DJ, 2007, MULTIVAR BEHAV RES, V42, P757, DOI 10.1080/00273170701710338; Bauer DJ., 2007, MODELING CONTEXTUAL, P255; Baughman HM, 2012, PERS INDIV DIFFER, V52, P571, DOI 10.1016/j.paid.2011.11.020; Blair R. J., 2008, PSYCHOPATHY RUTTERS, VFifth, P852; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Buckels EE, 2014, PERS INDIV DIFFER, V67, P97, DOI 10.1016/j.paid.2014.01.016; Buckels EE, 2013, PSYCHOL SCI, V24, P2201, DOI 10.1177/0956797613490749; Campbell WK, 2007, FRONT SOC PSYCHOL, P115; Chabrol H, 2015, PERS INDIV DIFFER, V83, P97, DOI 10.1016/j.paid.2015.03.051; Christie R., 1970, STUDIES MACHIAVELLIA; Clark SL, 2013, STRUCT EQU MODELING, V20, P681, DOI 10.1080/10705511.2013.824786; De Boeck P, 2005, PSYCHOL REV, V112, P129, DOI 10.1037/0033-295X.112.1.129; Dickinson KA, 2003, J PERS DISORD, V17, P188, DOI 10.1521/pedi.17.3.188.22146; Egan V, 2014, PERS INDIV DIFFER, V67, P17, DOI 10.1016/j.paid.2014.01.004; Falkenbach D, 2008, PERS INDIV DIFFER, V44, P821, DOI 10.1016/j.paid.2007.10.012; Falkenbach DM, 2014, PERSONAL DISORD, V5, P10, DOI 10.1037/per0000021; Foster JD, 2007, PERS INDIV DIFFER, V43, P1321, DOI 10.1016/j.paid.2007.04.003; Furnham A, 2013, SOC PERSONAL PSYCHOL, V7, P199, DOI 10.1111/spc3.12018; Gibb ZG, 2014, COMPUT HUM BEHAV, V38, P8, DOI 10.1016/j.chb.2014.05.009; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Guay JP, 2007, J ABNORM PSYCHOL, V116, P701, DOI 10.1037/0021-843X.116.4.701; Gunnthorsdottir A, 2002, J ECON PSYCHOL, V23, P49, DOI 10.1016/S0167-4870(01)00067-8; Hare R. D., 1993, CONSCIENCE DISTURBIN; HARRIS GT, 1994, J CONSULT CLIN PSYCH, V62, P387, DOI 10.1037/0022-006X.62.2.387; He J, 2015, CROSS CULT ADV POSIT, V11, P189, DOI 10.1007/978-94-017-9415-2_14; Henson JM, 2007, STRUCT EQU MODELING, V14, P202, DOI 10.1080/10705510709336744; Hicks BM, 2004, PSYCHOL ASSESSMENT, V16, P276, DOI 10.1037/1040-3590.16.3.276; Hodson G, 2009, J RES PERS, V43, P686, DOI 10.1016/j.jrp.2009.02.005; Holtzman NS, 2013, SOC PSYCHOL PERS SCI, V4, P461, DOI 10.1177/1948550612461284; Holtzman NS, 2010, J RES PERS, V44, P478, DOI 10.1016/j.jrp.2010.06.001; Holtzman NS, 2010, J RES PERS, V44, P133, DOI 10.1016/j.jrp.2009.10.004; Jakobwitz S, 2006, PERS INDIV DIFFER, V40, P331, DOI 10.1016/j.paid.2005.07.006; Jonason P.K., 2010, INDIVIDUAL DIFFERENC, V8, P111; Jonason PK, 2016, PERS INDIV DIFFER, V90, P273, DOI 10.1016/j.paid.2015.11.023; Jonason PK, 2012, REV GEN PSYCHOL, V16, P192, DOI 10.1037/a0027914; Jonason PK, 2010, PERS INDIV DIFFER, V49, P606, DOI 10.1016/j.paid.2010.05.030; Jonason PK, 2010, PSYCHOL ASSESSMENT, V22, P420, DOI 10.1037/a0019265; Jonason PK, 2009, EUR J PERSONALITY, V23, P5, DOI 10.1002/per.698; Jones DN, 2014, ASSESSMENT, V21, P28, DOI 10.1177/1073191113514105; Jones DN, 2013, EUR J PERSONALITY, V27, P521, DOI 10.1002/per.1893; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kajonius PJ, 2015, PERS INDIV DIFFER, V77, P173, DOI 10.1016/j.paid.2014.12.055; Kam C, 2016, J MANAGE, V42, P1462, DOI 10.1177/0149206313503010; Kam CCS, 2015, ORGAN RES METHODS, V18, P512, DOI 10.1177/1094428115571894; Lee K, 2013, EUR J PERSONALITY, V27, P169, DOI 10.1002/per.1860; Lubke G, 2007, STRUCT EQU MODELING, V14, P26, DOI 10.1207/s15328007sem1401_2; Magnusson D, 2003, NEW DIR CHILD ADOLES, V101, P3, DOI 10.1002/cd.79; Marsh AA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00181; Martin RA, 2012, PERS INDIV DIFFER, V52, P178, DOI 10.1016/j.paid.2011.10.010; McLarnon MJW, 2015, J CAREER ASSESSMENT, V23, P166, DOI 10.1177/1069072714523251; Meehl P. E., 1982, HDB RES METHODS CLIN, P127; Morin AJS, 2011, MULTIVAR BEHAV RES, V46, P157, DOI 10.1080/00273171.2010.546731; Muthun, NEW DEV TECHNIQUES S, P1; Nagin DS, 2010, HANDBOOK OF QUANTITATIVE CRIMINOLOGY, P53, DOI 10.1007/978-0-387-77650-7_4; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; PATRICK CJ, 1994, PSYCHOPHYSIOLOGY, V31, P319, DOI 10.1111/j.1469-8986.1994.tb02440.x; Paulhus D., 2011, M SOC PERS SOC PSYCH; Paulhus DL, 2014, CURR DIR PSYCHOL SCI, V23, P421, DOI 10.1177/0963721414547737; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; RASKIN R, 1991, J CLIN PSYCHOL, V47, P490, DOI 10.1002/1097-4679(199107)47:4<490::AID-JCLP2270470404>3.0.CO;2-J; Russ E, 2008, AM J PSYCHIAT, V165, P1473, DOI 10.1176/appi.ajp.2008.07030376; RYCKMAN RM, 1994, J PERS ASSESS, V62, P84, DOI 10.1207/s15327752jpa6201_8; Schneider TJ, 2015, PERS INDIV DIFFER, V73, P78, DOI 10.1016/j.paid.2014.09.026; Skeem J, 2007, J ABNORM PSYCHOL, V116, P395, DOI 10.1037/0021-843X.116.2.395; Trull TJ, 2005, ANNU REV CLIN PSYCHO, V1, P355, DOI 10.1146/annurev.clinpsy.1.102803.144009; Turner K, 2008, CRIM JUSTICE BEHAV, V35, P879, DOI 10.1177/0093854808318922; Turnipseed DL, 2015, PERS INDIV DIFFER, V82, P72, DOI 10.1016/j.paid.2015.03.003; VECCHIO RP, 1991, J ORGAN BEHAV, V12, P73, DOI 10.1002/job.4030120107; Vernon PA, 2008, PERS INDIV DIFFER, V44, P445, DOI 10.1016/j.paid.2007.09.007; Wilson DS, 1996, PSYCHOL BULL, V119, P285, DOI 10.1037/0033-2909.119.2.285; Woodley HJR, 2014, PERS INDIV DIFFER, V67, P103, DOI 10.1016/j.paid.2014.03.003; Zyphur MJ, 2009, ACAD MANAGE REV, V34, P677, DOI 10.5465/AMR.2009.44885862	81	14	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161628	10.1371/journal.pone.0161628	http://dx.doi.org/10.1371/journal.pone.0161628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27580224	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400032
J	Bzdega, K; Janlak, A; Kslazczyk, T; Lewandowska, A; Gancarek, M; Sliwinska, E; Tokarska-Guzik, B				Bzdega, Katarzyna; Janlak, Agnieszka; Kslazczyk, Tomasz; Lewandowska, Agata; Gancarek, Malgorzata; Sliwinska, Elwira; Tokarska-Guzik, Barbara			A Survey of Genetic Variation and Genome Evolution within the Invasive Fallopia Complex	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; POLYMORPHISM AFLP MARKERS; SEX-CHROMOSOME SYSTEM; HOUTT. RONSE DECR.; POLYGONACEAE COMPLEX; SPP. POLYGONACEAE; MULTIPLE SOURCES; BRASSICA-NAPUS; CENTRAL-EUROPE; DNA-SEQUENCES	The knotweed taxa Fallopia japonica, F. sachalinensis and their interspecific hybrid F. x bohemica are some of the most aggressive invaders in Europe and North America and they are serious threats to native biodiversity. At the same time, they constitute a unique model system for the creation of hybrids and studies of the initiation of evolutionary processes. In the presented study, we focused on (i) examining genetic diversity in selected populations of three Fallopia taxa in the invaded (Poland) and native ranges (Japan), (ii) establishing genome size and ploidy levels and (iii) identifying ribosomal DNA (rDNA)-bearing chromosomes in all of the taxa from the invaded range. We found that the genetic diversity within particular taxa was generally low regardless of their geographical origin. A higher level of clonality was observed for the Polish populations compared to the Japanese populations. Our study suggests that the co-occurrence of F. sachalinensis together with the other two taxa in the same stand may be the source of the higher genetic variation within the F. x bohemica hybrid. Some shift towards the contribution of F. japonica alleles was also observed for selected F. x bohemica individuals, which indicates the possibility of producing more advanced generations of F. x bohemica hybrids. All of the F. sachalinensis individuals were hexaploid (2n = 6x = 66; 2C = 6.01 pg), while those of F. japonica were mostly octoploid (2n = 8x = 88; 2C = 8.87 pg) and all of the F. x bohemica plants except one were hexaploid (2n = 6x = 66; 2C = 6.46 pg). Within the chromosome complement of F. japonica, F. sachalinensis and F. x bohemica, the physical mapping of the rDNA loci provided markers for 16, 13 and 10 chromosomes, respectively. In F. x bohemica, a loss of some of rDNA loci was observed, which indicates the occurrence of genome changes in the hybrid.	[Bzdega, Katarzyna; Lewandowska, Agata; Gancarek, Malgorzata; Tokarska-Guzik, Barbara] Univ Silesia, Dept Bot & Nat Protect, Katowice, Poland; [Janlak, Agnieszka] Univ Silesia, Dept Genet, Katowice, Poland; [Kslazczyk, Tomasz] Polish Acad Sci, Inst Plant Genet, Dept Environm Stress Biol, Poznan, Poland; [Sliwinska, Elwira] UTP Univ Sci & Technol, Dept Plant Genet Physiol & Biotechnol, Bydgoszcz, Poland	University of Silesia in Katowice; University of Silesia in Katowice; Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; Bydgoszcz University of Science & Technology	Bzdega, K (corresponding author), Univ Silesia, Dept Bot & Nat Protect, Katowice, Poland.	katarzyna.bzdega@us.edu.pl	Tokarska-Guzik, Barbara/L-8891-2019; Sliwinska, Elwira K/J-3920-2019	Sliwinska, Elwira K/0000-0001-6597-5309; Tokarska-Guzik, Barbara/0000-0002-4058-1220; Bzdega, Katarzyna/0000-0002-4603-2847; Janiak, Agnieszka/0000-0003-0225-7216	Ministry of Science and Higher Education, Poland [N N305 384738]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by N N305 384738 of 2010-2014, Ministry of Science and Higher Education, Poland, http://www.nauka.gov.pl/en/.	Amsellem L, 2000, MOL ECOL, V9, P443, DOI 10.1046/j.1365-294x.2000.00876.x; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Bailey J, 2013, HEREDITY, V110, P105, DOI 10.1038/hdy.2012.98; Bailey J, 2003, PLANT INVASIONS: ECOLOGICAL THREATS AND MANAGEMENT SOLUTIONS, P183; Bailey J. P., 2000, Watsonia, V23, P93; Bailey JP, 2007, ECOL RES, V22, P920, DOI 10.1007/s11284-007-0419-3; Bailey JP, 2009, BIOL INVASIONS, V11, P1189, DOI 10.1007/s10530-008-9381-4; BAILEY JP, 1992, PLANT SYST EVOL, V180, P29, DOI 10.1007/BF00940396; Barney JN, 2006, CAN J PLANT SCI, V86, P887, DOI 10.4141/P05-170; BEERLING DJ, 1994, J ECOL, V82, P959, DOI 10.2307/2261459; Blocka-Wandas M, 2007, SEX PLANT REPROD, V20, P171, DOI 10.1007/s00497-007-0053-9; Buhk C, 2015, PERSPECT PLANT ECOL, V17, P274, DOI 10.1016/j.ppees.2015.05.001; Bzdega K, 2012, FLORA, V207, P636, DOI 10.1016/j.flora.2012.05.002; CHILD L, 2000, JAPANESE KNOTWEED MA; Choi JH, 2000, BIOINFORMATICS, V16, P1056, DOI 10.1093/bioinformatics/16.11.1056; Chrtek J., 1983, CASOPIS NARODNIHO MU, V152, P120; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; Dlugosch KM, 2008, MOL ECOL, V17, P4583, DOI 10.1111/j.1365-294X.2008.03932.x; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Doyle J. J., 1987, PHYTOCHEM B, P11; Du ZY, 2009, AQUAT BOT, V91, P47, DOI 10.1016/j.aquabot.2009.02.006; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; EXCOFFIER L, 1992, GENETICS, V131, P479; Fukui S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116111; Gammon MA, 2007, AM J BOT, V94, P948, DOI 10.3732/ajb.94.6.948; Garcia S, 2009, CHROMOSOMA, V118, P85, DOI 10.1007/s00412-008-0179-z; Gaskin JF, 2014, BIOL INVASIONS, V16, P2127, DOI 10.1007/s10530-014-0652-y; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Gibbs Russell G. E., 1987, BOT SURV S AFRICA 1, V2, P1; Grabowska-Joachimiak A, 2015, CHROMOSOME RES, V23, P187, DOI 10.1007/s10577-014-9446-4; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Hasterok R, 2006, ANN BOT-LONDON, V97, P205, DOI 10.1093/aob/mcj031; Henry P, 2009, MOL ECOL, V18, P2819, DOI 10.1111/j.1365-294X.2009.04237.x; Hollingsworth ML, 1998, MOL ECOL, V7, P1681, DOI 10.1046/j.1365-294x.1998.00498.x; Jager EJ, 1995, SCHR R VEGETAT KDE, V27, P395; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Krebs C, 2010, PLANT BIOLOGY, V12, P215, DOI 10.1111/j.1438-8677.2009.00219.x; Ksiazczyk T, 2015, PROTOPLASMA, V252, P985, DOI 10.1007/s00709-014-0734-9; Ksiazczyk T, 2011, CHROMOSOMA, V120, P557, DOI 10.1007/s00412-011-0331-z; Lembicz M, 2011, FLORA, V206, P792, DOI 10.1016/j.flora.2011.04.006; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; Mandak B, 2005, PLANT SYST EVOL, V253, P219, DOI 10.1007/s00606-005-0316-6; Mandak B, 2003, ANN BOT-LONDON, V92, P265, DOI 10.1093/aob/mcg141; Matesanz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093217; Mishima M, 2002, CHROMOSOMA, V110, P550, DOI 10.1007/s00412-001-0175-z; Novak SJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P201; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Owen S. J., 1996, ECOLOGICAL WEEDS CON; Parepa M, 2014, EVOL APPL, V7, P413, DOI 10.1111/eva.12139; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; PIELOU E C, 1969, P286; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Pysek P, 2013, INVAD NAT SPRING SER, V7, P209, DOI 10.1007/978-94-007-7750-7_11; Richards CL, 2008, AM J BOT, V95, P931, DOI 10.3732/ajb.2007364; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Richards Moorehead & Laing Ltd, 1990, JAP KNOTW REYN JAP W; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saldana A, 2009, GAYANA BOT, V66, P283; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Stout JC, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu087; Suda J, 2010, PRESLIA, V82, P97; SUKOPP H, 1995, PLANT INVASIONS, P151; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Tiebre MS, 2007, AM J BOT, V94, P1900, DOI 10.3732/ajb.94.11.1900; Tiebre MS, 2007, ANN BOT-LONDON, V99, P193, DOI 10.1093/aob/mcl242; Tokarska-Guzik B., 2012, ROSLINY OBCEGO POCHO, P1; Tokarska-Guzik B., 2005, ESTABLISHMENT SPREAD; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Urgenson LS, 2009, BIOL CONSERV, V142, P1536, DOI 10.1016/j.biocon.2009.02.023; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vila M., 2000, BIOL INVASIONS, V2, P207, DOI 10.1023/ A:1010003603310; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wan T, 2012, PLANT SYST EVOL, V298, P1195, DOI 10.1007/s00606-012-0621-9; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Xiong ZY, 2011, P NATL ACAD SCI USA, V108, P7908, DOI 10.1073/pnas.1014138108; Zhang YY, 2010, MOL ECOL, V19, P1774, DOI 10.1111/j.1365-294X.2010.04609.x	81	11	12	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161854	10.1371/journal.pone.0161854	http://dx.doi.org/10.1371/journal.pone.0161854			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575805	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877200043
J	Kopylov, PK; Platonov, ME; Ablamunits, VG; Kombarova, TI; Ivanov, SA; Kadnikova, LA; Somov, AN; Dentovskaya, SV; Uversky, VN; Anisimov, AP				Kopylov, Pavel Kh.; Platonov, Mikhail E.; Ablamunits, Vitaly G.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Kadnikova, Lidiya A.; Somov, Aleksey N.; Dentovskaya, Svetlana V.; Uversky, Vladimir N.; Anisimov, Andrey P.			Yersinia pestis Caf1 Protein: Effect of Sequence Polymorphism on Intrinsic Disorder Propensity, Serological Cross-Reactivity and Cross-Protectivity of Isoforms	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; UNSTRUCTURED PROTEINS; PLAGUE VACCINES; F1 ANTIGEN; WEB SERVER; B-CELL; BINDING; PREDICTION; REGIONS; PHAGOCYTOSIS	Yersinia pestis Caf1 is a multifunctional protein responsible for antiphagocytic activity and is a key protective antigen. It is generally conserved between globally distributed Y. pestis strains, but Y. pestis subsp. microtus biovar caucasica strains circulating within populations of common voles in Georgia and Armenia were reported to carry a single substitution of alanine to serine. We investigated polymorphism of the Caf1 sequences among other Y. pestis subsp. microtus strains, which have a limited virulence in guinea pigs and in humans. Sequencing of caf1 genes from 119 Y. pestis strains belonging to different biovars within subsp. microtus showed that the Caf1 proteins exist in three isoforms, the global type Caf1(NT1) (Ala48 Phe117), type Caf1(NT2) (Ser48 Phe117) found in Transcaucasian-highland and Pre-Araks natural plague foci #4-7, and a novel Caf1(NT3) type (Ala48 Val117) endemic in Dagestan-highland natural plague focus #39. Both minor types are the progenies of the global isoform. In this report, Caf1 polymorphism was analyzed by comparing predicted intrinsic disorder propensities and potential protein-protein interactivities of the three Caf1 isoforms. The analysis revealed that these properties of Caf1 protein are minimally affected by its polymorphism. All protein isoforms could be equally detected by an immunochromatography test for plague at the lowest protein concentration tested (1.0 ng/mL), which is the detection limit. When compared to the classic Caf1(NT1) isoform, the endemic Caf1(NT2) or Caf1(NT3) had lower immunoreactivity in ELISA and lower indices of self-and cross-protection. Despite a visible reduction in cross-protection between all Caf1 isoforms, our data suggest that polymorphism in the caf1 gene may not allow the carriers of Caf1(NT2) or Caf1(NT3) variants escaping from the Caf1(NT1)-mediated immunity to plague in the case of a low-dose flea-borne infection.	[Kopylov, Pavel Kh.; Platonov, Mikhail E.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Kadnikova, Lidiya A.; Somov, Aleksey N.; Dentovskaya, Svetlana V.; Anisimov, Andrey P.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia; [Ablamunits, Vitaly G.] St Petersburg Med Pediat Univ, St Petersburg, Russia; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino, Moscow Region, Russia	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences	Anisimov, AP (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia.; Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino, Moscow Region, Russia.	vuversky@health.usf.edu; a-p-anisimov@yandex.ru	Anisimov, Andrey P/D-2217-2009; Platonov, Mikhail E/S-1209-2016; Dentovskaya, Svetlana/F-4623-2017; Ivanov, Sergey/GSD-3061-2022; Michael, Platonov/GZG-8615-2022; Somov, Alexey N/Q-1577-2017; Anisimov, Andrey P./H-5257-2012; Uversky, Vladimir N./F-4515-2011	Anisimov, Andrey P/0000-0002-5499-7999; Dentovskaya, Svetlana/0000-0002-1996-8949; Anisimov, Andrey P./0000-0002-5499-7999; Uversky, Vladimir N./0000-0002-4037-5857; Platonov, Mihail/0000-0003-3946-1755	Russian Science Foundation (Ru) [14-15-00599]; Russian Science Foundation [14-15-00599] Funding Source: Russian Science Foundation	Russian Science Foundation (Ru)(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This research and PKK MEP TIK SAI LAK SVD APA were supported by the Russian Science Foundation (Ru) (grant 14-15-00599; http://www.rscf.ru/en/).	Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Daughdrill GW, 2005, HDB PROTEIN FOLDING, P271; Dennis DT, 1999, WKLY EPIDEMIOL REC, V74, P447; Dentovskaya SV, 2013, MOL GENET MICROBIOL+, V28, P87, DOI 10.3103/S089141681303004X; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; Feodorova VA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.34; FINNEY D. J., 1978, STAT METHOD BIOL ASS; Galen JE, 2015, INFECT IMMUN, V83, P161, DOI 10.1128/IAI.02443-14; GALYOV EE, 1990, FEBS LETT, V277, P230, DOI 10.1016/0014-5793(90)80852-A; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Golubov A, 2004, INFECT IMMUN, V72, P5613, DOI 10.1128/IAI.72.10.5613-5621.2004; Gupta G, 2010, SCAND J IMMUNOL, V71, P186, DOI 10.1111/j.1365-3083.2009.02365.x; Huang SS, 2014, INT J NANOMED, V9, P813, DOI 10.2147/IJN.S56260; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Kiefer D, 2012, VECTOR-BORNE ZOONOT, V12, P183, DOI 10.1089/vbz.2011.0748; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Musson JA, 2006, J BIOL CHEM, V281, P26129, DOI 10.1074/jbc.M605482200; Neubauer H., 1998, MEDISCHE MICROBIOLOG, V6, pS10; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938; Platonov ME, 2013, MOL GENET MICROBIOL+, V28, P41, DOI 10.3103/S0891416813020067; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Quenee LE, 2009, HUM VACCINES, V5, P817, DOI 10.4161/hv.9866; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Revazishvili T, 2008, CLIN MICROBIOL INFEC, V14, P429, DOI 10.1111/j.1469-0691.2008.01953.x; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Russell P, 1997, BRIT J BIOMED SCI, V54, P231; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2012, J MOL BIOL, V418, P267, DOI 10.1016/j.jmb.2012.02.034; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; WILLIAMS RC, 1972, J INFECT DIS, V126, P235, DOI 10.1093/infdis/126.3.235; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662; ZAVYALOV V, 1995, IMMUNOL LETT, V45, P19, DOI 10.1016/0165-2478(94)00194-V; Zhang X, 2014, SCAND J IMMUNOL, V79, P157, DOI 10.1111/sji.12146	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162308	10.1371/journal.pone.0162308	http://dx.doi.org/10.1371/journal.pone.0162308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606595	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255600037
J	Bondarenko, VS; Gelfand, MS				Bondarenko, Vladyslav S.; Gelfand, Mikhail S.			Evolution of the Exon-Intron Structure in Ciliate Genomes	PLOS ONE			English	Article							MESSENGER-RNA; DNA-SEQUENCES; GENES; DEFINITION; SELECTION; ORIGIN	A typical eukaryotic gene is comprised of alternating stretches of regions, exons and introns, retained in and spliced out a mature mRNA, respectively. Although the length of introns may vary substantially among organisms, a large fraction of genes contains short introns in many species. Notably, some Ciliates (Paramecium and Nyctotherus) possess only ultra-short introns, around 25 bp long. In Paramecium, ultra-short introns with length divisible by three (3n) are under strong evolutionary pressure and have a high frequency of in-frame stop codons, which, in the case of intron retention, cause premature termination of mRNA translation and consequent degradation of the mis-spliced mRNA by the nonsense-mediated decay mechanism. Here, we analyzed introns in five genera of Ciliates, Paramecium, Tetrahymena, Ichthyophthirius, Oxytricha, and Stylonychia. Introns can be classified into two length classes in Tetrahymena and Ichthyophthirius (with means 48 bp, 69 bp, and 55 bp, 64 bp, respectively), but, surprisingly, comprise three distinct length classes in Oxytricha and Stylonychia (with means 33-35 bp, 47-51 bp, and 78-80 bp). In most ranges of the intron lengths, 3n introns are underrepresented and have a high frequency of in-frame stop codons in all studied species. Introns of Paramecium, Tetrahymena, and Ichthyophthirius are preferentially located at the 5' and 3' ends of genes, whereas introns of Oxytricha and Stylonychia are strongly skewed towards the 5' end. Analysis of evolutionary conservation shows that, in each studied genome, a significant fraction of intron positions is conserved between the orthologs, but intron lengths are not correlated between the species. In summary, our study provides a detailed characterization of introns in several genera of Ciliates and highlights some of their distinctive properties, which, together, indicate that splicing spellchecking is a universal and evolutionarily conserved process in the biogenesis of short introns in various representatives of Ciliates.	[Bondarenko, Vladyslav S.] NASU, Inst Mol Biol & Genet, Zabolotnogo Str 150, UA-03680 Kiev, Ukraine; [Gelfand, Mikhail S.] RAS, AA Kharkevich Inst Informat Transmiss Problems, Bolshoy Karetny Per 19, Moscow 127994, Russia; [Gelfand, Mikhail S.] Skolkovo Inst Sci & Technol, Moscow 143026, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Vorobievy Gory 1-73,GSP 1, Moscow 119234, Russia	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University	Bondarenko, VS (corresponding author), NASU, Inst Mol Biol & Genet, Zabolotnogo Str 150, UA-03680 Kiev, Ukraine.	vladyslav.bon@gmail.com	Gelfand, Mikhail S/F-3425-2012	Bondarenko, Vladyslav/0000-0003-3388-2743; Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-24-00155]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation (grant 14-24-00155).; This study was supported by the Russian Science Foundation (grant 14-24-00155). It was initiated at the Winter School "Modern Biology-Future Biotech-2013".	Aeschlimann SH, 2014, GENOME BIOL EVOL, V6, P1707, DOI 10.1093/gbe/evu139; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Benaglia T, 2009, J STAT SOFTW, V32, P1; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Cavalier-Smith T, 2006, P NATL ACAD SCI USA, V103, P9379, DOI 10.1073/pnas.0603505103; Chang WJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-6; Chang WJ, 2005, P NATL ACAD SCI USA, V102, P15149, DOI 10.1073/pnas.0507682102; Chen X, 2015, GENOME BIOL EVOL, V7, P2859, DOI 10.1093/gbe/evv172; Coyne RS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; Derr LK, 1998, GENETICS, V148, P937; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lin K, 2005, NUCLEIC ACIDS RES, V33, P6522, DOI 10.1093/nar/gki970; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Niu DK, 2005, MOL BIOL EVOL, V22, P1475, DOI 10.1093/molbev/msi138; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1999, ANN NY ACAD SCI, V870, P301, DOI 10.1111/j.1749-6632.1999.tb08892.x; Prescott DM, 2002, PROTIST, V153, P71, DOI 10.1078/1434-4610-00084; PRESCOTT DM, 1992, BIOESSAYS, V14, P317, DOI 10.1002/bies.950140505; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Slamovits CH, 2009, MOL BIOL EVOL, V26, P1699, DOI 10.1093/molbev/msp081; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov D V, 2012, Mol Biol (Mosk), V46, P361; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602	42	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161476	10.1371/journal.pone.0161476	http://dx.doi.org/10.1371/journal.pone.0161476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603699	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200015
J	Sola-Carmona, JJ; Lopez-Liria, R; Padilla-Gongora, D; Daza, MT; Aguilar-Parra, JM; Salido-Campos, MA				Jesus Sola-Carmona, Juan; Lopez-Liria, Remedios; Padilla-Gongora, David; Teresa Daza, Maria; Manuel Aguilar-Parra, Jose; Angeles Salido-Campos, Maria			Factors Associated with the Anxiety, Subjective Psychological Well-Being and Self-Esteem of Parents of Blind Children	PLOS ONE			English	Article							INTELLECTUAL DISABILITIES; YOUNG-CHILDREN; BEHAVIOR PROBLEMS; HEALTH; FAMILIES; MOTHERS; STRESS; IMPACT; PERCEPTIONS; ADJUSTMENT	The objective was to examine the connection of the personal, social and family context, educational variables with the levels of anxiety, subjective psychological well-being and self-esteem in a sample of 61 parents of blind children. Results suggest that parents present less anxiety when they have only one child, possess a technical degree, receive remuneration for their work, their child's visual impairment is not progressive, their knowledge about their child's disability is appropriate, and their leisure and labour possibilities have not been affected. Their psychological well-being is higher when they are married in first nuptials and perceive that their health is good. Their well-being is negatively related to reduced leisure, and self-esteem is lower when labour possibilities have been affected. In order for these families to achieve a more pleasant life, with greater psychological well-being, lower anxiety and higher self-esteem, professionals should be aware of the aspects with a negative impact.	[Jesus Sola-Carmona, Juan] Natl Org Spanish Blind ONCE, Almeria, Spain; [Lopez-Liria, Remedios] Univ Almeria, Dept Nursing Sci Physiotherapy & Med, Fac Hlth Sci, Almeria, Spain; [Padilla-Gongora, David; Teresa Daza, Maria; Manuel Aguilar-Parra, Jose] Univ Almeria, Fac Psychol, Dept Psychol, Almeria, Spain; [Angeles Salido-Campos, Maria] Complejo Hosp Torrecardenas Junta de Andalucia, Almeria, Spain; [Lopez-Liria, Remedios; Padilla-Gongora, David; Teresa Daza, Maria; Manuel Aguilar-Parra, Jose] Univ Almeria, Carretera Sacramento S-N, La Canada De San Urbano, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Universidad de Almeria	Lopez-Liria, R (corresponding author), Univ Almeria, Dept Nursing Sci Physiotherapy & Med, Fac Hlth Sci, Almeria, Spain.	rll040@ual.es	Daza, María Teresa/A-2670-2015; López-Liria, Remedios/V-3851-2019; PARRA, JOSE MANUEL AGUILAR/AAD-6978-2019	Daza, María Teresa/0000-0002-6561-8982; López-Liria, Remedios/0000-0002-3416-2791; PARRA, JOSE MANUEL AGUILAR/0000-0002-6703-0680				Argyle M., 1989, RECENT ADV SOCIAL PS, p189?247, DOI DOI 10.1111/J.1758-0854.20.10.01032.X; Badia M, 2002, SIGLO CERO, V33, P5; Banos RM, 2000, PSYCHOL REP, V87, P269, DOI 10.2466/pr0.2000.87.1.269; BECKMAN PJ, 1991, AM J MENT RETARD, V95, P585; Benn R, 2012, DEV PSYCHOL, V48, P1476, DOI 10.1037/a0027537; Benzies KM, 2009, J PEDIATR PSYCHOL, V36, P506, DOI [10.1093/jpepsy/jsq081, DOI 10.1093/JPEPSY/JSQ081]; Bingham A, 2000, INTERV SCH CLIN, V35, P294, DOI [DOI 10.1177/105345120003500507, 10.1177/105345120003500507]; Brehaut JC, 2009, AM J PUBLIC HEALTH, V99, P1254, DOI 10.2105/AJPH.2007.129817; Bumbalo J, 2005, MATERN CHILD HLTH J, V9, pS3, DOI 10.1007/s10995-005-4350-3; BYRNE EA, 1985, J CHILD PSYCHOL PSYC, V26, P847, DOI 10.1111/j.1469-7610.1985.tb00602.x; Calvo C., 2004, PSICOLOG A CEGUERA M, P243; Checa J, 2004, PSYCHOL BLINDNESS MA; Cordoba L., 2003, SIGLO CERO, V34, P19; Cordoba L, 2006, ROMPIENDO INERCIAS A, P443; CUMMINGS ST, 1976, AM J ORTHOPSYCHIAT, V46, P246, DOI 10.1111/j.1939-0025.1976.tb00925.x; Dempsey I, 2004, J INTELLECT DEV DIS, V29, P40, DOI 10.1080/13668250410001662874; Dempsey I, 2008, TOP EARLY CHILD SPEC, V28, P42, DOI 10.1177/0271121408316699; Dempsey I, 2009, RES DEV DISABIL, V30, P558, DOI 10.1016/j.ridd.2008.08.005; Dunst C. J., 2007, INT J DISABIL DEV ED, V54, P305, DOI [DOI 10.1080/10349120701488772, 10.1080/10349120701488772]; Dunst CJ, 1999, TOP EARLY CHILD SPEC, V19, P141, DOI 10.1177/027112149901900302; DUNST CJ, 1986, AM J MENT DEF, V90, P403; Dunst CJ, 2002, J SPEC EDUC, V36, P139; Dykens EM, 2005, MENT RETARD, V43, P360; Eisenhower AS, 2009, SOC SCI MED, V68, P89, DOI 10.1016/j.socscimed.2008.09.033; Emerson E, 2008, AM J MENT RETARD, V113, P143, DOI 10.1352/0895-8017(2008)113[143:SWOWAM]2.0.CO;2; Femenias M., 2003, SIGLO CERO, V34, P19; Feniger-Schaal R, 2013, RES DEV DISABIL, V34, P306, DOI 10.1016/j.ridd.2012.08.007; Fierro Alfredo, 2006, Clínica y Salud, V17, P297; FRIEDRICH WN, 1981, AM J MENT DEF, V85, P551; Goudie A, 2014, FAM SYST HEALTH, V32, P280, DOI 10.1037/fsh0000027; Guillen-Riquelme A, 2011, PSICOTHEMA, V23, P510; Guralnick MJ, 1998, AM J MENT RETARD, V102, P319; Hatton C, 2010, J APPL RES INTELLECT, V23, P63, DOI 10.1111/j.1468-3148.2009.00544.x; Hinojosa MS, 2012, J PEDIATR NURS, V27, P500, DOI 10.1016/j.pedn.2011.06.013; HOLROYD J, 1976, AM J MENT DEF, V80, P431; Holroyd J, 1975, AM J COMMUN PSYCHOL, V3, P26; Hutchinson KC, 2009, PSYCHO-ONCOLOGY, V18, P515, DOI 10.1002/pon.1421; Sola-Carmona JJ, 2013, RES DEV DISABIL, V34, P1886, DOI 10.1016/j.ridd.2013.03.002; Jimenez A., 2010, POLITICA SOC, V47, P165; KAZAK AE, 1987, J ABNORM CHILD PSYCH, V15, P137, DOI 10.1007/BF00916471; Keen D., 2007, INT J DISABIL DEV ED, V54, P339, DOI [10.1080/10349120701488855, DOI 10.1080/10349120701488855]; King G, 2003, CHILD HEALTH CARE, V32, P191, DOI 10.1207/S15326888CHC3203_2; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; KRAUSS MW, 1993, AM J MENT RETARD, V97, P393; Kuhlthau K, 2010, MATERN CHILD HLTH J, V14, P155, DOI 10.1007/s10995-008-0434-1; Lafuente M. A., 2000, ATENCION TEMPRANA NI; Leyser Y, 2001, 2 INT C PAR DIS THEI; Gras RML, 2007, AN PSICOL, V23, P201; Lloyd T, 2008, J INTELL DISABIL RES, V52, P37, DOI 10.1111/j.1365-2788.2007.00974.x; MacDonald EE, 2010, J APPL RES INTELLECT, V23, P27, DOI 10.1111/j.1468-3148.2009.00546.x; Mahoney G, 1998, TOP EARLY CHILD SPEC, V18, P83, DOI 10.1177/027112149801800204; Martin-Albo J, 2007, SPAN J PSYCHOL, V10, P458, DOI 10.1017/S1138741600006727; Martorell A, 2011, RES DEV DISABIL, V32, P2847, DOI 10.1016/j.ridd.2011.05.021; Mayo ME, 2006, 4 C VIRT INTEREDVISU; Mayo ME, 2007, CUADERNOS TERAPIA FA, V21, P231; Mayo ME, 2011, FAMILY FACE CHILDS V; Naseef R, 2002, EYE CONTACT AUTUMN, P39; Navarro J, 2004, ENFERMEDAD FAMILIA M; O'Neil ME, 2001, PHYS THER, V81, P1412, DOI 10.1093/ptj/81.8.1412; Pallero R, 2008, INTEGRACION, V55, P34; Papadopoulos K, 2011, RES DEV DISABIL, V32, P1086, DOI 10.1016/j.ridd.2011.01.021; Piazza VE, 2014, AJIDD-AM J INTELLECT, V119, P186, DOI 10.1352/1944-7558-119.2.186; Ponce A, 2008, DE PADRES A PADRES; Puga Dolores, 2005, Rev. Esp. Salud Publica, V79, P327, DOI 10.1590/s1135-57272005000300001; Reich S, 2004, J EMOT BEHAV DISORD, V12, P99, DOI 10.1177/10634266040120020401; Rodger S, 2008, J APPL RES INTELLECT, V21, P174, DOI 10.1111/j.1468-3148.2007.00393.x; Rosa F, 2001, INTEGRACION, V36, P40; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sanchez-Canovas J, 2007, ESCALA BIENESTAR PSI; SERRADAS FONSECA Marian, 2003, Rev. Ped, V24, P447; Singer GH, 1990, CRITICAL ISSUES LIVE, P271; Smith AM, 2014, FAM SYST HEALTH, V32, P303, DOI 10.1037/fsh0000049; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spielberger CD., 1982, STAI CUESTIONARIO AN; Troster H, 2001, J VISUAL IMPAIR BLIN, V95, P623, DOI 10.1177/0145482X0109501005; Van Riper M, 1999, RES NURS HEALTH, V22, P357, DOI 10.1002/(SICI)1098-240X(199910)22:5<357::AID-NUR2>3.0.CO;2-Q; van Schie PEM, 2004, CHILD CARE HLTH DEV, V30, P529, DOI 10.1111/j.1365-2214.2004.00451.x; WALLANDER JL, 1988, J CLIN CHILD PSYCHOL, V17, P336, DOI 10.1207/s15374424jccp1704_7	78	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162294	10.1371/journal.pone.0162294	http://dx.doi.org/10.1371/journal.pone.0162294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603670	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200054
J	Kar, A; Beam, H; Borror, MB; Luckow, M; Gao, XL; Rea, SL				Kar, Adwitiya; Beam, Haley; Borror, Megan B.; Luckow, Michael; Gao, Xiaoli; Rea, Shane L.			CLD1 Reverses the Ubiquinone Insufficiency of Mutant cat5/coq7 in a Saccharomyces cerevisiae Model System	PLOS ONE			English	Article							COENZYME-Q BIOSYNTHESIS; PARA-AMINOBENZOIC ACID; CAENORHABDITIS-ELEGANS; LIFE-SPAN; MITOCHONDRIAL-FUNCTION; CEREBELLAR-ATAXIA; Q(6) BIOSYNTHESIS; BARTH-SYNDROME; ENZYME CLK-1; MIT MUTANTS	Ubiquinone (Q(n)) functions as a mobile electron carrier in mitochondria. In humans, Q biosynthetic pathway mutations lead to Q(10) deficiency, a life threatening disorder. We have used a Saccharomyces cerevisiae model of Q(6) deficiency to screen for new modulators of ubiquinone biosynthesis. We generated several hypomorphic alleles of coq7/cat5 (clk-1 in Caenorhabditis elegans) encoding the penultimate enzyme in Q biosynthesis which converts 5-demethoxy Q(6) (DMQ(6)) to 5-demethyl Q(6), and screened for genes that, when overexpressed, suppressed their inability to grow on non-fermentable ethanol-implying recovery of lost mitochondrial function. Through this approach we identified Cardiolipin-specific Deacylase 1 (CLD1), a gene encoding a phospholipase A(2) required for cardiolipin acyl remodeling. Interestingly, not all coq7 mutants were suppressed by Cld1p overexpression, and molecular modeling of the mutant Coq7p proteins that were suppressed showed they all contained disruptions in a hydrophobic alpha-helix that is predicted to mediate membrane-binding. CLD1 overexpression in the suppressible coq7 mutants restored the ratio of DMQ(6) to Q(6) toward wild type levels, suggesting recovery of lost Coq7p function. Identification of a spontaneous Cld1p loss-of-function mutation illustrated that Cld1p activity was required for coq7 suppression. This observation was further supported by HPLC-ESI-MS/MS profiling of monolysocardiolipin, the product of Cld1p. In summary, our results present a novel example of a lipid remodeling enzyme reversing a mitochondrial ubiquinone insufficiency by facilitating recovery of hypomorphic enzymatic function.	[Kar, Adwitiya; Beam, Haley; Borror, Megan B.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Kar, Adwitiya; Beam, Haley; Borror, Megan B.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Luckow, Michael] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Gao, Xiaoli] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Kar, Adwitiya] Univ Colorado, Dept Endocrinol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Luckow, Michael] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rea, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.; Rea, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	reas3@uthscsa.edu			NIH [1S10RR031586-01]; Ellison Medical Foundation [AG-NS-051908]; National Institute on Aging [AG-025207, AG-047561]; National Institute for General Medical Sciences [K12-GM111726]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM111726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG025207, R21AG047561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Mass spectrometry analyses were conducted in the Metabolomics Core Facility of the Mass Spectrometry Laboratory at the University of Texas Health Science Center at San Antonio, with instrumentation funded in part by NIH Grant 1S10RR031586-01. Additional financial support was provided by the Ellison Medical Foundation (http://www.ellisonfoundation.org/; AG-NS-051908; S.L.R.), the National Institute on Aging (https://www.nia.nih.gov/; AG-025207, AG-047561; S.L.R.), and the National Institute for General Medical Sciences (https://www.nigms.nih.gov,; K12-GM111726; M.B.B.).	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Behan RK, 2010, BIOCHEMISTRY-US, V49, P9679, DOI 10.1021/bi101475z; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Busso C, 2015, BIOCHIMIE, V119, P92, DOI 10.1016/j.biochi.2015.10.016; Butler JA, 2013, AGING CELL, V12, P130, DOI 10.1111/acel.12029; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Doimo M, 2014, BBA-MOL BASIS DIS, V1842, P1, DOI 10.1016/j.bbadis.2013.10.007; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7; Gonzalez-Mariscal I, 2014, MOL SYNDROMOL, V5, P107, DOI 10.1159/000362897; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Licitra F, 2014, MOL SYNDROMOL, V5, P180, DOI 10.1159/000362942; Lohman DC, 2014, P NATL ACAD SCI USA, V111, pE4697, DOI 10.1073/pnas.1413128111; Lu TT, 2013, BIOCHEMISTRY-US, V52, P2236, DOI 10.1021/bi301674p; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; METZLER DE, 1977, BIOCHEMISTRY CHEM RE; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170; Mowbray SL, 2006, PROTEIN SCI, V15, P1628, DOI 10.1110/ps.051792106; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Poon WW, 1997, MOL ASPECTS MED, V18, pS121; Quinzii CM, 2007, MITOCHONDRION, V7, pS122, DOI 10.1016/j.mito.2007.03.004; Rea S, 2001, FEBS LETT, V509, P389, DOI 10.1016/S0014-5793(01)03099-X; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schultz JR, 1996, BIOCHEMISTRY-US, V35, P6595, DOI 10.1021/bi960245h; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Wang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7393; Wasko BM, 2014, BIOL CHEM, V14, P148, DOI [10.1111/1567-1364.12104, DOI 10.1074/JBC.M113.474494]; Wasko BM, 2014, FEMS YEAST RES, V14, P148, DOI 10.1111/1567-1364.12104; WONG A, 1995, GENETICS, V139, P1247; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487	64	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162165	10.1371/journal.pone.0162165	http://dx.doi.org/10.1371/journal.pone.0162165			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603010	Green Published, gold, Green Submitted			2022-12-27	WOS:000383255200049
J	Barardi, A; Garcia-Ojalvo, J; Mazzoni, A				Barardi, Alessandro; Garcia-Ojalvo, Jordi; Mazzoni, Alberto			Transition between Functional Regimes in an Integrate-And-Fire Network Model of the Thalamus	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ELECTROPHYSIOLOGICAL PROPERTIES; SOMATOSENSORY CORTEX; RETICULAR NUCLEUS; DYNAMICS; INFORMATION; NEURONS; OSCILLATIONS; INHIBITION; FREQUENCY	The thalamus is a key brain element in the processing of sensory information. During the sleep and awake states, this brain area is characterized by the presence of two distinct dynamical regimes: in the sleep state activity is dominated by spindle oscillations (7 - 15 Hz) weakly affected by external stimuli, while in the awake state the activity is primarily driven by external stimuli. Here we develop a simple and computationally efficient model of the thalamus that exhibits two dynamical regimes with different information-processing capabilities, and study the transition between them. The network model includes glutamatergic thalamocortical (TC) relay neurons and GABAergic reticular (RE) neurons described by adaptive integrate-and-fire models in which spikes are induced by either depolarization or hyperpolarization rebound. We found a range of connectivity conditions under which the thalamic network composed by these neurons displays the two aforementioned dynamical regimes. Our results show that TC-RE loops generate spindle-like oscillations and that a minimum level of clustering (i.e. local connectivity density) in the RE-RE connections is necessary for the coexistence of the two regimes. We also observe that the transition between the two regimes occurs when the external excitatory input on TC neurons (mimicking sensory stimulation) is large enough to cause a significant fraction of them to switch from hyper-polarization-rebound-driven firing to depolarization-driven firing. Overall, our model gives a novel and clear description of the role that the two types of neurons and their connectivity play in the dynamical regimes observed in the thalamus, and in the transition between them. These results pave the way for the development of efficient models of the transmission of sensory information from periphery to cortex.	[Barardi, Alessandro; Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Dr Aiguader 88, Barcelona 08003, Spain; [Barardi, Alessandro] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Rambla St Nebridi 22, Terrassa 08222, Spain; [Mazzoni, Alberto] Scuola Super Sant Anna, BioRobot Inst, I-56026 Pontedera, Italy	Pompeu Fabra University; Universitat Politecnica de Catalunya; Scuola Superiore Sant'Anna	Garcia-Ojalvo, J (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Dr Aiguader 88, Barcelona 08003, Spain.; Mazzoni, A (corresponding author), Scuola Super Sant Anna, BioRobot Inst, I-56026 Pontedera, Italy.	jordi.g.ojalvo@upf.edu; a.mazzoni@sssup.it	Mazzoni, Alberto/AGO-5998-2022; Mazzoni, Alberto/A-5433-2018; Garcia-Ojalvo, Jordi/A-4574-2009; Mazzoni, Alberto/N-6960-2016	Mazzoni, Alberto/0000-0002-9632-1831; Mazzoni, Alberto/0000-0002-9632-1831; Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Mazzoni, Alberto/0000-0002-9632-1831	European Commission under ITN project NETT (FP7) [289146]; Spanish Ministry of Economy and Competitiveness and FEDER [FIS2015-66503-C3-1-P1]; Generalitat de Catalunya [2014SGR0947]; NEBIAS European project [EUFP7-ICT-611687]; PRIN/HandBot Italian project [B81J12002680008, 20102YF2RY]; Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on; ICREA Academia programme; "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness) [MDM-2014-0370]	European Commission under ITN project NETT (FP7); Spanish Ministry of Economy and Competitiveness and FEDER(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); NEBIAS European project; PRIN/HandBot Italian project; Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on; ICREA Academia programme(ICREA); "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness)	This work was supported by the European Commission under ITN project NETT (FP7 contract 289146), by the Spanish Ministry of Economy and Competitiveness and FEDER (project FIS2015-66503-C3-1-P1), and by the Generalitat de Catalunya (project 2014SGR0947). A.M. was supported by the NEBIAS European project (EUFP7-ICT-611687), by the PRIN/HandBot Italian project (CUP: B81J12002680008; prot.: 20102YF2RY), and by the Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on "Brain network mechanisms for integration of natural tactile input patterns". J.G.O. also acknowledges support from the ICREA Academia programme and from the "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness, MDM-2014-0370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank two anonymous reviewers for their constructive comments. This work was supported by the European Commission under ITN project NETT (FP7 contract 289146), by the Spanish Ministry of Economy and Competitiveness and FEDER (project FIS2015-66503-C3-1-P), and by the Generalitat de Catalunya (project 2014SGR0947). A.M. was supported by the NEBIAS European project (EUFP7-ICT-611687), by the PRIN/HandBot Italian project (CUP: B81J12002680008; prot.: 20102YF2RY), and by the Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on "Brain network mechanisms for integration of natural tactile input patterns". J.G.O. also acknowledges support from the ICREA Academia programme and from the "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness, MDM-2014-0370).	ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; Barardi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003723; Barbieri F, 2014, J NEUROSCI, V34, P14589, DOI 10.1523/JNEUROSCI.5365-13.2014; Battaglia D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002176; Bazhenov M, 1999, NAT NEUROSCI, V2, P168, DOI 10.1038/5729; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; DESTEXHE A, 1993, BIOPHYS J, V65, P2473, DOI 10.1016/S0006-3495(93)81297-9; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Destexhe A, 2000, J PHYSIOLOGY-PARIS, V94, P391, DOI 10.1016/S0928-4257(00)01093-7; Destexhe A, 2009, J COMPUT NEUROSCI, V27, P493, DOI 10.1007/s10827-009-0164-4; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; El Boustani S, 2007, J PHYSIOL-PARIS, V101, P99, DOI 10.1016/j.jphysparis.2007.10.001; Fitzgibbon T, 1995, J COMP NEUROL, V363, P489, DOI 10.1002/cne.903630311; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Golomb D, 1996, J NEUROPHYSIOL, V75, P750, DOI 10.1152/jn.1996.75.2.750; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Ince RAA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.011.2010; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Klinshov VV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094292; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Ladenbauer J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002478; LAND PW, 1995, SOMATOSENS MOT RES, V12, P127, DOI 10.3109/08990229509101504; Lewis LD, 2015, ELIFE, V4, DOI 10.7554/eLife.08760; Linden H., 2014, FRONT NEUROINFORM, V7, P41, DOI DOI 10.3389/fninf.2013.00041; Litwin-Kumar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6319; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; Mazzoni A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004584; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; MINDERHOUD JM, 1971, EXP BRAIN RES, V12, P435; Muller L, 2012, J PHYSIOL-PARIS, V106, P222, DOI 10.1016/j.jphysparis.2012.06.005; Naud R, 2008, BIOL CYBERN, V99, P335, DOI 10.1007/s00422-008-0264-7; Pais-Vieira M, 2015, J NEUROPHYSIOL, V114, P1652, DOI 10.1152/jn.00108.2015; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Reinhold K, 2015, NAT NEUROSCI, V18, P1789, DOI 10.1038/nn.4153; Schwartz A, 2015, SCIENCE, V350, P11, DOI 10.1126/science.aad5010; Servello D, 2008, J NEUROL NEUROSUR PS, V79, P136, DOI 10.1136/jnnp.2006.104067; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M., 2003, NEURONAL SUBSTRATES; Steriade M. M., 2005, BRAIN CONTROL WAKEFU; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Touboul J, 2008, BIOL CYBERN, V99, P319, DOI 10.1007/s00422-008-0267-4; Victor Jonathan D, 2006, Biol Theory, V1, P302, DOI 10.1162/biot.2006.1.3.302; Willis AM, 2015, J NEUROPHYSIOL, V114, P2353, DOI 10.1152/jn.00926.2014; Wimmer K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7177; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	73	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161934	10.1371/journal.pone.0161934	http://dx.doi.org/10.1371/journal.pone.0161934			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598260	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800026
J	Watanabe, M; Zemack, H; Johansson, H; Hagbard, L; Jorns, C; Li, M; Ellis, E				Watanabe, Masaaki; Zemack, Helen; Johansson, Helene; Hagbard, Louise; Jorns, Carl; Li, Meng; Ellis, Ewa			Maintenance of Hepatic Functions in Primary Human Hepatocytes Cultured on Xeno-Free and Chemical Defined Human Recombinant Laminins	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; EXPRESSION; CELLS; ADHESION; ANOIKIS; CHAIN	Refined methods for maintaining specific functions of isolated hepatocytes under xeno-free and chemical defined conditions is of great importance for the development of hepatocyte research and regenerative therapy. Laminins, a large family of heterotrimeric basement membrane adhesion proteins, are highly cell and tissue type specific components of the extracellular matrix and strongly influence the behavior and function of associated cells and/or tissues. However, detailed biological functions of many laminin isoforms are still to be evaluated. In this study, we determined the distribution of laminin isoforms in human liver tissue and isolated primary human hepatocytes by western blot analysis, and investigated the efficacy of different human recombinant laminin isoforms on hepatic functions during culture. Protein expressions of laminin-chain alpha 2, alpha 3, alpha 4, beta 1, beta 3, gamma 1, and gamma 2 were detected in both isolated human hepatocytes and liver tissue. No alpha 1 and alpha 5 expression could be detected in liver tissue or hepatocytes. Hepatocytes were isolated from five different individual livers, and cultured on human recombinant laminin isoforms -111, -211, -221, -332, -411, -421, -511, and -521 (Biolamina AB), matrigel (extracted from Engelbreth-Holm-Swarm sarcoma), or collagen type IV (Collagen). Hepatocytes cultured on laminin showed characteristic hexagonal shape in a flat cell monolayer. Viability, double stranded DNA concentration, and Ki67 expression for hepatocytes cultured for six days on laminin were comparable to those cultured on EHS and Collagen. Hepatocytes cultured on laminin also displayed production of human albumin, alpha-1-antitrypsin, bile acids, and gene expression of liver-enriched factors, such as hepatocyte nuclear factor 4 alpha, glucose-6-phosphate, cytochrome P450 3A4, and multidrug resistance-associated protein 2. We conclude that all forms of human recombinant laminin tested maintain cell viability and liver-specific functions of primary human hepatocytes, and that recombinant laminin is a promising xeno-free and chemical defined strategy for preservation of hepatocyte specific function in vitro.	[Watanabe, Masaaki; Zemack, Helen; Johansson, Helene; Jorns, Carl; Li, Meng; Ellis, Ewa] Karolinska Inst, Div Transplantat Surg, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Hagbard, Louise] BioLamina AB, Stockholm, Sweden	Karolinska Institutet	Watanabe, M (corresponding author), Karolinska Inst, Div Transplantat Surg, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.	masaaki@w8.dion.ne.jp	Johansson, Helene/AGR-5090-2022; Jorns, Carl/AAE-6925-2021; Watanabe, Masaaki/AAV-7033-2020; Ellis, Ewa C S/D-5370-2014	Jorns, Carl/0000-0001-7727-8113; Ellis, Ewa C S/0000-0002-3057-5337; Johansson, Helene/0000-0001-5519-0401	BioLamina AB	BioLamina AB	The funder BioLamina AB provided support in the form of salaries for author LH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific role of the author is articulated in the 'author contributions' section.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Cheng N, 2008, TISSUE ENG PT A, V14, P1, DOI 10.1089/ten.a.2007.0131; Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134; Crestani M, 1998, J LIPID RES, V39, P2192; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Ellis E, 1998, HEPATOLOGY, V27, P615, DOI 10.1002/hep.510270241; EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112; Fisher RA, 2004, CELL TRANSPLANT, V13, P677, DOI 10.3727/000000004783983576; Fu T, 2001, CELL TRANSPLANT, V10, P59; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671; Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Jorns C, 2014, CELL TRANSPLANT, V23, P1009, DOI 10.3727/096368913X667484; Kikkawa Y, 2005, EXP CELL RES, V305, P99, DOI 10.1016/j.yexcr.2005.01.005; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2009, BIOMATERIALS, V30, P6888, DOI 10.1016/j.biomaterials.2009.09.011; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miranda JP, 2010, TISSUE ENG PART C-ME, V16, P1223, DOI [10.1089/ten.tec.2009.0784, 10.1089/ten.TEC.2009.0784]; Ohashi K, 2004, TRANSPL P, V36, P2469, DOI 10.1016/j.transproceed.2004.07.072; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Smets FN, 2002, MOL GENET METAB, V75, P344, DOI 10.1016/S1096-7192(02)00004-5; Spencer VA, 2010, J MAMMARY GLAND BIOL, V15, P65, DOI 10.1007/s10911-010-9163-3; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161383	10.1371/journal.pone.0161383	http://dx.doi.org/10.1371/journal.pone.0161383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598296	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800007
J	Li, B; Schmidt, NW				Li, Bing; Schmidt, Nathan W.			Epidermal Fatty Acid Binding Protein (E-FABP) Is Not Required for the Generation or Maintenance of Effector and Memory T Cells following Infection with Listeria monocytogenes	PLOS ONE			English	Article							METABOLISM; IMMUNITY; DIFFERENTIATION; CARBOXYLASE; EXPRESSION; AQP9	Following activation of naive T cells there are dynamic changes in the metabolic pathways used by T cells to support both the energetic needs of the cell and the macromolecules required for growth and proliferation. Among other changes, lipid metabolism undergoes dynamic transitions between fatty acid oxidation and fatty acid synthesis as cells progress from naive to effector and effector to memory T cells. The hydrophobic nature of lipids requires that they be bound to protein chaperones within a cell. Fatty acid binding proteins (FABPs) represent a large class of lipid chaperones, with epidermal FABP (E-FABP) expressed in T cells. The objective of this study was to determine the contribution of E-FABP in antigen-specific T cell responses. Following infection with Listeria monocytogenes, we observed similar clonal expansion, contraction and formation of memory CD8 T cells in WT and E-FABP-/- mice, which also exhibited similar phenotypic and functional characteristics. Analysis of Listeria-specific CD4 T cells also revealed no defect in the expansion, contraction, and formation of memory CD4 T cells in E-FABP-/- mice. These data demonstrate that E-FABP is dispensable for antigen-specific T cell responses following a bacterial infection.	[Li, Bing; Schmidt, Nathan W.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA	University of Louisville	Schmidt, NW (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	nathan.schmidt@louisville.edu			National Institutes of Health [1R21AI113386, CA18098601A1, CA17767901A1]; American Cancer Society [RSG-14-057-01-MPC]; NATIONAL CANCER INSTITUTE [R01CA180986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (1R21AI113386) and the American Cancer Society (Research Scholar Grant, RSG-14-057-01-MPC) to NWS, and the National Institutes of Health (CA18098601A1, CA17767901A1) to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Lee JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137776; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nolz JC, 2014, J CLIN INVEST, V124, P1013, DOI 10.1172/JCI72039; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Park BV, 2015, MOL IMMUNOL, V68, P497, DOI 10.1016/j.molimm.2015.07.027; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Tvinnereim AR, 2002, INFECT IMMUN, V70, P153, DOI 10.1128/IAI.70.1.153-162.2002; Zhang YW, 2014, CANCER RES, V74, P2986, DOI 10.1158/0008-5472.CAN-13-2689	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162427	10.1371/journal.pone.0162427	http://dx.doi.org/10.1371/journal.pone.0162427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588422	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877800061
J	Li, ZY; Xiong, CL; Mo, S; Tian, HY; Yu, MQ; Mao, TT; Chen, Q; Luo, HT; Li, QZ; Lu, JX; Zhao, Y; Li, W				Li, Ziyang; Xiong, Chaoliang; Mo, Suo; Tian, Haiying; Yu, Mengqian; Mao, Tingting; Chen, Qian; Luo, Haitao; Li, Quanzhen; Lu, Jianxin; Zhao, Yi; Li, Wei			Comprehensive Transcriptome Analyses of the Fructose-Fed Syrian Golden Hamster Liver Provides Novel Insights into Lipid Metabolism	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEINS; LONG NONCODING RNAS; INSULIN-RESISTANCE; EFFECTOR C; SECRETION; GENE; MECHANISMS; OVERPRODUCTION; OVEREXPRESSION	Dyslipidemia has been widely proven to contribute to cardiovascular diseases and other metabolic disorders, especially in insulin resistance and type 2 diabetes. The overproduction of VLDL is a significant characteristic of dyslipidemia, indicating the dysfunction of hepatic lipid metabolism, from triglyceride synthesis to transport. The fructose-fed Syrian golden hamster is an established animal model for the study of VLDL assembly with insulin resistance, however, it remains unknown how VLDL production is regulated at the transcriptional level due to the absence of a complete hamster genome. Here, we performed deep sequencing and constructed an mRNA-miRNA-lncRNA interaction network of Syrian golden hamster liver in order to reveal the global transcription profile and find potential RNA molecular regulation of VLDL production. We identified 4,450 novel multi-exon hamster lncRNAs and 755 miRNAs expressed in liver. Additionally, 146 differentially expressed coding genes, 27 differentially expressed lncRNA genes, as well as 16 differentially expressed miRNAs were identified. We then constructed an mRNA-miRNA-lncRNA interaction network that may potentially regulate VLDL production, and interestingly found several micro-RNA-centered regulatory networks. In order to verify our interpretation, miR-486 was selected for further experiments. Overexpression or down-regulation of miR-486 in fructose-fed hamsters resulted in altered hepatic expression of proteins involved in VLDL production, and in modulated levels of circulating VLDL. Our findings implicated that miR-486 is a potential regulator of circulating VLDL levels. These results provide new insights and a valuable resource for further study of the molecular mechanisms of VLDL secretion.	[Li, Ziyang; Xiong, Chaoliang; Mo, Suo; Tian, Haiying; Yu, Mengqian; Mao, Tingting; Chen, Qian; Lu, Jianxin; Zhao, Yi; Li, Wei] Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou 325035, Peoples R China; [Lu, Jianxin; Li, Wei] Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Peoples R China; [Luo, Haitao; Zhao, Yi] Chinese Acad Sci, Adv Comp Res Ctr, Inst Comp Technol, Key Lab Intelligent Informat Proc,State Key Lab C, Beijing 100190, Peoples R China; [Li, Quanzhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Quanzhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA	Ministry of Education, China; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Institute of Computing Technology, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lu, JX; Zhao, Y; Li, W (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou 325035, Peoples R China.; Lu, JX; Li, W (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Peoples R China.; Zhao, Y (corresponding author), Chinese Acad Sci, Adv Comp Res Ctr, Inst Comp Technol, Key Lab Intelligent Informat Proc,State Key Lab C, Beijing 100190, Peoples R China.	jxlu313@163.com; biozy@ict.ac.cn; liweiwzmc@163.com	Zhao, Yi/A-2962-2011	Zhao, Yi/0000-0001-6046-8420; Xiong, Chaoliang/0000-0003-0124-2530	National Natural Science Foundation of China [81170749, 31370795]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Top Key Discipline in Clinical Medicine (Laboratory Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Top Key Discipline in Clinical Medicine (Laboratory Medicine)	This work was supported by National Natural Science Foundation of China (81170749 and 31370795), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (Wei Li), and Zhejiang Provincial Top Key Discipline in Clinical Medicine (Laboratory Medicine).	Adeli K, 2011, AM J PHYSIOL-ENDOC M, V301, pE1051, DOI 10.1152/ajpendo.00399.2011; Adiels M, 2006, CURR OPIN LIPIDOL, V17, P238, DOI 10.1097/01.mol.0000226115.97436.c0; ARBEENY CM, 1992, J LIPID RES, V33, P843; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai ZW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1283-0; Fu SX, 2012, CELL PHYSIOL BIOCHEM, V30, P1005, DOI 10.1159/000341477; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Jeon TI, 2013, CELL METAB, V18, P51, DOI 10.1016/j.cmet.2013.06.010; Ji J, 2015, SCI REPORTS, P5; Jiang Y, 2014, SCI REPORTS, P4; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Luo HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070835; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsusue K, 2010, BIOL PHARM BULL, V33, P346, DOI 10.1248/bpb.33.346; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Qiu W, 2004, DIABETES, V53, P3057, DOI 10.2337/diabetes.53.12.3057; Qiu W, 2008, HEPATOLOGY, V48, P1799, DOI 10.1002/hep.22565; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schmucki R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-237; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Stillemark P, 2000, J BIOL CHEM, V275, P10506, DOI 10.1074/jbc.275.14.10506; SWIFT LL, 1995, J LIPID RES, V36, P395; Taghibiglou C, 2000, J BIOL CHEM, V275, P8416, DOI 10.1074/jbc.275.12.8416; Taghibiglou C, 2000, J LIPID RES, V41, P499; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tchitchek N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112617; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang J, 2013, MOL BIOL REP, V40, P6765, DOI 10.1007/s11033-013-2793-y; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	51	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162402	10.1371/journal.pone.0162402	http://dx.doi.org/10.1371/journal.pone.0162402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589064	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877800056
J	Marrachelli, VG; Rentero, P; Mansego, ML; Morales, JM; Galan, I; Pardo-Tendero, M; Martinez, F; Martin-Escudero, JC; Briongos, L; Chaves, FJ; Redon, J; Monleon, D				Marrachelli, Vannina G.; Rentero, Pilar; Mansego, Maria L.; Manuel Morales, Jose; Galan, Inma; Pardo-Tendero, Mercedes; Martinez, Fernando; Carlos Martin-Escudero, Juan; Briongos, Laisa; Javier Chaves, Felipe; Redon, Josep; Monleon, Daniel			Genomic and Metabolomic Profile Associated to Clustering of Cardio-Metabolic Risk Factors	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; PATHWAYS; DISEASE; HEALTH; IDENTIFICATION; HYPERTENSION; POPULATION; PREVALENCE; BIOMARKERS	Background To identify metabolomic and genomic markers associated with the presence of clustering of cardiometabolic risk factors (CMRFs) from a general population. Methods and Findings One thousand five hundred and two subjects, Caucasian, > 18 years, representative of the general population, were included. Blood pressure measurement, anthropometric parameters and metabolic markers were measured. Subjects were grouped according the number of CMRFs (Group 1: <2; Group 2: 2; Group 3: 3 or more CMRFs). Using SNPlex, 1251 SNPs potentially associated to clustering of three or more CMRFs were analyzed. Serum metabolomic profile was assessed by H-1 NMR spectra using a Brucker Advance DRX 600 spectrometer. From the total population, 1217 (mean age 54 +/- 19, 50.6% men) with high genotyping call rate were analysed. A differential metabolomic profile, which included products from mitochondrial metabolism, extra mitochondrial metabolism, branched amino acids and fatty acid signals were observed among the three groups. The comparison of metabolomic patterns between subjects of Groups 1 to 3 for each of the genotypes associated to those subjects with three or more CMRFs revealed two SNPs, the rs174577_AA of FADS2 gene and the rs3803_TT of GATA2 transcription factor gene, with minimal or no statistically significant differences. Subjects with and without three or more CMRFs who shared the same genotype and metabolomic profile differed in the pattern of CMRFS cluster. Subjects of Group 3 and the AA genotype of the rs174577 had a lower prevalence of hypertension compared to the CC and CT genotype. In contrast, subjects of Group 3 and the TT genotype of the rs3803 polymorphism had a lower prevalence of T2DM, although they were predominantly males and had higher values of plasma creatinine. Conclusions The results of the present study add information to the metabolomics profile and to the potential impact of genetic factors on the variants of clustering of cardiometabolic risk factors.	[Marrachelli, Vannina G.; Manuel Morales, Jose; Pardo-Tendero, Mercedes] INCLIVA, Hlth Res Inst, Metabol & Mol Image Lab, Valencia, Spain; [Rentero, Pilar; Galan, Inma; Javier Chaves, Felipe] INCLIVA, Hlth Res Inst, Genotyping & Genet Diag Unit, Valencia, Spain; [Mansego, Maria L.] Univ Navarra, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Martinez, Fernando; Briongos, Laisa; Redon, Josep] Univ Valencia, INCLIVA Res Inst, Valencia, Spain; [Carlos Martin-Escudero, Juan] Hosp Rio Hortega, Internal Med, Valladolid, Spain; [Javier Chaves, Felipe] Hlth Inst Carlos III, CIBERDem, Madrid, Spain; [Redon, Josep] Hlth Inst Carlos III, CIBERObn, Madrid, Spain	University of Navarra; University of Valencia; Hospital del Rio Hortega; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Redon, J (corresponding author), Univ Valencia, INCLIVA Res Inst, Valencia, Spain.; Redon, J (corresponding author), Hlth Inst Carlos III, CIBERObn, Madrid, Spain.	josep.redon@uv.es	MartÃnez, Fernando/AAO-5879-2021; Rentero-Garrido, Pilar/AAC-1788-2019; Monleon, Daniel/A-5078-2010; Pardo-Tendero, María Mercedes/AAV-3301-2021; Chaves-Martinez, Felipe Javier/ABC-3294-2021; tatay, jose manuel morales/L-7972-2014; Monleon, Daniel/GNP-4083-2022; REDON, JOSEP/E-1719-2019; marrachelli, vannina G/L-6041-2014; Redon, Josep/L-5997-2019	MartÃnez, Fernando/0000-0001-8562-4477; Monleon, Daniel/0000-0002-4803-1573; Pardo-Tendero, María Mercedes/0000-0001-8878-8311; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; tatay, jose manuel morales/0000-0002-4404-6735; Monleon, Daniel/0000-0002-4803-1573; marrachelli, vannina G/0000-0002-4097-3312; Redon, Josep/0000-0001-8777-6773; Rentero-Garrido, Pilar/0000-0002-6158-0104; Martin-Escudero, Juan Carlos/0000-0002-6209-6509	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH European Commission, 7th Framework Programme [2011.2.4.2-2]; FEDER; EU;  [PS09/02014];  [SAF2011-23029];  [PI 12/02615]	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH European Commission, 7th Framework Programme; FEDER(European Commission); EU(European Commission); ; ; 	The study has been funded by the Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, 2011.2.4.2-2 European Commission, 7th Framework Programme; and the grants PS09/02014, SAF2011-23029, PI 12/02615 and Research Funds from FEDER, EU.	Alegria E, 2005, REV ESP CARDIOL, V58, P797, DOI 10.1157/13077231; BRADY PS, 1982, J BIOL CHEM, V257, P9290; Chang YC, 2001, ELS; Duarte IF, 2014, J PHARMACEUT BIOMED, V93, P17, DOI 10.1016/j.jpba.2013.09.025; Fernandez-Berges D, 2011, GAC SANIT, V25, P519, DOI 10.1016/j.gaceta.2011.05.009; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guallar-Castillon P, 2014, REV ESP CARDIOL, V67, P367, DOI [10.1016/j.rec.2013.08.014, 10.1016/j.recesp.2013.08.014]; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; IWASAKI Y, 1980, GASTROENTEROLOGY, V78, P677; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim OY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-24; Kordalewska M, 2015, J PHARMACEUT BIOMED, V113, P121, DOI 10.1016/j.jpba.2015.04.021; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lin Z, 2014, ANAL CHIM ACTA, V827, P22, DOI [10.1016/j.aca.2014.04.008, 10.1016/j.aca.2014.04.039]; Medina S, 2014, CURR MED CHEM, V21, P823, DOI 10.2174/0929867320666131119124056; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Stoffel W, 2014, EMBO REP, V15, P110, DOI 10.1002/embr.201338041; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2003, DRUG NEWS PERSPECT, V16, P585, DOI 10.1358/dnp.2003.16.9.829340; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Walsh MC, 2014, BRIT J NUTR, V111, P424, DOI 10.1017/S0007114513002602; Wiklund PK, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-40; Yu ZR, 2014, J HUAZHONG U SCI-MED, V34, P276, DOI 10.1007/s11596-014-1271-7; Zhang AH, 2014, CLIN CHIM ACTA, V429, P106, DOI 10.1016/j.cca.2013.11.037; Zhang AH, 2012, ANALYST, V137, P4200, DOI 10.1039/c2an35780a; Zhong L, 2014, EUR REV MED PHARMACO, V18, P3673	35	10	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0160656	10.1371/journal.pone.0160656	http://dx.doi.org/10.1371/journal.pone.0160656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589269	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800004
J	Corral, A; Garcia-Millan, R; Font-Clos, F				Corral, Alvaro; Garcia-Millan, Rosalba; Font-Clos, Francesc			Exact Derivation of a Finite-Size Scaling Law and Corrections to Scaling in the Geometric Galton-Watson Process	PLOS ONE			English	Article							THERMODYNAMICS	The theory of finite-size scaling explains how the singular behavior of thermodynamic quantities in the critical point of a phase transition emerges when the size of the system becomes infinite. Usually, this theory is presented in a phenomenological way. Here, we exactly demonstrate the existence of a finite-size scaling law for the Galton-Watson branching processes when the number of offsprings of each individual follows either a geometric distribution or a generalized geometric distribution. We also derive the corrections to scaling and the limits of validity of the finite-size scaling law away the critical point. A mapping between branching processes and random walks allows us to establish that these results also hold for the latter case, for which the order parameter turns out to be the probability of hitting a distant boundary.	[Corral, Alvaro] Ctr Recerca Matemat, Edifici C,Campus Bellaterra, E-08193 Barcelona, Spain; [Corral, Alvaro] Univ Autonoma Barcelona, Fac Ciencies, Dept Matemat, E-08193 Barcelona, Spain; [Garcia-Millan, Rosalba] London Math Lab, 14 Buckingham St, London WC2N 6DF, England; [Garcia-Millan, Rosalba] Math Inst, Andrew Wiles Bldg,Woodstock Rd, Oxford OX2 6GG, England; [Font-Clos, Francesc] ISI Fdn, Via Alassio 11-c, I-10126 Turin, Italy	Centre de Recerca Matematica (CRM); Autonomous University of Barcelona; University of Oxford	Corral, A (corresponding author), Ctr Recerca Matemat, Edifici C,Campus Bellaterra, E-08193 Barcelona, Spain.; Corral, A (corresponding author), Univ Autonoma Barcelona, Fac Ciencies, Dept Matemat, E-08193 Barcelona, Spain.	alvaro.corral@uab.es	Corral, Alvaro/I-5590-2015	Corral, Alvaro/0000-0002-5280-2692; Font-Clos, Francesc/0000-0003-4938-2452	Spanish MINECO [FIS2012-31324]; AGAUR [2014SGR-1307]	Spanish MINECO(Spanish Government); AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by FIS2012-31324, from Spanish MINECO, http://www.mineco.gob.es/portal/site/mineco/; and 2014SGR-1307, from AGAUR, http://agaur.gencat.cat/ca/inici/. MINECO (Spanish Government) and AGAUR (Catalan Government) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTROM P, 1988, PHYS REV A, V38, P4905, DOI 10.1103/PhysRevA.38.4905; Barber M., 1983, PHASE TRANSITIONS CR, P145; BHATTACHARJEE SM, 1985, PHYS REV A, V31, P3199, DOI 10.1103/PhysRevA.31.3199; Bhattacharjee SM, 2001, S COND MATTER PHYS, P69; BREZIN E, 1982, J PHYS-PARIS, V43, P15, DOI 10.1051/jphys:0198200430101500; Bustamante C, 2005, PHYS TODAY, V58, P43, DOI 10.1063/1.2012462; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; Corral A., 2013, SELF ORG CRITICALITY, P183; Font-Clos F, 160503764 ARXIV; Garcia-Millan R, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042122; Harris T. E., 1963, THEORY BRANCHING PRO; HARRIS TE, 1952, T AM MATH SOC, V73, P471, DOI 10.2307/1990803; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kimmel M., 2002, BRANCHING PROCESSES; Kuzemsky AL, 2014, INT J MOD PHYS B, V28, DOI 10.1142/S0217979214300047; Parrondo JMR, 2015, NAT PHYS, V11, P131, DOI 10.1038/NPHYS3230; Pazsit I, 2008, NEUTRON FLUCTUATIONS: A TREATISE ON THE PHYSICS OF BRANCHING PROCESSES, P1; Privman V., 1990, FINITE SIZE SCALING, P1; Pruessner G, 2012, SELF-ORGANISED CRITICALITY: THEORY, MODELS AND CHARACTERISATION, P1; Stanley H.E., 1973, PHYS TODAY, V26, P71; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; Turalska M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061142; Watson H.W., 1875, J ANTHR I GREAT BRIT, V4, P138, DOI DOI 10.2307/2841222; Weisstein Eric W., MATHWORLD; Yeomans J.M., 1992, STAT MECH PHASE TRAN, VVolume 19; ZAPPERI S, 1995, PHYS REV LETT, V75, P4071, DOI 10.1103/PhysRevLett.75.4071	26	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161586	10.1371/journal.pone.0161586	http://dx.doi.org/10.1371/journal.pone.0161586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584596	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600043
J	Ding, N; Wang, X; Weisskopf, MG; Sparrow, D; Schwartz, J; Hu, H; Park, SK				Ding, Ning; Wang, Xin; Weisskopf, Marc G.; Sparrow, David; Schwartz, Joel; Hu, Howard; Park, Sung Kyun			Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ACID DEHYDRATASE GENOTYPE; X-RAY-FLUORESCENCE; OXIDATIVE STRESS; BLOOD LEAD; VITAMIN-D; PULSE PRESSURE; APOE GENOTYPE; NITRIC-OXIDE; POLYMORPHISM	Background Cumulative exposure to lead is associated with cardiovascular outcomes. Polymorphisms in the delta-aminolevulinic acid dehydratase (ALAD), hemochromatosis (HFE), heme oxygenase-1 (HMOX1), vitamin D receptor (VDR), glutathione S-transferase (GST) supergene family (GSTP1, GSTT1, GSTM1), apolipoprotein E (APOE), angiotensin II receptor-1 (AGTR1) and angiotensinogen (AGT) genes, are believed to alter toxicokinetics and/or toxi-codynamics of lead. Objectives We assessed possible effect modification by genetic polymorphisms in ALAD, HFE, HMOX1, VDR, GSTP1, GSTT1, GSTM1, APOE, AGTR1 and AGT individually and as the genetic risk score (GRS) on the association between cumulative lead exposure and incident coronary heart disease (CHD) events. Methods We used K-shell-X-ray fluorescence to measure bone lead levels. GRS was calculated on the basis of 22 lead-related loci. We constructed Cox proportional hazard models to compute adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CHD. We applied inverse probability weighting to account for potential selection bias due to recruitment into the bone lead sub-study. Results Significant effect modification was found by VDR, HMOX1, GSTP1, APOE, and AGT genetic polymorphisms when evaluated individually. Further, the bone lead-CHD associations became larger as GRS increases. After adjusting for potential confounders, a HR of CHD was 2.27 (95%CI: 1.50-3.42) with 2-fold increase in patella lead levels, among participants in the top tertile of GRS. We also detected an increasing trend in HRs across tertiles of GRS (p-trend = 0.0063). Conclusions Our findings suggest that lead-related loci as a whole may play an important role in susceptibility to lead-related CHD risk. These findings need to be validated in a separate cohort containing bone lead, lead-related genetic loci and incident CHD data.	[Ding, Ning; Wang, Xin; Park, Sung Kyun] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Weisskopf, Marc G.; Schwartz, Joel] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Sparrow, David] Vet Affairs Boston Healthcare Syst, Vet Affairs Normat Aging Study, Boston, MA USA; [Sparrow, David] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Hu, Howard] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hu, Howard; Park, Sung Kyun] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Toronto; University of Michigan System; University of Michigan	Park, SK (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Park, SK (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	sungkyun@umich.edu	Ding, Ning/AAQ-2262-2020; Hu, Howard/AAV-5360-2021	Ding, Ning/0000-0001-5244-2909; Wang, Xin/0000-0002-0851-6605; Hu, Howard/0000-0002-3676-2707; Park, Sung Kyun/0000-0001-9981-6250	National Institute of Environmental Health Sciences (NIEHS) [R01-ES005257, K01-ES016587, P30-ES017885]; Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH) [T42-OH008455]; VA Research Career Scientist Award; Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES016587, P30ES017885, R01ES005257] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH); VA Research Career Scientist Award; Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS) R01-ES005257, K01-ES016587 and P30-ES017885, and by the Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH) grant T42-OH008455. Dr. David Sparrow was supported by a VA Research Career Scientist Award. The VA Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS) R01-ES005257, K01-ES016587 and P30-ES017885, and by the Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH) grant T42-OH008455. Dr. David Sparrow was supported by a VA Research Career Scientist Award. The VA Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts.	Alexander BH, 1998, ENVIRON HEALTH PERSP, V106, P213, DOI 10.2307/3433966; ARO ACA, 1994, PHYS MED BIOL, V39, P2263, DOI 10.1088/0031-9155/39/12/009; Ashrafunnisa Begum AV, 2014, INT J SCI RES, V3, P318; Ballatori N, 1994, Adv Pharmacol, V27, P271, DOI 10.1016/S1054-3589(08)61036-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergdahl IA, 1997, PHARMACOL TOXICOL, V81, P153, DOI 10.1111/j.1600-0773.1997.tb02061.x; Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004; Birdsall RE, 2010, J PROTEOME RES, V9, P4443, DOI 10.1021/pr100204g; Calafat AM, 2012, INT J HYG ENVIR HEAL, V215, P99, DOI 10.1016/j.ijheh.2011.08.014; CAMPBELL BC, 1985, TOXICOL LETT, V25, P25, DOI 10.1016/0378-4274(85)90096-7; Choi SH, 2009, CLIN ENDOCRINOL, V71, P644, DOI 10.1111/j.1365-2265.2009.03535.x; Colton CA, 2002, NEUROBIOL AGING, V23, P777, DOI 10.1016/S0197-4580(02)00016-7; Cooper GS, 1996, J BONE MINER RES, V11, P1841; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; Dietze EC, 1996, BIOCHEMISTRY-US, V35, P11938, DOI 10.1021/bi961073r; Ekong EB, 2006, KIDNEY INT, V70, P2074, DOI 10.1038/sj.ki.5001809; Ercal N, 1996, TOXICOLOGY, V108, P57, DOI 10.1016/S0300-483X(95)03273-I; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Gunnar F N, 2014, HDB TOXICOLOGY METAL, Vfourth; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Haynes EN, 2003, ENVIRON HEALTH PERSP, V111, P1665, DOI 10.1289/ehp.6167; Hu H, 2001, ENVIRON HEALTH PERSP, V109, P827, DOI 10.2307/3454826; HU H, 1995, ENVIRON HEALTH PERSP, V103, P105, DOI 10.2307/3432024; Hurwitz S, 1996, CRIT REV BIOCHEM MOL, V31, P41, DOI 10.3109/10409239609110575; Jhun MA, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-5; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kim HK, 2014, J RENIN ANGIOTENSIN; Li HM, 2014, ANGIOLOGY, V65, P614, DOI 10.1177/0003319713491309; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Mannila MN, 2013, ARTERIOSCL THROM VAS, V33, P1063, DOI 10.1161/ATVBAHA.112.300353; Coral-Vazquez RM, 2013, CLIN BIOCHEM, V46, P627, DOI 10.1016/j.clinbiochem.2012.12.016; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Miyaki K, 2009, INT J ENV RES PUB HE, V6, P999, DOI 10.3390/ijerph6030999; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Park SK, 2009, ENVIRON HEALTH PERSP, V117, P80, DOI 10.1289/ehp.11559; Pawlas N, 2012, NEUROTOXICOLOGY, V33, P37, DOI 10.1016/j.neuro.2011.10.012; Pilbrow AP, 2007, HYPERTENSION, V49, P322, DOI 10.1161/01.HYP.0000253061.30170.68; POUNDS JG, 1984, NEUROTOXICOLOGY, V5, P295; Program NT, 2012, NTP MON, pi; Rezende VB, 2008, ARCH TOXICOL, V82, P29, DOI 10.1007/s00204-007-0231-4; Rodriguez-Iturbe B, 2005, ANTIOXID REDOX SIGN, V7, P1269, DOI 10.1089/ars.2005.7.1269; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; SCHWARTZ BS, 1995, AM J EPIDEMIOL, V142, P738, DOI 10.1093/oxfordjournals.aje.a117705; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Sheng-jie Nie TW, 2009, CLIN BIOCHEM, V43, P253, DOI [10.1016/j.clinbiochem, DOI 10.1016/J.CLINBIOCHEM]; Sirivarasai J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/474963; Stewart WF, 2002, ENVIRON HEALTH PERSP, V110, P501, DOI 10.1289/ehp.02110501; Tanaka G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-117; Theppeang K, 2008, ENVIRON HEALTH PERSP, V116, P784, DOI 10.1289/ehp.10977; Tolonen S, 2011, BONE, V48, P1058, DOI 10.1016/j.bone.2011.01.013; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Warrell DA, 2010, OXFORD TXB MED; WASSERMAN RH, 1995, J NUTR, V125, pS1971, DOI 10.1093/jn/125.suppl_7.1971S; Weisskopf MG, 2015, ENVIRON HEALTH PERSP, V123, P1113, DOI 10.1289/ehp.1408888; WETMUR JG, 1994, ENVIRON HEALTH PERSP, V102, P215, DOI 10.2307/3431789; Wilker E, 2011, J OCCUP ENVIRON MED, V53, P850, DOI 10.1097/JOM.0b013e31822589a9; Willerson JT, 2015, CARDIOVASC MED-LOND, P461, DOI 10.1007/978-1-4471-2828-1_18; Wright RO, 2004, ENVIRON HEALTH PERSP, V112, P746, DOI 10.1289/ehp.6581; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Zhang AM, 2010, ENVIRON HEALTH PERSP, V118, P1261, DOI 10.1289/ehp.1002251	64	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161472	10.1371/journal.pone.0161472	http://dx.doi.org/10.1371/journal.pone.0161472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584680	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600032
J	Garcia-Martin, E; Garcia-Campayo, J; Puebla-Guedea, M; Ascaso, FJ; Roca, M; Gutierrez-Ruiz, F; Vilades, E; Polo, V; Larrosa, JM; Pablo, LE; Satue, M				Garcia-Martin, Elena; Garcia-Campayo, Javier; Puebla-Guedea, Marta; Ascaso, Francisco J.; Roca, Miguel; Gutierrez-Ruiz, Fernando; Vilades, Elisa; Polo, Vicente; Larrosa, Jose M.; Pablo, Luis E.; Satue, Maria			Fibromyalgia Is Correlated with Retinal Nerve Fiber Layer Thinning	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LINEAR DISCRIMINANT FUNCTION; SPANISH VERSION; HEALTH-STATUS; DISEASE; THICKNESS; REPRODUCIBILITY; QUESTIONNAIRE; DISABILITY; PERFUSION	Objective To investigate whether fibromyalgia induces axonal damage in the optic nerve that can be detected using optical coherence tomography (OCT), as the retinal nerve fiber layer (RNFL) is atrophied in patients with fibromyalgia compared with controls. Methods Fibromyalgia patients (n = 116) and age-matched healthy controls (n = 144) were included in this observational and prospective cohort study. All subjects underwent visual acuity measurement and structural analysis of the RNFL using two OCT devices (Cirrus and Spectralis). Fibromyalgia patients were evaluated according to Giesecke's fibromyalgia subgroups, the Fibromyalgia Impact Questionnaire (FIQ), and the European Quality of Life-5 Dimensions (EQ5D) scale. We compared the differences between fibromyalgia patients and controls, and analyzed the correlations between OCT measurements, disease duration, fibromyalgia subgroups, severity, and quality of life. The impact on quality of life in fibromyalgia subgroups and in patients with different disease severity was also analyzed. Results A significant decrease in the RNFL was detected in fibromyalgia patients compared with controls using the two OCT devices: Cirrus OCT ganglion cell layer analysis registered a significant decrease in the minimum thickness of the inner plexiform layer (74.99 +/- 16.63 vs 79.36 +/- 3.38 mu m, respectively; p = 0.023), nasal inferior, temporal inferior and temporal superior sectors (p = 0.040; 0.011 and 0.046 respectively). The Glaucoma application of the Spectralis OCT revealed thinning in the nasal, temporal inferior and temporal superior sectors (p = 0.009, 0.006, and 0.002 respectively) of fibromyalgia patients and the Axonal application in all sectors, except the nasal superior and temporal sectors. The odds ratio (OR) to estimate the size effect of FM in RNFL thickness was 1.39. RNFL atrophy was detected in patients with FIQ scores <60 (patients in early disease stages) compared with controls in the temporal inferior sector (78.74 +/- 17.75 vs 81.65 +/- 3.61; p = 0.020) and the temporal superior sector (78.20 +/- 14.50 vs 80.74 +/- 3.88; p = 0.039) with Cirrus OCT; in the temporal inferior sector (145.85 +/- 24.32 vs 150.18 +/- 19.71; p = 0.012) and temporal superior sector (131.54 +/- 20.53 vs 138.13 +/- 16.67; p = 0.002) with the Glaucoma application of the Spectralis OCT; and in all sectors, except the average, nasal superior, and temporal sectors, and parameters with the Axonal application of the Spectralis OCT. Temporal inferior RNFL thickness was significantly reduced in patients with severe fibromyalgia (FIQ >= 60) compared with patients with mild fibromyalgia (FIQ<60; 145.85 +/- 24.32 vs 138.99 +/- 18.09 mu m, respectively; 145.43 +/- 13.21 vs 139.85 +/- 13.09 mu m, p = 0.032 with the Glaucoma application and p = 0.021 with the Axonal application). The subgroup with biologic fibromyalgia exhibited significant thinning in the temporal inferior and superior sectors (115.17 +/- 20.82 mu m and 117.05 +/- 24.19 mu m, respectively) compared with the depressive (130.83 +/- 22.97 mu m and 127.71 +/- 26.10 mu m, respectively) and atypical (128.60 +/- 26.54 mu m and 125.55 +/- 23.65 mu m, respectively) subgroups (p = 0.005 and 0.001 respectively). Conclusions Fibromyalgia causes subclinical axonal damage in the RNFL that can be detected using innocuous and non-invasive OCT, even in the early disease stages. The impact on the RNFL in the temporal sectors is greater in patients with biologic fibromyalgia, suggesting the presence of neurodegenerative processes in this subgroup of patients with fibromyalgia.	[Garcia-Martin, Elena; Gutierrez-Ruiz, Fernando; Vilades, Elisa; Polo, Vicente; Larrosa, Jose M.; Pablo, Luis E.; Satue, Maria] Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Garcia-Martin, Elena; Garcia-Campayo, Javier; Puebla-Guedea, Marta; Ascaso, Francisco J.; Gutierrez-Ruiz, Fernando; Vilades, Elisa; Polo, Vicente; Larrosa, Jose M.; Pablo, Luis E.; Satue, Maria] IIS Aragon, Aragones Inst Hlth Res, Zaragoza, Spain; [Garcia-Campayo, Javier; Puebla-Guedea, Marta] Miguel Servet Univ Hosp, Dept Psychiat, Red Invest Atenc Primaria REDIAPP, Zaragoza, Spain; [Ascaso, Francisco J.] Lozano Blesa Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Roca, Miguel] Univ Balearic Isl, Inst Univ Invest Ciencies Salut IUNICS, Palma De Mallorca, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Universitat de les Illes Balears	Garcia-Martin, E (corresponding author), Miguel Servet Univ Hosp, Dept Ophthalmol, Zaragoza, Spain.; Garcia-Martin, E (corresponding author), IIS Aragon, Aragones Inst Hlth Res, Zaragoza, Spain.	egmvivax@yahoo.com	PUYUELO, FCO. JAVIER ASCASO/I-8426-2019; Roca, Miquel/T-9897-2017	Roca, Miquel/0000-0001-7301-8373; Polo Llorens, Vicente/0000-0002-1402-3129; Garcia-Campayo, Javier/0000-0002-3797-4218; GARCIA-MARTIN, ELENA/0000-0001-6258-2489; Satue, Maria/0000-0002-1609-5994; Perez-Olivan, Susana/0000-0003-3513-4714; Larrosa, Jose Manuel/0000-0003-4403-4854; Larrosa Poves, Jose Manuel/0000-0002-6745-7668; Pablo, Luis/0000-0003-2389-8282				Aaker GD, 2010, CLIN OPHTHALMOL, V4, P1427, DOI 10.2147/OPTH.S15136; Almarcegui C, 2010, NEUROPHYSIOL CLIN, V40, P129, DOI 10.1016/j.neucli.2009.12.001; Badia X, 1999, MED CLIN-BARCELONA, V112, P79; Bennett RM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-27; Clauw DJ, 2011, MAYO CLIN PROC, V86, P907, DOI 10.4065/mcp.2011.0206; Foerster BR, 2011, AM J NEURORADIOL, V32, P1873, DOI 10.3174/ajnr.A2614; Garcia-Campayo J, 2009, CURR OPIN PSYCHIATR, V22, P224, DOI 10.1097/YCO.0b013e3283252d43; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Garcia-Martin E, 2013, NEUROLOGY, V81, P76, DOI 10.1212/WNL.0b013e318299ccd9; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P1705, DOI 10.1016/j.ophtha.2012.01.046; Garcia-Martin E, 2011, BRIT J OPHTHALMOL, V95, P1577, DOI 10.1136/bjo.2010.199232; Giesecke T, 2003, ARTHRITIS RHEUM, V48, P2916, DOI 10.1002/art.11272; Goldenberg DL, 2009, AM J MED, V122, P14; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Grazioli E, 2008, J NEUROL SCI, V268, P12, DOI 10.1016/j.jns.2007.10.020; Gupta Preeya K, 2011, Open Neurol J, V5, P1, DOI 10.2174/1874205X01105010001; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Larrosa JM, 2014, INVEST OPHTH VIS SCI, V55, P3043, DOI 10.1167/iovs.13-13629; Mountz JM, 1998, AM J MED SCI, V315, P385, DOI 10.1097/00000441-199806000-00007; Noval S, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/472790; Polo V, 2014, EYE, V28, P680, DOI 10.1038/eye.2014.51; Pulicken M, 2007, NEUROLOGY, V69, P2085, DOI 10.1212/01.wnl.0000294876.49861.dc; Ratchford JN, 2009, NEUROLOGY, V73, P302, DOI 10.1212/WNL.0b013e3181af78b8; Rivera J, 2004, CLIN EXP RHEUMATOL, V22, P554; Saidha S, 2013, JAMA NEUROL, V70, P34, DOI 10.1001/jamaneurol.2013.573; Satue M, 2014, BRIT J OPHTHALMOL, V98, P350, DOI 10.1136/bjophthalmol-2013-304152; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Shokouhi M, 2016, CLIN J PAIN, V32, P495, DOI 10.1097/AJP.0000000000000295; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wu ZQ, 2009, J GLAUCOMA, V18, P213, DOI 10.1097/IJG.0b013e31817eee20	32	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161574	10.1371/journal.pone.0161574	http://dx.doi.org/10.1371/journal.pone.0161574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584145	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600042
J	Ramalhosa, F; Soares-Cunha, C; Seixal, RM; Sousa, N; Carvalho, F				Ramalhosa, Fatima; Soares-Cunha, Carina; Seixal, Rui Miguel; Sousa, Nuno; Carvalho, Franky			The Impact of Prenatal Exposure to Dexamethasone on Gastrointestinal Function in Rats	PLOS ONE			English	Article							NEONATAL MATERNAL SEPARATION; ENTERIC NERVOUS-SYSTEM; IRRITABLE-BOWEL-SYNDROME; EPIDERMAL-GROWTH-FACTOR; INTERSTITIAL-CELLS; ANTENATAL CORTICOSTEROIDS; GASTRIC-MOTILITY; POSTNATAL-DEVELOPMENT; TRYPTOPHAN-HYDROXYLASE; INTESTINAL MOTILITY	Antenatal treatment with synthetic glucocorticoids is commonly used in pregnant women at risk of preterm delivery to accelerate tissue maturation. Exposure to glucocorticoids during development has been hypothesized to underlie different functional gastrointestinal (GI) and motility disorders. Herein, we investigated the impact of in utero exposure to synthetic glucocorticoids (iuGC) on GI function of adult rats. Wistar male rats, born from pregnant dams treated with dexamethasone (DEX), were studied at different ages. Length, histologic analysis, proliferation and apoptosis assays, GI transit, permeability and serotonin (5-HT) content of GI tract were measured. iuGC treatment decreased small intestine size and decreased gut transit. However, iuGC had no impact on intestinal permeability. iuGC differentially impacts the structure and function of the GI tract, which leads to long-lasting alterations in the small intestine that may predispose subjects prone to disorders of the GI tract.	[Ramalhosa, Fatima; Soares-Cunha, Carina; Seixal, Rui Miguel; Sousa, Nuno; Carvalho, Franky] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal; [Ramalhosa, Fatima; Soares-Cunha, Carina; Seixal, Rui Miguel; Sousa, Nuno; Carvalho, Franky] Life & Hlth Sci Res Inst Biomaterials, Biodegradables & Biometr Associate Lab, Braga, Portugal; [Carvalho, Franky] Hosp Braga, Dept Gen Surg, Braga, Portugal; [Sousa, Nuno] Univ Minho, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal	Universidade do Minho; Hospital de Braga; Universidade do Minho	Ramalhosa, F (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal.; Ramalhosa, F (corresponding author), Life & Hlth Sci Res Inst Biomaterials, Biodegradables & Biometr Associate Lab, Braga, Portugal.	fatimaramalhosa@ecsaude.uminho.pt	Ramalhosa, FÃtima/L-3648-2019; Sousa, Nuno JC/N-9137-2017; Soares-Cunha, Carina/T-5091-2018	Sousa, Nuno JC/0000-0002-8755-5126; Seixal, Rui/0000-0002-6932-9432; Soares-Cunha, Carina/0000-0001-9470-644X; Ramalhosa, Fatima/0000-0003-4986-4320; Carvalho, Ana/0000-0002-5901-0399	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/52058/2012, SFRH/BD/51992/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	We acknowledge the Portuguese Foundation for Science and Technology (FCT) for providing a fellowship to Fatima Ramalhosa (SFRH/BD/52058/2012) and Carina Soares-Cunha (SFRH/BD/51992/2012).	Anderson RB, 2000, LANDES BIOSCIENCE; AZMITIA EC, 1993, J NEUROSCI, V13, P5041, DOI 10.1523/JNEUROSCI.13-12-05041.1993; Babygirija R, 2010, AM J PHYSIOL-REG I, V298, pR157, DOI 10.1152/ajpregu.00328.2009; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; BERSETH CL, 1987, AM J PHYSIOL, V253, pG662, DOI 10.1152/ajpgi.1987.253.5.G662; Biology C, 1998, SITU, P36; Jimenez MB, 2009, REV ESP ENFERM DIG, V101, P553, DOI 10.4321/s1130-01082009000800006; BLAKE HH, 1983, AM J PHYSIOL, V244, pR537, DOI 10.1152/ajpregu.1983.244.4.R537; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; BRANCHEK TA, 1989, J COMP NEUROL, V285, P262, DOI 10.1002/cne.902850208; BRANCHEK TA, 1987, J COMP NEUROL, V258, P597, DOI 10.1002/cne.902580409; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Bulbul M, 2012, AM J PHYSIOL-GASTR L, V302, pG702, DOI 10.1152/ajpgi.00447.2011; Burns AJ, 2009, SEMIN PEDIATR SURG, V18, P196, DOI 10.1053/j.sempedsurg.2009.07.001; Carai MAM, 2004, EUR J PHARMACOL, V494, P221, DOI 10.1016/j.ejphar.2004.05.005; Chang L, 2009, NEUROGASTROENT MOTIL, V21, P149, DOI 10.1111/j.1365-2982.2008.01171.x; Chen M, 2011, WORLD J GASTROENTERO, V17, P2933, DOI 10.3748/wjg.v17.i24.2933; Chmielewski V, 2000, IMMUNOL CELL BIOL, V78, P238, DOI 10.1046/j.1440-1711.2000.00905.x; Cho Won Kyoung, 2016, Korean J Pediatr, V59, P1, DOI 10.3345/kjp.2016.59.1.1; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Clarke G, 2009, TRENDS MOL MED, V15, P478, DOI 10.1016/j.molmed.2009.08.001; Coates MD, 2006, NEUROGASTROENT MOTIL, V18, P464, DOI 10.1111/j.1365-2982.2006.00792.x; Collins J, 2014, NEUROGASTROENT MOTIL, V26, P98, DOI 10.1111/nmo.12236; Costalos C, 2003, EARLY HUM DEV, V74, P83, DOI 10.1016/S0378-3782(03)00087-2; Coutinho SV, 2002, AM J PHYSIOL-GASTR L, V282, pG307, DOI 10.1152/ajpgi.00240.2001; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Crowther CA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-104; Der-Silaphet T, 1998, GASTROENTEROLOGY, V114, P724, DOI 10.1016/S0016-5085(98)70586-4; Di Mauro A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-15; DIORIO D, 1993, J NEUROSCI, V13, P3839; Enomoto H, 2009, NEUROGASTROENT MOTIL, V21, P684, DOI 10.1111/j.1365-2982.2009.01325.x; Falcone RA, 2000, J PEDIATR SURG, V35, P365, DOI 10.1016/S0022-3468(00)90042-3; FaussonePellegrini MS, 1996, ACTA ANAT, V155, P113; Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3; Finlay BL, 1998, BRAIN BEHAV EVOLUT, V52, P232, DOI 10.1159/000006566; French NP, 2004, AM J OBSTET GYNECOL, V190, P588, DOI 10.1016/j.ajog.2003.12.016; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gartner H, 2003, J CELL PHYSIOL, V194, P80, DOI 10.1002/jcp.10189; Gianino S, 2003, DEVELOPMENT, V130, P2187, DOI 10.1242/dev.00433; Gordon PV, 2001, PEDIATR DEVEL PATHOL, V4, P532, DOI 10.1007/s10024001-0096-0; Guan YF, 2003, BRAIN RES, V984, P33, DOI 10.1016/S0006-8993(03)03016-6; Gwynne RM, 2007, AM J PHYSIOL-GASTR L, V292, pG1162, DOI 10.1152/ajpgi.00441.2006; Han J, 2010, HISTOCHEM CELL BIOL, V133, P163, DOI 10.1007/s00418-009-0655-4; Hao MM, 2010, NEUROGASTROENT MOTIL, V22, pe127, DOI 10.1111/j.1365-2982.2009.01462.x; Hassan AHS, 1996, EXP NEUROL, V140, P43, DOI 10.1006/exnr.1996.0113; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; He X, 2012, CELLS TISSUES ORGANS, V196, P175, DOI 10.1159/000332381; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; Hiroi R, 2016, NEUROSCIENCE, V320, P43, DOI 10.1016/j.neuroscience.2016.01.055; Hirvikoski T, 2007, J CLIN ENDOCR METAB, V92, P542, DOI 10.1210/jc.2006-1340; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; HURLEYGIUS KM, 1986, BRAIN RES, V365, P241, DOI 10.1016/0006-8993(86)91635-5; KEDINGER M, 1990, DIFFERENTIATION, V43, P87, DOI 10.1111/j.1432-0436.1990.tb00434.x; Keightley MC, 1998, ENDOCRINOLOGY, V139, P2479, DOI 10.1210/en.139.5.2479; Klooker TK, 2009, AM J GASTROENTEROL, V104, P2250, DOI 10.1038/ajg.2009.282; LEES GJ, 1993, J NEUROL SCI, V114, P119, DOI 10.1016/0022-510X(93)90285-7; Liu DR, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-30; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Lundgren O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016295; Luo JC, 2003, J PHARMACOL EXP THER, V307, P692, DOI 10.1124/jpet.103.055202; MAJUMDAR APN, 1985, SCAND J GASTROENTERO, V20, P65, DOI 10.3109/00365528509089634; Marciniak B, 2011, CURR PHARM BIOTECHNO, V12, P750, DOI 10.2174/138920111795470868; MARTIN GR, 1984, AM J PHYSIOL, V246, pG695, DOI 10.1152/ajpgi.1984.246.6.G695; Matini P, 1997, CELL TISSUE RES, V288, P11, DOI 10.1007/s004410050788; Mesquita AR, 2009, SEMIN FETAL NEONAT M, V14, P130, DOI 10.1016/j.siny.2008.11.002; MIETTINEN PJ, 1993, PEDIATR RES, V33, P481, DOI 10.1203/00006450-199305000-00012; Mihatsch WA, 2005, BIOL NEONATE, V87, P160, DOI 10.1159/000082367; Miracle X, 2008, J PERINAT MED, V36, P191, DOI 10.1515/JPM.2008.032; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Nagano M, 2012, NEUROPHARMACOLOGY, V63, P292, DOI 10.1016/j.neuropharm.2012.03.027; Nahata M, 2014, NEUROGASTROENT MOTIL, V26, P821, DOI 10.1111/nmo.12336; Nanthakumar NN, 2013, GLYCOBIOLOGY, V23, P1131, DOI 10.1093/glycob/cwt050; NANTHAKUMAR NN, 1993, AM J PHYSIOL, V264, pG306, DOI 10.1152/ajpgi.1993.264.2.G306; Nasyrova DI, 2009, J EVOL BIOCHEM PHYS+, V45, P78, DOI 10.1134/S0022093009010074; Neal CR, 2004, AM J PHYSIOL-REG I, V287, pR375, DOI 10.1152/ajpregu.00012.2004; Nijenhuis CM, 2012, BRIT J CLIN PHARMACO, V73, P16, DOI 10.1111/j.1365-2125.2011.04075.x; Noorlander CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085671; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; Oines E, 2012, PHYSIOL BEHAV, V105, P1058, DOI 10.1016/j.physbeh.2011.11.024; Oliveira M, 2006, BIOL PSYCHIAT, V59, P844, DOI 10.1016/j.biopsych.2005.08.020; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Orazizadeh M, 2010, ANDROLOGIA, V42, P247, DOI 10.1111/j.1439-0272.2009.00985.x; Pacha J, 2003, PEDIATR RES, V53, P808, DOI 10.1203/01.PDR.0000058923.08017.6F; Panteleev S, 2000, AUTON NEUROSCI-BASIC, V86, P78, DOI 10.1016/S1566-0702(00)00249-6; PRESSLEY L, 1975, ENDOCRINOLOGY, V97, P588, DOI 10.1210/endo-97-3-588; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Rich-Edwards JW, 2005, BMJ-BRIT MED J, V330, P1115, DOI 10.1136/bmj.38434.629630.E0; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts RR, 2010, J PHYSIOL-LONDON, V588, P1153, DOI 10.1113/jphysiol.2009.185421; Rodrigues AJ, 2012, MOL PSYCHIATR, V17, P1295, DOI 10.1038/mp.2011.126; Roque S, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00004; Sanders KM, 2006, ANNU REV PHYSIOL, V68, P307, DOI 10.1146/annurev.physiol.68.040504.094718; Schaeffer C, 2000, GUT, V47, P192, DOI 10.1136/gut.47.2.192; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Severi C, 2014, EUR J HISTOCHEM, V58, P307, DOI 10.4081/ejh.2014.2457; Sheppard KE, 1999, AM J PHYSIOL-GASTR L, V277, pG541, DOI 10.1152/ajpgi.1999.277.3.G541; Sikander A, 2009, CLIN CHIM ACTA, V403, P47, DOI 10.1016/j.cca.2009.01.028; Smith JT, 2000, ENDOCRINOLOGY, V141, P2422, DOI 10.1210/en.141.7.2422; Sze CI, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/628094; SZE PY, 1980, DEV NEUROSCI-BASEL, V3, P217, DOI 10.1159/000112394; Thacker M, 2011, NEUROGASTROENT MOTIL, V23, pE500, DOI 10.1111/j.1365-2982.2011.01696.x; TRAUTMAN PD, 1995, PSYCHONEUROENDOCRINO, V20, P439, DOI 10.1016/0306-4530(94)00070-0; VANEEKELEN JAM, 1992, PROG HISTOCHEM CYTOC, V26, P250, DOI 10.1016/S0079-6336(11)80102-6; Velisek L, 2006, NEUROPSYCHOPHARMACOL, V31, P2140, DOI 10.1038/sj.npp.1301016; Wallace AS, 2009, NEUROGASTROENT MOTIL, V21, P768, DOI 10.1111/j.1365-2982.2009.01309.x; Ward SM, 2004, NEUROGASTROENT MOTIL, V16, P112, DOI 10.1111/j.1743-3150.2004.00485.x; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; WEST MJ, 1990, PROG BRAIN RES, V83, P13; Wester T, 1999, GUT, V44, P65, DOI 10.1136/gut.44.1.65; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Young HM, 1996, DEV BIOL, V180, P97, DOI 10.1006/dbio.1996.0287	116	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161750	10.1371/journal.pone.0161750	http://dx.doi.org/10.1371/journal.pone.0161750			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584049	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600053
J	Zhong, BN; Zhang, J; Wang, PF; Du, JX; Chen, DS				Zhong, Bineng; Zhang, Jun; Wang, Pengfei; Du, Jixiang; Chen, Duansheng			Jointly Feature Learning and Selection for Robust Tracking via a Gating Mechanism	PLOS ONE			English	Article							OBJECT	To achieve effective visual tracking, a robust feature representation composed of two separate components (i.e., feature learning and selection) for an object is one of the key issues. Typically, a common assumption used in visual tracking is that the raw video sequences are clear, while real-world data is with significant noise and irrelevant patterns. Consequently, the learned features may be not all relevant and noisy. To address this problem, we propose a novel visual tracking method via a point-wise gated convolutional deep network (CPGDN) that jointly performs the feature learning and feature selection in a unified framework. The proposed method performs dynamic feature selection on raw features through a gating mechanism. Therefore, the proposed method can adaptively focus on the task-relevant patterns (i.e., a target object), while ignoring the task-irrelevant patterns (i.e., the surrounding background of a target object). Specifically, inspired by transfer learning, we firstly pre-train an object appearance model offline to learn generic image features and then transfer rich feature hierarchies from an offline pre-trained CPGDN into online tracking. In online tracking, the pre-trained CPGDN model is fine-tuned to adapt to the tracking specific objects. Finally, to alleviate the tracker drifting problem, inspired by an observation that a visual target should be an object rather than not, we combine an edge box-based object proposal method to further improve the tracking accuracy. Extensive evaluation on the widely used CVPR2013 tracking benchmark validates the robustness and effectiveness of the proposed method.	[Zhong, Bineng; Zhang, Jun; Wang, Pengfei; Du, Jixiang; Chen, Duansheng] Huaqiao Univ, Dept Comp Sci & Technol, Xiamen 361021, Fujian, Peoples R China	Huaqiao University	Zhong, BN (corresponding author), Huaqiao Univ, Dept Comp Sci & Technol, Xiamen 361021, Fujian, Peoples R China.	bnzhong@hqu.edu.cn			Natural Science Foundation of China [61572205, 61175121]; Natural Science Foundation of Fujian Province [2015J01257, 2013J06014]; Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University [ZQN-PY210, ZQN-YX108]; Program for New Century Excellent Talents in Fujian Province University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University; Program for New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET))	This work is supported by Natural Science Foundation of China (No. 61572205 and 61175121) (http://www.nsfc.gov.cn/), Natural Science Foundation of Fujian Province (No. 2015J01257 and 2013J06014) (http://www.fjkjt.gov.cn/), Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (No.ZQN-PY210 and ZQN-YX108), and 2015 Program for New Century Excellent Talents in Fujian Province University. (http://www.hqu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Natural Science Foundation of China (No. 61572205 and 61175121), Natural Science Foundation of Fujian Province (No. 2015J01257 and 2013J06014), Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (No.ZQN-PY210 and ZQN-YX108), and 2015 Program for New Century Excellent Talents in Fujian Province University.	[Anonymous], IEEE INT C COMP VIS; [Anonymous], 2016, CVPR; [Anonymous], 2015, ARXIV150905520; [Anonymous], 2009, IEEE INT C COMP VIS; [Anonymous], 2016, IEEE INT C COMP VIS; [Anonymous], 2015, INT C MACH LEARN; [Anonymous], 2014, IEEE INT C COMP VIS; [Anonymous], BRIT MACH VIS C; [Anonymous], 2016, ICCV; [Anonymous], 2013, IEEE INT C COMP VIS; [Anonymous], 2015, ARXIV150708085; [Anonymous], IEEE WORKSH VIS SURV; [Anonymous], INT C MACH LEARN; [Anonymous], 2013, LEARNING DEEP COMPAC; [Anonymous], ARTIFICIAL INTELLIGE; [Anonymous], 2012, EUR C COMP VIS; [Anonymous], 2015, P IEEE C COMP VIS PA; [Anonymous], 2014, EUR C COMP VIS; [Anonymous], IEEE INT C COMP VIS; [Anonymous], INT C MACH LEARN; [Anonymous], ARXIV151007945; [Anonymous], IEEE INT C COMP VIS; [Anonymous], 2014, EUR C COMP VIS; [Anonymous], 2012, LNCS, DOI DOI 10.1007/978-3-642-33765-9_51; [Anonymous], 2015, IEEE INT C COMP VIS; [Anonymous], IEEE INT C COMP VIS; [Anonymous], ARXIV150100909; [Anonymous], IEEE INT C COMP VIS; [Anonymous], IEEE INT C COMP VIS; [Anonymous], IEEE INT C COMP VIS; [Anonymous], IEEE INT C COMP VIS; Avidan S, 2004, IEEE T PATTERN ANAL, V26, P1064, DOI 10.1109/TPAMI.2004.53; Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35; Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Collins RT, 2005, IEEE T PATTERN ANAL, V27, P1631, DOI 10.1109/TPAMI.2005.205; Comaniciu D, 2003, IEEE T PATTERN ANAL, V25, P564, DOI 10.1109/TPAMI.2003.1195991; Fan JL, 2012, IEEE T PATTERN ANAL, V34, P1633, DOI 10.1109/TPAMI.2011.257; Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251; Henriques JF, 2015, IEEE T PATTERN ANAL, V37, P583, DOI 10.1109/TPAMI.2014.2345390; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Jiang N, 2011, IEEE T IMAGE PROCESS, V20, P2288, DOI 10.1109/TIP.2011.2114895; Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239; Kang X, 2013, IEEE ICC; Krizhevsky A., 2012, PROC INT C NEURAL IN, P1106; Leistner C, 2009, IEEE I CONF COMP VIS, P506, DOI 10.1109/ICCV.2009.5459198; Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039; Liang PP, 2015, IEEE T IMAGE PROCESS, V24, P5630, DOI 10.1109/TIP.2015.2482905; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Ma C, 2015, IEEE INFOCOM SER; Simonyan Karen, ICLR 2015; Smeulders AWM, 2014, IEEE T PATTERN ANAL, V36, P1442, DOI 10.1109/TPAMI.2013.230; Uijlings JRR, 2013, INT J COMPUT VISION, V104, P154, DOI 10.1007/s11263-013-0620-5; Wang YR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146763; Yilmaz A, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1177352.1177355; Zhang Jianming, 2014, EUROPEAN C COMPUTER; Zhang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124685; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	59	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161808	10.1371/journal.pone.0161808	http://dx.doi.org/10.1371/journal.pone.0161808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575684	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877200041
J	Gannon, MA; Knapp, AA; Adams, TG; Long, SM; Parks, NA				Gannon, Matthew A.; Knapp, Ashley A.; Adams, Thomas G.; Long, Stephanie M.; Parks, Nathan A.			Spatial Scaling of the Profile of Selective Attention in the Visual Field	PLOS ONE			English	Article							PERCEPTUAL LOAD; NORMALIZATION MODEL; EVOKED-POTENTIALS; NEURAL MECHANISMS; FOCAL ATTENTION; CORTEX; OBJECTS; COMPETITION; RESPONSES; SUPPRESSION	Neural mechanisms of selective attention must be capable of adapting to variation in the absolute size of an attended stimulus in the ever-changing visual environment. To date, little is known regarding how attentional selection interacts with fluctuations in the spatial expanse of an attended object. Here, we use event-related potentials (ERPs) to investigate the scaling of attentional enhancement and suppression across the visual field. We measured ERPs while participants performed a task at fixation that varied in its attentional demands (attentional load) and visual angle (1.0 degrees or 2.5 degrees). Observers were presented with a stream of task-relevant stimuli while foveal, parafoveal, and peripheral visual locations were probed by irrelevant distractor stimuli. We found two important effects in the N1 component of visual ERPs. First, N1 modulations to task-relevant stimuli indexed attentional selection of stimuli during the load task and further correlated with task performance. Second, with increased task size, attentional modulation of the N1 to distractor stimuli showed a differential pattern that was consistent with a scaling of attentional selection. Together, these results demonstrate that the size of an attended stimulus scales the profile of attentional selection across the visual field and provides insights into the attentional mechanisms associated with such spatial scaling.	[Gannon, Matthew A.; Knapp, Ashley A.; Long, Stephanie M.; Parks, Nathan A.] Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA; [Adams, Thomas G.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University of Arkansas System; University of Arkansas Fayetteville; Yale University	Gannon, MA (corresponding author), Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA.	magannon@uark.edu	Knapp, Ashley/Q-4136-2019	Knapp, Ashley/0000-0002-0073-1466	Arkansas Biosciences Institute [000482-00001]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH062994] Funding Source: NIH RePORTER	Arkansas Biosciences Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant (to NAP) from the Arkansas Biosciences Institute, http://arbiosciences.org/, grant number 000482-00001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Boehler CN, 2009, CEREB CORTEX, V19, P982, DOI 10.1093/cercor/bhn139; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Davis G, 2000, VISION RES, V40, P1323, DOI 10.1016/S0042-6989(99)00189-3; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Ding YL, 2014, HUM BRAIN MAPP, V35, P3008, DOI 10.1002/hbm.22381; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; He X, 2004, J COGNITIVE NEUROSCI, V16, P1085, DOI 10.1162/0898929041502689; Heinemann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005560; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2006, P NATL ACAD SCI USA, V103, P1053, DOI 10.1073/pnas.0507746103; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacoby O, 2012, NEUROIMAGE, V61, P1050, DOI 10.1016/j.neuroimage.2012.03.040; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0205; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 2006, J COGNITIVE NEUROSCI, V18, P298, DOI 10.1162/089892906775783642; Martinez A, 2007, J NEUROSCI, V27, P7963, DOI 10.1523/JNEUROSCI.0031-07.2007; Muller MM, 2002, PSYCHOL SCI, V13, P119, DOI 10.1111/1467-9280.00422; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Parks NA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00050; Parks NA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00275; Parks NA, 2011, J COGNITIVE NEUROSCI, V23, P1113, DOI 10.1162/jocn.2010.21460; Pinsk MA, 2004, J NEUROPHYSIOL, V92, P622, DOI 10.1152/jn.00974.2003; Plainis S, 2001, PERCEPTION, V30, P1203, DOI 10.1068/p3117; Rauss K, 2012, HUM BRAIN MAPP, V33, P63, DOI 10.1002/hbm.21193; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rorden C, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.004.2008; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Weber TA, 1997, BIOL PSYCHOL, V45, P159, DOI 10.1016/S0301-0511(96)05227-1	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162190	10.1371/journal.pone.0162190	http://dx.doi.org/10.1371/journal.pone.0162190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606426	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255600026
J	Chan, S; Jantama, SS; Kanchanatawee, S; Jantama, K				Chan, Sitha; Jantama, Sirima Suvarnakuta; Kanchanatawee, Sunthorn; Jantama, Kaemwich			Process Optimization on Micro-Aeration Supply for High Production Yield of 2,3-Butanediol from Maltodextrin by Metabolically-Engineered Klebsiella oxytoca	PLOS ONE			English	Article							ESCHERICHIA-COLI; FERMENTATION; PNEUMONIAE; LACTATE; ACID; DEHYDROGENASE; 1,3-PROPANEDIOL; EXPRESSION; GLYCEROL; GENES	An optimization process with a cheap and abundant substrate is considered one of the factors affecting the price of the production of economical 2,3-Butanediol (2,3-BD). A combination of the conventional method and response surface methodology (RSM) was applied in this study. The optimized levels of pH, aeration rate, agitation speed, and substrate concentration (maltodextrin) were investigated to determine the cost-effectiveness of fermentative 2,3-BD production by metabolically-engineered Klebsiella oxytoca KMS005. Results revealed that pH, aeration rate, agitation speed, and maltodextrin concentration at levels of 6.0, 0.8 vvm, 400 rpm, and 150 g/L respectively were the optimal conditions. RSM also indicated that the agitation speed was the most influential parameter when either agitation and aeration interaction or agitation and substrate concentration interaction played important roles for 2,3-BD production by the strain from maltodextrin. Under interim fed-batch fermentation, 2,3-BD concentration, yield, and productivity were obtained at 88.1 +/- 0.2 g/L, 0.412 +/- 0.001 g/g, and 1.13 +/- 0.01 g/L/h respectively within 78 h.	[Chan, Sitha; Kanchanatawee, Sunthorn; Jantama, Kaemwich] Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Metab Engn Res Unit, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand; [Jantama, Sirima Suvarnakuta] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Div Biopharm, Warinchamrap 34190, Ubon Ratchathan, Thailand	Suranaree University of Technology; Ubon Ratchathani University	Jantama, K (corresponding author), Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Metab Engn Res Unit, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand.	kaemwich@sut.ac.th	jantama, kaemwich/K-6880-2017	jantama, kaemwich/0000-0002-5405-6304	National Research Council of Thailand (NRCT) [PK/2555-138]	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This work was financially supported by National Research Council of Thailand (NRCT) under the contract number PK/2555-138 to KJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by National Research Council of Thailand (NRCT) under the contract number PK/2555-138 to KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thanks also to Bob Tremayne, Ubon Ratchathani University Division of International Relations, for assistance with English.	[Anonymous], 1985, COMPREHENSIVE BIOTEC; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; Banks GT, 1979, TOP ENZYME FERMENT B, V3, P170; BENDER H, 1990, CARBOHYD RES, V206, P257, DOI 10.1016/0008-6215(90)80065-B; Biebl H, 1998, APPL MICROBIOL BIOT, V50, P24, DOI 10.1007/s002530051251; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Cheng KK, 2010, PROCESS BIOCHEM, V45, P613, DOI 10.1016/j.procbio.2009.12.009; Cho JH, 2012, BIOPROC BIOSYST ENG, V35, P1081, DOI 10.1007/s00449-012-0691-7; Cho S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138109; FAOSTAT, 2011, PROD CROPS CASS 2010; FERENCI T, 1986, BIOCHIM BIOPHYS ACTA, V860, P44, DOI 10.1016/0005-2736(86)90496-7; Formanek J, 1997, APPL ENVIRON MICROB, V63, P2306, DOI 10.1128/AEM.63.6.2306-2310.1997; Ge L., 2011, J BIOMATER NANOBIOTE, V2, P335, DOI DOI 10.4236/JBNB.2011.23041; GOTTSCHALK G, 1986, BACTERIAL METABOLISM, P237; Han SH, 2013, NEW BIOTECHNOL, V30, P166, DOI 10.1016/j.nbt.2012.09.004; Jantama K, 2015, METAB ENG, V30, P16, DOI 10.1016/j.ymben.2015.04.004; Ji XJ, 2011, APPL MICROBIOL BIOT, V89, P1119, DOI 10.1007/s00253-010-2940-5; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P5214, DOI 10.1016/j.biortech.2009.05.036; Jiang LQ, 2012, BIORESOURCE TECHNOL, V107, P405, DOI 10.1016/j.biortech.2011.12.083; Kamm B, 2004, APPL MICROBIOL BIOT, V64, P137, DOI 10.1007/s00253-003-1537-7; Kearsley MW, 1995, HDB STARCH HYDROLYSI, P230; KHURI AI, 1988, TECHNOMETRICS, V30, P95, DOI 10.2307/1270325; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Lee SM, 2013, BIOTECHNOL BIOPROC E, V18, P1210, DOI 10.1007/s12257-013-0396-z; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Martinez A, 2007, BIOTECHNOL LETT, V29, P397, DOI 10.1007/s10529-006-9252-y; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; Nie ZK, 2011, APPL BIOCHEM BIOTECH, V163, P946, DOI 10.1007/s12010-010-9098-6; Pajatsch M, 1998, J BACTERIOL, V180, P2630, DOI 10.1128/JB.180.10.2630-2635.1998; Park JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-20; PARK SJ, 1995, J BACTERIOL, V177, P6652, DOI 10.1128/jb.177.22.6652-6656.1995; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Roehr M., 1996, BIOTECHNOLOGY, V6, P269; Sangproo M, 2012, BIORESOURCE TECHNOL, V119, P191, DOI 10.1016/j.biortech.2012.05.114; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Stanbury PF, 1995, PRINCIPLES FERMENTAT; STORMER F C, 1968, Febs Letters, V2, P36, DOI 10.1016/0014-5793(68)80094-8; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; Wang AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040442; Wong CL, 2014, BIORESOURCE TECHNOL, V152, P169, DOI 10.1016/j.biortech.2013.10.101; YU EKC, 1983, APPL ENVIRON MICROB, V46, P630, DOI 10.1128/AEM.46.3.630-635.1983; Zeng AP, 2011, CURR OPIN BIOTECH, V22, P749, DOI 10.1016/j.copbio.2011.05.005; Zhuge B, 2010, APPL MICROBIOL BIOT, V87, P2177, DOI 10.1007/s00253-010-2678-0	49	13	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161503	10.1371/journal.pone.0161503	http://dx.doi.org/10.1371/journal.pone.0161503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603922	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200017
J	Chen, CJ; He, WC; Nassirou, TY; Zhou, W; Yin, YL; Dong, XL; Rao, QQ; Shi, H; Zhao, WB; Efisue, A; Jin, DM				Chen, Caijin; He, Wenchuang; Nassirou, Tondi Yacouba; Zhou, Wei; Yin, Yilong; Dong, Xilong; Rao, Quanqin; Shi, Han; Zhao, Wubin; Efisue, Andrew; Jin, Deming			Genetic Diversity and Phenotypic Variation in an Introgression Line Population Derived from an Interspecific Cross between Oryza glaberrima and Oryza sativa	PLOS ONE			English	Article							GRAIN QUALITY TRAITS; LINKAGE DISEQUILIBRIUM; BACKCROSS POPULATION; CULTIVATED RICE; MAJOR QTL; AFLP; L.; TOLERANCE; IDENTIFICATION; RESISTANCE	The introduction of closely related species genomic fragments is an effective way to enrich genetic diversity and creates new germplasms in crops. Here, we studied the genetic diversity of an introgression line (IL) population composed of 106 ILs derived from an interspecific tetra cross between O. glaberrima and O. sativa (RAM3/Jin23B//Jin23B///YuetaiB). The proportion of O. glaberrima genome (PGG) in the ILs ranged from 0.3% to 36.7%, with an average value of 12.32% which is close to the theoretically expected proportion. A total of 250 polymorphic alleles were amplified by 21 AFLP primer combinations with an average of 12 alleles per primer. Population structure analysis revealed that the IL population can be divided into four genetically distinct subpopulations. Both principal component analysis and neighbor-joining tree analysis showed that ILs with a higher PGG displayed greater genetic diversity. Canonical discriminant analysis identified six phenotypic traits (plant height, yield per plant, filled grain percentage, panicle length, panicle number and days to flowering) as the main discriminatory traits among the ILs and between the subpopulations and showed significant phenotypic distances between subpopulations. The effects of PGG on phenotypic traits in the ILs were estimated using a linear admixed model, which showed a significant positive effect on grain yield per plant (0.286 +/- 0.117), plant height (0.418 +/- 0.132), panicle length (0.663 +/- 0.107), and spikelet number per panicle (0.339 +/- 0.128), and a significant negative effect on filled grain percentage (-0.267 +/- 0.123) and days to flowering (-0.324 +/- 0.075). We found that an intermediate range (10% - 20%) of PGG was more effective for producing ILs with favorable integrated agronomic traits. Our results confirm that construction of IL population carrying O. glaberrima genomic fragments could be an effective approach to increase the genetic diversity of O. sativa genome and an appropriate level of PGG could facilitate pyramiding more favorable genes for developing more adaptive and productive rice.	[Chen, Caijin; He, Wenchuang; Nassirou, Tondi Yacouba; Zhou, Wei; Yin, Yilong; Dong, Xilong; Rao, Quanqin; Shi, Han; Zhao, Wubin; Jin, Deming] Huazhong Agr Univ, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Efisue, Andrew] Univ Port Harcourt, Dept Crop & Soil Sci, Port Harcourt, Nigeria	Huazhong Agricultural University; University of Port Harcourt	Jin, DM (corresponding author), Huazhong Agr Univ, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Coll Plant Sci & Technol, Wuhan, Peoples R China.	djin@mail.hzau.edu.cn		He, Wenchuang/0000-0001-5568-7215	Fundamental Research Funds for the Central Universities [2013PY134]; Development Programme (863 Programme) of China [2012AA101101]; Specialized Research Fund for the Doctoral Program of Higher Education [20130146110026]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Development Programme (863 Programme) of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded by the Fundamental Research Funds for the Central Universities with program no. 2013PY134 (DJ), Development Programme (863 Programme) of China with grant no. 2012AA101101 (www.863.gov.cn, DJ), Specialized Research Fund for the Doctoral Program of Higher Education with grant no. 20130146110026 (www.cutech.edu.cn, DJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedze YMN, 2016, J AGR SCI-CAMBRIDGE, V154, P367, DOI 10.1017/S002185961500026X; Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Bimpong IK, 2011, J PLANT BIOL, V54, P237, DOI 10.1007/s12374-011-9161-z; Bocco R, 2012, PLANT SCI, V183, P65, DOI 10.1016/j.plantsci.2011.09.010; Deng XJ, 2012, J INTEGR AGR, V11, P1059, DOI 10.1016/S2095-3119(12)60098-7; Deng XJ, 2012, J ANHUI AGR SCI, V40, P1336; Doi K, 1998, BREEDING SCI, V48, P395; Doi K., 1999, RICE GENET NEWSL, V16, P65; Efisue AA, 2009, J CROP IMPROV, V23, P383, DOI 10.1080/15427520902976471; Eric F, 2015, PEERJ PREPRINTS; Felix DT, 2014, CONSERV GENET, V15, P1315, DOI 10.1007/s10592-014-0619-7; Fujita D, 2010, BREEDING SCI, V60, P336, DOI 10.1270/jsbbs.60.336; Gonzalo GA, 2010, BMC PLANT BIOL, V10, P1; Gouy M, 2015, FIELD CROP RES, V171, P99, DOI 10.1016/j.fcr.2014.11.002; Guei RG., 2005, AGRON AFR, V5, P17; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Hu FY, 2006, EUPHYTICA, V151, P273, DOI 10.1007/s10681-006-9146-z; Huang F, 2013, CROP SCI, V53, P132, DOI 10.2135/cropsci2012.07.0444; Johnson DE, 1998, WEED RES, V38, P207, DOI 10.1046/j.1365-3180.1998.00092.x; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Kaya HB, 2014, PLANT SYST EVOL, V300, P1337, DOI 10.1007/s00606-013-0965-9; Koide Y, 2008, NEW PHYTOL, V179, P888, DOI 10.1111/j.1469-8137.2008.02490.x; Lai Yong, 2012, Acta Agronomica Sinica, V38, P1640; Lamine M, 2015, APPL BIOCHEM BIOTECH, V175, P2996, DOI 10.1007/s12010-015-1477-6; Li F, 2011, PLANT BREEDING, V130, P165, DOI 10.1111/j.1439-0523.2010.01845.x; Li JM, 2004, GENOME, V47, P697, DOI [10.1139/g04-029, 10.1139/G04-029]; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Maduakor H. O., 1989, Journal of Root Crops, V15, P115; MAJI T, 2001, ORYZA, V38, P17; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Ndjiondjop MN, 2012, CROP SCI, V52, P524, DOI 10.2135/cropsci2011.05.0287; Ndjiondjop MN, 2010, PLANT SCI, V179, P364, DOI 10.1016/j.plantsci.2010.06.006; Nie XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141064; Pariasca-Tanaka J, 2014, THEOR APPL GENET, V127, P1387, DOI 10.1007/s00122-014-2306-y; Plowright RA, 1999, NEMATOLOGY, V1, P745, DOI 10.1163/156854199508775; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Pritchard JK, 2000, GENETICS, V155, P945; Roy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129607; Saikumar S, 2014, FIELD CROP RES, V163, P119, DOI 10.1016/j.fcr.2014.03.011; Saito K, 2010, CROP SCI, V50, P227, DOI 10.2135/cropsci2009.06.0284; SANO Y, 1983, J HERED, V74, P435, DOI 10.1093/oxfordjournals.jhered.a109832; Sarla N, 2005, CURR SCI INDIA, V89, P955; SAUPHANOR B, 1985, INSECT SCI APPL, V6, P429, DOI 10.1017/S1742758400004756; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Suh JungPil, 2005, Korean Journal of Breeding, V37, P214; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Vaylay R, 2002, CROP SCI, V42, P534, DOI 10.2135/cropsci2002.0534; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wasano K, 1986, B FACULTY AGR, V60, P45; Watanabe H, 2006, PLANT PROD SCI, V9, P287, DOI 10.1626/pps.9.287; Wiredu A. N., 2014, Journal of Sustainable Development, V7, P167; Xiao JH, 1998, GENETICS, V150, P899; Yao DARA, 2015, GENET RESOUR CROP EV, V62, P863, DOI 10.1007/s10722-014-0197-z	57	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161746	10.1371/journal.pone.0161746	http://dx.doi.org/10.1371/journal.pone.0161746			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603678	gold, Green Published, Green Submitted			2022-12-27	WOS:000383255200024
J	Li, YQ; Poroyko, V; Yan, ZL; Pan, LY; Feng, Y; Zhao, PH; Xie, ZLL; Hong, L				Li, Yuqing; Poroyko, Valeriy; Yan, Zhilong; Pan, Liya; Feng, Yi; Zhao, Peihua; Xie, Zhoulonglong; Hong, Li			Characterization of Intestinal Microbiomes of Hirschsprung's Disease Patients with or without Enterocolitis Using Illumina-MiSeq High-Throughput Sequencing	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; CLOSTRIDIUM-DIFFICILE; PATHOGENESIS; COMMUNITIES; FUTURE; TRIAL	Hirschsprung-associated enterocolitis (HAEC) is a life-threatening complication of Hirschsprung's disease (HD). Although the pathological mechanisms are still unclear, studies have shown that HAEC has a close relationship with the disturbance of intestinal microbiota. This study aimed to investigate the characteristics of the intestinal microbiome of HD patients with or without enterocolitis. During routine or emergency surgery, we collected 35 intestinal content samples from five patients with HAEC and eight HD patients, including three HD patients with a history of enterocolitis who were in a HAEC remission (HAEC-R) phase. Using Illumina-MiSeq high-throughput sequencing, we sequenced the V4 region of bacterial 16S rRNA, and operational taxonomic units (OTUs) were defined by 97% sequence similarity. Principal coordinate analysis (PCoA) of weighted UniFrac distances was performed to evaluate the diversity of each intestinal microbiome sample. The microbiota differed significantly between the HD patients (characterized by the prevalence of Bacteroidetes) and HAEC patients (characterized by the prevalence of Proteobacteria), while the microbiota of the HAEC-R patients was more similar to that of the HAEC patients. We also observed that the specimens from different intestinal sites of each HD patient differed significantly, while the specimens from different intestinal sites of each HAEC and HAEC-R patient were more similar. In conclusion, the microbiome pattern of the HAEC-R patients was more similar to that of the HAEC patients than to that of the HD patients. The HD patients had a relatively distinct, more stable community than the HAEC and HAEC-R patients, suggesting that enterocolitis may either be caused by or result in a disruption of the patient's uniquely adapted intestinal flora. The intestinal microbiota associated with enterocolitis may persist following symptom resolution and can be implicated in the symptom recurrence.	[Li, Yuqing; Pan, Liya; Feng, Yi; Hong, Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Clin Nutr, Shanghai, Peoples R China; [Poroyko, Valeriy] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA; [Yan, Zhilong; Xie, Zhoulonglong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Surg, Shanghai, Peoples R China; [Zhao, Peihua] East China Normal Univ, Inst Mol Ecol & Evolut, SKLEC, Shanghai, Peoples R China; [Zhao, Peihua] East China Normal Univ, IECR, Shanghai, Peoples R China	Shanghai Jiao Tong University; City of Hope; Shanghai Jiao Tong University; East China Normal University; East China Normal University	Hong, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Clin Nutr, Shanghai, Peoples R China.	lihongscmc@aliyun.com			Shanghai Science & Technology Commission Project [13ZR1426300]; Project HOPE "The Abbott Fund Institute of Nutrition Science" [AFINS-HOPE-2013-18]	Shanghai Science & Technology Commission Project; Project HOPE "The Abbott Fund Institute of Nutrition Science"	This study is supported by a grant from Shanghai Science & Technology Commission Project (No. 13ZR1426300, to HONG L) and Project HOPE "The Abbott Fund Institute of Nutrition Science (AFINS-HOPE-2013-18, to HONG L)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Burkardt DD, 2014, CLIN PEDIATR, V53, P71, DOI 10.1177/0009922813500846; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003; De Filippo C, 2010, PEDIATR SURG INT, V26, P465, DOI 10.1007/s00383-010-2586-5; El-Sawaf M, 2013, J PEDIATR SURG, V48, P111, DOI 10.1016/j.jpedsurg.2012.10.028; ELHALABY EA, 1995, J PEDIATR SURG, V30, P76, DOI 10.1016/0022-3468(95)90615-0; Frykman PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124172; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Langer JC, 2013, CURR OPIN PEDIATR, V25, P368, DOI 10.1097/MOP.0b013e328360c2a0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Menezes M, 2006, PEDIATR SURG INT, V22, P316, DOI 10.1007/s00383-006-1639-2; Moore SW, 2008, J PEDIATR SURG, V43, P1439, DOI 10.1016/j.jpedsurg.2007.12.057; Morowitz MJ, 2011, ANN SURG, V253, P1094, DOI 10.1097/SLA.0b013e31821175d7; Parsons SJ, 2005, J PAEDIATR CHILD H, V41, P689, DOI 10.1111/j.1440-1754.2005.00762.x; Pastor AC, 2009, J PEDIATR SURG, V44, P251, DOI 10.1016/j.jpedsurg.2008.10.052; Polytarchou C, 2014, CURR OPIN GASTROEN, V30, P339, DOI 10.1097/MOG.0000000000000081; Reding R, 1997, J PEDIATR SURG, V32, P1221, DOI 10.1016/S0022-3468(97)90686-2; RIETRA PJG, 1978, LANCET, V2, P319; Schaubeck M, 2015, CURR OPIN GASTROEN, V31, P464, DOI 10.1097/MOG.0000000000000216; Snoek SA, 2010, EXPERT REV GASTROENT, V4, P637, DOI [10.1586/egh.10.51, 10.1586/EGH.10.51]; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; THOMAS DFM, 1982, LANCET, V1, P78; THOMAS DFM, 1986, J PEDIATR SURG, V21, P22, DOI 10.1016/S0022-3468(86)80644-3; Vieten Daniela, 2004, Semin Pediatr Surg, V13, P263, DOI 10.1053/j.sempedsurg.2004.10.014; Wang JS, 2004, PEDIATR SURG INT, V20, P525, DOI 10.1007/s00383-004-1213-8; Wang XL, 2015, INT J COLORECTAL DIS, V30, P105, DOI 10.1007/s00384-014-2054-0; WILSON-STOREY D, 1988, Journal of the Royal College of Surgeons of Edinburgh, V33, P185; WILSONSTOREY D, 1989, J PEDIATR SURG, V24, P462, DOI 10.1016/S0022-3468(89)80402-6; WILSONSTOREY D, 1990, ARCH DIS CHILD, V65, P1338, DOI 10.1136/adc.65.12.1338; Yan ZL, 2014, BIOCHEM BIOPH RES CO, V445, P269, DOI 10.1016/j.bbrc.2014.01.104	32	26	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162079	10.1371/journal.pone.0162079	http://dx.doi.org/10.1371/journal.pone.0162079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603009	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255200039
J	Albers, T; Maniak, M; Beitz, E; von Bulow, J				Albers, Tineke; Maniak, Markus; Beitz, Eric; von Buelow, Julia			The C Isoform of Dictyostelium Tetraspanins Localizes to the Contractile Vacuole and Contributes to Resistance against Osmotic Stress	PLOS ONE			English	Article							DISCOIDEUM AMEBAS; CELL-ADHESION; PROTEINS; PALMITOYLATION; ORGANIZATION; MICRODOMAINS; EVOLUTION; MOTILITY; DOMAINS; SYSTEM	Tetraspanins (Tsps) are membrane proteins that are widely expressed in eukaryotic organisms. Only recently, Tsps have started to acquire relevance as potential new drug targets as they contribute, via protein-protein interactions, to numerous pathophysiological processes including infectious diseases and cancer. However, due to a high number of iso-forms and functional redundancy, knowledge on specific functions of most Tsps is still scarce. We set out to characterize five previously annotated Tsps, TspA-E, from Dictyostelium discoideum, a model for studying proteins that have human orthologues. Using reverse transcriptase PCRs, we found mRNAs for TspA-E in the multicellular slug stage, whereas vegetative cells expressed only TspA, TspC and, to a lesser extent, TspD. We raised antibodies against TspA, TspC and TspD and detected endogenous TspA, as well as heterologously expressed TspA and TspC by Western blot. N-deglycosylation assays and mutational analyses showed glycosylation of TspA and TspC in vivo. GFP-tagged Tsps colocalized with the proton pump on the contractile vacuole network. Deletion strains of TspC and TspD exibited unaltered growth, adhesion, random motility and development. Yet, tspC(-) cells showed a defect in coping with hypo-osmotic stress, due to accumulation of contractile vacuoles, but heterologous expression of TspC rescued their phenotype. In conclusion, our data fill a gap in Dictyostelium research and open up the possibility that Tsps in contractile vacuoles of e.g. Trypanosoma may one day constitute a valuable drug target for treating sleeping sickness, one of the most threatening tropical diseases.	[Albers, Tineke; Beitz, Eric; von Buelow, Julia] Univ Kiel, Dept Med & Pharmaceut Chem, Kiel, Germany; [Maniak, Markus] Univ Kassel, Dept Cell Biol, Kassel, Germany	University of Kiel; Universitat Kassel	von Bulow, J (corresponding author), Univ Kiel, Dept Med & Pharmaceut Chem, Kiel, Germany.	jbuelow@pharmazie.uni-kiel.de		Maniak, Markus/0000-0001-6442-5372				Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; ASHWORTH JM, 1970, BIOCHEM J, V119, P175, DOI 10.1042/bj1190175; AUBRY L, 1993, J CELL SCI, V105, P861; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F., 2013, TETRASPANINS; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Boavida LC, 2013, PLANT PHYSIOL, V163, P696, DOI 10.1104/pp.113.216598; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Bozzaro Salvatore, 2013, Methods Mol Biol, V983, P17, DOI 10.1007/978-1-62703-302-2_2; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; Du F, 2008, EMBO J, V27, P2064, DOI 10.1038/emboj.2008.131; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Essid M, 2012, MOL BIOL CELL, V23, P1267, DOI 10.1091/mbc.E11-06-0576; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Garcia R, 2013, CYTOSKELETON, V70, P269, DOI 10.1002/cm.21107; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; Heijnen HFG, 1998, BLOOD, V91, P2313, DOI 10.1182/blood.V91.7.2313.2313_2313_2325; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Humbel BM, SCANNING MICROSC, V6, P817; Jenne N, 1998, J CELL SCI, V111, P61; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; Monk Peter N., 2012, Infectious Disorders - Drug Targets, V12, P4; Monnat J, 1997, FEBS LETT, V418, P357, DOI 10.1016/S0014-5793(97)01415-4; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; Neuhaus EM, 1998, J STRUCT BIOL, V121, P326, DOI 10.1006/jsbi.1998.3971; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Rai A, 2011, CELL MOL LIFE SCI, V68, P2751, DOI 10.1007/s00018-010-0590-5; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Sesaki H, 1997, J CELL BIOL, V138, P939, DOI 10.1083/jcb.138.4.939; Sriskanthadevan S, 2013, FEBS J, V280, P1795, DOI 10.1111/febs.12203; Sriskanthadevan S, 2009, J BIOL CHEM, V284, P36377, DOI 10.1074/jbc.M109.057257; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; von Bulow J, 2015, BIOL BULL-US, V229, P38, DOI 10.1086/BBLv229n1p38; von Bulow J, 2015, BIOL CELL, V107, P78, DOI 10.1111/boc.201400070; von Bulow J, 2012, J BIOL CHEM, V287, P7487, DOI 10.1074/jbc.M111.329102; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	59	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162065	10.1371/journal.pone.0162065	http://dx.doi.org/10.1371/journal.pone.0162065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597994	gold, Green Submitted, Green Published			2022-12-27	WOS:000383254800035
J	Nishikawa, S; Aoyama, H; Kamiya, M; Higuchi, J; Kato, A; Soga, M; Kawai, T; Yoshimura, K; Kumazawa, S; Tsuda, T				Nishikawa, Sho; Aoyama, Hiroki; Kamiya, Misa; Higuchi, Jun; Kato, Aiko; Soga, Minoru; Kawai, Taeko; Yoshimura, Kazuki; Kumazawa, Shigenori; Tsuda, Takanori			Artepillin C, a Typical Brazilian Propolis-Derived Component, Induces Brown-Like Adipocyte Formation in C3H10T1/2 Cells, Primary Inguinal White Adipose Tissue-Derived Adipocytes, and Mice	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; GENE-EXPRESSION; PROTEIN-KINASE; INSULIN ACTION; FAT; PRDM16; CONSTITUENTS; ACTIVATION; MUSCLE	Induction of brown-like adipocytes (beige/brite cells) in white adipose tissue (WAT) suggests a new approach for preventing and treating obesity via induction of thermogenesis associated with uncoupling protein 1 (UCP1). However, whether diet-derived factors can directly induce browning of white adipocytes has not been well established. In addition, the underlying mechanism of induction of brown-like adipocytes by diet-derived factors has been unclear. Here, we demonstrate that artepillin C (ArtC), which is a typical Brazilian propolis-derived component, significantly induces brown-like adipocytes in murine C3H10T1/2 cells and primary inguinal WAT (iWAT)-derived adipocytes. This significant induction is due to activation of peroxisome proliferator-activated receptor. and stabilization of PRD1-BF-1-RIZ1 homologous domain-containing protein-16 (PRDM16). Furthermore, the oral administration of ArtC (10 mg/kg) for 4 weeks significantly induced brown-like adipocytes accompanied by significant expression of UCP1 and PRDM16 proteins in iWAT of mice, and was independent of the beta 3-adrenergic signaling pathway via the sympathetic nervous system. These findings may provide insight into browning of white adipocytes including the molecular mechanism mediated by dietary factors and demonstrate that ArtC has a novel biological function with regard to increasing energy expenditure by browning of white adipocytes.	[Nishikawa, Sho; Aoyama, Hiroki; Kamiya, Misa; Higuchi, Jun; Kato, Aiko; Soga, Minoru; Kawai, Taeko; Tsuda, Takanori] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan; [Yoshimura, Kazuki; Kumazawa, Shigenori] Univ Shizuoka, Dept Food & Nutr Sci, Suruga Ku, Shizuoka, Shizuoka 4228526, Japan	Chubu University; University of Shizuoka	Tsuda, T (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan.	tsudat@isc.chubu.ac.jp	Kumazawa, Shigenori/A-2067-2013	NISHIKAWA, SHO/0000-0001-8219-6825	Japan Society for Promotion of Science [26450168]; Yamada Research Grant	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamada Research Grant	This work was supported by Grants-in-Aid for Scientific Research (No. 26450168) from the Japan Society for Promotion of Science and Yamada Research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahn MR, 2009, MOL NUTR FOOD RES, V53, P643, DOI 10.1002/mnfr.200800021; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Ikeda R, 2011, BBA-GEN SUBJECTS, V1810, P695, DOI 10.1016/j.bbagen.2011.04.007; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Kumazawa S, 2003, CHEM PHARM BULL, V51, P740, DOI 10.1248/cpb.51.740; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau P, 2015, AM J PHYSIOL-ENDOC M, V308, pE159, DOI 10.1152/ajpendo.00056.2014; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nakajima Y, 2009, PHYTOTHER RES, V23, P1431, DOI 10.1002/ptr.2797; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; Takikawa M, 2013, MOL NUTR FOOD RES, V57, P1794, DOI 10.1002/mnfr.201300041; Tani H, 2010, BIOORGAN MED CHEM, V18, P151, DOI 10.1016/j.bmc.2009.11.007; Tazawa S, 1998, CHEM PHARM BULL, V46, P1477, DOI 10.1248/cpb.46.1477; TRAYHURN P, 1987, P NUTR SOC, V46, P135, DOI 10.1079/PNS19870017; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Yang XY, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00149; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zhang GQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00029	36	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162512	10.1371/journal.pone.0162512	http://dx.doi.org/10.1371/journal.pone.0162512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598888	Green Published, gold, Green Submitted			2022-12-27	WOS:000383254800073
J	Enooku, K; Uranbileg, B; Ikeda, H; Kurano, M; Sato, M; Kudo, H; Maki, H; Koike, K; Hasegawa, K; Kokudo, N; Yatomi, Y				Enooku, Kenichiro; Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Sato, Masaya; Kudo, Hiroki; Maki, Harufumi; Koike, Kazuhiko; Hasegawa, Kiyoshi; Kokudo, Norihiro; Yatomi, Yutaka			Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels	PLOS ONE			English	Article							PLASMA LYSOPHOSPHATIDIC ACID; PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHOLIPASE-D; INTRAHEPATIC METASTASIS; PHOSPHOLIPASE A(1); STELLATE CELLS; RHO; MOTILITY; TUMORIGENICITY; IDENTIFICATION	Hepatocellular carcinoma (HCC) commonly develops in patients with liver fibrosis; in these patients, the blood levels of lysophosphatidic acid (LPA) and its generating enzyme autotaxin (ATX) increase with the liver fibrosis stage. We aimed to examine the potential relevance of ATX and LPA in HCC. Fifty-eight HCC patients who underwent surgical treatment were consecutively enrolled in the study. Among the LPA receptors in HCC, higher LPA2 mRNA levels correlated with poorer differentiation, and higher LPA6 mRNA levels correlated with microvascular invasion, which suggested a higher malignant potential of HCC with increased LPA2 and LPA6 expression. In patients with primary HCC, neither LPA2 nor LPA6 mRNA levels were associated with recurrence. However, when serum ATX levels were combined for analysis as a surrogate for plasma LPA levels, the cumulative intrahepatic recurrence rate was higher in patients in whom both serum ATX levels and LPA2 or LPA6 mRNA levels were higher than the median. However, the mRNA level of phosphatidic acid-selective phospholipase A1., another LPA-generating enzyme, in HCC patients was not associated with pathological findings or recurrence, even in combination with the expression of LPA receptors. Higher LPA2 mRNA levels were associated with poorer differentiation, and higher LPA6 levels were associated with microvascular invasion in HCC; both became a risk factor for recurrence after surgical treatment when combined with increased serum ATX levels. ATX and LPA receptors merit consideration as therapeutic targets of HCC.	[Enooku, Kenichiro; Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; [Uranbileg, Baasanjav; Ikeda, Hitoshi; Kurano, Makoto; Sato, Masaya; Yatomi, Yutaka] Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan; [Kudo, Hiroki; Maki, Harufumi; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Hepatobiliary Pancreat Surg Div, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Ikeda, H (corresponding author), Univ Tokyo, Dept Clin Lab Med, Tokyo, Japan.	ikeda-1im@h.u-tokyo.ac.jp		Maki, Harufumi/0000-0002-9032-1371; Yatomi, Yutaka/0000-0003-1719-4297	JSPS KAKENHI [15H05906]; CREST from JST/AMED	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST from JST/AMED	This work was supported by JSPS KAKENHI Grant Number 15H05906 (Y.Y.) and CREST from JST/AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2002, J BIOL CHEM, V277, P48737, DOI 10.1074/jbc.M206812200; Baker DL, 2002, JAMA-J AM MED ASSOC, V287, P3081, DOI 10.1001/jama.287.23.3081; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Ikeda H, 1998, BIOCHEM BIOPH RES CO, V248, P436, DOI 10.1006/bbrc.1998.8983; Ikeda H, 2003, AM J PHYSIOL-GASTR L, V285, pG880, DOI 10.1152/ajpgi.00039.2003; Ishii S, 2015, BIOCHEM BIOPH RES CO, V461, P59, DOI 10.1016/j.bbrc.2015.03.169; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kondo M, 2014, CLIN CHIM ACTA, V433, P128, DOI 10.1016/j.cca.2014.03.006; Lin SB, 2010, AM J PHYSIOL-GASTR L, V299, pG1128, DOI 10.1152/ajpgi.00321.2010; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Machiela MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11843; Mazzocca A, 2015, CANCER RES, V75, P532, DOI 10.1158/0008-5472.CAN-14-1607; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Moolenaar WH, 2002, J CELL BIOL, V158, P197, DOI 10.1083/jcb.200206094; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Nakamura K, 2008, CLIN CHIM ACTA, V388, P51, DOI 10.1016/j.cca.2007.10.005; Nakamura K, 2007, CLIN BIOCHEM, V40, P274, DOI 10.1016/j.clinbiochem.2006.10.009; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Sokolov E, 2013, J SURG RES, V180, P104, DOI 10.1016/j.jss.2012.10.054; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Takamura M, 2001, HEPATOLOGY, V33, P577, DOI 10.1053/jhep.2001.22652; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Watanabe N, 2007, LIFE SCI, V81, P1009, DOI 10.1016/j.lfs.2007.08.013; Watanabe N, 2007, J CLIN GASTROENTEROL, V41, P616, DOI 10.1097/01.mcg.0000225642.90898.0e; Yamamoto K, 2010, J GASTROENTEROL, V45, P1272, DOI 10.1007/s00535-010-0278-5; Yamashita H, 2006, J SURG ONCOL, V93, P30, DOI 10.1002/jso.20397; Yanase M, 2000, BIOCHEM BIOPH RES CO, V277, P72, DOI 10.1006/bbrc.2000.3634; Yanase M, 2003, BIOCHEM BIOPH RES CO, V305, P223, DOI 10.1016/S0006-291X(03)00726-5; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378	37	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161825	10.1371/journal.pone.0161825	http://dx.doi.org/10.1371/journal.pone.0161825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583415	Green Submitted, Green Published, gold			2022-12-27	WOS:000382855600065
J	Hatta, T; Giambini, H; Zhao, CF; Sperling, JW; Steinmann, SP; Itoi, E; An, KN				Hatta, Taku; Giambini, Hugo; Zhao, Chunfeng; Sperling, John W.; Steinmann, Scott P.; Itoi, Eiji; An, Kai-Nan			Biomechanical Effect of Margin Convergence Techniques: Quantitative Assessment of Supraspinatus Muscle Stiffness	PLOS ONE			English	Article							ROTATOR CUFF TEARS; SHEAR-WAVE ELASTOGRAPHY; TENSION OVERLOAD; REPAIR INTEGRITY; NATURAL-HISTORY; STRAIN; FEASIBILITY; DOMINANCE; FAILURE; HAND	Although the margin convergence (MC) technique has been recognized as an option for rotator cuff repair, little is known about the biomechanical effect on repaired rotator cuff muscle, especially after supplemented footprint repair. The purpose of this study was to assess the passive stiffness changes of the supraspinatus (SSP) muscle after MC techniques using shear wave elastography (SWE). A 30 x 40-mm U-shaped rotator cuff tear was created in 8 cadaveric shoulders. Each specimen was repaired with 6 types of MC technique (1-, 2-, 3-suture MC with/without footprint repair, in a random order) at 30 degrees glenohumeral abduction. Passive stiffness of four anatomical regions in the SSP muscle was measured based on an established SWE method. Data were obtained from the SSP muscle at 0 degrees abduction under 8 different conditions: intact (before making a tear), torn, and postoperative conditions with 6 techniques. MC techniques using 1-, or 2-suture combined with footprint repair showed significantly higher stiffness values than the intact condition. Passive stiffness of the SSP muscle was highest after a 1-suture MC with footprint repair for all regions when compared among all repair procedures. There was no significant difference between the intact condition and a 3-suture MC with footprint repair. MC techniques with single stitch and subsequent footprint repair may have adverse effects on muscle properties and tensile loading on repair, increasing the risk of retear of repairs. Adding more MC stitches could reverse these adverse effects.	[Hatta, Taku; Giambini, Hugo; Zhao, Chunfeng; An, Kai-Nan] Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA; [Giambini, Hugo; Sperling, John W.; Steinmann, Scott P.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA; [Itoi, Eiji] Tohoku Univ, Dept Orthopaed Surg, Sch Med, Sendai, Miyagi, Japan	Mayo Clinic; Mayo Clinic; Tohoku University	An, KN (corresponding author), Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA.	an.kainan@mayo.edu	Hatta, Taku/AEI-5559-2022		National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health [R21 AR065550]; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32-AR56950]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065550, T32AR056950] Funding Source: NIH RePORTER	National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health under Award Number R21 AR065550. We would also like to acknowledge the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program T32-AR56950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawis-Puri N, 2009, J BIOMECH, V42, P158, DOI 10.1016/j.jbiomech.2008.10.020; Brandenburg JE, 2015, J ULTRAS MED, V34, P663, DOI 10.7863/ultra.34.4.663; Burkhart SS, 1997, ARTHROSCOPY, V13, P720, DOI 10.1016/S0749-8063(97)90006-2; Burkhart SS, 1997, ARTHROSCOPY, V13, P172, DOI 10.1016/S0749-8063(97)90151-1; Burkhart SS, 2000, ARTHROSCOPY, V16, P82, DOI 10.1016/S0749-8063(00)90133-6; Burkhart SS, 2004, ANN BIOMED ENG, V32, P166, DOI 10.1023/B:ABME.0000007801.44277.df; Burkhart SS, 1996, ARTHROSCOPY, V12, P335, DOI 10.1016/S0749-8063(96)90070-5; Burkhart SS, 2001, CLIN ORTHOP RELAT R, P107; Dierckman BD, 2012, ARTHROSCOPY, V28, P52, DOI 10.1016/j.arthro.2011.07.014; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Ferraioli G, 2014, J ULTRAS MED, V33, P197, DOI 10.7863/ultra.33.2.197; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; HARRYMAN DT, 1991, J BONE JOINT SURG AM, V73A, P982, DOI 10.2106/00004623-199173070-00004; Hatta T, 2015, J BIOMECH, DOI [10.1016/j.jbiomech.2015.09.038, DOI 10.1002/CA.20896]; Iannotti, 1994, J Am Acad Orthop Surg, V2, P87; Itoigawa Y, 2015, CLIN ANAT, V28, P213, DOI 10.1002/ca.22498; Kim KC, 2013, J BONE JOINT SURG AM, V95A, P536, DOI 10.2106/JBJS.L.00397; Kim S, 2010, CLIN ANAT, V23, P48, DOI 10.1002/ca.20896; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Lovric V, 2013, KNEE SURG SPORT TR A, V21, P466, DOI 10.1007/s00167-012-1972-z; Mall NA, 2010, J BONE JOINT SURG AM, V92A, P2623, DOI 10.2106/JBJS.I.00506; Maman E, 2009, J BONE JOINT SURG AM, V91A, P1898, DOI 10.2106/JBJS.G.01335; Mazzocca AD, 2011, ARTHROSCOPY, V27, P330, DOI 10.1016/j.arthro.2010.09.003; Mazzocca AD, 2010, ARTHROSCOPY, V26, P592, DOI 10.1016/j.arthro.2010.02.009; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Minagawa H, 2013, J ORTHOP, V10, P8, DOI 10.1016/j.jor.2013.01.008; Murray TF, 2002, J SHOULDER ELB SURG, V11, P19, DOI 10.1067/mse.2002.120142; Park HY, 2014, ULTRASOUND MED BIOL, V40, P1058, DOI 10.1016/j.ultrasmedbio.2013.12.021; Park MC, 2007, J SHOULDER ELB SURG, V16, P461, DOI 10.1016/j.jse.2006.09.010; Safran O, 2011, AM J SPORT MED, V39, P710, DOI 10.1177/0363546510393944; Sano H, 2013, AM J SPORT MED, V41, P2262, DOI 10.1177/0363546513497565; Schwartz C, 2014, J SHOULDER ELB SURG, V23, P873, DOI 10.1016/j.jse.2013.08.020; Shindle Michael K, 2011, HSS J, V7, P208; Taniguchi K, 2015, SCAND J MED SCI SPOR, V25, P32, DOI 10.1111/sms.12146; Wolf EM, 2005, ARTHROSCOPY, V21, P881, DOI 10.1016/j.arthro.2005.03.014; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Yamaguchi K, 2001, J SHOULDER ELB SURG, V10, P199, DOI 10.1067/mse.2001.113086	37	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162110	10.1371/journal.pone.0162110	http://dx.doi.org/10.1371/journal.pone.0162110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583402	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600105
J	Patel, A; Vieira, MMC; Abraham, J; Reid, N; Tran, T; Tomecsek, K; Vissoci, JRN; Eucker, S; Gerardo, CJ; Staton, CA				Patel, Anjni; Coelho Vieira, Mateus Mazorra; Abraham, John; Reid, Nick; Tu Tran; Tomecsek, Kevin; Vissoci, Joao Ricardo N.; Eucker, Stephanie; Gerardo, Charles J.; Staton, Catherine A.			Quality of the Development of Traumatic Brain Injury Clinical Practice Guidelines: A Systematic Review	PLOS ONE			English	Review							SEVERE HEAD-INJURY; MANAGEMENT; MILD; IMPLEMENTATION; OUTCOMES; CARE; ADAPTATION; ADHERENCE; CHILDREN; ADULT	Traumatic brain injury (TBI) is a leading cause of death worldwide and is increasing exponentially particularly in low and middle income countries (LMIC). To inform the development of a standard Clinical Practice Guideline (CPG) for the acute management of TBI that can be implemented specifically for limited resource settings, we conducted a systematic review to identify and assess the quality of all currently available CPGs on acute TBI using the AGREE II instrument. In accordance with PRISMA guidelines, from April 2013 to December 2015 we searched MEDLINE, EMBASE, Google Scholar and the Duke University Medical Center Library Guidelines for peer-reviewed published Clinical Practice Guidelines on the acute management of TBI (less than 24 hours), for any level of traumatic brain injury in both high and low income settings. A comprehensive reference and citation analysis was performed. CPGs found were assessed using the AGREE II instrument by five independent reviewers and scores were aggregated and reported in percentage of total possible score. An initial 2742 articles were evaluated with an additional 98 articles from the citation and reference analysis, yielding 273 full texts examined. A total of 24 final CPGs were included, of which 23 were from high income countries (HIC) and 1 from LMIC. Based on the AGREE II instrument, the best score on overall assessment was 100.0 for the CPG from the National Institute for Health and Clinical Excellence (NIHCE, 2007), followed by the New Zealand Guidelines Group (NZ, 2006) and the National Clinical Guideline (SIGN, 2009) both with a score of 96.7. The CPG from a LMIC had lower scores than CPGs from higher income settings. Our study identified and evaluated 24 CPGs with the highest scores in clarity and presentation, scope and purpose, and rigor of development. Most of these CPGs were developed in HICs, with limited applicability or utility for resource limited settings. Stakeholder involvement, Applicability, and Editorial independence remain weak and insufficiently described specifically with piloting, addressing potential costs and implementation barriers, and auditing for quality improvement.	[Patel, Anjni; Abraham, John; Reid, Nick; Tomecsek, Kevin; Eucker, Stephanie; Gerardo, Charles J.; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Coelho Vieira, Mateus Mazorra] Ctr Univ Unicesumar, Maringa, Parana, Brazil; [Tu Tran; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Vissoci, Joao Ricardo N.; Staton, Catherine A.] Duke Univ, Med Ctr, Div Neurosurg, Div Global Neurosci & Neurosurg, Durham, NC 27710 USA; [Vissoci, Joao Ricardo N.] Fac Inga, Dept Med, BR-87005240 Maringa, Parana, Brazil	Duke University; UniCesumar - Centro Universitario Cesumar; Duke University; Duke University; Centro Universitario Inga (UNINGA)	Staton, CA (corresponding author), Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA.; Staton, CA (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Staton, CA (corresponding author), Duke Univ, Med Ctr, Div Neurosurg, Div Global Neurosci & Neurosurg, Durham, NC 27710 USA.	catherine.staton@duke.edu	Eucker, Stephanie/AAL-1828-2021	Eucker, Stephanie/0000-0001-9986-5773; Joiner, Anjni/0000-0002-8907-182X; Staton, Catherine/0000-0002-6468-2894	Fogarty International Center [K01 TW010000-01A1]; FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors received no research funding for this work. Dr. Staton would like to acknowledge salary support funding from the Fogarty International Center (Staton, K01 TW010000-01A1).	Alexander T, 2009, S AFR J SURG, V47, P120; [Anonymous], 2016, SEARCH CLIN TOOLS LI; [Anonymous], 2016, WORLD BANK COUNTR LE; [Anonymous], 2015, R PROJ STAT COMP VER; [Anonymous], 2013, GLOB STAT REP ROAD S; [Anonymous], 2016, HEAD INJ TRAIG ASS I; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bergman DA, 1999, PEDIATRICS, V104, P1407; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Bratton S.L., 2007, J NEUROTRAUMA S, V24, pS37, DOI DOI 10.1089/NEU.2007.9999; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carson S, 2016, J NEUROTRAUM S1, V24, P1; Carson S, 2007, J NEUROTRAUM, V24, pS1; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; de Andrade AF, 2001, WORLD J SURG, V25, P1186; Alarcon JD, 2013, J TRAUMA ACUTE CARE, V75, P311, DOI 10.1097/TA.0b013e3182924bf8; Dries D., 2016, DEFINING NEED CRITIC; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fervers B, 2006, INT J QUAL HEALTH C, V18, P167, DOI 10.1093/intqhc/mzi108; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Grimmer K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-63; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Harrison MB, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-49; Hebb MO, 2007, CAN J SURG, V50, P187; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kamerling SN, 2003, PEDIATR EMERG CARE, V19, P431, DOI 10.1097/01.pec.0000092590.40174.1f; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lee JC, 2015, INJURY, V46, P854, DOI 10.1016/j.injury.2014.12.023; Liao KH, 2009, SURG NEUROL, V72, P66, DOI 10.1016/j.surneu.2009.07.004; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; NSW Ministry of Health, 2007, ANN REP 2006 2007, P1; O'Lynnger TM, 2016, J NEUROSURG-PEDIATR, V17, P19, DOI 10.3171/2015.5.PEDS1544; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Piek J, 1998, INTENS CARE MED, V24, P1221, DOI 10.1007/s001340050748; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rusnak M, 2008, BRATISL MED J, V109, P374; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Scottish Intercollegiate Guidelines Network, 2009, EARL MAN PAT HEAD IN; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; [The Brain Trauma Foundation The American Association of Neurological Surgeons The Joint Section on Neurotrauma and Critical Care], 2000, J NEUROTRAUM, V17, P463; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Vukic M, 1999, ACTA NEUROCHIR, V141, P1203, DOI 10.1007/s007010050419; Wong JJ, 2015, DISABIL REHABIL, V37, P471, DOI 10.3109/09638288.2014.932448	58	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161554	10.1371/journal.pone.0161554	http://dx.doi.org/10.1371/journal.pone.0161554			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27583787	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600040
J	Tang, LH; Zhu, C; Lin, ZL; Shi, JM; Zhang, WM				Tang, Luohao; Zhu, Cheng; Lin, Zaili; Shi, Jianmai; Zhang, Weiming			Reliable Facility Location Problem with Facility Protection	PLOS ONE			English	Article							DESIGN; DISRUPTIONS	This paper studies a reliable facility location problem with facility protection that aims to hedge against random facility disruptions by both strategically protecting some facilities and using backup facilities for the demands. An Integer Programming model is proposed for this problem, in which the failure probabilities of facilities are site-specific. A solution approach combining Lagrangian Relaxation and local search is proposed and is demonstrated to be both effective and efficient based on computational experiments on random numerical examples with 49, 88, 150 and 263 nodes in the network. A real case study for a 100-city network in Hunan province, China, is presented, based on which the properties of the model are discussed and some managerial insights are analyzed.	[Tang, Luohao; Zhu, Cheng; Shi, Jianmai; Zhang, Weiming] Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China; [Lin, Zaili] Chongqing Univ Sci & Technol, Coll Mech & Power Engn, Chongqing, Peoples R China	National University of Defense Technology - China; Chongqing University of Science & Technology	Zhu, C (corresponding author), Natl Univ Def Technol, Sci & Technol Informat Syst Engn Lab, Changsha, Hunan, Peoples R China.	zhucheng@nudt.edu.cn			National Science Foundation of China [61273322, 71571186, 71201169]; China Scholarship Council [20123013]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by the National Science Foundation of China Grant (61273322, 71571186, 71201169: http://www.nsfc.gov.cn/). LT was also supported by the China Scholarship Council (20123013: http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksen D, 2010, CENT EUR J OPER RES, V18, P269, DOI 10.1007/s10100-009-0110-6; Albareda-Sambola M, 2015, EUR J OPER RES, V245, P656, DOI 10.1016/j.ejor.2015.03.049; Berman O, 2007, OPER RES, V55, P332, DOI 10.1287/opre.1060.0348; Berman O, 2009, DECISION SCI, V40, P845, DOI 10.1111/j.1540-5915.2009.00253.x; Clark D, 2011, WALL STREET J AS MAR; Crowder HP, 1976, COMPUTATIONAL IMPROV; Cui TT, 2010, OPER RES, V58, P998, DOI 10.1287/opre.1090.0801; Daskin M.S., 2013, NETWORK DISCRETE LOC, V2nd; Drezner Z, 2002, FACILITY LOCATION APPLICATIONS AND THEORY, P1; Fisher M. L., 2004, Management Science, V50, P1861, DOI 10.1287/mnsc.1040.0263; FISHER ML, 1985, INTERFACES, V15, P10, DOI 10.1287/inte.15.2.10; Kim CR, 2012, REUTERS; Li QW, 2013, TRANSPORT RES E-LOG, V50, P138, DOI 10.1016/j.tre.2012.10.004; Li QW, 2013, COMPUT OPER RES, V40, P901, DOI 10.1016/j.cor.2012.11.012; Li XP, 2010, TRANSPORT RES B-METH, V44, P535, DOI 10.1016/j.trb.2009.09.004; Liberatore F, 2012, OMEGA-INT J MANAGE S, V40, P21, DOI 10.1016/j.omega.2011.03.003; Lim M, 2010, NAV RES LOG, V57, P58, DOI 10.1002/nav.20385; Medal HR, 2014, EUR J OPER RES, V237, P257, DOI 10.1016/j.ejor.2014.01.040; Melo MT, 2009, EUR J OPER RES, V196, P401, DOI 10.1016/j.ejor.2008.05.007; Owen SH, 1998, EUR J OPER RES, V111, P423, DOI 10.1016/S0377-2217(98)00186-6; Scaparra MP, 2008, COMPUT OPER RES, V35, P1905, DOI 10.1016/j.cor.2006.09.019; Sheffi Y., 2013, RESILIENT ENTERPRISE, V1, P41; Shen ZJM, 2011, INFORMS J COMPUT, V23, P470, DOI 10.1287/ijoc.1100.0414; Snyder L., 2012, SSRN ELECT J, V48; Snyder L. V., 2006, PLANNING DISRUPTIONS; Snyder L. V., 2006, IIE T, V38, P547, DOI [DOI 10.1080/07408170500216480, DOI 10.1061/(ASCE)0733-9488(2007)133:1(51)]; Snyder LV, 2005, TRANSPORT SCI, V39, P400, DOI 10.1287/trsc.1040.0107; Tang C., 2006, INT J LOGIST-RES APP, V9, P33, DOI [10.1080/13675560500405584, DOI 10.1080/13675560500405584]; Yun LF, 2015, TRANSPORT RES B-METH, V81, P596, DOI 10.1016/j.trb.2014.10.010; Zhu YN, 2013, COMPUT OPER RES, V40, P451, DOI 10.1016/j.cor.2012.07.017	30	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161532	10.1371/journal.pone.0161532	http://dx.doi.org/10.1371/journal.pone.0161532			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583542	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600037
J	Yagdiran, Y; Tallkvist, J; Artursson, K; Oskarsson, A				Yagdiran, Yagmur; Tallkvist, Jonas; Artursson, Karin; Oskarsson, Agneta			Staphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory Biomarkers	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; P-GLYCOPROTEIN EXPRESSION; BETA-CASEIN GENE; MULTIDRUG-RESISTANCE; DECREASED EXPRESSION; MEMBRANE-VESICLES; ABC TRANSPORTERS; INDUCED MASTITIS; UP-REGULATION; HEALTHY COWS	Inflammation in the mammary gland (mastitis) is the most common disease in dairy herds worldwide, often caused by the pathogens Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Little is known about the effects of mastitis on drug transporters and the impact on transporter-mediated excretion of drugs into milk. We used murine mammary epithelial HC11 cells, after lactogenic differentiation into a secreting phenotype, and studied gene expressions of ABC- and SLC- transporters after treatment of cells with S. aureus and lipopolysaccharide, an endotoxin secreted by E. coli. The studied transporters were Bcrp, Mdr1, Mrp1, Oatp1a5, Octn1 and Oct1. In addition, Csn2, the gene encoding beta-casein, was analyzed. As biomarkers of the inflammatory response, gene expressions of the cytokines Il6 and Tnf alpha and the chemokine Cxcl2 were determined. Our results show that S. aureus and LPS treatment of cells, at non-cytotoxic concentrations, induced an up-regulation of Mdr1 and of the inflammatory biomarkers, except that Tnf alpha was not affected by lipopolysac-charide. By simple regression analysis we could demonstrate statistically significant positive correlations between each of the transporters with each of the inflammatory biomarkers in cells treated with S. aureus. The coefficients of determination (R-2) were 0.7-0.9 for all but one correlation. After treatment of cells with lipopolysaccharide, statistically significant correlations were only found between Mdr1 and the two parameters Cxcl2 and Il6. The expression of Csn2 was up-regulated in cells treated with S. aureus, indicating that the secretory function of the cells was not impaired. The strong correlation in gene expressions between transporters and inflammatory biomarkers may suggest a co-regulation and that the transporters have a role in the transport of cytokines and chemokines. Our results demonstrate that transporters in mammary cells can be affected by infection, which may have an impact on transport of essential compounds and contaminants into milk.	[Yagdiran, Yagmur; Tallkvist, Jonas; Oskarsson, Agneta] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Artursson, Karin] Natl Vet Inst, Uppsala, Sweden	Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Oskarsson, A (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden.	agneta.oskarsson@slu.se		Oskarsson, Agneta/0000-0002-3134-7811	TvarLivs; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Sweden's Innovation Agency (Vinnova); Swedish Farmer's Foundation for Agricultural Research; Swedish Food Federation; Swedish Food Retailer's Federation [2011-281]	TvarLivs; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Sweden's Innovation Agency (Vinnova)(Vinnova); Swedish Farmer's Foundation for Agricultural Research; Swedish Food Federation; Swedish Food Retailer's Federation	This research project was funded by a grant from the research program TvarLivs, which is co-sponsored by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), Sweden's Innovation Agency (Vinnova), Swedish Farmer's Foundation for Agricultural Research, the Swedish Food Federation and the Swedish Food Retailer's Federation (grant number 2011-281).	Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Alvarez AI, 2008, J PHARM SCI-US, V97, P3483, DOI 10.1002/jps.21233; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen QX, 2014, DRUG METAB PHARMACOK, V29, P223, DOI 10.2133/dmpk.DMPK-13-SH-068; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Cressman AM, 2014, DRUG METAB DISPOS, V42, P603, DOI 10.1124/dmd.113.053983; Cressman AM, 2012, EXPERT REV CLIN PHAR, V5, P69, DOI [10.1586/ecp.11.66, 10.1586/ECP.11.66]; Desrivieres S, 2003, MOL CELL PROTEOMICS, V2, P1039, DOI 10.1074/mcp.M300032-MCP200; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Eriksson H, 2009, VET MICROBIOL, V137, P98, DOI 10.1016/j.vetmic.2008.12.016; Fu YH, 2013, VET IMMUNOL IMMUNOP, V155, P245, DOI 10.1016/j.vetimm.2013.08.003; Gandhi A, 2012, CURR DRUG METAB, V13, P1327, DOI 10.2174/138920012803341302; Gilchrist SE, 2010, FUND CLIN PHARMACOL, V24, P205, DOI 10.1111/j.1472-8206.2009.00760.x; Gips M, 1999, J VET PHARMACOL THER, V22, P202, DOI 10.1046/j.1365-2885.1999.00210.x; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Han LQ, 2010, GENET MOL RES, V9, P449, DOI 10.4238/vol9-1gmr724; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Heemskerk S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525180; HYNES NE, 1990, MOL CELL BIOL, V10, P4027, DOI 10.1128/MCB.10.8.4027; Ingman WV, 2014, J MAMMARY GLAND BIOL, V19, P161, DOI 10.1007/s10911-014-9325-9; Ito S, 2003, ADV DRUG DELIVER REV, V55, P653, DOI 10.1016/S0169-409X(03)00031-0; Jaeger A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0178-z; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Kissell LW, 2015, JAVMA-J AM VET MED A, V246, P118, DOI 10.2460/javma.246.1.118; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lamhonwah AM, 2011, BIOCHEM BIOPH RES CO, V404, P1010, DOI 10.1016/j.bbrc.2010.12.100; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li Y, 2009, BIOCHIMIE, V91, P58, DOI 10.1016/j.biochi.2008.04.014; Liptrott NJ, 2009, BRIT J PHARMACOL, V156, P497, DOI 10.1111/j.1476-5381.2008.00050.x; Liptrott NJ, 2011, EXPERT OPIN DRUG MET, V7, P341, DOI 10.1517/17425255.2011.553600; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; LOHUIS JACM, 1991, J VET PHARMACOL THER, V14, P219, DOI 10.1111/j.1365-2885.1991.tb00830.x; Lucas MF, 2010, J VET PHARMACOL THER, V33, P132, DOI 10.1111/j.1365-2885.2009.01128.x; Mahnke H, 2016, DRUG METAB DISPOS, V44, P700, DOI 10.1124/dmd.115.068940; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Martinez M, 2008, J VET PHARMACOL THER, V31, P285, DOI 10.1111/j.1365-2885.2008.00964.x; Mealey KL, 2012, J VET PHARMACOL THER, V35, P105, DOI 10.1111/j.1365-2885.2011.01313.x; Merino G, 2006, DRUG METAB DISPOS, V34, P690, DOI 10.1124/dmd.105.008219; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Mosaffa F, 2009, INFLAMM RES, V58, P669, DOI 10.1007/s00011-009-0034-6; Pawlik A, 2005, J PHARM PHARMACOL, V57, P1421, DOI 10.1211/jpp.57.11.0007; Petrovic V, 2007, MOL INTERV, V7, P99, DOI 10.1124/mi.7.2.10; Piquette-Miller M, 1998, PHARMACEUT RES, V15, P706, DOI 10.1023/A:1011962818051; Rantala M, 2002, J VET PHARMACOL THER, V25, P251, DOI 10.1046/j.1365-2885.2002.00411.x; Royster E, 2015, VET CLIN N AM-FOOD A, V31, P17, DOI 10.1016/j.cvfa.2014.11.010; Sai Y, 2004, DRUG DISCOV TODAY, V9, P712, DOI 10.1016/S1359-6446(04)03198-8; Schrickx JA, 2008, EUR J PHARMACOL, V585, P510, DOI 10.1016/j.ejphar.2008.03.014; Schuetz JD, 2014, DRUG METAB DISPOS, V42, P541, DOI 10.1124/dmd.114.057539; Schukken YH, 2011, VET IMMUNOL IMMUNOP, V144, P270, DOI 10.1016/j.vetimm.2011.08.022; Sigal N, 2015, INFECT IMMUN, V83, P2358, DOI 10.1128/IAI.00380-15; Stein U, 1997, JNCI-J NATL CANCER I, V89, P807, DOI 10.1093/jnci/89.11.807; Sukhai M, 2001, INFLAMM RES, V50, P362, DOI 10.1007/PL00000257; Tallkvist J, 2015, CELL BIOL TOXICOL, V31, P111, DOI 10.1007/s10565-015-9298-5; Teng S, 2008, MOL PHARMACEUT, V5, P67, DOI 10.1021/mp700102q; Theron D, 2003, BIOCHEM PHARMACOL, V66, P579, DOI 10.1016/S0006-2952(03)00340-X; van de Ven R, 2009, J LEUKOCYTE BIOL, V86, P1075, DOI 10.1189/jlb.0309147; Vos TA, 1998, HEPATOLOGY, V28, P1637, DOI 10.1002/hep.510280625; Yagdiran Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151904; Zheng JM, 2006, INFECT IMMUN, V74, P1907, DOI 10.1128/IAI.74.3.1907-1915.2006	66	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161346	10.1371/journal.pone.0161346	http://dx.doi.org/10.1371/journal.pone.0161346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584666	Green Submitted, gold, Green Published			2022-12-27	WOS:000382855600022
J	Zhou, SM; Xu, RH; He, FS; Zhou, JX; Wang, Y; Zhou, JL; Wang, MB; Zhou, WH				Zhou, Shaoming; Xu, Ruihuan; He, Fusheng; Zhou, Jiaxiu; Wang, Yan; Zhou, Jianli; Wang, Mingbang; Zhou, Wenhao			Diversity of Gut Microbiota Metabolic Pathways in 10 Pairs of Chinese Infant Twins	PLOS ONE			English	Article							FATTY-ACIDS; LIFE; DYNAMICS; DISEASE; SHAPES; GENES	Early colonization of gut microbiota in human gut is a complex process. It remains unclear when gut microbiota colonization occurs and how it proceeds. In order to study gut microbiota composition in human early life, the present study recruited 10 healthy pairs of twins, including five monozygotic (MZ) and five dizygotic (DZ) twin pairs, whose age ranged from 0 to 6 years old. 20 fecal samples from these twins were processed by shotgun metagenomic sequencing, and their averaged data outputs were generated as 2G per sample. We used MEGAN5 to perform taxonomic and functional annotation of the metagenomic data, and systematically analyzed those 20 samples, including Jaccard index similarity, principle component, clustering, and correlation analyses. Our findings indicated that within our study group: 1) MZ-twins share more microbes than DZ twins or non-twin pairs, 2) gut microbiota distribution is relatively stable at metabolic pathways level, 3) age represents the strongest factor that can account for variation in gut microbiota, and 4) a clear metabolic pathway shift can be observed, which speculatively occurs around the age of 1 year old. This research will serve as a base for future studies of gut microbiota-related disease research.	[Zhou, Shaoming; Zhou, Jianli] Shenzhen Childrens Hosp, Div Gastroenterol, Shenzhen, Guangdong, Peoples R China; [Xu, Ruihuan] Longgang Cent Hosp, Clin Lab, Shenzhen, Guangdong, Peoples R China; [He, Fusheng; Wang, Mingbang] Shenzhen Following Precis Med Res Inst, Shenzhen, Guangdong, Peoples R China; [Zhou, Jiaxiu] Shenzhen Childrens Hosp, Div Psychol, Shenzhen, Guangdong, Peoples R China; [Wang, Yan; Wang, Mingbang] Shenzhen Imuno Biotech Co Ltd, Shenzhen, Peoples R China; [Wang, Mingbang; Zhou, Wenhao] Fudan Univ, Childrens Hosp, Div Neonatol, Shanghai, Peoples R China; [Wang, Mingbang; Zhou, Wenhao] Fudan Univ, Childrens Hosp, Key Lab Birth Defects, Shanghai, Peoples R China; [Zhou, Wenhao] Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Zhou, SM (corresponding author), Shenzhen Childrens Hosp, Div Gastroenterol, Shenzhen, Guangdong, Peoples R China.; Wang, MB (corresponding author), Shenzhen Following Precis Med Res Inst, Shenzhen, Guangdong, Peoples R China.; Wang, MB (corresponding author), Shenzhen Imuno Biotech Co Ltd, Shenzhen, Peoples R China.; Wang, MB; Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Div Neonatol, Shanghai, Peoples R China.; Wang, MB; Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Key Lab Birth Defects, Shanghai, Peoples R China.; Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai, Peoples R China.	zhousm15d@aliyun.com; Mingbang.wang.bgi@qq.com; zwhchfu@126.com	Wang, Mingbang/F-4457-2018; wenhao, zhou/AAA-1505-2020	Wang, Mingbang/0000-0002-5989-5377; Zhou, Wenhao/0000-0001-8956-7238	Shenzhen Science Technology Research & Development Fund from Shenzhen Science Technology and Innovation Commission [JCYJ20140416141331514, JCYJ20140411150159429, JCYJ20140415151845360, JCYJ20130401114111453]; Longgang District Science Fundamental Research fund from Longgang District Science Technology and Innovation Commission of Shenzhen [201406063001021]; Shanghai Municipal Commission of Health and Family Planning [2013ZYJB0015]; Science and Technology Commission of Shanghai Municipal [14411950402]; Shenzhen Imuno Biotech Co., Ltd [20150308]	Shenzhen Science Technology Research & Development Fund from Shenzhen Science Technology and Innovation Commission; Longgang District Science Fundamental Research fund from Longgang District Science Technology and Innovation Commission of Shenzhen; Shanghai Municipal Commission of Health and Family Planning; Science and Technology Commission of Shanghai Municipal(Science & Technology Commission of Shanghai Municipality (STCSM)); Shenzhen Imuno Biotech Co., Ltd	This project was support by Shenzhen Science Technology Research & Development Fund (No. JCYJ20140416141331514, JCYJ20140411150159429, JCYJ20140415151845360, and JCYJ20130401114111453) from Shenzhen Science Technology and Innovation Commission, Longgang District Science Fundamental Research fund (No. 201406063001021) from Longgang District Science Technology and Innovation Commission of Shenzhen, Shanghai Municipal Commission of Health and Family Planning (No. 2013ZYJB0015), Science and Technology Commission of Shanghai Municipal (No. 14411950402) and by Shenzhen Imuno Biotech Co., Ltd (No. 20150308). The funder listed provided support, only Shenzhen Imuno Biotech Co., Ltd provide in the form of salaries for authors MW and YW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Ardeshir A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008791; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; FernandezBanares F, 1997, CLIN NUTR, V16, P177, DOI 10.1016/S0261-5614(97)80003-9; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Suchodolski JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127378; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang AH, 2013, MOL BIOSYST, V9, P2259, DOI 10.1039/c3mb70171a	28	24	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161627	10.1371/journal.pone.0161627	http://dx.doi.org/10.1371/journal.pone.0161627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583441	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600046
J	AL Nahdi, A; de Leaniz, CG; King, AJ				AL Nahdi, Abdullah; de Leaniz, Carlos Garcia; King, Andrew J.			Spatio-Temporal Variation in Length-Weight Relationships and Condition of the Ribbonfish Trichiurus lepturus (Linnaeus, 1758): Implications for Fisheries Management	PLOS ONE			English	Article							ARABIAN SEA; REPRODUCTIVE-BIOLOGY; PATTERNS; BIOMASS; GROWTH; BIAS	Knowledge of length-weight relationships for commercially exploited fish is an important tool for assessing and managing of fish stocks. However, analyses of length-weight relationship fisheries data typically do not consider the inherent differences in length-weight relationships for fish caught from different habitats, seasons, or years, and this can affect the utility of these data for developing condition indices or calculating fisheries biomass. Here, we investigated length-weight relationships for ribbonfish Trichiurus lepturus in the waters of the Arabian Sea off Oman collected during three periods (2001-02, 2007-08, and 2014-15) and showed that a multivariate modelling approach that considers the areas and seasons in which ribbonfish were caught improved estimation of length-weight relationships. We used the outputs of these models to explore spatio-temporal variations in condition indices and relative weights among ribbonfish, revealing fish of 85-125 cm were in the best overall condition. We also found that condition differed according to where and when fish were caught, with condition lowest during spring and pre-south-west monsoon periods and highest during and after the south-west monsoons. We interpret these differences to be a consequence of variability in temperature and food availability. Based on our findings, we suggest fishing during seasons that have the lowest impact on fish condition and which are commercially most viable; such fishery management would enhance fisheries conservation and economic revenue in the region.	[AL Nahdi, Abdullah; de Leaniz, Carlos Garcia; King, Andrew J.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales; [AL Nahdi, Abdullah] Minist Agr & Fisheries Wealth, Directorate Fisheries Res, Marine Sci & Fisheries Ctr, Muscat, Oman	Swansea University	AL Nahdi, A (corresponding author), Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales.; AL Nahdi, A (corresponding author), Minist Agr & Fisheries Wealth, Directorate Fisheries Res, Marine Sci & Fisheries Ctr, Muscat, Oman.	750302@swansea.ac.uk	Al Nahdi, Abdullah/M-6688-2015	Al Nahdi, Abdullah/0000-0001-6205-3405	Swansea University, UK; Ministry of Agriculture and Fisheries Wealth, Oman; Ministry of Agriculture and Fisheries Wealth (Sultanate of Oman)	Swansea University, UK; Ministry of Agriculture and Fisheries Wealth, Oman; Ministry of Agriculture and Fisheries Wealth (Sultanate of Oman)	This research was supported by Swansea University, UK (http://www.swansea.ac.uk/) and funded by the Ministry of Agriculture and Fisheries Wealth, Oman (http://maf.gov.om/pages/index.aspx?lang=AR&DId=0&I=0&CId=0&CMSId=40) and for postgraduate assistantship by Agriculture and Fisheries Development Fund (http://www.afdf.gov.om/index.php/home?lang=english) to AN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the scientific staff and crew of R/V Independent 1 which were part of the "Fish Resources Survey of the Arabian Sea Coast of Oman" project for providing data. Thanks also to the biologists in the Marine Science and Fisheries Centre for their assistance in sample collection and technical support in the laboratory. The Ministry of Agriculture and Fisheries Wealth (Sultanate of Oman) provided resources and support to enable this study. All data used in this manuscript are presented as a supplementary file. We thank Heather M. Patterson and an anonymous reviewer for their constructive comments on the previous versions of the manuscript.	Al-Nahdi A, 2009, INDIAN J FISH, V56, P73; Anderson RO, 1996, FISHERIES TECHNIQUES, P447; [Anonymous], 2015, FISHERIES STAT BOOK, P250; Ashjian CJ, 2002, DEEP-SEA RES PT II, V49, P2377, DOI 10.1016/S0967-0645(02)00041-3; Bailey T, 1995, INTERACTIVE SPATIAL; Blackwell Brian G., 2000, Reviews in Fisheries Science, V8, P1, DOI 10.1080/10641260091129161; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carron, 1999, ARABIAN MARGINAL SEA; Cheng CH, 2001, FISHERIES SCI, V67, P3, DOI 10.1046/j.1444-2906.2001.00192.x; Claereboudt MR, 2005, FISH RES, V73, P273, DOI 10.1016/j.fishres.2005.02.009; Earth N, 2013, 1 10M CULTURAL VECTO; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Fulton T. W., 1902, RATE GROWTH SEA FISH; Ghosh S, 2014, INDIAN J GEO-MAR SCI, V43, P755; Godad SP, 2011, MAR MICROPALEONTOL, V78, P25, DOI 10.1016/j.marmicro.2010.09.006; HAYES DB, 1995, CAN J FISH AQUAT SCI, V52, P84, DOI 10.1139/f95-008; HILBORN R, 1992; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Kang HJ, 2015, OCEAN SCI J, V50, P237, DOI 10.1007/s12601-015-0021-5; Kwok KY, 1999, MAR ECOL PROG SER, V176, P39, DOI 10.3354/meps176039; Lai HL, 2004, FISH RES, V70, P377, DOI 10.1016/j.fishres.2004.08.014; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; LIAO HS, 1995, T AM FISH SOC, V124, P387, DOI 10.1577/1548-8659(1995)124<0387:RWWRAA>2.3.CO;2; McIlwain J, 2006, J APPL ICHTHYOL, V22, P167, DOI 10.1111/j.1439-0426.2006.00723.x; MURPHY B R, 1990, North American Journal of Fisheries Management, V10, P85, DOI 10.1577/1548-8675(1990)010<0085:EOTRWW>2.3.CO;2; Naqvi S.W.A., 2010, ARABIAN SEA HIGH NUT; Neumann RM, 2012, FISHERIES TECHNIQUES, THIRD EDITION, P637; Ogle D.H., 2014, FSA FISHERIES STOCK; Ogle DH, 2009, N AM J FISH MANAGE, V29, P850, DOI 10.1577/M08-176.1; Pardoe H, 2008, MAR ECOL PROG SER, V362, P261, DOI 10.3354/meps07409; Piontkovski S, 2015, INT J ENVIRON STUD, P1; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Pope KL, 2001, ASSESSMENT FISH COND; Randall JE., 1995, COASTAL FISHES OMAN, DOI DOI 10.2307/1447687; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; Team RC, 2014, R LANG ENV STAT COMP; van Overzee HMJ, 2015, REV FISH BIOL FISHER, V25, P65, DOI 10.1007/s11160-014-9370-x; Zhou SJ, 2010, P NATL ACAD SCI USA, V107, P9485, DOI 10.1073/pnas.0912771107	40	18	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161989	10.1371/journal.pone.0161989	http://dx.doi.org/10.1371/journal.pone.0161989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579485	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400050
J	Andonian, P; Viallon, M; Le Goff, C; de Bourguignon, C; Tourel, C; Morel, J; Giardini, G; Gergele, L; Millet, GP; Croisille, P				Andonian, Pierre; Viallon, Magalie; Le Goff, Caroline; de Bourguignon, Charles; Tourel, Charline; Morel, Jerome; Giardini, Guido; Gergele, Laurent; Millet, Gregoire P.; Croisille, Pierre			Shear-Wave Elastography Assessments of Quadriceps Stiffness Changes prior to, during and after Prolonged Exercise: A Longitudinal Study during an Extreme Mountain Ultra-Marathon	PLOS ONE			English	Article							INDUCED MUSCLE DAMAGE; ECCENTRIC EXERCISE; MECHANICAL-PROPERTIES; SKELETAL-MUSCLE; SOFT-TISSUE; FORCE; RESPONSES; ULTRAMARATHON; BIOMECHANICS; RELIABILITY	In sports medicine, there is increasing interest in quantifying the elastic properties of skeletal muscle, especially during extreme muscular stimulation, to improve our understanding of the impact of alterations in skeletal muscle stiffness on resulting pain or injuries, as well as the mechanisms underlying the relationships between these parameters. Our main objective was to determine whether real-time shear-wave elastography (SWE) can monitor changes in quadriceps muscle elasticity during an extreme mountain ultra-marathon, a powerful mechanical stress model. Our study involved 50 volunteers participating in an extreme mountain marathon (distance: 330 km, elevation: + 24,000 m). Quantitative SWE velocity and shear modulus measurements were performed in most superficial quadriceps muscle heads at the following 4 time points: before the race, halfway through the race, upon finishing the race and after recovery (+ 48 h). Blood biomarker levels were also measured. A significant decrease in the quadriceps shear modulus was observed upon finishing the race (3.31 +/- 0.61 kPa) (p < 0.001) compared to baseline (3.56 +/- 0.63 kPa), followed by a partial recovery + 48 h after the race (3.45 +/- 0.6 kPa) (p = 0.002) across all muscle heads, as well as for each of the following three muscle heads: the rectus femoris (p = 0.003), the vastus medialis (p = 0.033) and the vastus lateralis (p = 0.001). Our study is the first to assess changes in muscle stiffness during prolonged extreme physical endurance exercises based on shear modulus measurements using non-invasive SWE. We concluded that decreases in stiffness, which may have resulted from quadriceps overuse in the setting of supra-physiological stress caused by the extreme distance and unique elevation of the race, may have been responsible for the development of inflammation and muscle swelling. SWE may hence represent a promising tool for monitoring physiologic or pathological variations in muscle stiffness and may be useful for diagnosing and monitoring muscle changes.	[Andonian, Pierre; Viallon, Magalie; de Bourguignon, Charles; Croisille, Pierre] Univ Jean Monnet, CHU St Etienne, Dept Radiol, St Etienne, France; [Viallon, Magalie; Croisille, Pierre] Univ Lyon, UJM St Etienne, CREATIS, INSERM U1206,CNRS UMR 5520,INSA, F-42023 St Etienne, France; [Le Goff, Caroline] Univ Liege, CHU Sart Tilman, Dept Clin Chem, EuSpLM, Liege, Belgium; [Tourel, Charline; Morel, Jerome; Gergele, Laurent] CHU St Etienne, Dept Intens Care, St Etienne, France; [Giardini, Guido] Valle DAosta Reg Hosp, Mt Med Ctr, Dept Neurol & Neurophysiol, Aosta, Italy; [Millet, Gregoire P.] Univ Lausanne ISSUL, Inst Sport Sci, Lausanne, Switzerland	CHU de St Etienne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); University of Liege; CHU de St Etienne; Azienda USL della Valle d'Aosta	Croisille, P (corresponding author), Univ Jean Monnet, CHU St Etienne, Dept Radiol, St Etienne, France.; Croisille, P (corresponding author), Univ Lyon, UJM St Etienne, CREATIS, INSERM U1206,CNRS UMR 5520,INSA, F-42023 St Etienne, France.	pierre.croisille@creatis.insa-lyon.fr	Millet, Gregoire P/F-4104-2012; Croisille, Pierre/H-4928-2014; Le Goff, Caroline/AAE-8177-2021; Viallon, Magalie/H-4471-2014	Millet, Gregoire P/0000-0001-8081-4423; Croisille, Pierre/0000-0003-4019-3460; Viallon, Magalie/0000-0001-9118-0438	Universite de Lyon, within the program "Investissements d'Avenir" [ANR-11-LABX-0063, ANR-11-IDEX-0007]	Universite de Lyon, within the program "Investissements d'Avenir"(French National Research Agency (ANR))	The authors are especially grateful to Supersonic Imagine, who contributed to this study by providing two of their ultrasound diagnostic systems equipped with the most advanced SWE module during the Tor des Geants. The authors also thank Sysmex for their support in providing a pocH-100i (TM) automated hematology analyzer (Sysmex, Villepinte, France). This work was performed within the framework of the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi R, 2014, SCAND J MED SCI SPOR, V24, P950, DOI 10.1111/sms.12111; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Avela J, 1999, J APPL PHYSIOL, V86, P1292, DOI 10.1152/jappl.1999.86.4.1292; Balnave CD, 1996, J PHYSIOL-LONDON, V492, P705, DOI 10.1113/jphysiol.1996.sp021339; Bell RAV, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0086-6; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Blazevich AJ, 2006, SPORTS MED, V36, P1003, DOI 10.2165/00007256-200636120-00002; Botanlioglu H, 2013, SKELETAL RADIOL, V42, P659, DOI 10.1007/s00256-012-1520-4; Bouillard K, 2014, J NEUROPHYSIOL, V111, P768, DOI 10.1152/jn.00595.2013; Brandenburg JE, 2014, ARCH PHYS MED REHAB, V95, P2207, DOI 10.1016/j.apmr.2014.07.007; Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI [10.1097/00002060-200211001-00007, 10.1097/01.PHM.0000029772.45258.43]; CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cowan S. M., 2000, PHYS THER SPORT, V1, P129, DOI DOI 10.1054/PTSP.2000.0036; Crommert ME, 2015, SCAND J MED SCI SPOR, V25, pE490, DOI 10.1111/sms.12341; DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611, DOI 10.1152/jappl.1986.61.2.611; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; DIETZ V, 1981, BRAIN, V104, P431, DOI 10.1093/brain/104.3.431; Dubois G, 2015, ULTRASOUND MED BIOL, V41, P2284, DOI 10.1016/j.ultrasmedbio.2015.04.020; Eby SF, 2015, CLIN BIOMECH, V30, P22, DOI 10.1016/j.clinbiomech.2014.11.011; Feasson L, 2006, Ann Readapt Med Phys, V49, P289, DOI 10.1016/j.annrmp.2006.04.015; FRIDEN J, 1981, EXPERIENTIA, V37, P506, DOI 10.1007/BF01986165; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; Fulford J, 2015, SCAND J MED SCI SPOR, V25, pE28, DOI 10.1111/sms.12234; Gennisson JL, 2007, J ACOUST SOC AM, V122, P3211, DOI 10.1121/1.2793605; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Giovanelli N, 2016, INT J SPORT PHYSIOL, V11, P522, DOI 10.1123/ijspp.2014-0602; Green MA, 2012, NMR BIOMED, V25, P852, DOI 10.1002/nbm.1801; Guilhem G, 2016, ACTA PHYSIOL, V217, P152, DOI 10.1111/apha.12654; Guilhem G, 2013, MED SCI SPORT EXER, V45, P326, DOI 10.1249/MSS.0b013e31826e7066; Heroux ME, 2013, ACTA PHYSIOL, V208, P294, DOI 10.1111/apha.12133; HIKIDA RS, 1983, J NEUROL SCI, V59, P185, DOI 10.1016/0022-510X(83)90037-0; Hill JC, 2014, PHYSICIAN SPORTSMED, V42, P45, DOI 10.3810/psm.2014.09.2075; Hjorth M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12473; HOWELL JN, 1993, J PHYSIOL-LONDON, V464, P183, DOI 10.1113/jphysiol.1993.sp019629; Hug F, 2015, EXERC SPORT SCI REV, V43, P125, DOI 10.1249/JES.0000000000000049; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; Kim Jooyoung, 2015, J Exerc Nutrition Biochem, V19, P123, DOI 10.5717/jenb.2015.15061910; Kjaer M, 2006, J ANAT, V208, P445, DOI 10.1111/j.1469-7580.2006.00549.x; Knechtle B, 2008, J SPORT SCI MED, V7, P357; Koo TK, 2014, CLIN BIOMECH, V29, P33, DOI 10.1016/j.clinbiomech.2013.11.009; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kreider R B, 1991, Int J Sport Nutr, V1, P3; Lacourpaille L, 2014, ACTA PHYSIOL, V211, P135, DOI 10.1111/apha.12272; Lacourpaille L, 2015, MUSCLE NERVE, V51, P284, DOI 10.1002/mus.24445; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lakens D, 2015, CALCULATING REPORTIN, P1, DOI [10.3389/fpsyg.2013.00863/abstract, DOI 10.3389/FPSYG.2013.00863/ABSTRACT]; Lee SSM, 2015, CLIN BIOMECH, V30, P269, DOI 10.1016/j.clinbiomech.2015.01.004; LEHMANN JF, 1989, ARCH PHYS MED REHAB, V70, P6; Leonard CT, 2003, ARCH PHYS MED REHAB, V84, P928, DOI 10.1016/S0003-9993(03)00006-6; Lieber RL, 2004, MUSCLE NERVE, V29, P615, DOI 10.1002/mus.20059; MANFREDI TG, 1991, MED SCI SPORT EXER, V23, P1028; Garcia-Manso JM, 2011, J SPORT SCI, V29, P619, DOI 10.1080/02640414.2010.548822; Maufrais C, 2016, AM J PHYSIOL-HEART C, V310, pH1340, DOI 10.1152/ajpheart.00037.2016; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Mueller SM, 2015, EUR J APPL PHYSIOL, V115, P795, DOI 10.1007/s00421-014-3051-2; Neumayr G, 2003, INT J SPORTS MED, V24, P131, DOI 10.1055/s-2003-38205; NEWHAM DJ, 1987, J APPL PHYSIOL, V63, P1381, DOI 10.1152/jappl.1987.63.4.1381; Newton MJ, 2008, J STRENGTH COND RES, V22, P597, DOI 10.1519/JSC.0b013e3181660003; Nieman DC, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0003-z; Overgaard K, 2002, J APPL PHYSIOL, V92, P1891, DOI 10.1152/japplphysiol.00669.2001; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Proske U, 2001, J PHYSIOL-LONDON, V537, P333, DOI 10.1111/j.1469-7793.2001.00333.x; RADIN EL, 1986, ACTA MED SCAND, P143; Regueme SC, 2005, EUR J APPL PHYSIOL, V93, P398, DOI 10.1007/s00421-004-1221-3; Roth SM, 1999, J APPL PHYSIOL, V86, P1833, DOI 10.1152/jappl.1999.86.6.1833; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; Sahlin K, 2010, J APPL PHYSIOL, V108, P780, DOI 10.1152/japplphysiol.00966.2009; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Semmler A, 2013, J NEUROL, V260, P151, DOI 10.1007/s00415-012-6605-4; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Stupka N, 2000, J APPL PHYSIOL, V89, P2325, DOI 10.1152/jappl.2000.89.6.2325; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Vitiello D, 2015, EXTREME PHYSIOL MED, V4, DOI 10.1186/s13728-015-0037-6; Voloshina AS, 2015, J EXP BIOL, V218, P711, DOI 10.1242/jeb.106518; Warren GL, 2008, HUMAN ANIMAL EXPT MU; Weismann C, 2011, BREAST CARE, V6, P98, DOI 10.1159/000327504; Whitehead NP, 2001, J PHYSIOL-LONDON, V533, P593, DOI 10.1111/j.1469-7793.2001.0593a.x; YAMAKOSHI Y, 1990, IEEE T ULTRASON FERR, V37, P45, DOI 10.1109/58.46969; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012	86	65	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161855	10.1371/journal.pone.0161855	http://dx.doi.org/10.1371/journal.pone.0161855			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579699	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400044
J	Liu, WS; Zhao, Y; You, JL; Qi, DH; Zhou, Y; Chen, JK; Song, ZP				Liu, Wensheng; Zhao, Yao; You, Jianling; Qi, Danhui; Zhou, Yin; Chen, Jiakuan; Song, Zhiping			Morphological and Genetic Variation along a North-to-South Transect in Stipa purpurea, a Dominant Grass on the Qinghai-Tibetan Plateau: Implications for Response to Climate Change	PLOS ONE			English	Article							LOCAL ADAPTATION; ALPINE PLANT; ALTITUDINAL GRADIENT; FLOW; GROWTH; REPRODUCTION; EVOLUTIONARY; PLASTICITY; ALLOMETRY; DIVERSITY	Estimating the potential of species to cope with rapid environmental climatic modifications is of vital importance for determining their future viability and conservation. The variation between existing populations along a climatic gradient may predict how a species will respond to future climate change. Stipa purpurea is a dominant grass species in the alpine steppe and meadow of the Qinghai-Tibetan Plateau (QTP). Ecological niche modelling was applied to S. purpurea, and its distribution was found to be most strongly correlated with the annual precipitation and the mean temperature of the warmest quarter. We established a north-to-south transect over 2000 km long on the QTP reflecting the gradients of temperature and precipitation, and then we estimated the morphological by sampling fruited tussocks and genetic divergence by using 11 microsatellite markers between 20 populations along the transect. Reproductive traits (the number of seeds and reproductive shoots), the reproductive-vegetative growth ratio and the length of roots in the S. purpurea populations varied significantly with climate variables. S. purpurea has high genetic diversity (He = 0.585), a large effective population size (Ne > 1,000), and a considerable level of gene flow between populations. The S. purpurea populations have a mosaic genetic structure: some distant populations (over 1000 km apart) clustered genetically, whereas closer populations (< 100 km apart) had diverged significantly, suggesting local adaptation. Asymmetrical long-distance inter-population gene flow occurs along the sampling transect and might be mediated by seed dispersal via migratory herbivores, such as the chiru (Pantholops hodgsonii). These findings suggest that population performance variation and gene flow both facilitate the response of S. purpurea to climate change.	[Liu, Wensheng; Zhao, Yao; You, Jianling; Zhou, Yin; Chen, Jiakuan; Song, Zhiping] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai, Peoples R China; [Liu, Wensheng; Qi, Danhui] Southwest Forestry Univ, Coll Environm Sci & Engn, Kunming, Peoples R China; [Liu, Wensheng] Cent South Univ Forestry & Technol, Coll Life Sci & Technol, Changsha, Hunan, Peoples R China	Fudan University; Southwest Forestry University - China; Central South University of Forestry & Technology	Song, ZP (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai, Peoples R China.	songzp@fudan.edu.cn	liu, wen/HGE-3071-2022	you, jianling/0000-0002-0683-7915	Ministry of Science and Technology [2014CB954103]; Applied Fundamental Research Foundation of Yunnan Province [2014GA003]; National Natural Science Foundation of China [31160048]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Applied Fundamental Research Foundation of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Ministry of Science and Technology (Grant No. 2014CB954103), the Applied Fundamental Research Foundation of Yunnan Province (2014GA003), and the National Natural Science Foundation of China (Grant No. 31160048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to X.Y. Pan, H. Guo and W. Zhou for assistance with data analyses, and Y. G. Wang, W.J. Zhang and J. Yang for their comments on the paper. This research was funded by the Ministry of Science and Technology (Grant No. 2014CB954103), the Applied Fundamental Research Foundation of Yunnan Province (2014GA003), and the National Natural Science Foundation of China (Grant No. 31160048).	Alsos IG, 2007, SCIENCE, V316, P1606, DOI 10.1126/science.1139178; Beerli P., 2008, MIGRATE VERSION 3 0; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Blass C, 2010, J ARID ENVIRON, V74, P991, DOI 10.1016/j.jaridenv.2009.12.002; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Byars SG, 2009, ANN BOT-LONDON, V103, P885, DOI 10.1093/aob/mcp018; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Durka W, 2013, PLANT SYST EVOL, V299, P259, DOI 10.1007/s00606-012-0719-0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falster DS, 2006, USERS GUIDE TO SMATR; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Garcia-Fernandez A, 2012, ANN BOT-LONDON, V110, P1221, DOI 10.1093/aob/mcs195; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Guo H, 2012, J ECOL, V100, P452, DOI 10.1111/j.1365-2745.2011.01884.x; Hadfield JD, 2016, ECOL LETT, V19, P780, DOI 10.1111/ele.12614; Hamasha HR, 2013, PLANT BIOLOGY, V15, P882, DOI 10.1111/j.1438-8677.2012.00689.x; HENDRIX SD, 1991, NEW PHYTOL, V119, P299, DOI 10.1111/j.1469-8137.1991.tb01034.x; Johansson F, 2013, MOL ECOL, V22, P5608, DOI 10.1111/mec.12497; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; KLINKHAMER PGL, 1992, FUNCT ECOL, V6, P308, DOI 10.2307/2389522; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Lind MI, 2011, J EVOLUTION BIOL, V24, P2696, DOI 10.1111/j.1420-9101.2011.02393.x; Liu WS, 2009, ANN APPL BIOL, V154, P57, DOI 10.1111/j.1744-7348.2008.00274.x; Liu WS, 2011, AM J BOT, V98, pE150, DOI 10.3732/ajb.1000444; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071749; Manel S, 2012, MOL ECOL, V21, P3729, DOI 10.1111/j.1365-294X.2012.05656.x; Matter P, 2013, ANN BOT-LONDON, V111, P611, DOI 10.1093/aob/mct021; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peakall R, 2001, GENAIEX GENETIC ANAL; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ronnenberg K, 2011, BASIC APPL ECOL, V12, P141, DOI 10.1016/j.baae.2010.12.002; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sexton JP, 2011, P NATL ACAD SCI USA, V108, P11704, DOI 10.1073/pnas.1100404108; Shen DF, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S11; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasseur F, 2012, ECOL LETT, V15, P1149, DOI 10.1111/j.1461-0248.2012.01839.x; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Weppler T, 2006, J ECOL, V94, P869, DOI 10.1111/j.1365-2745.2006.01134.x; Wilson GA, 2003, GENETICS, V163, P1177; Wrange AL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-156; Yue PP, 2011, RUSS J ECOL+, V42, P50, DOI 10.1134/S1067413611010140; Zhang FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060712; [张镱锂 Zhang Yili], 2002, [地理研究, Geographical Research], V21, P1	50	16	17	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161972	10.1371/journal.pone.0161972	http://dx.doi.org/10.1371/journal.pone.0161972			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580056	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400049
J	Ma, XL; Wang, XS; Huang, JW; Chen, YT; Zhang, J; Zhang, BL; Shi, CL; Liu, L				Ma, Xuelei; Wang, Xiaoshan; Huang, Jingwen; Chen, Yingtai; Zhang, Jing; Zhang, Binglan; Shi, Changle; Liu, Lei			Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-II TRIAL; CONTROLLED SUPERIORITY TRIAL; PLUS ADJUVANT CHEMOTHERAPY; TAXANE-BASED CHEMOTHERAPY; QUALITY-OF-LIFE; CONSERVING SURGERY; OPEN-LABEL; PREOPERATIVE CHEMOTHERAPY; 1ST-LINE TREATMENT	Background Neoadjuvant therapy is administered to breast cancer patients as an induction process before surgery or radiotherapy to reduce tumor size. Human epidermal growth factor receptor-2 (HER-2) negative breast cancer lacks effective standard target therapy. Bevacizumab has a controversial role in the treatment of breast cancer and we conduct a meta-analysis to evaluate the value of adding bevacizumab in neoadjuvant regimen. Methods Potentially eligible studies were retrieved using PubMed, EMBASE and Medline. Clinical characteristics of patients and statistical data with pathological complete response (pCR) data were collected. Then a meta-analysis model was established to investigate the correlation between administration of bevacizumab in neoadjuvant therapy and pCR rates in HER2 negative breast cancer. Results Seven eligible studies and 5408 patients were yielded. The pCR rates for "breast" or "breast plus lymph node" were similar. In subgroup analysis, we emphasized on patients with triple-negative breast cancer (TNBC). In the criterion of "lesions in breast" the pooled ORs was 1.55 [1.29, 1.86], P<0.00001 and regarding to the evaluation criterion of "lesions in breast and lymph nodes", the pooled ORs was 1.48 [1.23, 1.78], P<0.0001, in favor of bevacizumab administration. Conclusion According to our pooled results, we finally find that bevacizumab addition as a neoadjuvant chemotherapy component, for induction use with limited cycle to improve the pCR rates and patients may avoid long-term adverse event and long-term invalid survival improvement. Especially in subgroup analysis, pCR rates could be improved significantly and physicians could consider bevacizumab with caution. As patients could avoid the adverse event caused by long-term using of bevacizumab, long-term quality of life improvement may be achieved, especially in TNBC.	[Ma, Xuelei; Zhang, Binglan] Sichuan, West China Hosp, West China Med Sch, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Ma, Xuelei; Zhang, Binglan] Sichuan, West China Hosp, West China Med Sch, Ctr Canc, Chengdu, Sichuan, Peoples R China; [Wang, Xiaoshan] Sichuan Prov Peoples Hosp, Dept Clin Oncol, Chengdu, Sichuan, Peoples R China; [Huang, Jingwen; Zhang, Jing; Shi, Changle; Liu, Lei] Sichuan Univ, West China Hosp, Dept Med Oncol, Ctr Canc, Chengdu, Sichuan, Peoples R China; [Chen, Yingtai] Chinese Acad Med Sci, Peking Union Med Coll, Canc Hosp, Dept Abdominal Surg, Beijing, Peoples R China	Sichuan Provincial People's Hospital; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Liu, L (corresponding author), Sichuan Univ, West China Hosp, Dept Med Oncol, Ctr Canc, Chengdu, Sichuan, Peoples R China.	liuleihx@gmail.com			National Natural Science Foundation of China, Beijing, China [81101991]; Research Award Fund for New Young Teachers in Higher Education Institutions, China [20120181120024]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Research Award Fund for New Young Teachers in Higher Education Institutions, China	This study was supported by the National Natural Science Foundation of China, Beijing, China (Grant No. 81101991) and Research Award Fund for New Young Teachers in Higher Education Institutions, China (Grant No. 20120181120024). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the article.	Bahri S, 2009, ANN SURG ONCOL, V16, P1619, DOI 10.1245/s10434-009-0441-5; Bertucci F, 2016, LANCET ONCOL, V17, P600, DOI 10.1016/S1470-2045(16)00011-5; Boughey JC, 2014, ANN SURG, V260, P608, DOI 10.1097/SLA.0000000000000924; Brodowicz T, 2014, BRIT J CANCER, V111, P2051, DOI 10.1038/bjc.2014.504; Buzdar AU, 2007, CLIN CANCER RES, V13, P228, DOI 10.1158/1078-0432.CCR-06-1345; Cao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145442; Chen JH, 2008, CANCER-AM CANCER SOC, V112, P17, DOI 10.1002/cncr.23130; Chen XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108405; Clavarezza M, 2013, BREAST, V22, P470, DOI 10.1016/j.breast.2013.03.012; Cobleigh MA, 2003, SEMIN ONCOL, V30, P117, DOI 10.1053/j.seminoncol.2003.08.013; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Cortes J, 2012, EUR J CANCER, V48, P475, DOI 10.1016/j.ejca.2011.11.021; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Gerber B, 2013, ANN ONCOL, V24, P2978, DOI 10.1093/annonc/mdt361; Gerber B, 2014, ANN SURG ONCOL, V21, P2517, DOI 10.1245/s10434-014-3606-9; Gianni L, 2014, LANCET ONCOL, V15, P640, DOI 10.1016/S1470-2045(14)70080-4; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Greenberg S, 2010, CANCER J, V16, P33, DOI 10.1097/PPO.0b013e3181d38514; Greil R, 2009, EJSO-EUR J SURG ONC, V35, P1048, DOI 10.1016/j.ejso.2009.01.014; Guarneri V, 2015, ANN SURG ONCOL, V22, P2881, DOI 10.1245/s10434-015-4371-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hurvitz SA, 2013, J CLIN ONCOL, V31, P1157, DOI 10.1200/JCO.2012.44.9694; Killelea BK, 2015, J AM COLL SURGEONS, V220, P1063, DOI 10.1016/j.jamcollsurg.2015.02.011; Kim HR, 2013, ANN ONCOL, V24, P1485, DOI 10.1093/annonc/mds658; Luangdilok S, 2014, J BREAST CANCER, V17, P376, DOI 10.4048/jbc.2014.17.4.376; Maass N, 2013, J CANCER RES CLIN, V139, P2047, DOI 10.1007/s00432-013-1518-x; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Makhoul I, 2016, AM J CLIN ONCOL-CANC, V39, P248, DOI 10.1097/COC.0000000000000046; Makhoul I, 2015, AM J CLIN ONCOL-CANC, V38, P74, DOI 10.1097/COC.0b013e31828940c3; Martin M, 2011, LANCET ONCOL, V12, P369, DOI 10.1016/S1470-2045(11)70037-7; Montagna E, 2012, CLIN BREAST CANCER, V12, P207, DOI 10.1016/j.clbc.2012.03.008; Mrozek E, 2014, CLIN BREAST CANCER, V14, P228, DOI 10.1016/j.clbc.2014.02.005; Nalwoga H, 2011, BREAST CANCER RES TR, V130, P1063, DOI 10.1007/s10549-011-1740-7; Oizumi S, 2012, ONCOLOGIST, V17, P863, DOI 10.1634/theoncologist.2011-0426; Perez EA, 2014, J CLIN ONCOL, V32, P3744, DOI 10.1200/JCO.2014.55.5730; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Rastogi P, 2011, CLIN BREAST CANCER, V11, P228, DOI 10.1016/j.clbc.2011.04.001; Rose S, 2011, CANCER DISCOV, V1, DOI 10.1158/2159-8290.CD-ND112311OL-08; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rouzier R, 2004, CANCER, V101, P918, DOI 10.1002/cncr.20491; Sanchez-Rovira P, 2013, CLIN TRANSL ONCOL, V15, P810, DOI 10.1007/s12094-013-1006-4; Schneider BP, 2013, CLIN CANCER RES, V19, P1281, DOI 10.1158/1078-0432.CCR-12-3029; Sharma SP, 2012, J NATL CANCER I, V104, P800, DOI 10.1093/jnci/djs265; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Thongprasert S, 2011, J THORAC ONCOL, V6, P1872, DOI 10.1097/JTO.0b013e31822adaf7; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Truong PT, 2007, INT J RADIAT ONCOL, V68, P59, DOI 10.1016/j.ijrobp.2006.12.017; Vergine M, 2013, G CHIR, V34, P254, DOI 10.11138/gchir/2013.34.9.254; von Minckwitz G, 2014, ANN ONCOL, V25, P2363, DOI 10.1093/annonc/mdu455; von Minckwitz G, 2014, ANN ONCOL, V25, P81, DOI 10.1093/annonc/mdt410; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; von Minckwitz G, 2010, J CLIN ONCOL, V28, P2015, DOI 10.1200/JCO.2009.23.8303; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303	54	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160148	10.1371/journal.pone.0160148	http://dx.doi.org/10.1371/journal.pone.0160148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579484	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400002
J	McNeill, JB; Avens, L; Hall, AG; Goshe, LR; Harms, CA; Owens, DW				McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.; Harms, Craig A.; Owens, David W.			Female-Bias in a Long-Term Study of a Species with Temperature-Dependent Sex Determination: Monitoring Sex Ratios for Climate Change Research	PLOS ONE			English	Article							TURTLES; IMPACTS	Alterations have occurred and continue to manifest in the Earth's biota as a result of climate change. Animals exhibiting temperature dependent sex determination (TSD), including sea turtles, are perhaps most vulnerable to a warming of the Earth as highly skewed sex ratios can result, potentially leading to population extinction resulting from decreased male recruitment. Recent studies have begun to quantify climate change impacts to sea turtle populations, especially in terms of predicting effects on hatchling sex ratios. However, given the inherent difficulty in studying sex ratios at this life stage, a more accurate assessment of changes in population sex ratios might be derived by evaluating the juvenile portion of foraging aggregations. We investigated the long-term trend in sex ratio of a juvenile logger-head (Caretta caretta) sea turtle population inhabiting Pamlico and Core Sounds, North Carolina, USA. We used plasma testosterone reference ranges measured using radioimmunoassay (RIA) to assign sex for 959 turtles and confirmed sex assignment of a subset (N = 58) of the sampled turtles through laparoscopic examination of their gonads. Our results demonstrate that for this particular population of loggerheads, sex ratios (3Females: 1Male) had not significantly changed over a 10 year period (1998-2007), nor showed any significant difference among 5-cm straight carapace length (SCL) size classes. Ultimately, these findings provide a basis for comparison with future sex ratios, and highlight the importance of establishing similar long-term studies monitoring secondary, rather than primary, sex ratios, so that needed mitigation measures to climate change impacts can be implemented.	[McNeill, Joanne Braun; Avens, Larisa; Hall, April Goodman; Goshe, Lisa R.] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Beaufort, NC 28516 USA; [Harms, Craig A.] North Carolina State Univ, Ctr Marine Sci & Technol, Coll Vet Med, Morehead City, NC USA; [Owens, David W.] Univ Charleston South Carolina, Coll Charleston, Charleston, SC USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; North Carolina State University; College of Charleston	McNeill, JB (corresponding author), NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Beaufort, NC 28516 USA.	joanne.b.mcneill@noaa.gov	Braun McNeill, Joanne/M-5653-2016	Braun McNeill, Joanne/0000-0002-3209-1547				Avens L, 2015, MAR BIOL, V162, P1749, DOI 10.1007/s00227-015-2705-x; Bass AL, 2004, CONSERV GENET, V5, P783, DOI 10.1007/s10592-004-1979-1; Braun-McNeill J, 2007, HERPETOLOGICA, V63, P275, DOI 10.1655/0018-0831(2007)63[275:SROTRR]2.0.CO;2; Broderick AC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P161, DOI 10.1086/319661; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Delgado C, 2010, MAR BIOL, V157, P979, DOI 10.1007/s00227-009-1378-8; Epperly Sheryan P., 2007, Endangered Species Research, V3, P283, DOI 10.3354/esr00054; Freedberg S, 2001, EVOLUTION, V55, P1049, DOI 10.1554/0014-3820(2001)055[1049:CIAAMF]2.0.CO;2; Fuentes MMPB, 2013, ECOL MODEL, V251, P150, DOI 10.1016/j.ecolmodel.2012.12.020; Fuentes MMPB, 2010, J EXP MAR BIOL ECOL, V383, P56, DOI 10.1016/j.jembe.2009.11.003; GUTHRIE JF, 1973, MAR FISH REV, V35, P27; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hamann M., 2007, CLIMATE CHANGE GREAT, P466; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes LA, 2013, AQUAT BIOL, V18, P9, DOI 10.3354/ab00475; Hays Graeme C., 2014, Frontiers in Marine Science, V1, P00043; Higgins E, 1928, EXAMINATION SUMMER F, P29; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hulin V, 2009, OECOLOGIA, V160, P493, DOI 10.1007/s00442-009-1313-1; JANZEN FJ, 1991, Q REV BIOL, V66, P149, DOI 10.1086/417143; Janzen FJ, 1994, P NATL ACAD SCI USA, V91, P7847; Kallimanis AS, 2010, OIKOS, V119, P197, DOI 10.1111/j.1600-0706.2009.17674.x; Laloe JO, 2016, J EXP MAR BIOL ECOL, V474, P92, DOI 10.1016/j.jembe.2015.09.015; Laloe JO, 2014, NAT CLIM CHANGE, V4, P513, DOI 10.1038/NCLIMATE2236; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Lutcavage Molly E., 1997, P387; Maffucci F, 2013, MAR BIOL, V160, P1097, DOI 10.1007/s00227-012-2160-x; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; MROSOVSKY N, 1994, J EXP ZOOL, V270, P16, DOI 10.1002/jez.1402700104; MROSOVSKY N, 1984, SCIENCE, V225, P739, DOI 10.1126/science.225.4663.739; Mrosovsky N., 2009, Endangered Species Research, V8, P147, DOI 10.3354/esr00200; Owens D.W., 1978, Florida Marine Research Publications, P12; Owens David W., 1997, P315; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patino-Martinez J, 2012, GLOBAL CHANGE BIOL, V18, P401, DOI 10.1111/j.1365-2486.2011.02532.x; Saba VS, 2012, NATURE CLIMATE CHANG; Tomillo PS, 2014, BIOL CONSERV, V176, P71, DOI 10.1016/j.biocon.2014.05.011; Scott R, 2012, FUNCT ECOL, V26, P227, DOI 10.1111/j.1365-2435.2011.01915.x; Shoop C. Robert, 1998, Chelonian Conservation and Biology, V3, P93; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Tucker JK, 2008, CHELONIAN CONSERV BI, V7, P60, DOI 10.2744/CCB-0670.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; WIBBELS T, 1991, CAN J ZOOL, V69, P2973, DOI 10.1139/z91-419; Wibbels T, 2003, CRC MAR BIOL SER, P103; Wibbels Thane, 2000, Chelonian Conservation and Biology, V3, P756; Wibbels TR, 1987, SEXING TECHNIQUES SE; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; Wyneken J, 2006, 26 ANN S SEA TURTL B; Wyneken J, 2007, HERPETOLOGICA, V63, P19, DOI 10.1655/0018-0831(2007)63[19:DSIPLS]2.0.CO;2; Wyneken J, 2015, J EXP ZOOL PART B, V324, P295, DOI 10.1002/jez.b.22620; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; Zar J.H., 2010, BIOSTAT ANAL	58	14	14	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160911	10.1371/journal.pone.0160911	http://dx.doi.org/10.1371/journal.pone.0160911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579608	Green Published, Green Submitted, gold			2022-12-27	WOS:000382877400011
J	Yokoe, M; Takayama-Watanabe, E; Saito, Y; Kutsuzawa, M; Fujita, K; Ochi, H; Nakauchi, Y; Watanabe, A				Yokoe, Misato; Takayama-Watanabe, Eriko; Saito, Yoko; Kutsuzawa, Megumi; Fujita, Kosuke; Ochi, Haruki; Nakauchi, Yuni; Watanabe, Akihiko			A Novel Cysteine Knot Protein for Enhancing Sperm Motility That Might Facilitate the Evolution of Internal Fertilization in Amphibians	PLOS ONE			English	Article							CYNOPS-PYRRHOGASTER; INITIATING SUBSTANCE; NEWT; SPERMATOZOA; CHEMOATTRACTANT; MECHANISMS; PEPTIDE; OVIDUCT; EGGS	Internal fertilization ensures successful reproduction of tetrapod vertebrates on land, although how this mode of reproduction evolved is unknown. Here, we identified a novel gene encoding sperm motility-initiating substance (SMIS), a key protein for the internal fertilization of the urodele Cynops pyrrhogaster by Edman degradation of an isolated protein and subsequent reverse transcription polymerase chain reaction. The SMIS gene encoded a 150 amino-acid sequence including the cysteine knot (CK) motif. No gene with substantial similarity to the SMIS was in the data bank of any model organisms. An active site of the SMIS was in the C-terminal region of the 2nd loop of CK motif. A synthetic peptide including the active site sequence bound to the midpiece and initiated/enhanced the circular motion of C. pyrrhogaster sperm, which allows penetration of the egg jelly specialized for the internal fertilization of this species. The synthetic peptide bound to whole sperm of Rhacophorus arboreus and enhanced the rotary motion, which is adapted to propel the sperm through egg coat matrix specialized for arboreal reproduction, while it bound to the tip of head and tail of Bufo japonicus sperm, and enhanced the vibratory motion, which is suited to sperm penetration through the egg jelly specialized for the reproduction of that species in freshwater. The polyclonal antibody against the active site of the SMIS specifically bound to egg coat matrix of R. arboreus. These findings suggest that diversification of amphibian reproductive modes accompanies the specialization of egg coat and the adaptation of sperm motility to penetrate the specialized egg coat, and SMIS acts as the sperm motility enhancer of anurans and urodeles that might facilitate to adaptively optimize sperm motility for allowing the establishment of internal fertilization.	[Yokoe, Misato; Saito, Yoko; Kutsuzawa, Megumi; Fujita, Kosuke; Nakauchi, Yuni; Watanabe, Akihiko] Yamagata Univ, Fac Sci, Dept Biol, Yamagata, Japan; [Takayama-Watanabe, Eriko] Yamagata Univ, Inst Arts & Sci, Yamagata, Japan; [Ochi, Haruki] Yamagata Univ, Sch Med, Yamagata, Japan	Yamagata University; Yamagata University; Yamagata University	Watanabe, A (corresponding author), Yamagata Univ, Fac Sci, Dept Biol, Yamagata, Japan.	watan@sci.kj.yamagata-u.ac.jp	Ochi, Haruki/AAR-7235-2020	Ochi, Haruki/0000-0002-0088-581X; Takayama-Watanabe, Eriko/0000-0001-5950-6207; Watanabe, Akihiko/0000-0002-0382-5433; Nakauchi, Yuni/0000-0003-1152-6123	JSPS KAKENHI [JP24570246, JP16K07459, 15K07165]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI No. JP24570246 AW, JSPS KAKENHI No. JP16K07459 AW, and JSPS KAKENHI No. 15K07165 ET-W.	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; ASHIZAWA K, 1987, J REPROD FERTIL, V81, P495, DOI 10.1530/jrf.0.0810495; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; Boschert V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081710; CLAPPER DL, 1982, GAMETE RES, V6, P315, DOI 10.1002/mrd.1120060404; Greven H, 1998, J EXP ZOOL, V282, P507; Mizuno J, 1999, ZYGOTE, V7, P329, DOI 10.1017/S0967199499000738; MORISAWA M, 1980, SCIENCE, V210, P1145, DOI 10.1126/science.7444445; MORISAWA M, 1994, ZOOL SCI, V11, P647; Muto K, 2011, J MORPHOL, V272, P1422, DOI 10.1002/jmor.10994; Muto K, 2009, CELL MOTIL CYTOSKEL, V66, P281, DOI 10.1002/cm.20358; Neubaum DM, 1999, CURR TOP DEV BIOL, V41, P67; ODA S, 1995, DEV GROWTH DIFFER, V37, P257; Ohta M, 2010, ZOOL SCI, V27, P875, DOI 10.2108/zsj.27.875; Olson JH, 2001, P NATL ACAD SCI USA, V98, P11205, DOI 10.1073/pnas.211316798; OSANAI M, 1989, INVERTEBR REPROD DEV, V15, P97, DOI 10.1080/07924259.1989.9672029; Perez-Vilar J, 1998, J BIOL CHEM, V273, P14442, DOI 10.1074/jbc.273.23.14442; PILLAI MC, 1993, J EXP ZOOL, V265, P336, DOI 10.1002/jez.1402650316; Scheltinga David M., 2003, P119; Sive H.L., 2000, EARLY DEV XENOPUS LA, P249; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Takahashi T, 2013, DEV GROWTH DIFFER, V55, P657, DOI 10.1111/dgd.12073; Takayama-Watanabe E, 2012, ZYGOTE, V20, P417, DOI 10.1017/S0967199412000226; Ukita M, 1999, ZOOL SCI, V16, P793, DOI 10.2108/zsj.16.793; van der Horst G, 1995, ADV SPERMATOZOAL PHY, P333; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wake MH, 1998, J EXP ZOOL, V282, P477; WARD GE, 1985, J CELL BIOL, V101, P2324, DOI 10.1083/jcb.101.6.2324; Watanabe A., 2003, REPROD BIOL PHYLOGEN, p423 ; Watanabe T, 2010, INT J DEV BIOL, V54, P591, DOI 10.1387/ijdb.092894tw; YANAGIMACHI R, 1994, PHYSL REPROD, V0002, P00189; Yoshida M, 2002, P NATL ACAD SCI USA, V99, P14831, DOI 10.1073/pnas.242470599	32	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0160445	10.1371/journal.pone.0160445	http://dx.doi.org/10.1371/journal.pone.0160445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579691	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877400004
J	Liu, MF; Zhang, CY; Cai, H; Liu, FF; Liu, Y; Li, JJ; Pan, YQ; Guo, CH; He, ZH; Ke, Y				Liu, Mengfei; Zhang, Chanyuan; Cai, Hong; Liu, Fangfang; Liu, Ying; Li, Jingjing; Pan, Yaqi; Guo, Chuanhai; He, Zhonghu; Ke, Yang			The Willingness to Change Risky Health Behaviors among Chinese Rural Residents: What We Learned from a Population-Based Esophageal Cancer Cohort Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL CARCINOMA; ALCOHOL; SMOKING; MEN	Background The effectiveness of health interventions can be impaired by low socio-economic status and poor living conditions of the target population. However, the specifics of this problem in rural China are still unclear, and appropriate strategies should be explored. Methods In 2013, we conducted a questionnaire-based investigation among 410 participants from a population-based esophageal cancer cohort study in rural Anyang, China. Information regarding their demographic characteristics, levels of exposure to four health-risk behaviors, including smoking, alcohol consumption, risky dietary behaviors and poor hygiene, as well as willingness to change these behaviors, and data on potential predictors of willingness to change behaviors were collected. Results In this study, 33.3%(23/69), 25.0%(13/52), 60.7%(68/112) and 62.2%(237/381) of respondents reported that they were willing to change smoking, alcohol consumption, risky dietary behaviors and poor hygiene, respectively. Older people had higher exposure levels and less willingness to change these four health-risk behaviors. The levels of these four health-risk behaviors were negatively associated with willingness to change, while faith in people and behavioral change in surrounding people increased willingness to change risky behaviors. Conclusions In behavior-intervention-based health-promotion programs in rural China, the elderly and highly exposed populations should be the most difficult part and community-or household-based intervention would be more efficient.	[Liu, Mengfei; Zhang, Chanyuan; Cai, Hong; Liu, Fangfang; Liu, Ying; Li, Jingjing; Pan, Yaqi; Guo, Chuanhai; He, Zhonghu; Ke, Yang] Peking Univ, Canc Hosp & Inst, Genet Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China	Peking University	He, ZH; Ke, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Genet Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.	zhonghuhe@foxmail.com; keyang@bjmu.edu.cn		He, Zhonghu/0000-0002-4444-7950	Charity Project of National Ministry of Health [201202014]; "973" Project of National Ministry of Science and Technology Grant [2012CB910803]; "863" Key Projects of National Ministry of Science and Technology Grant [2012AA02A209, 2012AA022502]; Beijing Municipal Science and Technology Commission [Z141100002114046]; Natural Science Foundation of China [81473033]	Charity Project of National Ministry of Health; "973" Project of National Ministry of Science and Technology Grant; "863" Key Projects of National Ministry of Science and Technology Grant; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Charity Project of National Ministry of Health [grant number 201202014]; "973" Project of National Ministry of Science and Technology Grant [grant number 2012CB910803]; "863" Key Projects of National Ministry of Science and Technology Grant [grant numbers 2012AA02A209, 2012AA022502]; and Beijing Municipal Science and Technology Commission [grant number Z141100002114046] to Y. Ke. Natural Science Foundation of China [grant number 81473033] to Z. He. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto M, 2004, ALCOHOL ALCOHOLISM, V39, P532, DOI 10.1093/alcalc/agh090; Blankenship KM, 2000, AIDS, V14, pS11, DOI 10.1097/00002030-200006001-00003; Chai J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1253-6; Christiansen BA, 2015, NICOTINE TOB RES, V17, P1002, DOI 10.1093/ntr/ntu345; Deborah L. EG., 2004, SMOKING RELATED BEHA; Fan YH, 2008, NUTR CANCER, V60, P354, DOI 10.1080/01635580701883011; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Guo FC, 2012, CANCER EPIDEM BIOMAR, V21, P780, DOI 10.1158/1055-9965.EPI-11-1206; He ZH, 2014, CARCINOGENESIS, V35, P816, DOI 10.1093/carcin/bgt483; He ZH, 2013, EMERG INFECT DIS, V19, P992, DOI 10.3201/eid1906.111597; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013; Li J Y, 1982, Natl Cancer Inst Monogr, V62, P113; Li K, 2002, INT J CANCER, V102, P271, DOI [10.1002/ijc.10706, 10.1002/jhc.10706]; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018776; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; Liu MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10986; Liu MF, 2014, CANCER EPIDEM BIOMAR, V23, P2857, DOI 10.1158/1055-9965.EPI-14-0365; Lyu Jun, 2014, Zhonghua Liu Xing Bing Xue Za Zhi, V35, P875; McCahon D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1502-8; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; Wu M, 2009, INT J CANCER, V124, P1907, DOI 10.1002/ijc.24142; YANG CS, 1980, CANCER RES, V40, P2633; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	28	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161999	10.1371/journal.pone.0161999	http://dx.doi.org/10.1371/journal.pone.0161999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575990	gold, Green Published, Green Submitted			2022-12-27	WOS:000382877200054
J	Broggini, T; Piffko, A; Hoffmann, CJ; Harms, C; Vajkoczy, P; Czabanka, M				Broggini, Thomas; Piffko, Andras; Hoffmann, Christian J.; Harms, Christoph; Vajkoczy, Peter; Czabanka, Marcus			Passive Entrapment of Tumor Cells Determines Metastatic Dissemination to Spinal Bone and Other Osseous Tissues	PLOS ONE			English	Article							IN-VITRO; COLONIZATION; MIGRATION; ORGAN; GROWTH; BRAIN; MICE	During the metastatic process tumor cells circulate in the blood stream and are carried to various organs. In order to spread to different organs tumor cell-endothelial cell interactions are crucial for extravasation mechanisms. It remains unclear if tumor cell dissemination to the spinal bone occurs by passive entrapment of circulating tumor cells or by active cellular mechanisms mediated by cell surface molecules or secreted factors. We investigated the seeding of three different tumor cell lines (melanoma, lung and prostate carcinoma) to the microvasculature of different organs. Their dissemination was compared to biologically passive microbeads. The spine and other organs were resected three hours after intraarterial injection of tumor cells or microbeads. Ex vivo homogenization and fluorescence analysis allowed quantification of tumor cells or microbeads in different organs. Interestingly, tumor cell distribution to the spinal bone was comparable to dissemination of microbeads independent of the tumor cell type (melanoma: 5.646% +/- 7.614%, lung: 6.007% +/- 1.785%, prostate: 3.469% +/- 0.602%, 7 mu m beads: 9.884% +/- 7.379%, 16 mu m beads: 7.23% +/- 1.488%). Tumor cell seeding differed significantly between tumor cells and microbeads in all soft tissue organs. Moreover, there were significant differences between the different tumor cell lines in their dissemination behaviour to soft tissue organs only. These findings demonstrate that metastatic dissemination of tumor cells to spinal bone and other osseous organs is mediated by passive entrapment of tumor cells similar to passive plugging of microvasculature observed after intraarterial microbeads injection.	[Broggini, Thomas; Piffko, Andras; Vajkoczy, Peter; Czabanka, Marcus] Charite, Dept Neurosurg, Berlin, Germany; [Hoffmann, Christian J.; Harms, Christoph] Charite, Dept Expt Neurol, Berlin, Germany; [Broggini, Thomas] Univ Calif San Diego, Dept Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego	Vajkoczy, P; Czabanka, M (corresponding author), Charite, Dept Neurosurg, Berlin, Germany.	peter.vajkoczy@charite.de; marcus.czabanka@charite.de	Harms, Christoph/HIK-2989-2022; Harms, Christoph/AAD-7895-2021	Harms, Christoph/0000-0002-2063-2860; Hoffmann, Christian Johannes/0000-0003-0861-2418; Vajkoczy, Peter/0000-0003-4350-392X; Piffko, Andras/0000-0001-5300-6594	German research foundation (DFG GEPRIS) [267716524]; Swiss National Science Foundation; 'Berliner Krebsgesellschaft e.V.' as a doctoral student of the Medical Neuroscience Charite PhD Program; Volkswagen Foundation; Charite Foundation	German research foundation (DFG GEPRIS)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 'Berliner Krebsgesellschaft e.V.' as a doctoral student of the Medical Neuroscience Charite PhD Program; Volkswagen Foundation(Volkswagen); Charite Foundation	This work was supported by the German research foundation (DFG GEPRIS: 267716524) T.B. received the Early Postdoc.Mobility fellowship from the Swiss National Science Foundation and the Ernst von Leyden fellowship from the 'Berliner Krebsgesellschaft e.V.' as a doctoral student of the Medical Neuroscience Charite PhD Program. M.C. was part of the Friedrich C. Luft Clinical Scientist Pilot Program funded by the Volkswagen Foundation and the Charite Foundation. The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	[Anonymous], 2000, ECONOMETRIC FDN PACK; Aoudjit F, 1998, J IMMUNOL, V161, P2333; ARGUELLO F, 1988, CANCER RES, V48, P6876; BADENOCHJONES P, 1984, INVAS METAST, V4, P98; Broggini T, 2015, EUR SPINE J, V24, P2173, DOI 10.1007/s00586-015-3811-7; Campbell J. P., 2012, JOVE-J VIS EXP, V67, pe4260, DOI DOI 10.3791/4260; FARHOOD A, 1995, J LEUKOCYTE BIOL, V57, P368, DOI 10.1002/jlb.57.3.368; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; FOGELQUIST S, 1991, INVAS METAST, V11, P261; Heroult M, 2010, MOL CANCER RES, V8, P1297, DOI 10.1158/1541-7786.MCR-09-0453; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Jeevan DS, 2016, ANTICANCER RES, V36, P523; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; LAPIS K, 1988, CLIN EXP METASTAS, V6, P73, DOI 10.1007/BF01580408; Li Shuling, 2012, Clin Epidemiol, V4, P87, DOI 10.2147/CLEP.S28339; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mina LA, 2011, NAT REV CLIN ONCOL, V8, P325, DOI 10.1038/nrclinonc.2011.59; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; SanchezSweatman OH, 1997, EUR J CANCER, V33, P918, DOI 10.1016/S0959-8049(97)00513-3; SARIN SK, 1990, AM J PHYSIOL, V258, pG365, DOI 10.1152/ajpgi.1990.258.3.G365; SCHACKERT G, 1988, CANCER RES, V48, P3478; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Tavassoli M, 1981, Prog Clin Biol Res, V59B, P249; VALLE EF, 1992, CLIN EXP METASTAS, V10, P419, DOI 10.1007/BF00133471; Wibmer C, 2011, SPINE, V36, P1977, DOI 10.1097/BRS.0b013e3182011f84; YOUNG MR, 1985, CANCER RES, V45, P3918	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162540	10.1371/journal.pone.0162540	http://dx.doi.org/10.1371/journal.pone.0162540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603673	Green Published, Green Submitted, gold			2022-12-27	WOS:000383255200074
J	Kuriakose, M; Skotak, M; Misistia, A; Kahali, S; Sundaramurthy, A; Chandra, N				Kuriakose, Matthew; Skotak, Maciej; Misistia, Anthony; Kahali, Sudeepto; Sundaramurthy, Aravind; Chandra, Namas			Tailoring the Blast Exposure Conditions in the Shock Tube for Generating Pure, Primary Shock Waves: The End Plate Facilitates Elimination of Secondary Loading of the Specimen	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INDUCED NEUROTRAUMA; NERVOUS-SYSTEM; PRESSURE; IMPACT; MODEL; RAT	The end plate mounted at the mouth of the shock tube is a versatile and effective implement to control and mitigate the end effects. We have performed a series of measurements of incident shock wave velocities and overpressures followed by quantification of impulse values (integral of pressure in time domain) for four different end plate configurations (0.625, 2, 4 inches, and an open end). Shock wave characteristics were monitored by high response rate pressure sensors allocated in six positions along the length of 6 meters long 229 mm square cross section shock tube. Tests were performed at three shock wave intensities, which was controlled by varying the Mylar membrane thickness (0.02, 0.04 and 0.06 inch). The end reflector plate installed at the exit of the shock tube allows precise control over the intensity of reflected waves penetrating into the shock tube. At the optimized distance of the tube to end plate gap the secondary waves were entirely eliminated from the test section, which was confirmed by pressure sensor at T4 location. This is pronounced finding for implementation of pure primary blast wave animal model. These data also suggest only deep in the shock tube experimental conditions allow exposure to a single shock wave free of artifacts. Our results provide detailed insight into spatiotemporal dynamics of shock waves with Friedlander waveform generated using helium as a driver gas and propagating in the air inside medium sized tube. Diffusion of driver gas (helium) inside the shock tube was responsible for velocity increase of reflected shock waves. Numerical simulations combined with experimental data suggest the shock wave attenuation mechanism is simply the expansion of the internal pressure. In the absence of any other postulated shock wave decay mechanisms, which were not implemented in the model the agreement between theory and experimental data is excellent.	[Kuriakose, Matthew; Skotak, Maciej; Misistia, Anthony; Kahali, Sudeepto; Sundaramurthy, Aravind; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Dept Biomed Engn, Newark, NJ 07102 USA	New Jersey Institute of Technology	Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Dept Biomed Engn, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Skotak, Maciej/H-4769-2019; Sundaramurthy, Aravind/O-2047-2019; Kahali, Sudeepto/G-9413-2018	Skotak, Maciej/0000-0003-2584-7294; Kahali, Sudeepto/0000-0001-8675-7466; Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. Army Medical Research and Materiel Command [14059001]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by grant no. 14059001 entitled "Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tubes" received from the U.S. Army Medical Research and Materiel Command.	BECKER H, 1965, J APPL POLYM SCI, V9, P911, DOI 10.1002/app.1965.070090309; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Burnside R, 1965, J AUSTRALIAN MATH SO, V5, P258; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I., 2015, FRONTIERS NEUROENGIN; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cullis I G, 2001, J R Army Med Corps, V147, P16; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DRYER M, 1967, J GEOPHYS RES, V72, P2955, DOI 10.1029/JZ072i011p02955; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; EMRICH RJ, 1953, J APPL PHYS, V24, P360, DOI 10.1063/1.1721279; GLASS II, 1955, J AERONAUT SCI, V22, P73, DOI 10.2514/8.3282; Gould KE, 1981, DTIC DOCUMENT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOOKER WJ, 1963, J CHEM PHYS, V38, P214, DOI 10.1063/1.1733464; Hyde D., 2004, CONWEP 2 1 0 8; KIEFER JH, 1985, J PHYS CHEM-US, V89, P2013, DOI 10.1021/j100256a043; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; MIURA H, 1990, FLUID DYN RES, V6, P251, DOI 10.1016/0169-5983(90)90015-Q; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Needham C. E., 2010, BLAST WAVE PROPAGATI; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Newman AJ, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002183; PARK C, 1973, COMBUST FLAME, V20, P369, DOI 10.1016/0010-2180(73)90029-1; Rafaels KA, 2010, BLAST BRAIN INJURY R; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; SLEPICKA F, 1966, PHYS FLUIDS, V9, P1865, DOI 10.1063/1.1761946; SOMMERFELD M, 1985, EXP FLUIDS, V3, P197; Stuhmiller J. H., 1991, CONVENTIONAL WARFARE, P241; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vieille P., 1899, CR HEBD ACAD SCI, V129, P1228; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Zel'dovlch YB, 1965, PHYS SHOCK WAVES HIG, P1966	44	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161597	10.1371/journal.pone.0161597	http://dx.doi.org/10.1371/journal.pone.0161597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603017	gold, Green Submitted, Green Published			2022-12-27	WOS:000383255200019
J	Xu, WS; Luo, PY; Sun, L; Lin, N				Xu, W. S.; Luo, P. Y.; Sun, L.; Lin, N.			A Prediction Model of the Capillary Pressure J-Function	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY	The capillary pressure J-function is a dimensionless measure of the capillary pressure of a fluid in a porous medium. The function was derived based on a capillary bundle model. However, the dependence of the J-function on the saturation S-w is not well understood. A prediction model for it is presented based on capillary pressure model, and the J-function prediction model is a power function instead of an exponential or polynomial function. Relative permeability is calculated with the J-function prediction model, resulting in an easier calculation and results that are more representative.	[Xu, W. S.; Luo, P. Y.; Sun, L.] Southwest Petr Univ, State Key Oil & Gas Reservoir Geol & Exploitat, Chengdu 610500, Sichuan, Peoples R China; [Xu, W. S.; Lin, N.] PetroChina, Tarim Oilfield Co, Korla 841000, Xinjiang, Peoples R China	Southwest Petroleum University; China National Petroleum Corporation	Xu, WS (corresponding author), Southwest Petr Univ, State Key Oil & Gas Reservoir Geol & Exploitat, Chengdu 610500, Sichuan, Peoples R China.; Xu, WS (corresponding author), PetroChina, Tarim Oilfield Co, Korla 841000, Xinjiang, Peoples R China.	shujia2012@163.com			Tarim Oilfield Company	Tarim Oilfield Company	The funding organization (Tarim Oilfield Company) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. I have reviewed the statements relating to the author contributions. The funder provided support in the form of salaries for authors [Employee ID No. 00699778], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bakke S, 1997, SPE J, V2, P136, DOI 10.2118/35479-PA; Bartley JT, 1999, TRANSPORT POROUS MED, V36, P161, DOI 10.1023/A:1006575231732; Brooks R. H., 1964, HYDROLOGY PAPERS COL, P72; Brown H. W., 1951, PETROL T AIME, V192, P67; BURDINE NT, 1953, T AM I MIN MET ENG, V198, P71; Donaldson EC, 1991, J PETROL SCI ENG, V6, P249, DOI 10.1016/0920-4105(91)90017-H; Dong MZ, 2005, TRANSPORT POROUS MED, V59, P1, DOI 10.1007/s11242-004-0763-5; Dullien FLA, 1992, POROUS MEDIA FLUID T; Gao HJ, 2014, INT J HEAT MASS TRAN, V69, P26, DOI 10.1016/j.ijheatmasstransfer.2013.10.006; Gerhard J. I., 2003, WATER RESOUR RES, V39, P1; Guo ZL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195310; He G.S., 2011, PETROPHYSICS; Kevin G. M., 2011, VADOSE ZONE J, V10, P1162; Leverett M. C., 1941, PETROLEUM T AIME, V27, P152; Li KW, 2010, J PETROL SCI ENG, V73, P20, DOI 10.1016/j.petrol.2010.05.002; MCCUEN RH, 1981, WATER RESOUR RES, V17, P1005, DOI 10.1029/WR017i004p01005; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Oren PE, 1998, SPE J, V3, P324, DOI 10.2118/52052-PA; Oren PE, 2002, TRANSPORT POROUS MED, V46, P311, DOI 10.1023/A:1015031122338; Osisanya S. O., 2014, J CANADIAN PETROLEUM, V40, P30; Purcell W. R., 1949, PETROLEUM T AIME, V2, P39; Rose W., 1949, PETROLEUM T AIME, V5, P127; Thomeer J. H. M., 1960, J PETROL TECHNOL, V3, P73; Tiab D., PETROPHYSICS; Touati M., 2009, 2009 SPE SAUD AR SEC; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wo SC, 2001, COLLOID SURFACE A, V187, P449, DOI 10.1016/S0927-7757(01)00613-6; Wu T.-R., 2004, THESIS CORNELL U USA; ZuwaOmoregle S., 1986, SPE J, V3, P146, DOI [10.2118/15384-pa, DOI 10.2118/15384-PA]	29	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162123	10.1371/journal.pone.0162123	http://dx.doi.org/10.1371/journal.pone.0162123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603701	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200045
J	Ye, WX; Ren, WB; Kong, LQ; Zhang, WJ; Wang, T				Ye, Wenxing; Ren, Weibo; Kong, Lingqi; Zhang, Wanjun; Wang, Tao			Transcriptomic Profiling Analysis of Arabidopsis thaliana Treated with Exogenous Myo-Inositol	PLOS ONE			English	Article							GLUCOSE 6-PHOSPHATE/PHOSPHATE TRANSLOCATOR; CELL-WALL POLYSACCHARIDE; GENOME-WIDE ANALYSIS; DEFENSE RESPONSES; DROUGHT TOLERANCE; OXYGENASE GENE; HISTONE H2A; RNA-SEQ; INOSITOL; METABOLISM	Myo-insositol (MI) is a crucial substance in the growth and developmental processes in plants. It is commonly added to the culture medium to promote adventitious shoot development. In our previous work, MI was found in influencing Agrobacterium-mediated transformation. In this report, a high-throughput RNA sequencing technique (RNA-Seq) was used to investigate differently expressed genes in one-month-old Arabidopsis seedling grown on MI free or MI supplemented culture medium. The results showed that 21,288 and 21,299 genes were detected with and without MI treatment, respectively. The detected genes included 184 new genes that were not annotated in the Arabidopsis thaliana reference genome. Additionally, 183 differentially expressed genes were identified (DEGs, FDR <= 0.05, log(2) FC >= 1), including 93 up-regulated genes and 90 down-regulated genes. The DEGs were involved in multiple pathways, such as cell wall biosynthesis, biotic and abiotic stress response, chromosome modification, and substrate transportation. Some significantly differently expressed genes provided us with valuable information for exploring the functions of exogenous MI. RNA-Seq results showed that exogenous MI could alter gene expression and signaling transduction in plant cells. These results provided a systematic understanding of the functions of exogenous MI in detail and provided a foundation for future studies.	[Ye, Wenxing; Zhang, Wanjun] China Agr Univ, Dept Grassland Sci, Beijing, Peoples R China; [Wang, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Ye, Wenxing; Zhang, Wanjun; Wang, Tao] China Agr Univ, Beijing Key Lab Grassland Sci, Beijing, Peoples R China; [Ren, Weibo; Kong, Lingqi] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Inner Mongolia, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Zhang, WJ (corresponding author), China Agr Univ, Dept Grassland Sci, Beijing, Peoples R China.; Wang, T (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Zhang, WJ; Wang, T (corresponding author), China Agr Univ, Beijing Key Lab Grassland Sci, Beijing, Peoples R China.	wjzhang@cau.edu.cn; wangt@cau.edu.cn	Kong, Lingxue/D-8216-2011	Kong, Lingxue/0000-0001-6219-3897	DaBeiNong young scholars funding [1041-2415002]; Co construction project of Beijing Municipal Education commission [25016056]	DaBeiNong young scholars funding; Co construction project of Beijing Municipal Education commission	This research was funded by DaBeiNong young scholars funding (grant no. 1041-2415002) and Co construction project of Beijing Municipal Education commission (grant no. 25016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alford SR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00069; Ayadi A, 2015, PLANT PHYSIOL, V167, P1511, DOI 10.1104/pp.114.252338; BECK E, 1989, ANNU REV PLANT PHYS, V40, P95, DOI 10.1146/annurev.pp.40.060189.000523; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Bleeker PM, 2011, PLANT MOL BIOL, V77, P323, DOI 10.1007/s11103-011-9813-x; Bluthgen Nils, 2005, Genome Inform, V16, P106; Boss Wendy E., 2006, V39, P181; Casas-Mollano JA, 2006, J EXP BOT, V57, P3301, DOI 10.1093/jxb/erl093; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaouch S, 2010, NEW PHYTOL, V188, P711, DOI 10.1111/j.1469-8137.2010.03453.x; Chatterjee J, 2010, PROTOPLASMA, V245, P165, DOI 10.1007/s00709-010-0170-4; Chen MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035904; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; de Jong F, 2014, PLANT PHYSIOL, V164, P308, DOI 10.1104/pp.113.230599; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Dyson BC, 2014, ANN BOT-LONDON, V113, P643, DOI 10.1093/aob/mct298; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Fellenberg C, 2009, PHYTOCHEMISTRY, V70, P1392, DOI 10.1016/j.phytochem.2009.08.010; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Gelvin SB, 2010, CURR OPIN MICROBIOL, V13, P53, DOI 10.1016/j.mib.2009.11.003; Gelvin SB, 2006, METH MOL B, V343, P105; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hosmani PS, 2013, P NATL ACAD SCI USA, V110, P14498, DOI 10.1073/pnas.1308412110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kim CY, 2008, NEW PHYTOL, V180, P57, DOI 10.1111/j.1469-8137.2008.02557.x; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; LOEWUS FA, 1990, PLANT BIOL, V9, P1; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Loewus Frank A., 2006, V39, P21; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma JK, 2011, NEW PHYTOL, V191, P733, DOI 10.1111/j.1469-8137.2011.03735.x; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Mosblech A, 2008, MOL PLANT, V1, P249, DOI 10.1093/mp/ssm028; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Mysore KS, 2000, P NATL ACAD SCI USA, V97, P948, DOI 10.1073/pnas.97.2.948; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Nelson DE, 1998, PLANT CELL, V10, P753; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Sengupta S, 2012, J PLANT BIOCHEM BIOT, V21, pS15, DOI 10.1007/s13562-012-0132-3; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Shen XY, 2014, PLANT MOL BIOL, V86, P303, DOI 10.1007/s11103-014-0230-9; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; Wang H, 1996, PLANT CELL, V8, P375, DOI 10.1105/tpc.8.3.375; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wirsing L, 2011, ANAL BIOCHEM, V408, P220, DOI 10.1016/j.ab.2010.09.029; Wyatt HR, 2003, GENETICS, V164, P47; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Yadav V, 2014, PLANT CELL, V26, P3569, DOI 10.1105/tpc.114.129049; Zhang WJ, 2013, PLANT MOL BIOL, V81, P273, DOI 10.1007/s11103-012-9997-8; Zhao GR, 2002, BBA-GENE STRUCT EXPR, V1574, P370, DOI 10.1016/S0167-4781(01)00311-6	78	6	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161949	10.1371/journal.pone.0161949	http://dx.doi.org/10.1371/journal.pone.0161949			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603208	Green Submitted, Green Published, gold			2022-12-27	WOS:000383255200031
J	Kist, AM; Sagafos, D; Rush, AM; Neacsu, C; Eberhardt, E; Schmidt, R; Lunden, LK; Orstavik, K; Kaluza, L; Meents, J; Zhang, ZP; Carr, TH; Salter, H; Malinowsky, D; Wollberg, P; Krupp, J; Kleggetveit, IP; Schmelz, M; Jorum, E; Lampert, A; Namer, B				Kist, Andreas M.; Sagafos, Dagrun; Rush, Anthony M.; Neacsu, Cristian; Eberhardt, Esther; Schmidt, Roland; Lunden, Lars Kristian; Orstavik, Kristin; Kaluza, Luisa; Meents, Jannis; Zhang, Zhiping; Carr, Thomas Hedley; Salter, Hugh; Malinowsky, David; Wollberg, Patrik; Krupp, Johannes; Kleggetveit, Inge Petter; Schmelz, Martin; Jorum, Ellen; Lampert, Angelika; Namer, Barbara			SCN10A Mutation in a Patient with Erythromelalgia Enhances C-Fiber Activity Dependent Slowing	PLOS ONE			English	Article							INHERITED ERYTHROMELALGIA; STATE INACTIVATION; NOCICEPTORS; NA(V)1.7; NEURONS; SCN9A; EXPRESSION; CHANNELS; ONSET	Gain-of-function mutations in the tetrodotoxin (TTX) sensitive voltage-gated sodium channel (Nav) Nav1.7 have been identified as a key mechanism underlying chronic pain in inherited erythromelalgia. Mutations in TTX resistant channels, such as Nav1.8 or Nav1.9, were recently connected with inherited chronic pain syndromes. Here, we investigated the effects of the p.M650K mutation in Nav1.8 in a 53 year old patient with erythromelalgia by micro-neurography and patch-clamp techniques. Recordings of the patient's peripheral nerve fibers showed increased activity dependent slowing (ADS) in CMi and less spontaneous firing compared to a control group of erythromelalgia patients without Nav mutations. To evaluate the impact of the p. M650K mutation on neuronal firing and channel gating, we performed current and voltage-clamp recordings on transfected sensory neurons (DRGs) and neuroblastoma cells. The p. M650K mutation shifted steady-state fast inactivation of Nav1.8 to more hyperpolarized potentials and did not significantly alter any other tested gating behaviors. The AP half-width was significantly broader and the stimulated action potential firing rate was reduced for M650K transfected DRGs compared to WT. We discuss the potential link between enhanced steady state fast inactivation, broader action potential width and the potential physiological consequences.	[Kist, Andreas M.; Neacsu, Cristian; Eberhardt, Esther; Lampert, Angelika; Namer, Barbara] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany; [Sagafos, Dagrun; Lunden, Lars Kristian; Orstavik, Kristin; Kleggetveit, Inge Petter; Jorum, Ellen] Oslo Univ Hosp, Rikshosp, Dept Neurol, Clin Neurophysiol Sect, Oslo, Norway; [Rush, Anthony M.; Zhang, Zhiping; Salter, Hugh; Malinowsky, David; Wollberg, Patrik; Krupp, Johannes] AstraZeneca R&D, Sodertalje, Sweden; [Eberhardt, Esther] Univ Erlangen Nurnberg, Dept Anesthesiol, Erlangen, Germany; [Schmidt, Roland] Uppsala Univ, Dept Neurosci, Clin Neurophysiol, Uppsala, Sweden; [Kaluza, Luisa; Meents, Jannis; Lampert, Angelika] RWTH Aachen Univ Hosp, Inst Physiol, Aachen, Germany; [Carr, Thomas Hedley] AstraZeneca R&D, Cambridge, England; [Namer, Barbara] Heidelberg Univ, Dept Anesthesiol Mannheim, Mannheim, Germany; [Kist, Andreas M.] Max Planck Inst Neurobiol, Martinsried, Germany; [Rush, Anthony M.] Metrion Biosci, Bldg B501,Babraham Res Campus, Cambridge CB22 3AT, England; [Salter, Hugh] Karolinska Inst, Dept Clin Neurosci, S-10401 Stockholm, Sweden; [Salter, Hugh] Moderna Therapeut, Stockholm, Sweden; [Malinowsky, David] Sybicon, Huddinge, Sweden; [Wollberg, Patrik] GE Healthcare, Life Sci, Bjorkgatan 30, SE-75323 Uppsala, Sweden; [Krupp, Johannes] Ipsen Innovat, 5 Ave Canada, F-91940 Les Ulis, France	University of Erlangen Nuremberg; University of Oslo; National Hospital Norway; AstraZeneca; University of Erlangen Nuremberg; Uppsala University; RWTH Aachen University; RWTH Aachen University Hospital; AstraZeneca; Ruprecht Karls University Heidelberg; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Karolinska Institutet; General Electric; Ipsen	Lampert, A; Namer, B (corresponding author), Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Erlangen, Germany.; Jorum, E (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Neurol, Clin Neurophysiol Sect, Oslo, Norway.; Lampert, A (corresponding author), RWTH Aachen Univ Hosp, Inst Physiol, Aachen, Germany.; Namer, B (corresponding author), Heidelberg Univ, Dept Anesthesiol Mannheim, Mannheim, Germany.	ellen.jorum@medisin.uio.no; alampert@ukaachen.de; namer@physiologie1.uni-erlangen.de	Kist, Andreas/AAU-3236-2021; Lampert, Angelika/F-7198-2010; Schmelz, Martin/A-9327-2013; Namer, Barbara/AAG-2003-2019; Meents, Jannis E/F-4134-2017	Kist, Andreas/0000-0003-3643-7776; Lampert, Angelika/0000-0001-6319-6272; Schmelz, Martin/0000-0002-9736-7241; Meents, Jannis E/0000-0001-9423-0453; Carr, Thomas/0000-0002-8147-9855	AstraZeneca (Sodertalje, Sweden); German Research Council (DFG) [NA 970/1-1, LA2740/2 1, SFB 1158, A1]; ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the FAU Erlangen-Nurnberg [11.05.30.1]; German Israeli Foundation (GIF) [1091-27.1/2010]; Research line of the Medical Faculty, University of Oslo	AstraZeneca (Sodertalje, Sweden)(AstraZeneca); German Research Council (DFG)(German Research Foundation (DFG)); ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the FAU Erlangen-Nurnberg; German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Research line of the Medical Faculty, University of Oslo	The project was supported by AstraZeneca (Sodertalje, Sweden). Research was supported by the German Research Council (DFG, NA 970/1-1 to BN, LA2740/2 1 to AL; SFB 1158 project A1 to MS), ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the FAU Erlangen-Nurnberg (11.05.30.1 to AL) and the German Israeli Foundation (GIF, 1091-27.1/2010 to AL). Dagrun Sagafos and Lars Kristian Lunden are supported by the Research line of the Medical Faculty, University of Oslo. Employees of one of the funders (AstraZeneca, listed as authors) had a role in study design, data interpretation, decision to publish and preparation of the manuscript. Other funders had no such direct roles in the study.; The project was supported by AstraZeneca (Sodertalje, Sweden). Research was supported by the German Research Council (DFG, NA 970/1-1 to BN, LA2740/2 1 to AL; SFB 1158 project A1 to MS), ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung) of the FAU Erlangen-Nurnberg (11.05.30.1 to AL) and the German Israeli Foundation (GIF, 1091-27.1/2010 to AL). Dagrun Sagafos and Lars Kristian Lunden are supported by the Research line of the Medical Faculty, University of Oslo. Employees of one of the funders (AstraZeneca, listed as authors) had a role in study design, data interpretation, decision to publish and preparation of the manuscript. Other funders had no such direct roles in the study.	Abrahamsen B, 2008, SCIENCE, V321, P702, DOI 10.1126/science.1156916; Amaya F, 2000, MOL CELL NEUROSCI, V15, P331, DOI 10.1006/mcne.1999.0828; Blair NT, 2003, J NEUROSCI, V23, P10338; Campero M, 2004, ACTA PHYSIOL SCAND, V182, P305, DOI 10.1111/j.1365-201X.2004.01357.x; Cheng X, 2011, BRAIN, V134, P1972, DOI 10.1093/brain/awr143; Choi JS, 2010, BRAIN, V133, P1823, DOI 10.1093/brain/awq114; Cummins TR, 1998, J NEUROSCI, V18, P9607; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; De Col Roberto, 2012, J Physiol, V590, P725, DOI 10.1113/jphysiol.2011.220624; Deng PY, 2013, NEURON, V77, P696, DOI 10.1016/j.neuron.2012.12.018; Eberhardt M, 2014, J BIOL CHEM, V289, P1971, DOI 10.1074/jbc.M113.502211; Estacion M, 2015, J NEUROPHYSIOL, V114, P1554, DOI 10.1152/jn.00195.2015; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Garrison SR, 2014, PAIN, V155, P896, DOI 10.1016/j.pain.2014.01.012; Genebriera J, 2012, CLIN EXP DERMATOL, V37, P350, DOI 10.1111/j.1365-2230.2011.04330.x; Han CY, 2014, J NEUROL NEUROSUR PS, V85, P499, DOI 10.1136/jnnp-2013-306095; Han CY, 2009, BRAIN, V132, P1711, DOI 10.1093/brain/awp078; Harty TP, 2006, J NEUROSCI, V26, P12566, DOI 10.1523/JNEUROSCI.3424-06.2006; Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017; Hu D, 2014, J AM COLL CARDIOL, V64, P66, DOI 10.1016/j.jacc.2014.04.032; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Kankel J, 2012, J PAIN, V13, P1232, DOI 10.1016/j.jpain.2012.09.008; Kleggetveit IP, 2012, PAIN, V153, P2040, DOI 10.1016/j.pain.2012.05.017; Lampert Angelika, 2014, Handb Exp Pharmacol, V221, P91, DOI 10.1007/978-3-642-41588-3_5; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Magerl W, 2010, PAIN, V151, P598, DOI 10.1016/j.pain.2010.07.026; McDonnell A, 2016, BRAIN, V139, P1052, DOI 10.1093/brain/aww007; Namer B, 2009, J PHYSIOL-LONDON, V587, P419, DOI 10.1113/jphysiol.2008.162941; Namer B, 2015, PAIN, V156, P1637, DOI 10.1097/j.pain.0000000000000229; Novakovic SD, 1998, J NEUROSCI, V18, P2174; Orstavik K, 2003, BRAIN, V126, P567, DOI 10.1093/brain/awg060; Pattillo JM, 1999, J PHYSIOL-LONDON, V514, P719, DOI 10.1111/j.1469-7793.1999.719ad.x; Petersson ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103556; Ramachandra R, 2013, CHANNELS, V7, P34, DOI 10.4161/chan.22445; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Shields SD, 2012, PAIN, V153, P2017, DOI 10.1016/j.pain.2012.04.022; Tigerholm J, 2015, BIOPHYS J, V108, P1057, DOI 10.1016/j.bpj.2014.12.034; Tigerholm J, 2014, J NEUROPHYSIOL, V111, P1721, DOI 10.1152/jn.00777.2012; TOREBJORK HE, 1974, J NEUROL NEUROSUR PS, V37, P653, DOI 10.1136/jnnp.37.6.653; Vasylyev DV, 2012, J NEUROPHYSIOL, V108, P729, DOI 10.1152/jn.00091.2012; Weidner C, 1999, J NEUROSCI, V19, P10184; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yang Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2184; Zhang ZP, 2014, SCAND J PAIN, V5, P217, DOI 10.1016/j.sjpain.2014.09.002	45	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161789	10.1371/journal.pone.0161789	http://dx.doi.org/10.1371/journal.pone.0161789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598514	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800020
J	Shieh, G				Shieh, Gwowen			Exact Power and Sample Size Calculations for the Two One-Sided Tests of Equivalence	PLOS ONE			English	Article							BIOEQUIVALENCE; HYPOTHESIS; TRIALS	Equivalent testing has been strongly recommended for demonstrating the comparability of treatment effects in a wide variety of research fields including medical studies. Although the essential properties of the favorable two one-sided tests of equivalence have been addressed in the literature, the associated power and sample size calculations were illustrated mainly for selecting the most appropriate approximate method. Moreover, conventional power analysis does not consider the allocation restrictions and cost issues of different sample size choices. To extend the practical usefulness of the two one-sided tests procedure, this article describes exact approaches to sample size determinations under various allocation and cost considerations. Because the presented features are not generally available in common software packages, both R and SAS computer codes are presented to implement the suggested power and sample size computations for planning equivalence studies. The exact power function of the TOST procedure is employed to compute optimal sample sizes under four design schemes allowing for different allocation and cost concerns. The proposed power and sample size methodology should be useful for medical sciences to plan equivalence studies.	[Shieh, Gwowen] Natl Chiao Tung Univ, Dept Management Sci, Hsinchu 30010, Taiwan	National Yang Ming Chiao Tung University	Shieh, G (corresponding author), Natl Chiao Tung Univ, Dept Management Sci, Hsinchu 30010, Taiwan.	gwshieh@mail.nctu.edu.tw	Shieh, Gwowen/E-2837-2013	Shieh, Gwowen/0000-0001-8611-4495				Allan TA, 2013, CAN J BEHAV SCI, V45, P320, DOI 10.1037/a0033357; Allison DB, 1997, PSYCHOL METHODS, V2, P20, DOI 10.1037/1082-989X.2.1.20; [Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; BRISTOL DR, 1993, COMMUN STAT THEORY, V22, P1953, DOI 10.1080/03610929308831127; CANNON DS, 1990, PSYCHOL ASSESSMENT, V2, P51; Chow, 2002, J BIOPHARM STAT, V12, P295, DOI [10.1081/BIP-120014560, DOI 10.1081/BIP-120014560]; Chow S. C., 2003, SAMPLE SIZE CALCULAT; Chow SC, 2001, J PHARMACOKINET PHAR, V28, P155, DOI 10.1023/A:1011503032353; Chow Shein-Chung, 2002, J Biopharm Stat, V12, P441, DOI 10.1081/BIP-120016229; Cribbie RA, 2004, J CLIN PSYCHOL, V60, P1, DOI 10.1002/jclp.10217; DILETTI E, 1991, INT J CLIN PHARM TH, V29, P1; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; HEILBRUN LK, 1985, COMPUT STAT DATA AN, V3, P99, DOI 10.1016/0167-9473(85)90066-0; Jan SL, 2011, BEHAV RES METHODS, V43, P1014, DOI 10.3758/s13428-011-0095-7; Liu, 2008, DESIGN ANAL BIOAVAIL; LIU JP, 1992, J PHARMACOKINET BIOP, V20, P101, DOI 10.1007/BF01143188; Meyners M, 2012, FOOD QUAL PREFER, V26, P231, DOI 10.1016/j.foodqual.2012.05.003; MULLERCOHRS J, 1990, BIOMETRICAL J, V32, P259; NAM JM, 1973, BIOMETRICS, V29, P101, DOI 10.2307/2529679; Parkhurst DF, 2001, BIOSCIENCE, V51, P1051, DOI 10.1641/0006-3568(2001)051[1051:SSTEAR]2.0.CO;2; PENTICO DW, 1981, AM STAT, V35, P40, DOI 10.2307/2683582; PHILLIPS KF, 1990, J PHARMACOKINET BIOP, V18, P137, DOI 10.1007/BF01063556; Pigeot I., 2007, BIOEQUIVALENCE STUDI; R Development Core Team, R LANG ENV STAT COMP; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; SAS Institute, 2014, SAS IML US GUID VERS; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; SCHUIRMANN DL, 1981, BIOMETRICS, V37, P617; Siqueira AL, 2005, PHARM STAT, V4, P233, DOI 10.1002/pst.183; WESTLAKE WJ, 1981, BIOMETRICS, V37, P591	31	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162093	10.1371/journal.pone.0162093	http://dx.doi.org/10.1371/journal.pone.0162093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IT	27598468	gold, Green Submitted, Green Published			2022-12-27	WOS:000383254800040
J	Van Acker, N; Rage, M; Vermeirsch, H; Schrijvers, D; Nuydens, R; Byttebier, G; Timmers, M; De Schepper, S; Streffer, J; Andries, L; Plaghki, L; Cras, P; Meert, T				Van Acker, Nathalie; Rage, Michael; Vermeirsch, Hilde; Schrijvers, Dorien; Nuydens, Rony; Byttebier, Geert; Timmers, Maarten; De Schepper, Stefanie; Streffer, Johannes; Andries, Luc; Plaghki, Leon; Cras, Patrick; Meert, Theo			NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TOPICAL CAPSAICIN; VESSEL DEVELOPMENT; ATOPIC-DERMATITIS; SEMAPHORIN 3A; AXON GUIDANCE; NERVE; REGENERATION; NEUROPILIN-1; MECHANISMS	The in vivo cutaneous nerve regeneration model using capsaicin is applied extensively to study the regenerative mechanisms and therapeutic efficacy of disease modifying molecules for small fiber neuropathy (SFN). Since mismatches between functional and morphological nerve fiber recovery are described for this model, we aimed at determining the capability of the capsaicin model to truly mimic the morphological manifestations of SFN in diabetes. As nerve and blood vessel growth and regenerative capacities are defective in diabetes, we focused on studying the key regulator of these processes, the neuropilin-1 (NRP-1)/semaphorin pathway. This led us to the evaluation of NRP-1 receptor expression in epidermis and dermis of subjects presenting experimentally induced small fiber neuropathy, diabetic polyneuropathy and of diabetic subjects without clinical signs of small fiber neuropathy. The NRP-1 receptor was co-stained with CD31 vessel-marker using immunofluorescence and analyzed with Definiens (R) technology. This study indicates that capsaicin application results in significant loss of epidermal NRP-1 receptor expression, whereas diabetic subjects presenting small fiber neuropathy show full epidermal NRP-1 expression in contrast to the basal expression pattern seen in healthy controls. Capsaicin induced a decrease in dermal non-vascular NRP-1 receptor expression which did not appear in diabetic polyneuropathy. We can conclude that the capsaicin model does not mimic diabetic neuropathy related changes for cutaneous NRP-1 receptor expression. In addition, our data suggest that NRP-1 might play an important role in epidermal nerve fiber loss and/or defective regeneration and that NRP-1 receptor could change the epidermal environment to a nerve fiber repellant bed possibly through Sem3A in diabetes.	[Van Acker, Nathalie; Cras, Patrick] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium; [Van Acker, Nathalie; Vermeirsch, Hilde; Schrijvers, Dorien; De Schepper, Stefanie; Andries, Luc] HistoGeneX NV, Antwerp, Belgium; [Rage, Michael; Plaghki, Leon] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Nuydens, Rony; Byttebier, Geert; Timmers, Maarten; Streffer, Johannes; Meert, Theo] Janssen Pharmaceut NV, Janssen Res & Dev, Beerse, Belgium; [Timmers, Maarten; Streffer, Johannes] Univ Antwerp, Inst Born Bunge, Reference Ctr Biol Markers Dementia BIODEM, Antwerp, Belgium; [Cras, Patrick] Univ Antwerp, Univ Antwerp Hosp, Born Bunge Inst, Dept Neurol, Antwerp, Belgium	University of Antwerp; Universite Catholique Louvain; Johnson & Johnson; Janssen Pharmaceuticals; University of Antwerp; University of Antwerp	Van Acker, N (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium.; Van Acker, N (corresponding author), HistoGeneX NV, Antwerp, Belgium.	nathalie.vanacker@student.uantwerpen.be		Rolf Streffer, Johannes/0000-0002-9387-5951	Janssen Research and Development, a division of Janssen Pharmaceutica NV; HistoGeneX NV	Janssen Research and Development, a division of Janssen Pharmaceutica NV; HistoGeneX NV	RN, JS, MT and TM are employees of Janssen Pharmaceutica NV. NVA, HV, LA, DS and SDS are employees of HistoGeneX NV. The study was supported by Janssen Research and Development, a division of Janssen Pharmaceutica NV and HistoGeneX NV. The study was designed and conducted by LP and MR in collaboration with TM through MT. NVA coordinated the experiments and digitized the images which were analyzed by HV, LA and SDS. Statistical analysis was supported by LA and GB. PC, RN, DS and JS provided scientific support. HistoGeneX NV participated in study design, data collection and analysis. Both Janssen Research and Development and HistoGeneX NV participated in preparation of the manuscript.	Alik RAAM, 2010, DIABETIC NEUROPATHIE, V33, DOI [10.2337/dc10-1303, DOI 10.2337/DC10-1303]; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Aslam A., 2014, PAIN RES TREAT, V2014, DOI DOI 10.1155/2014/412041; Bagi Z, 2008, TISSUE SPECIFIC REGU, V73, P1405, DOI [10.1124/mol.107.043323, DOI 10.1124/MOL.107.043323]; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Cashman CR, 2015, NEUROSCI LETT, V596, P33, DOI 10.1016/j.neulet.2015.01.048; Chanda S, 2008, DRUG METAB DISPOS, V36, P670, DOI 10.1124/dmd.107.019240; Chao CYL, 2009, DIABETES-METAB RES, V25, P604, DOI 10.1002/dmrr.1004; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Divisova S, 2012, J PERIPHER NERV SYST, V17, P341, DOI 10.1111/j.1529-8027.2012.00420.x; Dux M, 2003, CAPSAICIN SENSITIVE, P859, DOI [10.1113/jphysiol.2003.050633, DOI 10.1113/JPHYSIOL.2003.050633]; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Gibbons CH, 2010, ANN NEUROL, V68, P888, DOI 10.1002/ana.22126; Goshima Y, 2000, JPN J PHARMACOL, V82, P273, DOI 10.1254/jjp.82.273; Han P, 2007, BIOCHEM PHARMACOL, V73, P1635, DOI 10.1016/j.bcp.2006.12.035; Hartemann A, 2011, DIABETES METAB, V37, P377, DOI 10.1016/j.diabet.2011.06.003; Kaku M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0609-2; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kou KZ, 2012, ACTA DERM-VENEREOL, V92, P521, DOI 10.2340/00015555-1350; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Kubanov AA, 2015, B EXP BIOL MED+, V159, P318, DOI 10.1007/s10517-015-2951-4; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Light AR, 2004, J NEUROPHYSIOL, V91, P2401, DOI 10.1152/jn.00090.2004; Mahdy RA, 2010, EYE, V24, P1576, DOI 10.1038/eye.2010.86; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; Marfella R, 2012, EXP DIABETES RES, DOI 10.1155/2012/892706; Mason L, 2004, BMJ-BRIT MED J, V328, P991, DOI 10.1136/bmj.38042.506748.EE; Masuda T, 2005, NEUROSCI RES, V51, P337, DOI 10.1016/j.neures.2005.01.007; Matthies AM, 2002, AM J PATHOL, V160, P289, DOI 10.1016/S0002-9440(10)64372-6; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Nabavi Nouri M, 2012, PLOS ONE, V7, DOI [10. 1371/ journal. pone. 0034807, DOI 10.1371/J0URNAL.P0NE.0034807]; Narayanaswamy H, 2012, J CLIN NEUROSCI, V19, P1490, DOI 10.1016/j.jocn.2011.12.026; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Oyenihi AB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/515042; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Polydefkis M, 2006, NEUROLOGY, V66, P259, DOI 10.1212/01.wnl.0000194209.37604.57; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Polydefkis M, 2007, CONTEMP DIABETES, P293, DOI 10.1007/978-1-59745-311-0_17; Quattrini C, 2008, DIABETES CARE, V31, P140, DOI 10.2337/dc07-1556; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Rage M, 2011, J NEUROL, V258, P1852, DOI 10.1007/s00415-011-6031-z; Rage M, 2010, CLIN NEUROPHYSIOL, V121, P1256, DOI 10.1016/j.clinph.2010.02.159; Raimondi C, 2016, PROG RETIN EYE RES, V52, P64, DOI 10.1016/j.preteyeres.2016.02.003; Riese A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050944; Rosenzweig S, 2010, GRAEF ARCH CLIN EXP, V248, P1423, DOI 10.1007/s00417-010-1377-y; Shahrabi-Farahani S, 2014, LAB INVEST, V94, P752, DOI 10.1038/labinvest.2014.66; Shun CT, 2004, BRAIN, V127, P1593, DOI 10.1093/brain/awh180; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Tesfaye S, 2004, ADV STUD MED, V4, P1014; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Tolofari SK, 2010, EXPRESSION SEMAPHORI, P1; Tominaga M, 2008, BRIT J DERMATOL, V158, P842, DOI 10.1111/j.1365-2133.2007.08410.x; Tominaga M, 2009, J DERMATOL SCI, V55, P40, DOI 10.1016/j.jdermsci.2009.03.007; Umapathi T, 2007, MUSCLE NERVE, V35, P591, DOI 10.1002/mus.20732; Vas PRJ, 2012, DIABETOLOGIA, V55, P795, DOI 10.1007/s00125-011-2417-9; Verheyen A, 2013, NEUROSCIENCE, V244, P77, DOI 10.1016/j.neuroscience.2013.03.050; Verkhratsky A, 2014, CELL CALCIUM, V56, P362, DOI 10.1016/j.ceca.2014.07.005; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; Vinik AI, 2001, DIABETES CARE, V24, P1468, DOI 10.2337/diacare.24.8.1468; Vlckova-Moravcova E, 2008, DIABETIC MED, V25, P692, DOI 10.1111/j.1464-5491.2008.02446.x; Xiao HJ, 2013, INT J MED SCI, V10, P1412, DOI 10.7150/ijms.5630; Yamaguchi J, 2008, J INVEST DERMATOL, V128, P2842, DOI 10.1038/jid.2008.150; Yuan L, 2002, DEVELOPMENT, V129, P4797; Yusof MI, 2008, SINGAP MED J, V49, P100	72	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161441	10.1371/journal.pone.0161441	http://dx.doi.org/10.1371/journal.pone.0161441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598321	Green Published, Green Submitted, gold			2022-12-27	WOS:000383254800008
J	Kim, S; So, WY; Kim, J; Sung, DJ				Kim, SoJung; So, Wi-Young; Kim, Jooyoung; Sung, Dong Jun			Relationship between Bone-Specific Physical Activity Scores and Measures for Body Composition and Bone Mineral Density in Healthy Young College Women	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; LEAN MASS; FAT; CHILDREN; OSTEOPOROSIS; ASSOCIATION; MUSCLE; BPAQ	Objective The purpose of this cross-sectional study was to investigate the relationship between bone-specific physical activity (BPAQ) scores, body composition, and bone mineral density (BMD) in healthy young college women. Methods Seventy-three college women (21.7 +/- 1.8 years; 162.1 +/- 4.6 cm; 53.9 +/- 5.8 kg) between the ages of 19 and 26 years were recruited from the universities in Seoul and Gyeonggi province, South Korea. We used dual energy X-ray absorptiometry to measure the lumbar spine (L2-L4) and proximal femur BMD (left side; total hip, femoral neck). The BPAQ scores (past, pBPAQ; current, cBPAQ; total, tBPAQ) were used to obtain a comprehensive account of lifetime physical activity related to bone health. We used X-scan plus II instrumentation to measure height (cm), weight (kg), fat free mass (FFM, kg), percent body fat (%), and body mass index (BMI). Participants were asked to record their 24-hour food intake in a questionnaire. Results There were positive correlations between BPAQ scores and total hip (pBPAQ r = 0.308, p = 0.008; tBPAQ, r = 0.286, p = 0.014) and FN BMD (pBPAQ r = 0.309, p = 0.008; tBPAQ, r = 0.311, p = 0.007), while no significant relationships were found in cBPAQ (p > 0.05). When FFM, Vitamin D intake, cBPAQ, pBPAQ, and tBPAQ were included in a stepwise multiple linear regression analysis, FFM and pBPAQ were predictors of total hip, accounting for 16% (p = 0.024), while FFM and tBPAQ predicted 14% of the variance in FN (p = 0.015). Only FFM predicted 15% of the variance in L2-L4 (p = 0.004). There was a positive correlation between Vitamin D intake and L2-L4 (p = 0.025), but other dietary intakes variables were not significant (p > 0.05). Conclusions BPAQ-derived physical activity scores and FFM were positively associated with total hip and FN BMD in healthy young college women. Our study suggests that osteoporosis awareness and effective bone healthy behaviors for college women are required to prevent serious bone diseases later in life.	[Kim, SoJung] Univ Massachusetts, Coll Hlth Sci, Dept Phys Therapy, Lowell, MA 01854 USA; [So, Wi-Young] Korea Natl Univ Transportat, Sports & Hlth Care Major, Coll Humanities & Arts, Chungju Si 27469, South Korea; [Kim, Jooyoung] Kookmin Univ, Hlth & Rehabil Major, Seoul 02707, South Korea; [Sung, Dong Jun] Konkuk Univ, Coll Sci & Technol, Div Sport Sci, Chungju Si 27478, South Korea	University of Massachusetts System; University of Massachusetts Lowell; Korea National University of Transportation; Kookmin University; Konkuk University	Sung, DJ (corresponding author), Konkuk Univ, Coll Sci & Technol, Div Sport Sci, Chungju Si 27478, South Korea.	sls98@kku.ac.kr			National Research Foundation of Korea Grant - Korean Government [NRF-2013S1A5B5A07046267]	National Research Foundation of Korea Grant - Korean Government	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2013S1A5B5A07046267).	Alghadir AH, 2015, J PHYS THER SCI, V27, P2261, DOI 10.1589/jpts.27.2261; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Ashok K, 2016, J OBSTET GYNECOL IND, V66, P52, DOI 10.1007/s13224-014-0629-x; BASSEY EJ, 1994, OSTEOPOROSIS INT, V4, P72, DOI 10.1007/BF01623226; Bolam KA, 2014, OSTEOPOROSIS INT, V25, P2663, DOI 10.1007/s00198-014-2797-z; Borer KT, 2005, SPORTS MED, V35, P779, DOI 10.2165/00007256-200535090-00004; Byeon YS, 2006, KOREAN J ADULT NURS, V18, P790; Cardadeiro G, 2014, OSTEOPOROSIS INT, V25, P2035, DOI 10.1007/s00198-014-2729-y; Chon Mi-Young, 2012, [Korean J Women Health Nurs, 여성건강간호학회지], V18, P190; Dolan SH, 2006, MED SCI SPORT EXER, V38, P1121, DOI 10.1249/01.mss.0000222841.96885.a8; Eun-nam Lee, 2009, [The Journal of Muscle and Joint Health, 근관절건강학회지], V16, P105; Farr JN, 2011, MED SCI SPORT EXER, V43, P476, DOI 10.1249/MSS.0b013e3181eeb2f2; Going S, 2006, Int J Body Compos Res, V4, P161; Heron N, 2014, BRIT J SPORT MED, V48, P1558, DOI 10.1136/bjsports-2012-091581; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Huang TH, 2016, ANN NY ACAD SCI, V1363, P26, DOI 10.1111/nyas.13004; Jho Kwang Hyun, 2014, [Journal of THE KOREAN DIETETIC ASSOCIATION, 대한영양사협회 학술지], V20, P110, DOI 10.14373/JKDA.2014.20.2.110; Kelley S, 2014, RES Q EXERCISE SPORT, V85, P245, DOI 10.1080/02701367.2014.897680; Kim W, 2014, J BONE MINER METAB, V32, P709, DOI 10.1007/s00774-013-0545-7; Kindler JM, 2015, INT J SPORT NUTR EXE, V25, P136, DOI 10.1123/ijsnem.2013-0258; Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Lee SM, 2012, J INT ACAD PHYS THER, V3, P345; Lewiecki E Michael, 2004, Clin Mol Allergy, V2, P9, DOI 10.1186/1476-7961-2-9; Li YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073186, 10.1371/journal.pone.0058272]; Liu Jian-Min, 2004, Osteoporos Int, V15, P238, DOI 10.1007/s00198-003-1536-7; Liu PY, 2014, INT J PREVENTIVE MED, V5, P1452; Na-Mi Chun，, 2015, [Korean J Women Health Nurs, 여성건강간호학회지], V21, P43; Park JH, 2012, BONE, V50, P1006, DOI 10.1016/j.bone.2012.01.015; Park KH, 2015, J BONE MINER METAB; Park YJ, 2014, J KOREAN ACAD NURS, V44, P504, DOI 10.4040/jkan.2014.44.5.504; Rantalainen T, 2015, BONE, V72, P101, DOI 10.1016/j.bone.2014.11.015; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sayed-Hassan R, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0149-9; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Weeks BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039133; Weeks BK, 2016, EUR J SPORT SCI, P1; Williams Bethan, 2002, Health Care Women Int, V23, P344, DOI 10.1080/0739933029008919; Winters-Stone KM, 2006, BONE, V39, P1203, DOI 10.1016/j.bone.2006.06.005; Wu CS, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0041-0; WU YT, 1993, PHYS THER, V73, P320, DOI 10.1093/ptj/73.5.320	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162127	10.1371/journal.pone.0162127	http://dx.doi.org/10.1371/journal.pone.0162127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589270	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877800031
J	Ma, YY; Sun, L; Chen, XJ; Wang, N; Yi, PF; Song, M; Zhang, B; Wang, YZ; Liang, QH				Ma, Yun-Yun; Sun, Lin; Chen, Xiu-Juan; Wang, Na; Yi, Peng-Fei; Song, Min; Zhang, Bo; Wang, Yu-Zhong; Liang, Qiu-Hua			Vinpocetine Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							CEREBROVASCULAR DISEASES; OXIDATIVE STRESS; IN-VIVO; CALCIFICATION; EXPRESSION; MECHANISMS; MICE	Vascular calcification is an active process of osteoblastic differentiation of vascular smooth muscle cells; however, its definite mechanism remains unknown. Vinpocetine, a derivative of the alkaloid vincamine, has been demonstrated to inhibit the high glucose-induced proliferation of vascular smooth muscle cells; however, it remains unknown whether vinpocetine can affect the osteoblastic differentiation of vascular smooth muscle cells. We hereby investigated the effect of vinpocetine on vascular calcification using a beta-glycerophosphate-induced cell model. Our results showed that vinpocetine significantly reduced the osteoblast-like phenotypes of vascular smooth muscle cells including ALP activity, osteocalcin, collagen type I, Runx2 and BMP-2 expression as well as the formation of mineralized nodule. Vinpocetine, binding to translocation protein, induced phosphorylation of extracellular signal-related kinase and Akt and thus inhibited the translocation of nuclear factor-kappa B into the nucleus. Silencing of translocator protein significantly attenuated the inhibitory effect of vinpocetine on osteoblastic differentiation of vascular smooth muscle cells. Taken together, vinpocetine may be a promising candidate for the clinical therapy of vascular calcification.	[Ma, Yun-Yun; Sun, Lin; Wang, Na; Yi, Peng-Fei; Song, Min; Zhang, Bo; Liang, Qiu-Hua] Jining Med Univ, Affiliated Hosp, Dept Endocrinol, Jining, Shandong, Peoples R China; [Ma, Yun-Yun; Chen, Xiu-Juan] Jining Med Univ, Jining, Shandong, Peoples R China; [Wang, Yu-Zhong] Jining Med Univ, Affiliated Hosp, Dept Neurol, Jining, Shandong, Peoples R China; [Wang, Yu-Zhong] Jining Med Univ, Affiliated Hosp, Cent Lab, Jining, Shandong, Peoples R China	Jining Medical University; Jining Medical University; Jining Medical University; Jining Medical University	Liang, QH (corresponding author), Jining Med Univ, Affiliated Hosp, Dept Endocrinol, Jining, Shandong, Peoples R China.	huaqiuliang@sohu.com			National Natural Science Foundation of China [81400860]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81400860).	Bagoly Edit, 2007, Orvosi Hetilap, V148, P1353, DOI 10.1556/OH.2007.28115; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Cai YJ, 2012, J PHARMACOL EXP THER, V343, P479, DOI 10.1124/jpet.112.195446; Deshmukh R, 2009, EUR J PHARMACOL, V620, P49, DOI 10.1016/j.ejphar.2009.08.027; Grainger DJ, 1998, J CELL SCI, V111, P2977; Jayalath RW, 2005, EUR J VASC ENDOVASC, V30, P476, DOI 10.1016/j.ejvs.2005.04.030; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Liang QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033126; Liu GY, 2014, ENDOCRINOLOGY, V155, P558, DOI 10.1210/en.2013-1298; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Patyar S, 2011, PHARMACOL REP, V63, P618, DOI 10.1016/S1734-1140(11)70574-6; Ruiz-Miyazawa KW, 2015, CHEM-BIOL INTERACT, V237, P9, DOI 10.1016/j.cbi.2015.05.007; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Wang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096894; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Zhao Yan-Yin, 2011, Neuron Glia Biol, V7, P187, DOI 10.1017/S1740925X12000129	18	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162295	10.1371/journal.pone.0162295	http://dx.doi.org/10.1371/journal.pone.0162295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589055	gold, Green Published			2022-12-27	WOS:000382877800047
J	Oremus, M; Xie, F; Gaebel, K				Oremus, Mark; Xie, Feng; Gaebel, Kathryn			Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study	PLOS ONE			English	Article							OF-LIFE; DEMENTIA; RATINGS; RECOMMENDATIONS; ASSOCIATION; PREDICTORS; CRITERIA; PEOPLE; STIGMA	Aims To develop clinical descriptions (vignettes) of life with Alzheimer's disease (AD), we conducted focus groups of persons with AD (n = 14), family caregivers of persons with AD (n = 20), and clinicians who see persons with AD in their practices (n = 5). Methods Group participants read existing descriptions of AD and commented on the realism and comprehensibility of the descriptions. We used thematic framework analysis to code the comments into themes and develop three new vignettes to describe mild, moderate, and severe AD. Results Themes included the types of symptoms to mention in the new vignettes, plus the manner in which the vignettes should be written. Since the vignette descriptions were based on focus group participants' first-hand knowledge of AD, the descriptions can be said to demonstrate content validity. Conclusion Members of the general public can read the vignettes and estimate their health-related quality-of-life (HRQoL) as if they had AD based on the vignette descriptions. This is especially important for economic evaluations of new AD medications, which require HRQoL to be assessed in a manner that persons with AD often find difficult to undertake. The vignettes will allow the general public to serve as a proxy and provide HRQoL estimates in place of persons with AD.	[Oremus, Mark] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Xie, Feng] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Xie, Feng] Program Hlth Econ & Outcome Measures PHENOM, Hamilton, ON, Canada; [Xie, Feng; Gaebel, Kathryn] St Josephs Healthcare Hamilton, Ctr Evaluat Med, Hamilton, ON, Canada	University of Waterloo; McMaster University; McMaster University	Oremus, M (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	moremus@uwaterloo.ca			Canadian Institutes of Health Research [IAO - 126567, IAO-126567]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (grant number IAO - 126567): http://www.cihr-irsc.gc.ca/e/193.html. The Co-principal investigators are: MO, FX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Canadian Institutes of Health Research (grant number IAO-126567).	Aguinis H, 2014, ORGAN RES METHODS, V17, P351, DOI 10.1177/1094428114547952; ALEXANDER CS, 1978, PUBLIC OPIN QUART, V42, P93, DOI 10.1086/268432; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arons AMM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-110; Au N, 2014, QUAL LIFE RES, V23, P1721, DOI 10.1007/s11136-013-0615-2; Sousa MFB, 2013, INT PSYCHOGERIATR, V25, P1097, DOI 10.1017/S1041610213000410; Bernard H. R., 2016, ANAL QUALITATIVE DAT; Black BS, 2012, QUAL LIFE RES, V21, P1379, DOI 10.1007/s11136-011-0044-z; Blay SL, 2008, ALZ DIS ASSOC DIS, V22, P79, DOI 10.1097/WAD.0b013e31815ccd47; Bosboom PR, 2013, ALZ DIS ASSOC DIS, V27, P363, DOI 10.1097/WAD.0b013e318293b5f8; Bruni RA, 2008, CAN MED ASSOC J, V179, P15, DOI 10.1503/cmaj.071656; Burgener SC, 2015, DEMENTIA-LONDON, V14, P609, DOI 10.1177/1471301213504202; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Conde-Sala JL, 2013, J GERIATR PSYCH NEUR, V26, P86, DOI 10.1177/0891988713481266; Crespo M, 2013, INT PSYCHOGERIATR, V25, P1687, DOI 10.1017/S1041610213000823; Foster NL, 2014, ALZHEIMERS DEMENT, V10, P503, DOI 10.1016/j.jalz.2014.05.003; Gove D, 2016, AGING MENT HEALTH, V20, P391, DOI 10.1080/13607863.2015.1015962; Hebert K., 2003, CLIN GERONTOLOGIST, V26, P17, DOI [10.1300/J018v26n01_03, DOI 10.1300/J018V26N01_03, DOI 10.1300/J018v26n01_03]; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Johnson R, 2015, SOC SCI MED, V143, P117, DOI 10.1016/j.socscimed.2015.08.031; Keeley T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085287; Magasi S, 2012, QUAL LIFE RES, V21, P739, DOI 10.1007/s11136-011-9990-8; Mansell Ian, 2004, Nurse Res, V11, P79; McDowell I, 2000, NEUROLOGY, V55, P66; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Naglie G, 2011, AM J GERIAT PSYCHIAT, V19, P881, DOI 10.1097/JGP.0b013e3182006a67; Naglie G, 2011, AM J GERIAT PSYCHIAT, V19, P891, DOI 10.1097/JGP.0b013e3182006a7f; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Oremus M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0207-4; Oremus M, 2015, DEMENTIA-LONDON, V14, P63, DOI 10.1177/1471301213490709; Oremus M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-246; Quail JM, 2007, EUR J AGEING, V4, P45, DOI 10.1007/s10433-007-0042-8; Randhawa H, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0179-x; Ready Rebecca E, 2007, Am J Alzheimers Dis Other Demen, V22, P528, DOI 10.1177/1533317507307032; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Rice N, 2011, EUR J HEALTH ECON, V12, P141, DOI 10.1007/s10198-010-0235-5; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Schulz R, 2013, AM J GERIAT PSYCHIAT, V21, P14, DOI 10.1016/j.jagp.2012.10.002; Szkultecka-Debek M, 2015, CURR ISS PHARM MED S, V28, P8, DOI 10.1515/cipms-2015-0032; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Werner P, 2004, INT J GERIATR PSYCH, V19, P391, DOI 10.1002/gps.1107; Woods RT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-94; Xie F, 2012, QUAL LIFE RES, V21, P593, DOI 10.1007/s11136-011-9966-8	45	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162422	10.1371/journal.pone.0162422	http://dx.doi.org/10.1371/journal.pone.0162422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589604	gold, Green Submitted, Green Published			2022-12-27	WOS:000382877800060
J	Padalino, B; Raidal, SL; Hall, E; Knight, P; Celi, P; Jeffcott, L; Muscatello, G				Padalino, Barbara; Raidal, Sharanne L.; Hall, Evelyn; Knight, Peter; Celi, Pietro; Jeffcott, Leo; Muscatello, Gary			A Survey on Transport Management Practices Associated with Injuries and Health Problems in Horses	PLOS ONE			English	Article							LONG-HAUL TRANSPORT; RISK-FACTORS; EQUINE INFLUENZA; BEHAVIOR; WELFARE; STRESS; TRAILER; BALANCE	An online survey was conducted to determine associations between transport management and transport-related injuries and diseases in horses in Australia. The survey was composed of three sections: respondents' demographic information, transport management strategies or procedures (before, during and after transportation) and transport diseases experienced in the previous two year period. Univariate and multivariate modelling was performed exploring associations between variables (respondents' details and transport management strategies) and the following transport-related diseases as outcomes: traumatic injuries, diarrhoea, heat stroke, muscular problems, laminitis, transport pneumonia and colic. The survey generated 797 responses. Traumatic injuries were the most common transport-related problem, with a reported incidence of 45.0%. Younger respondents (<40 years old) caring for large numbers of horses (>30 in a week) were more likely to report transport-related injuries. Injury risk was also linked to the use of protections and tranquilizers prior to transport, and checking horses after the journey. Diarrhoea (20.0%) and heat stroke (10.5%) were reported more by amateur than professional horse carers. Increased risk of heat stroke was linked to the restriction of hay and water prior to transportation. Muscular problems (13.0%) appeared to be exacerbated when horse health was not assessed before journey; whilst the risk of laminitis (2.9%) was around three fold greater when post transport recovery strategies were not applied. Associations were made between transport pneumonia (9.2%) and duration of journey, and with activity (horses involved in racing at greater risk). No associations were seen between the incidence of colic (10.3%) and the variables examined. Study findings should be interpreted with caution as they represent participant perceptions and recall. Nevertheless, results support many current recommendations for safe transportation of horses. They also highlight the need to further investigate many of identified management factors to refine existing policies and practices in equine transportation.	[Padalino, Barbara; Hall, Evelyn; Celi, Pietro; Jeffcott, Leo; Muscatello, Gary] Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Camden, NSW, Australia; [Padalino, Barbara] Univ Bari, Dept Vet Med, Bari, Italy; [Padalino, Barbara; Raidal, Sharanne L.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Knight, Peter] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Sydney, NSW, Australia; [Celi, Pietro] DSM Nutr Prod Anim Nutr & Hlth, Columbia, MD USA; [Celi, Pietro] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia	University of Sydney; Universita degli Studi di Bari Aldo Moro; Charles Sturt University; University of Sydney; DSM NV; University of Melbourne	Padalino, B (corresponding author), Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Camden, NSW, Australia.; Padalino, B (corresponding author), Univ Bari, Dept Vet Med, Bari, Italy.; Padalino, B (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.	barbara.padalino@sydney.edu.au	Muscatello, Gary/AAG-1047-2021; Knight, Peter/A-9555-2011; Padalino, Barbara/AAJ-7498-2020; Celi, Pietro/D-6567-2014; Jeffcott, Leo/S-8887-2017	Knight, Peter/0000-0002-1076-5379; Celi, Pietro/0000-0002-7933-3160; Jeffcott, Leo/0000-0002-2855-6946; Raidal, Sharanne/0000-0001-5558-3133; PADALINO, BARBARA/0000-0002-7630-8285	University of Sydney International Postgraduate Research Scholarship (IPRS) -	University of Sydney International Postgraduate Research Scholarship (IPRS) -	This study was funded by the University of Sydney International Postgraduate Research Scholarship (IPRS).	[Anonymous], 2014, PRACTICAL GUIDELINES, P36; Anzai Toru, 2001, Journal of Equine Science, V12, P135, DOI 10.1294/jes.12.135; AUSTIN SM, 1995, J AM VET MED ASSOC, V207, P325; Boden LA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-188; Christley RM, 2016, EQUINE VET J, V48, P138, DOI 10.1111/evj.12552; CLARK DK, 1993, APPL ANIM BEHAV SCI, V38, P179, DOI 10.1016/0168-1591(93)90018-K; Codazza D., 1974, Journal of the South African Veterinary Association., V45, P331; Cohen ND, 2005, JAVMA-J AM VET MED A, V226, P404, DOI 10.2460/javma.2005.226.404; Copas V, 2011, IN PRACTICE, V33, P155, DOI 10.1136/inp.d1811; Cregier S. E., 1984, Proceedings of the International Congress on Applied Ethology in Farm Animals, Kiel 1984, P175; Cregier SE, 2015, NONCOMMERCIAL HORSE; Cullinane A, 2014, EQUINE VET EDUC, V26, P456, DOI 10.1111/eve.12215; Darth AC, 2014, IDENTIFYING CAUSES P; Dean RS, 2015, EQUINE VET J, V47, P379, DOI 10.1111/evj.12429; DeAraugo J, 2016, ANIMALS, V6, DOI 10.3390/ani6020012; Giovagnoli G, 2002, LIVEST PROD SCI, V73, P247, DOI 10.1016/S0301-6226(01)00253-6; Gonzalez LA, 2012, J ANIM SCI, V90, P3640, DOI 10.2527/jas.2011-4796; Hillyer MH, 2002, EQUINE VET J, V34, P455, DOI 10.2746/042516402776117746; Hockenhull J, 2014, APPL ANIM BEHAV SCI, V155, P49, DOI 10.1016/j.applanim.2014.02.014; Houpt KA, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P315, DOI 10.1079/9781780643212.0315; Jones WE, 2003, J EQUINE VET SCI, V23, P543, DOI 10.1016/j.jevs.2003.11.014; Kohn CW, 2000, GUIDELINES HORSE TRA; LEADON D, 1989, J EQUINE VET SCI, V9, P200, DOI 10.1016/S0737-0806(89)80051-6; Leadon D.P., 2014, ATHLETIC HORSE PRINC, V2nd ed., P155, DOI DOI 10.1016/B978-0-7216-0075-8.00019-8; Leadon Des, 2008, Vet Ital, V44, P149; Lee J, 2001, J EQUINE VET SCI, V21, P237, DOI 10.1016/S0737-0806(01)70042-1; MANSMANN RA, 1995, J EQUINE VET SCI, V15, P141, DOI 10.1016/S0737-0806(06)81843-5; Marahrens M, 2011, PREV VET MED, V102, P157, DOI 10.1016/j.prevetmed.2011.04.010; Marlin DJ, 2004, TRANSPORT HORSES EQU, P1239; MCCLINTOCK SA, 1990, AUST VET J, V67, P265, DOI 10.1111/j.1751-0813.1990.tb07785.x; McGreevy PD, 2007, VET J, V174, P492, DOI 10.1016/j.tvjl.2006.09.008; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Noble B, 2013, INT LARGE ANIMAL RES, P10; Oikawa Masa-aki, 2004, Journal of Equine Science, V15, P99, DOI 10.1294/jes.15.99; Padalino B, 2016, AUST VET J, V94, P349, DOI 10.1111/avj.12486; Padalino B, 2015, ANIMALS, V5, P1296, DOI 10.3390/ani5040412; Padalino B, 2015, J VET BEHAV, V10, P272, DOI 10.1016/j.jveb.2015.02.002; Padalino B, 2012, J VET BEHAV, V7, P135, DOI 10.1016/j.jveb.2011.09.003; Pagan JD, 2004, IPPOLOGIA, V15, P5; Purswell JL, 2006, T ASABE, V49, P193, DOI 10.13031/2013.20238; Purswell JL, 2010, T ASABE, V53, P1885; RAIDAL SL, 1995, AUST VET J, V72, P45, DOI 10.1111/j.1751-0813.1995.tb15328.x; Reed SM, 2003, EQUINE INTERNAL MED, P1; Schemann K, 2011, PREV VET MED, V102, P304, DOI 10.1016/j.prevetmed.2011.08.002; Smyth GB, 2015, AUST VET J, V93, P433, DOI 10.1111/avj.12390; Tateo A, 2012, J VET BEHAV, V7, P33, DOI 10.1016/j.jveb.2011.04.007; Tinker MK, 1997, EQUINE VET J, V29, P454, DOI 10.1111/j.2042-3306.1997.tb03158.x; Waran N., 2007, WELFARE HORSES, P125; Waran NK, 1996, VET REC, V139, P7, DOI 10.1136/vr.139.1.7; Weeks CA, 2012, EQUINE VET EDUC, V24, P423, DOI 10.1111/j.2042-3292.2011.00293.x	51	19	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162371	10.1371/journal.pone.0162371	http://dx.doi.org/10.1371/journal.pone.0162371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588689	Green Published, gold			2022-12-27	WOS:000382877800053
J	Piantadosi, S; Aslin, R				Piantadosi, Steven; Aslin, Richard			Compositional Reasoning in Early Childhood	PLOS ONE			English	Article							PROTOTYPE THEORY; INFANTS; ACQUISITION; MODEL	Compositional "language of thought" models have recently been proposed to account for a wide range of children's conceptual and linguistic learning. The present work aims to evaluate one of the most basic assumptions of these models: children should have an ability to represent and compose functions. We show that 3.5-4.5 year olds are able to predictively compose two novel functions at significantly above chance levels, even without any explicit training or feedback on the composition itself. We take this as evidence that children at this age possess some capacity for compositionality, consistent with models that make this ability explicit, and providing an empirical challenge to those that do not.	[Piantadosi, Steven; Aslin, Richard] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Piantadosi, S (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	spiantado@gmail.com			Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [F32HD070544]; NIH research grant [HD-037082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037082, F32HD070544] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; NIH research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number F32HD070544 and an NIH research grant to R. Aslin and E. Newport (HD-037082). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; This work benefited greatly from discussions with Roman Feiman, Celeste Kidd, Noah Goodman, and members of AKlab. Children were run with the help of Holly Palmeri and the Rochester Babylab RAs. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number F32HD070544 and an NIH research grant to R. Aslin and E. Newport (HD-037082). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baillargeon R., 1994, 10 MONTH OLD I UNPUB; Barner D, 2008, CHILD DEV, V79, P594, DOI 10.1111/j.1467-8624.2008.01145.x; Boole G., 1854, INVESTIGATION LAWS T; Church A, 1936, AM J MATH, V58, P345, DOI 10.2307/2371045; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Fernald A, 2010, COGNITIVE PSYCHOL, V60, P190, DOI 10.1016/j.cogpsych.2009.12.002; Fodor J, 1996, COGNITION, V58, P253, DOI 10.1016/0010-0277(95)00694-X; Fodor J. A., 1975, LANGUAGE THOUGHT; Frege G, 1892, WITTGENSTEIN STUDIEN, V1; Gelman A., 2007, DATA ANAL USING REGR; Goodman ND, 2009, P 31 ANN C COGN SCI, P2188; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; Hindley J, 1986, INTRO COMBINATORS LA; KAMP H, 1995, COGNITION, V57, P129, DOI 10.1016/0010-0277(94)00659-9; Katz Y., 2008, P 30 ANN M COGN SCI; Kemp C, 2008, ADV NEURAL INFORM PR, V20, P753; Margolis E., 1999, CONCEPTS CORE READIN; MATTHEI EH, 1982, COGNITION, V11, P301, DOI 10.1016/0010-0277(82)90018-X; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Moher M, 2012, J EXP CHILD PSYCHOL, V112, P361, DOI 10.1016/j.jecp.2012.03.007; OSHERSON DN, 1981, COGNITION, V9, P35, DOI 10.1016/0010-0277(81)90013-5; Piantadosi ST, 2012, KELPY FREE LIB CHILD; Piantadosi ST, 2012, COGNITION, V123, P199, DOI 10.1016/j.cognition.2011.11.005; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Schonfinkel M, 1967, FREGE GODEL SOURCE B, P355; Siskind JM, 1996, COGNITION, V61, P39, DOI 10.1016/S0010-0277(96)00728-7; SMITH EE, 1988, COGNITIVE SCI, V12, P485, DOI 10.1207/s15516709cog1204_1; SMITH EE, 1984, COGNITIVE SCI, V8, P337, DOI 10.1016/S0364-0213(84)80006-3; Smith EE, 2002, EXEMPLAR VIEW FDN CO, P277; Smullyan RM, 1985, MOCK MOCKINGBIRD OTH; Syrett K, 2010, LANG LEARN DEV, V6, P258, DOI 10.1080/15475440903507905; Ullman TD, 2010, P 32 ANN M COGN SCI; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0147734	10.1371/journal.pone.0147734	http://dx.doi.org/10.1371/journal.pone.0147734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27588944	Green Submitted, gold, Green Published			2022-12-27	WOS:000382877800001
J	Djordjevic, J; Zhurov, AI; Richmond, S; Consortium, V				Djordjevic, Jelena; Zhurov, Alexei I.; Richmond, Stephen; Consortium, Visigen			Genetic and Environmental Contributions to Facial Morphological Variation: A 3D Population-Based Twin Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HERITABILITY; PROPORTIONS; PARAMETERS; PRECISION; PARENTS	Introduction Facial phenotype is influenced by genes and environment; however, little is known about their relative contributions to normal facial morphology. The aim of this study was to assess the relative genetic and environmental contributions to facial morphological variation using a three-dimensional (3D) population-based approach and the classical twin study design. Materials and Methods 3D facial images of 1380 female twins from the TwinsUK Registry database were used. All faces were landmarked, by manually placing 37 landmark points, and Procrustes registered. Three groups of traits were extracted and analysed: 19 principal components (uPC) and 23 principal components (sPC), derived from the unscaled and scaled landmark configurations respectively, and 1275 linear distances measured between 51 landmarks (37 manually identified and 14 automatically calculated). The intraclass correlation coefficients, r(MZ) and r(DZ), broad-sense heritability (h(2)), common (c(2)) and unique (e(2)) environment contributions were calculated for all traits for the monozygotic (MZ) and dizygotic (DZ) twins. Results Heritability of 13 uPC and 17 sPC reached statistical significance, with h2 ranging from 38.8% to 78.5% in the former and 30.5% to 84.8% in the latter group. Also, 1222 distances showed evidence of genetic control. Common environment contributed to one PC in both groups and 53 linear distances (4.3%). Unique environment contributed to 17 uPC and 20 sPC and 1245 distances. Conclusions Genetic factors can explain more than 70% of the phenotypic facial variation in facial size, nose (width, prominence and height), lips prominence and inter-ocular distance. A few traits have shown potential dominant genetic influence: the prominence and height of the nose, the lower lip prominence in relation to the chin and upper lip philtrum length. Environmental contribution to facial variation seems to be the greatest for the mandibular ramus height and horizontal facial asymmetry.	[Djordjevic, Jelena; Zhurov, Alexei I.; Richmond, Stephen; Consortium, Visigen] Univ Wales Coll Cardiff Sch Dent, Dept Appl Clin Res & Publ Hlth, Cardiff, S Glam, Wales	Cardiff University	Djordjevic, J (corresponding author), Univ Wales Coll Cardiff Sch Dent, Dept Appl Clin Res & Publ Hlth, Cardiff, S Glam, Wales.	drjelena05@gmail.com	Zhurov, Alexei I/P-4410-2014	Zhurov, Alexei I/0000-0002-5594-0740				Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11616; Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; AlKhudhairi TD, 2010, ANGLE ORTHOD, V80, P1010, DOI 10.2319/050410-66.1; Amini F, 2009, ORTHOD WAVES, V68, P72, DOI 10.1016/j.odw.2009.01.001; Baydas B, 2007, AM J ORTHOD DENTOFAC, V131, P504, DOI 10.1016/j.ajodo.2005.05.055; BURKE PH, 1989, ACTA GENET MED GEMEL, V38, P37, DOI 10.1017/S0001566000002816; BYERS D, 2008, NAT ED, V1, P1; Carels C, 2001, Clin Orthod Res, V4, P130, DOI 10.1034/j.1600-0544.2001.040303.x; Claes P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004725; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; Djordjevic J, 2013, ORTHOD CRANIOFAC RES, V16, P146, DOI 10.1111/ocr.12012; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Germine L, 2015, CURR BIOL, V25, P2684, DOI 10.1016/j.cub.2015.08.048; Good PI, 2006, RESAMPLING METHODS P, P5, DOI 10.1007/0-8176-4444-X_2; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Hallgrimsson B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004724; Hammond P, 2012, HUM MUTAT, V33, P817, DOI 10.1002/humu.22054; Hartsfield Jr JK, 2012, ORTHODONTICS BASIC A; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Hughes TE, 2014, AUST DENT J, V59, P101, DOI 10.1111/adj.12101; Jackson JE, 1991, USERS GUIDE PRINCIPA; Jelenkovic A, 2010, HOMO, V61, P191, DOI 10.1016/j.jchb.2009.10.003; Johannsdottir B, 2005, AM J ORTHOD DENTOFAC, V127, P200, DOI 10.1016/j.ajodo.2004.07.033; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Kau C H, 2005, Orthod Craniofac Res, V8, P85; Kau CH, 2010, 3 DIMENSIONAL IMAGIN; Kim Hyun-Jin, 2013, Genomics & Informatics, V11, P83, DOI 10.5808/GI.2013.11.2.83; Lahoti SK, 2013, J INDIAN ORTHOD SOC, V47, P419; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Lopes MS, 2015, G3-GENES GENOM GENET, V5, P2629, DOI 10.1534/g3.115.019513; Lubbers HT, 2010, J CRANIOFAC SURG, V21, P763, DOI 10.1097/SCS.0b013e3181d841f7; Manfredi C, 1997, AM J ORTHOD DENTOFAC, V111, P44, DOI 10.1016/S0889-5406(97)70301-9; Miko I., 2008, NAT ED, V1, P197; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Moss JP, 2006, EUR J ORTHODONT, V28, P416, DOI 10.1093/ejo/cjl025; Naini FB, 2004, AM J ORTHOD DENTOFAC, V126, P655, DOI 10.1016/j.ajodo.2003.08.034; Ort Rebecca, 2012, Plast Surg Int, V2012, P138090, DOI 10.1155/2012/138090; Paternoster L, 2012, AM J HUM GENET, V90, P478, DOI 10.1016/j.ajhg.2011.12.021; Peng J, 2005, EUR J ORTHODONT, V27, P556, DOI 10.1093/ejo/cji059; Peng SN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003375; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Proffit WR., 2013, CONT ORTHODONTICS, V5; R Core Team, 2021, R LANGUAGE ENV STAT; Richmond S, 2012, LECT NOTES COMPUTATI, V5, P105; Savoye I, 1998, ANGLE ORTHOD, V68, P467; Sidlauskas M, 2015, EUR J ORTHOD; Smeets D, 2010, FORENSIC SCI INT, V201, P125, DOI 10.1016/j.forsciint.2010.03.023; Stowell S., 2014, USING R STAT; Toma AM, 2012, EUR J ORTHODONT, V34, P655, DOI 10.1093/ejo/cjr106; Townsend G, 2009, ARCH ORAL BIOL, V54, pS45, DOI 10.1016/j.archoralbio.2008.06.009; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258; Weinberg S. M., 2013, DENTISTRY, V3000, P1, DOI DOI 10.5195/D3000.2013.14.WERKER; Windhager S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099009	57	42	42	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162250	10.1371/journal.pone.0162250	http://dx.doi.org/10.1371/journal.pone.0162250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584156	Green Published, gold, Green Accepted			2022-12-27	WOS:000382855600123
J	Gupta, S; Tang, C; Tran, M; Kadouri, DE				Gupta, Shilpi; Tang, Chi; Tran, Michael; Kadouri, Daniel E.			Effect of Predatory Bacteria on Human Cell Lines	PLOS ONE			English	Article							BDELLOVIBRIO-BACTERIOVORUS; MICAVIBRIO-AERUGINOSAVORUS; ACTIVATED MACROPHAGES; ANIMAL-MODELS; EXPRESSION; RECEPTORS; MONOCYTES; RESPONSES; CYTOKINE; BIOFILMS	Predatory bacteria are Gram-negative bacteria that prey on other Gram-negative bacteria and have been considered as potential therapeutic agents against multi-drug resistant pathogens. In vivo animal models have demonstrated that predatory bacteria are non-toxic and non-immunogenic in rodents. In order to consider the use of predatory bacteria as live antibiotics, it is important to investigate their effect on human cells. The aim of this study was to determine the effect of Bdellovibrio bacteriovorus strains 109J and HD100, and Micavibrio aeruginosavorus strain ARL-13 on cell viability and inflammatory responses of five human cell lines, representative of clinically relevant tissues. We found that the predators were not cytotoxic to any of the human cell lines tested. Microscopic imaging showed no signs of cell detachment, as compared to predator-free cells. In comparison to an E. coli control, exposure to higher concentrations of the predators did not trigger a significant elevation of pro-inflammatory cytokines in four of the five human cell lines tested. Our work underlines the non-pathogenic attributes of predatory bacteria on human cells and highlights their potential use as live antibiotics against human pathogens.	[Gupta, Shilpi; Tran, Michael; Kadouri, Daniel E.] Rutgers Sch Dent Med, Dept Oral Biol, Newark, NJ 07103 USA; [Tang, Chi] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA; [Tang, Chi] Rutgers New Jersey Med Sch, Ctr Emerging Pathogens, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kadouri, DE (corresponding author), Rutgers Sch Dent Med, Dept Oral Biol, Newark, NJ 07103 USA.	kadourde@sdm.rutgers.edu			Department of the ARMY USAMRAA grant [W81XWH-12-2-0067]; U.S. Army Research Office; Defense Advanced Research Projects Agency [W911NF-15-2-0036]	Department of the ARMY USAMRAA grant; U.S. Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The research was sponsored by the Department of the ARMY USAMRAA grant #W81XWH-12-2-0067 and by the U.S. Army Research Office and the Defense Advanced Research Projects Agency and accomplished under Cooperative Agreement Number W911NF-15-2-0036 to DEK. The authors would like to thank Robert Shanks and Nancy Connell for reviewing the work and for their constructive comments. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Office, DARPA, or the U.S. Government.	ABRAM D, 1974, J BACTERIOL, V118, P663, DOI 10.1128/JB.118.2.663-680.1974; Allen HK, 2014, ANN NY ACAD SCI, V1323, P91, DOI 10.1111/nyas.12468; Atterbury RJ, 2011, APPL ENVIRON MICROB, V77, P5794, DOI 10.1128/AEM.00426-11; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742, DOI 10.1128/CMR.10.4.742; Dashiff A, 2011, J APPL MICROBIOL, V110, P431, DOI 10.1111/j.1365-2672.2010.04900.x; Dashiff Aliza, 2009, Open Microbiol J, V3, P87, DOI 10.2174/1874285800903000087; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; de Waal Malefyt R., 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209; Dori-Bachash M, 2008, APPL ENVIRON MICROB, V74, P7152, DOI 10.1128/AEM.01736-08; DOYLE MP, 1991, INT J FOOD MICROBIOL, V12, P289, DOI 10.1016/0168-1605(91)90143-D; Dwidar M, 2012, BMB REP, V45, P71, DOI 10.5483/BMBRep.2012.45.2.71; El Fiky A, 2013, HUM IMMUNOL, V74, P1524, DOI 10.1016/j.humimm.2013.08.267; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Kadouri D, 2005, APPL ENVIRON MICROB, V71, P4044, DOI 10.1128/AEM.71.7.4044-4051.2005; Kadouri D, 2007, APPL ENVIRON MICROB, V73, P605, DOI 10.1128/AEM.01893-06; Kadouri DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063397; LAMBINA V A, 1983, Mikrobiologiya, V52, P777; LENZ RW, 1978, ARCH MICROBIOL, V119, P245, DOI 10.1007/BF00405402; MacGowan A, 2001, CLIN INFECT DIS, V33, pS214, DOI 10.1086/321850; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Maruyama M, 2007, BIOL PHARM BULL, V30, P2091, DOI 10.1248/bpb.30.2091; Mizoguchi K, 2003, APPL ENVIRON MICROB, V69, P170, DOI 10.1128/AEM.69.1.170-176.2003; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mukherjee S, 2016, APPL ENVIRON MICROB, V82, P1653, DOI 10.1128/AEM.03611-15; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Saltikov CW, 2003, P NATL ACAD SCI USA, V100, P10983, DOI 10.1073/pnas.1834303100; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shanks RMQ, 2014, FUTURE MICROBIOL, V9, P429, DOI [10.2217/FMB.14.19, 10.2217/fmb.14.19]; Shanks RMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066723; Shatzkes K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12899; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; SHILO M, 1965, J GEN MICROBIOL, V40, P317, DOI 10.1099/00221287-40-3-317; STOLP H, 1963, ANTON VAN LEE J M S, V29, P217, DOI 10.1007/BF02046064; Stolp H., 1962, J PHYTOPATHOL, V45, P364, DOI [10.1111/j.1439-0434.1962.tb02050.x, DOI 10.1111/J.1439-0434.1962.TB02050.X]; Takashiba S, 1999, INFECT IMMUN, V67, P5573, DOI 10.1128/IAI.67.11.5573-5578.1999; Theuretzbacher U, 2012, INT J ANTIMICROB AG, V39, P295, DOI 10.1016/j.ijantimicag.2011.12.006; VERKLOVA Z S, 1973, Gigiena i Sanitariya, V38, P10; Wall RJ, 2008, THERIOGENOLOGY, V69, P2, DOI 10.1016/j.theriogenology.2007.09.030; Wang Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-453; WESTERGAARD JM, 1977, APPL ENVIRON MICROB, V34, P506, DOI 10.1128/AEM.34.5.506-511.1977; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M	44	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161242	10.1371/journal.pone.0161242	http://dx.doi.org/10.1371/journal.pone.0161242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27579919	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400021
J	Hunley, K; Gwin, K; Liberman, B				Hunley, Keith; Gwin, Kiela; Liberman, Brendan			A Reassessment of the Impact of European Contact on the Structure of Native American Genetic Diversity	PLOS ONE			English	Article							SOUTH-AMERICA; POPULATION-STRUCTURE; CENTRAL ANDES; PATTERNS; HISTORY; FLOW; SETTLEMENT; PACKAGE; MEXICO; MTDNA	Our current understanding of pre-Columbian history in the Americas rests in part on several trends identified in recent genetic studies. The goal of this study is to reexamine these trends in light of the impact of post-Columbian admixture and the methods used to study admixture. The previously-published data consist of 645 autosomal microsatellite genotypes from 1046 individuals in 63 populations. We used STRUCTURE to estimate ancestry proportions and tested the sensitivity of these estimates to the choice of the number of clusters, K. We used partial correlation analyses to examine the relationship between gene diversity and geographic distance from Beringia, controlling for non-Native American ancestry (from Africa, Europe and East Asia), and taking into account alternative paths of migration. Principal component analysis and multidimensional scaling were used to investigate the relationships between Andean and non-Andean populations and to explore gene-language correspondence. We found that 1) European and East Asian ancestry estimates decline as K increases, especially in Native Canadian populations, 2) a north-south decline in gene diversity is driven by low diversity in Amazonian and Paraguayan populations, not serial founder effects from Beringia, 3) controlling for non-Native American ancestry, populations in the Andes and Mesoamerica have higher gene diversity than populations in other regions, and 4) patterns of genetic and linguistic diversity are poorly correlated. We conclude that patterns of diversity previously attributed to pre-Columbian processes may in part reflect post-Columbian admixture and the choice of K in STRUCTURE analyses. Accounting for admixture, the pattern of diversity is inconsistent with a north-south founder effect process, though the genetic similarities between Mesoamerican and Andean populations are consistent with rapid dispersal along the western coast of the Americas. Further, even setting aside the disruptive effects of European contact, gene-language congruence is unlikely to have ever existed at the geographic scale analyzed here.	[Hunley, Keith; Gwin, Kiela; Liberman, Brendan] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of New Mexico	Hunley, K (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	khunley@unm.edu		Hunley, Keith/0000-0003-0987-8277	National Science Foundation BCS (the Cultural and Biological Significance of Ethnic Substructure in New Mexican Hispanics) [0962825]	National Science Foundation BCS (the Cultural and Biological Significance of Ethnic Substructure in New Mexican Hispanics)	This work was funded by National Science Foundation BCS #0962825 (the Cultural and Biological Significance of Ethnic Substructure in New Mexican Hispanics).	Alves I, 2016, MOL BIOL EVOL, V33, P946, DOI 10.1093/molbev/msv332; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Bolnick DA, 2004, AM J HUM GENET, V75, P519; Bright W., 1988, AM REFERENCE BOOKS A, V19; Cabana GS, 2014, HUM BIOL, V86, P147; Campbell Lyle, 1997, AM INDIAN LANGUAGES; Chafe W., 1987, CURR ANTHROPOL, V28, P652; Crawford MH, 2001, THE ORIGINS OF NATIV; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagundes NJR, 2002, AM J PHYS ANTHROPOL, V117, P68, DOI 10.1002/ajpa.10015; Foster M., 1982, LANG SOC, V7, P7; Fuselli S, 2003, MOL BIOL EVOL, V20, P1682, DOI 10.1093/molbev/msg188; Goddard I, 1994, METHOD THEORY INVEST; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLLA V, 1988, AM ANTHROPOL, V90, P434, DOI 10.1525/aa.1988.90.2.02a00320; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Hill JH, 2001, AM ANTHROPOL, V103, P913, DOI 10.1525/aa.2001.103.4.913; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; Hunley K, 2005, P NATL ACAD SCI USA, V102, P1312, DOI 10.1073/pnas.0409301102; Hunley KL, 2007, AM J PHYS ANTHROPOL, V132, P622, DOI 10.1002/ajpa.20542; Hunley K, 2011, AM J PHYS ANTHROPOL, V146, P530, DOI 10.1002/ajpa.21506; Jari Oksanen, 2013, VEGAN COMMUNITY ECOL; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kim S, 2015, COMMUNICATIONS STAT, V22, P665, DOI DOI 10.5351/CSAM.2015.22.6.665; KRAUSS M, 1992, LANGUAGE, V68, P4, DOI 10.1353/lan.1992.0075; Krauss M, 1981, SUBARCTIC HANDBOOK O, V6; Lewis CM, 2008, MOL BIOL EVOL, V25, P478, DOI 10.1093/molbev/msm225; Lewis P. M., 2016, ETHNOLOGUE LANGUAGES, V19th; Luiselli D, 2000, AM J PHYS ANTHROPOL, V113, P5, DOI 10.1002/1096-8644(200009)113:1<5::AID-AJPA2>3.0.CO;2-U; MCMAHON AMS, 1995, T PHILOL SOC, V93, P125, DOI 10.1111/j.1467-968X.1995.tb00438.x; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Nei M., 1987, MOL EVOLUTIONARY GEN; Neuwirth E, 2011, RCOLORBREWER COLORBR; Nichols J, 1996, LANGUAGE, V72, P336, DOI 10.2307/416653; Nychka D., 2016, FIELDS TOOLS SPATIAL; Pemberton TJ, 2013, G3-GENES GENOM GENET, V3, P891, DOI 10.1534/g3.113.005728; Pritchard JK, 2000, GENETICS, V155, P945; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; RIBEIRO Darcy, 1962, POLITICA INDIGENISTA; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009	49	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161018	10.1371/journal.pone.0161018	http://dx.doi.org/10.1371/journal.pone.0161018			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EG	27579784	Green Submitted, Green Published, gold			2022-12-27	WOS:000382877400013
J	Matsuura, M; Hirasawa, K; Murata, H; Yanagisawa, M; Nakao, Y; Nakakura, S; Kiuchi, Y; Asaoka, R				Matsuura, Masato; Hirasawa, Kazunori; Murata, Hiroshi; Yanagisawa, Mieko; Nakao, Yoshitaka; Nakakura, Shunsuke; Kiuchi, Yoshiaki; Asaoka, Ryo			The Relationship between Corvis ST Tonometry and Ocular Response Analyzer Measurements in Eyes with Glaucoma	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE MEASUREMENTS; GOLDMANN APPLANATION TONOMETER; ZONE PARAPAPILLARY ATROPHY; BIOMECHANICAL PROPERTIES; DIABETES-MELLITUS; TONO-PEN; PROGRESSION; HYSTERESIS	It is important to compare the results of Corneal Visualization Scheimpflug Technology instrument (CST) measurements and Reichert Ocular Response Analyzer (ORA) parameters. The purpose of the study was to investigate the association between CST measurements and ORA parameters in ninety-five patients with primary open-angle glaucoma. Measurements of CST, ORA, axial length (AL), average corneal curvature (CC), central corneal thickness (CCT) and intraocular pressure (IOP) with Goldmann applanation tonometry (GAT) were carried out. The association between CST and ORA parameters was assessed using linear regression analysis, with model selection based on the second order bias corrected Akaike Information Criterion index. Measurements from ORA (corneal hysteresis [CH] and corneal response factor [CRF]) had high intraclass correlation coefficients (ICC) and low coefficients of variation, but some CST parameters showed much lower reproducibility, namely: A1 length, A2 length, highest concavity time and peak distance. Of 12 CST parameters tested, 8 were significantly correlated with CH and 10 were significantly correlated with CRF, however, the magnitude of the correlation coefficients were weak to moderate at best. The optimal model to explain CH using CST measurements was given by: CH = -76.3 + 4.6*A1 time + 1.9*A2 time + 3.1 * highest concavity deformation amplitude + 0.016*CCT (R-2 = 0.67, p < 0.001). Similarly, the optimal model for CRF was given by: CRF = -53.5 + 4.2*A1 time + 1.9*A1 length + 20.8*A1 deformation amplitude + 0.8*A2 time + 0.017*CCT (R-2 = 0.73, p < 0.001). ORA parameters show higher reproducibility than CST measurements. Although many CST parameters are significantly related to ORA parameters, the strengths of these relationships are weak to moderate.	[Matsuura, Masato; Hirasawa, Kazunori; Murata, Hiroshi; Yanagisawa, Mieko; Asaoka, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Hirasawa, Kazunori] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthopt & Visual Sci, Sagamihara, Kanagawa, Japan; [Nakakura, Shunsuke] Saneikai Tsukazaki Hosp, Dept Ophthalmol, Himeji, Hyogo, Japan; [Nakao, Yoshitaka; Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan	University of Tokyo; Kitasato University; Hiroshima University	Asaoka, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	rasaoka-tky@umin.ac.jp		Nakao, Yoshitaka/0000-0003-1280-2791; Hirasawa, Kazunori/0000-0001-5100-005X	Japan Science and Technology Agency (JST) -CREST from the Ministry of Education, Culture, Sports, Science and Technology of Japan [26462679]; Grants-in-Aid for Scientific Research [26462688] Funding Source: KAKEN	Japan Science and Technology Agency (JST) -CREST from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency (JST) -CREST and Grant 26462679 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Asaoka R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140385; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Costin BR, 2014, J GLAUCOMA, V23, P69, DOI 10.1097/IJG.0b013e318269804b; EHLERS N, 1975, ACTA OPHTHALMOL, P32; Feltgen N, 2001, BRIT J OPHTHALMOL, V85, P85, DOI 10.1136/bjo.85.1.85; Fontes BM, 2008, J REFRACT SURG, V24, P941, DOI 10.3928/1081597X-20081101-14; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Garway-Heath DF, 2015, LANCET, V385, P1295, DOI 10.1016/S0140-6736(14)62111-5; Goldich Y, 2009, J CATARACT REFR SURG, V35, P715, DOI 10.1016/j.jcrs.2008.12.013; Gunvant P, 2004, BRIT J OPHTHALMOL, V88, P518, DOI 10.1136/bjo.2003.019331; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hirneiss C, 2013, GRAEF ARCH CLIN EXP, V251, P2383, DOI 10.1007/s00417-013-2416-2; HOLMIN C, 1988, ACTA OPHTHALMOL, V66, P170; Inoue K, 2003, JPN J OPHTHALMOL, V47, P129, DOI 10.1016/S0021-5155(02)00667-6; Ishii K, 2013, CLIN EXP OPHTHALMOL, V41, P6, DOI 10.1111/j.1442-9071.2012.02830.x; JAY JL, 1988, BRIT J OPHTHALMOL, V72, P881, DOI 10.1136/bjo.72.12.881; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jung Y, 2016, OPHTHALMOLOGY, V123, P959, DOI 10.1016/j.ophtha.2015.12.043; Kaminski S, 1998, ACTA OPHTHALMOL SCAN, V76, P78, DOI 10.1034/j.1600-0420.1998.760114.x; Kamiya K, 2009, J REFRACT SURG, V25, P888, DOI 10.3928/1081597X-20090917-10; Kaushik S, 2012, AM J OPHTHALMOL, V153, P840, DOI 10.1016/j.ajo.2011.10.032; Khawaja AP, 2014, INVEST OPHTH VIS SCI, V55, P117, DOI 10.1167/iovs.13-13290; Kim YW, 2014, OPHTHALMOLOGY, V121, P1341, DOI 10.1016/j.ophtha.2014.01.008; Koprowski R, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-150; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; Kotecha A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-11; Kotecha A, 2010, J CATARACT REFR SURG, V36, P1822, DOI 10.1016/j.jcrs.2010.08.027; Kotecha A, 2009, INVEST OPHTH VIS SCI, V50, P4229, DOI 10.1167/iovs.08-2955; Lascaratos G, 2014, INTRAOCULAR PRESSURE; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; Mansouri K, 2012, AM J OPHTHALMOL, V153, P419, DOI 10.1016/j.ajo.2011.08.022; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P1533, DOI 10.1016/j.ophtha.2013.01.032; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Narayanaswamy A, 2011, OPHTHALMOLOGY, V118, P1253, DOI 10.1016/j.ophtha.2010.12.001; NIELSEN CB, 1985, ACTA OPHTHALMOL, V63, P351; Ozkok A, 2013, J GLAUCOMA, V22, P740, DOI 10.1097/IJG.0000000000000036; Pajic B, 2010, CURR MED RES OPIN, V26, P2213, DOI 10.1185/03007995.2010.508702; Pensyl D, 2012, EYE, V26, P1349, DOI 10.1038/eye.2012.164; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Roberts CJ, 2014, J CATARACT REFR SURG, V40, P862, DOI 10.1016/j.jcrs.2014.04.019; Sahin A, 2009, INVEST OPHTH VIS SCI, V50, P4597, DOI 10.1167/iovs.08-2763; Sawada A, 2014, JPN J OPHTHALMOL, V58, P423, DOI 10.1007/s10384-014-0336-2; Shah S, 1999, OPHTHALMOLOGY, V106, P2154, DOI 10.1016/S0161-6420(99)90498-0; Shimmyo M, 2003, AM J OPHTHALMOL, V136, P603, DOI 10.1016/S0002-9394(03)00424-0; Shin J, 2015, AM J OPHTHALMOL, V159, P144, DOI 10.1016/j.ajo.2014.10.007; Stodtmeister R, 1998, ACTA OPHTHALMOL SCAN, V76, P319, DOI 10.1034/j.1600-0420.1998.760313.x; Sullivan-Mee M, 2008, OPTOMETRY VISION SCI, V85, P463, DOI 10.1097/OPX.0b013e3181784673; Teng CC, 2011, OPHTHALMOLOGY, V118, P2409, DOI 10.1016/j.ophtha.2011.06.014; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Terai N, 2012, CURR EYE RES, V37, P553, DOI 10.3109/02713683.2012.669007; Tibshirani RJ, 2012, ANN STAT, V40, P1198, DOI 10.1214/12-AOS1003; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Zhong YS, 2011, CORNEA, V30, P861, DOI 10.1097/ICO.0b013e3182000c27	63	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2016	11	8							e0161742	10.1371/journal.pone.0161742	http://dx.doi.org/10.1371/journal.pone.0161742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EG	27580243	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877400040
J	Gao, HT; Xu, R; Cao, WX; Zhou, X; Yan, YHM; Lu, LG; Xu, Q; Shen, Y				Gao, Hai-Tao; Xu, Run; Cao, Wei-Xin; Zhou, Xu; Yan, Ye-Hui-Mei; Lu, Lingeng; Xu, Qian; Shen, Yang			Food Emulsifier Glycerin Monostearate Increases Internal Exposure Levels of Six Priority Controlled Phthalate Esters and Exacerbates Their Male Reproductive Toxicities in Rats	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; P-GLYCOPROTEIN; DI-(2-ETHYLHEXYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; DIETARY EXPOSURE; HUMAN-MILK; PVC TOYS; METABOLITES; CHINA; CHROMATOGRAPHY	Human beings are inevitably exposed to ubiquitous phthalate esters (PAEs). Processed, packaged foods are popular nowadays, in which emulsifiers are frequently added as food additives. It is unclear how emulsifiers affect the bioavailability of ingested PAEs contaminants and their toxicities. The purposes of our study were to explore whether food emulsifier Glycerin Monostearate (GMS) could increase the internal exposure levels of six priority controlled PAEs and affect their reproductive toxicities when male rats are exposed to PAEs mixture (MIXPs). The male rats were exposed to MIXPs by gavage for thirty days in combination with or without given GMS. Phthalate monoesters (MPAEs), primary metabolites of PAEs, in rat urine were used as biomarkers to predict the internal exposure levels of the six PAEs, and their concentrations were determined using UPLC-MS. The reproductive toxicity was evaluated using serum testosterone levels test and histopathology of testes. Results showed that compared to PAEs exposure alone, the internal exposure levels of PAEs increased by 30%-49% in the presence of GMS. PAEs exposure led to the reduction of testosterone level by 23.4%-42.1% in the presence and absence of GMS, respectively, compared to the baseline. Testosterone levels in MIXPs+GMS and DEHP+GMS group were decreased by 9.1% and 13.6%, respectively, compared with MIXPs and DEHP group. Histopathology showed that injuries of testis (deciduous spermatids) were observed, and GMS exacerbated the injuries. The results indicated food emulsifiers chronically taken up might increase safety risks of food PAEs contaminants.	[Gao, Hai-Tao; Xu, Run; Cao, Wei-Xin; Zhou, Xu; Yan, Ye-Hui-Mei; Xu, Qian] Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210009, Jiangsu, Peoples R China; [Xu, Qian] Southeast Univ, Suzhou Key Lab Environm & Biosafety, Suzhou 215123, Peoples R China; [Lu, Lingeng; Xu, Qian] Yale Univ, Sch Publ Hlth, Sch Med, Dept Chron Dis Epidemiol, 60 Coll St, New Haven, CT 06520 USA; [Shen, Yang] Southeast Univ, Sch Med, Zhong Da Hosp, Dept Obstet & Gynecol, Nanjing 210009, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Yale University; Southeast University - China	Xu, Q (corresponding author), Southeast Univ, Sch Publ Hlth, Minist Educ, Key Lab Environm Med Engn, Nanjing 210009, Jiangsu, Peoples R China.; Xu, Q (corresponding author), Southeast Univ, Suzhou Key Lab Environm & Biosafety, Suzhou 215123, Peoples R China.; Xu, Q (corresponding author), Yale Univ, Sch Publ Hlth, Sch Med, Dept Chron Dis Epidemiol, 60 Coll St, New Haven, CT 06520 USA.; Shen, Y (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Dept Obstet & Gynecol, Nanjing 210009, Jiangsu, Peoples R China.	q_xu68@163.com; shenyang0924@sina.cn		Gao, Haitao/0000-0003-3986-7261	Socail Development Research Program of Jiangsu Province Science and Technology Department [BE2015646]; Maternal and Child Healthcare Project of Jiangsu Province Health Department [F201407]; Youth Fund Project of Jiangsu Province Health Department [Q201305]; Science and Technology Project of Nanjing City [201201054]; Student Research Training Program [1510286111]	Socail Development Research Program of Jiangsu Province Science and Technology Department; Maternal and Child Healthcare Project of Jiangsu Province Health Department; Youth Fund Project of Jiangsu Province Health Department; Science and Technology Project of Nanjing City; Student Research Training Program	This work received financial support from Socail Development Research Program of Jiangsu Province Science and Technology Department (http://xmsb.jschina.com.cn/indexActionlto_index.action) Project No.: BE2015646, to QX, Maternal and Child Healthcare Project of Jiangsu Province Health Department (http://www.jswst.gov.cn/jsswshjhsywyh/index.html) Project No.:F201407, to YS, Youth Fund Project of Jiangsu Province Health Department (http://www.jswst.gov.cn/jsswshjhsywyh/index.html) Project No.:Q201305, to QX, Science and Technology Project of Nanjing City (http://www.njkj.gov.cn/) Project No.:201201054, to QX, and Student Research Training Program (http://srtp.seu.edu.cn/) 1510286111, to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235; Alvi MM, 2014, AAPS PHARMSCITECH, V15, P339, DOI 10.1208/s12249-013-0065-8; Amberg-Muller JP, 2010, J VERBRAUCH LEBENSM, V5, P429, DOI 10.1007/s00003-010-0620-0; Anderson WAC, 2001, FOOD ADDIT CONTAM A, V18, P1068, DOI 10.1080/02652030110050113; Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087; Barta CA, 2008, MOL PHARMACEUT, V5, P863, DOI 10.1021/mp800050q; Bhatia H, 2015, J APPL TOXICOL, V35, P806, DOI 10.1002/jat.3076; Biedermann-Brem S, 2008, CHROMATOGRAPHIA, V68, P227, DOI 10.1365/s10337-008-0672-9; Bouma K, 2002, FOOD ADDIT CONTAM, V19, P602, DOI 10.1080/02652030210125137; Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI 10.1016/j.jchromb.2004.02.006; Chang-Liao WL, 2013, MOLECULES, V18, P11452, DOI 10.3390/molecules180911452; Chen L, 2012, SCI TOTAL ENVIRON, V427, P60, DOI 10.1016/j.scitotenv.2012.03.090; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Chen XP, 2014, INT J ENV RES PUB HE, V11, P3156, DOI 10.3390/ijerph110303156; Cheng Z, 2013, ENVIRON INT, V57-58, P75, DOI 10.1016/j.envint.2013.04.005; Csaki KF, 2011, MED HYPOTHESES, V76, P676, DOI 10.1016/j.mehy.2011.01.030; David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.2307/3435032; Erkekoglu P, 2011, DRUG CHEM TOXICOL, V34, P379, DOI 10.3109/01480545.2010.547499; Farajzadeh MA, 2012, J SEP SCI, V35, P742, DOI 10.1002/jssc.201100853; Fujimaki Kayumi, 2006, Nihon Eiseigaku Zasshi, V61, P340; [高海涛 Gao Haitao], 2015, [食品工业科技, Science & Technology of Food Industry], V36, P280; Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804; Helal MAM, 2014, REPROD BIOL, V14, P182, DOI 10.1016/j.repbio.2014.04.002; Hennessy M, 2007, PHARMACOL RES, V55, P1, DOI 10.1016/j.phrs.2006.10.007; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077; Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272; Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205; Lerner A, 2015, AUTOIMMUN REV, V14, P479, DOI 10.1016/j.autrev.2015.01.009; Lu Y, 2014, TOXICOL SCI, V139, P317, DOI 10.1093/toxsci/kfu055; Lugea A, 2000, GUT, V46, P515, DOI 10.1136/gut.46.4.515; Moffit JS, 2007, TOXICOL PATHOL, V35, P719, DOI 10.1080/01926230701481931; Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0; National Health and Family Planning Commission (NHFPC), 2014, GB27602014 NHFPC; POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1; Roberts CL, 2013, J CROHNS COLITIS, V7, P338, DOI 10.1016/j.crohns.2013.01.004; Russo MV, 2014, ANAL METHODS-UK, V6, P7030, DOI [10.1039/c4ay00926f, 10.1039/C4AY00926F]; Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065; Schecter A, 2013, ENVIRON HEALTH PERSP, V121, P473, DOI 10.1289/ehp.1206367; Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018; Strac IV, 2013, J APPL TOXICOL, V33, P214, DOI 10.1002/jat.1741; Tellez-Rojo MM, 2013, SCI TOTAL ENVIRON, V461, P386, DOI 10.1016/j.scitotenv.2013.05.021; US EPA, 2007, PHTH SUMM 2007; Wang B, 2015, ENVIRON SCI TECHNOL, V49, P1120, DOI 10.1021/es504455a; Wang YX, 2016, ENVIRON RES, V150, P557, DOI 10.1016/j.envres.2015.11.023; Wang YX, 2016, ENVIRON POLLUT, V211, P173, DOI 10.1016/j.envpol.2015.12.052; Wu T, 2008, CHROMATOGRAPHIA, V68, P803, DOI 10.1365/s10337-008-0788-y; Xia DN, 2014, J PHARM SCI-US, V103, P697, DOI 10.1002/jps.23830; Ye T, 2014, AQUAT TOXICOL, V146, P115, DOI 10.1016/j.aquatox.2013.10.025; Yoshimura M, 2006, BUNSEKI KAGAKU, V55, P661, DOI 10.2116/bunsekikagaku.55.661; [于云江 Yu Yunjiang], 2014, [环境化学, Environmental Chemistry], V33, P194; Zhang HJ, 2003, ARCH PHARM RES, V26, P768, DOI 10.1007/BF02976689; Zhu SJ, 2009, EUR J PHARM SCI, V37, P573, DOI 10.1016/j.ejps.2009.05.001	54	15	17	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2016	11	8							e0161253	10.1371/journal.pone.0161253	http://dx.doi.org/10.1371/journal.pone.0161253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EE	27575856	Green Published, gold, Green Submitted			2022-12-27	WOS:000382877200021
J	Wang, HZ; Liu, J; Xu, XP; Huang, QM; Chen, SS; Yang, PQ; Chen, SJ; Song, YQ				Wang, Hongzhi; Liu, Jin; Xu, Xiaoping; Huang, Qingming; Chen, Shanshan; Yang, Peiqiang; Chen, Shaojiang; Song, Yiqiao			Fully-Automated High-Throughput NMR System for Screening of Haploid Kernels of Maize (Corn) by Measurement of Oil Content	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LOW-FIELD NMR; DOUBLED HAPLOIDS; INDUCTION; INDUCERS; SEEDS; IDENTIFICATION; QUALITY; PROTON	One of the modern crop breeding techniques uses doubled haploid plants that contain an identical pair of chromosomes in order to accelerate the breeding process. Rapid haploid identification method is critical for large-scale selections of double haploids. The conventional methods based on the color of the endosperm and embryo seeds are slow, manual and prone to error. On the other hand, there exists a significant difference between diploid and haploid seeds generated by high oil inducer, which makes it possible to use oil content to identify the haploid. This paper describes a fully-automated high-throughput NMR screening system for maize haploid kernel identification. The system is comprised of a sampler unit to select a single kernel to feed for measurement of NMR and weight, and a kernel sorter to distribute the kernel according to the measurement result. Tests of the system show a consistent accuracy of 94% with an average screening time of 4 seconds per kernel. Field test result is described and the directions for future improvement are discussed.	[Wang, Hongzhi; Xu, Xiaoping; Huang, Qingming; Chen, Shanshan] Shanghai Univ Med & Hlth Sci, Shanghai, Peoples R China; [Wang, Hongzhi; Yang, Peiqiang] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China; [Liu, Jin; Chen, Shaojiang] China Agr Univ, Natl Maize Improvement Ctr, Beijing, Peoples R China; [Song, Yiqiao] Schlumberger Doll Res Ctr, Cambridge, MA 02139 USA; [Song, Yiqiao] Mass Gen Hosp, Charlestown, MA 02114 USA	Shanghai University of Medicine & Health Sciences; East China Normal University; China Agricultural University; Schlumberger	Wang, HZ (corresponding author), Shanghai Univ Med & Hlth Sci, Shanghai, Peoples R China.; Wang, HZ (corresponding author), East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai, Peoples R China.; Chen, SJ (corresponding author), China Agr Univ, Natl Maize Improvement Ctr, Beijing, Peoples R China.; Song, YQ (corresponding author), Schlumberger Doll Res Ctr, Cambridge, MA 02139 USA.; Song, YQ (corresponding author), Mass Gen Hosp, Charlestown, MA 02114 USA.	wanghzhi2000@sina.com; chen368@126.com; ysong@nmr.mgh.harvard.edu		Song, Yiqiao/0000-0002-3416-4279; Chiu, Chih-Yu/0000-0002-6842-1253	13th Five-year National High-tech program: Maize Heterosis utilization technology and hybrid breeding, and Modern Maize Industry Technology System from China government [CARS-02-09]	13th Five-year National High-tech program: Maize Heterosis utilization technology and hybrid breeding, and Modern Maize Industry Technology System from China government	This work was supported by The 13th Five-year National High-tech program: Maize Heterosis utilization technology and hybrid breeding, and Modern Maize Industry Technology System (CARS-02-09) from China government. The funder provided support in the form of salaries for authors [HZW, JL, XPX, QMH and SSC], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blumich B, 2000, NMR IMAGING MAT; Chalyk ST, 2001, RUSS J GENET+, V37, P1382, DOI 10.1023/A:1013291711912; CHEN RS, 1994, J MAGN RESON SER A, V110, P77, DOI 10.1006/jmra.1994.1184; Chen ShaoJiang, 2003, Acta Agronomica Sinica, V29, P587; Colnago LA, 2007, ANAL CHEM, V79, P1271, DOI 10.1021/ac062091+; CONWAY TF, 1963, J AM OIL CHEM SOC, V40, P265, DOI 10.1007/BF02633686; Dang NC, 2012, EUPHYTICA, V183, P153, DOI 10.1007/s10681-011-0423-0; Dong X, 2014, MOL BREEDING, V34, P1147, DOI 10.1007/s11032-014-0106-3; Gambhir P. N., 1992, Trends in Food Science & Technology, V3, P191, DOI 10.1016/0924-2244(92)90188-3; Gao SQ, 2009, J MAGN RESON, V197, P208, DOI 10.1016/j.jmr.2008.12.022; Geiger HH, 2009, MAYDICA, V54, P485; Greener J, 2000, J AM CERAM SOC, V83, P623; Hills BP, 2006, ANNU REP NMR SPECTRO, V58, P177, DOI 10.1016/S0066-4103(05)58004-9; Kotyk JJ, 2005, J AM OIL CHEM SOC, V82, P855, DOI 10.1007/s11746-005-1155-5; Leslie HR, 1994, B MAGN RESON, V14, P86; Liu J., 2012, T CHINESE SOC AGR EN, V28, P233; Liu Z., 2000, ACTA AGRONOMICA SINI, V26, P570; Luetkmeyer L, 2007, MACROMOL SYMP, V258, P108, DOI 10.1002/masy.200751212; Marcone MF, 2013, FOOD RES INT, V51, P729, DOI 10.1016/j.foodres.2012.12.046; Melchinger AE, 2014, CROP SCI, V54, P1497, DOI 10.2135/cropsci2013.12.0851; Melchinger AE, 2013, SCI REP-UK, V3, DOI 10.1038/srep02129; Mitchell J, 2014, PROG NUCL MAG RES SP, V76, P1, DOI 10.1016/j.pnmrs.2013.09.001; Nordon A, 2001, ANALYST, V126, P260, DOI 10.1039/b009293m; Prestes RA, 2007, ANAL CHIM ACTA, V596, P325, DOI 10.1016/j.aca.2007.06.022; Prigge V, 2012, GENETICS, V190, P781, DOI 10.1534/genetics.111.133066; Prigge V, 2011, CROP SCI, V51, P1498, DOI 10.2135/cropsci2010.10.0568; Rober FK, 2005, MAYDICA, V50, P275; Samii-Saket G, 2011, J AM OIL CHEM SOC, V88, P1795, DOI 10.1007/s11746-011-1849-1; Song YQ, 2013, J MAGN RESON, V229, P12, DOI 10.1016/j.jmr.2012.11.010; Thygesen LG, 2001, LEBENSM-WISS TECHNOL, V34, P469, DOI 10.1006/fstl.2001.0788; Todt H, 2006, FOOD CHEM, V96, P436, DOI 10.1016/j.foodchem.2005.04.032	31	41	42	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2016	11	7							e0159444	10.1371/journal.pone.0159444	http://dx.doi.org/10.1371/journal.pone.0159444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ID	27583451	Green Submitted, gold, Green Published			2022-12-27	WOS:000381515200021
J	Wang, HC; Chou, CY; Chiou, CR; Tian, GL; Chiu, CY				Wang, Hsueh-Ching; Chou, Chiao-Ying; Chiou, Chyi-Rong; Tian, Guanglong; Chiu, Chih-Yu			Humic Acid Composition and Characteristics of Soil Organic Matter in Relation to the Elevation Gradient of Moso Bamboo Plantations	PLOS ONE			English	Article							CARBON POOLS; FOREST; DECOMPOSITION; MINERALIZATION; CHRONOSEQUENCE; SEQUESTRATION; RECALCITRANT; DYNAMICS; NITROGEN; LABILE	Studying the influence of climatic and/or site-specific factors on soil organic matter (SOM) along an elevation gradient is important for understanding the response of SOM to global warming. We evaluated the composition of SOM and structure of humic acids along an altitudinal gradient from 600 to 1400 m in moso bamboo (Phyllostachys edulis) plantations in central Taiwan using NMR spectroscopy and photometric analysis. Total organic C and total nitrogen (N) content increased with increasing elevation. Aromaticity decreased and Delta logK (the logarithm of the absorbance ratio of humic acids at 400 and 600 nm) increased with increasing elevation, which suggests that SOM humification decreased with increasing elevation. High temperature at low elevations seemed to enhance the decomposition (less accumulation of total organic C and N) and humification (high aromaticity and low Delta logK). The alkyl-C/O-alkyl-C (A/O-A) ratio of humic acids increased with increasing elevation, which suggests that SOM humification increased with increasing elevation; this finding was contrary to the trend observed for Delta logK and aromaticity. Such a discrepancy might be due to the relatively greater remaining of SOM derived from high alkyl-C broadleaf litter of previous forest at high elevations. The ratio of recalcitrant C to total organic C was low at low elevations, possibly because of enhanced decomposition of recalcitrant SOM from the previous broadleaf forest during long-term intensive cultivation and high temperature. Overall, the change in SOM pools and in the rate of humification with elevation was primarily affected by changes in climatic conditions along the elevation gradient in these bamboo plantations. However, when the composition of SOM, as assessed by NMR spectroscopy and photometric analysis was considered, site-specific factors such as residual SOM from previous forest and intensive cultivation history could also have an important effect on the humic acid composition and humification of SOM.	[Wang, Hsueh-Ching; Chiu, Chih-Yu] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Chou, Chiao-Ying] Natl Taiwan Univ, Biodivers Res Ctr, Taipei 10617, Taiwan; [Chiou, Chyi-Rong] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10617, Taiwan; [Tian, Guanglong] Lue Hing R&D Lab, Metropolitan Water Reclamat Dist Greater Chicago, Environm Monitoring & Res Div, Monitoring & Res Dept, 6001 W Pershing Rd, Cicero, IL 60804 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University	Chiu, CY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.	bochiu@sinica.edu.tw		Song, Yiqiao/0000-0002-3416-4279; Chiu, Chih-Yu/0000-0002-6842-1253	Academia Sinica; Ministry and Technology, Taiwan [MOST 104-2621-B-001-005]	Academia Sinica(Academia Sinica - Taiwan); Ministry and Technology, Taiwan	This study was sponsored by Academia Sinica and the Ministry and Technology, Taiwan (MOST 104-2621-B-001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; BEYER L, 1995, BIOL FERT SOILS, V19, P197, DOI 10.1007/BF00336159; Chang EH, 2016, APPL SOIL ECOL, V98, P213, DOI 10.1016/j.apsoil.2015.10.018; Chen T.H., 2014, Q J CHIN FOR, V47, P181; Chinese-American Joint Commission on Rural Reconstruction, 1956, LAND US FOR RES MAPS; Chung TL, 2012, J FOREST RES-JPN, V17, P458, DOI 10.1007/s10310-011-0319-9; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; FAO, 2005, PROGR SUST FOR MAN C, P107; Fu J., 2001, BAMBOO, V22, P5; Garten CT, 2006, GEODERMA, V136, P342, DOI 10.1016/j.geoderma.2006.03.049; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Garten CT, 2004, SOIL BIOL BIOCHEM, V36, P1491, DOI 10.1016/j.soilbio.2004.04.019; Gerzabek M, 1996, HUMIFICATION, P116; Gutierrez-Giron A, 2015, GEODERMA, V237, P1, DOI 10.1016/j.geoderma.2014.08.005; HATCHER PG, 1981, SOIL SCI SOC AM J, V45, P1089, DOI 10.2136/sssaj1981.03615995004500060016x; Huang CY, 2014, J SOIL SEDIMENT, V14, P1061, DOI 10.1007/s11368-014-0870-z; Jien SH, 2011, J FOREST RES-JPN, V16, P275, DOI 10.1007/s10310-010-0231-8; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Kumada K., 1987, Chemistry of soil organic matter., p241pp; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Li YF, 2013, FOREST ECOL MANAG, V303, P121, DOI 10.1016/j.foreco.2013.04.021; Lin H.L., 2000, CHRONICLES FORESTRY; Lin YT, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv033; Liu J, 2011, FOREST ECOL MANAG, V262, P1131, DOI 10.1016/j.foreco.2011.06.015; Lobovikov M., 2007, WORLD BAMBOO RESOURC, VVolume 18; McLauchlan KK, 2004, SOIL SCI SOC AM J, V68, P1616, DOI 10.2136/sssaj2004.1616; National Land Surveying and Mapping Center, 2012, 2 TIM LAND US INV PL; Ostertag R, 2008, ECOSYSTEMS, V11, P701, DOI 10.1007/s10021-008-9152-1; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Rossi CQ, 2016, AGR ECOSYST ENVIRON, V216, P34, DOI 10.1016/j.agee.2015.09.022; Rovira P, 2002, GEODERMA, V107, P109, DOI 10.1016/S0016-7061(01)00143-4; Schindlbacher A, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001191; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schoening I, 2005, BIOGEOCHEMISTRY, V73, P475, DOI 10.1007/s10533-004-0897-0; Shih TF, 1996, TAIWAN FORT MAPS REV; Stockmann U, 2013, AGR ECOSYST ENVIRON, V164, P80, DOI 10.1016/j.agee.2012.10.001; Wang JT, 2015, MICROB ECOL, V69, P135, DOI 10.1007/s00248-014-0465-7; Wei DW, 2008, MEASURE TAIWAN 1984; Zech W, 1997, GEODERMA, V79, P117, DOI 10.1016/S0016-7061(97)00040-2	43	41	42	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162193	10.1371/journal.pone.0162193	http://dx.doi.org/10.1371/journal.pone.0162193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583451	Green Published, gold, Green Submitted			2022-12-27	WOS:000382855600117
J	Zhou, Y; Shah, SZA; Yang, LF; Zhang, ZQ; Zhou, XM; Zhao, DM				Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhang, Zhongqiu; Zhou, Xiangmei; Zhao, Deming			Virulent Mycobacterium bovis Beijing Strain Activates the NLRP7 Inflammasome in THP-1 Macrophages	PLOS ONE			English	Article							AIM2 INFLAMMASOME; TUBERCULOSIS INFECTION; LISTERIA-MONOCYTOGENES; IL-1-BETA PRODUCTION; PROTEIN; SECRETION; HUMANS; RECOGNITION; LIPOPROTEIN; PYROPTOSIS	Mycobacterium bovis is the causative agent of tuberculosis in a wide range of mammals, including humans. Macrophages are the first line of host defense. They secrete proinflammatory cytokines, such as interleukin-1 beta (IL-1 beta), in response to mycobacterial infection, but the underlying mechanisms by which human macrophages are activated and release IL-1 beta following M. bovis infection are poorly understood. Here we show that the 'nucleotide binding and oligomerization of domain-like receptor (NLR) family pyrin domain containing 7 protein' (NLRP7) inflammasome is involved in IL-1 beta secretion and caspase-1 activation induced by M. bovis infection in THP-1 macrophages. NLRP7 inflammasome activation promotes the induction of pyroptosis as well as the expression of tumor necrosis factor alpha (TNF-alpha), Chemokine (C-C motif) ligand 3 (CCL3) and IL-1 beta mRNAs. Thus, the NLRP7 inflammasome contributes to IL-1 beta secretion and induction of pyroptosis in response to M. bovis infection in THP-1 macrophages.	[Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China; [Zhou, Yang; Shah, Syed Zahid Ali; Yang, Lifeng; Zhou, Xiangmei; Zhao, Deming] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhang, Zhongqiu] Minist Agr Peoples Republ China, Vet Bur, Beijing 100125, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, Coll Vet Med, Natl Anim Transmissible Spongiform Encephalopathy, Key Lab Anim Epidemiol & Zoonosis,Minist Agr, Beijing 100193, Peoples R China.; Zhou, XM; Zhao, DM (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	zhouxm@cau.edu.cn; zhaodm@cau.edu.cn	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	MoSTRCUK international cooperation project [2013DFG32500]; National Natural Science Foundation of China [31572487]; Funding of State Key Lab of Agrobiotechnology [2012SKLAB06-14]; CAU Foreign Experts Major Projects [2012z018]; Foreign Experts Recruitment Program [GDW20151100036]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	MoSTRCUK international cooperation project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding of State Key Lab of Agrobiotechnology; CAU Foreign Experts Major Projects; Foreign Experts Recruitment Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by MoSTRCUK international cooperation project (Project No. 2013DFG32500) http://www.istcp.org.cn, National Natural Science Foundation of China (Project No. 31572487) https://isisn.nsfc.gov.cn, Funding of State Key Lab of Agrobiotechnology (Project No. 2012SKLAB06-14) http://cbs.cau.edu.cn, 2015 CAU Foreign Experts Major Projects (Project No: 2012z018) http://cau.edu.cn, and High-end Foreign Experts Recruitment Program (Project No: GDW20151100036) http://cepms.safea.gov.cn.	Alfonso-Loeches S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00216; Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Baker MG, 2006, EPIDEMIOL INFECT, V134, P1068, DOI 10.1017/S0950268806005930; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bigi F, 1997, MICROBIOL-SGM, V143, P3599, DOI 10.1099/00221287-143-11-3599; Bigi F, 2000, MICROBIOL-UK, V146, P1011, DOI 10.1099/00221287-146-4-1011; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036292; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Fend R, 2005, J CLIN MICROBIOL, V43, P1745, DOI 10.1128/JCM.43.4.1745-1751.2005; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Lee HM, 2013, GLIA, V61, P441, DOI 10.1002/glia.22448; Loria JRD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066818; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Murdoch S, 2006, NAT GENET, V38, P300, DOI 10.1038/ng1740; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saiga H, 2012, INT IMMUNOL, V24, P637, DOI 10.1093/intimm/dxs062; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Schroder K, 2012, IMMUNOBIOLOGY, V217, P1325, DOI 10.1016/j.imbio.2012.07.020; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segueni N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126058; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Wiker HG, 1998, INFECT IMMUN, V66, P1445, DOI 10.1128/IAI.66.4.1445-1452.1998; Yang Y, 2013, J INFECT DIS, V208, P1849, DOI 10.1093/infdis/jit347; Zhou Y, 2015, ANTON LEEUW INT J G, V108, P163, DOI 10.1007/s10482-015-0475-6	41	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2016	11	4							e0152853	10.1371/journal.pone.0152853	http://dx.doi.org/10.1371/journal.pone.0152853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DI6EN	27583358	gold, Green Published, Green Submitted			2022-12-27	WOS:000373592100039
J	Zhou, YE; Buchowski, MS; Liu, JG; Schlundt, DG; Ukoli, FAM; Blot, WJ; Hargreaves, MK				Zhou, Yuan E.; Buchowski, Maciej S.; Liu, Jianguo; Schlundt, David G.; Ukoli, Flora A. M.; Blot, William J.; Hargreaves, Margaret K.			Plasma Lycopene Is Associated with Pizza and Pasta Consumption in Middle-Aged and Older African American and White Adults in the Southeastern USA in a Cross-Sectional Study	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; 3RD NATIONAL-HEALTH; ALPHA-TOCOPHEROL; DIETARY PATTERNS; UNITED-STATES; RACIAL-DIFFERENCES; NUTRIENT INTAKE; ENERGY-INTAKE; CANCER-RISK; NHANES-III	Background The role of dietary lycopene in chronic disease prevention is not well known. Methods This study examined intake of lycopene and other antioxidants from lycopene-rich foods (e.g., pizza and pasta) simultaneously with plasma levels of lycopene and other antioxidants in a representative cross-sectional sample (187 Blacks, 182 Whites, 40-79 years old) from the Southern Community Cohort Study (SCCS). The SCCS is an ongoing study conducted in populations at high risk for chronic diseases living in Southeastern United States. Dietary intake was assessed using a validated food frequency questionnaire (FFQ), and plasma levels of lycopene and other antioxidants were measured at baseline (2002-2005). The participants were classified into tertiles according to consumption of pizza and pasta food groups. Results Lycopene dietary intake and plasma lycopene concentrations were significantly higher in the highest (tertile 3) compared to tertiles 1 and 2 (both P < 0.01). Total energy intake ranged from 1964.3 +/- 117.1 kcal/day (tertile 1) to 3277.7 +/- 115.8 kcal/day (tertile 3) (P<0.0001). After adjusting for age and energy intake, total dietary fat, saturated fatty acids, trans-fatty acids, and sodium intakes were significantly higher in tertile 3 than tertiles 2 and 1 (all P < 0.01). Vitamin C intake was significantly lower in tertile 3 than tertiles 1 and 2 (P = 0.003). Except for gamma-tocopherol being higher in tertile 3 than tertiles 1 and 2 (P = 0.015), the plasma concentrations of antioxidants were lower in tertile 3 than tertiles 1 and 2 ( beta-carotene, alpha-carotene, lutein and zeaxanthin, all P<0.05). Conclusions In the SCCS population, pizza and pasta were the main sources of dietary lycopene and their intake was associated with plasma lycopene concentration. Diets with frequent pizza and pasta consumption were high in energy, saturated fatty acids, trans-fatty acids, sodium and low in other antioxidants. Future studies of lycopene as a protective dietary factor against chronic disease should consider the overall nutritional quality of lycopene-containing foods.	[Zhou, Yuan E.; Liu, Jianguo; Hargreaves, Margaret K.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Buchowski, Maciej S.; Blot, William J.] Vanderbilt Univ, Dept Med, Nashville, TN 37212 USA; [Schlundt, David G.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Ukoli, Flora A. M.] Meharry Med Coll, Dept Surg, Nashville, TN 37208 USA	Meharry Medical College; Vanderbilt University; Vanderbilt University; Meharry Medical College	Zhou, YE (corresponding author), Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA.	yzhou@mmc.edu	Shah, Syed Zahid Ali/GQQ-7452-2022; Buchowski, Maciej S./A-2683-2008	Buchowski, Maciej S./0000-0002-0566-1743; Shah, Syed Zahid Ali/0000-0003-4705-229X; Shah, Syed Zahid Ali/0000-0002-9638-5800	NCI grant from the National Cancer Institute [R01 CA092447]; CTSA grant from the National Center for Advancing Translational Sciences [202815-502001-20]; CNPC grant from the National Cancer Institute [3 U54 CA1 S3708-03]; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases [1 P30 DK092986]; Vanderbilt-Ingram Cancer Center (US) [P30CA068485]; NATIONAL CANCER INSTITUTE [R01CA092447] Funding Source: NIH RePORTER	NCI grant from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA grant from the National Center for Advancing Translational Sciences; CNPC grant from the National Cancer Institute; NIDDK grant from the National Institute of Diabetes and Digestive and Kidney Diseases; Vanderbilt-Ingram Cancer Center (US); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NCI grant R01 CA092447 from the National Cancer Institute, CTSA grant 202815-502001-20 from the National Center for Advancing Translational Sciences, CNPC grant 3 U54 CA1 S3708-03 from the National Cancer Institute, NIDDK grant 1 P30 DK092986 from the National Institute of Diabetes and Digestive and Kidney Diseases, and Vanderbilt-Ingram Cancer Center (US) P30CA068485. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron KJ, 2011, AM J CLIN NUTR, V94, P1071, DOI 10.3945/ajcn.111.013094; Block G, 2004, J FOOD COMPOS ANAL, V17, P439, DOI 10.1016/j.jfca.2004.02.007; Bovell-Benjamin A, 2010, J HEALTH CARE POOR U, V21, P57, DOI 10.1353/hpu.0.0361; Buchowski MS, 2003, CELL MOL BIOL, V49, P1295; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; COATES RJ, 1991, AM J EPIDEMIOL, V134, P658, DOI 10.1093/oxfordjournals.aje.a116138; Cook A, 2000, J EPIDEMIOL COMMUN H, V54, P611, DOI 10.1136/jech.54.8.611; CRAFT NE, 1988, CLIN CHEM, V34, P44; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; DI MASCIO P, 1989, ARCH BIOCHEM BIOPHYS, V274, P532, DOI 10.1016/0003-9861(89)90467-0; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Epplein M, 2009, CANCER EPIDEM BIOMAR, V18, P1962, DOI 10.1158/1055-9965.EPI-09-0003; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; FRANKE AA, 1993, J CHROMATOGR-BIOMED, V614, P43, DOI 10.1016/0378-4347(93)80222-P; Garcia AL, 2008, BRIT J NUTR, V99, P1293, DOI 10.1017/S0007114507868486; Gerster H, 1997, J AM COLL NUTR, V16, P109; Grainger EM, 2015, BRIT J NUTR, V114, P596, DOI 10.1017/S0007114515002202; Gross M, 2003, AM J CLIN NUTR, V77, P458, DOI 10.1093/ajcn/77.2.458; GROSS MD, 1995, CLIN CHEM, V41, P943; Gutierrez OM, 2014, AM J KIDNEY DIS, V64, P204, DOI 10.1053/j.ajkd.2014.02.013; Hajjar I, 2003, J NUTR, V133, P211, DOI 10.1093/jn/133.1.211; Hall WD, 1997, AM J MED SCI, V313, P195, DOI 10.1097/00000441-199704000-00002; Hargreaves MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084972; HORNE DW, 1988, CLIN CHEM, V34, P2357; Institute of Medicine, 2004, DIET REF INT WAT POT; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Johansson L, 1998, AM J CLIN NUTR, V68, P266, DOI 10.1093/ajcn/68.2.266; Judd SE, 2013, STROKE, V44, P3305, DOI 10.1161/STROKEAHA.113.002636; Kachan D, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140023; Kiage JN, 2014, AM J CLIN NUTR, V99, P1071, DOI 10.3945/ajcn.113.075713; Locher JL, 2004, ALABAMA HERITAGE, V74, P6; Mackinnon ES, 2011, J NUTR HEALTH AGING, V15, P133, DOI 10.1007/s12603-011-0026-4; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Mayne ST, 1999, J NUTR, V129, P849, DOI 10.1093/jn/129.4.849; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Obisesan TO, 2000, STROKE, V31, P19, DOI 10.1161/01.STR.31.1.19; Paeratakul S, 2003, J AM DIET ASSOC, V103, P1332, DOI 10.1016/S0002-8223(03)01086-1; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Rao AV, 2006, ADV FOOD NUTR RES, V51, P99, DOI 10.1016/S1043-4526(06)51002-2; Re R, 2003, EUR J CLIN NUTR, V57, P1545, DOI 10.1038/sj.ejcn.1601723; Riccioni G, 2008, EUR REV MED PHARMACO, V12, P183; Schwab U, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.25145; Shah M, 2010, J NUTR EDUC BEHAV, V42, P99, DOI 10.1016/j.jneb.2009.02.001; Shi J, 2000, CRIT REV FOOD SCI, V40, P1, DOI 10.1080/10408690091189275; Siega-Riz A M, 2001, J Am Med Womens Assoc (1972), V56, P44; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Signorello LB, 2010, AM J EPIDEMIOL, V171, P488, DOI 10.1093/aje/kwp402; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Soory Mena, 2012, Infectious Disorders - Drug Targets, V12, P388; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1895, DOI 10.1016/j.jada.2007.08.016; Stimpson JP, 2007, J AM DIET ASSOC, V107, P1218, DOI 10.1016/j.jada.2007.04.008; Talegawkar SA, 2007, J NUTR, V137, P2297, DOI 10.1093/jn/137.10.2297; Testa R, 2014, CURR OPIN CLIN NUTR, V17, P338, DOI 10.1097/MCO.0000000000000066; TONUCCI LH, 1995, J AGR FOOD CHEM, V43, P579, DOI 10.1021/jf00051a005; United States Department of Agriculture (USDA) National Agricultural Library, 2016, USDA NUTR DAT LISTS; Voeks JH, 2008, STROKE, V39, P1675, DOI 10.1161/STROKEAHA.107.507053; Wei MY, 2012, J ONCOL, V2012, DOI 10.1155/2012/271063; Whelton PK, 2014, CURR OPIN LIPIDOL, V25, P75, DOI 10.1097/MOL.0000000000000033; Williams CD, 2009, CANCER EPIDEM BIOMAR, V18, P1552, DOI 10.1158/1055-9965.EPI-08-1146	59	28	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161918	10.1371/journal.pone.0161918	http://dx.doi.org/10.1371/journal.pone.0161918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27583358	Green Published, Green Submitted, gold			2022-12-27	WOS:000382855600074
